PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Rebocho, AP; Marais, R				Rebocho, A. P.; Marais, R.			ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers	ONCOGENE			English	Article						ARAF; BRAF; CRAF; protein complexes; paradoxical activation	B-RAF; C-RAF; HUMAN CANCER; WILD-TYPE; KINASE-ACTIVITY; ONCOGENIC RAS; MUTATIONS; MELANOMA; PHOSPHORYLATION; ACTIVATION	The RAF proteins are cytosolic protein kinases that regulate cell responses to extracellular signals. There are three RAF proteins in cells, ARAF, BRAF and CRAF, and recent studies have shown that the formation of complexes by these different isoforms has an important role in their activation, particularly in response to RAF inhibitors. Here, we investigated the role of ARAF in cancer cell signaling and examined the role of ARAF in mediating paradoxical activation of the MAPK pathway in cells treated with RAF inhibitors. We show that two mutations that occur in ARAF in cancer inactivate the kinase. We also show that ARAF is not functionally redundant with CRAF and cannot substitute for CRAF downstream of RAS. We further show that ARAF binds to and is activated by BRAF and that ARAF also forms complexes with CRAF. Critically, ARAF seems to stabilize BRAF: CRAF complexes in cells treated with RAF inhibitors and thereby regulate cell signaling in a subtle manner to ensure signaling efficiency.	[Rebocho, A. P.; Marais, R.] Inst Canc Res, Div Canc Biol, Signal Transduct Team, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Marais, R (corresponding author), Univ Manchester, Paterson Inst Canc Res, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	Richard.Marais@picr.man.ac.uk		Marais, Richard/0000-0001-7484-4183	Fundacao para a Ciencia e Tecnologia [SFRH/BD/15904/2005]; Institute of Cancer Research; Cancer Research UK [C107/A10433]; Cancer Research UK [17240, 19279] Funding Source: researchfish	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Institute of Cancer Research; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was funded by Fundacao para a Ciencia e Tecnologia (SFRH/BD/15904/2005), the Institute of Cancer Research and Cancer Research UK (Ref: C107/A10433). We thank Professor Caroline Springer for providing sorafenib and PD184352.	Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2007, CURR OPIN GENET DEV, V17, P31, DOI 10.1016/j.gde.2006.12.005; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; Lee JW, 2005, APMIS, V113, P54, DOI 10.1111/j.1600-0463.2005.apm1130108.x; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Moretti S, 2009, BBA-MOL CELL RES, V1793, P1634, DOI 10.1016/j.bbamcr.2009.09.001; Packer LM, 2011, CANCER CELL, V20, P715, DOI 10.1016/j.ccr.2011.11.004; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	28	47	48	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 27	2013	32	26					3207	3212		10.1038/onc.2012.330	http://dx.doi.org/10.1038/onc.2012.330			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	172LL	22926515				2022-12-25	WOS:000321004600011
J	Hudson, BD; Christiansen, E; Tikhonova, IG; Grundmann, M; Kostenis, E; Adams, DR; Ulven, T; Milligan, G				Hudson, Brian D.; Christiansen, Elisabeth; Tikhonova, Irina G.; Grundmann, Manuel; Kostenis, Evi; Adams, David R.; Ulven, Trond; Milligan, Graeme			Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs	FASEB JOURNAL			English	Article						GPCR; RASSL	PROTEIN-COUPLED RECEPTORS; FUNCTIONAL-CHARACTERIZATION; INTERNATIONAL UNION; SORBIC ACID; BINDING; GPR43; IDENTIFICATION; ACTIVATION; ALLOSTERISM; DISCOVERY	When it is difficult to develop selective ligands within a family of related G-protein-coupled receptors (GPCRs), chemically engineered receptors activated solely by synthetic ligands (RASSLs) are useful alternatives for probing receptor function. In the present work, we explored whether a RASSL of the free fatty acid receptor 2 (FFA2) could be developed on the basis of pharmacological variation between species orthologs. For this, bovine FFA2 was characterized, revealing distinct ligand selectivity compared with human FFA2. Homology modeling and mutational analysis demonstrated a single mutation in human FFA2 of C4.57G resulted in a human FFA2 receptor with ligand selectivity similar to the bovine receptor. This was exploited to generate human FFA2-RASSL by the addition of a second mutation at a known orthosteric ligand interaction site, H6.55Q. The resulting FFA2-RASSL displayed a >100-fold loss of activity to endogenous ligands, while responding to the distinct ligand sorbic acid with pEC(50) values for inhibition of cAMP, 5.83 +/- 0.11; Ca2+ mobilization, 4.63 +/- 0.05; ERK phosphorylation, 5.61 +/- 0.06; and dynamic mass redistribution, 5.35 +/- 0.06. This FFA2-RASSL will be useful in future studies on this receptor and demonstrates that exploitation of pharmacological variation between species orthologs is a powerful method to generate novel chemically engineered GPCRs.-Hudson, B. D., Christiansen, E., Tikhonova, I. G., Grundmann, M., Kostenis, E., Adams, D. R., Ulven, T., Milligan, G. Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs. FASEB J. 26, 4951-4965 (2012). www.fasebj.org	[Hudson, Brian D.; Milligan, Graeme] Univ Glasgow, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Christiansen, Elisabeth; Ulven, Trond] Univ So Denmark, Dept Phys Chem & Pharm, Odense, Denmark; [Tikhonova, Irina G.] Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast, Antrim, North Ireland; [Grundmann, Manuel; Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Bonn, Germany; [Adams, David R.] Heriot Watt Univ, Dept Chem, Sch Engn & Phys Sci, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Southern Denmark; Queens University Belfast; University of Bonn; Heriot Watt University	Milligan, G (corresponding author), Univ Glasgow, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	graeme.milligan@glasgow.ac.uk	Milligan, Graeme/F-9426-2011; Rexen Ulven, Elisabeth/S-2026-2017; Adams, David R/E-3916-2010; Hudson, B. D./H-4845-2013; Ulven, Trond/H-5500-2015	Milligan, Graeme/0000-0002-6946-3519; Rexen Ulven, Elisabeth/0000-0003-1243-7587; Adams, David R/0000-0002-7154-7332; Hudson, B. D./0000-0001-7059-0091; Ulven, Trond/0000-0002-8135-1755; Grundmann, Manuel/0000-0002-4473-7851	Wellcome Trust [089600/Z/09/Z]; Danish Council for Strategic Research [11-116196]; Canadian Institutes of Health Research	Wellcome Trust(Wellcome TrustEuropean Commission); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	These studies were supported by the Wellcome Trust (grant 089600/Z/09/Z to G. M.), the Danish Council for Strategic Research (grant 11-116196 to T. U., G. M., and E. K.), and a Canadian Institutes of Health Research Fellowship (to B.D.H.).	Alvarez-Curto E, 2011, MOL PHARMACOL, V80, P1033, DOI 10.1124/mol.111.074674; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Claeysen S, 2003, J BIOL CHEM, V278, P699, DOI 10.1074/jbc.C200588200; Congreve M, 2011, ADV PHARMACOL, V62, P1, DOI 10.1016/B978-0-12-385952-5.00011-7; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Guettier JM, 2009, P NATL ACAD SCI USA, V106, P19197, DOI 10.1073/pnas.0906593106; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hudson BD, 2011, ADV PHARMACOL, V62, P175, DOI 10.1016/B978-0-12-385952-5.00006-3; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Knicky M, 2009, J SCI FOOD AGR, V89, P2659, DOI 10.1002/jsfa.3771; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; LUCK E, 1990, FOOD ADDIT CONTAM, V7, P711, DOI 10.1080/02652039009373936; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Milligan G, 2009, BRIT J PHARMACOL, V158, P146, DOI 10.1111/j.1476-5381.2009.00421.x; Offermanns S, 2011, PHARMACOL REV, V63, P269, DOI 10.1124/pr.110.003301; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sasaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020360; Schmidt J, 2011, J BIOL CHEM, V286, P10628, DOI 10.1074/jbc.M110.210872; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Sleeth ML, 2010, NUTR RES REV, V23, P135, DOI 10.1017/S0954422410000089; Smith NJ, 2011, MOL PHARMACOL, V80, P163, DOI 10.1124/mol.110.070789; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stoddart LA, 2010, METHOD ENZYMOL, V484, P569, DOI [10.1016/S0076-6879(10)84028-5, 10.1016/B978-0-12-381298-8.00028-9]; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Swaminath G, 2008, ARCH PHARM, V341, P755, DOI 10.1002/ardp.200800096; Tikhonova IG, 2008, J MED CHEM, V51, P625, DOI 10.1021/jm7012425; Tiwari A, 2010, CURR OPIN INVEST DR, V11, P385; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; WALKER R, 1990, FOOD ADDIT CONTAM, V7, P671, DOI 10.1080/02652039009373932; Wang A, 2012, J DAIRY SCI, V95, P1371, DOI 10.3168/jds.2011-4886; Wang A, 2009, J DAIRY SCI, V92, P2696, DOI 10.3168/jds.2009-2037; Zaibi MS, 2010, FEBS LETT, V584, P2381, DOI 10.1016/j.febslet.2010.04.027	47	60	60	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2012	26	12					4951	4965		10.1096/fj.12-213314	http://dx.doi.org/10.1096/fj.12-213314			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22919070	Green Published, Green Accepted			2022-12-25	WOS:000311838300018
J	Hulpke, S; Baldauf, C; Tampe, R				Hulpke, Sabine; Baldauf, Christoph; Tampe, Robert			Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing	FASEB JOURNAL			English	Article						ABC transporter; adaptive immunity; ER quality control; membrane protein complex; molecular immunology	CROSS-PRESENTATION; ENDOPLASMIC-RETICULUM; MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; TRANSPORTER; TAP; EXPRESSION; HLA; ASSOCIATION; COMPARTMENT	The loading of antigen-derived peptides onto MHC class I molecules for presentation to cytotoxic T cells is a key process in adaptive immune defense. Loading of MHC I is achieved by a sophisticated machinery, the peptide-loading complex (PLC), which is organized around the transporter associated with antigen processing (TAP) with the help of several auxiliary proteins. As an essential adapter protein recruiting MHC I molecules to TAP, tapasin catalyzes peptide loading of MHC I. However, the exact stoichiometry and basic molecular architecture of TAP and tapasin within the PLC remains elusive. Here, we demonstrate that two tapasin molecules are assembled in the PLC, with one tapasin bound to each TAP subunit. However, one tapasin molecule bound either to TAP1 or TAP2 is sufficient for efficient MHC I antigen presentation. By specifically blocking the interaction between tapasin-MHC I complexes and the translocation complex TAP, the MHC I surface expression is impaired to the same extent as with soluble tapasin. Thus, the proximity of the peptide supplier TAP to the acceptor MHC I is crucial for antigen processing. In summary, the human PLC consists maximally of 2x tapasin-ERp57/MHC I per TAP complex, but one tapasin-ERp57/MHC I in the PLC is essential and sufficient for antigen processing.-Hulpke, S., Baldauf, C., Tampe, R. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing. FASEB J. 26, 5071-5080 (2012). www.fasebj.org	[Hulpke, Sabine; Baldauf, Christoph; Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem Bioctr & Cluster Excellence Frankfur, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Tampe, R (corresponding author), Goethe Univ Frankfurt, Inst Biochem Bioctr & Cluster Excellence Frankfur, Max von Laue Str 9, D-60438 Frankfurt, Germany.	tampe@em.uni-frankfurt.de	Tampé, Robert/H-2953-2015	Tampé, Robert/0000-0002-0403-2160	European Commission; German Research Foundation [SFB 807, TA157/7]; European Drug Initiative on Channels and Transporters (EDICT)	European Commission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation(German Research Foundation (DFG)); European Drug Initiative on Channels and Transporters (EDICT)	The authors thank Drs. Rupert Abele, Peter Mayerhofer, Andreas Hinz, David Parcej, and Roger Draheim for helpful discussions and comments on the manuscript, as well as Hanna Fischbach for helping on experiments. The authors acknowledge the generous support by Daniel Oprian (Brandeis University, Waltham, MA, USA), who provided the anti-C8 mAb in the initial phase of the project. The anti-C8 mAb was obtained via the AIDS Research and Reference Reagent Program (Division of AIDS, National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health, Bethesda, MD, USA; Chessie 8 from Dr. George Lewis). The German Research Foundation (SFB 807 Transport and Communication across Biological Membranes and TA157/7 to R. T.) and the European Drug Initiative on Channels and Transporters (EDICT; to R. T.), funded by the European Commission Seventh Framework Program, supported this work.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Cormier JN, 1999, INT J CANCER, V80, P781, DOI 10.1002/(SICI)1097-0215(19990301)80:5<781::AID-IJC24>3.0.CO;2-A; de la Salle H, 1999, J CLIN INVEST, V103, pR9, DOI 10.1172/JCI5687; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; Everett MW, 2007, J IMMUNOL, V179, P7646, DOI 10.4049/jimmunol.179.11.7646; Garbi N, 2003, EUR J IMMUNOL, V33, P264, DOI 10.1002/immu.200390029; Garstka MA, 2011, FASEB J, V25, P3989, DOI 10.1096/fj.11-190249; Ghanem E, 2010, J CELL SCI, V123, P4271, DOI 10.1242/jcs.060632; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Hulpke S., 2012, MOL CELL LIFE SCI, DOI [10.1007/s00018-012-1005-6, DOI 10.1007/S00018-012-1005-6]; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Li SL, 1997, P NATL ACAD SCI USA, V94, P8708, DOI 10.1073/pnas.94.16.8708; MARINCOLA FM, 1994, J IMMUNOL, V153, P1225; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Panter MS, 2012, J BIOL CHEM, V287, P31172, DOI 10.1074/jbc.M112.387704; Papadopoulos M, 2007, J BIOL CHEM, V282, P9401, DOI 10.1074/jbc.M610429200; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]; Paulsson KM, 2006, J IMMUNOL, V176, P7482, DOI 10.4049/jimmunol.176.12.7482; Paulsson KM, 2002, J BIOL CHEM, V277, P18266, DOI 10.1074/jbc.M201388200; Paulsson KM, 2001, INT IMMUNOL, V13, P23, DOI 10.1093/intimm/13.1.23; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Petersen JL, 2005, J IMMUNOL, V174, P962, DOI 10.4049/jimmunol.174.2.962; Praveen PVK, 2010, EUR J IMMUNOL, V40, P214, DOI 10.1002/eji.200939342; Raghuraman G, 2002, J BIOL CHEM, V277, P41786, DOI 10.1074/jbc.M207128200; Rizvi SM, 2010, TRAFFIC, V11, P332, DOI 10.1111/j.1600-0854.2009.01025.x; Roder G, 2011, J BIOL CHEM, V286, P20547, DOI 10.1074/jbc.M111.230151; Rufer E, 2007, J IMMUNOL, V179, P5717, DOI 10.4049/jimmunol.179.9.5717; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Schneeweiss C, 2009, MOL IMMUNOL, V46, P2054, DOI 10.1016/j.molimm.2009.02.032; Schrodt S, 2006, J BIOL CHEM, V281, P6455, DOI 10.1074/jbc.M509784200; Simone LC, 2012, MOL IMMUNOL, V49, P628, DOI 10.1016/j.molimm.2011.11.002; Simone LC, 2009, MOL IMMUNOL, V46, P2147, DOI 10.1016/j.molimm.2009.03.006; Simone LC, 2009, IMMUNOGENETICS, V61, P43, DOI 10.1007/s00251-008-0335-x; STAM NJ, 1990, INT IMMUNOL, V2, P113, DOI 10.1093/intimm/2.2.113; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; Tan P, 2002, J IMMUNOL, V168, P1950, DOI 10.4049/jimmunol.168.4.1950; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Vigneron N, 2009, EUR J IMMUNOL, V39, P2371, DOI 10.1002/eji.200939536; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Zarling AL, 2003, J IMMUNOL, V171, P5287, DOI 10.4049/jimmunol.171.10.5287	52	20	25	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2012	26	12					5071	5080		10.1096/fj.12-217489	http://dx.doi.org/10.1096/fj.12-217489			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22923333				2022-12-25	WOS:000311838300028
J	Koutsoupakis, C; Soulimane, T; Varotsis, C				Koutsoupakis, Constantinos; Soulimane, Tewfik; Varotsis, Constantinos			Spectroscopic and Kinetic Investigation of the Fully Reduced and Mixed Valence States of ba(3)-Cytochrome c Oxidase from Thermus thermophilus A FOURIER TRANSFORM INFRARED (FTIR) AND TIME-RESOLVED STEP-SCAN FTIR STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-COPPER OXIDASES; ELECTRON-TRANSFER REACTIONS; CYTOCHROME BA(3) OXIDASE; LOW-SPIN HEME; PARACOCCUS-DENITRIFICANS; SINGLE-TURNOVER; DOCKING SITE; DYNAMICS; BINDING; PHOTODISSOCIATION	The complete understanding of a molecular mechanism of action requires the thermodynamic and kinetic characterization of different states and intermediates. Cytochrome c oxidase reduces O-2 to H2O, a reaction coupled to proton translocation across the membrane. Therefore, it is necessary to undertake a thorough characterization of the reduced form of the enzyme and the determination of the electron transfer processes and pathways between the redox-active centers. In this study Fourier transform infrared (FTIR) and time-resolved step-scan FTIR spectroscopy have been applied to study the fully reduced and mixed valence states of cytochrome ba(3) from Thermus thermophilus. We used as probe carbon monoxide (CO) to characterize both thermodynamically and kinetically the cytochrome ba(3)-CO complex in the 5.25-10.10 pH/pD range and to study the reverse intramolecular electron transfer initiated by the photolysis of CO in the two-electron reduced form. The time-resolved step-scan FTIR data revealed no pH/pD dependence in both the decay of the transient Cu-B 1(+)-CO complex and rebinding to heme a(3) rates, suggesting that no structural change takes place in the vicinity of the binuclear center. Surprisingly, photodissociation of CO from the mixed valence form of the enzyme does not lead to reverse electron transfer from the reduced heme a3 to the oxidized low-spin heme b, as observed in all the other aa(3) and bo(3) oxidases previously examined. The heme b-heme a(3) electron transfer is guaranteed, and therefore, there is no need for structural rearrangements and complex synchronized cooperativities. Comparison among the available structures of ba(3) and aa(3)-cytochrome c oxidases identifies possible active pathways involved in the electron transfer processes and key structural elements that contribute to the different behavior observed in cytochrome ba(3).	[Koutsoupakis, Constantinos; Varotsis, Constantinos] Cyprus Univ Technol, Dept Environm Sci & Technol, CY-3603 Lemesos, Cyprus; [Soulimane, Tewfik] Univ Limerick, Chem & Environm Sci Dept, Limerick, Ireland; [Soulimane, Tewfik] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland	Cyprus University of Technology; University of Limerick; University of Limerick	Varotsis, C (corresponding author), Cyprus Univ Technol, Dept Environm Sci & Technol, POB 50329, CY-3603 Lemesos, Cyprus.	c.varotsis@cut.ac.cy		Varotsis, Constantinos/0000-0003-2771-8891	Cyprus University of Technology research funds; Science Foundation Ireland Grant [BICF865]	Cyprus University of Technology research funds; Science Foundation Ireland Grant(Science Foundation Ireland)	This work was supported by Cyprus University of Technology research funds (to C. V.) and Science Foundation Ireland Grant BICF865 (to T. S.).	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; ADELROTH P, 1995, BIOCHEMISTRY-US, V34, P2844; ALBEN JO, 1981, P NATL ACAD SCI-BIOL, V78, P234, DOI 10.1073/pnas.78.1.234; [Anonymous], 2001, PYMOL MOL GRAPH SYST; Belevich I, 2006, BIOCHEMISTRY-US, V45, P4000, DOI 10.1021/bi052458p; Brzezinski P, 1996, BIOCHEMISTRY-US, V35, P5611, DOI 10.1021/bi960260m; BRZEZINSKI P, 1985, FEBS LETT, V187, P111, DOI 10.1016/0014-5793(85)81224-2; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Chang HY, 2009, P NATL ACAD SCI USA, V106, P16169, DOI 10.1073/pnas.0905264106; Daskalakis V, 2011, J PHYS CHEM B, V115, P3648, DOI 10.1021/jp1115993; EINARSDOTTIR O, 1989, J BIOL CHEM, V264, P2405; EINARSDOTTIR O, 1993, BIOCHEMISTRY-US, V32, P12013, DOI 10.1021/bi00096a011; Farver O, 2006, FEBS LETT, V580, P3417, DOI 10.1016/j.febslet.2006.05.013; Fee JA, 2008, J AM CHEM SOC, V130, P15002, DOI 10.1021/ja803112w; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Giuffre A, 1999, BIOCHEMISTRY-US, V38, P1057, DOI 10.1021/bi9815389; Giuffre A, 1999, P NATL ACAD SCI USA, V96, P14718, DOI 10.1073/pnas.96.26.14718; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GOLDBECK RA, 1992, BIOCHEMISTRY-US, V31, P9376, DOI 10.1021/bi00154a008; Gomes CM, 2001, FEBS LETT, V497, P159, DOI 10.1016/S0014-5793(01)02431-0; Gorbikova EA, 2006, BIOCHEMISTRY-US, V45, P5641, DOI 10.1021/bi060257v; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; Hayashi T, 2007, J AM CHEM SOC, V129, P14952, DOI 10.1021/ja074600a; Hellwig P, 1999, BIOCHEMISTRY-US, V38, P9648, DOI 10.1021/bi9903401; HILL BC, 1994, J BIOL CHEM, V269, P2419; Hunsicker-Wang LM, 2005, ACTA CRYSTALLOGR D, V61, P340, DOI 10.1107/S0907444904033906; Iwaki M, 2007, J AM CHEM SOC, V129, P2923, DOI 10.1021/ja067779i; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Jasaitis A, 2005, P NATL ACAD SCI USA, V102, P10882, DOI 10.1073/pnas.0503001102; Kaila VRI, 2010, CHEM REV, V110, P7062, DOI 10.1021/cr1002003; Kannt A, 1998, FEBS LETT, V434, P17, DOI 10.1016/S0014-5793(98)00942-9; KEIGHTLEY JA, 1995, J BIOL CHEM, V270, P20345, DOI 10.1074/jbc.270.35.20345; Koutsoupakis C, 2004, BIOPHYS J, V86, P2438, DOI 10.1016/S0006-3495(04)74300-3; Koutsoupakis C, 2003, J AM CHEM SOC, V125, P14728, DOI 10.1021/ja036107e; Koutsoupakis C, 2003, J BIOL CHEM, V278, P36806, DOI 10.1074/jbc.M307117200; Koutsoupakis K, 2003, J BIOL CHEM, V278, P14893, DOI 10.1074/jbc.M210293200; Koutsoupakis K, 2002, J BIOL CHEM, V277, P32860, DOI 10.1074/jbc.M204943200; Liu B, 2009, BIOCHEMISTRY-US, V48, P820, DOI 10.1021/bi801759a; Lyons JA, 2012, NATURE, V487, P514, DOI 10.1038/nature11182; Maneg O, 2003, J BIOL CHEM, V278, P46734, DOI 10.1074/jbc.M307594200; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Medvedev DM, 2000, J AM CHEM SOC, V122, P6571, DOI 10.1021/ja0000706; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; MOSER CC, 1995, J BIOENERG BIOMEMBR, V27, P263, DOI 10.1007/BF02110096; Nicholls P, 2004, BBA-BIOENERGETICS, V1655, P381, DOI 10.1016/j.bbabio.2003.06.007; Noor MR, 2012, BBA-BIOENERGETICS, V1817, P638, DOI 10.1016/j.bbabio.2011.08.004; Okuno D, 2003, J AM CHEM SOC, V125, P7209, DOI 10.1021/ja021302z; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Pilet E, 2004, P NATL ACAD SCI USA, V101, P16198, DOI 10.1073/pnas.0405032101; Pilet E, 2004, BIOCHEMISTRY-US, V43, P14118, DOI 10.1021/bi0488808; Pinakoulaki E, 2005, J AM CHEM SOC, V127, P15161, DOI 10.1021/ja0539490; Pinakoulaki E, 2004, J BIOL CHEM, V279, P22791, DOI 10.1074/jbc.C400124200; Prutsch A, 2002, BBA-BIOENERGETICS, V1554, P22, DOI 10.1016/S0005-2728(02)00207-4; Regan JJ, 1998, J BIOENERG BIOMEMBR, V30, P35, DOI 10.1023/A:1020551326307; Rost B, 1999, BIOCHEMISTRY-US, V38, P7565, DOI 10.1021/bi990225q; Siletsky SA, 2007, BBA-BIOENERGETICS, V1767, P1383, DOI 10.1016/j.bbabio.2007.09.010; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Sousa FL, 2008, BIOPHYS J, V94, P2434, DOI 10.1529/biophysj.107.122614; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Szundi I, 2007, BIOCHEMISTRY-US, V46, P12568, DOI 10.1021/bi700728g; Szundi I, 2010, P NATL ACAD SCI USA, V107, P21010, DOI 10.1073/pnas.1008603107; Tan ML, 2004, BIOPHYS J, V86, P1813, DOI 10.1016/S0006-3495(04)74248-4; Than M. E., 2001, BA3 CYTOCHROME OXIDA, P363; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Verkhovsky MI, 2001, BBA-BIOENERGETICS, V1506, P143, DOI 10.1016/S0005-2728(01)00220-1; WOODRUFF WH, 1993, J BIOENERG BIOMEMBR, V25, P177, DOI 10.1007/BF00762859; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; ZIMMERMANN BH, 1988, P NATL ACAD SCI USA, V85, P5779, DOI 10.1073/pnas.85.16.5779	71	7	7	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37495	37507		10.1074/jbc.M112.403600	http://dx.doi.org/10.1074/jbc.M112.403600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22927441	Green Published, hybrid			2022-12-25	WOS:000310588500078
J	Wong, AHM; Zhou, DX; Rini, JM				Wong, Alan H. M.; Zhou, Dongxia; Rini, James M.			The X-ray Crystal Structure of Human Aminopeptidase N Reveals a Novel Dimer and the Basis for Peptide Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOTRIENE A(4) HYDROLASE; RENIN-ANGIOTENSIN SYSTEM; TUMOR-NECROSIS-FACTOR; ACTIVE-SITE; CONFORMATIONAL-CHANGE; ESCHERICHIA-COLI; CD13; INHIBITORS; BINDING; RECEPTOR	Human aminopeptidase N (hAPN/hCD13) is a dimeric membrane protein and a member of the M1 family of zinc metallopeptidases. Within the rennin-angiotensin system, its enzymatic activity is responsible for processing peptide hormones angiotensin III and IV. In addition, hAPN is also involved in cell adhesion, endocytosis, and signal transduction and it is an important target for cancer therapy. Reported here are the high resolution x-ray crystal structures of the dimeric ectodomain of hAPN and its complexes with angiotensin IV and the peptidomimetic inhibitors, amastatin and bestatin. Each monomer of the dimer is found in what has been termed the closed form in other M1 enzymes and each monomer is characterized by an internal cavity surrounding the catalytic site as well as a unique substrate/inhibitor-dependent loop ordering, which in the case of the bestatin complex suggests a new route to inhibitor design. The hAPN structure provides the first example of a dimeric M1 family member and the observed structural features, in conjunction with a model for the open form, provide novel insights into the mechanism of peptide processing and signal transduction.	[Zhou, Dongxia; Rini, James M.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Wong, Alan H. M.; Rini, James M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Rini, JM (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	james.rini@utoronto.ca		Wong, Alan H.M./0000-0001-9763-6555	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Adams PD, 2009, ACTA CRYSTALLOGR D, V65, P567, DOI 10.1107/S0907444909011548; Addlagatta A, 2006, P NATL ACAD SCI USA, V103, P13339, DOI 10.1073/pnas.0606167103; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; ASHMUN RA, 1990, BLOOD, V75, P462; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bauvois B, 2006, MED RES REV, V26, P88, DOI 10.1002/med.20044; Bhagwat SV, 2001, BLOOD, V97, P652, DOI 10.1182/blood.V97.3.652; Bhagwat SV, 2003, BLOOD, V101, P1818, DOI 10.1182/blood-2002-05-1422; Birtley J. R., 2011, BIOCHEMISTRY; Chai SY, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S14; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; Curnis F, 2000, NAT BIOTECHNOL, V18, P1185, DOI 10.1038/81183; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Drag M, 2010, J BIOL CHEM, V285, P3310, DOI 10.1074/jbc.M109.060418; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAVALORO E, 1993, EXP HEMATOL, V21, P1695; FERACCI H, 1981, BIOCHIM BIOPHYS ACTA, V658, P148, DOI 10.1016/0005-2744(81)90258-8; Fujita K, 2000, BIOCHEM BIOPH RES CO, V267, P134, DOI 10.1006/bbrc.1999.1963; Gandhi A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00186; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; Ghosh M, 2012, J IMMUNOL, V188, P5489, DOI 10.4049/jimmunol.1103490; GORVEL JP, 1989, J CELL BIOL, V108, P2193, DOI 10.1083/jcb.108.6.2193; Guzman-Rojas L, 2012, P NATL ACAD SCI USA, V109, P1637, DOI 10.1073/pnas.1120790109; Helgstrand C, 2011, J MOL BIOL, V406, P120, DOI 10.1016/j.jmb.2010.11.059; HOLMES MA, 1981, BIOCHEMISTRY-US, V20, P6912, DOI 10.1021/bi00527a026; HUSSAIN MM, 1981, BIOCHEM J, V199, P179, DOI 10.1042/bj1990179; Ichinose Y, 2003, JNCI-J NATL CANCER I, V95, P605, DOI 10.1093/jnci/95.8.605; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Jacobsen FE, 2007, CHEMMEDCHEM, V2, P152, DOI 10.1002/cmdc.200600204; Jones PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028589; KANIA RK, 1977, J BIOL CHEM, V252, P4929; Kehlen A, 2003, CANCER RES, V63, P8500; Kehoe PG, 2009, TRENDS NEUROSCI, V32, P619, DOI 10.1016/j.tins.2009.07.006; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; Luciani N, 1998, BIOCHEMISTRY-US, V37, P686, DOI 10.1021/bi971705p; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Mina-Osorio P, 2008, TRENDS MOL MED, V14, P361, DOI 10.1016/j.molmed.2008.06.003; Mina-Osorio P, 2008, J LEUKOCYTE BIOL, V84, P448, DOI 10.1189/jlb.1107802; Nguyen TT, 2011, NAT STRUCT MOL BIOL, V18, P604, DOI 10.1038/nsmb.2021; Nocek B, 2008, PROTEINS, V70, P273, DOI 10.1002/prot.21276; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pak JE, 2006, METHOD ENZYMOL, V416, P30, DOI 10.1016/S0076-6879(06)16003-6; Pasqualini R, 2000, CANCER RES, V60, P722; Petrovic N, 2007, BLOOD, V110, P142, DOI 10.1182/blood-2006-02-002931; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Proost P, 2007, BLOOD, V110, P37, DOI 10.1182/blood-2006-10-049072; Rangel R, 2007, P NATL ACAD SCI USA, V104, P4588, DOI 10.1073/pnas.0611653104; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; RICH DH, 1984, J MED CHEM, V27, P417, DOI 10.1021/jm00370a001; Riemann D, 1999, IMMUNOL TODAY, V20, P83, DOI 10.1016/S0167-5699(98)01398-X; Roques BP, 2012, NAT REV DRUG DISCOV, V11, P292, DOI 10.1038/nrd3673; Ruiz-Ortega M, 2007, TRENDS CARDIOVAS MED, V17, P19, DOI 10.1016/j.tcm.2006.10.003; Santos AN, 2000, CELL IMMUNOL, V201, P22, DOI 10.1006/cimm.2000.1629; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SHIPP MA, 1993, BLOOD, V82, P1052, DOI 10.1182/blood.V82.4.1052.bloodjournal8241052; Tholander F, 2008, CHEM BIOL, V15, P920, DOI 10.1016/j.chembiol.2008.07.018; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; VALLEE BL, 1990, P NATL ACAD SCI USA, V87, P220, DOI 10.1073/pnas.87.1.220; XU Y, 1995, BIOCHEM BIOPH RES CO, V208, P664, DOI 10.1006/bbrc.1995.1390; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	62	103	107	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36804	36813		10.1074/jbc.M112.398842	http://dx.doi.org/10.1074/jbc.M112.398842			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22932899	hybrid, Green Published			2022-12-25	WOS:000310588500017
J	Hsu, SHC; Zhang, XY; Cheng, S; Wunder, JS; Hui, CC; Alman, BA				Hsu, Shu-Hsuan C.; Zhang, Xiaoyun; Cheng, Steven; Wunder, Jay S.; Hui, Chi-Chung; Alman, Benjamin A.			Suppressor of Fused (Sufu) Mediates the Effect of Parathyroid Hormone-like Hormone (Pthlh) on Chondrocyte Differentiation in the Growth Plate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTH/PTHRP RECEPTOR; HEDGEHOG; PTHRP; GLI2; PROLIFERATION; EXPRESSION; REGULATOR; REVEALS; MOUSE; KIF7	Growth plate chondrocytes undergo a coordinated process of differentiation, regulating long bone growth. Parathyroid hormone-like hormone (Pthlh) inhibits hypertrophic differentiation in the growth plate chondrocytes and reduces Hedgehog (Hh) signaling. In mice lacking the Hh mediator Suppressor of fused (Sufu), Pthlh treatment resulted in the up-regulation of Hh activity and an increased number of hypertrophic chondrocytes. Furthermore, Pthlh increased Sufu protein levels, and in chondrocytes lacking Sufu, it was unable to process Hh-regulated Gli transcription factors. Pthlh regulates chondrocyte differentiation and Gli activity in a Sufu-dependent manner, with Sufu acting as a molecular switch in its regulation of differentiation.	[Hsu, Shu-Hsuan C.; Zhang, Xiaoyun; Hui, Chi-Chung; Alman, Benjamin A.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; [Hsu, Shu-Hsuan C.; Alman, Benjamin A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Hui, Chi-Chung] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Cheng, Steven] Nanjing Med Univ, Dept Dev Genet, Nanjing 210029, Jiangsu, Peoples R China; [Cheng, Steven] Nanjing Med Univ, Ctr Regenerat Med, Nanjing 210029, Jiangsu, Peoples R China; [Wunder, Jay S.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Wunder, Jay S.] Mt Sinai Hosp, Dept Surg, Toronto, ON M5G 1X5, Canada; [Alman, Benjamin A.] Univ Toronto, Div Orthopaed Surg, Dept Surg, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Nanjing Medical University; Nanjing Medical University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Alman, BA (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada.	benjamin.alman@sickkids.ca			Canadian Institutes of Health Research [37913, 106587]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grants 37913 and 106587.	Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Beier F, 2001, MOL BIOL CELL, V12, P3852, DOI 10.1091/mbc.12.12.3852; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chen Y, 2011, J BIOL CHEM, V286, P13502, DOI 10.1074/jbc.M110.217604; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Datta NS, 2007, J BONE MINER RES, V22, P951, DOI 10.1359/JBMR.070328; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Guo J, 2002, DEV CELL, V3, P183, DOI 10.1016/S1534-5807(02)00218-6; Han LZ, 2012, J BIOL CHEM, V287, P20483, DOI 10.1074/jbc.M112.359299; Ho L, 2009, CANCER CELL, V16, P126, DOI 10.1016/j.ccr.2009.05.013; Hsu SHC, 2011, DEVELOPMENT, V138, P3791, DOI 10.1242/dev.069492; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kise Y, 2009, BIOCHEM BIOPH RES CO, V387, P569, DOI 10.1016/j.bbrc.2009.07.087; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LINSENMAYER TF, 1988, PATHOL IMMUNOPATH R, V7, P14, DOI 10.1159/000157085; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long FX, 2001, DEVELOPMENT, V128, P5099; Mak IWY, 2012, J BONE MINER RES, V27, P1976, DOI 10.1002/jbmr.1638; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Mau E, 2007, DEV BIOL, V305, P28, DOI 10.1016/j.ydbio.2007.01.031; Meng XW, 2001, J BIOL CHEM, V276, P40113, DOI 10.1074/jbc.M105317200; Minina E, 2001, DEVELOPMENT, V128, P4523; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P2577, DOI 10.1167/iovs.04-0001; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tiet TD, 2006, AM J PATHOL, V168, P321, DOI 10.2353/ajpath.2006.050001; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9	33	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36222	36228		10.1074/jbc.M112.382275	http://dx.doi.org/10.1074/jbc.M112.382275			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22930757	hybrid, Green Published			2022-12-25	WOS:000310364000043
J	Quade, N; Mendonca, C; Herbst, K; Heroven, AK; Ritter, C; Heinz, DW; Dersch, P				Quade, Nick; Mendonca, Chriselle; Herbst, Katharina; Heroven, Ann Kathrin; Ritter, Christiane; Heinz, Dirk W.; Dersch, Petra			Structural Basis for Intrinsic Thermosensing by the Master Virulence Regulator RovA of Yersinia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSULE GENE-CLUSTER; H-NS; TRANSCRIPTIONAL REGULATOR; ESCHERICHIA-COLI; SALMONELLA; EXPRESSION; SLYA; ENTEROCOLITICA; RESISTANCE; PROTEIN	Pathogens often rely on thermosensing to adjust virulence gene expression. In yersiniae, important virulence-associated traits are under the control of the master regulator RovA, which uses a built-in thermosensor to control its activity. Thermal upshifts encountered upon host entry induce conformational changes in the RovA dimer that attenuate DNA binding and render the protein more susceptible to proteolysis. Here, we report the crystal structure of RovA in the free and DNA-bound forms and provide evidence that thermo-induced loss of RovA activity is promoted mainly by a thermosensing loop in the dimerization domain and residues in the adjacent C-terminal helix. These determinants allow partial unfolding of the regulator upon an upshift to 37 degrees C. This structural distortion is transmitted to the flexible DNA-binding domain of RovA. RovA contacts mainly the DNA backbone in a low-affinity binding mode, which allows the immediate release of RovA from its operator sites. We also show that SlyA, a close homolog of RovA from Salmonella with a very similar structure, is not a thermosensor and remains active and stable at 37 degrees C. Strikingly, changes in only three amino acids, reflecting evolutionary replacements in SlyA, result in a complete loss of the thermosensing properties of RovA and prevent degradation. In conclusion, only minor alterations can transform a thermotolerant regulator into a thermosensor that allows adjustment of virulence and fitness determinants to their thermal environment.	[Quade, Nick; Ritter, Christiane; Heinz, Dirk W.] Helmholtz Ctr Infect Res, Dept Mol Struct Biol, D-38124 Braunschweig, Germany; [Mendonca, Chriselle; Herbst, Katharina; Heroven, Ann Kathrin; Dersch, Petra] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, D-38124 Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research	Heinz, DW (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Struct Biol, Inhoffenstr 7, D-38124 Braunschweig, Germany.	dirk.heinz@helmholtz-hzi.de; petra.dersch@helmholtz-hzi.de			German Research Foundation [IRTG1273]; Fonds der Chemischen Industrie	German Research Foundation(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Grant IRTG1273 from the German Research Foundation (to C. M.) and the Fonds der Chemischen Industrie (to P. D. and D. W. H.).	BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Corbett D, 2007, J BIOL CHEM, V282, P33326, DOI 10.1074/jbc.M703465200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Elsholz AKW, 2010, EMBO J, V29, P3621, DOI 10.1038/emboj.2010.228; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; Heroven AK, 2006, MOL MICROBIOL, V62, P1469, DOI 10.1111/j.1365-2958.2006.05458.x; Hurme R, 1997, CELL, V90, P55, DOI 10.1016/S0092-8674(00)80313-X; Klinkert B, 2009, CELL MOL LIFE SCI, V66, P2661, DOI 10.1007/s00018-009-0041-3; Kong W, 2008, J BIOL CHEM, V283, P16612, DOI 10.1074/jbc.M800547200; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Linehan SA, 2005, INFECT IMMUN, V73, P4354, DOI 10.1128/IAI.73.7.4354-4362.2005; Okada N, 2007, MICROBIOL-SGM, V153, P548, DOI 10.1099/mic.0.29259-0; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Revell PA, 2000, MOL MICROBIOL, V35, P677, DOI 10.1046/j.1365-2958.2000.01740.x; Schumann W, 2007, J BIOSCIENCES, V32, P549, DOI 10.1007/s12038-007-0054-8; Servant P, 2000, P NATL ACAD SCI USA, V97, P3538, DOI 10.1073/pnas.070426197; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; Uliczka F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002117; von Rhein C, 2009, INT J MED MICROBIOL, V299, P21, DOI 10.1016/j.ijmm.2008.06.004; Xue P, 2009, J BACTERIOL, V191, P1838, DOI 10.1128/JB.01388-08; Yang FK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012840; Zhao G, 2008, P NATL ACAD SCI USA, V105, P20924, DOI 10.1073/pnas.0807071106	30	33	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35796	35803		10.1074/jbc.M112.379156	http://dx.doi.org/10.1074/jbc.M112.379156			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936808	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000310364000003
J	Chang, FM; Reyna, SM; Granados, JC; Wei, SJ; Innis-Whitehouse, W; Maffi, SK; Rodriguez, E; Slaga, TJ; Short, JD				Chang, Fang-Mei; Reyna, Sara M.; Granados, Jose C.; Wei, Sung-Jen; Innis-Whitehouse, Wendy; Maffi, Shivani K.; Rodriguez, Edward; Slaga, Thomas J.; Short, John D.			Inhibition of Neddylation Represses Lipopolysaccharide-induced Proinflammatory Cytokine Production in Macrophage Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NEDD8-ACTIVATING ENZYME; HUMAN MONOCYTES; LEUKEMIA-CELLS; TNF-ALPHA; ACTIVATION; MLN4924; NEDD8; TRANSCRIPTION; EXPRESSION	Cullin-RING E3 ligases (CRLs) are a class of ubiquitin ligases that control the proteasomal degradation of numerous target proteins, including I kappa B, and the activity of these CRLs are positively regulated by conjugation of a Nedd8 polypeptide onto Cullin proteins in a process called neddylation. CRL-mediated degradation of I kappa B, which normally interacts with and retains NF-kappa B in the cytoplasm, permits nuclear translocation and transactivation of the NF-kappa B transcription factor. Neddylation occurs through a multistep enzymatic process involving Nedd8 activating enzymes, and recent studies have shown that the pharmacological agent, MLN4924, can potently inhibit Nedd8 activating enzymes, thereby preventing neddylation of Cullin proteins and preventing the degradation of CRL target proteins. In macrophages, regulation of NF-kappa B signaling functions as a primary pathway by which infectious agents such as lipopolysaccharides (LPSs) cause the up-regulation of proinflammatory cytokines. Here we have analyzed the effects of MLN4924, and compared the effects of MLN4924 with a known anti-inflammatory agent (dexamethasone), on certain proinflammatory cytokines (TNF-alpha and IL-6) and the NF-kappa B signaling pathway in LPS-stimulated macrophages. We also used siRNA to block neddylation to assess the role of this molecular process during LPS-induced cytokine responsiveness. Our results demonstrate that blocking neddylation, either pharmacologically or using siRNA, abrogates the increase in certain proinflammatory cytokines secreted from macrophages in response to LPS. In addition, we have shown that MLN4924 and dexamethasone inhibit LPS-induced cytokine up-regulation at the transcriptional level, albeit through different molecular mechanisms. Thus, neddylation represents a novel molecular process in macrophages that can be targeted to prevent and/or treat the LPS-induced up-regulation of proinflammatory cytokines and the disease processes associated with their up-regulation.	[Chang, Fang-Mei; Reyna, Sara M.; Granados, Jose C.; Wei, Sung-Jen; Innis-Whitehouse, Wendy; Maffi, Shivani K.; Rodriguez, Edward; Short, John D.] Univ Texas Hlth Sci Ctr San Antonio, Reg Acad Hlth Ctr, Div Med Res, Edinburg, TX 78541 USA; [Reyna, Sara M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Diabet, San Antonio, TX 78229 USA; [Wei, Sung-Jen; Slaga, Thomas J.; Short, John D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Maffi, Shivani K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Short, JD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Reg Acad Hlth Ctr, Div Med Res, Edinburg, TX 78541 USA.	shortj@uthscsa.edu		Reyna, Sara/0000-0002-4913-0186; Wei, Sung Jen/0000-0002-9810-9041				Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Anas AA, 2010, NETH J MED, V68, P147; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; AUWERX JH, 1988, BIOCHEMISTRY-US, V27, P2651, DOI 10.1021/bi00408a003; Bellezzo JM, 1996, AM J PHYSIOL-GASTR L, V270, pG956, DOI 10.1152/ajpgi.1996.270.6.G956; Bhargava P, 2012, BIOCHEM J, V442, P253, DOI 10.1042/BJ20111708; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Crinelli R, 2000, BLOOD CELL MOL DIS, V26, P211, DOI 10.1006/bcmd.2000.0298; Cuschieri J, 2004, CELL IMMUNOL, V227, P140, DOI 10.1016/j.cellimm.2004.03.005; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Fainboim L, 2007, CYTOKINE GROWTH F R, V18, P143, DOI 10.1016/j.cytogfr.2007.01.017; Gross KL, 2009, MOL CELL ENDOCRINOL, V300, P7, DOI 10.1016/j.mce.2008.10.001; Haas M, 1998, J LEUKOCYTE BIOL, V63, P395, DOI 10.1002/jlb.63.3.395; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Jia LJ, 2011, NEOPLASIA, V13, P561, DOI 10.1593/neo.11420; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Lukkarila JL, 2011, ACS MED CHEM LETT, V2, P577, DOI 10.1021/ml2000615; Majdalawieh A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823821; Meisel SR, 2002, ATHEROSCLEROSIS, V161, P35, DOI 10.1016/S0021-9150(01)00616-5; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Moynagh PN, 2009, TRENDS IMMUNOL, V30, P33, DOI 10.1016/j.it.2008.10.001; Nazinitsky A, 2010, INFECT DIS CLIN PRAC, V18, P188, DOI DOI 10.1097/IPC.0B013E3181D2EE41; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Ortiz-Lazareno PC, 2008, IMMUNOLOGY, V124, P534, DOI 10.1111/j.1365-2567.2008.02806.x; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Swords RT, 2010, BLOOD, V115, P3796, DOI 10.1182/blood-2009-11-254862; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TRANTHI TA, 1995, HEPATOLOGY, V22, P613, DOI 10.1016/0270-9139(95)90587-1; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wang M, 2011, EXPERT OPIN THER TAR, V15, P253, DOI 10.1517/14728222.2011.550877; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Wei DP, 2012, CANCER RES, V72, P282, DOI 10.1158/0008-5472.CAN-11-2866; Weiss T, 2004, ANTIMICROB AGENTS CH, V48, P1974, DOI 10.1128/AAC.48.6.1974-1982.2004; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yuk Jae-Min, 2011, Journal of Bacteriology and Virology, V41, P225	57	63	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35756	35767		10.1074/jbc.M112.397703	http://dx.doi.org/10.1074/jbc.M112.397703			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927439	hybrid, Green Published			2022-12-25	WOS:000309968000086
J	Godfrey, KM; Haugen, G; Kiserud, T; Inskip, HM; Cooper, C; Harvey, NCW; Crozier, SR; Robinson, SM; Davies, L; Hanson, MA				Godfrey, Keith M.; Haugen, Guttorm; Kiserud, Torvid; Inskip, Hazel M.; Cooper, Cyrus; Harvey, Nicholas C. W.; Crozier, Sarah R.; Robinson, Sian M.; Davies, Lucy; Hanson, Mark A.		Southampton Womens Survey Study	Fetal Liver Blood Flow Distribution: Role in Human Developmental Strategy to Prioritize Fat Deposition versus Brain Development	PLOS ONE			English	Article							DUCTUS-VENOSUS; GENE-EXPRESSION; GROWTH; PREGNANCY; OBESITY; RESTRICTION; VELOCIMETRY; MECHANISMS; CHILDHOOD; PROFILE	Among primates, human neonates have the largest brains but also the highest proportion of body fat. If placental nutrient supply is limited, the fetus faces a dilemma: should resources be allocated to brain growth, or to fat deposition for use as a potential postnatal energy reserve? We hypothesised that resolving this dilemma operates at the level of umbilical blood distribution entering the fetal liver. In 381 uncomplicated pregnancies in third trimester, we measured blood flow perfusing the fetal liver, or bypassing it via the ductus venosus to supply the brain and heart using ultrasound techniques. Across the range of fetal growth and independent of the mother's adiposity and parity, greater liver blood flow was associated with greater offspring fat mass measured by dual-energy X-ray absorptiometry, both in the infant at birth (r = 0.43, P<0.001) and at age 4 years (r = 0.16, P = 0.02). In contrast, smaller placentas less able to meet fetal demand for essential nutrients were associated with a brain-sparing flow pattern (r = 0.17, p = 0.02). This flow pattern was also associated with a higher degree of shunting through ductus venosus (P = 0.04). We propose that humans evolved a developmental strategy to prioritize nutrient allocation for prenatal fat deposition when the supply of conditionally essential nutrients requiring hepatic inter-conversion is limited, switching resource allocation to favour the brain if the supply of essential nutrients is limited. Facilitated placental transfer mechanisms for glucose and other nutrients evolved in environments less affluent than those now prevalent in developed populations, and we propose that in circumstances of maternal adiposity and nutrient excess these mechanisms now also lead to prenatal fat deposition. Prenatal developmental influences play important roles in the human propensity to deposit fat.	[Godfrey, Keith M.; Haugen, Guttorm; Hanson, Mark A.] Univ Southampton, Inst Dev Sci, Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Godfrey, Keith M.; Inskip, Hazel M.; Cooper, Cyrus; Harvey, Nicholas C. W.; Crozier, Sarah R.; Robinson, Sian M.; Davies, Lucy; Southampton Womens Survey Study] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Godfrey, Keith M.; Cooper, Cyrus; Hanson, Mark A.] Univ Hosp Southampton NHS Fdn Trust, Southampton Natl Inst Hlth Res Biomed Res Ctr, Southampton, Hants, England; [Haugen, Guttorm] Univ Oslo, Rikshosp, Dept Obstet, Oslo Univ Hosp, N-0027 Oslo, Norway; [Kiserud, Torvid] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Kiserud, Torvid] Univ Bergen, Dept Clin Med, Bergen, Norway	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Oslo; National Hospital Norway; University of Bergen; Haukeland University Hospital; University of Bergen	Godfrey, KM (corresponding author), Univ Southampton, Inst Dev Sci, Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England.	guttorm.haugen@ous-hf.no	Hanson, Mark/AAE-8236-2019; Inskip, Hazel/L-5467-2018	Hanson, Mark/0000-0002-6907-613X; Crozier, Sarah/0000-0002-9524-1127; Inskip, Hazel/0000-0001-8897-1749; Robinson, Sian/0000-0003-1766-7269; Cooper, Cyrus/0000-0003-3510-0709; Kiserud, Torvid/0000-0003-1825-1660; Godfrey, Keith/0000-0002-4643-0618; Harvey, Nicholas/0000-0002-8194-2512	British Heart Foundation; Wessex Medical Trust; University of Southampton; UK Medical Research Council; Research Council of Norway; National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; British Heart Foundation [RG/07/009/23120] Funding Source: researchfish; Medical Research Council [MC_UP_A620_1014, MC_UP_A620_1017, U1475000001] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; MRC [MC_UP_A620_1017] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Wessex Medical Trust; University of Southampton; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Council of Norway(Research Council of Norway); National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the charities the British Heart Foundation and Wessex Medical Trust, by the University of Southampton and by the UK Medical Research Council, and the Research Council of Norway. KMG is supported by the National Institute for Health Research through the NIHR Southampton Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellotti M, 2004, AM J OBSTET GYNECOL, V190, P1347, DOI 10.1016/j.ajog.2003.11.018; Brawley L, 2004, J PHYSIOL-LONDON, V554, P497, DOI 10.1113/jphysiol.2003.052068; Desai M, 1997, AM J PHYSIOL-GASTR L, V273, pG899, DOI 10.1152/ajpgi.1997.273.4.G899; EDELSTONE D I, 1980, Journal of Developmental Physiology (Eynsham), V2, P219; Gluckman PD, 2006, MISMATCH LIFESTYLE D; Godfrey K, 1996, BRIT MED J, V312, P410, DOI 10.1136/bmj.312.7028.410; Godfrey K M, 2001, Public Health Nutr, V4, P611; Haugen G, 2005, CIRC RES, V96, P12, DOI 10.1161/01.RES.0000152391.45273.A2; Haugen G, 2004, ULTRASOUND OBST GYN, V24, P599, DOI 10.1002/uog.1744; HODGKIN DD, 1988, J DEV PHYSIOL, V10, P383; Hsieh YY, 2001, ULTRASOUND OBST GYN, V17, P125, DOI 10.1046/j.1469-0705.2001.00329.x; Inskip HM, 2006, INT J EPIDEMIOL, V35, P42, DOI 10.1093/ije/dyi202; Kessler J, 2008, PEDIATR RES, V63, P315, DOI 10.1203/PDR.0b013e318163a1de; Kessler J, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.038; Kiserud T, 2006, ULTRASOUND OBST GYN, V28, P143, DOI 10.1002/uog.2784; Kiserud T, 2000, AM J OBSTET GYNECOL, V182, P147, DOI 10.1016/S0002-9378(00)70504-7; Kiserud T, 1998, ULTRASOUND MED BIOL, V24, P1301, DOI 10.1016/S0301-5629(98)00131-8; Kiserud T, 1998, ULTRASOUND OBST GYN, V11, P419, DOI 10.1046/j.1469-0705.1998.11060419.x; KISERUD T, 1991, LANCET, V338, P1412, DOI 10.1016/0140-6736(91)92720-M; Kiserud T, 1997, AM J OBSTET GYNECOL, V177, P86, DOI 10.1016/S0002-9378(97)70442-3; Koletzko B, 1998, BRIT J NUTR, V80, pS5, DOI 10.1079/BJN19980104; Kuzawa CW, 1998, YEARB PHYS ANTHROPOL, V41, P177; Leary SD, 2003, PLACENTA, V24, P276, DOI 10.1053/plac.2002.0888; LEY D, 1992, EARLY HUM DEV, V31, P171, DOI 10.1016/0378-3782(92)90045-I; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; Office of Population Censuses and Surveys, 1980, CLASS OCC; OWENS JA, 1987, J DEV PHYSIOL, V9, P137; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; PASSINGH.RE, 1973, BRAIN BEHAV EVOLUT, V7, P337, DOI 10.1159/000124422; PAULICK RP, 1991, AM J PHYSIOL, V260, pH1205, DOI 10.1152/ajpheart.1991.260.4.H1205; PEDERSEN JF, 1980, BRIT MED J, V281, P1253, DOI 10.1136/bmj.281.6250.1253; Pennati G, 1996, ULTRASOUND MED BIOL, V22, P1017, DOI 10.1016/S0301-5629(96)00117-2; Symonds ME, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P255, DOI 10.1017/CBO9780511544699.019; Tchirikov M, 2003, J PHYSIOL-LONDON, V548, P519, DOI 10.1113/jphysiol.2002.034470; Tchirikov M, 2002, PLACENTA, V23, pS153, DOI 10.1053/plac.2002.0810; Thompson NM, 2007, ENDOCRINOLOGY, V148, P2345, DOI 10.1210/en.2006-1641; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; WLADIMIROFF JW, 1987, OBSTET GYNECOL, V69, P705; ZAPOL WM, 1979, J APPL PHYSIOL, V47, P968, DOI 10.1152/jappl.1979.47.5.968; Zhang JL, 2000, AM J PHYSIOL-GASTR L, V278, pG128, DOI 10.1152/ajpgi.2000.278.1.G128	41	53	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41759	10.1371/journal.pone.0041759	http://dx.doi.org/10.1371/journal.pone.0041759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927915	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000308286300014
J	Oro, D; Jimenez, J; Curco, A				Oro, Daniel; Jimenez, Juan; Curco, Antoni			Some Clouds Have a Silver Lining: Paradoxes of Anthropogenic Perturbations from Study Cases on Long-Lived Social Birds	PLOS ONE			English	Article							POPULATION-DYNAMICS; FOOD AVAILABILITY; REGIME SHIFTS; CONSERVATION; DISPERSAL; RESILIENCE; ECOLOGY; DENSITY; CATASTROPHES; ECOSYSTEMS	In recent centuries and above all over the last few decades, human activities have generated perturbations (from mild to very severe or catastrophes) that, when added to those of natural origin, constitute a global threat to biodiversity. Predicting the effects of anthropogenic perturbations on species and communities is a great scientific challenge given the complexity of ecosystems and the need for detailed population data from both before and after the perturbations. Here we present three cases of well-documented anthropogenic severe perturbations (different forms of habitat loss and deterioration influencing fertility and survival) that have affected three species of birds (a raptor, a scavenger and a waterbird) for which we possess long-term population time series. We tested whether the perturbations caused serious population decline or whether the study species were resilient, that is, its population dynamics were relatively unaffected. Two of the species did decline, although to a relatively small extent with no shift to a state of lower population numbers. Subsequently, these populations recovered rapidly and numbers reached similar levels to before the perturbations. Strikingly, in the third species a strong breakpoint took place towards greater population sizes, probably due to the colonization of new areas by recruits that were queuing at the destroyed habitat. Even though it is difficult to draw patterns of resilience from only three cases, the study species were all long-lived, social species with excellent dispersal and colonization abilities, capable of skipping reproduction and undergoing a phase of significant long-term population increase. The search for such patterns is crucial for optimizing the limited resources allocated to conservation and for predicting the future impact of planned anthropogenic activities on ecosystems.	[Oro, Daniel] CSIC UIB, Inst Mediterrani Estudis Avancats IMEDEA, Esporles, Spain; [Curco, Antoni] Parc Nat Delta Ebre, Deltebre, Spain; [Jimenez, Juan] Generalitat Valenciana, Conselleria Medio Ambiente, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Oro, D (corresponding author), CSIC UIB, Inst Mediterrani Estudis Avancats IMEDEA, Esporles, Spain.	d.oro@uib.es	Oro, Daniel/H-4208-2012	Oro, Daniel/0000-0003-4782-3007	Spanish Ministry of Science [CGL2009-08298]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funds were provided by the Spanish Ministry of Science (grant ref. CGL2009-08298)(http://www.idi.mineco.gob.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, PROG PHYS GEOG, V23, P1, DOI 10.1177/030913339902300101; Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Akcakaya HR, 1996, OECOLOGIA, V105, P475, DOI 10.1007/BF00330010; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Arroyo B., 2007, AGUILUCHO CENIZO AGU; Avise JC, 2008, LIGHT EVOLUTION; Balkiz O, 2010, J ANIM ECOL, V79, P1045, DOI 10.1111/j.1365-2656.2010.01721.x; Barnosky AD, 2004, P NATL ACAD SCI USA, V101, P9297, DOI 10.1073/pnas.0402592101; Blake S, 2004, CONSERV BIOL, V18, P1191, DOI 10.1111/j.1523-1739.2004.01860.x; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; CEZILLY F, 1995, ECOLOGY, V76, P20, DOI 10.2307/1940628; Curco A, 2009, FLAMINGO SPECIAL PUB, V1, P37; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Davidson Z, 2011, BIOL CONSERV, V144, P114, DOI 10.1016/j.biocon.2010.08.005; Fernandez-Chacon A, 2011, GLOBAL CHANGE BIOL, V17, P3075, DOI 10.1111/j.1365-2486.2011.02469.x; Gaillard JM, 2008, P ROY SOC B-BIOL SCI, V275, P2025, DOI 10.1098/rspb.2008.0393; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; Genovart M, 2008, ZOOL STUD, V47, P11; Guitart R, 2010, VET J, V183, P260, DOI 10.1016/j.tvjl.2009.03.033; Hill D, 2012, J APPL ECOL, V49, P6, DOI 10.1111/j.1365-2664.2011.02095.x; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Iverson SA, 2010, ECOL APPL, V20, P1993, DOI 10.1890/09-1398.1; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; Johnson A, 2007, GREATER FLAMINGO; Kotze DJ, 2004, J NEGATIVE RESULTS, V1, P1; Lachish S, 2011, HEREDITY, V106, P172, DOI 10.1038/hdy.2010.17; Leighton PA, 2010, BIOL CONSERV, V143, P2156, DOI 10.1016/j.biocon.2010.05.028; Liminana R, 2012, EUR J WILD IN PRESS, V58; Liminana R, 2006, BIRD STUDY, V53, P126, DOI 10.1080/00063650609461425; Lindenmayer DB, 2010, FRONT ECOL ENVIRON, V8, P527, DOI 10.1890/090184; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; MANGEL M, 1994, ECOLOGY, V75, P607, DOI 10.2307/1941719; Martinez-Abrain A, 2009, ANIM CONSERV, V12, P204, DOI 10.1111/j.1469-1795.2009.00239.x; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; Massey JG, 2007, 9 INT EFF OIL WILDL; Matkin CO, 2008, MAR ECOL PROG SER, V356, P269, DOI 10.3354/meps07273; McDowall RM, 2010, REV FISH BIOL FISHER, V20, P87, DOI 10.1007/s11160-009-9125-2; Moller AP, 2011, BIOL CONSERV, V144, P2787, DOI 10.1016/j.biocon.2011.08.009; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; Oro D, 2004, P ROY SOC B-BIOL SCI, V271, P387, DOI 10.1098/rspb.2003.2609; Oro D, 1999, OECOLOGIA, V118, P438, DOI 10.1007/s004420050746; Oro D, 2011, OECOLOGIA, V165, P935, DOI 10.1007/s00442-010-1773-3; Parsons DM, 2010, BIOL CONSERV, V143, P2039, DOI 10.1016/j.biocon.2010.05.009; Penteriani V, 2011, ANIM CONSERV, V14, P233, DOI 10.1111/j.1469-1795.2010.00433.x; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Poethke HJ, 2002, P ROY SOC B-BIOL SCI, V269, P637, DOI 10.1098/rspb.2001.1936; Reed DH, 2003, ANIM CONSERV, V6, P109, DOI 10.1017/S1367943003003147; Romme WH, 2011, ECOSYSTEMS, V14, P1196, DOI 10.1007/s10021-011-9470-6; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Sahasrabudhe S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1163; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Sole R, 2007, NATURE, V449, P151, DOI 10.1038/449151a; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Soutullo A, 2006, OECOLOGIA, V149, P543, DOI 10.1007/s00442-006-0465-5; Thibault KM, 2008, P NATL ACAD SCI USA, V105, P3410, DOI 10.1073/pnas.0712282105; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661; Votier SC, 2008, J ANIM ECOL, V77, P974, DOI 10.1111/j.1365-2656.2008.01421.x; Wiens JA, 2010, CURR ORNITHOL, V17, P131, DOI 10.1007/978-1-4419-6421-2_4; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	60	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42753	10.1371/journal.pone.0042753	http://dx.doi.org/10.1371/journal.pone.0042753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936988	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300024
J	Yuen, WS; Merriman, JA; O'Bryan, MK; Jones, KT				Yuen, Wai Shan; Merriman, Julie A.; O'Bryan, Moira K.; Jones, Keith T.			DNA Double Strand Breaks but Not Interstrand Crosslinks Prevent Progress through Meiosis in Fully Grown Mouse Oocytes	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; ANEMIA CORE COMPLEX; FANCONI-ANEMIA; OXIDATIVE STRESS; HISTONE H2AX; CELL-CYCLE; TARGETED DISRUPTION; REDUCED FERTILITY; MALE-INFERTILITY; GENE-EXPRESSION	There is some interest in how mammalian oocytes respond to different types of DNA damage because of the increasing expectation of fertility preservation in women undergoing chemotherapy. Double strand breaks (DSBs) induced by ionizing radiation and agents such as neocarzinostatin (NCS), and interstrand crosslinks (ICLs) induced by alkylating agents such as mitomycin C (MMC), are toxic DNA lesions that need to be repaired for cell survival. Here we examined the effects of NCS and MMC treatment on oocytes collected from antral follicles in mice, because potentially such oocytes are readily collected from ovaries and do not need to be in vitro grown to achieve meiotic competency. We found that oocytes were sensitive to NCS, such that this ionizing radiation mimetic blocked meiosis I and caused fragmented DNA. In contrast, MMC had no impact on the completion of either meiosis I or II, even at extremely high doses. However, oocytes treated with MMC did show gamma-H2AX foci and following their in vitro maturation and parthenogenetic activation the development of the subsequent embryos was severely compromised. Addition of MMC to 1-cell embryos caused a similarly poor level of development, demonstrating oocytes have eventual sensitivity to this ICL-inducing agent but this does not occur during their meiotic division. In oocytes, the association of Fanconi Anemia protein, FANCD2, with sites of ICL lesions was not apparent until entry into the embryonic cell cycle. In conclusion, meiotic maturation of oocytes is sensitive to DSBs but not ICLs. The ability of oocytes to tolerate severe ICL damage and yet complete meiosis, means that this type of DNA lesion goes unrepaired in oocytes but impacts on subsequent embryo quality.	[Yuen, Wai Shan; Merriman, Julie A.; Jones, Keith T.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	University of Newcastle; Monash University	Yuen, WS (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	Keith.Jones@newcastle.edu.au	O'Bryan, Moira K/F-8256-2012; Jones, Keith/AAA-3479-2021; Jones, Keith/C-9821-2013	O'Bryan, Moira K/0000-0001-7298-4940; Jones, Keith/0000-0002-0294-0851; Jones, Keith/0000-0002-0294-0851	National Health and Medical Research Council (NHMRC); Australian Research Council; NHMRC fellowship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NHMRC fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC), and Australian Research Council funding to KTJ and MKOB. MKOB is the recipient of an NHMRC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Adriaens I, 2009, HUM REPROD UPDATE, V15, P359, DOI 10.1093/humupd/dmn063; Agoulnik AI, 2002, HUM MOL GENET, V11, P3047, DOI 10.1093/hmg/11.24.3047; Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Albertini DF, 2003, REPRODUCTION, P49; ALTER BP, 1991, BRIT J HAEMATOL, V77, P410, DOI 10.1111/j.1365-2141.1991.tb08593.x; BAKER RM, 1979, P NATL ACAD SCI USA, V76, P5249, DOI 10.1073/pnas.76.10.5249; Banuelos A, 2003, J PHARMACOL EXP THER, V306, P671, DOI 10.1124/jpet.103.051557; BEERMAN TA, 1977, BIOCHIM BIOPHYS ACTA, V475, P281, DOI 10.1016/0005-2787(77)90019-3; Ben-Yehoyada M, 2009, MOL CELL, V35, P704, DOI 10.1016/j.molcel.2009.08.014; BosMikich A, 1997, DEV BIOL, V182, P172, DOI 10.1006/dbio.1996.8468; BRADSHAW J, 1995, MOL REPROD DEV, V41, P503, DOI 10.1002/mrd.1080410413; Castillo P, 2011, DNA REPAIR, V10, P518, DOI 10.1016/j.dnarep.2011.02.007; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chang HY, 2011, J BIOL CHEM, V286, P14705, DOI 10.1074/jbc.M110.193227; Chang HY, 2009, DEVELOPMENT, V136, P4077, DOI 10.1242/dev.042143; Chen M, 1996, NAT GENET, V12, P448, DOI 10.1038/ng0496-448; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Choi E, 2012, DEV CELL, V22, P295, DOI 10.1016/j.devcel.2012.01.009; Collins NB, 2009, BLOOD, V113, P2181, DOI 10.1182/blood-2008-05-154294; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Derijck A, 2008, HUM MOL GENET, V17, P1922, DOI 10.1093/hmg/ddn090; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gharagozloo P, 2011, HUM REPROD, V26, P1628, DOI 10.1093/humrep/der132; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Hanoux V, 2007, CELL DEATH DIFFER, V14, P671, DOI 10.1038/sj.cdd.4402052; Hassold T, 2009, CURR OPIN PEDIATR, V21, P703, DOI 10.1097/MOP.0b013e328332c6ab; HATAYAMA T, 1979, BIOCHIM BIOPHYS ACTA, V563, P59, DOI 10.1016/0005-2787(79)90007-8; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Holt JE, 2010, DEVELOPMENT, V137, P1297, DOI 10.1242/dev.047555; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Jennings PC, 2011, HUM REPROD, V26, P878, DOI 10.1093/humrep/deq393; Jin SQ, 2009, J BIOL CHEM, V284, P22970, DOI 10.1074/jbc.M109.009134; Jones KT, 2008, HUM REPROD UPDATE, V14, P143, DOI 10.1093/humupd/dmm043; Kim JM, 2008, BLOOD, V111, P5215, DOI 10.1182/blood-2007-09-113092; Koomen M, 2002, HUM MOL GENET, V11, P273, DOI 10.1093/hmg/11.3.273; Kujjo LL, 2011, BIOL REPROD; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Lee HJ, 2011, FERTIL STERIL, V95, P1344, DOI 10.1016/j.fertnstert.2010.08.034; Lee M, 2011, ONCOGENE, V30, P3360, DOI 10.1038/onc.2011.55; Li J, 2010, BLOOD, V115, P1545, DOI 10.1182/blood-2009-07-234385; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Lister LM, 2010, CURR BIOL, V20, P1511, DOI 10.1016/j.cub.2010.08.023; Livera G, 2008, REPRODUCTION, V135, P3, DOI 10.1530/REP-07-0054; Marchetti F, 2007, P NATL ACAD SCI USA, V104, P17725, DOI 10.1073/pnas.0705257104; MATSUDA Y, 1989, INT J RADIAT BIOL, V55, P233, DOI 10.1080/09553008914550281; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Matzuk MM, 2012, ANNU REV PHYSIOL, V74, P503, DOI 10.1146/annurev-physiol-020911-153248; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Merriman JA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095711; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rego MA, 2009, MUTAT RES-FUND MOL M, V668, P27, DOI 10.1016/j.mrfmmm.2008.11.018; Revenkova E, 2010, CURR BIOL, V20, P1529, DOI 10.1016/j.cub.2010.08.024; Rodriguez-Mari A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001357; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rowley M, 2011, GASTROENTEROLOGY; Segal-Raz H, 2011, EMBO REP, V12, P713, DOI 10.1038/embor.2011.96; Shen X, 2009, MOL CELL, V35, P716, DOI 10.1016/j.molcel.2009.06.034; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tachibana-Konwalski K, 2010, GENE DEV, V24, P2505, DOI 10.1101/gad.605910; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Tsafriri A, 1996, DEV BIOL, V178, P393, DOI 10.1006/dbio.1996.0226; Vinciguerra P, 2010, J CLIN INVEST, V120, P3834, DOI 10.1172/JCI43391; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Whitney MA, 1996, BLOOD, V88, P49; Wong JCY, 2003, HUM MOL GENET, V12, P2063, DOI 10.1093/hmg/ddg219; Woodruff TK, 2010, NAT REV CLIN ONCOL, V7, P466, DOI 10.1038/nrclinonc.2010.81; Xiong B, 2008, BIOL REPROD, V79, P718, DOI 10.1095/biolreprod.108.069641	78	37	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43875	10.1371/journal.pone.0043875	http://dx.doi.org/10.1371/journal.pone.0043875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928046	gold, Green Accepted, Green Published			2022-12-25	WOS:000308286300096
J	Li, X; Lipowsky, R; Kierfeld, J				Li, Xin; Lipowsky, Reinhard; Kierfeld, Jan			Critical Motor Number for Fractional Steps of Cytoskeletal Filaments in Gliding Assays	PLOS ONE			English	Article							SINGLE KINESIN MOLECULES; HAND-OVER-HAND; MYOSIN-V; FORCE CLAMP; MECHANICS; CARGO; PROCESSIVITY; EQUILIBRIUM; SIMULATION; MOVEMENT	In gliding assays, filaments are pulled by molecular motors that are immobilized on a solid surface. By varying the motor density on the surface, one can control the number N of motors that pull simultaneously on a single filament. Here, such gliding assays are studied theoretically using Brownian (or Langevin) dynamics simulations and taking the local force balance between motors and filaments as well as the force-dependent velocity of the motors into account. We focus on the filament stepping dynamics and investigate how single motor properties such as stalk elasticity and step size determine the presence or absence of fractional steps of the filaments. We show that each gliding assay can be characterized by a critical motor number, N-c. Because of thermal fluctuations, fractional filament steps are only detectable as long as N < N-c. The corresponding fractional filament step size is l/N where l is the step size of a single motor. We first apply our computational approach to microtubules pulled by kinesin-1 motors. For elastic motor stalks that behave as linear springs with a zero rest length, the critical motor number is found to be N-c = 4, and the corresponding distributions of the filament step sizes are in good agreement with the available experimental data. In general, the critical motor number N-c depends on the elastic stalk properties and is reduced to N-c = 3 for linear springs with a nonzero rest length. Furthermore, N-c is shown to depend quadratically on the motor step size l. Therefore, gliding assays consisting of actin filaments and myosin-V are predicted to exhibit fractional filament steps up to motor number N = 31. Finally, we show that fractional filament steps are also detectable for a fixed average motor number < N > as determined by the surface density (or coverage) of the motors on the substrate surface.	[Li, Xin; Lipowsky, Reinhard; Kierfeld, Jan] Max Planck Inst Colloids & Interfaces, Potsdam, Germany; [Kierfeld, Jan] TU Dortmund Univ, Dept Phys, Dortmund, Germany	Max Planck Society; Dortmund University of Technology	Li, X (corresponding author), Max Planck Inst Colloids & Interfaces, Sci Pk Golm, Potsdam, Germany.	jan.kierfeld@tu-dortmund.de	Kierfeld, Jan/A-2659-2009; Li, Xin/H-6579-2014	Kierfeld, Jan/0000-0003-4291-0638; Li, Xin/0000-0002-2510-2236; Lipowsky, Reinhard/0000-0001-8417-8567				Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Clemen AEM, 2005, BIOPHYS J, V88, P4402, DOI 10.1529/biophysj.104.053504; Doi M., 1986, THEORY POLYM DYNAMIC, V1st ed.; Driver JW, 2011, BIOPHYS J, V101, P386, DOI 10.1016/j.bpj.2011.05.067; Driver JW, 2010, PHYS CHEM CHEM PHYS, V12, P10398, DOI 10.1039/c0cp00117a; ERMAK DL, 1975, J CHEM PHYS, V62, P4189, DOI 10.1063/1.430300; Fehr AN, 2008, BIOPHYS J, V94, pL20, DOI 10.1529/biophysj.107.126839; Flory P. J., 1969, STAT MECH CHAIN MOL, V8, P699, DOI [10.1002/bip.1969.360080514, DOI 10.1002/BIP.1969.360080514]; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard M, 2003, POLYM PHYS; Jeney S, 2004, CHEMPHYSCHEM, V5, P1150, DOI 10.1002/cphc.200301027; Kalafut B, 2008, COMPUT PHYS COMMUN, V179, P716, DOI 10.1016/j.cpc.2008.06.008; Kawaguchi K, 2003, BIOPHYS J, V84, P1103, DOI 10.1016/S0006-3495(03)74926-1; Kerssemakers J, 2006, P NATL ACAD SCI USA, V103, P15812, DOI 10.1073/pnas.0510400103; Kierfeld J, 2004, EUR PHYS J E, V14, P17, DOI 10.1140/epje/i2003-10089-3; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Kraikivski P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.258103; Lan GH, 2005, BIOPHYS J, V88, P999, DOI 10.1529/biophysj.104.047662; Landau D.P., 2000, MONTE CARLO SIMULATI; Leduc C, 2004, P NATL ACAD SCI USA, V101, P17096, DOI 10.1073/pnas.0406598101; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Nagy A, 2009, BIOPHYS J, V97, P3123, DOI 10.1016/j.bpj.2009.09.033; Schilstra MJ, 2006, J R SOC INTERFACE, V3, P153, DOI 10.1098/rsif.2005.0098; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Scholey J, 1993, CELL BIOL, V39; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Vilfan A, 2005, BIOPHYS J, V88, P3792, DOI 10.1529/biophysj.104.046763; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	36	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43219	10.1371/journal.pone.0043219	http://dx.doi.org/10.1371/journal.pone.0043219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927953	Green Published, Green Submitted, gold			2022-12-25	WOS:000307789700028
J	Preukschas, M; Hagel, C; Schulte, A; Weber, K; Lamszus, K; Sievert, H; Pallmann, N; Bokemeyer, C; Hauber, J; Braig, M; Balabanov, S				Preukschas, Michael; Hagel, Christian; Schulte, Alexander; Weber, Kristoffer; Lamszus, Katrin; Sievert, Henning; Paellmann, Nora; Bokemeyer, Carsten; Hauber, Joachim; Braig, Melanie; Balabanov, Stefan			Expression of Eukaryotic Initiation Factor 5A and Hypusine Forming Enzymes in Glioblastoma Patient Samples: Implications for New Targeted Therapies	PLOS ONE			English	Article							DEOXYHYPUSINE SYNTHASE ACTIVITY; YEAST SACCHAROMYCES-CEREVISIAE; ONTOLOGY LEGO VECTORS; GLIOMA-CELL LINES; PROTEIN EXPRESSION; GROWTH-FACTOR; CANCER-CELLS; AMINO-ACID; INDEPENDENT PREDICTOR; MALIGNANT GLIOMAS	Glioblastomas are highly aggressive brain tumors of adults with poor clinical outcome. Despite a broad range of new and more specific treatment strategies, therapy of glioblastomas remains challenging and tumors relapse in all cases. Recent work demonstrated that the posttranslational hypusine modification of the eukaryotic initiation factor 5A (eIF-5A) is a crucial regulator of cell proliferation, differentiation and an important factor in tumor formation, progression and maintenance. Here we report that eIF-5A as well as the hypusine-forming enzymes deoxyhypusine synthase (DHS) and deoxyhypusine hydroxylase (DOHH) are highly overexpressed in glioblastoma patient samples. Importantly, targeting eIF-5A and its hypusine modification with GC7, a specific DHS-inhibitor, showed a strong antiproliferative effect in glioblastoma cell lines in vitro, while normal human astrocytes were not affected. Furthermore, we identified p53 dependent premature senescence, a permanent cell cycle arrest, as the primary outcome in U87-MG cells after treatment with GC7. Strikingly, combined treatment with clinically relevant alkylating agents and GC7 had an additive antiproliferative effect in glioblastoma cell lines. In addition, stable knockdown of eIF-5A and DHS by short hairpin RNA (shRNA) could mimic the antiproliferative effects of GC7. These findings suggest that pharmacological inhibition of eIF-5A may represent a novel concept to treat glioblastomas and may help to substantially improve the clinical course of this tumor entity.	[Preukschas, Michael; Sievert, Henning; Paellmann, Nora; Bokemeyer, Carsten; Braig, Melanie; Balabanov, Stefan] Univ Med Ctr Hamburg Eppendorf, Hubertus Wald Tumorzentrum, Dept Oncol Haematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany; [Hagel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Neuropathol, Hamburg, Germany; [Schulte, Alexander; Lamszus, Katrin] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Weber, Kristoffer] Univ Med Ctr Hamburg Eppendorf, Clin Stem Cell Transplantat, Res Dept Cell & Gene Therapy, Hamburg, Germany; [Hauber, Joachim] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute	Preukschas, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Hubertus Wald Tumorzentrum, Dept Oncol Haematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany.	stefan.balabanov@usz.ch	Balabanov, Stefan/E-9765-2014; /H-8186-2012; Riecken, Kristoffer/AAD-2371-2020	Riecken, Kristoffer/0000-0001-9050-6766	Deutsche Forschungsgemeinschaft (DFG) [BA 3506/1-1, HA 2580/4-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	These studies were supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (BA 3506/1-1 and HA 2580/4-1; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBRUZZESE A, 1986, J BIOL CHEM, V261, P3085; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Balabanov S, 2007, BLOOD, V109, P1701, DOI 10.1182/blood-2005-03-037648; BENNE R, 1978, J BIOL CHEM, V253, P3070; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Caraglia M, 1997, BIOCHEM J, V324, P737, DOI 10.1042/bj3240737; Caraglia M, 2003, J BIOCHEM, V133, P757, DOI 10.1093/jb/mvg097; Caraglia M, 2001, AMINO ACIDS, V20, P91, DOI 10.1007/s007260170050; Caraglia M, 2011, AMINO ACIDS, P1; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; Chen W, 2009, CANCER EPIDEM BIOMAR, V18, P400, DOI 10.1158/1055-9965.EPI-08-0754; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; COOPER HL, 1982, CELL, V29, P791, DOI 10.1016/0092-8674(82)90441-X; Eckerich C, 2009, J NEUROCHEM, V109, P969, DOI 10.1111/j.1471-4159.2009.06027.x; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; He LR, 2011, INT J CANCER, V129, P143, DOI 10.1002/ijc.25669; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hirose Y, 2001, CANCER RES, V61, P1957; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; JAKUS J, 1993, J BIOL CHEM, V268, P13151; Jenkins ZA, 2001, GENOMICS, V71, P101, DOI 10.1006/geno.2000.6418; KLIER H, 1995, BIOCHEMISTRY-US, V34, P14693, DOI 10.1021/bi00045a010; Kunkel P, 2001, NEURO-ONCOLOGY, V3, P82, DOI 10.1093/neuonc/3.2.82; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Lam FF, 2010, PROTEOM CLIN APPL, V4, P60, DOI 10.1002/prca.200900084; Lee NP, 2009, INT J CANC, V9999; Li AL, 2004, J BIOL CHEM, V279, P49251, DOI 10.1074/jbc.M407165200; Lu ZJ, 2011, ELECTROPHORESIS, V32, P3612, DOI 10.1002/elps.201100230; Michaelis M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.129; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Noda SE, 2009, SEMIN RADIAT ONCOL, V19, P171, DOI 10.1016/j.semradonc.2009.02.005; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Park MH, 1998, J BIOL CHEM, V273, P1677, DOI 10.1074/jbc.273.3.1677; PARK MH, 1994, J BIOL CHEM, V269, P27827; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rahman-Roblick R, 2007, P NATL ACAD SCI USA, V104, P5401, DOI 10.1073/pnas.0700794104; Reardon DA, 2010, J NEURO-ONCOL, V96, P219, DOI 10.1007/s11060-009-9950-0; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; Shi XP, 1996, BBA-MOL CELL RES, V1310, P119, DOI 10.1016/0167-4889(95)00165-4; SHIBA T, 1971, BIOCHIM BIOPHYS ACTA, V244, P523, DOI 10.1016/0304-4165(71)90069-9; Specht S, 2008, PARASITOL RES, V102, P1177, DOI 10.1007/s00436-008-0891-x; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun Z, 2010, J CELL PHYSIOL, V223, P798, DOI 10.1002/jcp.22100; Taylor CA, 2007, EXP CELL RES, V313, P437, DOI 10.1016/j.yexcr.2006.09.030; Templin AT, 2011, CELL CYCLE, V10, P1043, DOI 10.4161/cc.10.7.15206; Tome ME, 1997, BIOCHEM J, V328, P847; Tome ME, 1997, BIOL SIGNAL, V6, P150; Van Meir E. G., 2009, CNS CANC MODELS MARK; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Weber K, 2010, GENE THER, V17, P511, DOI 10.1038/gt.2009.149; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wick W, 2010, J CLIN ONCOL, V28, pE188, DOI 10.1200/JCO.2009.26.9027; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Wolff EC, 2011, METHODS MOL BIOL, V720, P195, DOI 10.1007/978-1-61779-034-8_12; Yang GF, 2009, GYNECOL ONCOL, V112, P314, DOI 10.1016/j.ygyno.2008.10.024; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914	65	40	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43468	10.1371/journal.pone.0043468	http://dx.doi.org/10.1371/journal.pone.0043468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927971	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000307789700035
J	Saubi, N; Mbewe-Mvula, A; Gea-Mallorqui, E; Rosario, M; Gatell, JM; Hanke, T; Joseph, J				Saubi, Narcis; Mbewe-Mvula, Alice; Gea-Mallorqui, Ester; Rosario, Maximillian; Maria Gatell, Josep; Hanke, Tomas; Joseph, Joan			Pre-Clinical Development of BCG.HIVA(CAT), an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-BOVIS BCG; IMMUNODEFICIENCY-VIRUS TYPE-1; FREE PLASMID SELECTION; TO-CHILD TRANSMISSION; TUBERCULOSIS COMPLEX; IMMUNE-RESPONSES; RECOMBINANT BCG; REPRESSOR TITRATION; CELL RESPONSES	In the past, we proposed to develop a heterologous recombinant BCG prime-recombinant modified vaccinia virus Ankara (MVA) boost dual pediatric vaccine platform against transmission of breast milk HIV-1 and Mycobacterium tuberculosis (Mtb). In this study, we assembled an E. coli-mycobacterial shuttle plasmid pJH222.HIVA(CAT) expressing HIV-1 clade A immunogen HIVA. This shuttle vector employs an antibiotic resistance-free mechanism based on Operator-Repressor Titration (ORT) system for plasmid selection and maintenance in E. coli and lysine complementation in mycobacteria. This shuttle plasmid was electroporated into parental lysine auxotroph (safer) strain of BCG to generate vaccine BCG.HIVA(CAT). All procedures complied with Good Laboratory Practices (GLPs). We demonstrated that the episomal plasmid pJH222.HIVA(CAT) was stable in vivo over a 20-week period, and genetically and phenotypically characterized the BCG.HIVA(CAT) vaccine strain. The BCG.HIVA(CAT) vaccine in combination with MVA.HIVA induced HIV-1- and Mtb-specific interferon gamma-producing T-cell responses in newborn and adult BALB/c mice. On the other hand, when adult mice were primed with BCG.HIVA(CAT) and boosted with MVA. HIVA. 85A, HIV-1-specific CD8(+) T-cells producing IFN-gamma, TNF-alpha, IL-2 and CD107a were induced. To assess the biosafety profile of BCG.HIVA(CAT)- MVA.HIVA regimen, body mass loss of newborn mice was monitored regularly throughout the vaccination experiment and no difference was observed between the vaccinated and naive groups of animals. Thus, we demonstrated T-cell immunogenicity of a novel, safer, GLP-compatible BCG-vectored vaccine using prototype immunogen HIVA. Second generation immunogens derived from HIV-1 as well as other major pediatric pathogens can be constructed in a similar fashion to prime protective responses soon after birth.	[Saubi, Narcis; Gea-Mallorqui, Ester; Maria Gatell, Josep; Joseph, Joan] Univ Barcelona, AIDS Res Grp, Hosp Clin IDIBAPS HIVACAT, Sch Med, Barcelona, Spain; [Mbewe-Mvula, Alice; Hanke, Tomas] Univ Oxford, Jenner Inst, Oxford, England; [Rosario, Maximillian; Hanke, Tomas] Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Oxford; Jenner Institute; University of Oxford	Saubi, N (corresponding author), Univ Barcelona, AIDS Res Grp, Hosp Clin IDIBAPS HIVACAT, Sch Med, Barcelona, Spain.	jjoseph@clinic.ub.es	Gatell, Jose M/ABC-3607-2020; rosario, maxim/O-6098-2019; Rosario, Max/P-3111-2017	Saubi, Narcis/0000-0001-5493-1044; Gea-Mallorqui, Ester/0000-0002-6915-074X	EDCTP [CT.2006.33111.002]; MRC, United Kingdom [G1001757]; HIVACAT: AIDS Vaccine Research Project; MRC [G1001757, MC_U137884179] Funding Source: UKRI; Medical Research Council [G1001757, MC_U137884179] Funding Source: researchfish	EDCTP; MRC, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HIVACAT: AIDS Vaccine Research Project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The sources of funding that have supported the work are: EDCTP (Grant: CT.2006.33111.002; http://www.edctp.org); MRC, United Kingdom (Grant: G1001757; http://www.mrc.ac.uk/); and HIVACAT: AIDS Vaccine Research Project (http://www.hivacat.org/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDOVINI A, 1991, NATURE, V351, P479, DOI 10.1038/351479a0; Ami Y, 2005, J VIROL, V79, P12871, DOI 10.1128/JVI.79.20.12871-12879.2005; Andersson SGE, 1996, MICROBIOL-UK, V142, P915, DOI 10.1099/00221287-142-4-915; Andre S, 1998, J VIROL, V72, P1497; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P193; Bedwell J, 2001, VACCINE, V19, P2146, DOI 10.1016/S0264-410X(00)00369-8; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Behr MA, 1999, VACCINE, V17, P915, DOI 10.1016/S0264-410X(98)00277-1; Borkowsky W, 2000, J INFECT DIS, V181, P890, DOI 10.1086/315298; Bueno SM, 2008, P NATL ACAD SCI USA, V105, P20822, DOI 10.1073/pnas.0806244105; Castillo-Rodal AI, 2006, INFECT IMMUN, V74, P1718, DOI 10.1128/IAI.74.3.1718-1724.2006; Cavarelli M, 2011, J INTERN MED, V270, P561, DOI 10.1111/j.1365-2796.2011.02458.x; Cayabyab MJ, 2009, J VIROL, V83, P5505, DOI 10.1128/JVI.02544-08; Cayabyab MJ, 2006, J VIROL, V80, P1645, DOI 10.1128/JVI.80.4.1645-1652.2006; Chege GK, 2009, VACCINE, V27, P4857, DOI 10.1016/j.vaccine.2009.05.064; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cranenburgh RM, 2004, J MOL MICROB BIOTECH, V7, P197, DOI 10.1159/000079828; Cranenburgh RM, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e26; European Pharmacopoeia, 2010, SECT 5 2 6 EUR PHARM; GHEORGHIU M, 1988, J BIOL STAND, V16, P15, DOI 10.1016/0092-1157(88)90025-X; Hanke T, 2000, NAT MED, V6, P951, DOI 10.1038/79626; Hesseling AC, 2008, INT J TUBERC LUNG D, V12, P1376; HONDA M, 1995, P NATL ACAD SCI USA, V92, P10693, DOI 10.1073/pnas.92.23.10693; Hopkins R, 2011, EUR J IMMUNOL, V41, P3542, DOI 10.1002/eji.201141962; Hopkins R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020067; Hovav AH, 2007, J VIROL, V81, P12793, DOI 10.1128/JVI.01519-07; Im EJ, 2007, J VIROL, V81, P9408, DOI 10.1128/JVI.00707-07; Johnson DC, 2005, J INFECT DIS, V192, P2129, DOI 10.1086/498163; Joseph J, 2006, EXPERT REV VACCINES, V5, P827, DOI 10.1586/14760584.5.6.827; Joseph J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/357370; Kasai, 1998, Genome Inform Ser Workshop Genome Inform, V9, P13; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; LAGRANDERIE M, 1993, VACCINE, V11, P1283, DOI 10.1016/0264-410X(93)90096-G; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Liebana E, 1996, J CLIN MICROBIOL, V34, P933; Lotte A, 1984, Adv Tuberc Res, V21, P107; Magdalena J, 1998, J CLIN MICROBIOL, V36, P2471, DOI 10.1128/JCM.36.9.2471-2476.1998; Marchant A, 1999, J IMMUNOL, V163, P2249; Matsuo Kazuhiro, 2011, Tuberc Res Treat, V2011, P574591, DOI 10.1155/2011/574591; McFarland EJ, 2006, AIDS, V20, P1481, DOI 10.1097/01.aids.0000237363.33994.45; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Nascimento IP, 2009, VACCINE, V27, P7346, DOI 10.1016/j.vaccine.2009.09.043; Niemann S, 2004, J CLIN MICROBIOL, V42, P3958, DOI 10.1128/JCM.42.9.3958-3962.2004; Niemann S, 2000, J CLIN MICROBIOL, V38, P3231, DOI 10.1128/JCM.38.9.3231-3234.2000; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Pan YL, 2011, J BACTERIOL, V193, P3152, DOI 10.1128/JB.00405-11; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Ranganathan UDK, 2009, VACCINE, V28, P152, DOI 10.1016/j.vaccine.2009.09.087; Richter E, 2003, J CLIN MICROBIOL, V41, P2672, DOI 10.1128/JCM.41.6.2672-2675.2003; Rosario M, 2010, J VIROL, V84, P7815, DOI 10.1128/JVI.00726-10; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; Saubi N, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/516219; STOVER CK, 1993, J EXP MED, V178, P197, DOI 10.1084/jem.178.1.197; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; Talbot EA, 1997, J CLIN MICROBIOL, V35, P566, DOI 10.1128/JCM.35.3.566-569.1997; Trovero A, 2010, REV ARGENT MICROBIOL, V42, P4, DOI 10.1590/S0325-75412010000100002; UNAIDS, 2011, WORLD REF DAY 2019 H; vanSoolingen D, 1997, INT J SYST BACTERIOL, V47, P1236, DOI 10.1099/00207713-47-4-1236; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Williams SG, 1998, NUCLEIC ACIDS RES, V26, P2120, DOI 10.1093/nar/26.9.2120; Zhu YD, 1997, J INFECT DIS, V176, P1445, DOI 10.1086/514140	62	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42559	10.1371/journal.pone.0042559	http://dx.doi.org/10.1371/journal.pone.0042559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927933	Green Published, gold, Green Submitted			2022-12-25	WOS:000307789700013
J	Schmiedel, JM; Axmann, IM; Legewie, S				Schmiedel, Joern Matthias; Axmann, Ilka Maria; Legewie, Stefan			Multi-Target Regulation by Small RNAs Synchronizes Gene Expression Thresholds and May Enhance Ultrasensitive Behavior	PLOS ONE			English	Article							SMALL NONCODING RNAS; ESCHERICHIA-COLI; TRANSLATIONAL REPRESSION; NEGATIVE FEEDBACK; SIGNALING NETWORK; SOLUBLE-RNA; HFQ; TARGET; ROBUSTNESS; MICRORNA	Cells respond to external cues by precisely coordinating multiple molecular events. Co-regulation may be established by the so-called single-input module (SIM), where a common regulator controls multiple targets. Using mathematical modeling, we compared the ability of SIM architectures to precisely coordinate protein levels despite environmental fluctuations and uncertainties in parameter values. We find that post-transcriptional co-regulation as exemplified by bacterial small RNAs (sRNAs) is particularly robust: sRNA-mediated regulation establishes highly synchronous gene expression thresholds for all mRNA targets without a need for fine-tuning of kinetic parameters. Our analyses reveal that the non-catalytic nature of sRNA action is essential for robust gene expression synchronization, and that sRNA sequestration effects underlie coupling of multiple mRNA pools. This principle also operates in the temporal regime, implying that sRNAs could robustly coordinate the kinetics of mRNA induction as well. Moreover, we observe that multi-target regulation by a small RNA can strongly enhance ultrasensitivity in mRNA expression when compared to the single-target case. Our findings may explain why bacterial small RNAs frequently coordinate all-or-none responses to cellular stress.	[Schmiedel, Joern Matthias; Axmann, Ilka Maria] Charite, Inst Theoret Biol, D-13353 Berlin, Germany; [Legewie, Stefan] Inst Mol Biol, Mainz, Rheinland Pfalz, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institute of Molecular Biology (IMB)	Schmiedel, JM (corresponding author), Charite, Inst Theoret Biol, D-13353 Berlin, Germany.	s.legewie@imb-mainz.de	Schmiedel, Jörn/K-6833-2017	Schmiedel, Jörn/0000-0002-6842-9837; Axmann, Ilka Maria/0000-0002-0856-8667; Legewie, Stefan/0000-0003-4111-0567	Bundesministerium fur Bildung und Forschung (Virtual Liver Network) through the FORSYS partner program [0315294]; DFG research training group Computational Systems Biology; European Commission [248919]	Bundesministerium fur Bildung und Forschung (Virtual Liver Network) through the FORSYS partner program(Federal Ministry of Education & Research (BMBF)); DFG research training group Computational Systems Biology(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Bundesministerium fur Bildung und Forschung (Virtual Liver Network) to SL and through the FORSYS partner program, grant number 0315294 (IMA). JMS acknowledges support by the DFG research training group Computational Systems Biology. This work was further supported by the European Commission, FP7-ICT-2009-4, BACTOCOM, Project Number 248919, to JMS and IMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Argaman L, 2000, J MOL BIOL, V300, P1101, DOI 10.1006/jmbi.2000.3942; Babitzke P, 2009, ANNU REV MICROBIOL, V63, P27, DOI 10.1146/annurev.micro.091208.073514; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Beisel CL, 2011, MOL CELL, V41, P286, DOI 10.1016/j.molcel.2010.12.027; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Fender A, 2010, GENE DEV, V24, P2621, DOI 10.1101/gad.591310; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; Gogol EB, 2011, P NATL ACAD SCI USA, V108, P12875, DOI 10.1073/pnas.1109379108; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Hao Y, 2011, P NATL ACAD SCI USA, V108, P12473, DOI 10.1073/pnas.1100432108; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kawamoto H, 2006, MOL MICROBIOL, V61, P1013, DOI 10.1111/j.1365-2958.2006.05288.x; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Lease RA, 1998, P NATL ACAD SCI USA, V95, P12456, DOI 10.1073/pnas.95.21.12456; Legewie S, 2008, BIOPHYS J, V95, P3232, DOI 10.1529/biophysj.108.133819; Legewie S, 2007, BIOPHYS J, V93, P2279, DOI 10.1529/biophysj.107.109132; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Levine E, 2008, CURR OPIN MICROBIOL, V11, P574, DOI 10.1016/j.mib.2008.09.016; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lovdok L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000171; Maki K, 2008, P NATL ACAD SCI USA, V105, P10332, DOI 10.1073/pnas.0803106105; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mather WH, 2010, BIOPHYS J, V99, P3172, DOI 10.1016/j.bpj.2010.09.057; Mehta P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.58; Mitarai N, 2007, PHYS BIOL, V4, P164, DOI 10.1088/1478-3975/4/3/003; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Morita T, 2006, P NATL ACAD SCI USA, V103, P4858, DOI 10.1073/pnas.0509638103; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Papenfort K, 2010, P NATL ACAD SCI USA, V107, P20435, DOI 10.1073/pnas.1009784107; Papenfort K, 2009, RES MICROBIOL, V160, P278, DOI 10.1016/j.resmic.2009.03.004; Paulsen M, 2011, P NATL ACAD SCI USA, V108, P10202, DOI 10.1073/pnas.1100179108; Salazar C, 2009, FEBS J, V276, P3177, DOI 10.1111/j.1742-4658.2009.07027.x; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Santos SDM, 2008, NATURE, V454, P288, DOI 10.1038/454288a; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; Ventura AC, 2010, P NATL ACAD SCI USA, V107, P10032, DOI 10.1073/pnas.0913815107; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348; Zhdanov VP, 2011, CHAOS, V21, DOI 10.1063/1.3605464; Zhdanov VP, 2011, PHYS REP, V500, P1, DOI 10.1016/j.physrep.2010.12.002; Zhdanov VP, 2009, MOL BIOSYST, V5, P638, DOI 10.1039/b808095j	57	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42296	10.1371/journal.pone.0042296	http://dx.doi.org/10.1371/journal.pone.0042296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927924	Green Published, Green Submitted, gold			2022-12-25	WOS:000307789700008
J	Sountoulidis, A; Stavropoulos, A; Giaglis, S; Apostolou, E; Monteiro, R; Lopes, SMCD; Chen, HY; Stripp, BR; Mummery, C; Andreakos, E; Sideras, P				Sountoulidis, Alexandros; Stavropoulos, Athanasios; Giaglis, Stavros; Apostolou, Eirini; Monteiro, Rui; Lopes, Susana M. Chuva de Sousa; Chen, Huaiyong; Stripp, Barry R.; Mummery, Christine; Andreakos, Evangelos; Sideras, Paschalis			Activation of the Canonical Bone Morphogenetic Protein (BMP) Pathway during Lung Morphogenesis and Adult Lung Tissue Repair	PLOS ONE			English	Article							EMBRYONIC MOUSE LUNG; STEM-CELLS; BRANCHING MORPHOGENESIS; STEM/PROGENITOR CELLS; SIGNAL-TRANSDUCTION; PULMONARY-FIBROSIS; EPITHELIAL-CELLS; SELF-RENEWAL; EXPRESSION; GROWTH	Signaling by Bone Morphogenetic Proteins (BMP) has been implicated in early lung development, adult lung homeostasis and tissue-injury repair. However, the precise mechanism of action and the spatio-temporal pattern of BMP-signaling during these processes remains inadequately described. To address this, we have utilized a transgenic line harboring a BMP-responsive eGFP-reporter allele (BRE-eGFP) to construct the first detailed spatiotemporal map of canonical BMP-pathway activation during lung development, homeostasis and adult-lung injury repair. We demonstrate that during the pseudoglandular stage, when branching morphogenesis progresses in the developing lung, canonical BMP-pathway is active mainly in the vascular network and the sub-epithelial smooth muscle layer of the proximal airways. Activation of the BMP-pathway becomes evident in epithelial compartments only after embryonic day (E) 14.5 primarily in cells negative for epithelial-lineage markers, located in the proximal portion of the airway-tree, clusters adjacent to neuro-epithelial-bodies (NEBs) and in a substantial portion of alveolar epithelial cells. The pathway becomes activated in isolated E12.5 mesenchyme-free distal epithelial buds cultured in Matrigel suggesting that absence of reporter activity in these regions stems from a dynamic cross-talk between endoderm and mesenchyme. Epithelial cells with activated BMP-pathway are enriched in progenitors capable of forming colonies in three-dimensional Matrigel cultures. As lung morphogenesis approaches completion, eGFP-expression declines and in adult lung its expression is barely detectable. However, upon tissue-injury, either with naphthalene or bleomycin, the canonical BMP-pathways is re-activated, in bronchial or alveolar epithelial cells respectively, in a manner reminiscent to early lung development and in tissue areas where reparatory progenitor cells reside. Our studies illustrate the dynamic activation of canonical BMP-pathway during lung development and adult lung tissue-repair and highlight its involvement in two important processes, namely, the early development of the pulmonary vasculature and the management of epithelial progenitor pools both during lung development and repair of adult lung tissue-injury.	[Sountoulidis, Alexandros; Stavropoulos, Athanasios; Giaglis, Stavros; Apostolou, Eirini; Andreakos, Evangelos; Sideras, Paschalis] Acad Athens, Biomed Res Fdn, Ctr Immunol & Transplantat, Athens, Greece; [Monteiro, Rui; Lopes, Susana M. Chuva de Sousa; Mummery, Christine] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Chen, Huaiyong; Stripp, Barry R.] Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care, Durham, NC USA	Academy of Athens; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Duke University	Sountoulidis, A (corresponding author), Acad Athens, Biomed Res Fdn, Ctr Immunol & Transplantat, Athens, Greece.	sideras@bioacademy.gr	Stripp, Barry/AAI-1467-2021; Monteiro, Rui/AAL-4904-2020; Giaglis, Stavros/GSO-0043-2022; Chen, Huaiyong/G-3822-2014	Monteiro, Rui/0000-0002-4223-8506; Giaglis, Stavros/0000-0003-2216-9539; Stavropoulos, Athanasios/0000-0002-5101-1899; Mummery, Christine/0000-0002-4549-6535; Sideras, Paschalis/0000-0003-0701-1258; Stripp, Barry/0000-0003-4348-2137	Hellenic Ministries of Health and Education; Hellenic Ministry of Development [03ED245, 09SYN-12-1075]; Hellenic Ministry of Finances; European Economic Area-EEA [EL0084]; Interuniversity Attraction Poles (PAI) [P6/20]; General Secretariat of Research and Technology	Hellenic Ministries of Health and Education; Hellenic Ministry of Development; Hellenic Ministry of Finances; European Economic Area-EEA; Interuniversity Attraction Poles (PAI); General Secretariat of Research and Technology(Greek Ministry of Development-GSRT)	This work was supported by core funding from the Hellenic Ministries of Health and Education and by grant awards from the Hellenic Ministry of Development, General Secretariat of Research and Technology (PENED "03ED245" and SYNERGASIA "09SYN-12-1075"), the Hellenic Ministry of Finances and the European Economic Area-EEA (EL0084). SMCSL and CM were supported by the Interuniversity Attraction Poles (PAI) (P6/20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandre-Alcazar MA, 2007, DEV DYNAM, V236, P2825, DOI 10.1002/dvdy.21293; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bellusci S, 1997, DEVELOPMENT, V124, P53; Blank U, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-86; Blewett CJ, 1996, J PEDIATR SURG, V31, P869, DOI 10.1016/S0022-3468(96)90400-5; Bragg AD, 2001, MECH DEVELOP, V109, P13, DOI 10.1016/S0925-4773(01)00508-1; BUCKPITT A, 1995, MOL PHARMACOL, V47, P74; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Domyan ET, 2011, DEVELOPMENT, V138, P971, DOI 10.1242/dev.053694; Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006; Farkas L, 2010, AM J RESP CELL  0603; Fulcoli FG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006049; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Giangreco A, 2009, P NATL ACAD SCI USA, V106, P9286, DOI 10.1073/pnas.0900668106; Hogan B, 1994, MANIPULATING MOUSE E; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; JONES AW, 1978, J PATHOL, V124, P227, DOI 10.1002/path.1711240407; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim Namjin, 2006, Birth Defects Research, V78, P80, DOI 10.1002/bdrc.20062; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; Lazarus A, 2011, DEVELOPMENT, V138, P2359, DOI 10.1242/dev.060723; Lebeche D, 1999, MECH DEVELOP, V86, P125, DOI 10.1016/S0925-4773(99)00124-0; Leeuwis JW, 2011, J PATHOL, V224, P121, DOI 10.1002/path.2844; Li Y, 2008, DEV BIOL, V322, P145, DOI 10.1016/j.ydbio.2008.07.021; Ling TY, 2006, P NATL ACAD SCI USA, V103, P9530, DOI 10.1073/pnas.0510232103; LIU F, 1995, MOL CELL BIOL, V15, P3479; Liu XM, 2006, METHOD ENZYMOL, V419, P285, DOI 10.1016/S0076-6879(06)19012-6; Liu YR, 2003, DEV BIOL, V261, P10, DOI 10.1016/S0012-1606(03)00359-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu MM, 2001, DEV DYNAM, V222, P667, DOI 10.1002/dvdy.1231; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Millino C, 2000, DEV DYNAM, V218, P414, DOI 10.1002/1097-0177(200007)218:3<414::AID-DVDY1002>3.0.CO;2-H; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Monteiro RM, 2008, GENESIS, V46, P335, DOI 10.1002/dvg.20402; Myllarniemi M, 2008, J PATHOL, V214, P456, DOI 10.1002/path.2300; Myllarniemi M, 2008, AM J RESP CRIT CARE, V177, P321, DOI 10.1164/rccm.200706-945OC; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Que JW, 2006, DIFFERENTIATION, V74, P422, DOI 10.1111/j.1432-0436.2006.00096.x; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Rosendahl A, 2002, AM J RESP CELL MOL, V27, P160, DOI 10.1165/ajrcmb.27.2.4779; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Song YL, 2008, AM J PHYSIOL-HEART C, V295, pH677, DOI 10.1152/ajpheart.91519.2007; Sun JP, 2008, AM J PATHOL, V172, P571, DOI 10.2353/ajpath.2008.070286; Sylva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022616; Teisanu RM, 2011, AM J RESP CELL MOL, V44, P794, DOI 10.1165/rcmb.2010-0098OC; Warburton D, 2004, CURR TOP DEV BIOL, V64, P1, DOI 10.1016/S0070-2153(04)64001-4; Warburton D, 2003, RESP RES, V4, DOI 10.1186/1465-9921-4-5; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Weaver M, 2003, DEV BIOL, V258, P169, DOI 10.1016/S0012-1606(03)00117-9; Weaver M, 2000, DEVELOPMENT, V127, P2695; Weaver M, 1999, DEVELOPMENT, V126, P4005; Wiley DM, 2011, SEMIN CELL DEV BIOL, V22, P1012, DOI 10.1016/j.semcdb.2011.10.005; Xu B, 2011, DEVELOPMENT, V138, P925, DOI 10.1242/dev.062687; Xu JS, 2006, J BIOL CHEM, V281, P38894, DOI 10.1074/jbc.M609339200; Yang XD, 2007, AM J RESP CELL MOL, V37, P598, DOI 10.1165/rcmb.2006-0360OC; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	68	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41460	10.1371/journal.pone.0041460	http://dx.doi.org/10.1371/journal.pone.0041460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916109	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800012
J	Hino, H; Takahashi, H; Suzuki, Y; Tanaka, J; Ishii, E; Fukuda, M				Hino, Hitomi; Takahashi, Hisaaki; Suzuki, Yuka; Tanaka, Junya; Ishii, Eiichi; Fukuda, Mitsumasa			Anticonvulsive Effect of Paeoniflorin on Experimental Febrile Seizures in Immature Rats: Possible Application for Febrile Seizures in Children	PLOS ONE			English	Article							HYPERTHERMIA-INDUCED SEIZURES; POWER SPECTRUM CHANGES; PEONY ROOT EXTRACT; GLUTAMATE RECEPTORS; VALPROIC ACID; EPILEPSY; MODEL; MICE; HIPPOCAMPUS; MECHANISMS	Febrile seizures (FS) is the most common convulsive disorder in children, but there have been no clinical and experimental studies of the possible treatment of FS with herbal medicines, which are widely used in Asian countries. Paeoniflorin (PF) is a major bioactive component of Radix Paeoniae alba, and PF-containing herbal medicines have been used for neuromuscular, neuropsychiatric, and neurodegenerative disorders. In this study, we analyzed the anticonvulsive effect of PF and Keishikashakuyaku-to (KS; a PF-containing herbal medicine) for hyperthermia-induced seizures in immature rats as a model of human FS. When immature (P5) male rats were administered PF or KS for 10 days, hyperthermia-induced seizures were significantly suppressed compared to control rats. In cultured hippocampal neurons, PF suppressed glutamate-induced elevation of intracellular Ca2+ ([Ca2+](i)), glutamate receptor-mediated membrane depolarization, and glutamate-induced neuronal death. In addition, PF partially suppressed the elevation in [Ca2+](i) induced by activation of the metabotropic glutamate receptor 5 (mGluR5), but not that mediated by alpha-amino-3-hydroxy-5-methyl-4-isoxazolpropionic acid (AMPA) or N-methyl-D-aspartate (NMDA) receptors. However, PF did not affect production or release of gamma-aminobutyric acid (GABA) in hippocampal neurons. These results suggest that PF or PF-containing herbal medicines exert anticonvulsive effects at least in part by preventing mGluR5-dependent [Ca2+](i) elevations. Thus, it could be a possible candidate for the treatment of FS in children.	[Hino, Hitomi; Suzuki, Yuka; Ishii, Eiichi; Fukuda, Mitsumasa] Ehime Univ, Dept Pediat, Grad Sch Med, Toon, Ehime, Japan; [Takahashi, Hisaaki; Tanaka, Junya] Ehime Univ, Dept Mol & Cellular Physiol, Grad Sch Med, Toon, Ehime, Japan; [Takahashi, Hisaaki; Tanaka, Junya; Fukuda, Mitsumasa] Ehime Univ, Ehime Proteomed Res Ctr, Dept Basic & Clin Neurosci, Toon, Ehime, Japan	Ehime University; Ehime University; Ehime University	Hino, H (corresponding author), Ehime Univ, Dept Pediat, Grad Sch Med, Toon, Ehime, Japan.	fukumits@m.ehime-u.ac.jp	Tanaka, Junya/Y-1033-2019	Tanaka, Junya/0000-0003-1056-5948	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Epilepsy Research Foundation; Ehime University; Grants-in-Aid for Scientific Research [23659688] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Epilepsy Research Foundation; Ehime University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (C) of the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Research Grant of the Japan Epilepsy Research Foundation, and a Research Promotion Award of Ehime University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafez AA, 1999, BIOL PHARM BULL, V22, P491, DOI 10.1248/bpb.22.491; Anderson GD, 2002, EPILEPSIA, V43, P53, DOI 10.1046/j.1528-1157.43.s.3.5.x; Audenaert D, 2006, NEUROLOGY, V67, P687, DOI 10.1212/01.wnl.0000230145.73496.a2; BARAM TZ, 1991, DEV BRAIN RES, V61, P97, DOI 10.1016/0165-3806(91)90118-3; Bender RA, 2003, HIPPOCAMPUS, V13, P399, DOI 10.1002/hipo.10089; Camfield C, 2005, EPILEPTIC SYNDROMES; Castro-Gago M, 2011, J CHILD NEUROL, V26, P1522, DOI 10.1177/0883073811409227; Cendes F, 2005, EPILEPTIC SYNDROMES, P555; DEZAKI K, 1995, JPN J PHARMACOL, V69, P281, DOI 10.1254/jjp.69.281; DOBBING J, 1973, LANCET, V1, P48; Dube C, 2005, ANN NEUROL, V57, P152, DOI 10.1002/ana.20358; FRANDSEN A, 1993, J NEUROCHEM, V60, P1202, DOI 10.1111/j.1471-4159.1993.tb03278.x; Freeman A.R., 1976, Progress Neurobiol, V6, P137, DOI 10.1016/0301-0082(76)90012-5; Fukuda M, 1997, DEV BRAIN RES, V104, P197, DOI 10.1016/S0165-3806(97)00157-0; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Hiratsuka T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013280; HJERESEN DL, 1988, DEV PSYCHOBIOL, V21, P261, DOI 10.1002/dev.420210307; KNIGHT M, 1985, ARCH NEUROL-CHICAGO, V42, P474, DOI 10.1001/archneur.1985.04060050076011; Lu YM, 1997, J NEUROSCI, V17, P5196; Lux AL, 2010, BRAIN DEV-JPN, V32, P42, DOI 10.1016/j.braindev.2009.09.016; Mao QQ, 2010, CELL MOL NEUROBIOL, V30, P1059, DOI 10.1007/s10571-010-9537-5; MORIMOTO T, 1995, DEV BRAIN RES, V84, P204, DOI 10.1016/0165-3806(94)00173-W; NAGAKUBO S, 1993, JPN J PSYCHIAT NEUR, V47, P609; Nakanishi S, 1998, BRAIN RES REV, V26, P230, DOI 10.1016/S0165-0173(97)00033-7; Neville B, 2010, DEV MED CHILD NEUROL, V52, P1151, DOI 10.1111/j.1469-8749.2010.03745.x; Nicoletti F, 1996, TRENDS NEUROSCI, V19, P267, DOI 10.1016/S0166-2236(96)20019-0; Pal S, 2001, CELL CALCIUM, V30, P285, DOI 10.1054/ceca.2001.0236; Qu LT, 2008, J NEUROCHEM, V106, P2158, DOI 10.1111/j.1471-4159.2008.05576.x; RATING D, 1983, J NEUROL, V230, P217, DOI 10.1007/BF00313697; Raza M, 2001, BRAIN RES, V903, P1, DOI 10.1016/S0006-8993(01)02127-8; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shitak R, 2007, METHOD FIND EXP CLIN, V29, P11, DOI 10.1358/mf.2007.29.1.1063489; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; SUGAYA A, 1991, J ETHNOPHARMACOL, V33, P159, DOI 10.1016/0378-8741(91)90174-C; SUGAYA E, 1988, EPILEPSY RES, V2, P337, DOI 10.1016/0920-1211(88)90043-5; SUGAYA E, 1988, EPILEPSY RES, V2, P27, DOI 10.1016/0920-1211(88)90006-X; Suzuki Y, 2009, BRAIN RES, V1268, P17, DOI 10.1016/j.brainres.2009.02.074; Tanabe T, 2011, EPILEPSIA, V52, P837, DOI 10.1111/j.1528-1167.2010.02958.x; Tang NY, 2010, AM J CHINESE MED, V38, P51, DOI 10.1142/S0192415X10007786; Tsuda T, 1997, EXP NEUROL, V146, P518, DOI 10.1006/exnr.1997.6570; Verrotti A, 2011, OBES REV, V12, pe32, DOI 10.1111/j.1467-789X.2010.00800.x; Watanabe H, 1997, BEHAV BRAIN RES, V83, P135, DOI 10.1016/S0166-4328(97)86057-3; Zarate CA, 1999, J CLIN PSYCHIAT, V60, P232, DOI 10.4088/JCP.v60n0405; Zhang LL, 2011, EPILEPTIC DISORD, V13, P349, DOI 10.1684/epd.2011.0444	44	25	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42920	10.1371/journal.pone.0042920	http://dx.doi.org/10.1371/journal.pone.0042920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916181	Green Published, Green Submitted, gold			2022-12-25	WOS:000307824300021
J	Larsson, EC; Thorson, AE; Pariyo, G; Waiswa, P; Kadobera, D; Marrone, G; Ekstrom, AM				Larsson, Elin C.; Thorson, Anna Ekeus; Pariyo, George; Waiswa, Peter; Kadobera, Daniel; Marrone, Gaetano; Ekstrom, Anna Mia			Missed Opportunities: Barriers to HIV Testing during Pregnancy from a Population Based Cohort Study in Rural Uganda	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; EASTERN UGANDA; ANTENATAL CARE; OPT-OUT; PREVENTION; SERVICES; BOTSWANA; ZIMBABWE; NEWBORN; WOMEN	The aim was to assess population-level HIV-testing uptake among pregnant women, key for access to prevention-of mother to child transmission (PMTCT) services, and to identify risk factors for not being HIV tested, The study was conducted May 2008-May 2010 in the Iganga/Mayuge Health and Demographic Surveillance Site (HDSS), Eastern Uganda, during regular surveillance of 68,000 individuals. All women identified to be pregnant May-July 2008 (n = 881) were interviewed about pregnancy-related issues and linked to the HDSS database for socio-demographic data. Women were followed-up via antenatal care (ANC) register reviews at the health facilities to collect data related to ANC services received, including HIV testing. Adjusted relative risk (aRR), and 95% confidence intervals (CI) for not being HIV tested were calculated using multivariable binomial regression among the 544 women who remained after record review. Despite high ANC attendance (96%), the coverage of HIV testing was 64%. Only 6% of pregnant women who sought ANC at a facility without HIV testing services were referred for testing and only 20% received counseling regarding HIV. At ANC facilities with HIV testing services, 85% were tested. Only 4% of the women tested had been couple tested for HIV. Living more than three kilometers away from a health facility with HIV testing services was associated with not being tested both among the poorest (aRR, CI; 1.44,1.02-2.04) and the least poor women (aRR, CI; 1.72,1.12-2.63). The lack of onsite HIV testing services and distant ANC facilities lead to missed opportunities for PMTCT, especially for the poorest women. Referral systems for HIV testing need to be improved and testing should be expanded to lower level health facilities. This is in order to ensure that the policy of HIV testing during pregnancy is implemented more effectively and that testing is accessible for all.	[Larsson, Elin C.; Thorson, Anna Ekeus; Marrone, Gaetano; Ekstrom, Anna Mia] Karolinska Inst, Div Global Hlth, Dept Publ Hlth Sci, Stockholm, Sweden; [Pariyo, George; Waiswa, Peter] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Pariyo, George; Waiswa, Peter; Kadobera, Daniel] Iganga Mayuge Hlth & Demog Surveillance Site, Iganga, Uganda	Karolinska Institutet; Makerere University	Larsson, EC (corresponding author), Karolinska Inst, Div Global Hlth, Dept Publ Hlth Sci, Stockholm, Sweden.	elinlarsson7@yahoo.se	Larsson, Elin/AAQ-5596-2020; Pariyo, George W/K-2335-2017; Ekström, Anna Mia/H-6901-2013	Pariyo, George W/0000-0002-4411-2309; Marrone, Gaetano/0000-0002-2991-1663; Larsson, Elin C./0000-0002-5189-808X; Thorson, Anna/0000-0002-8703-6561	European Union, through the European Community; Swedish International Development Cooperation Agency (Sida); Karolinska Institutet	European Union, through the European Community; Swedish International Development Cooperation Agency (Sida); Karolinska Institutet(Karolinska Institutet)	This study was funded by grants from The European Union, through the European Community's FP6, the Swedish International Development Cooperation Agency (Sida), and Karolinska Institutet's funds for PhD students (KID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio P, 2009, AIDS CARE, V21, P1537, DOI 10.1080/09540120902903719; [Anonymous], 2007, MANUAL ESTIMATING NA; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Byamugisha R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-290; Byamugisha R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-12; Chandisarewa W, 2007, B WORLD HEALTH ORGAN, V85, P843, DOI 10.2471/BLT.06.035188; Chicago IL, 2007, STAT SOFTW; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Ettarh R, 2010, HLTH PLACE; Falnes EF, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-36; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Filmer D, 1999, SOC SCI MED, V49, P1309, DOI 10.1016/S0277-9536(99)00150-1; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hirsch JS, 2009, GOING PUBLIC MODERN; Homsy J, 2007, JAIDS-J ACQ IMM DEF, V44, P366, DOI 10.1097/QAI.0b013e31802f1303; Homsy J, 2006, JAIDS-J ACQ IMM DEF, V42, P149, DOI 10.1097/01.qai.0000225032.52766.c2; Katz DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007602; Kilewo C, 2008, J ACQUIR IMMUNE DEFI; Larsson EC, 2011, HLTH POLICY PLAN; Larsson EC, 2012, HEALTH POLICY PLANN, V27, P69, DOI 10.1093/heapol/czr009; Larsson EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-769; Larsson EC, 2009, AIDS, V23, P1924, DOI 10.1097/QAD.0b013e32832eff81; Mbonye AK, 2009, SEX TRANSM INFECT, V85, P534, DOI 10.1136/sti.2009.037986; *MIN HLTH UG, 2006, POL GUID PREV MOTH T; Ministry of Health Uganda, 2000, HLTH SECT STRAT PLAN; Namukwaya Z, 2010, J ACQUIR IMMUNE DEFI; Perez F, 2006, JAIDS-J ACQ IMM DEF, V41, P514, DOI 10.1097/01.qai.0000191285.70331.a0; Sanjana P, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-44; StataCorp L, 2007, STAT DAT AN STAT SOF; Steen TW, 2007, JAIDS-J ACQ IMM DEF, V44, P484, DOI 10.1097/QAI.0b013e318030ffa9; Thorsen VC, 2008, DEV WORLD BIOETH, V8, P43, DOI 10.1111/j.1471-8847.2008.00227.x; Uganda Bureau of Statistics & Macro International, 2007, UG DEM HLTH SURV; Uganda Ministry of Health and ORC Macro, 2006, UG HIV AIDS SER SURV; UNAIDS, 2011, GLOB PLAN EL NEW HIV; UNAIDS, 2010, GLOB REP UNAIDS REP; Waiswa P, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-9; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; WHO, 2006, ANT DRUGS TREAT PREG; *WHO, 2009, RAP ADV US ANT DRUGS; WHO UNICEF & UNAIDS., 2011, UN ACC, P1; [No title captured]	42	31	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e37590	10.1371/journal.pone.0037590	http://dx.doi.org/10.1371/journal.pone.0037590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AN	22916089	Green Published, gold, Green Submitted			2022-12-25	WOS:000307824300001
J	Nejepinska, J; Malik, R; Moravec, M; Svoboda, P				Nejepinska, Jana; Malik, Radek; Moravec, Martin; Svoboda, Petr			Deep Sequencing Reveals Complex Spurious Transcription from Transiently Transfected Plasmids	PLOS ONE			English	Article							LUCIFERASE REPORTER GENE; MAMMALIAN-CELLS; PRL-TK; EXPRESSION; VECTORS; RNA; ASSAYS; DNA; INHIBITION; EFFICIENCY	Transient plasmid transfection is a common approach in studies in cultured mammalian cells. To examine behavior of transfected plasmids, we analyzed their transcriptional landscape by deep sequencing. We have found that the entire plasmid sequence is transcribed at different levels. Spurious transcription may have undesirable effects as some plasmids, when co-transfected, inhibited expression of luciferase reporters in a dose-dependent manner. In one case, we attributed this effect to a Kan/Neo resistance cassette, which generated a unique population of edited sense and antisense small RNAs. The unexpected complexity of expression from transiently transfected plasmids underscores the importance of appropriate experimental controls.	[Nejepinska, Jana; Malik, Radek; Moravec, Martin; Svoboda, Petr] Inst Mol Genet AS CR, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Nejepinska, J (corresponding author), Inst Mol Genet AS CR, Prague, Czech Republic.	petr.svoboda@img.cas.cz	Urbanova, Jana/G-2748-2014; Svoboda, Petr/G-3890-2012; Malik, Radek/G-3578-2014	Urbanova, Jana/0000-0001-9778-6289; Svoboda, Petr/0000-0002-4370-3705; Malik, Radek/0000-0002-6783-1146	Czech Science Foundation [GACR 204/09/0085]; RVO [68378050]; European Molecular Biology Organization Strategic Development Installation Grant [0001488];  [AV0Z50520514]	Czech Science Foundation(Grant Agency of the Czech Republic); RVO; European Molecular Biology Organization Strategic Development Installation Grant; 	This research was supported by the Czech Science Foundation (grant GACR 204/09/0085), institutional support AV0Z50520514 and RVO 68378050, and the European Molecular Biology Organization Strategic Development Installation Grant (program 0001488, partial). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHANG LJ, 1985, MOL CELL BIOL, V5, P2341, DOI 10.1128/MCB.5.9.2341; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; FARR A, 1992, NUCLEIC ACIDS RES, V20, P920, DOI 10.1093/nar/20.4.920; Ghazawi I, 2005, J INTERF CYTOK RES, V25, P92, DOI 10.1089/jir.2005.25.92; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Hong SJ, 2002, BIOTECHNIQUES, V33, P1236, DOI 10.2144/02336bm11; KALVAKOLANU DVR, 1991, J BIOL CHEM, V266, P873; Kaname T, 2001, GENE, V266, P147, DOI 10.1016/S0378-1119(01)00375-4; Kaufman RJ, 1997, METHODS, V11, P361, DOI 10.1006/meth.1996.0434; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Lorenz WW, 1996, J BIOLUM CHEMILUM, V11, P31, DOI 10.1002/(SICI)1099-1271(199601)11:1<31::AID-BIO398>3.0.CO;2-M; Nejepinska J, 2012, NUCLEIC ACIDS RES, V40, P399, DOI 10.1093/nar/gkr702; Osborne SA, 2002, BIOTECHNIQUES, V33, P1240, DOI 10.2144/02336bm12; Paguio A., 2005, PROMEGA NOTES, V89, P7; Schagat T, 2007, CELL NOTES, V17, P9; SCHULE R, 1988, SCIENCE, V242, P1418, DOI 10.1126/science.3201230; Shifera AS, 2010, ANAL BIOCHEM, V396, P167, DOI 10.1016/j.ab.2009.09.043; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; SORSCHER DH, 1994, CARCINOGENESIS, V15, P1093, DOI 10.1093/carcin/15.5.1093; Terenzi F, 1999, NUCLEIC ACIDS RES, V27, P4369, DOI 10.1093/nar/27.22.4369; Thavathiru E, 2001, BIOTECHNIQUES, V31, P528, DOI 10.2144/01313st06; Thirunavukkarasu K, 2000, BIOTECHNIQUES, V28, P506, DOI 10.2144/00283st09; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vopalensky V, 2008, RNA, V14, P1720, DOI 10.1261/rna.831808	28	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43283	10.1371/journal.pone.0043283	http://dx.doi.org/10.1371/journal.pone.0043283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916237	Green Published, Green Submitted, gold			2022-12-25	WOS:000307824300037
J	Zhou, JD; Zhang, SY; Xue, J; Avery, J; Wu, JC; Lind, SE; Ding, WQ				Zhou, Jundong; Zhang, Shuyu; Xue, Jing; Avery, Jori; Wu, Jinchang; Lind, Stuart E.; Ding, Wei-Qun			Activation of Peroxisome Proliferator-activated Receptor alpha (PPAR alpha) Suppresses Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) Signaling in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN OVARIAN-CANCER; DOCOSAHEXAENOIC ACID; IN-VITRO; PROTEASOME INHIBITORS; GENE-EXPRESSION; CLOFIBRIC ACID; DNA-BINDING; HIF-ALPHA; GROWTH; ANGIOGENESIS	Activation of peroxisome proliferator-activated receptor alpha (PPAR alpha) has been demonstrated to inhibit tumor growth and angiogenesis, yet the mechanisms behind these actions remain to be characterized. In this study, we examined the effects of PPAR alpha activation on the hypoxia-inducible factor-1 alpha (HIF-1 alpha) signaling pathway in human breast (MCF-7) and ovarian (A2780) cancer cells under hypoxia. Incubation of cancer cells under 1% oxygen for 16 h significantly induced HIF-1 alpha expression and activity as assayed by Western blotting and reporter gene analysis. Treatment of the cells with PPAR alpha agonists, but not a PPAR gamma agonist, prior to hypoxia diminished hypoxia-induced HIF-1 alpha expression and activity, and addition of a PPAR alpha antagonist attenuated the suppression of HIF-1 alpha signaling. Activation of PPAR alpha attenuated hypoxia-induced HA-tagged HIF-1 alpha protein expression without affecting the HA-tagged HIF-1 alpha mutant protein level, indicating that PPAR alpha activation promotes HIF-1 alpha degradation in these cells. This was further confirmed using proteasome inhibitors, which reversed PPAR alpha-mediated suppression of HIF-1 alpha expression under hypoxia. Using the co-immunoprecipitation technique, we found that activation of PPAR alpha enhances the binding of HIF-1 alpha to von Hippel-Lindau tumor suppressor (pVHL), a protein known to mediate HIF-1 alpha degradation through the ubiquitin-proteasome pathway. Following PPAR alpha mediated suppression of HIF-1 alpha signaling, VEGF secretion from the cancer cells was significantly reduced, and tube formation by endothelial cells was dramatically impaired. Taken together, these findings demonstrate for the first time that activation of PPAR alpha suppresses hypoxia-induced HIF-1 alpha signaling in cancer cells, providing novel insight into the anticancer properties of PPAR alpha agonists.	[Zhou, Jundong; Zhang, Shuyu; Xue, Jing; Avery, Jori; Ding, Wei-Qun] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Zhou, Jundong; Xue, Jing; Wu, Jinchang] Nanjing Med Univ, Suzhou Hosp, Dept Radiooncol, Suzhou 205123, Peoples R China; [Zhang, Shuyu] Soochow Univ, Sch Radiat Med & Protect, Suzhou 205123, Peoples R China; [Lind, Stuart E.] Univ Colorado Denver, Dept Pathol, Denver, CO 80217 USA; [Lind, Stuart E.] Univ Colorado Denver, Dept Med, Denver, CO 80217 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Nanjing Medical University; Soochow University - China; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ding, WQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, 975 NE 10th St,BRC 411A, Oklahoma City, OK 73104 USA.	weiqun-ding@ouhsc.edu			National Institutes of Health Oklahoma IDeA Network of Biomedical Research Excellence (OK-INBRE) Program [3P20RR016478-09S2]; American Cancer Society [CNE-117557]; Susan G. Komen for the Cure Foundation [KG081083]; Oklahoma Center for the Advancement of Science and Technology [HR09-025]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016478] Funding Source: NIH RePORTER	National Institutes of Health Oklahoma IDeA Network of Biomedical Research Excellence (OK-INBRE) Program; American Cancer Society(American Cancer Society); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Oklahoma Center for the Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Oklahoma IDeA Network of Biomedical Research Excellence (OK-INBRE) Program Grant 3P20RR016478-09S2. This work was also supported by American Cancer Society Grant CNE-117557, Susan G. Komen for the Cure Foundation Grant KG081083, and Oklahoma Center for the Advancement of Science and Technology Grant HR09-025.	Adams M, 1997, J CLIN INVEST, V100, P3149, DOI 10.1172/JCI119870; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Belanger AJ, 2007, BIOCHEM BIOPH RES CO, V364, P567, DOI 10.1016/j.bbrc.2007.10.062; Benndorf R, 2003, CIRC RES, V93, P438, DOI 10.1161/01.RES.0000088358.99466.04; Birle DC, 2007, CANCER RES, V67, P1735, DOI 10.1158/0008-5472.CAN-06-2722; Brahimi-Horn Christiane, 2006, Bull Cancer, V93, pE73; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chang TT, 2011, MOL PHARMACEUT, V8, P117, DOI 10.1021/mp100137q; Cui Y, 2012, J CELL PHYSIOL, V227, P772, DOI 10.1002/jcp.22789; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Ding WQ, 2006, MOL CANCER THER, V5, P1864, DOI 10.1158/1535-7163.MCT-06-0067; Ding WQ, 2005, CANCER RES, V65, P3389, DOI 10.1158/0008-5472.CAN-04-3577; Drukala J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-159; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Grabacka M, 2004, ARCH DERMATOL RES, V296, P54, DOI 10.1007/s00403-004-0479-y; Grabacka M, 2006, CLIN CANCER RES, V12, P3028, DOI 10.1158/1078-0432.CCR-05-2556; Grau R, 2006, BIOCHEM J, V395, P81, DOI 10.1042/BJ20050964; Grau R, 2008, PPAR RES, V2008, DOI 10.1155/2008/352437; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kunz Manfred, 2003, Mol Cancer, V2, P23, DOI 10.1186/1476-4598-2-23; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Meissner M, 2004, CIRC RES, V94, P324, DOI 10.1161/01.RES.0000113781.08139.81; Meriin AB, 1998, J BIOL CHEM, V273, P6373, DOI 10.1074/jbc.273.11.6373; Nardinocchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015048; Narravula S, 2001, J IMMUNOL, V166, P7543, DOI 10.4049/jimmunol.166.12.7543; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shigeto T, 2007, ONCOL REP, V18, P833; Shim JS, 2010, JNCI-J NATL CANCER I, V102, P1855, DOI 10.1093/jnci/djq457; Tuller ER, 2009, MOL PHARMACOL, V76, P588, DOI 10.1124/mol.109.057430; Tuller ER, 2009, BIOCHEM PHARMACOL, V77, P1480, DOI 10.1016/j.bcp.2009.02.002; Urbanska K, 2008, INT J CANCER, V123, P1015, DOI 10.1002/ijc.23588; Yokoyama Y, 2007, MOL CANCER THER, V6, P1379, DOI 10.1158/1535-7163.MCT-06-0722; Zak Z, 2010, LEUKEMIA, V24, P1476, DOI 10.1038/leu.2010.117; Zhang XX, 2011, J BIOL CHEM, V286, P1429, DOI 10.1074/jbc.M110.146530	46	58	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35161	35169		10.1074/jbc.M112.367367	http://dx.doi.org/10.1074/jbc.M112.367367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22932900	Green Published, hybrid			2022-12-25	WOS:000309968000026
J	Kothawala, A; Kilpatrick, K; Novoa, JA; Segatori, L				Kothawala, Ahmed; Kilpatrick, Kiri; Novoa, Jose Andres; Segatori, Laura			Quantitative Analysis of alpha-Synuclein Solubility in Living Cells Using Split GFP Complementation	PLOS ONE			English	Article							FAMILIAL PARKINSONS-DISEASE; GREEN FLUORESCENT PROTEIN; IN-VITRO; PROTEASOMAL INHIBITION; LEWY BODIES; AGGREGATION; MUTATIONS; FILAMENTS; NEUROINFLAMMATION; NEURODEGENERATION	Presently incurable, Parkinson's disease (PD) is the most common neurodegenerative movement disorder and affects 1% of the population over 60 years of age. The hallmarks of PD pathogenesis are the loss of dopaminergic neurons in the substantia nigra pars compacta, and the occurrence of proteinaceous cytoplasmic inclusions (Lewy bodies) in surviving neurons. Lewy bodies are mainly composed of the pre-synaptic protein alpha-synuclein (alpha syn), an intrinsically unstructured, misfolding-prone protein with high propensity to aggregate. Quantifying the pool of soluble asyn and monitoring asyn aggregation in living cells is fundamental to study the molecular mechanisms of alpha syn-induced cytotoxicity and develop therapeutic strategies to prevent asyn aggregation. In this study, we report the use of a split GFP complementation assay to quantify alpha syn solubility. Particularly, we investigated a series of naturally occurring and rationally designed asyn variants and showed that this method can be used to study how alpha syn sequence specificity affects its solubility. Furthermore, we demonstrated the utility of this assay to explore the influence of the cellular folding network on alpha syn solubility. The results presented underscore the utility of the split GFP assay to quantify alpha syn solubility in living cells.	[Kothawala, Ahmed; Kilpatrick, Kiri; Novoa, Jose Andres; Segatori, Laura] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77251 USA; [Segatori, Laura] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Segatori, Laura] Rice Univ, Dept Bioengn, Houston, TX USA	Rice University; Rice University; Rice University	Kothawala, A (corresponding author), Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77251 USA.	segatori@rice.edu			Div Of Chem, Bioeng, Env, & Transp Sys [1159640] Funding Source: National Science Foundation	Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Baba M, 1998, AM J PATHOL, V152, P879; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chun WJ, 2007, J NEUROCHEM, V103, P2529, DOI 10.1111/j.1471-4159.2007.04941.x; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; Etzkorn M, 2011, J BIOMOL NMR, V49, P121, DOI 10.1007/s10858-011-9468-6; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Goncalves SA, 2010, TRENDS BIOCHEM SCI, V35, P643, DOI 10.1016/j.tibs.2010.05.007; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Klucken J, 2006, FASEB J, V20, P2050, DOI 10.1096/fj.05-5422com; Koo HJ, 2008, BIOCHEM BIOPH RES CO, V368, P772, DOI 10.1016/j.bbrc.2008.01.140; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; McNaught KS, 2002, NEUROREPORT, V13, P1437, DOI 10.1097/00001756-200208070-00018; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Schwach G, 2010, J MOL NEUROSCI, V41, P80, DOI 10.1007/s12031-009-9289-1; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen D, 2011, CELL BIOCHEM BIOPHYS, V60, P173, DOI 10.1007/s12013-010-9138-4; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Soldatenkov VA, 1997, CANCER RES, V57, P3881; Taschenberger G, 2011, ACTA NEUROPATHOL, P1; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	53	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43505	10.1371/journal.pone.0043505	http://dx.doi.org/10.1371/journal.pone.0043505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927976	gold, Green Submitted, Green Published			2022-12-25	WOS:000308286300057
J	Nasr, MAF; Nicol, CJ; Murrell, JC				Nasr, Mohammed A. F.; Nicol, Christine J.; Murrell, Joanna C.			Do Laying Hens with Keel Bone Fractures Experience Pain?	PLOS ONE			English	Article							FOWL GALLUS-GALLUS; DOMESTIC-FOWL; ARTICULAR PAIN; BROILER-CHICKENS; PERIOPERATIVE ANALGESIA; BUTORPHANOL TARTRATE; THERMAL NOCICEPTION; OPIOID RECEPTORS; MORPHINE; BEHAVIOR	The European ban on battery cages has forced a change towards the use of non-cage or furnished cage systems, but unexpectedly this has been associated with an increased prevalence of keel bone fractures in laying hens. Bone fractures are acutely painful in mammals, but the effect of fractures on bird welfare is unclear. We recently reported that keel bone fractures have an effect on bird mobility. One possible explanation for this is that flying becomes mechanically impaired. However it is also possible that if birds have a capacity to feel pain, then ongoing pain resulting from the fracture could contribute to decreased mobility. The aim was to provide proof of concept that administration of appropriate analgesic drugs improves mobility in birds with keel fracture; thereby contributing to the debate about the capacity of birds to experience pain and whether fractures are associated with pain in laying hens. In hens with keel fractures, butorphanol decreased the latency to land from perches compared with latencies recorded for these hens following saline (mean (SEM) landing time (seconds) birds with keel fractures treated with butorphanol and saline from the 50, 100 and 150 cm perch heights respectively 1.7 (0.3), 2.2 (0.3), p = 0.05, 50 cm; 12.5 (6.6), 16.9 (6.7), p = 0.03, 100 cm; 20.6 (7.4), 26.3 (7.6), p = 0.02 150 cm). Mobility indices were largely unchanged in birds without keel fractures following butorphanol. Critically, butorphanol can be considered analgesic in our study because it improved the ability of birds to perform a complex behaviour that requires both motivation and higher cognitive processing. This is the first study to provide a solid evidential base that birds with keel fractures experience pain, a finding that has significant implications for the welfare of laying hens that are housed in non-cage or furnished caged systems.	[Nasr, Mohammed A. F.; Nicol, Christine J.; Murrell, Joanna C.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Nasr, Mohammed A. F.] Zagazig Univ, Dept Anim Wealth Dev, Fac Vet Med, Sharkia, Egypt	University of Bristol; Egyptian Knowledge Bank (EKB); Zagazig University	Nasr, MAF (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	Jo.Murrell@bristol.ac.uk	Nasr, Mohammed/X-7106-2019; Nicol, Christine J/B-4841-2011	Nicol, Christine J/0000-0001-6734-2177	Biotechnology and Biological Sciences Research Council BSRC [BB/G000921/1]; Egyptian Government (The Egyptian Educational and Cultural Bureau); BBSRC [BB/G000921/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G000921/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council BSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Egyptian Government (The Egyptian Educational and Cultural Bureau); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Sources of funding for the study: Biotechnology and Biological Sciences Research Council BSRC Grant Ref. BB/G000921/1 (http://www.bbsrc.ac.uk/). The Egyptian Government (The Egyptian Educational and Cultural Bureau) funded Mohammed A.F. Nasr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDO MT, 1978, PHARMACOL BIOCHEM BE, V9, P147, DOI 10.1016/0091-3057(78)90027-8; Bove SE, 2009, BRAIN RES REV, V60, P187, DOI 10.1016/j.brainresrev.2008.12.012; Brown DC, 2010, JAVMA-J AM VET MED A, V237, P66, DOI 10.2460/javma.237.1.66; Capner CA, 1999, VET REC, V145, P95; Commiskey S, 2005, J PHARMACOL SCI, V98, P109, DOI 10.1254/jphs.CRJ05001X; Costantini R, 2011, INT J CLIN PHARM TH, V49, P116, DOI 10.5414/CP201401; Danbury TC, 1999, PAIN ASS LAMENESS BR; de Mos M, 2007, PAIN, V129, P12, DOI 10.1016/j.pain.2006.09.008; Freeman KT, 2008, ANESTHESIOLOGY, V108, P473, DOI 10.1097/ALN.0b013e3181649351; Gentle MJ, 1997, PHYSIOL BEHAV, V61, P493, DOI 10.1016/S0031-9384(96)00461-1; Gentle MJ, 1997, PHYSIOL BEHAV, V62, P581, DOI 10.1016/S0031-9384(97)00164-9; Gentle MJ, 2003, BRAIN RES, V968, P26, DOI 10.1016/S0006-8993(02)04245-2; Gentle MJ, 1999, PHARMACOL BIOCHEM BE, V63, P339, DOI 10.1016/S0091-3057(99)00029-5; Guzman DSM, 2011, J AVIAN MED SURG, V25, P185, DOI 10.1647/2009-054.1; Hawkins MG, 2009, VET CLIN N AM EXOT A, V14, P61; Hocking PM, 2005, RES VET SCI, V78, P69, DOI 10.1016/j.rvsc.2004.05.005; Hocking PM, 2001, RES VET SCI, V71, P161, DOI 10.1053/rvsc.2001.0510; Hocking PM, 1997, RES VET SCI, V63, P263, DOI 10.1016/S0034-5288(97)90031-X; Hothersall B, 2012, CHALLENGES DETERMINI; HUGHES RA, 1992, PHARMACOL BIOCHEM BE, V42, P535, DOI 10.1016/0091-3057(92)90151-5; HUGHES RA, 1990, BEHAV NEUROSCI, V104, P619, DOI 10.1037/0735-7044.104.4.619; HUGHES RA, 1991, PHARMACOL BIOCHEM BE, V38, P247, DOI 10.1016/0091-3057(91)90273-5; Hugonnard M, 2004, VET ANAESTH ANALG, V31, P154, DOI 10.1111/j.1467-2987.2004.00175.x; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jimenez-Andrade JM, 2009, NEUROSCIENCE, V162, P1244, DOI 10.1016/j.neuroscience.2009.05.065; Liang M, 2011, J NEUROSCI, V31, P8976, DOI 10.1523/JNEUROSCI.6207-10.2011; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; May A, 2007, NEUROL SCI, V28, pS101, DOI 10.1007/s10072-007-0760-x; Mc Geown D, 1999, VET REC, V144, P668, DOI 10.1136/vr.144.24.668; McKeegan DEF, 2004, BRAIN RES REV, V46, P146, DOI 10.1016/j.brainresrev.2004.07.012; Nagase H, 2012, J PHARMACOL TOX MET, V65, P29, DOI 10.1016/j.vascn.2011.10.002; Nasr MAF, 2012, ANIM WELFARE, V21, P127, DOI 10.7120/096272812799129376; Paul-Murphy JR, 2009, AM J VET RES, V70, P1211, DOI 10.2460/ajvr.70.10.1211; Paul-Murphy JR, 1999, AM J VET RES, V60, P1218; RAGER DR, 1986, PHYSIOL BEHAV, V37, P269, DOI 10.1016/0031-9384(86)90231-3; Richards GJ, 2011, VET REC, V169, P279, DOI 10.1136/vr.d4404; Robertson SA, 2004, J FELINE MED SURG, V6, P321, DOI 10.1016/j.jfms.2003.10.002; Santy J, 2001, J CLIN NURS, V10, P521, DOI 10.1046/j.1365-2702.2001.00506.x; SCHNEIDER C, 1961, NATURE, V191, P607, DOI 10.1038/191607b0; Silverman J, 2005, CONTEMP TOP LAB ANIM, V44, P34; Singh PM, 2011, VET REC, V168, DOI 10.1136/vr.d1191; Singh PM, 2010, J VET PHARMACOL THER, V33, P515, DOI 10.1111/j.1365-2885.2010.01182.x; Sladky KK, 2006, AM J VET RES, V67, P775, DOI 10.2460/ajvr.67.5.775; SUFKA KJ, 1994, PHYSIOL BEHAV, V55, P741, DOI 10.1016/0031-9384(94)90054-X; Waran N, 2010, NEW ZEAL VET J, V58, P274, DOI 10.1080/00480169.2010.69402; Weaver LA, 2010, J AM ASSOC LAB ANIM, V49, P845; Wilkins LJ, 2011, VET REC, V169, P414, DOI 10.1136/vr.d4831; Wilkins LJ, 2004, VET REC, V155, P547, DOI 10.1136/vr.155.18.547; Witter J, 2004, ARTHRITIS RES THER, V6, P279, DOI 10.1186/ar1450; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646	51	93	94	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42420	10.1371/journal.pone.0042420	http://dx.doi.org/10.1371/journal.pone.0042420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927930	gold, Green Published, Green Submitted			2022-12-25	WOS:000308286300021
J	Rivera-Perez, C; Nouzova, M; Noriega, FG				Rivera-Perez, Crisalejandra; Nouzova, Marcela; Noriega, Fernando G.			A Quantitative Assay for the Juvenile Hormones and Their Precursors Using Fluorescent Tags	PLOS ONE			English	Article							CORPORA-ALLATA; MASS-SPECTROMETRY; CARBOXYLIC-ACIDS; ADULT STAGES; BENZOFURAZAN STRUCTURE; ORTHO-PHTHALALDEHYDE; FLUOROGENIC REAGENT; METHYL FARNESOATE; TOBACCO HORNWORM; SODIUM SULFIDE	Background: The juvenile hormones (JHs) are sesquiterpenoid compounds that play a central role in insect reproduction, development and behavior. The lipophilic nature of JHs and their precursors, in conjunction with their low concentration in tissues and susceptibility to degradation had made their quantification difficult. A variety of methods exist for JH quantification but few can quantify on the femtomole range. Currently applied methods are expensive and time consuming. In the present study we sought to develop a novel method for accurate detection and quantification of JHs and their precursors. Methods: A sensitive and robust method was developed to quantify the precursor, farnesoic acid (FA) and juvenile hormone III (JH III) in biological samples. The assay is based on the derivatization of analytes with fluorescent tags, with subsequent analysis by reverse phase high performance liquid chromatography coupled to a fluorescent detector (HPLC-FD). The carboxyl group of FA was derivatized with 4-Acetamido-7-mercapto-2,1,3-benzoxadiazole (AABD-SH). Tagging the epoxide group of JH III required a two-step reaction: the opening of the epoxide ring with sodium sulfide and derivatization with the fluorescent tag 4-(N,N-Dimethylaminosulfonyl)-7-(N-chloroformylmethyl-N-methylamino)-2,1,3-benzoxadiazole (DBD-COCI). Conclusions: The method developed in the present study showed high sensitivity, accuracy and reproducibility. Linear responses were obtained over the range of 10-20 to 1000 fmols. Recovery efficiencies were over 90% for JH III and 98% for FA with excellent reproducibility. Significance: The proposed method is applicable when sensitive detection and accurate quantification of limited amount of sample is needed. Examples include corpora allata, hemolymph and whole body of female adult Aedes aegypti and whole body Drosophila melanogaster. A variety of additional functional groups can be targeted to add fluorescent tags to the remaining JH III precursors.	[Rivera-Perez, Crisalejandra; Nouzova, Marcela; Noriega, Fernando G.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	State University System of Florida; Florida International University	Rivera-Perez, C (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	noriegaf@fiu.edu	Nouzova, Marcela/AAK-8609-2021; Rivera-Perez, Crisalejandra/AAM-1269-2021	Nouzova, Marcela/0000-0002-4562-1383; Rivera Perez, Crisalejandra/0000-0002-9746-3225	National Institutes of Health Grant [AI 45545]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI 45545 to FGN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER FC, 1983, J LIPID RES, V24, P1586; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Bendena WG, 2011, GEN COMP ENDOCR, V172, P56, DOI 10.1016/j.ygcen.2011.02.014; BERGOT BJ, 1981, J CHROMATOGR, V204, P231, DOI 10.1016/S0021-9673(00)81664-7; Bloch G, 2000, J INSECT PHYSIOL, V46, P47, DOI 10.1016/S0022-1910(99)00101-8; BOWNES M, 1987, EUR J BIOCHEM, V164, P709, DOI 10.1111/j.1432-1033.1987.tb11184.x; Cao L, 2009, BIOCHEM BIOPH RES CO, V380, P188, DOI 10.1016/j.bbrc.2009.01.079; Chen Z, 2007, INSECT BIOCHEM MOLEC, V37, P799, DOI 10.1016/j.ibmb.2007.05.019; DUCHATEAU ALL, 1993, J CHROMATOGR, V637, P29, DOI 10.1016/0021-9673(93)83095-A; EDWARDS JP, 1995, J INSECT PHYSIOL, V41, P641, DOI 10.1016/0022-1910(95)00031-O; FEYEREISEN R, 1981, ANAL BIOCHEM, V111, P372, DOI 10.1016/0003-2697(81)90575-3; Feyereisen R, 1985, METHOD ENZYMOL, P530; Gilbert LI, 1960, T AM MICROSC SOC, V70, P38; GOODMAN WG, 1993, ARCH INSECT BIOCHEM, V23, P147, DOI 10.1002/arch.940230306; GOODMAN WG, 2005, COMPREHENSIVE MOL IN, V3, P319; Hamnett A. F., 1981, JUVENILE HORMONE BIO, P93; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Henneman L, 2008, ANAL BIOCHEM, V383, P18, DOI 10.1016/j.ab.2008.08.023; IMAI K, 1994, ANAL CHIM ACTA, V290, P3, DOI 10.1016/0003-2670(94)80034-0; JUDY KJ, 1973, P NATL ACAD SCI USA, V70, P1509, DOI 10.1073/pnas.70.5.1509; Kubota K, 2005, BIOMED CHROMATOGR, V19, P788, DOI 10.1002/bmc.518; KUHNZ W, 1981, ORG MAGN RESONANCE, V16, P138, DOI 10.1002/mrc.1270160216; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; Li YP, 2003, INSECT BIOCHEM MOLEC, V33, P1307, DOI 10.1016/j.ibmb.2003.07.003; Mayoral JG, 2009, P NATL ACAD SCI USA, V106, P21091, DOI 10.1073/pnas.0909938106; MEYER AS, 1970, ARCH BIOCHEM BIOPHYS, V137, P190, DOI 10.1016/0003-9861(70)90427-3; NAKAMURA H, 1982, ANAL LETT PT A, V15, P1393, DOI 10.1080/00032718208064437; Navare AT, 2010, ANAL BIOANAL CHEM, V398, P3005, DOI 10.1007/s00216-010-4269-4; PRATT GE, 1974, LIFE SCI, V14, P575, DOI 10.1016/0024-3205(74)90372-5; Qayum AA, 2011, JOVE-J VIS EXP, DOI 10.3791/2772; REMBOLD H, 1985, J CHROMATOGR, V323, P355, DOI 10.1016/S0021-9673(01)90397-8; Rembold H, 1981, JUVENILE HORMONE BIO, P11; SANO A, 1985, ANAL CHEM, V57, P1687, DOI 10.1021/ac00285a039; Santa T, 1999, ANALYST, V124, P1689, DOI 10.1039/a906204a; Santa T, 2008, BIOMED CHROMATOGR, V22, P343, DOI 10.1002/bmc.945; SHAPIRO AB, 1986, J INSECT PHYSIOL, V32, P867, DOI 10.1016/0022-1910(86)90102-2; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Shu SQ, 1997, J INSECT PHYSIOL, V43, P719, DOI 10.1016/S0022-1910(97)00048-6; SLAMA K, 1974, P477; SMITH JG, 1984, SYNTHESIS-STUTTGART, P629; STRAMBI C, 1981, EUR J BIOCHEM, V118, P401; Taub-Montemayor TE, 2005, J INSECT PHYSIOL, V51, P427, DOI 10.1016/j.jinsphys.2004.12.015; Teal PEA, 2000, ANAL BIOCHEM, V277, P206, DOI 10.1006/abio.1999.4377; TOBE SS, 1985, ADV INSECT PHYSIOL, V18, P305; TOBE SS, 1974, BIOCHEM J, V144, P107, DOI 10.1042/bj1440107; Trumbo ST, 2008, J INSECT PHYSIOL, V54, P630, DOI 10.1016/j.jinsphys.2007.12.012; Uchiyama S, 2001, ANAL CHEM, V73, P2165, DOI 10.1021/ac001232j; Vilaro F, 2012, J AGR FOOD CHEM, V60, P3020, DOI 10.1021/jf204621h; Westerlund SA, 2004, ANAL BIOANAL CHEM, V379, P540, DOI 10.1007/s00216-004-2598-x; Woodward FN, 1948, J CHEM SOC; Yagi KJ, 2001, J INSECT PHYSIOL, V47, P1227, DOI 10.1016/S0022-1910(01)00124-X; YAGI KJ, 1991, GEN COMP ENDOCR, V81, P284, DOI 10.1016/0016-6480(91)90013-V; YIN CM, 1995, J INSECT PHYSIOL, V41, P473, DOI 10.1016/0022-1910(94)00134-3	53	26	26	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43784	10.1371/journal.pone.0043784	http://dx.doi.org/10.1371/journal.pone.0043784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928033	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300089
J	Wang, F; Letort, V; Lu, Q; Bai, XF; Guo, Y; de Reffye, P; Li, BG				Wang, Feng; Letort, Veronique; Lu, Qi; Bai, Xuefeng; Guo, Yan; de Reffye, Philippe; Li, Baoguo			A Functional and Structural Mongolian Scots Pine (Pinus sylvestris var. mongolica) Model Integrating Architecture, Biomass and Effects of Precipitation	PLOS ONE			English	Article							TREE GROWTH-MODEL; STOCHASTIC-MODEL; PLANT-GROWTH; L-SYSTEMS; WATER; SIMULATION; GREENLAB; COMPETITION; PLASTICITY; CARBON	Mongolian Scots pine (Pinus sylvestris var. mongolica) is one of the principal tree species in the network of Three-North Shelterbelt for windbreak and sand stabilisation in China. The functions of shelterbelts are highly correlated with the architecture and eco-physiological processes of individual tree. Thus, model-assisted analysis of canopy architecture and function dynamic in Mongolian Scots pine is of value for better understanding its role and behaviour within shelterbelt ecosystems in these arid and semiarid regions. We present here a single-tree functional and structural model, derived from the GreenLab model, which is adapted for young Mongolian Scots pines by incorporation of plant biomass production, allocation, allometric rules and soil water dynamics. The model is calibrated and validated based on experimental measurements taken on Mongolian Scots pines in 2007 and 2006 under local meteorological conditions. Measurements include plant biomass, topology and geometry, as well as soil attributes and standard meteorological data. After calibration, the model allows reconstruction of three-dimensional (3D) canopy architecture and biomass dynamics for trees from one- to six-year-old at the same site using meteorological data for the six years from 2001 to 2006. Sensitivity analysis indicates that rainfall variation has more influence on biomass increment than on architecture, and the internode and needle compartments and the aboveground biomass respond linearly to increases in precipitation. Sensitivity analysis also shows that the balance between internode and needle growth varies only slightly within the range of precipitations considered here. The model is expected to be used to investigate the growth of Mongolian Scots pines in other regions with different soils and climates.	[Wang, Feng; Guo, Yan; Li, Baoguo] China Agr Univ, Key Lab Plant Soil Interact, Minist Educ, Dept Soil & Water Sci, Beijing 100094, Peoples R China; [Letort, Veronique] Ecole Cent Paris, Dept Appl Math, Chatenay Malabry, France; [Wang, Feng; Lu, Qi] Chinese Acad Forestry, Inst Desertificat, Beijing, Peoples R China; [Bai, Xuefeng] Liaoning Sand Stabilisat & Afforestat Inst, Fuxing, Peoples R China; [de Reffye, Philippe] UMR AMAP, CIRAD, Montpellier, France	China Agricultural University; UDICE-French Research Universities; Universite Paris Saclay; Chinese Academy of Forestry; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Wang, F (corresponding author), China Agr Univ, Key Lab Plant Soil Interact, Minist Educ, Dept Soil & Water Sci, Beijing 100094, Peoples R China.	luqi@caf.ac.cn; libg@cau.edu.cn	lu, qi/HHS-2115-2022		National Natural Science Foundation of China [31100518]; Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2012BAD16B0205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period	This study was supported by National Natural Science Foundation of China (Grant No 31100518) and Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2012BAD16B0205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MT, 2005, NEW PHYTOL, V166, P869, DOI 10.1111/j.1469-8137.2005.01348.x; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Almeida AC, 2007, FOREST ECOL MANAG, V251, P10, DOI 10.1016/j.foreco.2007.06.009; Balandier P, 2000, ANN FOREST SCI, V57, P571; Bang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011061; Barthelemy D, 2007, ANN BOT-LONDON, V99, P375, DOI 10.1093/aob/mcl260; Bosc A, 2000, ANN FOREST SCI, V57, P555; CHILDS SW, 1977, T ASAE, V20, P858, DOI 10.13031/2013.35664; Cournede PH, 2011, MATH MODEL NAT PHENO, V6, P133, DOI 10.1051/mmnp/20116205; Cournede PH, 2006, SIMUL-T SOC MOD SIM, V82, P427, DOI 10.1177/0037549706069341; Diao J, 2012, COMPUT ELECTRON AGR, V80, P105, DOI 10.1016/j.compag.2011.10.019; Dingkuhn M, 2005, AUST J AGR RES, V56, P1289, DOI 10.1071/AR05063; Dong QX, 2008, ANN BOT-LONDON, V101, P1195, DOI 10.1093/aob/mcm317; Drouet JL, 2007, ECOL MODEL, V206, P231, DOI 10.1016/j.ecolmodel.2007.03.036; Eschenbach C, 2005, ECOL MODEL, V186, P470, DOI 10.1016/j.ecolmodel.2005.02.013; Feng Wang, 2010, Proceedings of the Third International Symposium on Plant Growth Modeling, Simulation, Visualization and Applications (PMA 2009), P26, DOI 10.1109/PMA.2009.35; Godin C, 2005, NEW PHYTOL, V166, P705, DOI 10.1111/j.1469-8137.2005.01445.x; Guo H, 2012, TREES-STRUCT FUNCT, V26, P1057, DOI 10.1007/s00468-012-0683-x; Guo Y, 2006, ANN BOT-LONDON, V97, P217, DOI 10.1093/aob/mcj033; Host GE, 2008, FUNCT PLANT BIOL, V35, P976, DOI 10.1071/FP08075; James G. B., 1976, VEGETATION ATMOSPHER, V2; Kang MZ, 2008, ANN BOT-LONDON, V101, P1099, DOI 10.1093/aob/mcm212; Kang MZ, 2012, NEW PHYTOL, V195, P384, DOI 10.1111/j.1469-8137.2012.04177.x; Landsberg J., 2010, PHYSL ECOLOGY FOREST; Landsberg J. J, 1999, WAYS TREE USE WATER, P54; Le Chevalier V, 2007, J COMPUT SCI TECH-CH, V22, P835, DOI 10.1007/s11390-007-9105-8; Letort V, 2008, FUNCT PLANT BIOL, V35, P951, DOI 10.1071/FP08065; Lopez G, 2008, FUNCT PLANT BIOL, V35, P761, DOI 10.1071/FP08039; Ma Q, 2004, INT FOREST REV, V6, P327, DOI 10.1505/ifor.6.3.327.59972; Marcelis LFM, 1996, J EXP BOT, V47, P1281, DOI 10.1093/jxb/47.Special_Issue.1281; Mathieu A, 2009, ANN BOT-LONDON, V103, P1173, DOI 10.1093/aob/mcp054; Middleton N., 1992, WORLD ATLAS DESERTIF, P69; Pearcy RW, 2005, NEW PHYTOL, V166, P791, DOI 10.1111/j.1469-8137.2005.01328.x; Perttunen J, 1998, ECOL MODEL, V108, P189, DOI 10.1016/S0304-3800(98)00028-3; Perttunen J, 1996, ANN BOT-LONDON, V77, P87, DOI 10.1006/anbo.1996.0011; Purves DW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000870; RAUSCHER HM, 1990, TREE PHYSIOL, V7, P255, DOI 10.1093/treephys/7.1-2-3-4.255; Renton M, 2005, ECOL MODEL, V184, P277, DOI 10.1016/j.ecolmodel.2004.10.008; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Sievanen R, 2000, ANN FOREST SCI, V57, P399; Simunek J, 2009, ECOL MODEL, V220, P505, DOI 10.1016/j.ecolmodel.2008.11.004; Steduto P, 2005, AGR FOREST METEOROL, V130, P269, DOI 10.1016/j.agrformet.2005.04.003; Steduto P, 2007, IRRIGATION SCI, V25, P189, DOI 10.1007/s00271-007-0064-1; Sterck FJ, 2005, NEW PHYTOL, V166, P827, DOI 10.1111/j.1469-8137.2005.01342.x; Wang F, 2007, NEW ZEAL J AGR RES, V50, P903, DOI 10.1080/00288230709510366; Wang F, 2011, ANN BOT-LONDON, V107, P781, DOI 10.1093/aob/mcq218; Wu L, 2007, ECOL MODEL, V200, P343, DOI 10.1016/j.ecolmodel.2006.08.010; Yan HP, 2004, ANN BOT-LONDON, V93, P591, DOI 10.1093/aob/mch078; Zhan ZG, 2003, PLANT GROWTH MODELING AND APPLICATIONS, PROCEEDINGS, P236; Zheng BY, 2008, FUNCT PLANT BIOL, V35, P900, DOI 10.1071/FP08060	50	10	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43531	10.1371/journal.pone.0043531	http://dx.doi.org/10.1371/journal.pone.0043531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927982	Green Published, gold			2022-12-25	WOS:000308286300062
J	Borrel, G; Lehours, AC; Crouzet, O; Jezequel, D; Rockne, K; Kulczak, A; Duffaud, E; Joblin, K; Fonty, G				Borrel, Guillaume; Lehours, Anne-Catherine; Crouzet, Olivier; Jezequel, Didier; Rockne, Karl; Kulczak, Amelie; Duffaud, Emilie; Joblin, Keith; Fonty, Gerard			Stratification of Archaea in the Deep Sediments of a Freshwater Meromictic Lake: Vertical Shift from Methanogenic to Uncultured Archaeal Lineages	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; POLYMERASE-CHAIN-REACTION; MARINE BENTHIC ARCHAEA; RIBOSOMAL-RNA GENES; COMMUNITY STRUCTURE; MICROBIAL COMMUNITIES; ANAEROBIC OXIDATION; CRATER LAKE; HYPERSALINE LAKE; LAC-PAVIN	As for lineages of known methanogens, several lineages of uncultured archaea were recurrently retrieved in freshwater sediments. However, knowledge is missing about how these lineages might be affected and structured according to depth. In the present study, the vertical changes of archaeal communities were characterized in the deep sediment of the freshwater meromictic Lake Pavin. For that purpose, an integrated molecular approach was performed to gain information on the structure, composition, abundance and vertical stratification of archaeal communities thriving in anoxic freshwater sediments along a gradient of sediments encompassing 130 years of sedimentation. Huge changes occurred in the structure and composition of archaeal assemblages along the sediment core. Methanogenic taxa (i.e. Methanosaeta and Methanomicrobiales) were progressively replaced by uncultured archaeal lineages (i.e. Marine Benthic Group-D (MBG-D) and Miscellaneous Crenarchaeal Group (MCG)) which are suspected to be involved in the methane cycle.	[Borrel, Guillaume; Lehours, Anne-Catherine; Crouzet, Olivier; Kulczak, Amelie; Duffaud, Emilie; Joblin, Keith; Fonty, Gerard] Univ Blaise Pascal, Clermont Univ, UMR CNRS 6023, Lab Microorganismes Genome & Environm, Aubiere, France; [Borrel, Guillaume; Lehours, Anne-Catherine; Crouzet, Olivier; Kulczak, Amelie; Duffaud, Emilie; Joblin, Keith; Fonty, Gerard] Univ Auvergne, Aubiere, France; [Jezequel, Didier] Univ Paris 07, UMR CNRS 7154, Inst Phys Globe Paris, Lab Geochim Eaux, Paris, France; [Rockne, Karl] Univ Illinois, Dept Civil & Mat Engn, Chicago, IL USA	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Borrel, G (corresponding author), Univ Blaise Pascal, Clermont Univ, UMR CNRS 6023, Lab Microorganismes Genome & Environm, Aubiere, France.	Guillaume.borrel@univ-bpclermont.fr	JEZEQUEL, DIDIER/K-8269-2012; Rockne, Karl J/C-1281-2008	Rockne, Karl J/0000-0002-4976-4955; LEHOURS, Anne-catherine/0000-0001-9151-4389	French Centre National de la Recherche Scientifique; region Auvergne	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); region Auvergne(Region Auvergne-Rhone-Alpes)	This work was funded by the Programme EC2CO of the French Centre National de la Recherche Scientifique (Projects Methanolac and Interlac). The work was also supported by a grant to GB from the region Auvergne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschbach-Hertig W, 1999, GEOCHIM COSMOCHIM AC, V63, P3357, DOI 10.1016/S0016-7037(99)00257-4; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Barberan A, 2011, MOL ECOL, V20, P1988, DOI 10.1111/j.1365-294X.2011.05057.x; Bastviken D, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000608; Batisson I, 2007, MICROB ECOL, V54, P761, DOI 10.1007/s00248-007-9241-2; Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Bhattarai S, MICROB ECOL IN PRESS; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Borrel G, 2011, RES MICROBIOL, V162, P832, DOI 10.1016/j.resmic.2011.06.004; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Buckley DR, 2004, ENVIRON SCI TECHNOL, V38, P1732, DOI 10.1021/es034926t; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; Cadillo-Quiroz H, 2006, ENVIRON MICROBIOL, V8, P1428, DOI 10.1111/j.1462-2920.2006.01036.x; CAPONE DG, 1988, LIMNOL OCEANOGR, V33, P725, DOI 10.4319/lo.1988.33.4_part_2.0725; Chan OC, 2005, ENVIRON MICROBIOL, V7, P1139, DOI 10.1111/j.1462-2920.2005.00790.x; Clarke K. R., 2001, CHANGES MARINE COMMU; Cole J, 2006, NUCLEIC ACIDS RES, V35, P169; Conrad R, 2010, LIMNOL OCEANOGR, V55, P689, DOI 10.4319/lo.2009.55.2.0689; Coolen MJL, 2007, ENVIRON MICROBIOL, V9, P238, DOI 10.1111/j.1462-2920.2006.01134.x; Danovaro R, 1999, DEEP-SEA RES PT I, V46, P1077, DOI 10.1016/S0967-0637(98)00101-0; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Falz KZ, 1999, APPL ENVIRON MICROB, V65, P2402; Fenchel T., 1979, BACTERIA MINERAL CYC; Galand PE, 2003, ENVIRON MICROBIOL, V5, P1133, DOI 10.1046/j.1462-2920.2003.00520.x; Glissmann K, 2004, MICROB ECOL, V48, P389, DOI 10.1007/s00248-003-2027-2; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P4983; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Jiang HC, 2008, ENVIRON MICROBIOL, V10, P2355, DOI 10.1111/j.1462-2920.2008.01661.x; Jiang HC, 2007, ENVIRON MICROBIOL, V9, P2603, DOI 10.1111/j.1462-2920.2007.01377.x; Jurgens G, 2000, FEMS MICROBIOL ECOL, V34, P45, DOI 10.1111/j.1574-6941.2000.tb00753.x; Kemnitz D, 2005, ENVIRON MICROBIOL, V7, P553, DOI 10.1111/j.1462-2920.2005.00723.x; Kerkhof L, 1999, FEMS MICROBIOL ECOL, V30, P253; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Koizumi Y, 2004, ENVIRON MICROBIOL, V6, P622, DOI 10.1111/j.1462-2920.2004.00620.x; Koizumi Y, 2003, FEMS MICROBIOL ECOL, V46, P147, DOI 10.1016/S0168-6496(03)00212-5; Koizumi Y, 2004, FEMS MICROBIOL ECOL, V48, P285, DOI 10.1016/j.femsec.2004.02.013; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lehours AC, 2005, APPL ENVIRON MICROB, V71, P7389, DOI 10.1128/AEM.71.11.7389-7400.2005; Lehours AC, 2007, APPL ENVIRON MICROB, V73, P2016, DOI 10.1128/AEM.01490-06; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Lopes F, 2011, APPL GEOCHEM, V26, P1919, DOI 10.1016/j.apgeochem.2011.06.021; Loy A, 2008, ENVIRON MICROBIOL, V10, P2894, DOI 10.1111/j.1462-2920.2008.01706.x; Magurran A E, 1988, ECOLOGICAL DIVERSITY; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nam YD, 2008, J MICROBIOL, V46, P125, DOI 10.1007/s12275-007-0189-1; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Nusslein B, 2001, ENVIRON MICROBIOL, V3, P460, DOI 10.1046/j.1462-2920.2001.00215.x; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; OPPENHEIMER CH, 1960, GEOCHIM COSMOCHIM AC, V19, P244, DOI 10.1016/0016-7037(60)90032-6; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Purdy KJ, 2003, APPL ENVIRON MICROB, V69, P3181, DOI 10.1128/AEM.69.6.3181-3191.2003; Purdy KJ, 1996, APPL ENVIRON MICROB, V62, P3905, DOI 10.1128/AEM.62.10.3905-3907.1996; Reysenbach Anna-Louise, 1995, P101; Roussel EG, 2009, ENVIRON MICROBIOL, V11, P2446, DOI 10.1111/j.1462-2920.2009.01976.x; Schettler G, 2007, CHEM GEOL, V240, P11, DOI 10.1016/j.chemgeo.2007.01.003; Schink B., 1988, BIOL ANAEROBIC MICRO, P771; Schubert CJ, 2011, FEMS MICROBIOL ECOL, V76, P26, DOI 10.1111/j.1574-6941.2010.01036.x; Schwarz JIK, 2008, LIMNOL OCEANOGR, V53, P113, DOI 10.4319/lo.2008.53.1.0113; Schwarz JIK, 2007, SYST APPL MICROBIOL, V30, P239, DOI 10.1016/j.syapm.2006.05.004; SEGERER A, 1988, SYST APPL MICROBIOL, V10, P161, DOI 10.1016/S0723-2020(88)80031-6; Skillman LC, 2004, ANAEROBE, V10, P277, DOI 10.1016/j.anaerobe.2004.05.003; SMITH PF, 1975, J BACTERIOL, V124, P884, DOI 10.1128/JB.124.2.884-892.1975; Swan BK, 2010, APPL ENVIRON MICROB, V76, P757, DOI 10.1128/AEM.02409-09; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Takano Y, 2010, NAT GEOSCI, V3, P858, DOI 10.1038/NGEO983; Tamura K, 2011, MOL BIOL EVOL, DOI [10.1093/molbev/msr1121, DOI 10.1093/MOLBEV/MSR1121]; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Vetriani C, 1999, APPL ENVIRON MICROB, V65, P4375; Viollier E, 1997, CHEM GEOL, V142, P225, DOI 10.1016/S0009-2541(97)00093-4; VIOLLIER E, 1995, CHEM GEOL, V125, P61, DOI 10.1016/0009-2541(95)00059-U; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Webster G, 2011, FEMS MICROBIOL ECOL, V77, P248, DOI 10.1111/j.1574-6941.2011.01109.x; WOLIN MJ, 1974, AM J CLIN NUTR, V27, P1320, DOI 10.1093/ajcn/27.11.1320; Ye WJ, 2009, FEMS MICROBIOL ECOL, V70, P263, DOI 10.1111/j.1574-6941.2009.00761.x; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zhang Y, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-137	84	59	61	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43346	10.1371/journal.pone.0043346	http://dx.doi.org/10.1371/journal.pone.0043346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927959	Green Published, gold			2022-12-25	WOS:000307789700030
J	Perez-Gil, J; Uros, EM; Sauret-Gueto, S; Lois, LM; Kirby, J; Nishimoto, M; Baidoo, EEK; Keasling, JD; Boronat, A; Rodriguez-Concepcion, M				Perez-Gil, Jordi; Uros, Eva Maria; Sauret-Gueeto, Susanna; Maria Lois, L.; Kirby, James; Nishimoto, Minobu; Baidoo, Edward E. K.; Keasling, Jay D.; Boronat, Albert; Rodriguez-Concepcion, Manuel			Mutations in Escherichia coli aceE and ribB Genes Allow Survival of Strains Defective in the First Step of the Isoprenoid Biosynthesis Pathway	PLOS ONE			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE; ISOPENTENYL DIPHOSPHATE ISOMERASE; PENTOSE-PHOSPHATE CYCLE; NON-MEVALONATE PATHWAY; 2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE; DIMETHYLALLYL DIPHOSPHATE; FOSMIDOMYCIN RESISTANCE; PYRUVATE-DEHYDROGENASE; DISTINCT PATHWAYS; MEP PATHWAY	A functional 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway is required for isoprenoid biosynthesis and hence survival in Escherichia coli and most other bacteria. In the first two steps of the pathway, MEP is produced from the central metabolic intermediates pyruvate and glyceraldehyde 3-phosphate via 1-deoxy-D-xylulose 5-phosphate (DXP) by the activity of the enzymes DXP synthase (DXS) and DXP reductoisomerase (DXR). Because the MEP pathway is absent from humans, it was proposed as a promising new target to develop new antibiotics. However, the lethal phenotype caused by the deletion of DXS or DXR was found to be suppressed with a relatively high efficiency by unidentified mutations. Here we report that several mutations in the unrelated genes aceE and ribB rescue growth of DXS-defective mutants because the encoded enzymes allowed the production of sufficient DXP in vivo. Together, this work unveils the diversity of mechanisms that can evolve in bacteria to circumvent a blockage of the first step of the MEP pathway.	[Perez-Gil, Jordi; Uros, Eva Maria; Sauret-Gueeto, Susanna; Maria Lois, L.; Boronat, Albert; Rodriguez-Concepcion, Manuel] CSIC IRTA UAB UB, CRAG, Barcelona, Spain; [Kirby, James; Nishimoto, Minobu; Baidoo, Edward E. K.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA; [Boronat, Albert] Univ Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of Barcelona	Perez-Gil, J (corresponding author), CSIC IRTA UAB UB, CRAG, Campus UAB Bellaterra, Barcelona, Spain.	manuel.rodriguez@cragenomica.es	Lois, L. Maria/N-3272-2019; Perez-Gil, Jordi/I-1853-2013; Rodriguez-Concepcion, Manuel/I-7229-2015; Keasling, Jay D/J-9162-2012; Lois, L.Maria/N-5822-2014	Lois, L. Maria/0000-0003-0638-1484; Perez-Gil, Jordi/0000-0002-5632-9556; Rodriguez-Concepcion, Manuel/0000-0002-1280-2305; Keasling, Jay D/0000-0003-4170-6088; Lois, L.Maria/0000-0003-0638-1484	Spanish Direccion General de Investigacion (DGI); FEDER [BIO2011-23680, BIO2009-09523]; US Department of Energy [DE-AC02-05CH11231]; DGI; Generalitat de Catalunya	Spanish Direccion General de Investigacion (DGI)(Spanish Government); FEDER(European Commission); US Department of Energy(United States Department of Energy (DOE)); DGI; Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported in part by grants from the Spanish Direccion General de Investigacion (DGI) and FEDER to MRC (BIO2011-23680) and AB (BIO2009-09523). Work performed at JBEI was supported by the US Department of Energy contract DE-AC02-05CH11231. JPG and SSG received PhD fellowships from DGI and Generalitat de Catalunya, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacher A, 2000, ANNU REV NUTR, V20, P153, DOI 10.1146/annurev.nutr.20.1.153; Boucher Y, 2000, MOL MICROBIOL, V37, P703, DOI 10.1046/j.1365-2958.2000.02004.x; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; Brown AC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-78; Campos N, 2001, BIOCHEM J, V353, P59, DOI 10.1042/bj3530059; Davey MS, 2011, ANTIMICROB AGENTS CH, V55, P3635, DOI 10.1128/AAC.00382-11; Ershov YV, 2002, J BACTERIOL, V184, P5045, DOI 10.1128/JB.184.18.5045-5051.2002; Fujisaki S, 1996, GENE, V175, P83, DOI 10.1016/0378-1119(96)00128-X; Hemmerlin A, 2012, PROG LIPID RES, V51, P95, DOI 10.1016/j.plipres.2011.12.001; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; Kakinuma K, 2001, J AM CHEM SOC, V123, P1238, DOI 10.1021/ja003390y; Kaneda K, 2001, P NATL ACAD SCI USA, V98, P932, DOI 10.1073/pnas.020472198; Kirby J, 2008, NAT PROD REP, V25, P656, DOI 10.1039/b802939c; Kuzuyama T, 2003, NAT PROD REP, V20, P171, DOI 10.1039/b109860h; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P4509, DOI 10.1016/S0040-4039(98)00802-8; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Laupitz R, 2004, EUR J BIOCHEM, V271, P2658, DOI 10.1111/j.1432-1033.2004.04194.x; Lichtenthaler HK, 1997, PHYSIOL PLANTARUM, V101, P643, DOI 10.1111/j.1399-3054.1997.tb01049.x; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Perez-Gil J, 2012, J BIOL CHEM, V287, P15803, DOI 10.1074/jbc.M112.354811; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Poliquin K, 2004, J BACTERIOL, V186, P4685, DOI 10.1128/JB.186.14.4685-4693.2004; Richter G, 1997, METHOD ENZYMOL, V280, P374; Rodriguez-Concepcion M, 2000, FEBS LETT, V473, P328, DOI 10.1016/S0014-5793(00)01552-0; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepcion M, 2012, ISOPRENOID SYNTHESIS; Rodriguez-Concepcion Manuel, 2006, Phytochemistry Reviews, V5, P1, DOI 10.1007/s11101-005-3130-4; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Rohdich F, 2005, BIOCHEM SOC T, V33, P785, DOI 10.1042/BST0330785; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Sakamoto Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2030, DOI 10.1271/bbb.67.2030; Sangari FJ, 2010, P NATL ACAD SCI USA, V107, P14081, DOI 10.1073/pnas.1001962107; Sauret-Gueto S, 2006, FEBS LETT, V580, P736, DOI 10.1016/j.febslet.2005.12.092; Schorken U, 1998, BBA-PROTEIN STRUCT M, V1385, P229, DOI 10.1016/S0167-4838(98)00071-5; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Steinbacher S, 2003, J BIOL CHEM, V278, P18401, DOI 10.1074/jbc.M300993200; Takahashi S, 1998, PSYCHIAT CLIN NEUROS, V52, P1; Wungsintaweekul J, 2001, EUR J BIOCHEM, V268, P310, DOI 10.1046/j.1432-1327.2001.01875.x; YOKOTA A, 1986, AGR BIOL CHEM TOKYO, V50, P2517, DOI 10.1080/00021369.1986.10867789; Zeidler J, 1998, Z NATURFORSCH C, V53, P980	42	22	23	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43775	10.1371/journal.pone.0043775	http://dx.doi.org/10.1371/journal.pone.0043775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928031	Green Published, gold, Green Submitted			2022-12-25	WOS:000307789700052
J	de Hoog, MLA; van Eijsden, M; Stronks, K; Gemke, RJBJ; Vrijkotte, TGM				de Hoog, Marieke L. A.; van Eijsden, Manon; Stronks, Karien; Gemke, Reinoud J. B. J.; Vrijkotte, Tanja G. M.			Ethnic Differences in Cardiometabolic Risk Profile at Age 5-6 Years: The ABCD Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; BODY-MASS INDEX; DENSITY-LIPOPROTEIN CHOLESTEROL; TYPE-2 DIABETES-MELLITUS; AMSTERDAM BORN CHILDREN; METABOLIC SYNDROME; RACIAL-DIFFERENCES; WAIST CIRCUMFERENCE	Background: To examine ethnic differences in cardiometabolic risk profile in early age, and explore whether such differences can be explained by differences in body mass index (BMI) or waist circumference (WC). Method: Anthropometric measurements, blood pressure and (in a subsample) fasting blood were collected during a health check of 2,509 children aged 5-6 years. Four ethnic groups were distinguished: Dutch (n = 2,008; blood n = 1,300), African descent (n = 199; blood n = 105), Turkish (n = 108; blood n = 57) and Moroccan (n = 194; blood n = 94). Ethnic differences in diastolic and systolic blood pressure (DBP/SBP), fasting glucose, low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglyceride levels were determined and the explanatory role of BMI and WC was examined with regression analysis. Results: After adjustment for confounders, African descent children showed higher DBP (beta 2.22 mmHg; 95% CI: 1.09-3.36) and HDL levels (beta:0.09 mmol/l; 95% CI: 0.03-0.16) compared to Dutch children (reference group). Turkish children showed higher SBP (beta:1.89 mmHg; 95% CI: 0.25-3.54), DBP (beta:2.62 mmHg; 95% CI: 1.11-4.13), glucose (beta:0.12 mmol/L; 95% CI: 0.00-0.25) and triglyceride levels (beta:0.13 mmol/L; 95% CI: 0.02-0.25). Higher BMI values were found in all non-Dutch groups (differences ranged from 0.53-1.03 kg/m(2)) and higher WC in Turkish (beta:1.68 cm; 95% CI: 0.99-2.38) and Moroccan (beta:1.65 cm; 95% CI:1.11-2.19) children. BMI and WC partly explained the higher SBP/DBP and triglyceride levels in Turkish children. Conclusion: Ethnic differences in cardiometabolic profile exist early in life and are partly explained by differences in BMI and WC. African children showed favourable HDL levels and Turkish children the most unfavourable overall profile, whereas their Moroccan peers have less increased cardiometabolic risk in spite of their high BMI and WC.	[de Hoog, Marieke L. A.; Stronks, Karien; Vrijkotte, Tanja G. M.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [de Hoog, Marieke L. A.; van Eijsden, Manon] Publ Hlth Serv, Dept Epidemiol Documentat & Hlth Promot, Amsterdam, Netherlands; [van Eijsden, Manon] Vrije Univ Amsterdam, Inst Hlth Sci, Amsterdam, Netherlands; [Gemke, Reinoud J. B. J.] Vrije Univ Amsterdam Med Ctr, Med Ctr, Inst Cardiovasc Res, Dept Paediat,EMGO Inst, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	de Hoog, MLA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.l.dehoog@amc.uva.nl		Stronks, Karien/0000-0002-0921-2232; Vrijkotte, Tanja/0000-0003-3641-4048	Academic Medical Centre, Amsterdam; Public Health Services, Amsterdam; Netherlands Organization for Health Research and Development (ZonMw) [2100.0076]	Academic Medical Centre, Amsterdam; Public Health Services, Amsterdam(United States Department of Health & Human ServicesUnited States Public Health Service); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by the Academic Medical Centre, Amsterdam, the Public Health Services, Amsterdam, and by the Netherlands Organization for Health Research and Development (ZonMw; grant number: 2100.0076), The Hague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyemang C, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-7; Allcock DM, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/108187; BECKETT LA, 1992, AM J EPIDEMIOL, V135, P1166, DOI 10.1093/oxfordjournals.aje.a116217; Bos V, 2004, INT J EPIDEMIOL, V33, P1112, DOI 10.1093/ije/dyh189; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Corvalan C, 2010, AM J CLIN NUTR, V91, P166, DOI 10.3945/ajcn.2009.27547; Corvalan C, 2009, AM J CLIN NUTR, V90, P547, DOI 10.3945/ajcn.2008.27318; de Hoog MLA, 2011, BRIT J NUTR, V106, P1592, DOI 10.1017/S0007114511002327; de Hoog MLA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-611; Desilets MC, 2006, OBESITY, V14, P1019, DOI 10.1038/oby.2006.117; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Dijkshoorn H, 2003, Ned Tijdschr Geneeskd, V147, P1362; Donin AS, 2010, AM J CLIN NUTR, V92, P776, DOI 10.3945/ajcn.2010.29533; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; El Fakiri F, 2008, J IMMIGR MINOR HEALT, V10, P559, DOI 10.1007/s10903-008-9144-4; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Fredriks AM, 2005, ACTA PAEDIATR, V94, P496, DOI [10.1080/08035250410024240, 10.1111/j.1651-2227.2005.tb01923.x]; Freedman DS, 2005, OBES RES, V13, P928, DOI 10.1038/oby.2005.107; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Gootjes J, 2009, CLIN CHIM ACTA, V401, P152, DOI 10.1016/j.cca.2008.12.016; Harding S, 2006, J HYPERTENS, V24, P1507, DOI 10.1097/01.hjh.0000239285.20315.4d; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hirschler V, 2005, ARCH PEDIAT ADOL MED, V159, P740, DOI 10.1001/archpedi.159.8.740; Hoffman RP, 2009, CURR DIABETES REV, V5, P259, DOI 10.2174/157339909789804332; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Johnson ST, 2010, J PEDIATR-US, V156, P247, DOI 10.1016/j.jpeds.2009.08.010; Kolsgaard MLP, 2008, ACTA PAEDIATR, V97, P1557, DOI 10.1111/j.1651-2227.2008.00955.x; Kurian AK, 2007, ETHNIC DIS, V17, P143; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Lynch WC, 2007, BODY IMAGE, V4, P179, DOI 10.1016/j.bodyim.2007.01.001; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Morrison JA, 2008, J PEDIATR-US, V152, P201, DOI 10.1016/j.jpeds.2007.09.010; Morrison JA, 2007, PEDIATRICS, V120, P340, DOI 10.1542/peds.2006-1699; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; Owen CG, 2010, DIABETOLOGIA, V53, P1620, DOI 10.1007/s00125-010-1781-1; Palacios C, 2010, AM J CLIN NUTR, V91, P597, DOI 10.3945/ajcn.2009.28400; Savica V, 2010, ANNU REV NUTR, V30, P365, DOI 10.1146/annurev-nutr-010510-103954; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Smith SC, 2005, CIRCULATION, V111, pE134, DOI 10.1161/01.CIR.0000157743.54710.04; Srinivasan SR, 2006, PEDIATRICS, V118, P201, DOI 10.1542/peds.2005-1856; Sumner Anne E, 2009, J Pediatr, V155, DOI 10.1016/j.jpeds.2009.04.049; Thiering E, 2012, J HYPERTENS, V30, P1114, DOI 10.1097/HJH.0b013e328352d699; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Turban S, 2008, J AM SOC NEPHROL, V19, P1396, DOI 10.1681/ASN.2007101142; Uitewaal PJM, 2004, PREV MED, V39, P1068, DOI 10.1016/j.ypmed.2004.04.009; Ujcic-Voortman JK, 2011, ATHEROSCLEROSIS, V218, P511, DOI 10.1016/j.atherosclerosis.2011.06.051; Ujcic-Voortman JK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-740; van Dijk AE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-251; van Dis SJ, 2002, HART VAATZIEKTEN BIJ; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; van Vliet M, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-106; van Vliet M, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-2; Vega GL, 1998, J LIPID RES, V39, P228; Walker SE, 2012, NUTR METAB CARDIOVAS, V22, P141, DOI 10.1016/j.numecd.2010.05.006; Wang J, 2003, AM J CLIN NUTR, V77, P379, DOI 10.1093/ajcn/77.2.379; Whincup PH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000263; Whincup PH, 2002, BRIT MED J, V324, P635, DOI 10.1136/bmj.324.7338.635; Winkleby MA, 1999, JAMA-J AM MED ASSOC, V281, P1006, DOI 10.1001/jama.281.11.1006; Zoratti R, 1998, EUR J EPIDEMIOL, V14, P9, DOI 10.1023/A:1007492202045	61	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43667	10.1371/journal.pone.0043667	http://dx.doi.org/10.1371/journal.pone.0043667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916294	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800092
J	Fyhrquist, N; Wolff, H; Lauerma, A; Alenius, H				Fyhrquist, Nanna; Wolff, Henrik; Lauerma, Antti; Alenius, Harri			CD8+T Cell Migration to the Skin Requires CD4+Help in a Murine Model of Contact Hypersensitivity	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; CD8(+) T-CELLS; DERMATITIS; EFFECTOR; INFLAMMATION; SENSITIVITY; CD4(+)	The relative roles of CD4+ and CD8+ T cells in contact hypersensitivity responses have not been fully solved, and remain an important question. Using an adoptive transfer model, we investigated the role of the respective T cell subset. Magnetic bead separated CD4+ and CD8+ T cells from oxazolone sensitized C57BL/6 mice were transferred into RAG(-/-) mice, followed by hapten challenge and analysis of inflammatory parameters at 24 hours post exposure. The CD4+ T cell recipient mice developed partial contact hypersensitivity responses to oxazolone. CD8+ T cells caused significant amplification of the response in recipients of both CD4+ and CD8+ T cells including ear swelling, type 1 inflammatory mediators, and cell killing. Unexpectedly, CD8+ T cells were not sufficient to mediate contact hypersensitivity, although abundantly present in the lymph nodes in the CD8+ T cell reconstituted mice. There were no signs of inflammation at the site of hapten exposure, indicating impaired recruitment of CD8+ T cells in the absence of CD4+ T cells. These data show that CD4+ T cells mediate contact hypersensitivity to oxazolone, but CD8+ T cells contribute with the most potent effector mechanisms. Moreover, our results suggest that CD4+ T cell function is required for the mobilization of CD8+ effector T cells to the site of hapten exposure. The results shed new light on the relative importance of CD4+ and CD8+ T cells during the effector phase of contact hypersensitivity.	[Fyhrquist, Nanna; Alenius, Harri] Finnish Inst Occupat Hlth, Unit Excellence Immunotoxicol, Helsinki, Finland; [Wolff, Henrik] Finnish Inst Occupat Hlth, Team Biol Mechanisms & Prevent Work Related Dis, Helsinki, Finland; [Wolff, Henrik] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Lauerma, Antti] Univ Helsinki, Dept Dermatol Venereol & Allergol, Helsinki, Finland	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Fyhrquist, N (corresponding author), Finnish Inst Occupat Hlth, Unit Excellence Immunotoxicol, Helsinki, Finland.	nanna.fyhrquist@ttl.fi	Lauerma, Antti/J-8180-2016	Alenius, Harri/0000-0003-0106-8923; Fyhrquist, Nanna Theresia/0000-0002-5408-0005	Academy of Finland [213072, 214479]	Academy of Finland(Academy of Finland)	This work was partly supported by grants from the Academy of Finland (Contracts No 213072 and 214479). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bangert C, 2003, J INVEST DERMATOL, V121, P1409, DOI 10.1111/j.1523-1747.2003.12623.x; BOUR H, 1995, EUR J IMMUNOL, V25, P3006, DOI 10.1002/eji.1830251103; Cavani A, 2001, TRENDS IMMUNOL, V22, P118, DOI 10.1016/S1471-4906(00)01815-9; Chen AI, 1999, IMMUNITY, V11, P689, DOI 10.1016/S1074-7613(00)80143-0; Coenraads P-J, 2007, Eur J Dermatol, V17, P564; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Dearman RJ, 1996, IMMUNOLOGY, V89, P502, DOI 10.1046/j.1365-2567.1996.d01-778.x; deLuca LS, 2012, NAT REV IMMUNOL, V12, P339, DOI 10.1038/nri3193; GOCINSKI BL, 1990, J IMMUNOL, V144, P4121; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Martin S, 2000, J INVEST DERMATOL, V115, P260, DOI 10.1046/j.1523-1747.2000.00038.x; Meller S, 2007, J ALLERGY CLIN IMMUN, V119, P1470, DOI 10.1016/j.jaci.2006.12.654; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x	17	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41038	10.1371/journal.pone.0041038	http://dx.doi.org/10.1371/journal.pone.0041038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916101	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800007
J	Huart, AS; MacLaine, NJ; Narayan, V; Hupp, TR				Huart, Anne-Sophie; MacLaine, Nicola J.; Narayan, Vikram; Hupp, Ted R.			Exploiting the MDM2-CK1 alpha Protein-Protein Interface to Develop Novel Biologics That Induce UBL-Kinase-Modification and Inhibit Cell Growth	PLOS ONE			English	Article							MELANOMA-CELLS; I-ALPHA; P53; MDM2; PHOSPHORYLATION; DOMAIN; ACTIVATION; CANCER; BETA; UBIQUITINATION	Protein-protein interactions forming dominant signalling events are providing ever-growing platforms for the development of novel Biologic tools for controlling cell growth. Casein Kinase 1 alpha (CK1 alpha) forms a genetic and physical interaction with the murine double minute chromosome 2 (MDM2) oncoprotein resulting in degradation of the p53 tumour suppressor. Pharmacological inhibition of CK1 increases p53 protein level and induces cell death, whilst small interfering RNA-mediated depletion of CK1 alpha stabilizes p53 and induces growth arrest. We mapped the dominant protein-protein interface that stabilizes the MDM2 and CK1 alpha complex in order to determine whether a peptide derived from the core CK1 alpha-MDM2 interface form novel Biologics that can be used to probe the contribution of the CK1-MDM2 protein-protein interaction to p53 activation and cell viability. Overlapping peptides derived from CK1 alpha were screened for dominant MDM2 binding sites using (i) ELISA with recombinant MDM2; (ii) cell lysate pull-down towards endogenous MDM2; (iii) MDM2-CK1 alpha complex-based competition ELISA; and (iv) MDM2-mediated ubiquitination. One dominant peptide, peptide 35 was bioactive in all four assays and its transfection induced cell death/growth arrest in a p53-independent manner. Ectopic expression of flag-tagged peptide 35 induced a novel ubiquitin and NEDD8 modification of CK1 alpha, providing one of the first examples whereby NEDDylation of a protein kinase can be induced. These data identify an MDM2 binding motif in CK1 alpha which when isolated as a small peptide can (i) function as a dominant negative inhibitor of the CK1 alpha-MDM2 interface, (ii) be used as a tool to study NEDDylation of CK1 alpha, and (iii) reduce cell growth. Further, this approach provides a technological blueprint, complementing siRNA and chemical biology approaches, by exploiting protein-protein interactions in order to develop Biologics to manipulate novel types of signalling pathways such as cross-talk between NEDDylation, protein kinase signalling, and cell survival.	[Huart, Anne-Sophie; MacLaine, Nicola J.; Hupp, Ted R.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Signal Transduct Grp P53, Edinburgh, Midlothian, Scotland; [Narayan, Vikram] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Interferon & Cell Signalling Grp, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Huart, AS (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Signal Transduct Grp P53, Edinburgh, Midlothian, Scotland.	ted.hupp@ed.ac.uk	Narayan, Vikram/AAF-3964-2020	Narayan, Vikram/0000-0002-6128-7944; Huart, Anne-Sophie/0000-0003-0913-1501	Cancer Research UK [C483/A10706]	Cancer Research UK(Cancer Research UK)	The research was supported by the Cancer Research UK (C483/A10706). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MM, 1996, J BIOL CHEM, V271, P29231, DOI 10.1074/jbc.271.46.29231; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Banerjee D, 2010, CELL CYCLE, V9, P4748, DOI 10.4161/cc.9.23.14092; Bedri S, 2007, ARCH BIOCHEM BIOPHYS, V466, P242, DOI 10.1016/j.abb.2007.06.010; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; BROCKMAN JL, 1992, P NATL ACAD SCI USA, V89, P9454, DOI 10.1073/pnas.89.20.9454; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Budini M, 2009, J CELL BIOCHEM, V106, P399, DOI 10.1002/jcb.22019; Burzio V, 2002, J CELL BIOCHEM, V86, P805, DOI 10.1002/jcb.10263; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Dahlberg CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004766; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Foldynova-Trantirkova S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2581; Fu Z, 2001, EXP CELL RES, V269, P275, DOI 10.1006/excr.2001.5324; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gross SD, 1997, J CELL SCI, V110, P3083; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Halasi M, 2009, CELL CYCLE, V8, P2850, DOI 10.4161/cc.8.17.9414; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; Hutchinson JA, 2011, J BIOL CHEM, V286, P8688, DOI 10.1074/jbc.M110.141754; Ikeda K, 2011, MOL BIOL CELL, V22, P1321, DOI 10.1091/mbc.E10-09-0741; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knippschild U, 1997, ONCOGENE, V15, P1727, DOI 10.1038/sj.onc.1201541; Kulikov R, 2006, J BIOL CHEM, V281, P28575, DOI 10.1074/jbc.M513311200; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee JY, 2009, PLANT SIGNAL BEHAV, V4, P652, DOI [10.1104/pp.108.129346, 10.4161/psb.4.7.8991]; MacLaine NJ, 2008, J BIOL CHEM, V283, P28563, DOI 10.1074/jbc.M804433200; MacLaine NJ, 2011, CELL CYCLE, V10, P916, DOI 10.4161/cc.10.6.15076; Maclaine NJ, 2009, AGING-US, V1, P490, DOI 10.18632/aging.100047; Maslon MM, 2010, TRENDS CELL BIOL, V20, P542, DOI 10.1016/j.tcb.2010.06.005; Meek DW, 2003, MOL CANCER RES, V1, P1017; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Narayan V, 2009, J BIOL CHEM, V284, P25889, DOI 10.1074/jbc.M109.019505; Perez DI, 2011, MED RES REV, V31, P924, DOI 10.1002/med.20207; Perry ME, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000968; Pettersson S, 2009, BIOCHEM J, V418, P575, DOI 10.1042/BJ20082087; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rumpf C, 2010, CELL CYCLE, V9, P2657, DOI 10.4161/cc.9.13.12146; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Sczaniecka M, 2012, J BIOL CHEM, V287, P14052, DOI 10.1074/jbc.M111.303875; Seigneuric R, 2011, ONCOTARGET, V2, P557, DOI 10.18632/oncotarget.297; Shallal HM, 2011, EUR J MED CHEM, V46, P2043, DOI 10.1016/j.ejmech.2011.02.057; Shanware NP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.224014; Sinnberg T, 2010, CANCER RES, V70, P6999, DOI 10.1158/0008-5472.CAN-10-0645; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Stoter M, 2005, ONCOGENE, V24, P7964, DOI 10.1038/sj.onc.1208941; Surade S, 2012, CHEM BIOL, V19, P42, DOI 10.1016/j.chembiol.2011.12.013; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Utz AC, 2010, J HISTOCHEM CYTOCHEM, V58, P1, DOI 10.1369/jhc.2009.954628; Venerando A, 2010, CELL MOL LIFE SCI, V67, P1105, DOI 10.1007/s00018-009-0236-7; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wallace M, 2006, AM BOOK REV, V27, P3, DOI 10.1353/abr.2006.0081; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Winter M, 2004, BIOCHEMISTRY-US, V43, P16356, DOI 10.1021/bi0489255; Worralll EG, 2010, J MOL BIOL, V398, P414, DOI 10.1016/j.jmb.2010.03.023; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Yang WS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r92; Zhang JR, 1996, BIOCHEMISTRY-US, V35, P16319, DOI 10.1021/bi9614444	64	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43391	10.1371/journal.pone.0043391	http://dx.doi.org/10.1371/journal.pone.0043391			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916255	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800064
J	McEvoy, J; Ulyanov, A; Brennan, R; Wu, G; Pounds, S; Zhang, JH; Dyer, MA				McEvoy, Justina; Ulyanov, Anatoly; Brennan, Rachel; Wu, Gang; Pounds, Stanley; Zhang, Jinghui; Dyer, Michael A.			Analysis of MDM2 and MDM4 Single Nucleotide Polymorphisms, mRNA Splicing and Protein Expression in Retinoblastoma	PLOS ONE			English	Article							TUMOR-FORMATION; P53; CELLS; GENE; IDENTIFICATION; PROGRESSION; VARIANTS; THERAPY; PATHWAY; DISEASE	Retinoblastoma is a childhood cancer of the developing retina that begins in utero and is diagnosed in the first years of life. Biallelic RB1 gene inactivation is the initiating genetic lesion in retinoblastoma. The p53 gene is intact in human retinoblastoma but the pathway is believed to be suppressed by increased expression of MDM4 (MDMX) and MDM2. Here we quantify the expression of MDM4 and MDM2 mRNA and protein in human fetal retinae, primary retinoblastomas, retinoblastoma cell lines and several independent orthotopic retinoblastoma xenografts. We found that MDM4 is the major p53 antagonist expressed in retinoblastoma and in the developing human retina. We also discovered that MDM4 protein steady state levels are much higher in retinoblastoma than in human fetal retinae. This increase would not have been predicted based on the mRNA levels. We explored several possible post-transcriptional mechanisms that may contribute to the elevated levels of MDM4 protein. A proportion of MDM4 transcripts are alternatively spliced to produce protein products that are reported to be more stable and oncogenic. We also discovered that a microRNA predicted to target MDM4 (miR191) was downregulated in retinoblastoma relative to human fetal retinae and a subset of samples had somatic mutations that eliminated the miR-191 binding site in the MDM4 mRNA. Taken together, these data suggest that post-transcriptional mechanisms may contribute to stabilization of the MDM4 protein in retinoblastoma.	[McEvoy, Justina; Brennan, Rachel; Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Ulyanov, Anatoly; Wu, Gang; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Pounds, Stanley] St Jude Childrens Res Hosp, Dept Stat, Memphis, TN 38105 USA; [Dyer, Michael A.] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; [Dyer, Michael A.] Howard Hughes Med Inst, Chevy Chase, MD USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Howard Hughes Medical Institute	McEvoy, J (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.dyer@stjude.org	Zhang, Jing/GWZ-7332-2022; Dyer, Michael/N-8134-2018; Wu, Gang/M-8012-2014; Pounds, Stanley B/N-2480-2018	Wu, Gang/0000-0002-1678-5864; Pounds, Stanley B/0000-0002-9167-2114; McEvoy, Justina/0000-0003-0382-1288	Cancer Center [CA21765]; National Institutes of Health [EY014867, EY018599]; American Cancer Society; Research to Prevent Blindness Foundation; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014867, R01EY018599] Funding Source: NIH RePORTER	Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Cancer Center Support NCI (CA21765); National Institutes of Health (EY014867 and EY018599); American Cancer Society; Research to Prevent Blindness Foundation; American Lebanese Syrian Associated Charities (ALSAC). MD is a Howard Hughes Medical Institute Early Career Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal GS, 2009, P NATL ACAD SCI USA, V106, P10236, DOI 10.1073/pnas.0901298106; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Castera L, 2010, J NATL CANCER I, V102, P1805, DOI 10.1093/jnci/djq416; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Dyer MA, 2005, PLOS MED, V2, P971, DOI 10.1371/journal.pmed.0020332; Elison JR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1269, DOI 10.1001/archopht.124.9.1269; Harbour JW, 2002, ARCH OPHTHALMOL-CHIC, V120, P1341, DOI 10.1001/archopht.120.10.1341; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Kato MV, 1996, CANCER LETT, V106, P75, DOI 10.1016/0304-3835(96)04305-4; Kulkarni DA, 2009, CARCINOGENESIS, V30, P1910, DOI 10.1093/carcin/bgp224; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Mancini F, 2009, CURR GENOMICS, V10, P42, DOI 10.2174/138920209787581280; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marine JC, 2004, CELL CYCLE, V3, P900; McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005; McKenzie PP, 1999, CLIN CANCER RES, V5, P4199; Rallapalli R, 2003, J CELL BIOCHEM, V89, P563, DOI 10.1002/jcb.10535; Rallapalli R, 1999, J BIOL CHEM, V274, P8299, DOI 10.1074/jbc.274.12.8299; Thompson J, 1997, CLIN CANCER RES, V3, P423; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	26	57	64	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42739	10.1371/journal.pone.0042739	http://dx.doi.org/10.1371/journal.pone.0042739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916154	gold, Green Submitted, Green Published			2022-12-25	WOS:000307733800027
J	Fowler, TW; McKelvey, KD; Akel, NS; Schilden, JV; Bacon, AW; Bracey, JW; Sowder, T; Skinner, RA; Swain, FL; Hogue, WR; Leblanc, DB; Gaddy, D; Wenger, GR; Suva, LJ				Fowler, Tristan W.; McKelvey, Kent D.; Akel, Nisreen S.; Schilden, Jaclyn Vander; Bacon, Anthony W.; Bracey, John W.; Sowder, Timothy; Skinner, Robert A.; Swain, Frances L.; Hogue, William R.; Leblanc, Donna B.; Gaddy, Dana; Wenger, Galen R.; Suva, Larry J.			Low Bone Turnover and Low BMD in Down Syndrome: Effect of Intermittent PTH Treatment	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED OSTEOPOROSIS; MINERAL DENSITY; MOUSE MODEL; POSTMENOPAUSAL WOMEN; ANIMAL-MODEL; YOUNG MEN; MASS; TERIPARATIDE; STRENGTH; ADULTS	Trisomy 21 affects virtually every organ system and results in the complex clinical presentation of Down syndrome (DS). Patterns of differences are now being recognized as patients' age and these patterns bring about new opportunities for disease prevention and treatment. Low bone mineral density (BMD) has been reported in many studies of males and females with DS yet the specific effects of trisomy 21 on the skeleton remain poorly defined. Therefore we determined the bone phenotype and measured bone turnover markers in the murine DS model Ts65Dn. Male Ts65Dn DS mice are infertile and display a profound low bone mass phenotype that deteriorates with age. The low bone mass was correlated with significantly decreased osteoblast and osteoclast development, decreased bone biochemical markers, a diminished bone formation rate and reduced mechanical strength. The low bone mass observed in 3 month old Ts65Dn mice was significantly increased after 4 weeks of intermittent PTH treatment. These studies provide novel insight into the cause of the profound bone fragility in DS and identify PTH as a potential anabolic agent in the adult low bone mass DS population.	[Fowler, Tristan W.; Akel, Nisreen S.; Gaddy, Dana; Suva, Larry J.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Fowler, Tristan W.; Akel, Nisreen S.; Schilden, Jaclyn Vander; Bacon, Anthony W.; Bracey, John W.; Sowder, Timothy; Skinner, Robert A.; Swain, Frances L.; Hogue, William R.; Gaddy, Dana; Suva, Larry J.] Univ Arkansas Med Sci, Ctr Orthopaed Res, Dept Orthopaed Surg, Little Rock, AR 72205 USA; [McKelvey, Kent D.; Leblanc, Donna B.] Univ Arkansas Med Sci, Dept Genet, Little Rock, AR 72205 USA; [Wenger, Galen R.] Univ Arkansas Med Sci, Dept Pharmacol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Fowler, TW (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.	suvalarryj@uams.edu		Suva, Larry/0000-0002-2892-9757	NIH [R01-DK54044, R21-74024, R01 HD047656]; UAMS Translational Research Institute (TRI) [UL1RR029884]; Winthrop P Rockefeller Chair in Clinical Genetics; Carl L. Nelson Endowed Chair in Orthopaedic Creativity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047656] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAMS Translational Research Institute (TRI); Winthrop P Rockefeller Chair in Clinical Genetics; Carl L. Nelson Endowed Chair in Orthopaedic Creativity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH R01-DK54044 and R21-74024 (DG), NIH R01 HD047656 (GRW), UAMS Translational Research Institute (TRI) clinical award (KGM), UAMS TRI UL1RR029884, the Winthrop P Rockefeller Chair in Clinical Genetics (KDM) and the Carl L. Nelson Endowed Chair in Orthopaedic Creativity (LJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford KA, 2010, BLOOD, V115, P2928, DOI 10.1182/blood-2009-06-227629; Angelopoulou N, 1999, EUR RADIOL, V9, P648, DOI 10.1007/s003300050726; Angelopoulou N, 2000, CALCIFIED TISSUE INT, V66, P176, DOI 10.1007/s002230010035; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Baptista F, 2005, OSTEOPOROSIS INT, V16, P380, DOI 10.1007/s00198-004-1687-1; Bittles AH, 2004, DEV MED CHILD NEUROL, V46, P282, DOI 10.1017/S0012162204000441; Blazek JD, 2011, BONE, V48, P275, DOI 10.1016/j.bone.2010.09.028; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; CAMPBELL WA, 1982, J MED GENET, V19, P98, DOI 10.1136/jmg.19.2.98; Down JL, 1866, CLIN LECT REPORTS LO, V3, P259; Gaddy-Kurten D, 2002, ENDOCRINOLOGY, V143, P74, DOI 10.1210/en.143.1.74; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; Gonzalez-Aguero A, 2011, OSTEOPOROSIS INT, V22, P2151, DOI 10.1007/s00198-010-1443-7; Granholm ACE, 2002, PHYSIOL BEHAV, V77, P371, DOI 10.1016/S0031-9384(02)00884-3; Grimwood JS, 2000, HISTOPATHOLOGY, V36, P279; Guijarro M, 2008, J INTELL DISABIL RES, V52, P182, DOI 10.1111/j.1365-2788.2007.00992.x; Hawli Y, 2009, NAT REV ENDOCRINOL, V5, P327, DOI 10.1038/nrendo.2009.80; Hui S L, 1990, Osteoporos Int, V1, P30, DOI 10.1007/BF01880413; JOHANNISSON R, 1983, HUM GENET, V63, P132, DOI 10.1007/BF00291532; KAO CH, 1992, NUCL MED COMMUN, V13, P773, DOI 10.1097/00006231-199213100-00012; Kirsammer G, 2008, BLOOD, V111, P767, DOI 10.1182/blood-2007-04-085670; Leffler A, 1999, ANN ANAT, V181, P247, DOI 10.1016/S0940-9602(99)80039-9; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Lindsay R, 2006, J BONE MINER RES, V21, P366, DOI 10.1359/JBMR.051109; Ma YFL, 2006, J BONE MINER RES, V21, P855, DOI 10.1359/JBMR.060314; da Silva VZM, 2010, RES DEV DISABIL, V31, P1585, DOI 10.1016/j.ridd.2010.05.003; McKelvey KD, 2012, OSTEOPOROS IN PRESS; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Olson LE, 2011, AM J MED GENET A, V155A, P2436, DOI 10.1002/ajmg.a.34203; Ominsky MS, 2011, J BONE MINER RES, V26, P1012, DOI 10.1002/jbmr.307; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parsons T, 2007, ANAT REC, V290, P414, DOI 10.1002/ar.20494; Perrien DS, 2007, ENDOCRINOLOGY, V148, P1654, DOI 10.1210/en.2006-0848; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Roy A, 2009, BRIT J HAEMATOL, V147, P3, DOI 10.1111/j.1365-2141.2009.07789.x; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Saag KG, 2007, NEW ENGL J MED, V357, P2028, DOI 10.1056/NEJMoa071408; Saag KG, 2009, ARTHRITIS RHEUM-US, V60, P3346, DOI 10.1002/art.24879; Sakadamis A, 2002, EUR J OBSTET GYN R B, V100, P208, DOI 10.1016/S0301-2115(01)00478-X; SEEMAN E, 1994, OSTEOPOROSIS INT, V4, P15; SEPULVEDA D, 1995, AM J MENT RETARD, V100, P109; Stefanidis K, 2011, ANDROLOGIA, V43, P353, DOI 10.1111/j.1439-0272.2010.01043.x; Suva LJ, 2008, AM J PATHOL, V172, P430, DOI 10.2353/ajpath.2008.070417; SUVA LJ, 1993, J BONE MINER RES, V8, P379; Van Allen MI, 1999, AM J MED GENET, V89, P100, DOI 10.1002/(SICI)1096-8628(19990625)89:2<100::AID-AJMG8>3.3.CO;2-E	46	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42967	10.1371/journal.pone.0042967	http://dx.doi.org/10.1371/journal.pone.0042967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916188	gold, Green Submitted, Green Published			2022-12-25	WOS:000307500800034
J	Azevedo, EPC; Guimaraes-Costa, AB; Torezani, GS; Braga, CA; Palhano, FL; Kelly, JW; Saraiva, EM; Foguel, D				Azevedo, Estefania P. C.; Guimaraes-Costa, Anderson B.; Torezani, Guilherme S.; Braga, Carolina A.; Palhano, Fernando L.; Kelly, Jeffery W.; Saraiva, Elvira M.; Foguel, Debora			Amyloid Fibrils Trigger the Release of Neutrophil Extracellular Traps (NETs), Causing Fibril Fragmentation by NET-associated Elastase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; PATHOGENESIS; MECHANISMS; EXPRESSION; VARIANT; ESCAPE; DNA	The accumulation of amyloid fibrils is a feature of amyloid diseases, where cell toxicity is due to soluble oligomeric species that precede fibril formation or are formed by fibril fragmentation, but the mechanism(s) of fragmentation is still unclear. Neutrophil-derived elastase and histones were found in amyloid deposits from patients with different systemic amyloidoses. Neutrophil extracellular traps (NETs) are key players in a death mechanism in which neutrophils release DNA traps decorated with proteins such as elastase and histones to entangle pathogens. Here, we asked whether NETs are triggered by amyloid fibrils, reasoning that because proteases are present in NETs, protease digestion of amyloid may generate soluble, cytotoxic species. We show that amyloid fibrils from three different sources (alpha-synuclein, Sup35, and transthyretin) induced NADPH oxidase-dependent NETs in vitro from human neutrophils. Surprisingly, NET-associated elastase digested amyloid fibrils into short species that were cytotoxic for BHK-21 and HepG2 cells. In tissue sections from patients with primary amyloidosis, we also observed the co-localization of NETs with amyloid deposits as well as with oligomers, which are probably derived from elastase-induced fibril degradation (amyloidolysis). These data reveal that release of NETs, so far described to be elicited by pathogens, can also be triggered by amyloid fibrils. Moreover, the involvement of NETs in amyloidoses might be crucial for the production of toxic species derived from fibril fragmentation.	[Guimaraes-Costa, Anderson B.; Saraiva, Elvira M.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Dept Imunol, BR-21941902 Rio De Janeiro, Brazil; [Azevedo, Estefania P. C.; Torezani, Guilherme S.; Braga, Carolina A.; Palhano, Fernando L.; Foguel, Debora] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; [Braga, Carolina A.] Univ Fed Rio de Janeiro, BR-25245390 Duque De Caxias, Brazil; [Palhano, Fernando L.; Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Scripps Research Institute	Saraiva, EM (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Dept Imunol, Bloco D, BR-21941902 Rio De Janeiro, Brazil.	esaraiva@micro.ufrj.br; foguel@bioqmed.ufrj.br	Costa, Anderson G. B./K-1059-2012; Azevedo, Estefania/I-3807-2012; Palhano, Fernando/AAB-3144-2021; Saraiva, Elvira M/L-2864-2017; Palhano, Fernando/C-2586-2008; Braga, Carolina/E-3471-2013	Costa, Anderson G. B./0000-0003-4582-1980; Palhano, Fernando/0000-0001-5336-632X; Saraiva, Elvira M/0000-0002-6388-5286; Palhano, Fernando/0000-0001-5336-632X; Foguel, Debora/0000-0001-7312-7115	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Instituto Nacional de Ciencia e Tecnologia emBiologia Estrutural e Bioimagem; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia emBiologia Estrutural e Bioimagem; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Instituto Nacional de Ciencia e Tecnologia emBiologia Estrutural e Bioimagem, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro.	Azevedo EPC, 2011, BIOCHEMISTRY-US, V50, P11070, DOI 10.1021/bi201365r; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Braga CA, 2011, J MOL BIOL, V405, P254, DOI 10.1016/j.jmb.2010.10.027; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BRUUN CF, 1994, SCAND J IMMUNOL, V40, P337, DOI 10.1111/j.1365-3083.1994.tb03470.x; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Carrano A, 2011, ANTIOXID REDOX SIGN, V15, P1167, DOI 10.1089/ars.2011.3895; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; ELGHETANY MT, 1988, STAIN TECHNOL, V63, P201, DOI 10.3109/10520298809107185; Enqvist S, 2009, J PATHOL, V219, P473, DOI 10.1002/path.2607; Farfara D, 2008, J CELL MOL MED, V12, P762, DOI 10.1111/j.1582-4934.2008.00314.x; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gertz MA, 2011, AM J HEMATOL, V86, P181, DOI 10.1002/ajh.21934; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Komissarov AA, 2011, J BIOL CHEM, V286, P41949, DOI 10.1074/jbc.M111.301218; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lashuel HA, 1998, BIOCHEMISTRY-US, V37, P17851, DOI 10.1021/bi981876+; Lee WL, 2004, SCIENCE, V303, P1477, DOI 10.1126/science.1095484; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Mumford AD, 2000, BRIT J HAEMATOL, V110, P454, DOI 10.1046/j.1365-2141.2000.02183.x; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; NORDSTOGA K, 1994, J VET MED A, V41, P741, DOI 10.1111/j.1439-0442.1994.tb00144.x; Palhano FL, 2009, BIOCHEMISTRY-US, V48, P6811, DOI 10.1021/bi9000276; Palhano FL, 2009, J BIOL CHEM, V284, P1443, DOI 10.1074/jbc.M807100200; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; PRELLI F, 1991, SCAND J IMMUNOL, V33, P783, DOI 10.1111/j.1365-3083.1991.tb02553.x; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; SARAIVA MJM, 1983, T ASSOC AM PHYSICIAN, V96, P261; Sekijima Y, 2003, LAB INVEST, V83, P409, DOI 10.1097/01.LAB.0000059937.11023.1F; Serio TR, 2002, ADV PROTEIN CHEM, V59, P391; STONE PJ, 1993, BIOCHEM BIOPH RES CO, V197, P130, DOI 10.1006/bbrc.1993.2451; SUMEGI I, 1973, ACTA DERM-VENEREOL, V53, P99; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; Weldon DT, 1998, J NEUROSCI, V18, P2161; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809	50	49	50	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37206	37218		10.1074/jbc.M112.369942	http://dx.doi.org/10.1074/jbc.M112.369942			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22918834	Green Published, hybrid			2022-12-25	WOS:000310588500054
J	Willis, CM; Kluppel, M				Willis, Catherine M.; Klueppel, Michael			Inhibition by Chondroitin Sulfate E Can Specify Functional Wnt/beta-Catenin Signaling Thresholds in NIH3T3 Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT PROTEINS; DISEASE; CHONDROITIN-4-SULFOTRANSFERASE-1; PROLIFERATION; HEMATOPOIESIS; TRANSCRIPTION; MAINTENANCE; EXPRESSION; APOPTOSIS; PATHWAY	Aberrant activation of the Wnt/beta-catenin signaling pathway is frequently associated with human disease, including cancer, and thus represents a key therapeutic target. However, Wnt/beta catenin signaling also plays critical roles in many aspects of normal adult tissue homeostasis. The identification of mechanisms and strategies to selectively inhibit the disease-related functions of Wnt signaling, while preserving normal physiological functions, is in its infancy. Here, we report the identification of exogenous chondroitin sulfate-E (CS-E) as an inhibitor of specific molecular and biological outcomes of Wnt3a signaling in NIH3T3 fibroblasts. We demonstrate that CS-E can decrease Wnt3a signaling through the negative regulation of LRP6 receptor activation. However, this inhibitory effect of CS-E only affected Wnt3a-mediated induction, but not repression, of target gene expression. We went on to identify a critical Wnt3a signaling threshold that differentially affects target gene induction versus repression. This signaling threshold also controlled the effects of Wnt3a on proliferation and serum starvation-induced apoptosis. Limiting Wnt3a signaling to this critical threshold, either by CS-E treatment or by ligand dilution, interfered with Wnt3a-mediated stimulation of proliferation but did not impair Wnt3a-mediated reduction of serum starvation-induced apoptosis. Treatment with pharmacological inhibitors demonstrated that both induction and repression of Wnt3a target genes in NIH3T3 cells require the canonical Wnt/beta-catenin signaling cascade. Our data establish the feasibility of selective inhibition of Wnt/beta-catenin transcriptional programs and biological outcomes through the exploitation of intrinsic signaling thresholds.	[Willis, Catherine M.; Klueppel, Michael] Childrens Hosp Chicago Res Ctr, Human Mol Genet Program, Chicago, IL 60614 USA; [Willis, Catherine M.; Klueppel, Michael] Northwestern Univ, Dept Pediat, Chicago, IL 60614 USA; [Klueppel, Michael] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60614 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Kluppel, M (corresponding author), Childrens Hosp Chicago Res Ctr, Human Mol Genet Program, 2430 N Halsted St, Chicago, IL 60614 USA.	m-kluppel@northwestern.edu			Children's Hospital of Chicago Research Center	Children's Hospital of Chicago Research Center	This work was supported by the Children's Hospital of Chicago Research Center.	Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Atcha FA, 2007, MOL CELL BIOL, V27, P8352, DOI 10.1128/MCB.02132-06; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; Behrens J, 2004, INT J DEV BIOL, V48, P477, DOI 10.1387/ijdb.041815jb; Blankesteijn WM, 2008, TRENDS PHARMACOL SCI, V29, P175, DOI 10.1016/j.tips.2008.01.003; Blauwkamp TA, 2008, EMBO J, V27, P1436, DOI 10.1038/emboj.2008.80; Buchert M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000816; Cadigan KM, 2008, CURR BIOL, V18, pR943, DOI 10.1016/j.cub.2008.08.017; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chakraborty PK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-102; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen SQ, 2007, J CELL COMMUN SIGNAL, V1, P175, DOI 10.1007/s12079-007-0015-x; Chien AJ, 2007, FRONT BIOSCI-LANDMRK, V12, P448, DOI 10.2741/2074; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Hinek A, 2005, AM J MED GENET A, V133A, P1, DOI 10.1002/ajmg.a.30495; Huelsken J, 2009, EUR J IMMUNOL, V39, P3582, DOI 10.1002/eji.200838982; Jia LW, 2008, CELL BIOL INT, V32, P807, DOI 10.1016/j.cellbi.2008.03.011; Karangelis DE, 2010, CURR MED CHEM, V17, P4018; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kluppel M, 2012, EUR J HUM GENET, V20, P870, DOI 10.1038/ejhg.2012.12; Kluppel M, 2011, MOL CELL BIOCHEM, V351, P1, DOI 10.1007/s11010-010-0705-1; Kluppel M, 2010, PROG MOL BIOL TRANSL, V93, P113, DOI 10.1016/S1877-1173(10)93006-8; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kluppel M, 2002, MECH DEVELOP, V118, P77, DOI 10.1016/S0925-4773(02)00198-3; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Li J, 2007, EMBO J, V26, P2284, DOI 10.1038/sj.emboj.7601667; Li Q, 2005, CANCER RES, V65, P8622, DOI 10.1158/0008-5472.CAN-05-2145; Luis TC, 2012, LEUKEMIA, V26, P414, DOI 10.1038/leu.2011.387; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Maeda Nobuaki, 2010, Front Biosci (Landmark Ed), V15, P626; Mirkovic I, 2002, MECH DEVELOP, V119, P9, DOI 10.1016/S0925-4773(02)00289-7; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon Randall T, 2005, Sci STKE, V2005, pcm1; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nadanaka S, 2011, J BIOL CHEM, V286, P4199, DOI 10.1074/jbc.M110.155093; Nalesso G, 2011, J CELL BIOL, V193, P551, DOI 10.1083/jcb.201011051; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Nusse R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011163; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Prinz RD, 2011, GENET MOL RES, V10, P3901, DOI 10.4238/2011.December.8.9; Shih YL, 2007, INT J CANCER, V121, P1028, DOI 10.1002/ijc.22750; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Uebelhart D, 2008, OSTEOARTHR CARTILAGE, V16, pS19, DOI 10.1016/j.joca.2008.06.006; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Vangsness CT, 2009, ARTHROSCOPY, V25, P86, DOI 10.1016/j.arthro.2008.07.020; Wei J, 2011, ARTHRITIS RHEUM-US, V63, P1707, DOI 10.1002/art.30312; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	53	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37042	37056		10.1074/jbc.M112.391490	http://dx.doi.org/10.1074/jbc.M112.391490			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22915582	hybrid, Green Published			2022-12-25	WOS:000310588500039
J	Chiyomaru, T; Yamamura, S; Zaman, MS; Majid, S; Deng, GR; Shahryari, V; Saini, S; Hirata, H; Ueno, K; Chang, I; Tanaka, Y; Tabatabai, ZL; Enokida, H; Nakagawa, M; Dahiya, R				Chiyomaru, Takeshi; Yamamura, Soichiro; Zaman, Mohd Saif; Majid, Shahana; Deng, Guoren; Shahryari, Varahram; Saini, Sharanjot; Hirata, Hiroshi; Ueno, Koji; Chang, Inik; Tanaka, Yuichiro; Tabatabai, Z. Laura; Enokida, Hideki; Nakagawa, Masayuki; Dahiya, Rajvir			Genistein Suppresses Prostate Cancer Growth through Inhibition of Oncogenic MicroRNA-151	PLOS ONE			English	Article							GENE-EXPRESSION; JAPANESE MEN; CHROMOSOMAL-ABERRATIONS; RISK; ISOFLAVONES; CARCINOMA; FAMILY; CELLS; CONSUMPTION; INVASION	Genistein has been shown to suppress the growth of several cancers through modulation of various pathways. However, the effects of genistein on the regulation of oncogenic microRNA-151 (miR-151) have not been reported. In this study, we investigated whether genistein could alter the expression of oncogenic miR-151 and its target genes that are involved in the progression and metastasis of prostate cancer (PCa). Real-time RT-PCR showed that the expression of miR-151 was higher in PC3 and DU145 cells compared with RWPE-1 cells. Treatment of PC3 and DU145 cells with 25 mu M genistein down-regulated the expression of miR-151 compared with vehicle control. Inhibition of miR-151 in PCa cells by genistein significantly inhibited cell migration and invasion. In-silico analysis showed that several genes (CASZ1, IL1RAPL1, SOX17, N4BP1 and ARHGDIA) suggested to have tumor suppressive functions were target genes of miR-151. Luciferase reporter assays indicated that miR-151 directly binds to specific sites on the 3'UTR of target genes. Quantitative real-time PCR analysis showed that the mRNA expression levels of the five target genes in PC3 and DU145 were markedly changed with miR-151 mimics and inhibitor. Kaplan-Meier curves and log-rank tests revealed that high expression levels of miR-151 had an adverse effect on survival rate. This study suggests that genistein mediated suppression of oncogenic miRNAs can be an important dietary therapeutic strategy for the treatment of PCa.	[Chiyomaru, Takeshi; Yamamura, Soichiro; Zaman, Mohd Saif; Majid, Shahana; Deng, Guoren; Shahryari, Varahram; Saini, Sharanjot; Hirata, Hiroshi; Ueno, Koji; Chang, Inik; Tanaka, Yuichiro; Dahiya, Rajvir] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA; [Chiyomaru, Takeshi; Yamamura, Soichiro; Zaman, Mohd Saif; Majid, Shahana; Deng, Guoren; Shahryari, Varahram; Saini, Sharanjot; Hirata, Hiroshi; Ueno, Koji; Chang, Inik; Tanaka, Yuichiro; Dahiya, Rajvir] San Francisco VA Med Ctr, Dept Pathol, San Francisco, CA USA; [Chiyomaru, Takeshi; Yamamura, Soichiro; Zaman, Mohd Saif; Majid, Shahana; Deng, Guoren; Shahryari, Varahram; Saini, Sharanjot; Hirata, Hiroshi; Ueno, Koji; Chang, Inik; Tanaka, Yuichiro; Tabatabai, Z. Laura; Dahiya, Rajvir] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Enokida, Hideki; Nakagawa, Masayuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 890, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Kagoshima University	Chiyomaru, T (corresponding author), San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA.	rdahiya@urology.ucsf.edu	Jackson, Benjamin L/C-4297-2012		National Center for Research Resources of the National Institutes of Health [R01CA160079, R01CA138642, T32DK007790]; VA Merit Review and VA Program Project; NATIONAL CANCER INSTITUTE [R01CA138642, R01CA160079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007790] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Review and VA Program Project(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the National Center for Research Resources of the National Institutes of Health through Grant Numbers R01CA160079, R01CA138642, T32DK007790 and VA Merit Review and VA Program Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaza H, 2004, JPN J CLIN ONCOL, V34, P86, DOI 10.1093/jjco/hyh015; Barnabas N, 2011, PROSTATE, V71, P857, DOI 10.1002/pros.21302; Barone I, 2011, JNCI-J NATL CANCER I, V103, P538, DOI 10.1093/jnci/djr058; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Caren H, 2007, BRIT J CANCER, V97, P1416, DOI 10.1038/sj.bjc.6604032; Chen Y, 2011, CANCER PREV RES, V4, P76, DOI 10.1158/1940-6207.CAPR-10-0167; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Climent J, 2007, CANCER RES, V67, P818, DOI 10.1158/0008-5472.CAN-06-3307; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; de Souza PL, 2010, NUTR REV, V68, P542, DOI 10.1111/j.1753-4887.2010.00314.x; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Enjuanes A, 2008, CANCER RES, V68, P10178, DOI 10.1158/0008-5472.CAN-08-2221; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Jia Y, 2010, EPIGENETICS-US, V5, P743, DOI 10.4161/epi.5.8.13104; Kurahashi N, 2007, CANCER EPIDEM BIOMAR, V16, P538, DOI 10.1158/1055-9965.EPI-06-0517; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Lips EH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-314; Liu CL, 1996, J NEUROIMMUNOL, V66, P41, DOI 10.1016/0165-5728(96)00016-1; Liu Z, 2011, CELL DEATH DIFFER, V18, P1174, DOI 10.1038/cdd.2010.187; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Matsuda R, 2011, BRIT J CANCER, V104, P376, DOI 10.1038/sj.bjc.6605990; McAvoy S, 2007, CYTOGENET GENOME RES, V119, P196, DOI 10.1159/000112061; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; Monzon FA, 2011, MODERN PATHOL, V24, P1470, DOI 10.1038/modpathol.2011.107; Murillas R, 2002, J BIOL CHEM, V277, P2897, DOI 10.1074/jbc.M110047200; Nagata Y, 2007, J NUTR, V137, P1974, DOI 10.1093/jn/137.8.1974; Nelson CJ, 2008, CANCER, V113, P1097, DOI 10.1002/cncr.23658; Oberst A, 2007, P NATL ACAD SCI USA, V104, P11280, DOI 10.1073/pnas.0701773104; Ozasa K, 2004, CANCER SCI, V95, P65, DOI 10.1111/j.1349-7006.2004.tb03172.x; Pavese JM, 2010, CANCER METAST REV, V29, P465, DOI 10.1007/s10555-010-9238-z; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; Sun QM, 2009, ONCOL REP, V22, P563, DOI 10.3892/or_00000472; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Uchida M, 2010, J PATHOL, V221, P96, DOI 10.1002/path.2686; Wong MP, 2003, CANCER, V97, P1263, DOI 10.1002/cncr.11183; Yan L, 2009, AM J CLIN NUTR, V89, P1155, DOI 10.3945/ajcn.2008.27029; Ye YW, 2011, CANCER LETT, V307, P124, DOI 10.1016/j.canlet.2011.03.024; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060; Zhang W, 2008, CANCER RES, V68, P2764, DOI 10.1158/0008-5472.CAN-07-6349; Zhu YZ, 2012, PROSTATE, V72, P392, DOI 10.1002/pros.21441	43	90	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43812	10.1371/journal.pone.0043812	http://dx.doi.org/10.1371/journal.pone.0043812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928040	gold, Green Published, Green Submitted			2022-12-25	WOS:000308224700028
J	Rai, V; Hapuarachchi, HC; Ng, LC; Soh, SH; Leo, YS; Toh, CS				Rai, Varun; Hapuarachchi, Hapuarachchige C.; Ng, Lee Ching; Soh, Siew Hwa; Leo, Yee Sin; Toh, Chee-Seng			Ultrasensitive cDNA Detection of Dengue Virus RNA Using Electrochemical Nanoporous Membrane-Based Biosensor	PLOS ONE			English	Article							SEQUENCE-SPECIFIC DETECTION; DNA; SENSOR; NANOBIOSENSOR	A nanoporous alumina membrane-based ultrasensitive DNA biosensor is constructed using 5'-aminated DNA probes immobilized onto the alumina channel walls. Alumina nanoporous membrane-like structure is carved over platinum wire electrode of 76 mm diameter dimension by electrochemical anodization. The hybridization of complementary target DNA with probe DNA molecules attached inside the pores influences the pore size and ionic conductivity. The biosensor demonstrates linear range over 6 order of magnitude with ultrasensitive detection limit of 9.55x10(-12) M for the quantification of ss-31 mer DNA sequence. Its applicability is challenged against real time cDNA PCR sample of dengue virus serotype1 derived from asymmetric PCR. Excellent specificity down to one nucleotide mismatch in target DNA sample of DENV3 is also demonstrated.	[Rai, Varun; Toh, Chee-Seng] Nanyang Technol Univ, Sch Phys & Math Sci, Div Chem & Biol Chem, Singapore, Singapore; [Hapuarachchi, Hapuarachchige C.; Ng, Lee Ching] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore; [Soh, Siew Hwa; Leo, Yee Sin] Tan Tock Seng Hosp, Communicable Dis Ctr, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Tan Tock Seng Hospital	Rai, V (corresponding author), Nanyang Technol Univ, Sch Phys & Math Sci, Div Chem & Biol Chem, Singapore, Singapore.	cstoh@ntu.edu.sg		Rai, Varun/0000-0002-5872-3303; Hapuarachchi, Hapuarachchige Chanditha/0000-0001-7079-8538	Nanyang Technological University; Singapore Immunology Network-Agency for Science (SIgN-A*STAR) [SIgN 09-023]; National Environment Agency; Ministry of Education - NUS scholarship	Nanyang Technological University(Nanyang Technological University); Singapore Immunology Network-Agency for Science (SIgN-A*STAR); National Environment Agency; Ministry of Education - NUS scholarship	We thankfully acknowledge financial support from Nanyang Technological University grant, the Singapore Immunology Network-Agency for Science (SIgN-A*STAR) for research grant (SIgN 09-023), National Environment Agency and the Ministry of Education - NUS scholarship for VR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2010, ACS NANO, V4, P7267, DOI 10.1021/nn102119q; Bockisch B, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni101; Cheng MS, 2011, ENVIRON SCI TECHNOL, V45, P6453, DOI 10.1021/es200884a; Ding S, 2009, ANAL CHEM, V81, P6649, DOI 10.1021/ac9006705; Du H, 2003, J AM CHEM SOC, V125, P4012, DOI 10.1021/ja0290781; Ekanayake EMIM, 2007, BIOSENS BIOELECTRON, V23, P107, DOI 10.1016/j.bios.2007.03.022; Heilmann A, 2003, J NANOSCI NANOTECHNO, V3, P375, DOI 10.1166/jnn.2003.224; Kang MC, 2005, ANAL CHEM, V77, P6243, DOI 10.1021/ac0508907; Koh G, 2007, ELECTROCHIM ACTA, V53, P803, DOI 10.1016/j.electacta.2007.07.055; Koh G, 2007, ELECTROCHIM ACTA, V52, P2815, DOI 10.1016/j.electacta.2006.08.065; Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012; Liu G, 2008, J AM CHEM SOC, V130, P6820, DOI 10.1021/ja800554t; Long YT, 2004, ANAL CHEM, V76, P4059, DOI 10.1021/ac049482d; Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x; Martin CR, 2007, SCIENCE, V317, P331, DOI 10.1126/science.1146126; Moretti M, 2008, BIOSENS BIOELECTRON, V24, P141, DOI 10.1016/j.bios.2008.03.047; Mussi V, 2010, J PHYS CONDENS MATT, V22, P225; Mussi V, 2011, BIOSENS BIOELECTRON, V29, P125, DOI 10.1016/j.bios.2011.08.005; Nguyen BTT, 2009, ANAL CHEM, V81, P7226, DOI 10.1021/ac900761a; Rai V, 2012, BIOSENS BIOELECTRON, V32, P133, DOI 10.1016/j.bios.2011.11.046; Takmakov P, 2006, ANALYST, V131, P1248, DOI 10.1039/b608084g; Vlassiouk I, 2004, LANGMUIR, V20, P9913, DOI 10.1021/la047959a; Wang QX, 2011, ELECTROCHIM ACTA, V56, P3829, DOI 10.1016/j.electacta.2011.02.042; Wei F, 2005, J AM CHEM SOC, V127, P5306, DOI 10.1021/ja043661v; Zairi S, 2001, APPL SURF SCI, V172, P225, DOI 10.1016/S0169-4332(00)00856-4	25	53	54	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e42346	10.1371/journal.pone.0042346	http://dx.doi.org/10.1371/journal.pone.0042346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927927	Green Published, gold			2022-12-25	WOS:000308224700005
J	Caro, LN; Moreau, CJ; Estrada-Mondragon, A; Ernst, OP; Vivaudou, M				Caro, Lydia N.; Moreau, Christophe J.; Estrada-Mondragon, Argel; Ernst, Oliver P.; Vivaudou, Michel			Engineering of an Artificial Light-Modulated Potassium Channel	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; BOVINE RHODOPSIN; XENOPUS-OOCYTES; PROTEIN; RECEPTORS; ACTIVATION; TRANSDUCIN; EXPRESSION; MUTATIONS; DIFFUSION	Ion Channel-Coupled Receptors (ICCRs) are artificial receptor-channel fusion proteins designed to couple ligand binding to channel gating. We previously validated the ICCR concept with various G protein-coupled receptors (GPCRs) fused with the inward rectifying potassium channel Kir6.2. Here we characterize a novel ICCR, consisting of the light activated GPCR, opsin/rhodopsin, fused with Kir6.2. To validate our two-electrode voltage clamp (TEVC) assay for activation of the GPCR, we first co-expressed the apoprotein opsin and the G protein-activated potassium channel Kir3.1(F137S) (Kir3.1*) in Xenopus oocytes. Opsin can be converted to rhodopsin by incubation with 11-cis retinal and activated by light-induced retinal cis -> trans isomerization. Alternatively opsin can be activated by incubation of oocytes with all-trans-retinal. We found that illumination of 11-cis-retinal-incubated oocytes co-expressing opsin and Kir3.1* caused an immediate and long-lasting channel opening. In the absence of 11-cis retinal, all-trans-retinal also opened the channel persistently, although with slower kinetics. We then used the oocyte/TEVC system to test fusion proteins between opsin/rhodopsin and Kir6.2. We demonstrate that a construct with a C-terminally truncated rhodopsin responds to light stimulus independent of G protein. By extending the concept of ICCRs to the light-activatable GPCR rhodopsin we broaden the potential applications of this set of tools.	[Caro, Lydia N.; Moreau, Christophe J.; Estrada-Mondragon, Argel; Vivaudou, Michel] CNRS, Inst Biol Struct, Grenoble, France; [Caro, Lydia N.; Moreau, Christophe J.; Estrada-Mondragon, Argel; Vivaudou, Michel] CEA, Inst Biol Struct, LabEx ICST, Grenoble, France; [Caro, Lydia N.; Moreau, Christophe J.; Estrada-Mondragon, Argel; Vivaudou, Michel] Univ Grenoble 1, Inst Biol Struct, Grenoble, France; [Caro, Lydia N.; Ernst, Oliver P.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Ernst, Oliver P.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Toronto; University of Toronto	Caro, LN (corresponding author), CNRS, Inst Biol Struct, Grenoble, France.	vivaudou@ibs.fr	Vivaudou, Michel/C-5338-2008; MOREAU, Christophe J/D-3736-2009; MOREAU, Christophe/AAC-7912-2020	Vivaudou, Michel/0000-0002-9777-3127; MOREAU, Christophe J/0000-0002-5463-9593; MOREAU, Christophe/0000-0002-5463-9593; Estrada, Argel/0000-0002-1359-4659	Agence Nationale de la Recherche (ICCR project) [ANR-09-PIRI-0010]; Canada Excellence Research Chair program; ANR	Agence Nationale de la Recherche (ICCR project)(French National Research Agency (ANR)); Canada Excellence Research Chair program; ANR(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche (ICCR project, grant ANR-09-PIRI-0010 to M.V.) and the Canada Excellence Research Chair program (to O.P.E.). The Vivaudou laboratory is a member of the French National Laboratory of Excellence "Ion Channel Science and Therapeutics" supported by a network grant from ANR. O.P.E. holds the Anne and Max Tanenbaum Chair in Neuroscience at the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BORNANCIN F, 1992, EUR J BIOCHEM, V210, P33, DOI 10.1111/j.1432-1033.1992.tb17387.x; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Caro LN, 2012, BIOPHYS J, V102, p539A, DOI 10.1016/j.bpj.2011.11.2943; Caro LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018226; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; Govardovskii VI, 2009, MOL VIS, V15, P1717; Hosy E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.043307; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; KNOWLES A, 1978, VISION RES, V18, P115, DOI 10.1016/0042-6989(78)90086-X; KNOX BE, 1993, J PHYSIOL-LONDON, V466, P157; Lambert NA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125re5; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; Lin YW, 2006, J BIOL CHEM, V281, P3006, DOI 10.1074/jbc.M511875200; Madani N, 1998, P NATL ACAD SCI USA, V95, P8005, DOI 10.1073/pnas.95.14.8005; Mangmool S, 2011, TOXINS, V3, P884, DOI 10.3390/toxins3070884; McAllister SD, 1999, J PHARMACOL EXP THER, V291, P618; Moreau C, 2005, J MOL CELL CARDIOL, V38, P951, DOI 10.1016/j.yjmcc.2004.11.030; Moreau CJ, 2008, NAT NANOTECHNOL, V3, P620, DOI 10.1038/nnano.2008.242; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Orsini F, 2009, EUR BIOPHYS J BIOPHY, V38, P903, DOI 10.1007/s00249-009-0464-7; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Piechnick R, 2012, P NATL ACAD SCI USA, V109, P5247, DOI 10.1073/pnas.1117268109; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Sahlhollm K, 2007, EUR J PHARMACOL, V567, P206, DOI 10.1016/j.ejphar.2007.04.032; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Saugstad JA, 1996, J NEUROSCI, V16, P5979; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Sui JL, 1999, ADV SEC MESS PHOSPH, V33, P179; Terakita A, 2002, J BIOL CHEM, V277, P40, DOI 10.1074/jbc.M104960200; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Werner P, 1996, MOL PHARMACOL, V49, P656; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	52	13	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43766	10.1371/journal.pone.0043766	http://dx.doi.org/10.1371/journal.pone.0043766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928030	gold, Green Submitted, Green Published			2022-12-25	WOS:000308286300087
J	Wu, YH; Jiang, WJ; Wang, YM; Wu, J; Saiyin, H; Qiao, XJ; Mei, XY; Guo, B; Fang, X; Zhang, L; Lou, HL; Wu, CQ; Qiao, SY				Wu, Yanhua; Jiang, Wenjun; Wang, Yingming; Wu, Jun; Saiyin, Hexige; Qiao, Xiaojing; Mei, Xinyu; Guo, Bin; Fang, Xiao; Zhang, Lu; Lou, Huiling; Wu, Chaoqun; Qiao, Shouyi			Breast Cancer Metastasis Suppressor 1 Regulates Hepatocellular Carcinoma Cell Apoptosis via Suppressing Osteopontin Expression	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; DISEASE-FREE SURVIVAL; PROGNOSTIC-SIGNIFICANCE; TUMOR-METASTASIS; DOWN-REGULATION; CURATIVE RESECTION; ENDOTHELIAL-CELLS; CHROMOSOME 11Q13; BRMS1 EXPRESSION; GENE-EXPRESSION	Breast cancer metastasis suppressor 1 (BRMS1) was originally identified as an active metastasis suppressor in human breast cancer. Loss of BRMS1 expression correlates with tumor progression, and BRMS1 suppresses several steps required for tumor metastasis. However, the role of BRMS1 in hepatocellular carcinoma (HCC) remains elusive. In this study, we found that the expression level of BRMS1 was significantly down-regulated in HCC tissues. Expression of BRMS1 in SK-Hep1 cells did not affect cell growth under normal culture conditions, but sensitized cells to apoptosis induced by serum deprivation or anoikis. Consistently, knockdown of endogenous BRMS1 expression in Hep3B cells suppressed cell apoptosis. We identified that BRMS1 suppresses osteopontin (OPN) expression in HCC cells and that there is a negative correlation between BRMS1 and OPN mRNA expression in HCC tissues. Moreover, knockdown of endogenous OPN expression reversed the anti-apoptosis effect achieved by knockdown of BRMS1. Taken together, our results show that BRMS1 sensitizes HCC cells to apoptosis through suppressing OPN expression, suggesting a potential role of BRMS1 in regulating HCC apoptosis and metastasis.	[Wu, Yanhua; Jiang, Wenjun; Wang, Yingming; Wu, Jun; Saiyin, Hexige; Qiao, Xiaojing; Mei, Xinyu; Guo, Bin; Fang, Xiao; Zhang, Lu; Lou, Huiling; Wu, Chaoqun; Qiao, Shouyi] Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Fudan University	Wu, YH (corresponding author), Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	syqiao@fudan.edu.cn	Wu, Yanhua/GWU-9872-2022; wang, yingying/GRS-3058-2022	Wu, Yanhua/0000-0002-2803-809X; Saiyin, Hexige/0000-0003-2993-6817	National Natural Science foundation of China [31000558]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science foundation of China (31000558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi MS, 2004, BLOOD, V103, P4180, DOI 10.1182/blood-2003-06-2144; Champine PJ, 2007, CLIN EXP METASTAS, V24, P551, DOI 10.1007/s10585-007-9092-8; Chen RX, 2011, ONCOL REP, V25, P803, DOI 10.3892/or.2010.1116; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; Cicek M, 2004, CLIN EXP METASTAS, V21, P149, DOI 10.1023/B:CLIN.0000024729.19084.f0; Cook LM, 2012, CLIN EXP METASTAS, V29, P315, DOI 10.1007/s10585-012-9452-x; Courter D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009633; Edmonds MD, 2009, INT J CANCER, V125, P1778, DOI 10.1002/ijc.24616; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Giannelli G, 2001, LAB INVEST, V81, P613, DOI 10.1038/labinvest.3780270; Graessmann M, 2007, ONCOGENE, V26, P2840, DOI 10.1038/sj.onc.1210096; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hedley BD, 2008, INT J CANCER, V123, P526, DOI 10.1002/ijc.23542; Hicks DG, 2006, CLIN CANCER RES, V12, P6702, DOI 10.1158/1078-0432.CCR-06-0635; Hsieh YH, 2006, CANCER RES, V66, P7119, DOI 10.1158/0008-5472.CAN-06-1002; Hu HZ, 2011, GUT, V60, P710, DOI 10.1136/gut.2010.220020; Huang CS, 2008, J NUTR, V138, P538, DOI 10.1093/jn/138.3.538; Huang H, 2010, CANCER SCI, V101, P1314, DOI 10.1111/j.1349-7006.2010.01524.x; Hurst DR, 2011, INT REV CEL MOL BIO, V286, P107, DOI 10.1016/B978-0-12-385859-7.00003-3; Ito Y, 1999, BRIT J CANCER, V81, P747, DOI 10.1038/sj.bjc.6690758; Ito Y, 2000, BRIT J CANCER, V82, P1211; Jiang C, 2001, CANCER RES, V61, P3062; Jiang Jie, 2007, Zhonghua Fu Chan Ke Za Zhi, V42, P398; Kapoor P, 2004, INT J CANCER, V111, P693, DOI 10.1002/ijc.20318; Kim J, 2006, AM J GASTROENTEROL, V101, P2051, DOI 10.1111/j.1572-0241.2006.00679.x; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Li HP, 2005, CELL RES, V15, P262, DOI 10.1038/sj.cr.7290295; Li WC, 2006, CLIN CANCER RES, V12, P7140, DOI 10.1158/1078-0432.CCR-06-0484; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Lombardi G, 2007, INT J CANCER, V120, P1169, DOI 10.1002/ijc.22379; Malyankar UM, 2000, J BIOL CHEM, V275, P20959, DOI 10.1074/jbc.C000290200; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Metge BJ, 2008, CLIN EXP METASTAS, V25, P753, DOI 10.1007/s10585-008-9187-x; Nagai H, 1999, DNA Res, V6, P219, DOI 10.1093/dnares/6.4.219; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487; Phillips KK, 1996, CANCER RES, V56, P1222; Rivera J, 2007, J PROTEOME RES, V6, P4006, DOI 10.1021/pr0703167; Rytomaa M, 1999, CURR BIOL, V9, P1043, DOI 10.1016/S0960-9822(99)80454-0; Samant RS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-6; Samant RS, 2001, CLIN EXP METASTAS, V18, P683, DOI 10.1023/A:1013124725690; Saunders MM, 2001, CANCER RES, V61, P1765; Seraj MJ, 2000, CANCER RES, V60, P2764; Shevde LA, 2002, EXP CELL RES, V273, P229, DOI 10.1006/excr.2001.5452; Shi YH, 2008, HEPATOLOGY, V48, P497, DOI 10.1002/hep.22393; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Smith PW, 2009, CANCER LETT, V276, P196, DOI 10.1016/j.canlet.2008.11.024; Song G, 2008, CANCER SCI, V99, P1901, DOI 10.1111/j.1349-7006.2008.00911.x; Stafford LJ, 2008, INT J BIOCHEM CELL B, V40, P874, DOI 10.1016/j.biocel.2007.12.016; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; Wu YH, 2009, CLIN CANCER RES, V15, P60, DOI 10.1158/1078-0432.CCR-08-1028; Xue YH, 2010, HEPATOLOGY, V52, P2012, DOI 10.1002/hep.23942; Yang GH, 2008, ONCOLOGIST, V13, P1155, DOI 10.1634/theoncologist.2008-0081; Yang JY, 2011, LUNG CANCER, V74, P305, DOI 10.1016/j.lungcan.2011.03.002; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Yu MC, 2011, ANN SURG ONCOL; Zainabadi K, 2005, GENOMICS, V85, P704, DOI 10.1016/j.ygeno.2005.02.014; Zhang CH, 2012, INT J CANCER, V130, P2685, DOI 10.1002/ijc.26301; Zhang H, 2006, J CANCER RES CLIN, V132, P709, DOI 10.1007/s00432-006-0119-3; Zhang S, 2006, INT J GYNECOL CANCER, V16, P522, DOI 10.1111/j.1525-1438.2006.00547.x; Zhang ZH, 2006, CLIN CANCER RES, V12, P6410, DOI 10.1158/1078-0432.CCR-06-1347; Zhao J, 2008, GASTROENTEROLOGY, V135, P956, DOI 10.1053/j.gastro.2008.05.025; Zhao J, 2008, HEPATOLOGY, V48, P265, DOI 10.1002/hep.22280	65	22	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42976	10.1371/journal.pone.0042976	http://dx.doi.org/10.1371/journal.pone.0042976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927944	Green Submitted, Green Published, gold			2022-12-25	WOS:000307789700019
J	Dubois, F; Belzile, A				Dubois, Frederique; Belzile, Alexandra			Audience Effect Alters Male Mating Preferences in Zebra Finches (Taeniopygia guttata)	PLOS ONE			English	Article							MALE MATE CHOICE; SIAMESE FIGHTING FISH; SEXUAL SELECTION; PAIR	The social environment of animals strongly influences the mating preferences of both the choosing and the observing individuals. Notably, there is recent evidence that polygamous males decrease their selectivity when being observed by competitors in order to direct their rivals' attention away from their true interest and, consequently, reduce sperm competition risk. Yet, other mechanisms, whose importance remains unexplored, could induce similar effects. In monogamous species with mutual choice, particularly, if males adjust their selectivity according to the risk of being rejected by their preferred mate, they should as well become less selective when potential rivals are present. Here, we investigated whether the presence of bystanders modifies male mating preferences when the risk of sperm competition is low, by carrying out mate-choice experiments with male zebra finches (Taeniopygia guttata) whose preferences for two females were measured twice: with and without an audience. We found that the presence of potential rivals had no effect on the males' choosiness. However, with an audience, they spent more time with the female that was considered as the less attractive one in the control condition. These findings support the hypothesis that monogamous males alter their mate choice decisions in the presence of a male audience to reduce the risk of remaining unpaired. Thus, our results indicate that several explanations can account for the changes in male preferences due to the presence of competitors and highlight the importance of assessing the relative role of each mechanism potentially involved, to be able to make conclusions about the effect of an audience on signal evolution.	[Dubois, Frederique; Belzile, Alexandra] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Dubois, F (corresponding author), Univ Montreal, Dept Sci Biol, CP 6128, Montreal, PQ H3C 3J7, Canada.	frederique.dubois@UMontreal.ca			Natural Sciences and Engineering Research Council of Canada [312133]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	FD acknowledged financial support from Natural Sciences and Engineering Research Council of Canada www.crsng-nserc.gc.ca(#312133). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltz AP, 1997, ANIM BEHAV, V53, P1017, DOI 10.1006/anbe.1996.0354; Birkhead TR, 2010, EMU, V110, P189, DOI 10.1071/MU09086; BIRKHEAD TR, 1990, BEHAV ECOL SOCIOBIOL, V27, P315, DOI 10.1007/BF00164002; BURLEY N, 1987, ETHOLOGY, V76, P133; BURLEY N, 1982, ANIM BEHAV, V30, P444, DOI 10.1016/S0003-3472(82)80055-9; BURLEY N, 1986, AM NAT, V127, P415, DOI 10.1086/284493; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; Burley NT, 2006, ANIM BEHAV, V72, P713, DOI 10.1016/j.anbehav.2006.01.017; Cote K-A, 2006, THESIS U QUEBEC MONT; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Doutrelant C, 2001, BEHAV ECOL, V12, P283, DOI 10.1093/beheco/12.3.283; Drullion D, 2008, BEHAV ECOL SOCIOBIOL, V63, P269, DOI 10.1007/s00265-008-0658-5; DUGATKIN LA, 1993, BEHAV ECOL, V4, P289, DOI 10.1093/beheco/4.4.289; Dugatkin LA, 2000, IMITATION FACTOR EVO; Fisher HS, 2007, BIOL LETTERS, V3, P5, DOI 10.1098/rsbl.2006.0556; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Griffith SC, 2010, ANIM BEHAV, V79, P261, DOI 10.1016/j.anbehav.2009.11.031; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Jones KM, 2001, ANIM BEHAV, V62, P1021, DOI 10.1006/anbe.2001.1843; Matos RJ, 2002, BEHAVIOUR, V139, P1211, DOI 10.1163/15685390260437344; McGregor PK, 2005, ANIMAL COMMUNICATION; Monaghan P, 1996, P ROY SOC B-BIOL SCI, V263, P1183, DOI 10.1098/rspb.1996.0173; Padur L, 2009, BEHAVIOUR, V146, P1739, DOI 10.1163/000579509X12483520922124; Plath M, 2008, ANIM BEHAV, V75, P21, DOI 10.1016/j.anbehav.2007.05.013; Plath M, 2010, ACTA ETHOL, V13, P49, DOI 10.1007/s10211-010-0074-5; Plath M, 2009, BEHAV ECOL SOCIOBIOL, V63, P381, DOI 10.1007/s00265-008-0672-7; PRUETTJONES S, 1992, AM NAT, V140, P1000, DOI 10.1086/285452; Royle NJ, 2006, ANIM BEHAV, V72, P123, DOI 10.1016/j.anbehav.2005.09.023; Stohr S, 1998, ANIM BEHAV, V55, P893, DOI 10.1006/anbe.1997.0674; Swaddle JP, 2005, P ROY SOC B-BIOL SCI, V272, P1053, DOI 10.1098/rspb.2005.3054; Ung D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022686; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; Wagner RH, 2010, OIKOS, V119, P203, DOI 10.1111/j.1600-0706.2009.17315.x; White DJ, 2004, LEARN BEHAV, V32, P105; Witte K., 2006, FISH COGNITION BEHAV, P70, DOI DOI 10.1002/9780470996058.CH5; Witte K, 2006, ETHOL ECOL EVOL, V18, P195, DOI 10.1080/08927014.2006.9522707; Wong BBM, 2009, BEHAV ECOL, V20, P278, DOI 10.1093/beheco/arp010; Zann R. A., 1996, ZEBRA FINCHES SYNTHE; Ziege M, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-17	39	17	17	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43697	10.1371/journal.pone.0043697	http://dx.doi.org/10.1371/journal.pone.0043697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916298	gold, Green Submitted, Green Published			2022-12-25	WOS:000307733800096
J	Lee, TH; Wu, TS; Tseng, CP; Qiu, JT				Lee, Ta-Hsien; Wu, Tzong-Shoon; Tseng, Ching-Ping; Qiu, Jiantai Timothy			High-Resolution Melting Molecular Signatures for Rapid Identification of Human Papillomavirus Genotypes	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CERVICAL-CANCER; CONSENSUS PCR; HPV GENOTYPES; DNA; RISK; INFECTIONS; ASSAY; HYBRIDIZATION; PERSISTENCE	Background: Genotyping of human papillomarvirus (HPV) is crucial for patient management in a clinical setting. This study accesses the combined use of broad-range real-time PCR and high-resolution melting (HRM) analysis for rapid identification of HPV genotypes. Methods: Genomic DNA sequences of 8 high-risk genotypes (HPV16/18/39/45/52/56/58/68) were subject to bioinformatic analysis to select for appropriate PCR amplicon. Asymmetric broad-range real-time PCR in the presence of HRM dye and two unlabeled probes specific to HPV16 and 18 was employed to generate HRM molecular signatures for HPV genotyping. The method was validated via assessment of 119 clinical HPV isolates. Results: A DNA fragment within the L1 region was selected as the PCR amplicon ranging from 215-221 bp for different HPV genotypes. Each genotype displayed a distinct HRM molecular signature with minimal inter-assay variability. According to the HRM molecular signatures, HPV genotypes can be determined with one PCR within 3 h from the time of viral DNA isolation. In the validation assay, a 91% accuracy rate was achieved when the genotypes were in the database. Concomitantly, the HRM molecular signatures for additional 6 low-risk genotypes were established. Conclusions: This assay provides a novel approach for HPV genotyping in a rapid and cost-effective manner.	[Lee, Ta-Hsien; Wu, Tzong-Shoon; Tseng, Ching-Ping; Qiu, Jiantai Timothy] Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Wu, Tzong-Shoon; Qiu, Jiantai Timothy] Coll Med, Dept Biomed Sci, Tao Yuan, Taiwan; [Tseng, Ching-Ping] Coll Med, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Tseng, Ching-Ping] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan; [Qiu, Jiantai Timothy] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital	Lee, TH (corresponding author), Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	ctseng@mail.cgu.edu.tw; jtqiu@cgmh.org.tw	Timothy, Qiu J./AAV-3086-2020	Qiu, JT/0000-0001-7090-6906; TSENG, CHING-PING/0000-0002-2587-210X	National Science Council [NMRPD180311]; Department of Health [DOH99-TD-C-111-006]; Chang Gung Molecular Medicine Research Center [EMRPD1B0151]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; Chang Gung Molecular Medicine Research Center	This work was supported by the National Science Council [NMRPD180311 to J.T.Q.], Department of Health [DOH99-TD-C-111-006 to J.T.Q.] and Chang Gung Molecular Medicine Research Center [EMRPD1B0151 to C.-P.T.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baay MFD, 1996, J CLIN MICROBIOL, V34, P745, DOI 10.1128/JCM.34.3.745-747.1996; Chang SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020303; Chao A, 2004, AM J OBSTET GYNECOL, V190, P1046, DOI 10.1016/j.ajog.2003.09.054; Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286; Chua KL, 1996, CANCER, V77, P121, DOI 10.1002/(SICI)1097-0142(19960101)77:1<121::AID-CNCR20>3.0.CO;2-6; Cope JU, 1997, J CLIN MICROBIOL, V35, P2262, DOI 10.1128/JCM.35.9.2262-2265.1997; Coutlee F, 2011, J MED VIROL, V83, P1034, DOI 10.1002/jmv.22081; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Dames S, 2007, CLIN CHEM, V53, P1847, DOI 10.1373/clinchem.2007.090761; Dames S, 2007, J MOL DIAGN, V9, P290, DOI 10.2353/jmoldx.2007.060139; Depuydt CE, 2007, J CELL MOL MED, V11, P881, DOI 10.1111/j.1582-4934.2007.00073.x; Franco EL, 2006, LANCET ONCOL, V7, P527, DOI 10.1016/S1470-2045(06)70735-5; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; Herrmann MG, 2006, CLIN CHEM, V52, P494, DOI 10.1373/clinchem.2005.063438; HILDESHEIM A, 1994, J INFECT DIS, V169, P235, DOI 10.1093/infdis/169.2.235; Huang HJ, 2004, INT J GYNECOL CANCER, V14, P639, DOI 10.1111/j.1048-891X.2004.14418.x; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; HUSMAN AMD, 1995, BRIT J CANCER, V72, P412, DOI 10.1038/bjc.1995.347; Iftner T, 2009, J CLIN MICROBIOL, V47, P2106, DOI 10.1128/JCM.01907-08; Jacobs MV, 1999, J CLIN PATHOL, V52, P498, DOI 10.1136/jcp.52.7.498; Kulasingam SL, 2007, VACCINE, V25, P8110, DOI 10.1016/j.vaccine.2007.09.035; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Lai CH, 2007, INT J CANCER, V120, P1999, DOI 10.1002/ijc.22538; Lin JH, 2008, J CLIN MICROBIOL, V46, P1090, DOI 10.1128/JCM.02015-07; Lin P, 2001, CANCER EPIDEM BIOMAR, V10, P1037; LOW SH, 1990, JPN J CANCER RES, V81, P1118, DOI 10.1111/j.1349-7006.1990.tb02522.x; Manos MM, 1999, JAMA-J AM MED ASSOC, V281, P1605, DOI 10.1001/jama.281.17.1605; Mori S, 2011, CANCER SCI, V102, P1223, DOI 10.1111/j.1349-7006.2011.01922.x; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Raj GV, 1998, CANCER-AM CANCER SOC, V82, P1419, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1419::AID-CNCR1>3.0.CO;2-4; Sandri MT, 2006, J CLIN MICROBIOL, V44, P2141, DOI 10.1128/JCM.00049-06; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; Schmitz M, 2009, J CLIN VIROL, V44, P302, DOI 10.1016/j.jcv.2009.01.006; Seipp MT, 2007, J MOL DIAGN, V9, P284, DOI 10.2353/jmoldx.2007.060136; Sjoeborg KD, 2010, GYNECOL ONCOL, V118, P29, DOI 10.1016/j.ygyno.2010.03.007; Stephens AJ, 2008, CLIN CHEM, V54, P432, DOI 10.1373/clinchem.2007.093658; Tajiri-Utagawa E, 2009, J CLIN MICROBIOL, V47, P435, DOI 10.1128/JCM.01247-08; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129; Tucker RA, 2001, MOL DIAGN, V6, P39, DOI 10.2165/00066982-200106010-00005; van Ham MAPC, 2005, J CLIN MICROBIOL, V43, P2662, DOI 10.1128/JCM.43.6.2662-2667.2005; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Won H, 2010, J CLIN MICROBIOL, V48, P3410, DOI 10.1128/JCM.00718-10; Yang S, 2009, J CLIN MICROBIOL, V47, P2252, DOI 10.1128/JCM.00033-09; Zhou LM, 2004, CLIN CHEM, V50, P1328, DOI 10.1373/clinchem.2004.034322; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	49	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42051	10.1371/journal.pone.0042051	http://dx.doi.org/10.1371/journal.pone.0042051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916117	gold, Green Submitted, Green Published			2022-12-25	WOS:000307733800015
J	Shivaraj, MC; Marcy, G; Low, GL; Ryu, JR; Zhao, XF; Rosales, FJ; Goh, ELK				Shivaraj, Mattu Chetana; Marcy, Guillaume; Low, Guoliang; Ryu, Jae Ryun; Zhao, Xianfeng; Rosales, Francisco J.; Goh, Eyleen L. K.			Taurine Induces Proliferation of Neural Stem Cells and Synapse Development in the Developing Mouse Brain	PLOS ONE			English	Article							DENTATE GYRUS; HIPPOCAMPAL-NEURONS; PRECURSOR CELLS; GRANULE CELLS; IN-VITRO; FETAL; PROGENITOR; MICE; RAT; DIFFERENTIATION	Taurine is a sulfur-containing amino acid present in high concentrations in mammalian tissues. It has been implicated in several processes involving brain development and neurotransmission. However, the role of taurine in hippocampal neurogenesis during brain development is still unknown. Here we show that taurine regulates neural progenitor cell (NPC) proliferation in the dentate gyrus of the developing brain as well as in cultured early postnatal (P5) hippocampal progenitor cells and hippocampal slices derived from P5 mice brains. Taurine increased cell proliferation without having a significant effect on neural differentiation both in cultured P5 NPCs as well as cultured hippocampal slices and in vivo. Expression level analysis of synaptic proteins revealed that taurine increases the expression of Synapsin 1 and PSD 95. We also found that taurine stimulates the phosphorylation of ERK1/2 indicating a possible role of the ERK pathway in mediating the changes that we observed, especially in proliferation. Taken together, our results demonstrate a role for taurine in neural stem/progenitor cell proliferation in developing brain and suggest the involvement of the ERK1/2 pathways in mediating these actions. Our study also shows that taurine influences the levels of proteins associated with synapse development. This is the first evidence showing the effect of taurine on early postnatal neuronal development using a combination of in vitro, ex-vivo and in vivo systems.	[Shivaraj, Mattu Chetana; Marcy, Guillaume; Low, Guoliang; Ryu, Jae Ryun; Goh, Eyleen L. K.] Duke NUS Grad Med Sch, Program Neurosci & Behav Disorder, Singapore, Singapore; [Zhao, Xianfeng; Rosales, Francisco J.] Asia Pacific Ctr, Cognit Ctr Excellence Abbott Nutr Res & Dev, Singapore, Singapore; [Goh, Eyleen L. K.] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Goh, Eyleen L. K.] A STAR Duke NUS Neurosci Res Partnership, Singapore, Singapore	National University of Singapore; National University of Singapore	Shivaraj, MC (corresponding author), Duke NUS Grad Med Sch, Program Neurosci & Behav Disorder, Singapore, Singapore.	eyleen.goh@duke-nus.edu.sg	Goh, Eyleen/A-8006-2013; Marcy, Geoff/AAC-6050-2019; Marcy, Guillaume/M-8063-2014	Goh, Eyleen/0000-0002-8244-6959; Marcy, Guillaume/0000-0002-3469-8131	Duke-NUS Graduate Medical School, Singapore [169857]; Abbott Nutrition Research & Development, Singapore [138668]	Duke-NUS Graduate Medical School, Singapore; Abbott Nutrition Research & Development, Singapore	The present research is supported by: A Startup fund from Duke-NUS Graduate Medical School, Singapore 169857 and Abbott Nutrition Research & Development, Singapore 138668. The funders had no role in study design, data collection, decision to publish and analysis or preparation of the manuscript.	AGRAWAL HC, 1968, J NEUROCHEM, V15, P917, DOI 10.1111/j.1471-4159.1968.tb11633.x; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Boyer P, 2007, BRAIN RES REV, V54, P92, DOI 10.1016/j.brainresrev.2006.12.008; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Chen XC, 1998, ADV EXP MED BIOL, V442, P397; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Coecke S, 2007, ENVIRON HEALTH PERSP, V115, P924, DOI 10.1289/ehp.9427; Davidson S, 2010, BRAIN RES, V1307, P43, DOI 10.1016/j.brainres.2009.10.024; De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228; El-Hussein AE, 2000, SCIENCE, V290, P1364; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Goh ELK, 2003, J HEMATOTH STEM CELL, V12, P671, DOI 10.1089/15258160360732696; Goh ELK, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-10; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Hernandez-Benitez R, 2010, J NEUROSCI RES, V88, P1673, DOI 10.1002/jnr.22328; Hu SX, 2006, J PHARMACOL EXP THER, V318, P1280, DOI 10.1124/jpet.106.103853; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Jeon SH, 2007, FEBS LETT, V581, P5929, DOI 10.1016/j.febslet.2007.11.035; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kelly CM, 2005, BRAIN RES BULL, V68, P83, DOI 10.1016/j.brainresbull.2005.08.020; Kuriyama K, 1983, Prog Clin Biol Res, V125, P127; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Militante JD, 2002, NUTR NEUROSCI, V5, P75, DOI 10.1080/10284150290018991; Militante JD, 1999, BRAIN RES, V818, P368, DOI 10.1016/S0006-8993(98)01318-3; Miller TJ, 2000, COMP BIOCHEM PHYS A, V125, P45, DOI 10.1016/S1095-6433(99)00160-9; Muramatsu R, 2007, NEUROSCIENCE, V148, P593, DOI 10.1016/j.neuroscience.2007.06.040; NEURINGER M, 1990, PROG CLIN BIOL RES, V351, P415; PALACKAL T, 1986, J NEUROSCI RES, V15, P223, DOI 10.1002/jnr.490150212; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Park HR, 2011, ANN NY ACAD SCI, V1229, P23, DOI 10.1111/j.1749-6632.2011.06089.x; Peltier J., 2010, ISOLATION ADULT HIPP, P57; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Radio NM, 2008, NEUROTOXICOLOGY, V29, P361, DOI 10.1016/j.neuro.2008.02.011; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Rao A, 1998, J NEUROSCI, V18, P1217; Rosales FJ, 2008, NUTR NEUROSCI, V11, P135, DOI 10.1179/147683008X301522; SCHULLERLEVIS G, 1990, J LEUKOCYTE BIOL, V47, P321, DOI 10.1002/jlb.47.4.321; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; STURMAN JA, 1975, J NEUROCHEM, V25, P831, DOI 10.1111/j.1471-4159.1975.tb04414.x; STURMAN JA, 1985, J NEUROSCI RES, V13, P405, DOI 10.1002/jnr.490130307; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; TAPPAZ M, 1992, NEUROCHEM RES, V17, P849, DOI 10.1007/BF00993260; Taupin P, 2009, EXPERT OPIN THER PAT, V19, P523, DOI 10.1517/13543770902721279; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Wharton BA, 2004, ARCH DIS CHILD-FETAL, V89, pF497, DOI 10.1136/adc.2003.048389; Whittle N, 2007, PEDIATRICS, V120, pE1465, DOI 10.1542/peds.2006-3448	48	62	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42935	10.1371/journal.pone.0042935	http://dx.doi.org/10.1371/journal.pone.0042935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916184	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800037
J	Biber, A; Abuelaish, I; Rahav, G; Raz, M; Cohen, L; Valinsky, L; Taran, D; Goral, A; Elhamdany, A; Regev-Yochay, G				Biber, Asaf; Abuelaish, Izeldeen; Rahav, Galia; Raz, Meir; Cohen, Liran; Valinsky, Lea; Taran, Dianna; Goral, Aviva; Elhamdany, Abedalla; Regev-Yochay, Gili		PICR Study Grp	A Typical Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Clone Is Widespread in the Community in the Gaza Strip	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; EPIDEMIC MRSA; INFECTIONS; PREVALENCE; MULTIPLEX; EMERGENCE; OUTBREAK; GERMANY; STRAIN; GENE	Epidemiological data on community acquired methicillin-resistant-Staphylococcus aureus (CA-MRSA) carriage and infection in the Middle-East region is scarce with only few reports in the Israeli and Palestinian populations. As part of a Palestinian-Israeli collaborative research, we have conducted a cross-sectional survey of nasal S. aureus carriage in healthy children and their parents throughout the Gaza strip. Isolates were characterized for antibiotic susceptibility, mec gene presence, PFGE, spa type, SCCmec-type, presence of PVL genes and multi-locus-sequence-type (MLST). S. aureus was carried by 28.4% of the 379 screened children-parents pairs. MRSA was detected in 45% of S. aureus isolates, that is, in 12% of the study population. A single ST22-MRSA-IVa, spa t223, PVL-gene negative strain was detected in 64% of MRSA isolates. This strain is typically susceptible to all non-beta-lactam antibiotics tested. The only predictor for MRSA carriage in children was having an MRSA carrier-parent (OR = 25.5, P = 0.0004). Carriage of the Gaza strain was not associated with prior hospitalization. The Gaza strain was closely related genetically to a local MSSA spa t223 strain and less so to EMRSA15, one of the pandemic hospital-acquired-MRSA clones, scarcely reported in the community. The rapid spread in the community may be due to population determinants or due to yet unknown advantageous features of this particular strain.	[Biber, Asaf; Rahav, Galia; Cohen, Liran; Goral, Aviva; Regev-Yochay, Gili] Tel Aviv Univ, Infect Dis Unit, Sackler Sch Med, Sheba Med Ctr, Ramat Gan, Israel; [Biber, Asaf; Cohen, Liran; Goral, Aviva; Regev-Yochay, Gili] Gertner Inst Epidemiol & Hlth Policy Res, Infect Dis Epidemiol Sect, Ramat Gan, Israel; [Abuelaish, Izeldeen] Univ Toronto, Global Hlth Div, Dala Lana Sch Publ Hlth, Toronto, ON, Canada; [Raz, Meir] Maccabi Healthcare Serv, Jerusalem Hashfela Dist, Modiin, Israel; [Valinsky, Lea] Minist Hlth, Govt Cent Labs, Jerusalem, Israel; [Taran, Dianna] Maccabi Healthcare Serv, Cent Lab, Rehovot, Israel; [Elhamdany, Abedalla] Keystone Consulting Serv, Gaza City, The Gaza Strip, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Toronto	Biber, A (corresponding author), Tel Aviv Univ, Infect Dis Unit, Sackler Sch Med, Sheba Med Ctr, Ramat Gan, Israel.	asafbib@gmail.com; gregev@hsph.harvard.edu	Goral, Aviva/K-8254-2016; Biber, Asaf/AAX-2966-2021	Goral, Aviva/0000-0002-0784-0569; Biber, Asaf/0000-0001-6007-0383; Regev-Yochay, Gili/0000-0001-7163-4607	Gertner Institute for Epidemiology Research and Health Policy; Maccabi Healthcare Services Research Institute [RC-24010]	Gertner Institute for Epidemiology Research and Health Policy; Maccabi Healthcare Services Research Institute	This study was funded by the Gertner Institute for Epidemiology Research and Health Policy 2009 and by Maccabi Healthcare Services Research Institute RC-24010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2010, J CLIN MICROBIOL, V48, P531, DOI 10.1128/JCM.02290-08; Campbell KM, 2004, J CLIN MICROBIOL, V42, P4050, DOI 10.1128/JCM.42.9.4050-4053.2004; Carmichael IC, 1999, J ANTIMICROB CHEMOTH, V44, P293, DOI 10.1093/jac/44.2.293; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Charlebois ED, 2002, CLIN INFECT DIS, V34, P425, DOI 10.1086/338069; Cuny C, 2009, INT J MED MICROBIOL, V300, P109; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Fontanilla JM, 2010, J CLIN MICROBIOL, V48, P609, DOI 10.1128/JCM.02297-09; Ghebremedhin B, 2007, J MED MICROBIOL, V56, P365, DOI 10.1099/jmm.0.46883-0; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Huijsdens XW, 2006, J CLIN MICROBIOL, V44, P2994, DOI 10.1128/JCM.00846-06; Kaibni MH, 2009, J MED MICROBIOL, V58, P644, DOI 10.1099/jmm.0.007617-0; Kajita E, 2007, NAT REV MICROBIOL, V5, P700, DOI 10.1038/nrmicro1660; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Mollaghan AM, 2010, EPIDEMIOL INFECT, V138, P673, DOI 10.1017/S0950268810000191; O'Neill GL, 2001, J CLIN MICROBIOL, V39, P1540, DOI 10.1128/JCM.39.4.1540-1548.2001; Regev-Yochay G, 2006, EUR J CLIN MICROBIOL, V25, P719, DOI 10.1007/s10096-006-0210-3; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Simoes RR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017630, 10.1371/journal.pone.0029279]; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Witte W, 2001, INT J MED MICROBIOL, V290, P677, DOI 10.1016/S1438-4221(01)80006-0; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	27	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42864	10.1371/journal.pone.0042864	http://dx.doi.org/10.1371/journal.pone.0042864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916171	Green Published, Green Submitted, gold			2022-12-25	WOS:000307824300020
J	Grooman, B; Fujiwara, I; Otey, C; Upadhyaya, A				Grooman, Brian; Fujiwara, Ikuko; Otey, Carol; Upadhyaya, Arpita			Morphology and Viscoelasticity of Actin Networks Formed with the Mutually Interacting Crosslinkers: Palladin and Alpha-actinin	PLOS ONE			English	Article							CYTOSKELETAL POLYMER NETWORKS; F-ACTIN; MECHANICAL-PROPERTIES; FILAMENT NETWORKS; BINDING PROTEINS; CELL MECHANICS; GELS; DETERMINES; ELASTICITY; STIFFNESS	Actin filaments and associated actin binding proteins play an essential role in governing the mechanical properties of eukaryotic cells. Even though cells have multiple actin binding proteins (ABPs) that exist simultaneously to maintain the structural and mechanical integrity of the cellular cytoskeleton, how these proteins work together to determine the properties of actin networks is not clearly understood. The ABP, palladin, is essential for the maintenance of cell morphology and the regulation of cell movement. Palladin coexists with alpha-actinin in stress fibers and focal adhesions and binds to both actin and alpha-actinin. To obtain insight into how mutually interacting actin crosslinking proteins modulate the properties of actin networks, we characterized the micro-structure and mechanics of actin networks crosslinked with palladin and alpha-actinin. We first showed that palladin crosslinks actin filaments into bundled networks which are viscoelastic in nature. Our studies also showed that composite networks of alpha-actinin/palladin/actin behave very similar to pure palladin or pure alpha-actinin networks. However, we found evidence that palladin and alpha-actinin synergistically modify network viscoelasticity. To our knowledge, this is the first quantitative characterization of the physical properties of actin networks crosslinked with two mutually interacting crosslinkers.	[Grooman, Brian] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Fujiwara, Ikuko] NHLBI, NIH, Bethesda, MD 20892 USA; [Otey, Carol] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Upadhyaya, Arpita] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Upadhyaya, Arpita] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of North Carolina; University of North Carolina Chapel Hill; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Grooman, B (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.	arpitau@umd.edu	Fujiwara, Ikuko/H-5717-2016	Fujiwara, Ikuko/0000-0002-9361-636X	Alfred P. Sloan Foundation; National Science Foundation [112170]; Direct For Biological Sciences [1121710] Funding Source: National Science Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work has been supported by the Alfred P. Sloan Foundation and the National Science Foundation (Grant 112170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrego-Diaz E, 2006, J STRUCT BIOL, V155, P230, DOI 10.1016/j.jsb.2006.01.013; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; Esue O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004411; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Gardel ML, 2008, METHOD CELL BIOL, V89, P487, DOI 10.1016/S0091-679X(08)00619-5; Gardel ML, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088102; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382; Jin L, 2009, J BIOL CHEM, V284, P2121, DOI 10.1074/jbc.M806095200; Kas J, 1996, BIOPHYS J, V70, P609, DOI 10.1016/S0006-3495(96)79630-3; Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002; Lieleg O, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.158105; Lieleg O, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.108101; Lieleg O, 2009, BIOPHYS J, V96, P4725, DOI 10.1016/j.bpj.2009.03.038; Lindstrom SB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051905; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mickel W, 2008, BIOPHYS J, V95, P6072, DOI 10.1529/biophysj.108.135939; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Ronty M, 2004, FEBS LETT, V566, P30, DOI 10.1061/j.febslet.2004.04.006; SATO M, 1987, NATURE, V325, P828, DOI 10.1038/325828a0; Schmoller KM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.118102; Schmoller KM, 2009, BIOPHYS J, V97, P83, DOI 10.1016/j.bpj.2009.04.040; Shin JH, 2004, P NATL ACAD SCI USA, V101, P9636, DOI 10.1073/pnas.0308733101; Stein AM, 2008, J MICROSC-OXFORD, V232, P463, DOI 10.1111/j.1365-2818.2008.02141.x; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Strehle D, 2011, EUR BIOPHYS J BIOPHY, V40, P93, DOI 10.1007/s00249-010-0621-z; Tempel M, 1996, PHYS REV E, V54, P1802, DOI 10.1103/PhysRevE.54.1802; Tseng Y, 2005, BIOCHEM BIOPH RES CO, V334, P183, DOI 10.1016/j.bbrc.2005.05.205; Tseng Y, 2001, BIOPHYS J, V81, P1643, DOI 10.1016/S0006-3495(01)75818-3; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103; Ward SMV, 2008, BIOPHYS J, V95, P4915, DOI 10.1529/biophysj.108.131722	44	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42773	10.1371/journal.pone.0042773	http://dx.doi.org/10.1371/journal.pone.0042773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916157	Green Published, gold, Green Submitted			2022-12-25	WOS:000307824300015
J	Masloboeva, N; Reutimann, L; Stiefel, P; Follador, R; Leimer, N; Hennecke, H; Mesa, S; Fischer, HM				Masloboeva, Nadezda; Reutimann, Luzia; Stiefel, Philipp; Follador, Rainer; Leimer, Nadja; Hennecke, Hauke; Mesa, Socorro; Fischer, Hans-Martin			Reactive Oxygen Species-Inducible ECF sigma Factors of Bradyrhizobium japonicum	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASE; BACTERIAL 2-HYBRID SYSTEM; OXIDATIVE STRESS; SINGLET OXYGEN; TRANSCRIPTIONAL REGULATOR; MYXOCOCCUS-XANTHUS; SIGNALING CASCADE; HEAT-SHOCK; GENE; EXPRESSION	Extracytoplasmic function (ECF) sigma factors control the transcription of genes involved in different cellular functions, such as stress responses, metal homeostasis, virulence-related traits, and cell envelope structure. The genome of Bradyrhizobium japonicum, the nitrogen-fixing soybean endosymbiont, encodes 17 putative ECF sigma factors belonging to nine different ECF sigma factor families. The genes for two of them, ecfQ (bll1028) and ecfF (blr3038), are highly induced in response to the reactive oxygen species hydrogen peroxide (H2O2) and singlet oxygen (O-1(2)). The ecfF gene is followed by the predicted anti-sigma factor gene osrA (blr3039). Mutants lacking EcfQ, EcfF plus OsrA, OsrA alone, or both sigma factors plus OsrA were phenotypically characterized. While the symbiotic properties of all mutants were indistinguishable from the wild type, they showed increased sensitivity to singlet oxygen under free-living conditions. Possible target genes of EcfQ and EcfF were determined by microarray analyses, and candidate genes were compared with the H2O2-responsive regulon. These experiments disclosed that the two sigma factors control rather small and, for the most part, distinct sets of genes, with about half of the genes representing 13% of the members of H2O2-responsive regulon. To get more insight into transcriptional regulation of both sigma factors, the 5' ends of ecfQ and ecfF mRNA were determined. The presence of conserved sequence motifs in the promoter region of ecfQ and genes encoding EcfQ-like sigma factors in related alpha-proteobacteria suggests regulation via a yet unknown transcription factor. By contrast, we have evidence that ecfF is autoregulated by transcription from an EcfF-dependent consensus promoter, and its product is negatively regulated via protein-protein interaction with OsrA. Conserved cysteine residues 129 and 179 of OsrA are required for normal function of OsrA. Cysteine 179 is essential for release of EcfF from an EcfF-OsrA complex upon H2O2 stress while cysteine 129 is possibly needed for EcfF-OsrA interaction.	[Masloboeva, Nadezda; Reutimann, Luzia; Stiefel, Philipp; Follador, Rainer; Leimer, Nadja; Hennecke, Hauke; Mesa, Socorro; Fischer, Hans-Martin] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Masloboeva, N (corresponding author), ETH, Inst Microbiol, CH-8092 Zurich, Switzerland.	fischerh@micro.biol.ethz.ch	Leimer, Nadja/AAC-3822-2022; Mesa, Socorro/G-7775-2015	Mesa, Socorro/0000-0001-7285-3940; Leimer, Nadja/0000-0002-5355-2197	ETH Zurich; Swiss National Foundation for Scientific Research [31003A-122371]	ETH Zurich(ETH Zurich); Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF))	This work was supported by grants from ETH Zurich and from the Swiss National Foundation for Scientific Research (grant no. 31003A-122371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamuri P, 2004, MOL MICROBIOL, V53, P1397, DOI 10.1111/j.1365-2958.2004.04190.x; ALEXEYEV MF, 1995, BIOTECHNIQUES, V18, P52; Alvarez-Martinez CE, 2006, J BACTERIOL, V188, P1835, DOI 10.1128/JB.188.5.1835-1846.2006; Alvarez-Martinez CE, 2007, MOL MICROBIOL, V66, P1240, DOI 10.1111/j.1365-2958.2007.06005.x; Anthony JR, 2005, P NATL ACAD SCI USA, V102, P6502, DOI 10.1073/pnas.0502225102; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Atack JM, 2008, MICROBIOL-SGM, V154, P2219, DOI 10.1099/mic.0.2008/019711-0; Bastiat B, 2010, J BACTERIOL, V192, P2255, DOI 10.1128/JB.01666-09; Becana M, 2010, NEW PHYTOL, V188, P960, DOI 10.1111/j.1469-8137.2010.03512.x; Beck C, 1997, J BACTERIOL, V179, P364, DOI 10.1128/jb.179.2.364-369.1997; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; Bussmann M, 2010, J BIOL CHEM, V285, P29305, DOI 10.1074/jbc.M110.156372; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Campbell EA, 2007, MOL CELL, V27, P793, DOI 10.1016/j.molcel.2007.07.009; Chang C, 2009, MOL PLANT, V2, P370, DOI 10.1093/mp/ssn090; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dolla A, 2006, J BIOTECHNOL, V126, P87, DOI 10.1016/j.jbiotec.2006.03.041; Donati AJ, 2011, APPL ENVIRON MICROB, V77, P3633, DOI 10.1128/AEM.00047-11; Dufour YS, 2008, J MOL BIOL, V383, P713, DOI 10.1016/j.jmb.2008.08.017; Evans PJ, 1999, PLANTA, V208, P73, DOI 10.1007/s004250050536; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Fontes M, 2003, MOL MICROBIOL, V47, P561, DOI 10.1046/j.1365-2958.2003.03319.x; Galbis-Martinez L, 2008, MICROBIOL-SGM, V154, P895, DOI 10.1099/mic.0.2007/013359-0; Glaeser J, 2011, ADV MICROB PHYSIOL, V58, P141, DOI 10.1016/B978-0-12-381043-4.00004-0; Gorham HC, 1996, MOL MICROBIOL, V19, P171, DOI 10.1046/j.1365-2958.1996.360888.x; GOTTFERT M, 1990, MOL PLANT MICROBE IN, V3, P308, DOI 10.1094/MPMI-3-308; Gourion B, 2009, MOL MICROBIOL, V73, P291, DOI 10.1111/j.1365-2958.2009.06769.x; Greenwell R, 2011, J MOL BIOL, V407, P477, DOI 10.1016/j.jmb.2011.01.055; Grote A, 2009, NUCLEIC ACIDS RES, V37, pD61, DOI 10.1093/nar/gkn837; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Gunesekere IC, 2006, J BACTERIOL, V188, P3463, DOI 10.1128/JB.188.10.3463-3469.2006; HAHN M, 1984, PLANT MOL BIOL, V3, P159, DOI 10.1007/BF00016063; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hauser F, 2006, MOL GENET GENOMICS, V275, P55, DOI 10.1007/s00438-005-0059-7; Hauser F, 2007, MOL GENET GENOMICS, V278, P255, DOI 10.1007/s00438-007-0246-9; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Hoopman TC, 2011, INFECT IMMUN, V79, P745, DOI 10.1128/IAI.01060-10; Hopman CTP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-164; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jeon JM, 2011, MOL PLANT MICROBE IN, V24, P1472, DOI 10.1094/MPMI-03-11-0072; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawasaki S, 2005, APPL ENVIRON MICROB, V71, P8442, DOI 10.1128/AEM.71.12.8442-8450.2005; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Latch DE, 2006, SCIENCE, V311, P1743, DOI 10.1126/science.1121636; LEWIN A, 1990, MOL PLANT MICROBE IN, V3, P317, DOI 10.1094/MPMI-3-317; Lindemann A, 2007, J BACTERIOL, V189, P8928, DOI 10.1128/JB.01088-07; Liu X, 2001, Pac Symp Biocomput, P127; Lourenco RF, 2011, MOL MICROBIOL, V80, P1598, DOI 10.1111/j.1365-2958.2011.07668.x; Lourenco RF, 2009, MOL MICROBIOL, V72, P1159, DOI 10.1111/j.1365-2958.2009.06714.x; Martinez-Salazar JM, 2009, J BACTERIOL, V191, P4122, DOI 10.1128/JB.01626-08; Mesa S, 2005, J BACTERIOL, V187, P3329, DOI 10.1128/JB.187.10.3329-3338.2005; Mesa S, 2008, J BACTERIOL, V190, P6568, DOI 10.1128/JB.00748-08; Mesa S, 2009, P NATL ACAD SCI USA, V106, P21860, DOI 10.1073/pnas.0908097106; Miller JH., 1972, EXPT MOL GENETICS; Mishra MN, 2011, MICROBIOL-SGM, V157, P988, DOI 10.1099/mic.0.046672-0; Mitchell JE, 2003, NUCLEIC ACIDS RES, V31, P4689, DOI 10.1093/nar/gkg694; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moskovitz J, 2005, CURR PHARM DESIGN, V11, P1451, DOI 10.2174/1381612053507846; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Nicholas Jr KBNHB, 1997, EMBNETNEWS, V4; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Panek HR, 2004, J BACTERIOL, V186, P7874, DOI 10.1128/JB.186.23.7874-7880.2004; Pauly N, 2006, J EXP BOT, V57, P1769, DOI 10.1093/jxb/erj184; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Rudolph G, 2006, J BACTERIOL, V188, P2294, DOI 10.1128/JB.188.6.2294.2006; Sambrook J., 2001, MOL CLONING LAB MANU; Santos R, 2001, MOL PLANT MICROBE IN, V14, P86, DOI 10.1094/MPMI.2001.14.1.86; Singh VK, 2003, MICROBIOL-SGM, V149, P2739, DOI 10.1099/mic.0.26442-0; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Stockwell SB, 2012, MOL PLANT MICROBE IN, V25, P119, DOI 10.1094/MPMI-07-11-0188; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; VANBOGELEN RA, 1987, J BACTERIOL, V169, P26, DOI 10.1128/jb.169.1.26-32.1987; Vattanaviboon P, 2005, J BACTERIOL, V187, P5831, DOI 10.1128/JB.187.16.5831-5836.2005; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Yeoman KH, 2003, FEMS MICROBIOL LETT, V223, P239, DOI 10.1016/S0378-1097(03)00386-0; Yeoman KH, 1999, MOL PLANT MICROBE IN, V12, P994, DOI 10.1094/MPMI.1999.12.11.994; Zhao C, 2010, INFECT IMMUN, V78, P3889, DOI 10.1128/IAI.00165-10	89	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43421	10.1371/journal.pone.0043421	http://dx.doi.org/10.1371/journal.pone.0043421			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916258	gold, Green Published, Green Submitted			2022-12-25	WOS:000307824300047
J	Vatin, M; Burgio, G; Renault, G; Laissue, P; Firlej, V; Mondon, F; Montagutelli, X; Vaiman, D; Serres, C; Ziyyat, A				Vatin, Magalie; Burgio, Gaetan; Renault, Gilles; Laissue, Paul; Firlej, Virginie; Mondon, Francoise; Montagutelli, Xavier; Vaiman, Daniel; Serres, Catherine; Ziyyat, Ahmed			Refined Mapping of a Quantitative Trait Locus on Chromosome 1 Responsible for Mouse Embryonic Death	PLOS ONE			English	Article							RECURRENT MISCARRIAGE; SPONTANEOUS-ABORTION; CYTOGENETIC ANALYSIS; CELL-PROLIFERATION; GENE; MICE; DISRUPTION; LETHALITY; MUTATION; DEFECTS	Recurrent spontaneous abortion (RSA) is defined as the loss of three or more consecutive pregnancies during the first trimester of embryonic intrauterine development. This kind of human infertility is frequent among the general population since it affects 1 to 5% of women. In half of the cases the etiology remains unelucidated. In the present study, we used interspecific recombinant congenic mouse strains (IRCS) in the aim to identify genes responsible for embryonic lethality. Applying a cartographic approach using a genotype/phenotype association, we identified a minimal QTL region, of about 6 Mb on chromosome 1, responsible for a high rate of embryonic death (similar to 30%). Genetic analysis suggests that the observed phenotype is linked to uterine dysfunction. Transcriptomic analysis of the uterine tissue revealed a preferential deregulation of genes of this region compared to the rest of the genome. Some genes from the QTL region are associated with VEGF signaling, mTOR signaling and ubiquitine/proteasome-protein degradation pathways. This work may contribute to elucidate the molecular basis of a multifactorial and complex human disorder as RSA.	[Vatin, Magalie; Renault, Gilles; Firlej, Virginie; Mondon, Francoise; Vaiman, Daniel; Serres, Catherine; Ziyyat, Ahmed] Univ Paris 05, Inst Cochin Inserm CNRS UMR 8104 U1016, Paris, France; [Burgio, Gaetan; Montagutelli, Xavier] Inst Pasteur, Unite Genet Mammiferes, F-75724 Paris, France; [Burgio, Gaetan] Univ Tasmania, Menzies Res Inst, Dept Genet, Hobart, Tas, Australia; [Laissue, Paul] Univ Del Rosario, Fac Med, Unidad Genet, Bogota, Colombia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Tasmania; Menzies Institute for Medical Research	Vatin, M (corresponding author), Univ Paris 05, Inst Cochin Inserm CNRS UMR 8104 U1016, Paris, France.	ahmed.ziyyat@parisdescartes.fr	Firlej, Virginie/AFQ-6362-2022; Firlej, Virginie/R-2065-2018; Laissue, Paul/C-6787-2012; Vaiman, Daniel/O-6030-2015; ZIYYAT, Ahmed/F-7617-2019; ZIYYAT, Ahmed/ABB-1861-2021; Burgio, Gaetan/B-6722-2015	Firlej, Virginie/0000-0003-4132-0695; Laissue, Paul/0000-0003-4180-4796; Vaiman, Daniel/0000-0002-1915-0717; ZIYYAT, Ahmed/0000-0001-9724-3831; ZIYYAT, Ahmed/0000-0001-9724-3831; Burgio, Gaetan/0000-0002-7434-926X; Renault, Gilles/0000-0003-2273-1229	French Ministry of Research (Doctoral School Gc2ID, Universite Paris-Descartes)	French Ministry of Research (Doctoral School Gc2ID, Universite Paris-Descartes)	MV is a PhD student funded by the French Ministry of Research (Doctoral School Gc2ID, Universite Paris-Descartes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013663; Benayoun BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008789; Berbari NF, 2011, DEV BIOL, V360, P66, DOI 10.1016/j.ydbio.2011.09.001; Blois S, 2005, J IMMUNOL, V174, P1820, DOI 10.4049/jimmunol.174.4.1820; Bogdarina I, 2004, LIFE SCI, V74, P1407, DOI 10.1016/j.lfs.2003.08.017; Brezillon NM, 2008, CELL TRANSPLANT, V17, P803, DOI 10.3727/096368908786516800; Burgio G, 2007, GENETICS, V177, P2321, DOI 10.1534/genetics.107.078006; Clark DA, 1998, J IMMUNOL, V160, P545; CLARK DA, 1991, CRIT REV IMMUNOL, V11, P215; CLARK DA, 1994, AM J REPROD IMMUNOL, V32, P15, DOI 10.1111/j.1600-0897.1994.tb00874.x; Critchley HOD, 1996, HUM REPROD, V11, P2257; DEANESLY R, 1973, J REPROD FERTIL, V35, P183; Diao HL, 2011, BIOL REPROD, V84, P255, DOI 10.1095/biolreprod.110.086942; Dong YL, 2007, BIOL REPROD, V76, P892, DOI 10.1095/biolreprod.106.059089; DUCLOS AJ, 1995, AM J REPROD IMMUNOL, V33, P354, DOI 10.1111/j.1600-0897.1995.tb00904.x; Fogal V, 2009, ANGIOGENESIS, V12, P91, DOI 10.1007/s10456-009-9137-5; Foster FS, 2000, ULTRASOUND MED BIOL, V26, P1, DOI 10.1016/S0301-5629(99)00096-4; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Girardi G, 2006, J EXP MED, V203, P2165, DOI 10.1084/jem.20061022; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaare M, 2006, MOL HUM REPROD, V12, P25, DOI 10.1093/molehr/gah255; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Laissue P, 2009, INT J DEV BIOL, V53, P623, DOI 10.1387/ijdb.082613pl; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Li TC, 2002, HUM REPROD UPDATE, V8, P463, DOI 10.1093/humupd/8.5.463; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Mercier E, 2007, NEW ENGL J MED, V357, P1984, DOI 10.1056/NEJMc071528; Norris W, 2011, PLACENTA, V32, pS182, DOI 10.1016/j.placenta.2011.01.009; Ouyang YQ, 2009, HYPERTENS PREGNANCY, V28, P56, DOI 10.1080/10641950802233064; Park Y, 2009, J BIOL CHEM, V284, P1540, DOI 10.1074/jbc.M807554200; Philipp T, 2003, HUM REPROD, V18, P1724, DOI 10.1093/humrep/deg309; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Rey E, 2003, LANCET, V361, P901, DOI 10.1016/S0140-6736(03)12771-7; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Salim R, 2003, HUM REPROD, V18, P162, DOI 10.1093/humrep/deg030; Singh J, 2011, HYPERTENSION, V58, P716, DOI 10.1161/HYPERTENSIONAHA.111.175919; Stephenson MD, 2002, HUM REPROD, V17, P446, DOI 10.1093/humrep/17.2.446; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; TULPPALA M, 1993, HUM REPROD, V8, P764, DOI 10.1093/oxfordjournals.humrep.a138137; Wang ZG, 2010, BIOCHEM J, V428, P347, DOI 10.1042/BJ20100379; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Zheng K, 2010, J ANDROL, V31, P79, DOI 10.2164/jandrol.109.008193	44	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43356	10.1371/journal.pone.0043356	http://dx.doi.org/10.1371/journal.pone.0043356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916247	gold, Green Published, Green Accepted			2022-12-25	WOS:000307824300044
J	Swanson, JM; Wood, GC; Xu, LJ; Tang, LE; Meibohm, B; Homayouni, R; Croce, MA; Fabian, TC				Swanson, Joseph M.; Wood, G. Christopher; Xu, Lijing; Tang, Lisa E.; Meibohm, Bernd; Homayouni, Ramin; Croce, Martin A.; Fabian, Timothy C.			Developing a Gene Expression Model for Predicting Ventilator-Associated Pneumonia in Trauma Patients: A Pilot Study	PLOS ONE			English	Article							POSTTRAUMATIC PNEUMONIA; NEUTROPHIL RECRUITMENT; SEVERE SEPSIS; L-SELECTIN; POLYMORPHISMS; ACTIVATION; RIBOLEUKOGRAM; INHIBITION; CYTOKINES; UTILITY	Background: Ventilator-associated pneumonia (VAP) carries significant mortality and morbidity. Predicting which patients will become infected could lead to measures to reduce the incidence of VAP. Methodology/Principal Findings: The goal was to begin constructing a model for VAP prediction in critically-injured trauma patients, and to identify differentially expressed genes in patients who go on to develop VAP compared to similar patients who do not. Gene expression profiles of lipopolysaccharide stimulated blood cells in critically injured trauma patients that went on to develop ventilator-associated pneumonia (n = 10) was compared to those that never developed the infection (n = 10). Eight hundred and ten genes were differentially expressed between the two groups (ANOVA, P<0.05) and further analyzed by hierarchical clustering and principal component analysis. Functional analysis using Gene Ontology and KEGG classifications revealed enrichment in multiple categories including regulation of protein translation, regulation of protease activity, and response to bacterial infection. A logistic regression model was developed that accurately predicted critically-injured trauma patients that went on to develop VAP (VAP+) and those that did not (VAP-). Five genes (PIK3R3, ATP2A1, PI3, ADAM8, and HCN4) were common to all top 20 significant genes that were identified from all independent training sets in the cross validation. Hierarchical clustering using these five genes accurately categorized 95% of patients and PCA visualization demonstrated two discernable groups (VAP+ and VAP-). Conclusions/Significance: A logistic regression model using cross-validation accurately predicted patients that developed ventilator-associated pneumonia and should now be tested on a larger cohort of trauma patients.	[Swanson, Joseph M.; Wood, G. Christopher] Univ Tennessee, Ctr Hlth Sci, Dept Clin Pharm, Memphis, TN 38163 USA; [Tang, Lisa E.; Meibohm, Bernd] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Croce, Martin A.; Fabian, Timothy C.] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; [Homayouni, Ramin] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Xu, Lijing; Homayouni, Ramin] Univ Memphis, Bioinformat Program, Memphis, TN 38152 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Memphis	Swanson, JM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Clin Pharm, Memphis, TN 38163 USA.	jswanson@uthsc.edu	Homayouni, Ramin/U-2837-2019; Homayouni, Ramin/B-3547-2009	Homayouni, Ramin/0000-0003-0186-5076; Homayouni, Ramin/0000-0003-0186-5076; Meibohm, Bernd/0000-0003-3923-3648	Society of Infectious Diseases Pharmacists/Cubist Research Award	Society of Infectious Diseases Pharmacists/Cubist Research Award	This study was funded by the Society of Infectious Diseases Pharmacists/Cubist Research Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Baruscotti M, 2010, PFLUG ARCH EUR J PHY, V460, P405, DOI 10.1007/s00424-010-0810-8; Bryant PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019556; Cobb JP, 2009, ANN SURG, V250, P531, DOI [10.1097/SLA.0b013e3181b8fbd5, 10.1097/SLA.0b013e3181b81bd5]; Croce MA, 2001, AM SURGEON, V67, P105; Croce MA, 1998, ANN SURG, V227, P743, DOI 10.1097/00000658-199805000-00015; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Ferrandi C, 2007, J PHARMACOL EXP THER, V322, P923, DOI 10.1124/jpet.107.123026; Gomez-Gaviro M, 2007, J IMMUNOL, V178, P8053, DOI 10.4049/jimmunol.178.12.8053; Heagy Wyrta, 2003, Surg Infect (Larchmt), V4, P171, DOI 10.1089/109629603766956960; Hedrick TL, 2008, J TRAUMA, V64, P714, DOI 10.1097/TA.0b013e31811ec18e; Heesen M, 2002, INTENS CARE MED, V28, P1161, DOI 10.1007/s00134-002-1389-0; Heitner SB, 2009, CRIT CARE, V13, DOI 10.1186/cc7752; Hovnanian A., 2007, V45, P337; Lowe PR, 2003, CRIT CARE MED, V31, P34, DOI 10.1097/00003246-200301000-00005; Ma PG, 2002, CRIT CARE MED, V30, P1046, DOI 10.1097/00003246-200205000-00015; McDunn JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001564; Namath A, 2009, CRIT CARE CLIN, V25, P835, DOI 10.1016/j.ccc.2009.06.004; O'Dwyer MJ, 2006, SHOCK, V26, P544, DOI 10.1097/01.shk.0000235091.38174.8d; SALLENAVE JM, 1994, AM J RESP CELL MOL, V11, P733, DOI 10.1165/ajrcmb.11.6.7946401; Sasaki T, 2002, J BIOCHEM, V131, P495, DOI 10.1093/oxfordjournals.jbchem.a003126; Simon R, 2002, GENET EPIDEMIOL, V23, P21, DOI 10.1002/gepi.202; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Stassen NA, 2002, SURGERY, V132, P289, DOI 10.1067/msy.2002.127167; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swanson JM, 2008, J TRAUMA, V65, P1271, DOI 10.1097/TA.0b013e3181574d6a; Textoris J, 2011, ANESTHESIOLOGY, V115, P344, DOI 10.1097/ALN.0b013e318225ba26; Wilkinson TS, 2009, AM J PATHOL, V174, P1338, DOI 10.2353/ajpath.2009.080746; Wood GC, 2002, PHARMACOTHERAPY, V22, P972, DOI 10.1592/phco.22.12.972.33596; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	31	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42065	10.1371/journal.pone.0042065	http://dx.doi.org/10.1371/journal.pone.0042065			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916119	gold, Green Published, Green Submitted			2022-12-25	WOS:000307823600008
J	Wu, XC; Liu, HY; Guo, DL; Anenkhonov, OA; Badmaeva, NK; Sandanov, DV				Wu, Xiuchen; Liu, Hongyan; Guo, Dali; Anenkhonov, Oleg A.; Badmaeva, Natalya K.; Sandanov, Denis V.			Growth Decline Linked to Warming-Induced Water Limitation in Hemi-Boreal Forests	PLOS ONE			English	Article							CLIMATE-CHANGE; SOIL-MOISTURE; TEMPORAL VARIABILITY; LARIX-SIBIRICA; RADIAL GROWTH; WOODY BIOMASS; WHITE SPRUCE; PLANT-GROWTH; TREE-GROWTH; DROUGHT	Hemi-boreal forests, which make up the transition from temperate deciduous forests to boreal forests in southern Siberia, have experienced significant warming without any accompanying increase in precipitation during the last 80 years. This climatic change could have a profound impact on tree growth and on the stability of forest ecosystems in this region, but at present evidence for these impacts is lacking. In this study, we report a recent dramatic decline in the growth of hemi-boreal forests, based on ring width measurements from three dominant tree-species (Pinus sylvestris, Larix sibirica and Larix gmelinii), sampled from eight sites in the region. We found that regional tree growth has become increasingly limited by low soil water content in the pre- and early-growing season (from October of the previous year to July of the current year) over the past 80 years. A warming-induced reduction in soil water content has also increased the climate sensitivity of these three tree species. Beginning in the mid-1980s, a clear decline in growth is evident for both the pine forests and the larch forests, although there are increasing trends in the proxy of soil water use efficiencies. Our findings are consistent with those from other parts of the world and provide valuable insights into the regional carbon cycle and vegetation dynamics, and should be useful for devising adaptive forest management strategies.	[Wu, Xiuchen; Liu, Hongyan; Guo, Dali] Peking Univ, Dept Ecol, Coll Urban & Environm Sci, Beijing 100871, Peoples R China; [Anenkhonov, Oleg A.; Badmaeva, Natalya K.; Sandanov, Denis V.] Russian Acad Sci, Inst Gen & Expt Biol, Siberian Branch, Ulan Ude, Russia	Peking University; Russian Academy of Sciences	Wu, XC (corresponding author), Max Planck Inst Biogeochem, Jena, Germany.	xcwu@bgc-jena.mpg.de; lhy@urban.pku.edu.cn	Anenkhonov, Oleg/J-8690-2016; Badmaeva, Natalia/AAC-2817-2022; Guo, Dali/G-2158-2014; Guo, Dali/C-3498-2012; Sandanov, Denis V/J-6472-2018	Anenkhonov, Oleg/0000-0001-8633-7154; Sandanov, Denis V/0000-0002-8504-3485	National Natural Science Foundation [40711120173]; Russian Foundation for Basic Research [06-04-39012]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This research was funded by the National Natural Science Foundation (40711120173) and Russian Foundation for Basic Research (06-04-39012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JC, 2009, HYDROL PROCESS, V23, P962, DOI 10.1002/hyp.7201; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Andreu L, 2007, GLOBAL CHANGE BIOL, V13, P804, DOI 10.1111/j.1365-2486.2007.01322.x; Anisimov O, 2006, AMBIO, V35, P169, DOI 10.1579/0044-7447(2006)35[169:PACCTR]2.0.CO;2; [Anonymous], 1985, TIME SERIES ANAL APP; Badmaev NB, 2006, DIVERSITY SOILS PERM; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Biondi F, 1999, ECOL APPL, V9, P216, DOI 10.1890/1051-0761(1999)009[0216:CTRCAR]2.0.CO;2; Bogaert J, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001075; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bunn AG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023646; Bunn AG, 2006, EARTH INTERACT, V10; Cook E., 1990, METHODS DENDROCHRONO, P104, DOI 10.1007/978-94-015-7879-0; Cook ER, 2007, EARTH-SCI REV, V81, P93, DOI 10.1016/j.earscirev.2006.12.002; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Dong JR, 2003, REMOTE SENS ENVIRON, V84, P393, DOI 10.1016/S0034-4257(02)00130-X; Dulamsuren C, 2010, GLOBAL CHANGE BIOL, V16, P3024, DOI 10.1111/j.1365-2486.2009.02147.x; Dulamsuren C, 2010, OECOLOGIA, V163, P1091, DOI 10.1007/s00442-010-1689-y; Dulamsuren C, 2009, CAN J FOREST RES, V39, P2520, DOI 10.1139/X09-156; Dulamsuren C, 2009, TREE PHYSIOL, V29, P99, DOI 10.1093/treephys/tpn008; Fang JY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024231; Fritts H., 1976, TREE RINGS CLIMATE; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Hogg EH, 2005, CAN J FOREST RES, V35, P610, DOI 10.1139/X04-211; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Holmes RL, 1992, DENDROCHRONOLOGY PRO; Johnson EA, 1998, J VEG SCI, V9, P603, DOI 10.2307/3237276; Kagawa A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003019; Kasyanova LN, 2004, ECOLOGY PLANTS BAIKA; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Kendall M. G., 1962, RANK CORRELATION MET; Klos RJ, 2009, ECOL APPL, V19, P699, DOI 10.1890/08-0330.1; Laurent M, 2003, FOREST ECOL MANAG, V183, P47, DOI 10.1016/S0378-1127(03)00098-7; Lawrence DM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL025080; Leithead MD, 2010, OECOLOGIA, V164, P1095, DOI 10.1007/s00442-010-1769-z; Leshchikov FN, 1993, DIVISION DISTRICTS A; Li JB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025803; Li SG, 2007, TREES-STRUCT FUNCT, V21, P479, DOI 10.1007/s00468-007-0142-2; Liang EY, 2005, INT J REMOTE SENS, V26, P2901, DOI 10.1080/01431160500056931; Lloyd AH, 2002, CLIMATIC CHANGE, V52, P481, DOI 10.1023/A:1014278819094; Lopatin E, 2006, BOREAL ENVIRON RES, V11, P341; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Myneni RB, 2001, P NATL ACAD SCI USA, V98, P14784, DOI 10.1073/pnas.261555198; Nealis VG, 2004, CAN J FOREST RES, V34, P1870, DOI [10.1139/x04-061, 10.1139/X04-061]; Paruelo JM, 1997, ECOLOGY, V78, P953, DOI 10.1890/0012-9658(1997)078[0953:AEFNFT]2.0.CO;2; PHIPPS RL, 1988, CAN J FOREST RES, V18, P24, DOI 10.1139/x88-005; Piovesan G, 2008, GLOBAL CHANGE BIOL, V14, P1265, DOI 10.1111/j.1365-2486.2008.01570.x; Poutou E, 2004, CLIM DYNAM, V23, P621, DOI 10.1007/s00382-004-0459-0; ROBOCK A, 1995, J CLIMATE, V8, P15, DOI 10.1175/1520-0442(1995)008<0015:UOMSMA>2.0.CO;2; Rouault G, 2006, ANN FOREST SCI, V63, P613, DOI 10.1051/forest:2006044; Sidorova OV, 2009, OECOLOGIA, V161, P825, DOI 10.1007/s00442-009-1411-0; Silva LCR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011543; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sugimoto A, 2002, ECOL RES, V17, P493, DOI 10.1046/j.1440-1703.2002.00506.x; Tchebakova NM, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045013; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Velisevich SN, 2006, RUSS J ECOL+, V37, P241, DOI 10.1134/S1067413606040047; Vinnikov KY, 1996, J GEOPHYS RES-ATMOS, V101, P7163, DOI 10.1029/95JD02753; Wang WZ, 2012, FOREST ECOL MANAG, V275, P14, DOI 10.1016/j.foreco.2012.02.027; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Ye HC, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016873	70	28	33	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42619	10.1371/journal.pone.0042619	http://dx.doi.org/10.1371/journal.pone.0042619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916142	Green Published, gold			2022-12-25	WOS:000307823600019
J	Gupta, V; Bhinge, KN; Hosain, SB; Xiong, K; Gu, X; Shi, RH; Ho, MY; Khoo, KH; Li, SC; Li, YT; Ambudkar, SV; Jazwinski, SM; Liu, YY				Gupta, Vineet; Bhinge, Kaustubh N.; Hosain, Salman B.; Xiong, Katherine; Gu, Xin; Shi, Runhua; Ho, Ming-Yi; Khoo, Kay-Hooi; Li, Su-Chen; Li, Yu-Teh; Ambudkar, Suresh V.; Jazwinski, S. Michal; Liu, Yong-Yu			Ceramide Glycosylation by Glucosylceramide Synthase Selectively Maintains the Properties of Breast Cancer Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-RESISTANCE; SELF-RENEWAL; BONE-MARROW; IN-VITRO; EXPRESSION; GLYCOSPHINGOLIPIDS; CARCINOMA; INHIBITOR; PATHWAY; DIFFERENTIATION	Cancer stem cells are distinguished from normal adult stem cells by their stemness without tissue homeostasis control. Glycosphingolipids (GSLs), particularly globo-series GSLs, are important markers of undifferentiated embryonic stem cells, but little is known about whether or not ceramide glycosylation, which controls glycosphingolipid synthesis, plays a role in modulating stem cells. Here, we report that ceramide glycosylation catalyzed by glucosylceramide synthase, which is enhanced in breast cancer stem cells (BCSCs) but not in normal mammary epithelial stem cells, maintains tumorous pluripotency of BCSCs. Enhanced ceramide glycosylation and globotriosylceramide (Gb3) correlate well with the numbers of BCSCs in breast cancer cell lines. In BCSCs sorted with CD44(+)/ESA(+)/CD24(-) markers, Gb3 activates c-Src/beta-catenin signaling and up-regulates the expression of FGF-2, CD44, and Oct-4 enriching tumorigenesis. Conversely, silencing glucosylceramide synthase expression disrupts Gb3 synthesis and selectively kills BCSCs through deactivation of c-Src/beta-catenin signaling. These findings highlight the unexploited role of ceramide glycosylation in selectively maintaining the tumorous pluripotency of cancer stem cells. It speculates that disruption of ceramide glycosylation or globo-series GSL is a useful approach to specifically target BCSCs specifically.	[Gupta, Vineet; Bhinge, Kaustubh N.; Hosain, Salman B.; Xiong, Katherine; Liu, Yong-Yu] Univ Louisiana Monroe, Dept Basic Pharmaceut Sci, Monroe, LA 71209 USA; [Gu, Xin] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, Shreveport, LA 71130 USA; [Shi, Runhua; Khoo, Kay-Hooi] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA; [Ho, Ming-Yi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Li, Su-Chen; Li, Yu-Teh] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Jazwinski, S. Michal] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Jazwinski, S. Michal] Tulane Univ, Sch Med, Tulane Ctr Aging, New Orleans, LA 70112 USA; [Ambudkar, Suresh V.] NCI, Cell Biol Lab, Bethesda, MD 20892 USA	University of Louisiana System; University of Louisiana Monroe; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Academia Sinica - Taiwan; Tulane University; Tulane University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Liu, YY (corresponding author), Univ Louisiana Monroe, Dept Basic Pharmaceut Sci, 700 Univ Ave, Monroe, LA 71209 USA.	yliu@ulm.edu	Ambudkar, Suresh V/L-1317-2016; Liu, Yong-Yu/H-8593-2014; Khoo, Kay-Hooi/E-1989-2019	Khoo, Kay-Hooi/0000-0003-2906-406X; Liu, Yong-Yu/0000-0002-7968-0162; Xiong, Katherine/0000-0002-1603-2037	National Institutes of Health, National Center for Research Resources [5P20RR016456-11]; National Institute of General Medical Sciences [8 P20 GM103424-11]; Mizutani Foundation for Glycoscience, Japan; Center for Cancer Research, NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010030, R15CA167476] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Mizutani Foundation for Glycoscience, Japan; Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P20RR016456-11 from the National Center for Research Resources and 8 P20 GM103424-11 from the National Institute of General Medical Sciences (to Y.-Y. L.). This work was also supported by funds from the Mizutani Foundation for Glycoscience, Japan (to Y.-Y. L.).; Supported by the Intramural Research Program, Center for Cancer Research, NCI, National Institutes of Health.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; BASU S, 1968, J BIOL CHEM, V243, P5802; Battula VL, 2012, J CLIN INVEST, V122, P2066, DOI 10.1172/JCI59735; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Booker-Dwyer T, 2008, DEV NEUROBIOL, V68, P859, DOI 10.1002/dneu.20606; Bussolati B, 2009, J CELL MOL MED, V13, P309, DOI 10.1111/j.1582-4934.2008.00338.x; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; Carney D N, 1982, Stem Cells, V1, P149; Chang WW, 2008, P NATL ACAD SCI USA, V105, P11667, DOI 10.1073/pnas.0804979105; DELL A, 1994, METHOD ENZYMOL, V230, P108; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Guo Y, 2008, STEM CELLS, V26, P30, DOI 10.1634/stemcells.2007-0401; Gupta V, 2011, METHODS MOL BIOL, V716, P179, DOI 10.1007/978-1-61779-012-6_11; Gupta V, 2010, J LIPID RES, V51, P866, DOI 10.1194/jlr.D002949; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; INOKUCHI J, 1990, CANCER RES, V50, P6731; Juul N, 2010, LANCET ONCOL, V11, P358, DOI 10.1016/S1470-2045(10)70018-8; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Katagiri YU, 1999, J BIOL CHEM, V274, P35278, DOI 10.1074/jbc.274.49.35278; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Korkaya H, 2009, CLIN CANCER RES, V15, P1845, DOI 10.1158/1078-0432.CCR-08-3087; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Lim SK, 2011, FASEB J, V25, P3004, DOI 10.1096/fj.10-169136; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Liu YY, 2011, INT J ONCOL, V39, P425, DOI 10.3892/ijo.2011.1052; Liu YY, 2011, CANCER RES, V71, P2276, DOI 10.1158/0008-5472.CAN-10-3107; Liu YY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-145; Liu YY, 2004, J LIPID RES, V45, P933, DOI 10.1194/jlr.M300486-JLR200; Liu YY, 1999, J BIOL CHEM, V274, P1140, DOI 10.1074/jbc.274.2.1140; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Maupas-Schwalm F, 2005, CANCER RES, V65, P526; MEHTA K, 1994, INT J CANCER, V58, P400, DOI 10.1002/ijc.2910580316; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Pandey PR, 2011, BREAST CANCER RES TR, V130, P387, DOI 10.1007/s10549-010-1300-6; Patwardhan GA, 2011, PROG LIPID RES, V50, P104, DOI 10.1016/j.plipres.2010.10.003; Patwardhan GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006938; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; RADIN NS, 1994, MOL CHEM NEUROPATHOL, V21, P111, DOI 10.1007/BF02815346; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Shiota M, 2007, EXP CELL RES, V313, P1008, DOI 10.1016/j.yexcr.2006.12.017; Steelant WF, 2002, FEBS LETT, V531, P93, DOI 10.1016/S0014-5793(02)03484-1; Suila H, 2011, J MOL CELL BIOL, V3, P99, DOI 10.1093/jmcb/mjq041; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Tang C, 2007, FASEB J, V21, P3777, DOI 10.1096/fj.07-8560rev; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Xu JX, 2007, EXP CELL RES, V313, P1877, DOI 10.1016/j.yexcr.2007.03.006; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Yokoyama N, 2009, J CELL SCI, V122, P4439, DOI 10.1242/jcs.051847; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; ZHOU B, 1989, J BIOL CHEM, V264, P12272	71	52	54	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37195	37205		10.1074/jbc.M112.396390	http://dx.doi.org/10.1074/jbc.M112.396390			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22936806	hybrid, Green Published			2022-12-25	WOS:000310588500053
J	Anderson, DM; George, R; Noyes, MB; Rowton, M; Liu, WJ; Jiang, RL; Wolfe, SA; Wilson-Rawls, J; Rawls, A				Anderson, Douglas M.; George, Rajani; Noyes, Marcus B.; Rowton, Megan; Liu, Wenjin; Jiang, Rulang; Wolfe, Scot A.; Wilson-Rawls, Jeanne; Rawls, Alan			Characterization of the DNA-binding Properties of the Mohawk Homeobox Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; NEGATIVE AUTOREGULATION; MOUSE DEVELOPMENT; SKELETAL-MUSCLE; FIBER-TYPE; SOX6; FAMILY; DIFFERENTIATION; IDENTIFICATION; SPECIFICITIES	The homeobox transcription factor Mohawk (Mkx) is a potent transcriptional repressor expressed in the embryonic precursors of skeletal muscle, cartilage, and bone. MKX has recently been shown to be a critical regulator of musculoskeletal tissue differentiation and gene expression; however, the genetic pathways through which MKX functions and its DNA-binding properties are currently unknown. Using a modified bacterial one-hybrid site selection assay, we determined the core DNA-recognition motif of the mouse monomeric Mkx homeodomain to be A-C-A. Using cell-based assays, we have identified a minimal Mkx-responsive element (MRE) located within the Mkx promoter, which is composed of a highly conserved inverted repeat of the core Mkx recognition motif. Using the minimal MRE sequence, we have further identified conserved MREs within the locus of Sox6, a transcription factor that represses slow fiber gene expression during skeletal muscle differentiation. Real-time PCR and immunostaining of in vitro differentiated muscle satellite cells isolated from Mkx-null mice revealed an increase in the expression of Sox6 and down-regulation of slow fiber structural genes. Together, these data identify the unique DNA-recognition properties of MKX and reveal a novel role for Mkx in promoting slow fiber type specification during skeletal muscle differentiation.	[Anderson, Douglas M.; George, Rajani; Rowton, Megan; Wilson-Rawls, Jeanne; Rawls, Alan] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Anderson, Douglas M.; George, Rajani; Rowton, Megan] Arizona State Univ, Mol & Cellular Biol Grad Program, Tempe, AZ 85287 USA; [Rawls, Alan] Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ 85287 USA; [Noyes, Marcus B.; Wolfe, Scot A.] Univ Massachusetts, Med Ctr, Program Gene Funct & Express, Worcester, MA 01605 USA; [Noyes, Marcus B.; Wolfe, Scot A.] Univ Massachusetts, Med Ctr, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Liu, Wenjin; Jiang, Rulang] Univ Rochester, Sch Med & Dent, Dept Biomed Genet, Rochester, NY 14642 USA; [Liu, Wenjin; Jiang, Rulang] Univ Rochester, Sch Med & Dent, Ctr Oral Biol, Rochester, NY 14642 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Rochester; University of Rochester	Rawls, A (corresponding author), Arizona State Univ, Sch Life Sci, Box 874501,Life Sci C Bldg,Rm 544, Tempe, AZ 85287 USA.	alan.rawls@asu.edu	George, Rajani Mary/AAM-7256-2020	George, Rajani Mary/0000-0002-9153-5523; Jiang, Rulang/0000-0001-7842-4696; Wilson-Rawls, Jeanne/0000-0002-3704-6956	National Institutes of Health [1R01HG004744]; National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01HG004744 (to S. A. W.) and National Science Foundation (to J.A.R. and J.W.R.).	ADES SE, 1995, BIOCHEMISTRY-US, V34, P14601, DOI 10.1021/bi00044a040; Anderson DM, 2006, DEV DYNAM, V235, P792, DOI 10.1002/dvdy.20671; Anderson DM, 2009, DEV DYNAM, V238, P572, DOI 10.1002/dvdy.21873; Bao ZZ, 1999, SCIENCE, V283, P1161, DOI 10.1126/science.283.5405.1161; Bateman E, 1998, PROG NUCLEIC ACID RE, V60, P133, DOI 10.1016/S0079-6603(08)60892-2; Bellefroid EJ, 1998, EMBO J, V17, P191, DOI 10.1093/emboj/17.1.191; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bessho Y, 2003, CURR OPIN GENET DEV, V13, P379, DOI 10.1016/S0959-437X(03)00083-2; Bilioni A, 2005, P NATL ACAD SCI USA, V102, P14671, DOI 10.1073/pnas.0502480102; Bosse A, 1997, MECH DEVELOP, V69, P169, DOI 10.1016/S0925-4773(97)00165-2; Brent AE, 2005, DEVELOPMENT, V132, P515, DOI 10.1242/dev.01605; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Cohen DR, 2000, MECH DEVELOP, V91, P317, DOI 10.1016/S0925-4773(99)00263-4; Crews ST, 2009, CURR BIOL, V19, pR241, DOI 10.1016/j.cub.2009.01.015; Dumitriu B, 2006, GENESIS, V44, P219, DOI 10.1002/dvg.20210; Fu DC, 2003, MOL CELL BIOL, V23, P4439, DOI 10.1128/MCB.23.13.4439-4448.2003; Furukawa K, 2002, GENES CELLS, V7, P1135, DOI 10.1046/j.1365-2443.2002.00587.x; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Hagiwara N, 2005, DEV DYNAM, V234, P301, DOI 10.1002/dvdy.20535; Hagiwara N, 2007, DEV DYNAM, V236, P2062, DOI 10.1002/dvdy.21223; Houweling AC, 2001, MECH DEVELOP, V107, P169, DOI 10.1016/S0925-4773(01)00451-8; IRVINE KD, 1993, DEVELOPMENT, V117, P387; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Liu H, 2006, GENE EXPR PATTERNS, V6, P632, DOI 10.1016/j.modgep.2005.11.012; Liu WJ, 2010, MOL CELL BIOL, V30, P4797, DOI 10.1128/MCB.00207-10; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; NEUTEBOOM STC, 1995, P NATL ACAD SCI USA, V92, P9166, DOI 10.1073/pnas.92.20.9166; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Semsey S, 2009, J BACTERIOL, V191, P4487, DOI 10.1128/JB.00056-09; Takeuchi JK, 2007, GENE EXPR PATTERNS, V7, P51, DOI 10.1016/j.modgep.2006.05.007; Thijs G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Wilson-Rawls J, 2004, J BIOL CHEM, V279, P37685, DOI 10.1074/jbc.M401319200; Wilson-Rawls J, 1999, DEVELOPMENT, V126, P5217; Wolberger C, 1996, CURR OPIN STRUC BIOL, V6, P62, DOI 10.1016/S0959-440X(96)80096-0; Wong WF, 2011, J BIOL CHEM, V286, P11110, DOI 10.1074/jbc.M110.166694; Zabet NR, 2011, J THEOR BIOL, V284, P82, DOI 10.1016/j.jtbi.2011.06.021	45	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35351	35359		10.1074/jbc.M112.399386	http://dx.doi.org/10.1074/jbc.M112.399386			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22923612	Green Published, hybrid			2022-12-25	WOS:000309968000044
J	Shi, M; Huang, WZ; Lin, L; Zheng, DY; Zuo, Q; Wang, L; Wang, NN; Wu, YJ; Liao, YL; Liao, WJ				Shi, Min; Huang, Weizhen; Lin, Li; Zheng, Dayong; Zuo, Qiang; Wang, Lin; Wang, Nina; Wu, Yajun; Liao, Yulin; Liao, Wangjun			Silencing of XB130 Is Associated with Both the Prognosis and Chemosensitivity of Gastric Cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; ADAPTER PROTEIN; GROWTH-FACTOR; EXPRESSION; ONCOGENE; INVASION; P53	XB130 is a newly characterized adaptor protein that was reported to promote thyroid tumor growth, but its role in the progression of other kinds of cancer such as gastric cancer (GC) remains unknown. Accordingly, we investigated the association between XB130 expression and the prognosis of GC patients. The subjects were 411 patients with GC in stages I to IV. XB130 expression was examined in surgical specimens of GC. Kaplan-Meier analysis and the Cox proportional hazards model were used to assess the prognostic significance of XB130 for survival and recurrence. Moreover, GC cells stably transfected with XB130 short hairpin RNA were established to analyze the effect of XB130 on sensitivity of chemotherapy. The results show that both XB130 mRNA and protein expression were detectable in normal gastric tissues. The overall survival time of stage IV patients and the disease-free period after radical resection of GC in stage I-III patients were significantly shorter when immunohistochemical staining for XB130 was low than when staining was high (both p < 0.05). XB130 expression also predicted tumor sensitivity to several chemotherapy agents. Viability of both XB130-silenced SGC7901 cells and wild-type cells was suppressed by 5-fluorouracil (5-FU), cisplatin, and irinotecan in a dose-dependent way, but cisplatin and irinotecan were more sensitive against sXB130-silenced GC cells and 5-FU showed higher sensitivity to wild-type cells. When treated by 5-FU, patients with high expression of XB130 tumors had a higher survival rate than those with low expression tumors. These findings indicate that reduced XB130 protein expression is a prognostic biomarker for shorter survival and a higher recurrence rate in patients with GC, as well as for the response to chemotherapy.	[Shi, Min; Huang, Weizhen; Lin, Li; Zheng, Dayong; Zuo, Qiang; Wang, Lin; Wang, Nina; Wu, Yajun; Liao, Wangjun] So Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Liao, Yulin] So Med Univ, Nanfang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Liao, WJ (corresponding author), So Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China.	Liao18@msn.com; nfyyliaowj@163.com	Liao, Yulin/AAP-6315-2021	Wangjun, Liao/0000-0002-1364-8442	National Program on Key Basic Research Project [2012CB945100]; Natural Science Foundation of Guangdong Province, China [S2011030003134]	National Program on Key Basic Research Project(National Basic Research Program of China); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Program on Key Basic Research Project (2012CB945100, to WL and YL), the Team Program of Natural Science Foundation of Guangdong Province, China (S2011030003134, to WL and YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae IH, 2006, CANCER RES, V66, P4991, DOI 10.1158/0008-5472.CAN-05-4254; DAMM K, 1993, FASEB J, V7, P904, DOI 10.1096/fasebj.7.10.8102105; Feng CW, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-8; Johnson DG, 2000, MOL CARCINOGEN, V27, P151, DOI 10.1002/(SICI)1098-2744(200003)27:3<151::AID-MC1>3.0.CO;2-C; Kos FT, 2011, CHEMOTHERAPY, V57, P230, DOI 10.1159/000327840; Kossatz U, 2007, CELL RES, V17, P832, DOI 10.1038/cr.2007.86; Lodyga M, 2009, ONCOGENE, V28, P937, DOI 10.1038/onc.2008.447; Lodyga M, 2010, J CELL SCI, V123, P4156, DOI 10.1242/jcs.071050; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; Montagnani F, 2011, GASTRIC CANCER, V14, P50, DOI 10.1007/s10120-011-0007-7; Murai T, 2006, BIOCHEM J, V395, P65, DOI 10.1042/BJ20050582; Pan WS, 2003, J SURG ONCOL, V82, P104, DOI 10.1002/jso.10204; Shiozaki Atsushi, 2011, J Clin Bioinforma, V1, P10, DOI 10.1186/2043-9113-1-10; Shiozaki A, 2011, AM J PATHOL, V178, P391, DOI 10.1016/j.ajpath.2010.11.024; Takiuchi H, 2011, GASTRIC CANCER, V14, P1, DOI 10.1007/s10120-011-0018-4; Testino G, 2002, PANMINERVA MED, V44, P369; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yamanaka D, 2012, MOL ENDOCRINOL, V26, P1043, DOI 10.1210/me.2011-1349; Zhang J, 2010, FUTURE ONCOL, V6, P587, DOI [10.2217/fon.10.15, 10.2217/FON.10.15]	19	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e41660	10.1371/journal.pone.0041660	http://dx.doi.org/10.1371/journal.pone.0041660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927913	Green Submitted, Green Published, gold			2022-12-25	WOS:000308224700003
J	Ni, M; Martire, D; Scotet, E; Bonneville, M; Sanchez, F; Lafont, V				Ni, Ming; Martire, Delphine; Scotet, Emmanuel; Bonneville, Marc; Sanchez, Francoise; Lafont, Virginie			Full Restoration of Brucella-Infected Dendritic Cell Functionality through V gamma 9V delta 2 T Helper Type 1 Crosstalk	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CYTOKINE PRODUCTION; IN-VITRO; MATURATION; SUIS; LYMPHOCYTES; ACTIVATION; CARCINOMA; ANTIGEN; IMMUNOTHERAPY	V gamma 9V delta 2 T cells play an important role in the immune response to infectious agents but the mechanisms contributing to this immune process remain to be better characterized. Following their activation, V gamma 9V delta 2 T cells develop cytotoxic activity against infected cells, secrete large amounts of cytokines and influence the function of other effectors of immunity, notably cells playing a key role in the initiation of the adaptive immune response such as dendritic cells. Brucella infection dramatically impairs dendritic cell maturation and their capacity to present antigens to T cells. Herein, we investigated whether V T cells have the ability to restore the full functional capacities of Brucella-infected dendritic cells. Using an in vitro multicellular infection model, we showed that: 1/Brucella-infected dendritic cells activate V gamma 9V delta 2 T cells through contact-dependent mechanisms, 2/activated V gamma 9V delta 2 T cells induce full differentiation into IL-12 producing cells of Brucella-infected dendritic cells with functional antigen presentation activity. Furthermore, phosphoantigen-activated V gamma 9V delta 2 T cells also play a role in triggering the maturation process of dendritic cells already infected for 24 h. This suggests that activated V gamma 9V delta 2 T cells could be used to modulate the outcome of infectious diseases by promoting an adjuvant effect in dendritic cell-based cellular therapies.	[Ni, Ming; Martire, Delphine; Sanchez, Francoise; Lafont, Virginie] Univ Montpellier I, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, Montpellier, France; [Ni, Ming; Martire, Delphine; Sanchez, Francoise; Lafont, Virginie] CNRS, UMR 5236, CPBS, F-34965 Montpellier, France; [Ni, Ming; Martire, Delphine; Sanchez, Francoise; Lafont, Virginie] Univ Montpellier 2, CPBS, F-34095 Montpellier, France; [Scotet, Emmanuel; Bonneville, Marc] Univ Nantes, INSERM, Unite Mixte Rech 892, Ctr Rech Canc Nantes Angers,Inst Rech Therapeut, Nantes, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Ni, M (corresponding author), Univ Montpellier I, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, Montpellier, France.	virginie.lafont@cpbs.cnrs.fr	SCOTET, Emmanuel/AAC-9971-2019; SCOTET, Emmanuel/L-2576-2015; Lafont, Virginie/R-9356-2017	SCOTET, Emmanuel/0000-0001-8010-9556; SCOTET, Emmanuel/0000-0001-8010-9556; Lafont, Virginie/0000-0001-9612-3934	CNRS; Universites de Montpellier 1 and 2; Infectiopole fund	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universites de Montpellier 1 and 2; Infectiopole fund	This work was supported by CNRS, Universites de Montpellier 1 and 2 and the Infectiopole fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atluri VL, ANN REV MICROBIOL, V65, P523; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bennouna J, 2008, CANCER IMMUNOL IMMUN, V57, P1599, DOI 10.1007/s00262-008-0491-8; Billard E, 2005, INFECT IMMUN, V73, P8418, DOI 10.1128/IAI.73.12.8418-8424.2005; Billard E, 2007, INFECT IMMUN, V75, P4980, DOI 10.1128/IAI.00637-07; Bonneville M, NAT REV IMMUNOL, V10, P467; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252; Devilder MC, 2006, J IMMUNOL, V176, P1386, DOI 10.4049/jimmunol.176.3.1386; Dieli F, 2001, J INFECT DIS, V184, P1082, DOI 10.1086/323600; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Dudal S, 2006, J IMMUNOL, V177, P5533, DOI 10.4049/jimmunol.177.8.5533; Dunne MR, CANC IMMUNOL IMMUNOT, V59, P1109; Hanekom WA, 2003, J INFECT DIS, V188, P257, DOI 10.1086/376451; HOLOSHITZ J, 1993, INT IMMUNOL, V5, P1437, DOI 10.1093/intimm/5.11.1437; Ismaili J, 2002, CLIN IMMUNOL, V103, P296, DOI 10.1006/clim.2002.5218; Jomaa H, 1999, FEMS IMMUNOL MED MIC, V25, P371, DOI 10.1111/j.1574-695X.1999.tb01362.x; Kobayashi H, 2007, CANCER IMMUNOL IMMUN, V56, P469, DOI 10.1007/s00262-006-0199-6; Kunzmann V, 1999, NEW ENGL J MED, V340, P737, DOI 10.1056/NEJM199903043400914; Kunzmann V, 2000, BLOOD, V96, P384; Lafont V, 2001, J BIOL CHEM, V276, P15961, DOI 10.1074/jbc.M008684200; Mattarollo SR, 2007, CANCER IMMUNOL IMMUN, V56, P1285, DOI 10.1007/s00262-007-0279-2; Meraviglia S, 2010, J IMMUNOL, V185, P1770, DOI 10.4049/jimmunol.1000966; Morel Y, 2001, J IMMUNOL, V167, P2479, DOI 10.4049/jimmunol.167.5.2479; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Oliaro J, 2005, J LEUKOCYTE BIOL, V77, P652, DOI 10.1189/jlb.0704433; Ottones F, 2000, J IMMUNOL, V165, P7133, DOI 10.4049/jimmunol.165.12.7133; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Shannon JG, 2005, P NATL ACAD SCI USA, V102, P8722, DOI 10.1073/pnas.0501863102; Sicard H, 2000, INFECT IMMUN, V68, P4375, DOI 10.1128/IAI.68.8.4375-4377.2000; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Thompson K, 2004, J BONE MINER RES, V19, P278, DOI 10.1359/JBMR.0301230; Viey E, 2005, J IMMUNOL, V174, P1338, DOI 10.4049/jimmunol.174.3.1338; Wurtzen PA, 2001, SCAND J IMMUNOL, V53, P579, DOI 10.1046/j.1365-3083.2001.00910.x	36	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43613	10.1371/journal.pone.0043613	http://dx.doi.org/10.1371/journal.pone.0043613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928003	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300073
J	Liu, Q; Collin, RWJ; Cremers, FPM; den Hollander, AI; van den Born, LI; Pierce, EA				Liu, Qin; Collin, Rob W. J.; Cremers, Frans P. M.; den Hollander, Anneke I.; van den Born, L. Ingeborgh; Pierce, Eric A.			Expression of Wild-Type Rp1 Protein in Rp1 Knock-in Mice Rescues the Retinal Degeneration Phenotype	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; LEBER CONGENITAL AMAUROSIS; GENE-THERAPY; RNA SURVEILLANCE; MUTANT RHODOPSIN; TRANSGENIC MICE; MOUSE MODEL; MUTATIONS; FAMILIES; VISION	Mutations in the retinitis pigmentosa 1 (RP1) gene are a common cause of autosomal dominant retinitis pigmentosa (adRP), and have also been found to cause autosomal recessive RP (arRP) in a few families. The 33 dominant mutations and 6 recessive RP1 mutations identified to date are all nonsense or frameshift mutations, and almost exclusively (38 out of 39) are located in the 4th and final exon of RP1. To better understand the underlying disease mechanisms of and help develop therapeutic strategies for RP1 disease, we performed a series of human genetic and animal studies using gene targeted and transgenic mice. Here we report that a frameshift mutation in the 3rd exon of RP1 (c.686delC; p.P229QfsX35) found in a patient with recessive RP1 disease causes RP in the homozygous state, whereas the heterozygous carriers are unaffected, confirming that haploinsufficiency is not the causative mechanism for RP1 disease. We then generated Rp1 knock-in mice with a nonsense Q662X mutation in exon 4, as well as Rp1 transgenic mice carrying a wild-type BAC Rp1 transgene. The Rp1-Q662X allele produces a truncated Rp1 protein, and homozygous Rp1-Q662X mice experience a progressive photoreceptor degeneration characterized disorganization of photoreceptor outer segments. This phenotype could be prevented by expression of a normal amount of Rp1 protein from the BAC transgene without removal of the mutant Rp1-Q662X protein. Over-expression of Rp1 protein in additional BAC Rp1 transgenic lines resulted in retinal degeneration. These findings suggest that the truncated Rp1-Q662X protein does not exert a toxic gain-of-function effect. These results also imply that in principle gene augmentation therapy could be beneficial for both recessive and dominant RP1 patients, but the levels of RP1 protein delivered for therapy will have to be carefully controlled.	[Liu, Qin; Pierce, Eric A.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Ocular Genom Inst, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA; [Collin, Rob W. J.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Collin, Rob W. J.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Collin, Rob W. J.; Cremers, Frans P. M.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [van den Born, L. Ingeborgh] Rotterdam Eye Hosp, Rotterdam, Netherlands	Harvard University; Massachusetts Eye & Ear Infirmary; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Rotterdam Eye Hospital	Liu, Q (corresponding author), Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Ocular Genom Inst, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA.	eric_pierce@meei.harvard.edu	Collin, Rob/N-3575-2014; Cremers, Frans/A-5625-2014; Hollander, Anneke den/N-4911-2014	Cremers, Frans/0000-0002-4954-5592; Pierce, Eric/0000-0002-2354-4102	NIH [EY12910]; Foundation Fighting Blindness USA; F.M. Kirby Foundation; Research to Prevent Blindness; Rosanne Silbermann Foundation; Mackall Foundation Trust; Stichting Wetenschappelijk; Onderzoek Oogziekenhuis Rotterdam Prof. dr. H.J. Flieringa Foundation, Rotterdam, the Netherlands [2005-13]; Netherlands Organisation for Scientific Research [91209047]; NATIONAL EYE INSTITUTE [R01EY012910] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness USA; F.M. Kirby Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Rosanne Silbermann Foundation; Mackall Foundation Trust; Stichting Wetenschappelijk; Onderzoek Oogziekenhuis Rotterdam Prof. dr. H.J. Flieringa Foundation, Rotterdam, the Netherlands; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by grants from the NIH (EY12910 to EAP), the Foundation Fighting Blindness USA (EAP, QL), the F.M. Kirby Foundation, Research to Prevent Blindness, Rosanne Silbermann Foundation (EAP), the Mackall Foundation Trust, Stichting Wetenschappelijk, Onderzoek Oogziekenhuis Rotterdam Prof. dr. H.J. Flieringa Foundation (grant 2005-13 to LIvdB, AIdH and FPMC), Rotterdam, the Netherlands, and the Netherlands Organisation for Scientific Research (ZonMw Topsubsidy grant 91209047 to FPMC and AIdH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Baum L, 2001, Hum Mutat, V17, P436, DOI 10.1002/humu.1127; Berson EL, 2001, INVEST OPHTH VIS SCI, V42, P2217; Bowne SJ, 1999, HUM MOL GENET, V8, P2121, DOI 10.1093/hmg/8.11.2121; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Chadderton N, 2009, MOL THER, V17, P593, DOI 10.1038/mt.2008.301; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chapple JP, 2001, TRENDS MOL MED, V7, P414, DOI 10.1016/S1471-4914(01)02103-7; Cheeseman I. M., 2005, SCI STKE, V2005, P11; Chen LJ, 2010, INVEST OPHTH VIS SCI, V51, P2236, DOI 10.1167/iovs.09-4437; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Collin RWJ, 2011, INVEST OPHTH VIS SCI, V52, P2227, DOI 10.1167/iovs.10-6185; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Dietrich K, 2002, BRIT J OPHTHALMOL, V86, P328, DOI 10.1136/bjo.86.3.328; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; Gamundi MJ, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-35; Gao JG, 2002, P NATL ACAD SCI USA, V99, P5698, DOI 10.1073/pnas.042122399; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gorbatyuk M, 2007, VISION RES, V47, P1202, DOI 10.1016/j.visres.2006.11.026; Gorbatyuk MS, 2008, ADV EXP MED BIOL, V613, P107, DOI 10.1007/978-0-387-74904-4_11; Guillonneau X, 1999, HUM MOL GENET, V8, P1541, DOI 10.1093/hmg/8.8.1541; Haider NB, 2002, HUM MOL GENET, V11, P1195, DOI 10.1093/hmg/11.10.1195; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Jacobson SG, 2000, INVEST OPHTH VIS SCI, V41, P1898; Kawamura M, 2004, AM J OPHTHALMOL, V137, P1137, DOI 10.1016/j.ajo.2003.12.037; Khaliq S, 2005, J MED GENET, V42, P436, DOI 10.1136/jmg.2004.024281; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Liu Q, 2003, INVEST OPHTH VIS SCI, V44, P4171, DOI 10.1167/iovs.03-0410; Liu Q, 2002, INVEST OPHTH VIS SCI, V43, P22; Liu Q, 2009, INVEST OPHTH VIS SCI, V50, P1566, DOI 10.1167/iovs.08-2776; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Mao HY, 2011, HUM GENE THER, V22, P567, DOI 10.1089/hum.2010.140; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45; Michaelson D, 2006, METHOD ENZYMOL, V406, P296, DOI 10.1016/S0076-6879(06)06022-8; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nagy A., 2003, MANIPULATING MOUSE E; Nour M, 2004, INVEST OPHTH VIS SCI, V45, P2514, DOI 10.1167/iovs.04-0065; Nour M, 2008, ADV EXP MED BIOL, V613, P129, DOI 10.1007/978-0-387-74904-4_14; O'Reilly M, 2007, AM J HUM GENET, V81, P127, DOI 10.1086/519025; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Payne A, 2000, INVEST OPHTH VIS SCI, V41, P4069; Pierce EA, 1999, NAT GENET, V22, P248, DOI 10.1038/10305; Pierce EA, 2001, BIOESSAYS, V23, P605, DOI 10.1002/bies.1086; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2264, DOI 10.1167/iovs.04-1280; Roberts L, 2006, MOL VIS, V12, P177; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Saliba RS, 2002, J CELL SCI, V115, P2907; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Singh HP, 2009, INVEST OPHTH VIS SCI, V50, P4065, DOI 10.1167/iovs.09-3479; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; Sullivan LS, 1999, NAT GENET, V22, P255, DOI 10.1038/10314; Tam LCS, 2008, HUM MOL GENET, V17, P2084, DOI 10.1093/hmg/ddn107; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Veitia RA, 2009, J PATHOL, V218, P409, DOI 10.1002/path.2583; Wilson JH, 2003, MOL NEUROBIOL, V28, P149, DOI 10.1385/MN:28:2:149; Xu L, 2006, EUR J OPHTHALMOL, V16, P865; Zhang PM, 2002, NAT GENET, V30, P31, DOI 10.1038/ng797; Ziviello C, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.031682	75	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43251	10.1371/journal.pone.0043251	http://dx.doi.org/10.1371/journal.pone.0043251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927954	Green Published, Green Submitted, gold			2022-12-25	WOS:000307789700029
J	Hefferan, MP; Galik, J; Kakinohana, O; Sekerkova, G; Santucci, C; Marsala, S; Navarro, R; Hruska-Plochan, M; Johe, K; Feldman, E; Cleveland, DW; Marsala, M				Hefferan, Michael P.; Galik, Jan; Kakinohana, Osamu; Sekerkova, Gabriela; Santucci, Camila; Marsala, Silvia; Navarro, Roman; Hruska-Plochan, Marian; Johe, Karl; Feldman, Eva; Cleveland, Don W.; Marsala, Martin			Human Neural Stem Cell Replacement Therapy for Amyotrophic Lateral Sclerosis by Spinal Transplantation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SOD1 TRANSGENIC RATS; MOTOR-NEURONS; SUPEROXIDE-DISMUTASE; PROGENITOR CELLS; ALS MICE; CORTICOSPINAL TRACT; FAMILIAL ALS; DORSAL-HORN; CORD-INJURY	Background: Mutation in the ubiquitously expressed cytoplasmic superoxide dismutase (SOD1) causes an inherited form of Amyotrophic Lateral Sclerosis (ALS). Mutant synthesis in motor neurons drives disease onset and early disease progression. Previous experimental studies have shown that spinal grafting of human fetal spinal neural stem cells (hNSCs) into the lumbar spinal cord of SOD1(G93A) rats leads to a moderate therapeutical effect as evidenced by local alpha-motoneuron sparing and extension of lifespan. The aim of the present study was to analyze the degree of therapeutical effect of hNSCs once grafted into the lumbar spinal ventral horn in presymptomatic immunosuppressed SOD1(G93A) rats and to assess the presence and functional integrity of the descending motor system in symptomatic SOD1(G93A) animals. Methods/Principal Findings: Presymptomatic SOD1(G93A) rats (60-65 days old) received spinal lumbar injections of hNSCs. After cell grafting, disease onset, disease progression and lifespan were analyzed. In separate symptomatic SOD1(G93A) rats, the presence and functional conductivity of descending motor tracts (corticospinal and rubrospinal) was analyzed by spinal surface recording electrodes after electrical stimulation of the motor cortex. Silver impregnation of lumbar spinal cord sections and descending motor axon counting in plastic spinal cord sections were used to validate morphologically the integrity of descending motor tracts. Grafting of hNSCs into the lumbar spinal cord of SOD1(G93A) rats protected alpha-motoneurons in the vicinity of grafted cells, provided transient functional improvement, but offered no protection to alpha-motoneuron pools distant from grafted lumbar segments. Analysis of motor-evoked potentials recorded from the thoracic spinal cord of symptomatic SOD1(G93A) rats showed a near complete loss of descending motor tract conduction, corresponding to a significant (50-65%) loss of large caliber descending motor axons. Conclusions/Significance: These data demonstrate that in order to achieve a more clinically-adequate treatment, cell-replacement/gene therapy strategies will likely require both spinal and supraspinal targets.	[Hefferan, Michael P.; Kakinohana, Osamu; Santucci, Camila; Marsala, Silvia; Navarro, Roman; Hruska-Plochan, Marian; Marsala, Martin] Univ Calif San Diego, Dept Anesthesiol, Neuroregenerat Lab, La Jolla, CA 92093 USA; [Galik, Jan; Marsala, Martin] Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia; [Galik, Jan] Pavol Jozef Safarik Univ, Fac Sci, Inst Biol & Ecol, Kosice, Slovakia; [Sekerkova, Gabriela] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Johe, Karl] Neuralstem Inc, Rockville, MD USA; [Feldman, Eva] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Cleveland, Don W.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Cleveland, Don W.] Univ Calif San Diego, Sch Med, Ludwig Inst, La Jolla, CA 92093 USA; [Hruska-Plochan, Marian] Acad Sci Czech Republic, Inst Anim Physiol & Genet, Libechov, Czech Republic; [Hruska-Plochan, Marian] Charles Univ Prague, Dept Cell Biol, Fac Sci, Prague, Czech Republic	University of California System; University of California San Diego; Slovak Academy of Sciences; University of Pavol Jozef Safarik Kosice; Northwestern University; Feinberg School of Medicine; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Charles University Prague	Hefferan, MP (corresponding author), Univ Calif San Diego, Dept Anesthesiol, Neuroregenerat Lab, La Jolla, CA 92093 USA.	mmarsala@ucsd.edu	Hruska-Plochan, Marian/I-3982-2014; Galik, Jan/I-2324-2016; Cleveland, Don/AAN-9783-2021	Galik, Jan/0000-0001-9581-9585; Feldman, Eva/0000-0002-9162-2694; Cleveland, Don/0000-0002-1934-3682; Hruska-Plochan, Marian/0000-0002-9253-4362	California Institute for Regenerative Medicine [RC1-00131-1-M.M.]; Taubman Foundation	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Taubman Foundation	This work was supported by the California Institute for Regenerative Medicine (RC1-00131-1-M.M.) and by Taubman Foundation (M.M., E.F., M.H.).; Funding provided by Taubmann Foundation (EF, MM, MH) and California Institute of Regenerative Medicine (MM-RC1-00131-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; BRAAK H, 1988, STAIN TECHNOL, V63, P197, DOI 10.3109/10520298809107184; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; CASTRO AJ, 1972, BRAIN RES, V44, P313, DOI 10.1016/0006-8993(72)90305-8; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cosottini M, 2005, RADIOLOGY, V237, P258, DOI 10.1148/radiol.2371041506; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; da Rocha AJ, 2004, AM J NEURORADIOL, V25, P1509; DalCanto MC, 1997, ACTA NEUROPATHOL, V93, P537; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Davison C, 1941, ARCH NEURO PSYCHIATR, V46, P1039, DOI 10.1001/archneurpsyc.1941.02280240094006; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; FEHLINGS MG, 1987, NEUROSURGERY, V20, P125; FEHLINGS MG, 1988, ELECTROEN CLIN NEURO, V69, P65, DOI 10.1016/0013-4694(88)90036-3; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Horner PJ, 2000, J NEUROSCI, V20, P2218; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Hughes DI, 2005, P NATL ACAD SCI USA, V102, P9038, DOI 10.1073/pnas.0503646102; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kakinohana O, 2006, NEUROSCIENCE, V141, P1569, DOI 10.1016/j.neuroscience.2006.04.083; Kakinohana O, 2004, EXP NEUROL, V190, P122, DOI 10.1016/j.expneurol.2004.07.014; Kakinohana O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030561; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Mackie M, 2003, NEUROSCIENCE, V119, P461, DOI 10.1016/S0306-4522(03)00174-X; Magnus T, 2008, GLIA, V56, P200, DOI 10.1002/glia.20604; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Miller TM, 2005, ANN NEUROL, V57, P773, DOI 10.1002/ana.20453; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Ozdinler PH, 2011, J NEUROSCI, V31, P4166, DOI 10.1523/JNEUROSCI.4184-10.2011; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; SCHWARZ M, 1994, NEUROREPORT, V5, P1981, DOI 10.1097/00001756-199410000-00036; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Suzuki M, 2008, MOL THER, V16, P2002, DOI 10.1038/mt.2008.197; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; Takasawa K, 2002, J CEREBR BLOOD F MET, V22, P299, DOI 10.1097/00004647-200203000-00007; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Xu LY, 2011, NEUROSCI LETT, V494, P222, DOI 10.1016/j.neulet.2011.03.017; Xu LY, 2009, J COMP NEUROL, V514, P297, DOI 10.1002/cne.22022; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zai LJ, 2005, GLIA, V50, P247, DOI 10.1002/glia.20176; ZAPPULLA RA, 1988, NEUROSURGERY, V22, P846, DOI 10.1227/00006123-198805000-00005	55	64	68	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42614	10.1371/journal.pone.0042614	http://dx.doi.org/10.1371/journal.pone.0042614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916141	gold, Green Published			2022-12-25	WOS:000307733800022
J	Imanian, B; Pombert, JF; Dorrell, RG; Burki, F; Keeling, PJ				Imanian, Behzad; Pombert, Jean-Francois; Dorrell, Richard G.; Burki, Fabien; Keeling, Patrick J.			Tertiary Endosymbiosis in Two Dinotoms Has Generated Little Change in the Mitochondrial Genomes of Their Dinoflagellate Hosts and Diatom Endosymbionts	PLOS ONE			English	Article							SP-NOV DINOPHYCEAE; PERIDINIUM-BALTICUM; BINUCLEATE DINOFLAGELLATE; MOLECULAR-BIOLOGY; SOUTH-AFRICA; EVOLUTION; SEQUENCE; PLASTIDS; ULTRASTRUCTURE; NUCLEOMORPH	Background: Mitochondria or mitochondrion-derived organelles are found in all eukaryotes with the exception of secondary or tertiary plastid endosymbionts. In these highly reduced systems, the mitochondrion has been lost in all cases except the diatom endosymbionts found in a small group of dinoflagellates, called 'dinotoms', the only cells with two evolutionarily distinct mitochondria. To investigate the persistence of this redundancy and its consequences on the content and structure of the endosymbiont and host mitochondrial genomes, we report the sequences of these genomes from two dinotoms. Methodology/Principal Findings: The endosymbiont mitochondrial genomes of Durinskia baltica and Kryptoperidinium foliaceum exhibit nearly identical gene content with other diatoms, and highly conserved gene order (nearly identical to that of the raphid pennate diatom Fragilariopsis cylindrus). These two genomes are differentiated from other diatoms' by the fission of nad11 and by an insertion within nad2, in-frame and unspliced from the mRNA. Durinskia baltica is further distinguished from K. foliaceum by two gene fusions and its lack of introns. The host mitochondrial genome in D. baltica encodes cox1 and cob plus several fragments of LSU rRNA gene in a hugely expanded genome that includes numerous pseudogenes, and a trans-spliced cox3 gene, like in other dinoflagellates. Over 100 distinct contigs were identified through 454 sequencing, but intact full-length genes for cox1, cob and the 59 exon of cox3 were present as a single contig each, suggesting most of the genome is pseudogenes. The host mitochondrial genome of K. foliaceum was difficult to identify, but fragments of all the three protein-coding genes, corresponding transcripts, and transcripts of several LSU rRNA fragments were all recovered. Conclusions/Significance: Overall, the endosymbiont and host mitochondrial genomes in the two dinotoms have changed surprisingly little from those of free-living diatoms and dinoflagellates, irrespective of their long coexistence side by side in dinotoms.	[Imanian, Behzad; Pombert, Jean-Francois; Dorrell, Richard G.; Burki, Fabien; Keeling, Patrick J.] Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada	Canadian Institute for Advanced Research (CIFAR); University of British Columbia	Imanian, B (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada.	pkeeling@mail.ubc.ca	Burki, Fabien/F-4818-2010; Dorrell, Richard G/I-8908-2012; Imanian, Behzad/CAJ-3190-2022	Dorrell, Richard G/0000-0001-6263-9115; Imanian, Behzad/0000-0002-8768-0453; Keeling, Patrick/0000-0002-7644-0745; Pombert, Jean-Francois/0000-0002-3449-8375; Burki, Fabien/0000-0002-8248-8462	Natural Sciences and Engineering Research Council of Canada (NSERC) [227301]; NSERC; Fonds Quebecois de la Recherche sur la Nature et les Technologies/Genome Quebec	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Technologies/Genome Quebec	This work was supported by a grant [227301] from the Natural Sciences and Engineering Research Council of Canada (NSERC). BI is supported by a doctoral scholarship from NSERC and J-FP by a Louis-Berlinguet Postdoctoral Fellowship from the Fonds Quebecois de la Recherche sur la Nature et les Technologies/Genome Quebec. PJK is a Fellow of the Canadian Institute for Advanced Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; Archibald JM, 2007, BIOESSAYS, V29, P392, DOI 10.1002/bies.20551; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; CHESNICK JM, 1987, BIOSYSTEMS, V21, P69, DOI 10.1016/0303-2647(87)90007-4; CHESNICK JM, 1989, AM J BOT, V76, P1060, DOI 10.2307/2444528; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; COX ER, 1976, J PHYCOL, V12, P21; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DODGE JD, 1971, PROTOPLASMA, V73, P145, DOI 10.1007/BF01275591; Ehara M, 2000, CURR GENET, V37, P29; Feagin JE, 1997, NUCLEIC ACIDS RES, V25, P438, DOI 10.1093/nar/25.2.438; Figueroa RI, 2009, PROTIST, V160, P285, DOI 10.1016/j.protis.2008.12.003; Gabrielsen TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019132; Gilson PR, 2006, P NATL ACAD SCI USA, V103, P9566, DOI 10.1073/pnas.0600707103; Gilson PR, 2002, GENETICA, V115, P13, DOI 10.1023/A:1016011812442; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Greenwood A. D., 1974, 8 INT C ELECT MICROS, P566; HORIGUCHI T, 1991, BOT MAR, V34, P123, DOI 10.1515/botm.1991.34.2.123; HORIGUCHI T, 1994, EUR J PHYCOL, V29, P237, DOI 10.1080/09670269400650691; Imanian B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-172; Imanian B, 2007, J EUKARYOT MICROBIOL, V54, P146, DOI 10.1111/j.1550-7408.2007.00245.x; Imanian B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010711; Jackson CJ, 2012, GENOME BIOL EVOL, V4, P59, DOI 10.1093/gbe/evr122; Jackson CJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-41; JEFFREY SW, 1976, J PHYCOL, V12, P450, DOI 10.1111/j.1529-8817.1976.tb02872.x; Kamikawa R, 2009, PROTIST, V160, P364, DOI 10.1016/j.protis.2009.02.003; Kaneko T, 1996, DNA Res, V3, P109; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lane CE, 2006, MOL BIOL EVOL, V23, P856, DOI 10.1093/molbev/msj066; Lin SJ, 2002, J MOL BIOL, V320, P727, DOI 10.1016/S0022-2836(02)00468-0; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McFadden GI, 2001, J PHYCOL, V37, P951, DOI 10.1046/j.1529-8817.2001.01126.x; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; Nash EA, 2007, MOL BIOL EVOL, V24, P1528, DOI 10.1093/molbev/msm074; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Norman JE, 2001, J MOL EVOL, V53, P351, DOI 10.1007/s002390010225; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Pienaar RN, 2007, J PLANT RES, V120, P247, DOI 10.1007/s10265-006-0047-y; Ravin NV, 2010, CURR GENET, V56, P215, DOI 10.1007/s00294-010-0293-3; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Secq MPOL, 2011, GENE, V476, P20, DOI 10.1016/j.gene.2011.02.001; Secq MPO, 2006, CURR GENET, V49, P47, DOI 10.1007/s00294-005-0031-4; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; Takano Y, 2008, PHYCOLOGIA, V47, P41, DOI 10.2216/07-36.1; Tamura M, 2005, J PHYCOL, V41, P658, DOI 10.1111/j.1529-8817.2005.00085.x; Tengs T, 2000, MOL BIOL EVOL, V17, P718, DOI 10.1093/oxfordjournals.molbev.a026350; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; TIPPIT DH, 1976, J CELL SCI, V21, P273; TOMAS RN, 1973, J PHYCOL, V9, P304; Waller RF, 2009, BIOESSAYS, V31, P237, DOI 10.1002/bies.200800164; Zhang HA, 2005, J EUKARYOT MICROBIOL, V52, P538, DOI 10.1111/j.1550-7408.2005.00060.x	58	39	40	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43763	10.1371/journal.pone.0043763	http://dx.doi.org/10.1371/journal.pone.0043763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916303	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800100
J	Maehata, Y; Miyagawa, S; Sawa, Y				Maehata, Yoshito; Miyagawa, Shigeru; Sawa, Yoshiki			Activated Protein C Has a Protective Effect against Myocardial I/R Injury by Improvement of Endothelial Function and Activation of AKT1	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION; ISCHEMIA/REPERFUSION INJURY; INDUCED APOPTOSIS; RAT HEARTS; IN-VIVO; INHIBITION; RECEPTOR-1; INSULIN; INFLAMMATION; PATHWAY	Objectives: Activated protein C (APC) has a protective efficacy against ischemia-reperfusion (I/R) injury in several organs. The objective of this study was to investigate effect of APC in myocardium with possible mechanism. Methods: We used regional and global myocardial I/R injury models of rats. They consisted of I/R injuries (1) by ligation of left coronary artery, or (2) using Langendorff apparatus. Langendorff was used to focus the mechanism of APC excluding coagulation cascade in a working heart. Each experiment had an APC group (n = 10) and a control group with normal saline (n = 10). Injections of these solutions into rats were performed 30 minutes before the planned-I/R injury. Cardiac performance after the procedure was evaluated by echocardiography or indices with Langendorff apparatus. Coronary flow (CF) was measured in the global I/R injury model. Western blotting was performed to detect the change of AKT1 signal in myocardium after global I/R injury. Results: LV function improved significantly in the APC group: %EF at 2 weeks after procedure, 70.8%+/- 4.5% vs. 56.5%+/- 0.7%; APC vs. control; p<0.01. Percent LV development pressure (LVDP) also improved in the APC group significantly, 88.8%+/- 45.3% vs. 28.1%+/- 15.4%; APC vs. control; p<0.01. In APC group, %CF improved significantly, 88.5%+/- 15.8% vs. 65.0%+/- 13.4%; APC vs. control; p<0.01. It was enhanced significantly when acetylcholine was administered; % CF: 103.5%+/- 9.9% vs. 87.0%+/- 12.1%; APC vs. control; p<0.05. Western blotting revealed that APC significantly induced activation of phosphorylated AKT1 in myocardium (p<0.05). Conclusions: APC has a novel effect to protect myocardium and cardiac performance against I/R injury through improvement of endothelial function and activation of AKT1.	[Maehata, Yoshito; Miyagawa, Shigeru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Surg, Div Cardiovasc Surg, Osaka, Japan	Osaka University	Maehata, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Surg, Div Cardiovasc Surg, Osaka, Japan.	yoppymae@yahoo.co.jp		Miyagawa, Shigeru/0000-0003-0015-6569				Abraham Edward, 2005, Proc Am Thorac Soc, V2, P243, DOI 10.1513/pats.200501-004AC; Aikawa R, 2000, CIRCULATION, V102, P2873; Chang WL, 2004, NITRIC OXIDE-BIOL CH, V11, P307, DOI 10.1016/j.niox.2004.10.004; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Dossumbekova A, 2008, AM J PHYSIOL-HEART C, V295, pH2417, DOI 10.1152/ajpheart.00501.2008; Favory R, 2006, INTENS CARE MED, V32, P899, DOI 10.1007/s00134-006-0166-x; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Fernandez JA, 2006, CARDIOVASC DRUG THER, V20, P113, DOI 10.1007/s10557-006-7448-y; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; Fukui S, 2008, ANN THORAC SURG, V85, P562, DOI 10.1016/j.athoracsur.2007.06.002; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Gaudreault N, 2008, ARTERIOSCL THROM VAS, V28, P1527, DOI 10.1161/ATVBAHA.108.166975; Griffin JH, 2004, CRIT CARE MED, V32, pS247, DOI 10.1097/01.CCM.0000126127.87484.2B; Guo H, 2004, NEURON, V41, P563, DOI 10.1016/S0896-6273(04)00019-4; Isobe H, 2001, CIRCULATION, V104, P1171, DOI 10.1161/hc3501.093799; Jackson CJ, 2005, WOUND REPAIR REGEN, V13, P284, DOI 10.1111/j.1067-1927.2005.00130311.x; Joyce DE, 2002, CRIT CARE MED, V30, pS288, DOI 10.1097/00003246-200205001-00019; Liakopoulos OJ, 2006, EUR J CARDIO-THORAC, V30, P263, DOI 10.1016/j.ejcts.2006.04.019; Loubele STBG, 2009, ARTERIOSCL THROM VAS, V29, P1087, DOI 10.1161/ATVBAHA.109.188656; Matsui T, 2001, CIRCULATION, V104, P330; Mizutani A, 2000, BLOOD, V95, P3781; Morissette MR, 2005, CURR OPIN PHARMACOL, V5, P165, DOI 10.1016/j.coph.2005.01.004; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Nagoshi T, 2005, J CLIN INVEST, V115, P2128, DOI 10.1172/JCI23073; Nick JA, 2004, BLOOD, V104, P3878, DOI 10.1182/blood-2004-06-2140; Ono M, 2005, EUR J CARDIO-THORAC, V27, P117, DOI 10.1016/j.ejcts.2004.09.025; Pirat B, 2007, CORONARY ARTERY DIS, V18, P61, DOI 10.1097/MCA.0b013e328010a44a; RUBANYI GM, 1993, J CARDIOVASC PHARM, V22, pS1, DOI 10.1097/00005344-199304000-00002; Swaidi JA, 2000, NY TIMES        1026, V101, P948; Uchiba M, 2004, CIRC RES, V95, P34, DOI 10.1161/01.RES.0000133680.87668.FA; Yamauchi T, 2006, STROKE, V37, P1081, DOI 10.1161/01.STR.0000206280.30972.21; Yamenel L, 2005, CRIT CARE, V9, pR184, DOI 10.1186/cc3485	33	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e38738	10.1371/journal.pone.0038738	http://dx.doi.org/10.1371/journal.pone.0038738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916090	gold, Green Submitted, Green Published			2022-12-25	WOS:000307733800002
J	Salmona, J; Salamolard, M; Fouillot, D; Ghestemme, T; Larose, J; Centon, JF; Sousa, V; Dawson, DA; Thebaud, C; Chikhi, L				Salmona, Jordi; Salamolard, Marc; Fouillot, Damien; Ghestemme, Thomas; Larose, Jerry; Centon, Jean-Francois; Sousa, Vitor; Dawson, Deborah A.; Thebaud, Christophe; Chikhi, Lounes			Signature of a Pre-Human Population Decline in the Critically Endangered Reunion Island Endemic Forest Bird Coracina newtoni	PLOS ONE			English	Article							GENETIC DIVERSITY; COMPUTER-PROGRAM; LA REUNION; MASCARENE ISLANDS; INDIAN-OCEAN; SIZE; CONSERVATION; DISTANCE; CUCKOOSHRIKE; CONTRACTION	The exceptional biodiversity of Reunion Island is threatened by anthropogenic landscape changes that took place during the 350 years of human colonization. During this period the human population size increased dramatically from 250 to 800,000. The arrival of humans together with the development of agriculture, invasive species such as rats and cats, and deforestation has lead to the extinction of more than half of the original vertebrate species of the island. For the remaining species, significant work is being carried out to identify threats and conservation status, but little genetic work has been carried on some of the most endangered species. In the last decade theoretical studies have shown the ability of neutral genetic markers to infer the demographic history of endangered species and identify and date past population size changes (expansions or bottlenecks). In this study we provide the first genetic data on the critically endangered species the Reunion cuckoo-shrike Coracina newtoni. The Reunion cuckoo-shrike is a rare endemic forest bird surviving in a restricted 12-km(2) area of forested uplands and mountains. The total known population consists of less than one hundred individuals out of which 45 were genotyped using seventeen polymorphic microsatellite loci. We found a limited level of genetic variability and weak population structure, probably due to the limited geographic distribution. Using Bayesian methods, we identified a strong decline in population size during the Holocene, most likely caused by an ancient climatic or volcanic event around 5000 years ago. This result was surprising as it appeared in apparent contradiction with the accepted theory of recent population collapse due to deforestation and predator introduction. These results suggest that new methods allowing for more complex demographic models are necessary to reconstruct the demographic history of populations.	[Salmona, Jordi; Salamolard, Marc; Fouillot, Damien; Ghestemme, Thomas; Larose, Jerry; Centon, Jean-Francois] SEOR, St Andre, Reunion, France; [Salmona, Jordi; Sousa, Vitor; Chikhi, Lounes] Inst Gulbenkian Cienca, Oeiras, Portugal; [Dawson, Deborah A.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Thebaud, Christophe; Chikhi, Lounes] Univ Toulouse 3, Lab Evolut & Divers Biol, F-31062 Toulouse, France; [Chikhi, Lounes] Univ Toulouse, Toulouse, France	Instituto Gulbenkian de Ciencia; University of Sheffield; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse	Salmona, J (corresponding author), SEOR, St Andre, Reunion, France.	jordi.salmona@gmail.com	Salmona, Jordi/P-5996-2017; Thébaud, Christophe/N-3916-2016; Sousa, Vitor C/P-1871-2016	Salmona, Jordi/0000-0002-1950-5805; Thébaud, Christophe/0000-0002-8586-1234; Sousa, Vitor C/0000-0003-3575-0875; Chikhi, Lounes/0000-0002-1140-0718	French "Ministere de l'Ecologie et du Developpement Durable"; European Fund for Regional Development (FEDER); Departement de La Reunion; Portuguese Science Foundation ('Fundacao para a Ciencia e a Tecnologia' FCT) [PTDC/BIA-BEC/100176/2008]; Institut Francais de la Biodiversite, Programme Biodiversite de l'Ocean Indien [CD-AOOI-07-003]; Groupement de Recherche International (GDRI) Madagascar; Laboratoire d'Excellence (LABEX) [ANR -10-LABX-41]; FCT [H200741/re-equip/2005]; French "Ministere de l'Ecologie et du Developpement Durable"; European Fund for Regional Development (FEDER); Departement de La Reunion; Portuguese Science Foundation ('Fundacao para a Ciencia e a Tecnologia' FCT) [PTDC/BIA-BEC/100176/2008]; Institut Francais de la Biodiversite, Programme Biodiversite de l'Ocean Indien [CD-AOOI-07-003]; Groupement de Recherche International (GDRI) Madagascar; Laboratoire d'Excellence (LABEX) [ANR -10-LABX-41]; FCT [H200741/re-equip/2005]; NERC [NBAF010001] Funding Source: UKRI; Natural Environment Research Council [NBAF010001] Funding Source: researchfish	French "Ministere de l'Ecologie et du Developpement Durable"; European Fund for Regional Development (FEDER)(European Commission); Departement de La Reunion; Portuguese Science Foundation ('Fundacao para a Ciencia e a Tecnologia' FCT)(Portuguese Foundation for Science and Technology); Institut Francais de la Biodiversite, Programme Biodiversite de l'Ocean Indien; Groupement de Recherche International (GDRI) Madagascar; Laboratoire d'Excellence (LABEX); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); French "Ministere de l'Ecologie et du Developpement Durable"; European Fund for Regional Development (FEDER)(European Commission); Departement de La Reunion; Portuguese Science Foundation ('Fundacao para a Ciencia e a Tecnologia' FCT)(Portuguese Foundation for Science and Technology); Institut Francais de la Biodiversite, Programme Biodiversite de l'Ocean Indien; Groupement de Recherche International (GDRI) Madagascar; Laboratoire d'Excellence (LABEX); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The C.newtoni's conservation and research program managed by the "Societe d'Etudes Ornithologiques de La Reunion" (SEOR) was funded by the French "Ministere de l'Ecologie et du Developpement Durable" and European Fund for Regional Development (FEDER). The SEOR's work in the "Reserve Naturelle de la Roche Ecrite" is also supported the "Departement de La Reunion". Statistical and population genetics analyses were performed at the Instituto Gulbenkian de Ciencia (IGC), in LC's team partly funded by the Portuguese Science Foundation ('Fundacao para a Ciencia e a Tecnologia' FCT ref.PTDC/BIA-BEC/100176/2008), the Institut Francais de la Biodiversite, Programme Biodiversite de l'Ocean Indien [ref. CD-AOOI-07-003], the Groupement de Recherche International (GDRI) Madagascar, and the "Laboratoire d'Excellence (LABEX)" entitled TULIP (ANR -10-LABX-41). The 'High-Performance Computing Center' (HERMES) was founded by FCT (grant H200741/re-equip/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-384; Barau A, 2005, OIS REUN ORPH; Baret S, 2006, AUSTRAL ECOL, V31, P747, DOI 10.1111/j.1442-9993.2006.01636.x; Beaumont MA, 1999, GENETICS, V153, P2013; Beaumont MA, 2004, HEREDITY, V92, P365, DOI 10.1038/sj.hdy.6800447; Belkhir K., 2001, 5000 CNRS UMR LAB GE; Bourke BP, 2010, CONSERV GENET, P1; Bray TC, 2010, MOL ECOL RESOUR, V10, P538, DOI 10.1111/j.1755-0998.2009.02766.x; Cheke AS, 1987, ECOLOGICAL HIST MASC; CHEVALLIER L, 1982, B VOLCANOL, V45, P285, DOI DOI 10.1007/BF02597253; Chikhi L, 2008, HEREDITY, V101, P471, DOI 10.1038/hdy.2008.106; Chikhi L, 2004, MAMMALIAN GENOMICS, P539, DOI 10.1079/9780851999104.0539; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; Coamteur J, 1999, COMPT REND SESS BAG, V9, P4; Cornuet JM, 1996, GENETICS, V144, P2001; Coulon A, 2008, MOL ECOL, V17, P1685, DOI 10.1111/j.1365-294X.2008.03705.x; Crowley BE, 2010, QUATERNARY SCI REV; Drake DR, 2009, BIOL INVASIONS, V11, P1483, DOI 10.1007/s10530-008-9392-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Falush D, 2003, GENETICS, V164, P1567; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Ghestemme T, 2007, OSTRICH, V78, P255, DOI 10.2989/OSTRICH.2007.78.2.21.101; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; *IUCN, 2010, 2010 IUCN RED LIST T; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnson JA, 2009, MOL ECOL, V18, P54, DOI [10.1111/j.1365-294X.2009.04240.x, 10.1111/j.1365-294X.2008.04012.x]; Jonsson KA, 2010, J BIOGEOGR, V37, P1767, DOI 10.1111/j.1365-2699.2010.02328.x; JULVEZ J, 1990, ANN SOC BELG MED TR, V70, P249; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KIEFFER G, 1993, CR ACAD SCI II, V317, P835; Lagabrielle E, 2009, BIOL CONSERV, V142, P1523, DOI 10.1016/j.biocon.2009.02.022; Leblois R, 2006, MOL ECOL, V15, P3601, DOI 10.1111/j.1365-294X.2006.03046.x; Lopes JS, 2009, BIOINFORMATICS, V25, P2747, DOI 10.1093/bioinformatics/btp487; MANTEL N, 1967, CANCER RES, V27, P209; Mohamed-Abchir MA, 1996, THESIS; Mourer-Chauvire C, 1999, SM C PALEOB, P1; NEI M, 1978, GENETICS, V89, P583; Olivieri GL, 2008, BIOL CONSERV, V141, P1257, DOI 10.1016/j.biocon.2008.02.025; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peter BM, 2010, MOL ECOL, V19, P4648, DOI 10.1111/j.1365-294X.2010.04783.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pollen FPL, 1865, B SOC ACCLIMATATION; Pritchard JK, 2000, GENETICS, V155, P945; Probst JM, 1999, B PHAETHON, P24; Probst JM, 1995, B PHAETHON RIVIERE E; Quemere E, 2012, P NATL ACAD SCI; Quemere E, 2010, CONSERV GENET, V11, P675, DOI 10.1007/s10592-009-9837-9; Reed DH, 2010, ANIM CONSERV, V13, P448, DOI 10.1111/j.1469-1795.2010.00353.x; Rosenberg NA, 2004, DISTRUCT 1 1 PROGRAM; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Salamolard M, 2004, PLAN CONSERVATION EC; Salmona J, 2010, CONSERV GENET RESOUR, V2, P361, DOI 10.1007/s12686-010-9254-x; SEOR, 2008, COG RES ROCH ECR; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Sousa V, 2011, HEREDITY; Sousa V, 2008, CONSERV GENET, V9, P791, DOI 10.1007/s10592-007-9399-7; Stadler T, 2009, GENETICS, V182, P205, DOI 10.1534/genetics.108.094904; STAUDACHER T, 1993, EARTH PLANET SC LETT, V119, P395, DOI 10.1016/0012-821X(93)90147-2; Storz JF, 2002, EVOLUTION, V56, P154; Strasberg D, 2005, BIODIVERS CONSERV, V14, P3015, DOI 10.1007/s10531-004-0258-2; Thiollay JM, 1999, BIOL CONSERV, V87, P191, DOI 10.1016/S0006-3207(98)00062-7; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Virah-Sawmy M, 2010, J BIOGEOGR, V37, P506, DOI 10.1111/j.1365-2699.2009.02203.x; Wakeley J, 1999, GENETICS, V153, P1863; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5	75	17	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43524	10.1371/journal.pone.0043524	http://dx.doi.org/10.1371/journal.pone.0043524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916272	Green Published, gold, Green Accepted			2022-12-25	WOS:000307733800075
J	Sun, K; Liu, Y; Dai, M; Li, M; Yang, Z; Xu, M; Xu, Y; Lu, JL; Chen, YH; Liu, JM; Ning, G; Bi, YF				Sun, Kan; Liu, Yu; Dai, Meng; Li, Mian; Yang, Zhi; Xu, Min; Xu, Yu; Lu, Jieli; Chen, Yuhong; Liu, Jianmin; Ning, Guang; Bi, Yufang			Accessing Autonomic Function Can Early Screen Metabolic Syndrome	PLOS ONE			English	Article							SYMPATHETIC ACTIVITY; OBESITY; TOOL; HYPERTENSION; PREVALENCE; ACTIVATION; MECHANISMS; NEUROPATHY; CHILDREN; DISEASE	Background: Clinical diagnosis of the metabolic syndrome is time-consuming and invasive. Convenient instruments that do not require laboratory or physical investigation would be useful in early screening individuals at high risk of metabolic syndrome. Examination of the autonomic function can be taken as a directly reference and screening indicator for predicting metabolic syndrome. Methodology and Principal Findings: The EZSCAN test, as an efficient and noninvasive technology, can access autonomic function through measuring electrochemical skin conductance. In this study, we used EZSCAN value to evaluate autonomic function and to detect metabolic syndrome in 5,887 participants aged 40 years or older. The EZSCAN test diagnostic accuracy was analyzed by receiver operating characteristic curves. Among the 5,815 participants in the final analysis, 2,541 were diagnosed as metabolic syndrome and the overall prevalence was 43.7%. Prevalence of the metabolic syndrome increased with the elevated EZSCAN risk level (p for trend <0.0001). Moreover, EZSCAN value was associated with an increase in the number of metabolic syndrome components (p for trend <0.0001). Compared with the no risk group (EZSCAN value 0-24), participants at the high risk group (EZSCAN value: 50-100) had a 2.35 fold increased risk of prevalent metabolic syndrome after the multiple adjustments. The area under the curve of the EZSCAN test was 0.62 (95% confidence interval [CI], 0.61-0.64) for predicting metabolic syndrome. The optimal operating point for the EZSCAN value to detect a high risk of prevalent metabolic syndrome was 30 in this study, while the sensitivity and specificity were 71.2% and 46.7%, respectively. Conclusions and Significance: In conclusion, although less sensitive and accurate when compared with the clinical definition of metabolic syndrome,	[Sun, Kan; Liu, Yu; Dai, Meng; Li, Mian; Yang, Zhi; Xu, Min; Xu, Yu; Lu, Jieli; Chen, Yuhong; Liu, Jianmin; Ning, Guang; Bi, Yufang] Shanghai Jiao Tong Univ, Sch Med, Key Lab Endocrine & Metab Dis, Minist Hlth,Rui Jin Hosp,E Inst Shanghai Univ, Shanghai 200030, Peoples R China; [Sun, Kan; Liu, Yu; Dai, Meng; Li, Mian; Yang, Zhi; Xu, Min; Xu, Yu; Lu, Jieli; Chen, Yuhong; Liu, Jianmin; Ning, Guang; Bi, Yufang] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrinol & Metab,Rui Jin Hosp,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Key Lab Endocrine & Metab Dis, Minist Hlth,Rui Jin Hosp,E Inst Shanghai Univ, Shanghai 200030, Peoples R China.	byf10784@rjh.com.cn	Li, Mian/HGE-6038-2022		Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; Sector Funds of Ministry of Health [201002002]; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology [2012ZX09303006-001]; Creative Research Group of Ministry of Education [IRT0932]; Major Project of Shanghai Committee of Science and Technology [09DZ1950200]	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; Sector Funds of Ministry of Health; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology; Creative Research Group of Ministry of Education; Major Project of Shanghai Committee of Science and Technology	This study was supported by the grants from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), the Sector Funds of Ministry of Health (201002002), the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (2012ZX09303006-001), the Creative Research Group of Ministry of Education (IRT0932), and the Major Project of Shanghai Committee of Science and Technology (09DZ1950200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Birklein F, 1999, FORTSCHR NEUROL PSYC, V67, P287, DOI 10.1055/s-2007-994979; Brunswick P, 2007, P ANN INT IEEE EMBS, P4544, DOI 10.1109/IEMBS.2007.4353350; Cheshire WP, 2003, SEMIN NEUROL, V23, P399; Chizmadzhev YA, 1998, BIOPHYS J, V74, P843, DOI 10.1016/S0006-3495(98)74008-1; Davy KP, 2009, NEUROSCI BIOBEHAV R, V33, P116, DOI 10.1016/j.neubiorev.2008.05.024; Gallop RJ, 2003, UNDERSTAND STAT, V2, P219, DOI DOI 10.1207/S15328031US0204_01; Grassi G, 2006, J HYPERTENS, V24, P47, DOI 10.1097/01.hjh.0000198040.47128.4c; Grassi G, 2005, DIABETOLOGIA, V48, P1359, DOI 10.1007/s00125-005-1798-z; Grassi G, 1999, J HYPERTENS, V17, P719, DOI 10.1097/00004872-199917060-00001; Grassi G, 2007, HYPERTENSION, V49, P535, DOI 10.1161/01.HYP.0000255983.32896.b9; Grundy SM, 2004, CIRCULATION, V109, P551, DOI 10.1161/01.CIR.0000112379.88385.67; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Hubert D, 2011, J CYST FIBROS, V10, P15, DOI 10.1016/j.jcf.2010.09.002; Huggett RJ, 2004, HYPERTENSION, V44, P847, DOI 10.1161/01.HYP.0000147893.08533.d8; Kimpinski K, 2009, NEUROLOGY, V73, P1501, DOI 10.1212/WNL.0b013e3181bf995f; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Low VA, 2006, MUSCLE NERVE, V34, P57, DOI 10.1002/mus.20551; Mayaudon H, 2010, DIABETES METAB, V36, P450, DOI 10.1016/j.diabet.2010.05.004; Ozaki R, 2011, DIABETES TECHNOL THE, V13, P937, DOI 10.1089/dia.2011.0023; Peltier A, 2009, MUSCLE NERVE, V39, P529, DOI 10.1002/mus.21210; Ramachandran A, 2010, DIABETES RES CLIN PR, V88, P302, DOI 10.1016/j.diabres.2010.01.023; Sheng CS, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-36; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Straznicky NE, 2005, J CLIN ENDOCR METAB, V90, P5998, DOI 10.1210/jc.2005-0961; Xu HQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-13; Yang SH, 2010, NEW ENGL J MED, V362, P2425; ZWEIG MH, 1993, CLIN CHEM, V39, P561	28	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43449	10.1371/journal.pone.0043449	http://dx.doi.org/10.1371/journal.pone.0043449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916265	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800069
J	Yan, F; Lu, YW; Lin, L; Zheng, HY; Chen, JP				Yan, Fei; Lu, Yuwen; Lin, Lin; Zheng, Hongying; Chen, Jianping			The Ability of PVX p25 to Form RL Structures in Plant Cells Is Necessary for Its Function in Movement, but Not for Its Suppression of RNA Silencing	PLOS ONE			English	Article							POTATO-VIRUS-X; TRIPLE GENE BLOCK; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; NICOTIANA-BENTHAMIANA; MOSAIC POTEXVIRUS; PROTEIN; TRAFFICKING; VESICLES; SIGNAL	The p25 triple gene block protein of Potato virus X (PVX) is multifunctional, participating in viral movement and acting as a suppressor of RNA silencing. The cell-to-cell movement of PVX is known to depend on the suppression function of p25. GFP-fused p25 accumulates in rod-like (RL) structures with intense fluorescence in cells. By monitoring the location of fluorescence at different times, we have now shown that the RL structure is composed of filaments. P25 mutants without the conditional ability to recover movement function could not form RL structures while the mutants that had the ability did form the structure, suggesting that the ability of p25 to form RL structures is necessary for its function in cell-to-cell movement, but not for its suppressor function. Moreover, chemical inhibition of microfilaments in cells destroyed the formation of the complete RL structure. Additionally, TGBp2 and TGBp3 were recruited into the RL structure, suggesting a relationship between the TGBps in virus movement.	[Yan, Fei; Lu, Yuwen; Lin, Lin; Zheng, Hongying; Chen, Jianping] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Yan, Fei; Lu, Yuwen; Lin, Lin; Zheng, Hongying; Chen, Jianping] Zhejiang Acad Agr Sci, Key Lab Biotechnol Plant Protect, Minist China, Hangzhou, Zhejiang, Peoples R China; [Yan, Fei; Lu, Yuwen; Lin, Lin; Zheng, Hongying] Zhejiang Acad Agr Sci, Inst Virol & Biotechnol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences	Yan, F (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China.	fei.yan@mail.zaas.ac.cn; jpchen2001@yahoo.com.cn		Yan, Fei/0000-0002-0049-8588	National Natural Science Foundation of China [30771402, 31101414]; Zhejiang Provincial Natural Science Foundation of China [Y3090148]; Department of Science and Technology, Zhejiang Provincial Government [2011R09032-05, 2011R09032-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Department of Science and Technology, Zhejiang Provincial Government	This work was financially supported by the National Natural Science Foundation of China (30771402, 31101414) and Zhejiang Provincial Natural Science Foundation of China (Y3090148) and a grant from the Department of Science and Technology, Zhejiang Provincial Government (2011R09032-05, 2011R09032-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne EH, 2005, PLANT J, V44, P471, DOI 10.1111/j.1365-313X.2005.02539.x; Chiu MH, 2010, MOL PLANT PATHOL, V11, P641, DOI [10.1111/j.1364-3703.2010.00634.x, 10.1111/J.1364-3703.2010.00634.X]; DAVIES C, 1993, VIROLOGY, V197, P166, DOI 10.1006/viro.1993.1577; Harries PA, 2009, P NATL ACAD SCI USA, V106, P17594, DOI 10.1073/pnas.0909239106; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hsu HT, 2004, ARCH VIROL, V149, P1027, DOI 10.1007/s00705-003-0254-y; Ju HJ, 2005, PLANT PHYSIOL, V138, P1877, DOI 10.1104/pp.105.066019; Ju HJ, 2007, J VIROL, V81, P1899, DOI 10.1128/JVI.02009-06; Krishnamurthy K, 2003, VIROLOGY, V309, P135, DOI 10.1016/S0042-6822(02)00102-2; Leshchiner AD, 2008, BIOCHEMISTRY-MOSCOW+, V73, P50, DOI 10.1134/S0006297908010070; Lough TJ, 2000, MOL PLANT MICROBE IN, V13, P962, DOI 10.1094/MPMI.2000.13.9.962; Lu YW, 2011, MOL PLANT PATHOL, V12, P666, DOI [10.1111/j.1364-3703.2010.00699.x, 10.1111/J.1364-3703.2010.00699.X]; Mitra R, 2003, VIROLOGY, V312, P35, DOI 10.1016/S0042-6822(03)00180-6; Morozov SY, 2003, J GEN VIROL, V84, P1351, DOI 10.1099/vir.0.18922-0; Qu F, 2005, J VIROL, V79, P15209, DOI 10.1128/JVI.79.24.15209-15217.2005; ROULEAU M, 1994, VIROLOGY, V204, P254, DOI 10.1006/viro.1994.1530; Sambrook J., 2002, MOL CLONING LAB MANU; Samuels TD, 2007, VIROLOGY, V367, P375, DOI 10.1016/j.virol.2007.05.022; Schepetilnikov MV, 2005, J GEN VIROL, V86, P2379, DOI 10.1099/vir.0.80865-0; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Tilsner J, 2012, PLANT PHYSL; Verchot-Lubicz J, 2007, J GEN VIROL, V88, P1643, DOI 10.1099/vir.0.82667-0; Verchot-Lubicz J, 2010, MOL PLANT MICROBE IN, V23, P1231, DOI 10.1094/MPMI-04-10-0086; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Wu CH, 2011, J CELL BIOL, V193, P521, DOI 10.1083/jcb.201006023; Xie Q, 2006, VIRUS RES, V118, P1, DOI 10.1016/j.virusres.2005.11.012	26	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43242	10.1371/journal.pone.0043242	http://dx.doi.org/10.1371/journal.pone.0043242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916231	Green Published, gold, Green Submitted			2022-12-25	WOS:000307824300034
J	Costa, TL; Barboni, MTS; Moura, ALD; Bonci, DMO; Gualtieri, M; Silveira, LCD; Ventura, DF				Costa, Thiago Leiros; Salgueiro Barboni, Mirella Telles; de Araujo Moura, Ana Laura; Oliveira Bonci, Daniela Maria; Gualtieri, Mirella; de Lima Silveira, Luiz Carlos; Ventura, Dora Fix			Long-Term Occupational Exposure to Organic Solvents Affects Color Vision, Contrast Sensitivity and Visual Fields	PLOS ONE			English	Article							ABUSED SOLVENT; MERCURY-VAPOR; IMPAIRMENT; TOLUENE; WORKERS; PERFORMANCE; POTENTIALS; RECEPTORS; INDICATOR; MIXTURES	The purpose of this study was to evaluate the visual outcome of chronic occupational exposure to a mixture of organic solvents by measuring color discrimination, achromatic contrast sensitivity and visual fields in a group of gas station workers. We tested 25 workers (20 males) and 25 controls with no history of chronic exposure to solvents (10 males). All participants had normal ophthalmologic exams. Subjects had worked in gas stations on an average of 9.6 +/- 6.2 years. Color vision was evaluated with the Lanthony D15d and Cambridge Colour Test (CCT). Visual field assessment consisted of white-on-white 24-2 automatic perimetry (Humphrey II-750i). Contrast sensitivity was measured for sinusoidal gratings of 0.2, 0.5, 1.0, 2.0, 5.0, 10.0 and 20.0 cycles per degree (cpd). Results from both groups were compared using the Mann-Whitney U test. The number of errors in the D15d was higher for workers relative to controls (p<0.01). Their CCT color discrimination thresholds were elevated compared to the control group along the protan, deutan and tritan confusion axes (p<0.01), and their ellipse area and ellipticity were higher (p<0.01). Genetic analysis of subjects with very elevated color discrimination thresholds excluded congenital causes for the visual losses. Automated perimetry thresholds showed elevation in the 9 degrees, 15 degrees and 21 degrees of eccentricity (p<0.01) and in MD and PSD indexes (p<0.01). Contrast sensitivity losses were found for all spatial frequencies measured (p<0.01) except for 0.5 cpd. Significant correlation was found between previous working years and deutan axis thresholds (rho = 0.59; p<0.05), indexes of the Lanthony D15d (rho = 0.52; p<0.05), perimetry results in the fovea (rho = -0.51; p<0.05) and at 3, 9 and 15 degrees of eccentricity (rho = -0.46; p<0.05). Extensive and diffuse visual changes were found, suggesting that specific occupational limits should be created.	[Costa, Thiago Leiros; Salgueiro Barboni, Mirella Telles; de Araujo Moura, Ana Laura; Oliveira Bonci, Daniela Maria; Gualtieri, Mirella; Ventura, Dora Fix] Univ Sao Paulo, Inst Psicol, Sao Paulo, Brazil; [Costa, Thiago Leiros; Salgueiro Barboni, Mirella Telles; de Araujo Moura, Ana Laura; Oliveira Bonci, Daniela Maria; Gualtieri, Mirella; Ventura, Dora Fix] Univ Sao Paulo, Nucleo Neurociencias & Comportamento, Sao Paulo, Brazil; [de Lima Silveira, Luiz Carlos] Fed Univ Para, Dept Fisiol, BR-66059 Belem, Para, Brazil; [de Lima Silveira, Luiz Carlos] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Para; Universidade Federal do Para	Costa, TL (corresponding author), Univ Sao Paulo, Inst Psicol, Sao Paulo, Brazil.	e.thiagocosta@gmail.com	Silveira, Luiz Carlos L/H-9647-2014; Ventura, Dora F/B-9071-2012; Barboni, Mirella T. S./C-9874-2014; Gualtieri, Mirella/L-2781-2016	Silveira, Luiz Carlos L/0000-0001-9414-1573; Ventura, Dora F/0000-0002-7616-4031; Gualtieri, Mirella/0000-0002-1091-1321	FAPESP Projeto Tematico [08/58731-2, 02/12733-8]; FAPESP Master's Degree scholarship [2009/07089-1]; FAPESP [07/55125-1, 08/52427-0]	FAPESP Projeto Tematico(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP Master's Degree scholarship; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by grants from FAPESP Projeto Tematico #08/58731-2 and #02/12733-8. TLC had FAPESP Master's Degree scholarship #2009/07089-1. MTSB and ALM had doctoral scholarships (FAPESP 07/55125-1 and 08/52427-0). LCLS is a CNPq research fellow. DFV is a CNPq 1A research fellow. FAPESP = Fundacao de Amparo a Pesquisa do Estado de Sao Paulo http://www.fapesp.br/. CNPq = Conselho Nacional de Desenvolvimento Cientifico e Tecnologico http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANP Anuario, 2010, EST BRAS PETR GAS NA; Bale AS, 2002, BRIT J PHARMACOL, V137, P375, DOI 10.1038/sj.bjp.0704874; Bengtsson B, 1997, ACTA OPHTHALMOL SCAN, V75, P368; Boeckelmann I, 2003, J OCCUP ENVIRON MED, V45, P25, DOI 10.1097/00043764-200301000-00009; Castillo L, 2001, AM J IND MED, V39, P351, DOI 10.1002/ajim.1025; Correa SM, 2006, 36 ENC NAC ENG PROD; Costa MF, 2007, AM J HUM GENET, V80, P1064, DOI 10.1086/518127; Costa MF, 2006, VISUAL NEUROSCI, V23, P461, DOI 10.1017/S095252380623311X; Cruz SL, 1998, J PHARMACOL EXP THER, V286, P334; Lacerda EMDB, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/784390; Edling C, 1997, INT ARCH OCC ENV HEA, V70, P180, DOI 10.1007/s004200050204; Eisenberg D.P., 2003, EINSTEIN QJ BIOL MED, V19, P150; Feitosa-Santana C, 2007, BRAZ J MED BIOL RES, V40, P409, DOI 10.1590/S0100-879X2006005000063; Feitosa-Santana C, 2010, OPHTHAL PHYSL OPT, V30, P717, DOI 10.1111/j.1475-1313.2010.00776.x; Garcia-Perez MA, 1998, VISION RES, V38, P1861, DOI 10.1016/S0042-6989(97)00340-4; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; Geller AM, 2001, NEUROTOXICOL TERATOL, V23, P265, DOI 10.1016/S0892-0362(01)00139-8; Gobba F, 2003, NEUROTOXICOLOGY, V24, P675, DOI 10.1016/S0161-813X(03)00038-X; Gobba F, 2003, NEUROTOXICOLOGY, V24, P693, DOI 10.1016/S0161-813X(03)00037-8; Gobba F, 2000, NEUROTOXICOLOGY, V21, P857; Gobba F, 2000, NEUROTOXICOLOGY, V21, P777; Gong YY, 2003, NEUROTOXICOLOGY, V24, P703, DOI 10.1016/S0161-813X(03)00034-2; Greenberg MM, 1997, ENVIRON RES, V72, P1, DOI 10.1006/enrs.1996.3686; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; Hinrichsen SL, 2004, REV BRAS MED, V61, P529; Kiyokawa M, 1999, JPN J OPHTHALMOL, V43, P438, DOI 10.1016/S0021-5155(99)00102-1; Laurentino L, 2007, 11 ENC SBQ, P124; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; MERGLER D, 1988, TOXICOLOGY, V49, P341, DOI 10.1016/0300-483X(88)90017-0; MERGLER D, 1987, INT ARCH OCC ENV HEA, V59, P313, DOI 10.1007/BF00405275; Meyer-Baron M, 2008, NEUROTOXICOLOGY, V29, P349, DOI 10.1016/j.neuro.2008.02.005; MORATA TC, 1995, ARCH TOXICOL, V69, P431, DOI 10.1007/s002040050196; Moura ALA, 2008, VISUAL NEUROSCI, V25, P1; Muttray A, 1997, INT ARCH OCC ENV HEA, V70, P407, DOI 10.1007/s004200050237; Nasanen R, 2005, ENVIRON TOXICOL PHAR, V19, P497, DOI 10.1016/j.etap.2004.12.013; NEITZ M, 1995, SCIENCE, V267, P1013, DOI 10.1126/science.7863325; Neitz M, 2004, VISUAL NEUROSCI, V21, P205, DOI 10.1017/S0952523804213293; Paallysaho J, 2007, HUM EXP TOXICOL, V26, P375, DOI 10.1177/0960327107076820; Pacheco-Cutillas M, 1999, BRIT J OPHTHALMOL, V83, P1396, DOI 10.1136/bjo.83.12.1396; Paramei GV, 2004, NEUROTOXICOLOGY, V25, P803, DOI 10.1016/j.neuro.2004.01.006; REGAN BC, 1994, VISION RES, V34, P1279, DOI 10.1016/0042-6989(94)90203-8; Barboni MTS, 2009, J OCCUP ENVIRON MED, V51, P1403, DOI 10.1097/JOM.0b013e3181bca9ea; Schaper M, 2004, TOXICOL LETT, V151, P193, DOI 10.1016/j.toxlet.2004.01.020; Sekhar GC, 2000, OPHTHALMOLOGY, V107, P1303, DOI 10.1016/S0161-6420(00)00140-8; Semple S, 2000, OCCUP ENVIRON MED, V57, P582, DOI 10.1136/oem.57.9.582; SHAPLEY R, 1990, ANNU REV PSYCHOL, V41, P635, DOI 10.1146/annurev.psych.41.1.635; Soderkvist P, 1996, SCAND J WORK ENV HEA, V22, P360; URBAN P, 1990, BRIT J IND MED, V47, P819; Ventura DF, 2005, ENVIRON TOXICOL PHAR, V19, P523, DOI 10.1016/j.etap.2004.12.016; Ventura DF, 2004, VISUAL NEUROSCI, V21, P421, DOI 10.1017/S0952523804213372; Ventura DSF, 2003, NORMAL DEFECTIVE COL; Visser I, 2008, ANN NEUROL, V63, P572, DOI 10.1002/ana.21364; Wani JS, 2005, JK PRACTITIONER, V12, P219; Zavalic M, 1998, INT ARCH OCC ENV HEA, V71, P194, DOI 10.1007/s004200050270	54	18	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42961	10.1371/journal.pone.0042961	http://dx.doi.org/10.1371/journal.pone.0042961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916187	gold, Green Published, Green Submitted			2022-12-25	WOS:000307823600035
J	Ligresti, G; Aplin, AC; Dunn, BE; Morishita, A; Nicosia, RF				Ligresti, Giovanni; Aplin, Alfred C.; Dunn, Bruce E.; Morishita, Ann; Nicosia, Roberto F.			The Acute Phase Reactant Orosomucoid-1 Is a Bimodal Regulator of Angiogenesis with Time- and Context-Dependent Inhibitory and Stimulatory Properties	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ENDOTHELIAL GROWTH-FACTOR; AORTIC RING MODEL; IN-VIVO MODEL; ALPHA(1)-ACID GLYCOPROTEIN; ALPHA-1-ACID GLYCOPROTEIN; RAT AORTA; TNF-ALPHA; PROINFLAMMATORY CYTOKINES; INFLAMMATORY CYTOKINES	Background: Tissues respond to injury by releasing acute phase reaction (APR) proteins which regulate inflammation and angiogenesis. Among the genes upregulated in wounded tissues are tumor necrosis factor-alpha (TNF alpha) and the acute phase reactant orosomucoid-1 (ORM1). ORM1 has been shown to modulate the response of immune cells to TNF alpha, but its role on injury- and TNF alpha-induced angiogenesis has not been investigated. This study was designed to characterize the role of ORM1 in the angiogenic response to injury and TNF alpha. Methods and Results: Angiogenesis was studied with in vitro, ex vivo, and in vivo angiogenesis assays. Injured rat aortic rings cultured in collagen gels produced an angiogenic response driven by macrophage-derived TNF alpha. Microarray analysis and qRT-PCR showed that TNF alpha and ORM1 were upregulated prior to angiogenic sprouting. Exogenous ORM1 delayed the angiogenic response to injury and inhibited the proangiogenic effect of TNF alpha in cultures of aortic rings or isolated endothelial cells, but stimulated aortic angiogenesis over time while promoting VEGF production and activity. ORM1 inhibited injury- and TNF alpha-induced phosphorylation of MEK1/2 and p38 MAPK in aortic rings, but not of NF kappa B. This effect was injury/TNF alpha-specific since ORM1 did not inhibit VEGF-induced signaling, and cell-specific since ORM1 inhibited TNF alpha-induced phosphorylation of MEK1/2 and p38 MAPK in macrophages and endothelial cells, but not mural cells. Experiments with specific inhibitors demonstrated that the MEK/ERK pathway was required for angiogenesis. ORM1 inhibited angiogenesis in a subcutaneous in vivo assay of aortic ring-induced angiogenesis, but stimulated developmental angiogenesis in the chorioallantoic membrane (CAM) assay. Conclusion: ORM1 regulates injury-induced angiogenesis in a time- and context-dependent manner by sequentially dampening the initial TNF alpha-induced angiogenic response and promoting the downstream stimulation of the angiogenic process by VEGF. The context-dependent nature of ORM1 angioregulatory function is further demonstrated in the CAM assay where ORM1 stimulates developmental angiogenesis without exerting any inhibitory activity.	[Ligresti, Giovanni; Aplin, Alfred C.; Morishita, Ann; Nicosia, Roberto F.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Nicosia, Roberto F.] Vet Adm Puget Sound Hlth Care Syst, Pathol & Lab Med Serv, Seattle, WA USA; [Dunn, Bruce E.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Dunn, Bruce E.] Dept Vet Affairs Med Ctr, Pathol & Lab Med Serv, Milwaukee, WI USA	University of Washington; University of Washington Seattle; Medical College of Wisconsin	Ligresti, G (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	roberto.nicosia@va.gov	Ligresti, Giovanni/AAB-9881-2019	Aplin, Alfred/0000-0002-3346-9484	National Heart, Lung, and Blood Institute [HL52585]; United States Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052585] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Work presented in the paper was supported by National Heart, Lung, and Blood Institute Grant HL52585 and a Merit Review Grant from United States Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagappan VKT, 2005, CELL BIOCHEM BIOPHYS, V43, P119, DOI 10.1385/CBB:43:1:119; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Aplin AC, 2006, PHYSIOL GENOMICS, V27, P20, DOI 10.1152/physiolgenomics.00048.2006; Atemezem A, 2001, BIOCHEM J, V356, P121, DOI 10.1042/0264-6021:3560121; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Benelli R, 2006, CURR PHARM DESIGN, V12, P3101, DOI 10.2174/138161206777947461; Ceciliani F, 2007, CURR PROTEIN PEPT SC, V8, P91, DOI 10.2174/138920307779941497; Chu SC, 2004, J ENDODONT, V30, P704, DOI 10.1097/01.DON.0000129962.65752.C6; COSTELLO MJ, 1984, CLIN EXP IMMUNOL, V55, P465; Cray C, 2009, COMPARATIVE MED, V59, P517; Di Marco GS, 2009, J AM SOC NEPHROL, V20, P2235, DOI 10.1681/ASN.2009010061; DUNN BE, 1981, ANAT REC, V199, P33, DOI 10.1002/ar.1091990105; Elg SA, 1997, CANCER, V80, P1448, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1448::AID-CNCR12>3.3.CO;2-D; FAJARDO LF, 1992, AM J PATHOL, V140, P539; Fogel Eric, 2007, Angiogenesis, V10, P287, DOI 10.1007/s10456-007-9082-0; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Gao BC, 2002, AM J PHYSIOL-CELL PH, V283, pC1196, DOI 10.1152/ajpcell.00064.2002; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gelati M, 2008, J IMMUNOL, V181, P5711, DOI 10.4049/jimmunol.181.8.5711; Gunnarsson P, 2007, FASEB J, V21, P4059, DOI 10.1096/fj.07-8534com; Hlushchuk R, 2007, MICROCIRCULATION, V14, P813, DOI 10.1080/10739680701370021; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Irmak S, 2009, EXP CELL RES, V315, P3201, DOI 10.1016/j.yexcr.2009.07.024; Jupp OJ, 2001, BIOCHEM J, V359, P525, DOI 10.1042/0264-6021:3590525; Kim I, 2000, BIOCHEM BIOPH RES CO, V269, P361, DOI 10.1006/bbrc.2000.2296; LAINE E, 1990, INFLAMMATION, V14, P1, DOI 10.1007/BF00914025; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Lee YS, 2010, J BIOL CHEM, V285, P22174, DOI 10.1074/jbc.M109.085464; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; LIBERT C, 1994, J EXP MED, V180, P1571, DOI 10.1084/jem.180.4.1571; Ligresti G, 2011, ARTERIOSCL THROM VAS, V31, P1151, DOI 10.1161/ATVBAHA.111.223917; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo DH, 2006, AM J PATHOL, V169, P1886, DOI 10.2353/ajpath.2006.060603; Matsumoto K, 2010, DRUG METAB PHARMACOK, V25, P101, DOI 10.2133/dmpk.25.101; Montrucchio G, 1997, AM J PATHOL, V151, P557; Muchitsch EM, 1996, ARCH INT PHARMACOD T, V331, P313; Muchitsch EM, 1998, FUNDAM CLIN PHARM, V12, P173, DOI 10.1111/j.1472-8206.1998.tb00938.x; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; NICOSIA RF, 1990, LAB INVEST, V63, P115; NICOSIA RF, 1994, IN VITRO CELL DEV-AN, V30A, P394, DOI 10.1007/BF02634360; Nicosia RF, 2011, INT J DEV BIOL, V55, P447, DOI 10.1387/ijdb.103222rn; Niida Hirohito, 1995, Neurologia Medico-Chirurgica, V35, P209, DOI 10.2176/nmc.35.209; Otani N, 2003, ACT NEUR S, V86, P287; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; ROESEL JF, 1995, J SURG RES, V58, P449, DOI 10.1006/jsre.1995.1071; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; SATO N, 1987, J NATL CANCER I, V79, P1383; SCHWEIGERER L, 1987, BIOCHEM BIOPH RES CO, V143, P997, DOI 10.1016/0006-291X(87)90350-0; Scott BB, 2005, BIOCHEM BIOPH RES CO, V328, P409, DOI 10.1016/j.bbrc.2004.12.180; SNYDER S, 1976, ARCH INTERN MED, V136, P778, DOI 10.1001/archinte.136.7.778; Sorensson J, 2000, AM J PHYSIOL-HEART C, V278, pH1725, DOI 10.1152/ajpheart.2000.278.5.H1725; TILG H, 1993, J EXP MED, V178, P1629, DOI 10.1084/jem.178.5.1629; Van Hauwermeiren F, 2011, CYTOKINE GROWTH F R, V22, P311, DOI 10.1016/j.cytogfr.2011.09.004; van Hinsbergh V W, 1997, EXS, V79, P391; Vanderslice P, 1998, Angiogenesis, V2, P265, DOI 10.1023/A:1009296700991; VanMolle W, 1997, J IMMUNOL, V159, P3555; VILLASCHI S, 1994, IN VITRO CELL DEV-AN, V30A, P589; Yang H, 2004, J SURG RES, V122, P249, DOI 10.1016/j.jss.2004.05.007; Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284; Zhu WH, 2002, AM J PATHOL, V161, P823, DOI 10.1016/S0002-9440(10)64242-3; Zorzi P, 2010, J LEUKOCYTE BIOL, V88, P1051, DOI 10.1189/jlb.0310178	64	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e41387	10.1371/journal.pone.0041387	http://dx.doi.org/10.1371/journal.pone.0041387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916107	gold, Green Published, Green Submitted			2022-12-25	WOS:000307500800005
J	Rodriguez, GP; Song, JB; Crouse, GF				Rodriguez, Gina P.; Song, Joseph B.; Crouse, Gray F.			Transformation with Oligonucleotides Creating Clustered Changes in the Yeast Genome	PLOS ONE			English	Article							SINGLE-STRANDED OLIGONUCLEOTIDES; MISMATCH REPAIR PROTEIN; SACCHAROMYCES-CEREVISIAE; DNA OLIGONUCLEOTIDES; SYNTHETIC OLIGONUCLEOTIDES; ESCHERICHIA-COLI; REPLICATION FORK; GENE DISRUPTION; IN-VIVO; POLYMERASES	We have studied single-strand oligonucleotide (oligo) transformation of yeast by using 40-nt long oligos that create multiple base changes to the yeast genome spread throughout the length of the oligos, making it possible to measure the portions of an oligo that are incorporated during transformation. Although the transformation process is greatly inhibited by DNA mismatch repair (MMR), the pattern of incorporation is essentially the same in the presence or absence of MMR, whether the oligo anneals to the leading or lagging strand of DNA replication, or whether phosphorothioate linkages are used at either end. A central core of approximately 15 nt is incorporated with a frequency of >90%; the ends are incorporated with a lower frequency, and loss of the two ends appears to be by different mechanisms. Bases that are 5-10 nt from the 5' end are generally lost with a frequency of >95%, likely through a process involving flap excision. On the 3' end, bases 5-10 nt from the 3' end are lost about 1/3 of the time. These results indicate that oligos can be used to create multiple simultaneous changes to the yeast genome, even in the presence of MMR.	[Rodriguez, Gina P.; Song, Joseph B.; Crouse, Gray F.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Crouse, Gray F.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Rodriguez, GP (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	gcrouse@biology.emory.edu			National Institutes of Health [R01 GM80754]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [R01 GM80754 to GFC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2011, GENE THER, V18, P213, DOI 10.1038/gt.2010.161; Aarts M, 2010, NUCLEIC ACIDS RES, V38, P6956, DOI 10.1093/nar/gkq589; Agarwal S, 2003, BIOMOL ENG, V20, P7, DOI 10.1016/S1389-0344(02)00088-6; Balakrishnan L, 2011, J BIOL CHEM, V286, P6865, DOI 10.1074/jbc.R110.209502; Bonner M, 2009, MUTAT RES-FUND MOL M, V669, P85, DOI 10.1016/j.mrfmmm.2009.05.004; Brachman EE, 2003, GENETICS, V163, P527; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Dekker M, 2006, GENE THER, V13, P686, DOI 10.1038/sj.gt.3302689; Dekker M, 2011, MUTAT RES-FUND MOL M, V715, P52, DOI 10.1016/j.mrfmmm.2011.07.008; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guga P, 2011, CHEM BIODIVERS, V8, P1642, DOI 10.1002/cbdv.201100130; Hegele H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-14; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kow YW, 2007, P NATL ACAD SCI USA, V104, P11352, DOI 10.1073/pnas.0704695104; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li XT, 2003, NUCLEIC ACIDS RES, V31, P6674, DOI 10.1093/nar/gkg844; Maguire KK, 2007, GENE, V386, P107, DOI 10.1016/j.gene.2006.08.014; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P21070, DOI 10.1073/pnas.1013048107; MOERSCHELL RP, 1988, P NATL ACAD SCI USA, V85, P524, DOI 10.1073/pnas.85.2.524; Olsen PA, 2009, DNA REPAIR, V8, P298, DOI 10.1016/j.dnarep.2008.11.011; Papaioannou I, 2009, J GENE MED, V11, P267, DOI 10.1002/jgm.1296; Pavlov YI, 2010, MUTAT RES-FUND MOL M, V685, P45, DOI 10.1016/j.mrfmmm.2009.08.002; Radecke S, 2006, J GENE MED, V8, P217, DOI 10.1002/jgm.828; Rios X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036697; Rodriguez GP, 2012, P NATL ACAD SCI USA, V109, P6153, DOI 10.1073/pnas.1115361109; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SKERRA A, 1992, NUCLEIC ACIDS RES, V20, P3551, DOI 10.1093/nar/20.14.3551; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Wang TCV, 2005, BIOESSAYS, V27, P633, DOI 10.1002/bies.20233; Williams TM, 2005, GENETICS, V170, P1423, DOI 10.1534/genetics.105.042697; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; YAMAMOTO T, 1992, GENETICS, V131, P811; YAMAMOTO T, 1992, YEAST, V8, P935, DOI 10.1002/yea.320081104; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048	39	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42905	10.1371/journal.pone.0042905	http://dx.doi.org/10.1371/journal.pone.0042905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916177	Green Submitted, Green Published, gold			2022-12-25	WOS:000307500800029
J	Streitburger, DP; Arelin, K; Kratzsch, J; Thiery, J; Steiner, J; Villringer, A; Mueller, K; Schroeter, ML				Streitbuerger, Daniel-Paolo; Arelin, Katrin; Kratzsch, Juergen; Thiery, Joachim; Steiner, Johann; Villringer, Arno; Mueller, Karsten; Schroeter, Matthias L.			Validating Serum S100B and Neuron-Specific Enolase as Biomarkers for the Human Brain - A Combined Serum, Gene Expression and MRI Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; CALCIUM-BINDING PROTEINS; NO PREVIOUS HISTORY; SEX-RELATED CHANGES; ADULT HUMAN BRAINS; CEREBROSPINAL-FLUID; WHITE-MATTER; NEUROLOGICAL DISORDER; NEUROENDOCRINE CELLS; SPATIAL STATISTICS	Introduction: Former studies have investigated the potential of serum biomarkers for diseases affecting the human brain. In particular the glial protein S100B, a neuro-and gliotrophin inducing plasticity, seems to be involved in the pathogenesis and treatment of psychiatric diseases such as major depression and schizophrenia. Neuron-specific enolase (NSE) is a specific serum marker for neuronal damage. However, the specificity of these biomarkers for cell type and brain region has not been investigated in vivo until now. Methods: We acquired two magnetic resonance imaging parameters sensitive to changes in gray and white matter (T-1-weighted/diffusion tensor imaging) and obtained serum S100B and NSE levels of 41 healthy subjects. Additionally, we analyzed whole brain gene expressions of S100B in another male cohort of three subjects using the Allen Brain Atlas. Furthermore, a female post mortal brain was investigated using double immunofluorescence labelling with oligodendrocyte markers. Results: We show that S100B is specifically related to white matter structures, namely the corpus callosum, anterior forceps and superior longitudinal fasciculus in female subjects. This effect was observed in fractional anisotropy and radial diffusivity - the latest an indicator of myelin changes. Histological data confirmed a co-localization of S100B with oligodendrocyte markers in the human corpus callosum. S100B was most abundantly expressed in the corpus callosum according to the whole genome Allen Human Brain Atlas. In addition, NSE was related to gray matter structures, namely the amygdala. This effect was detected across sexes. Conclusion: Our data demonstrates a very high S100B expression in white matter tracts, in particular in human corpus callosum. Our study is the first in vivo study validating the specificity of the glial marker S100B for the human brain, and supporting the assumption that radial diffusivity represents a myelin marker. Our results open a new perspective for future studies investigating major neuropsychiatric disorders.	[Streitbuerger, Daniel-Paolo; Arelin, Katrin; Villringer, Arno; Mueller, Karsten; Schroeter, Matthias L.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Arelin, Katrin; Villringer, Arno; Schroeter, Matthias L.] Univ Leipzig, Clin Cognit Neurol, Leipzig, Germany; [Arelin, Katrin; Thiery, Joachim; Villringer, Arno; Schroeter, Matthias L.] Univ Leipzig, Leipzig Res Ctr Civilizat Dis, Leipzig, Germany; [Kratzsch, Juergen; Thiery, Joachim] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Steiner, Johann] Univ Magdeburg, Dept Psychiat, D-39106 Magdeburg, Germany; [Steiner, Johann] Univ Cambridge, Pembroke Coll, Cambridge, England; [Schroeter, Matthias L.] Consortium Frontotemporal Lobar Degenerat, Ulm, Germany	Max Planck Society; Leipzig University; Leipzig University; Leipzig University; Otto von Guericke University; University of Cambridge; Ulm University	Streitburger, DP (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	paolo@cbs.mpg.de		Villringer, Arno/0000-0003-2604-2404; Steiner, Johann/0000-0002-2611-2268	LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union; Free State of Saxony within the framework of the excellence initiative; German Consortium for Frontotemporal Lobar Degeneration; German Federal Ministry of Education and Research	LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union(European Commission); Free State of Saxony within the framework of the excellence initiative; German Consortium for Frontotemporal Lobar Degeneration; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	KA, JT, AV and MLS are supported by LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig - funded by the European Union, European Regional Development Fund and by Free State of Saxony within the framework of the excellence initiative. MLS is supported by the German Consortium for Frontotemporal Lobar Degeneration, funded by the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and no additional external funding has been received for this study.	Abdul-Khaliq H, 2000, CLIN CHEM LAB MED, V38, P1169, DOI 10.1515/CCLM.2000.180; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bernstein HG, 2009, EXPERT REV NEUROTHER, V9, P1059, DOI [10.1586/ern.09.59, 10.1586/ERN.09.59]; Brandner FA, 1933, BIOMETRIKA, V25, P102, DOI 10.2307/2332265; Brenneis C, 2003, MOVEMENT DISORD, V18, P1132, DOI 10.1002/mds.10502; Busnello JV, 2006, LIFE SCI, V78, P3013, DOI 10.1016/j.lfs.2005.11.028; CAMMERMEYER J, 1960, AM J ANAT, V107, P107, DOI 10.1002/aja.1001070203; Casmiro M, 2005, EUR J NEUROL, V12, P369, DOI 10.1111/j.1468-1331.2004.01021.x; Chen XH, 2007, NEUROIMAGE, V36, P691, DOI 10.1016/j.neuroimage.2007.03.063; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Haglid KG, 1997, BRAIN RES, V753, P196, DOI 10.1016/S0006-8993(96)01463-1; Holtkamp K, 2008, J NEURAL TRANSM, V115, P937, DOI 10.1007/s00702-008-0041-8; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; KAISER E, 1989, CLIN CHIM ACTA, V183, P13, DOI 10.1016/0009-8981(89)90268-4; Karas GB, 2003, NEUROIMAGE, V18, P895, DOI 10.1016/S1053-8119(03)00041-7; Kassubek J, 2004, J NEUROL NEUROSUR PS, V75, P213; KLIGMAN D, 1985, P NATL ACAD SCI USA, V82, P7136, DOI 10.1073/pnas.82.20.7136; Kochunov P, 2007, NEUROIMAGE, V35, P478, DOI 10.1016/j.neuroimage.2006.12.021; Lambert JC, 2007, MOL PSYCHIATR, V12, P870, DOI 10.1038/sj.mp.4001974; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Meyer-Lindenberg A, 2008, NEUROIMAGE, V40, P655, DOI 10.1016/j.neuroimage.2007.11.058; Meyer-Lindenberg A, 2007, J CLIN INVEST, V117, P672, DOI 10.1172/JCI30413; Mueller K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018544; Nygaard O, 1997, CLIN CHEM, V43, P541; Nygaard O, 1998, SCAND J CLIN LAB INV, V58, P183; Otto M, 1998, BMJ-BRIT MED J, V316, P577, DOI 10.1136/bmj.316.7131.577; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; Portela LVC, 2002, CLIN CHEM, V48, P950; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rothermundt M, 2002, SCHIZOPHR RES, V53, P152; Sacher J, 2011, J AFFECT DISORD; Schaf DV, 2005, PARKINSONISM RELAT D, V11, P39, DOI 10.1016/j.parkreldis.2004.07.002; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SCHMECHEL D, 1978, NATURE, V276, P834, DOI 10.1038/276834a0; Schmierer K, 2008, MAGN RESON MED, V59, P268, DOI 10.1002/mrm.21487; Schroeter ML, 2009, MOL PSYCHIATR, V14, P235, DOI 10.1038/mp.2008.85; Schroeter M.L., 2010, CARDIOVASC PSYCHIAT, V2010; Schroeter ML, 2011, J AFFECT DISORDERS, V134, P32, DOI 10.1016/j.jad.2010.11.008; Schroeter ML, 2009, PSYCHIAT RES, V167, P66, DOI 10.1016/j.psychres.2008.01.002; Schroeter ML, 2008, J AFFECT DISORDERS, V111, P271, DOI 10.1016/j.jad.2008.03.005; Schroeter ML, 2003, SCHIZOPHR RES, V62, P231, DOI 10.1016/S0920-9964(02)00383-3; Schroeter ML, 2002, NEUROREPORT, V13, P1675, DOI 10.1097/00001756-200209160-00021; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Steiner J, 2010, NEUROSCIENCE, V167, P1025, DOI 10.1016/j.neuroscience.2010.03.010; Steiner J, 2010, MOL PSYCHIATR, V15, P3, DOI 10.1038/mp.2009.87; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Steiner J, 2011, CLIN CHEM LAB MED, V49, P409, DOI 10.1515/CCLM.2011.083; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Stroick M, 2006, CURR MED CHEM, V13, P3053, DOI 10.2174/092986706778521751; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Whitford TJ, 2011, SCHIZOPHR RES, V132, P69, DOI 10.1016/j.schres.2011.07.010; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	73	55	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43284	10.1371/journal.pone.0043284	http://dx.doi.org/10.1371/journal.pone.0043284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916238	Green Published, gold			2022-12-25	WOS:000307500800071
J	Richardson, GD; Breault, D; Horrocks, G; Cormack, S; Hole, N; Owens, A				Richardson, Gavin D.; Breault, David; Horrocks, Grace; Cormack, Suzanne; Hole, Nicholas; Owens, Andrew			Telomerase expression in the mammalian heart	FASEB JOURNAL			English	Article						mTert; transgenic; cardiac; stem cell; regeneration	MYOCYTE CELLULAR HYPERPLASIA; ENDOTHELIAL GROWTH-FACTOR; CARDIAC STEM-CELLS; PROGENITOR CELLS; TUMOR-CELLS; PROLIFERATION; FAILURE; DIFFERENTIATION; REGENERATION; CANCER	While the mammalian heart has low, but functionally significant, levels of telomerase expression, the cellular population responsible remains incompletely characterized. This study aimed to identify the cell types responsible for cardiac telomerase activity in neonatal, adult, and cryoinjured adult hearts using transgenic mice expressing green fluorescent protein (GFP), driven by the promoter for murine telomerase reverse transcriptase (mTert), which is a necessary and rate-limiting component of telomerase. A rare population of mTert-GFP-expressing cells was identified that possessed all detectable cardiac telomerase RNA and telomerase activity. It was heterogeneous and included cells coexpressing markers of cardiomyocytic, endothelial, and mesenchymal lineages, putative cardiac stem cell markers, and, interestingly, cardiomyocytes with a differentiated phenotype. Quantification using both flow cytometry and immunofluorescence identified a significant decline in mTert-GFP cells in adult animals compared to neonates (similar to 9- and similar to 20-fold, respectively). Cardiac injury resulted in a similar to 6.45-fold expansion of this population (P<0.005) compared with sham-operated controls. This study identifies the cells responsible for cardiac telomerase activity, demonstrates a significant diminution with age but a marked response to injury, and, given the relationship between telomerase activity and stem cell populations, suggests that they represent a potential target for further investigation of cardiac regenerative potential.-Richardson, G. D., Breault, D., Horrocks, G., Cormack, S., Hole, N., Owens, W. A. Telomerase expression in the mammalian heart. FASEB J. 26, 4832-4840 (2012). www.fasebj.org	[Richardson, Gavin D.; Owens, Andrew] Newcastle Univ, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Breault, David] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Endocrinol, Boston, MA USA; [Breault, David] Harvard Stem Cell Inst, Cambridge, MA USA; [Horrocks, Grace; Cormack, Suzanne; Hole, Nicholas] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Owens, Andrew] S Tees Hosp Natl Hlth Serv NHS Fdn Trust, Dept Cardiothorac Surg, Middlesbrough, Cleveland, England	Newcastle University - UK; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Durham University	Richardson, GD (corresponding author), Newcastle Univ, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	gavin.richardson2@ncl.ac.uk	Owens, Andrew/K-4776-2012; Owens, W Andrew/AAG-6073-2020; Richardson, Gavin/M-2128-2019; Breault, David/HDN-6048-2022	Owens, Andrew/0000-0001-9836-9209; Owens, W Andrew/0000-0001-9836-9209; Richardson, Gavin/0000-0002-2310-9987; 	British Heart Foundation [PG/06/110/21521]; U.S. National Institutes of Health [R01 DK084056]; Harvard Stem Cell Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084056] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the British Heart Foundation, project grant PG/06/110/21521, U.S. National Institutes of Health grant R01 DK084056 (D. T. B), and the Harvard Stem Cell Institute (D. T. B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; ANVERSA P, 1990, CIRC RES, V67, P871, DOI 10.1161/01.RES.67.4.871; Armstrong L, 2000, MECH DEVELOP, V97, P109, DOI 10.1016/S0925-4773(00)00423-8; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Blasco MA, 2002, EUR J CANCER, V38, P2222, DOI 10.1016/S0959-8049(02)00450-1; Borges A, 1997, J MOL CELL CARDIOL, V29, P2717, DOI 10.1006/jmcc.1997.0503; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Endl E, 2000, EXP CELL RES, V257, P231, DOI 10.1006/excr.2000.4888; Erusalimsky JD, 2009, EXP PHYSIOL, V94, P299, DOI 10.1113/expphysiol.2008.043133; Gonzalez-Suarez E, 2005, ONCOGENE, V24, P2256, DOI 10.1038/sj.onc.1208413; Greider CW, 1998, P NATL ACAD SCI USA, V95, P90, DOI 10.1073/pnas.95.1.90; Juan G, 1998, CYTOMETRY, V32, P71, DOI 10.1002/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO;2-H; KAJSTURA J, 1994, CIRC RES, V74, P383, DOI 10.1161/01.RES.74.3.383; Kurz David J, 2003, Arterioscler Thromb Vasc Biol, V23, pe54, DOI 10.1161/01.ATV.0000100112.21118.A1; Kurz DJ, 2003, ARTERIOSCL THROM VAS, V23, P748, DOI 10.1161/01.ATV.0000069624.55424.61; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; Leri A, 2000, J MOL CELL CARDIOL, V32, P385, DOI 10.1006/jmcc.1999.1084; Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013; Leri A, 2001, Ital Heart J, V2 Suppl 3, p12S; Leri A, 2001, P NATL ACAD SCI USA, V98, P8626, DOI 10.1073/pnas.151013298; Liu T, 2006, AM J RESP CELL MOL, V34, P625, DOI 10.1165/rcmb.2005-0252OC; Liu TJ, 2002, AM J RESP CELL MOL, V26, P534, DOI 10.1165/ajrcmb.26.5.4668; Madonna R., EUR HEART J, V32, P1190; MARINO TA, 1991, CIRC RES, V69, P1353, DOI 10.1161/01.RES.69.5.1353; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Montgomery R. K., P NATL ACAD SCI US, V108, P179; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Oh H, 2003, P NATL ACAD SCI USA, V100, P5378, DOI 10.1073/pnas.0836098100; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Porrello ER, SCIENCE, V331, P1078; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Sussman MA, 2004, ANNU REV PHYSIOL, V66, P29, DOI 10.1146/annurev.physiol.66.032102.140723; Tateishi K, 2007, J CELL SCI, V120, P1791, DOI 10.1242/jcs.006122; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Walsh S., CARDIOVASC RES, V86, P365; Wong LSM, 2009, CARDIOVASC RES, V81, P244, DOI 10.1093/cvr/cvn337; Wu YL, 2006, J CELL SCI, V119, P2797, DOI 10.1242/jcs.03001; Yamaguchi Y, 1998, EXP CELL RES, V242, P120, DOI 10.1006/excr.1998.4102; Zaccagnini G, 2005, J BIOL CHEM, V280, P14790, DOI 10.1074/jbc.M414644200; Zhu XL, 1996, P NATL ACAD SCI USA, V93, P6091, DOI 10.1073/pnas.93.12.6091	43	50	51	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2012	26	12					4832	4840		10.1096/fj.12-208843	http://dx.doi.org/10.1096/fj.12-208843			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22919071	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000311838300007
J	Das, D; Samanta, D; Hasan, S; Das, A; Bhattacharya, A; Dasgupta, S; Chakrabarti, A; Ghorai, P; Das Gupta, C				Das, Debasis; Samanta, Dibyendu; Hasan, Salman; Das, Anindita; Bhattacharya, Arpita; Dasgupta, Santanu; Chakrabarti, Abhijit; Ghorai, Pradip; Das Gupta, Chanchal			Identical RNA-Protein Interactions in Vivo and in Vitro and a Scheme of Folding the Newly Synthesized Proteins by Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL TRANSFERASE CENTER; ESCHERICHIA-COLI RIBOSOME; CARBONIC-ANHYDRASE-I; EXIT TUNNEL; MOLECULAR-DYNAMICS; DOMAIN-V; CHAIN; SUBUNIT; SITE; REACTIVATION	A distinct three-dimensional shape of rRNA inside the ribosome is required for the peptidyl transfer activity of its peptidyltransferase center (PTC). In contrast, even the in vitro transcribed PTC RNA interacts with unfolded protein(s) at about five sites to let them attain their native states. We found that the same set of conserved nucleotides in the PTC interact identically with nascent and chemically unfolded proteins in vivo and in vitro, respectively. The time course of this interaction, difficult to follow in vivo, was observed in vitro. It suggested nucleation of folding of cytosolic globular proteins vectorially from hydrophilic N to hydrophobic C termini, consistent with our discovery of a regular arrangement of cumulative hydrophobic indices of the peptide segments of cytosolic proteins from N to C termini. Based on this observation, we propose a model here for the nucleation of folding of the nascent protein chain by the PTC.	[Ghorai, Pradip] Indian Inst Sci Educ & Research Kolkata, Dept Chem Sci, Nadia 741252, W Bengal, India; [Hasan, Salman; Das Gupta, Chanchal] Indian Inst Sci Educ & Research Kolkata, Dept Biol Sci, Nadia 741252, W Bengal, India; [Das, Debasis; Samanta, Dibyendu; Das, Anindita; Bhattacharya, Arpita; Das Gupta, Chanchal] Univ Calcutta, Univ Coll Sci, Dept Biophys Mol Biol & Bioinformat, Kolkata 700009, W Bengal, India; [Chakrabarti, Abhijit] Saha Inst Nucl Phys, Struct Genom Div, Kolkata 700064, W Bengal, India; [Dasgupta, Santanu] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden	Indian Institute of Science Education & Research (IISER) - Kolkata; Indian Institute of Science Education & Research (IISER) - Kolkata; University of Calcutta; Saha Institute of Nuclear Physics; Uppsala University	Ghorai, P (corresponding author), Indian Inst Sci Educ & Research Kolkata, Dept Chem Sci, Nadia 741252, W Bengal, India.	pradip.ghorai@gmail.com; chanchaldg2000@yahoo.com	Matyushov, Dmitry V./B-1343-2008	Matyushov, Dmitry V./0000-0002-9352-764X; Bhattacharya, Arpita/0000-0002-0252-1550	Department of Science and Technology Grant [SR/SO/BB-26/2004]; Council of Scientific and Industrial Research Grant CSIR from the Government of India [37(1213)/04/EMR-II]	Department of Science and Technology Grant; Council of Scientific and Industrial Research Grant CSIR from the Government of India	This work was supported in part by Department of Science and Technology Grant SR/SO/BB-26/2004 and Council of Scientific and Industrial Research Grant CSIR 37(1213)/04/EMR-II from the Government of India.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Amit M, 2005, FEBS LETT, V579, P3207, DOI 10.1016/j.febslet.2005.03.023; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Baldwin TO, 1999, NAT CELL BIOL, V1, pE154, DOI 10.1038/14107; Bashan A, 2008, TRENDS MICROBIOL, V16, P326, DOI 10.1016/j.tim.2008.05.001; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P592, DOI 10.1016/j.bbrc.2007.11.142; BERA AK, 1994, BIOCHEM MOL BIOL INT, V32, P315; Chattopadhyay S, 1996, P NATL ACAD SCI USA, V93, P8284, DOI 10.1073/pnas.93.16.8284; Chattopadhyay S, 1999, BBA-PROTEIN STRUCT M, V1429, P293, DOI 10.1016/S0167-4838(98)00179-4; Choi KM, 1998, NUCLEIC ACIDS RES, V26, P887, DOI 10.1093/nar/26.4.887; Das A, 2011, J BIOL CHEM, V286, P43771, DOI 10.1074/jbc.M111.263574; DAS B, 1992, BIOCHEM BIOPH RES CO, V183, P774, DOI 10.1016/0006-291X(92)90550-5; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Ellis RJ, 1997, BIOCHEM BIOPH RES CO, V238, P687, DOI 10.1006/bbrc.1997.7339; ENGSTRAND C, 1995, EUR J BIOCHEM, V229, P696, DOI 10.1111/j.1432-1033.1995.tb20516.x; Fedyukina DV, 2011, ANNU REV BIOPHYS, V40, P337, DOI 10.1146/annurev-biophys-042910-155338; Ghosh J, 2003, MOL MICROBIOL, V48, P1679, DOI 10.1046/j.1365-2958.2003.03538.x; Gilbert RJC, 2004, MOL CELL, V14, P57, DOI 10.1016/S1097-2765(04)00163-7; Gregory ST, 1999, J MOL BIOL, V285, P1475, DOI 10.1006/jmbi.1998.2410; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jermutus L, 1998, CURR OPIN BIOTECH, V9, P534, DOI 10.1016/S0958-1669(98)80042-6; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Khaitovich P, 1999, RNA, V5, P605, DOI 10.1017/S1355838299990295; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; Lee W, 2010, J BIOL CHEM, V285, P38167, DOI 10.1074/jbc.M110.179697; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Liu ZR, 2005, J MOL BIOL, V349, P872, DOI 10.1016/j.jmb.2005.03.084; Mitra K, 2006, ANNU REV BIOPH BIOM, V35, P299, DOI 10.1146/annurev.biophys.35.040405.101950; Mohanty AK, 1998, J BIOSCIENCES, V23, P235, DOI 10.1007/BF02720025; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Pal S, 1999, J BIOL CHEM, V274, P32771, DOI 10.1074/jbc.274.46.32771; Petrone PM, 2008, P NATL ACAD SCI USA, V105, P16549, DOI 10.1073/pnas.0801795105; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ramu H, 2011, MOL CELL, V41, P321, DOI 10.1016/j.molcel.2010.12.031; Rao AR, 2001, EMBO J, V20, P2977, DOI 10.1093/emboj/20.11.2977; Rodriguez-Larrea D, 2006, BIOPHYS J, V91, pL48, DOI 10.1529/biophysj.106.087932; Samanta D, 2008, J BACTERIOL, V190, P3344, DOI 10.1128/JB.01800-07; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Sessions RB, 2004, J MOL BIOL, V343, P1125, DOI 10.1016/j.jmb.2004.08.105; SINCLAIR JF, 1994, NAT STRUCT BIOL, V1, P320, DOI 10.1038/nsb0594-320; Ugrinov KG, 2010, BIOPHYS J, V98, P1312, DOI 10.1016/j.bpj.2009.12.4291; Vazquez-Laslop N, 2011, P NATL ACAD SCI USA, V108, P5931, DOI 10.1073/pnas.1103011108; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; YONATH A, 1992, ANNU REV BIOPH BIOM, V21, P77, DOI 10.1146/annurev.biophys.21.1.77	49	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37508	37521		10.1074/jbc.M112.396127	http://dx.doi.org/10.1074/jbc.M112.396127			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22932895	Green Published, hybrid			2022-12-25	WOS:000310588500079
J	Douse, CH; Green, JL; Salgado, PS; Simpson, PJ; Thomas, JC; Langsley, G; Holder, AA; Tate, EW; Cota, E				Douse, Christopher H.; Green, Judith L.; Salgado, Paula S.; Simpson, Peter J.; Thomas, Jemima C.; Langsley, Gordon; Holder, Anthony A.; Tate, Edward W.; Cota, Ernesto			Regulation of the Plasmodium Motor Complex PHOSPHORYLATION OF MYOSIN A TAIL-INTERACTING PROTEIN (MTIP) LOOSENS ITS GRIP ON MyoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ERYTHROCYTE INVASION; TOXOPLASMA-GONDII; GLIDING MOTILITY; NMR-SPECTROSCOPY; FALCIPARUM; PARASITE; EXPRESSION; ASSIGNMENT; SYSTEM	The interaction between the C-terminal tail of myosin A (MyoA) and its light chain, myosin A tail domain interacting protein (MTIP), is an essential feature of the conserved molecular machinery required for gliding motility and cell invasion by apicomplexan parasites. Recent data indicate that MTIP Ser-107 and/or Ser-108 are targeted for intracellular phosphorylation. Using an optimized MyoA tail peptide to reconstitute the complex, we show that this region of MTIP is an interaction hotspot using x-ray crystallography and NMR, and S107E and S108E mutants were generated to mimic the effect of phosphorylation. NMR relaxation experiments and other biophysical measurements indicate that the S108E mutation serves to break the tight clamp around the MyoA tail, whereas S107E has a smaller but measurable impact. These data are consistent with physical interactions observed between recombinant MTIP and native MyoA from Plasmodium falciparum lysates. Taken together these data support the notion that the conserved interactions between MTIP and MyoA may be specifically modulated by this post-translational modification.	[Douse, Christopher H.; Tate, Edward W.; Cota, Ernesto] Univ London Imperial Coll Sci Technol & Med, Inst Biol Chem, London SW7 2AZ, England; [Douse, Christopher H.; Salgado, Paula S.; Simpson, Peter J.; Cota, Ernesto] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Douse, Christopher H.; Thomas, Jemima C.; Tate, Edward W.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England; [Green, Judith L.; Holder, Anthony A.] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Langsley, Gordon] Univ Paris 05, CNRS, Inst Cochin, UMR 8104, F-75014 Paris, France	Imperial College London; Imperial College London; Imperial College London; MRC National Institute for Medical Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Tate, EW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Biol Chem, London SW7 2AZ, England.	e.tate@imperial.ac.uk; e.cota@imperial.ac.uk	Salgado, Paula/AAR-5782-2021; Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; Tate, Edward/0000-0003-2213-5814; Simpson, Pete/0000-0002-2679-9303; Salgado, Paula S./0000-0002-2820-3024; Douse, Christopher/0000-0002-1604-8944; Green, Judith/0000-0001-6825-9404	Royal Society [2008/R1]; UK Medical Research Council [U117532067]; Institute of Chemical Biology Engineering and Physical Sciences Research Council Doctoral Training Centre; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/D02014X/1] Funding Source: researchfish; Medical Research Council [MC_U117532067] Funding Source: researchfish; BBSRC [BB/D02014X/1] Funding Source: UKRI; MRC [MC_U117532067] Funding Source: UKRI	Royal Society(Royal Society of London); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Chemical Biology Engineering and Physical Sciences Research Council Doctoral Training Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Royal Society Grant 2008/R1 (to E. W. T. and E. C.) and UK Medical Research Council Grant U117532067 (to A. A. H.).; Recipient of an Institute of Chemical Biology Engineering and Physical Sciences Research Council Doctoral Training Centre MRes/Ph.D. studentship (to C. H. D.).; Recipient of an Engineering and Physical Sciences Research Council Collaborative Awards in Science and Engineering studentship award (to J. C. T.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agop-Nersesian C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001029; Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bieri M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-421; Bosch J, 2006, P NATL ACAD SCI USA, V103, P4852, DOI 10.1073/pnas.0510907103; Bosch J, 2007, J MOL BIOL, V372, P77, DOI 10.1016/j.jmb.2007.06.016; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delmotte A, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Farrow RE, 2011, SEMIN CELL DEV BIOL, V22, P953, DOI 10.1016/j.semcdb.2011.09.022; Frenal K, 2009, CELL HOST MICROBE, V5, P602, DOI 10.1016/j.chom.2009.05.013; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jung YS, 2004, J BIOMOL NMR, V30, P25, DOI 10.1023/B:JNMR.0000042955.14647.77; Kappe SHI, 2004, TRENDS PARASITOL, V20, P13, DOI 10.1016/j.pt.2003.10.011; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Kortagere S, 2010, J CHEM INF MODEL, V50, P840, DOI 10.1021/ci100039k; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2012, MICROBES INFECT, V14, P811, DOI 10.1016/j.micinf.2012.04.008; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; LUZ Z, 1963, J CHEM PHYS, V39, P366, DOI 10.1063/1.1734254; Marchant J, 2008, BIOMOL NMR ASSIGN, V2, P119, DOI 10.1007/s12104-008-9100-1; Masino L, 2000, PROTEIN SCI, V9, P1519, DOI 10.1110/ps.9.8.1519; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mulder FAA, 2001, J AM CHEM SOC, V123, P967, DOI 10.1021/ja003447g; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; Thomas JC, 2010, MOL BIOSYST, V6, P494, DOI 10.1039/b922093c; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; WISHART DS, 1994, J BIOMOL NMR, V4, P171	45	20	22	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36968	36977		10.1074/jbc.M112.379842	http://dx.doi.org/10.1074/jbc.M112.379842			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22932904	Green Published, hybrid			2022-12-25	WOS:000310588500032
J	Kotani, N; Ishiura, Y; Yamashita, R; Ohnishi, T; Honke, K				Kotani, Norihiro; Ishiura, Yoshihito; Yamashita, Ryusuke; Ohnishi, Tomoko; Honke, Koichi			Fibroblast Growth Factor Receptor 3 (FGFR3) Associated with the CD20 Antigen Regulates the Rituximab-induced Proliferation Inhibition in B-cell Lymphoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ANTI-CD20 MONOCLONAL-ANTIBODY; MULTIPLE-MYELOMA; BLADDER-CANCER; EXPRESSION; APOPTOSIS; MUTATION; THERAPY; KINASE; CHEMOIMMUNOTHERAPY	Rituximab is reported to inhibit the proliferation of lymphoma cells through an unknown CD20-mediated signal transduction pathway. Herein, we investigated cell surface molecules involved in the CD20-mediated signal transduction pathway by using a recently developed technique named enzyme-mediated activation of radical sources. Using this method, we found that under stimulation with rituximab and another anti-CD20 antibody B-Ly1, CD20 was physically associated with fibroblast growth factor receptor 3 (FGFR3) as well as some other receptor tyrosine kinases in Raji cells. However, under stimulation with a noncytotoxic anti-CD20 antibody 2H7, CD20 was not associated with FGFR3 but with the PDGF receptor beta. When the tyrosine kinase activity of FGFR3 was inhibited by the chemical inhibitor PD173074 or an siRNA knockdown strategy, the proliferation inhibition by rituximab was attenuated, indicating that FGFR3 participates in the rituximab-dependent signal transduction pathway leading to proliferation inhibition. These observations raise the possibility that concomitant targeted therapy toward FGFR3 might improve the efficacy and safety of the rituximab therapy.	[Kotani, Norihiro; Honke, Koichi] Kochi Univ, Sch Med, Ctr Innovat & Translat Med, Nankoku, Kochi 7838505, Japan; [Kotani, Norihiro] Saitama Med Univ, Dept Biochem, Saitama 3500495, Japan; [Ishiura, Yoshihito; Yamashita, Ryusuke; Ohnishi, Tomoko; Honke, Koichi] Kochi Univ, Sch Med, Dept Biochem, Nankoku, Kochi 7838505, Japan; [Kotani, Norihiro; Honke, Koichi] Kochi Univ, Sch Med, Kochi Syst Glycobiol Ctr, Nankoku, Kochi 7838505, Japan; [Yamashita, Ryusuke] Kochi Univ, Sch Med, Ctr Promote Creat Med Educ, Nankoku, Kochi 7838505, Japan; [Ishiura, Yoshihito] Osaka Kouseinenkin Hosp, Dept Pediat, Osaka 5530003, Japan	Kochi University; Saitama Medical University; Kochi University; Kochi University; Kochi University	Honke, K (corresponding author), Kochi Univ, Sch Med, Ctr Innovat & Translat Med, Nankoku, Kochi 7838505, Japan.	khonke@kochi-u.ac.jp		Kotani, Norihiro/0000-0003-3739-6478				Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Chang H, 2005, BLOOD, V106, P353, DOI 10.1182/blood-2005-01-0033; Chen J, 2005, ONCOGENE, V24, P8259, DOI 10.1038/sj.onc.1208989; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Cragg MS, 1999, CURR OPIN IMMUNOL, V11, P541, DOI 10.1016/S0952-7915(99)00010-2; Czuczman MS, 1999, J CLIN ONCOL, V17, P268, DOI 10.1200/JCO.1999.17.1.268; Deans JP, 1998, J BIOL CHEM, V273, P344, DOI 10.1074/jbc.273.1.344; Deans JP, 2002, IMMUNOLOGY, V107, P176, DOI 10.1046/j.1365-2567.2002.01495.x; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hofmeister JK, 2000, BLOOD CELL MOL DIS, V26, P133, DOI 10.1006/bcmd.2000.0287; Honke K, 2011, J NEUROCHEM, V116, P690, DOI 10.1111/j.1471-4159.2010.07027.x; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Jang JH, 2001, CANCER RES, V61, P3541; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; Li ZH, 2001, BLOOD, V97, P2413, DOI 10.1182/blood.V97.8.2413; MALONEY DG, 1994, BLOOD, V84, P2457; Miyake M, 2010, J PHARMACOL EXP THER, V332, P795, DOI 10.1124/jpet.109.162768; Mossner E, 2010, BLOOD, V115, P4393, DOI 10.1182/blood-2009-06-225979; PRESS OW, 1987, BLOOD, V69, P584; REFF ME, 1994, BLOOD, V83, P435; Sharkey RM, 2011, MOL CANCER THER, V10, P1072, DOI 10.1158/1535-7163.MCT-11-0115; Stebbings R, 2009, CURR OPIN BIOTECH, V20, P673, DOI 10.1016/j.copbio.2009.10.002; Tam CS, 2010, NAT REV CLIN ONCOL, V7, P521, DOI 10.1038/nrclinonc.2010.101; Trudel S, 2004, BLOOD, V103, P3521, DOI 10.1182/blood-2003-10-3650; van Rhijn BWG, 2001, CANCER RES, V61, P1265; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; White CA, 2001, ANNU REV MED, V52, P125, DOI 10.1146/annurev.med.52.1.125; Yamashita R, 2011, J BIOCHEM, V149, P347, DOI 10.1093/jb/mvq148; Zhang Y, 2005, INT J CANCER, V117, P166, DOI 10.1002/ijc.21145	30	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37109	37118		10.1074/jbc.M112.404178	http://dx.doi.org/10.1074/jbc.M112.404178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22932894	Green Published, hybrid			2022-12-25	WOS:000310588500045
J	Schwenk, RW; Angin, Y; Steinbusch, LKM; Dirkx, E; Hoebers, N; Coumans, WA; Bonen, A; Broers, JLV; van Eys, GJJM; Glatz, JFC; Luiken, JJFP				Schwenk, Robert W.; Angin, Yeliz; Steinbusch, Laura K. M.; Dirkx, Ellen; Hoebers, Nicole; Coumans, Will A.; Bonen, Arend; Broers, Jos L. V.; van Eys, Guillaume J. J. M.; Glatz, Jan F. C.; Luiken, Joost J. F. P.			Overexpression of Vesicle-associated Membrane Protein (VAMP) 3, but Not VAMP2, Protects Glucose Transporter (GLUT) 4 Protein Translocation in an in Vitro Model of Cardiac Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID UPTAKE; HUMAN SKELETAL-MUSCLE; AS160 PHOSPHORYLATION; PLASMA-MEMBRANE; KINASE-C; EXERCISE; TRIACYLGLYCEROL; CONTRACTION; CARDIOMYOCYTES; METABOLISM	Cardiac glucose utilization is regulated by reversible translocation of the glucose transporter GLUT4 from intracellular stores to the plasma membrane. During the onset of diet-induced insulin resistance, elevated lipid levels in the circulation interfere with insulin-stimulated GLUT4 translocation, leading to impaired glucose utilization. Recently, we identified vesicle-associated membrane protein (VAMP) 2 and 3 to be required for insulin- and contraction-stimulated GLUT4 translocation, respectively, in cardiomyocytes. Here, we investigated whether overexpression of VAMP2 and/or VAMP3 could protect insulin- stimulated GLUT4 translocation under conditions of insulin resistance. HL-1 atrial cardiomyocytes transiently overexpressing either VAMP2 or VAMP3 were cultured for 16 h with elevated concentrations of palmitate and insulin. Upon subsequent acute stimulation with insulin, we measured GLUT4 translocation, plasmalemmal presence of the fatty acid transporter CD36, and myocellular lipid accumulation. Overexpression of VAMP3, but not VAMP2, completely prevented lipid-induced inhibition of insulin- stimulated GLUT4 translocation. Furthermore, the plasmalemmal presence of CD36 and intracellular lipid levels remained normal in cells overexpressing VAMP3. However, insulin signaling was not retained, indicating an effect of VAMP3 overexpression downstream of PKB/Akt. Furthermore, we revealed that endogenous VAMP3 is bound by the contraction-activated protein kinase D (PKD), and contraction and VAMP3 overexpression protect insulin-stimulated GLUT4 translocation via a common mechanism. These observations indicate that PKD activates GLUT4 translocation via a VAMP3-dependent trafficking step, which pathway might be valuable to rescue constrained glucose utilization in the insulin-resistant heart.	[Schwenk, Robert W.; Angin, Yeliz; Steinbusch, Laura K. M.; Dirkx, Ellen; Hoebers, Nicole; Coumans, Will A.; van Eys, Guillaume J. J. M.; Glatz, Jan F. C.; Luiken, Joost J. F. P.] Maastricht Univ, Dept Mol Genet, Cardiovasc Res Inst Maastricht CARIM, NL-6200 MD Maastricht, Netherlands; [Broers, Jos L. V.] Maastricht Univ, Dept Mol Cell Biol, Cardiovasc Res Inst Maastricht CARIM, NL-6200 MD Maastricht, Netherlands; [Bonen, Arend] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	Maastricht University; Maastricht University; University of Guelph	Schwenk, RW (corresponding author), German Inst Human Nutr DIfE Potsdam Rehbruecke, Dept Expt Diabetol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.	robert.schwenk@dife.de			Transnational University Limburg; Center for Translational Molecular Medicine, project PREDICCt [01C-104]; Netherlands Heart Foundation, Dutch Diabetes Research Foundation [2006.00.044]; Dutch Kidney Foundation	Transnational University Limburg; Center for Translational Molecular Medicine, project PREDICCt; Netherlands Heart Foundation, Dutch Diabetes Research Foundation; Dutch Kidney Foundation	This work was supported by the Transnational University Limburg. Part of this research was performed within the framework of CTMM, the Center for Translational Molecular Medicine, project PREDICCt, Grant 01C-104, and supported by the Netherlands Heart Foundation, Dutch Diabetes Research Foundation Grant 2006.00.044, and the Dutch Kidney Foundation.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Bachmann OP, 2001, DIABETES, V50, P2579, DOI 10.2337/diabetes.50.11.2579; Bergman BC, 2009, AM J PHYSIOL-ENDOC M, V296, pE358, DOI 10.1152/ajpendo.90747.2008; Bertrand L, 2006, AM J PHYSIOL-HEART C, V291, pH239, DOI 10.1152/ajpheart.01269.2005; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Bonen A, 2009, AM J PHYSIOL-REG I, V297, pR1202, DOI 10.1152/ajpregu.90820.2008; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; Coll T, 2010, ENDOCRINOLOGY, V151, P1560, DOI 10.1210/en.2009-1211; Coort SLM, 2004, BIOCHEM SOC T, V32, P83, DOI 10.1042/BST0320083; Coort SLM, 2004, DIABETES, V53, P1655, DOI 10.2337/diabetes.53.7.1655; Coort SLM, 2002, MOL CELL BIOCHEM, V239, P213, DOI 10.1023/A:1020539932353; DELA F, 1995, DIABETES, V44, P1010, DOI 10.2337/diabetes.44.9.1010; Dirkx E, 2012, J BIOL CHEM, V287, P5871, DOI 10.1074/jbc.M111.281881; Eisele JC, 2008, BASIC RES CARDIOL, V103, P12, DOI 10.1007/s00395-007-0684-x; Frosig C, 2007, DIABETES, V56, P2093, DOI 10.2337/db06-1698; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Hage Hassan R, 2012, DIABETOLOGIA, V55, P204, DOI 10.1007/s00125-011-2328-9; Hawley JA, 2008, ACTA PHYSIOL, V192, P127, DOI 10.1111/j.1748-1716.2007.01783.x; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Itani SI, 2000, DIABETES, V49, P1353, DOI 10.2337/diabetes.49.8.1353; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; Kolter T, 1997, AM J PHYSIOL-ENDOC M, V273, pE59, DOI 10.1152/ajpendo.1997.273.1.E59; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Luiken JJFP, 1997, J LIPID RES, V38, P745; Luiken JJFP, 2008, CELL SIGNAL, V20, P543, DOI 10.1016/j.cellsig.2007.11.007; Luiken JJFP, 2009, BIOCHEM J, V419, P447, DOI 10.1042/BJ20082159; Maier VH, 2000, DIABETES, V49, P618, DOI 10.2337/diabetes.49.4.618; Muoio DM, 2010, BBA-MOL CELL BIOL L, V1801, P281, DOI 10.1016/j.bbalip.2009.11.007; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Ouwens DM, 2007, DIABETOLOGIA, V50, P1938, DOI 10.1007/s00125-007-0735-8; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Rose AJ, 2009, AM J PHYSIOL-REG I, V297, pR1228, DOI 10.1152/ajpregu.00258.2009; Schrauwen P, 2010, BBA-MOL CELL BIOL L, V1801, P266, DOI 10.1016/j.bbalip.2009.09.011; Schwenk RW, 2010, DIABETOLOGIA, V53, P2209, DOI 10.1007/s00125-010-1832-7; Sinha S, 2004, J BIOL CHEM, V279, P41294, DOI 10.1074/jbc.M406514200; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; TREADWAY JL, 1989, AM J PHYSIOL, V256, pE138, DOI 10.1152/ajpendo.1989.256.1.E138; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; UPHUES I, 1995, BIOCHEM J, V311, P161, DOI 10.1042/bj3110161; van Oort MM, 2008, BBA-MOL CELL BIOL L, V1781, P61, DOI 10.1016/j.bbalip.2007.11.006; Wang CH, 2009, J BIOL CHEM, V284, P2038, DOI 10.1074/jbc.M806336200; Watson ML, 2009, BIOCHEM J, V417, P791, DOI 10.1042/BJ20081149; Wojtaszewski JFP, 2000, DIABETES, V49, P325, DOI 10.2337/diabetes.49.3.325	48	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37530	37539		10.1074/jbc.M112.363630	http://dx.doi.org/10.1074/jbc.M112.363630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22936810	hybrid, Green Published			2022-12-25	WOS:000310588500081
J	Mukherjee, S; Sen Santara, S; Das, S; Bose, M; Roy, J; Adak, S				Mukherjee, Supratim; Sen Santara, Sumit; Das, Shantanabha; Bose, Moumita; Roy, Jayasree; Adak, Subrata			NAD(P)H Cytochrome b(5) Oxidoreductase Deficiency in Leishmania major Results in Impaired Linoleate Synthesis Followed by Increased Oxidative Stress and Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; RAT-LIVER MICROSOMES; APOPTOSIS-LIKE DEATH; DONOVANI PROMASTIGOTES; ASCORBATE-PEROXIDASE; LONG-CHAIN; AFRICAN TRYPANOSOMES; GENE-TRANSCRIPTION; SULFITE OXIDASE; DEFINED MEDIA	NAD(P)H cytochrome b(5) oxidoreductase (Ncb5or), comprising cytochrome b(5) and cytochrome b(5) reductase domains, is widely distributed in eukaryotic organisms. Although Ncb5or plays a crucial role in lipid metabolism of mice, so far no Ncb5or gene has been reported in the unicellular parasitic protozoa Leishmania species. We have cloned, expressed, and characterized Ncb5or gene from Leishmania major. Steady state catalysis and spectral studies show that NADH can quickly reduce the ferric state of the enzyme to the ferrous state and is able to donate an electron(s) to external acceptors. To elucidate its exact physiological role in Leishmania, we attempted to create NAD(P) H cytochrome b(5) oxidoreductase from L. major (LmNcb5or) knock-out mutants by targeted gene replacement technique. A free fatty acid profile in knock-out (KO) cells reveals marked deficiency in linoleate and linolenate when compared with wild type (WT) or overexpressing cells. KO culture has a higher percentage of dead cells compared with both WT and overexpressing cells. Increased O-2 uptake, uncoupling and ATP synthesis, and loss of mitochondrial membrane potential are evident in KO cells. Flow cytometric analysis reveals the presence of a higher concentration of intracellular H2O2, indicative of increased oxidative stress in parasites lacking LmNcb5or. Cell death is significantly reduced when the KO cells are pretreated with BSA bound linoleate. Real time PCR studies demonstrate a higher Delta 12 desaturase, superoxide dismutase, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA with a concomitant fall in Delta 9 desaturase mRNA expression in LmNcb5or null cell line. Together these findings suggest that decreased linoleate synthesis, and increased oxidative stress and apoptosis are the major consequences of LmNcb5or deficiency in Leishmania.	[Mukherjee, Supratim; Sen Santara, Sumit; Das, Shantanabha; Bose, Moumita; Roy, Jayasree; Adak, Subrata] Indian Inst Chem Biol, Council Sci & Ind Res, Div Struct Biol & Bioinformat, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Adak, S (corresponding author), 4 Raja SC Mullick Rd, Kolkata 700032, India.	adaks@iicb.res.in	sarkar, sabyasachi/A-9896-2010	sarkar, sabyasachi/0000-0002-8954-4375; sen santara, sumit/0000-0003-2881-0825; MUKHERJEE, SUPRATIM/0000-0002-0356-8879	Council of Scientific and Industrial Research (CSIR) [NWP 0038]; UGC; CSIR-SPM Fellowships	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); UGC(University Grants Commission, India); CSIR-SPM Fellowships	This work was supported by Council of Scientific and Industrial Research (CSIR) Project NWP 0038, UGC Fellowships (to S. M.), CSIR Fellowships (to S. D., M. B.), and CSIR-SPM Fellowships (to S. S. S.).	Adak S, 2005, BIOCHEM J, V390, P465, DOI 10.1042/BJ20050311; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Alloatti A, 2011, MOL BIOCHEM PARASIT, V175, P126, DOI 10.1016/j.molbiopara.2010.10.006; Alloatti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014239; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Calvo AM, 2001, J BIOL CHEM, V276, P25766, DOI 10.1074/jbc.M100732200; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Choi JY, 1996, J BIOL CHEM, V271, P3581; Clarke SD, 2001, AM J PHYSIOL-GASTR L, V281, pG865, DOI 10.1152/ajpgi.2001.281.4.G865; Das M, 2001, J CELL SCI, V114, P2461; Dolai S, 2007, BBA-GEN SUBJECTS, V1770, P247, DOI 10.1016/j.bbagen.2006.10.001; Dolai S, 2008, FREE RADICAL BIO MED, V45, P1520, DOI 10.1016/j.freeradbiomed.2008.08.029; Dolai S, 2011, J BIOL CHEM, V286, P13638, DOI 10.1074/jbc.M110.201889; Dolai S, 2009, EUKARYOT CELL, V8, P1721, DOI 10.1128/EC.00198-09; Duplus E, 2000, J BIOL CHEM, V275, P30749, DOI 10.1074/jbc.R000015200; FOLCH J, 1957, J BIOL CHEM, V226, P497; FUKUSHIMA H, 1981, J BIOL CHEM, V256, P4822; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Hermesh O, 1998, J BIOL CHEM, V273, P3937, DOI 10.1074/jbc.273.7.3937; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; HYDE GE, 1991, J BIOL CHEM, V266, P23542; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; KANG JX, 1995, P NATL ACAD SCI USA, V92, P3997, DOI 10.1073/pnas.92.9.3997; KEYES SR, 1980, J BIOL CHEM, V255, P1357; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Larade K, 2007, BIOCHEM J, V404, P467, DOI 10.1042/BJ20061859; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Livore VI, 2007, FEBS J, V274, P264, DOI 10.1111/j.1742-4658.2006.05581.x; Loughran PA, 2001, ARCH BIOCHEM BIOPHYS, V385, P311, DOI 10.1006/abbi.2000.2136; LUVISETTO S, 1987, BIOCHEMISTRY-US, V26, P7332, DOI 10.1021/bi00397a021; LUVISETTO S, 1990, J BIOENERG BIOMEMBR, V22, P635, DOI 10.1007/BF00809068; MCCARTHYBURKE C, 1991, EXP PARASITOL, V73, P385, DOI 10.1016/0014-4894(91)90112-A; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Morita YS, 2000, SCIENCE, V288, P140, DOI 10.1126/science.288.5463.140; Mukherjee SB, 2002, J BIOL CHEM, V277, P24717, DOI 10.1074/jbc.M201961200; Mulligan CM, 2012, CARDIOVASC RES, V94, P460, DOI 10.1093/cvr/cvs118; Napier JA, 1999, TRENDS PLANT SCI, V4, P2, DOI 10.1016/S1360-1385(98)01357-0; OSHINO N, 1971, J BIOCHEM, V69, P155, DOI 10.1093/oxfordjournals.jbchem.a129444; Oshino N., 1980, HEPATIC CYTOCHROME P, P407; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Pal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011271; PALTAUF F, 1974, J BIOL CHEM, V249, P2661; PAUL KG, 1953, ACTA CHEM SCAND, V7, P1284, DOI 10.3891/acta.chem.scand.07-1284; Paul KS, 2001, TRENDS PARASITOL, V17, P381, DOI 10.1016/S1471-4922(01)01984-5; PIETROBON D, 1987, BIOCHEMISTRY-US, V26, P7339, DOI 10.1021/bi00397a022; PUGH EL, 1977, J BIOL CHEM, V252, P68; REDDY VVR, 1977, J BIOL CHEM, V252, P2797; ROTTENBERG H, 1986, BIOCHEMISTRY-US, V25, P1747, DOI 10.1021/bi00355a045; ROTTENBERG H, 1990, BIOCHIM BIOPHYS ACTA, V1018, P1, DOI 10.1016/0005-2728(90)90103-B; Rudolph MJ, 2003, ACTA CRYSTALLOGR D, V59, P1183, DOI 10.1107/S0907444903009934; Santhamma KR, 1995, MOL BIOCHEM PARASIT, V75, P43, DOI 10.1016/0166-6851(95)02510-3; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; STEIGER RF, 1977, J PROTOZOOL, V24, P437, DOI 10.1111/j.1550-7408.1977.tb04771.x; STRITTMATTER P, 1982, J BIOL CHEM, V257, P1883; THIEDE MA, 1986, J BIOL CHEM, V261, P3230; Tripodi K. E., 2011, ENZYME RES; Tripodi KEJ, 2006, FEBS J, V273, P271, DOI 10.1111/j.1742-4658.2005.05049.x; Uttaro AD, 2006, IUBMB LIFE, V58, P563, DOI 10.1080/15216540600920899; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Wilson RA, 2004, MICROBIOL-SGM, V150, P2881, DOI 10.1099/mic.0.27207-0; WOITCZAK L, 1993, BIOCHIM BIOPHYS ACTA, V1183, P41, DOI 10.1016/0005-2728(93)90004-Y; WOJTCZAK L, 1976, J BIOENERG BIOMEMBR, V8, P293; XIA ZX, 1987, P NATL ACAD SCI USA, V84, P2629, DOI 10.1073/pnas.84.9.2629; Xie JX, 2004, P NATL ACAD SCI USA, V101, P10750, DOI 10.1073/pnas.0404044101; Xu M, 2011, J BIOL CHEM, V286, P11141, DOI 10.1074/jbc.M110.196543; Zhang YZ, 2010, J LIPID RES, V51, P53, DOI 10.1194/jlr.M900146-JLR200; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zhu H, 2004, J BIOL CHEM, V279, P30316, DOI 10.1074/jbc.M402664200; Zhu H, 1999, P NATL ACAD SCI USA, V96, P14742, DOI 10.1073/pnas.96.26.14742	72	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34992	35003		10.1074/jbc.M112.389338	http://dx.doi.org/10.1074/jbc.M112.389338			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22923617	Green Published, hybrid			2022-12-25	WOS:000309968000012
J	Vindry, C; Lauwers, A; Hutin, D; Soin, R; Wauquier, C; Kruys, V; Gueydan, C				Vindry, Caroline; Lauwers, Aurelien; Hutin, David; Soin, Romuald; Wauquier, Corinne; Kruys, Veronique; Gueydan, Cyril			dTIS11 Protein-dependent Polysomal Deadenylation Is the Key Step in AU-rich Element-mediated mRNA Decay in Drosophila Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCR4-NOT COMPLEX; BINDING-PROTEINS; GENE-EXPRESSION; BODY FORMATION; TRISTETRAPROLIN; DEGRADATION; TTP; RECRUITMENT; EXOSOME; TURNOVER	The destabilization of AU-rich element (ARE)-containing mRNAs mediated by proteins of the TIS11 family is conserved among eukaryotes including Drosophila. Previous studies have demonstrated that Tristetraprolin, a human protein of the TIS11 family, induces the degradation of ARE-containing mRNAs through a large variety of mechanisms including deadenylation, decapping, and P-body targeting. We have previously shown that the degradation of the mRNA encoding the antimicrobial peptide Cecropin A1 (CecA1) is controlled by the TIS11 protein (dTIS11) in Drosophila cells. In this study, we used CecA1 mRNA as a model to investigate the molecular mechanism of dTIS11-mediated mRNA decay. We observed that during the biphasic deadenylation and decay process of this mRNA, dTIS11 enhances deadenylation performed by the CCR4-CAF-NOT complex while the mRNA is still associated with ribosomes. Sequencing of mRNA degradation intermediates revealed that the complete deadenylation of the mRNA triggers its decapping and decay in both the 5'-3' and the 3'-5' directions. Contrary to the observations made for its mammalian homologs, overexpression of dTIS11 does not promote the localization of ARE-containing mRNAs in P-bodies but rather decreases the accumulation of CecA1 mRNA in these structures by enhancing the degradation process. Therefore, our results suggest that proteins of the TIS11 family may have acquired additional functions in the course of evolution from invertebrates to mammals.	[Vindry, Caroline; Lauwers, Aurelien; Soin, Romuald; Wauquier, Corinne; Kruys, Veronique; Gueydan, Cyril] Univ Libre Brussels, Fac Sci, Lab Biol Mol Gene, B-6041 Gosselies, Belgium; [Hutin, David] Univ Libre Brussels, Fac Sci, Immunobiol Lab, B-6041 Gosselies, Belgium; [Kruys, Veronique] Univ Libre Brussels, Fac Sci, Ctr Microscopy & Mol Imaging, B-6041 Gosselies, Belgium		Gueydan, C (corresponding author), Univ Libre Brussels, Fac Sci, Lab Biol Mol Gene, 12 Rue Pr Jeener & Brachet, B-6041 Gosselies, Belgium.	cgueydan@ulb.ac.be	Kruys, Veronique I/N-6613-2018	Gueydan, Cyril/0000-0003-3097-7667; Kruys, Veronique/0000-0002-3144-5403; Vindry, Caroline/0000-0002-2038-0288	Fund for Medical Scientific Research (Belgium) [2.4.511.00.F]; Fonds Brachet; Fonds Van Buuren; "Actions de Recherches Concertees" [AV.06/11-345]; Fonds pour la Recherche en Industrie et Agriculture; Fond Van Buuren	Fund for Medical Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds Brachet; Fonds Van Buuren; "Actions de Recherches Concertees"; Fonds pour la Recherche en Industrie et Agriculture(Fonds de la Recherche Scientifique - FNRS); Fond Van Buuren	This work was supported by the Fund for Medical Scientific Research (Belgium, Grant 2.4.511.00.F), the Fonds Brachet, the Fonds Van Buuren, and the "Actions de Recherches Concertees" (Grant AV.06/11-345).; Supported by a doctoral grant of the Fonds pour la Recherche en Industrie et Agriculture and by the Fond Van Buuren.	Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Bonisch C, 2007, J BIOL CHEM, V282, P21818, DOI 10.1074/jbc.M702998200; Cairrao F, 2009, MOL CELL BIOL, V29, P2636, DOI 10.1128/MCB.01506-08; Cao H, 2007, EXPERT REV PROTEOMIC, V4, P711, DOI 10.1586/14789450.4.6.711; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CYA, 2011, WIRES RNA, V2, P167, DOI 10.1002/wrna.40; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Horn T, 2010, NUCLEIC ACIDS RES, V38, pW332, DOI 10.1093/nar/gkq317; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kim T, 2005, NAT IMMUNOL, V6, P211, DOI 10.1038/ni1159; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lauwers A, 2009, J BIOL CHEM, V284, P8973, DOI 10.1074/jbc.M806778200; Li Y, 2011, RNA, V17, P419, DOI 10.1261/rna.2439811; Lin WJ, 2007, J BIOL CHEM, V282, P19958, DOI 10.1074/jbc.M702281200; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Marchese FP, 2010, J BIOL CHEM, V285, P27590, DOI 10.1074/jbc.M110.136473; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Pfeiffer JR, 2011, MOL CELL BIOL, V31, P277, DOI 10.1128/MCB.00775-10; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Spasic M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002433; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Temme C, 2010, RNA, V16, P1356, DOI 10.1261/rna.2145110; Vergara SV, 2008, BIOCHEM SOC T, V36, P1088, DOI 10.1042/BST0361088; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196	39	16	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35527	35538		10.1074/jbc.M112.356188	http://dx.doi.org/10.1074/jbc.M112.356188			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22932903	hybrid, Green Published			2022-12-25	WOS:000309968000061
J	Sekine, S; Kanamaru, Y; Koike, M; Nishihara, A; Okada, M; Kinoshita, H; Kamiyama, M; Maruyama, J; Uchiyama, Y; Ishihara, N; Takeda, K; Ichijo, H				Sekine, Shiori; Kanamaru, Yusuke; Koike, Masato; Nishihara, Ayako; Okada, Masahiro; Kinoshita, Hideyuki; Kamiyama, Miki; Maruyama, Junichi; Uchiyama, Yasuo; Ishihara, Naotada; Takeda, Kohsuke; Ichijo, Hidenori			Rhomboid Protease PARL Mediates the Mitochondrial Membrane Potential Loss-induced Cleavage of PGAM5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-AAA PROTEASE; OPA1; FUSION; MORPHOLOGY; PINK1; PHOSPHATASE; IMPORT; IDENTIFICATION; LYMPHOCYTES; APOPTOSIS	Regulated intramembrane proteolysis is a widely conserved mechanism for controlling diverse biological processes. Considering that proteolysis is irreversible, it must be precisely regulated in a context-dependent manner. Here, we show that phosphoglycerate mutase 5 (PGAM5), a mitochondrial Ser/Thr protein phosphatase, is cleaved in its N-terminal transmembrane domain in response to mitochondrial membrane potential (Delta Psi(m)) loss. This Delta Psi(m) loss-dependent cleavage of PGAM5 was mediated by presenilin-associated rhomboid-like (PARL). PARL is a mitochondrial resident rhomboid serine protease and has recently been reported to mediate the cleavage of PINK1, a mitochondrial Ser/Thr protein kinase, in healthy mitochondria with intact Delta Psi(m). Intriguingly, we found that PARL dissociated from PINK1 and reciprocally associated with PGAM5 in response to Delta Psi(m) loss. These results suggest that PARL mediates differential cleavage of PINK1 and PGAM5 depending on the health status of mitochondria. Our data provide a prototypical example of stress-dependent regulation of PARL-mediated regulated intramembrane proteolysis.	[Takeda, Kohsuke] Nagasaki Univ, Div Cell Regulat, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Takeda, Kohsuke] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ishihara, Naotada] Kurume Univ, Inst Life Sci, Dept Prot Biochem, Kurume, Fukuoka 8390864, Japan; [Koike, Masato; Uchiyama, Yasuo] Juntendo Univ, Dept Cell Biol & Neurosci, Grad Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Sekine, Shiori; Kanamaru, Yusuke; Nishihara, Ayako; Okada, Masahiro; Kinoshita, Hideyuki; Kamiyama, Miki; Maruyama, Junichi; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, Tokyo 1130033, Japan	Nagasaki University; Japan Science & Technology Agency (JST); Kurume University; Juntendo University; University of Tokyo	Takeda, K (corresponding author), Nagasaki Univ, Div Cell Regulat, Grad Sch Biomed Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	takeda-k@nagasaki-u.ac.jp	Kamiyama, Miki/K-4044-2019; Koike, Masato/F-9584-2010	Kamiyama, Miki/0000-0002-9817-6703; Koike, Masato/0000-0002-3174-5684; Takeda, Kohsuke/0000-0002-8359-8399; Ishihara, Naotada/0000-0002-6305-7149; MARUYAMA, Junichi/0000-0002-3665-2700; Ichijo, Hidenori/0000-0002-5005-6438	Japan Science and Technology Agency PRESTO program; KAKENHI from the Japan Society for the Promotion of Science and Ministry of Education, Culture, Sports, Science, and Technology of Japan; Global Center of Education and Research for Chemical Biology of the Diseases; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Naito Foundation Natural Science Scholarship; Cosmetology Research Foundation; Tokyo Biochemical Research Foundation; Ministry of Education, Science, Sports, and Culture of Japan; Grants-in-Aid for Scientific Research [24659027] Funding Source: KAKEN	Japan Science and Technology Agency PRESTO program(Japan Science & Technology Agency (JST)); KAKENHI from the Japan Society for the Promotion of Science and Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global Center of Education and Research for Chemical Biology of the Diseases; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation Natural Science Scholarship; Cosmetology Research Foundation; Tokyo Biochemical Research Foundation; Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Science and Technology Agency PRESTO program, KAKENHI from the Japan Society for the Promotion of Science and Ministry of Education, Culture, Sports, Science, and Technology of Japan, Global Center of Education and Research for Chemical Biology of the Diseases, the "Understanding of molecular and environmental bases for brain health" conducted under the Strategic Research Program for Brain Sciences by Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Naito Foundation Natural Science Scholarship, the Cosmetology Research Foundation, and the Tokyo Biochemical Research Foundation.; Supported by a grant-in-aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports, and Culture of Japan. To whom correspondence should be addressed: Division of Cell Regulation, Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan. Tel: 81-95-819-2417; Fax: 81-95-819-2472; E-mail: takeda-k@nagasaki-u.ac.jp.	Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Duvezin-Caubet S, 2007, MOL BIOL CELL, V18, P3582, DOI 10.1091/mbc.E07-02-0164; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Eura Y, 2006, J CELL SCI, V119, P4913, DOI 10.1242/jcs.03253; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Ishida Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030265; Ishihara N, 1998, J BIOCHEM-TOKYO, V123, P722; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jedrzejas MJ, 2000, PROG BIOPHYS MOL BIO, V73, P263, DOI 10.1016/S0079-6107(00)00007-9; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Jofuku A, 2005, BIOCHEM BIOPH RES CO, V333, P650, DOI 10.1016/j.bbrc.2005.05.154; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mori Y, 2008, TRAFFIC, V9, P1728, DOI 10.1111/j.1600-0854.2008.00796.x; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Sado Y, 2006, ACTA HISTOCHEM CYTOC, V39, P89, DOI 10.1267/ahc.06001; Shi G, 2011, HUM MOL GENET, V20, P1966, DOI 10.1093/hmg/ddr077; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Suzuki H, 2002, J CELL SCI, V115, P1895; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109	42	105	109	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34635	34645		10.1074/jbc.M112.357509	http://dx.doi.org/10.1074/jbc.M112.357509			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22915595	hybrid, Green Published			2022-12-25	WOS:000309654200066
J	Nieznanski, K; Choi, JK; Chen, SG; Surewicz, K; Surewicz, WK				Nieznanski, Krzysztof; Choi, Jin-Kyu; Chen, Shugui; Surewicz, Krystyna; Surewicz, Witold K.			Soluble Prion Protein Inhibits Amyloid-beta (A beta) Fibrillization and Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR PRION; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; OLIGOMERS; IMPAIRMENT; PEPTIDE; PATHOGENESIS; AGGREGATION; ASSEMBLIES; MECHANISMS	The pathogenesis of Alzheimer disease appears to be strongly linked to the aggregation of amyloid-beta (A beta) peptide and, especially, formation of soluble A beta 1-42 oligomers. It was recently demonstrated that the cellular prion protein, PrPC, binds with high affinity to these oligomers, acting as a putative receptor that mediates at least some of their neurotoxic effects. Here we show that the soluble (i.e. glycophosphatidylinositol anchorfree) prion protein and its N-terminal fragment have a strong effect on the aggregation pathway of A beta 1-42, inhibiting its assembly into amyloid fibrils. Furthermore, the prion protein prevents formation of spherical oligomers that normally occur during A beta fibrillogenesis, acting as a potent inhibitor of A beta 1-42 toxicity as assessed in experiments with neuronal cell culture. These findings may provide a molecular level foundation to explain the reported protective action of the physiologically released N-terminal N1 fragment of PrPC against A beta neurotoxicity. They also suggest a novel approach to pharmacological intervention in Alzheimer disease.	[Nieznanski, Krzysztof; Choi, Jin-Kyu; Chen, Shugui; Surewicz, Krystyna; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Surewicz, WK (corresponding author), 2109 Adelbert Rd, Cleveland, OH 44106 USA.	witold.surewicz@case.edu	Nieznanski, Krzysztof/R-4220-2016	Nieznanski, Krzysztof/0000-0003-0440-2632	National Institutes of Health [NS44158, AG14359]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS44158 and AG14359 (to W. K. S.).	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Benilova I, 2010, EMBO MOL MED, V2, P289, DOI 10.1002/emmm.201000088; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Griffiths HH, 2011, J BIOL CHEM, V286, P33489, DOI 10.1074/jbc.M111.278556; Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hetenyi C, 2002, BIOCHEM BIOPH RES CO, V292, P931, DOI 10.1006/bbrc.2002.6745; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Rangachari V, 2009, BIOPOLYMERS, V91, P456, DOI 10.1002/bip.21151; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Vincent B, 2001, J BIOL CHEM, V276, P37743; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	34	68	69	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33104	33108		10.1074/jbc.C112.400614	http://dx.doi.org/10.1074/jbc.C112.400614			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22915585	Green Published, hybrid			2022-12-25	WOS:000309602100001
J	Choi, J; Song, SH; Bak, CW; Sung, SR; Yoon, TK; Lee, DR; Shim, SH				Choi, Jin; Song, Seung-Hun; Bak, Chong Won; Sung, Se Ra; Yoon, Tae Ki; Lee, Dong Ryul; Shim, Sung Han			Impaired Spermatogenesis and gr/gr Deletions Related to Y Chromosome Haplogroups in Korean Men	PLOS ONE			English	Article							HAN-CHINESE POPULATION; FACTOR-C REGION; MALE-INFERTILITY; AZFC REGION; DNA VARIATION; RISK-FACTOR; SUBDELETION; FAILURE; DUPLICATIONS; ASSOCIATION	Microdeletion of the Azoospermia Factor (AZF) regions in Y chromosome is a well-known genetic cause of male infertility resulting from spermatogenetic impairment. However, the partial deletions of AZFc region related to spermatogenetic impairment are controversial. In this study, we characterized partial deletion of AZFc region in Korean patients with spermatogenetic impairment and assessed whether the DAZ and CDY1 contributes to the phenotype in patients with gr/gr deletions. Total of 377 patients with azoo-/oligozoospermia and 217controls were analyzed using multiplex polymerase chain reaction (PCR), analysis of DAZ-CDY1 sequence family variants (SFVs), and quantitative fluorescent (QF)-PCR. Of the 377 men with impaired spermatogenesis, 59 cases (15.6%) had partial AZFc deletions, including 32 gr/gr (8.5%), 22 b2/b3 (5.8%), four b1/b3 (1.1%) and one b3/b4 (0.3%) deletion. In comparison, 14 of 217 normozoospermic controls (6.5%) had partial AZFc deletions, including five gr/gr (2.3%) and nine b2/b3 (4.1%) deletions. The frequency of gr/gr deletions was significantly higher in the azoo-/oligozoospermic group than in the normozoospermic control group (p = 0.003; OR = 3.933; 95% CI = 1.509-10.250). Concerning Y haplogroup, we observed no significant differences in the frequency of gr/gr deletions between the case and the control groups in the YAP+ lineages, while gr/gr deletion were significantly higher in azoo-/oligozoospermia than normozoospermia in the YAP- lineage (p = 0.004; OR = 6.341; 95% CI = 1.472-27.312). Our data suggested that gr/gr deletion is associated with impaired spermatogenesis in Koreans with YAP- lineage, regardless of the gr/gr subtypes.	[Choi, Jin; Sung, Se Ra; Shim, Sung Han] CHA Gangnam Med Ctr, Fertil Ctr, Genet Lab, Seoul, South Korea; [Song, Seung-Hun; Bak, Chong Won] CHA Univ, Dept Urol, Fertil Ctr, CHA Gangnam Med Ctr, Seoul, South Korea; [Yoon, Tae Ki] CHA Univ, Dept Obstet & Gynecol, Fertil Ctr, CHA Gangnam Med Ctr, Seoul, South Korea; [Lee, Dong Ryul; Shim, Sung Han] CHA Univ, Dept Biomed Sci, Seoul, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University	Choi, J (corresponding author), CHA Gangnam Med Ctr, Fertil Ctr, Genet Lab, Seoul, South Korea.	shshim@cha.ac.kr			Ministry for Health, Welfare and Family Affairs, Republic of Korea [A084923]	Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant (A084923) of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Carvalho CMB, 2006, J HUM GENET, V51, P794, DOI 10.1007/s10038-006-0024-2; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Eloualid A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034902; Ferlin A, 2005, J MED GENET, V42, P209, DOI 10.1136/jmg.2004.025833; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Fernando L, 2006, ASIAN J ANDROL, V8, P39, DOI 10.1111/j.1745-7262.2006.00100.x; Ferras C, 2004, MOL HUM REPROD, V10, P755, DOI 10.1093/molehr/gah104; Giachini C, 2005, J MED GENET, V42, P497, DOI 10.1136/jmg.2004.028191; Giachini C, 2008, HUM GENET, V124, P399, DOI 10.1007/s00439-008-0561-1; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Jin HJ, 2003, HUM GENET, V114, P27, DOI 10.1007/s00439-003-1019-0; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kim W, 2000, J HUM GENET, V45, P76, DOI 10.1007/s100380050015; Krausz C, 2009, J MED GENET, V46, P21, DOI 10.1136/jmg.2008.059915; Kucklenbroich K, 2005, HUM REPROD, V20, P191, DOI 10.1098/humrep/deh558; Lin YW, 2007, HUM MUTAT, V28, P486, DOI 10.1002/humu.20473; Lu CC, 2011, HUM MOL GENET, V20, P4411, DOI 10.1093/hmg/ddr369; Lu CC, 2009, HUM MOL GENET, V18, P1122, DOI 10.1093/hmg/ddn427; Lynch M, 2005, MOL HUM REPROD, V11, P507, DOI 10.1093/molehr/gah191; Machev N, 2004, J MED GENET, V41, P814, DOI 10.1136/jmg.2004.022111; Navarro-Costa P, 2010, HUM REPROD UPDATE, V16, P525, DOI 10.1093/humupd/dmq005; Noordam MJ, 2006, CURR OPIN GENET DEV, V16, P225, DOI 10.1016/j.gde.2006.04.018; Plaseski T, 2008, GENET TEST, V12, P595, DOI 10.1089/gte.2008.0068; Ravel C, 2006, FERTIL STERIL, V85, P229, DOI 10.1016/j.fertnstert.2005.07.1278; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Repping S, 2004, GENOMICS, V83, P1046, DOI 10.1016/j.ygeno.2003.12.018; Shahid M, 2011, EUR J HUM GENET, V19, P23, DOI 10.1038/ejhg.2010.151; Sin HS, 2010, HUM REPROD, V25, P2396, DOI 10.1093/humrep/deq191; Stouffs K, 2008, HUM REPROD, V23, P1193, DOI 10.1093/humrep/den069; Stouffs K, 2011, HUM REPROD UPDATE, V17, P197, DOI 10.1093/humupd/dmq046; Visser L, 2009, HUM REPROD, V24, P2667, DOI 10.1093/humrep/dep243; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; World Health Organization, 1999, WHO LAB MAN EX HUM S; Wu B, 2007, HUM REPROD, V22, P1107, DOI 10.1093/humrep/del499; Yang Y, 2006, FERTIL STERIL, V85, P1061, DOI 10.1016/j.fertnstert.2005.09.025; Yang Y, 2010, INT J ANDROL, V33, P745, DOI 10.1111/j.1365-2605.2009.01015.x; Yen P, 2001, NAT GENET, V29, P243, DOI 10.1038/ng1101-243; Zhang F, 2006, ANN HUM GENET, V70, P304, DOI 10.1111/j.1469-1809.2005.00231.x	39	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43550	10.1371/journal.pone.0043550	http://dx.doi.org/10.1371/journal.pone.0043550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927988	Green Published, gold			2022-12-25	WOS:000308224700017
J	Krammer, F; Margine, I; Tan, GS; Pica, N; Krause, JC; Palese, P				Krammer, Florian; Margine, Irina; Tan, Gene S.; Pica, Natalie; Krause, Jens C.; Palese, Peter			A Carboxy-Terminal Trimerization Domain Stabilizes Conformational Epitopes on the Stalk Domain of Soluble Recombinant Hemagglutinin Substrates	PLOS ONE			English	Article							INFLUENZA-A VIRUS; MONOCLONAL-ANTIBODIES; NEUTRALIZING EPITOPE; H1N1; EFFICACY; H5N1; CELLS	Recently, a new class of broadly neutralizing anti-influenza virus antibodies that target the stalk domain of the viral hemagglutinin was discovered. As such, induction, isolation, characterization, and quantification of these novel antibodies has become an area of intense research and great interest. Since most of these antibodies bind to conformational epitopes, the structural integrity of hemagglutinin substrates for the detection and quantification of these antibodies is of high importance. Here we evaluate the binding of these antibodies to soluble, secreted hemagglutinins with or without a carboxy-terminal trimerization domain based on the natural trimerization domain of T4 phage fibritin. The lack of such a domain completely abolishes binding to group 1 hemagglutinins and also affects binding to group 2 hemagglutinins. Additionally, the presence of a trimerization domain positively influences soluble hemagglutinin stability during expression and purification. Our findings suggest that a carboxy-terminal trimerization domain is a necessary requirement for the structural integrity of stalk epitopes on recombinant soluble influenza virus hemagglutinin.	[Krammer, Florian; Margine, Irina; Tan, Gene S.; Pica, Natalie; Krause, Jens C.; Palese, Peter] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Palese, Peter] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Margine, Irina; Pica, Natalie] Mt Sinai Sch Med, Grad Sch Biol Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Krammer, F (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY USA.	peter.palese@mssm.edu	Krammer, Florian/H-3237-2019	Krammer, Florian/0000-0003-4121-776X; Palese, Peter/0000-0002-0337-5823; Tan, Gene/0000-0002-0975-0719	Erwin Schrodinger fellowship from the Austrian Science Fund (FWF) [J 3232]; PATH; CEIRS (Centers for Excellence for Influenza Research and Surveillance) [HHSN26620070010C]	Erwin Schrodinger fellowship from the Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); PATH; CEIRS (Centers for Excellence for Influenza Research and Surveillance)	Florian Krammer was supported by an Erwin Schrodinger fellowship (J 3232) from the Austrian Science Fund (FWF). This work was partially supported by PATH and by CEIRS (Centers for Excellence for Influenza Research and Surveillance, HHSN26620070010C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cox MMJ, 2008, INFLUENZA OTHER RESP, V2, P211, DOI 10.1111/j.1750-2659.2008.00053.x; Dinca Luminita, 1993, Viral Immunology, V6, P75, DOI 10.1089/vim.1993.6.75; Du LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016555; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Khurana S, 2011, VACCINE, V29, P5657, DOI 10.1016/j.vaccine.2011.06.014; Khurana S, 2011, J VIROL, V85, P1246, DOI 10.1128/JVI.02107-10; KRAMMER F, 2010, MOL BIOTECHNOL; Krammer F, 2010, TRENDS MOL MED, V16, P313, DOI 10.1016/j.molmed.2010.05.002; Krammer F, 2010, BIOTECHNOL J, V5, P17, DOI 10.1002/biot.200900267; Krause JC, 2012, J VIROL, V86, P6334, DOI 10.1128/JVI.07158-11; Lin SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020052; Meghrous J, 2009, VACCINE, V28, P309, DOI 10.1016/j.vaccine.2009.10.048; Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079; MORAN T, 1984, P NATL ACAD SCI-BIOL, V81, P1809, DOI 10.1073/pnas.81.6.1809; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Palese P., 2006, FIELDS VIROLOGY, P1648; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Treanor JJ, 2011, VACCINE, V29, P7733, DOI 10.1016/j.vaccine.2011.07.128; Vareckova E, 2003, ACTA VIROL, V47, P229; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466	34	123	139	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43603	10.1371/journal.pone.0043603	http://dx.doi.org/10.1371/journal.pone.0043603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928001	gold, Green Published, Green Submitted			2022-12-25	WOS:000308224700020
J	Coviello, L; Franceschetti, M; McCubbins, MD; Paturi, R; Vattani, A				Coviello, Lorenzo; Franceschetti, Massimo; McCubbins, Mathew D.; Paturi, Ramamohan; Vattani, Andrea			Human Matching Behavior in Social Networks: An Algorithmic Perspective	PLOS ONE			English	Article							DYNAMICS	We argue that algorithmic modeling is a powerful approach to understanding the collective dynamics of human behavior. We consider the task of pairing up individuals connected over a network, according to the following model: each individual is able to propose to match with and accept a proposal from a neighbor in the network; if a matched individual proposes to another neighbor or accepts another proposal, the current match will be broken; individuals can only observe whether their neighbors are currently matched but have no knowledge of the network topology or the status of other individuals; and all individuals have the common goal of maximizing the total number of matches. By examining the experimental data, we identify a behavioral principle called prudence, develop an algorithmic model, analyze its properties mathematically and by simulations, and validate the model with human subject experiments for various network sizes and topologies. Our results include i) a 1/2-approximate maximum matching is obtained in logarithmic time in the network size for bounded degree networks; ii) for any constant epsilon>0, a (1-epsilon)-approximate maximum matching is obtained in polynomial time, while obtaining a maximum matching can require an exponential time; and iii) convergence to a maximum matching is slower on preferential attachment networks than on small-world networks. These results allow us to predict that while humans can find a "good quality" matching quickly, they may be unable to find a maximum matching in feasible time. We show that the human subjects largely abide by prudence, and their collective behavior is closely tracked by the above predictions.	[Coviello, Lorenzo; Franceschetti, Massimo] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [McCubbins, Mathew D.] Univ So Calif, Dept Polit Sci, Los Angeles, CA USA; [Paturi, Ramamohan; Vattani, Andrea] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Southern California; University of California System; University of California San Diego	Coviello, L (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.	lcoviell@ucsd.edu		McCubbins, Mathew/0000-0003-0606-2109	National Science Foundation [0905645]; Army Research Office [W911NF-11-1-0363]	National Science Foundation(National Science Foundation (NSF)); Army Research Office	This work was partially supported by the National Science Foundation under grant number 0905645 and the Army Research Office under grant W911NF-11-1-0363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2011, IEEE DECIS CONTR P, P2329, DOI 10.1109/CDC.2011.6160999; Ashlagi I, 2011, P 12 ACM C EL COMM, P335; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bollobas B, 2001, RANDOM STRUCT ALGOR, V18, P279, DOI 10.1002/rsa.1009; Bovier A., 2006, STAT MECH DISORDERED, V18; Brandt C, 2012, STOC'12: PROCEEDINGS OF THE 2012 ACM SYMPOSIUM ON THEORY OF COMPUTING, P789; Brautbar M, 2011, LECT NOTES COMPUT SC, V6982, P224, DOI 10.1007/978-3-642-24829-0_21; Cebrian M, 2012, STOC'12: PROCEEDINGS OF THE 2012 ACM SYMPOSIUM ON THEORY OF COMPUTING, P775; Cook M., 2004, COMPLEX SYST, V15, P1; Enemark D.P., 2011, P 12 ACM C EL COMM; GALE D, 1962, AM MATH MON, V69, P9, DOI 10.2307/2312726; Goyal S, 2012, STOC'12: PROCEEDINGS OF THE 2012 ACM SYMPOSIUM ON THEORY OF COMPUTING, P759; Hatfield J, 2010, P 11 ACM C EL COMM, P119; ISRAELI A, 1986, INFORM PROCESS LETT, V22, P77, DOI 10.1016/0020-0190(86)90144-4; Judd Stephen, 2011, Internet and Network Economics. Proceedings 7th International Workshop, WINE 2011, P242, DOI 10.1007/978-3-642-25510-6_21; Judd S, 2010, P NATL ACAD SCI USA, V107, P14978, DOI 10.1073/pnas.1001280107; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Karp, 1971, SWITCH AUT THEOR 197, P122, DOI [DOI 10.1109/SWAT.1971.1, 10.1109/SWAT.1971.1]; KARP RM, 1986, COMBINATORICA, V6, P35, DOI 10.1007/BF02579407; Kearns M, 2012, P ACM C EL COMM; Kearns M, 2006, SCIENCE, V313, P824, DOI 10.1126/science.1127207; Kearns M, 2009, P NATL ACAD SCI USA, V106, P1347, DOI 10.1073/pnas.0808147106; Kleinberg J, 2005, ANN IEEE SYMP FOUND, P132, DOI 10.1109/SFCS.2005.63; Liggett T. M, 1985, INTERACTING PARTICLE, V276; McCubbins MD, 2009, AM POLIT RES, V37, P899, DOI 10.1177/1532673X09337184; Montanari A, 2009, ANN IEEE SYMP FOUND, P303, DOI 10.1109/FOCS.2009.64; Pettie S, 2004, INFORM PROCESS LETT, V91, P271, DOI 10.1016/j.ipl.2004.05.007; PRATT JW, 1964, ECONOMETRICA, V32, P122, DOI 10.2307/1913738; Roth A.E., 1992, 2 SIDED MATCHING STU, V18; Simon H, 1976, ADM BEHAV, V3; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; von Neumann J, 1966, THEORY SELF PRODUCIN; Wang J, 2012, P ACM C EL COMM; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; [No title captured]; [No title captured]	36	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41900	10.1371/journal.pone.0041900	http://dx.doi.org/10.1371/journal.pone.0041900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927918	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300016
J	Hackstein, H; Hagel, N; Knoche, A; Kranz, S; Lohmeyer, J; von Wulffen, W; Kershaw, O; Gruber, AD; Bein, G; Baal, N				Hackstein, Holger; Hagel, Nicole; Knoche, Angela; Kranz, Sabine; Lohmeyer, Juergen; von Wulffen, Werner; Kershaw, Olivia; Gruber, Achim D.; Bein, Gregor; Baal, Nelli			Skin TLR7 Triggering Promotes Accumulation of Respiratory Dendritic Cells and Natural Killer Cells	PLOS ONE			English	Article							TOPICAL IMIQUIMOD; LIGANDS; ALPHA; TOLL-LIKE-RECEPTOR-7; RECOGNITION; LYMPHOCYTES; RNA	The TLR7 agonist imiquimod has been used successfully as adjuvant for skin treatment of virus-associated warts and basal cell carcinoma. The effects of skin TLR7 triggering on respiratory leukocyte populations are unknown. In a placebo-controlled experimental animal study we have used multicolour flow cytometry to systematically analyze the modulation of respiratory leukocyte subsets after skin administration of imiquimod. Compared to placebo, skin administration of imiquimod significantly increased respiratory dendritic cells (DC) and natural killer cells, whereas total respiratory leukocyte, alveolar macrophages, classical CD4+ T helper and CD8+ T killer cell numbers were not or only moderately affected. DC subpopulation analyses revealed that elevation of respiratory DC was caused by an increase of respiratory monocytic DC and CD11b(hi) DC subsets. Lymphocyte subpopulation analyses indicated a marked elevation of respiratory natural killer cells and a significant reduction of B lymphocytes. Analysis of cytokine responses of respiratory leukocytes after stimulation with Klebsiella pneumonia indicated reduced IFN-gamma and TNF-alpha expression and increased IL-10 and IL-12p70 production after 7 day low dose skin TLR7 triggering. Additionally, respiratory NK cytotoxic activity was increased after 7d skin TLR7 triggering. In contrast, lung histology and bronchoalveolar cell counts were not affected suggesting that skin TLR7 stimulation modulated respiratory leukocyte composition without inducing overt pulmonary inflammation. These data suggest the possibility to modulate respiratory leukocyte composition and respiratory cytokine responses against pathogens like Klebsiella pneumonia through skin administration of a clinically approved TLR7 ligand. Skin administration of synthetic TLR7 ligands may represent a novel, noninvasive means to modulate respiratory immunity.	[Hackstein, Holger; Hagel, Nicole; Knoche, Angela; Kranz, Sabine; Bein, Gregor; Baal, Nelli] Univ Giessen, Inst Clin Immunol & Transfus Med, D-6300 Giessen, Germany; [Lohmeyer, Juergen] Dept Internal Med 2, Giessen, Germany; [von Wulffen, Werner] Univ Munich, Klinikum Grosshadern, Dept Internal Med, Pulm Dis & Comprehens Pneumol Ctr 5, D-8000 Munich, Germany; [Kershaw, Olivia; Gruber, Achim D.] Free Univ Berlin, Dept Vet Pathol, Berlin, Germany	Justus Liebig University Giessen; University of Munich; Free University of Berlin	Hackstein, H (corresponding author), Univ Giessen, Inst Clin Immunol & Transfus Med, Langhansstr 7, D-6300 Giessen, Germany.	Holger.Hackstein@immunologie.med.uni-giessen.de	Gruber, Achim D./ABA-4514-2021		DFG, German Science Foundation [SFB Transregio 84]; Excellence cluster cardiopulmonary system (ECCPS, DFG); University of Giessen and Marburg Lung Center (UGMLC)	DFG, German Science Foundation(German Research Foundation (DFG)); Excellence cluster cardiopulmonary system (ECCPS, DFG)(German Research Foundation (DFG)); University of Giessen and Marburg Lung Center (UGMLC)	The work was supported by the SFB Transregio 84, DFG, German Science Foundation, Innate Immunity of the Lung: Mechanisms of Pathogen Attack and Host Defence in Pneumonia (SFB TR84, Project B3 HH, JL), the Excellence cluster cardiopulmonary system (ECCPS, DFG; HH) and the University of Giessen and Marburg Lung Center (UGMLC; HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Berghofer B, 2007, J IMMUNOL, V178, P4072, DOI 10.4049/jimmunol.178.7.4072; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Gaspari AA, 2009, J DRUGS DERMATOL, V8, P467; Gunzer M, 2005, BLOOD, V106, P2424, DOI 10.1182/blood-2005-01-0342; Hackstein H, 2004, NAT REV IMMUNOL, V4, P24, DOI 10.1038/nri1256; Hackstein H, RESP RES UNPUB; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Ito T, 2002, J EXP MED, V195, P1507, DOI 10.1084/jem.20020207; Kane KL, 1996, CLIN DIAGN LAB IMMUN, V3, P295, DOI 10.1128/CDLI.3.3.295-300.1996; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Larange A, 2009, J LEUKOCYTE BIOL, V85, P673, DOI 10.1189/jlb.0808504; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Lu HL, 2010, J IMMUNOL, V184, P5360, DOI 10.4049/jimmunol.0902997; Maus U, 2001, AM J PHYSIOL-LUNG C, V280, pL58, DOI 10.1152/ajplung.2001.280.1.L58; Miller RL, 2008, DRUG NEWS PERSPECT, V21, P69, DOI 10.1358/dnp.2008.21.2.1188193; Moisan J, 2006, AM J PHYSIOL-LUNG C, V290, pL987, DOI 10.1152/ajplung.00440.2005; Pasmatzi E, 2009, ACTA DERM-VENEREOL, V89, P134, DOI 10.2340/00015555-0597; Pockros PJ, 2007, J HEPATOL, V47, P174, DOI 10.1016/j.jhep.2007.02.025; Smits ELJM, 2008, ONCOLOGIST, V13, P859, DOI 10.1634/theoncologist.2008-0097; Stein P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027911; Wagstaff AJ, 2007, DRUGS, V67, P2187, DOI 10.2165/00003495-200767150-00006; Xiong ZM, 2011, J IMMUNOTHER, V34, P264, DOI 10.1097/CJI.0b013e318209eed4; Xirakia C, 2010, AM J RESP CRIT CARE, V181, P1207, DOI 10.1164/rccm.200908-1255OC	29	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43320	10.1371/journal.pone.0043320	http://dx.doi.org/10.1371/journal.pone.0043320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927956	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300041
J	Kruidhof, HM; Pashalidou, FG; Fatouros, NE; Figueroa, IA; Vet, LEM; Smid, HM; Huigens, ME				Kruidhof, H. Marjolein; Pashalidou, Foteini G.; Fatouros, Nina E.; Figueroa, Ilich A.; Vet, Louise E. M.; Smid, Hans M.; Huigens, Martinus E.			Reward Value Determines Memory Consolidation in Parasitic Wasps	PLOS ONE			English	Article							LONG-TERM-MEMORY; TRICHOGRAMMA WASPS; COTESIA-GLOMERATA; PROTEIN-SYNTHESIS; NATURAL VARIATION; APIS-MELLIFERA; LEARNING RATE; C-RUBECULA; DROSOPHILA; QUALITY	Animals can store learned information in their brains through a series of distinct memory forms. Short-lasting memory forms can be followed by longer-lasting, consolidated memory forms. However, the factors determining variation in memory consolidation encountered in nature have thus far not been fully elucidated. Here, we show that two parasitic wasp species belonging to different families, Cotesia glomerata (Hymenoptera: Braconidae) and Trichogramma evanescens (Hymenoptera; Trichogrammatidae), similarly adjust the memory form they consolidate to a fitness-determining reward: egg-laying into a host-insect that serves as food for their offspring. Protein synthesis-dependent long-term memory (LTM) was consolidated after single-trial conditioning with a high-value host. However, single-trial conditioning with a low-value host induced consolidation of a shorter-lasting memory form. For Cotesia glomerata, we subsequently identified this shorter-lasting memory form as anesthesia-resistant memory (ARM) because it was not sensitive to protein synthesis inhibitors or anesthesia. Associative conditioning using a single reward of different value thus induced a physiologically different mechanism of memory formation in this species. We conclude that the memory form that is consolidated does not only change in response to relatively large differences in conditioning, such as the number and type of conditioning trials, but is also sensitive to more subtle differences, such as reward value. Reward-dependent consolidation of exclusive ARM or LTM provides excellent opportunities for within-species comparison of mechanisms underlying memory consolidation.	[Kruidhof, H. Marjolein; Vet, Louise E. M.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [Pashalidou, Foteini G.; Fatouros, Nina E.; Figueroa, Ilich A.; Vet, Louise E. M.; Smid, Hans M.; Huigens, Martinus E.] Wageningen Univ, Entomol Lab, Wageningen, Netherlands; [Figueroa, Ilich A.] Fdn PROINPA, Cochabamba, Bolivia	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research	Kruidhof, HM (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands.	marjolein.kruidhof@gmail.com	Vet, Louise E.M./B-1342-2009; Pashalidou, Foteini/Y-3913-2019; Fatouros, Nina/AAO-9698-2020; KNAW, NIOO-KNAW/A-4320-2012	Vet, Louise E.M./0000-0002-2287-1128; Fatouros, Nina/0000-0003-0841-3144; Smid, Hans/0000-0001-5867-2799; KNAW, NIOO-KNAW/0000-0002-3835-159X; Paschalidou, Foteini/0000-0001-5746-8227	Netherlands Organisation for Scientific Research (NWO/ALW) VENI grants [863.05.020, 863.09.002]; NWO/ALW open competition grants [820.01.012, 818.01.007]; German Research Foundation (DFG) [FA 824/1-11]	Netherlands Organisation for Scientific Research (NWO/ALW) VENI grants; NWO/ALW open competition grants; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by The Netherlands Organisation for Scientific Research (NWO/ALW) VENI grants 863.05.020 (to MEH) and 863.09.002 (to NEF), NWO/ALW open competition grants 820.01.012 (to HMS) and 818.01.007 (to LEMV), and the German Research Foundation (DFG) grant FA 824/1-11 (to NEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2003, J CHEM ECOL, V29, P1489, DOI 10.1023/A:1024277823101; BAI BR, 1992, ENTOMOL EXP APPL, V64, P37, DOI 10.1007/BF00688992; Bleeker MAK, 2006, ANIM BEHAV, V71, P1343, DOI 10.1016/j.anbehav.2005.09.016; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Camacho FJ, 2009, PHYSIOL BEHAV, V98, P602, DOI 10.1016/j.physbeh.2009.09.012; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Cnaani J, 2006, ETHOLOGY, V112, P278, DOI 10.1111/j.1439-0310.2006.01174.x; Dubnau J, 2003, J NEUROGENET, V17, P295, DOI 10.1080/01677060390441859; Eisenhardt D, 2006, ANIM BIOL, V56, P259, DOI 10.1163/157075606777304249; ERBER J, 1976, J COMP PHYSIOL PSYCH, V90, P41, DOI 10.1037/h0077258; Fatouros NE, 2005, NATURE, V433, P704, DOI 10.1038/433704a; Feltwell J., 1982, LARGE WHITE BUTTERFL; Geervliet JBF, 1997, J CHEM ECOL, V23, P2935, DOI 10.1023/A:1022583515142; GEERVLIET JBF, 1994, ENTOMOL EXP APPL, V73, P289, DOI 10.1007/BF02382480; Geervliet JBF, 1996, J INSECT BEHAV, V9, P525, DOI 10.1007/BF02213877; Geervliet JBF, 1998, ENTOMOL EXP APPL, V86, P241, DOI 10.1023/A:1003186706517; Harvey JA, 2000, ECOL ENTOMOL, V25, P267, DOI 10.1046/j.1365-2311.2000.00265.x; Hase A., 1925, Arbeiten aus der Biologischen Reichsanstalt fuer Land- u Forstwirtschaft Berlin, V14, P171; Hoedjes KM, 2011, P ROY SOC B-BIOL SCI, V278, P889, DOI 10.1098/rspb.2010.2199; Huigens ME, 2010, BEHAV ECOL, V21, P470, DOI 10.1093/beheco/arq007; Huigens ME, 2009, P NATL ACAD SCI USA, V106, P820, DOI 10.1073/pnas.0812277106; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Izquierdo LA, 2002, CELL MOL NEUROBIOL, V22, P269, DOI 10.1023/A:1020715800956; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; LEMASURIER AD, 1994, J ANIM ECOL, V63, P677, DOI 10.2307/5233; McCullagh P, 1989, GEN LINEAR MODELS; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; QUINN WG, 1976, NATURE, V262, P576, DOI 10.1038/262576a0; Reaume CJ, 2011, PHILOS T R SOC B, V366, P2100, DOI 10.1098/rstb.2011.0028; ROOT RB, 1984, ECOLOGY, V65, P147, DOI 10.2307/1939467; SALT G., 1940, PROC ROY ENT SOC LONDON SER A, V15, P81; Sara SJ, 2006, LEARN MEMORY, V13, P515, DOI 10.1101/lm.338406; SCHMIDT JM, 1987, SCIENCE, V237, P903, DOI 10.1126/science.237.4817.903; Smid HM, 2007, P ROY SOC B-BIOL SCI, V274, P1539, DOI 10.1098/rspb.2007.0305; Stearns FW, 2011, GENETICS, V187, P355, DOI 10.1534/genetics.110.125021; Sulikowski D, 2007, BIOL LETTERS, V3, P245, DOI 10.1098/rsbl.2007.0122; SUZUKI Y, 1984, ANIM BEHAV, V32, P478, DOI 10.1016/S0003-3472(84)80284-5; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; van den Berg M, 2011, ANIM BEHAV, V81, P325, DOI 10.1016/j.anbehav.2010.11.002; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Wackers F, 2006, ANIM BIOL, V56, P193, DOI 10.1163/157075606777304230; Wright GA, 2009, P ROY SOC B-BIOL SCI, V276, P2597, DOI 10.1098/rspb.2009.0040	48	40	42	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e39615	10.1371/journal.pone.0039615	http://dx.doi.org/10.1371/journal.pone.0039615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936971	gold, Green Published, Green Submitted			2022-12-25	WOS:000308286300002
J	Woodham, AW; Da Silva, DM; Skeate, JG; Raff, AB; Ambroso, MR; Brand, HE; Isas, JM; Langen, R; Kast, WM				Woodham, Andrew W.; Da Silva, Diane M.; Skeate, Joseph G.; Raff, Adam B.; Ambroso, Mark R.; Brand, Heike E.; Isas, J. Mario; Langen, Ralf; Kast, W. Martin			The S100A10 Subunit of the Annexin A2 Heterotetramer Facilitates L2-Mediated Human Papillomavirus Infection	PLOS ONE			English	Article							MINOR CAPSID PROTEIN; VIRUS-LIKE PARTICLES; COMMON NEUTRALIZATION EPITOPE; CELL-SURFACE; HEPARAN-SULFATE; INHIBITOR SLPI; II BINDS; L2; ENTRY; INTEGRIN	Mucosotropic, high-risk human papillomaviruses (HPV) are sexually transmitted viruses that are causally associated with the development of cervical cancer. The most common high-risk genotype, HPV16, is an obligatory intracellular virus that must gain entry into host epithelial cells and deliver its double stranded DNA to the nucleus. HPV capsid proteins play a vital role in these steps. Despite the critical nature of these capsid protein-host cell interactions, the precise cellular components necessary for HPV16 infection of epithelial cells remains unknown. Several neutralizing epitopes have been identified for the HPV16 L2 minor capsid protein that can inhibit infection after initial attachment of the virus to the cell surface, which suggests an L2-specific secondary receptor or cofactor is required for infection, but so far no specific L2-receptor has been identified. Here, we demonstrate that the annexin A2 heterotetramer (A2t) contributes to HPV16 infection and co-immunoprecipitates with HPV16 particles on the surface of epithelial cells in an L2-dependent manner. Inhibiting A2t with an endogenous annexin A2 ligand, secretory leukocyte protease inhibitor (SLPI), or with an annexin A2 antibody significantly reduces HPV16 infection. With electron paramagnetic resonance, we demonstrate that a previously identified neutralizing epitope of L2 (aa 108-120) specifically interacts with the S100A10 subunit of A2t. Additionally, mutation of this L2 region significantly reduces binding to A2t and HPV16 pseudovirus infection. Furthermore, downregulation of A2t with shRNA significantly decreases capsid internalization and infection by HPV16. Taken together, these findings indicate that A2t contributes to HPV16 internalization and infection of epithelial cells and this interaction is dependent on the presence of the L2 minor capsid protein.	[Woodham, Andrew W.; Skeate, Joseph G.; Raff, Adam B.; Kast, W. Martin] Univ So Calif, Dept Mol Microbiol, Los Angeles, CA 90089 USA; [Woodham, Andrew W.; Skeate, Joseph G.; Raff, Adam B.; Kast, W. Martin] Univ So Calif, Dept Immunol, Los Angeles, CA USA; [Da Silva, Diane M.; Kast, W. Martin] Univ So Calif, Dept Obstet & Gynecol, Los Angeles, CA 90089 USA; [Da Silva, Diane M.; Brand, Heike E.; Kast, W. Martin] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Ambroso, Mark R.; Isas, J. Mario; Langen, Ralf] Univ So Calif, Dept Biochem, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Woodham, AW (corresponding author), Univ So Calif, Dept Mol Microbiol, Los Angeles, CA 90089 USA.	mkast@usc.edu		Skeate, Joseph/0000-0002-1765-5949; Kast, W Martin/0000-0003-2321-3159	National Institutes of Health [GM063915, R01 CA074397, RC2 CA148298]; NATIONAL CANCER INSTITUTE [R01CA074397, RC2CA148298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health grants GM063915 to R. Langen, and R01 CA074397 and RC2 CA148298 to W.M. Kast. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abban CY, 2010, VIROLOGY, V403, P1, DOI 10.1016/j.virol.2010.04.007; Bienkowska-Haba M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000524; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Buck C.B., 2007, PRODUCTION PAPILLOMA; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Compton T, 2004, TRENDS CELL BIOL, V14, P5, DOI 10.1016/j.tcb.2003.10.009; Conway MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016405; Cordes C, 2011, INT J ONCOL, V39, P185, DOI 10.3892/ijo.2011.1006; Cumming SA, 2008, BIOCHEM SOC T, V36, P522, DOI 10.1042/BST0360522; Dasgupta J, 2011, J BIOL CHEM, V286, P2617, DOI 10.1074/jbc.M110.160184; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2008, J VIROL, V82, P12565, DOI 10.1128/JVI.01631-08; Day PM, 2003, VIROLOGY, V307, P1, DOI 10.1016/S0042-6822(02)00143-5; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Dreier R, 1998, HISTOCHEM CELL BIOL, V110, P137, DOI 10.1007/s004180050275; Duncan CJA, 2011, VIRUSES-BASEL, V3, P2255, DOI 10.3390/v3112255; Embers ME, 2004, VACCINE, V22, P670, DOI 10.1016/j.vaccine.2003.08.037; Evander M, 1997, J VIROL, V71, P2449, DOI 10.1128/JVI.71.3.2449-2456.1997; Fakioglu E, 2008, J VIROL, V82, P9337, DOI 10.1128/JVI.00603-08; Faridi R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-269; Fausch SC, 2003, CANCER RES, V63, P3478; Fligge C, 2001, J VIROL, V75, P7727, DOI 10.1128/JVI.75.16.7727-7731.2001; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Hayes MJ, 2009, BBA-MOL CELL RES, V1793, P1086, DOI 10.1016/j.bbamcr.2008.10.007; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; Holmgren SC, 2005, J VIROL, V79, P3938, DOI 10.1128/JVI.79.7.3938-3948.2005; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; Kawana Y, 2001, J VIROL, V75, P2331, DOI 10.1128/JVI.75.5.2331-2336.2001; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; KRAMPS JA, 1984, AM REV RESPIR DIS, V129, P959; Langen R, 1998, J BIOL CHEM, V273, P22453, DOI 10.1074/jbc.273.35.22453; Longhi S, 2011, J PEPT SCI, V17, P315, DOI 10.1002/psc.1344; Ma G, 2004, J EXP MED, V200, P1337, DOI 10.1084/jem.20041115; Malhotra R, 2003, MICROBES INFECT, V5, P123, DOI 10.1016/S1286-4579(02)00079-5; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; Moriyama A, 1999, MOL HUM REPROD, V5, P656, DOI 10.1093/molehr/5.7.656; PARK M, 1983, EMBO J, V2, P1029, DOI 10.1002/j.1460-2075.1983.tb01541.x; Pena-Alonso E, 2008, CANCER LETT, V263, P89, DOI 10.1016/j.canlet.2007.12.029; Pereira R, 2009, ARCH VIROL, V154, P187, DOI 10.1007/s00705-009-0310-3; Puisieux A, 1996, BIOCHEM J, V313, P51, DOI 10.1042/bj3130051; RAWLS WE, 1968, SCIENCE, V161, P1255, DOI 10.1126/science.161.3847.1255; Raynor CM, 1999, BIOCHEMISTRY-US, V38, P5089, DOI 10.1021/bi982095b; Rescher U, 2008, PFLUG ARCH EUR J PHY, V455, P575, DOI 10.1007/s00424-007-0313-4; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Schelhaas M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002657; Schiller John T, 2010, Gynecol Oncol, V118, pS12, DOI 10.1016/j.ygyno.2010.04.004; Selinka HC, 2007, J VIROL, V81, P10970, DOI 10.1128/JVI.00998-07; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Serrels B, 2012, J CELL BIOL, V196, P185, DOI 10.1083/jcb.201112128; Shao CH, 2006, J BIOL CHEM, V281, P31689, DOI 10.1074/jbc.M604502200; Sieczkarski SB, 2005, CURR TOP MICROBIOL, V285, P1; SIMON J W, 1976, Gynecologic Oncology, V4, P108, DOI 10.1016/0090-8258(76)90011-1; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Spoden G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003313; Surviladze Z, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002519; VOGELMEIER C, 1991, J CLIN INVEST, V87, P482, DOI 10.1172/JCI115021; VOLPERS C, 1994, VIROLOGY, V200, P504, DOI 10.1006/viro.1994.1213; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115; Willis SH, 1998, J VIROL, V72, P5937, DOI 10.1128/JVI.72.7.5937-5947.1998; WRIGHT JF, 1994, BIOCHEM BIOPH RES CO, V198, P983, DOI 10.1006/bbrc.1994.1140; Yang RC, 2003, J VIROL, V77, P3531, DOI 10.1128/JVI.77.6.3531-3541.2003; Yang SL, 2011, J VIROL, V85, P11809, DOI 10.1128/JVI.00297-11; Zhang J, 2010, SAUDI MED J, V31, P374	76	104	106	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43519	10.1371/journal.pone.0043519	http://dx.doi.org/10.1371/journal.pone.0043519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927980	Green Submitted, gold, Green Published			2022-12-25	WOS:000308286300060
J	Zhao, LY; Tian, J; Wang, W; Qin, W; Shi, J; Li, Q; Yuan, K; Dong, MH; Yang, WC; Wang, YR; Sun, LL; Lu, L				Zhao, Li-Yan; Tian, Jie; Wang, Wei; Qin, Wei; Shi, Jie; Li, Qiang; Yuan, Kai; Dong, Ming-Hao; Yang, Wei-Chuang; Wang, Ya-Rong; Sun, Li-Li; Lu, Lin			The Role of Dorsal Anterior Cingulate Cortex in the Regulation of Craving by Reappraisal in Smokers	PLOS ONE			English	Article							ATTENTIONAL CONTROL; EMOTION REGULATION; RESPONSE CONFLICT; NEGATIVE EMOTION; DRUG-ADDICTION; SMOKING CUES; FMRI; AVAILABILITY; NEUROBIOLOGY; SUPPRESSION	Rationale and Objective: Drug cues can induce craving for drugs of abuse. Dysfunctional regulation of emotion and motivation regarding rewarding objects appears to be an integral part of addiction. It has been found that cognitive strategies decreased the intensity of craving in addicts. Reappraisal strategy is a type of cognitive strategy that requires participants to reinterpret the meaning of an emotional situation. In addition, studies have found that activation of the dorsal anterior cingulate cortex (dACC) is associated with the selection and application of cognitive reappraisal. In present study, we sought to determine whether such cognitive regulation engages the dACC and improves inhibition of craving in smokers. Methods: Sixteen smokers underwent functional magnetic resonance imaging (fMRI) during performance of a cigarette reward-conditioning procedure with cognitive reappraisal. We focused our analyses on the dACC as a key structure of cognitive control of craving. Cue induced craving under different conditions was obtained. Correlational analysis between the functional response in the dACC and the subjective craving was performed. Results: We found that using a cognitive reappraisal was successful in decreasing the conditioned craving. Right dACC (BA 24/32) engaged in the cognitive reappraisal. In addition, the individual's subjective craving was negatively correlated with the right dACC activation. Conclusions: These findings suggest that the dACC are important substrates of Inhibition of cue induced craving in smokers. Cognitive regulation by cognitive reappraisal may help addicted individuals avoid the anticipated situations where they are exposed to conditioned cues.	[Zhao, Li-Yan; Shi, Jie; Sun, Li-Li; Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Tian, Jie; Qin, Wei; Yuan, Kai; Dong, Ming-Hao] Xidian Univ, Xian, Peoples R China; [Wang, Wei; Li, Qiang; Yang, Wei-Chuang; Wang, Ya-Rong] Fourth Mil Med Univ, Tangdu Hosp, Xian 710032, Peoples R China	Peking University; Xidian University; Air Force Military Medical University	Zhao, LY (corresponding author), Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China.	zgywyls2006@bjmu.edu.cn	Yuan, Kai/I-4150-2016; SHI, JIE/GXG-3394-2022; Tian, Jie/H-1190-2011; Yuan, Kai/M-9403-2013; tian, jie/M-6336-2013; 秦, 伟/J-9770-2016; Dong, Minghao/A-6425-2014	Yuan, Kai/0000-0002-3098-1124; Tian, Jie/0000-0003-0498-0432; 秦, 伟/0000-0003-4583-0406; Dong, Minghao/0000-0002-0190-6985	National Basic Research Program of China (973 Program) [2009CB522000, 2011CB707800]; Natural Science Foundation of China [91132716, 31070958]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2009CB522000 and 2011CB707800) and the Natural Science Foundation of China (No: 91132716 and 31070958). The URL of the funder's website: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080/14622200020032051; Delgado MR, 2008, NAT NEUROSCI, V11, P880, DOI 10.1038/nn.2141; Domino EF, 2002, PROG NEURO-PSYCHOPH, V26, P1071, DOI 10.1016/S0278-5846(02)00224-5; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; DROUNGAS A, 1995, ADDICT BEHAV, V20, P657, DOI 10.1016/0306-4603(95)00029-C; Eippert F, 2007, HUM BRAIN MAPP, V28, P409, DOI 10.1002/hbm.20291; Engelmann JM, 2012, NEUROIMAGE, V60, P252, DOI 10.1016/j.neuroimage.2011.12.024; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Field M, 2001, BEHAV PHARMACOL, V12, P183, DOI 10.1097/00008877-200105000-00004; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Giuliani NR, 2011, NEUROIMAGE, V58, P10, DOI 10.1016/j.neuroimage.2011.06.028; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Heishman SJ, 2010, EXP CLIN PSYCHOPHARM, V18, P245, DOI 10.1037/a0019401; Juliano LM, 1998, EXP CLIN PSYCHOPHARM, V6, P45, DOI 10.1037/1064-1297.6.1.45; Kalisch R, 2005, J COGNITIVE NEUROSCI, V17, P874, DOI 10.1162/0898929054021184; Kalisch R, 2006, NEUROIMAGE, V30, P1458, DOI 10.1016/j.neuroimage.2005.11.011; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; O'Connell KA, 2007, HEALTH PSYCHOL, V26, P77, DOI 10.1037/0278-6133.26.1.77; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; Perkins K A, 2001, Nicotine Tob Res, V3, P141; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Ray RD, 2005, COGN AFFECT BEHAV NE, V5, P156, DOI 10.3758/CABN.5.2.156; Shiffman S, 2007, DRUG ALCOHOL DEPEN, V91, P159, DOI 10.1016/j.drugalcdep.2007.05.017; Staudinger MR, 2009, NEUROIMAGE, V47, P713, DOI 10.1016/j.neuroimage.2009.04.095; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931	39	24	26	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43598	10.1371/journal.pone.0043598	http://dx.doi.org/10.1371/journal.pone.0043598			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928000	gold, Green Submitted, Green Published			2022-12-25	WOS:000308286300071
J	Ye, B; Huang, L; Gao, ZL; Chen, P; Ni, H; Guan, SD; Zhu, Y; Wang, JH				Ye, Bing; Huang, Li; Gao, Zilong; Chen, Ping; Ni, Hong; Guan, Sudong; Zhu, Yan; Wang, Jin-Hui			The Functional Upregulation of Piriform Cortex Is Associated with Cross-Modal Plasticity in Loss of Whisker Tactile Inputs	PLOS ONE			English	Article							SEQUENTIAL SPIKES; INTERNEURONS; MOUSE; INHIBITION; SYNAPSES; NEURONS; OLFACTOMETER; TRANSMISSION; DYSFUNCTION; HOMEOSTASIS	Background: Cross-modal plasticity is characterized as the hypersensitivity of remaining modalities after a sensory function is lost in rodents, which ensures their awareness to environmental changes. Cellular and molecular mechanisms underlying cross-modal sensory plasticity remain unclear. We aim to study the role of different types of neurons in cross-modal plasticity. Methodology/Principal Findings: In addition to behavioral tasks in mice, whole-cell recordings at the excitatory and inhibitory neurons, and their two-photon imaging, were conducted in piriform cortex. We produced a mouse model of cross-modal sensory plasticity that olfactory function was upregulated by trimming whiskers to deprive their sensory inputs. In the meantime of olfactory hypersensitivity, pyramidal neurons and excitatory synapses were functionally upregulated, as well as GABAergic cells and inhibitory synapses were downregulated in piriform cortex from the mice of cross-modal sensory plasticity, compared with controls. A crosswire connection between barrel cortex and piriform cortex was established in cross-modal plasticity. Conclusion/Significance: An upregulation of pyramidal neurons and a downregulation of GABAergic neurons strengthen the activities of neuronal networks in piriform cortex, which may be responsible for olfactory hypersensitivity after a loss of whisker tactile input. This finding provides the clues for developing therapeutic strategies to promote sensory recovery and substitution.	[Ye, Bing; Huang, Li; Chen, Ping; Ni, Hong; Guan, Sudong; Zhu, Yan; Wang, Jin-Hui] Bengbu Med Coll, Dept Physiol, Bengbu, Anhui, Peoples R China; [Gao, Zilong; Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Bengbu Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ye, B (corresponding author), Bengbu Med Coll, Dept Physiol, Bengbu, Anhui, Peoples R China.	jhw@ibp.ac.cn			National Award for Outstanding Young Scientist [30325021]; Natural Science Foundation of China [30870517, 30990261, 81171033]; National Basic Research Program [2011CB504405]	National Award for Outstanding Young Scientist; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China)	This study was supported by National Award for Outstanding Young Scientist (30325021), Natural Science Foundation of China (30870517, 30990261 and 81171033) and National Basic Research Program (2011CB504405) to JHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Buck LB, 2000, SMELL TASTE CHEM SEN; Chen N, 2006, BIOCHEM BIOPH RES CO, V340, P151, DOI 10.1016/j.bbrc.2005.11.170; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P281, DOI 10.1016/j.bbrc.2006.05.120; Chen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011868; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Collignon O, 2009, EXP BRAIN RES, V192, P343, DOI 10.1007/s00221-008-1553-z; Davies CW, 1999, J MED ENG TECHNOL, V23, P73, DOI 10.1080/030919099294320; Davies CW, 1998, J MED ENG TECHNOL, V22, P182, DOI 10.3109/03091909809032538; Davis E, 2007, CELL, V130, P593, DOI 10.1016/j.cell.2007.08.007; Dye MWG, 2008, ANN NY ACAD SCI, V1145, P71, DOI 10.1196/annals.1416.013; Fanselow EE, 2008, J NEUROPHYSIOL, V100, P2640, DOI 10.1152/jn.90691.2008; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fujii T, 2009, NEUROSCI RES, V65, P175, DOI 10.1016/j.neures.2009.06.014; Ge RJ, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-19; Ge RJ, 2009, BIOCHEM BIOPH RES CO, V387, P585, DOI 10.1016/j.bbrc.2009.07.066; HABERLY LB, 1987, J COMP NEUROL, V266, P269, DOI 10.1002/cne.902660211; Halabisky B, 2006, J NEUROPHYSIOL, V96, P834, DOI 10.1152/jn.01079.2005; Huang L, 2010, BIOCHEM BIOPH RES CO, V394, P709, DOI 10.1016/j.bbrc.2010.03.056; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Kadosh RC, 2006, CURR BIOL, V16, pR962, DOI 10.1016/j.cub.2006.10.017; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lambertz N, 2005, COGNITIVE BRAIN RES, V25, P884, DOI 10.1016/j.cogbrainres.2005.09.010; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; McBride K, 2003, CHEM SENSES, V28, P659, DOI 10.1093/chemse/bjg053; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; Neville H, 2002, PROG BRAIN RES, V138, P177, DOI 10.1016/S0079-6123(02)38078-6; Ni H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013736; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Owens JG, 1996, FUND APPL TOXICOL, V33, P60, DOI 10.1006/faat.1996.0143; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pho V, 2005, BEHAV BRAIN RES, V161, P245, DOI 10.1016/j.bbr.2005.02.011; Popp R, 2004, ACTA NEUROBIOL EXP, V64, P171; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; Ptito Maurice, 2005, Journal of Integrative Neuroscience, V4, P479, DOI 10.1142/S0219635205000951; Regehr WG, 2001, PHYSL SYNAPTIC TRANS; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sanchez-Vives MV, 2006, PROG BRAIN RES, V155, P287, DOI 10.1016/S0079-6123(06)55017-4; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Tsukatani T, 2005, LARYNGOSCOPE, V115, P1114, DOI 10.1097/01.MLG.0000163754.16475.43; VIGOUROUX M, 1988, J NEUROSCI METH, V24, P57, DOI 10.1016/0165-0270(88)90033-7; Wang JH, 2004, BRAIN RES, V1004, P125, DOI 10.1016/j.brainres.2004.01.025; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wang JH, 1996, J NEUROPHYSIOL, V75, P1687, DOI 10.1152/jn.1996.75.4.1687; Wang JH, 2008, J CELL SCI, V121, P2951, DOI 10.1242/jcs.025684; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wei J, 2004, NEUROSCIENCE, V127, P637, DOI 10.1016/j.neuroscience.2004.05.056; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Xu FQ, 2005, J COMP NEUROL, V489, P491, DOI 10.1002/cne.20652; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012; Yu JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025219; Zhao J, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-12; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	60	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e41986	10.1371/journal.pone.0041986	http://dx.doi.org/10.1371/journal.pone.0041986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927919	Green Published, Green Submitted, gold			2022-12-25	WOS:000307789700007
J	Yin, G; Wang, YX; Zheng, ZY; Yang, H; Xu, L; Jonas, JB				Yin, Guo; Wang, Ya Xing; Zheng, Zhi Yun; Yang, Hua; Xu, Liang; Jonas, Jost B.		Beijing Eye Study Grp	Ocular Axial Length and Its Associations in Chinese: The Beijing Eye Study	PLOS ONE			English	Article							TANJONG-PAGAR SURVEY; ANTERIOR-CHAMBER DEPTH; REFRACTIVE ERROR; ADULT-POPULATION; ANGLE-CLOSURE; RURAL MYANMAR; MEIKTILA EYE; HIGH MYOPIA; BIOMETRY; DIMENSIONS	Purpose: To investigate the normative data of ocular axial length and its associations in Chinese. Method: The population-based Beijing Eye Study 2011 is a cross-sectional study performed in Greater Beijing. The study included 3468 individuals (1963 (56.6%) women) with a mean age of 64.6 +/- 9.8 years (range: 50-93 years). A detailed ophthalmic and medical examination was performed. Axial length was measured by optical low-coherence reflectometry. Results: Axial length measurements were available for 3159 (91.1%) study participants. Mean axial length was 23.25 +/- 1.14 mm (range: 18.96-30.88 mm). In multivariate analysis, axial length was significantly associated with the systemic parameters of higher age (P < 0.001), higher body height (P = 0.003), higher level of education (P < 0.001) and urban region of habitation (P < 0.001), and with the ocular parameters of thicker central cornea (P = 0.001), higher corneal curvature radius (P < 0.001), deeper anterior chamber (P < 0.001), thicker lens (P < 0.001), more myopic refractive error (P < 0.001), larger pupil diameter (P = 0.018), and higher best corrected visual acuity (P < 0.001). It was additionally and negatively associated with the lens vault (P < 0.001). In highly myopic eyes, axial length was significantly associated with lower level of education (P = 0.008), more myopic refractive error (P < 0.001), and lower best corrected visual acuity (P = 0.034). Conclusions: Mean ocular axial length in the older adult population of Greater Beijing (23.25 +/- 1.14 mm) was similar to the value measured in other urban populations and was higher than in a rural Central Indian population. The association between axial length and older age may potentially be associated with a survival artifact. The association between axial length and body height agrees with the general association between anthropomorphic measures and eye globe size. The association with the level of education and urban region of habitation confirms with previous studies. In contrast in highly myopic eyes, axial length was negatively associated with educational level and best corrected visual acuity.	[Yin, Guo; Wang, Ya Xing; Yang, Hua; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Zheng, Zhi Yun] PLA Gen Armament Dept, Yayuncun Clin, Beijing, Peoples R China; [Jonas, Jost B.] Univ Heidelberg, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Yin, G (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@163.com	You, Qisheng/A-3619-2014; You, Qisheng/AAG-7153-2020; Guo, Yin/ABC-2134-2020; wang, YA XING/K-9671-2016	You, Qisheng/0000-0003-0743-7320; You, Qisheng/0000-0003-0743-7320; Guo, Yin/0000-0003-3806-3771; wang, YA XING/0000-0003-2749-7793	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eysteinsson T, 2005, ACTA OPHTHALMOL SCAN, V83, P734, DOI 10.1111/j.1600-0420.2005.00540.x; Foster PJ, 2010, BRIT J OPHTHALMOL, V94, P827, DOI 10.1136/bjo.2009.163899; George R, 2003, BRIT J OPHTHALMOL, V87, P399, DOI 10.1136/bjo.87.4.399; He MG, 2009, INVEST OPHTH VIS SCI, V50, P5130, DOI 10.1167/iovs.09-3455; Iribarren R, 2012, INVEST OPHTH VIS SCI, V53, P543, DOI 10.1167/iovs.11-8523; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Lavanya R, 2010, INVEST OPHTH VIS SCI, V51, P6247, DOI 10.1167/iovs.10-5229; Lee KE, 2009, ARCH OPHTHALMOL-CHIC, V127, P88, DOI 10.1001/archophthalmol.2008.521; Liang YB, 2009, OPHTHAL EPIDEMIOL, V16, P115, DOI 10.1080/09286580902738159; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Nongpiur ME, 2010, OPHTHALMOLOGY, V117, P1967, DOI 10.1016/j.ophtha.2010.02.007; Ojaimi E, 2005, INVEST OPHTH VIS SCI, V46, P2748, DOI 10.1167/iovs.04-1324; Saw SM, 2007, AM J OPHTHALMOL, V144, P325, DOI 10.1016/j.ajo.2007.03.038; Saw SM, 2002, OPHTHALMOLOGY, V109, P2065, DOI 10.1016/S0161-6420(02)01220-4; Shufelt C, 2005, INVEST OPHTH VIS SCI, V46, P4450, DOI 10.1167/iovs.05-0435; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Warrier S, 2008, BRIT J OPHTHALMOL, V92, P1591, DOI 10.1136/bjo.2008.144477; Wickremasinghe S, 2004, INVEST OPHTH VIS SCI, V45, P776, DOI 10.1167/iovs.03-0456; Wojciechowski R, 2003, OPHTHALMOLOGY, V110, P365, DOI 10.1016/S0161-6420(02)01748-7; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P963, DOI 10.1136/bjo.86.9.963; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P1237; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P73; Wu HM, 2007, CLIN EXP OPHTHALMOL, V35, P834, DOI 10.1111/j.1442-9071.2007.01638.x; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Xu L, 2007, ACTA OPHTHALMOL SCAN, V85, P914, DOI 10.1111/j.1600-0420.2007.00966.x; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050	27	67	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43172	10.1371/journal.pone.0043172	http://dx.doi.org/10.1371/journal.pone.0043172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927949	Green Submitted, gold, Green Published			2022-12-25	WOS:000307789700025
J	Perez-Martinez, P; Perez-Caballero, AI; Garcia-Rios, A; Yubero-Serrano, EM; Camargo, A; Gomez-Luna, MJ; Marin, C; Gomez-Luna, P; Dembinska-Kiec, A; Rodriguez-Cantalejo, F; Tinahones, FJ; Roche, HM; Perez-Jimenez, F; Lopez-Miranda, J; Delgado-Lista, J				Perez-Martinez, Pablo; Perez-Caballero, Ana I.; Garcia-Rios, Antonio; Yubero-Serrano, Elena M.; Camargo, Antonio; Gomez-Luna, Maria J.; Marin, Carmen; Gomez-Luna, Purificacion; Dembinska-Kiec, Aldona; Rodriguez-Cantalejo, Fernando; Tinahones, Francisco J.; Roche, Helen M.; Perez-Jimenez, Francisco; Lopez-Miranda, Jose; Delgado-Lista, Javier			Effects of rs7903146 Variation in the Tcf7l2 Gene in the Lipid Metabolism of Three Different Populations	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; INSULIN-RESISTANCE; HEALTHY-MEN; ASSOCIATION; PLASMA; DISEASE; GLUCOSE; PROFILE; LIPGENE; SERUM	Background: TCF7L2 rs7903146 is an important genetic factor predicting type 2 diabetes (T2DM) which has also been linked to higher cardiovascular risk. To date, there is little information about the additional impact of this single nucleotide polymorphism (SNP) beyond glucose metabolism. Methodology/Principal Findings: We studied whether rs7903146 influenced postprandial lipid metabolism in three different populations (healthy young men, metabolic syndrome (MetS) patients and elderly persons). Eighty-eight healthy males were submitted to a single saturated fatty acid-rich test meal. Additionally, 110 middle-aged MetS patients and 20 healthy elderly persons (>= 65 years) were submitted to three different dietary models followed by test meals. Minor allele homozygotes for rs7903146 showed a worse postprandial lipemia profile in young males, as seen by a lower HDL-cholesterol and Apo A1 concentration during the postprandial lipemia and a trend towards higher triglycerides (TG), than the other genotypes. In healthy elderly persons, carriers of the minor allele showed higher total cholesterol, LDL-cholesterol, Apo B and TG in the fasting state, and a higher postprandial area under the curve for total cholesterol, Apo B, small-triglyceride rich lipoprotein (TRL) cholesterol and small-(TRL) triglycerides. These results were accompanied by differential changes in adipokines. We did not observe any influence of rs7903146 on the postprandium of MetS patients. Conclusions/Significance: Healthy young males and elderly persons who are carriers of the mutant allele for rs7903146 have an impaired postprandial lipid metabolism that may be mediated by an alteration in adipokine regulation, and may be related to the higher cardiovascular risk observed in these persons.	[Perez-Martinez, Pablo; Perez-Caballero, Ana I.; Garcia-Rios, Antonio; Yubero-Serrano, Elena M.; Camargo, Antonio; Gomez-Luna, Maria J.; Marin, Carmen; Gomez-Luna, Purificacion; Perez-Jimenez, Francisco; Lopez-Miranda, Jose; Delgado-Lista, Javier] Univ Cordoba, Hosp Univ Reina Sofia, IMIBIC, Lipids & Atherosclerosis Unit, Cordoba, Spain; [Perez-Martinez, Pablo; Perez-Caballero, Ana I.; Garcia-Rios, Antonio; Yubero-Serrano, Elena M.; Camargo, Antonio; Gomez-Luna, Maria J.; Marin, Carmen; Gomez-Luna, Purificacion; Tinahones, Francisco J.; Perez-Jimenez, Francisco; Lopez-Miranda, Jose; Delgado-Lista, Javier] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain; [Dembinska-Kiec, Aldona] Jagiellonian Univ, Coll Med, Dept Clin Biochem, Krakow, Poland; [Dembinska-Kiec, Aldona] Off Patients Clin Dyslipidemia & Obes Treatment, Krakow, Poland; [Rodriguez-Cantalejo, Fernando] Hosp Univ Reina Sofia, Biochem Lab, Cordoba, Spain; [Tinahones, Francisco J.] Hosp Clin Virgen de la Victoria, Serv Endocrinol & Nutr, Malaga, Spain; [Roche, Helen M.] Univ Coll Dublin, UCD Conway Inst, UCD Sch Publ Hlth & Populat Sci, Nutrigen Res Grp, Dublin 2, Ireland	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Jagiellonian University; Collegium Medicum Jagiellonian University; Hospital Universitario Reina Sofia - Cordoba; Hospital Virgen de la Victoria; University College Dublin	Perez-Martinez, P (corresponding author), Univ Cordoba, Hosp Univ Reina Sofia, IMIBIC, Lipids & Atherosclerosis Unit, Cordoba, Spain.	delgadolista@gmail.com	Jimenez, Francisco Perez/AAJ-9559-2021; Lopez-Miranda, Jose/Y-8306-2019; Tinahones, Francisco José/AAB-2882-2020; Camargo, Antonio/G-9720-2015; Roche, Helen M/AAF-4164-2019; Yubero-Serrano, Elena M/H-4832-2013; Marin Hinojosa, Carmen/AFO-1294-2022	Lopez-Miranda, Jose/0000-0002-8844-0718; Camargo, Antonio/0000-0002-0415-4184; Roche, Helen M/0000-0002-0628-3318; Marin Hinojosa, Carmen/0000-0003-2884-4806; Delgado Lista, Francisco Javier/0000-0002-2982-2716; Perez-Jimenez, Francisco/0000-0001-7499-7681; Yubero-Serrano, Elena M/0000-0002-2733-5359; Perez Jimenez, Francisco/0000-0001-9808-1280; Perez-Caballero, Ana Isabel/0000-0001-6315-1453; Tinahones, Francisco J/0000-0001-6871-4403; Perez Martinez, Pablo/0000-0001-7716-8117	Spanish Ministry of Science and Innovation [AGL 2004-07907, AGL2006-01979, AGL2009-12270, SAF07-62005, FIS PI10/01041, PI10/02412]; Consejeria de Economia, Innovacion y Ciencia, Proyectos de Investigacion de Excelencia, Junta de Andalucia [P06-CTS-01425, CTS5015, AGR922]; Consejeria de Salud, Junta de Andalucia [06/128, 07/43, PI0193/09, 06/129, 0118/08, PI-0252/09, PI-0058/10]; Fondo Europeo de Desarrollo Regional (FEDER); ISCIII (Program Rio-Hortega)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Economia, Innovacion y Ciencia, Proyectos de Investigacion de Excelencia, Junta de Andalucia(Junta de Andalucia); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); ISCIII (Program Rio-Hortega)	Supported in part by public funds: research grants from the Spanish Ministry of Science and Innovation (AGL 2004-07907, AGL2006-01979, and AGL2009-12270 to JL-M, SAF07-62005 to FP-J and FIS PI10/01041 to PP-M, PI10/02412 to FP-J); Consejeria de Economia, Innovacion y Ciencia, Proyectos de Investigacion de Excelencia, Junta de Andalucia (P06-CTS-01425 to JL-M, CTS5015 and AGR922 to FP-J); Consejeria de Salud, Junta de Andalucia (06/128, 07/43, and PI0193/09 to JL-M, 06/129 to FP-J, 0118/08 to FF-J, PI-0252/09 to JD-L, and PI-0058/10 to PP-M); Fondo Europeo de Desarrollo Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The CIBEROBN is an initiative of the Instituto de Salud Carlos III, Madrid, Spain. Dr. Garcia-Rios is supported by a research contract from ISCIII (Program Rio-Hortega).	Delgado-Lista J, 2010, ATHEROSCLER IN PRESS; Delgado-Lista J, 2007, J NUTR, V137, P2024; Delgado-Lista J, 2011, J CLIN ENDOCR METAB, V96, pE816, DOI 10.1210/jc.2010-2455; Delgado-Lista J, 2010, ARTERIOSCL THROM VAS, V30, P1051, DOI 10.1161/ATVBAHA.109.202580; Delgado-Lista J, 2010, J LIPID RES, V51, P63, DOI 10.1194/jlr.M800527-JLR200; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Florez JC, 2007, CURR OPIN CLIN NUTR, V10, P391, DOI 10.1097/MCO.0b013e3281e2c9be; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fukushima H, 2004, J AM COLL CARDIOL, V43, P2219, DOI 10.1016/j.jacc.2003.09.074; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Gutierrez-Mariscal FM, 2011, AGE DORDR; Hartwich J, 2010, SCAND J CLIN LAB INV, V70, P201, DOI 10.3109/00365511003663630; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCaffery JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021518; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; Mihas C, 2011, CURR VASC PHARMACOL, V9, P271, DOI 10.2174/157016111795495530; National Cholesterol Education Program, 2002, 3 NAT CHOL ED PROGR; Nedvidkova J, 2005, PHYSIOL RES, V54, P133, DOI 10.33549/physiolres.930600; Pang DX, 2012, NUTR METAB CARDIOVAS; Perez-Martinez P, 2011, NUTR METAB CARDIOVAS, V21, P39, DOI 10.1016/j.numecd.2009.07.008; Perez-Martinez P, 2008, AM J CLIN NUTR, V87, P744, DOI 10.1093/ajcn/87.3.744; Perez-Martinez P, 2011, CURR VASC PHARMACOL, V9, P287, DOI 10.2174/157016111795495495; Perez-Martinez P, 2010, ATHEROSCLEROSIS SUPP, V11, P39, DOI 10.1016/j.atherosclerosissup.2010.03.002; Pilgaard K, 2009, DIABETOLOGIA, V52, P1298, DOI 10.1007/s00125-009-1307-x; RIEPPONEN P, 1987, SCAND J CLIN LAB INV, V47, P739; Roche HM, 2005, P NUTR SOC, V64, P371, DOI 10.1079/PNS2005445; Ruano J, 2007, AM J CLIN NUTR, V86, P341, DOI 10.1093/ajcn/86.2.341; Schinner S, 2009, HORM METAB RES, V41, P159, DOI 10.1055/s-0028-1119408; Shaw DI, 2009, BRIT J NUTR, V101, P750, DOI 10.1017/S0007114508039962; Smushkin G, 2012, DIABETES, V61, P1082, DOI [10.2337/db11-1732, 10.2337/db12-0923]; Sousa AGP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007697; Stalenhoef AFH, 2008, CURR OPIN LIPIDOL, V19, P355, DOI 10.1097/MOL.0b013e328304b63c; Tabara Y, 2009, DIABETES, V58, P493, DOI 10.2337/db07-1785; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Taskinen MR, 2002, ATHEROSCLEROSIS SUPP, V3, P47, DOI 10.1016/S1567-5688(01)00006-X; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Warodomwichit D, 2009, J NUTR, V139, P439, DOI 10.3945/jn.108.096461; Williams KW, 2009, AM J CLIN NUTR, V89, p985S, DOI 10.3945/ajcn.2008.26788D; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Yubero-Serrano EM, 2011, J AM GERIATR SOC, V59, P938, DOI 10.1111/j.1532-5415.2011.03381.x	43	22	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43390	10.1371/journal.pone.0043390	http://dx.doi.org/10.1371/journal.pone.0043390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916254	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800063
J	Sun, TT; Yan, YW; Zhao, Y; Guo, F; Jiang, CY				Sun, Tingting; Yan, Yiwu; Zhao, Yan; Guo, Feng; Jiang, Chengyu			Copper Oxide Nanoparticles Induce Autophagic Cell Death in A549 Cells	PLOS ONE			English	Article							PSEUDOKIRCHNERIELLA-SUBCAPITATA; BULK ZNO; IN-VIVO; TOXICITY; PARTICLES; CANCER; TIO2; NANO; CUO; NANOMATERIALS	Metal oxide nanoparticles (NPs) are among the most highly produced nanomaterials, and have many diverse functions in catalysis, environmental remediation, as sensors, and in the production of personal care products. In this study, the toxicity of several widely used metal oxide NPs such as copper oxide, silica, titanium oxide and ferric oxide NPs, were evaluated In vitro. We exposed A549, H1650 and CNE-2Z cell lines to metal oxide NPs, and found CuO NPs to be the most toxic, SiO2 mild toxic, while the other metal oxide NPs had little effect on cell viability. Furthermore, the autophagic biomarker LC3-II significantly increased in A549 cells treated with CuO NPs, and the use of the autophagy inhibitors wortmannin and 3-methyladenin significantly improved cell survival. These results indicate that the cytoxicity of CuO NPs may involve the autophagic pathway in A549 cells.	[Sun, Tingting; Yan, Yiwu; Zhao, Yan; Guo, Feng; Jiang, Chengyu] Tsinghua Univ, Peking Union Med Coll, Chinese Acad Med Sci, State Key Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100084, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University	Sun, TT (corresponding author), Tsinghua Univ, Peking Union Med Coll, Chinese Acad Med Sci, State Key Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100084, Peoples R China.	jiang@pumc.edu.cn	Yan, Yiwu/P-5499-2017	Yan, Yiwu/0000-0001-8289-7277; Guo, Feng/0000-0002-4506-7618	Ministry of Science and Technology of China [2009CB522105, 2011CB933504]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The funds supporting this work are all from Ministry of Science and Technology of China, grant numbers 2009CB522105 and 2011CB933504. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2010, BIOCHEM BIOPH RES CO, V396, P578, DOI 10.1016/j.bbrc.2010.04.156; Aruoja V, 2009, SCI TOTAL ENVIRON, V407, P1461, DOI 10.1016/j.scitotenv.2008.10.053; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bergmann A, 2007, CELL, V131, P1032, DOI 10.1016/j.cell.2007.11.027; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Chen Y, 2005, BIOCHEM BIOPH RES CO, V337, P52, DOI 10.1016/j.bbrc.2005.09.018; Chen Z, 2006, TOXICOL LETT, V163, P109, DOI 10.1016/j.toxlet.2005.10.003; Cho WS, 2010, ENVIRON HEALTH PERSP, V118, P1699, DOI 10.1289/ehp.1002201; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Fahmy B, 2009, TOXICOL IN VITRO, V23, P1365, DOI 10.1016/j.tiv.2009.08.005; Franklin NM, 2007, ENVIRON SCI TECHNOL, V41, P8484, DOI 10.1021/es071445r; Griffitt RJ, 2007, ENVIRON SCI TECHNOL, V41, P8178, DOI 10.1021/es071235e; Gupta AK, 2005, BIOMATERIALS, V26, P1565, DOI 10.1016/j.biomaterials.2004.05.022; Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Jeng HA, 2006, J ENVIRON SCI HEAL A, V41, P2699, DOI 10.1080/10934520600966177; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karlsson HL, 2009, TOXICOL LETT, V188, P112, DOI 10.1016/j.toxlet.2009.03.014; Kasemets K, 2009, TOXICOL IN VITRO, V23, P1116, DOI 10.1016/j.tiv.2009.05.015; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Lei RH, 2008, TOXICOL APPL PHARM, V232, P292, DOI 10.1016/j.taap.2008.06.026; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595; Li CG, 2009, J MOL CELL BIOL, V1, P37, DOI 10.1093/jmcb/mjp002; Li JJ, 2010, BIOMATERIALS, V31, P5996, DOI 10.1016/j.biomaterials.2010.04.014; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Seleverstov O, 2006, NANO LETT, V6, P2826, DOI 10.1021/nl0619711; Service RF, 2003, SCIENCE, V300, P243; Yokohira M, 2008, TOXICOL PATHOL, V36, P620, DOI 10.1177/0192623308318214; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005; Zabirnyk O, 2007, AUTOPHAGY, V3, P278, DOI 10.4161/auto.3916	39	111	119	2	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43442	10.1371/journal.pone.0043442	http://dx.doi.org/10.1371/journal.pone.0043442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916263	gold, Green Submitted, Green Published			2022-12-25	WOS:000307733800067
J	Xue, ML; Ge, YL; Zhang, JY; Wang, Q; Hou, L; Liu, YC; Sun, LL; Li, Q				Xue, Meilan; Ge, Yinlin; Zhang, Jinyu; Wang, Qing; Hou, Lin; Liu, Yongchao; Sun, Lingling; Li, Quan			Anticancer Properties and Mechanisms of Fucoidan on Mouse Breast Cancer In Vitro and In Vivo	PLOS ONE			English	Article							CLADOSIPHON-OKAMURANUS-TOKIDA; BROWN SEAWEED; SARGASSUM-THUNBERGII; ANTITUMOR-ACTIVITY; CELL-DEATH; APOPTOSIS; POLYSACCHARIDE; METASTASIS; INHIBITION; ACTIVATION	Background: Fucoidan is a sulfated polysaccharide derived from brown algae that has been reported to perform multiple biological activities, including antitumor activity. In this study, we examined the influence of crude fucoidan on mouse breast cancer in vitro and in vivo. Materials and Methods: In vitro, fluorescent staining, flow cytometry and Western blot were performed to analyze apoptosis and vascular endothelial growth factor (VEGF) expression of mouse breast cancer 4T1 cells. In vivo, therapy experiments were conducted on Babl/c mice bearing breast cancer. The tumor volume and weight were measured. The number of apoptotic cells and microvascular density (MVD) in tumor tissues were assessed by TUNEL and CD34 immunostaining. Immunohistochemical assays and ELISA assay were used to detect the expression of VEGF in tissues. Results: In vitro studies showed that crude fucoidan significantly decreased the viable number of 4T1 cells, induced apoptosis and down-regulated the expression of VEGF. The expression of Bcl-2 was decreased, and the ratio of Bcl-2 to Bax was significantly decreased. The expression of Survivin and phosphorylated extracellular signal regulated protein kinases (ERKs) was decreased. Cytochrome C was released from mitochondria into cytosol, and the cleaved Caspase-3 protein rose after fucoidan treatment. Intraperitoneal injection of fucoidan in breast cancer models reduced the tumor volume and weight. The enhanced antitumor efficacy was associated with decreased angiogenesis and increased induction of apoptosis. Conclusion: These findings indicated that crude fucoidan inhibited mouse breast cancer growth in vitro and in vivo. These data suggest that fucoidan may serve as a potential therapeutic agent for breast cancer.	[Xue, Meilan; Ge, Yinlin; Zhang, Jinyu; Hou, Lin; Liu, Yongchao; Li, Quan] Qingdao Univ, Coll Med, Dept Biochem & Mol Biol, Qingdao 266071, Peoples R China; [Wang, Qing] Qingdao Univ, Affiliated Hosp, Dept Ophthalmol, Qingdao 266071, Peoples R China; [Sun, Lingling] Qingdao Univ, Affiliated Hosp, Dept Pathol, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Xue, ML (corresponding author), Qingdao Univ, Coll Med, Dept Biochem & Mol Biol, Qingdao 266071, Peoples R China.	geyinlin@126.com	Liu, Yong/GWQ-6163-2022					Aisa Y, 2005, AM J HEMATOL, V78, P7, DOI 10.1002/ajh.20182; Alekseyenko TV, 2007, B EXP BIOL MED+, V143, P730, DOI 10.1007/s10517-007-0226-4; Bilan MI, 2006, CARBOHYD RES, V341, P238, DOI 10.1016/j.carres.2005.11.009; Bilan MI, 2002, CARBOHYD RES, V337, P719, DOI 10.1016/S0008-6215(02)00053-8; Boo HJ, 2011, PHYTOTHER RES, V25, P1082, DOI 10.1002/ptr.3489; CARMICHAEL J, 1987, CANCER RES, V47, P943; Chevolot L, 2001, CARBOHYD RES, V330, P529, DOI 10.1016/S0008-6215(00)00314-1; COOMBE DR, 1987, INT J CANCER, V39, P82, DOI 10.1002/ijc.2910390115; Donovan M, 2004, BBA-MOL CELL RES, V1644, P133, DOI 10.1016/j.bbamcr.2003.08.011; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haneji K, 2005, NUTR CANCER, V52, P189, DOI 10.1207/s15327914nc5202_9; Ishii H, 2008, CANCER SCI, V99, P1871, DOI 10.1111/j.1349-7006.2008.00914.x; ITOH H, 1993, ANTICANCER RES, V13, P2045; Kim EJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-96; Koyanagi S, 2003, BIOCHEM PHARMACOL, V65, P173, DOI 10.1016/S0006-2952(02)01478-8; Li B, 2008, MOLECULES, V13, P1671, DOI 10.3390/molecules13081671; Li FZ, 2006, J CELL PHYSIOL, V208, P476, DOI 10.1002/jcp.20634; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Maruyama H, 2006, PLANTA MED, V72, P1415, DOI 10.1055/s-2006-951703; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Montanaro F, 2004, EXP CELL RES, V298, P144, DOI 10.1016/j.yexcr.2004.04.010; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Philchenkov A, 2007, Exp Oncol, V29, P181; Poulaki V, 2002, J CLIN INVEST, V109, P805, DOI 10.1172/JCI200213776; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Riou D, 1996, ANTICANCER RES, V16, P1213; Shakibaei M, 2001, J BIOL CHEM, V276, P13289, DOI 10.1074/jbc.M010859200; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; Teruya T, 2007, INT J BIOL MACROMOL, V41, P221, DOI 10.1016/j.ijbiomac.2007.02.010; Wang J, 2008, INT J BIOL MACROMOL, V42, P127, DOI 10.1016/j.ijbiomac.2007.10.003; Ye J, 2005, CYTOTECHNOLOGY, V47, P117, DOI 10.1007/s10616-005-3761-8; Zhang X, 2009, ONCOLOGY-BASEL, V77, P22, DOI 10.1159/000218201; Zhang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027441; ZHUANG C, 1995, BIOSCI BIOTECH BIOCH, V59, P563, DOI 10.1271/bbb.59.563	34	100	102	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43483	10.1371/journal.pone.0043483	http://dx.doi.org/10.1371/journal.pone.0043483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916270	gold, Green Published, Green Submitted			2022-12-25	WOS:000307733800073
J	Cantu, MA; Lupo, PJ; Bilgi, M; Hicks, MJ; Allen, CE; McClain, KL				Cantu, Maria A.; Lupo, Philip J.; Bilgi, Mrinalini; Hicks, M. John; Allen, Carl E.; McClain, Kenneth L.			Optimal Therapy for Adults with Langerhans Cell Histiocytosis Bone Lesions	PLOS ONE			English	Article							EOSINOPHILIC GRANULOMA; RADIOTHERAPY; EXPERIENCE	Background: There is little data on treatment of Langerhans cell histiocytosis (LCH) in adults. Available data is on small numbers of patients with short follow-up times and no comparison of results from different treatment regimens. We analyzed the responses of adult LCH patients with bone lesions to three primary chemotherapy treatments to define the optimal one. Methods and Findings: Fifty-eight adult patients with bone lesions, either as a solitary site or as a component of multisystem disease, were analyzed for disease location and response to surgery, curettage, steroids, radiation, vinblastine/prednisone, 2-Chlorodeoxyadenosine (2-CdA), or cytosine arabinoside (ARA-C). The mean age of patients was 32 years, with equal gender distribution. Twenty-nine patients had 1 lesion; 16, 2 lesions; 5, 3 lesions; and 8 had 4 or more. Most bone lesions were in the skull, spine, or jaw. Chemotherapy, surgery, curettage, or radiation, but not steroids alone, achieved improvement or resolution of lesions in a majority of patients. Comparison of the three chemotherapy regimens revealed 84% of patients treated with vinblastine/prednisone either did not respond or relapsed within a year, whereas 59% of patients treated with 2-CdA and 21% treated with ARA-C failed. Toxicity was worse with the vinblastine/prednisone group as 75% had grade 3-4 neuropathy. Grade 3-4 cytopenias occurred in 37% of the 2-CdA -treated patients and 20% of the ARA-C-treated patients. The major limitation of this study is it is retrospective and not a clinical trial. Conclusions: ARA-C is an effective and minimally toxic treatment for LCH bone lesions in adults. In contrast, vinblastine/prednisone results in poor overall responses and excessive toxicity.	[Cantu, Maria A.; Bilgi, Mrinalini; Allen, Carl E.; McClain, Kenneth L.] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Lupo, Philip J.] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol, Houston, TX USA; [Bilgi, Mrinalini; Allen, Carl E.; McClain, Kenneth L.] Baylor Coll Med, Hematol Ctr, Houston, TX 77030 USA; [Hicks, M. John] Texas Childrens Hosp, Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Texas Children's Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; Baylor College of Medicine	Cantu, MA (corresponding author), Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA.	klmcclai@txch.org	Lupo, Philip/R-8314-2019	Lupo, Philip/0000-0003-0978-5863; McClain, Kenneth/0000-0003-0725-6263	National Institutes of Health; Glaxo Smith Kline Company	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaxo Smith Kline Company	K. McClain owns common stock in the Johnson and Johnson Company, has research support from the National Institutes of Health, and clinical trial support from the Glaxo Smith Kline Company. C. Allen has research support for the National Institutes of Health and clinical trial support from the Glaxo Smith Kline Company. The other authors have no conflicts to report. The above is funding unrelated to this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online on the guide for authors.	Allen CE, 2010, J IMMUNOL, V184, P4557, DOI 10.4049/jimmunol.0902336; Ardekian L, 1999, ORAL SURG ORAL MED O, V87, P238, DOI 10.1016/S1079-2104(99)70279-9; Arico M, 2003, EUR J CANCER, V39, P2341, DOI 10.1016/S0959-8049(03)00672-5; Atalar B, 2010, ACTA ORTHOP BELG, V76, P663; Baumgartner I, 1997, MED PEDIATR ONCOL, V28, P9, DOI 10.1002/(SICI)1096-911X(199701)28:1<9::AID-MPO3>3.0.CO;2-P; Derenzini E, 2010, ANN ONCOL, V21, P1173, DOI 10.1093/annonc/mdp455; EGELER RM, 1993, MED PEDIATR ONCOL, V21, P265, DOI 10.1002/mpo.2950210406; Gadner H, 2008, BLOOD, V111, P2556, DOI 10.1182/blood-2007-08-106211; Gotz G, 2004, EUR J MED RES, V9, P510; Grois N, 2006, PEDIATR BLOOD CANCER, V46, P228, DOI 10.1002/pbc.20425; Huang WD, 2010, ACTA NEUROCHIR, V152, P1129, DOI 10.1007/s00701-010-0644-3; Islinger RB, 2000, CLIN ORTHOP RELAT R, P231; Malpas JS, 1996, MED PEDIATR ONCOL, V27, P540; Matsuki E, 2011, INTERNAL MED, V50, P909, DOI 10.2169/internalmedicine.50.4808; McClain KL, 2010, WILLIAMS HEMATOLOGY, P1047; Mittheisz E, 2007, PEDIATR BLOOD CANCER, V48, P50, DOI 10.1002/pbc.20760; Olschewski T, 2006, STRAHLENTHER ONKOL, V182, P629, DOI 10.1007/s00066-006-1630-9; Sivendran S, 2011, INT J HEMATOL, V93, P782, DOI 10.1007/s12185-011-0839-2; SLATER JM, 1980, MED PEDIATR ONCOL, V8, P151, DOI 10.1002/mpo.2950080208; Titgemeyer C, 2001, MED PEDIATR ONCOL, V37, P108, DOI 10.1002/mpo.1178; Weitzman S, 2005, HISTIOCYTIC DISORDERS OF CHILDREN AND ADULTS, P254, DOI 10.1017/CBO9780511545252.014; Weitzman S, 2009, PEDIATR BLOOD CANCER, V53, P1271, DOI 10.1002/pbc.22229	22	77	80	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43257	10.1371/journal.pone.0043257	http://dx.doi.org/10.1371/journal.pone.0043257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916233	Green Published, gold, Green Submitted			2022-12-25	WOS:000307823600062
J	Carson, CG; Halkjaer, LB; Jensen, SM; Bisgaard, H				Carson, Charlotte Giwercman; Halkjaer, Liselotte Brydensholt; Jensen, Signe Marie; Bisgaard, Hans			Alcohol Intake in Pregnancy Increases the Child's Risk of Atopic Dermatitis. The COPSAC Prospective Birth Cohort Study of a High Risk Population	PLOS ONE			English	Article							PRENATAL FACTORS; IMMUNE-SYSTEM; LIFE; ASTHMA; CONSUMPTION; ECZEMA; RHINITIS; DRINKS; WOMEN; ASSOCIATION	Background: Atopic dermatitis has increased four-fold over the recent decades in developed countries, indicating that changes in environmental factors associated with lifestyle may play an important role in this epidemic. It has been proposed that alcohol consumption may be one contributing risk factor in this development. Objective: To analyze the impact of alcohol intake during pregnancy on the development of atopic dermatitis during the first 7 years of life. Method: The COPSAC cohort is a prospective, longitudinal, birth cohort study of 411 children born to mothers with a history of asthma, followed up for 7 years with scheduled visits every 6 months as well as visits for acute exacerbations of atopic dermatitis. Risk of atopic dermatitis from any alcohol consumption during pregnancy was analyzed as time-to-diagnosis and adjusted for known risk factors. Results: 177 of 411 children developed atopic dermatitis before age 7 years. We found a significant effect of alcohol intake during pregnancy on atopic dermatitis development (HR 1.44, 95% CI 1.05-1.99 p = 0.024). This conclusion was unaffected after adjustment for smoking, mother's education and mother's atopic dermatitis. Limitations: The selection of a high-risk cohort, with all mothers suffering from asthma, and all children having a gestational age above 35 weeks with no congenital abnormality, systemic illness, or history of mechanical ventilation or lower airway infection. Conclusion: Alcohol intake by pregnant women with a history of asthma, is significantly associated with an increased risk for the child for developing atopic dermatitis during the first 7 years of life.	[Carson, Charlotte Giwercman; Halkjaer, Liselotte Brydensholt; Jensen, Signe Marie; Bisgaard, Hans] Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, Copenhagen, Denmark	University of Copenhagen	Carson, CG (corresponding author), Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, Copenhagen, Denmark.	bisgaard@copsac.com	Jensen, Signe/G-1026-2016; Bisgaard, Hans/N-4761-2016; Kronow, Joern/B-1054-2011	Jensen, Signe/0000-0002-7738-5231; Bisgaard, Hans/0000-0003-4131-7592; 	The Lundbeck Foundation; Pharmacy Foundation; Augustinus Foundation; Danish Medical Research Council; Danish Pediatric Asthma Centre	The Lundbeck Foundation(Lundbeckfonden); Pharmacy Foundation; Augustinus Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Pediatric Asthma Centre	Copenhagen Prospective Studies on Asthma in Childhood is funded by private and public research funds. The Lundbeck Foundation; the Pharmacy Foundation of 1991; Augustinus Foundation; the Danish Medical Research Council and The Danish Pediatric Asthma Centre provided the core funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; Bendtsen P, 2008, CLIN EXP ALLERGY, V38, P1179, DOI 10.1111/j.1365-2222.2008.02945.x; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2009, J ALLERGY CLIN IMMUN, V123, P1355, DOI 10.1016/j.jaci.2009.03.046; Bjerke T, 1994, Pediatr Allergy Immunol, V5, P88, DOI 10.1111/j.1399-3038.1994.tb00223.x; Bjorksten B, 1999, P NUTR SOC, V58, P729, DOI 10.1017/S0029665199000956; Bjorksten B, 1999, LANCET, V353, P167, DOI 10.1016/S0140-6736(05)77212-3; Bjorksten B, 1999, J ALLERGY CLIN IMMUN, V104, P1119; Bohme M, 2003, CLIN EXP ALLERGY, V33, P1226, DOI 10.1046/j.1365-2222.2003.01749.x; Bradley M, 2000, ACTA DERM-VENEREOL, V80, P106; Chawes BLK, 2009, ALLERGY, V64, P1547, DOI 10.1111/j.1398-9995.2009.02085.x; Cook RT, 1998, ALCOHOL CLIN EXP RES, V22, P1927, DOI 10.1097/00000374-199812000-00007; Ebrahim SH, 1998, OBSTET GYNECOL, V92, P187, DOI 10.1016/S0029-7844(98)00205-1; Fagt S, 2001, DEV DANISH DIET CONS, P38; Giwercman C, 2010, J ALLERGY CLIN IMMUN, V125, P866, DOI 10.1016/j.jaci.2010.01.026; Gonzalez-Quintela A, 1999, ANN ALLERG ASTHMA IM, V83, P61, DOI 10.1016/S1081-1206(10)63514-4; Halkjaer LB, 2006, ARCH DERMATOL, V142, P561, DOI 10.1001/archderm.142.5.561; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Harris JM, 2001, BRIT J DERMATOL, V144, P795, DOI 10.1046/j.1365-2133.2001.04135.x; Jones CA, 2000, ALLERGY, V55, P2, DOI 10.1034/j.1398-9995.2000.00109.x; Kazbariene Birute, 2007, Central European Journal of Public Health, V15, P13; Kesmodel U, 2002, AM J EPIDEMIOL, V155, P305, DOI 10.1093/aje/155.4.305; Krause TG, 2002, LANCET, V360, P691, DOI 10.1016/S0140-6736(02)09841-0; Kurzius-Spencer M, 2005, PEDIAT ALLERG IMM-UK, V16, P19, DOI 10.1111/j.1399-3038.2005.00233.x; Law M, 2005, BRIT MED J, V330, P1187, DOI 10.1136/bmj.38435.582975.AE; Linneberg A, 2008, CLIN EXP ALLERGY, V38, P145, DOI 10.1111/j.1365-2222.2007.02837.x; Linneberg A, 2004, CLIN EXP ALLERGY, V34, P1678, DOI 10.1111/j.1365-2222.2004.02101.x; Linneberg A, 2003, CLIN EXP ALLERGY, V33, P192, DOI 10.1046/j.1365-2222.2003.01515.x; Macaubas C, 2003, LANCET, V362, P1192, DOI 10.1016/S0140-6736(03)14542-4; Moore MM, 2004, PEDIATRICS, V113, P468, DOI 10.1542/peds.113.3.468; Nihlen U, 2005, RESP MED, V99, P762, DOI 10.1016/j.rmed.2004.11.010; OGSTON S A, 1992, International Journal of Epidemiology, V21, pS45; Olesen AB, 1997, BRIT MED J, V314, P1003, DOI 10.1136/bmj.314.7086.1003; OLSEN J, 1989, SCAND J SOC MED, V17, P277, DOI 10.1177/140349488901700404; Prescott SL, 2003, CURR OPIN ALLERGY CL, V3, P125, DOI 10.1097/01.all.0000064776.57552.32; RUIZ RGG, 1992, CLIN EXP ALLERGY, V22, P762, DOI 10.1111/j.1365-2222.1992.tb02816.x; Schultz LF, 1992, ACTA DERM-VENEREOL, V176, P7; Schultz LF, 1996, J AM ACAD DERMATOL 1, V34, P760; Vally H, 2000, J ALLERGY CLIN IMMUN, V105, P462, DOI 10.1067/mai.2000.104548; Vally H, 2003, ADDICT BIOL, V8, P3, DOI 10.1080/1355621031000069828; Vally H, 2003, CLIN EXP ALLERGY, V33, P156, DOI 10.1046/j.1365-2222.2003.01604.x; von Hertzen LC, 2004, ALLERGY, V59, P124, DOI 10.1046/j.1398-9995.2003.00433.x; Wadonda-Kabondo N, 2004, ARCH DIS CHILD, V89, P917, DOI 10.1136/adc.2003.034033; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P397, DOI 10.1111/j.1365-2133.1994.tb08531.x; Xu B, 1999, ALLERGY, V54, P829, DOI 10.1034/j.1398-9995.1999.00117.x	46	20	21	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42710	10.1371/journal.pone.0042710	http://dx.doi.org/10.1371/journal.pone.0042710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916148	Green Published, gold, Green Submitted			2022-12-25	WOS:000307823600023
J	Lee, HJ; Yang, YM; Kim, K; Shin, DM; Yoon, JH; Cho, HJ; Choi, JY				Lee, Hyun Jae; Yang, Yu-Mi; Kim, Kyubo; Shin, Dong Min; Yoon, Joo-Heon; Cho, Hyung-Ju; Choi, Jae Young			Protease-Activated Receptor 2 Mediates Mucus Secretion in the Airway Submucosal Gland	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; RESPIRATORY EPITHELIAL-CELLS; ION-TRANSPORT; CYSTIC-FIBROSIS; PAR-2; CFTR; EXPRESSION	Protease-activated receptor 2 (PAR2), a G protein-coupled receptor expressed in airway epithelia and smooth muscle, plays an important role in airway inflammation. In this study, we demonstrated that activation of PAR2 induces mucus secretion from the human airway gland and examined the underlying mechanism using the porcine and murine airway glands. The mucosa with underlying submucosal glands were dissected from the cartilage of tissues, pinned with the mucosal side up at the gas/bath solution interface of a physiological chamber, and covered with oil so that secretions from individual glands could be visualized as spherical bubbles in the oil. Secretion rates were determined by optical monitoring of the bubble diameter. The Ca2+-sensitive dye Fura2-AM was used to determine intracellular Ca2+ concentration ([Ca2+](i)) by means of spectrofluorometry. Stimulation of human tracheal mucosa with PAR2-activating peptide (PAR2-AP) elevated intracellular Ca2+ and induced glandular secretion equal to approximately 30% of the carbachol response in the human airway. Porcine gland tissue was more sensitive to PAR2-AP, and this response was dependent on Ca2+ and anion secretion. When the mouse trachea were exposed to PAR2-AP, large amounts of secretion were observed in both wild type and Delta F508 cystic fibrosis transmembrane conductance regulator mutant mice but there is no secretion from PAR-2 knock out mice. In conclusion, PAR2-AP is an agonist for mucus secretion from the airway gland that is Ca2+-dependent and cystic fibrosis transmembrane conductance regulator-independent.	[Lee, Hyun Jae; Yoon, Joo-Heon; Choi, Jae Young] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea; [Yoon, Joo-Heon; Cho, Hyung-Ju; Choi, Jae Young] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Yoon, Joo-Heon; Choi, Jae Young] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul, South Korea; [Lee, Hyun Jae; Yoon, Joo-Heon] Yonsei Univ, Coll Med, Res Ctr Human Nat Def Syst, Seoul, South Korea; [Yang, Yu-Mi; Shin, Dong Min] Yonsei Univ, Coll Dent, Dept Oral Biol, Oral Sci Res Ctr,Brain Korea Project 21, Seoul 120749, South Korea; [Kim, Kyubo] Hallym Univ, Coll Med, Dept Otorhinolaryngol, Kang Dong Sacred Heart Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hallym University	Lee, HJ (corresponding author), Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea.	jychoi@yuhs.ac	Lee, Hyun Jae/AAV-6015-2021; Yoon, Joo-Heon/E-5781-2016	Yoon, Joo-Heon/0000-0003-2404-7156; Cho, Hyung-Ju/0000-0002-2851-3225; Shin, Dong Min/0000-0001-6042-0435; choi, jae young/0000-0001-9493-3458	Ministry of Health & Welfare, Republic of Korea [A110096]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea (A110096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Cho HJ, 2011, J ALLERGY CLIN IMMUN; Cho HJ, 2010, J CELL BIOCHEM, V109, P1254, DOI 10.1002/jcb.22511; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; Choi JY, 2009, J CLIN INVEST, V119, P1189, DOI 10.1172/JCI37284; Chokki M, 2004, AM J RESP CELL MOL, V30, P470, DOI 10.1165/rcmb.2003-0199OC; Cocks TM, 2001, PULM PHARMACOL THER, V14, P183, DOI 10.1006/pupt.2001.0285; Cocks TM, 1999, NATURE, V398, P156, DOI 10.1038/18223; Danahay H, 2001, AM J PHYSIOL-CELL PH, V280, pC1455, DOI 10.1152/ajpcell.2001.280.6.C1455; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; HAWS C, 1994, AM J PHYSIOL, V266, pL502, DOI 10.1152/ajplung.1994.266.5.L502; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Joo NS, 2004, J BIOL CHEM, V279, P38854, DOI 10.1074/jbc.M407077200; Joo NS, 2002, J BIOL CHEM, V277, P50710, DOI 10.1074/jbc.M208826200; Joo NS, 2001, AM J PHYSIOL-LUNG C, V281, pL458, DOI 10.1152/ajplung.2001.281.2.L458; Knight DA, 2001, J ALLERGY CLIN IMMUN, V108, P797, DOI 10.1067/mai.2001.119025; Kunzelmann K, 2005, FASEB J, V19, P969, DOI 10.1096/fj.04-2469fje; Lin KW, 2008, INT J BIOCHEM CELL B, V40, P1379, DOI 10.1016/j.biocel.2007.10.031; Miotto D, 2002, THORAX, V57, P146, DOI 10.1136/thorax.57.2.146; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Palmer ML, 2006, AM J PHYSIOL-CELL PH, V290, pC1189, DOI 10.1152/ajpcell.00464.2005; Sato S, 2005, BRIT J PHARMACOL, V146, P397, DOI 10.1038/sj.bjp.0706330; Shpacovitch V, 2008, J LEUKOCYTE BIOL, V83, P1309, DOI 10.1189/jlb.0108001; Widdicombe JH, 2002, J ANAT, V201, P313, DOI 10.1046/j.1469-7580.2002.00098.x; Wine JJ, 2007, AUTON NEUROSCI-BASIC, V133, P35, DOI 10.1016/j.autneu.2007.01.008; Yasuoka S, 1997, AM J RESP CELL MOL, V16, P300, DOI 10.1165/ajrcmb.16.3.9070615	27	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43188	10.1371/journal.pone.0043188	http://dx.doi.org/10.1371/journal.pone.0043188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916223	Green Submitted, gold, Green Published			2022-12-25	WOS:000307823600055
J	Li, X; Wang, W; Gao, Q; Wu, LJ; Luo, YX; Tang, Z; Guo, XH				Li, Xia; Wang, Wei; Gao, Qi; Wu, Lijuan; Luo, Yanxia; Tang, Zhe; Guo, Xiuhua			The Trajectories and Correlation between Physical Limitation and Depression in Elderly Residents of Beijing, 1992-2009	PLOS ONE			English	Article							FUNCTIONAL DISABILITY; LATE-LIFE; DEVELOPMENTAL TRAJECTORIES; MENTAL-DISORDERS; SAS PROCEDURE; OLDER-PEOPLE; HEALTH-CARE; SYMPTOMS; PREVALENCE; CHINESE	Background: Physical limitation and psychological distress have been reported to be related, but studies describing the change of instrumental activities of daily living (IADLs) and depression syndrome over time or exploring the link pattern for their development are limited. The study was to assess distinctive patterns for the development of physical limitation and depression and to explore their correlation to form a proper prevention strategy. Methods: Dual trajectory analysis was conducted using data from the Beijing Longitudinal Study of Aging (BLSA) 1992-2009 hosted by Xuanwu hospital for subjects with full information on depression and physical limitation for all available visits. Physical limitation was measured by the Instrumental Activities of Daily Living (IADL) scale and depression by the Center for Epidemiological Studies Depression scale (CES-D). The covariates were gender, age at baseline and number of chronic conditions. Results: Three heterogeneous trajectories for physical limitation and two distinct groups for an increase in depression were detected. Among them, 10.13% of subjects experienced an increase in physical limitation, while 13.22% demonstrated a high, stable level of depressive mood. In all, 80.4% of the subjects enjoyed a relatively low, stable level of IADL and CES-D scores. People in the late increase group for IADL score were more likely to have depressive mood when adjusted for gender, age and number of chronic conditions (OR = 3.900, 95%CI = 1.347-11.290). Conclusions: The development of physical limitation among the elderly may significantly increase the risk for depressive symptoms.	[Li, Xia; Wang, Wei; Gao, Qi; Wu, Lijuan; Luo, Yanxia; Guo, Xiuhua] Capital Med Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Li, Xia; Wang, Wei; Gao, Qi; Wu, Lijuan; Luo, Yanxia; Guo, Xiuhua] Beijing Key Lab Clin Epidemiol, Beijing, Peoples R China; [Tang, Zhe] Capital Med Univ, Xuanwu Hosp, Dept Epidemiol & Social Med, Beijing, Peoples R China; [Tang, Zhe] Beijing Geriatr Clin & Res Ctr, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Li, X (corresponding author), Capital Med Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth & Family Med, Beijing, Peoples R China.	tangzhe@medmail.com.cn; guoxiuh@ccmu.edu.cn	liu, li/HGC-0900-2022; Gao, Qi/N-8721-2019	wang, wei/0000-0002-1430-1360	Funding Project for Beijing Municipal Natural Science Foundation [7122016]; Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality [PHR201007112]; National S&T Major Special Project on Major New Drug Innovation [2010ZX09401]; Basic and Clinical Scientific Research Cooperation Foundation [11JL19]	Funding Project for Beijing Municipal Natural Science Foundation; Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality; National S&T Major Special Project on Major New Drug Innovation; Basic and Clinical Scientific Research Cooperation Foundation	The research was supported by the Funding Project for Beijing Municipal Natural Science Foundation (7122016); Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (PHR201007112); National S&T Major Special Project on Major New Drug Innovation (2010ZX09401) and the Basic and Clinical Scientific Research Cooperation Foundation (11JL19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT SM, 2004, PUBLIC HLTH AGING IN; Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Braam AW, 2005, BRIT J PSYCHIAT, V187, P35, DOI 10.1192/bjp.187.1.35; Chemerinski E, 2001, STROKE, V32, P113, DOI 10.1161/01.STR.32.1.113; Chiu HC, 2005, INT J GERIATR PSYCH, V20, P635, DOI 10.1002/gps.1292; Chou KL, 2005, INT J GERIATR PSYCH, V20, P570, DOI 10.1002/gps.1328; Chou KL, 2005, INT J GERIATR PSYCH, V20, P41, DOI 10.1002/gps.1246; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Gao SJ, 2009, INT J GERIATR PSYCH, V24, P1358, DOI 10.1002/gps.2271; Gayman MD, 2008, J GERONTOL B-PSYCHOL, V63, pS219, DOI 10.1093/geronb/63.4.S219; HAYS RD, 1995, ARCH GEN PSYCHIAT, V52, P11; Himes CL, 2000, DEMOGRAPHY, V37, P73, DOI 10.2307/2648097; Huang JF, 2011, J AFFECT DISORDERS, V133, P499, DOI 10.1016/j.jad.2011.04.048; Jefferson AL, 2008, AM J GERIAT PSYCHIAT, V16, P375, DOI 10.1097/JGP.0b013e318162f197; Jiang Jingmei, 2002, Environ Health Prev Med, V7, P199, DOI 10.1007/BF02898005; Jiang JM, 2004, QUAL LIFE RES, V13, P1337, DOI 10.1023/B:QURE.0000037500.26166.0c; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Kessler RC, 2001, HEALTH SERV RES, V36, P987; Lenze EJ, 2005, J AM GERIATR SOC, V53, P569, DOI 10.1111/j.1532-5415.2005.53202.x; Liang J, 2001, J CLIN EPIDEMIOL, V54, P1126, DOI 10.1016/S0895-4356(01)00390-0; Mayo NE, 2009, STROKE, V40, P3299, DOI 10.1161/STROKEAHA.109.554410; Mayou RA, 2000, PSYCHOSOM MED, V62, P212, DOI 10.1097/00006842-200003000-00011; Mora PA, 2009, AM J EPIDEMIOL, V169, P24, DOI 10.1093/aje/kwn283; Mustillo S, 2003, PEDIATRICS, V111, P851, DOI 10.1542/peds.111.4.851; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Narrow WE, 2002, ARCH GEN PSYCHIAT, V59, P115, DOI 10.1001/archpsyc.59.2.115; Ormel J, 2002, J GERONTOL B-PSYCHOL, V57, pP338, DOI 10.1093/geronb/57.4.P338; Peters R, 2010, AGE AGEING, V39, P439, DOI 10.1093/ageing/afq042; Peytremann-Bridevaux I, 2008, J AFFECT DISORDERS, V105, P247, DOI 10.1016/j.jad.2007.04.011; Smalbrugge M, 2006, INT J GERIATR PSYCH, V21, P325, DOI 10.1002/gps.1466; Tang Z, 1999, ARCH GERONTOL GERIAT, V29, P115, DOI 10.1016/S0167-4943(99)00026-6; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; WOO J, 1994, ACTA PSYCHIAT SCAND, V89, P8, DOI 10.1111/j.1600-0447.1994.tb01478.x; Wu X., 2009, POPUL RES, V33, P54; Yang Y, 2005, J AGING HEALTH, V17, P263, DOI 10.1177/0898264305276295; Yang Y, 2006, J HEALTH SOC BEHAV, V47, P355, DOI 10.1177/002214650604700404; Zimmer Z, 2004, J AGING HEALTH, V16, P44, DOI 10.1177/0898264303260440; Zimmer Z, 2002, POP STUD-J DEMOG, V56, P265, DOI 10.1080/00324720215931	41	13	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42999	10.1371/journal.pone.0042999	http://dx.doi.org/10.1371/journal.pone.0042999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AG	22916193	Green Published, Green Submitted, gold			2022-12-25	WOS:000307823600038
J	Bardai, A; Lamberts, RJ; Blom, MT; Spanjaart, AM; Berdowski, J; van der Staal, SR; Brouwer, HJ; Koster, RW; Sander, JW; Thijs, RD; Tan, HL				Bardai, Abdennasser; Lamberts, Robert J.; Blom, Marieke T.; Spanjaart, Anne M.; Berdowski, Jocelyn; van der Staal, Sebastiaan R.; Brouwer, Henk J.; Koster, Rudolph W.; Sander, Josemir W.; Thijs, Roland D.; Tan, Hanno L.			Epilepsy Is a Risk Factor for Sudden Cardiac Arrest in the General Population	PLOS ONE			English	Article							NEURONAL SODIUM-CHANNEL; HEART-RATE-VARIABILITY; UNEXPECTED DEATH; FEBRILE SEIZURES; POTENTIAL ROLE; QT; REPOLARIZATION; MUTATIONS; INSIGHTS; LONG	Background: People with epilepsy are at increased risk for sudden death. The most prevalent cause of sudden death in the general population is sudden cardiac arrest (SCA) due to ventricular fibrillation (VF). SCA may contribute to the increased incidence of sudden death in people with epilepsy. We assessed whether the risk for SCA is increased in epilepsy by determining the risk for SCA among people with active epilepsy in a community-based study. Methods and Results: This investigation was part of the Amsterdam Resuscitation Studies (ARREST) in the Netherlands. It was designed to assess SCA risk in the general population. All SCA cases in the study area were identified and matched to controls (by age, sex, and SCA date). A diagnosis of active epilepsy was ascertained in all cases and controls. Relative risk for SCA was estimated by calculating the adjusted odds ratios using conditional logistic regression (adjustment was made for known risk factors for SCA). We identified 1019 cases of SCA with ECG-documented VF, and matched them to 2834 controls. There were 12 people with active epilepsy among cases and 12 among controls. Epilepsy was associated with a three-fold increased risk for SCA (adjusted OR 2.9 [95% CI 1.1-8.0.], p = 0.034). The risk for SCA in epilepsy was particularly increased in young and females. Conclusion: Epilepsy in the general population seems to be associated with an increased risk for SCA.	[Bardai, Abdennasser; Blom, Marieke T.; Spanjaart, Anne M.; van der Staal, Sebastiaan R.; Tan, Hanno L.] Univ Amsterdam, Heart Failure Res Ctr, Amsterdam, Netherlands; [Bardai, Abdennasser] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Lamberts, Robert J.; Sander, Josemir W.; Thijs, Roland D.] Netherlands Fdn, SEIN Epilepsy Inst, Heemstede, Netherlands; [Berdowski, Jocelyn; Koster, Rudolph W.; Tan, Hanno L.] Univ Amsterdam, Dept Cardiol, Amsterdam, Netherlands; [Brouwer, Henk J.] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Thijs, Roland D.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Sander, Josemir W.; Thijs, Roland D.] Univ Coll London Inst Neurol, Dept Clin & Expt Epilepsy, London, England	University of Amsterdam; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London	Bardai, A (corresponding author), Univ Amsterdam, Heart Failure Res Ctr, Amsterdam, Netherlands.	h.l.tan@amc.nl	Sander, Josemir W/C-1576-2008; , Bardai/AAL-2340-2020; Thijs, Roland D/AGE-5180-2022	Sander, Josemir W/0000-0001-6041-9661; Thijs, Roland D/0000-0003-1435-8970; Blom, Marieke Tabo/0000-0002-8088-1105	Netherlands Organization for Scientific Research (NWO) [ZonMW Vici 918.86.616, Mozaiek 017.003.084]; Dutch Medicines Evaluation Board (MEB/CBG); National Epilepsy Foundation Netherlands; Physio Control; Netherlands Heart Foundation [2006B179]; National Institutes of Health (National Board of Industrial Health/National Institute of Neurological Disorders and Stroke) [-1P20NS076965-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P20NS076965] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Medicines Evaluation Board (MEB/CBG); National Epilepsy Foundation Netherlands; Physio Control; Netherlands Heart Foundation(Netherlands Heart Foundation); National Institutes of Health (National Board of Industrial Health/National Institute of Neurological Disorders and Stroke); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	HLT was supported by the Netherlands Organization for Scientific Research (NWO, grant ZonMW Vici 918.86.616), the Dutch Medicines Evaluation Board (MEB/CBG), and the National Epilepsy Foundation Netherlands. The Arrest data collection was supported by an unconditional grant from Physio Control and a grant from the Netherlands Heart Foundation (grant 2006B179). AB was supported by the Netherlands Organization for Scientific Research (NWO, grant Mozaiek 017.003.084). RDT and JWS are part of the Prevention and Risk Identification of SUDEP Mortatlity Consortium which is funded by the National Institutes of Health (National Board of Industrial Health/National Institute of Neurological Disorders and Stroke -1P20NS076965-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AS, 2010, HEART RHYTHM, V7, P117, DOI 10.1016/j.hrthm.2009.08.005; [Anonymous], 1989, NEW ENGL J MED, V321, P406; [Anonymous], RICHTL DIAGN BEH; Arking DE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002158; Aurlien D, 2009, SEIZURE-EUR J EPILEP, V18, P158, DOI 10.1016/j.seizure.2008.07.008; Bardai A, 2011, J AM COLL CARDIOL, V57, P1822, DOI 10.1016/j.jacc.2010.11.054; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Bezzina CR, 2010, NAT GENET, V42, P688, DOI 10.1038/ng.623; Brotherstone R, 2010, EPILEPSIA, V51, P221, DOI 10.1111/j.1528-1167.2009.02281.x; Druschky A, 2001, BRAIN, V124, P2372, DOI 10.1093/brain/124.12.2372; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Ficker DM, 1998, NEUROLOGY, V51, P1270, DOI 10.1212/WNL.51.5.1270; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Goldman AM, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000289; Hesdorffer DC, 2012, EPILEPSIA, V53, P249, DOI 10.1111/j.1528-1167.2011.03354.x; Hindocha N, 2008, EPILEPSIA, V49, P360, DOI 10.1111/j.1528-1167.2007.01439_2.x; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Johnson JN, 2009, NEUROLOGY, V72, P224, DOI 10.1212/01.wnl.0000335760.02995.ca; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Lhatoo SD, 2001, ANN NEUROL, V49, P336; Maier SKG, 2002, P NATL ACAD SCI USA, V99, P4073, DOI 10.1073/pnas.261705699; Makikallio TH, 2001, J AM COLL CARDIOL, V37, P1395, DOI 10.1016/S0735-1097(01)01171-8; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; Nashef L, 1997, EPILEPSIA, V38, pS6, DOI 10.1111/j.1528-1157.1997.tb06130.x; Nashef L, 2012, EPILEPSIA, V53, P227, DOI 10.1111/j.1528-1167.2011.03358.x; Neufeld G, 2009, CARDIOLOGY, V114, P255, DOI 10.1159/000233236; Rees MI, 2010, SEIZURE-EUR J EPILEP, V19, P680, DOI 10.1016/j.seizure.2010.10.029; ROGERS WJ, 1992, NEW ENGL J MED, V327, P227; Ronkainen E, 2005, J NEUROL NEUROSUR PS, V76, P1382, DOI 10.1136/jnnp.2004.053777; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Stein PK, 1999, ANNU REV MED, V50, P249, DOI 10.1146/annurev.med.50.1.249; Stollberger C, 2004, EPILEPSY RES, V59, P51, DOI 10.1016/j.eplepsyres.2004.03.008; Sugawara T, 2001, NEUROLOGY, V57, P703, DOI 10.1212/WNL.57.4.703; Surges R, 2010, EPILEPSIA, V51, P738, DOI 10.1111/j.1528-1167.2010.02571.x; Surges R, 2010, NEUROLOGY, V74, P421, DOI 10.1212/WNL.0b013e3181ccc706; Surges R, 2010, EPILEPSIA, V51, P233, DOI 10.1111/j.1528-1167.2009.02330.x; Surges R, 2009, NAT REV NEUROL, V5, P492, DOI 10.1038/nrneurol.2009.118; Teh HS, 2007, NEUROLOGY ASIA S1, P68; Tomson T, 1998, EPILEPSY RES, V30, P77, DOI 10.1016/S0920-1211(97)00094-6; Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3; van Doormaal FF, 2010, ANN FAM MED, V8, P47, DOI 10.1370/afm.1058; Verkerk AO, 2007, EUROPACE, V9, P571, DOI 10.1093/europace/eum121; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516	46	70	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42749	10.1371/journal.pone.0042749	http://dx.doi.org/10.1371/journal.pone.0042749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916156	Green Submitted, Green Published, gold			2022-12-25	WOS:000307500800021
J	Zhang, XM; Zhao, L; Larson-Rabin, Z; Li, DZ; Guo, ZH				Zhang, Xue-Mei; Zhao, Lei; Larson-Rabin, Zachary; Li, De-Zhu; Guo, Zhen-Hua			De Novo Sequencing and Characterization of the Floral Transcriptome of Dendrocalamus latiflorus (Poaceae: Bambusoideae)	PLOS ONE			English	Article							SBP-BOX GENE; HIGH-SALINITY STRESSES; GENOME-WIDE ANALYSIS; FLOWERING-LOCUS-T; ARABIDOPSIS-THALIANA; DNA-BINDING; FUNCTIONAL-ANALYSIS; LEAF SENESCENCE; ORGAN IDENTITY; ABSCISIC-ACID	Background: Transcriptome sequencing can be used to determine gene sequences and transcript abundance in non-model species, and the advent of next-generation sequencing (NGS) technologies has greatly decreased the cost and time required for this process. Transcriptome data are especially desirable in bamboo species, as certain members constitute an economically and culturally important group of mostly semelparous plants with remarkable flowering features, yet little bamboo genomic research has been performed. Here we present, for the first time, extensive sequence and transcript abundance data for the floral transcriptome of a key bamboo species, Dendrocalamus latiflorus, obtained using the Illumina GAII sequencing platform. Our further goal was to identify patterns of gene expression during bamboo flower development. Results: Approximately 96 million sequencing reads were generated and assembled de novo, yielding 146,395 high quality unigenes with an average length of 461 bp. Of these, 80,418 were identified as putative homologs of annotated sequences in the public protein databases, of which 290 were associated with the floral transition and 47 were related to flower development. Digital abundance analysis identified 26,529 transcripts differentially enriched between two developmental stages, young flower buds and older developing flowers. Unigenes found at each stage were categorized according to their putative functional categories. These sequence and putative function data comprise a resource for future investigation of the floral transition and flower development in bamboo species. Conclusions: Our results present the first broad survey of a bamboo floral transcriptome. Although it will be necessary to validate the functions carried out by these genes, these results represent a starting point for future functional research on D. latiflorus and related species.	[Zhang, Xue-Mei; Zhao, Lei; Larson-Rabin, Zachary; Li, De-Zhu; Guo, Zhen-Hua] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Zhang, XM (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Yunnan, Peoples R China.	guozhenhua@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Zhao, Lei/0000-0002-2253-5319	Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-YW-N-067]; National Natural Science Foundation of China [30990244]; NSFC-Yunnan province joint foundation [U1136603]; Young Academic and Technical Leader Raising Foundation of Yunnan Province [2008PY065]; Yunnan Provincial Government; Chinese Academy of Sciences [2010312D11035]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Yunnan province joint foundation; Young Academic and Technical Leader Raising Foundation of Yunnan Province; Yunnan Provincial Government; Chinese Academy of Sciences(Chinese Academy of Sciences); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This project was supported by the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-YW-N-067); the National Natural Science Foundation of China (30990244); NSFC-Yunnan province joint foundation (U1136603); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry and the Young Academic and Technical Leader Raising Foundation of Yunnan Province (No. 2008PY065, awarded to Z-HG); Yunnan Provincial Government through an innovation team program; the Western Light Talent Culture Project of the Chinese Academy of Sciences (No. 2010312D11035, awarded to X-MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Alexandre CM, 2008, J EXP BOT, V59, P1127, DOI 10.1093/jxb/ern070; Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-600; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Bender J, 1998, P NATL ACAD SCI USA, V95, P5655, DOI 10.1073/pnas.95.10.5655; Benjamini Y, 2001, ANN STAT, V29, P1165; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bouveret R, 2006, DEVELOPMENT, V133, P1693, DOI 10.1242/dev.02340; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Bystriakova N, 2004, UNEP WCMC BIODIVERSI, V19; Bystriakova N, 2003, UNEP WCMC BIODIVERSI, V14; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Choi D, 2004, PLANT CELL PHYSIOL, V45, P897, DOI 10.1093/pcp/pch098; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Colasanti J, 2009, PLANT PHYSIOL, V149, P56, DOI 10.1104/pp.108.130500; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; DARLINGTON CD, 1945, CHROMOSOME ATLAS CUL; Dennis Elizabeth S., 2009, Journal of Biology (London), V8, P57, DOI 10.1186/jbiol156; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Dreni L, 2011, PLANT CELL, V23, P2850, DOI 10.1105/tpc.111.087007; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gechev TS, 2004, CELL MOL LIFE SCI, V61, P1185, DOI 10.1007/s00018-004-4067-2; Goetz M, 2007, PLANT PHYSIOL, V145, P351, DOI 10.1104/pp.107.104174; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; HARBERD NP, 1989, GENETICS, V121, P827; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hayama R, 2002, PLANT CELL PHYSIOL, V43, P494, DOI 10.1093/pcp/pcf059; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Hennig L, 2004, PLANT PHYSIOL, V135, P1765, DOI 10.1104/pp.104.043182; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Hilton-Taylor C., 2000, 2000 IUCN RED LIST T; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Hoth S, 2002, J CELL SCI, V115, P4891, DOI 10.1242/jcs.00175; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Huang YW, 2010, TECHNOL CANCER RES T, V9, P139, DOI 10.1177/153303461000900203; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; INBAR, 1999, SOC ISS CONSTR BAMB; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Jeon JS, 2000, PLANT CELL, V12, P871, DOI 10.1105/tpc.12.6.871; Jiao YL, 2003, PLANT PHYSIOL, V133, P1480, DOI 10.1104/pp.103.029439; John I, 1997, PLANT MOL BIOL, V33, P641, DOI 10.1023/A:1005746831643; Judziewicz EJ, 1999, AM BAMBOOS; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang HG, 1998, PLANT MOL BIOL, V38, P1021, DOI 10.1023/A:1006051911291; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kim JH, 2004, P NATL ACAD SCI USA, V101, P13374, DOI 10.1073/pnas.0405450101; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/s004380050046; Lagercrantz U, 2009, J EXP BOT, V60, P2501, DOI 10.1093/jxb/erp139; Li H., 2011, CHINESE B BOT, V46, P74, DOI [10.3724/SP.J.1259.2011.00074, DOI 10.3724/SP.J.1259.2011.00074]; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030987; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XL, 2001, ACTA PHYTOTAXON SIN, V39, P433; Lin EP, 2009, PLANTA, V231, P109, DOI 10.1007/s00425-009-1033-0; Lin JF, 2004, PLANT J, V39, P612, DOI 10.1111/j.1365-313X.2004.02160.x; Lin XC, 2010, GENET MOL RES, V9, P1085, DOI 10.4238/vol9-2gmr804; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028516; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Mane SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-264; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martin C, 2002, PHILOS T ROY SOC B, V357, P809, DOI 10.1098/rstb.2002.1089; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Matsubara K, 2008, PLANT PHYSIOL, V148, P1425, DOI 10.1104/pp.108.125542; McClung CR, 2008, CURR OPIN PLANT BIOL, V11, P514, DOI 10.1016/j.pbi.2008.06.010; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Moreno MA, 1997, GENE DEV, V11, P616, DOI 10.1101/gad.11.5.616; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; NADGAUDA RS, 1990, NATURE, V344, P335, DOI 10.1038/344335a0; Ness RW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-298; Nobuta K, 2010, METHODS MOL BIOL, V592, P89, DOI 10.1007/978-1-60327-005-2_7; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Park SJ, 2008, PLANT J, V56, P1018, DOI 10.1111/j.1365-313X.2008.03667.x; Peng JR, 2009, J INTEGR PLANT BIOL, V51, P1064, DOI 10.1111/j.1744-7909.2009.00881.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pilcher H. R., 2004, NATURE, DOI [10.1038/news040510-2, DOI 10.1038/NEWS040510-2]; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rao NN, 2008, P NATL ACAD SCI USA, V105, P3646, DOI 10.1073/pnas.0709059105; Ren T, 2000, PLANT CELL, V12, P1917, DOI 10.1105/tpc.12.10.1917; Riechmann JL, 1998, BIOL CHEM, V379, P633; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; ROUNSLEY SD, 1995, PLANT CELL, V7, P1259, DOI 10.1105/tpc.7.8.1259; Rouster J, 1997, PLANT J, V11, P513, DOI 10.1046/j.1365-313X.1997.11030513.x; Running MP, 1996, DEVELOPMENT, V122, P1261; Rushton PJ, 1995, PLANT MOL BIOL, V29, P691, DOI 10.1007/BF00041160; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Sanda SL, 1996, PLANT PHYSIOL, V111, P641, DOI 10.1104/pp.111.2.641; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Schmitz RJ, 2007, GENETICS, V176, P1359, DOI 10.1534/genetics.107.070649; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Simon R, 1996, NATURE, V384, P59, DOI 10.1038/384059a0; SINGLETON WR, 1946, J HERED, V37, P61, DOI 10.1093/oxfordjournals.jhered.a105582; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Stone JM, 2005, PLANT J, V41, P744, DOI 10.1111/j.1365-313X.2005.02334.x; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Tan QKG, 2006, PLANT PHYSIOL, V140, P1095, DOI 10.1104/pp.105.070565; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Tian B, 2005, CHINESE SCI BULL, V50, P217, DOI 10.1360/982004-304; Tian B, 2006, DNA SEQUENCE, V17, P143, DOI 10.1080/10425170600699877; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; TZVELEV NN, 1989, BOT REV, V55, P141, DOI 10.1007/BF02858328; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; van der Knaap E, 2000, PLANT PHYSIOL, V122, P695, DOI 10.1104/pp.122.3.695; Vandenabeele S, 2004, PLANT J, V39, P45, DOI 10.1111/j.1365-313X.2004.02105.x; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203; Walter KS, 1998, 1997 IUCN RED LIST T; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Y, 2009, INT J MOL SCI, V10, P116, DOI 10.3390/ijms10010116; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Wellmer F, 2004, PLANT CELL, V16, P1314, DOI 10.1105/tpc.021741; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; WINKLER RG, 1994, PLANTA, V193, P341, DOI 10.1007/BF00201811; Wu CF, 2008, J NEUROGENET, V22, P1, DOI 10.1080/01677060801918016; Wu Man, 2010, Cotton Science, V22, P387; Wu ZY, 2006, FLORAL CHINA POACEAE; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xu H, 2010, BIOTECHNOL LETT, V32, P1961, DOI 10.1007/s10529-010-0362-1; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yamaguchi T, 2006, PLANT CELL, V18, P15, DOI 10.1105/tpc.105.037200; Yang PZ, 1999, PLANT J, V18, P141, DOI 10.1046/j.1365-313X.1999.00437.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zahn LM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r101; Zhang DF, 2008, PLANT SCI, V175, P809, DOI 10.1016/j.plantsci.2008.08.002; Zhang GC, 1985, GUANGDONG FOR SCI TE, V85, P16; ZHANG W, 1990, Forest Research, V3, P250; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463	173	82	98	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42082	10.1371/journal.pone.0042082	http://dx.doi.org/10.1371/journal.pone.0042082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916120	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500800008
J	Schmidt-Strassburger, U; Schips, TG; Maier, HJ; Kloiber, K; Mannella, F; Braunstein, KE; Holzmann, K; Ushmorov, A; Liebau, S; Boeckers, TM; Wirth, T				Schmidt-Strassburger, Uta; Schips, Tobias G.; Maier, Harald J.; Kloiber, Katharina; Mannella, Francesca; Braunstein, Kerstin E.; Holzmann, Karlheinz; Ushmorov, Alexey; Liebau, Stefan; Boeckers, Tobias M.; Wirth, Thomas			Expression of constitutively active FoxO3 in murine forebrain leads to a loss of neural progenitors	FASEB JOURNAL			English	Article						adult neurogenesis; apoptosis; Pik3ip1; stem cell	TRANSCRIPTION FACTORS; CELL; BRAIN; CNS; RESTRICTION; DISRUPTION; ACTIVATION; PATHWAYS; PIK3IP1; MICE	Inactivation of FoxO proteins by phosphorylation is the result of a number of stimuli, including the insulin/IGF pathway. We were interested in the consequence of blunting this pathway by employing transgenic mice with tetracycline-controllable conditional expression of a constitutively active allele of FOXO3 under the control of the forebrain-specific CaMKII alpha promoter. Although transgene-expressing mice were viable, brain weight was reduced by 30% in adult animals. Brains showed an isocortex compression with normal cortical layering, and a size reduction in regions known to depend on adult neurogenesis, i.e., the olfactory bulbs and the dentate gyrus. On postnatal activation of the transgene, adult neurogenesis was also severely affected. Investigating the molecular basis of this phenotype, we observed enhanced apoptosis starting from embryonic day E10.5 and a subsequent loss of progenitors in the ventricular/subventricular zones, but not in the isocortex or the striatum of adult mice. The enhanced apoptosis was accompanied by increased expression of PIK3IP1, which we identified as a direct transcriptional target of FOXO3. Transfection of Pik3ip1 into differentiating neural progenitors resulted in a significant reduction of viable cells. We therefore conclude that neural progenitors are particularly vulnerable to FOXO3-induced apoptosis, which is mediated by PIK3IP1, a negative PI3 kinase regulator.-Schmidt-Strassburger, U., Schips, T. G., Maier, H. J., Kloiber, K., Mannella, F., Braunstein, K. E., Holzmann, K., Ushmorov, A., Liebau, S., Boeckers, T. M., Wirth, T. Expression of constitutively active FoxO3 in murine forebrain leads to a loss of neural progenitors. FASEB J. 26, 4990-5001 (2012). www.fasebj.org	[Schmidt-Strassburger, Uta; Schips, Tobias G.; Maier, Harald J.; Kloiber, Katharina; Mannella, Francesca; Ushmorov, Alexey; Wirth, Thomas] Univ Ulm, Inst Physiol Chem, D-89081 Ulm, Germany; [Braunstein, Kerstin E.] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany; [Holzmann, Karlheinz] Univ Ulm, Chip Facil, IZKF, D-89081 Ulm, Germany; [Liebau, Stefan; Boeckers, Tobias M.] Univ Ulm, Inst Anat & Cell Biol, D-89081 Ulm, Germany	Ulm University; Ulm University; Ulm University; Ulm University	Wirth, T (corresponding author), Univ Ulm, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany.	thomas.wirth@uni-ulm.de	Wirth, Thomas/X-7172-2019; Liebau, Stefan/C-3374-2015; Ushmorov, Alexey/AAI-6445-2020	Liebau, Stefan/0000-0003-0721-8187; Ushmorov, Alexey/0000-0003-3724-7253; Schmidt-Strassburger, Uta/0000-0003-1777-3010	Deutsche Forschungsgemeinschaft, Klinische Forschergruppe 142 [WI-789/3-2]; Rudolf und Clothilde Eberhardt-Stiftung;  [L.SBN.0039]	Deutsche Forschungsgemeinschaft, Klinische Forschergruppe 142; Rudolf und Clothilde Eberhardt-Stiftung; 	The authors are particularly indebted to Nina Ushmorova for her excellent help with all experiments. Also, the authors thank Lucia Flossbach for her help in the initial in vivo analyses, Renate Zienecker and Melanie Gerstenlauer for their excellent histology work, Karin Lanz for the microarray hybridizations, and Katja Fiedler for her help with the FACS analyses. The authors are equally indebted to the animal caretakers Nikolai Derksen and Ralf Bocksrocker. The Bcl11b antibody was a kind gift from Stefan Britsch (Ulm University). The CaMKIIa-tTA; tetO-Cre mice were kindly provided by Ruth Simon (Ulm University), and the Z/AP mice and staining procedures were kindly provided by Martin Wagner, Melanie Guthle, and Ursula Mohnle (Ulm University). This project was supported by the Deutsche Forschungsgemeinschaft (grant WI-789/3-2 to T. W. as part of the Klinische Forschergruppe 142) and an intramural grant (Baustein grant L.SBN.0039 to U. S. S). The Microm HM355S microtome was funded by a grant from the Rudolf und Clothilde Eberhardt-Stiftung to H.J.M.	ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Bakker WJ, 2004, J CELL BIOL, V164, P175, DOI 10.1083/jcb.200307056; BAYER SA, 1990, EXP NEUROL, V107, P48, DOI 10.1016/0014-4886(90)90062-W; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; He X, 2008, CANCER RES, V68, P5591, DOI 10.1158/0008-5472.CAN-08-0025; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Katayama K, 2008, ONCOGENE, V27, P1677, DOI 10.1038/sj.onc.1210813; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Polter A, 2009, BIOL PSYCHIAT, V65, P150, DOI 10.1016/j.biopsych.2008.08.005; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Schips TG, 2011, CARDIOVASC RES, V91, P587, DOI 10.1093/cvr/cvr144; Schuff M, 2010, DEV BIOL, V337, P259, DOI 10.1016/j.ydbio.2009.10.036; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Vue TY, 2007, J COMP NEUROL, V505, P73, DOI 10.1002/cne.21467; Xie LK, 2012, BLOOD, V119, P3503, DOI 10.1182/blood-2011-09-381905; Zheng JY, 2005, AGING CELL, V4, P209, DOI 10.1111/j.1474-9726.2005.00159.x; Zhu ZQ, 2007, BIOCHEM BIOPH RES CO, V358, P66, DOI 10.1016/j.bbrc.2007.04.096	46	24	24	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					4990	5001		10.1096/fj.12-208587	http://dx.doi.org/10.1096/fj.12-208587			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22935140				2022-12-25	WOS:000311838300021
J	Janda, A; Eryilmaz, E; Nakouzi, A; Cowburn, D; Casadevall, A				Janda, Alena; Eryilmaz, Ertan; Nakouzi, Antonio; Cowburn, David; Casadevall, Arturo			Variable Region Identical Immunoglobulins Differing in Isotype Express Different Paratopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYPTOCOCCUS-NEOFORMANS; NMR-SPECTROSCOPY; CONSTANT-REGION; ANTIGEN-BINDING; FINE SPECIFICITY; ANTIBODY; AFFINITY; PEPTIDE; PROTEIN; POLYSACCHARIDE	The finding that the antibody (Ab) constant (C) region can influence fine specificity suggests that isotype switching contributes to the generation of Ab diversity and idiotype restriction. Despite the centrality of this observation for diverse immunological effects such as vaccine responses, isotype-restricted antibody responses, and the origin of primary and secondary responses, the molecular mechanism(s) responsible for this phenomenon are not understood. In this study, we have taken a novel approach to the problem by probing the paratope with N-15 label peptide mimetics followed by NMR spectroscopy and fluorescence emission spectroscopy. Specifically, we have explored the hypothesis that the C region imposes conformational constraints on the variable (V) region to affect paratope structure in a V region identical IgG(1), IgG(2a), IgG(2b), and IgG(3) mAbs. The results reveal isotype-related differences in fluorescence emission spectroscopy and temperature-related differences in binding and cleavage of a peptide mimetic. We conclude that the C region can modify the V region structure to alter the Ab paratope, thus providing an explanation for how isotype can affect Ab specificity.	[Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Dept Med, Bronx, NY 10461 USA; [Eryilmaz, Ertan; Cowburn, David] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Casadevall, A (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	arturo.casadevall@einstein.yu.edu	Cowburn, David/A-8448-2008; Markmann, Alena Janda/AAD-7310-2019	Markmann, Alena Janda/0000-0003-3656-9322; Cowburn, David/0000-0001-6770-7172	National Institutes of Health [2P41RR001081, HL059842, AI033774, AI052733, AI033142]; National Institute of General Medical Sciences Grant [9P41GM103311]; Institutional AIDS Training Grant [T32-AI007501]; NIH MSTP Training Grant [T32-GM007288]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033142, R01AI033774, T32AI007501, R01AI052733, R01AI033142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288, P41GM103311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Institutional AIDS Training Grant; NIH MSTP Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2P41RR001081. This work was also supported by National Institute of General Medical Sciences Grant 9P41GM103311.; Supported by Institutional AIDS Training Grant T32-AI007501 and NIH MSTP Training Grant T32-GM007288.	Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Bianchi E, 2009, ADV EXP MED BIOL, V611, P121, DOI 10.1007/978-0-387-73657-0_54; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Casadevall A, 1998, ANTIMICROB AGENTS CH, V42, P1437, DOI 10.1128/AAC.42.6.1437; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Casadevall A, 2012, P NATL ACAD SCI USA, V109, P12272, DOI 10.1073/pnas.1209750109; Case DA, 2010, AMBER11; COOPER LJN, 1994, MOL IMMUNOL, V31, P577, DOI 10.1016/0161-5890(94)90165-1; COOPER LJN, 1993, J IMMUNOL, V150, P2231; Dadachova E, 2006, J INFECT DIS, V193, P1427, DOI 10.1086/503369; Dam TK, 2008, J BIOL CHEM, V283, P31366, DOI 10.1074/jbc.M806473200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elkon K, 2008, NAT CLIN PRACT RHEUM, V4, P491, DOI 10.1038/ncprheum0895; ERHAN S, 1974, NATURE, V251, P353, DOI 10.1038/251353a0; Eryilmaz E, 2008, J MOL BIOL, V382, P402, DOI 10.1016/j.jmb.2008.07.006; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Gilliland GL, 2012, METHODS MOL BIOL, V841, P321, DOI 10.1007/978-1-61779-520-6_14; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang XL, 1998, J MOL BIOL, V281, P61, DOI 10.1006/jmbi.1998.1930; Janda A, 2010, MOL IMMUNOL, V47, P1421, DOI 10.1016/j.molimm.2010.02.018; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KATO K, 1991, BIOCHEMISTRY-US, V30, P6604, DOI 10.1021/bi00240a033; Lange H, 1996, EUR J IMMUNOL, V26, P2234, DOI 10.1002/eji.1830260940; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McFadden DC, 2006, J BIOL CHEM, V281, P1868, DOI 10.1074/jbc.M509465200; McLean GR, 2002, J IMMUNOL, V169, P1379, DOI 10.4049/jimmunol.169.3.1379; Messina TC, 2007, BIOPHYS J, V93, P579, DOI 10.1529/biophysj.107.103911; MORAHAN G, 1983, NATURE, V301, P720, DOI 10.1038/301720a0; Nicholas MP, 2010, PROG NUCL MAG RES SP, V57, P111, DOI 10.1016/j.pnmrs.2010.04.003; Nimrichter L, 2007, EUKARYOT CELL, V6, P1400, DOI 10.1128/EC.00122-07; Okochi N, 2007, APPL MICROBIOL BIOT, V77, P597, DOI 10.1007/s00253-007-1197-0; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pritsch O, 2000, EUR J IMMUNOL, V30, P3387, DOI 10.1002/1521-4141(2000012)30:12<3387::AID-IMMU3387>3.0.CO;2-K; REITAN SK, 1995, EUR J IMMUNOL, V25, P1601, DOI 10.1002/eji.1830250620; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; SPIRA G, 1992, J IMMUNOL METHODS, V148, P121, DOI 10.1016/0022-1759(92)90165-P; Tanford C, 1997, PROTEIN SCI, V6, P1358, DOI 10.1002/pro.5560060627; Torres M, 2005, J IMMUNOL, V174, P2132, DOI 10.4049/jimmunol.174.4.2132; Torres M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001310; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; TSANG P, 1992, BIOCHEMISTRY-US, V31, P3862, DOI 10.1021/bi00130a018; Tudor D, 2012, P NATL ACAD SCI USA, V109, P12680, DOI 10.1073/pnas.1200024109; Valadon P, 1996, J MOL BIOL, V261, P11, DOI 10.1006/jmbi.1996.0438; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Young ACM, 1997, J MOL BIOL, V274, P622, DOI 10.1006/jmbi.1997.1407; ZILBER B, 1990, BIOCHEMISTRY-US, V29, P10032, DOI 10.1021/bi00495a004	51	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35409	35417		10.1074/jbc.M112.404483	http://dx.doi.org/10.1074/jbc.M112.404483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22930758	Green Published, hybrid			2022-12-25	WOS:000309968000048
J	Cresi, F; Castagno, E; Storm, H; Silvestro, L; Miniero, R; Savino, F				Cresi, Francesco; Castagno, Emanuele; Storm, Hanne; Silvestro, Leandra; Miniero, Roberto; Savino, Francesco			Combined Esophageal Intraluminal Impedance, pH and Skin Conductance Monitoring to Detect Discomfort in GERD Infants	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; NORTH-AMERICAN-SOCIETY; PEDIATRIC-GASTROENTEROLOGY; POSTOPERATIVE PAIN; SYMPTOM ANALYSIS; SKELETAL-MUSCLE; CHILDREN; STIMULATION; RECOMMENDATIONS; DEFINITION	Background: The clinical significance of weakly acidic reflux in infants is unclear. Skin conductance is a novel not-invasive method to evaluate discomfort. The aim of our study was to evaluate reflux-induced discomfort in infants with gastroesophageal reflux disease using simultaneously combined skin conductance and esophageal multichannel intraluminal impedance and pH monitoring. Methodology/Principal Findings: Infants with gastroesophageal reflux symptoms were investigated for almost 20 hours divided into 120-second intervals. Temporal relationships between refluxes and discomfort were evaluated calculating the symptom association probability. Twelve infants aged 17-45 days were studied. Out of 194.38 hours of adequate artifact-free MII/pH and skin conductance monitoring, 584 reflux events were observed; 35.78% were positive for stress, of which 16.27% were acid and 83.73% weakly acidic. A significant association between refluxes and discomfort (p < 0.05) was present in all infants. The intervals with reflux events showed increased skin conductance values compared to reflux-free intervals (p < 0.001); SC values were similar for acid and weakly acidic reflux events. Conclusion/Signficance: Discomfort was significantly associated with reflux events and did not differ between weakly acidic and acid refluxes. Our results may raise concerns about the over-prescription use of antacid drugs in the management of gastroesophageal reflux symptoms in infancy.	[Cresi, Francesco; Silvestro, Leandra; Savino, Francesco] Univ Turin, Dept Pediat, S Anna Regina Margherita Childrens Hosp, I-10124 Turin, Italy; [Castagno, Emanuele] S Anna Regina Margherita Childrens Hosp, Div Pediat Emergency, Turin, Italy; [Storm, Hanne] Univ Oslo, Fac Med, Skill Simulat Lab, Oslo, Norway; [Miniero, Roberto] Magna Graecia Univ Catanzaro, Dept Internal Med & Surg, Catanzaro, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Oslo; Magna Graecia University of Catanzaro	Cresi, F (corresponding author), Univ Turin, Dept Pediat, S Anna Regina Margherita Childrens Hosp, I-10124 Turin, Italy.	francesco.cresi@unito.it	Savino, Francesco/J-6935-2019; Castagno, Emanuele/AAU-2634-2021; cresi, francesco/R-3118-2017	Savino, Francesco/0000-0001-9163-1016; Castagno, Emanuele/0000-0001-7756-5075; SILVESTRO, LEANDRA/0000-0002-5564-1580; Cresi, Francesco/0000-0002-2139-6855	Lions' Club Torino Crimea Italy; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica; University of Turin	Lions' Club Torino Crimea Italy; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR)); University of Turin	This study was supported by a Research Grant from the Lions' Club Torino Crimea Italy, the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica and the University of Turin 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammari M, 2012, J SLEEP RES, V21, P80, DOI 10.1111/j.1365-2869.2011.00915.x; BINI G, 1980, J PHYSIOL-LONDON, V306, P537, DOI 10.1113/jphysiol.1980.sp013413; Blondeau K, 2009, AM J GASTROENTEROL, V104, P2664, DOI 10.1038/ajg.2009.568; Drug and Therapeutics Bulletin, 2010, BMJ, V341, pc4420, DOI 10.1136/bmj.c4420; Gjerstad AC, 2008, PEDIATRICS, V122, pE848, DOI 10.1542/peds.2007-2545; HABLER HJ, 1993, J NEUROPHYSIOL, V70, P920, DOI 10.1152/jn.1993.70.3.920; Ham J, 2008, DEV PSYCHOBIOL, V50, P626, DOI 10.1002/dev.20317; Hanada A, 2003, J PHYSIOL-LONDON, V551, P635, DOI 10.1113/jphysiol.2003.044024; Harrison D, 2006, EARLY HUM DEV, V82, P603, DOI 10.1016/j.earlhumdev.2005.12.008; Hassall E, 2012, J PEDIATR-US, V160, P193, DOI 10.1016/j.jpeds.2011.08.067; Hellerud BC, 2002, EARLY HUM DEV, V70, P35, DOI 10.1016/S0378-3782(02)00070-1; Hullett B, 2009, ANESTHESIOLOGY, V111, P513, DOI 10.1097/ALN.0b013e3181b27c18; Khoshoo V, 2007, PEDIATRICS, V120, P946, DOI 10.1542/peds.2007-1146; LAM HGT, 1994, DIGEST DIS SCI, V39, P402, DOI 10.1007/BF02090215; Ledowski T, 2006, BRIT J ANAESTH, V97, P862, DOI 10.1093/bja/ael280; Loots CM, 2011, J PEDIATR GASTR NUTR, V53, P120, DOI 10.1097/MPG.0b013e318214c3cc; Macefield VG, 1996, J AUTONOM NERV SYST, V61, P277, DOI 10.1016/S0165-1838(96)00095-1; Munsters J, 2012, EARLY HUM DEV, V88, P21, DOI 10.1016/j.earlhumdev.2011.06.010; Omari TI, 2011, J PEDIATR GASTR NUTR, V52, P408, DOI 10.1097/MPG.0b013e3181f474c7; Pereira-da-Silva L, 2012, J MATERN-FETAL NEO M, V25, P796, DOI 10.3109/14767058.2011.587919; Peter CS, 2004, BIOL NEONATE, V85, P11, DOI 10.1159/000074951; Pilic D, 2011, J PEDIATR-US, V158, P650, DOI 10.1016/j.jpeds.2010.09.033; Riis Povl, 2003, New Rev Bioeth, V1, P15, DOI 10.1080/1740028032000131396; Roeggen I, 2011, EARLY HUM DEV, V87, P37, DOI 10.1016/j.earlhumdev.2010.09.373; Rosen R, 2011, J PEDIATR GASTR NUTR, V52, P404, DOI 10.1097/MPG.0b013e3182078081; Rudolph CD, 2001, J PEDIATR GASTR NUTR, V32, pS1, DOI 10.1097/00005176-200100002-00001; Savino F, 2008, PEDIATRICS, V121, P1070, DOI 10.1542/peds.2008-0179; Sherman PM, 2009, AM J GASTROENTEROL, V104, P1278, DOI 10.1038/ajg.2009.129; Storm H, 2000, ARCH DIS CHILD-FETAL, V83, pF143, DOI 10.1136/fn.83.2.F143; Storm H, 2002, ACTA PAEDIATR, V91, P555, DOI 10.1080/080352502753711687; Storm H, 2001, EARLY HUM DEV, V62, P149, DOI 10.1016/S0378-3782(01)00129-3; Storm H, 2008, CURR OPIN ANESTHESIO, V21, P796, DOI 10.1097/ACO.0b013e3283183fe4; STROBEL CT, 1979, J PEDIATR-US, V94, P81, DOI 10.1016/S0022-3476(79)80361-3; Vakil N, 2010, BEST PRACT RES CL GA, V24, P759, DOI 10.1016/j.bpg.2010.09.009; van der Pol RJ, 2011, PEDIATRICS, V127, P925, DOI 10.1542/peds.2010-2719; Vandenplas Y, 2009, J PEDIATR GASTR NUTR, V49, P498, DOI 10.1097/MPG.0b013e3181b7f563; WALLIN BG, 1975, PFLUG ARCH EUR J PHY, V358, P101, DOI 10.1007/BF00583921; Wenzl TG, 2012, J PEDIATR GASTR NUTR, V55, P230, DOI 10.1097/MPG.0b013e3182592b65; WEUSTEN BLAM, 1994, GASTROENTEROLOGY, V107, P1741, DOI 10.1016/0016-5085(94)90815-X; World Medical Association, 1991, Law Med Health Care, V19, P264	40	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43476	10.1371/journal.pone.0043476	http://dx.doi.org/10.1371/journal.pone.0043476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927972	gold, Green Submitted, Green Published			2022-12-25	WOS:000308224700015
J	Castro-Leyva, V; Espejel-Nunez, A; Barroso, G; Zaga-Clavellina, V; Flores-Pliego, A; Morales-Mendez, I; Giono-Cerezo, S; Walsh, SW; Estrada-Gutierrez, G				Castro-Leyva, Violeta; Espejel-Nunez, Aurora; Barroso, Gerardo; Zaga-Clavellina, Veronica; Flores-Pliego, Arturo; Morales-Mendez, Iyari; Giono-Cerezo, Silvia; Walsh, Scott W.; Estrada-Gutierrez, Guadalupe			Preserved Ex Vivo Inflammatory Status in Decidual Cells from Women with Preterm Labor and Subclinical Intrauterine Infection	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CERVICAL-MUCUS PLUG; MATRIX METALLOPROTEINASES; PROSTAGLANDIN BIOSYNTHESIS; AMNIOTIC-FLUID; BIRTH; PARTURITION; CYTOKINES; MEMBRANES; LIPOPOLYSACCHARIDE	Objective: To compare the inflammatory response preserved ex vivo by decidual cells isolated from women who experienced preterm labor with and without subclinical intrauterine infection. Methods: Fetal membranes were obtained after cesarean section from 35 women who delivered before 37 weeks of gestation following spontaneous preterm labor, with no clinical evidence of intrauterine infection. Decidua was microbiologically tested and cultured. Concentrations of anti-inflammatory cytokines (IL-2, IL-4, IL-10), pro-inflammatory cytokines (IL-6, IL-8, IL-1 beta and TNF-alpha), and matrix metalloproteinases (MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9) were measured in the supernatants using Bio-Plex, and prostaglandin E-2 (PGE(2)) was measured by enzyme immunoassay. Results: Subclinical infection was confirmed in 10 women (28.5%). Microorganisms isolated were Ureaplasma urealyticum (4), group B streptococci (3), Gardnerella vaginalis (1), and Escherichia coli (2). We found a significant increase of proinflammatory cytokines and a significant decrease of anti-inflammatory cytokines in supernatants from decidual cells obtained from women with preterm labor and subclinical intrauterine infection compared to women without infection. Secretion of MMP-1, MMP-8, MMP-9 and PGE(2) was significantly higher in infected women. Secretion of IL-8 by decidual cells from infected women persisted upon repeated in vitro culture passages. Conclusions: Almost 30% of idiopathic preterm labor cases were associated with subclinical intrauterine infection, and decidual cells isolated from these cases preserved an ex vivo inflammatory status after in vivo bacterial exposure.	[Castro-Leyva, Violeta; Morales-Mendez, Iyari; Estrada-Gutierrez, Guadalupe] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Dept Infectol, Mexico City, DF, Mexico; [Castro-Leyva, Violeta; Giono-Cerezo, Silvia] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico; [Espejel-Nunez, Aurora; Flores-Pliego, Arturo] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Dept Biochem & Mol Biol, Mexico City, DF, Mexico; [Barroso, Gerardo] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Div Clin Res, Mexico City, DF, Mexico; [Zaga-Clavellina, Veronica] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Dept Cellular Biol, Mexico City, DF, Mexico; [Walsh, Scott W.] Virginia Commonwealth Univ, Dept Obstet & Gynecol & Physiol & Biophys, Med Ctr, Richmond, VA USA	Instituto Politecnico Nacional - Mexico; Virginia Commonwealth University	Castro-Leyva, V (corresponding author), Inst Nacl Perinatol Isidro Espinosa de los Reyes, Dept Infectol, Mexico City, DF, Mexico.	gpestrad@yahoo.es	Estrada-Gutierrez, Guadalupe/AAM-4642-2021; Zaga-Clavellina, Veronica/ABB-9954-2020; Espejel, Aurora/AAO-6510-2021; Flores-Pliego, Arturo/GPK-6349-2022; Estrada, Guadalupe/AAT-3970-2021	Estrada-Gutierrez, Guadalupe/0000-0001-9551-9021; Zaga-Clavellina, Veronica/0000-0002-3365-2932; Flores-Pliego, Arturo/0000-0001-7876-6098; ESPEJEL NUNEZ, AURORA/0000-0001-9087-8017	Instituto Nacional de Perinatologia IER; CONACyT (Consejo Nacional de Ciencia y Tecnologia)	Instituto Nacional de Perinatologia IER; CONACyT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was funded by the Instituto Nacional de Perinatologia IER. VCL was sponsored by CONACyT (Consejo Nacional de Ciencia y Tecnologia.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arechavaleta-Velasco F, 2002, BIOL REPROD, V67, P1952, DOI 10.1095/biolreprod.102.004721; Becher N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-113; Becher N, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-45; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bowen JM, 2002, PLACENTA, V23, P257, DOI 10.1053/plac.2001.0782; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; DUDLEY DJ, 1992, J CLIN ENDOCR METAB, V75, P1081, DOI 10.1210/jc.75.4.1081; Estrada-Gutierrez G, 2005, MATRIX BIOL, V24, P306, DOI 10.1016/j.matbio.2005.05.001; Estrada-Gutierrez G, 2010, INFECT IMMUN, V78, P4792, DOI 10.1128/IAI.00522-10; Garcia-Lopez G, 2007, MOL HUM REPROD, V13, P409, DOI 10.1093/molehr/gam025; Gardella C, 2004, AM J PERINAT, V21, P319, DOI 10.1055/s-2004-831884; Gibbs R S, 2001, Ann Periodontol, V6, P153, DOI 10.1902/annals.2001.6.1.153; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Gonzalez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026877; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Jalava J, 1996, BRIT J OBSTET GYNAEC, V103, P664, DOI 10.1111/j.1471-0528.1996.tb09835.x; Jeffcoat MK, 2001, J AM DENT ASSOC, V132, P875, DOI 10.14219/jada.archive.2001.0299; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Klein LL, 2005, OBSTET GYN CLIN N AM, V32, P397, DOI 10.1016/j.ogc.2005.03.001; Lockwood CJ, 2006, AM J PATHOL, V169, P1294, DOI 10.2353/ajpath.2006.060185; Maymon E, 2000, AM J OBSTET GYNECOL, V183, P94, DOI 10.1067/mob.2000.105344; MITCHELL MD, 1990, PROSTAG LEUKOTR ESS, V41, P35, DOI 10.1016/0952-3278(90)90128-8; MITCHELL MD, 1993, PLACENTA, V14, P615, DOI 10.1016/S0143-4004(05)80379-0; MITCHELL MD, 1993, PLACENTA, V14, P249, DOI 10.1016/S0143-4004(05)80426-6; *NAT AC I MED, 2006, PRET BIRTH CAUS CONS; Peltier Morgan R, 2003, Reprod Biol Endocrinol, V1, P122; Riggs MA, 2004, CLIN OBSTET GYNECOL, V47, P796, DOI 10.1097/01.grf.0000141450.61310.81; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; SO T, 1992, BIOL REPROD, V46, P772, DOI 10.1095/biolreprod46.5.772; Vadillo-Ortega F, 2005, BJOG-INT J OBSTET GY, V112, P19, DOI 10.1111/j.1471-0528.2005.00579.x	31	13	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43605	10.1371/journal.pone.0043605	http://dx.doi.org/10.1371/journal.pone.0043605			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928002	gold, Green Published			2022-12-25	WOS:000308286300072
J	Sun, JG; Yeung, CA; Co, NN; Tsang, TY; Yau, E; Luo, KW; Wu, P; Wa, JCY; Fung, KP; Kwok, TT; Liu, FY				Sun, Jianguo; Yeung, Chilam Au; Co, Ngai Na; Tsang, Tsun Yee; Yau, Esmond; Luo, Kewang; Wu, Ping; Wa, Judy Chan Yuet; Fung, Kwok-Pui; Kwok, Tim-Tak; Liu, Feiyan			Clitocine Reversal of P-Glycoprotein Associated Multi-Drug Resistance through Down-Regulation of Transcription Factor NF-kappa B in R-HepG2 Cell Line	PLOS ONE			English	Article							MDR1 GENE-EXPRESSION; BREAST-CANCER CELLS; ANTICANCER DRUGS; AMINO NUCLEOSIDE; PROMOTER REGION; HEAT-SHOCK; INHIBITION; INDUCTION; APOPTOSIS; BINDING	Multidrug resistance(MDR) is one of the major reasons for failure in cancer chemotherapy and its suppression may increase the efficacy of therapy. The human multidrug resistance 1 (MDR1) gene encodes the plasma membrane P-glycoprotein (P-gp) that pumps various anti-cancer agents out of the cancer cell. R-HepG2 and MES-SA/Dx5 cells are doxorubicin induced P-gp over-expressed MDR sublines of human hepatocellular carcinoma HepG2 cells and human uterine carcinoma MES-SA cells respectively. Herein, we observed that clitocine, a natural compound extracted from Leucopaxillus giganteus, presented similar cytotoxicity in multidrug resistant cell lines compared with their parental cell lines and significantly suppressed the expression of P-gp in R-HepG2 and MES-SA/Dx5 cells. Further study showed that the clitocine increased the sensitivity and intracellular accumulation of doxorubicin in R-HepG2 cells accompanying down-regulated MDR1 mRNA level and promoter activity, indicating the reversal effect of MDR by clitocine. A 5'-serial truncation analysis of the MDR1 promoter defined a region from position -450 to -193 to be critical for clitocine suppression of MDR1. Mutation of a consensus NF-kappa B binding site in the defined region and overexpression of NF-kappa B p65 could offset the suppression effect of clitocine on MDR1 promoter. By immunohistochemistry, clitocine was confirmed to suppress the protein levels of both P-gp and NF-kappa B p65 in R-HepG2 cells and tumors. Clitocine also inhibited the expression of NF-kappa B p65 in MES-SA/Dx5. More importantly, clitocine could suppress the NF-kappa B activation even in presence of doxorubicin. Taken together; our results suggested that clitocine could reverse P-gp associated MDR via down-regulation of NF-kappa B.	[Sun, Jianguo; Luo, Kewang; Wu, Ping; Liu, Feiyan] Zhejiang Univ, Res Ctr Siyuan Nat Pharm & Biotoxicol, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Jianguo; Yeung, Chilam Au; Co, Ngai Na; Tsang, Tsun Yee; Yau, Esmond; Luo, Kewang; Wu, Ping; Wa, Judy Chan Yuet; Fung, Kwok-Pui; Kwok, Tim-Tak; Liu, Feiyan] Zhejiang Univ, Joint Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Jianguo; Yeung, Chilam Au; Co, Ngai Na; Tsang, Tsun Yee; Yau, Esmond; Luo, Kewang; Wu, Ping; Wa, Judy Chan Yuet; Fung, Kwok-Pui; Kwok, Tim-Tak; Liu, Feiyan] Chinese Univ Hong Kong Nat Prod & Toxicol Res, Hangzhou, Zhejiang, Peoples R China; [Yeung, Chilam Au; Co, Ngai Na; Tsang, Tsun Yee; Yau, Esmond; Wa, Judy Chan Yuet; Fung, Kwok-Pui; Kwok, Tim-Tak] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Zhejiang University; Zhejiang University; Chinese University of Hong Kong; Chinese University of Hong Kong	Sun, JG (corresponding author), Zhejiang Univ, Res Ctr Siyuan Nat Pharm & Biotoxicol, Coll Life Sci, Zijinggang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	tkwok2020@yahoo.com.hk; liuf64@zju.edu.cn	Fung, Kwok Pui/R-9708-2018	Fung, Kwok Pui/0000-0001-6214-5123; Chan, Judy/0000-0003-0423-5950	Nature Science Foundation of Zhejiang Province [LY12C02001]; Siyuan Foundation	Nature Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Siyuan Foundation	Grant support from the Nature Science Foundation of Zhejiang Province (LY12C02001 to FL) and Siyuan Foundation (to FL and TTK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Aydin C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-584; Bauer JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001313; Bentires-Alj M, 2003, ONCOGENE, V22, P90, DOI 10.1038/sj.onc.1206056; Bentires-Alj M, 1999, CANCER RES, V59, P811; Bosch I, 1996, BBA-REV CANCER, V1288, pF37, DOI 10.1016/0304-419X(96)00022-4; CHIN KV, 1990, J BIOL CHEM, V265, P221; CHIN KV, 1992, SCIENCE, V255, P459, DOI 10.1126/science.1346476; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chu ZL, 1999, J BIOL CHEM, V274, P15297, DOI 10.1074/jbc.274.22.15297; Chung SY, 2005, ARCH PHARM RES, V28, P823, DOI 10.1007/BF02977349; CORNWELL MM, 1993, J BIOL CHEM, V268, P19505; David GL, 2004, CANCER BIOL THER, V3, P540, DOI 10.4161/cbt.3.6.845; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fine RL, 1996, STEM CELLS, V14, P47, DOI 10.1002/stem.140047; Fortin H, 2006, CHEMMEDCHEM, V1, P189, DOI 10.1002/cmdc.200500029; Fujita T, 2005, CLIN CANCER RES, V11, P8837, DOI 10.1158/1078-0432.CCR-05-0945; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Hennessy M, 2007, PHARMACOL RES, V55, P1, DOI 10.1016/j.phrs.2006.10.007; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kim SN, 2009, MOL CANCER RES, V7, P735, DOI 10.1158/1541-7786.MCR-08-0296; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Kuo MT, 2002, ONCOGENE, V21, P1945, DOI 10.1038/sj.onc.1205117; Lee CH, 2001, BIOORG MED CHEM LETT, V11, P2419, DOI 10.1016/S0960-894X(01)00454-1; LING V, 1983, CANCER TREAT REP, V67, P869; Liu FY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016241; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; MOSS RJ, 1988, J MED CHEM, V31, P786, DOI 10.1021/jm00399a017; Mothana RA, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-7; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Patanasethanont D, 2007, EUR J PHARMACOL, V566, P67, DOI 10.1016/j.ejphar.2007.04.001; Ren G, 2008, CANCER LETT, V262, P190, DOI 10.1016/j.canlet.2007.12.013; SLATER L, 1995, LEUKEMIA RES, V19, P543, DOI 10.1016/0145-2126(95)00029-N; Tang PMK, 2007, CANCER BIOL THER, V6, P504, DOI 10.4161/cbt.6.4.3814; Tang XY, 2008, J CHEMOTHERAPY, V20, P355, DOI 10.1179/joc.2008.20.3.355; UEDA K, 1987, J BIOL CHEM, V262, P17432; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Yatouji S, 2007, INT J ONCOL, V30, P1003; YUSA K, 1989, CANCER RES, V49, P5002; Zhou G, 1997, J BIOL CHEM, V272, P15174, DOI 10.1074/jbc.272.24.15174; Zhou G, 1998, J BIOL CHEM, V273, P15387, DOI 10.1074/jbc.273.25.15387	48	48	56	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e40720	10.1371/journal.pone.0040720	http://dx.doi.org/10.1371/journal.pone.0040720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927901	gold, Green Published, Green Submitted			2022-12-25	WOS:000308286300003
J	Zhao, L; Zheng, CF				Zhao, Lei; Zheng, Chunfu			The First Identified Nucleocytoplasmic Shuttling Herpesviral Capsid Protein: Herpes Simplex Virus Type 1 VP19C	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; INTRACELLULAR-LOCALIZATION; SEQUENCE; SPECIFICITY; RECEPTOR; IMPORT; CRM1	VP19C is a structural protein of herpes simplex virus type 1 viral particle, which is essential for assembly of the capsid. In this study, a nuclear export signal (NES) of VP19C is for the first time identified and mapped to amino acid residues 342 to 351. Furthermore, VP19C is demonstrated to shuttle between the nucleus and the cytoplasm through the NES in a chromosomal region maintenance 1 (CRM1)-dependent manner involving RanGTP hydrolysis. This makes VP19C the first herpesviral capsid protein with nucleocytoplasmic shuttling property and adds it to the list of HSV-1 nucleocytoplasmic shuttling proteins.	[Zhao, Lei; Zheng, Chunfu] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China; [Zhao, Lei] NW A&F Univ, Div Sci Res, Yangling, Shaanxi, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Northwest A&F University - China	Zhao, L (corresponding author), Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China.	zheng.alan@hotmail.com	zheng, Chunfu/F-2404-2012	zheng, Chunfu/0000-0002-8797-1322	Major State Basic Research Development Program of China [2011CB504802, 2010CB530105]; National Natural Science Foundation of China [30870120, 30900059, 81000736]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Major State Basic Research Development Program of China (2011CB504802 and 2010CB530105) and National Natural Science Foundation of China (30870120, 30900059 and 81000736). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson WE, 2006, J VIROL, V80, P1537, DOI 10.1128/JVI.80.3.1537-1548.2006; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Boyle SM, 1999, J VIROL, V73, P6872, DOI 10.1128/JVI.73.8.6872-6881.1999; BRAUN DK, 1984, J VIROL, V50, P645, DOI 10.1128/JVI.50.2.645-648.1984; Cai MS, 2011, J GEN VIROL, V92, P621, DOI 10.1099/vir.0.027029-0; Cheng GF, 2002, J VIROL, V76, P9434, DOI 10.1128/JVI.76.18.9434-9445.2002; Ding Q, 2010, VIRUS RES, V149, P95, DOI 10.1016/j.virusres.2010.01.009; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Elfgang C, 1999, P NATL ACAD SCI USA, V96, P6229, DOI 10.1073/pnas.96.11.6229; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Isegawa Y, 2008, J VIROL, V82, P710, DOI 10.1128/JVI.00736-07; Kim FJ, 1996, MOL CELL BIOL, V16, P5147; Li ML, 2011, VIROLOGY, V417, P385, DOI 10.1016/j.virol.2011.06.004; Li Y, 2012, J GEN VIROL; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Mears WE, 1998, VIROLOGY, V242, P128, DOI 10.1006/viro.1997.9006; MEYER BE, 1994, GENE DEV, V8, P1538, DOI 10.1101/gad.8.13.1538; Okoye ME, 2006, J VIROL, V80, P929, DOI 10.1128/JVI.80.2.929-940.2006; Ossareh-Nazari B, 1999, EXP CELL RES, V252, P236, DOI 10.1006/excr.1999.4599; Person S, 1998, VIROLOGY, V242, P193, DOI 10.1006/viro.1997.9005; Rixon FJ, 1996, J GEN VIROL, V77, P2251, DOI 10.1099/0022-1317-77-9-2251; TATMAN JD, 1994, J GEN VIROL, V75, P1101, DOI 10.1099/0022-1317-75-5-1101; Wang JP, 2012, J VIROL, V86, P2273, DOI 10.1128/JVI.06010-11; Williams P, 2008, J VIROL, V82, P10946, DOI 10.1128/JVI.01403-08; Zheng CF, 2004, VIROLOGY, V324, P327, DOI 10.1016/j.virol.2004.03.042; Zheng CF, 2011, J VIROL METHODS, V177, P206, DOI 10.1016/j.jviromet.2011.08.004; ZWEIG M, 1979, VIROLOGY, V94, P442, DOI 10.1016/0042-6822(79)90474-4	30	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41825	10.1371/journal.pone.0041825	http://dx.doi.org/10.1371/journal.pone.0041825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927916	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300015
J	Yamaguchi, Y; Miyata, H; Uchiyama, K; Ootsuyama, A; Inubushi, S; Mori, T; Muramatsu, N; Katamine, S; Sakaguchi, S				Yamaguchi, Yoshitaka; Miyata, Hironori; Uchiyama, Keiji; Ootsuyama, Akira; Inubushi, Sachiko; Mori, Tsuyoshi; Muramatsu, Naomi; Katamine, Shigeru; Sakaguchi, Suehiro			Biological and Biochemical Characterization of Mice Expressing Prion Protein Devoid of the Octapeptide Repeat Region after Infection with Prions	PLOS ONE			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; PRP KNOCKOUT MICE; TRANSGENIC MICE; SCRAPIE; SUSCEPTIBILITY; IDENTIFICATION; ACCUMULATION; RESISTANT; STRAIN; AGENT	Accumulating lines of evidence indicate that the N-terminal domain of prion protein (PrP) is involved in prion susceptibility in mice. In this study, to investigate the role of the octapeptide repeat (OR) region alone in the N-terminal domain for the susceptibility and pathogenesis of prion disease, we intracerebrally inoculated RML scrapie prions into tg(PrP Delta OR)/Prnp(0/0) mice, which express mouse PrP missing only the OR region on the PrP-null background. Incubation times of these mice were not extended. Protease-resistant PrP Delta OR, or PrPSc Delta OR, was easily detectable but lower in the brains of these mice, compared to that in control wild-type mice. Consistently, prion titers were slightly lower and astrogliosis was milder in their brains. However, in their spinal cords, PrPSc Delta R and prion titers were abundant and astrogliosis was as strong as in control wild-type mice. These results indicate that the role of the OR region in prion susceptibility and pathogenesis of the disease is limited. We also found that the PrPSc Delta OR, including the pre-OR residues 23-50, was unusually protease-resistant, indicating that deletion of the OR region could cause structural changes to the pre-OR region upon prion infection, leading to formation of a protease-resistant structure for the pre-OR region.	[Yamaguchi, Yoshitaka; Uchiyama, Keiji; Inubushi, Sachiko; Mori, Tsuyoshi; Muramatsu, Naomi; Sakaguchi, Suehiro] Univ Tokushima, Div Mol Neurobiol, Inst Enzyme Res KOSOKEN, Tokushima 770, Japan; [Yamaguchi, Yoshitaka; Katamine, Shigeru; Sakaguchi, Suehiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki, Japan; [Miyata, Hironori] Univ Occupat & Environm Hlth, Sch Med, Anim Res Ctr, Kitakyushu, Fukuoka 807, Japan; [Ootsuyama, Akira] Univ Occupat & Environm Hlth, Sch Med, Dept Radiat Biol & Hlth, Kitakyushu, Fukuoka 807, Japan	Tokushima University; Nagasaki University; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Yamaguchi, Y (corresponding author), Univ Tokushima, Div Mol Neurobiol, Inst Enzyme Res KOSOKEN, Tokushima 770, Japan.	sakaguch@ier.tokushima-u.ac.jp	Yamaguchi, Yoshitaka/ABD-2499-2020	UCHIYAMA, KEIJI/0000-0002-5667-3509	bovine spongiform encephalopathy (BSE); Ministry of Agriculture, Forestry and Fisheries of Japan; Research Committee of Prion Disease and Slow Virus infection; Ministry of Health, Labour and Welfare of Japan; Institute for Enzyme Research; University of Tokushima	bovine spongiform encephalopathy (BSE); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Research Committee of Prion Disease and Slow Virus infection; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Institute for Enzyme Research; University of Tokushima	This work was partly supported by a Grant-in-Aid from the bovine spongiform encephalopathy (BSE) and other Prion Disease Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan, and Grants-in-Aid from the Research Committee of Prion Disease and Slow Virus infection, the Ministry of Health, Labour and Welfare of Japan. H.M. is partly supported by a Cooperative Research Grant of the Institute for Enzyme Research, the University of Tokushima. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Fujita K, 2011, CELL MOL NEUROBIOL, V31, P999, DOI 10.1007/s10571-011-9696-z; Gambetti P, 2011, ACTA NEUROPATHOL, V121, P79, DOI 10.1007/s00401-010-0761-3; MANSON JC, 1994, NEURODEGENERATION, V3, P331; PRIOLA SA, 1994, MOL NEUROBIOL, V8, P113, DOI 10.1007/BF02780661; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; REED J, 1938, AM J HYG, V27, P493; SAKAGUCHI S, 1995, J VIROL, V69, P7586, DOI 10.1128/JVI.69.12.7586-7592.1995; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Supattapone S, 2001, J VIROL, V75, P1408, DOI 10.1128/JVI.75.3.1408-1413.2001; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; Weissmann C, 2002, ACTA NEUROBIOL EXP, V62, P153; Yoshikawa D, 2008, J BIOL CHEM, V283, P24202, DOI 10.1074/jbc.M804212200	24	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43540	10.1371/journal.pone.0043540	http://dx.doi.org/10.1371/journal.pone.0043540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927985	Green Submitted, Green Published, gold			2022-12-25	WOS:000307789700037
J	Gross, S; Krause, Y; Wuelling, M; Vortkamp, A				Gross, Stefanie; Krause, Yvonne; Wuelling, Manuela; Vortkamp, Andrea			Hoxa11 and Hoxd11 Regulate Chondrocyte Differentiation Upstream of Runx2 and Shox2 in Mice	PLOS ONE			English	Article							INDIAN-HEDGEHOG; BONE-DEVELOPMENT; GENE-EXPRESSION; HOMEOBOX GENES; SHORT-STATURE; GROWTH-PLATE; MOUSE; LIMB; PROLIFERATION; ULNALESS	During limb development, posterior Hox genes of the Hoxa-and Hoxd cluster provide positional information along the limb axis. Here we report a new function for Hoxa11 and Hoxd11 in regulating the early steps of chondrocyte differentiation. We analyzed forelimbs of Hoxa11(-/-); d11(-/-) and Ulnaless mice, which are characterized by specifically shortened zeugopods. By detailed morphological and molecular analyses, we show that loss of Hoxa11 and Hoxd11 in the ulna of both mutants leads to an arrest of chondrocyte differentiation at a step before the separation into round and columnar cells takes place. Furthermore, we demonstrate that Hoxa11 and Hoxd11 act upstream of Runx2 and Shox2, two key regulators of chondrocyte differentiation. We hypothesize that Runx2 activates Shox2 in early chondrocytes, which at later stages induces Runx2 expression to regulate hypertrophic differentiation. These results give insight into mechanisms by which positional information might be translated into a specific bone pattern.	[Gross, Stefanie; Krause, Yvonne; Wuelling, Manuela; Vortkamp, Andrea] Univ Duisburg Essen, Ctr Med Biotechnol, Dept Dev Biol, Essen, Germany	University of Duisburg Essen	Gross, S (corresponding author), Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA.	andrea.vortkamp@uni-due.due		Wuelling, Manuela/0000-0003-4534-3528	Deutsche Forschungsgemeinschaft [VO620/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (VO620/5) to AV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Boulet AM, 2004, DEVELOPMENT, V131, P299, DOI 10.1242/dev.00936; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cobb J, 2006, P NATL ACAD SCI USA, V103, P4511, DOI 10.1073/pnas.0510544103; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; DAVISSON MT, 1990, J HERED, V81, P151; Deschamps J, 2004, SCIENCE, V304, P1610, DOI 10.1126/science.1099162; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DUBOULE D, 1992, BIOESSAYS, V14, P375, DOI 10.1002/bies.950140606; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; ELIMA K, 1993, BIOCHEM J, V289, P247, DOI 10.1042/bj2890247; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Herault Y, 1997, DEVELOPMENT, V124, P3493; IZPISUABELMONTE JC, 1991, EMBO J, V10, P2279, DOI 10.1002/j.1460-2075.1991.tb07764.x; Kahveci Z, 2000, BIOTECH HISTOCHEM, V75, P264, DOI 10.3109/10520290009085130; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; KRUMLAUF R, 1992, BIOESSAYS, V14, P245, DOI 10.1002/bies.950140408; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Long FX, 2001, DEVELOPMENT, V128, P5099; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Minina E, 2005, GENE EXPR PATTERNS, V6, P102, DOI 10.1016/j.modgep.2005.04.012; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Minina E, 2001, DEVELOPMENT, V128, P4523; Morris T, 1967, MOUSE NEWS LETT; Nelson CE, 1996, DEVELOPMENT, V122, P1449; NG LJ, 1993, DEV BIOL, V159, P403, DOI 10.1006/dbio.1993.1251; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Peichel CL, 1997, DEVELOPMENT, V124, P3481; Peichel CL, 1996, GENETICS, V144, P1757; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Tagariello A, 2008, MATRIX BIOL, V27, P3, DOI 10.1016/j.matbio.2007.07.004; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yu L, 2007, DEV BIOL, V306, P549, DOI 10.1016/j.ydbio.2007.03.518; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zinn AR, 2002, AM J MED GENET, V110, P158, DOI 10.1002/ajmg.10422	50	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43553	10.1371/journal.pone.0043553	http://dx.doi.org/10.1371/journal.pone.0043553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916278	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800077
J	Kim, HK; Park, WS; Warda, M; Park, SY; Ko, EA; Kim, MH; Jeong, SH; Heo, HJ; Choi, TH; Hwang, YW; Lee, SI; Ko, KS; Rhee, BD; Kim, N; Han, J				Kim, Hyoung Kyu; Park, Won Sun; Warda, Mohamad; Park, So Youn; Ko, Eun A.; Kim, Min Hee; Jeong, Seung Hun; Heo, Hye-Jin; Choi, Tae-Hoon; Hwang, Young-Won; Lee, Sun-Il; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Nari; Han, Jin			Beta Adrenergic Overstimulation Impaired Vascular Contractility via Actin-Cytoskeleton Disorganization in Rabbit Cerebral Artery	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; LEFT-VENTRICULAR HYPERTROPHY; INDUCED CARDIAC-HYPERTROPHY; OPPOSES RHO-KINASE; ANGIOTENSIN-II; RESISTANCE ARTERIES; CORONARY-ARTERY; PROTEIN-KINASES; ISCHEMIC-STROKE; K+ CHANNELS	Background and Purpose: Beta adrenergic overstimulation may increase the vascular damage and stroke. However, the underlying mechanisms of beta adrenergic overstimulation in cerebrovascular dysfunctions are not well known. We investigated the possible cerebrovascular dysfunction response to isoproterenol induced beta-adrenergic overstimulation (ISO) in rabbit cerebral arteries (CAs). Methods: ISO was induced in six weeks aged male New Zealand white rabbit (0.8-1.0 kg) by 7-days isoproterenol injection (300 mu g/kg/day). We investigated the alteration of protein expression in ISO treated CAs using 2DE proteomics and western blot analysis. Systemic properties of 2DE proteomics result were analyzed using bioinformatics software. ROS generation and following DNA damage were assessed to evaluate deteriorative effect of ISO on CAs. Intracellular Ca2+ level change and vascular contractile response to vasoactive drug, angiotensin II (Ang II), were assessed to evaluate functional alteration of ISO treated CAs. Ang II-induced ROS generation was assessed to evaluated involvement of ROS generation in CA contractility. Results: Proteomic analysis revealed remarkably decreased expression of cytoskeleton organizing proteins (e. g. actin related protein 1A and 2, alpha-actin, capping protein Z beta, and vimentin) and anti-oxidative stress proteins (e. g. heat shock protein 9A and stress-induced-phosphoprotein 1) in ISO-CAs. As a cause of dysregulation of actin-cytoskeleton organization, we found decreased level of RhoA and ROCK1, which are major regulators of actin-cytoskeleton organization. As functional consequences of proteomic alteration, we found the decreased transient Ca2+ efflux and constriction response to angiotensin II and high K+ in ISO-CAs. ISO also increased basal ROS generation and induced oxidative damage in CA; however, it decreased the Ang II-induced ROS generation rate. These results indicate that ISO disrupted actin cytoskeleton proteome network through down-regulation of RhoA/ROCK1 proteins and increased oxidative damage, which consequently led to contractile dysfunction in CA.	[Kim, Hyoung Kyu; Kim, Min Hee; Jeong, Seung Hun; Heo, Hye-Jin; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Nari; Han, Jin] Inje Univ, Cardiovasc & Metab Dis Ctr, Coll Med, Natl Res Lab Mitochondrial Signaling,Dept Physiol, Pusan, South Korea; [Park, Won Sun] Kangwon Natl Univ, Dept Physiol, Sch Med, Chunchon, South Korea; [Warda, Mohamad] Cairo Univ, Dept Biochem, Fac Vet Med, Cairo, Egypt; [Park, So Youn] Pusan Natl Univ, Dept Pharmacol, Coll Med, Pusan, South Korea; [Park, So Youn] Pusan Natl Univ, Med Res Ctr Ischem Tissue Regenerat, Pusan, South Korea; [Ko, Eun A.] Univ Illinois, Dept Med, Sect Pulm Crit Care & Sleep Med, Chicago, IL USA; [Choi, Tae-Hoon] Andong Sci Coll, Dept Phys Educ, Andong, South Korea; [Hwang, Young-Won; Lee, Sun-Il] Inje Univ, Busan Paik Hosp, Coll Med, Dept Neurosurg, Pusan, South Korea	Inje University; Kangwon National University; Egyptian Knowledge Bank (EKB); Cairo University; Pusan National University; Pusan National University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Inje University	Kim, HK (corresponding author), Inje Univ, Cardiovasc & Metab Dis Ctr, Coll Med, Natl Res Lab Mitochondrial Signaling,Dept Physiol, Pusan, South Korea.	phyhanj@inje.ac.kr		Kim, Hyoung Kyu/0000-0002-1791-7865; Warda, Mohamed/0000-0001-7004-8526; Warda, Mohamad/0000-0003-0516-4023	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0020224, NRF-2009-0067574]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0020224 and NRF-2009-0067574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; BENJAMIN IJ, 1989, CIRC RES, V65, P657, DOI 10.1161/01.RES.65.3.657; BIKKINA M, 1994, JAMA-J AM MED ASSOC, V272, P33, DOI 10.1001/jama.272.1.33; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Canales-Aguirre A, 2011, INT J ENV RES PUB HE, V8, P540, DOI 10.3390/ijerph8020540; Cipolla MJ, 1998, STROKE, V29, P1223, DOI 10.1161/01.STR.29.6.1223; Davel APC, 2008, AM J PHYSIOL-HEART C, V295, pH211, DOI 10.1152/ajpheart.00581.2007; Davel APC, 2006, BRIT J PHARMACOL, V148, P629, DOI 10.1038/sj.bjp.0706749; Di Tullio MR, 2003, STROKE, V34, P2380, DOI 10.1161/01.STR.0000089680.77236.60; Du T, 2010, J NEUROCHEM, V115, P1007, DOI 10.1111/j.1471-4159.2010.06995.x; Ennis IL, 2003, HYPERTENSION, V41, P1324, DOI 10.1161/01.HYP.0000071180.12012.6E; Gokina NI, 2000, AM J PHYSIOL-HEART C, V278, pH2094, DOI 10.1152/ajpheart.2000.278.6.H2094; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; JENSEN LJ, 2008, NUCL ACIDS RES; Zhang J, 2010, MOL MED, V16, P307, DOI 10.2119/molmed.2009.00121; Keles MS, 2009, MOL CELL BIOCHEM, V328, P109, DOI 10.1007/s11010-009-0080-y; Kim HK, 2007, AM J PHYSIOL-CELL PH, V293, pC761, DOI 10.1152/ajpcell.00043.2007; Kim JE, 2009, BIOL PHARM BULL, V32, P1047, DOI 10.1248/bpb.32.1047; Kim N, 2006, PROTEOMICS, V6, P1237, DOI 10.1002/pmic.200500291; Kim N, 2003, CIRC RES, V93, P541, DOI 10.1161/01.RES.0000090087.66390.F2; Kim N, 2006, BBA-MOL CELL RES, V1763, P1067, DOI 10.1016/j.bbamcr.2006.08.002; Kim Nari, 2001, Korean Journal of Physiology and Pharmacology, V5, P33; KOHYA T, 1988, J MOL CELL CARDIOL, V20, P159, DOI 10.1016/S0022-2828(88)80029-4; Kolch Walter, 2002, Expert Opin Pharmacother, V3, P709, DOI 10.1517/14656566.3.6.709; Kumar N, 2007, J BIOL CHEM, V282, P9244, DOI 10.1074/jbc.M605571200; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Leenen FHH, 2001, AM J PHYSIOL-HEART C, V281, pH2410, DOI 10.1152/ajpheart.2001.281.6.H2410; Li JM, 2002, CIRC RES, V90, P143, DOI 10.1161/hh0202.103615; Liu Y, 2005, MOL CELL BIOCHEM, V268, P45, DOI 10.1007/s11010-005-2996-1; Loufrani L, 2008, MED BIOL ENG COMPUT, V46, P451, DOI 10.1007/s11517-008-0306-2; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Meloche S, 2000, AM J PHYSIOL-HEART C, V279, pH741, DOI 10.1152/ajpheart.2000.279.2.H741; Moniri NH, 2007, BIOCHEM PHARMACOL, V74, P64, DOI 10.1016/j.bcp.2007.03.016; Nakamura M, 2000, AM J PHYSIOL-CELL PH, V279, pC480, DOI 10.1152/ajpcell.2000.279.2.C480; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Park WS, 2007, ARTERIOSCL THROM VAS, V27, P1768, DOI 10.1161/ATVBAHA.107.143339; Pereira-Leal JB, 2006, PHILOS T R SOC B, V361, P507, DOI 10.1098/rstb.2005.1807; Pozzi A, 2006, MOL BIOL CELL, V17, P2046, DOI 10.1091/mbc.E05-08-0800; PYE MP, 1992, CARDIOVASC RES, V26, P740, DOI 10.1093/cvr/26.8.740; Remondino A, 2003, CIRC RES, V92, P136, DOI 10.1161/01.RES.0000054624.03539.B4; Rodriguez CJ, 2002, J AM COLL CARDIOL, V39, P1482, DOI 10.1016/S0735-1097(02)01799-0; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Sakudo A, 2005, BIOCHEM BIOPH RES CO, V328, P14, DOI 10.1016/j.bbrc.2004.12.132; Samain E, 1999, AM J PHYSIOL-HEART C, V277, pH834, DOI 10.1152/ajpheart.1999.277.2.H834; Samain E, 2000, ANESTH ANALG, V90, P546, DOI 10.1097/00000539-200003000-00009; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Selvetella G, 2003, STROKE, V34, P1766, DOI 10.1161/01.STR.0000078310.98444.1D; Shcherbina A, 1999, BRIT J HAEMATOL, V106, P216, DOI 10.1046/j.1365-2141.1999.01508.x; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Tanaka Y, 1999, J IMMUNOL, V163, P6209; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Touyz RM, 2005, CAN J PHYSIOL PHARM, V83, P91, DOI 10.1139/Y05-006; Touyz RM, 1999, CIRCULATION, V99, P392, DOI 10.1161/01.CIR.99.3.392; Van Cuong D, 2007, AM J PHYSIOL-HEART C, V293, pH1457, DOI 10.1152/ajpheart.01282.2006; Verdecchia P, 2001, CIRCULATION, V104, P2039, DOI 10.1161/hc4201.097944; Voloboueva LA, 2008, J CEREBR BLOOD F MET, V28, P1009, DOI 10.1038/sj.jcbfm.9600600; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zou YZ, 2001, CIRCULATION, V104, P102, DOI 10.1161/hc2601.090987	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43884	10.1371/journal.pone.0043884	http://dx.doi.org/10.1371/journal.pone.0043884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916309	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800106
J	Kuramoto, T; Nakanishi, S; Ochiai, M; Nakagama, H; Voigt, B; Serikawa, T				Kuramoto, Takashi; Nakanishi, Satoshi; Ochiai, Masako; Nakagama, Hitoshi; Voigt, Birger; Serikawa, Tadao			Origins of Albino and Hooded Rats: Implications from Molecular Genetic Analysis across Modern Laboratory Rat Strains	PLOS ONE			English	Article							MISSENSE MUTATION; KIT EXPRESSION; MICE; ELEMENTS	Albino and hooded (or piebald) rats are one of the most frequently used laboratory animals for the past 150 years. Despite this fact, the origin of the albino mutation as well as the genetic basis of the hooded phenotype remained unclear. Recently, the albino mutation has been identified as the Arg299His missense mutation in the Tyrosinase gene and the hooded (H) locus has been mapped to the similar to 460-kb region in which only the Kit gene exists. Here, we surveyed 172 laboratory rat strains for the albino mutation and the hooded (h) mutation that we identified by positional cloning approach to investigate possible genetic roots and relationships of albino and hooded rats. All of 117 existing laboratory albino rats shared the same albino missense mutation, indicating they had only one single ancestor. Genetic fine mapping followed by de novo sequencing of BAC inserts covering the H locus revealed that an endogenous retrovirus (ERV) element was inserted into the first intron of the Kit gene where the hooded allele maps. A solitary long terminal repeat (LTR) was found at the same position to the ERV insertion in another allele of the H locus, which causes the so called Irish (h(i)) phenotype. The ERV and the solitary LTR insertions were completely associated with the hooded and Irish coat patterns, respectively, across all colored rat strains examined. Interestingly, all 117 albino rat strains shared the ERV insertion without any exception, which strongly suggests that the albino mutation had originally occurred in hooded rats.	[Kuramoto, Takashi; Nakanishi, Satoshi; Voigt, Birger; Serikawa, Tadao] Kyoto Univ, Fac Med, Inst Lab Anim, Grad Sch Med,Sakyo Ku, Kyoto 606, Japan; [Ochiai, Masako; Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Chuo Ku, Tokyo 104, Japan	Kyoto University; National Cancer Center - Japan	Kuramoto, T (corresponding author), Kyoto Univ, Fac Med, Inst Lab Anim, Grad Sch Med,Sakyo Ku, Kyoto 606, Japan.	tkuramot@anim.med.kyoto-u.ac.jp			Japan Society for the Promotion of Science [21300153]; Ministry of Health, Labour and Welfare; Fujiwara Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Fujiwara Memorial Foundation	This work was supported in part by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (21300153 to T. Kuramoto), a Grant-in-aid for Cancer Research from the Ministry of Health, Labour and Welfare, and the Fujiwara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter LL, 2004, PIGM CELL RES, V17, P215, DOI 10.1111/j.1600-0749.2004.00147.x; Beermann F, 2004, MAMM GENOME, V15, P749, DOI 10.1007/s00335-004-4002-8; Blaszczyk WM, 2005, PIGM CELL RES, V18, P144, DOI 10.1111/j.1600-0749.2005.00227.x; BOWES C, 1993, P NATL ACAD SCI USA, V90, P2955, DOI 10.1073/pnas.90.7.2955; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; CASTLE WE, 1951, GENETICS, V36, P254; Crampe II, 1885, LANDWIRTHSCHAFTLICHE; Donaldson HH, 1915, RAT DATA REFERENCE T; DUTTLINGER R, 1993, DEVELOPMENT, V118, P705; GERSHONIBARUCH R, 1994, AM J HUM GENET, V54, P586; Hofmann M, 1998, GENOMICS, V52, P107, DOI 10.1006/geno.1998.5409; Jurka J, 2009, REPBASE REPORTS, V9, P1214; KESHET E, 1991, EMBO J, V10, P2425, DOI 10.1002/j.1460-2075.1991.tb07782.x; Kluppel M, 1997, DEVELOPMENT, V124, P65; Kuramoto T, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-91; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Nakamuta M, 1989, Virus Genes, V3, P69, DOI 10.1007/BF00301988; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; SERIKAWA T, 1992, GENETICS, V131, P701; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Tokuda S, 2007, BRAIN RES, V1133, P168, DOI 10.1016/j.brainres.2006.10.086; Torigoe D, 2011, J VET MED SCI, V73, P707, DOI 10.1292/jvms.10-0529	22	22	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43059	10.1371/journal.pone.0043059	http://dx.doi.org/10.1371/journal.pone.0043059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916206	Green Submitted, Green Published, gold			2022-12-25	WOS:000307824300027
J	Marit, MR; Chohan, M; Matthew, N; Huang, K; Kuntz, DA; Rose, DR; Barber, DL				Marit, Michael R.; Chohan, Manprit; Matthew, Natasha; Huang, Kai; Kuntz, Douglas A.; Rose, David R.; Barber, Dwayne L.			Random Mutagenesis Reveals Residues of JAK2 Critical in Evading Inhibition by a Tyrosine Kinase Inhibitor	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; BCR-ABL; BLAST CRISIS; DOMAIN MUTATIONS; IMATINIB STI571; IN-VITRO; PROTEIN; RESISTANCE	Background: The non-receptor tyrosine kinase JAK2 is implicated in a group of myeloproliferative neoplasms including polycythemia vera, essential thrombocythemia, and primary myelofibrosis. JAK2-selective inhibitors are currently being evaluated in clinical trials. Data from drug-resistant chronic myeloid leukemia patients demonstrate that treatment with a small-molecule inhibitor generates resistance via mutation or amplification of BCR-ABL. We hypothesize that treatment with small molecule inhibitors of JAK2 will similarly generate inhibitor-resistant mutants in JAK2. Methodology: In order to identify inhibitor-resistant JAK2 mutations a priori, we utilized TEL-JAK2 to conduct an in vitro random mutagenesis screen for JAK2 alleles resistant to JAK Inhibitor-I. Isolated mutations were evaluated for their ability to sustain cellular growth, stimulate downstream signaling pathways, and phosphorylate a novel JAK2 substrate in the presence of inhibitor. Conclusions: Mutations were found exclusively in the kinase domain of JAK2. The panel of mutations conferred resistance to high concentrations of inhibitor accompanied by sustained activation of the Stat5, Erk1/2, and Akt pathways. Using a JAK2 substrate, enhanced catalytic activity of the mutant JAK2 kinase was observed in inhibitor concentrations 200-fold higher than is inhibitory to the wild-type protein. When testing the panel of mutations in the context of the Jak2 V617F allele, we observed that a subset of mutations conferred resistance to inhibitor, validating the use of TEL-JAK2 in the initial screen. These results demonstrate that small-molecule inhibitors select for JAK2 inhibitor-resistant alleles, and the design of next-generation JAK2 inhibitors should consider the location of mutations arising in inhibitor-resistant screens.	[Marit, Michael R.; Chohan, Manprit; Matthew, Natasha; Huang, Kai; Kuntz, Douglas A.; Rose, David R.; Barber, Dwayne L.] Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON, Canada; [Marit, Michael R.; Chohan, Manprit; Matthew, Natasha; Huang, Kai; Kuntz, Douglas A.; Rose, David R.; Barber, Dwayne L.] Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M4X 1K9, Canada; [Rose, David R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Waterloo	Marit, MR (corresponding author), Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON, Canada.	dbarber@uhnres.utoronto.ca		Barber, Dwayne/0000-0001-5528-8150	Canadian Institutes of Health Research [FRN-42428, FRN-79400]; Leukemia and Lymphoma Society of Canada; Doctoral Research Award from Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Leukemia and Lymphoma Society of Canada; Doctoral Research Award from Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (FRN-42428 to DLB and FRN-79400 to DRR) and Leukemia and Lymphoma Society of Canada. MRM was supported by a Doctoral Research Award from Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; BARBER DL, 1994, MOL CELL BIOL, V14, P2257, DOI 10.1128/MCB.14.4.2257; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Buchdunger E, 1996, CANCER RES, V56, P100; Chan WW, 2011, CANCER CELL, V19, P556, DOI 10.1016/j.ccr.2011.03.003; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Deshpande A, 2011, LEUKEMIA OFFICIAL J; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Grandage VL, 2006, BRIT J HAEMATOL, V135, P303, DOI 10.1111/j.1365-2141.2006.06291.x; Haan C, 2009, J IMMUNOL, V182, P2969, DOI 10.4049/jimmunol.0800572; Haan S, 2009, ONCOGENE, V28, P3069, DOI 10.1038/onc.2009.155; Hart S, 2011, LEUKEMIA, V25, P1751, DOI 10.1038/leu.2011.148; Hofmann WK, 2003, BLOOD, V102, P659, DOI 10.1182/blood-2002-06-1756; Hornakova T, 2011, HAEMATOL-HEMATOL J, V96, P845, DOI 10.3324/haematol.2010.036350; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2008, LEUKEMIA, V22, P2011, DOI 10.1038/leu.2008.290; Ju W, 2011, BLOOD, V117, P1938, DOI 10.1182/blood-2010-09-305425; Kantarjian HM, 2011, BLOOD, V117, P1141, DOI 10.1182/blood-2010-03-277152; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Li Z, 2007, EXP HEMATOL, V35, P1624, DOI 10.1016/j.exphem.2007.07.003; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; Opar A, 2010, NAT REV DRUG DISCOV, V9, P257, DOI 10.1038/nrd3155; Pardanani A, 2011, CURR OPIN HEMATOL, V18, P105, DOI 10.1097/MOH.0b013e3283439964; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; Pradhan A, 2010, J BIOL CHEM, V285, P16651, DOI 10.1074/jbc.M109.071191; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Santos FPS, 2010, BLOOD, V115, P1131, DOI 10.1182/blood-2009-10-246363; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Schaub FX, 2010, BLOOD, V115, P2003, DOI 10.1182/blood-2009-09-245381; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Stein BL, 2011, HAEMATOLOGICA; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tefferi A, 2011, J CLIN ONCOL, V29, P573, DOI 10.1200/JCO.2010.29.8711; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Vijayakrishnan L, 2011, TRENDS PHARMACOL SCI, V32, P25, DOI 10.1016/j.tips.2010.10.004; Weigert O, 2012, J EXP MED, V209, P259, DOI 10.1084/jem.20111694; Weisberg E, 2010, LEUKEMIA, V24, P1375, DOI 10.1038/leu.2010.107; Willis SG, 2005, BLOOD, V106, P2128, DOI 10.1182/blood-2005-03-1036; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	55	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43437	10.1371/journal.pone.0043437	http://dx.doi.org/10.1371/journal.pone.0043437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916261	Green Published, Green Submitted, gold			2022-12-25	WOS:000307824300049
J	Sundqvist, A; Zieba, A; Vasilaki, E; Hidalgo, CH; Soderberg, O; Koinuma, D; Miyazono, K; Heldin, CH; Landegren, U; ten Dijke, P; van Dam, H				Sundqvist, A.; Zieba, A.; Vasilaki, E.; Hidalgo, C. Herrera; Soderberg, O.; Koinuma, D.; Miyazono, K.; Heldin, C-H; Landegren, U.; ten Dijke, P.; van Dam, H.			Specific interactions between Smad proteins and AP-1 components determine TGF beta-induced breast cancer cell invasion	ONCOGENE			English	Article						invasion; spheroids; TGF beta; AP-1; Smad; PLA	GROWTH-FACTOR-BETA; MAMMARY-GLAND DEVELOPMENT; MESENCHYMAL TRANSITION; COLORECTAL CANCERS; PROXIMITY LIGATION; TUMOR-SUPPRESSOR; IN-SITU; TUMORIGENESIS; TRANSCRIPTION; PATHWAYS	Deregulation of the transforming growth factor beta (TGF beta) signal transduction cascade is functionally linked to cancer. In early phases, TGFb acts as a tumor suppressor by inhibiting tumor cell proliferation, whereas in late phases, it can act as a tumor promoter by stimulating tumor cell invasion and metastasis. Smad transcriptional effectors mediate TGF beta responses, but relatively little is known about the Smad-containing complexes that are important for epithelial-mesenchymal transition and invasion. In this study, we have tested the hypothesis that specific members of the AP-1 transcription factor family determine TGF beta signaling specificity in breast cancer cell invasion. Using a 3D model of collagen-embedded spheroids of MCF10A-MII premalignant human breast cancer cells, we identified the AP-1 transcription factor components c-Jun, JunB, c-Fos and Fra1 as essential factors for TGF beta-induced invasion and found that various mesenchymal and invasion-associated TGF beta-induced genes are co-regulated by these proteins. In situ proximity ligation assays showed that TGF beta signaling not only induces complexes between Smad3 and Smad4 in the nucleus but also complexes between Smad2/3 and Fra1, whereas complexes between Smad3, c-Jun and JunB could already be detected before TGF beta stimulation. Finally, chromatin immunoprecipitations showed that c-Jun, JunB and Fra1, but not c-Fos, are required for TGF beta-induced binding of Smad2/3 to the mmp-10 and pai-1 promoters. Together these results suggest that in particular formation of Smad2/3-Fra1 complexes may reflect activation of the Smad/AP-1-dependent TGF beta-induced invasion program.	[Sundqvist, A.; Vasilaki, E.; Hidalgo, C. Herrera; Miyazono, K.; Heldin, C-H; ten Dijke, P.; van Dam, H.] Uppsala Univ, Sci Life Lab, Ludwig Inst Canc Res, Uppsala, Sweden; [Zieba, A.; Soderberg, O.; Landegren, U.] Uppsala Univ, Rudbeck Lab, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Koinuma, D.; Miyazono, K.] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo, Japan; [ten Dijke, P.; van Dam, H.] Leiden Univ, Med Ctr, Ctr Biomed Genet, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University; University of Tokyo; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Dam, H (corresponding author), Leiden Univ, Med Ctr, Ctr Biomed Genet, Dept Mol Cell Biol, POB 9600, NL-2300 RC Leiden, Netherlands.	vdam@lumc.nl	Dijke, Peter ten/AAG-4660-2021; Landegren, Ulf D/A-8197-2019; Koinuma, Daizo/Y-8716-2018; Söderberg, Ola/O-5130-2017; Vasilaki, Eleftheria/AAY-6392-2020	Dijke, Peter ten/0000-0002-7234-342X; Koinuma, Daizo/0000-0001-5611-2122; Söderberg, Ola/0000-0003-2883-1925; van Dam, Hans/0000-0002-8307-4325	Swedish Cancerfonden [090773]; Netherlands Centre for Biomedical Genetics	Swedish Cancerfonden; Netherlands Centre for Biomedical Genetics	We thank our colleagues, in particular Aris Moustakas and Masato Morikawa, for their valuable discussion and help with experiments. This work was supported by the Swedish Cancerfonden (090773) and the Netherlands Centre for Biomedical Genetics.	Baan B, 2010, MOL CELL PROTEOMICS, V9, P1982, DOI 10.1074/mcp.M110.000943; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dumont N, 2000, BREAST CANCER RES, V2, P125, DOI 10.1186/bcr44; Dzwonek J, 2009, MOL CANCER RES, V7, P1342, DOI 10.1158/1541-7786.MCR-08-0558; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Laverty HG, 2009, CYTOKINE GROWTH F R, V20, P305, DOI 10.1016/j.cytogfr.2009.07.002; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Luo YP, 2010, ONCOGENE, V29, P662, DOI 10.1038/onc.2009.308; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Parvani JG, 2011, J MAMMARY GLAND BIOL, V16, P127, DOI 10.1007/s10911-011-9207-3; REICHMANN E, 1992, CELL, V71, P1103, DOI 10.1016/S0092-8674(05)80060-1; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sundqvist A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3066; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Verrecchia F, 2001, ONCOGENE, V20, P2205, DOI 10.1038/sj.onc.1204347; Wagner EF, 2010, ANN RHEUM DIS, V69, P86, DOI 10.1136/ard.2009.119396; Wakefield LM, 2001, J MAMMARY GLAND BIOL, V6, P67, DOI 10.1023/A:1009568532177; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	41	69	70	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 1	2013	32	31					3606	3615		10.1038/onc.2012.370	http://dx.doi.org/10.1038/onc.2012.370			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	194MW	22926518				2022-12-25	WOS:000322638400005
J	Gebeshuber, CA; Martinez, J				Gebeshuber, C. A.; Martinez, J.			miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling	ONCOGENE			English	Article						breast cancer; IGF2; miR-100	II MESSENGER-RNA; GENE-EXPRESSION; CANCER; INSULIN; MICRORNAS; CELLS; TUMOR	Dysregulation of micro RNAs is crucially implicated in tumorigenesis. We detected downregulation of miR-100 in breast cancer cells, leading to an upregulation of the proliferation- and survival-promoting oncogene insulin-like growth factor (IGF) 2. Stable overexpression of miR-100 strongly reduced IGF2 expression and inhibited tumor growth. In invasive human breast tumors, miR-100 was reduced about fourfold as compared with benign patient samples, whereas IGF2 was strongly enhanced. MiR-100 has also been shown to suppress other proteins of the IGF/mammalian target of rapamycin (mTOR) signaling cascade in different human tumors. Our results reveal miR-100 as a context-dependent master regulator of the IGF/mTOR pathway and a potential target for therapeutic approaches.	[Gebeshuber, C. A.; Martinez, J.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Gebeshuber, CA (corresponding author), Med Univ Vienna, Dept Pathol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	christoph.gebeshuber@meduniwien.ac.at; javier.martinez@imba.oeaw.ac.at		Gebeshuber, Christoph A/0000-0003-3293-4572; Martinez, Javier/0000-0001-9152-7323	FWF; Austrian Government's GENAU program; IMBA	FWF(Austrian Science Fund (FWF)); Austrian Government's GENAU program; IMBA	We thank Albin Rudisch and Marlies Schlauf for technical assistance and Florian Grebien and Wolfgang Sommergruber for critical comments on the manuscript. CG was funded from the FWF and the Austrian Government's GENAU program. JM was funded by the IMBA.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzini AA, SCIENCE, V336, P233; Burns JL, 2001, DEVELOPMENT, V128, P3819; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Dupont J, 2001, ENDOCRINOLOGY, V142, P4969, DOI 10.1210/en.142.11.4969; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Giani C, 1996, BREAST CANCER RES TR, V41, P43, DOI 10.1007/BF01807035; Hausser J, 2009, NUCLEIC ACIDS RES, V37, pW266, DOI 10.1093/nar/gkp412; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jones RA, 2007, ONCOGENE, V26, P1636, DOI 10.1038/sj.onc.1209955; Kauppinen S, 2006, HANDB EXP PHARM, V173, P405; McCann AH, 1996, HUM MOL GENET, V5, P1123, DOI 10.1093/hmg/5.8.1123; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; NIELSEN FC, 1995, NATURE, V377, P358, DOI 10.1038/377358a0; Pacher M, 2007, CARCINOGENESIS, V28, P49, DOI 10.1093/carcin/bgl091; Pollak M, 2008, BEST PRACT RES CL EN, V22, P625, DOI 10.1016/j.beem.2008.08.004; Pravtcheva DD, 1998, J EXP ZOOL, V281, P43, DOI 10.1002/(SICI)1097-010X(19980501)281:1<43::AID-JEZ7>3.3.CO;2-3; Romero-Cordoba S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031904; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; Shi W, 2010, INT J CANCER, V126, P2036, DOI 10.1002/ijc.24880; Tovar V, 2010, J HEPATOL, V52, P550, DOI 10.1016/j.jhep.2010.01.015; WILLISON K, 1991, TRENDS GENET, V7, P107, DOI 10.1016/0168-9525(91)90441-R	26	69	75	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 4	2013	32	27					3306	3310		10.1038/onc.2012.372	http://dx.doi.org/10.1038/onc.2012.372			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	176JZ	22926517				2022-12-25	WOS:000321301600010
J	Abderemane-Ali, F; Es-Salah-Lamoureux, Z; Delemotte, L; Kasimova, MA; Labro, AJ; Snyders, DJ; Fedida, D; Tarek, M; Baro, I; Loussouarn, G				Abderemane-Ali, Fayal; Es-Salah-Lamoureux, Zeineb; Delemotte, Lucie; Kasimova, Marina A.; Labro, Alain J.; Snyders, Dirk J.; Fedida, David; Tarek, Mounir; Baro, Isabelle; Loussouarn, Gildas			Dual Effect of Phosphatidyl (4,5)-Bisphosphate PIP2 on Shaker K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNELS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; G-PROTEINS; ACTIVATION; PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE; KV1.2; HERG; INACTIVATION	Phosphatidylinositol (4,5)-bisphosphate (PIP2) is a phospholipid of the plasma membrane that has been shown to be a key regulator of several ion channels. Functional studies and more recently structural studies of Kir channels have revealed the major impact of PIP2 on the open state stabilization. A similar effect of PIP2 on the delayed rectifiers Kv7.1 and Kv11.1, two voltage-gated K+ channels, has been suggested, but the molecular mechanism remains elusive and nothing is known on PIP2 effect on other Kv such as those of the Shaker family. By combining giant-patch ionic and gating current recordings in COS-7 cells, and voltage-clamp fluorimetry in Xenopus oocytes, both heterologously expressing the voltage-dependent Shaker channel, we show that PIP2 exerts 1) a gain-of-function effect on the maximal current amplitude, consistent with a stabilization of the open state and 2) a loss-of-function effect by positive-shifting the activation voltage dependence, most likely through a direct effect on the voltage sensor movement, as illustrated by molecular dynamics simulations.	[Loussouarn, Gildas] CNRS, Inst Thorax, Unite Inserm, UMR 1087,IRT UN,UMR 6291, F-44007 Nantes 1, France; [Abderemane-Ali, Fayal; Es-Salah-Lamoureux, Zeineb; Loussouarn, Gildas] INSERM, UMR 1087, F-44007 Nantes, France; [Abderemane-Ali, Fayal; Es-Salah-Lamoureux, Zeineb; Loussouarn, Gildas] Univ Nantes, Inst Thorax, F-44007 Nantes, France; [Es-Salah-Lamoureux, Zeineb; Fedida, David] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Delemotte, Lucie; Kasimova, Marina A.; Tarek, Mounir] Nancy Univ, CNRS, UMR Struct & Reactivite Syst Mol Complexes 7565, Nancy, France; [Delemotte, Lucie] Temple Univ, Inst Computat & Mol Sci, Philadelphia, PA 19122 USA; [Kasimova, Marina A.] Moscow MV Lomonosov State Univ, Dept Biophys, Fac Biol, Moscow 119991, Russia; [Labro, Alain J.; Snyders, Dirk J.] Univ Antwerp, Dept Biomed Sci, Lab Mol Biophys Physiol & Pharmacol, B-2610 Antwerp, Belgium	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Lomonosov Moscow State University; University of Antwerp	Baro, I (corresponding author), CNRS, Inst Thorax, Unite Inserm, UMR 1087,IRT UN,UMR 6291, 8 Quai Moncousu,BP 70721, F-44007 Nantes 1, France.	gildas.loussouarn@inserm.fr	TAREK, Mounir/B-8443-2012; Baró, Isabelle/D-3604-2015; Loussouarn, Gildas/ABH-6043-2020; Baró, Isabelle/ABH-5667-2020; Snyders, Dirk/A-2713-2013; Es-Salah-Lamoureux, Zeineb/D-3908-2015	Baró, Isabelle/0000-0003-4850-4171; Loussouarn, Gildas/0000-0001-8007-5931; Baró, Isabelle/0000-0003-4850-4171; Snyders, Dirk/0000-0001-7142-6672; Es-Salah-Lamoureux, Zeineb/0000-0003-4530-6655; Labro, Alain J/0000-0002-0871-7511; Delemotte, Lucie/0000-0002-0828-3899	Hubert Curien Program (Tournesol Program) [22628VD]; French Ministere de la Recherche; Lefoulon Delalande Foundation; Fondation de la Recherche Medicale; GENCI-CINES [2011-76742, 2011-75137]	Hubert Curien Program (Tournesol Program); French Ministere de la Recherche(Ministry of Research, France); Lefoulon Delalande Foundation; Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); GENCI-CINES	This work was supported by the Hubert Curien Program (Tournesol Program, Project Number 22628VD).; Recipient of a grant from the French Ministere de la Recherche.; Supported by fellowships from the Lefoulon Delalande Foundation and the Fondation de la Recherche Medicale.; Simulations were performed using HPC resources from GENCI-CINES Grant 2011-76742 and 2011-75137.	Bian JS, 2004, AM J PHYSIOL-HEART C, V287, pH2154, DOI 10.1152/ajpheart.00120.2004; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; Brew HM, 2007, J NEUROPHYSIOL, V98, P1501, DOI 10.1152/jn.00640.2006; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Delemotte L, 2011, P NATL ACAD SCI USA, V108, P6109, DOI 10.1073/pnas.1102724108; Es-Salah-Lamoureux Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010876; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Flynn GE, 2011, J BIOL CHEM, V286, P15535, DOI 10.1074/jbc.M110.214650; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Horne AJ, 2009, CAN J PHYSIOL PHARM, V87, P411, DOI [10.1139/y09-024, 10.1139/Y09-024]; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kruse M, 2012, J GEN PHYSIOL, V140, P189, DOI 10.1085/jgp.201210806; Lindner M, 2011, J PHYSIOL-LONDON, V589, P3149, DOI 10.1113/jphysiol.2011.208983; Loussouarn G, 2003, EMBO J, V22, P5412, DOI 10.1093/emboj/cdg526; Loussouarn Gildas, 2006, V337, P167; Lupyan D, 2010, BIOPHYS J, V98, P240, DOI 10.1016/j.bpj.2009.09.063; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mandal M, 2009, MOL PHARMACOL, V76, P1349, DOI 10.1124/mol.109.058701; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Michailidis IE, 2007, J NEUROSCI, V27, P5523, DOI 10.1523/JNEUROSCI.4378-06.2007; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rodriguez N, 2010, BIOPHYS J, V99, P1110, DOI 10.1016/j.bpj.2010.06.013; Rodriguez-Menchaca A. A., 2012, P NATL ACAD SCI US; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Thomas AM, 2011, J BIOL CHEM, V286, P2088, DOI 10.1074/jbc.M110.153551; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	49	38	38	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36158	36167		10.1074/jbc.M112.382085	http://dx.doi.org/10.1074/jbc.M112.382085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22932893	Green Published, hybrid			2022-12-25	WOS:000310364000037
J	Wang, RX; Yu, CR; Mahdi, RM; Egwuagu, CE				Wang, Ren-Xi; Yu, Cheng-Rong; Mahdi, Rashid M.; Egwuagu, Charles E.			Novel IL27p28/IL12p40 Cytokine Suppressed Experimental Autoimmune Uveitis by Inhibiting Autoreactive Th1/Th17 Cells and Promoting Expansion of Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-12 P40 HOMODIMER; INTERLEUKIN-27; IL-27; DIFFERENTIATION; INFLAMMATION; DISEASE; STAT3; PROLIFERATION; UVEORETINITIS; ACTIVATION	IL-12 family cytokines are important in host immunity. Whereas some members (IL-12, IL-23) play crucial roles in pathogenesis of organ-specific autoimmune diseases by inducing the differentiation of Th1 and Th17 lymphocytes, others (IL-27 and IL-35) suppress inflammatory responses and limit tissue injury induced by these T cell subsets. In this study, we have genetically engineered a novel IL27p28/IL12p40 heterodimeric cytokine (p28/p40) that antagonizes signaling downstream of the gp130 receptor. We investigated whether p28/p40 can be used to ameliorate uveitis, a CNS inflammatory disease. Experimental autoimmune uveitis (EAU) is the mouse model of human uveitis and is mediated by Th1 and Th17 cells. We show here that p28/p40 suppressed EAU by inhibiting the differentiation and inflammatory responses of Th1 and Th17 cells while promoting expansion of IL-10(+)- and Foxp3(+)-expressing regulatory T cells. Lymph node cells from mice treated with p28/p40 blocked adoptive transfer of EAU to naive syngeneic mice by immunopathogenic T cells and suppressive effects of p28/p40 derived in part from antagonizing STAT1 and STAT3 pathways induced by IL-27 and IL-6. Interestingly, IL27p28 also suppressed EAU, but to a lesser extent than p28/p40. The inhibition of uveitogenic lymphocyte proliferation and suppression of EAU by p28/p40 and IL27p28 establish efficacy of single chain and heterodimeric IL-12 family cytokines in treatment of a CNS autoimmune disease. Creation of the biologically active p28/p40 heterodimeric cytokine represents an important proof-of-concept experiment, suggesting that cytokines comprising unique IL-12 alpha- and beta-subunit pairing may exist in nature and may constitute a new class of therapeutic cytokines.	[Wang, Ren-Xi; Yu, Cheng-Rong; Mahdi, Rashid M.; Egwuagu, Charles E.] NEI, Mol Immunol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Egwuagu, CE (corresponding author), NEI, Mol Immunol Sect, Immunol Lab, NIH, Bldg 10,Rm 10N109A,10 Ctr Dr, Bethesda, MD 20892 USA.	egwuaguc@nei.nih.gov	Wang, Renxi/AAM-1326-2020	Wang, Renxi/0000-0003-4130-3334; Yu, Cheng-Rong/0000-0001-7246-0362	National Institutes of Health through the Intramural Research Programs of the NEI; NATIONAL EYE INSTITUTE [ZIAEY000350, ZIAEY000262] Funding Source: NIH RePORTER	National Institutes of Health through the Intramural Research Programs of the NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by the National Institutes of Health through the Intramural Research Programs of the NEI.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Caspi R. R., 2003, CURR PROTOC IMMUNOL, V15; Caspi RR, 2011, INVEST OPHTH VIS SCI, V52, P1873, DOI 10.1167/iovs.10-6909; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; CASPI RR, 1988, J IMMUNOL, V140, P1490; CHAN CC, 1990, J AUTOIMMUN, V3, P247, DOI 10.1016/0896-8411(90)90144-H; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Egwuagu CE, 2000, BRIT J OPHTHALMOL, V84, P1084; Egwuagu CE, 1997, J IMMUNOL, V159, P3109; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Forrester John V, 2007, Chem Immunol Allergy, V92, P228, DOI 10.1159/000099274; Gery Igal, 2002, Int Rev Immunol, V21, P89, DOI 10.1080/08830180212061; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; LING P, 1995, J IMMUNOL, V154, P116; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Matsumoto A, 2003, J EXP MED, V197, P425, DOI 10.1084/jem.20020939; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; NUSSENBLATT RB, 1991, INVEST OPHTH VIS SCI, V32, P3131; Nussenblatt RB, 2003, J AUTOIMMUN, V21, P283, DOI 10.1016/S0896-8411(03)00113-6; Nussenblatt RB, 1999, P NATL ACAD SCI USA, V96, P7462, DOI 10.1073/pnas.96.13.7462; NUSSENBLATT RB, 1990, INT OPHTHALMOL, V14, P303, DOI 10.1007/BF00163549; Oh HM, 2011, J IMMUNOL, V187, P3338, DOI 10.4049/jimmunol.1004019; Oh HM, 2011, J BIOL CHEM, V286, P30888, DOI 10.1074/jbc.M111.253500; Owaki T, 2006, J IMMUNOL, V176, P2773, DOI 10.4049/jimmunol.176.5.2773; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Takeda K, 1998, J IMMUNOL, V161, P4652; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377; Yu CR, 2011, EUR J IMMUNOL, V41, P3495, DOI 10.1002/eji.201141654; Yu CR, 2003, J BIOL CHEM, V278, P29752, DOI 10.1074/jbc.M300489200; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	47	67	70	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36012	36021		10.1074/jbc.M112.390625	http://dx.doi.org/10.1074/jbc.M112.390625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936807	Green Published, hybrid			2022-12-25	WOS:000310364000023
J	Li, LT; Miao, R; Bertram, S; Jia, X; Ward, DM; Kaplan, J				Li, Liangtao; Miao, Ren; Bertram, Sophie; Jia, Xuan; Ward, Diane M.; Kaplan, Jerry			A Role for Iron-Sulfur Clusters in the Regulation of Transcription Factor Yap5-dependent High Iron Transcriptional Responses in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PSEUDAMINOBACTER-SALICYLATOXIDANS; SCHIZOSACCHAROMYCES-POMBE; MONOTHIOL GLUTAREDOXIN; PROTEIN BIOGENESIS; FISSION YEAST; RING FISSION; MITOCHONDRIAL; EXPRESSION; FEP1	Yeast respond to increased cytosolic iron by activating the transcription factor Yap5 increasing transcription of CCC1, which encodes a vacuolar iron importer. Using a genetic screen to identify genes involved in Yap5 iron sensing, we discovered that a mutation in SSQ1, which encodes a mitochondrial chaperone involved in iron-sulfur cluster synthesis, prevented expression of Yap5 target genes. We demonstrated that mutation or reduced expression of other genes involved in mitochondrial iron-sulfur cluster synthesis (YFH1, ISU1) prevented induction of the Yap5 response. We took advantage of the iron-dependent catalytic activity of Pseudaminobacter salicylatoxidans gentisate 1,2-dioxygenase expressed in yeast to measure changes in cytosolic iron. We determined that reductions in iron-sulfur cluster synthesis did not affect the activity of cytosolic gentisate 1,2-dioxygenase. We show that loss of activity of the cytosolic iron-sulfur cluster assembly complex proteins or deletion of cytosolic glutaredoxins did not reduce expression of Yap5 target genes. These results suggest that the high iron transcriptional response, as well as the low iron transcriptional response, senses iron-sulfur clusters.	[Li, Liangtao; Miao, Ren; Bertram, Sophie; Jia, Xuan; Ward, Diane M.; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kaplan, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.	jerry.kaplan@path.utah.edu	Miao, Ren/B-9151-2012		National Institutes of Health, NIDDK [DK30534]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534, R37DK030534] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK30534 from the NIDDK (to J.K.).	Askwith C, 1997, J BIOL CHEM, V272, P401; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Belli G, 2004, J BIOL CHEM, V279, P12386, DOI 10.1074/jbc.M311879200; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen OS, 2002, P NATL ACAD SCI USA, V99, P12321, DOI 10.1073/pnas.192449599; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; HARPEL MR, 1990, J BIOL CHEM, V265, P6301; Hintner JP, 2004, J BIOL CHEM, V279, P37250, DOI 10.1074/jbc.M313500200; Hintner JP, 2001, J BACTERIOL, V183, P6936, DOI 10.1128/JB.183.23.6936-6942.2001; Irazusta V, 2010, FREE RADICAL BIO MED, V48, P411, DOI 10.1016/j.freeradbiomed.2009.11.010; Jbel M, 2011, EUKARYOT CELL, V10, P629, DOI 10.1128/EC.00015-11; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Kim KD, 2011, BIOCHEM BIOPH RES CO, V408, P609, DOI 10.1016/j.bbrc.2011.04.069; LAH MS, 1995, BIOCHEMISTRY-US, V34, P1646, DOI 10.1021/bi00005a021; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2011, J BIOL CHEM, V286, P38488, DOI 10.1074/jbc.M111.286666; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lutz T, 2001, J MOL BIOL, V307, P815, DOI 10.1006/jmbi.2001.4527; Matera I, 2008, J MOL BIOL, V380, P856, DOI 10.1016/j.jmb.2008.05.041; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Pelletier B, 2005, J BIOL CHEM, V280, P25146, DOI 10.1074/jbc.M502947200; Pimentel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037434; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Radisky DC, 1999, J BIOL CHEM, V274, P4497, DOI 10.1074/jbc.274.8.4497; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Stearman R, 1998, GENE, V212, P197, DOI 10.1016/S0378-1119(98)00179-6; Vachon P, 2012, EUKARYOT CELL, V11, P806, DOI 10.1128/EC.00060-12; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	38	42	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35709	35721		10.1074/jbc.M112.395533	http://dx.doi.org/10.1074/jbc.M112.395533			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22915593	Green Published, hybrid			2022-12-25	WOS:000309968000082
J	Yuan, ZY; Friedmann, DR; VanderWielen, BD; Collins, KJ; Kovall, RA				Yuan, Zhenyu; Friedmann, David R.; VanderWielen, Bradley D.; Collins, Kelly J.; Kovall, Rhett A.			Characterization of CSL (CBF-1, Su(H), Lag-1) Mutants Reveals Differences in Signaling Mediated by Notch1 and Notch2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE TRANSCRIPTION COMPLEX; PROTEIN SECONDARY STRUCTURE; RBP-J-KAPPA; CRYSTAL-STRUCTURE; BINDING; DNA; MASTERMIND; INSIGHTS; SYSTEM; DIFFERENTIATION	Notch is a conserved signaling pathway that plays essential roles during embryonic development and postnatally in adult tissues; misregulated signaling results in human disease. Notch receptor-ligand interactions trigger cleavage of the Notch receptor and release of its intracellular domain (NICD) from the membrane. NICD localizes to the nucleus where it forms a transcriptionally active complex with the DNA-binding protein CSL and the coactivator Mastermind (MAM) to up-regulate transcription from Notch target genes. Previous studies have determined the structure of the CSL-NICD-MAM ternary complex and characterized mutations that affect complex assembly in functional assays. However, as CSL is expressed in all cell types, these studies have been limited to analyzing mutations in NICD and MAM. Here, we describe a novel set of cellular reagents to characterize how mutations in CSL affect its function as a transcriptional activator. Using retrovirally transduced embryonic fibroblasts from a CSL-null mouse, we generated cell lines that express either wild-type or mutant CSL molecules. We then analyzed these mutants for defects in Notch1- (NICD1) or Notch2 (NICD2)-mediated activation from two different transcriptional reporters (HES-1 or 4xCBS). Our results show that mutations targeted to the different domains of CSL display significant differences in their ability to adversely affect transcription from the two reporters. Additionally, a subset of CSL mutants is sensitive to whether NICD1 or NICD2 was used to activate the reporter. Taken together, these studies provide important molecular insights into how Notch transcription complexes assemble at different target genes and promoter arrangements in vivo.	[Yuan, Zhenyu; VanderWielen, Bradley D.; Collins, Kelly J.; Kovall, Rhett A.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Friedmann, David R.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University System of Ohio; University of Cincinnati; The Wistar Institute	Kovall, RA (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	kovallra@ucmail.uc.edu			National Institutes of Health [CA120199]; Muscular Dystrophy Association; Leukemia and Lymphoma Society; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA120199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA120199. This work was also supported by Muscular Dystrophy Association and Leukemia and Lymphoma Society (to R. A. K.) and predoctoral fellowships from the American Heart Association (to K. J. R. and D. R. F.).	Arnett KL, 2010, NAT STRUCT MOL BIOL, V17, P1312, DOI 10.1038/nsmb.1938; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Friedmann DR, 2010, PROTEIN SCI, V19, P34, DOI 10.1002/pro.280; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314, DOI 10.1093/oxfordjournals.jbchem.a123898; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Johnson SE, 2010, J BIOL CHEM, V285, P6681, DOI 10.1074/jbc.M109.019968; Kato H, 1997, DEVELOPMENT, V124, P4133; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Kovall RA, 2007, CURR OPIN STRUC BIOL, V17, P117, DOI 10.1016/j.sbi.2006.11.004; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam YS, 2007, P NATL ACAD SCI USA, V104, P2103, DOI 10.1073/pnas.0611092104; OKA C, 1995, DEVELOPMENT, V121, P3291; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; VanderWielen BD, 2011, J BIOL CHEM, V286, P14892, DOI 10.1074/jbc.M110.181156; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644	37	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34904	34916		10.1074/jbc.M112.403287	http://dx.doi.org/10.1074/jbc.M112.403287			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22915591	hybrid, Green Published			2022-12-25	WOS:000309968000004
J	Jha, S; Allen, D; Liere, H; Perfecto, I; Vandermeer, J				Jha, Shalene; Allen, David; Liere, Heidi; Perfecto, Ivette; Vandermeer, John			Mutualisms and Population Regulation: Mechanism Matters	PLOS ONE			English	Article							ANT ATTENDANCE; BIODIVERSITY; PEST; PREDATORS; HOMOPTERA; HONEYDEW; BENEFITS; PATTERN; APHIDS; COSTS	For both applied and theoretical ecological science, the mutualism between ants and their hemipteran partners is iconic. In this well-studied interaction, ants are assumed to provide hemipterans protection from natural enemies in exchange for nutritive honeydew. Despite decades of research and the potential importance in pest control, the precise mechanism producing this mutualism remains contested. By analyzing maximum likelihood parameter estimates of a hemipteran population model, we show that the mechanism of the mutualism is direct, via improved hemipteran growth rates, as opposed to the frequently assumed indirect mechanism, via harassment of the specialist parasites and predators of the hemipterans. Broadly, this study demonstrates that the management of mutualism-based ecosystem services requires a mechanistic understanding of mutualistic interactions. A consequence of this finding is the counter intuitive demonstration that preserving ant participation in the ant-hemipteran mutualism may be the best way of insuring pest control.	[Jha, Shalene] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Allen, David] Middlebury Coll, Dept Biol, Middlebury, VT 05753 USA; [Liere, Heidi] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Perfecto, Ivette] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Vandermeer, John] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Austin; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jha, S (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	sjha@austin.utexas.edu		Allen, David/0000-0002-0712-9603	National Science Foundation [DEB-0349388]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by a National Science Foundation grant to I.P. and J.V. (DEB-0349388). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BANKS C. J., 1958, BULL ENT RES, V49, P701, DOI 10.1017/S0007485300053979; BANKS CJ, 1967, ANN APPL BIOL, V60, P445, DOI 10.1111/j.1744-7348.1967.tb04499.x; BARTLETT B. R., 1961, ANN ENT SOC AMER, V54, P543, DOI 10.1093/aesa/54.4.543; Bolker B, 2008, ECOLOGICAL MODELS DA, P169; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Brussaard L, 2007, AGR ECOSYST ENVIRON, V121, P233, DOI 10.1016/j.agee.2006.12.013; BUCKLEY RC, 1987, ANNU REV ECOL SYST, V18, P111, DOI 10.1146/annurev.es.18.110187.000551; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; FOKKEMA NJ, 1983, T BRIT MYCOL SOC, V81, P355, DOI 10.1016/S0007-1536(83)80087-4; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; HAINES IH, 1978, B ENTOMOL RES, V68, P627, DOI 10.1017/S0007485300009603; Harmon JP, 2007, OIKOS, V116, P1030, DOI 10.1111/j.2007.0030-1299.15578.x; Hsieh H, ECOLOGY EVO IN PRESS; Hsieh H, 2012, PSYCHE J ENTOMOLOGY, V2012, P1; Jha S, 2009, B INSECTOL, V62, P183; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; Liere H, 2008, ENVIRON ENTOMOL, V37, P143, DOI 10.1603/0046-225X(2008)37[143:COAMIB]2.0.CO;2; Liere H, 2010, OIKOS, V119, P1394, DOI 10.1111/j.1600-0706.2010.17985.x; MANTEL N, 1967, CANCER RES, V27, P209; MATLAB, 2003, VERS 6 5 1; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; NAULT LR, 1976, SCIENCE, V192, P1349, DOI 10.1126/science.1273595; Nixon G.E.J., 1951, ASS ANTS APHIDS COCC; Oliver TH, 2008, ECOL ENTOMOL, V33, P523, DOI 10.1111/j.1365-2311.2008.01009.x; Perfecto I, 2008, ECOLOGY, V89, P915, DOI 10.1890/06-2121.1; Ragsdale DW, 2004, ANN ENTOMOL SOC AM, V97, P204, DOI 10.1603/0013-8746(2004)097[0204:SABINA]2.0.CO;2; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; Stadler B, 2002, ECOL LETT, V5, P216, DOI 10.1046/j.1461-0248.2002.00300.x; Stadler B, 1998, J ANIM ECOL, V67, P454, DOI 10.1046/j.1365-2656.1998.00209.x; Stadler B, 2005, ANNU REV ECOL EVOL S, V36, P345, DOI 10.1146/annurev.ecolsys.36.091704.175531; Vandermeer J, 2006, SCIENCE, V311, P1000, DOI 10.1126/science.1121432; VANDERMEER J, 1995, ANNU REV ECOL SYST, V26, P201, DOI 10.1146/annurev.es.26.110195.001221; Vandermeer J, 2008, NATURE, V451, P457, DOI 10.1038/nature06477; Vandermeer J, 2010, BIOSCIENCE, V60, P527, DOI 10.1525/bio.2010.60.7.8; Volkl W, 1996, OECOLOGIA, V107, P498, DOI 10.1007/BF00333941; VOLKL W, 1995, J INSECT BEHAV, V8, P653, DOI 10.1007/BF01997236; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; Wimp GM, 2001, ECOLOGY, V82, P440, DOI 10.1890/0012-9658(2001)082[0440:BCOPAH]2.0.CO;2; Yao I, 2000, OIKOS, V89, P3, DOI 10.1034/j.1600-0706.2000.890101.x	40	19	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43510	10.1371/journal.pone.0043510	http://dx.doi.org/10.1371/journal.pone.0043510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927978	Green Published, gold			2022-12-25	WOS:000308224700016
J	Pauwels, E; Surdez, D; Stoll, G; Lescure, A; Del Nery, E; Delattre, O; Stoven, V				Pauwels, Edouard; Surdez, Didier; Stoll, Gautier; Lescure, Aurianne; Del Nery, Elaine; Delattre, Olivier; Stoven, Veronique			A Probabilistic Model for Cell Population Phenotyping Using HCS Data	PLOS ONE			English	Article							GENOME; RNAI; RECOGNITION; MICROSCOPY; REGRESSION	High Content Screening (HCS) platforms allow screening living cells under a wide range of experimental conditions and give access to a whole panel of cellular responses to a specific treatment. The outcome is a series of cell population images. Within these images, the heterogeneity of cellular response to the same treatment leads to a whole range of observed values for the recorded cellular features. Consequently, it is difficult to compare and interpret experiments. Moreover, the definition of phenotypic classes at a cell population level remains an open question, although this would ease experiments analyses. In the present work, we tackle these two questions. The input of the method is a series of cell population images for which segmentation and cellular phenotype classification has already been performed. We propose a probabilistic model to represent and later compare cell populations. The model is able to fully exploit the HCS-specific information: "dependence structure of population descriptors" and "within-population variability". The experiments we carried out illustrate how our model accounts for this specific information, as well as the fact that the model benefits from considering them. We underline that these features allow richer HCS data analysis than simpler methods based on single cellular feature values averaged over each well. We validate an HCS data analysis method based on control experiments. It accounts for HCS specificities that were not taken into account by previous methods but have a sound biological meaning. Biological validation of previously unknown outputs of the method constitutes a future line of work.	[Pauwels, Edouard; Stoven, Veronique] Mines ParisTech, Ctr Computat Biol, Fontainebleau, France; [Delattre, Olivier] Inst Curie, Unite Genet Somat, Paris, France; [Surdez, Didier; Delattre, Olivier] Inst Natl Sante & Rech Med, Unite Genet & Biol Canc, Paris, France; [Lescure, Aurianne; Del Nery, Elaine] Inst Curie, Dept Translat Res, Biophen Automated Imaging Lab, Paris, France	UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Pauwels, E (corresponding author), Mines ParisTech, Ctr Computat Biol, Fontainebleau, France.	edouard.pauwels@ensmp.fr	Surdez, Didier/ABG-4565-2020	DEL NERY, Elaine/0000-0002-9654-5202; Stoll, Gautier/0000-0002-0862-4139; delattre, olivier/0000-0002-8730-2276	Institut National du Cancer (SYBEwing project); European Union [n259348]	Institut National du Cancer (SYBEwing project); European Union(European Commission)	This work was supported by a grant from the Institut National du Cancer (SYBEwing project). The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement n259348 (ASSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Chang GT, 2007, COMPUT STAT DATA AN, V51, P6242, DOI 10.1016/j.csda.2007.01.008; Conrad C, 2004, GENOME RES, V14, P1130, DOI 10.1101/gr.2383804; Cox DR, 1974, THEORETICAL STAT; Elidan G., 2010, PROC INT C NEURAL IN, P559; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; GENEST C, 1995, BIOMETRIKA, V82, P543, DOI 10.2307/2337532; Genest C, 2007, J HYDROL ENG, V12, P347, DOI 10.1061/(ASCE)1084-0699(2007)12:4(347); Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Hoffman MD, 2010, ADV NEURAL INFORM PR, V23, P559; Hollander M., 1973, NONPARAMETRIC STAT M; Jajuga K, 2006, STUD CLASS DATA ANAL, P606, DOI 10.1007/3-540-31314-1_74; Joe H., 1996, 166 U BRIT COL DEP S; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Kim G, 2007, COMPUT STAT DATA AN, V51, P2836, DOI 10.1016/j.csda.2006.10.009; Kim JM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-225; Koller D., 2009, PROBABILISTIC GRAPHI; Li D., 2000, J FIXED INCOME, V9, P43, DOI DOI 10.3905/JFI.2000.319253; Nelsen R.B., 1998, LECT NOTES STAT; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Onken A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000577; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Rieber N, 2009, BIOINFORMATICS, V25, P678, DOI 10.1093/bioinformatics/btp014; Scholzel C, 2008, NONLINEAR PROC GEOPH, V15, P761, DOI 10.5194/npg-15-761-2008; Shih JH, 1995, BIOMETRICS, V51, P1384, DOI 10.2307/2533269; Sklar M., 1959, PUBLICATIONS I STAT, V8, P229, DOI DOI 10.1007/978-3-642-33590-7; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Smola AJ, 1998, ALGORITHMICA, V22, P211, DOI 10.1007/PL00013831; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Song PXK, 2000, SCAND J STAT, V27, P305, DOI 10.1111/1467-9469.00191; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Wang J, 2008, J BIOMOL SCREEN, V13, P29, DOI 10.1177/1087057107311223	36	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e42715	10.1371/journal.pone.0042715	http://dx.doi.org/10.1371/journal.pone.0042715			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927936	Green Published, gold			2022-12-25	WOS:000308224700007
J	Abbott, AD; Colman, RJ; Tiefenthaler, R; Dumesic, DA; Abbott, DH				Abbott, Andrew D.; Colman, Ricki J.; Tiefenthaler, Ross; Dumesic, Daniel A.; Abbott, David H.			Early-to-Mid Gestation Fetal Testosterone Increases Right Hand 2D:4D Finger Length Ratio in Polycystic Ovary Syndrome-Like Monkeys	PLOS ONE			English	Article							FEMALE RHESUS-MONKEYS; CONGENITAL ADRENAL-HYPERPLASIA; PRENATAL ANDROGEN EXPOSURE; 4TH DIGIT LENGTH; FOLLICLE-STIMULATING-HORMONE; NONHUMAN PRIMATE MODEL; IN-VITRO FERTILIZATION; HUMAN 2D INDEX; LUTEINIZING-HORMONE; ANATOMICAL EVIDENCE	A smaller length ratio for the second relative to the fourth finger (2D:4D) is repeatedly associated with fetal male-typical testosterone (T) and is implicated as a biomarker for a variety of traits and susceptibility to a number of diseases, but no experimental human studies have been performed. The present study utilizes the rhesus monkey, a close relative of humans, and employs discrete gestational exposure of female monkeys to fetal male-typical T levels for 15-35 days during early-to-mid (40-76 days; n = 7) or late (94-139 days; n = 7) gestation (term:165 days) by daily subcutaneous injection of their dams with 10 mg T propionate. Such gestational exposures are known to enhance male-typical behavior. In this study, compared to control females (n = 19), only early-to-mid gestation T exposure virilizes female external genitalia while increasing 2D:4D ratio in the right hand (RH) by male-like elongation of RH2D. RH2D length and 2D:4D positively correlate with androgen-dependent anogenital distance (AG), and RH2D and AG positively correlate with duration of early-to-mid gestation T exposure. Male monkeys (n = 9) exhibit a sexually dimorphic 2D:4D in the right foot, but this trait is not emulated by early-to-mid or late gestation T exposed females. X-ray determined phalanx measurements indicate elongated finger and toe phalanx length in males, but no other phalanx-related differences. Discrete T exposure during early-to-mid gestation in female rhesus monkeys thus appears to increase RH2D:4D through right-side biased, non-skeletal tissue growth. As variation in timing and duration of gestational T exposure alter male-like dimensions of RH2D independently of RH4D, postnatal RH2D:4D provides a complex biomarker for fetal T exposure.	[Abbott, Andrew D.; Colman, Ricki J.; Tiefenthaler, Ross; Dumesic, Daniel A.; Abbott, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Abbott, David H.] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA; [Abbott, David H.] Univ Wisconsin, Endocrinol Reprod Physiol Program, Madison, WI USA; [Dumesic, Daniel A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Abbott, AD (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.	aabbott@primate.wisc.edu		Dumesic, Daniel/0000-0003-0387-1277; Colman, Ricki/0000-0001-9706-0525	National Institutes of Health [R01 RR013635, U01 HD044650, P51 RR000167]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD044650] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167, C06RR020141, R01RR013635, C06RR015459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by National Institutes of Health grants R01 RR013635, U01 HD044650, P51 RR000167 (Wisconsin National Primate Research Centre (WNPRC) base operating grant), and was partly conducted at a facility (WNPRC) constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2008, BIOL REPROD, V79, P154, DOI 10.1095/biolreprod.108.067702; Abbott DH, 2010, AM J PHYSIOL-ENDOC M, V299, pE741, DOI 10.1152/ajpendo.00058.2010; Abbott DH, 2009, AM J PRIMATOL, V71, P776, DOI 10.1002/ajp.20679; Abbott David H., 2008, V13, P145, DOI 10.1159/000134831; Abbott DH, 2005, HUM REPROD UPDATE, V11, P357, DOI 10.1093/humupd/dmi013; Abbott DH, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740001; Abbott DH, 1998, TRENDS ENDOCRIN MET, V9, P62, DOI 10.1016/S1043-2760(98)00019-8; ADAMS J, 1986, BRIT MED J, V293, P355, DOI 10.1136/bmj.293.6543.355; Alpanes M, 2012, EXPERT REV ENDOCRINO, V7, P91, DOI [10.1586/EEM.11.85, 10.1586/eem.11.85]; Anderson H, 2010, J CLIN ENDOCR METAB, V95, P2180, DOI 10.1210/jc.2009-2651; Angwin J, 2004, J RHEUMATOL, V31, P1050; Auger J, 2011, INT J ANDROL, V34, pE49, DOI 10.1111/j.1365-2605.2010.01124.x; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; BARBIERI RL, 1986, AM J OBSTET GYNECOL, V154, P1039, DOI 10.1016/0002-9378(86)90746-5; Barry JA, 2010, J OBSTET GYNAECOL, V30, P444, DOI 10.3109/01443615.2010.485254; Beaton AA, 2011, LATERALITY, V16, P136, DOI 10.1080/13576500903410369; BECKPECCOZ P, 1991, J CLIN ENDOCR METAB, V73, P525, DOI 10.1210/jcem-73-3-525; Berenbaum SA, 2009, ENDOCRINOLOGY, V150, P5119, DOI 10.1210/en.2009-0774; Bescos R, 2009, J SPORT SCI, V27, P625, DOI 10.1080/02640410802707029; Boets B, 2007, NEUROREPORT, V18, P1487, DOI 10.1097/WNR.0b013e3282e9a754; Bourne VJ, 2009, PSYCHONEUROENDOCRINO, V34, P1214, DOI 10.1016/j.psyneuen.2009.03.010; Brabin L, 2008, AM J HUM BIOL, V20, P337, DOI 10.1002/ajhb.20731; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Brown WM, 2002, HORM BEHAV, V42, P380, DOI 10.1006/hbeh.2002.1830; Bruns CM, 2007, INT J OBESITY, V31, P1579, DOI 10.1038/sj.ijo.0803638; Buck JJ, 2003, HUM REPROD, V18, P976, DOI 10.1093/humrep/deg198; Carmina E, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.008; Cattrall FR, 2005, FERTIL STERIL, V84, P1689, DOI 10.1016/j.fertnstert.2005.05.061; Chen XQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002709; Chura LR, 2010, PSYCHONEUROENDOCRINO, V35, P122, DOI 10.1016/j.psyneuen.2009.09.009; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen-Bendahan CCC, 2005, NEUROSCI BIOBEHAV R, V29, P353, DOI 10.1016/j.neubiorev.2004.11.004; Cole B, 2006, J CLIN ENDOCR METAB, V91, P3654, DOI 10.1210/jc.2006-0641; Colman RJ, 1999, J CLIN ENDOCR METAB, V84, P4144, DOI 10.1210/jc.84.11.4144; Dawson PA, 2011, SEMIN CELL DEV BIOL, V22, P653, DOI 10.1016/j.semcdb.2011.03.004; De Bruin EI, 2009, AUTISM, V13, P511, DOI 10.1177/1362361309335720; DIERSCHKE DJ, 1976, J MED PRIMATOL, V5, P100; Dressler SG, 2011, DEV PSYCHOBIOL, V53, P69, DOI 10.1002/dev.20488; Dumesic DA, 2002, J CLIN ENDOCR METAB, V87, P1111, DOI 10.1210/jc.87.3.1111; Dumesic DA, 2003, BIOL REPROD, V69, P1213, DOI 10.1095/biolreprod.102.015164; Dumesic DA, 1997, FERTIL STERIL, V67, P155, DOI 10.1016/S0015-0282(97)81873-0; Dumesic DA, 2007, REV ENDOCR METAB DIS, V8, P127, DOI 10.1007/s11154-007-9046-0; Ecker A, 1875, ARCH ANTHR, V8, P68; Eisner JR, 2003, OBES RES, V11, P279, DOI 10.1038/oby.2003.42; Eisner JR, 2002, FERTIL STERIL, V77, P167, DOI 10.1016/S0015-0282(01)02947-8; Eisner JR, 2000, J CLIN ENDOCR METAB, V85, P1206, DOI 10.1210/jc.85.3.1206; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Foecking EM, 2005, BIOL REPROD, V72, P1475, DOI 10.1095/biolreprod.105.039800; Fowler PA, 2011, J CLIN ENDOCR METAB, V96, pE1502, DOI 10.1210/jc.2011-1100; Galis F, 2010, ARCH SEX BEHAV, V39, P57, DOI 10.1007/s10508-009-9485-7; GARN SM, 1975, AM J PHYS ANTHROPOL, V43, P327, DOI 10.1002/ajpa.1330430305; Gillam L, 2008, J ANAT, V213, P325, DOI 10.1111/j.1469-7580.2008.00940.x; Goy R W, 1972, Recent Prog Horm Res, V28, P707; GOY RW, 1988, HORM BEHAV, V22, P552, DOI 10.1016/0018-506X(88)90058-X; Goy RW, 1988, TOXICITY HORMONES PE, P127; GOY RW, 1982, BANBURY REPORT, V11, P355; GOY RW, 1976, HDB SEXOLOGY, P139; Herman RA, 2000, HORM BEHAV, V38, P52, DOI 10.1006/hbeh.2000.1608; Hickey M, 2011, HUM REPROD, V26, P1469, DOI 10.1093/humrep/der102; Hickey M, 2009, J CLIN ENDOCR METAB, V94, P3714, DOI 10.1210/jc.2009-0544; Hill R, 2012, J SPORT SCI, V30, P129, DOI 10.1080/02640414.2011.637947; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Hopp RN, 2011, AM J HUM BIOL, V23, P423, DOI 10.1002/ajhb.21144; JAMISON CS, 1994, AM J PHYS ANTHROPOL, V94, P409, DOI 10.1002/ajpa.1330940309; JAMISON CS, 1993, AM J PHYS ANTHROPOL, V90, P185, DOI 10.1002/ajpa.1330900205; KEMNITZ JW, 1994, DIABETES, V43, P204, DOI 10.2337/diabetes.43.2.204; Lorda-Diez CI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024546; Lujan ME, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-156; Lujan ME, 2010, HUM REPROD, V25, P204, DOI 10.1093/humrep/dep363; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Malas MA, 2006, EARLY HUM DEV, V82, P469, DOI 10.1016/j.earlhumdev.2005.12.002; Manning JT, 2009, LATERALITY, V14, P528, DOI 10.1080/13576500802637872; Manning JT, 2006, ANN HUM BIOL, V33, P480, DOI 10.1080/03014460600802551; Manning JT, 2011, P NATL ACAD SCI USA, V108, P16143, DOI 10.1073/pnas.1113312108; Manning JT, 2003, MED HYPOTHESES, V60, P340, DOI 10.1016/S0306-9877(02)00400-0; Manning JT, 2001, BREAST, V10, P355, DOI 10.1054/brst.2001.0284; Manning JT, 2001, DEV MED CHILD NEUROL, V43, P160, DOI 10.1017/S0012162201000317; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT, 2001, EVOL HUM BEHAV, V22, P61, DOI 10.1016/S1090-5138(00)00063-5; Manning JT., 2002, DIGIT RATIO POINTER; Martel MM, 2008, BEHAV NEUROSCI, V122, P273, DOI 10.1037/0735-7044.122.2.273; Mayhew TM, 2007, J ANAT, V211, P630, DOI 10.1111/j.1469-7580.2007.00801.x; McFadden D, 2005, HORM BEHAV, V47, P99, DOI 10.1016/j.yhbeh.2004.08.013; McFadden D, 2002, HORM BEHAV, V42, P492, DOI 10.1006/hbeh.2002.1833; McFadden D, 2005, ARCH SEX BEHAV, V34, P341, DOI 10.1007/s10508-005-3123-9; McFadden D, 2009, EARLY HUM DEV, V85, P117, DOI 10.1016/j.earlhumdev.2008.07.001; McIntyre MH, 2009, J HUM EVOL, V56, P361, DOI 10.1016/j.jhevol.2008.12.004; McIntyre MH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-10; McIntyre MH, 2006, AM J PHYS ANTHROPOL, V129, P143, DOI 10.1002/ajpa.20240; McIntyre MH, 2005, P ROY SOC B-BIOL SCI, V272, P1473, DOI 10.1098/rspb.2005.3100; MEIER RJ, 1993, FOLIA PRIMATOL, V60, P164, DOI 10.1159/000156685; Muller DC, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-57; Nelson E, 2010, AM J PHYS ANTHROPOL, V141, P395, DOI 10.1002/ajpa.21157; Nelson E, 2010, PRIMATES, V51, P1, DOI 10.1007/s10329-009-0173-y; New MI, 1999, P NATL ACAD SCI USA, V96, P12790, DOI 10.1073/pnas.96.22.12790; Noipayak Pongsak, 2009, Journal of the Medical Association of Thailand, V92, P1040; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Poretsky L, 1999, ENDOCR REV, V20, P535, DOI 10.1210/er.20.4.535; RESKO JA, 1987, BIOL REPROD, V37, P1185, DOI 10.1095/biolreprod37.5.1185; Roney JR, 2004, HORM BEHAV, V45, P285, DOI 10.1016/j.yhbeh.2003.12.008; Roos N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6309; Sir-Petermann T, 2009, J CLIN ENDOCR METAB, V94, P1923, DOI 10.1210/jc.2008-2836; Smith AR, 2010, INT J EAT DISORDER, V43, P543, DOI 10.1002/eat.20736; Speiser PW, 2010, J CLIN ENDOCR METAB, V95, P4133, DOI 10.1210/jc.2009-2631; Stoyanov Z, 2009, INT J NEUROSCI, V119, P1006, DOI 10.1080/03008200802323883; Stricker S, 2011, DEV DYNAM, V240, P990, DOI 10.1002/dvdy.22565; Sullivan SD, 2004, P NATL ACAD SCI USA, V101, P7129, DOI 10.1073/pnas.0308058101; Talarovicova A, 2009, HORM BEHAV, V55, P235, DOI 10.1016/j.yhbeh.2008.10.010; Thornton J, 2009, HORM BEHAV, V55, P633, DOI 10.1016/j.yhbeh.2009.03.015; Vehmas T, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-12; Voracek M, 2007, AM J HUM BIOL, V19, P142, DOI 10.1002/ajhb.20581; Voracek M, 2006, PERCEPT MOTOR SKILL, V103, P427, DOI 10.2466/PMS.103.2.427-446; Voracek M, 2010, PERCEPT MOTOR SKILL, V110, P33, DOI 10.2466/PMS.110.1.33-47; Voracek M, 2010, SCAND J PSYCHOL, V51, P146, DOI 10.1111/j.1467-9450.2009.00758.x; Voracek M, 2009, AM J PHYS ANTHROPOL, V140, P376, DOI 10.1002/ajpa.21105; Wallen K, 2009, ENDOCRINOLOGY, V150, P4819, DOI 10.1210/en.2009-0986; West C, 2001, MOL CELL ENDOCRINOL, V185, P51, DOI 10.1016/S0303-7207(01)00632-3; Witchel SF, 2011, J PEDIATR ADOL GYNEC, V24, P116, DOI 10.1016/j.jpag.2010.10.001; Xu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027286; Zawadski J., 1992, POLYCYSTIC OVARY SYN, P377; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108; Zhou R, 2005, J CLIN ENDOCR METAB, V90, P6630, DOI 10.1210/jc.2005-0691; Zhou R, 2007, REPROD TOXICOL, V23, P438, DOI 10.1016/j.reprotox.2006.12.009	126	49	51	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42372	10.1371/journal.pone.0042372	http://dx.doi.org/10.1371/journal.pone.0042372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927929	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300020
J	Bonechi, C; Martini, S; Ciani, L; Lamponi, S; Rebmann, H; Rossi, C; Ristori, S				Bonechi, Claudia; Martini, Silvia; Ciani, Laura; Lamponi, Stefania; Rebmann, Herbert; Rossi, Claudio; Ristori, Sandra			Using Liposomes as Carriers for Polyphenolic Compounds: The Case of Trans-Resveratrol	PLOS ONE			English	Article							IN-VIVO; CANCER; SPECTROSCOPY; PERSPECTIVES; RESONANCE; MEMBRANES	Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a polyphenol found in various plants, especially in the skin of red grapes. The effect of resveratrol on human health is the topic of numerous studies. In fact this molecule has shown anti-cancer, anti-inflammatory, blood-sugar-lowering ability and beneficial cardiovascular effects. However, for many polyphenol compounds of natural origin bioavailability is limited by low solubility in biological fluids, as well as by rapid metabolization in vivo. Therefore, appropriate carriers are required to obtain efficient therapeutics along with low administration doses. Liposomes are excellent candidates for drug delivery purposes, due to their biocompatibility, wide choice of physico-chemical properties and easy preparation. In this paper liposome formulations made by a saturated phosphatidyl-choline (DPPC) and cholesterol (or its positively charged derivative DC-CHOL) were chosen to optimize the loading of a rigid hydrophobic molecule such as resveratrol. Plain and resveratrol loaded liposomes were characterized for size, surface charge and structural details by complementary techniques, i.e. Dynamic Light Scattering (DLS), Zeta potential and Small Angle X-ray Scattering (SAXS). Nuclear and Electron Spin magnetic resonances (NMR and ESR, respectively) were also used to gain information at the molecular scale. The obtained results allowed to give an account of loaded liposomes in which resveratrol interacted with the bilayer, being more deeply inserted in cationic liposomes than in zwitterionic liposomes. Relevant properties such as the mean size and the presence of oligolamellar structures were influenced by the loading of RESV guest molecules. The toxicity of all these systems was tested on stabilized cell lines (mouse fibroblast NIH-3T3 and human astrocytes U373-MG), showing that cell viability was not affected by the administration of liposomial resveratrol.	[Bonechi, Claudia; Martini, Silvia; Lamponi, Stefania; Rossi, Claudio] Univ Siena, Dept Pharmaceut, I-53100 Siena, Italy; [Bonechi, Claudia; Martini, Silvia; Lamponi, Stefania; Rossi, Claudio] Univ Siena, Dept Appl Chem, I-53100 Siena, Italy; [Bonechi, Claudia; Martini, Silvia; Lamponi, Stefania; Rossi, Claudio] Univ Siena, CSGI, I-53100 Siena, Italy; [Ciani, Laura; Ristori, Sandra] Univ Florence, Chem Dept Ugo Schiff, Sesto Fiorentino, Italy; [Ciani, Laura; Ristori, Sandra] Univ Florence, CSGI, Sesto Fiorentino, Italy; [Rebmann, Herbert] Phospholipid Res Ctr, Heidelberg, Germany	University of Siena; University of Siena; University of Siena; University of Florence; University of Florence	Bonechi, C (corresponding author), Univ Siena, Dept Pharmaceut, Via Laterina 8, I-53100 Siena, Italy.	ristori@unifi.it	Ristori, Sandra/J-9887-2014; lamponi, stefania/AAM-5490-2021; Ristori, Sandra/ABC-4731-2020	Ristori, Sandra/0000-0003-0708-3956; lamponi, stefania/0000-0002-2788-8797; BONECHI, CLAUDIA/0000-0002-4328-3253; ROSSI, CLAUDIO/0000-0001-6032-1015	Phospholipids Research Center (Heidelberg, Germany)	Phospholipids Research Center (Heidelberg, Germany)	This study was conducted in the framework of a Phospholipids Research Center (Heidelberg, Germany) funded research project. Dr. Herbert Rebmann, a member of the Phospholipids Research Center, took part to the work and co-authored this manuscript. Apart from Dr. Rebmann, who contributed as co-author, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Aziz MH, 2003, INT J ONCOL, V23, P17; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bonechi C, 2008, MAGN RESON CHEM, V46, P625, DOI 10.1002/mrc.2217; Caddeo C, 2008, INT J PHARMACEUT, V363, P183, DOI 10.1016/j.ijpharm.2008.07.024; CEVC G, 1993, CHEM PHYS LIPIDS, V64, P163, DOI 10.1016/0009-3084(93)90064-A; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fahr A, 2005, EUR J PHARM SCI, V26, P251, DOI 10.1016/j.ejps.2005.05.012; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Gregoriadis G., 1993, LIPOSOMES DRUG DELIV; Hunter R. J., 1988, ZETA POTENTIAL COLLO; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kolouchova-Hanzlikova I, 2004, FOOD CHEM, V87, P151, DOI 10.1016/j.foodchem.2004.01.028; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; Lindner P, 2002, NEUTRON XRAYS LIGHT; Mauer N, 2001, EXPERT OPIN BIOL TH, V6, P923; Morandi S, 2004, BBA-BIOMEMBRANES, V1664, P53, DOI 10.1016/j.bbamem.2004.04.002; Narayanan NK, 2009, INT J CANCER, V125, P1, DOI 10.1002/ijc.24336; Pabst Georg, 2006, Biophysical Reviews and Letters, V1, P57, DOI 10.1142/S1793048006000069; Padamwar MN, 2006, INT J PHARMACEUT, V320, P37, DOI 10.1016/j.ijpharm.2006.04.001; Rius C, 2012, IMMUNOLOGY, V185, P3718; Romberg B, 2006, BIOCONJUGATE CHEM, V17, P860, DOI 10.1021/bc060045a; Rossi C, 2011, SEMIN CANCER BIOL, V21, P207, DOI 10.1016/j.semcancer.2011.04.003; Shu XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027484; Shu XH, 2010, BIOCHEM PHARMACOL, V79, P1516, DOI 10.1016/j.bcp.2010.01.022; Vartorelli MR, 2008, J PHYS CHEM B, V112, P16830, DOI 10.1021/jp806476a	26	81	81	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41438	10.1371/journal.pone.0041438	http://dx.doi.org/10.1371/journal.pone.0041438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936976	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300007
J	Gavidia, R; Fuentes, SL; Vasquez, R; Bonilla, M; Ethier, MC; Diorio, C; Caniza, M; Howard, SC; Sung, LL				Gavidia, Ronald; Fuentes, Soad L.; Vasquez, Roberto; Bonilla, Miguel; Ethier, Marie-Chantal; Diorio, Caroline; Caniza, Miguela; Howard, Scott C.; Sung, Lillian			Low Socioeconomic Status Is Associated with Prolonged Times to Assessment and Treatment, Sepsis and Infectious Death in Pediatric Fever in El Salvador	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HEALTH LITERACY; CHILDREN; PREDICTORS; MORTALITY; ADHERENCE; THERAPY	Background: Infection remains the most common cause of death from toxicity in children with cancer in low-and middle-income countries. Rapid administration of antibiotics when fever develops can prevent progression to sepsis and shock, and serves as an important indicator of the quality of care in children with acute lymphoblastic leukemia and acute myeloid leukemia. We analyzed factors associated with (1) Longer times from fever onset to hospital presentation/antibiotic treatment and (2) Sepsis and infection-related mortality. Method: This prospective cohort study included children aged 0-16 years with newly diagnosed acute leukemia treated at Benjamin Bloom Hospital, San Salvador. We interviewed parents/caregivers within one month of diagnosis and at the onset of each new febrile episode. Times from initial fever to first antibiotic administration and occurrence of sepsis and infection-related mortality were documented. Findings: Of 251 children enrolled, 215 had acute lymphoblastic leukemia (85.7%). Among 269 outpatient febrile episodes, median times from fever to deciding to seek medical care was 10.0 hours (interquartile range [IQR] 5.0-20.0), and from decision to seek care to first hospital visit was 1.8 hours (IQR 1.0-3.0). Forty-seven (17.5%) patients developed sepsis and 7 (2.6%) died of infection. Maternal illiteracy was associated with longer time from fever to decision to seek care (P = 0.029) and sepsis (odds ratio [OR] 3.06, 95% confidence interval [CI] 1.09-8.63; P = 0.034). More infectious deaths occurred in those with longer travel time to hospital (OR 1.36, 95% CI 1.03-1.81; P = 0.031) and in families with an annual household income <US$2,000 (OR 13.90, 95% CI 1.62-119.10; P = 0.016). Interpretation: Illiteracy, poverty, and longer travel times are associated with delays in assessment and treatment of fever and with sepsis and infectious mortality in pediatric leukemia. Providing additional education to high-risk families and staying at a nearby guest house during periods of neutropenia may decrease sepsis and infectious mortality.	[Gavidia, Ronald; Fuentes, Soad L.; Vasquez, Roberto; Bonilla, Miguel] Benjamin Bloom Natl Childrens Hosp, San Salvador, El Salvador; [Sung, Lillian] Hosp Sick Children, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada; [Caniza, Miguela] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Howard, Scott C.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Caniza, Miguela; Howard, Scott C.] St Jude Childrens Res Hosp, Int Outreach Program, Memphis, TN 38105 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Gavidia, R (corresponding author), Benjamin Bloom Natl Childrens Hosp, San Salvador, El Salvador.	lillian.sung@sickkids.ca	caniza, miguela a/N-8138-2018; Howard, Scott C/K-3401-2013; Gavidia, Ronald/GQP-2855-2022; Gavidia, Ronald/CAH-3976-2022	caniza, miguela a/0000-0002-7846-9605; Howard, Scott C/0000-0003-2244-1686; Gavidia, Ronald/0000-0002-2090-693X; Gavidia, Ronald/0000-0002-2090-693X; Diorio, Caroline/0000-0002-8005-3836	Canadian Institutes of Health Research [87719]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Dr. Sung is supported by a New Investigator Award from the Canadian Institutes of Health Research (Grant No. 87719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bonilla M, 2009, INT J CANCER, V125, P2144, DOI 10.1002/ijc.24534; Bouza E, 2000, CLIN INFECT DIS, V30, P306, DOI 10.1086/313648; Chirouze C, 2002, CLIN INFECT DIS, V35, P156, DOI 10.1086/341023; Creutzig U, 2001, J CLIN ONCOL, V19, P2705, DOI 10.1200/JCO.2001.19.10.2705; FENAUX P, 1993, BLOOD, V82, P3241; Fronkova E, 2008, LEUKEMIA, V22, P989, DOI 10.1038/leu.2008.22; Gellad WF, 2011, AM J GERIATR PHARMAC, V9, P11, DOI 10.1016/j.amjopharm.2011.02.004; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Gupta S, 2009, BRIT J CANCER, V100, P1026, DOI 10.1038/sj.bjc.6604895; Gupta S, 2011, J PEDIAT HEMATOL ONC, V33, P276, DOI 10.1097/MPH.0b013e31820ff632; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Lie SO, 2003, BRIT J HAEMATOL, V122, P217, DOI 10.1046/j.1365-2141.2003.04418.x; Murray MD, 2009, CLIN PHARMACOL THER, V85, P651, DOI 10.1038/clpt.2009.7; Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002; Phillips B, 2010, EUR J CANCER, V46, P2950, DOI 10.1016/j.ejca.2010.05.024; Pui C.-H., 2004, Annals of Hematology, V83, pS124; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Ribeiro RC, 2008, LANCET ONCOL, V9, P721, DOI 10.1016/S1470-2045(08)70194-3; Seliverstov I, 2011, J THROMB THROMBOLYS, V31, P321, DOI 10.1007/s11239-011-0560-2	20	33	34	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43639	10.1371/journal.pone.0043639	http://dx.doi.org/10.1371/journal.pone.0043639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928008	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300077
J	Yassai, M; Cooley, B; Gorski, J				Yassai, Maryam; Cooley, Brian; Gorski, Jack			Developmental Dynamics of Post-Selection Thymic DN iNKT	PLOS ONE			English	Article							NKT-CELL-DEVELOPMENT; POSITIVE THYMOCYTES; ALPHA-CHAIN; MATURATION; CD4; PRECURSORS; LINEAGE; CD1D	Background: Invariant natural killer T (iNKT) cells develop in the thymus and branch off from the maturation pathway of conventional T cell at the DP stage. While different stages of iNKT cellular development have been defined, the actual time that iNKT cell precursors spend at each stage is still unknown. Methodology/Principal Finding: Here we report on maturation dynamics of post-selection DN iNKT cells by injecting wild-type DPdim thymocytes into the thymus of TCR alpha(-/-) mice and using the V alpha 14-J alpha 18 rearrangements as a molecular marker to follow the maturation dynamics of these cells. Conclusion/Significance: This study shows that the developmental dynamics of DN iNKT cells in DPdim are very rapid and that it takes less than 1 day to down-regulate CD4 and CD8 and become DN. These DN cells are precursors of peripheral DN iNKT cells and appear in the spleen in 1-2 days. Thymic DN iNKT residents are predominantly derived from cells that quickly return from the periphery. The expansion of a very small subset of DN iNKT precursors could also play a small role in this process. These data are an example of measuring T cell maturation in the thymus and show that the maturation dynamics of selected DN iNKT cells fall within the same general time frame as conventional alpha beta T cells.	[Yassai, Maryam; Gorski, Jack] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Cooley, Brian] Med Coll Wisconsin, Dept Orthoped Surg, Milwaukee, WI 53226 USA; [Gorski, Jack] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Yassai, M (corresponding author), BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI USA.	maryam.yassai@bcw.edu			Blood Center Research Foundation; National Institutes of Health (NIH) grant [RO1-AI26085]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026085] Funding Source: NIH RePORTER	Blood Center Research Foundation; National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Blood Center Research Foundation and National Institutes of Health (NIH) grant RO1-AI26085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARASE H, 1992, P NATL ACAD SCI USA, V89, P6506, DOI 10.1073/pnas.89.14.6506; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Berzins SP, 2006, J IMMUNOL, V176, P4059, DOI 10.4049/jimmunol.176.7.4059; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Chen XX, 2007, J LEUKOCYTE BIOL, V82, P1455, DOI 10.1189/jlb.0307163; Dao T, 2004, EUR J IMMUNOL, V34, P3542, DOI 10.1002/eji.200425546; Das R, 2010, IMMUNOL REV, V238, P195, DOI 10.1111/j.1600-065X.2010.00962.x; Dose M, 2009, P NATL ACAD SCI USA, V106, P8641, DOI 10.1073/pnas.0812255106; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; GUIDOS CJ, 1989, P NATL ACAD SCI USA, V86, P7542, DOI 10.1073/pnas.86.19.7542; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; Kronenberg M, 2007, CURR OPIN IMMUNOL, V19, P186, DOI 10.1016/j.coi.2007.02.009; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; MACDONALD HR, 1990, CURR TOP MICROBIOL, V159, P97; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; McNab FW, 2005, J IMMUNOL, V175, P3762, DOI 10.4049/jimmunol.175.6.3762; NIKOLICZUGIC J, 1988, P NATL ACAD SCI USA, V85, P8633, DOI 10.1073/pnas.85.22.8633; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; SPANGRUDE GJ, 1988, J EXP MED, V167, P1671, DOI 10.1084/jem.167.5.1671; Thedrez A, 2007, BLOOD, V110, P251, DOI 10.1182/blood-2007-01-066217; Yassai M, 2000, J IMMUNOL, V165, P3706, DOI 10.4049/jimmunol.165.7.3706; Yassai M, 2002, J IMMUNOL, V168, P3801, DOI 10.4049/jimmunol.168.8.3801; YASSAI M, 1997, ANTIGEN T CELL RECEP, P326	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43509	10.1371/journal.pone.0043509	http://dx.doi.org/10.1371/journal.pone.0043509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927977	gold, Green Published, Green Submitted			2022-12-25	WOS:000308286300058
J	Hernandez-Zimbron, LF; Luna-Munoz, J; Mena, R; Vazquez-Ramirez, R; Kubli-Garfias, C; Cribbs, DH; Manoutcharian, K; Gevorkian, G				Fernando Hernandez-Zimbron, Luis; Luna-Munoz, Jose; Mena, Raul; Vazquez-Ramirez, Ricardo; Kubli-Garfias, Carlos; Cribbs, David H.; Manoutcharian, Karen; Gevorkian, Goar			Amyloid-beta Peptide Binds to Cytochrome C Oxidase Subunit 1	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; A-BETA; OXIDATIVE STRESS; MOUSE MODEL; MITOCHONDRIAL DYSFUNCTION; PROTEIN; ACCUMULATION; PATHOLOGY; NEURODEGENERATION; TOXICITY	Extracellular and intraneuronal accumulation of amyloid-beta aggregates has been demonstrated to be involved in the pathogenesis of Alzheimer's disease (AD). However, the precise mechanism of amyloid-beta neurotoxicity is not completely understood. Previous studies suggest that binding of amyloid-beta to a number of macromolecules has deleterious effects on cellular functions. Mitochondria were found to be the target for amyloid-beta, and mitochondrial dysfunction is well documented in AD. In the present study we have shown for the first time that A beta 1-42 bound to a peptide comprising the amino-terminal region of cytochrome c oxidase subunit 1. Phage clone, selected after screening of a human brain cDNA library expressed on M13 phage and bearing a 61 amino acid fragment of cytochrome c oxidase subunit 1, bound to A beta 142 in ELISA as well as to A beta aggregates present in AD brain. A beta 1-42 and cytochrome c oxidase subunit 1 coimmunoprecipitated from mitochondrial fraction of differentiated human neuroblastoma cells. Likewise, molecular dynamics simulation of the cytochrome c oxidase subunit 1 and the A beta 1-42 peptide complex resulted in a reliable helix-helix interaction, supporting the experimental results. The interaction between A beta 1-42 and cytochrome c oxidase subunit 1 may explain, in part, the diminished enzymatic activity of respiratory chain complex IV and subsequent neuronal metabolic dysfunction observed in AD.	[Fernando Hernandez-Zimbron, Luis; Vazquez-Ramirez, Ricardo; Kubli-Garfias, Carlos; Manoutcharian, Karen; Gevorkian, Goar] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Luna-Munoz, Jose; Mena, Raul] CINVESTAV IPN, Dept Neurosci, Mexico City, DF, Mexico; [Cribbs, David H.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA; [Cribbs, David H.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA	Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of California System; University of California Irvine; University of California System; University of California Irvine	Hernandez-Zimbron, LF (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico.	gokar@servidor.unam.mx		HERNANDEZ ZIMBRON, LUIS FERNANDO/0000-0002-5098-367X; VAZQUEZ-RAMIREZ, RICARDO/0000-0002-7002-0934	Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) [IN209610]; Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico [58081]; CONACyT; Doctorado en Ciencias Biomedicas, UNAM, Mexico	Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Doctorado en Ciencias Biomedicas, UNAM, Mexico	This work was supported by grants from Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) grant number IN209610, and Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico, grant number 58081 to GG. LFHZ is the recipient of a doctoral scholarship from CONACyT and Doctorado en Ciencias Biomedicas, UNAM, Mexico. These funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleardi AM, 2005, J BIOENERG BIOMEMBR, V37, P207, DOI 10.1007/s10863-005-6631-3; [Anonymous], 2007, HYPERCHEM PROF REL 8; ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Blass JP, 2000, ANN NY ACAD SCI, V903, P204, DOI 10.1111/j.1749-6632.2000.tb06370.x; Blurton-Jones Mathew, 2006, Current Alzheimer Research, V3, P437, DOI 10.2174/156720506779025242; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Butterfield DA, 2004, BRAIN PATHOL, V14, P426; Canevari L, 2004, NEUROCHEM RES, V29, P637, DOI 10.1023/B:NERE.0000014834.06405.af; Canevari L, 1999, FEBS LETT, V457, P131, DOI 10.1016/S0014-5793(99)01028-5; Cardoso SM, 2001, FASEB J, V15, P1439, DOI 10.1096/fj.00-0561fje; Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cassano T, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.021; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Dragicevic N, 2010, J ALZHEIMERS DIS, V20, pS535, DOI 10.3233/JAD-2010-100342; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003; Eckert A, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt74; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Frautschy SA, 2010, MOL NEUROBIOL, V41, P392, DOI 10.1007/s12035-010-8137-1; Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104; Gevorkian G, 2008, NEUROCHEM INT, V52, P1030, DOI 10.1016/j.neuint.2007.10.020; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang XD, 2004, ANN NY ACAD SCI, V1012, P153, DOI 10.1196/annals.1306.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Luna-Munoz J, 2008, ACTA NEUROPATHOL, V116, P507, DOI 10.1007/s00401-008-0431-x; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Medecigo M, 2010, J NEUROIMMUNOL, V223, P104, DOI 10.1016/j.jneuroim.2010.03.023; Moreira PI, 2002, J NEUROSCI RES, V69, P257, DOI 10.1002/jnr.10282; Munguia ME, 2006, NEUROSCI LETT, V397, P79, DOI 10.1016/j.neulet.2005.11.061; Muramoto K, 2010, P NATL ACAD SCI USA, V107, P7740, DOI 10.1073/pnas.0910410107; Pavlov PF, 2011, FASEB J, V25, P78, DOI 10.1096/fj.10-157230; Perez-Garmendia R, 2010, J NEUROIMMUNOL, V229, P248, DOI 10.1016/j.jneuroim.2010.08.020; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Santos RX, 2010, J ALZHEIMERS DIS, V20, pS401, DOI 10.3233/JAD-2010-100666; Singh P, 2009, BIOINFORMATION, V3, P440, DOI 10.6026/97320630003440; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; Tillement L, 2006, STEROIDS, V71, P725, DOI 10.1016/j.steroids.2006.05.003; Tillement L, 2011, MITOCHONDRION, V11, P13, DOI 10.1016/j.mito.2010.08.009; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Yan SD, 2005, INT J EXP PATHOL, V86, P161, DOI 10.1111/j.0959-9673.2005.00427.x; Yan SD, 1997, NATURE, V389, P689; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yao J, 2011, J NEUROSCI, V31, P2313, DOI 10.1523/JNEUROSCI.4717-10.2011; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	59	67	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42344	10.1371/journal.pone.0042344	http://dx.doi.org/10.1371/journal.pone.0042344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927926	Green Published, gold			2022-12-25	WOS:000307789700010
J	Liu, JK; Tang, XF; Gao, LY; Gao, YF; Li, YX; Huang, SX; Sun, XC; Miao, M; Zeng, H; Tian, XF; Niu, XL; Zheng, L; Giovannoni, J; Xiao, FM; Liu, YS				Liu, Jikai; Tang, Xiaofeng; Gao, Lanyang; Gao, Yongfeng; Li, Yuxiang; Huang, Shengxiong; Sun, Xiaochun; Miao, Min; Zeng, Hui; Tian, Xuefen; Niu, Xiangli; Zheng, Lei; Giovannoni, Jim; Xiao, Fangming; Liu, Yongsheng			A Role of Tomato UV-Damaged DNA Binding Protein 1 (DDB1) in Organ Size Control via an Epigenetic Manner	PLOS ONE			English	Article							HISTONE H4; SIGNAL-TRANSDUCTION; GENE; CELL; METHYLTRANSFERASE; METHYLATION; INTERACTS; WEE1; CUL4-DDB1; INTEGRITY	Epigenetic modification generally refers to phenotypic changes by a mechanism other than changes in DNA sequence and plays a significant role in developmental processes. In this study, we found that overexpression of one alternatively spliced tomato DDB1 transcript, DDB1 F that is prevalently present in all tested tissues, resulted in reduction of organ size. Transgenic plants constitutively expressing the DDB1 F from a strong cauliflower mosaic virus (CaMV) 35S promoter displayed moderately reduced size in vegetative organs (leaves and stems) and radically decreased size in reproductive organs (flowers, seeds and fruits), in which several genes encoding negative regulators for cell division were upregulated. Significantly, reduction of organ size conferred by overexpression of DDB1 F transgene appears not to segregate in the subsequent generations, suggesting the phenotypic alternations are manipulated in an epigenetic manner and can be transmitted over generations. This notion was further substantiated by analysis of DNA methylation level at the SlWEE1 gene (encoding a negative regulator of cell division), revealing a correlation between less methylation in the promoter region and elevated expression level of this gene. Thus, our results suggest DDB1 plays an important role in regulation of the epigenetic state of genes involved in organogenesis, despite the underlying mechanism remains to be elucidated.	[Liu, Jikai; Tang, Xiaofeng; Gao, Lanyang; Gao, Yongfeng; Li, Yuxiang; Huang, Shengxiong; Sun, Xiaochun; Miao, Min; Zeng, Hui; Tian, Xuefen; Liu, Yongsheng] Sichuan Univ, Minist Educ, State Key Lab Hydraul & Mt River Engn, Key Lab Bioresource & Ecoenvironm,Coll Life Sci, Chengdu 610064, Peoples R China; [Liu, Jikai; Tang, Xiaofeng; Niu, Xiangli; Zheng, Lei; Liu, Yongsheng] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China; [Miao, Min; Xiao, Fangming] Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA; [Giovannoni, Jim] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Giovannoni, Jim] Cornell Univ, USDA ARS, Robert Holly Ctr, Ithaca, NY 14853 USA	Sichuan University; Hefei University of Technology; Idaho; University of Idaho; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; United States Department of Agriculture (USDA)	Liu, JK (corresponding author), Sichuan Univ, Minist Educ, State Key Lab Hydraul & Mt River Engn, Key Lab Bioresource & Ecoenvironm,Coll Life Sci, Chengdu 610064, Peoples R China.	fxiao@uidaho.edu; liuyongsheng1122@yahoo.com.cn	Li, Yuxiang/GXH-5272-2022; Zheng, Lei/AAF-6159-2019; huang, shengxiong/E-8111-2012	Li, Yuxiang/0000-0002-7284-3985; Huang, Shengxiong/0000-0003-2268-3001	National Science Fund for Distinguished Young Scholars [30825030]; National Natural Science Foundation of China [31171179]; National Science and Technology Key Project of China [2009ZX08001-011B, 2009ZX08009-072B, 2011CB100401]; University of Idaho Startup Funding	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Key Project of China; University of Idaho Startup Funding	This work was supported by the National Science Fund for Distinguished Young Scholars (No. 30825030), the National Natural Science Foundation of China (No. 31171179), the National Science and Technology Key Project of China (Nos. 2009ZX08001-011B, 2009ZX08009-072B and 2011CB100401) to Y. Liu and the University of Idaho Startup Funding for F. Xiao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Azari R, 2010, J EXP BOT, V61, P3627, DOI 10.1093/jxb/erq176; Azari R, 2010, BIOTECHNOL ADV, V28, P108, DOI 10.1016/j.biotechadv.2009.10.003; Biedermann S, 2010, PLANT J, V62, P404, DOI 10.1111/j.1365-313X.2010.04157.x; Bino RJ, 2005, NEW PHYTOL, V166, P427, DOI 10.1111/j.1469-8137.2005.01362.x; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Caspi N, 2008, PLANT SIGNAL BEHAV, V3, P641, DOI 10.4161/psb.3.9.6413; Castells E, 2011, EMBO J, V30, P1162, DOI 10.1038/emboj.2011.20; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chen HD, 2010, PLANT CELL, V22, P108, DOI 10.1105/tpc.109.065490; Cheniclet C, 2005, PLANT PHYSIOL, V139, P1984, DOI 10.1104/pp.105.068767; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; Ding Y, 2007, PLANT CELL, V19, P9, DOI 10.1105/tpc.106.048124; Dumbliauskas E, 2011, EMBO J, V30, P731, DOI 10.1038/emboj.2010.359; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; FILLATTI JJ, 1987, BIO-TECHNOL, V5, P726, DOI 10.1038/nbt0787-726; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Gonzalez N, 2004, PLANT MOL BIOL, V56, P849, DOI 10.1007/s11103-004-5110-2; Gonzalez N, 2007, PLANT J, V51, P642, DOI 10.1111/j.1365-313X.2007.03167.x; Gu XF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002366; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Kolotilin I, 2007, PLANT PHYSIOL, V145, P389, DOI 10.1104/pp.107.102962; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; Kotake Y, 2009, CANCER RES, V69, P1809, DOI 10.1158/0008-5472.CAN-08-2739; Lee JH, 2010, PLANT CELL, V22, P1716, DOI 10.1105/tpc.109.073783; Lewis ZA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001196; Li YH, 2008, GENE DEV, V22, P1331, DOI 10.1101/gad.463608; Lieberman M, 2004, THEOR APPL GENET, V108, P1574, DOI 10.1007/s00122-004-1584-1; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; Liu JK, 2012, MOL PLANT PATHOL, V13, P123, DOI 10.1111/j.1364-3703.2011.00735.x; Liu YS, 2004, P NATL ACAD SCI USA, V101, P9897, DOI 10.1073/pnas.0400935101; Mathieu-Rivet E, 2010, PLANT J, V62, P727, DOI 10.1111/j.1365-313X.2010.04198.x; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Pazhouhandeh M, 2011, P NATL ACAD SCI USA, V108, P3430, DOI 10.1073/pnas.1018242108; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Sambrook J, 2001, MOL CLONING LAB MANU; Sun YJ, 1999, P NATL ACAD SCI USA, V96, P4180, DOI 10.1073/pnas.96.7.4180; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Vanstraelen M, 2009, P NATL ACAD SCI USA, V106, P11806, DOI 10.1073/pnas.0901193106; Wang SH, 2008, PLANT J, V55, P89, DOI 10.1111/j.1365-313X.2008.03489.x; Xu H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001132; Yen HC, 1997, THEOR APPL GENET, V95, P1069, DOI 10.1007/s001220050664; Zhao YB, 2010, J BIOL CHEM, V285, P4355, DOI 10.1074/jbc.M109.034710	52	13	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42621	10.1371/journal.pone.0042621	http://dx.doi.org/10.1371/journal.pone.0042621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927934	Green Published, Green Submitted, gold			2022-12-25	WOS:000307789700014
J	Seo, KW; Holt, R; Jung, YS; Rodriguez, CO; Chen, X; Rebhun, RB				Seo, Kyoung Won; Holt, Roseline; Jung, Yong-Sam; Rodriguez, Carlos O., Jr.; Chen, Xinbin; Rebhun, Robert B.			Fluoroquinolone-Mediated Inhibition of Cell Growth, S-G(2)/M Cell Cycle Arrest, and Apoptosis in Canine Osteosarcoma Cell Lines	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; IN-VITRO; METABOLITE CIPROFLOXACIN; CORTICAL ALLOGRAFT; OSTEOBLASTIC CELLS; TENDON CELLS; DOGS; PROLIFERATION; ENROFLOXACIN; DNA	Despite significant advancements in osteosarcoma research, the overall survival of canine and human osteosarcoma patients has remained essentially static over the past 2 decades. Post-operative limb-spare infection has been associated with improved survival in both species, yet a mechanism for improved survival has not been clearly established. Given that the majority of canine osteosarcoma patients experiencing post-operative infections were treated with fluoroquinolone antibiotics, we hypothesized that fluoroquinolone antibiotics might directly inhibit the survival and proliferation of canine osteosarcoma cells. Ciprofloxacin or enrofloxacin were found to inhibit p21(WAF1) expression resulting in decreased proliferation and increased S-G(2)/M accumulation. Furthermore, fluoroquinolone exposure induced apoptosis of canine osteosarcoma cells as demonstrated by cleavage of caspase-3 and PARP, and activation of caspase-3/7. These results support further studies examining the potential impact of quinolones on survival and proliferation of osteosarcoma.	[Seo, Kyoung Won] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Seo, Kyoung Won; Holt, Roseline; Jung, Yong-Sam; Rodriguez, Carlos O., Jr.; Chen, Xinbin; Rebhun, Robert B.] Chungnam Natl Univ, Coll Vet Med, Dept Internal Med, Taejon, South Korea	University of California System; University of California Davis; Chungnam National University	Seo, KW (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA.	rbrebhun@ucdavis.edu		Rebhun, Robert/0000-0002-8047-3494; Seo, Kyoung won/0000-0002-1561-3278; Rodriguez Jr, Carlos O/0000-0001-8865-2684	Anne Keleman Estate; Center for Companion Animal Health; UC Davis School of Veterinary Medicine; Bernice Barbour Foundation; NCRR [K01 RR031272]; Office of Research Infrastructure Programs [8K01OD011111-02]; NATIONAL CANCER INSTITUTE [R01CA081237, R01CA123227, P30CA093373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR031272] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD011111] Funding Source: NIH RePORTER	Anne Keleman Estate; Center for Companion Animal Health; UC Davis School of Veterinary Medicine; Bernice Barbour Foundation; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a gift from the Anne Keleman Estate, Center for Companion Animal Health, UC Davis School of Veterinary Medicine, the Bernice Barbour Foundation, and NCRR K01 RR031272 (currently supported by the Office of Research Infrastructure Programs 8K01OD011111-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranha O, 2000, CLIN CANCER RES, V6, P891; Aranha O, 2003, INT J ONCOL, V22, P787; Bellido T, 1998, J BIOL CHEM, V273, P21137, DOI 10.1074/jbc.273.33.21137; Bezwada P, 2008, CURR MED RES OPIN, V24, P419, DOI 10.1185/030079908X261005; Boothe D M, 2001, Vet Ther, V2, P120; Cole LK, 2009, VET DERMATOL, V20, P51, DOI 10.1111/j.1365-3164.2008.00730.x; Dalhoff A, 2003, LANCET INFECT DIS, V3, P359, DOI 10.1016/S1473-3099(03)00658-3; Donato NJ, 1998, J BIOL CHEM, V273, P5067, DOI 10.1074/jbc.273.9.5067; Dow S, 2005, HUM GENE THER, V16, P937, DOI 10.1089/hum.2005.16.937; Gartel AL, 2002, MOL CANCER THER, V1, P639; Herold C, 2002, BRIT J CANCER, V86, P443, DOI 10.1038/sj.bjc.6600079; Holtom PD, 2000, J ORTHOP RES, V18, P721, DOI 10.1002/jor.1100180507; Jackson JR, 2000, CANCER RES, V60, P566; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Jeys LM, 2007, ANN SURG ONCOL, V14, P2887, DOI 10.1245/s10434-007-9483-8; Jun YT, 2003, ANTIMICROB AGENTS CH, V47, P1161, DOI 10.1128/AAC.47.3.1161-1164.2003; Khanna C, 2003, CURR CANCER DRUG TAR, V3, P265, DOI 10.2174/1568009033481903; KUNG K, 1993, J VET PHARMACOL THER, V16, P462, DOI 10.1111/j.1365-2885.1993.tb00212.x; Kurzman ID, 1995, CLIN CANCER RES, V1, P1595; Lascelles BDX, 2005, ANN SURG ONCOL, V12, P1073, DOI 10.1245/ASO.2005.01.011; Lawrence JW, 1996, MOL PHARMACOL, V50, P1178; Legare ME, 2011, J CANCER, V2, P262, DOI 10.7150/jca.2.262; Lim S, 2008, VET RES COMMUN, V32, P243, DOI 10.1007/s11259-007-9024-8; Liptak JM, 2006, VET SURG, V35, P518, DOI 10.1111/j.1532-950X.2006.00185.x; Miclau T, 1998, J ORTHOPAED RES, V16, P509, DOI 10.1002/jor.1100160417; Multhaupt HAB, 2001, J BONE JOINT SURG AM, V83A, P56, DOI 10.2106/00004623-200100021-00012; Norris MD, 2001, MED PEDIATR ONCOL, V36, P177, DOI 10.1002/1096-911X(20010101)36:1<177::AID-MPO1042>3.0.CO;2-Q; OWEN LN, 1974, EUR J CANCER, V10, P775, DOI 10.1016/0014-2964(74)90133-9; Senderowicz AM, 2000, JNCI-J NATL CANCER I, V92, P376, DOI 10.1093/jnci/92.5.376; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Sottnik JL, 2010, CANCER IMMUNOL IMMUN, V59, P367, DOI 10.1007/s00262-009-0755-y; SPODNICK GJ, 1992, J AM VET MED ASSOC, V200, P995; THRALL DE, 1990, INT J RADIAT ONCOL, V18, P1351, DOI 10.1016/0360-3016(90)90308-7; Tsai WC, 2008, ARTHRITIS RHEUM-US, V58, P1657, DOI 10.1002/art.23518; WALKER RD, 1992, AM J VET RES, V53, P2315; Withrow S., 2007, WITHROW MACEWENS SMA; Zhang J, 2009, MOL CANCER RES, V7, P67, DOI 10.1158/1541-7786.MCR-08-0347	37	28	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42960	10.1371/journal.pone.0042960	http://dx.doi.org/10.1371/journal.pone.0042960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927942	Green Published, gold, Green Submitted			2022-12-25	WOS:000307789700017
J	Spanswick, SC; Dyck, RH				Spanswick, Simon C.; Dyck, Richard H.			Object/Context Specific Memory Deficits following Medial Frontal Cortex Damage in Mice	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; PREFRONTAL CORTEX; PERIRHINAL CORTEX; TEMPORAL-ORDER; HIPPOCAMPUS; RAT; LESIONS; PLACE; FEAR; PROJECTIONS	Recent evidence suggests that the medial prefrontal cortex (MFC) is important for processing contextual information. Here we evaluate the performance of mice with MFC damage in a discrimination task that requires an association between an object and the context in which it was experienced (the object/context mismatch task), as well as a version of the novel object preference task that does not require knowledge of contextual information to resolve. Adult C57/BL6 mice received aspiration lesions of the MFC or control surgery. Upon recovery, mice were tested in the object/context mismatch and novel object preference tasks. The object/context mismatch task involved exposing mice to two different contexts, each of which housed a unique pair of identical objects. After a brief delay, mice were re-exposed to one of the contexts, this time with one object that was congruent with that context and one that was not. Novel object preference was performed within a single context, housing an identical pair of objects. After the initial exposure and following a brief delay, mice were re-exposed to the context, this time housing a familiar and a novel object. Control mice were able to successfully resolve the object/context mismatch and novel object preference discriminations, investigating the incongruent/novel object within each task significantly greater than chance. Mice with MFC damage experienced deficits in the object/context mismatch task but not the novel object preference task. These findings add to a growing body of evidence that demonstrate a critical role for the MFC in contextual information processing.	[Spanswick, Simon C.; Dyck, Richard H.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [Spanswick, Simon C.; Dyck, Richard H.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Spanswick, SC (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	scspansw@ucalgary.ca		Dyck, Richard/0000-0002-3254-8332	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes for Health Research; Alberta Innovates; Hotchkiss Brain Institute Provincial Program on Perinatal Determinants of Brain and Mental Health	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates; Hotchkiss Brain Institute Provincial Program on Perinatal Determinants of Brain and Mental Health	The authors wish to acknowledge funding support from the Natural Sciences and Engineering Research Council of Canada, the Canadian Institutes for Health Research and the CIHR Training Program in Genetics, Child Development and Health, as well as the Alberta Innovates and Hotchkiss Brain Institute Provincial Program on Perinatal Determinants of Brain and Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker GRI, 2011, EUR J NEUROSCI, V33, P705, DOI 10.1111/j.1460-9568.2010.07555.x; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Bossert JM, 2011, NAT NEUROSCI, V14, P420, DOI 10.1038/nn.2758; Browning PGF, 2005, EUR J NEUROSCI, V22, P3281, DOI 10.1111/j.1460-9568.2005.04477.x; Buckmaster CA, 2004, J NEUROSCI, V24, P9811, DOI 10.1523/JNEUROSCI.1532-04.2004; Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107; Coutellier L, 2009, BEHAV BRAIN RES, V203, P312, DOI 10.1016/j.bbr.2009.05.001; Devito LM, 2010, BEHAV BRAIN RES, V20, P108; DeVito LM, 2011, J NEUROSCI, V31, P3169, DOI 10.1523/JNEUROSCI.4202-10.2011; DeVito LM, 2010, BEHAV BRAIN RES, V215, P318, DOI 10.1016/j.bbr.2009.09.014; DeVito LM, 2010, LEARN MEMORY, V17, P161, DOI 10.1101/lm.1685710; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; Ennaceur A, 1997, BEHAV BRAIN RES, V88, P181, DOI 10.1016/S0166-4328(97)02297-3; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hannesson DK, 2004, BEHAV BRAIN RES, V153, P273, DOI 10.1016/j.bbr.2003.12.004; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Judo C, 2010, NEUROSCIENCE, V169, P1705, DOI 10.1016/j.neuroscience.2010.06.035; Kesner RP, 2003, BEHAV BRAIN RES, V146, P159, DOI 10.1016/j.bbr.2003.09.024; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Li JS, 2011, BEHAV BRAIN RES, V218, P94, DOI 10.1016/j.bbr.2010.11.044; Mitchell JB, 1998, BEHAV BRAIN RES, V97, P107, DOI 10.1016/S0166-4328(98)00032-1; Mouton P.R., 2001, PRINCIPLES PRACTICES; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; O'Brien N, 2006, BEHAV BRAIN RES, V170, P156, DOI 10.1016/j.bbr.2006.02.008; Piterkin P, 2008, LEARN MEMORY, V15, P785, DOI 10.1101/lm.1035508; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Sannino S, 2012, LEARN MEMORY, V19, P211, DOI 10.1101/lm.025213.111; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Stanahan AM, 2011, BEHAV NEUROSCI, V125, P791; Sutherland RJ, 2010, NEUROPSYCHOLOGIA, V48, P2357, DOI 10.1016/j.neuropsychologia.2010.04.015; Van De Werd HJJM, 2010, BRAIN STRUCT FUNCT, V214, P339, DOI 10.1007/s00429-010-0247-z; Van der Jeugd A, 2009, BEHAV NEUROSCI, V123, P109, DOI 10.1037/a0013990; Verwer RWH, 1997, HIPPOCAMPUS, V7, P397, DOI 10.1002/(SICI)1098-1063(1997)7:4<397::AID-HIPO5>3.0.CO;2-G; Wan HM, 1999, J NEUROSCI, V19, P1142	35	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43698	10.1371/journal.pone.0043698	http://dx.doi.org/10.1371/journal.pone.0043698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928019	gold, Green Published, Green Submitted			2022-12-25	WOS:000307789700047
J	Boerner, S; McGinnis, KM				Boerner, Susan; McGinnis, Karen M.			Computational Identification and Functional Predictions of Long Noncoding RNA in Zea mays	PLOS ONE			English	Article							MESSENGER-RNA; REGULATORY ROLES; DNA METHYLATION; GENE-EXPRESSION; POLYMERASE-IV; GENOME-WIDE; TRANSCRIPTION; MAIZE; PROTEIN; PARAMUTATION	Background: Computational analysis of cDNA sequences from multiple organisms suggests that a large portion of transcribed DNA does not code for a functional protein. In mammals, noncoding transcription is abundant, and often results in functional RNA molecules that do not appear to encode proteins. Many long noncoding RNAs (IncRNAs) appear to have epigenetic regulatory function in humans, including HOTAIR and XIST. While epigenetic gene regulation is clearly an essential mechanism in plants, relatively little is known about the presence or function of IncRNAs in plants. Methodology/Principal Findings: To explore the connection between IncRNA and epigenetic regulation of gene expression in plants, a computational pipeline using the programming language Python has been developed and applied to maize full length cDNA sequences to identify, classify, and localize potential IncRNAs. The pipeline was used in parallel with an SVM tool for identifying ncRNAs to identify the maximal number of ncRNAs in the dataset. Although the available library of sequences was small and potentially biased toward protein coding transcripts, 15% of the sequences were predicted to be noncoding. Approximately 60% of these sequences appear to act as precursors for small RNA molecules and may function to regulate gene expression via a small RNA dependent mechanism. ncRNAs were predicted to originate from both genic and intergenic loci. Of the IncRNAs that originated from genic loci, similar to 20% were antisense to the host gene loci. Conclusions/Significance: Consistent with similar studies in other organisms, noncoding transcription appears to be widespread in the maize genome. Computational predictions indicate that maize IncRNAs may function to regulate expression of other genes through multiple RNA mediated mechanisms.	[Boerner, Susan; McGinnis, Karen M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Boerner, S (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	mcginnis@bio.fsu.edu			National Science Foundation and Genome Systems [MCB-027129]	National Science Foundation and Genome Systems	This work was funded by the National Science Foundation and Genome Systems grant through award number MCB-027129 to KMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arteaga-Vazquez M, 2010, P NATL ACAD SCI USA, V107, P12986, DOI 10.1073/pnas.1007972107; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bardou F, 2011, BIOCHIMIE, V93, P1950, DOI 10.1016/j.biochi.2011.07.028; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Campalans A, 2004, PLANT CELL, V16, P1047, DOI 10.1105/tpc.019406; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Castrignano T, 2004, NUCLEIC ACIDS RES, V32, pW624, DOI 10.1093/nar/gkh486; Chen DJ, 2011, RNA, V17, P1012, DOI 10.1261/rna.2589011; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chooniedass-Kothari S, 2004, FEBS LETT, V566, P43, DOI 10.1016/j.febslet.2004.03.104; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Gendler K, 2008, NUCLEIC ACIDS RES, V36, pD298, DOI 10.1093/nar/gkm768; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Haun WJ, 2007, PLANT J, V49, P325, DOI 10.1111/j.1365-313X.2006.02965.x; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Hennig L, 2009, TRENDS GENET, V25, P414, DOI 10.1016/j.tig.2009.07.002; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Jenny A, 2006, DEVELOPMENT, V133, P2827, DOI 10.1242/dev.02456; Jia Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000737; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kloc M, 2005, DEVELOPMENT, V132, P3445, DOI 10.1242/dev.01919; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Liang CZ, 2009, GENOME RES, V19, P1912, DOI 10.1101/gr.088997.108; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; McGinnis KM, 2006, GENETICS, V173, P1637, DOI 10.1534/genetics.106.058669; Meng YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031163; Mercer TR, 2010, GENOME RES, V20, P1639, DOI 10.1101/gr.112128.110; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nobuta K, 2008, P NATL ACAD SCI USA, V105, P14958, DOI 10.1073/pnas.0808066105; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Redrup L, 2009, DEVELOPMENT, V136, P525, DOI 10.1242/dev.031328; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Soderlund C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000740; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Voss B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-123; Wang J, 2004, NATURE, V431, DOI 10.1038/nature03016; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Wen Jiayu, 2007, In Silico Biology, V7, P485; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	78	132	144	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43047	10.1371/journal.pone.0043047	http://dx.doi.org/10.1371/journal.pone.0043047			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916204	Green Published, Green Submitted, gold			2022-12-25	WOS:000307824300026
J	Neumann, S; Bidon, T; Branschadel, M; Krippner-Heidenreich, A; Scheurich, P; Doszczak, M				Neumann, Simon; Bidon, Tobias; Branschaedel, Marcus; Krippner-Heidenreich, Anja; Scheurich, Peter; Doszczak, Malgorzata			The Transmembrane Domains of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Receptors 1 and 2 Co-Regulate Apoptotic Signaling Capacity	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CELL-DEATH; CD95; DR4; PALMITOYLATION; COLOCALIZATION; APO2L/TRAIL; RESISTANCE; COMPLEX	TNF-related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor (TNF) ligand family that exerts its apoptotic activity in human cells by binding to two transmembrane receptors, TRAILR1 and TRAILR2. In cells co-expressing both receptors the particular contribution of either protein to the overall cellular response is not well defined. Here we have investigated whether differences in the signaling capacities of TRAILR1 and TRAILR2 can be attributed to certain functional molecular subdomains. We generated and characterized various chimeric receptors comprising TRAIL receptor domains fused with parts from other members of the TNF death receptor family. This allowed us to compare the contribution of particular domains of the two TRAIL receptors to the overall apoptotic response and to identify elements that regulate apoptotic signaling. Our results show that the TRAIL receptor death domains are weak apoptosis inducers compared to those of CD95/Fas, because TRAILR-derived constructs containing the CD95/Fas death domain possessed strongly enhanced apoptotic capabilities. Importantly, major differences in the signaling strengths of the two TRAIL receptors were linked to their transmembrane domains in combination with the adjacent extracellular stalk regions. This was evident from receptor chimeras comprising the extracellular part of TNFR1 and the intracellular signaling part of CD95/Fas. Both receptor chimeras showed comparable ligand binding affinities and internalization kinetics. However, the respective TRAILR2-derived molecule more efficiently induced apoptosis. It also activated caspase-8 and caspase-3 more strongly and more quickly, albeit being expressed at lower levels. These results suggest that the transmembrane domains together with their adjacent stalk regions can play a major role in control of death receptor activation thereby contributing to cell type specific differences in TRAILR1 and TRAILR2 signaling.	[Neumann, Simon; Bidon, Tobias; Branschaedel, Marcus; Scheurich, Peter; Doszczak, Malgorzata] Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany; [Krippner-Heidenreich, Anja] Newcastle Univ, Fac Med Sci, Musculoskeletal Res Grp, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Stuttgart; Newcastle University - UK	Neumann, S (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany.	malgorzata.doszczak@izi.uni-stuttgart.de			German Federal Ministry of Education and Research (BMBF) within the FORSYS-Partner program [0315-280A]; German Research Foundation (DFG) within the Cluster of Excellence in Simulation Technology at the University of Stuttgart [310/1]	German Federal Ministry of Education and Research (BMBF) within the FORSYS-Partner program(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG) within the Cluster of Excellence in Simulation Technology at the University of Stuttgart(German Research Foundation (DFG))	This work was supported by the German Federal Ministry of Education and Research (BMBF;www.bmbf.de) within the FORSYS-Partner program (grant nr. 0315-280A) and the German Research Foundation (DFG, www.dfg.de) within the Cluster of Excellence in Simulation Technology (EXC 310/1) at the University of Stuttgart. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Branschadel M, 2010, CELL SIGNAL, V22, P404, DOI 10.1016/j.cellsig.2009.10.011; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Fox NL, 2010, EXPERT OPIN BIOL TH, V10, P1, DOI 10.1517/14712590903319656; Gerspach J, 2011, RECENT PAT ANTI-CANC, V6, P294, DOI 10.2174/157489211796957739; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Kelley RF, 2005, J BIOL CHEM, V280, P2205, DOI 10.1074/jbc.M410660200; Krippner-Heidenreich A, 2002, J BIOL CHEM, V277, P44155, DOI 10.1074/jbc.M207399200; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Lee HW, 2005, BIOCHEM BIOPH RES CO, V330, P1205, DOI 10.1016/j.bbrc.2005.03.101; Lemke J, 2010, J MOL MED, V88, P729, DOI 10.1007/s00109-010-0619-0; Leverkus M, 2003, MOL CELL BIOL, V23, P777, DOI 10.1128/MCB.23.3.777-790.2003; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muhlenbeck F, 2000, J BIOL CHEM, V275, P32208, DOI 10.1074/jbc.M000482200; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Ouyang W, 2011, INT J ONCOL, V39, P1577, DOI 10.3892/ijo.2011.1129; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Reis CR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002808; Rossin A, 2009, BIOCHEM J, V419, P185, DOI 10.1042/BJ20081212; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Truneh A, 2000, J BIOL CHEM, V275, P23319, DOI 10.1074/jbc.M910438199; Tur V, 2008, J BIOL CHEM, V283, P20560, DOI 10.1074/jbc.M800457200; van Geelen CMM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-39; Wajant H, 2001, ONCOGENE, V20, P4101, DOI 10.1038/sj.onc.1204558	36	7	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42526	10.1371/journal.pone.0042526	http://dx.doi.org/10.1371/journal.pone.0042526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22916132	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100119
J	Kusuma, S; Zhao, S; Gerecht, S				Kusuma, Sravanti; Zhao, Stephen; Gerecht, Sharon			The extracellular matrix is a novel attribute of endothelial progenitors and of hypoxic mature endothelial cells	FASEB JOURNAL			English	Article						vasculature; collagen I; collagen IV; hypoxia-inducible factors	SMOOTH-MUSCLE-CELLS; STEM-CELLS; INDUCIBLE FACTOR-2-ALPHA; VASCULAR MORPHOGENESIS; MOLECULAR DISTINCTION; COLLAGEN; TISSUE; HIF-2-ALPHA; ARTERIES; KINASE	Extracellular matrix (ECM) production is critical to preserve the function and integrity of mature blood vessels. Toward the engineering of blood vessels, studies have centered on ECM production by supporting cells, whereas few studies implicate endothelial cells (ECs) with ECM synthesis. Here, we elucidate variations between cultured human arterial, venous, and progenitor ECs with respect to ECM deposition assembly, composition, and response to biomolecular and physiological factors. Our studies reveal that progenitor ECs, endothelial colony-forming cells (ECFCs), deposit collagen IV, fibronectin, and laminin that assemble to an organized weblike structure, as confirmed by decellularized cultures. Mature ECs only express these ECM proteins intracellularly. ECFC-derived ECM is abrogated in response to TGF beta signaling inhibition and actin cytoskeleton disruption. Hypoxic (1%) and physiological (5%) O-2 tension stimulate ECM deposition from mature ECs. Interestingly, deposition of collagen I is observed only under 5% O-2 tension. ECM production from all ECs is found to be regulated by hypoxia-inducible factors 1 alpha and 2 alpha but differentially in the different cell lines. Collectively, we suggest that ECM deposition and assembly by ECs is dependent on maturation stage and oxygen supply and that these findings can be harnessed to advance engineered vascular therapeutics.-Kusuma, S., Zhao, S., Gerecht, S. The extracellular matrix is a novel attribute of endothelial progenitors and of hypoxic mature endothelial cells. FASEB J. 26, 4925-4936 (2012). www.fasebj.org	[Kusuma, Sravanti; Zhao, Stephen; Gerecht, Sharon] Johns Hopkins Univ, Dept Chem & Biomol Engn, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Kusuma, Sravanti; Zhao, Stephen; Gerecht, Sharon] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA; [Kusuma, Sravanti] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Gerecht, S (corresponding author), 3400 N Charles St, Baltimore, MD 21218 USA.	gerecht@jhu.edu	Gerecht, Sharon/A-3388-2010		American Heart Association; U.S. National Institutes of Health (NIH) [F31HL112644]; NIH [R01HL107938]; National Science Foundation [1054415]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL112644, R01HL107938] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Abigail Hielscher and Hasan Erbil Abaci for their assistance and productive discussions and Bradley Isaacs for technical assistance. The research was funded by predoctoral awards from the American Heart Association and the U.S. National Institutes of Health (NIH; grant F31HL112644) to S. K., and by NIH grant R01HL107938, an American Heart Association Scientist Development grant, and National Science Foundation grant 1054415 to S.G.	Abaci HE, 2011, AM J PHYSIOL-CELL PH, V301, pC431, DOI 10.1152/ajpcell.00074.2011; Abaci HE, 2010, AM J PHYSIOL-CELL PH, V298, pC1527, DOI 10.1152/ajpcell.00484.2009; Aitsebaomo J, 2008, CIRC RES, V103, P929, DOI 10.1161/CIRCRESAHA.108.184937; Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745; Chapados R, 2006, CIRC RES, V99, P837, DOI 10.1161/01.RES.0000246172.77441.f1; Critser PJ, 2011, CELL PROLIFERAT, V44, P15, DOI 10.1111/j.1365-2184.2010.00719.x; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Davis GE, 2008, CURR OPIN HEMATOL, V15, P197, DOI 10.1097/MOH.0b013e3282fcc321; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dickinson LE, 2011, MACROMOL BIOSCI, V11, P36, DOI 10.1002/mabi.201000245; Dickinson LE, 2010, SOFT MATTER, V6, P5109, DOI 10.1039/c0sm00233j; Duan LJ, 2005, CIRCULATION, V111, P2227, DOI 10.1161/01.CIR.0000163580.98098.A3; Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924; Gui LQ, 2009, TISSUE ENG PT A, V15, P2665, DOI [10.1089/ten.tea.2008.0526, 10.1089/ten.TEA.2008.0526]; Hanjaya-Putra D, 2011, BLOOD, V118, P804, DOI 10.1182/blood-2010-12-327338; Heydarkhan-Hagvall S, 2006, TISSUE ENG, V12, P831, DOI 10.1089/ten.2006.12.831; Hielscher AC, 2012, AM J PHYSIOL-CELL PH, V302, pC1243, DOI 10.1152/ajpcell.00011.2012; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; IRUELAARISPE ML, 1991, ARTERIOSCLER THROMB, V11, P805, DOI 10.1161/01.ATV.11.4.805; Ito Y, 2005, J BIOMED MATER RES A, V74A, P659, DOI 10.1002/jbm.a.30360; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jeon H, 1996, BIOSCI BIOTECH BIOCH, V60, P856, DOI 10.1271/bbb.60.856; Kraehenbuehl TP, 2009, BIOMATERIALS, V30, P4318, DOI 10.1016/j.biomaterials.2009.04.057; Kuruvilla L, 2007, CELL BIOCHEM BIOPHYS, V47, P65, DOI 10.1385/CBB:47:1:65; Kusuma S, 2010, EXPERT REV CARDIOVAS, V8, P1433, DOI [10.1586/erc.10.121, 10.1586/ERC.10.121]; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Li L., 2011, EXP NEUROL, V233, P283; Madri JA, 1997, TRANSPL IMMUNOL, V5, P179, DOI 10.1016/S0966-3274(97)80035-4; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4; Mathews A, 2012, J TISSUE ENG REGEN M, V6, P451, DOI 10.1002/term.449; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Nilsson I, 2004, EXP CELL RES, V299, P476, DOI 10.1016/j.yexcr.2004.06.005; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Papadimitrio E., 1993, ENDOTHELIUM-J ENDOTH, V1, P207, DOI [10.3109/10623329309102698, DOI 10.3109/10623329309102698]; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Pickering JG, 1997, ARTERIOSCL THROM VAS, V17, P475, DOI 10.1161/01.ATV.17.3.475; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Sansilvestri-Morel P, 2002, CIRCULATION, V106, P479, DOI 10.1161/01.CIR.0000022846.22923.46; Schechner JS, 2003, FASEB J, V17, P2250, DOI 10.1096/fj.03-0257com; Schenke-Layland K, 2004, MATRIX BIOL, V23, P113, DOI 10.1016/j.matbio.2004.03.005; Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4; Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105; Skuli N, 2009, BLOOD, V114, P469, DOI 10.1182/blood-2008-12-193581; Soucy PA, 2009, MATRIX BIOL, V28, P273, DOI 10.1016/j.matbio.2009.04.005; Stratman AN, 2012, MICROSC MICROANAL, V18, P68, DOI 10.1017/S1431927611012402; Sun GM, 2012, MACROMOL BIOSCI, V12, P21, DOI 10.1002/mabi.201100258; Takahashi R, 2004, BIOCHEM BIOPH RES CO, V317, P84, DOI 10.1016/j.bbrc.2004.03.010; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Torres-Vaazquez J, 2003, CELL TISSUE RES, V314, P43, DOI 10.1007/s00441-003-0771-8; TSENG SCG, 1982, EUR J BIOCHEM, V122, P355, DOI 10.1111/j.1432-1033.1982.tb05888.x; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Vartanian KB, 2009, J BIOMED MATER RES A, V91A, P528, DOI 10.1002/jbm.a.32225; VILLANUEVA AG, 1991, CIRC RES, V69, P134, DOI 10.1161/01.RES.69.1.134; Vo E, 2010, STEM CELL REV REP, V6, P237, DOI 10.1007/s12015-010-9144-3; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Williams SK, 2011, J BIOMED MATER RES A, V99A, P67, DOI 10.1002/jbm.a.33138; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yang B, 2010, TISSUE ENG PART C-ME, V16, P1201, DOI [10.1089/ten.tec.2009.0311, 10.1089/ten.TEC.2009.0311]; Yoder MC, 2009, J THROMB HAEMOST, V7, P49, DOI 10.1111/j.1538-7836.2009.03407.x; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684; Zeiger AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037904; Zhou M, 2009, ARTIF ORGANS, V33, P230, DOI 10.1111/j.1525-1594.2009.00713.x	70	49	53	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					4925	4936		10.1096/fj.12-209296	http://dx.doi.org/10.1096/fj.12-209296			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22919069	Green Published			2022-12-25	WOS:000311838300016
J	Shaltiel, L; Paparizos, C; Fenske, S; Hassan, S; Gruner, C; Rotzer, K; Biel, M; Wahl-Schott, CA				Shaltiel, Lior; Paparizos, Christos; Fenske, Stefanie; Hassan, Sami; Gruner, Christian; Roetzer, Katrin; Biel, Martin; Wahl-Schott, Christian A.			Complex Regulation of Voltage-dependent Activation and Inactivation Properties of Retinal Voltage-gated Cav1.4 L-type Ca2+ Channels by Ca2+-binding Protein 4 (CaBP4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEINS; POTASSIUM CURRENT; BETA(2) SUBUNIT; CALMODULIN; MUTATION; FRET; ROD; CA(V)1.4-ALPHA-1; CA(V)1.3; CURRENTS	Cav1.4 L-type Ca2+ channels are crucial for synaptic transmission in retinal photoreceptors and bipolar neurons. Recent studies suggest that the activity of this channel is regulated by the Ca2+-binding protein 4 (CaBP4). In the present study, we explored this issue by examining functional effects of CaBP4 on heterologously expressed Cav1.4. We show that CaBP4 dramatically increases Cav1.4 channel availability. This effect crucially depends on the presence of the C-terminal ICDI (inhibitor of Ca2+-dependent inactivation) domain of Cav1.4 and is absent in a Cav1.4 mutant lacking the ICDI. Using FRET experiments, we demonstrate that CaBP4 interacts with the IQ motif of Cav1.4 and that it interferes with the binding of the ICDI domain. Based on these findings, we suggest that CaBP4 increases Cav1.4 channel availability by relieving the inhibitory effects of the ICDI domain on voltage-dependent Cav1.4 channel gating. We also functionally characterized two CaBP4 mutants that are associated with a congenital variant of human night blindness and other closely related nonstationary retinal diseases. Although both mutants interact with Cav1.4 channels, the functional effects of CaBP4 mutants are only partially preserved, leading to a reduction of Cav1.4 channel availability and loss of function. In conclusion, our study sheds new light on the functional interaction between CaBP4 and Cav1.4. Moreover, it provides insights into the mechanism by which CaBP4 mutants lead to loss of Cav1.4 function and to retinal disease.	Univ Munich, Ctr Integrated Prot Sci CIPS M, D-81377 Munich, Germany; Univ Munich, Zentrum Pharmaforsch, Dept Pharm, D-81377 Munich, Germany	University of Munich; University of Munich	Wahl-Schott, CA (corresponding author), Univ Munich, Dept Pharm Pharmakol Nat Wissensch, Butenandtstr 5-13, D-81377 Munich, Germany.	christian.wahl@cup.uni-muenchen.de	Wahl-Schott, Christian A/J-2623-2015; Biel, Martin/G-1175-2014	Biel, Martin/0000-0002-9974-3052; Fenske, Stefanie/0000-0002-6994-8401; Hassan, Sami/0000-0002-8784-143X	Deutsche Forschungsgemeinschaft (DFG); Bayerische Forschungsstiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bayerische Forschungsstiftung	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) and by the Bayerische Forschungsstiftung.	Aldahmesh MA, 2010, MOL VIS, V16, P207; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dong Y, 2003, J NEUROSCI, V23, P2686; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Griessmeier K, 2009, J BIOL CHEM, V284, P29809, DOI 10.1074/jbc.M109.048082; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Koschak A, 2003, J NEUROSCI, V23, P6041, DOI 10.1523/JNEUROSCI.23-14-06041.2003; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Littink KW, 2009, INVEST OPHTH VIS SCI, V50, P2344, DOI 10.1167/iovs.08-2553; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Moriondo A, 2001, EUR J NEUROSCI, V14, P19, DOI 10.1046/j.0953-816x.2001.01605.x; Nejatbakhsh N, 2011, ACTA PHARMACOL SIN, V32, P741, DOI 10.1038/aps.2011.64; Oz S, 2011, J BIOL CHEM, V286, P13945, DOI 10.1074/jbc.M110.198424; Peloquin JB, 2008, NEUROSCIENCE, V151, P1066, DOI 10.1016/j.neuroscience.2007.11.053; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Schneeweis DM, 2000, VISUAL NEUROSCI, V17, P659, DOI 10.1017/S0952523800175017; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; Striessnig J, 2010, PFLUG ARCH EUR J PHY, V460, P361, DOI 10.1007/s00424-010-0800-x; Takahashi SX, 2003, BIOPHYS J, V84, P3007, DOI 10.1016/S0006-3495(03)70027-7; Tan GMY, 2012, J BIOL CHEM, V287, P832, DOI 10.1074/jbc.M111.268722; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Witkovsky P, 1997, J NEUROSCI, V17, P7297; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Yasuda T, 2004, J GEN PHYSIOL, V123, P401, DOI 10.1085/jgp.200308967; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004	40	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36312	36321		10.1074/jbc.M112.392811	http://dx.doi.org/10.1074/jbc.M112.392811			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936811	hybrid, Green Published			2022-12-25	WOS:000310364000052
J	Kang, JW; Park, YS; Lee, DH; Kim, JH; Kim, MS; Bak, Y; Hong, J; Yoon, DY				Kang, Jeong-Woo; Park, Yun Sun; Lee, Dong Hun; Kim, Jung-Hee; Kim, Man Sub; Bak, Yesol; Hong, Jintae; Yoon, Do-Young			Intracellular Interaction of Interleukin (IL)-32 alpha with Protein Kinase C epsilon (PKC epsilon) and STAT3 Protein Augments IL-6 Production in THP-1 Promonocytic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ANXIETY-LIKE BEHAVIOR; PROINFLAMMATORY CYTOKINE; MACROPHAGE DIFFERENTIATION; RHEUMATOID-ARTHRITIS; SYNOVIAL FIBROBLASTS; SIGNALING PATHWAY; CANCER-CELLS; ACTIVATION; EXPRESSION	IL-32 alpha is known as a proinflammatory cytokine. However, several evidences implying its action in cells have been recently reported. In this study, we present for the first time that IL-32 alpha plays an intracellular mediatory role in IL-6 production using constitutive expression systems for IL-32 alpha in THP-1 cells. We show that phorbol 12-myristate 13-acetate (PMA)-induced increase in IL-6 production by IL-32 alpha -expressing cells was higher than that by empty vector-expressing cells and that this increase occurred in a time-and dose-dependent manner. Treatment with MAPK inhibitors did not diminish this effect of IL-32 alpha, and NF-kappa B signaling activity was similar in the two cell lines. Because the augmenting effect of IL-32 alpha was dependent on the PKC activator PMA, we tested various PKC inhibitors. The pan-PKC inhibitor Go6850 and the PKC epsilon inhibitor Ro-31-8220 abrogated the augmenting effect of IL-32 alpha on IL-6 production, whereas the classical PKC inhibitor Go6976 and the PKC delta inhibitor rottlerin did not. In addition, IL-32 alpha was co-immuno-precipitated with PMA-activated PKC epsilon, and this interaction was totally inhibited by the PKC epsilon inhibitor Ro-31-8220. PMA-induced enhancement of STAT3 phosphorylation was observed only in IL-32 alpha-expressing cells, and this enhancement was inhibited by Ro-31-8220, but not by Go6976. We demonstrate that IL-32 alpha mediated STAT3 phosphorylation by forming a trimeric complex with PKC epsilon and enhanced STAT3 localization onto the IL-6 promoter and thereby increased IL-6 expression. Thus, our data indicate that the intracellular interaction of IL-32 alpha with PKC epsilon and STAT3 promotes STAT3 binding to the IL-6 promoter by enforcing STAT3 phosphorylation, which results in increased production of IL-6.	[Kang, Jeong-Woo; Park, Yun Sun; Lee, Dong Hun; Kim, Jung-Hee; Kim, Man Sub; Bak, Yesol; Yoon, Do-Young] Konkuk Univ, Biomol Informat Ctr, Dept Biosci & Biotechnol, Seoul 143701, South Korea; [Hong, Jintae] Chungbuk Natl Univ, Coll Pharm, Cheongju 361463, Chungbuk, South Korea; [Hong, Jintae] Chungbuk Natl Univ, Med Res Ctr, Cheongju 361463, Chungbuk, South Korea	Konkuk University; Chungbuk National University; Chungbuk National University	Yoon, DY (corresponding author), Konkuk Univ, Biomol Informat Ctr, Dept Biosci & Biotechnol, 1 Hwayang Dong, Seoul 143701, South Korea.	ydy4218@konkuk.ac.kr			National Research Foundation of Korea (NRF) [2010-0019306, 2012R1A2A2A 02008751]; NRF Grant [2009-R1AAA002-351-2009-1-E00007]; Priority Research Centres Program Grant [2012-0006686]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NRF Grant(National Research Foundation of Korea); Priority Research Centres Program Grant	This work was supported by Basic Program Grants 2010-0019306 and 2012R1A2A2A 02008751 from the National Research Foundation of Korea (NRF), NRF Grant 2009-R1AAA002-351-2009-1-E00007 (to J.-W. K.), and Priority Research Centres Program Grant 2012-0006686 (to D.-Y. Y.).	Aksoy E, 2004, INT J BIOCHEM CELL B, V36, P183, DOI 10.1016/S1357-2725(03)00210-3; Ammit AJ, 2002, AM J RESP CELL MOL, V26, P465, DOI 10.1165/ajrcmb.26.4.4681; Aziz MH, 2007, MOL CARCINOGEN, V46, P646, DOI 10.1002/mc.20356; Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Budas GR, 2007, BIOCHEM SOC T, V35, P1052, DOI 10.1042/BST0351052; Calabrese F, 2008, AM J RESP CRIT CARE, V178, P894, DOI 10.1164/rccm.200804-646OC; Cheon S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.159756; Choi J, 2010, P NATL ACAD SCI USA, V107, P21082, DOI 10.1073/pnas.1015418107; Churchill EN, 2007, BIOCHEM SOC T, V35, P1040, DOI 10.1042/BST0351040; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Fima E, 1999, EUR CYTOKINE NETW, V10, P491; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; Goda C, 2006, INT IMMUNOL, V18, P233, DOI 10.1093/intimm/dxh339; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Hasegawa H, 2011, CYTOKINE, V53, P74, DOI 10.1016/j.cyto.2010.09.002; Heinhuis B, 2012, J BIOL CHEM, V287, P5733, DOI 10.1074/jbc.M111.288290; Heinhuis B, 2011, ANN RHEUM DIS, V70, P660, DOI 10.1136/ard.2010.139196; Hodge CW, 2002, J CLIN INVEST, V110, P1003, DOI 10.1172/JCI200215903; Jain N, 1999, J BIOL CHEM, V274, P24392, DOI 10.1074/jbc.274.34.24392; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kang JW, 2009, IMMUNOLOGY, V128, pe532, DOI 10.1111/j.1365-2567.2008.03025.x; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Kim KH, 2008, J IMMUNOL METHODS, V333, P38, DOI 10.1016/j.jim.2007.12.017; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kiriyama Y, 2001, ENDOCRINOLOGY, V142, P3563, DOI 10.1210/en.142.8.3563; Kobayashi H, 2009, CYTOKINE, V46, P351, DOI 10.1016/j.cyto.2009.03.007; Kovanen PE, 2000, BLOOD, V95, P1626, DOI 10.1182/blood.V95.5.1626.005k21_1626_1632; Lesscher HMB, 2008, GENES BRAIN BEHAV, V7, P323, DOI 10.1111/j.1601-183X.2007.00356.x; Lumelsky NL, 1997, BBA-MOL CELL RES, V1358, P79, DOI 10.1016/S0167-4889(97)00051-7; Mabilleau G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004173; MISCHAK H, 1993, J BIOL CHEM, V268, P20110; Mun SH, 2009, ARTHRITIS RHEUM-US, V60, P678, DOI 10.1002/art.24299; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Newton PM, 2006, PHARMACOL THERAPEUT, V109, P227, DOI 10.1016/j.pharmthera.2005.07.004; Nishida A, 2008, AM J PHYSIOL-GASTR L, V294, pG831, DOI 10.1152/ajpgi.00535.2007; Nishida A, 2009, J BIOL CHEM, V284, P17868, DOI 10.1074/jbc.M900368200; Nold-Petry CA, 2009, P NATL ACAD SCI USA, V106, P3883, DOI 10.1073/pnas.0813334106; Pathak SK, 2006, J IMMUNOL, V177, P7950, DOI 10.4049/jimmunol.177.11.7950; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Shirai Y, 2008, FEBS J, V275, P3988, DOI 10.1111/j.1742-4658.2008.06556.x; Smyth DC, 2006, J IMMUNOL, V177, P8740, DOI 10.4049/jimmunol.177.12.8740; TONETTI DA, 1994, J BIOL CHEM, V269, P23230; van Kolen K, 2008, J NEUROCHEM, V104, P1, DOI 10.1111/j.1471-4159.2007.04986.x; Yoon S, 2012, ONCOGENE, V31, P3467, DOI 10.1038/onc.2011.517; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547	52	48	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35556	35564		10.1074/jbc.M112.400911	http://dx.doi.org/10.1074/jbc.M112.400911			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927445	Green Published, hybrid			2022-12-25	WOS:000309968000068
J	Chung, D; Farkas, J; Huddleston, JR; Olivar, E; Westpheling, J				Chung, Daehwan; Farkas, Joel; Huddleston, Jennifer R.; Olivar, Estefania; Westpheling, Janet			Methylation by a Unique alpha-class N4-Cytosine Methyltransferase Is Required for DNA Transformation of Caldicellulosiruptor bescii DSM6725	PLOS ONE			English	Article							ESCHERICHIA-COLI; THERMOPHILIC BACTERIUM; PLANT BIOMASS; HYPERTHERMOPHILIC ARCHAEA; GENOME SEQUENCE; RESTRICTION; GENE; THERMOANAEROBACTER; ETHANOL; SYSTEM	Thermophilic microorganisms capable of using complex substrates offer special advantages for the conversion of lignocellulosic biomass to biofuels and bioproducts. Members of the Gram-positive bacterial genus Caldicellulosiruptor are anaerobic thermophiles with optimum growth temperatures between 65 degrees C and 78 degrees C and are the most thermophilic cellulolytic organisms known. In fact, they efficiently use biomass non-pretreated as their sole carbon source and in successive rounds of application digest 70% of total switchgrass substrate. The ability to genetically manipulate these organisms is a prerequisite to engineering them for use in conversion of these complex substrates to products of interest as well as identifying gene products critical for their ability to utilize non-pretreated biomass. Here, we report the first example of DNA transformation of a member of this genus, C. bescii. We show that restriction of DNA is a major barrier to transformation (in this case apparently absolute) and that methylation with an endogenous unique alpha-class N4-Cytosine methyltransferase is required for transformation of DNA isolated from E. coli. The use of modified DNA leads to the development of an efficient and reproducible method for DNA transformation and the combined frequencies of transformation and recombination allow marker replacement between non-replicating plasmids and chromosomal genes providing the basis for rapid and efficient methods of genetic manipulation.	[Chung, Daehwan; Farkas, Joel; Huddleston, Jennifer R.; Olivar, Estefania; Westpheling, Janet] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Chung, Daehwan; Farkas, Joel; Huddleston, Jennifer R.; Olivar, Estefania; Westpheling, Janet] Oak Ridge Natl Lab, Dept Energy, BioEnergy Sci Ctr, Oak Ridge, TN USA	University System of Georgia; University of Georgia; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Chung, D (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	janwest@uga.edu			BioEnergy Science Center, which is a U.S. Department of Energy Bioenergy Research Center; Office of Biological and Environmental Research in the DOE Office of Science [FG02-08ER64690]; predoctoral Graduate Training In Genetics grant [NIH 5T32GM007103-30]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007103] Funding Source: NIH RePORTER	BioEnergy Science Center, which is a U.S. Department of Energy Bioenergy Research Center; Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); predoctoral Graduate Training In Genetics grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the BioEnergy Science Center, which is a U.S. Department of Energy Bioenergy Research Center administered by Oak Ridge National Laboratory and supported by the Office of Biological and Environmental Research (FG02-08ER64690) in the DOE Office of Science. JF was supported by a predoctoral Graduate Training In Genetics grant (NIH 5T32GM007103-30) to the Genetics Department of the University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetto T, 2005, FEMS MICROBIOL LETT, V247, P177, DOI 10.1016/j.femsle.2005.05.016; Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; ARBER W, 1962, J MOL BIOL, V5, P18, DOI 10.1016/S0022-2836(62)80058-8; Argyros DA, 2011, APPL ENVIRON MICROB, V77, P8288, DOI 10.1128/AEM.00646-11; Bart A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni121; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Blumer-Schuette SE, 2008, CURR OPIN BIOTECH, V19, P210, DOI 10.1016/j.copbio.2008.04.007; Blumer-Schuette SE, 2011, J BACTERIOL, V193, P1483, DOI 10.1128/JB.01515-10; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Broschard TH, 1998, CARCINOGENESIS, V19, P305, DOI 10.1093/carcin/19.2.305; Cannio R, 2001, EXTREMOPHILES, V5, P153, DOI 10.1007/s007920100189; Chen CK, 1996, FEMS MICROBIOL LETT, V140, P185, DOI 10.1016/0378-1097(96)00177-2; Chung DH, 2011, J IND MICROBIOL BIOT, V38, P1867, DOI 10.1007/s10295-011-0976-x; Cohen HM, 2002, NUCLEIC ACIDS RES, V30, P3880, DOI 10.1093/nar/gkf507; Crowe ML, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-133; Cue D, 1997, APPL ENVIRON MICROB, V63, P1406, DOI 10.1128/AEM.63.4.1406-1420.1997; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Donahue JP, 2000, MOL MICROBIOL, V37, P1066, DOI 10.1046/j.1365-2958.2000.02036.x; EHRLICH M, 1985, NUCLEIC ACIDS RES, V13, P1399, DOI 10.1093/nar/13.4.1399; Elkins JG, 2010, J BACTERIOL, V192, P6099, DOI 10.1128/JB.00950-10; Gallagher LA, 2008, J BACTERIOL, V190, P7830, DOI 10.1128/JB.01188-08; Grogan DW, 2003, J BACTERIOL, V185, P4657, DOI 10.1128/JB.185.15.4657-4661.2003; Guss Adam M, 2012, Biotechnol Biofuels, V5, P30, DOI 10.1186/1754-6834-5-30; Hethke C, 1996, NUCLEIC ACIDS RES, V24, P2369, DOI 10.1093/nar/24.12.2369; Jennert KCB, 2000, MICROBIOL-SGM, V146, P3071, DOI 10.1099/00221287-146-12-3071; KARNIK SS, 1983, ARCH MICROBIOL, V136, P275, DOI 10.1007/BF00425216; Kataeva IA, 2009, J BACTERIOL, V191, P3760, DOI 10.1128/JB.00256-09; Kawarabayasi Y, 1998, DNA Res, V5, P147, DOI 10.1093/dnares/5.2.147; KLIMASAUSKAS S, 1989, NUCLEIC ACIDS RES, V17, P9823, DOI 10.1093/nar/17.23.9823; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Lucas S, 2002, APPL ENVIRON MICROB, V68, P5528, DOI 10.1128/AEM.68.11.5528-5536.2002; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Mai V, 1997, FEMS MICROBIOL LETT, V148, P163, DOI 10.1016/S0378-1097(97)00028-1; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Matveyev AV, 2001, NUCLEIC ACIDS RES, V29, P1491, DOI 10.1093/nar/29.7.1491; Negro MJ, 2003, APPL BIOCHEM BIOTECH, V105, P87, DOI 10.1385/ABAB:105:1-3:87; Noll KM, 1997, ARCH MICROBIOL, V168, P73, DOI 10.1007/s002030050472; Peck RF, 2000, MOL MICROBIOL, V35, P667, DOI 10.1046/j.1365-2958.2000.01739.x; Peng H, 2006, BIOTECHNOL LETT, V28, P1913, DOI 10.1007/s10529-006-9184-6; PETERANDERL R, 1993, APPL ENVIRON MICROB, V59, P3498, DOI 10.1128/AEM.59.10.3498-3501.1993; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Rao BS, 1998, NUCLEIC ACIDS RES, V26, P2505, DOI 10.1093/nar/26.10.2505; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; Shaw AJ, 2008, P NATL ACAD SCI USA, V105, P13769, DOI 10.1073/pnas.0801266105; Shaw AJ, 2010, APPL ENVIRON MICROB, V76, P4713, DOI 10.1128/AEM.00402-10; Shaw AJ, 2009, J BACTERIOL, V191, P6457, DOI 10.1128/JB.00497-09; TIMINSKAS A, 1995, GENE, V157, P3, DOI 10.1016/0378-1119(94)00783-O; TRIEUCUOT P, 1987, FEMS MICROBIOL LETT, V48, P289, DOI 10.1111/j.1574-6968.1987.tb02558.x; Tyurin MV, 2004, APPL ENVIRON MICROB, V70, P883, DOI 10.1128/AEM.70.2.883-890.2004; van de Werken HJG, 2008, APPL ENVIRON MICROB, V74, P6720, DOI 10.1128/AEM.00968-08; Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009; Yang SJ, 2009, APPL ENVIRON MICROB, V75, P4762, DOI 10.1128/AEM.00236-09; Zhang YHP, 2007, BIOTECHNOL BIOENG, V97, P214, DOI 10.1002/bit.21386	58	62	63	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43844	10.1371/journal.pone.0043844	http://dx.doi.org/10.1371/journal.pone.0043844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928042	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300093
J	Dirks, JH; Taylor, D				Dirks, Jan-Henning; Taylor, David			Veins Improve Fracture Toughness of Insect Wings	PLOS ONE			English	Article							LOCUST SCHISTOCERCA-GREGARIA; MICRO-AIR VEHICLES; DESERT LOCUST; FUNCTIONAL-MORPHOLOGY; MECHANICAL-PROPERTIES; FLEXURAL STIFFNESS; FLIGHT; CUTICLE; MEMBRANE; REPAIR	During the lifetime of a flying insect, its wings are subjected to mechanical forces and deformations for millions of cycles. Defects in the micrometre thin membranes or veins may reduce the insect's flight performance. How do insects prevent crack related material failure in their wings and what role does the characteristic vein pattern play? Fracture toughness is a parameter, which characterises a material's resistance to crack propagation. Our results show that, compared to other body parts, the hind wing membrane of the migratory locust S. gregaria itself is not exceptionally tough (1.04 +/- 0.25 MPa root m). However, the cross veins increase the wing's toughness by 50% by acting as barriers to crack propagation. Using fracture mechanics, we show that the morphological spacing of most wing veins matches the critical crack length of the material (1132 mu m). This finding directly demonstrates how the biomechanical properties and the morphology of locust wings are functionally correlated in locusts, providing a mechanically 'optimal' solution with high toughness and low weight. The vein pattern found in insect wings thus might inspire the design of more durable and lightweight artificial 'venous' wings for micro-air-vehicles. Using the vein spacing as indicator, our approach might also provide a basis to estimate the wing properties of endangered or extinct insect species.	[Dirks, Jan-Henning; Taylor, David] Trinity Coll Dublin, Dept Mech & Mfg Engn, Trinity Ctr Bioengn, Dublin, Ireland	Trinity College Dublin	Dirks, JH (corresponding author), Trinity Coll Dublin, Dept Mech & Mfg Engn, Trinity Ctr Bioengn, Dublin, Ireland.	jan-henning.dirks@web.de	Dirks, Jan-Henning/B-9706-2011		Irish Research Council for Science, Engineering and Technology (IRCSET)	Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology)	This study was financially supported by a postdoctoral fellowship of the Irish Research Council for Science, Engineering and Technology (IRCSET, http://www.ircset.ie) to Dr. Dirks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOCH ROBERT, 1941, BOT REV, V7, P110, DOI 10.1007/BF02872446; Combes SA, 2003, J EXP BIOL, V206, P2979, DOI 10.1242/jeb.00523; Combes SA, 2003, J EXP BIOL, V206, P2989, DOI 10.1242/jeb.00524; Dirks JH, 2012, J EXP BIOL, V215, P1502, DOI 10.1242/jeb.068221; Dirks JH, 2011, J MECH BEHAV BIOMED, V4, P2031, DOI 10.1016/j.jmbbm.2011.07.002; Dudley R., 2000, BIOMECHANICS INSECT; Ellington CP, 1999, J EXP BIOL, V202, P3439; ENNOS AR, 1989, ZOOL J LINN SOC-LOND, V96, P27, DOI 10.1111/j.1096-3642.1989.tb01820.x; Ha NS, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046003; HAMILTON K G A, 1972, Journal of the Kansas Entomological Society, V45, P145; Herbert RC, 2000, J EXP BIOL, V203, P2945; Jongerius SR, 2010, EXP MECH, V50, P1323, DOI 10.1007/s11340-010-9411-x; Kesel AB, 2000, J EXP BIOL, V203, P3125; Khan ZA, 2011, AIAA J, V49, P1354, DOI 10.2514/1.J050447; LAIFOOK J, 1968, J MORPHOL, V124, P37, DOI 10.1002/jmor.1051240104; Lovejoy NR, 2006, P ROY SOC B-BIOL SCI, V273, P767, DOI 10.1098/rspb.2005.3381; Marcus JM, 2001, J ANAT, V199, P211, DOI 10.1046/j.1469-7580.2001.19910211.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Meng XG, 2011, J EXP BIOL, V214, P432, DOI 10.1242/jeb.046375; Nel Andre, 2001, Revue Francaise d'Entomologie (Nouvelle Serie), V23, P257; Park JH, 2008, J BIONIC ENG, V5, P39, DOI 10.1016/S1672-6529(08)60005-0; Richter C, 2011, ARTIF LIFE, V17, P73, DOI 10.1162/artl_a_00020; Smith CW, 2000, J EXP BIOL, V203, P2933; Song F, 2007, MAT SCI ENG A-STRUCT, V457, P254, DOI 10.1016/j.msea.2007.01.136; Sutton G, 2011, J EXP BIOL, V214, P2997, DOI 10.1242/jeb.056663; Taylor D, 2007, THEORY CRITICAL DIST; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Tofilski A, 2004, J INSECT SCI, V4, DOI [10.1093/JIS/4.1.17, 10.1093/jis/4.1.17]; TORVIK PJ, 1979, J APPL MECH-T ASME, V46, P611, DOI 10.1115/1.3424615; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Walker SM, 2009, J R SOC INTERFACE, V6, P735, DOI 10.1098/rsif.2008.0435; WEISFOGH T, 1956, PHILOS T ROY SOC B, V239, P415, DOI 10.1098/rstb.1956.0007; WEISFOGH T, 1956, PHILOS T ROY SOC B, V239, P459, DOI 10.1098/rstb.1956.0008; Wootton RJ, 2000, J EXP BIOL, V203, P2921; WOOTTON RJ, 1992, ANNU REV ENTOMOL, V37, P113, DOI 10.1146/annurev.en.37.010192.000553; Wootton RJ, 1998, SCIENCE, V282, P749, DOI 10.1126/science.282.5389.749; Wootton Robin J., 1995, Proceedings of the Royal Society of London Series B Biological Sciences, V262, P181, DOI 10.1098/rspb.1995.0194	37	59	61	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43411	10.1371/journal.pone.0043411	http://dx.doi.org/10.1371/journal.pone.0043411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927966	Green Submitted, gold, Green Published			2022-12-25	WOS:000308286300049
J	Dong, HL; Jin, XW; Hu, J; Li, HF; He, XL; Liu, XN; Bao, GQ				Dong, Honglin; Jin, Xiaowei; Hu, Jie; Li, Haifeng; He, Xianli; Liu, Xiaonan; Bao, Guoqiang			High gamma-Radiation Sensitivity Is Associated with Increased Gastric Cancer Risk in a Chinese Han Population: A Case-Control Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; UPPER AERODIGESTIVE TRACT; DNA-REPAIR CAPACITY; MUTAGEN SENSITIVITY; BREAST-CANCER; DIOL-EPOXIDE; LUNG-CANCER; CHROMOSOME SENSITIVITY; BIOLOGICAL MARKER; CHROMATID BREAKS	Hypersensitivity to radiation exposure has been suggested to be a risk factor for the development of several malignancies, but not including gastric cancer. In this case-control study, radiation sensitivity as measured by chromatid breaks per cell (b/c) was examined in cultured peripheral blood lymphocytes (PBLs) from 517 patients with gastric cancer and 525 healthy controls. Our results showed that b/c values were significantly higher in cases than in controls (Mean [SD], 0.47 [0.20] vs. 0.34 [0.17]; P<0.001). Using the 50th percentile value for controls (0.34 b/c) as the cutoff point, unconditional logistic regression analysis revealed that gamma-radiation-sensitive individuals were at significantly higher risk for gastric cancer (adjusted odds ratio [OR] 2.01, 95% confidence interval [CI] 1.49-3.13). Quartile stratification analysis indicated a dose-response relationship between gamma-radiation sensitivity and gastric cancer risk (P for trend <0.001). When using the subjects in first quartile of b/c values as reference, the adjusted ORs and corresponding CIs for the subjects in second, third, and fourth quartiles were 1.48 (0.91-2.17), 2.42 (1.76-3.64), and 3.40 (2.11-5.29), respectively. The gamma-radiation sensitivity was related to age and smoking status. In addition, a clear joint effect on cancer risk was found between gamma-Radiation sensitivity and smoking status. The risk for ever smokers with high sensitivity was higher than those for never smokers with high sensitivity and ever smokers with low sensitivity (OR [CI], 4.67 [2.31-6.07] vs. 2.14 [1.40-3.06] vs. 2.42 [1.57-3.95], respectively). No significant interaction was found between both factors (P for interaction = 0.42). We conclude that chromatid radiosensitivity is associated with gastric cancer susceptibility in a Chinese population.	[Dong, Honglin; Hu, Jie; Li, Haifeng] Shanxi Med Univ, Dept Gen Surg, Hosp 2, Taiyuan, Peoples R China; [Jin, Xiaowei] Gen Hosp Air Forces PLA, Dept Digest Dis, Beijing, Peoples R China; [He, Xianli; Bao, Guoqiang] Fourth Mil Med Univ, Dept Gen Surg, Tangdu Hosp, Xian 710032, Peoples R China; [Liu, Xiaonan] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China	Shanxi Medical University; Air Force Military Medical University; Air Force Military Medical University	Dong, HL (corresponding author), Shanxi Med Univ, Dept Gen Surg, Hosp 2, Taiyuan, Peoples R China.	liuxnys@fmmu.edu.cn; Guoqiang@fmmu.edu.cn			National Natural Science Foundation of China [30700810, 30972930]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants 30700810 and 30972930 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Au WW, 2005, ENVIRON MOL MUTAGEN, V45, P222, DOI 10.1002/em.20114; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Bondy ML, 2001, J NATL CANCER I, V93, P1553, DOI 10.1093/jnci/93.20.1553; Buchholz TA, 2001, INT J RADIAT ONCOL, V49, P533, DOI 10.1016/S0360-3016(00)01502-9; Chao DL, 2006, CANCER EPIDEM BIOMAR, V15, P1935, DOI 10.1158/1055-9965.EPI-06-0492; Cheng L, 1999, CANCER EPIDEM BIOMAR, V8, P801; CHERRY LM, 1983, ANTICANCER RES, V3, P367; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; El-Zein RA, 2006, CANCER RES, V66, P6449, DOI 10.1158/0008-5472.CAN-06-0326; Erdei E, 2006, MUTAGENESIS, V21, P261, DOI 10.1093/mutage/gel030; Gajecka M, 2004, ONCOL REP, V12, P153; Gianfagna F, 2008, CURR GENOMICS, V9, P361, DOI 10.2174/138920208785699544; Gu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028971; Gu J, 1999, CANCER GENET CYTOGEN, V110, P65, DOI 10.1016/S0165-4608(98)00189-7; HAGMAR L, 1994, CANCER RES, V54, P2919; HSU TC, 1991, CANCER EPIDEM BIOMAR, V1, P83; HSU TC, 1985, CANCER GENET CYTOGEN, V17, P307, DOI 10.1016/0165-4608(85)90114-1; HSU TC, 1989, INT J CANCER, V43, P403, DOI 10.1002/ijc.2910430310; HSU TC, 1983, HEREDITAS, V98, P1, DOI 10.1111/j.1601-5223.1983.tb00574.x; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Lee JJ, 1996, CANCER EPIDEM BIOMAR, V5, P191; Malik Manzoor A, 2009, J Gastrointest Cancer, V40, P26, DOI 10.1007/s12029-009-9072-0; Natarajan TG, 2006, CANCER EPIDEM BIOMAR, V15, P437, DOI 10.1158/1055-9965.EPI-05-0353; PANDITA TK, 1995, INT J CANCER, V61, P738, DOI 10.1002/ijc.2910610524; Patel RK, 1997, INT J CANCER, V73, P20, DOI 10.1002/(SICI)1097-0215(19970926)73:1<20::AID-IJC4>3.0.CO;2-3; SEETHARAM S, 1991, MUTAT RES, V254, P97, DOI 10.1016/0921-8777(91)90045-Q; Setiawan VW, 2001, CANCER CAUSE CONTROL, V12, P673, DOI 10.1023/A:1011261602940; Shao L, 2005, GENE CHROMOSOME CANC, V44, P415, DOI 10.1002/gcc.20254; Shen HB, 2003, INT J CANCER, V107, P84, DOI 10.1002/ijc.11346; Spitz MR, 1996, J CELL BIOCHEM, P80; SPITZ MR, 1995, CANCER EPIDEM BIOMAR, V4, P99; SPITZ MR, 1989, CANCER RES, V49, P4626; Udumudi A, 1998, MUTAT RES-GEN TOX EN, V412, P195, DOI 10.1016/S1383-5718(97)00164-2; Wang LE, 2005, JNCI-J NATL CANCER I, V97, P1822, DOI 10.1093/jnci/dji429; Wang LE, 2000, RADIAT RES, V154, P20, DOI 10.1667/0033-7587(2000)154[0020:GDISEO]2.0.CO;2; Wang LE, 1998, CLIN CANCER RES, V4, P1773; Wang LE, 2006, J INVEST DERMATOL; Wang LE, 2012, BREAST CANC RES TREA; Wei QY, 1996, CANCER EPIDEM BIOMAR, V5, P199; Wu XF, 1998, CANCER EPIDEM BIOMAR, V7, P567; Wu XF, 1998, J NATL CANCER I, V90, P1393, DOI 10.1093/jnci/90.18.1393; Wu XF, 2002, CANCER RES, V62, P2813; Wu XF, 2006, CANCER RES, V66, P5993, DOI 10.1158/0008-5472.CAN-06-1007; Xia HHX, 2002, ALIMENT PHARM THERAP, V16, P521, DOI 10.1046/j.1365-2036.2002.01176.x; Xiong P, 2001, CANCER RES, V61, P8465	46	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43625	10.1371/journal.pone.0043625	http://dx.doi.org/10.1371/journal.pone.0043625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928006	Green Submitted, Green Published, gold			2022-12-25	WOS:000308286300076
J	Sun, Y; Li, Y; Luo, DZ; Liao, DJ				Sun, Yuan; Li, Yan; Luo, Dianzhong; Liao, D. Joshua			Pseudogenes as Weaknesses of ACTB (Actb) and GAPDH (Gapdh) Used as Reference Genes in Reverse Transcription and Polymerase Chain Reactions	PLOS ONE			English	Article							UCSC GENOME BROWSER; RT-PCR; FREE AMPLIFICATION; CYCLIN D1; C-MYC; EXPRESSION; NORMALIZATION; RNA; SELECTION; CANCER	The genes encoding beta-actin (ACTB in human or Actb in mouse) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH in human or Gapdh in mouse) are the two most commonly used references for sample normalization in determination of the mRNA level of interested genes by reverse transcription (RT) and ensuing polymerase chain reactions (PCR). In this study, bioinformatic analyses revealed that the ACTB, Actb, GAPDH and Gapdh had 64, 69, 67 and 197 pseudogenes (PGs), respectively, in the corresponding genome. Most of these PGs are intronless and similar in size to the authentic mRNA. Alignment of several PGs of these genes with the corresponding mRNA reveals that they are highly homologous. In contrast, the hypoxanthine phosphoribosyltransferase-1 gene (HPRT1 in human or Hprt in mouse) only had 3 or 1 PG, respectively, and the mRNA has unique regions for primer design. PCR with cDNA or genomic DNA (gDNA) as templates revealed that our HPRT1, Hprt and GAPDH primers were specific, whereas our ACTB and Actb primers were not specific enough both vertically (within the cDNA) and horizontally (compared cDNA with gDNA). No primers could be designed for the Gapdh that would not mis-prime PGs. Since most of the genome is transcribed, we suggest to peers to forgo ACTB (Actb) and GAPDH (Dapdh) as references in RT-PCR and, if there is no surrogate, to use our primers with extra caution. We also propose a standard operation procedure in which design of primers for RT-PCR starts from avoiding mis-priming PGs and all primers need be tested for specificity with both cDNA and gDNA.	[Sun, Yuan; Li, Yan; Liao, D. Joshua] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Sun, Yuan; Luo, Dianzhong] Guangxi Med Univ, Dept Pathol, Nanning, Guangxi, Peoples R China	University of Minnesota System; Guangxi Medical University	Sun, Y (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	luodianzhong@yahoo.com.cn; djliao@hi.umn.edu	Li, Yan/L-2129-2013		United States Department of Defense (DOD Award) [W81XWH-11-1-0119]	United States Department of Defense (DOD Award)	This work was supported by a grant from the United States Department of Defense (DOD Award W81XWH-11-1-0119) to DJL. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biliran H, 2007, CLIN CANCER RES, V13, P2811, DOI 10.1158/1078-0432.CCR-06-1844; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Calabrese FM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S15; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Cinar Mehmet Ulas, 2012, BMC Res Notes, V5, P107, DOI 10.1186/1756-0500-5-107; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Dupont M, 2002, BIOTECHNIQUES, V33, P158, DOI 10.2144/02331md04; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Guo R, 2011, EUR J PROTISTOL, DOI org/10.1016/j.ejop.2011.11.001; Guo XP, 2012, CLIN EXP MED, V12, P207, DOI 10.1007/s10238-011-0163-4; Harper LV, 2003, MOL CELL PROBE, V17, P261, DOI 10.1016/S0890-8508(03)00063-X; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kim Insook, 2011, BMC Res Notes, V4, P440, DOI 10.1186/1756-0500-4-440; Ledderose Carola, 2011, BMC Res Notes, V4, P427, DOI 10.1186/1756-0500-4-427; Lehmann MH, 2002, BIOTECHNIQUES, V33, P766, DOI 10.2144/02334bm10; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Louhichi A, 2011, GENE, V488, P35, DOI 10.1016/j.gene.2011.08.013; Manjarin R, 2011, J DAIRY SCI, V94, P4950, DOI 10.3168/jds.2011-4147; Markovic D, 2009, CELL MOL LIFE SCI, V66, P3337, DOI 10.1007/s00018-009-0093-4; McDonell L, 2012, GENOME, V55, P147, DOI 10.1139/G2012-002; Penna I, 2011, INT J MOL SCI, V12, P5461, DOI 10.3390/ijms12095461; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Ponting CP, 2010, HUM MOL GENET, V19, pR162, DOI 10.1093/hmg/ddq362; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Stecyk JAW, 2012, COMP BIOCHEM PHYS D, V7, P59, DOI 10.1016/j.cbd.2011.11.001; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Sun JH, 2012, INT J LEGAL MED, V126, P113, DOI 10.1007/s00414-011-0604-3; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang Y, 2007, CANCER RES, V67, P3698, DOI 10.1158/0008-5472.CAN-06-4000; Williams TK, 2008, CANCER LETT, V271, P81, DOI 10.1016/j.canlet.2008.05.033; Zhang G, 2012, MOL BIOL REP, V39, P5905, DOI 10.1007/s11033-011-1402-1; Zhao SD, 2011, J PATHOL, V223, P672, DOI 10.1002/path.2827	37	57	61	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41659	10.1371/journal.pone.0041659	http://dx.doi.org/10.1371/journal.pone.0041659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927912	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300012
J	Murray, BD; Holmes, SA; Webster, CR; Witt, JC				Murray, Bryan D.; Holmes, Stacie A.; Webster, Christopher R.; Witt, Jill C.			Post-Disturbance Plant Community Dynamics following a Rare Natural-Origin Fire in a Tsuga canadensis Forest	PLOS ONE			English	Article							GREAT-LAKES REGION; HEMLOCK-HARDWOOD FORESTS; OLD-GROWTH; EASTERN HEMLOCK; VEGETATION DYNAMICS; DEER; PATTERNS; REGENERATION; ASSEMBLAGES; RECRUITMENT	Opportunities to directly study infrequent forest disturbance events often lead to valuable information about vegetation dynamics. In mesic temperate forests of North America, stand-replacing crown fire occurs infrequently, with a return interval of 2000-3000 years. Rare chance events, however, may have profound impacts on the developmental trajectories of forest ecosystems. For example, it has been postulated that stand-replacing fire may have been an important factor in the establishment of eastern hemlock (Tsuga canadensis) stands in the northern Great Lakes region. Nevertheless, experimental evidence linking hemlock regeneration to non-anthropogenic fire is limited. To clarify this potential relationship, we monitored vegetation dynamics following a rare lightning-origin crown fire in a Wisconsin hemlock-hardwood forest. We also studied vegetation in bulldozer-created fire breaks and adjacent undisturbed forest. Our results indicate that hemlock establishment was rare in the burned area but moderately common in the scarified bulldozer lines compared to the reference area. Early-successional, non-arboreal species including Rubus spp., Vaccinium angustifolium, sedges (Carex spp.), grasses, Epilobium ciliatum, and Pteridium aquilinium were the most abundant post-fire species. Collectively, our results suggest that competing vegetation and moisture stress resulting from drought may reduce the efficacy of scarification treatments as well as the usefulness of fire for preparing a suitable seedbed for hemlock. The increasing prevalence of growing-season drought suggests that silvicultural strategies based on historic disturbance regimes may need to be reevaluated for mesic species.	[Murray, Bryan D.; Webster, Christopher R.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Ecosyst Sci Ctr, Houghton, MI 49931 USA; [Holmes, Stacie A.] U S Dept Interior, Bur Indian Affairs, Branch Forest Resources Planning, Lakewood, CO USA; [Witt, Jill C.] Little River Band Ottawa Indians, Dept Nat Resources, Manistee, MI USA	Michigan Technological University; United States Department of the Interior	Murray, BD (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Ecosyst Sci Ctr, Houghton, MI 49931 USA.	bdmurray@mtu.edu	Murray, Bryan/K-5934-2019		McIntire-Stennis Cooperative Forestry Research Program; Ecosystem Science Center; School of Forest Resources and Environmental Science, Michigan Technological University	McIntire-Stennis Cooperative Forestry Research Program; Ecosystem Science Center; School of Forest Resources and Environmental Science, Michigan Technological University	The research was supported by the McIntire-Stennis Cooperative Forestry Research Program, the Ecosystem Science Center (http://www.ecosystem.mtu.edu), and the School of Forest Resources and Environmental Science, Michigan Technological University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MD, 1998, BIOSCIENCE, V48, P355, DOI 10.2307/1313374; ALVERSON WS, 1988, CONSERV BIOL, V2, P348, DOI 10.1111/j.1523-1739.1988.tb00199.x; ANDERSON RC, 1979, J APPL ECOL, V16, P855, DOI 10.2307/2402859; [Anonymous], 1972, P C CONSERVATION PRO; Becker C, 1996, HENLOCK ECOLOGY MANA; Calcote R, 2003, HOLOCENE, V13, P215, DOI 10.1191/0959683603hl608rp; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Davis MB, 1998, ECOLOGY, V79, P2641, DOI 10.2307/176507; Donoso PJ, 2006, NORTH J APPL FOR, V23, P288, DOI 10.1093/njaf/23.4.288; Duchesne LC, 1999, CAN FIELD NAT, V113, P264; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Eckstein R.G., 1980, 104 WISC DEP NAT RES; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Foster DR, 2006, ECOLOGY, V87, P2959, DOI 10.1890/0012-9658(2006)87[2959:ACDFAM]2.0.CO;2; Foster DR, 1998, ECOSYSTEMS, V1, P497, DOI 10.1007/s100219900046; FOSTER DR, 1988, J ECOL, V76, P105, DOI 10.2307/2260457; Frelich L.E., 2002, FOREST DYNAMICS DIST, Vfirst; FRELICH LE, 1994, CAN J FOREST RES, V24, P1939, DOI 10.1139/x94-249; FRELICH LE, 1991, ECOL MONOGR, V61, P145, DOI 10.2307/1943005; FRELICH LE, 1993, ECOLOGY, V74, P513, DOI 10.2307/1939312; FRELICH LE, 1985, BIOL CONSERV, V34, P99, DOI 10.1016/0006-3207(85)90103-X; George Lisa O., 2003, P265; George LO, 1999, ECOLOGY, V80, P846, DOI 10.1890/0012-9658(1999)080[0846:TFUAAE]2.0.CO;2; Gilliam Frank S., 2003, P3; Godman R., 1990, SILVICS N AM; Goff FG, 1967, WISCONSIN GEOLOGICAL; Goff FG, 1967, SOIL SERIES U WISCON; GRAHAM S. A., 1941, JOUR FOREST, V39, P567; Hayhoe K, 2010, J GREAT LAKES RES, V36, P7, DOI 10.1016/j.jglr.2010.03.012; He HS, 1999, ECOLOGY, V80, P81, DOI 10.1890/0012-9658(1999)080[0081:SEASSO]2.0.CO;2; HIBBS DE, 1982, CAN J FOREST RES, V12, P522, DOI 10.1139/x82-081; Hough A. F., 1943, ECOL MONOGR, V13, P299, DOI 10.2307/1943224; Houle G, 1999, J ECOL, V87, P413, DOI 10.1046/j.1365-2745.1999.00352.x; Howe R. W., 1996, HEMLOCK ECOLOGY MANA, P125; Iverson L, 2008, MITIG ADAPT STRAT GL, V13, P487, DOI 10.1007/s11027-007-9129-y; Jenkins MA, 2004, FOREST SCI, V50, P781; Johnston W., 1990, SILVICS N AM; Kartesz JT, 1999, SYNTHESIS N AM FLORA; Krapfl KJ, 2011, J TORREY BOT SOC, V138, P93, DOI 10.3159/10-RA-031.1; MAISSUROW D. K., 1941, JOUR FOREST, V39, P201; Marx L, 2008, J ECOL, V96, P505, DOI 10.1111/j.1365-2745.2008.01360.x; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McCune B., 2006, PC ORD MULTIVARIATE; Mielke P. W., 2001, PERMUTATION METHODS; MILES M. L., 1960, FOREST CHRON, V36, P375; Minitab Inc, 2010, MIN REL 16 WIND; MLADENOFF DJ, 1993, CONSERV BIOL, V7, P889, DOI 10.1046/j.1523-1739.1993.740889.x; National Climatic Data Center, 2012, CLIM MON REP PROD PD; Pubanz DM, 1996, HEMLOCK ECOLOGY MANA, P175; Roberts Mark R., 2003, P302; Rooney TP, 1998, FOREST ECOL MANAG, V111, P211, DOI 10.1016/S0378-1127(98)00333-8; Rooney TP, 2000, ECOL APPL, V10, P1119, DOI 10.1890/1051-0761(2000)010[1119:RVIROH]2.0.CO;2; RUNKLE JR, 1982, ECOLOGY, V63, P1533, DOI 10.2307/1938878; Salk TT, 2011, FOREST ECOL MANAG, V261, P1998, DOI 10.1016/j.foreco.2011.02.026; SIMPSON TB, 1990, LANDSCAPE ECOSYSTEMS; Snyder CD, 2002, CAN J FISH AQUAT SCI, V59, P262, DOI 10.1139/F02-003; Stueve KM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00062.1; Turner MG, 2003, FRONT ECOL ENVIRON, V1, P351, DOI 10.2307/3868187; Walters RS, 1990, SILVICS N AM; Western Regional Climate Center, 2012, US DIV CLIM DAT; WinSCANOPY, 2005, WINSCANOPY 2005A HEM; Witt JC, 2010, FOREST ECOL MANAG, V260, P519, DOI 10.1016/j.foreco.2010.05.007; Wydeven AP, 1996, HEMLOCK ECOLOGY MANA, P115; Yamasaki M, 2000, USDA NE EXP, V267, P135; Ziegler SS, 2000, GLOBAL ECOL BIOGEOGR, V9, P373, DOI 10.1046/j.1365-2699.2000.00191.x	65	2	2	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43867	10.1371/journal.pone.0043867	http://dx.doi.org/10.1371/journal.pone.0043867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928044	gold, Green Submitted, Green Published			2022-12-25	WOS:000307789700053
J	Sager, KL; Wuu, J; Herskowitz, JH; Mufson, EJ; Levey, AI; Lah, JJ				Sager, Kristen L.; Wuu, Joanne; Herskowitz, Jeremy H.; Mufson, Elliott J.; Levey, Allan I.; Lah, James J.			Neuronal LR11 Expression Does Not Differentiate between Clinically-Defined Alzheimer's Disease and Control Brains	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; LR11/SORLA EXPRESSION; GENETIC-VARIANTS; NUCLEUS BASALIS; RECEPTOR LR11; SORL1 GENE; ASSOCIATION; CONSORTIUM; ESTABLISH	Alzheimer's disease (AD) is the leading cause of dementia in the elderly. Because the pathological changes underlying this disease can begin decades prior to the onset of cognitive impairment, identifying the earliest events in the AD pathological cascade has critical implications for both the diagnosis and treatment of this disease. We previously reported that compared to autopsy confirmed healthy control brain, expression of LR11 (or SorLA) is markedly reduced in AD brain as well as in a subset of people with mild cognitive impairment (MCI), a prodromal clinical stage of AD. Recent studies of the LR11 gene SORL1 have suggested that the association between SORL1 single nucleotide polymorphisms (SNPs) and AD risk may not be universal. Therefore, we sought to confirm our earlier findings in a population chosen solely based on clinical criteria, as in most genetic studies. Quantitative immunohistochemistry was used to measure LR11 expression in 43 cases from the Religious Orders Study that were chosen based on a final pre-mortem clinical diagnosis of MCI, mild/moderate AD or no cognitive impairment (NCI). LR11 expression was highly variable in all three diagnostic groups, with no significant group differences. Low LR11 cases were identified using the lowest tertile of LR11 expression observed across all cases as a threshold. Contrary to previous reports, low LR11 expression was found in only 29% of AD cases. A similar proportion of both the MCI and NCI cases also displayed low LR11 expression. AD-associated lesions were present in the majority of cases regardless of diagnostic group, although we found no association between LR11 levels and pathological variables. These findings suggest that the relationship between LR11 expression and the development of AD may be more complicated than originally believed.	[Sager, Kristen L.; Herskowitz, Jeremy H.; Levey, Allan I.; Lah, James J.] Emory Univ, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Wuu, Joanne] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Mufson, Elliott J.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Herskowitz, Jeremy H.; Levey, Allan I.; Lah, James J.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA	Emory University; University of Miami; Rush University; Emory University	Sager, KL (corresponding author), Emory Univ, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA.	jlah@emory.edu	Levey, Allan/F-2104-2011	Levey, Allan/0000-0002-3153-502X	NIH [PO1AG14449, P50AG025688, F31NS054436]; ADR, a program of the American Health Assistance Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688, P01AG014449] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADR, a program of the American Health Assistance Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants PO1AG14449, P50AG025688, and F31NS054436. Acknowledgement is also made to the donors of ADR, a program of the American Health Assistance Foundation, for support of this research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Bettens K, 2008, HUM MUTAT, V29, P769, DOI 10.1002/humu.20725; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chow N, 1998, P NATL ACAD SCI USA, V95, P9620, DOI 10.1073/pnas.95.16.9620; Cochran EJ, 1998, J NEUROPATH EXP NEUR, V57, P508, DOI 10.1097/00005072-199805000-00175; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; Engler H, 2006, BRAIN, V129, P2856, DOI 10.1093/brain/awl178; Fillenbaum GG, 2008, ALZHEIMERS DEMENT, V4, P96, DOI 10.1016/j.jalz.2007.08.005; Gilmor ML, 1999, J COMP NEUROL, V411, P693; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Herskowitz JH, 2011, J BIOL CHEM, V286, P6117, DOI 10.1074/jbc.M110.167239; Herskowitz JH, 2010, J PROTEOME RES, V9, P6368, DOI 10.1021/pr100666c; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kauwe JSK, 2010, J ALZHEIMERS DIS, V21, P833, DOI 10.3233/JAD-2010-091711; Kolsch H, 2009, BRAIN RES, V1264, P1, DOI 10.1016/j.brainres.2009.01.044; Laumet G, 2010, J ALZHEIMERS DIS, V20, P1181, DOI 10.3233/JAD-2010-100126; Lee JH, 2007, NEUROSCI LETT, V425, P105, DOI 10.1016/j.neulet.2007.08.042; Lee JH, 2007, ARCH NEUROL-CHICAGO, V64, P501, DOI 10.1001/archneur.64.4.501; Li Y, 2008, NEUROBIOL DIS, V29, P293, DOI 10.1016/j.nbd.2007.09.001; Liu F, 2009, J ALZHEIMERS DIS, V18, P51, DOI 10.3233/JAD-2009-1137; Markesbery WR, 2006, ARCH NEUROL-CHICAGO, V63, P38, DOI 10.1001/archneur.63.1.38; Meng Y, 2007, NEUROREPORT, V18, P1761, DOI 10.1097/WNR.0b013e3282f13e7a; Minster RL, 2008, NEUROSCI LETT, V440, P190, DOI 10.1016/j.neulet.2008.05.082; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Mufson EJ, 1997, EXP NEUROL, V146, P91, DOI 10.1006/exnr.1997.6504; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sager KL, 2007, ANN NEUROL, V62, P640, DOI 10.1002/ana.21190; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; TOMLINSON BE, 1968, J NEUROL SCI, V7, P331, DOI 10.1016/0022-510X(68)90154-8; Wolk DA, 2009, ANN NEUROL, V65, P557, DOI 10.1002/ana.21598; Zaudig M, 1992, Int Psychogeriatr, V4 Suppl 2, P203	40	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e40527	10.1371/journal.pone.0040527	http://dx.doi.org/10.1371/journal.pone.0040527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927900	Green Published, gold, Green Submitted			2022-12-25	WOS:000307789700001
J	Chamie, G; Kwarisiima, D; Clark, TD; Kabami, J; Jain, V; Geng, E; Petersen, ML; Thirumurthy, H; Kamya, MR; Havlir, DV; Charlebois, ED				Chamie, Gabriel; Kwarisiima, Dalsone; Clark, Tamara D.; Kabami, Jane; Jain, Vivek; Geng, Elvin; Petersen, Maya L.; Thirumurthy, Harsha; Kamya, Moses R.; Havlir, Diane V.; Charlebois, Edwin D.		SEARCH Collaboration	Leveraging Rapid Community-Based HIV Testing Campaigns for Non-Communicable Diseases in Rural Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; INCOME COUNTRIES; HEALTH-CARE; HYPERTENSION; KENYA; TUBERCULOSIS; PREVENTION; INITIATION; TANZANIA; COSTS	Background: The high burden of undiagnosed HIV in sub-Saharan Africa limits treatment and prevention efforts. Community-based HIV testing campaigns can address this challenge and provide an untapped opportunity to identify non-communicable diseases (NCDs). We tested the feasibility and diagnostic yield of integrating NCD and communicable diseases into a rapid HIV testing and referral campaign for all residents of a rural Ugandan parish. Methods: A five-day, multi-disease campaign, offering diagnostic, preventive, treatment and referral services, was performed in May 2011. Services included point-of-care screening for HIV, malaria, TB, hypertension and diabetes. Finger-prick diagnostics eliminated the need for phlebotomy. HIV-infected adults met clinic staff and peer counselors on-site; those with CD4 <= 100/mu L underwent intensive counseling and rapid referral for antiretroviral therapy (ART). Community participation, case-finding yield, and linkage to care three months post-campaign were analyzed. Results: Of 6,300 residents, 2,323/3,150 (74%) adults and 2,020/3,150 (69%) children participated. An estimated 95% and 52% of adult female and male residents participated respectively. Adult HIV prevalence was 7.8%, with 46% of HIV-infected adults newly diagnosed. Thirty-nine percent of new HIV diagnoses linked to care. In a pilot subgroup with CD4 <= 100, 83% linked and started ART within 10 days. Malaria was identified in 10% of children, and hypertension and diabetes in 28% and 3.5% of adults screened, respectively. Sixty-five percent of hypertensives and 23% of diabetics were new diagnoses, of which 43% and 61% linked to care, respectively. Screening identified suspected TB in 87% of HIV-infected and 19% of HIV-uninfected adults; 52% percent of HIV-uninfected TB suspects linked to care. Conclusions: In an integrated campaign engaging 74% of adult residents, we identified a high burden of undiagnosed HIV, hypertension and diabetes. Improving male attendance and optimizing linkage to care require new approaches. The campaign demonstrates the feasibility of integrating hypertension, diabetes and communicable diseases into HIV initiatives.	[Chamie, Gabriel; Clark, Tamara D.; Jain, Vivek; Geng, Elvin; Havlir, Diane V.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA; [Chamie, Gabriel; Clark, Tamara D.; Kabami, Jane; Jain, Vivek; Geng, Elvin; Kamya, Moses R.; Havlir, Diane V.; Charlebois, Edwin D.] Makerere Univ Univ Calif San Francisco MU UCSF Re, Mbarara, Uganda; [Kwarisiima, Dalsone] Mulago Mbarara Joint AIDS Program, Kampala, Uganda; [Kwarisiima, Dalsone] Mulago Mbarara Joint AIDS Program, Mbarara, Uganda; [Petersen, Maya L.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Thirumurthy, Harsha] Univ N Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Med, Kampala, Uganda; [Charlebois, Edwin D.] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; University of California System; University of California Berkeley; University of North Carolina; University of North Carolina Chapel Hill; Makerere University; University of California System; University of California San Francisco	Chamie, G (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA.	Gabriel.chamie@ucsf.edu		Thirumurthy, Harsha/0000-0002-3308-7603	National Institutes of Health/National Institute of Allergy and Infectious Diseases [3P30AI027763-19S1]; National Institute of Mental Health's Traineeships in AIDS Prevention Studies [T32 MH-19105-21]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI099959, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019105] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health's Traineeships in AIDS Prevention Studies; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The National Institutes of Health/National Institute of Allergy and Infectious Diseases (grant 3P30AI027763-19S1 to D. V. H.), and the National Institute of Mental Health's Traineeships in AIDS Prevention Studies (grant T32 MH-19105-21 to G. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; [Anonymous], 2010, WHO GUID INT TUB CAS; [Anonymous], 2006, DEF DIAGN DIAB MELL, P1; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Boehme CC, 2010, N ENGL J MED; Bovet P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-407; Buregyeya E, 2011, INT J TUBERC LUNG D, V15, P938, DOI 10.5588/ijtld.10.0211; Bwambale FM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-263; Clark CM, 2000, JAMA-J AM MED ASSOC, V284, P363, DOI 10.1001/jama.284.3.363; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kahn JG, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-346; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lugada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012435; Maher D, 2011, J HYPERTENS, V29, P1061, DOI 10.1097/HJH.0b013e3283466e90; MarquesVidal P, 1997, J HUM HYPERTENS, V11, P213, DOI 10.1038/sj.jhh.1000426; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Mills EJ, 2009, LANCET, V374, P275, DOI 10.1016/S0140-6736(09)61348-9; Ministry of Health, 2009, NAT ANT TREATM GUID; Ministry of Health, 2005, UG NAT POL GUID HIV; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sendagire I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014459; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; Uganda Bureau of Statistics, 2008, POP PROJ 2008 2012; United Nations, 2011, UN HIGH LEV M NONC D; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; WHO, 2004, ADD DEW VIT A DISTR; World Health Organization,, 2011, GUID VIT A SUPPL INF; World Health Organization (WHO), 2006, GUID COTR PROPH HIV; 2000, LANCET, V356, P103	35	103	103	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43400	10.1371/journal.pone.0043400	http://dx.doi.org/10.1371/journal.pone.0043400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916256	gold, Green Published, Green Submitted			2022-12-25	WOS:000307733800065
J	Malik, DJ; Trochimczuk, AW; Ronka, S				Malik, Danish J.; Trochimczuk, Andrzej W.; Ronka, Sylwia			Nanostructured Synthetic Carbons Obtained by Pyrolysis of Spherical Acrylonitrile/Divinylbenzene Copolymers	PLOS ONE			English	Article							STYRENE-DIVINYLBENZENE COPOLYMER; PHOSPHORIC-ACID; HEAT-TREATMENT; ADSORPTION; POLYCARBODIIMIDE; STABILIZATION; CARBONIZATION; POLYSTYRENE; PRECURSORS; SORBENTS	Novel carbon materials have been prepared by the carbonization of acrylonitrile (AN)/divinylbenzene (DVB) suspension porous copolymers having nominal crosslinking degrees in the range of 30-70% and obtained in the presence of various amounts of porogens. The carbons were obtained by pre-oxidation of AN/DVB copolymers at 250-350 degrees C in air followed by pyrolysis at 850 degrees C in an N-2 atmosphere. Both processes were carried out in one furnace and the resulting material needed no further activation. Resulting materials were characterized by XPS and low temperature nitrogen adsorption/desorption. It was found that maximum pyrolysis yield was ca. 50% depending on the oxidation conditions but almost independent of the crosslinking degree of the polymers. Porous structure of the carbons was characterized for the presence of micropores and macropores, when obtained from highly crosslinked polymers or polymers oxidized at 350 degrees C and meso-and macropores in all other cases. The latter pores are prevailing in the structure of carbons obtained from less porous AN/DVB resins. Specific surface area (BET) of polymer derived carbons can vary between 440 m(2)/g and 250 m(2)/g depending on the amount of porogen used in the synthesis of the AN/DVB polymeric precursors.	[Malik, Danish J.] Univ Loughborough, Dept Chem Engn, Loughborough, Leics, England; [Trochimczuk, Andrzej W.; Ronka, Sylwia] Wroclaw Univ Technol, Fac Chem, PL-50370 Wroclaw, Poland	Loughborough University; Wroclaw University of Science & Technology	Malik, DJ (corresponding author), Univ Loughborough, Dept Chem Engn, Loughborough, Leics, England.	d.j.malik@lboro.ac.uk	Ronka, Sylwia/AAH-8700-2020	Ronka, Sylwia/0000-0003-4754-1798	Engineering and Physical Sciences Research Council [EP/C517660/1, EP/D033837/1] Funding Source: researchfish; EPSRC [EP/D033837/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Duranoglu D, 2012, CHEM ENG J, V187, P193, DOI 10.1016/j.cej.2012.01.120; Ermolenko N, 1990, CHEM MODIFIED CARBON, P147; Gupta A, 1997, CARBON, V35, P809, DOI 10.1016/S0008-6223(97)00025-0; Inomata K, 2009, J MATER SCI, V44, P4200, DOI 10.1007/s10853-009-3560-2; Kocirik M, 2001, CARBON, V39, P1919, DOI 10.1016/S0008-6223(00)00326-2; KOLARZ BN, 1994, J POLYM SCI POL PHYS, V32, P1977, DOI 10.1002/polb.1994.090321204; Laszlo K, 2000, CARBON, V38, P1965, DOI 10.1016/S0008-6223(00)00038-5; Lenghaus K, 2002, CARBON, V40, P743, DOI 10.1016/S0008-6223(01)00194-4; Li WJ, 1996, ADSORPTION, V3, P67; Malik DJ, 2008, CARBON, V46, P310, DOI 10.1016/j.carbon.2007.11.041; Malik DJ, 2005, CARBON, V43, P2317, DOI 10.1016/j.carbon.2005.04.038; MATSUDA M, 1987, J POLYM SCI POL CHEM, V25, P669, DOI 10.1002/pola.1987.080250218; Moon S, 2009, CARBON, V47, P2829, DOI 10.1016/j.carbon.2009.06.027; Morawski AW, 1997, J MATER SCI, V32, P789, DOI 10.1023/A:1018520709777; Nakagawa H, 1999, CARBON, V37, P1455, DOI 10.1016/S0008-6223(99)00008-1; NEELY JW, 1981, CARBON, V19, P27, DOI 10.1016/0008-6223(81)90101-9; PELS JR, 1995, CARBON, V33, P1641, DOI 10.1016/0008-6223(95)00154-6; Puziy AM, 2007, APPL SURF SCI, V253, P5736, DOI 10.1016/j.apsusc.2006.12.034; Puziy AM, 2002, CARBON, V40, P1493, DOI 10.1016/S0008-6223(01)00317-7; Puziy AM, 2002, CARBON, V40, P1507, DOI 10.1016/S0008-6223(01)00318-9; Rahaman MSA, 2007, POLYM DEGRAD STABIL, V92, P1421, DOI 10.1016/j.polymdegradstab.2007.03.023; Ronka S, 2008, CARBON, V46, P1098, DOI 10.1016/j.carbon.2008.02.026; Schmiers H, 1999, CARBON, V37, P1965, DOI 10.1016/S0008-6223(99)00071-8; Shioya M, 1996, CARBON, V34, P1229, DOI 10.1016/0008-6223(96)00083-8; Trochimczuk AW, 2001, REACT FUNCT POLYM, V46, P259, DOI 10.1016/S1381-5148(00)00056-0; Wang Q, 2009, FUEL PROCESS TECHNOL, V90, P381, DOI 10.1016/j.fuproc.2008.10.008; WINSLOW FH, 1955, J POLYM SCI, V16, P101, DOI 10.1002/pol.1955.120168202; Yamashita J, 1999, CARBON, V37, P71, DOI 10.1016/S0008-6223(98)00188-2	28	6	6	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43354	10.1371/journal.pone.0043354	http://dx.doi.org/10.1371/journal.pone.0043354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916245	Green Published, Green Submitted, gold			2022-12-25	WOS:000307824300042
J	Garcia-Linares, C; Mercade, J; Gel, B; Biayna, J; Terribas, E; Lazaro, C; Serra, E				Garcia-Linares, Carles; Mercade, Jaume; Gel, Bernat; Biayna, Josep; Terribas, Ernest; Lazaro, Conxi; Serra, Eduard			Applying Microsatellite Multiplex PCR Analysis (MMPA) for Determining Allele Copy-Number Status and Percentage of Normal Cells within Tumors	PLOS ONE			English	Article							HETEROZYGOSITY; DNA; QUANTIFICATION; IMBALANCE; LOH; NF1	The study of somatic genetic alterations in tumors contributes to the understanding and management of cancer. Genetic alterations, such us copy number or copy neutral changes, generate allelic imbalances (AIs) that can be determined using polymorphic markers. Here we report the development of a simple set of calculations for analyzing microsatellite multiplex PCR data from control-tumor pairs that allows us to obtain accurate information not only regarding the AI status of tumors, but also the percentage of tumor-infiltrating normal cells, the locus copy-number status and the mechanism involved in AI. We validated this new approach by re-analyzing a set of Neurofibromatosis type 1-associated dermal neurofibromas and comparing newly generated data with results obtained for the same tumors in a previous study using MLPA, Paralog Ratio Analysis and SNP-array techniques. Microsatellite multiplex PCR analysis (MMPA) should be particularly useful for analyzing specific regions of the genome containing tumor suppressor genes and also for determining the percentage of infiltrating normal cells within tumors allowing them to be sorted before they are analyzed by more expensive techniques.	[Garcia-Linares, Carles; Mercade, Jaume; Gel, Bernat; Biayna, Josep; Terribas, Ernest; Serra, Eduard] Inst Predict & Personalized Med Canc IMPPC, Barcelona, Spain; [Lazaro, Conxi] Inst Catala Oncol ICO IDIBELL, Lab Recerca Translac, Programa Diagnost Mol Canc Hereditari, Barcelona, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Garcia-Linares, C (corresponding author), Inst Predict & Personalized Med Canc IMPPC, Barcelona, Spain.	eserra@imppc.org	Terribas, Ernest/H-8731-2017; Serra, Eduard/K-1332-2013; GARCIA, CONXI LAZARO/Q-2410-2016; Rodriguez, Josep Biayna/AAM-1263-2021; Gel Moreno, Bernat/B-8806-2016	Terribas, Ernest/0000-0002-7921-9683; Serra, Eduard/0000-0003-2895-9857; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Gel Moreno, Bernat/0000-0001-8878-349X; Biayna Rodriguez, josep/0000-0002-0842-7530	Spanish Health Research Foundation: Instituto de Salud Carlos III [PI051155, PI081871, PI10/01422, ISCIII-RTICC RD06/0020/1050, ISCIII-RTICC RD06/0020/1051]; Government of Catalonia [2009SGR290]; Asociacion Espanola Contra el Cancer (AECC)	Spanish Health Research Foundation: Instituto de Salud Carlos III; Government of Catalonia(Generalitat de Catalunya); Asociacion Espanola Contra el Cancer (AECC)	This work was supported by grants from the Spanish Health Research Foundation: Instituto de Salud Carlos III (PI051155, PI081871, PI10/01422 and ISCIII-RTICC RD06/0020/1050; RD06/0020/1051); the Government of Catalonia (2009SGR290); the Asociacion Espanola Contra el Cancer (AECC) that recognizes and supports our group as a Grupo Estable de Investigacion Oncologica 2010. The authors would like to especially acknowledge the Asociacion Espanola de Afectados de Neurofibromatosis for their constant support to our research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bieche I, 1998, INT J CANCER, V78, P661, DOI 10.1002/(SICI)1097-0215(19981123)78:5<661::AID-IJC22>3.3.CO;2-9; BRANDT B, 1995, GENE, V159, P29, DOI 10.1016/0378-1119(94)00651-8; CAWKWELL L, 1994, BRIT J CANCER, V70, P813, DOI 10.1038/bjc.1994.404; Dworkin AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001136; Garcia-Linares C, 2011, HUM MUTAT, V32, P78, DOI 10.1002/humu.21387; Goransson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006057; HAHN M, 1995, BIOTECHNIQUES, V18, P1040; Kumps C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-298; Li A, 2011, NUCLEIC ACIDS RES, V39, P4928, DOI 10.1093/nar/gkr014; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Postma C, 2005, J PATHOL, V205, P514, DOI 10.1002/path.1733; Serra E, 2001, NAT GENET, V28, P294, DOI 10.1038/90148; Skotheim RI, 2001, CANCER GENET CYTOGEN, V127, P64, DOI 10.1016/S0165-4608(00)00433-7; Slebos RJC, 2004, LAB INVEST, V84, P649, DOI 10.1038/labinvest.3700076; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0	17	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42682	10.1371/journal.pone.0042682	http://dx.doi.org/10.1371/journal.pone.0042682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916147	Green Submitted, gold, Green Published			2022-12-25	WOS:000307823600022
J	Pioz, M; Guis, H; Crespin, L; Gay, E; Calavas, D; Durand, B; Abrial, D; Ducrot, C				Pioz, Maryline; Guis, Helene; Crespin, Laurent; Gay, Emilie; Calavas, Didier; Durand, Benoit; Abrial, David; Ducrot, Christian			Why Did Bluetongue Spread the Way It Did? Environmental Factors Influencing the Velocity of Bluetongue Virus Serotype 8 Epizootic Wave in France	PLOS ONE			English	Article							BREVITARSIS KIEFFER DIPTERA; CULICOIDES BITING MIDGES; SPATIAL AUTOCORRELATION; OBSOLETUS COMPLEX; ARBOVIRUS VECTOR; ABIOTIC FACTORS; WESTERN-EUROPE; CLIMATE-CHANGE; CATTLE; RISK	Understanding where and how fast an infectious disease will spread during an epidemic is critical for its control. However, the task is a challenging one as numerous factors may interact and drive the spread of a disease, specifically when vector-borne diseases are involved. We advocate the use of simultaneous autoregressive models to identify environmental features that significantly impact the velocity of disease spread. We illustrate this approach by exploring several environmental factors influencing the velocity of bluetongue (BT) spread in France during the 2007-2008 epizootic wave to determine which ones were the most important drivers. We used velocities of BT spread estimated in 4,495 municipalities and tested sixteen covariates defining five thematic groups of related variables: elevation, meteorological-related variables, landscape-related variables, host availability, and vaccination. We found that ecological factors associated with vector abundance and activity (elevation and meteorological-related variables), as well as with host availability, were important drivers of the spread of the disease. Specifically, the disease spread more slowly in areas with high elevation and when heavy rainfall associated with extreme temperature events occurred one or two months prior to the first clinical case. Moreover, the density of dairy cattle was correlated negatively with the velocity of BT spread. These findings add substantially to our understanding of BT spread in a temperate climate. Finally, the approach presented in this paper can be used with other infectious diseases, and provides a powerful tool to identify environmental features driving the velocity of disease spread.	[Pioz, Maryline; Crespin, Laurent; Abrial, David; Ducrot, Christian] INRA, Epidemiol Anim UR346, Paris, France; [Pioz, Maryline; Guis, Helene] CIRAD, UMR CMAEE, Montpellier, France; [Crespin, Laurent] Univ Lyon, Lab Biometrie & Biol Evolut, Lyon, France; [Crespin, Laurent] Univ Lyon 1, F-69622 Villeurbanne, France; [Crespin, Laurent] CNRS, UMR5558, Villeurbanne, France; [Gay, Emilie; Calavas, Didier] French Agcy Food Environm & Occupat Hlth Safety, Lyon, France; [Durand, Benoit] French Agcy Food Environm & Occupat Hlth Safety, Maisons Alfort, France	INRAE; CIRAD; VetAgro Sup; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Pioz, M (corresponding author), INRA, Epidemiol Anim UR346, Paris, France.	maryline.pioz@hotmail.fr	Durand, Benoit/GSE-2511-2022; Pioz, Maryline/AAI-3325-2020	Pioz, Maryline/0000-0003-0331-4403; Durand, Benoit/0000-0003-0669-1394; Crespin, Laurent/0000-0001-8930-215X; Guis, Helene/0000-0002-0355-0898	French Ministry of Agriculture	French Ministry of Agriculture	This study was funded by the French Ministry of Agriculture. The funder had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Agency T, 2007, CLC 2006 TECHN GUID; Allepuz A, 2010, PREV VET MED, V96, P263, DOI 10.1016/j.prevetmed.2010.06.005; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Anselin L, 1996, REG SCI URBAN ECON, V26, P77, DOI 10.1016/0166-0462(95)02111-6; Backer JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023066; Baylis M, 2010, MED VET ENTOMOL, V24, P38, DOI 10.1111/j.1365-2915.2009.00842.x; Bishop AL, 2000, PREV VET MED, V47, P243, DOI 10.1016/S0167-5877(00)00175-6; Bishop AL, 2004, PREV VET MED, V65, P135, DOI 10.1016/j.prevetmed.2004.06.011; Bivand RS, 2008, USE R, P1; Bivand RS, 2002, J GEOGRAPHICAL SYSTE, V4, P405, DOI [DOI 10.1007/S101090300096, 10.1007/s101090300096]; Boyer TC, 2010, AM J TROP MED HYG, V83, P789, DOI 10.4269/ajtmh.2010.10-0132; Calvete C, 2009, VET J, V182, P235, DOI 10.1016/j.tvjl.2008.06.010; Caporale V, 2010, REV SCI TECH OIE, V29, P573, DOI 10.20506/rst.29.3.2001; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Carpenter S, 2006, J MED ENTOMOL, V43, P73, DOI 10.1603/0022-2585(2006)043[0073:OSTBVO]2.0.CO;2; Carpenter S, 2008, J APPL ECOL, V45, P1237, DOI 10.1111/j.1365-2664.2008.01511.x; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; de Koeijer AA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-53; De Liberato C, 2005, VET REC, V156, P301, DOI 10.1136/vr.156.10.301; De Liberato C, 2010, J MED ENTOMOL, V47, P313, DOI 10.1603/ME09148; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Ducheyne E, 2007, GEOSPATIAL HEALTH, V1, P177, DOI 10.4081/gh.2007.266; Ducheyne E, 2011, PREV VET MED, V99, P48, DOI 10.1016/j.prevetmed.2011.01.003; Durand B, 2010, EMERG INFECT DIS, V16, P1861, DOI 10.3201/eid1612.100412; Fassotte C, 2008, PREV VET MED, V87, P74, DOI 10.1016/j.prevetmed.2008.06.007; Gerbier G, 2008, PREV VET MED, V87, P119, DOI 10.1016/j.prevetmed.2008.06.012; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Guis H, 2007, VET RES, V38, P669, DOI 10.1051/vetres:2007025; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; Haining R., 2003, SPATIAL DATA ANAL TH; Haining R, 1990, SPATIAL DATA ANAL SO; Hanspach J, 2011, GLOBAL ECOL BIOGEOGR, V20, P779, DOI 10.1111/j.1466-8238.2011.00649.x; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; Hendrickx G, 2008, PREV VET MED, V87, P162, DOI 10.1016/j.prevetmed.2008.06.009; Kao RR, 2002, TRENDS MICROBIOL, V10, P279, DOI 10.1016/S0966-842X(02)02371-5; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Keitt TH, 2002, ECOGRAPHY, V25, P616, DOI 10.1034/j.1600-0587.2002.250509.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kuhn I, 2007, DIVERS DISTRIB, V13, P66, DOI 10.1111/j.1472-4642.2006.00293.x; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; LILLIE TH, 1985, J AM MOSQUITO CONTR, V1, P463; Meiswinkel R, 2008, PREV VET MED, V87, P182, DOI 10.1016/j.prevetmed.2008.06.008; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; MELLOR PS, 1979, B ENTOMOL RES, V69, P229, DOI 10.1017/S0007485300017697; Mellor PS, 2009, BIOL ANIM INFECT, P1; Mullens BA, 2004, VETER ITAL SER, V40, P160; MURRAY JD, 1986, PROC R SOC SER B-BIO, V229, P111, DOI 10.1098/rspb.1986.0078; MURRAY MD, 1995, VET MICROBIOL, V46, P91, DOI 10.1016/0378-1135(95)00075-L; Olden JD, 2000, ECOSCIENCE, V7, P501, DOI 10.1080/11956860.2000.11682622; Patta C, 2004, Vet Ital, V40, P601; Pioz M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-60; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; R Development Core Team, 2010, R FDN STAT COMP R ST; R package version 0.5-37, 2011, R PACKAGE VERSION 0; R package version 1.6-35, 2001, R PACKAGE VERSION 1; Racloz V, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-42; Sanders CJ, 2011, J APPL ECOL, V48, P1355, DOI 10.1111/j.1365-2664.2011.02051.x; Santman-Berends IMGA, 2010, VET MICROBIOL, V142, P268, DOI 10.1016/j.vetmic.2009.10.026; Savill Nicholas J, 2006, BMC Vet Res, V2, P3, DOI 10.1186/1746-6148-2-3; Savini G, 2004, VETER ITAL SER, V40, P286; Savini G, 2005, VET REC, V157, P133, DOI 10.1136/vr.157.5.133; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; Smith GC, 2002, ECOL MODEL, V150, P45, DOI 10.1016/S0304-3800(01)00471-9; Swinton J, 1998, J ANIM ECOL, V67, P54, DOI 10.1046/j.1365-2656.1998.00176.x; Szmaragd C, 2010, EPIDEMICS-NETH, V2, P139, DOI 10.1016/j.epidem.2010.05.002; Szmaragd C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009353; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Tognelli MF, 2004, ECOGRAPHY, V27, P427, DOI 10.1111/j.0906-7590.2004.03732.x; Vidal JP, 2010, INT J CLIMATOL, V30, P1627, DOI 10.1002/joc.2003; WARD MP, 1995, PREV VET MED, V24, P129, DOI 10.1016/0167-5877(94)00458-U; Ward MP, 1996, VET RES COMMUN, V20, P273, DOI 10.1007/BF00366925; WARD MP, 1994, VET REC, V134, P407, DOI 10.1136/vr.134.16.407; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Wittmann EJ, 2000, VET J, V160, P107, DOI 10.1053/tvjl.2000.0470; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020891	79	37	37	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43360	10.1371/journal.pone.0043360	http://dx.doi.org/10.1371/journal.pone.0043360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916249	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600073
J	Wu, XH; Wang, Y; Zhuo, Z; Jiang, F; Wu, YD				Wu, Xian-Hui; Wang, Yang; Zhuo, Zhu; Jiang, Fan; Wu, Yun-Dong			Identifying the Hotspots on the Top Faces of WD40-Repeat Proteins from Their Primary Sequences by beta-Bulges and DHSW Tetrads	PLOS ONE			English	Article							WD40 REPEAT DOMAIN; SER/THR-TRP TETRAD; CRYSTAL-STRUCTURE; MOLECULAR RECOGNITION; HISTONE H3; HOT-SPOTS; COMPLEX; BINDING; COMMON; IDENTIFICATION	The analysis of 36 available crystal structures of WD40 repeat proteins reveals widespread existence of a beta-bulge formed at the beginning of strand a and the end of strand b, termed as WDb-a bulge: among a total of 259 WD40 blades, there are 243 such beta-bulges. The R-1 positions in these WDb-a bulges have fair distributions of Arg, His, Ile, Leu, Lys, Met, Phe, Trp, Tyr and Val residues. These residues protrude on the top face of the WD40 proteins and can serve as hotspots for protein-protein interactions. An analysis of 29 protein complexes formed by 17 WD proteins reveals that these R-1 residues, along with two other residues (R-1-2 and D-1), are indeed widely involved in protein-protein interactions. Interestingly, these WDb-a bulges can be easily identified by the 4-amino acid sequences of (V, L, I), R-1, R-2, (V, L, I), along with some other significant amino acids. Thus, the hotspots of WD40 proteins on the top face can be readily predicted based on the primary sequences of the proteins. The literature-reported mutagenesis studies for Met30, MDV1, Tup11, COP1 and SPA1, which crystal structures are not available, can be readily understood based on the feature-based method. Applying the method, the twelve potential hotspots on the top face of Tup11 from S. japonicas have been identified. Our ITC measurements confirm seven of them, Tyr382, Arg284, Tyr426, Tyr508, Leu559, Lys575 and Ile601, are essential for recognizing Fep1. The ITC measurements further convinced that the feature-based method provides accurate prediction of hotspots on the top face.	[Wu, Xian-Hui; Wang, Yang; Zhuo, Zhu; Jiang, Fan; Wu, Yun-Dong] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Lab Computat Chem & Drug Design, Shenzhen, Peoples R China; [Wu, Yun-Dong] Peking Univ, Coll Chem, Beijing 100871, Peoples R China	Peking University; University Town of Shenzhen; Peking University	Wu, XH (corresponding author), Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Lab Computat Chem & Drug Design, Shenzhen, Peoples R China.	wuxh@pkusz.edu.cn; wuyd@pkusz.edu.cn	Z, Z/AEN-2153-2022; Wang, Yang/AAN-7740-2020; z, z/HHN-3970-2022; z, z/GXZ-4805-2022; Wu, Yun-Dong/G-8463-2013; Jiang, Fan/E-2771-2012		National Natural Science Foundation of China [21133002]; Shenzhen Graduate School of Peking University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Graduate School of Peking University	The authors are grateful for the financial supports from the National Natural Science Foundation of China(grant No.21133002; http://www.nsfc.gov.cn/Portal0/default152.htm) and the Shenzhen Graduate School of Peking University for Financial Support of this research (www.pkusz.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Axe DD, 1999, J MOL BIOL, V286, P1471, DOI 10.1006/jmbi.1999.2569; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Brunson LE, 2005, MOL GENET GENOMICS, V273, P361, DOI 10.1007/s00438-005-1137-6; Buscarlet M, 2008, J BIOL CHEM, V283, P24881, DOI 10.1074/jbc.M800722200; Cerna D, 2005, J MOL BIOL, V351, P923, DOI 10.1016/j.jmb.2005.06.025; Cerveny KL, 2003, MOL BIOL CELL, V14, P4126, DOI 10.1091/mbc.E03-02-0092; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; Chen PY, 2001, PROTEIN SCI, V10, P2063, DOI 10.1110/ps.07101; Cheng ZH, 2004, PROTEIN SCI, V13, P2673, DOI 10.1110/ps.04856504; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; DionSchultz A, 1997, PROTEIN ENG, V10, P263, DOI 10.1093/protein/10.3.263; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; Komachi K, 1997, MOL CELL BIOL, V17, P6023, DOI 10.1128/MCB.17.10.6023; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Larsen NA, 2004, J MOL BIOL, V344, P885, DOI 10.1016/j.jmb.2004.09.094; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mishra P, 2009, J BIOCHEM, V146, P563, DOI 10.1093/jb/mvp106; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Pickles LM, 2002, STRUCTURE, V10, P751, DOI 10.1016/S0969-2126(02)00768-2; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Sprague ER, 2000, EMBO J, V19, P3016, DOI 10.1093/emboj/19.12.3016; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu XH, 2010, BIOCHEMISTRY-US, V49, P10237, DOI 10.1021/bi101321y; Wu XH, 2010, PROTEINS, V78, P1186, DOI 10.1002/prot.22638; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yang JP, 2006, PLANT J, V47, P564, DOI 10.1111/j.1365-313X.2006.02811.x; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Znaidi S, 2004, J BIOL CHEM, V279, P9462, DOI 10.1074/jbc.M312787200; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	61	35	35	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43005	10.1371/journal.pone.0043005	http://dx.doi.org/10.1371/journal.pone.0043005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916195	Green Published, Green Submitted, gold			2022-12-25	WOS:000307823600039
J	Yao, JK; Condray, R; Dougherty, GG; Keshavan, MS; Montrose, DM; Matson, WR; McEvoy, J; Kaddurah-Daouk, R; Reddy, RD				Yao, Jeffrey K.; Condray, Ruth; Dougherty, George G., Jr.; Keshavan, Matcheri S.; Montrose, Debra M.; Matson, Wayne R.; McEvoy, Joseph; Kaddurah-Daouk, Rima; Reddy, Ravinder D.			Associations between Purine Metabolites and Clinical Symptoms in Schizophrenia	PLOS ONE			English	Article							SERUM URIC-ACID; NEUROLOGIC EXAMINATION ABNORMALITIES; NEUROLEPTIC-NAIVE; NEUROPSYCHOLOGICAL PERFORMANCE; ACHIEVEMENT BEHAVIOR; SOFT SIGNS; CHOLESTEROL; CATABOLISM; MOTIVATION; RADICALS	Background: The antioxidant defense system, which is known to be dysregulated in schizophrenia, is closely linked to the dynamics of purine pathway. Thus, alterations in the homeostatic balance in the purine pathway may be involved in the pathophysiology of schizophrenia. Methodology/Principal Findings: Breakdown products in purine pathway were measured using high-pressure liquid chromatography coupled with a coulometric multi-electrode array system for 25 first-episode neuroleptic-naive patients with schizophrenia at baseline and at 4-weeks following initiation of treatment with antipsychotic medication. Associations between these metabolites and clinical and neurological symptoms were examined at both time points. The ratio of uric acid and guanine measured at baseline predicted clinical improvement following four weeks of treatment with antipsychotic medication. Baseline levels of purine metabolites also predicted clinical and neurological symtpoms recorded at baseline; level of guanosine was associated with degree of clinical thought disturbance, and the ratio of xanthosine to guanosine at baseline predicted degree of impairment in the repetition and sequencing of actions. Conclusions/Significance: Findings suggest an association between optimal levels of purine byproducts and dynamics in clinical symptoms and adjustment, as well as in the integrity of sensory and motor processing. Taken together, alterations in purine catabolism may have clinical relevance in schizophrenia pathology.	[Yao, Jeffrey K.; Condray, Ruth; Dougherty, George G., Jr.; Reddy, Ravinder D.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15206 USA; [Yao, Jeffrey K.; Condray, Ruth; Dougherty, George G., Jr.; Keshavan, Matcheri S.; Montrose, Debra M.; Reddy, Ravinder D.] Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Med Ctr, Pittsburgh, PA 15213 USA; [Yao, Jeffrey K.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Keshavan, Matcheri S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Keshavan, Matcheri S.] Harvard Univ, Boston, MA 02115 USA; [Matson, Wayne R.] Bedford Vet Affairs Med Ctr, Bedford, MA USA; [McEvoy, Joseph; Kaddurah-Daouk, Rima] Duke Univ, Med Ctr, Durham, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Duke University	Yao, JK (corresponding author), Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15206 USA.	jkyao@pitt.edu		Kaddurah-Daouk, Rima/0000-0003-1858-5732	Department of Veterans Affairs (VA); Veterans Health Administration; Office of Research and Development; Biomedical Laboratory Research Development; Senior Research Career Scientist Award; VA Pittsburgh Healthcare System; National Institutes of Health [MH58141, MH64118, MH45203, MH84941, R24 GM078233, c UL1 RR024153, M01 RR00056]; Metabolomics Research Network; Stanley Medical Research Institute; National Alliance for Research on Schizophrenia and Affective Disorders; Merck; Psychogenics; Roche; Sunovion; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153, M01RR000056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM078233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045203, K08MH064118, R01MH058141, R01MH084941] Funding Source: NIH RePORTER	Department of Veterans Affairs (VA)(US Department of Veterans Affairs); Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; Biomedical Laboratory Research Development(US Department of Veterans Affairs); Senior Research Career Scientist Award; VA Pittsburgh Healthcare System(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Metabolomics Research Network; Stanley Medical Research Institute; National Alliance for Research on Schizophrenia and Affective Disorders(NARSAD); Merck(Merck & Company); Psychogenics; Roche(Roche Holding); Sunovion; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This material is based on work supported in part by the grants from the Department of Veterans Affairs (VA), Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research & Development [Merit Reviews (JKY) and Senior Research Career Scientist Award (JKY)], VA Pittsburgh Healthcare System (JKY, GGD), National Institutes of Health [MH58141 (JKY), MH64118 (RDR), MH45203 (MSK), MH84941 (RKD), R24 GM078233 (RKD), c UL1 RR024153 and NIH/NCRR/GCRC Grant M01 RR00056], Metabolomics Research Network (RKD); Stanley Medical Research Institute (RKD), and National Alliance for Research on Schizophrenia and Affective Disorders (RKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article do not represent the views of the Department of Veterans Affairs or the United States Government.; Dr. McEvoy received honoraria from Lilly, Merck, and Sunovion, and grant supports from Merck, Psychogenics, Roche, and Sunovion. Dr. Kaddurah-Daouk is a co-inventor on a series of patents in the metabolomics field. (1. One patent Issued (3/20/12) "Lipidomic approaches to determine drug response - Phenotypes in cardiovascular disease" Patent # 8137977, expires 12/10/27. 2. One patent pending: "Lipidomic approaches for central nervous system disorders" Application # 12/091,213 filed 12/10/08, Publication # US 2009/0305323 12/10/09.) All other authors declare no conflict of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Annanmaki T, 2008, PARKINSONISM RELAT D, V14, P576, DOI 10.1016/j.parkreldis.2007.11.001; Arango C, 1999, AM J PSYCHIAT, V156, P1349; BARRERA CM, 1988, BIOL PSYCHIAT, V24, P344, DOI 10.1016/0006-3223(88)90205-3; BARRERA CM, 1989, PHARMACOL BIOCHEM BE, V33, P367, DOI 10.1016/0091-3057(89)90515-7; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Bruning J.L., 1987, COMPUTATIONAL HDB ST; BUCHANAN RW, 1989, PSYCHIAT RES, V27, P335, DOI 10.1016/0165-1781(89)90148-0; CADET JL, 1987, INTEGRATIVE PSYCHIAT, V5, P40; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; GUPTA S, 1995, AM J PSYCHIAT, V152, P191; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; ISHAY JS, 1979, PSYCHOPHARMACOLOGY, V65, P299, DOI 10.1007/BF00492219; KASL SV, 1970, J AMER MED ASSOC, V213, P1291, DOI 10.1001/jama.213.8.1291; KASL SV, 1970, J AMER MED ASSOC, V213, P1158, DOI 10.1001/jama.213.7.1158; Keshavan MS, 2003, AM J PSYCHIAT, V160, P1298, DOI 10.1176/appi.ajp.160.7.1298; Kristal Bruce S., 2007, V358, P159, DOI 10.1007/978-1-59745-244-1_10; Kristal BS, 1999, ARCH BIOCHEM BIOPHYS, V370, P22, DOI 10.1006/abbi.1999.1387; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Linden J., 2006, BASIC NEUROCHEMISTRY, P303; LOHR JB, 1991, ARCH GEN PSYCHIAT, V48, P1097; Matsuzawa D, 2009, AM J MED GENET B, V150B, P86, DOI 10.1002/ajmg.b.30776; Mohr F, 2003, PSYCHIAT RES, V121, P21, DOI 10.1016/S0165-1781(03)00203-8; Nagamine T, 2010, NEUROPSYCH DIS TREAT, V6, P281; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Reddy R, 2003, SCHIZOPHR RES, V62, P205, DOI 10.1016/S0920-9964(02)00407-3; Reddy RD, 1996, PROSTAG LEUKOTR ESS, V55, P33, DOI 10.1016/S0952-3278(96)90143-X; RUBIN P, 1994, ACTA PSYCHIAT SCAND, V90, P385, DOI 10.1111/j.1600-0447.1994.tb01611.x; Sanders RD, 2006, SCHIZOPHR RES, V86, P172, DOI 10.1016/j.schres.2006.06.012; Sanders RD, 2004, J NEUROPSYCH CLIN N, V16, P480, DOI 10.1176/appi.neuropsych.16.4.480; Sanders RD, 2000, PSYCHIAT RES, V95, P237, DOI 10.1016/S0165-1781(00)00176-1; Schiavo S, 2008, ANAL CHEM, V80, P5912, DOI 10.1021/ac800507y; Shi HL, 2002, ANAL BIOCHEM, V302, P239, DOI 10.1006/abio.2001.5568; STETTEN D, 1959, SCIENCE, V129, P1737, DOI 10.1126/science.129.3365.1737; Strazzullo P, 2007, NUTR METAB CARDIOVAS, V17, P409, DOI 10.1016/j.numecd.2007.02.011; Yao JK, 2010, MOL PSYCHIATR, V15, P938, DOI 10.1038/mp.2009.33; Yao JK, 2006, DIS MARKERS, V22, P83, DOI 10.1155/2006/248387; Yao JK, 2011, ANTIOXID REDOX SIGN, V15, P2011, DOI 10.1089/ars.2010.3603; Yao JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009508; Yao JK, 1998, PSYCHIAT RES, V80, P29, DOI 10.1016/S0165-1781(98)00051-1	44	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42165	10.1371/journal.pone.0042165	http://dx.doi.org/10.1371/journal.pone.0042165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OQ	22916123	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000307500800009
J	Hull, RL; Peters, MJ; Perigo, SP; Chan, CK; Wight, TN; Kinsella, MG				Hull, Rebecca L.; Peters, Michael J.; Perigo, Susan Potter; Chan, Christina K.; Wight, Thomas N.; Kinsella, Michael G.			Overall Sulfation of Heparan Sulfate from Pancreatic Islet beta-TC3 Cells Increases Maximal Fibril Formation but Does Not Determine Binding to the Amyloidogenic Peptide Islet Amyloid Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; FORMATION IN-VITRO; TRANSFORMING GROWTH-FACTOR-BETA-1; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; FORMATION RATHER; MOUSE MODEL; PROTEOGLYCAN; PROTEINS	Islet amyloid, a pathologic feature of type 2 diabetes, contains the islet beta-cell peptide islet amyloid polypeptide (IAPP) as its unique amyloidogenic component. Islet amyloid also contains heparan sulfate proteoglycans (HSPGs) that may contribute to amyloid formation by binding IAPP via their heparan sulfate (HS) chains. We hypothesized that beta-cells produce HS that bind IAPP via regions of highly sulfated disaccharides. Unexpectedly, HS from the beta-cell line beta-TC3 contained fewer regions of highly sulfated disaccharides compared with control normal murine mammary gland (NMuMG) cells. The proportion of HS that bound IAPP was similar in both cell lines ( 65%). The sulfation pattern of IAPP-bound versus non-bound HS from beta-TC3 cells was similar. In contrast, IAPP-bound HS from NMuMG cells contained frequent highly sulfated regions, whereas the nonbound material demonstrated fewer sulfated regions. Fibril formation from IAPP was stimulated equally by IAPP-bound beta-TC3 HS, non-bound beta-TC3 HS, and non-bound NMuMG HS but was stimulated to a greater extent by the highly sulfated IAPP-bound NMuMG HS. Desulfation of HS decreased the ability of both beta-TC3 and NMuMG HS to stimulate IAPP maximal fibril formation, but desulfated HS from both cell types still accelerated fibril formation relative to IAPP alone. In summary, neither binding to nor acceleration of fibril formation from the amyloidogenic peptide IAPP is dependent on overall sulfation in HS synthesized by beta-TC3 cells. This information will be important in determining approaches to reduce HS-IAPP interactions and ultimately prevent islet amyloid formation and its toxic effects in type 2 diabetes.	[Hull, Rebecca L.; Peters, Michael J.] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; [Hull, Rebecca L.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Wight, Thomas N.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Perigo, Susan Potter; Chan, Christina K.; Wight, Thomas N.; Kinsella, Michael G.] Benaroya Res Inst Virginia Mason, Hope Heart Matrix Biol Program, Seattle, WA 98101 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Benaroya Research Institute; Virginia Mason Medical Center	Hull, RL (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, 1660 S Columbian Way, Seattle, WA 98108 USA.	rhull@u.washington.edu	Hull-Meichle, Rebecca L./CAG-5879-2022	Hull, Rebecca/0000-0001-9690-4087	Department of Veterans Affairs, Veterans Affairs Puget Sound Health Care System (Seattle, WA); National Institutes of Health [DK74404, HL18645, HL92969, DK17047]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645, P01HL092969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088082, K01DK074404, P30DK017047] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Affairs Puget Sound Health Care System (Seattle, WA)(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Department of Veterans Affairs, Veterans Affairs Puget Sound Health Care System (Seattle, WA) and National Institutes of Health Grants DK74404 (to R. L. H.), HL18645 and HL92969 (to T. N. W.), and DK17047 (to the University of Washington Diabetes Research Center).	Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Aston-Mourney K, 2011, DIABETOLOGIA, V54, P1756, DOI 10.1007/s00125-011-2143-3; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Castillo GM, 1997, J NEUROCHEM, V69, P2452; Charge SBP, 1996, J PATHOL, V179, P443; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Hull RL, 2007, AM J PHYSIOL-CELL PH, V293, pC1586, DOI 10.1152/ajpcell.00208.2007; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Hull RL, 2003, DIABETES, V52, P372, DOI 10.2337/diabetes.52.2.372; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; KATO M, 1994, J BIOL CHEM, V269, P18881; KAZATCHKINE MD, 1981, J CLIN INVEST, V67, P223, DOI 10.1172/JCI110017; KINSELLA MG, 1988, BIOCHEMISTRY-US, V27, P2136, DOI 10.1021/bi00406a048; Knox S, 2002, J BIOL CHEM, V277, P14657, DOI 10.1074/jbc.M111826200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lindahl B, 1997, J BIOL CHEM, V272, P26091, DOI 10.1074/jbc.272.42.26091; LINDAHL U, 1973, J BIOL CHEM, V248, P7234; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3; OHSAWA H, 1991, ACTA ENDOCRINOL-COP, V124, P45, DOI 10.1530/acta.0.1240045; Park K, 2001, J BIOL CHEM, V276, P16611, DOI 10.1074/jbc.M008423200; Potter-Perigo S, 2003, ARCH BIOCHEM BIOPHYS, V413, P182, DOI 10.1016/S0003-9861(03)00116-4; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; SCHONHERR E, 1993, ARTERIOSCLER THROMB, V13, P1026, DOI 10.1161/01.ATV.13.7.1026; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; WESTERMARK P, 1978, DIABETOLOGIA, V15, P417, DOI 10.1007/BF01219652; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; WIGHT TN, 1991, CELL BIOL EXTRACELLU, P45, DOI DOI 10.1007/978-1-4615-3770-0_3; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; Zraika S, 2007, BIOCHEM BIOPH RES CO, V354, P234, DOI 10.1016/j.bbrc.2006.12.187; Zraika S, 2010, J BIOL CHEM, V285, P18177, DOI 10.1074/jbc.M109.082032	38	6	6	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37154	37164		10.1074/jbc.M112.409847	http://dx.doi.org/10.1074/jbc.M112.409847			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22936797	hybrid, Green Published			2022-12-25	WOS:000310588500049
J	Nakaya, N; Sultana, A; Lee, HS; Tomarev, SI				Nakaya, Naoki; Sultana, Afia; Lee, Hee-Sheung; Tomarev, Stanislav I.			Olfactomedin 1 Interacts with the Nogo A Receptor Complex to Regulate Axon Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; REGENERATION; EXPRESSION; GENE; INHIBITION; PANCORTINS; MUTATIONS; A2-PANCORTINS; PROTEINS; EPILEPSY	Olfm1, a secreted highly conserved glycoprotein, is detected in peripheral and central nervous tissues and participates in neural progenitor maintenance, cell death in brain, and optic nerve arborization. In this study, we identified Olfm1 as a molecule promoting axon growth through interaction with the Nogo A receptor (NgR1) complex. Olfm1 is coexpressed with NgR1 in dorsal root ganglia and retinal ganglion cells in embryonic and postnatal mice. Olfm1 specifically binds to NgR1, as judged by alkaline phosphatase assay and coimmunoprecipitation. The addition of Olfm1 inhibited the growth cone collapse of dorsal root ganglia neurons induced by myelin-associated inhibitors, indicating that Olfm1 attenuates the NgR1 receptor functions. Olfm1 caused the inhibition of NgR1 signaling by interfering with interaction between NgR1 and its coreceptors p75NTR or LINGO-1. In zebrafish, inhibition of optic nerve extension by olfm1 morpholino oligonucleotides was partially rescued by dominant negative ngr1 or lingo-1. These data introduce Olfm1 as a novel NgR1 ligand that may modulate the functions of the NgR1 complex in axonal growth.	[Nakaya, Naoki; Sultana, Afia; Lee, Hee-Sheung; Tomarev, Stanislav I.] NEI, Sect Mol Mech Glaucoma, Retinal Cell & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Tomarev, SI (corresponding author), NEI, Sect Mol Mech Glaucoma, Retinal Cell & Mol Biol Lab, NIH, Bldg 6,Room 212,6 Ctr Dr,MSC 0606, Bethesda, MD 20892 USA.	tomarevs@nei.nih.gov			National Eye Institute, National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000311] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Eye Institute, National Institutes of Health.	Ando K, 2005, NEUROSCIENCE, V133, P947, DOI 10.1016/j.neuroscience.2005.03.009; Barembaum M, 2000, NAT CELL BIOL, V2, P219, DOI 10.1038/35008643; Bartsch U, 1995, NEURON, V15, P1375, DOI 10.1016/0896-6273(95)90015-2; Brosamle C, 2009, MOL CELL NEUROSCI, V40, P401, DOI 10.1016/j.mcn.2008.10.009; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Cheng AW, 2007, J NEUROSCI, V27, P1519, DOI 10.1523/JNEUROSCI.5154-06.2007; DANIELSON PE, 1994, J NEUROSCI RES, V38, P468, DOI 10.1002/jnr.490380413; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Harvey PA, 2009, J NEUROSCI, V29, P6285, DOI 10.1523/JNEUROSCI.5885-08.2009; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Kulkarni NH, 2000, GENET RES, V76, P41, DOI 10.1017/S0016672300004584; Llorens F, 2011, FASEB J, V25, P463, DOI 10.1096/fj.10-162792; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; Morante-Redolat JM, 2002, HUM MOL GENET, V11, P1119, DOI 10.1093/hmg/11.9.1119; Moreno TA, 2005, DEV BIOL, V288, P434, DOI 10.1016/j.ydbio.2005.09.050; Moreno TA, 2001, DEV BIOL, V240, P340, DOI 10.1006/dbio.2001.0472; Nagano T, 1998, MOL BRAIN RES, V53, P13, DOI 10.1016/S0169-328X(97)00271-4; Nagano T, 2000, J NEUROCHEM, V75, P1, DOI 10.1046/j.1471-4159.2000.0750001.x; Nakaya N, 2008, J NEUROSCI, V28, P7900, DOI 10.1523/JNEUROSCI.0617-08.2008; Nakaya N, 2007, GENE EXPR PATTERNS, V7, P723, DOI 10.1016/j.modgep.2007.06.005; O'Brien GS, 2009, CURR BIOL, V19, P2086, DOI 10.1016/j.cub.2009.10.051; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; SNYDER DA, 1991, BIOCHEMISTRY-US, V30, P9143, DOI 10.1021/bi00102a004; Sultana A, 2011, INVEST OPHTH VIS SCI, V52, P2584, DOI 10.1167/iovs.10-6356; Thomas R, 2010, J NEUROSCI, V30, P6607, DOI 10.1523/JNEUROSCI.5147-09.2010; Tomarev SI, 2003, INVEST OPHTH VIS SCI, V44, P2588, DOI 10.1167/iovs.02-1099; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Torrado M, 2002, HUM MOL GENET, V11, P1291, DOI 10.1093/hmg/11.11.1291; Veroni C, 2007, J NEUROSCI RES, V85, P2631, DOI 10.1002/jnr.21186; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yoda H, 2004, MECH DEVELOP, V121, P715, DOI 10.1016/j.mod.2004.03.021	36	51	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37171	37184		10.1074/jbc.M112.389916	http://dx.doi.org/10.1074/jbc.M112.389916			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22923615	Green Published, hybrid			2022-12-25	WOS:000310588500051
J	Izumi, S; Saito, A; Kanemoto, S; Kawasaki, N; Asada, R; Iwamoto, H; Oki, M; Miyagi, H; Ochi, M; Imaizumi, K				Izumi, Soutarou; Saito, Atsushi; Kanemoto, Soshi; Kawasaki, Noritaka; Asada, Rie; Iwamoto, Hideo; Oki, Mami; Miyagi, Hidetaka; Ochi, Mitsuo; Imaizumi, Kazunori			The Endoplasmic Reticulum Stress Transducer BBF2H7 Suppresses Apoptosis by Activating the ATF5-MCL1 Pathway in Growth Plate Cartilage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR; ATF/CREB FAMILY; ER; INTERFERENCE; EXPRESSION; SURVIVAL; OASIS; ATF5; DIFFERENTIATION	BBF2H7 (box B-binding factor 2 human homolog on chromosome 7) is a basic leucine zipper transmembrane transcription factor that belongs to the cyclic AMP-responsive element-binding protein (CREB)/activating transcription factor (ATF) family. This novel endoplasmic reticulum (ER) stress transducer is localized in the ER and is cleaved in its transmembrane region in response to ER stress. BBF2H7 has been shown to be expressed in proliferating chondrocytes in cartilage during the development of long bones. The target of BBF2H7 is Sec23a, one of the coat protein complex II components. Bbf2h7-deficient (Bbf2h7(-/-)) mice exhibit severe chondrodysplasia, with expansion of the rough ER in proliferating chondrocytes caused by impaired secretion of extracellular matrix (ECM) proteins. We observed a decrease in the number of proliferating chondrocytes in the cartilage of Bbf2h7(-/-) mice. TUNEL staining of the cartilage showed that apoptosis was promoted in Bbf2h7(-/-) chondrocytes. Atf5 (activating transcription factor 5), another member of the CREB/ATF family and an antiapoptotic factor, was also found to be a target of BBF2H7 in chondrocytes. ATF5 activated the transcription of Mcl1 (myeloid cell leukemia sequence 1), which belongs to the antiapoptotic B-cell leukemia/lymphoma 2 family, to suppress apoptosis. Finally, we found that the BBF2H7-ATF5-MCL1 pathway specifically suppressed ER stress-induced apoptosis in chondrocytes. Taken together, our findings indicate that BBF2H7 is activated in response to ER stress caused by synthesis of abundant ECM proteins and plays crucial roles as a bifunctional regulator to accelerate ECM protein secretion and suppress ER stress-induced apoptosis by activating the ATF5-MCL1 pathway during chondrogenesis.	[Izumi, Soutarou; Saito, Atsushi; Kanemoto, Soshi; Kawasaki, Noritaka; Asada, Rie; Iwamoto, Hideo; Oki, Mami; Miyagi, Hidetaka; Imaizumi, Kazunori] Hiroshima Univ, Dept Biochem, Inst Biomed & Hlth Sci, Minami Ku, Hiroshima 7348553, Japan; [Izumi, Soutarou; Ochi, Mitsuo] Hiroshima Univ, Dept Orthoped Surg, Fac Med, Minami Ku, Hiroshima 7348553, Japan	Hiroshima University; Hiroshima University	Saito, A (corresponding author), Hiroshima Univ, Dept Biochem, Inst Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	asaito@hiroshima-u.ac.jp; imaizumi@hiroshima-u.ac.jp		Kitamura, Rie/0000-0001-8347-6909	Japan Society for the Promotion of Science KAKENHI [22020030, 24689058, 24659678]; Sumitomo Foundation; Suzuken Memorial Foundation; Kanae Foundation; Mitsui Sumitomo Insurance Welfare Foundation; Kowa Life Science Foundation; Ichiro Kanehara Foundation; Uehara Memorial Foundation; Senri Life Science Foundation; Hokuto Foundation for Bioscience; Japan Prize Foundation; Nakatomi Foundation; Takeda Science Foundation; Pharmacological Research Foundation Tokyo; Daiichi-Sankyo Foundation of Life Science; Inamori Foundation; Naito Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sumitomo Foundation; Suzuken Memorial Foundation; Kanae Foundation; Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation); Kowa Life Science Foundation; Ichiro Kanehara Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Senri Life Science Foundation; Hokuto Foundation for Bioscience(Hokuto Foundation for Bioscience); Japan Prize Foundation(Japan Prize Foundation); Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Pharmacological Research Foundation Tokyo(Pharmacological Research Foundation, Tokyo); Daiichi-Sankyo Foundation of Life Science; Inamori Foundation; Naito Foundation(Naito Memorial Foundation)	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 22020030, 24689058, and 24659678, the Sumitomo Foundation, the Suzuken Memorial Foundation, the Kanae Foundation, the Mitsui Sumitomo Insurance Welfare Foundation, the Kowa Life Science Foundation, the Ichiro Kanehara Foundation, the Uehara Memorial Foundation, the Senri Life Science Foundation, the Hokuto Foundation for Bioscience, the Japan Prize Foundation, the Nakatomi Foundation, the Takeda Science Foundation, the Pharmacological Research Foundation Tokyo, the Daiichi-Sankyo Foundation of Life Science, the Inamori Foundation, and the Naito Foundation.	Al Sarraj J, 2005, BIOL CHEM, V386, P873, DOI 10.1515/BC.2005.102; Angelastro JM, 2006, ONCOGENE, V25, P907, DOI 10.1038/sj.onc.1209116; Asada R, 2012, J BIOL CHEM, V287, P8144, DOI 10.1074/jbc.M111.332593; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Delezoide AL, 1997, HUM MOL GENET, V6, P1899, DOI 10.1093/hmg/6.11.1899; Dong SM, 2005, J NEUROPATH EXP NEUR, V64, P948, DOI 10.1097/01.jnen.0000186940.14779.90; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hail N, 2006, APOPTOSIS, V11, P889, DOI 10.1007/s10495-006-6712-8; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Katiyar P., 2011, INT J BIOMED RES, V2, P422; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Legeai-Mallet L, 1998, J BIOL CHEM, V273, P13007, DOI 10.1074/jbc.273.21.13007; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Pakula TM, 2003, J BIOL CHEM, V278, P45011, DOI 10.1074/jbc.M302372200; Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Peters CS, 2001, J BIOL CHEM, V276, P13718, DOI 10.1074/jbc.M011562200; Rodriguez D, 2011, BBA-MOL CELL RES, V1813, P564, DOI 10.1016/j.bbamcr.2010.11.012; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Saito A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1971; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sheng Z, 2010, NAT MED, V16, P671, DOI 10.1038/nm.2158; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tohmonda T, 2011, EMBO REP, V12, P451, DOI 10.1038/embor.2011.34; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang H, 2007, CELL BIOL INT, V31, P1309, DOI 10.1016/j.cellbi.2007.05.002; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018	44	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36190	36200		10.1074/jbc.M112.373746	http://dx.doi.org/10.1074/jbc.M112.373746			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936798	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000310364000040
J	Alves, H; van Ginkel, J; Groen, N; Hulsman, M; Mentink, A; Reinders, M; van Blitterswijk, C; de Boer, J				Alves, Hugo; van Ginkel, Jetty; Groen, Nathalie; Hulsman, Marc; Mentink, Anouk; Reinders, Marcel; van Blitterswijk, Clemens; de Boer, Jan			A Mesenchymal Stromal Cell Gene Signature for Donor Age	PLOS ONE			English	Article							STEM-CELLS; BONE TISSUE; SKELETAL-MUSCLE; MESSENGER-RNA; EXPRESSION; FOLLISTATIN; ACTIVIN; OVEREXPRESSION; IDENTIFICATION; TELOMERASE	Human aging is associated with loss of function and regenerative capacity. Human bone marrow derived mesenchymal stromal cells (hMSCs) are involved in tissue regeneration, evidenced by their capacity to differentiate into several lineages and therefore are considered the golden standard for cell-based regeneration therapy. Tissue maintenance and regeneration is dependent on stem cells and declines with age and aging is thought to influence therapeutic efficacy, therefore, more insight in the process of aging of hMSCs is of high interest. We, therefore, hypothesized that hMSCs might reflect signs of aging. In order to find markers for donor age, early passage hMSCs were isolated from bone marrow of 61 donors, with ages varying from 17-84, and clinical parameters, in vitro characteristics and microarray analysis were assessed. Although clinical parameters and in vitro performance did not yield reliable markers for aging since large donor variations were present, genome-wide microarray analysis resulted in a considerable list of genes correlating with human age. By comparing the transcriptional profile of aging in human with the one from rat, we discovered follistatin as a common marker for aging in both species. The gene signature presented here could be a useful tool for drug testing to rejuvenate hMSCs or for the selection of more potent, hMSCs for cell-based therapy.	[Alves, Hugo; van Ginkel, Jetty; Groen, Nathalie; Mentink, Anouk; van Blitterswijk, Clemens; de Boer, Jan] Univ Twente, Dept Tissue Regenerat, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [Hulsman, Marc; Reinders, Marcel] Delft Univ Technol, Informat & Commun Theory Grp, Fac Elect Engn Math & Comp Sci, Delft, Netherlands	University of Twente; Delft University of Technology	Alves, H (corresponding author), Univ Twente, Dept Tissue Regenerat, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.	j.deboer@tnw.utwente.nl		de Boer, Jan/0000-0001-9188-9324; van Blitterswijk, Clemens/0000-0003-2371-4615	Netherlands Technology Foundation [TGT.6745]; Senter/Novem research grant	Netherlands Technology Foundation(Technologiestichting STW); Senter/Novem research grant	This work was supported by The Netherlands Technology Foundation (STW grant TGT.6745) and Senter/Novem research grant (RS, RL, JdB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves H, 2009, J CELL MOL MED; Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106; Bellantuono Ilaria, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S146239940700049X; Bellantuono I, 2009, BBA-MOL BASIS DIS, V1792, P364, DOI 10.1016/j.bbadis.2009.01.008; Both SK, 2007, TISSUE ENG, V13, P3, DOI 10.1089/ten.2005.0513; Browner WS, 2004, AM J MED, V117, P851, DOI 10.1016/j.amjmed.2004.06.033; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Carey KA, 2007, J GERONTOL A-BIOL, V62, P9, DOI 10.1093/gerona/62.1.9; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Dalbo VJ, 2011, J GERONTOL A-BIOL, V66, P855, DOI 10.1093/gerona/glr091; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; de Magalhaes JP, 2003, BIOGERONTOLOGY, V4, P119, DOI 10.1023/A:1023356005749; Dickson BC, 2007, MODERN PATHOL, V20, P685, DOI 10.1038/modpathol.3800785; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eijken M, 2007, FASEB J, V21, P2949, DOI 10.1096/fj.07-8080com; FRIEDENSTEIN AJ, 1992, BONE MINER, V18, P199, DOI 10.1016/0169-6009(92)90807-P; Gaddy-Kurten D, 2002, ENDOCRINOLOGY, V143, P74, DOI 10.1210/en.143.1.74; Gajos-Michniewicz A, 2012, J BONE MINER METAB, V30, P426, DOI 10.1007/s00774-011-0347-8; Greenwood MJ, 2003, ARCH MED RES, V34, P489, DOI 10.1016/j.arcmed.2003.07.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensky NE, 2007, EUR J APPL PHYSIOL, V101, P473, DOI 10.1007/s00421-007-0521-9; Kerber RA, 2009, AGING CELL, V8, P239, DOI 10.1111/j.1474-9726.2009.00467.x; Klein NA, 2000, J CLIN ENDOCR METAB, V85, P4520, DOI 10.1210/jc.85.12.4520; Koc ON, 1999, EXP HEMATOL, V27, P1675, DOI 10.1016/S0301-472X(99)00101-0; Kodama N, 2009, BONE, V44, P699, DOI 10.1016/j.bone.2008.12.017; Li HW, 2006, BIOCHEM BIOPH RES CO, V341, P320, DOI 10.1016/j.bbrc.2005.12.182; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Meijer GJ, 2007, PLOS MED, V4, P260, DOI 10.1371/journal.pmed.0040009; Park SK, 2009, AGING CELL, V8, P484, DOI 10.1111/j.1474-9726.2009.00496.x; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Ryu E, 2008, BIOCHEM BIOPH RES CO, V371, P431, DOI 10.1016/j.bbrc.2008.04.111; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; Teixeira S, 2010, J BIOMED MATER RES A, V93A, P567, DOI 10.1002/jbm.a.32532; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wang J, 2006, J HUM GENET, V51, P934, DOI 10.1007/s10038-006-0042-0; Wennmalm K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r109; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zhuo YF, 2010, J THORAC CARDIOV SUR, V139, P1286, DOI 10.1016/j.jtcvs.2009.08.052	44	49	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e42908	10.1371/journal.pone.0042908	http://dx.doi.org/10.1371/journal.pone.0042908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927939	Green Published, Green Submitted, gold			2022-12-25	WOS:000308224700009
J	Yu, B; Morales, JF; O'Rourke, SM; Tatsuno, GP; Berman, PW				Yu, Bin; Morales, Javier F.; O'Rourke, Sara M.; Tatsuno, Gwen P.; Berman, Phillip W.			Glycoform and Net Charge Heterogeneity in gp120 Immunogens Used in HIV Vaccine Trials	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN; NEUTRALIZING ANTIBODIES; SUBTYPE-C; GLYCOSYLATION; POTENT; BROAD; INFECTION; VARIANTS; GLYCANS	Background: The RV144 clinical trial showed for the first time that vaccination could provide modest but significant protection from HIV-1 infection. To understand the protective response, and to improve upon the vaccine's efficacy, it is important to define the structure of the immunogens used in the prime/boost regimen. Here we examined the heterogeneity in net charge, attributable to glycoform variation, of the gp120 immunogens contained in the AIDSVAX B/E vaccine. Methodology/Principal Findings: Isoelectric focusing and glycosidase digestion were used to assess variation in net charge of the gp120s contained in the AIDSVAX B/E vaccine used in the RV144 trial. We observed 16 variants of MN-rgp120 and 24 variants of A244-rgp120. Glycoform variation in gp120 produced in Chinese hamster ovary cells was compared to glycoform variation in gp120 produced in the 293F human embryonic kidney cell line, often used for neutralization assays. We found that gp120 variants produced in CHO cells were distinctly more acidic than gp120 variants produced in 293 cells. The effect of glycoform heterogeneity on antigenicity was assessed using monoclonal antibodies. The broadly neutralizing PG9 MAb bound to A244-rgp120, but not to MN-rgp120, whether produced in CHO or in 293. However, PG9 was able to bind with high affinity to MN-rgp120 and A244-rgp120 produced in 293 cells deficient in N-acetylglucosaminyltransferase I. Conclusions/Significance: MN- and A244-rgp120 used in the RV144 trial exhibited extensive heterogeneity in net charge due to variation in sialic acid-containing glycoforms. These differences were cell line-dependent, affected the antigenicity of recombinant envelope proteins, and may affect assays used to measure neutralization. These studies, together with recent reports documenting broadly neutralizing antibodies directed against carbohydrate epitopes of gp120, suggest that glycoform variation is a key variable to be considered in the production and evaluation of subunit vaccines designed to prevent HIV infection.	[Yu, Bin; Morales, Javier F.; O'Rourke, Sara M.; Tatsuno, Gwen P.; Berman, Phillip W.] Univ Calif Santa Cruz, Dept Biomol Engn, Baskin Sch Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Yu, B (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Baskin Sch Engn, Santa Cruz, CA 95064 USA.	pwb@soe.ucsc.edu			University of California; Jack Baskin Chair Fund; National Institutes of Health, NIAID, NIH [R01 AI 089378-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089378] Funding Source: NIH RePORTER	University of California(University of California System); Jack Baskin Chair Fund; National Institutes of Health, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the University of California, the Jack Baskin Chair Fund, and the National Institutes of Health (R01 AI 089378-01, NIAID, NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman PW, 1999, VIROLOGY, V265, P1, DOI 10.1006/viro.1999.0031; BERMAN PW, 1983, SCIENCE, V222, P524, DOI 10.1126/science.6312563; BERMAN PW, 1988, J VIROL, V62, P3135, DOI 10.1128/JVI.62.9.3135-3142.1988; Berman PW, 1998, AIDS RES HUM RETROV, V14, pS277; BERMAN PW, 1990, NATURE, V345, P622, DOI 10.1038/345622a0; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; GEYER H, 1988, J BIOL CHEM, V263, P11760; Go EP, 2011, J VIROL, V85, P8270, DOI 10.1128/JVI.05053-11; GOOCHEE CF, 1990, BIO-TECHNOL, V8, P421, DOI 10.1038/nbt0590-421; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Kang SM, 2005, VIROLOGY, V331, P20, DOI 10.1016/j.virol.2004.10.005; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Kong L, 2010, J MOL BIOL, V403, P131, DOI 10.1016/j.jmb.2010.08.033; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; KORNFELD R, 1976, ANNU REV BIOCHEM, V45, P217, DOI 10.1146/annurev.bi.45.070176.001245; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; Lavine CL, 2012, J VIROL, V86, P2153, DOI 10.1128/JVI.06201-11; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Lian Y, 2005, J VIROL, V79, P13338, DOI 10.1128/JVI.79.21.13338-13349.2005; Mascola JR, 2003, NAT MED, V9, P393, DOI 10.1038/nm0403-393; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; MIZUOCHI T, 1988, BIOCHEM J, V254, P599, DOI 10.1042/bj2540599; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pejchal R, 2011, SCIENCE; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; SHELIKOFF M, 1994, CYTOTECHNOLOGY, V15, P195, DOI 10.1007/BF00762394; SMITH DH, 1987, SCIENCE, V238, P1704, DOI 10.1126/science.3500514; Srivastava IK, 2002, J VIROL, V76, P2835, DOI 10.1128/JVI.76.6.2835-2847.2002; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Walker LM, 2011, NATURE; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weikert S, 1999, NAT BIOTECHNOL, V17, P1116, DOI 10.1038/15104; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yu B, 2010, J VIROL, V84, P1513, DOI 10.1128/JVI.01765-09; Zhu JW, 2012, BIOTECHNOL ADV, V30, P1158, DOI 10.1016/j.biotechadv.2011.08.022; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	54	22	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43903	10.1371/journal.pone.0043903	http://dx.doi.org/10.1371/journal.pone.0043903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928048	Green Published, gold			2022-12-25	WOS:000308286300098
J	Cornman, RS; Tarpy, DR; Chen, YP; Jeffreys, L; Lopez, D; Pettis, JS; vanEngelsdorp, D; Evans, D				Cornman, R. Scott; Tarpy, David R.; Chen, Yanping; Jeffreys, Lacey; Lopez, Dawn; Pettis, Jeffery S.; vanEngelsdorp, Dennis; Evans, D.			Pathogen Webs in Collapsing Honey Bee Colonies	PLOS ONE			English	Article							ACUTE PARALYSIS VIRUS; DICISTROVIRUS AFFECTING HONEYBEES; NOSEMA-CERANAE; SEQUENCES; INFECTION; MICROBES; DISORDER; LOSSES; ISRAEL	Recent losses in honey bee colonies are unusual in their severity, geographical distribution, and, in some cases, failure to present recognized characteristics of known disease. Domesticated honey bees face numerous pests and pathogens, tempting hypotheses that colony collapses arise from exposure to new or resurgent pathogens. Here we explore the incidence and abundance of currently known honey bee pathogens in colonies suffering from Colony Collapse Disorder (CCD), otherwise weak colonies, and strong colonies from across the United States. Although pathogen identities differed between the eastern and western United States, there was a greater incidence and abundance of pathogens in CCD colonies. Pathogen loads were highly covariant in CCD but not control hives, suggesting that CCD colonies rapidly become susceptible to a diverse set of pathogens, or that co-infections can act synergistically to produce the rapid depletion of workers that characterizes the disorder. We also tested workers from a CCD-free apiary to confirm that significant positive correlations among pathogen loads can develop at the level of individual bees and not merely as a secondary effect of CCD. This observation and other recent data highlight pathogen interactions as important components of bee disease. Finally, we used deep RNA sequencing to further characterize microbial diversity in CCD and non-CCD hives. We identified novel strains of the recently described Lake Sinai viruses (LSV) and found evidence of a shift in gut bacterial composition that may be a biomarker of CCD. The results are discussed with respect to host-parasite interactions and other environmental stressors of honey bees.	[Cornman, R. Scott; Chen, Yanping; Lopez, Dawn; Pettis, Jeffery S.; Evans, D.] ARS, Bee Res Lab, USDA, Beltsville, MD USA; [Tarpy, David R.; Jeffreys, Lacey] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [vanEngelsdorp, Dennis] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; University System of Maryland; University of Maryland College Park	Cornman, RS (corresponding author), ARS, Bee Res Lab, USDA, Beltsville, MD USA.	Jay.evans@ars.usda.gov	vanEngelsdorp, Dennis/E-7934-2010; Evans, Jay/C-8408-2012	Tarpy, David/0000-0001-8601-6094; Evans, Jay/0000-0002-0036-4651	National Honey Board; Pennsylvania Department of Agriculture; North American Pollinator Protection Campaign; Apiary Inspectors of America; USDA-CSREES Coordinated Agricultural Project for Pollinator Health	National Honey Board; Pennsylvania Department of Agriculture; North American Pollinator Protection Campaign; Apiary Inspectors of America; USDA-CSREES Coordinated Agricultural Project for Pollinator Health	This work was supported by the National Honey Board, the Pennsylvania Department of Agriculture, the North American Pollinator Protection Campaign, the Apiary Inspectors of America and the USDA-CSREES Coordinated Agricultural Project for Pollinator Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; Blanchard P, 2008, J INVERTEBR PATHOL, V99, P348, DOI 10.1016/j.jip.2008.07.006; Boncristiani H, 2011, APIDOLOGIE, V42, P457, DOI 10.1007/s13592-011-0009-9; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Cornman SR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-602; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Forsgren E, 2010, J INVERTEBR PATHOL, V103, pS5, DOI 10.1016/j.jip.2009.06.016; Foster LJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006387; Fujiyuki T, 2005, ADV VIRUS RES, V65, P1, DOI 10.1016/S0065-3527(05)65001-4; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Ghabrial S.A., 2008, ENCY VIROLOGY, V5, P68, DOI DOI 10.1016/B978-012374410-4.00573-2; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Morse R.A., 1997, HONEY BEE PESTS PRED; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Novakova E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-143; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Palacios G, 2008, J VIROL, V82, P6209, DOI 10.1128/JVI.00251-08; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin X, 2006, INSECT MOL BIOL, V15, P715, DOI 10.1111/j.1365-2583.2006.00694.x; Ribiere M, 2010, J INVERTEBR PATHOL, V103, pS120, DOI 10.1016/j.jip.2009.06.013; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Schmid-Hempel R, 2010, J EUKARYOT MICROBIOL, V57, P337, DOI 10.1111/j.1550-7408.2010.00480.x; Shimanuki H, 1997, HONEY BEE PESTS PRED, P534; Underwood R., 2007, BEE CULTURE, V35, P13; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; vanEngelsdorp D, 2011, J APICULT RES, V50, P1, DOI 10.3896/IBRA.1.50.1.01; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WILSON WT, 1979, AM BEE J, V119, P184; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	51	291	304	6	376	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43562	10.1371/journal.pone.0043562	http://dx.doi.org/10.1371/journal.pone.0043562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927991	Green Published, Green Submitted, gold			2022-12-25	WOS:000307789700040
J	Boyle, PA; Yu, L; Wilson, RS; Gamble, K; Buchman, AS; Bennett, DA				Boyle, Patricia A.; Yu, Lei; Wilson, Robert S.; Gamble, Keith; Buchman, Aron S.; Bennett, David A.			Poor Decision Making Is a Consequence of Cognitive Decline among Older Persons without Alzheimer's Disease or Mild Cognitive Impairment	PLOS ONE			English	Article							MEDICARE PART-D; CAPACITY; MEMORY; ADULTS	Objective: Decision making is an important determinant of health and well-being across the lifespan but is critical in aging, when many influential decisions are made just as cognitive function declines. Increasing evidence suggests that older adults, even those without dementia, often make poor decisions and are selectively vulnerable to scams. To date, however, the factors associated with poor decision making in old age are unknown. The objective of this study was to test the hypothesis that poor decision making is a consequence of cognitive decline among older persons without Alzheimer's disease or mild cognitive impairment. Methods: Participants were 420 non-demented persons from the Memory and Aging Project, a longitudinal, clinical-pathologic cohort study of aging in the Chicago metropolitan area. All underwent repeated cognitive evaluations and subsequently completed assessments of decision making and susceptibility to scams. Decision making was measured using 12 items from a previously established performance-based measure and a self-report measure of susceptibility to scams. Results: Cognitive function data were collected over an average of 5.5 years prior to the decision making assessment. Regression analyses were used to examine whether the prior rate of cognitive decline predicted the level of decision making and susceptibility to scams; analyses controlled for age, sex, education, and starting level of cognition. Among 420 persons without dementia, more rapid cognitive decline predicted poorer decision making and increased susceptibility to scams (p's<0.001). Further, the relations between cognitive decline, decision making and scams persisted in analyses restricted to persons without any cognitive impairment (i.e., no dementia or even mild cognitive impairment). Conclusions: Poor decision making is a consequence of cognitive decline among older persons without Alzheimer's disease or mild cognitive impairment, those widely considered "cognitively healthy.'' These findings suggest that even very subtle age-related changes in cognition have detrimental effects on judgment.	[Boyle, Patricia A.; Yu, Lei; Wilson, Robert S.; Gamble, Keith; Buchman, Aron S.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Boyle, Patricia A.] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Yu, Lei; Wilson, Robert S.; Buchman, Aron S.; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Gamble, Keith] Depaul Univ, Dept Finance, Chicago, IL 60604 USA	Rush University; Rush University; Rush University; DePaul University	Boyle, PA (corresponding author), Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA.	Patricia_Boyle@Rush.edu	Yu, Lei/AAT-3685-2020		National Institute on Aging [R01AG17917, R01AG34374, R01AG33678, R21AG30765]; Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING [R01AG017917, R01AG034374, R01AG033678, R21AG030765] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute on Aging Grants R01AG17917 (DAB), R01AG34374 (PAB), R01AG33678 (PAB), R21AG30765 (DAB), and the Illinois Department of Public Health. The funding agencies had no role in the design, conduct, or interpretation of the data or preparation of the manuscript.	AARP, 1996, TEL FRAUD OLD PERS A; Agarwal S, 2009, BROOKINGS PAP ECO AC, P51, DOI 10.1353/eca.0.0067; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; [Anonymous], 2009, SAS 9 2 HELP DOC COM; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2005, NEUROEPIDEMIOLOGY, V25, P163, DOI 10.1159/000087446; Boyle PA, 2006, NEUROLOGY, V67, P441, DOI 10.1212/01.wnl.0000228244.10416.20; Denburg NL, 2009, ANN BEHAV MED, V37, P164, DOI 10.1007/s12160-009-9094-7; Denburg NL, 2005, NEUROPSYCHOLOGIA, V43, P1099, DOI 10.1016/j.neuropsychologia.2004.09.012; Finucane ML, 2010, PSYCHOL AGING, V25, P271, DOI 10.1037/a0019106; Finucane ML, 2005, PSYCHOL AGING, V20, P71, DOI 10.1037/0882-7974.20.1.71; Griffith HR, 2005, NEUROLOGY, V65, P483, DOI 10.1212/01.wnl.0000171346.02965.80; Grober E, 2008, J INT NEUROPSYCH SOC, V14, P266, DOI 10.1017/S1355617708080302; Heiss F, 2006, HEALTH AFFAIR, V25, pW344, DOI 10.1377/hlthaff.25.w344; Johnson DK, 2009, ARCH NEUROL-CHICAGO, V66, P1254, DOI 10.1001/archneurol.2009.158; Karlawish J, 2008, NEUROSIGNALS, V16, P91, DOI 10.1159/000109763; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Okonkwo OC, 2008, NEUROLOGY, V71, P1474, DOI 10.1212/01.wnl.0000334301.32358.48; Skarupski KA, 2009, GERONTOLOGIST, V49, P828, DOI 10.1093/geront/gnp055; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Triebel KL, 2009, NEUROLOGY, V73, P928, DOI 10.1212/WNL.0b013e3181b87971; Van Wielingen LE, 2004, AGING MENT HEALTH, V8, P374, DOI 10.1080/13607860410001709728; Zamarian L, 2011, J GERONTOL B-PSYCHOL, V66, P23, DOI 10.1093/geronb/gbq067	23	103	103	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43647	10.1371/journal.pone.0043647	http://dx.doi.org/10.1371/journal.pone.0043647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	991WJ	22916287	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800086
J	Fogg, PCM; Westbye, AB; Beatty, JT				Fogg, Paul C. M.; Westbye, Alexander B.; Beatty, J. Thomas			One for All or All for One: Heterogeneous Expression and Host Cell Lysis Are Key to Gene Transfer Agent Activity in Rhodobacter capsulatus	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; BACTERIOPHAGE; PEPTIDOGLYCAN; BIOSYNTHESIS; BACTERIAL; PROTEINS; ENZYMES; BACTERIOCHLOROPHYLL	The gene transfer agent (RcGTA) of Rhodobacter capsulatus is the model for a family of novel bacteriophage-related genetic elements that carry out lateral transfer of essentially random host DNA. Genuine and putative gene transfer agents have been discovered in diverse genera and are becoming recognized as potentially an important source of genetic exchange and microbial evolution in the oceans. Despite being discovered over 30 years ago, little is known about many essential aspects of RcGTA biology. Here, we validate the use of direct fluorescence reporter constructs, which express the red fluorescent protein mCherry in R. capsulatus. A construct containing the RcGTA promoter fused to mCherry was used to examine the single-cell expression profiles of wild type and RcGTA overproducer R. capsulatus populations, under different growth conditions and growth phases. The majority of RcGTA production clearly arises from a small, distinct sub-set of the population in the wild type strain and a larger sub-set in the overproducer. The most likely RcGTA release mechanism concomitant with this expression pattern is host cell lysis and we present direct evidence for the release of an intracellular enzyme accompanying RcGTA release. RcGTA ORF s is annotated as a 'cell wall peptidase' but we rule out a role in host lysis and propose an alternative function as a key contributor to RcGTA invasion of a target cell during infection.	[Fogg, Paul C. M.; Westbye, Alexander B.; Beatty, J. Thomas] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Fogg, PCM (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	j.beatty@ubc.ca		Fogg, Paul/0000-0001-5324-4293; Westbye, Alexander B/0000-0003-2619-4192	Canadian Institutes of Health Research [MOP93779]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Research was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), Operating Grant MOP93779. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ADAMS CW, 1989, J BACTERIOL, V171, P473, DOI 10.1128/jb.171.1.473-482.1989; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; Barbian KD, 2000, MICROBIOL-UK, V146, P599, DOI 10.1099/00221287-146-3-599; BEATTY JT, 1981, ARCH MICROBIOL, V129, P335, DOI 10.1007/BF00406457; Berglund EC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000546; Biers EJ, 2008, APPL ENVIRON MICROB, V74, P2933, DOI 10.1128/AEM.02129-07; Chen F, 2009, J PROTEOME RES, V8, P967, DOI 10.1021/pr8006045; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eiserling F, 1999, J GEN VIROL, V80, P3305, DOI 10.1099/0022-1317-80-12-3305; FEICK R, 1980, BIOCHIM BIOPHYS ACTA, V593, P241, DOI 10.1016/0005-2728(80)90062-6; Florizone SM, 2006, STUDIES REGULATION G; Fogg PCM, 2011, VIROLOGY, V421, P211, DOI 10.1016/j.virol.2011.09.028; Fraser JS, 2007, CURR OPIN MICROBIOL, V10, P382, DOI 10.1016/j.mib.2007.05.018; Fukushima T, 2006, J BACTERIOL, V188, P5541, DOI 10.1128/JB.00188-06; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; Hasmann A, 2011, DIAGN MICR INFEC DIS, V71, P12, DOI 10.1016/j.diagmicrobio.2010.09.009; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; HOFSCHNEIDER PH, 1963, J MOL BIOL, V7, P450, DOI 10.1016/S0022-2836(63)80038-8; Huang SK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-124; Humphrey SB, 1997, J BACTERIOL, V179, P323, DOI 10.1128/jb.179.2.323-329.1997; Hynes AP, 2012, MOL MICROBIOL; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001; Lang AS, 2012, NAT REV MICROBIOL, V10, P472, DOI 10.1038/nrmicro2802; Lang AS, 2002, J MOL EVOL, V55, P534, DOI 10.1007/s00239-002-2348-7; Leung MM, 2010, CTRA GTAR 2 SYSTEMS; Leung MM, 2012, MOL MICROBIOL, V83, P759, DOI 10.1111/j.1365-2958.2011.07963.x; LONGCHAMP PF, 1994, MICROBIOL-UK, V140, P1855, DOI 10.1099/13500872-140-8-1855; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Margot P, 1998, J BACTERIOL, V180, P749, DOI 10.1128/JB.180.3.749-752.1998; MARRS B, 1974, P NATL ACAD SCI USA, V71, P971, DOI 10.1073/pnas.71.3.971; Matson EG, 2005, J BACTERIOL, V187, P5885, DOI 10.1128/JB.187.17.5885-5892.2005; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; Mercer RG, 2010, J BACTERIOL, V192, P2701, DOI 10.1128/JB.00160-10; Pradel N, 2007, BIOCHEM BIOPH RES CO, V353, P493, DOI 10.1016/j.bbrc.2006.12.054; RAPP BJ, 1987, P NATL ACAD SCI USA, V84, P9128, DOI 10.1073/pnas.84.24.9128; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; Rodriguez L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-138; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; SCOLNIK PA, 1980, J BIOL CHEM, V255, P2427; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; SOLIOZ M, 1975, J BACTERIOL, V123, P651, DOI 10.1128/JB.123.2.651-657.1975; Strnad H, 2010, J BACTERIOL, V192, P3545, DOI 10.1128/JB.00366-10; Taylor TA, 2000, EVOLUTION REGULATION; van Niel CB, 1944, BACTERIOL REV, V8, P1; WALL JD, 1975, ARCH MICROBIOL, V105, P217, DOI 10.1007/BF00447140; WEAVER PF, 1975, ARCH MICROBIOL, V105, P207, DOI 10.1007/BF00447139; YEN HC, 1976, J BACTERIOL, V126, P619, DOI 10.1128/JB.126.2.619-629.1976; YEN HC, 1979, J MOL BIOL, V131, P157, DOI 10.1016/0022-2836(79)90071-8; ZHU YS, 1986, P NATL ACAD SCI USA, V83, P7613, DOI 10.1073/pnas.83.20.7613	57	34	34	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43772	10.1371/journal.pone.0043772	http://dx.doi.org/10.1371/journal.pone.0043772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916305	gold, Green Published, Green Submitted			2022-12-25	WOS:000307733800102
J	Galeotti, P; Bernini, G; Locatello, L; Sacchi, R; Fasola, M; Rubolini, D				Galeotti, Paolo; Bernini, Guido; Locatello, Lisa; Sacchi, Roberto; Fasola, Mauro; Rubolini, Diego			Sperm Traits Negatively Covary with Size and Asymmetry of a Secondary Sexual Trait in a Freshwater Crayfish	PLOS ONE			English	Article							WHITE-CLAWED CRAYFISH; AUSTROPOTAMOBIUS-PALLIPES LEREBOULLET; COLORFUL MALE GUPPIES; MALE BODY-SIZE; MALE PHENOTYPE; COPULATION BEHAVIOR; EJACULATE QUALITY; MATE CHOICE; TRADE-OFF; COMPETITION	In species where females mate promiscuously, the reproductive success of males depends both on their ability to acquire mates (pre-copulatory sexual selection) and ability of their ejaculates to outcompete those of other males (post-copulatory sexual selection). Sperm competition theory predicts a negative relationship between investment in body traits favouring mate acquisition (secondary sexual characters, SSCs) and investment in ejaculate size or quality, due to the inherent costs of sperm production. In contrast, the phenotype-linked fertility hypothesis posits that male fertilizing efficiency is reliably reflected by the phenotypic expression of male SSCs, allowing females to obtain direct benefits by selecting more ornamented males as copulation partners. In this study, we investigated the relationships between male SSCs and size and quality (viability and longevity) of ejaculates allocated to females in mating trials of the freshwater crayfish Austropotamobius italicus. We showed that the relative size of male weapons, the chelae, was negatively related to ejaculate size, and that chelae asymmetry, resulting from regeneration of lost chelipeds, negatively covaried with sperm longevity. Moreover, males allocated more viable sperm to mates from their own rather than different stream of origin. Our findings thus suggest that, according to sperm competition theory, pre-copulatory sexual selection for large weapons used in male fighting may counteract post-copulatory sperm competition in this crayfish species, and that investment in cheliped regeneration may impair ejaculate quality.	[Galeotti, Paolo; Bernini, Guido; Sacchi, Roberto; Fasola, Mauro] Univ Pavia, Dipartimento Sci Terra & Ambiente, I-27100 Pavia, Italy; [Locatello, Lisa] Univ Padua, Dipartimento Biol, Padua, Italy; [Rubolini, Diego] Univ Milan, Dipartimento Biosci, Milan, Italy	University of Pavia; University of Padua; University of Milan	Galeotti, P (corresponding author), Univ Pavia, Dipartimento Sci Terra & Ambiente, Via Palestro 3, I-27100 Pavia, Italy.	diego.rubolini@unimi.it	LOCATELLO, LISA/AAC-5612-2020; Sacchi, Roberto/E-2141-2011; Rubolini, Diego/F-2851-2011	Sacchi, Roberto/0000-0002-6199-0074; Rubolini, Diego/0000-0003-2703-5783; LOCATELLO, LISA/0000-0002-3530-2565; FASOLA, MAURO/0000-0002-7366-5893	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [CUP F11J10000010001]	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research was funded by a Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) grant to PG (PRIN 2008, CUP F11J10000010001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquistapace P, 2002, CAN J ZOOL, V80, P2041, DOI [10.1139/z02-171, 10.1139/Z02-171]; Barki A, 2003, J EXP BIOL, V206, P1791, DOI 10.1242/jeb.00335; Bernasconi G, 2002, J INSECT PHYSIOL, V48, P197, DOI 10.1016/S0022-1910(01)00164-0; Birkhead TR, 1995, P ROY SOC B-BIOL SCI, V262, P329, DOI 10.1098/rspb.1995.0213; Bluhm CK, 2004, ANIM BEHAV, V68, P985, DOI 10.1016/j.anbehav.2004.01.012; Bolund E, 2009, P R SOC B, V276, P707, DOI 10.1098/rspb.2008.1251; DUDENHAUSEN EE, 1983, CAN J ZOOL, V61, P182, DOI 10.1139/z83-023; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Evans JP, 2010, P ROY SOC B-BIOL SCI, V277, P3195, DOI 10.1098/rspb.2010.0826; Fitzpatrick JL, 2007, BIOL REPROD, V77, P280, DOI 10.1095/biolreprod.106.059550; Fratini S, 2005, HEREDITY, V94, P108, DOI 10.1038/sj.hdy.6800581; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Galeotti P, 2006, P ROY SOC B-BIOL SCI, V273, P1105, DOI 10.1098/rspb.2005.3345; Galeotti P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1739, DOI 10.1007/s00265-008-0602-8; Galeotti P, 2007, BEHAV ECOL SOCIOBIOL, V61, P711, DOI 10.1007/s00265-006-0301-2; Galeotti P, 2009, BEHAVIOUR, V146, P45, DOI 10.1163/156853908X390922; Gherardi F, 2000, MAR FRESHW BEHAV PHY, V33, P187, DOI 10.1080/10236240009387090; Gherardi F, 2006, ARCH HYDROBIOL, V165, P557, DOI 10.1127/0003-9136/2006/0165-0557; Grandjean F, 1997, CRUSTACEANA, V70, P31, DOI 10.1163/156854097X00320; Grandjean F, 2000, J CRUSTACEAN BIOL, V20, P522, DOI 10.1651/0278-0372(2000)020[0522:SOTEEC]2.0.CO;2; Holman L, 2009, BEHAV ECOL SOCIOBIOL, V63, P1679, DOI 10.1007/s00265-009-0816-4; Ingle RW, 1977, REP UNDERWATER ASS, V2, P1; JAMIESON B G M, 1991, Memoirs of the Queensland Museum, V31, P109; Janhunen M, 2009, BIOL J LINN SOC, V98, P794, DOI 10.1111/j.1095-8312.2009.01317.x; Juanes F, 1995, J EXP MAR BIOL ECOL, V193, P197, DOI 10.1016/0022-0981(95)00118-2; Kilgallon SJ, 2005, BIOL LETTERS, V1, P253, DOI 10.1098/rsbl.2005.0324; Klaus SP, 2011, ETHOLOGY, V117, P154, DOI 10.1111/j.1439-0310.2010.01857.x; Locatello L, 2008, J FISH BIOL, V73, P1600, DOI 10.1111/j.1095-8649.2008.02034.x; Locatello L, 2006, J EVOLUTION BIOL, V19, P1595, DOI 10.1111/j.1420-9101.2006.01117.x; Lockwood R, 1998, J AVIAN BIOL, V29, P273, DOI 10.2307/3677110; Malo AF, 2005, P ROY SOC B-BIOL SCI, V272, P149, DOI 10.1098/rspb.2004.2933; MARCONATO A, 1995, J FISH BIOL, V47, P292, DOI 10.1006/jfbi.1995.0134; Matthews MA, 1995, BIOL ENVIRON, V95B, P99; McClelland EK, 2007, CONSERV GENET, V8, P397, DOI 10.1007/s10592-006-9178-x; Merila J, 1999, HEREDITY, V83, P103, DOI 10.1038/sj.hdy.6885850; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P120, DOI 10.1098/rspb.1990.0114; PARKER GA, 1998, SPERM COMPETITION SE, P1; Pilastro A, 2002, P ROY SOC B-BIOL SCI, V269, P1325, DOI 10.1098/rspb.2002.2017; Pilastro A, 2008, BEHAV ECOL, V19, P374, DOI 10.1093/beheco/arm140; Pitcher TE, 2009, J FISH BIOL, V74, P1450, DOI 10.1111/j.1095-8649.2009.02210.x; Pizzari T, 2004, P ROY SOC B-BIOL SCI, V271, P51, DOI 10.1098/rspb.2003.2577; Pizzari T, 2007, P ROY SOC B-BIOL SCI, V274, P853, DOI 10.1098/rspb.2006.0080; Rasband WS, 1997, IMAGEJ; Rasotto MB, 2010, J ZOOL, V281, P161, DOI 10.1111/j.1469-7998.2009.00688.x; Reinhardt K, 2005, AM NAT, V165, P718, DOI 10.1086/430010; REYNOLDS JD, 1992, INVERTEBR REPROD DEV, V22, P253, DOI 10.1080/07924259.1992.9672278; Reynolds JD, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P152; RHODES CP, 1979, AQUACULTURE, V17, P345, DOI 10.1016/0044-8486(79)90089-9; Rogers DW, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-236; Rowe M, 2010, ANIM BEHAV, V79, P1239, DOI 10.1016/j.anbehav.2010.02.020; Rubolini D, 2007, FRESHWATER BIOL, V52, P1898, DOI 10.1111/j.1365-2427.2007.01814.x; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V60, P212, DOI 10.1007/s00265-005-0158-9; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1729, DOI 10.1098/rspb.2002.2088; Sato T, 2007, ANIM BEHAV, V74, P903, DOI 10.1016/j.anbehav.2006.09.027; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; SIMMONS LW, 2001, SPERM COMPETITION; SNEDDEN WA, 1990, BEHAVIOUR, V115, P100, DOI 10.1163/156853990X00301; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; STEIN RA, 1976, CAN J ZOOL, V54, P220, DOI 10.1139/z76-024; Tazzyman SJ, 2009, AM NAT, V174, pE71, DOI 10.1086/603612; Thomas ML, 2007, AM NAT, V170, P190, DOI 10.1086/519404; Tudge Christopher, 2009, Crustacean Issues, V18, P101; Villanelli F, 1998, FRESHWATER BIOL, V40, P305, DOI 10.1046/j.1365-2427.1998.00355.x; Vogt G, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P53; Wedell N, 1999, P ROY SOC B-BIOL SCI, V266, P1033, DOI 10.1098/rspb.1999.0740; Wilson RS, 2007, AM NAT, V170, P284, DOI 10.1086/519399	67	19	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43771	10.1371/journal.pone.0043771	http://dx.doi.org/10.1371/journal.pone.0043771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916304	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800101
J	Kearney, BD; Byrne, PG; Reina, RD				Kearney, Brian D.; Byrne, Phillip G.; Reina, Richard D.			Larval Tolerance to Salinity in Three Species of Australian Anuran: An Indication of Saline Specialisation in Litoria aurea	PLOS ONE			English	Article							CRAB-EATING FROG; TADPOLES; ADAPTATION; WATER; SALINIZATION; POPULATIONS; SURVIVAL	Recent anthropogenic influences on freshwater habitats are forcing anuran populations to rapidly adapt to high magnitude changes in environmental conditions or face local extinction. We examined the effects of ecologically relevant elevated salinity levels on larval growth, metamorphosis and survival of three species of Australian anuran; the spotted marsh frog (Limnodynastes tasmaniensis), the painted burrowing frog (Neobatrachus sudelli) and the green and golden bell frog (Litoria aurea), in order to better understand the responses of these animals to environmental change. Elevated salinity (16% seawater) negatively impacted on the survival of L. tasmaniensis (35% survival) and N sudelli (0% survival), while reduced salinity had a negative impact on L. aurea. (16% seawater: 85% survival; 0.4% seawater: 35% survival). L. aurea tadpoles survived in salinities much higher than previously reported for this species, indicating the potential for inter-populations differences in salinity tolerance. In L. tasmaniensis and L. aurea, development to metamorphosis was fastest in low and high salinity treatments suggesting it is advantageous for tadpoles to invest energy in development in both highly favourable and developmentally challenging environments. We propose that this response might either maximise potential lifetime fecundity when tadpoles experience favourable environments, or, facilitate a more rapid escape from pond environments where there is a reduced probability of survival.	[Kearney, Brian D.; Reina, Richard D.] Monash Univ, Sch Biol Sci, Australian Ctr Biodivers, Clayton, Vic, Australia; [Byrne, Phillip G.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Byrne, Phillip G.] Univ Wollongong, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia	Monash University; Monash University; University of Wollongong	Kearney, BD (corresponding author), Monash Univ, Sch Biol Sci, Australian Ctr Biodivers, Clayton, Vic, Australia.	brian.kearney@monash.edu	Reina, Richard/AAC-7017-2019	Kearney, Brian/0000-0002-6971-1850; Byrne, Phillip/0000-0003-2183-9959	Monash University	Monash University(Monash University)	Funding was supplied by Monash University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstis M., 2002, TADPOLES S E AUSTR G; Bailey PCE, 2006, ECOLOGY OF DESERT RIVERS, P280; BALINSKY JB, 1981, J EXP ZOOL, V215, P335, DOI 10.1002/jez.1402150311; BENNETT AF, 1993, EVOLUTION, V47, P1, DOI 10.1111/j.1558-5646.1993.tb01194.x; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Boutilier Robert G., 1992, P81; Byrne PG, 2011, BEHAV ECOL, V22, P385, DOI 10.1093/beheco/arq153; CADEH, 2006, THREAT AB PLAN INF A; Chinathamby K, 2006, AUST J ZOOL, V54, P97, DOI 10.1071/ZO06006; Christy MT, 2002, AMPHIBIA-REPTILIA, V23, P1, DOI 10.1163/156853802320877582; Gomez-Mestre I, 2004, PHYSIOL BIOCHEM ZOOL, V77, P267, DOI 10.1086/378143; Gomez-Mestre I, 2003, EVOLUTION, V57, P1889; GORDON MS, 1965, J EXP BIOL, V42, P437; Gosner K. L., 1960, Herpetologica, V16, P183; HART BT, 1991, HYDROBIOLOGIA, V210, P105, DOI 10.1007/BF00014327; Hazell D, 2003, WILDLIFE RES, V30, P193, DOI 10.1071/WR02075; Herczeg AL, 2001, MAR FRESHWATER RES, V52, P41, DOI 10.1071/MF00040; Laurila A, 2000, FRESHWATER BIOL, V43, P161, DOI 10.1046/j.1365-2427.2000.00533.x; LENSKI RE, 1993, AM NAT, V142, pS47, DOI 10.1086/285522; MAHAJAN CL, 1979, INDIAN J EXP BIOL, V17, P1244; Mann RM, 2009, ENVIRON POLLUT, V157, P2903, DOI 10.1016/j.envpol.2009.05.015; Marshall NA, 2004, MAR FRESHWATER RES, V55, P509, DOI 10.1071/MF03018; Mayr E., 1963, ANIMAL SPECIES EVOLU, P12; NICIEZA AG, 1994, OECOLOGIA, V99, P243, DOI 10.1007/BF00627736; Nielsen DL, 2003, AUST J BOT, V51, P655, DOI 10.1071/BT02115; Reznick David, 1996, P243; Sinervo Barry, 1996, P149; Smekens MJ, 2001, ACTA OECOL, V22, P187, DOI 10.1016/S1146-609X(01)01120-1; Smith MJ, 2007, FRESHWATER BIOL, V52, P75, DOI 10.1111/j.1365-2427.2006.01672.x; UCHIYAMA M, 1992, CELL TISSUE RES, V267, P35, DOI 10.1007/BF00318689; Viertel B, 1999, AMPHIBIA-REPTILIA, V20, P161, DOI 10.1163/156853899X00178; VIERTEL B., 1999, TADPOLES BIOL ANURAN; Williams WD, 2001, HYDROBIOLOGIA, V466, P329, DOI 10.1023/A:1014598509028	33	34	34	0	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43427	10.1371/journal.pone.0043427	http://dx.doi.org/10.1371/journal.pone.0043427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916260	Green Published, gold			2022-12-25	WOS:000307733800066
J	Zhou, YH; Yao, ZH; Liu, FL; Li, H; Jiang, L; Zhu, JW; Zheng, YT				Zhou, Yan-Heng; Yao, Zhi-Hong; Liu, Feng-Liang; Li, Hong; Jiang, Li; Zhu, Jia-Wu; Zheng, Yong-Tang			High Prevalence of HIV, HCV, HBV and Co-Infection and Associated Risk Factors among Injecting Drug Users in Yunnan Province, China	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTION; POPULATIONS; HIV/AIDS; DEHONG; AREA	Objective: To estimate the prevalence of HIV, HCV, HBV and co-infection with 2 or 3 viruses and evaluate risk factors among injecting drug users (IDUs) in Yunnan province, China. Methods: 2080 IDUs were recruited from 5 regions of Yunnan Province, China to detect the infection status of HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV). Statistical analysis was performed to evaluate risk factors related to HIV, HCV and HBV infections. Results: The infection rates among all participants were 25.5% for HIV, 77.7% for HCV, 19.2% for HBV, 15% for HIV/HCV, 0.3% for HIV/HBV, 7.8% for HCV/HBV and 7.1% for HIV/HCV/HBV. The prevalence of virus infection varied widely by region in Yunnan of China. Statistical analyses indicated that high prevalence of HIV and HCV among IDUs was positively associated with the duration of drug injection and sharing needles/syringes; besides, HCV infection was associated with the frequency of drug injection. Conclusions: HIV, HCV, HBV infections and co-infections were still very prevalent among IDUs in Yunnan province because of drug use behaviors.	[Zhou, Yan-Heng; Yao, Zhi-Hong; Liu, Feng-Liang; Zhu, Jia-Wu; Zheng, Yong-Tang] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Kunming, Peoples R China; [Li, Hong; Jiang, Li] Yunnan Ctr Dis Control & Prevent, Kunming, Peoples R China; [Zhou, Yan-Heng; Yao, Zhi-Hong; Zhu, Jia-Wu] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, YH (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Kunming, Peoples R China.	zhengyt@mail.kiz.ac.cn	Liu, Feng-Liang/O-4000-2019	Liu, Feng-Liang/0000-0002-5038-5012; jiang, li/0000-0002-2804-6460	Scientific and Technological Program of China [2009ZX10004-902, 2009ZX09501-029, 2012ZX10001-006, 2012ZX10001-007]; Scientific and Technological Program of Yunnan province [2010GA001]; National Basic Research Program of China [2009CB522306]; Chinese Academy of Sciences [KSCX1-YW-10]	Scientific and Technological Program of China; Scientific and Technological Program of Yunnan province; National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by grants from the Scientific and Technological Program of China (2009ZX10004-902, 2009ZX09501-029, 2012ZX10001-006, 2012ZX10001-007) and Yunnan province (2010GA001), National Basic Research Program of China (2009CB522306), and the Chinese Academy of Sciences (KSCX1-YW-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Baozhang T, 1997, EPIDEMIOL INFECT, V119, P343, DOI 10.1017/S0950268897007784; Cheng H, 1993, Zhonghua Liu Xing Bing Xue Za Zhi, V14, P275; Duan S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-180; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Jia YJ, 2008, INT J EPIDEMIOL, V37, P1287, DOI 10.1093/ije/dyn196; Jin L, 2005, OCCUPATION HLTH, V21, P1508; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Kretzschmar M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-108; Li JH, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-4; Liu Zhihua, 2006, Int J Med Sci, V3, P57; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008467; Lu L., 2006, J CHIN AIDS STD, V12, P517; Lu L., 2005, J CHINA AIDSSTD, V11, P172; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Ma Y, 1990, ZHONGHUA LIU XING BI, V11, P184; Ma YL, 2011, J DERMATOL VENEREOL, V33, P230; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; Ruan YH, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000304695.54884.4f; Solomon SS, 2008, JAIDS-J ACQ IMM DEF, V49, P327, DOI 10.1097/QAI.0b013e3181831e85; Soriano V, 2010, ANTIVIR RES, V85, P303, DOI 10.1016/j.antiviral.2009.10.021; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Tian KL, 2009, CHIN J PUBLIC HLTH, V25, P742; Vickerman P, 2010, ADDICTION, V105, P311, DOI 10.1111/j.1360-0443.2009.02759.x; Xiao Y, 2007, SOC SCI MED, V64, P665, DOI 10.1016/j.socscimed.2006.09.019; Yang JF, 2011, YI YAO QIANYAN, V01, P109; Yao Y, 2009, INT J INFECT DIS, V13, P154, DOI 10.1016/j.ijid.2008.05.1228; Zhang CY, 2002, J ACQ IMMUN DEF SYND, V29, P191, DOI 10.1097/00042560-200202010-00014; Zhang L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-250; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; Zhou YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016349; Zhou YH, 2010, J DERMATOL VENEREOL, V32, P20	34	54	60	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42937	10.1371/journal.pone.0042937	http://dx.doi.org/10.1371/journal.pone.0042937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916185	gold, Green Published, Green Submitted			2022-12-25	WOS:000307824300023
J	Neumetzler, L; Humphrey, T; Lumba, S; Snyder, S; Yeats, TH; Usadel, B; Vasilevski, A; Patel, J; Rose, JKC; Persson, S; Bonetta, D				Neumetzler, Lutz; Humphrey, Tania; Lumba, Shelley; Snyder, Stephen; Yeats, Trevor H.; Usadel, Bjoern; Vasilevski, Aleksandar; Patel, Jignasha; Rose, Jocelyn K. C.; Persson, Staffan; Bonetta, Dario			The FRIABLE1 Gene Product Affects Cell Adhesion in Arabidopsis	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; SUSPENSION-CULTURED CELLS; GLUCURONOXYLAN BIOSYNTHESIS; PUTATIVE METHYLTRANSFERASE; PECTIC HOMOGALACTURONAN; CELLULOSE BIOSYNTHESIS; BREFELDIN-A; WALL; XYLOGLUCAN; THALIANA	Cell adhesion in plants is mediated predominantly by pectins, a group of complex cell wall associated polysaccharides. An Arabidopsis mutant, friable1 (frb1), was identified through a screen of T-DNA insertion lines that exhibited defective cell adhesion. Interestingly, the frb1 plants displayed both cell and organ dissociations and also ectopic defects in organ separation. The FRB1 gene encodes a Golgi-localized, plant specific protein with only weak sequence similarities to known proteins (DUF246). Unlike other cell adhesion deficient mutants, frb1 mutants do not have reduced levels of adhesion related cell wall polymers, such as pectins. Instead, FRB1 affects the abundance of galactose- and arabinose-containing oligosaccharides in the Golgi. Furthermore, frb1 mutants displayed alteration in pectin methylesterification, cell wall associated extensins and xyloglucan microstructure. We propose that abnormal FRB1 action has pleiotropic consequences on wall architecture, affecting both the extensin and pectin matrices, with consequent changes to the biomechanical properties of the wall and middle lamella, thereby influencing cell-cell adhesion.	[Neumetzler, Lutz; Usadel, Bjoern; Vasilevski, Aleksandar; Persson, Staffan] Max Planck Inst Mol Plant Physiol, Golm, Germany; [Humphrey, Tania] Vineland Res & Innovat Ctr, Vineland Stn, ON, Canada; [Lumba, Shelley; Patel, Jignasha] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Snyder, Stephen; Yeats, Trevor H.; Rose, Jocelyn K. C.] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Bonetta, Dario] Univ Ontario Inst Technol, Fac Sci, Oshawa, ON, Canada	Max Planck Society; University of Toronto; Cornell University; Ontario Tech University	Neumetzler, L (corresponding author), Max Planck Inst Mol Plant Physiol, Golm, Germany.	Persson@mpimp-golm.mpg.de; dario.bonetta@uoit.ca	Persson, Staffan/S-8399-2016; Usadel, Björn/E-1932-2011	Persson, Staffan/0000-0002-6377-5132; Usadel, Björn/0000-0003-0921-8041	Natural Sciences and Engineering Research Council of Canada; Max-Planck Gesellschaft; NSF Plant Genome Research Program [DBI-0606595]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Max-Planck Gesellschaft; NSF Plant Genome Research Program	Natural Sciences and Engineering Research Council of Canada; Max-Planck Gesellschaft; NSF Plant Genome Research Program (DBI-0606595). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALDWIN TC, 1993, PLANT PHYSIOL, V103, P115, DOI 10.1104/pp.103.1.115; Bartels D, 2001, PLANT PHYSIOL, V127, P1346, DOI 10.1104/pp.010765; Bechtold N, 1998, METH MOL B, V82, P259; Bischoff V, 2010, PLANT PHYSIOL, V153, P590, DOI 10.1104/pp.110.153320; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Boevink P, 1998, PLANT J, V15, P441, DOI 10.1046/j.1365-313X.1998.00208.x; Bougourd S, 2000, PLANT J, V24, P543, DOI 10.1046/j.1365-313x.2000.00892.x; Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Brandizzi F, 2002, PLANT CELL, V14, P1293, DOI 10.1105/tpc.001586; Brett C. T., 1996, Physiology and biochemistry of plant cell walls.; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; Brummell DA, 2006, FUNCT PLANT BIOL, V33, P103, DOI 10.1071/FP05234; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cumming CM, 2005, PLANTA, V222, P546, DOI 10.1007/s00425-005-1560-2; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dische Z, 1964, METHODS CARBOHYDRATE; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Francis KE, 2006, PLANT PHYSIOL, V142, P1004, DOI 10.1104/pp.106.085274; Gunl M, 2011, PLANT CELL, V23, P4025, DOI 10.1105/tpc.111.089193; Gunl M, 2011, PLANTA, V233, P707, DOI 10.1007/s00425-010-1330-7; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Harris E.L.V., 1989, PROTEIN PURIFICATION; HEIM DR, 1991, PESTIC BIOCHEM PHYS, V39, P93, DOI 10.1016/0048-3575(91)90129-A; His I, 2001, PLANTA, V212, P348, DOI 10.1007/s004250000437; Iwai H, 2002, P NATL ACAD SCI USA, V99, P16319, DOI 10.1073/pnas.252530499; JARVIS MC, 1984, PLANT CELL ENVIRON, V7, P153, DOI 10.1111/1365-3040.ep11614586; Jarvis MC, 2003, PLANT CELL ENVIRON, V26, P977, DOI 10.1046/j.1365-3040.2003.01034.x; Jenks Matthew A, 2002, Arabidopsis Book, V1, pe0016, DOI 10.1199/tab.0016; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Krupkova E, 2007, PLANT J, V50, P735, DOI 10.1111/j.1365-313X.2007.03123.x; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Leboeuf E, 2005, J EXP BOT, V56, P3171, DOI 10.1093/jxb/eri314; Lerouxel O, 2002, PLANT PHYSIOL, V130, P1754, DOI 10.1104/pp.011965; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Lolle SJ, 1997, DEV BIOL, V189, P311, DOI 10.1006/dbio.1997.8671; Madson M, 2003, PLANT CELL, V15, P1662, DOI 10.1105/tpc.009837; MANIATIS T, 1982, MOL CLONING LAB MANU; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; McCann MC, 1997, PHYSIOL PLANTARUM, V100, P729, DOI 10.1034/j.1399-3054.1997.1000337.x; McCartney L, 2002, J EXP BOT, V53, P707, DOI 10.1093/jexbot/53.369.707; Mouille G, 2007, PLANT J, V50, P605, DOI 10.1111/j.1365-313X.2007.03086.x; Nawrath C, 2006, CURR OPIN PLANT BIOL, V9, P281, DOI 10.1016/j.pbi.2006.03.001; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Neumetzler L, 2010, IDENTIFICATION CHARA; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; Obel N, 2009, MOL PLANT, V2, P922, DOI 10.1093/mp/ssp046; Ordaz-Ortiz JJ, 2009, MOL PLANT, V2, P910, DOI 10.1093/mp/ssp049; Orfila C, 2005, PLANTA, V222, P613, DOI 10.1007/s00425-005-0008-z; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pena MJ, 2004, PLANT PHYSIOL, V134, P443, DOI 10.1104/pp.103.027508; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; Persson S, 2007, PLANT CELL, V19, P237, DOI 10.1105/tpc.106.047720; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Ryser U, 2003, PLANTA, V216, P854, DOI 10.1007/s00425-002-0938-7; Sage TL, 1999, AM J BOT, V86, P855, DOI 10.2307/2656706; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sampedro J, 2001, PLANT PHYSIOL, V126, P910, DOI 10.1104/pp.126.2.910; Sampedro J, 2010, PLANT PHYSIOL, V154, P1105, DOI 10.1104/pp.110.163212; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Seki Motoaki, 2002, Funct Integr Genomics, V2, P282, DOI 10.1007/s10142-002-0070-6; Shao HB, 2005, COLLOID SURFACE B, V45, P131, DOI 10.1016/j.colsurfb.2005.07.017; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1361; Sieber P, 2000, PLANT CELL, V12, P721, DOI 10.1105/tpc.12.5.721; Singh SK, 2005, PLANT J, V43, P384, DOI 10.1111/j.1365-313X.2005.02455.x; SMALLWOOD M, 1995, PLANTA, V196, P510, DOI 10.1007/BF00203651; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; SWORDS KMM, 1993, PLANT PHYSIOL, V102, P891, DOI 10.1104/pp.102.3.891; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka T, 2004, PLANT J, V37, P139, DOI 10.1046/j.1365-313X.2003.01946.x; Toole GA, 2004, CARBOHYD RES, V339, P629, DOI 10.1016/j.carres.2003.11.010; Valentin R, 2010, LANGMUIR, V26, P9891, DOI 10.1021/la100265d; Vanzin GF, 2002, P NATL ACAD SCI USA, V99, P3340, DOI 10.1073/pnas.052450699; Varki A, 2009, ESSENTIALS GLYCOBIOL, V2; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Weigel D., 2002, ARABIDOPSIS LAB MANU; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Willats WGT, 2001, J BIOL CHEM, V276, P19404, DOI 10.1074/jbc.M011242200; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x	92	34	66	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42914	10.1371/journal.pone.0042914	http://dx.doi.org/10.1371/journal.pone.0042914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916179	Green Published, gold			2022-12-25	WOS:000307500800030
J	Kunkeaw, N; Jeon, SH; Lee, K; Johnson, BH; Tanasanvimon, S; Javle, M; Pairojkul, C; Chamgramol, Y; Wongfieng, W; Gong, B; Leelayuwat, C; Lee, YS				Kunkeaw, N.; Jeon, S. H.; Lee, K.; Johnson, B. H.; Tanasanvimon, S.; Javle, M.; Pairojkul, C.; Chamgramol, Y.; Wongfieng, W.; Gong, B.; Leelayuwat, C.; Lee, Y. S.			Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma	ONCOGENE			English	Article						nc886; cholangiocarcinoma; PKR; eIF2 alpha; NF-kappa B	GUANINE-NUCLEOTIDE EXCHANGE; INITIATION-FACTORS EIF-4E; UP-REGULATION; TRANSLATIONAL CONTROL; INCREASED EXPRESSION; CANCER CELLS; PKR ACTIVITY; VIRUS; INHIBITION; APOPTOSIS	We have recently identified nc886 (pre-miR-886 or vtRNA2-1) as a novel type of non-coding RNA that inhibits activation of protein kinase R (PKR). PKR's pro-apoptotic role through eukaryotic initiation factor 2 alpha (eIF2 alpha) phosphorylation is well established in the host defense against viral infection. Paradoxically, some cancer patients have elevated PKR activity; however, its cause and consequence are not understood. Initially, we evaluated the expression of nc886, PKR and eIF2 alpha in non-malignant cholangiocyte and cholangiocarcinoma (CCA) cells. nc886 is repressed in CCA cells and this repression is the cause of PKR's activation therein. nc886 alone is necessary and sufficient for suppression of PKR via direct physical interaction. Consistently, artificial suppression of nc886 in cholangiocyte cells activates the canonical PKR/eIF2 alpha cell death pathway, suggesting a potential significance of the nc886 suppression and the consequent PKR activation in eliminating pre-malignant cells during tumorigenesis. In comparison, active PKR in CCA cells does not induce phospho-eIF2 alpha nor apoptosis, but promotes the pro-survival nuclear factor-kappa B pathway. Thus, PKR has a dual life or death role during tumorigenesis. Similarly to the CCA cell lines, nc886 tends to be decreased but PKR tends to be activated in our clinical samples from CCA patients. Collectively from our data, we propose a tumor surveillance model for nc886's role in the PKR pathway during tumorigenesis.	[Kunkeaw, N.; Jeon, S. H.; Lee, K.; Johnson, B. H.; Lee, Y. S.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Kunkeaw, N.; Wongfieng, W.; Leelayuwat, C.] Khon Kaen Univ, Fac Associated Med Sci, Ctr Res & Dev, Med Diagnost Labs, Khon Kaen, Thailand; [Jeon, S. H.] Hallym Univ, Dept Life Sci, Chunchon, South Korea; [Tanasanvimon, S.] Chulalongkorn Univ, Fac Med, King Chulalongkorn Mem Hosp, Dept Med, Bangkok 10330, Thailand; [Tanasanvimon, S.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Javle, M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Pairojkul, C.; Chamgramol, Y.; Leelayuwat, C.] Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Gong, B.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; Khon Kaen University; Hallym University; Chulalongkorn University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Khon Kaen University; University of Texas System; University of Texas Medical Branch Galveston	Lee, YS (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, 7-138H Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA.	yslee@utmb.edu	Jeon, Sung Ho/B-9728-2009; , Alsevier/V-1974-2019	Piwphankum, Jirawut/0000-0001-6129-8830	National Cancer Institute [CA16672]; American Cancer Society [RSG-12-187-01-RMC]; Sealy Center for Cancer Biology at the University of Texas Medical Branch; Royal Golden Jubilee (RGJ) scholarship of Thailand Research Fund (TRF) [PHD/0105/2550]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0022022]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Sealy Center for Cancer Biology at the University of Texas Medical Branch; Royal Golden Jubilee (RGJ) scholarship of Thailand Research Fund (TRF); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Sopit Wongkham, Dr Kanlayanee Sawanyawisuth and Ms Sirinapa Sribenja (Khon Kaen University) for CCA cells and helpful discussion; Dr Inhan Lee (miRcore, MI) for helpful advice; Research Histology Core Laboratory Facility, University of Texas, MD Anderson Cancer Center (funded by the National Cancer Institute Grant # CA16672) for tissue preparation and IHC. This work was supported by a Research Scholar Grant, RSG-12-187-01-RMC from the American Cancer Society to YSL, by start-up funding from the Sealy Center for Cancer Biology at the University of Texas Medical Branch to YSL, by the Royal Golden Jubilee (RGJ) scholarship (PHD/0105/2550) of Thailand Research Fund (TRF) to NK and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0022022) to SHJ.	Alisi A, 2011, J HEPATOL, V54, P956, DOI 10.1016/j.jhep.2010.08.016; Balachandran S, 2004, CANCER CELL, V5, P51, DOI 10.1016/S1535-6108(03)00330-1; Basu S, 1997, CANCER RES, V57, P943; Beretta L, 1996, ONCOGENE, V12, P1593; Blalock WL, 2009, J CELL PHYSIOL, V221, P232, DOI 10.1002/jcp.21848; Datta B, 2000, BIOCHIMIE, V82, P95, DOI 10.1016/S0300-9084(00)00383-7; Fabian JR, 1998, PROTEIN EXPRES PURIF, V13, P16, DOI 10.1006/prep.1998.0860; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Haines GK, 1996, TUMOR BIOL, V17, P5, DOI 10.1159/000217961; Haines GK, 1998, TUMOR BIOL, V19, P52, DOI 10.1159/000029974; Hiasa Y, 2003, AM J GASTROENTEROL, V98, P2528, DOI 10.1016/S0002-9270(03)01696-4; Hii SI, 2004, INT J CANCER, V109, P329, DOI 10.1002/ijc.11714; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Jeon SH, 2012, FEBS LETT IN PRESS, DOI DOI 10.1016/J.FEBSLET.2012.07.076); Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kim SH, 2002, ONCOGENE, V21, P8741, DOI 10.1038/sj.onc.1205987; Kim SH, 2000, ONCOGENE, V19, P3086, DOI 10.1038/sj.onc.1203632; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee K, 2011, RNA, V17, P1076, DOI 10.1261/rna.2701111; LEE TG, 1994, MOL CELL BIOL, V14, P2331, DOI 10.1128/MCB.14.4.2331; Li YJ, 2011, INT J MOL MED, V28, P215, DOI 10.3892/ijmm.2011.666; Lobo MVT, 2000, HISTOCHEM J, V32, P139, DOI 10.1023/A:1004091122351; Maruyama M, 2004, TRANSPLANTATION, V77, P446, DOI 10.1097/01.TP.0000110292.73873.25; Mounir Z, 2010, FUTURE ONCOL, V6, P643, DOI 10.2217/FON.10.45; Murad JM, 2005, BLOOD CELL MOL DIS, V34, P1, DOI 10.1016/j.bcmd.2004.08.025; Nandy C, 2009, J MOL BIOL, V388, P776, DOI 10.1016/j.jmb.2009.03.031; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Onori P, 2009, INT J CANCER, V125, P565, DOI 10.1002/ijc.24271; Pataer A, 2002, CANCER RES, V62, P2239; Pataer A, 2010, CLIN CANCER RES, V16, P5522, DOI 10.1158/1078-0432.CCR-10-0753; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Raught B, 1996, CANCER RES, V56, P4382; REICHEL PA, 1985, NATURE, V313, P196, DOI 10.1038/313196a0; Rosenwald IB, 1996, CANCER LETT, V102, P113, DOI 10.1016/0304-3835(96)04171-7; Rosenwald IB, 2001, CANCER-AM CANCER SOC, V92, P2164, DOI 10.1002/1097-0142(20011015)92:8<2164::AID-CNCR1559>3.0.CO;2-A; ROSENWALD IB, 1993, P NATL ACAD SCI USA, V90, P6175, DOI 10.1073/pnas.90.13.6175; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Savinova O, 1999, INT J BIOCHEM CELL B, V31, P175, DOI 10.1016/S1357-2725(98)00140-X; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Stadler PF, 2009, MOL BIOL EVOL, V26, P1975, DOI 10.1093/molbev/msp112; Tepsiri N, 2005, WORLD J GASTROENTERO, V11, P2748, DOI 10.3748/wjg.v11.i18.2748; Terada T, 2000, HUM PATHOL, V31, P817, DOI 10.1053/hupa.2000.8443; Treppendahl MB, 2012, BLOOD, V119, P206, DOI 10.1182/blood-2011-06-362541; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yonglitthipagon P, 2010, INT J PARASITOL, V40, P1203, DOI 10.1016/j.ijpara.2010.05.002	47	52	56	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 8	2013	32	32					3722	3731		10.1038/onc.2012.382	http://dx.doi.org/10.1038/onc.2012.382			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	198EH	22926522	Green Accepted			2022-12-25	WOS:000322904400007
J	Schepeler, T; Lamy, P; Hvidberg, V; Laurberg, JR; Fristrup, N; Reinert, T; Bartkova, J; Tropia, L; Bartek, J; Halazonetis, TD; Pan, CC; Borre, M; Dyrskjot, L; Orntoft, TF				Schepeler, T.; Lamy, P.; Hvidberg, V.; Laurberg, J. R.; Fristrup, N.; Reinert, T.; Bartkova, J.; Tropia, L.; Bartek, J.; Halazonetis, T. D.; Pan, C-C; Borre, M.; Dyrskjot, L.; Orntoft, T. F.			A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response	ONCOGENE			English	Article						bladder cancer; SNP array; DNA damage response; Timeless	ANTICANCER BARRIER; MAMMALIAN TIMELESS; TIPIN; CHECKPOINT; GENE; INSTABILITY; PROGRESSION; SIGNATURES; ONCOGENE; COMPLEX	One major challenge in cancer research is to understand the complex interplay between the DNA damage response (DDR), genomic integrity, and tumor development. To address these issues, we analyzed 43 bladder tumor genomes from 22 patients using single nucleotide polymorphism (SNP) arrays, and tissue expression of multiple DDR proteins, including Timeless and its interaction partner Tipin. The SNP profiles confirmed and extended known copy number alterations (CNAs) at high resolution, showed clustering of CNAs at nine common fragile sites, and revealed that most metachronous tumors were clonally related. The occurrence of many novel uniparental disomy regions (UPDs) was of potential functional importance in some tumors because UPDs spanned mutated FGFR3 and PIK3CA alleles, and also homozygous deletion of the CDKN2A tumor suppressor locus. The DDR signaling as evaluated by phospho-epitope-specific antibodies against Ser139-phosphorylated H2A histone family member X (gamma H2AX), ataxia telangiectasia mutated (ATM), and ATM- and Rad3-related (ATR) was commonly activated in tumors with both moderate and high extent of accumulated genomic aberrations, the latter tumors showing a more frequent loss of ATM expression. Strikingly, the tumor genomes exhibiting the most complex alterations were associated with a high Ki67-proliferation index, abundant Timeless but not Tipin expression, aberrant p53 expression, and homozygous CDKN2A deletions. Of clinical relevance, evaluation of a tissue microarray (TMA; n = 319) showed that abundant Timeless expression was associated with risk of progression to muscle-invasive disease (P<0.0005; hazard ratio, 2.4; 95% confidence interval, 1.6-3.8) and higher T stage (P<0.05). Univariate analysis confirmed this association (P = 0.006) in an independent cohort (n = 241) but statistical significance was not reached in a multivariate model. Overall, our results are consistent with DDR activation preceding the accumulation of genomic aberrations. Tumors with extensive genomic rearrangements were associated with inactivation of CDKN2A, excessive proliferation, and robust Timeless expression, the latter also correlating with the risk of disease progression. Moreover, we provide evidence to suggest that UPDs likely contribute to bladder tumorigenesis.	[Schepeler, T.; Lamy, P.; Hvidberg, V.; Laurberg, J. R.; Fristrup, N.; Reinert, T.; Dyrskjot, L.; Orntoft, T. F.] Aarhus Univ Hosp, Dept Mol Med, DK-8200 Aarhus N, Denmark; [Bartkova, J.; Bartek, J.] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Tropia, L.; Halazonetis, T. D.] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Bartek, J.] Palacky Univ, Inst Mol & Translat Med, CR-77147 Olomouc, Czech Republic; [Halazonetis, T. D.] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Pan, C-C] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan; [Borre, M.] Aarhus Univ Hosp, Dept Urol, DK-8200 Aarhus N, Denmark	Aarhus University; Danish Cancer Society; University of Geneva; Palacky University Olomouc; University of Geneva; Taipei Veterans General Hospital; Aarhus University	Orntoft, TF (corresponding author), Aarhus Univ Hosp, Dept Mol Med, Brendstrupgaardsvej, DK-8200 Aarhus N, Denmark.	orntoft@ki.au.dk	Bartek, Jiri/G-5870-2014	Dyrskjot, Lars/0000-0001-7061-9851; Borre, Michael/0000-0002-1519-9185; Reinert, Thomas/0000-0003-4835-4804	John and Birthe Meyer Foundation; Danish Cancer Society; Danish National Research Foundation; Ministry of Technology and Science; Lundbeck Foundation; European Community's Seventh Framework program [201663]	John and Birthe Meyer Foundation; Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); Ministry of Technology and Science; Lundbeck Foundation(Lundbeckfonden); European Community's Seventh Framework program(European Commission)	We thank The John and Birthe Meyer Foundation, the Danish Cancer Society, the Danish National Research Foundation, the Ministry of Technology and Science, the Lundbeck Foundation, and the European Community's Seventh Framework program (projects Infla-Care, Biomedreg, DDresponse, and Grant agreement no. 201663).	Aly A, 2011, J MOL CELL BIOL, V3, P66, DOI 10.1093/jmcb/mjq055; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dereli-Oz A, 2011, MOL ONCOL, V5, P308, DOI 10.1016/j.molonc.2011.05.002; Dheekollu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019596; Duggan BJ, 2004, J UROLOGY, V171, P419, DOI 10.1097/01.ju.0000100105.27708.6c; Fu A, 2011, MOL CARCINOG, V17, DOI [10.1002/mc.20862, DOI 10.1002/MC.20862)]; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Hafner C, 2002, INT J CANCER, V101, P1, DOI 10.1002/ijc.10544; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Koed K, 2005, CANCER RES, V65, P34; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Langbein S, 2002, LAB INVEST, V82, P639, DOI 10.1038/labinvest.3780458; Lapunzina P, 2011, BIOL CELL, V103, P303, DOI 10.1042/BC20110013; Le Tallec B, 2011, NAT STRUCT MOL BIOL, V18, P1421, DOI 10.1038/nsmb.2155; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lu ML, 2002, CLIN CANCER RES, V8, P171; Martin SA, 2010, J PATHOL, V220, P281, DOI 10.1002/path.2631; McFarlane RJ, 2010, CELL CYCLE, V9, P700, DOI 10.4161/cc.9.4.10676; Mo L, 2007, J CLIN INVEST, V117, P314, DOI 10.1172/JCI30062; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Reinert T, 2011, CLIN CANCER RES, V17, P5582, DOI 10.1158/1078-0432.CCR-10-2659; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Santarius T, 2010, GENE CHROMOSOME CANC, V49, P711, DOI 10.1002/gcc.20784; Schepeler Troels, 2007, J Mol Signal, V2, P6, DOI 10.1186/1750-2187-2-6; Smith-Roe SL, 2011, CELL CYCLE, V10, P1618, DOI 10.4161/cc.10.10.15613; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Takacova S, 2012, CANCER CELL, V21, P517, DOI 10.1016/j.ccr.2012.01.021; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Vetter G, 2010, ONCOGENE, V29, P4436, DOI 10.1038/onc.2010.181; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Wu QO, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-16; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yang XM, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.050237; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zieger K, 2009, INT J CANCER, V125, P2095, DOI 10.1002/ijc.24619; Zieger K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-149	56	24	26	0	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 1	2013	32	31					3577	3586		10.1038/onc.2012.381	http://dx.doi.org/10.1038/onc.2012.381			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	194MW	22926521				2022-12-25	WOS:000322638400002
J	Meyer, BS; Rademann, J				Meyer, B. Sina; Rademann, Joerg			Extra- and Intracellular Imaging of Human Matrix Metalloprotease 11 (hMMP-11) with a Cell-penetrating FRET Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; PROGNOSTIC RELEVANCE; HUMAN STROMELYSIN-3; PEPTIDE-SYNTHESIS; INHIBITORS; CANCER; IDENTIFICATION; MOUSE; MMP; ACTIVATION	Matrix metalloprotease 11 (MMP-11), a protease associated with invasion and aggressiveness of cancerous tissue, was postulated as a prognostic marker for pancreatic, breast, and colon cancer patients. Expression analysis, however, did not reveal localization and regulation of this protease. Thus, cellular tools for the visualization of MMP-11 are highly desirable to monitor presence and activity and to elucidate the functional role of MMP-11. Therefore, fluorescein-Dabcyl-labeled Foerster resonance energy transfer (FRET) substrates were developed. The design focused on enhanced peptide binding to human MMP-11, employing an unusual amino acid for the specificity pocket P1'. The addition of several arginines resulted in a cell-permeable FRET substrate SM-P124 (Ac-GRRRK(Dabcyl)-GGAANC-(MeOBn)RMGG-fluorescein). In vitro evaluation of SM-P124 with human MMP-11 showed a 25-fold increase of affinity (k(cat)/K-m = 9.16 x 10(3) M-1 s(-1), K-m = 8 mu M) compared with previously published substrates. Incubation of pancreatic adenocarcinoma cell line MIA PaCa-2 and mamma adenocarcinoma cell line MCF-7 with the substrate SM-P124 (5 mu M) indicated intra-and extracellular MMP-11 activity. A negative control cell line (Jurkat) showed no fluorescent signal either intra-or extra-cellularly. Negative control FRET substrate SM-P123 produced only insignificant extracellular fluorescence without any intracellular fluorescence. SM-P124 therefore enabled intra-and extracellular tracking of MMP-11-overexpressing cancers such as pancreatic and breast adenocarcinoma and might contribute to the understanding of the activation pathways leading to MMP-11-mediated invasive processes.	[Rademann, Joerg] Univ Leipzig, Dept Pharmaceut Chem, D-04103 Leipzig, Germany; [Meyer, B. Sina] Free Univ Berlin, Dept Organ Chem, D-14195 Berlin, Germany; [Meyer, B. Sina; Rademann, Joerg] Leibniz Inst Mol Pharmacol, Dept Med Chem, D-13125 Berlin, Germany	Leipzig University; Free University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Rademann, J (corresponding author), Univ Leipzig, Dept Pharmaceut Chem, Bruderstr 34, D-04103 Leipzig, Germany.	rademann@uni-leipzig.de	Rademann, Jörg/F-4893-2017	Rademann, Jörg/0000-0001-6678-3165	MolDiag-PaCa [LSH.2004-1.2.2.1]	MolDiag-PaCa	This work was supported by MolDiag-PaCa, Sixth Framework Programme Priority Grant LSH.2004-1.2.2.1.	Ahmad A, 1998, AM J PATHOL, V152, P721; Andreini C, 2004, J PROTEOME RES, V3, P21, DOI 10.1021/pr0340476; Apte SS, 1997, J BIOL CHEM, V272, P25511, DOI 10.1074/jbc.272.41.25511; Arora S, 2005, CLIN CANCER RES, V11, P2272, DOI 10.1158/1078-0432.CCR-04-0572; Balakrishnan A, 2006, J BIOL CHEM, V281, P16691, DOI 10.1074/jbc.M513648200; Baldini E, 2004, THYROID, V14, P881, DOI 10.1089/thy.2004.14.881; Barbacid MD, 1998, PROTEIN EXPRES PURIF, V13, P243, DOI 10.1006/prep.1998.0899; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; Bremer C, 2001, RADIOLOGY, V221, P523, DOI 10.1148/radiol.2212010368; Chaussain-Miller C, 2006, J DENT RES, V85, P22, DOI 10.1177/154405910608500104; Coin I, 2007, NAT PROTOC, V2, P3247, DOI 10.1038/nprot.2007.454; DELAIN E, 1992, ELECTRON MICROSC REV, V5, P231, DOI 10.1016/0892-0354(92)90012-F; Denys H, 2004, BRIT J CANCER, V90, P1443, DOI 10.1038/sj.bjc.6601661; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Fromigue O, 2003, INT J CANCER, V106, P355, DOI 10.1002/ijc.11232; Fuchs SM, 2007, PROTEIN ENG DES SEL, V20, P505, DOI 10.1093/protein/gzm051; Gall AL, 2001, J MOL BIOL, V307, P577, DOI 10.1006/jmbi.2001.4493; Hartmann W, 2005, AM J PATHOL, V166, P1153, DOI 10.1016/S0002-9440(10)62335-8; Holtz B, 1999, BIOCHEMISTRY-US, V38, P12174, DOI 10.1021/bi990876m; Isidro-Llobet A, 2009, CHEM REV, V109, P2455, DOI 10.1021/cr800323s; Jones LE, 2004, CLIN CANCER RES, V10, P2832, DOI 10.1158/1078-0432.CCR-1157-03; Kannan R, 1999, PROTEIN EXPRES PURIF, V16, P76, DOI 10.1006/prep.1999.1068; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Kovar JL, 2007, ANAL BIOCHEM, V367, P1, DOI 10.1016/j.ab.2007.04.011; Laurell H, 2006, WORLD J GASTROENTERO, V12, P3344, DOI 10.3748/wjg.v12.i21.3344; LeDour G, 2008, BIOORGAN MED CHEM, V16, P8745, DOI 10.1016/j.bmc.2008.07.041; Lee S, 2010, CHEM REV, V110, P3087, DOI 10.1021/cr900361p; Leivo I, 2005, CANCER GENET CYTOGEN, V156, P104, DOI 10.1016/j.cancergencyto.2004.04.016; Luo DC, 2002, J BIOL CHEM, V277, P25527, DOI 10.1074/jbc.M202494200; Manes S, 1997, J BIOL CHEM, V272, P25706, DOI 10.1074/jbc.272.41.25706; Masson R, 1998, J CELL BIOL, V140, P1535, DOI 10.1083/jcb.140.6.1535; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Mucha A, 1998, J BIOL CHEM, V273, P2763, DOI 10.1074/jbc.273.5.2763; Nazarenko IA, 1997, NUCLEIC ACIDS RES, V25, P2516, DOI 10.1093/nar/25.12.2516; NOEL A, 1995, J BIOL CHEM, V270, P22866, DOI 10.1074/jbc.270.39.22866; Nuti E, 2009, J MED CHEM, V52, P6347, DOI 10.1021/jm900335a; Pan WJ, 2003, J BIOL CHEM, V278, P27820, DOI 10.1074/jbc.M304436200; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Peruzzi D, 2009, CLIN CANCER RES, V15, P4104, DOI 10.1158/1078-0432.CCR-08-3226; RAMAGE R, 1991, TETRAHEDRON, V47, P6353, DOI 10.1016/S0040-4020(01)86564-9; ROUYER N, 1994, INVAS METAST, V14, P269; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Schmitt M, 1997, THROMB HAEMOSTASIS, V78, P285; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Thewes M, 1996, DIAGN MOL PATHOL, V5, P284, DOI 10.1097/00019606-199612000-00010; Uryga-Polowy V, 2008, CHEMBIOCHEM, V9, P2452, DOI 10.1002/cbic.200800329; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316; Wood WJL, 2005, J AM CHEM SOC, V127, P15521, DOI 10.1021/ja0547230; Yamashita K, 2004, INT J CANCER, V110, P201, DOI 10.1002/ijc.20067; Yang J, 2007, BBA-MOL CELL RES, V1773, P400, DOI 10.1016/j.bbamcr.2006.11.002	52	18	18	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.371500	http://dx.doi.org/10.1074/jbc.M112.371500			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22927434	Green Published, hybrid			2022-12-25	WOS:000310642200022
J	Ramirez-Tapia, LE; Martin, CT				Ramirez-Tapia, Luis E.; Martin, Craig T.			New Insights into the Mechanism of Initial Transcription THE T7 RNA POLYMERASE MUTANT P266L TRANSITIONS TO ELONGATION AT LONGER RNA LENGTHS THAN WILD TYPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; ESCHERICHIA-COLI SIGMA(70); LAC UV5 PROMOTER; STRUCTURAL BASIS; ELONGATION COMPLEX; ABORTIVE TRANSCRIPTION; ANGSTROM RESOLUTION; T7-RNA POLYMERASE; TRANSITION; DNA	RNA polymerases undergo substantial structural and functional changes in transitioning from sequence-specific initial transcription to stable and relatively sequence-independent elongation. Initially, transcribing complexes are characteristically unstable, yielding short abortive products on the path to elongation. However, protein mutations have been isolated in RNA polymerases that dramatically reduce abortive instability. Understanding these mutations is essential to understanding the energetics of initial transcription and promoter clearance. We demonstrate here that the P266L point mutation in T7 RNA polymerase, which shows dramatically reduced abortive cycling, also transitions to elongation later, i.e. at longer lengths of RNA. These two properties of the mutant are not necessarily coupled, but rather we propose that they both derive from a weakening of the barrier to RNA-DNA hybrid-driven rotation of the promoter binding N-terminal platform, a motion necessary to achieve programmatically timed release of promoter contacts in the transition to elongation. Parallels in the multisubunit RNA polymerases are discussed.	[Martin, Craig T.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Ramirez-Tapia, Luis E.; Martin, Craig T.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Martin, CT (corresponding author), Univ Massachusetts, Dept Chem, 710 N Pleasant St,LGRT 104, Amherst, MA 01003 USA.	cmartin@chem.umass.edu	Martin, Craig T/L-3596-2013	Martin, Craig T/0000-0003-1029-5239	National Institutes of Health Grant [1RO1 GM55002]; National Research Service Award from the National Institutes of Health [T32 GM08515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515, R01GM055002] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1 GM55002 (to C. T. M.).; Supported by National Research Service Award T32 GM08515 from the National Institutes of Health (to L. E. R.-T.).	Anand VS, 2006, J BIOL CHEM, V281, P35677, DOI 10.1074/jbc.M608180200; Bandwar RP, 2007, J BIOL CHEM, V282, P22879, DOI 10.1074/jbc.M702589200; Bandwar RP, 2006, J MOL BIOL, V360, P466, DOI 10.1016/j.jmb.2006.05.029; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Cashel M, 2003, J BIOL CHEM, V278, P5539, DOI 10.1074/jbc.M211430200; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Esposito EA, 2004, J BIOL CHEM, V279, P44270, DOI 10.1074/jbc.M407688200; Goldman SR, 2009, SCIENCE, V324, P927, DOI 10.1126/science.1169237; Gong P, 2004, J BIOL CHEM, V279, P44277, DOI 10.1074/jbc.M409118200; Guillerez J, 2005, P NATL ACAD SCI USA, V102, P5958, DOI 10.1073/pnas.0407141102; He B, 1997, PROTEIN EXPRES PURIF, V9, P142, DOI 10.1006/prep.1996.0663; Hernandez VJ, 1996, J BIOL CHEM, V271, P18775, DOI 10.1074/jbc.271.31.18775; IKEDA RA, 1987, J BIOL CHEM, V262, P3800; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; KING GC, 1986, BIOCHEMISTRY-US, V25, P36, DOI 10.1021/bi00349a006; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; MASLAK M, 1993, BIOCHEMISTRY-US, V32, P4281, DOI 10.1021/bi00067a017; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MULLER DK, 1988, BIOCHEMISTRY-US, V27, P5763, DOI 10.1021/bi00415a055; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; SOUSA R, 1992, J MOL BIOL, V224, P319, DOI 10.1016/0022-2836(92)90997-X; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tang GQ, 2005, J BIOL CHEM, V280, P40707, DOI 10.1074/jbc.M508013200; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; Temiakov D, 2002, J BIOL CHEM, V277, P47035, DOI 10.1074/jbc.M208923200; Ujvari A, 1997, J MOL BIOL, V273, P775, DOI 10.1006/jmbi.1997.1350; Vahia AV, 2011, BIOCHEMISTRY-US, V50, P7015, DOI 10.1021/bi200620q; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	36	13	14	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37352	37361		10.1074/jbc.M112.370643	http://dx.doi.org/10.1074/jbc.M112.370643			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22923611	hybrid, Green Published			2022-12-25	WOS:000310588500066
J	Pang, XY; Cao, J; Addington, L; Lovell, S; Battaile, KP; Zhang, N; Rao, JLUM; Dennis, EA; Moise, AR				Pang, Xiao-Yan; Cao, Jian; Addington, Linsee; Lovell, Scott; Battaile, Kevin P.; Zhang, Na; Rao, J. L. Uma Maheswar; Dennis, Edward A.; Moise, Alexander R.			Structure/Function Relationships of Adipose Phospholipase A(2) Containing a Cys-His-His Catalytic Triad	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II TUMOR-SUPPRESSOR; HORMONE-SENSITIVE LIPASE; DIET-INDUCED OBESITY; ESCHERICHIA-COLI; DOWN-REGULATION; GENE; PROTEIN; IDENTIFICATION; EXPRESSION; LIPOLYSIS	Adipose phospholipase A(2) (AdPLA or Group XVI PLA(2)) plays an important role in the onset of obesity by suppressing adipose tissue lipolysis. As a consequence, AdPLA-deficient mice are resistant to obesity induced by a high fat diet or leptin deficiency. It has been proposed that AdPLA mediates its antilipo-lytic effects by catalyzing the release of arachidonic acid. Based on sequence homology, AdPLA is part of a small family of acyltransferases and phospholipases related to lecithin: retinol acyltransferase (LRAT). To better understand the enzymatic mechanism of AdPLA and LRAT-related proteins, we solved the crystal structure of AdPLA. Our model indicates that AdPLA bears structural similarity to proteins from the NlpC/P60 family of cysteine proteases, having its secondary structure elements configured in a circular permutation of the classic papain fold. Using both structural and biochemical evidence, we demonstrate that the enzymatic activity of AdPLA is mediated by a distinctive Cys-His-His catalytic triad and that the C-terminal transmembrane domain of AdPLA is required for the interfacial catalysis. Analysis of the enzymatic activity of AdPLA toward synthetic and natural substrates indicates that AdPLA displays PLA(1) in addition to PLA(2) activity. Thus, our results provide insight into the enzymatic mechanism and biochemical properties of AdPLA and LRAT-related proteins and lead us to propose an alternate mechanism for AdPLA in promoting adipose tissue lipolysis that is not contingent on the release of arachidonic acid and that is compatible with its combined PLA(1)/A(2) activity.	[Pang, Xiao-Yan; Addington, Linsee; Rao, J. L. Uma Maheswar; Moise, Alexander R.] Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA; [Cao, Jian; Dennis, Edward A.] Univ Calif San Diego, Sch Med, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Cao, Jian; Dennis, Edward A.] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Lovell, Scott; Zhang, Na] Univ Kansas, Del Shankel Struct Biol Ctr, Lawrence, KS 66047 USA; [Battaile, Kevin P.] Hauptman Woodward Med Res Inst, IMCA CAT, Argonne, IL 60439 USA	University of Kansas; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Kansas; Hauptman Woodward Medical Research Institute	Moise, AR (corresponding author), Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, 5060 Malott Hall,1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	alexmoise@ku.edu	Dennis, Edward A./M-5554-2019; AR, Moise/P-2474-2019; Moise, Alexander R/C-9498-2009	Dennis, Edward A./0000-0003-3738-3140; AR, Moise/0000-0003-2307-6035; Moise, Alexander R/0000-0003-2307-6035; Battaile, Kevin/0000-0003-0833-3259	National Institutes of Health [5P20RR017708-10, 3P20RR017708-07S1]; National Center for Research Resources; NIGMS [8 P20 GM103420-10, R01 GM20501]; Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501, P20GM103420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P20RR017708-10 and 3P20RR017708-07S1, subawards of grants from the National Center for Research Resources (to A. R. M.), Grant 8 P20 GM103420-10) from the NIGMS (to A. R. M.), and Grant R01 GM20501 (to E. A. D.).; We thank Drs. Rick Dobrowsky, Hei Sook Sul, Robert Hanzlik, Jeff Staudinger, and Ross Stein for valuable discussions. Wethank Sara Billings for advice and help in the preparation of the manuscript. We thank Dan Brown and Amanda Wise for help in cloning and initial assay development and Dr. Fei Philip Gao for help in designing the protein purification strategy. We thank Drs. Marcin Golczak and Krzysztof Palczewski for the gift of the pET30b-HRASLS3 bacterial expression construct. Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was also supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BATZRI S, 1973, BIOCHIM BIOPHYS ACTA, V298, P1015, DOI 10.1016/0005-2736(73)90408-2; Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brown JM, 2010, J LIPID RES, V51, P3306, DOI 10.1194/jlr.M010256; Burke JE, 2008, BIOCHEMISTRY-US, V47, P6451, DOI 10.1021/bi8000962; Cao J, 2011, BIOCHEMISTRY-US, V50, P5314, DOI 10.1021/bi101916w; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COPPACK SW, 1994, J LIPID RES, V35, P177; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; DIGUAN C, 1988, GENE, V67, P21, DOI 10.1016/0378-1119(88)90004-2; DiSepio D, 1998, P NATL ACAD SCI USA, V95, P14811, DOI 10.1073/pnas.95.25.14811; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; DORFMAN ML, 1974, ARCH DERMATOL, V110, P261, DOI 10.1001/archderm.110.2.261; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; Dusaulcy R, 2009, J PHYSIOL BIOCHEM, V65, P345, DOI 10.1007/BF03185929; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fain JN, 2000, J LIPID RES, V41, P1689; Federico L, 2012, MOL ENDOCRINOL, V26, P786, DOI 10.1210/me.2011-1229; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Golczak M, 2012, J BIOL CHEM, V287, P23790, DOI 10.1074/jbc.M112.361550; Golczak M, 2010, J BIOL CHEM, V285, P29217, DOI 10.1074/jbc.M110.152314; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HAJNAL A, 1994, ONCOGENE, V9, P479; HOLM C, 1988, SCIENCE, V241, P1503, DOI 10.1126/science.3420405; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; Hummasti S, 2008, J LIPID RES, V49, P2535, DOI 10.1194/jlr.M800269-JLR200; Husmann K, 1998, ONCOGENE, V17, P1305, DOI 10.1038/sj.onc.1202060; Ishikawa S, 1998, J BACTERIOL, V180, P2549, DOI 10.1128/JB.180.9.2549-2555.1998; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jin XH, 2009, BBA-MOL CELL BIOL L, V1791, P32, DOI 10.1016/j.bbalip.2008.09.006; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; Kienesberger PC, 2008, J BIOL CHEM, V283, P5908, DOI 10.1074/jbc.M709598200; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Lord CC, 2012, DIABETES, V61, P355, DOI 10.2337/db11-0994; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Moise AR, 2004, J VIROL, V78, P454, DOI 10.1128/JVI.78.1.454-463.2004; Montero-Moran G, 2010, J LIPID RES, V51, P709, DOI 10.1194/jlr.M001917; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Plante M, 2009, METHODS MOL BIOL, V579, P469, DOI 10.1007/978-1-60761-322-0_23; PLUCKTHUN A, 1982, BIOCHEMISTRY-US, V21, P1743; POLGAR L, 1974, FEBS LETT, V47, P15, DOI 10.1016/0014-5793(74)80415-1; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Qin HJ, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-51; Ren XB, 2010, FEBS LETT, V584, P4222, DOI 10.1016/j.febslet.2010.09.015; Ren XB, 2010, BIOMOL NMR ASSIGN, V4, P175, DOI 10.1007/s12104-010-9238-5; Roder K, 2002, J BIOL CHEM, V277, P30543, DOI 10.1074/jbc.M111891200; Roer K, 2002, BIOCHEM BIOPH RES CO, V294, P63, DOI 10.1016/S0006-291X(02)00440-0; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Sers C, 2002, ONCOGENE, V21, P2829, DOI 10.1038/sj.onc.1205377; Sers C, 1997, J CELL BIOL, V136, P935, DOI 10.1083/jcb.136.4.935; Shinohara N, 2011, J LIPID RES, V52, P1927, DOI 10.1194/jlr.M015081; Siegrist S, 2001, ONCOGENE, V20, P5155, DOI 10.1038/sj.onc.1204658; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Uyama T, 2012, J BIOL CHEM, V287, P31905, DOI 10.1074/jbc.M112.368712; Uyama T, 2012, J BIOL CHEM, V287, P2706, DOI 10.1074/jbc.M111.267575; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Xie MX, 2003, ARCH BIOCHEM BIOPHYS, V416, P137, DOI 10.1016/S0003-9861(03)00264-9; Xu QP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022013; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	88	34	36	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35260	35274		10.1074/jbc.M112.398859	http://dx.doi.org/10.1074/jbc.M112.398859			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22923616	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000309968000036
J	Li, L; Chang, SH; Xiang, JF; Li, Q; Liang, HH; Tang, YL; Liu, YF				Li, Lin; Chang, Shenghai; Xiang, Junfeng; Li, Qian; Liang, Huanhuan; Tang, Yalin; Liu, Yingfang			Screen Anti-influenza Lead Compounds That Target the PA(C) Subunit of H5N1 Viral RNA Polymerase	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; PA SUBUNIT; CRYSTAL-STRUCTURE; ACTIVE-SITE; ENDONUCLEASE; INFECTION; AGENTS; STRATEGIES; MUTATION; BINDING	The avian influenza (H5N1) viral RNA polymerase protein PA(C) was used as a target to screen nine chlorogenic acid derivatives for their polymerase inhibitor activity. Among them, seven compounds were PAC ligands, and four inhibited influenza RNA polymerase activity. These results aid in the design of anti-influenza agents based on caffeoylquinic acid.	[Li, Lin; Xiang, Junfeng; Li, Qian; Tang, Yalin] Chinese Acad Sci, Inst Chem, State Key Lab Struct Chem Unstable & Stable Speci, BNLMS,Ctr Mol Sci, Beijing 100080, Peoples R China; [Chang, Shenghai; Liang, Huanhuan; Liu, Yingfang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Li, Lin; Chang, Shenghai; Li, Qian] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Chemistry, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Inst Chem, State Key Lab Struct Chem Unstable & Stable Speci, BNLMS,Ctr Mol Sci, Beijing 100080, Peoples R China.	tangyl@iccas.ac.cn; liuy@ibp.ac.cn			National Natural Science Foundation of China [81072576, 30925011]; Ministry of Science and Technology 863 Project [2006AA02A314]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology 863 Project(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (81072576) to Y. L. Tang, the National Natural Science Foundation of China (30925011) and the Ministry of Science and Technology 863 Project (2006AA02A314) to Y. F. Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; De Clereq E, 2007, TRENDS PHARMACOL SCI, V28, P280, DOI 10.1016/j.tips.2007.04.005; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Ge F, 2007, PHYTOCHEM ANALYSIS, V18, P213, DOI 10.1002/pca.974; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Iwai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019825; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Ko HC, 2006, J ETHNOPHARMACOL, V107, P205, DOI 10.1016/j.jep.2006.03.004; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Lepre CA, 2004, CHEM REV, V104, P3641, DOI 10.1021/cr030409h; Li L, 2011, CHEM LETT, V40, P801, DOI 10.1246/cl.2011.801; Luo RS, 1999, SPECTROCHIM ACTA A, V55, P1897, DOI 10.1016/S1386-1425(99)00052-9; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Nakazawa M, 2008, ANTIVIR RES, V78, P194, DOI 10.1016/j.antiviral.2007.12.010; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Regan JF, 2006, J VIROL, V80, P252, DOI 10.1128/JVI.80.1.252-261.2006; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; Su CY, 2010, P NATL ACAD SCI USA, V107, P19151, DOI 10.1073/pnas.1013592107; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhang SJ, 2010, J BIOL CHEM, V285, P41194, DOI 10.1074/jbc.M110.130062	26	12	13	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e35234	10.1371/journal.pone.0035234	http://dx.doi.org/10.1371/journal.pone.0035234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936968	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500001
J	Lerman, SB; Warren, PS; Gan, H; Shochat, E				Lerman, Susannah B.; Warren, Paige S.; Gan, Hilary; Shochat, Eyal			Linking Foraging Decisions to Residential Yard Bird Composition	PLOS ONE			English	Article							PREDATION RISK; PATCH-USE; LONG-TERM; HABITAT; CONSERVATION; BEHAVIOR; BIODIVERSITY; COMMUNITY; URBANIZATION; STRATEGIES	Urban bird communities have higher densities but lower diversity compared with wildlands. However, recent studies show that residential urban yards with native plantings have higher native bird diversity compared with yards with exotic vegetation. Here we tested whether landscape designs also affect bird foraging behavior. We estimated foraging decisions by measuring the giving-up densities (GUD; amount of food resources remaining when the final forager quits foraging on an artificial food patch, i.e seed trays) in residential yards in Phoenix, AZ, USA. We assessed how two yard designs (mesic: lush, exotic vegetation; xeric: drought-tolerant and native vegetation) differed in foraging costs. Further, we developed a statistical model to calculate GUDs for every species visiting the seed tray. Birds foraging in mesic yards depleted seed trays to a lower level (i.e. had lower GUDs) compared to birds foraging in xeric yards. After accounting for bird densities, the lower GUDs in mesic yards appeared largely driven by invasive and synanthropic species. Furthermore, behavioral responses of individual species were affected by yard design. Species visiting trays in both yard designs had lower GUDs in mesic yards. Differences in resource abundance (i.e., alternative resources more abundant and of higher quality in xeric yards) contributed to our results, while predation costs associated with foraging did not. By enhancing the GUD, a common method for assessing the costs associated with foraging, our statistical model provided insights into how individual species and bird densities influenced the GUD. These differences we found in foraging behavior were indicative of differences in habitat quality, and thus our study lends additional support for native landscapes to help reverse the loss of urban bird diversity.	[Warren, Paige S.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Gan, Hilary; Shochat, Eyal] Arizona State Univ, Global Inst Sustainabil, Tempe, AZ USA; [Shochat, Eyal] Yeruham Ctr Ornithol & Ecol, Yeruham, Israel; [Lerman, Susannah B.] Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; Arizona State University; Arizona State University-Tempe; University of Massachusetts System; University of Massachusetts Amherst	Lerman, SB (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.	slerman@cns.umass.edu		Warren, Paige/0000-0003-0787-4635; Shochat, Eyal/0000-0003-0991-9366; Lerman, Susannah/0000-0002-2331-8439	Switzer Environmental Fellowship from the Robert and Patricia Switzer Foundation; National Science Foundation, Central Arizona-Phoenix Long-Term Ecological Research (CAP LTER) [DEB-0423704]; Division Of Environmental Biology [1026865] Funding Source: National Science Foundation	Switzer Environmental Fellowship from the Robert and Patricia Switzer Foundation; National Science Foundation, Central Arizona-Phoenix Long-Term Ecological Research (CAP LTER); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	S. B. Lerman was supported by a Switzer Environmental Fellowship from the Robert and Patricia Switzer Foundation. This material is based upon work supported by the National Science Foundation under Grant No. DEB-0423704, Central Arizona-Phoenix Long-Term Ecological Research (CAP LTER). Any opinions, findings and conclusions or recommendation expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation (NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker PJ, 2005, MAMMAL REV, V35, P302, DOI 10.1111/j.1365-2907.2005.00071.x; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bormann F. H., 2001, REDESIGNING AM LAWN; Bowers MA, 1996, ECOL APPL, V6, P1135, DOI 10.2307/2269597; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Buchholz R, 2007, TRENDS ECOL EVOL, V22, P401, DOI 10.1016/j.tree.2007.06.002; Burghardt KT, 2009, CONSERV BIOL, V23, P219, DOI 10.1111/j.1523-1739.2008.01076.x; Carrascal LM, 2006, OIKOS, V112, P51, DOI 10.1111/j.0030-1299.2006.13787.x; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chiron F, 2007, J WILDLIFE MANAGE, V71, P2624, DOI 10.2193/2006-105; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Daniels GD, 2006, BIOL CONSERV, V133, P326, DOI 10.1016/j.biocon.2006.06.011; EMLEN JT, 1974, CONDOR, V76, P184, DOI 10.2307/1366729; Fokidis HB, 2011, HORM BEHAV, V59, P133, DOI 10.1016/j.yhbeh.2010.11.002; Gammage G., 1999, PHOENIX PERSPECTIVE; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Green DA, 2003, LANDSCAPE URBAN PLAN, V63, P225, DOI 10.1016/S0169-2046(02)00195-0; KOTLER BP, 1994, AUST J ZOOL, V42, P449, DOI 10.1071/ZO9940449; Kotler BP, 2007, ISR J ECOL EVOL, V53, P237, DOI 10.1560/IJEE.53.3.237; Kotler BP, 2010, P ROY SOC B-BIOL SCI, V277, P1469, DOI 10.1098/rspb.2009.2036; Lerman SB, 2011, ECOL APPL, V21, P1327, DOI 10.1890/10-0423.1; Leston LFV, 2006, BIOL CONSERV, V131, P566, DOI 10.1016/j.biocon.2006.03.003; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1990, OIKOS, V58, P151, DOI 10.2307/3545422; Major RE, 1996, AUST J ECOL, V21, P399, DOI 10.1111/j.1442-9993.1996.tb00626.x; Marzluff John M., 2001, P19; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Morris DW, 2000, ECOLOGY, V81, P2061, DOI 10.1890/0012-9658(2000)081[2061:OFMMPU]2.0.CO;2; Oksanen J., 2009, VEGAN COMMUNITY ECOL; Olsson O, 1999, OIKOS, V87, P264, DOI 10.2307/3546741; Olsson O, 2002, ANIM BEHAV, V63, P981, DOI 10.1006/anbe.2001.1985; Olsson O, 2007, ISR J ECOL EVOL, V53, P263, DOI 10.1560/IJEE.53.3.263; Ovadia O, 2001, BEHAV ECOL, V12, P219, DOI 10.1093/beheco/12.2.219; Oyugi JO, 2003, CONDOR, V105, P130, DOI 10.1650/0010-5422(2003)105[130:GUDAHP]2.0.CO;2; R Core Team, 2022, R LANG ENV STAT COMP; ROSENBERG KV, 1987, WILSON BULL, V99, P642; Schmidt KA, 1999, OIKOS, V85, P151, DOI 10.2307/3546801; Shochat E, 2004, AM NAT, V164, P232, DOI 10.1086/422222; Shochat E, 2010, BIOSCIENCE, V60, P199, DOI 10.1525/bio.2010.60.3.6; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Sorace A, 2002, ORNIS FENNICA, V79, P60; Stenberg M, 2006, OIKOS, V112, P332, DOI 10.1111/j.0030-1299.2006.13459.x; Stephens D.W., 1986, pi; VALONE TJ, 1989, ECOLOGY, V70, P1800, DOI 10.2307/1938113; Whelan CJ, 2005, FUNCT ECOL, V19, P529, DOI 10.1111/j.1365-2435.2005.00996.x; [No title captured]	48	19	19	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43497	10.1371/journal.pone.0043497	http://dx.doi.org/10.1371/journal.pone.0043497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927974	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300056
J	Rae, BD; Long, BM; Badger, MR; Price, GD				Rae, Benjamin D.; Long, Benedict M.; Badger, Murray R.; Price, G. Dean			Structural Determinants of the Outer Shell of beta-Carboxysomes in Synechococcus elongatus PCC 7942: Roles for CcmK2, K3-K4, CcmO, and CcmL	PLOS ONE			English	Article							INORGANIC CARBON LIMITATION; CO2 CONCENTRATING MECHANISMS; NITRATE ASSIMILATION OPERON; SP STRAIN PCC-7942; CO2-CONCENTRATING MECHANISM; PCC7942 REVEALS; CYANOBACTERIUM; PROTEIN; GENE; EXPRESSION	Cyanobacterial CO2-fixation is supported by a CO2-concentrating mechanism which improves photosynthesis by saturating the primary carboxylating enzyme, ribulose 1, 5-bisphosphate carboxylase/oxygenase (RuBisCO), with its preferred substrate CO2. The site of CO2-concentration is a protein bound micro-compartment called the carboxysome which contains most, if not all, of the cellular RuBisCO. The shell of beta-type carboxysomes is thought to be composed of two functional layers, with the inner layer involved in RuBisCO scaffolding and bicarbonate dehydration, and the outer layer in selective permeability to dissolved solutes. Here, four genes (ccmK2-4, ccmO), whose products were predicted to function in the outer shell layer of beta-carboxysomes from Synechococcus elongatus PCC 7942, were investigated by analysis of defined genetic mutants. Deletion of the ccmK2 and ccmO genes resulted in severe high-CO2-requiring mutants with aberrant carboxysomes, whilst deletion of ccmK3 or ccmK4 resulted in cells with wild-type physiology and normal ultrastructure. However, a tandem deletion of ccmK3-4 resulted in cells with wild-type carboxysome structure, but physiologically deficient at low CO2 conditions. These results revealed the minimum structural determinants of the outer shell of beta-carboxysomes from this strain: CcmK2, CcmO and CcmL. An accessory set of proteins was required to refine the function of the pre-existing shell: CcmK3 and CcmK4. These data suggested a model for the facet structure of beta-carboxysomes with CcmL forming the vertices, CcmK2 forming the bulk facet, and CcmO, a "zipper protein," interfacing the edges of carboxysome facets.	[Rae, Benjamin D.; Long, Benedict M.; Badger, Murray R.; Price, G. Dean] Australian Natl Univ, Div Plant Sci, Res Sch Biol, Canberra, ACT 0200, Australia	Australian National University	Rae, BD (corresponding author), Australian Natl Univ, Div Plant Sci, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	dean.price@anu.edu.au	Price, G Dean/C-9505-2009; Rae, Benjamin D/C-3045-2011; Badger, Murray R/C-8153-2009; Long, Benedict M/B-3799-2008	Price, G Dean/0000-0001-5906-4912; Rae, Benjamin D/0000-0003-2199-1205; Long, Benedict M/0000-0002-4616-2967	Australian National University; Australian Research Council	Australian National University(Australian National University); Australian Research Council(Australian Research Council)	The work was supported by an Australian National University PhD scholarship and partial funding from an Australian Research Council grant to GDP and MRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aichi M, 1997, J BACTERIOL, V179, P4671, DOI 10.1128/jb.179.15.4671-4675.1997; ALLEN MM, 1968, J GEN MICROBIOL, V51, P199, DOI 10.1099/00221287-51-2-199; BADGER MR, 1982, PLANT PHYSIOL, V70, P517, DOI 10.1104/pp.70.2.517; Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; BADGER MR, 1991, CAN J BOT, V69, P974, DOI 10.1139/b91-125; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Baker SH, 2000, ARCH MICROBIOL, V173, P278, DOI 10.1007/s002030000141; Baker SH, 1999, ARCH MICROBIOL, V172, P233, DOI 10.1007/s002030050765; Bonacci W, 2012, P NATL ACAD SCI USA, V109, P478, DOI 10.1073/pnas.1108557109; Cai F, 2012, ADV PHOTOSYNTH RESP, V33, P345, DOI 10.1007/978-94-007-1533-2_14; Cai F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007521; CANNON GC, 1983, ARCH MICROBIOL, V134, P52, DOI 10.1007/BF00429407; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Choudhary S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033342; CODD GA, 1984, BIOL REV, V59, P389, DOI 10.1111/j.1469-185X.1984.tb00710.x; Cot SSW, 2008, J BACTERIOL, V190, P936, DOI 10.1128/JB.01283-07; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; DZELZKALNS VA, 1984, NUCLEIC ACIDS RES, V12, P8917, DOI 10.1093/nar/12.23.8917; Espie GS, 2011, PHOTOSYNTH RES, V109, P7, DOI 10.1007/s11120-011-9656-y; FRIEDBERG D, 1989, J BACTERIOL, V171, P6069, DOI 10.1128/jb.171.11.6069-6076.1989; FRIEDBERG D, 1993, MOL MICROBIOL, V9, P1193, DOI 10.1111/j.1365-2958.1993.tb01248.x; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Heldt D, 2009, BIOCHEM J, V423, P199, DOI 10.1042/BJ20090780; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; Kinney JN, 2011, PHOTOSYNTH RES, V109, P21, DOI 10.1007/s11120-011-9624-6; Klein MG, 2009, J MOL BIOL, V392, P319, DOI 10.1016/j.jmb.2009.03.056; KUHLEMEIER CJ, 1983, PLASMID, V10, P156, DOI 10.1016/0147-619X(83)90068-9; Long BM, 2007, J BIOL CHEM, V282, P29323, DOI 10.1074/jbc.M703896200; Long BM, 2011, PHOTOSYNTH RES, V109, P33, DOI 10.1007/s11120-011-9659-8; Long BM, 2010, PLANT PHYSIOL, V153, P285, DOI 10.1104/pp.110.154948; Long BM, 2005, CAN J BOT, V83, P746, DOI 10.1139/B05-058; Maeda S, 1998, J BACTERIOL, V180, P4080, DOI 10.1128/JB.180.16.4080-4088.1998; MARCO E, 1994, APPL ENVIRON MICROB, V60, P1018, DOI 10.1128/AEM.60.3.1018-1020.1994; Marin B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-85; Martinez I, 1997, PLANT PHYSIOL BIOCH, V35, P137; Pang A, 2011, ACTA CRYSTALLOGR D, V67, P91, DOI 10.1107/S0907444910050201; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Price GD, 2011, PHOTOSYNTH RES, V109, P47, DOI 10.1007/s11120-010-9608-y; PRICE GD, 1989, PLANT PHYSIOL, V91, P514, DOI 10.1104/pp.91.2.514; PRICE GD, 1992, PLANT PHYSIOL, V100, P784, DOI 10.1104/pp.100.2.784; PRICE GD, 1991, CAN J BOT, V69, P963, DOI 10.1139/b91-124; PRICE GD, 1989, PLANT PHYSIOL, V89, P37, DOI 10.1104/pp.89.1.37; Price GD, 1998, CAN J BOT, V76, P973, DOI 10.1139/b98-081; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Rae BD, 2011, PHOTOSYNTH RES, V109, P59, DOI 10.1007/s11120-011-9641-5; Rippka R., 1981, PROKARYOTES HDB HABI, V1, P212, DOI DOI 10.1007/978-3-662-13187-9_8; Roberts EW, 2012, J BACTERIOL, V194, P787, DOI 10.1128/JB.06444-11; Sagermann M, 2009, P NATL ACAD SCI USA, V106, P8883, DOI 10.1073/pnas.0902324106; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; SCHWARZ R, 1988, PLANT PHYSIOL, V88, P284, DOI 10.1104/pp.88.2.284; Slabas AR, 2006, PROTEOMICS, V6, P845, DOI 10.1002/pmic.200500196; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; SULTEMEYER D, 1995, PLANTA, V196, P217; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; Woodger FJ, 2005, PLANT PHYSIOL, V139, P1959, DOI 10.1104/pp.105.069146; Woodger FJ, 2003, PLANT PHYSIOL, V133, P2069, DOI 10.1104/pp.103.029728; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418; Zhang SL, 2004, J BACTERIOL, V186, P875, DOI 10.1128/JB.186.3.875-879.2004	67	60	66	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43871	10.1371/journal.pone.0043871	http://dx.doi.org/10.1371/journal.pone.0043871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928045	Green Submitted, Green Published, gold			2022-12-25	WOS:000308286300095
J	Lee, JH; Skalnik, DG				Lee, Jeong-Heon; Skalnik, David G.			Rbm15-Mkl1 Interacts with the Setd1b Histone H3-Lys4 Methyltransferase via a SPOC Domain That Is Required for Cytokine-Independent Proliferation	PLOS ONE			English	Article							ACUTE MEGAKARYOBLASTIC LEUKEMIA; SERUM RESPONSE FACTOR; CPG-BINDING PROTEIN; STEM-CELL; HUMAN TRITHORAX; MESSENGER-RNA; MOTIF PROTEIN; SPEN PROTEINS; COMPLEX; GENES	The Rbm15-Mkl1 fusion protein is associated with acute megakaryoblastic leukemia (AMKL), although little is known regarding the molecular mechanism(s) whereby this fusion protein contributes to leukemogenesis. Here, we show that both Rbm15 and the leukemogenic Rbm15-Mkl1 fusion protein interact with the Setd1b histone H3-Lys4 methyltransferase (also known as KMT2G). This interaction is direct and requires the Rbm15 SPOC domain and the Setd1b LSD motif. Over-expression of Rbm15-Mkl1 in the 6133 megakaryoblastic leukemia cell line, previously established by expression of the Rbm15-Mkl1 fusion protein in mice (Mercher et al., [2009] J. Clin. Invest. 119, 852-864), leads to decreased levels of endogenous Rbm15 and increased levels of endogenous Mkl1. These cells exhibit enhanced proliferation and cytokine-independent cell growth, which requires an intact Rbm15 SPOC domain that mediates interaction between the Rbm15-Mkl1 fusion protein and the Setd1b methyltransferase. These results reveal altered Setd1b complex function and consequent altered epigenetic regulation as a possible molecular mechanism that mediates the leukemogenic activity of the Rbm15-Mkl1 fusion protein in AMKL.	[Lee, Jeong-Heon; Skalnik, David G.] Indiana Univ Sch Med, Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN USA; [Lee, Jeong-Heon; Skalnik, David G.] Indiana Univ Sch Med, Wells Ctr Pediat Res, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Skalnik, David G.] Indiana Univ Purdue Univ, Dept Biol, Sch Sci, Indianapolis, IN 46205 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Lee, JH (corresponding author), Indiana Univ Sch Med, Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN USA.	jeonglee@iupui.edu; dskalnik@iupui.edu			National Science Foundation grant [MCB-0641851]; Simmon's Clinical study funds; Riley Children's Foundation; Lilly Endowment	National Science Foundation grant(National Science Foundation (NSF)); Simmon's Clinical study funds; Riley Children's Foundation; Lilly Endowment	This work was supported by the National Science Foundation grant MCB-0641851 (to DGS), Simmon's Clinical study funds (to JHL), the Riley Children's Foundation, and the Lilly Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; CARROLL A, 1991, BLOOD, V78, P748; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Cheng EC, 2009, BLOOD, V113, P2826, DOI 10.1182/blood-2008-09-180596; Descot A, 2008, MOL CELL BIOL, V28, P6171, DOI 10.1128/MCB.00303-08; Dorrance AM, 2006, J CLIN INVEST, V116, P2707, DOI 10.1172/JCI25546; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; Hiriart E, 2005, J BIOL CHEM, V280, P36935, DOI 10.1074/jbc.M501725200; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kuang B, 2000, DEVELOPMENT, V127, P1517; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2010, J BIOL CHEM, V285, P24466, DOI 10.1074/jbc.M110.109801; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JH, 2002, J BIOL CHEM, V277, P42259, DOI 10.1074/jbc.M205054200; Lindtner S, 2006, J BIOL CHEM, V281, P36915, DOI 10.1074/jbc.M608745200; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Ma XY, 2007, MOL CELL BIOL, V27, P3056, DOI 10.1128/MCB.01339-06; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Mercher T, 2009, J CLIN INVEST, V119, P852, DOI 10.1172/JCI35901; Niu C, 2009, BLOOD, V114, P2087, DOI 10.1182/blood-2009-01-197921; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Paredes-Aguilera R, 2003, AM J HEMATOL, V73, P71, DOI 10.1002/ajh.10320; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Raffel GD, 2007, P NATL ACAD SCI USA, V104, P6001, DOI 10.1073/pnas.0609041104; Raffel GD, 2009, MOL CELL BIOL, V29, P333, DOI 10.1128/MCB.00370-08; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; Sanchez-Pulido L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-91; Sawada T, 2008, J BIOL CHEM, V283, P26820, DOI 10.1074/jbc.M802315200; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Somervaille TCP, 2010, INT J HEMATOL, V91, P735, DOI 10.1007/s12185-010-0579-8; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Uranishi H, 2009, J BIOL CHEM, V284, P26106, DOI 10.1074/jbc.M109.040113; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Wiellette EL, 1999, DEVELOPMENT, V126, P5373; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Zolotukhin AS, 2009, NUCLEIC ACIDS RES, V37, P7151, DOI 10.1093/nar/gkp782	42	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42965	10.1371/journal.pone.0042965	http://dx.doi.org/10.1371/journal.pone.0042965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927943	Green Published, Green Submitted, gold			2022-12-25	WOS:000307789700018
J	Sun, SB; Wang, JJ; Zhu, LL; Liao, DH; Gu, MA; Ren, LX; Kapulnik, Y; Xu, GH				Sun, Shubin; Wang, Jingjing; Zhu, Lingling; Liao, Dehua; Gu, Mian; Ren, Lixuan; Kapulnik, Yoram; Xu, Guohua			An Active Factor from Tomato Root Exudates Plays an Important Role in Efficient Establishment of Mycorrhizal Symbiosis	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZA; DIFFUSIBLE FACTOR; FUNGI; EXPRESSION; INFECTION; RESPONSES; SIGNALS; SPORES; GROWTH; MUTANT	Root exudates play an important role in the early signal exchange between host plants and arbuscular mycorrhizal fungi. M161, a pre-mycorrhizal infection (pmi) mutant of the tomoto (Solanum lycopersicum) cultivar Micro-Tom, fails to establish normal arbuscular mycorrhizal symbioses, and produces exudates that are unable to stimulate hyphal growth and branching of Glomus intraradices. Here, we report the identification of a purified active factor (AF) that is present in the root exudates of wild-type tomato, but absent in those of M161. A complementation assay using the dual root organ culture system showed that the AF could induce fungal growth and branching at the pre-infection stage and, subsequently, the formation of viable new spores in the M161 background. Since the AF-mediated stimulation of hyphal growth and branching requires the presence of the M161 root, our data suggest that the AF is essential but not sufficient for hyphal growth and branching. We propose that the AF, which remains to be chemically determined, represents a plant signal molecule that plays an important role in the efficient establishment of mycorrhizal symbioses.	[Sun, Shubin; Wang, Jingjing; Zhu, Lingling; Liao, Dehua; Gu, Mian; Ren, Lixuan; Xu, Guohua] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Sun, Shubin; Wang, Jingjing; Zhu, Lingling; Liao, Dehua; Gu, Mian; Ren, Lixuan; Xu, Guohua] Nanjing Agr Univ, Minist Agr, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Nanjing, Jiangsu, Peoples R China; [Kapulnik, Yoram] Agr Res Org, Volcani Ctr, Dept Agron & Nat Resources, IL-50250 Bet Dagan, Israel	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Sun, SB (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	ghxu@njau.edu.cn	dehua, liao/AGW-5646-2022; Xu, Guohua/J-1840-2012	Xu, Guohua/0000-0002-3283-2392	China National Natural Science Foundation [30971855]; China 863 project [2006AA10Z134]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China 863 project(National High Technology Research and Development Program of China)	This work was supported by the China National Natural Science Foundation (30971855) and the China 863 project (2006AA10Z134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; BECARD G, 1992, METHOD MICROBIOL, V24, P89, DOI 10.1016/S0580-9517(08)70089-8; Becard G., 1992, APPL ENVIRON MICROB, V68, P1260; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Bonfante P, 2011, CURR OPIN PLANT BIOL, V14, P451, DOI 10.1016/j.pbi.2011.03.014; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; Bucher M, 2009, CURR OPIN PLANT BIOL, V12, P500, DOI 10.1016/j.pbi.2009.06.001; Buee M, 2000, MOL PLANT MICROBE IN, V13, P693, DOI 10.1094/MPMI.2000.13.6.693; Chen AQ, 2007, NEW PHYTOL, V173, P817, DOI 10.1111/j.1469-8137.2006.01962.x; David-Schwartz R, 2003, MOL PLANT MICROBE IN, V16, P382, DOI 10.1094/MPMI.2003.16.5.382; David-Schwartz R, 2001, PLANT J, V27, P561, DOI 10.1046/j.1365-313X.2001.01113.x; DONER LW, 1995, CARBOHYD RES, V273, P225, DOI 10.1016/0008-6215(95)00115-A; Fortin JA, 2002, CAN J BOT, V80, P1, DOI 10.1139/b01-139; Gadkar V, 2003, FEMS MICROBIOL LETT, V223, P193, DOI 10.1016/S0378-1097(03)00357-4; Giovannetti M, 1996, NEW PHYTOL, V133, P65, DOI 10.1111/j.1469-8137.1996.tb04342.x; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Harrison MJ, 2005, ANNU REV MICROBIOL, V59, P19, DOI 10.1146/annurev.micro.58.030603.123749; Harrison MJ, 1999, ANNU REV PLANT PHYS, V50, P361, DOI 10.1146/annurev.arplant.50.1.361; Kosuta S, 2003, PLANT PHYSIOL, V131, P952, DOI 10.1104/pp.011882; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Nagahashi G, 2000, MYCOL RES, V104, P1453, DOI 10.1017/S0953756200002860; Nagahashi G, 2011, FUNGAL BIOL-UK, V115, P351, DOI 10.1016/j.funbio.2011.01.006; Navazio L, 2007, PLANT PHYSIOL, V144, P673, DOI 10.1104/pp.106.086959; Olah B, 2005, PLANT J, V44, P195, DOI 10.1111/j.1365-313X.2005.02522.x; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Paszkowski U, 2006, NEW PHYTOL, V172, P35, DOI 10.1111/j.1469-8137.2006.01840.x; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Tamasloukht M, 2003, PLANT PHYSIOL, V131, P1468, DOI 10.1104/pp.012898; VOLPIN H, 1994, PLANT PHYSIOL, V104, P683, DOI 10.1104/pp.104.2.683	30	12	13	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43385	10.1371/journal.pone.0043385	http://dx.doi.org/10.1371/journal.pone.0043385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927963	Green Published, Green Submitted, gold			2022-12-25	WOS:000307789700033
J	Dal Piaz, F; Vassallo, A; Chini, MG; Cordero, FM; Cardona, F; Pisano, C; Bifulco, G; De Tommasi, N; Brandi, A				Dal Piaz, Fabrizio; Vassallo, Antonio; Chini, Maria Giovanna; Cordero, Franca M.; Cardona, Francesca; Pisano, Claudio; Bifulco, Giuseppe; De Tommasi, Nunziatina; Brandi, Alberto			Natural Iminosugar (+)-Lentiginosine Inhibits ATPase and Chaperone Activity of Hsp90	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GLYCOSIDASE INHIBITORS; CLIENT PROTEIN; CANCER; HYDROLYSIS; MOLECULES; UPDATE; DOMAIN; BINDS	Heat shock protein 90 (Hsp90) is a significant target in the development of rational cancer therapy due to its role at the crossroads of multiple signaling pathways associated with cell proliferation and cell viability. The relevance of Hsp90 as a therapeutic target for numerous diseases states has prompted the identification and optimization of novel Hsp90 inhibitors as an emerging therapeutic strategy. We performed a screening aimed to identify novel Hsp90 inhibitors among several natural compounds and we focused on the iminosugar (+)-lentiginosine, a natural amyloglucosidases inhibitor, for its peculiar bioactivity profile. Characterization of Hsp90 inhibition was performed using a panel of chemical and biological approaches, including limited proteolysis, biochemical and cellular assays. Our result suggested that the middle domain of Hsp90, as opposed to its ATP-binding pocket, is a promising binding site for new classes of Hsp90 inhibitors with multi-target anti-cancer potential.	[Dal Piaz, Fabrizio; Chini, Maria Giovanna; Bifulco, Giuseppe; De Tommasi, Nunziatina] Univ Salerno, Dipartimento Sci Farmaceut & Biomed, Fisciano, Italy; [Vassallo, Antonio] Univ Basilicata, Dipartimento Chim, I-85100 Potenza, Italy; [Cordero, Franca M.; Cardona, Francesca; Brandi, Alberto] Univ Florence, Dept Chim Ugo Schiff, Sesto Fiorentino, Italy; [Pisano, Claudio] Sigma Tau Pharmaceut Co, Pomezia, Italy	University of Salerno; University of Basilicata; University of Florence; Leadiant Biosciences	Dal Piaz, F (corresponding author), Univ Salerno, Dipartimento Sci Farmaceut & Biomed, Fisciano, Italy.	detommasi@unisa.it	Chini, Maria Giovanna/C-8066-2014; Cardona, Francesca/AAA-4098-2022; De Tommasi, Nunziatina/A-7768-2011; Dal Piaz, Fabrizio/D-1843-2010; Vassallo, Antonio/R-4508-2019; Cordero, Franca M./J-3102-2012; Bifulco, Giuseppe/A-5413-2011; Brandi, Alberto/B-5699-2014	Cardona, Francesca/0000-0002-6766-4624; De Tommasi, Nunziatina/0000-0003-1707-4156; Dal Piaz, Fabrizio/0000-0002-8643-5018; Vassallo, Antonio/0000-0001-7937-3309; Cordero, Franca M./0000-0001-6005-5941; Bifulco, Giuseppe/0000-0002-1788-5170; Brandi, Alberto/0000-0001-8273-6369; pisano, claudio/0000-0001-8624-2980; Chini, Maria Giovanna/0000-0002-3943-5883	University of Salerno	University of Salerno	This work was supported by the following grant: University of Salerno (Intramural ex 60% (FARB) funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Asano N, 2003, GLYCOBIOLOGY, V13, p93R, DOI 10.1093/glycob/cwg090; Asano N, 2000, TETRAHEDRON-ASYMMETR, V11, P1645, DOI 10.1016/S0957-4166(00)00113-0; BRANDI A, 1995, J ORG CHEM, V60, P6806, DOI 10.1021/jo00126a033; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Calderwood SK, 2008, INT J HYPERTHER, V24, P31, DOI 10.1080/02656730701858305; Cardona F, 2007, EUR J ORG CHEM, V2007, P1551, DOI 10.1002/ejoc.200600633; Cordero FM, 2012, CHEMPLUSCHEM, V77, P224, DOI 10.1002/cplu.201100069; Cordero FM, 2011, TETRAHEDRON, V67, P9555, DOI 10.1016/j.tet.2011.10.008; Cordero FM, 2009, ADV SYNTH CATAL, V351, P1155, DOI 10.1002/adsc.200800806; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Dal Piaz F, 2012, PHYTOCHEMISTRY, V75, P78, DOI 10.1016/j.phytochem.2011.12.002; Dal Piaz F, 2010, CHEMBIOCHEM, V11, P818, DOI 10.1002/cbic.200900721; Dal Piaz F, 2009, J MED CHEM, V52, P3814, DOI 10.1021/jm801637f; Didelot C, 2007, CURR MED CHEM, V14, P2839, DOI 10.2174/092986707782360079; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Giommarelli C, 2010, CELL MOL LIFE SCI, V67, P995, DOI 10.1007/s00018-009-0233-x; Hahn JS, 2009, BMB REP, V42, P623, DOI 10.5483/BMBRep.2009.42.10.623; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Lee CC, 2011, PLOS ONE, V6, p[e1996, 11]; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Macchi B, 2010, GLYCOBIOLOGY, V20, P500, DOI 10.1093/glycob/cwp202; Mahalingam D, 2009, BRIT J CANCER, V100, P1523, DOI 10.1038/sj.bjc.6605066; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nash RJ, 2011, FUTURE MED CHEM, V3, P1513, DOI [10.4155/FMC.11.117, 10.4155/fmc.11.117]; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Sausville EA, 2003, CURR CANCER DRUG TAR, V3, P377, DOI 10.2174/1568009033481831; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Sellers RP, 2010, BIOORGAN MED CHEM, V18, P6822, DOI 10.1016/j.bmc.2010.07.042; Shu LM, 2010, CANCER METAST REV, V29, P483, DOI 10.1007/s10555-010-9239-y; Sirangelo I, 2003, BIOCHEMISTRY-US, V42, P312, DOI 10.1021/bi020447f; SWOPE WC, 1982, J CHEM PHYS, V76, P637, DOI 10.1063/1.442716; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Watson AA, 2001, PHYTOCHEMISTRY, V56, P265, DOI 10.1016/S0031-9422(00)00451-9	39	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43316	10.1371/journal.pone.0043316	http://dx.doi.org/10.1371/journal.pone.0043316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916240	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800059
J	Kumar, P; Lehmann, J; Libchaber, A				Kumar, Pradeep; Lehmann, Jean; Libchaber, Albert			Kinetics of Bulge Bases in Small RNAs and the Effect of Pressure on It	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; HYDROTHERMAL VENTS; WATER; SIMULATION; ORIGIN; LIFE; SOLVATION; LENGTH; ORDER; MODEL	Due to their self-catalytic properties, small RNAs with bulge bases are hypothesized to be primordial molecules which could form elementary translation systems. Using molecular dynamics simulations, we study the binding propensity of small RNAs by calculating the free energy barrier corresponding to the looped out conformations of bulge bases, which presumably act as the binding sites for ligands in these small RNAs. We find that base flipping kinetics can proceed at atmospheric pressure but with a very small propensity. Furthermore, the free energy barrier associated with base flipping depends on the stacking with neighboring bases. Next, we studied the base flipping kinetics with pressure. We find that the free energy associated with base looping out increases monotonically as the pressure is increased. Furthermore, we calculate the mean first-passage time of conformational looping out of the bulge base using the diffusion of reaction coordinate associated with the base flipping on the underlying free energy surface. We find that the mean first-passage time associated with bulge looping out increases slowly upon increasing pressures P up to 2000 atm but changes dramatically for P > 2000 atm. Finally, we discuss our results in the light of the role of hydration shell of water around RNA. Our results are relevant for the RNA world hypothesis.	[Kumar, Pradeep; Lehmann, Jean; Libchaber, Albert] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Rockefeller University	Kumar, P (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	pradeep.kumar@rockefeller.edu	Kumar, Pradeep/N-8106-2013	Kumar, Pradeep/0000-0002-7417-9467; Lehmann, Jean/0000-0002-9887-8123	National Academies Keck Future Initiatives award; National Science Foundation [PHY-0848815]	National Academies Keck Future Initiatives award; National Science Foundation(National Science Foundation (NSF))	This work is supported by National Academies Keck Future Initiatives award (http://www.keckfutures.org/) to PK. Authors also acknowledge the support from National Science Foundation grant PHY-0848815. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbaugh HS, 2002, J CHEM PHYS, V116, P2907, DOI 10.1063/1.1436479; Auffinger P, 2007, CURR OPIN STRUC BIOL, V17, P325, DOI 10.1016/j.sbi.2007.05.008; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Barthel A, 2006, BIOPHYS J, V90, P2450, DOI 10.1529/biophysj.105.076158; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Buldyrev SV, 2007, P NATL ACAD SCI USA, V104, P20177, DOI 10.1073/pnas.0708427104; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CECH TR, 1987, SCIENCE, V236, P1532, DOI 10.1126/science.2438771; Chau PL, 1998, MOL PHYS, V93, P511, DOI 10.1080/002689798169195; Debenedetti PG, 2003, PHYS TODAY, V56, P40, DOI 10.1063/1.1595053; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Errington JR, 2001, NATURE, V409, P318, DOI 10.1038/35053024; Feig M, 2001, BIOPHYS J, V81, P352, DOI 10.1016/S0006-3495(01)75705-0; Franks F, 1972, WATER COMPREHENSIVE, V1-7; Gardiner C., 2009, STOCHASTIC METHODS; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Hermann T, 2000, STRUCTURE, V8, pR47, DOI 10.1016/S0969-2126(00)00110-6; Hummer G, 1996, P NATL ACAD SCI USA, V93, P8951, DOI 10.1073/pnas.93.17.8951; Illangasekare M, 1999, RNA, V5, P1482, DOI 10.1017/S1355838299991264; Kumar P, 2009, P NATL ACAD SCI USA, V106, P22130, DOI 10.1073/pnas.0911094106; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lehmann J, 2007, RNA, V13, P1191, DOI 10.1261/rna.500907; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Lustig B, 1998, NUCLEIC ACIDS RES, V26, P5212, DOI 10.1093/nar/26.22.5212; Maeda YT, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.038301; Martin W, 2008, NAT REV MICROBIOL, V6, P805, DOI 10.1038/nrmicro1991; PATEL DJ, 1982, BIOCHEMISTRY-US, V21, P445, DOI 10.1021/bi00532a004; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pradeep Kumar, 2010, DYNAMICS 2D MONOLAYE; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; van Kampen N. G., 1981, STOCHASTIC PROCESSES; VERLANDER MS, 1973, J MOL EVOL, V2, P303, DOI 10.1007/BF01654098; Widom B, 2003, PHYS CHEM CHEM PHYS, V5, P3085, DOI 10.1039/b304038k; Woodson SA, 1989, BICHEMISTRY, V28, P4512; WYATT JR, 1989, BIOESSAYS, V11, P100, DOI 10.1002/bies.950110406	36	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42052	10.1371/journal.pone.0042052	http://dx.doi.org/10.1371/journal.pone.0042052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916118	Green Submitted, gold, Green Published			2022-12-25	WOS:000307733800016
J	Suenaga, A; Okimoto, N; Hirano, Y; Fukui, K				Suenaga, Atsushi; Okimoto, Noriaki; Hirano, Yoshinori; Fukui, Kazuhiko			An Efficient Computational Method for Calculating Ligand Binding Affinities	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; MOLECULAR-DYNAMICS SIMULATIONS; RAY CRYSTAL-STRUCTURES; GENETIC ALGORITHM; SCORING FUNCTIONS; ACCURATE DOCKING; FLEXIBLE DOCKING; FKBP LIGANDS; FORCE-FIELD; MM-PBSA	Virtual compound screening using molecular docking is widely used in the discovery of new lead compounds for drug design. However, the docking scores are not sufficiently precise to represent the protein-ligand binding affinity. Here, we developed an efficient computational method for calculating protein-ligand binding affinity, which is based on molecular mechanics generalized Born/surface area (MM-GBSA) calculations and Jarzynski identity. Jarzynski identity is an exact relation between free energy differences and the work done through non-equilibrium process, and MM-GBSA is a semimacroscopic approach to calculate the potential energy. To calculate the work distribution when a ligand is pulled out of its binding site, multiple protein-ligand conformations are randomly generated as an alternative to performing an explicit single-molecule pulling simulation. We assessed the new method, multiple random conformation/MM-GBSA (MRC-MMGBSA), by evaluating ligand-binding affinities (scores) for four target proteins, and comparing these scores with experimental data. The calculated scores were qualitatively in good agreement with the experimental binding affinities, and the optimal docking structure could be determined by ranking the scores of the multiple docking poses obtained by the molecular docking process. Furthermore, the scores showed a strong linear response to experimental binding free energies, so that the free energy difference of the ligand binding (Delta Delta G) could be calculated by linear scaling of the scores. The error of calculated Delta Delta G was within approximate to +/- 1.5 kcal.mol(-1) of the experimental values. Particularly, in the case of flexible target proteins, the MRC-MMGBSA scores were more effective in ranking ligands than those generated by the MM-GBSA method using a single protein-ligand conformation. The results suggest that, owing to its lower computational costs and greater accuracy, the MRC-MMGBSA offers efficient means to rank the ligands, in the post-docking process, according to their binding affinities, and to compare these directly with the experimental values.	[Suenaga, Atsushi; Fukui, Kazuhiko] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo, Japan; [Suenaga, Atsushi; Okimoto, Noriaki; Hirano, Yoshinori] RIKEN, Computat Biol Res Core, Quantitat Biol Ctr, Kobe, Hyogo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); RIKEN	Suenaga, A (corresponding author), Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo, Japan.	atsushi.suenaga@aist.go.jp	Okimoto, Noriaki/AAI-4656-2020; Hirano, Yoshinori/AAT-1397-2021	Okimoto, Noriaki/0000-0002-2956-1317; Hirano, Yoshinori/0000-0001-8219-7991	RIKEN	RIKEN	AS and NO acknowledge RIKEN's support through the Strategic Programs for R&D (President's Discretionary Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bramson HN, 2001, J MED CHEM, V44, P4339, DOI 10.1021/jm010117d; Case DA., 2010, AMBER 11; Colizzi F, 2010, J AM CHEM SOC, V132, P7361, DOI 10.1021/ja100259r; Cuendet MA, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2338535; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dullweber F, 2001, J MOL BIOL, V313, P593, DOI 10.1006/jmbi.2001.5062; DUNTEN P, 1995, PROTEIN SCI, V4, P2327, DOI 10.1002/pro.5560041110; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fujitani H, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1999637; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; HOLT DA, 1993, J AM CHEM SOC, V115, P9925, DOI 10.1021/ja00075a008; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jiao D, 2008, P NATL ACAD SCI USA, V105, P6290, DOI 10.1073/pnas.0711686105; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; LEE FS, 1992, PROTEIN ENG, V5, P215, DOI 10.1093/protein/5.3.215; Michel J, 2010, J COMPUT AID MOL DES, V24, P639, DOI 10.1007/s10822-010-9363-3; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Nickitenko AV, 1995, BIOCHEMISTRY-US, V34, P16585, DOI 10.1021/bi00051a006; Okimoto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000528; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Payne JW, 2000, ARCH BIOCHEM BIOPHYS, V384, P9, DOI 10.1006/abbi.2000.2084; Pearlman DA, 2001, J MED CHEM, V44, P3417, DOI 10.1021/jm0100279; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Sham YY, 2000, PROTEINS, V39, P393, DOI 10.1002/(SICI)1097-0134(20000601)39:4<393::AID-PROT120>3.3.CO;2-8; Singh N, 2010, PROTEINS, V78, P1705, DOI 10.1002/prot.22687; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Stahl M, 2001, J MED CHEM, V44, P1035, DOI 10.1021/jm0003992; Talhout R, 2003, J AM CHEM SOC, V125, P10570, DOI 10.1021/ja034676g; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; TURK D, 1991, FEBS LETT, V287, P133, DOI 10.1016/0014-5793(91)80033-Y; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007; Wyss PC, 2003, J MED CHEM, V46, P2304, DOI 10.1021/jm020495y; Xiong H, 2006, THEOR CHEM ACC, V116, P338, DOI 10.1007/s00214-005-0072-2	48	30	30	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42846	10.1371/journal.pone.0042846	http://dx.doi.org/10.1371/journal.pone.0042846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916168	gold, Green Published, Green Submitted			2022-12-25	WOS:000307733800031
J	Wang, ZQ; Nie, BB; Li, DH; Zhao, ZL; Han, Y; Song, HQ; Xu, JY; Shan, BC; Lu, J; Li, KC				Wang, Zhiqun; Nie, Binbin; Li, Donghong; Zhao, Zhilian; Han, Ying; Song, Haiqing; Xu, Jianyang; Shan, Baoci; Lu, Jie; Li, Kuncheng			Effect of Acupuncture in Mild Cognitive Impairment and Alzheimer Disease: A Functional MRI Study	PLOS ONE			English	Article							RESTING-STATE FMRI; BRAIN NETWORKS; DEFAULT-MODE; HIPPOCAMPAL CONNECTIVITY; PATTERNS; ACTIVATION; RESPONSES; DEMENTIA; THALAMUS; SYSTEM	We aim to clarify the mechanisms of acupuncture in treating mild cognitive impairment (MCI) and Alzheimer disease (AD) by using functional magnetic resonance imaging (fMRI). Thirty-six right-handed subjects (8 MCI patients, 14 AD patients, and 14 healthy elders) participated in this study. Clinical and neuropsychological examinations were performed on all the subjects. MRI data acquisition was performed on a SIEMENS verio 3-Tesla scanner. The fMRI study used a single block experimental design. We first acquired the baseline resting state data in the initial 3 minutes; we then acquired the fMRI data during the procession of acupuncture stimulation on the acupoints of Tai chong and Hegu for the following 3 minutes. Last, we acquired fMRI data for another 10 minutes after the needle was withdrawn. The preprocessing and data analysis were performed using the statistical parametric mapping (SPM8) software. Then the two-sample t-tests were performed between each two groups of different states. We found that during the resting state, brain activities in AD and MCI patients were different from those of control subjects. During the acupuncture and the second resting state after acupuncture, when comparing to resting state, there are several regions showing increased or decreased activities in MCI, AD subjects compared to normal subjects. Most of the regions were involved in the temporal lobe and the frontal lobe, which were closely related to the memory and cognition. In conclusion, we investigated the effect of acupuncture in AD and MCI patients by combing fMRI and traditional acupuncture. Our fMRI study confirmed that acupuncture at Tai chong (Liv3) and He gu (LI4) can activate certain cognitive-related regions in AD and MCI patients.	[Wang, Zhiqun; Zhao, Zhilian; Lu, Jie; Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Nie, Binbin; Shan, Baoci] Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China; [Li, Donghong; Xu, Jianyang] Gen Hosp Chinese Peoples Armed Police Forces, Beijing, Peoples R China; [Han, Ying; Song, Haiqing] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Li, Kuncheng] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Capital Medical University	Wang, ZQ (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China.	lujie@xwh.ccmu.edu.cn; likuncheng@xwh.ccmu.edu.cn	Han, Ying/H-7111-2017; Lu, Jie/GNW-3367-2022	Nie, Binbin/0000-0002-8038-7772; Shan, Baoci/0000-0001-7417-5063	Scientific Research Foundation for the Returned Overseas Chinese Scholars; Natural Science Foundation of China [81000606, 61105118, 81141018]; city government [Z101107052210002]	Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); city government	This work was supported by the Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, the Natural Science Foundation of China (Grant No. 81000606, 61105118, 81141018) and Key Work of Special Project supported by the city government (Z101107052210002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Bai LJ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-73; Bai LJ, 2009, PROG NAT SCI-MATER, V19, P827, DOI 10.1016/j.pnsc.2008.09.009; Bai LJ, 2009, BRAIN RES, V1279, P37, DOI 10.1016/j.brainres.2009.04.056; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Dickerson BC, 2008, NEUROPSYCHOLOGIA, V46, P1624, DOI 10.1016/j.neuropsychologia.2007.11.030; Feng YY, 2012, MAGN RESON IMAGING, V30, P672, DOI 10.1016/j.mri.2012.01.003; Feng YY, 2011, MAGN RESON IMAGING, V29, P958, DOI 10.1016/j.mri.2011.04.009; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hamalainen A, 2007, NEUROBIOL AGING, V28, P1889, DOI 10.1016/j.neurobiolaging.2006.08.008; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Li G, 2011, COMPLEMENT THER MED, V19, pS49, DOI 10.1016/j.ctim.2010.11.004; Lu L, 2009, AM J DRUG ALCOHOL AB, V35, P1, DOI 10.1080/00952990802455469; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036838; Wang ZQ, 2012, EUR J RADIOL, V81, P277, DOI 10.1016/j.ejrad.2010.12.044; Wang ZQ, 2011, J NEUROL SCI, V309, P79, DOI 10.1016/j.jns.2011.07.017; Wu MT, 1999, RADIOLOGY, V212, P133, DOI 10.1148/radiology.212.1.r99jl04133; Yan B, 2005, NEUROSCI LETT, V383, P236, DOI 10.1016/j.neulet.2005.04.021; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang G, 2012, J ALTERN COMPLEM MED, V18, P387, DOI 10.1089/acm.2010.0205; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zhong CG, 2012, J MAGN RESON IMAGING, V35, P572, DOI 10.1002/jmri.22887; Zhong XY, 2009, J TRADIT CHIN MED, V29, P174, DOI 10.1016/S0254-6272(09)60058-3; Zhou YL, 2008, ACUPUNCTURE ELECTRO, V33, P9, DOI 10.3727/036012908803861186	37	71	82	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42730	10.1371/journal.pone.0042730	http://dx.doi.org/10.1371/journal.pone.0042730			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916152	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800026
J	Xu, RG; Wang, JM; Li, CD; Johnson, P; Lu, C; Zhou, MX				Xu, Rugen; Wang, Junmei; Li, Chengdao; Johnson, Peter; Lu, Chao; Zhou, Meixue			A Single Locus Is Responsible for Salinity Tolerance in a Chinese Landrace Barley (Hordeum vulgare L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SALT TOLERANCE; WATERLOGGING TOLERANCE; COMBINING ABILITY; GENETIC DIVERSITY; SEEDLING STAGE; CONSENSUS MAP; DART MARKERS; K+ FLUX; GROWTH	Introduction: Salinity and waterlogging are two major abiotic stresses severely limiting barley production. The lack of a reliable screening method makes it very hard to improve the tolerance through breeding programs. Methods: This work used 188 DH lines from a cross between a Chinese landrace variety, TX9425 (waterlogging and salinity tolerant), and a Japanese malting barley, Naso Nijo (waterlogging and salinity sensitive), to identify QTLs associated with the tolerance. Results: Four QTLs were found for waterlogging tolerance. The salinity tolerance was evaluated with both a hydroponic system and in potting mixture. In the trial with potting mixture, only one major QTL was identified to associate with salinity tolerance. This QTL explained nearly 50% of the phenotypic variation, which makes it possible for further fine mapping and cloning of the gene. This QTL was also identified in the hydroponic experiment for different salt-related traits. The position of this QTL was located at a similar position to one of the major QTLs for waterlogging tolerance, indicating the possibility of similar mechanisms controlling both waterlogging and salinity tolerance. Conclusion: The markers associated with the QTL provided a unique opportunity in breeding programs for selection of salinity and waterlogging tolerance.	[Xu, Rugen; Lu, Chao] Yangzhou Univ, Jiangsu Prov Key Lab Crop Genet & Physiol, Yangzhou, Peoples R China; [Xu, Rugen; Lu, Chao] Yangzhou Univ, Barley Res Inst, Yangzhou, Peoples R China; [Wang, Junmei] Zhejiang Acad Agr Sci, Inst Crop & Nucl Technol Utilizat, Hangzhou, Zhejiang, Peoples R China; [Li, Chengdao] Govt Western Australia, Dept Agr & Food, S Perth, WA, Australia; [Johnson, Peter; Zhou, Meixue] Univ Tasmania, Tasmanian Inst Agr, Kings Meadows, Tas, Australia	Yangzhou University; Yangzhou University; Zhejiang Academy of Agricultural Sciences; Government of Western Australia; Department of Agriculture & Food - Western Australia; University of Tasmania	Xu, RG (corresponding author), Yangzhou Univ, Jiangsu Prov Key Lab Crop Genet & Physiol, Yangzhou, Peoples R China.	Meixue.Zhou@utas.edu.au	, Meixue/C-2387-2014	, Meixue/0000-0003-3009-7854	National Natural Science Foundation of China [31128014, 30971779, 31071407]; Grains Research and Development Corporation of Australia; Jiangsu Natural Science Foundation [11KJA210002]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grains Research and Development Corporation of Australia(Grains R&D Corp); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China (31128014, 30971779, 31071407); Grains Research and Development Corporation of Australia; Jiangsu Natural Science Foundation (11KJA210002); the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop BP, 2011, MOL BREEDING, V27, P77, DOI 10.1007/s11032-010-9415-3; [Anonymous], 2011, SAV GROW; ASLAM M, 1993, PLANT SOIL, V150, P99, DOI 10.1007/BF00779180; Barrett-Lennard EG, 2003, PLANT SOIL, V253, P35, DOI 10.1023/A:1024574622669; Chen HT, 2008, AUST J AGR RES, V59, P1086, DOI 10.1071/AR08104; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen Z, 2005, PLANT CELL ENV, P28; Chen ZG, 2008, CROP SCI, V48, P1382, DOI 10.2135/cropsci2007.10.0557; Compagnucci R, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P191; Eleuch L, 2008, J INTEGR PLANT BIOL, V50, P1004, DOI 10.1111/j.1744-7909.2008.00670.x; FAO, 2000, CROPS DROPS MAKING B; Farshadfar E., 2008, Asian Journal of Plant Sciences, V7, P149; Foolad MR, 2001, GENOME, V44, P444, DOI 10.1139/gen-44-3-444; HAMACHI Y, 1990, JPN J BREED, V40, P361; Jaradat AA, 2004, CROP SCI, V44, P997, DOI 10.2135/cropsci2004.0997; Lee SY, 2007, PLANT BREEDING, V126, P43, DOI 10.1111/j.1439-0523.2007.01265.x; Lee SY, 2006, MOL CELLS, V21, P192; Li HB, 2011, MOL BREEDING, V27, P479, DOI 10.1007/s11032-010-9445-x; Li HB, 2009, THEOR APPL GENET, V118, P903, DOI 10.1007/s00122-008-0948-3; Li HB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-401; Mano Y, 1997, EUPHYTICA, V94, P263, DOI 10.1023/A:1002968207362; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pang JY, 2006, PLANT CELL ENVIRON, V29, P1107, DOI 10.1111/j.1365-3040.2005.01486.x; Pang JY, 2007, PLANT PHYSIOL, V145, P266, DOI 10.1104/pp.107.102624; Pang JY, 2004, AUST J AGR RES, V55, P895, DOI 10.1071/AR03097; Rivandi J, 2011, J EXP BOT, V62, P1201, DOI 10.1093/jxb/erq346; Setter TL, 2003, PLANT SOIL, V253, P1, DOI 10.1023/A:1024573305997; Shavrukov Y, 2010, FUNCT INTEGR GENOMIC, V10, P277, DOI 10.1007/s10142-009-0153-8; Siahsar BA, 2009, NEW BIOTECHNOL, V25, pS304, DOI 10.1016/j.nbt.2009.06.761; SLAVICH PG, 1990, AUST J EXP AGR, V30, P551, DOI 10.1071/EA9900551; Tajbakhsh M, 2006, AUST J EXP AGR, V46, P555, DOI 10.1071/EA05026; Teakle NL, 2007, J EXP BOT, V58, P2169, DOI 10.1093/jxb/erm102; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang JM, 2010, EUPHYTICA, V175, P331, DOI 10.1007/s10681-010-0175-2; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Xue DW, 2010, J ZHEJIANG UNIV-SC B, V11, P169, DOI 10.1631/jzus.B0900332; Xue DW, 2009, EUPHYTICA, V169, P187, DOI 10.1007/s10681-009-9919-2; Zhou GF, 2012, MOL BREEDING, V29, P427, DOI 10.1007/s11032-011-9559-9; Zhou M, 2011, PLANT BREEDING, V130, P203, DOI 10.1111/j.1439-0523.2010.01792.x; Zhou MX, 2007, CROP SCI, V47, P278, DOI 10.2135/cropsci2006.02.0065; Zhou MX, 2009, ADV TOP SCI TECH CHI, P1, DOI 10.1007/978-3-642-01279-2_1; Zhou MX, 2012, CROP SCI, DOI [10.2135/cropsci201, DOI 10.2135/CROPSCI201]	47	44	47	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43079	10.1371/journal.pone.0043079	http://dx.doi.org/10.1371/journal.pone.0043079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916210	gold, Green Published			2022-12-25	WOS:000307733800045
J	Sarkar, R; Lenders, L; Wilkinson, KA; Wilkinson, RJ; Nicol, MP				Sarkar, Rajesh; Lenders, Laura; Wilkinson, Katalin A.; Wilkinson, Robert J.; Nicol, Mark P.			Modern Lineages of Mycobacterium tuberculosis Exhibit Lineage-Specific Patterns of Growth and Cytokine Induction in Human Monocyte-Derived Macrophages	PLOS ONE			English	Article							SOUTH-AFRICA; INTRACELLULAR GROWTH; BEIJING/W STRAINS; IMMUNE-RESPONSE; CAPE-TOWN; VIRULENT; INTERLEUKIN-12; PHAGOCYTOSIS; PATHOGENESIS; DEFICIENCY	Background: Strains of Mycobacterium tuberculosis vary in virulence. Strains that have caused outbreaks in the United States and United Kingdom have been shown to subvert the innate immune response as a potential immune evasion mechanism. There is, however, little information available as to whether these patterns of immune subversion are features of individual strains or characteristic of broad clonal lineages of M. tuberculosis. Methods: Strains from two major modern lineages (lineage 2 [East-Asian] and lineage 4 [Euro-American]) circulating in the Western Cape in South Africa as well as a comparator modern lineage (lineage 3 [CAS/Delhi]) were identified. We assessed two virulence associated characteristics: mycobacterial growth (in liquid broth and monocyte derived macrophages) and early pro-inflammatory cytokine induction. Results: In liquid culture, Lineage 4 strains grew more rapidly and reached higher plateau levels than other strains (lineage 4 vs. lineage 2 p = 0.0024; lineage 4 vs. lineage 3 p = 0.0005). Lineage 3 strains were characterized by low and early plateau levels, while lineage 2 strains showed an intermediate growth phenotype. In monocyte-derived macrophages, lineage 2 strains grew faster than lineage 3 strains (p<0.01) with lineage 4 strains having an intermediate phenotype. Lineage 2 strains induced the lowest levels of pro-inflammatory TNF and IL-12p40 as compared to other lineages (lineage 2: median TNF 362 pg/ml, IL-12p40 91 pg/ml; lineage 3: median TNF 1818 pg/ml, IL-12p40 123 pg/ml; lineage 4: median TNF 1207 pg/ml, IL-12p40 205 pg/ml;). In contrast, lineage 4 strains induced high levels of IL-12p40 and intermediate level of TNF. Lineage 3 strains induced high levels of TNF and intermediate levels of IL-12p40. Conclusions: Strains of M. tuberculosis from the three major modern strain lineages possess distinct patterns of growth and cytokine induction. Rapid growth and immune subversion may be key characteristics to the success of these strains in different human populations.	[Sarkar, Rajesh; Lenders, Laura; Nicol, Mark P.] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa; [Nicol, Mark P.] Groote Schuur Hosp, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Wilkinson, Katalin A.; Wilkinson, Robert J.; Nicol, Mark P.] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa; [Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Wilkinson, Katalin A.; Wilkinson, Robert J.] MRC Natl Inst Med Res, London, England	University of Cape Town; University of Cape Town; University of Cape Town; Imperial College London; MRC National Institute for Medical Research	Sarkar, R (corresponding author), Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa.	Mark.Nicol@uct.ac.za	Wilkinson, Katalin/AAQ-7713-2021; Nicol, Mark/W-4149-2019; Wilkinson, Katalin/AAF-6805-2020	Wilkinson, Katalin/0000-0002-9796-2040; Nicol, Mark/0000-0002-1366-4805; Wilkinson, Robert/0000-0002-2753-1800	Wellcome Trust [084323, 088316, 085251/Z/08/Z]; Medical Research Council [U.1175.02.002.00014.01]; National Research Foundation of South Africa; Medical Research Council [MC_U117588499] Funding Source: researchfish; MRC [MC_U117588499] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of South Africa(National Research Foundation - South Africa); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for R.J. Wilkinson from Wellcome Trust (084323 and 088316) and Medical Research Council (U.1175.02.002.00014.01), the Wellcome Trust (085251/Z/08/Z), and the National Research Foundation of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Altare F, 2001, J INFECT DIS, V184, P231, DOI 10.1086/321999; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Cooper AM, 2007, CURR OPIN IMMUNOL, V19, P441, DOI 10.1016/j.coi.2007.07.004; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gascoyne-Binzi DM, 2002, INT J TUBERC LUNG D, V6, P492; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; HIRSCH CS, 1994, J INFECT DIS, V170, P1229, DOI 10.1093/infdis/170.5.1229; Hoal-Van Helden EG, 2001, CELL BIOL INT, V25, P71, DOI 10.1006/cbir.2000.0679; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Li Q, 2002, INFECT IMMUN, V70, P6489, DOI 10.1128/IAI.70.11.6489-6493.2002; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Manca C, 1999, J IMMUNOL, V162, P6740; Mankia S, 2011, CLIN RHEUMATOL, V30, P399, DOI 10.1007/s10067-010-1605-1; Marais BJ, 2006, J CLIN MICROBIOL, V44, P3539, DOI 10.1128/JCM.01291-06; Newton SM, 2006, P NATL ACAD SCI USA, V103, P15594, DOI 10.1073/pnas.0604283103; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Nicol MP, 2005, J CLIN MICROBIOL, V43, P5779, DOI 10.1128/JCM.43.11.5779-5781.2005; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Rakotosamimanana N, 2010, CLIN VACCINE IMMUNOL, V17, P1094, DOI 10.1128/CVI.00049-10; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Tanveer M, 2009, T ROY SOC TROP MED H, V103, P581, DOI 10.1016/j.trstmh.2009.03.014; Theus SA, 2005, J INFECT DIS, V191, P453, DOI 10.1086/425936; Torrelles JB, 2008, J BIOL CHEM, V283, P31417, DOI 10.1074/jbc.M806350200; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; van der Spuy GD, 2009, TUBERCULOSIS, V89, P120, DOI 10.1016/j.tube.2008.09.003; Wang CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013594; WHO, 2010, WHO TUB GLOB FACTSH; Wong KC, 2007, CLIN VACCINE IMMUNOL, V14, P1279, DOI 10.1128/CVI.00190-07; Zhang M, 1999, J INFECT DIS, V179, P1213, DOI 10.1086/314738; Zhang M, 1998, INFECT IMMUN, V66, P794, DOI 10.1128/IAI.66.2.794-799.1998	41	48	48	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43170	10.1371/journal.pone.0043170	http://dx.doi.org/10.1371/journal.pone.0043170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916219	gold, Green Published, Green Submitted			2022-12-25	WOS:000307824300032
J	Zhang, QL; He, JF; Wu, D; Wang, ZJ; Zhong, XG; Zhong, HJ; Ding, F; Liu, ZQ; Wang, SW; Huang, ZY; Zhang, YH; Ke, CW; Yuan, DK; Liang, WJ; Li, DQ; Chen, PH				Zhang Qiaoli; He Jianfeng; Wu De; Wang Zijun; Zhong Xinguang; Zhong Haojie; Ding Fan; Liu Zhiquan; Wang Shiwen; Huang Zhenyu; Zhang Yonghui; Ke Changwen; Yuan Dakang; Liang Wenjia; Li Deqiong; Chen Pinghua			Maiden Outbreak of Chikungunya in Dongguan City, Guangdong Province, China: Epidemiological Characteristics	PLOS ONE			English	Article							VIRUS; REEMERGENCE; INFECTION	Background: This study was conducted to identify epidemiological characteristics of the first documented CHIK fever outbreak in China and evaluate the effect of the preventive measures taken. Methodology/Principal Findings: From September 1 to October 29, 2010, China's first documented outbreak of CHIK fever occurred in the Xincun community of Wanjiang District of Dongguan city, Guangdong province; 253 case-patients were recorded, of which 129 were laboratory confirmed, with an attack rate of 1%. Before September 18th the number of CHIK fever cases remained relatively low in the Xincun community; from September 19th onwards, the number of cases increased drastically, with an outbreak peak on October 4th. Cases were distributed across nine small village groups in the Xincun community, with an attack rate of 0-12% at the village level. The household attack rates ranged between 20% and 100%. No significant difference was found in the attack rate between males and females. There was a significant difference in the attack rate in different age groups (chi-square = 18.35, p = 0.005); highest in patients aged 60 years or older and the lowest in patients aged under 10. The major clinical characteristics of patients are fever (100%), joint pain (79%) and rash (54%). Phylogenetic analysis of the E1 gene on the five earliest confirmed cases showed that the strains of CHIKV isolated from their sera were highly homologous (up to 99%) with isogeneic strains isolated in Thailand in 2009. After control measures were taken, including killing adult mosquitoes and cleaning breeding habitats of Aedes mosquitoes, the Breteau index and Mosq-ovitrap index decreased rapidly, and the outbreak ended on October 29. Conclusion/Significance: The infection source of the outbreak was imported. Cases showed obvious temporal, spatial, and population aggregation during the outbreak. Comprehensive control measures based on reducing the density of Aedes mosquitoes were effective in controlling the epidemic.	[Zhang Qiaoli; Zhong Xinguang; Liu Zhiquan; Huang Zhenyu; Yuan Dakang; Chen Pinghua] Dongguan Municipal CDC, Dongguan, Guangdong, Peoples R China; [He Jianfeng; Wu De; Zhong Xinguang; Zhang Yonghui; Ke Changwen; Liang Wenjia] Guangdong Prov CDC, Guangzhou, Guangdong, Peoples R China; [Wang Zijun; Ding Fan; Wang Shiwen] China CDC, Beijing, Peoples R China; [Li Deqiong] Wanjiang Hosp, Dongguan, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention	Zhang, QL (corresponding author), Dongguan Municipal CDC, Dongguan, Guangdong, Peoples R China.	zql@dg.gov.cn; hjf@vip.sina.com	Wang, Zhiquan/HHS-6768-2022		Provisional Emergency Dedicated Fund of the Dongguan Municipal Government [B10A06008001166]	Provisional Emergency Dedicated Fund of the Dongguan Municipal Government	This study was funded by the Provisional Emergency Dedicated Fund of the Dongguan Municipal Government for the fiscal year 2010 and delivered by the Dongguan Municipal Finance Bureau. The fund code is [2010]37, coded as B10A06008001166. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Hapuarachchi HC, 2010, J GEN VIROL, V91, P1067, DOI 10.1099/vir.0.015743-0; Kaur P, 2008, EMERG INFECT DIS, V14, P1623, DOI 10.3201/eid1410.070569; Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013; Li F, 2007, INT J EPIDEMIOL INFE, V34, P240; Lin M, 2008, CHINESE J FRONTIER H, V4, P221; Ma S-X, 2008, CHIN J ZOONOSES, V24, P188; Manimunda SP, 2010, AM J TROP MED HYG, V83, P751, DOI 10.4269/ajtmh.2010.09-0433; Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322; Muyembe-Tamfum J J, 2003, Med Trop (Mars), V63, P637; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Renault P, 2007, AM J TROP MED HYG, V77, P727; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; World Health Organization, 2011, CHIK FEV SIT IND 200; Xianzhao X, 2011, PREVENTION TREATMENT; 吴凡, 2007, [中国媒介生物学及控制杂志, Chinese Journal of Vector Biology and Control], V18, P527	19	13	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42830	10.1371/journal.pone.0042830	http://dx.doi.org/10.1371/journal.pone.0042830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916166	Green Submitted, gold, Green Published			2022-12-25	WOS:000307824300018
J	Faryna, M; Konermann, C; Aulmann, S; Bermejo, JL; Brugger, M; Diederichs, S; Rom, J; Weichenhan, D; Claus, R; Rehli, M; Schirmacher, P; Sinn, HP; Plass, C; Gerhauser, C				Faryna, Marta; Konermann, Carolin; Aulmann, Sebastian; Bermejo, Justo Lorenzo; Brugger, Markus; Diederichs, Sven; Rom, Joachim; Weichenhan, Dieter; Claus, Rainer; Rehli, Michael; Schirmacher, Peter; Sinn, Hans-Peter; Plass, Christoph; Gerhauser, Clarissa			Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis	FASEB JOURNAL			English	Article						estrogen receptor-positive; EpiTyper MassArray; CpG island array; methyl-CpG immunoprecipitation; DMR; ductal carcinoma in situ	CARCINOMA IN-SITU; DNA METHYLATION; PROMOTER HYPERMETHYLATION; PROTOCADHERIN PCDH10; RECEPTOR STATUS; EARLY EVENT; FREQUENT; SUPPRESSOR; PATTERNS; EXPRESSION	Aberrant DNA methylation constitutes a well-established epigenetic marker for breast cancer. Changes in methylation early in cancer development may be clinically relevant for cancer detection and prognosis-based therapeutic decisions. In the present study, a combination of methyl-CpG immunoprecipitation (MCIp) and human CpG island (CGI) arrays was applied to compare genome-wide DNA methylation profiles in 10 low-grade in situ and invasive breast cancers against 10 normal breast samples. In total, 214 CGIs were found to be hypermethylated in >= 6 of 10 tumors. Functional term enrichment analyses revealed an overrepresentation of homeobox genes and genes involved in transcription and regulation of transcription. Significant hypermethylation of 11 selected genes in tumor vs. normal tissue was validated in two independent sample sets (45 tumors and 11 controls, 43 tumors and 8 controls) using quantitative EpiTyper technology. In tumors, median methylation levels of BCAN, HOXD1, KCTD8, KLF11, NXPH1, POU4F1, SIM1, and TCF7L1 were >= 30% higher than in normal samples, representing potential biomarkers for tumor diagnosis. Using the 90th percentile of methylation levels in normal tissue as cutoff value, 62-92% of in situ samples (n = 13), 72-97% of invasive samples from the first validation set (n = 32), and 86-100% of invasive samples from the second validation set (n = 43) were classified as hypermethylated. Hypermethylation of KLF11 and SIM1 might also be associated with increased risk of developing metastases. In summary, early methylation changes are frequent in the low-grade pathway of breast cancer and may be useful in the development of differential diagnostic and possibly also prognostic markers.-Faryna, M., Konermann, C., Aulmann, S., Bermejo, J. L., Brugger, M., Diederichs, S., Rom, J., Weichenhan, D., Claus, R., Rehli, M., Schirmacher, P., Sinn, H.-P., Plass, C., Gerhauser, C. Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis. FASEB J. 26, 4937-4950 (2012). www.fasebj.org	[Faryna, Marta; Konermann, Carolin; Weichenhan, Dieter; Claus, Rainer; Plass, Christoph; Gerhauser, Clarissa] German Canc Res Ctr, Div Epigen & Canc Risk Factors, D-69120 Heidelberg, Germany; [Diederichs, Sven] German Canc Res Ctr, Helmholtz Univ Grp Mol RNA Biol & Canc, D-69120 Heidelberg, Germany; [Konermann, Carolin; Aulmann, Sebastian; Diederichs, Sven; Schirmacher, Peter; Sinn, Hans-Peter] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Bermejo, Justo Lorenzo; Brugger, Markus] Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany; [Rom, Joachim] Univ Heidelberg Hosp, Dept Gynecol & Obstet, Heidelberg, Germany; [Claus, Rainer] Univ Freiburg, Med Ctr, Div Hematol & Oncol, Dept Med, D-79106 Freiburg, Germany; [Rehli, Michael] Univ Hosp Regensburg, Dept Hematol & Oncol, Regensburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Freiburg; University of Regensburg	Gerhauser, C (corresponding author), German Canc Res Ctr, Div Epigen & Canc Risk Factors, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	c.gerhauser@dkfz-heidelberg.de	Claus, Rainer/AAZ-5606-2020; Plass, Christoph/H-7192-2014; Sinn, Hans-Peter/C-5661-2008; Rehli, Michael/E-9093-2011; Diederichs, Sven/J-6237-2012	Claus, Rainer/0000-0003-2617-8766; Sinn, Hans-Peter/0000-0003-2836-6699; Rehli, Michael/0000-0003-3992-932X; Diederichs, Sven/0000-0001-7901-4752; Gerhauser, Clarissa/0000-0002-5792-3901	FRONTIER Innovation Fund, Excellence Initiative of Heidelberg University; Deutsche Forschungsgemeinschaft (DFG) [SFB/TRR77, CL 427/2-1]; Helmholtz Society [VH-NG-504]; German Research Foundation [DFG Transregio TRR77, TP B03]; Marie Curie Program of the European Commission	FRONTIER Innovation Fund, Excellence Initiative of Heidelberg University; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Helmholtz Society(Helmholtz Association); German Research Foundation(German Research Foundation (DFG)); Marie Curie Program of the European Commission(European Commission)	The authors thank Manuela Zucknick for statistical support in array analysis and Julia Strathmann for providing DNA from MCF7 cells. The authors thank Oliver Mucke, Sandra Hahn, and Tina Philipp for excellent technical assistance. This project was funded by the FRONTIER Innovation Fund as part of the Excellence Initiative of Heidelberg University. J.L.B. and M. B. were supported by a grant of the Deutsche Forschungsgemeinschaft (DFG; SFB/TRR77, project Z2). Research in the S. D. laboratory is supported by the Helmholtz Society (VH-NG-504), the German Research Foundation (DFG Transregio TRR77, TP B03) and the Marie Curie Program of the European Commission. R. C. was supported by a DFG grant (CL 427/2-1). The authors declare no conflicts of interest.	Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Dedeurwaerder S, 2011, EMBO MOL MED, V3, P726, DOI 10.1002/emmm.201100801; Dedeurwaerder S, 2011, CURR OPIN ONCOL, V23, P559, DOI 10.1097/CCO.0b013e32834bd481; Deli T, 2007, INT J CANCER, V121, P55, DOI 10.1002/ijc.22621; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fackler MJ, 2011, CANCER RES, V71, P6195, DOI 10.1158/0008-5472.CAN-11-1630; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Ferlay J, 2010, GLOBOCAN 2008 V1 2 C; Flanagan JM, 2010, AM J HUM GENET, V86, P420, DOI 10.1016/j.ajhg.2010.02.008; Gebhard C, 2006, CANCER RES, V66, P6118, DOI 10.1158/0008-5472.CAN-06-0376; Goeppert B, 2010, HEPATOLOGY, V52, P2023, DOI 10.1002/hep.23939; Hill VK, 2011, CANCER RES, V71, P2988, DOI 10.1158/0008-5472.CAN-10-4026; Holleczek B, 2011, CANCER EPIDEMIOL, V35, P399, DOI 10.1016/j.canep.2011.01.008; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Hoque MO, 2009, CANCER EPIDEM BIOMAR, V18, P2694, DOI 10.1158/1055-9965.EPI-08-0821; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang Y, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2925; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kamalakaran S, 2011, MOL ONCOL, V5, P77, DOI 10.1016/j.molonc.2010.11.002; Killian JK, 2011, AM J PATHOL, V179, P55, DOI 10.1016/j.ajpath.2011.03.022; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Lee JS, 2007, VIRCHOWS ARCH, V450, P637, DOI 10.1007/s00428-007-0421-8; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lehmann U, 2002, AM J PATHOL, V160, P605, DOI 10.1016/S0002-9440(10)64880-8; Li LA, 2010, HUM MOL GENET, V19, P4273, DOI 10.1093/hmg/ddq351; Moelans CB, 2011, J PATHOL, V225, P222, DOI 10.1002/path.2930; Muggerud AA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2466; Narayan G, 2011, GENE CHROMOSOME CANC, V50, P1043, DOI 10.1002/gcc.20922; Narayan G, 2009, GENE CHROMOSOME CANC, V48, P983, DOI 10.1002/gcc.20703; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Ohm JE, 2007, CELL CYCLE, V6, P1040, DOI 10.4161/cc.6.9.4210; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Ordway JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001314; Park SY, 2011, VIRCHOWS ARCH, V458, P73, DOI 10.1007/s00428-010-1013-6; Pasquali L, 2007, CANCER LETT, V257, P136, DOI 10.1016/j.canlet.2007.07.010; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Rauch TA, 2008, P NATL ACAD SCI USA, V105, P252, DOI 10.1073/pnas.0710735105; Schilling E, 2007, GENOMICS, V90, P314, DOI 10.1016/j.ygeno.2007.04.011; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tommasi S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2233; Umbricht CB, 2001, ONCOGENE, V20, P3348, DOI 10.1038/sj.onc.1204438; Van der Auwera I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012616; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; VOLLENWEIDERZERARGUI L, 1986, CANCER-AM CANCER SOC, V57, P1171, DOI 10.1002/1097-0142(19860315)57:6<1171::AID-CNCR2820570618>3.0.CO;2-X; Weigelt B, 2009, NAT REV CLIN ONCOL, V6, P718, DOI 10.1038/nrclinonc.2009.166; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050	58	69	73	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					4937	4950		10.1096/fj.12-209502	http://dx.doi.org/10.1096/fj.12-209502			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22930747	Green Submitted			2022-12-25	WOS:000311838300017
J	McGuire, H; Aurousseau, MRP; Bowie, D; Blunck, R				McGuire, Hugo; Aurousseau, Mark R. P.; Bowie, Derek; Blunck, Rikard			Automating Single Subunit Counting of Membrane Proteins in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS OOCYTES; ACETYLCHOLINE-RECEPTORS; FLUORESCENCE; STOICHIOMETRY; REVEALS; CHANNEL; SPECTROSCOPY; MICROSCOPY; TRANSIENT; BINDING	Elucidating subunit stoichiometry of neurotransmitter receptors is preferably carried out in a mammalian expression system where the rules of native protein assembly are strictly obeyed. Although successful in Xenopus oocytes, single subunit counting, manually counting photobleaching steps of GFP-tagged subunits, has been hindered in mammalian cells by high background fluorescence, poor control of expression, and low GFP maturation efficiency. Here, we present a fully automated single-molecule fluorescence counting method that separates tagged proteins on the plasma membrane from background fluorescence and contaminant proteins in the cytosol or the endoplasmic reticulum and determines the protein stoichiometry. Lower GFP maturation rates observed in cells cultured at 37 degrees C were partly offset using a monomeric version of superfolder GFP. We were able to correctly identify the stoichiometry of GluK2 and alpha 1 glycine receptors. Our approach permits the elucidation of stoichiometry for a wide variety of plasma membrane proteins in mammalian cells with any commercially available TIRF microscope.	[McGuire, Hugo; Blunck, Rikard] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Blunck, Rikard] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [McGuire, Hugo; Aurousseau, Mark R. P.; Bowie, Derek; Blunck, Rikard] Univ Montreal, Grp Etud Prot Membranaires, Montreal, PQ H3C 3J7, Canada; [Aurousseau, Mark R. P.; Bowie, Derek] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 0B1, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University	Blunck, R (corresponding author), Univ Montreal, Dept Phys, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	rikard.blunck@umontreal.ca	Blunck, Rikard/L-4226-2013; Blunck, Rikard/AAM-3078-2020	Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907; Bowie, Derek/0000-0001-9491-8768	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Fonds de Recherche du Quebec-Nature et Technologies fellowship; Canadian Institutes of Health Research fellowship; Canada Research Chair award in Receptor Pharmacology; Canada Research Chair award on Molecular Mechanisms of Membrane Proteins; Fonds de la Recherche en Sante du Quebec	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Nature et Technologies fellowship; Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); Canada Research Chair award in Receptor Pharmacology; Canada Research Chair award on Molecular Mechanisms of Membrane Proteins; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by operating grants from Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research (to R. B. and D. B.).; Recipient of a Fonds de Recherche du Quebec-Nature et Technologies fellowship.; Recipient of a Canadian Institutes of Health Research fellowship.; Recipient of Canada Research Chair award in Receptor Pharmacology.; Recipient of Canada Research Chair award on Molecular Mechanisms of Membrane Proteins.; We thank Elise Faure for stimulating discussions and comments on the manuscript. GEPROM is a research group funded by the Fonds de la Recherche en Sante du Quebec.	AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; BENSON RC, 1979, J HISTOCHEM CYTOCHEM, V27, P44, DOI 10.1177/27.1.438504; Blunck R, 2004, BIOPHYS J, V86, P3966, DOI 10.1529/biophysj.103.034512; Blunck R, 2006, J GEN PHYSIOL, V128, P569, DOI 10.1085/jgp.200609638; Blunck R, 2008, P NATL ACAD SCI USA, V105, P20263, DOI 10.1073/pnas.0807056106; BULLER AL, 1990, MOL PHARMACOL, V37, P423; Carter BC, 2008, BIOPHYS J, V94, P306, DOI 10.1529/biophysj.107.110601; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; CHUNG SH, 1991, J NEUROSCI METH, V40, P71, DOI 10.1016/0165-0270(91)90118-J; Craggs TD, 2009, CHEM SOC REV, V38, P2865, DOI 10.1039/b903641p; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Ding H, 2009, BIOPHYS J, V97, P912, DOI 10.1016/j.bpj.2009.05.035; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Garcia-Parajo MF, 2001, P NATL ACAD SCI USA, V98, P14392, DOI 10.1073/pnas.251525598; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Godin AG, 2011, P NATL ACAD SCI USA, V108, P7010, DOI 10.1073/pnas.1018658108; Groulx N, 2011, J BIOL CHEM, V286, P42274, DOI 10.1074/jbc.M111.296103; HAGIWARA S, 1979, ANNU REV BIOPHYS BIO, V8, P385, DOI 10.1146/annurev.bb.08.060179.002125; Kask P, 1999, P NATL ACAD SCI USA, V96, P13756, DOI 10.1073/pnas.96.24.13756; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Park M, 2005, B CHEM SOC JPN, V78, P1612, DOI 10.1246/bcsj.78.1612; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pierce DW, 1997, NATURE, V388, P338, DOI 10.1038/41009; Qin F, 2000, BIOPHYS J, V79, P1928, DOI 10.1016/S0006-3495(00)76442-3; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Reiner A, 2012, CELL REP, V1, P234, DOI 10.1016/j.celrep.2012.01.003; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schmidt C, 2008, J MOL BIOL, V376, P658, DOI 10.1016/j.jmb.2007.11.105; Schmidt C, 2009, J MOL BIOL, V390, P182, DOI 10.1016/j.jmb.2009.05.008; Schmidt T, 1996, ANAL CHEM, V68, P4397, DOI 10.1021/ac960710g; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shu D, 2007, EMBO J, V26, P527, DOI 10.1038/sj.emboj.7601506; Siemering KR, 1996, CURR BIOL, V6, P1653, DOI 10.1016/S0960-9822(02)70789-6; Simonson PD, 2010, BIOPHYS J, V99, pL81, DOI 10.1016/j.bpj.2010.08.076; Sivilotti LG, 1997, J PHYSIOL-LONDON, V500, P123, DOI 10.1113/jphysiol.1997.sp022004; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Spitzer NC, 2012, NAT REV NEUROSCI, V13, P94, DOI 10.1038/nrn3154; Swift JL, 2011, P NATL ACAD SCI USA, V108, P7016, DOI 10.1073/pnas.1018280108; Terasaki M, 2001, MOL BIOL CELL, V12, P1103, DOI 10.1091/mbc.12.4.1103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Wallace W, 2001, BIOTECHNIQUES, V31, P1076, DOI 10.2144/01315bi01; Xiao J, 2009, HANDBOOK OF SINGLE-MOLECULE BIOPHYSICS, P43, DOI 10.1007/978-0-387-76497-9_3; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1	52	59	61	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35912	35921		10.1074/jbc.M112.402057	http://dx.doi.org/10.1074/jbc.M112.402057			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22930752	hybrid, Green Published			2022-12-25	WOS:000310364000013
J	Minond, D; Cudic, M; Bionda, N; Giulianotti, M; Maida, L; Houghten, RA; Fields, GB				Minond, Dmitriy; Cudic, Mare; Bionda, Nina; Giulianotti, Marc; Maida, Laura; Houghten, Richard A.; Fields, Gregg B.			Discovery of Novel Inhibitors of a Disintegrin and Metalloprotease 17 (ADAM17) Using Glycosylated and Non-glycosylated Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE EXOSITE INHIBITORS; ALPHA CONVERTING-ENZYME; BIOLOGICAL-ACTIVITY; ACTIVE-SITE; FACTOR VIIA; TNF-ALPHA; IN-VIVO; SPECIFICITY; CONFORMATION; TARGET	A disintegrin and metalloprotease (ADAM) proteases are implicated in multiple diseases, but no drugs based on ADAM inhibition exist. Most of the ADAM inhibitors developed to date feature zinc-binding moieties that target the active site zinc, which leads to a lack of selectivity and off-target toxicity. We hypothesized that secondary binding site (exosite) inhibitors should provide a viable alternative to active site inhibitors. Potential exosites in ADAM structures have been reported, but no studies describing substrate features necessary for exosite interactions exist. Analysis of ADAM cognate substrates revealed that glycosylation is often present in the vicinity of the scissile bond. To study whether glycosylation plays a role in modulating ADAM activity, a tumor necrosis factor alpha (TNF alpha) substrate with and without a glycan moiety attached was synthesized and characterized. Glycosylation enhanced ADAM8 and -17 activities and decreased ADAM10 activity. Metalloprotease (MMP) activity was unaffected by TNF alpha substrate glycosylation. High throughput screening assays were developed using glycosylated and non-glycosylated substrate, and positional scanning was conducted. A novel chemotype of ADAM17-selective probes was discovered from the TPIMS library (Houghten, R. A., Pinilla, C., Giulianotti, M. A., Appel, J. R., Dooley, C. T., Nefzi, A., Ostresh, J. M., Yu, Y., Maggiora, G. M., Medina-Franco, J. L., Brunner, D., and Schneider, J. (2008) Strategies for the use of mixture-based synthetic combinatorial libraries. Scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods. J. Comb. Chem. 10, 3-19; Pinilla, C., Appel, J. R., Borras, E., and Houghten, R. A. (2003) Advances in the use of synthetic combinatorial chemistry. Mixture-based libraries. Nat. Med. 9, 118-122) that preferentially inhibited glycosylated substrate hydrolysis and spared ADAM10, MMP-8, and MMP-14. Kinetic studies revealed that ADAM17 inhibition occurred via a non-zinc-binding mechanism. Thus, modulation of proteolysis via glycosylation may be used for identifying novel, potentially exosite binding compounds. The newly described ADAM17 inhibitors represent research tools to investigate the role of ADAM17 in the progression of various diseases.	[Minond, Dmitriy; Cudic, Mare; Bionda, Nina; Giulianotti, Marc; Maida, Laura; Houghten, Richard A.; Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA	Torrey Pines Institute for Molecular Studies, Florida	Minond, D (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	dminond@tpims.org		Minond, Dmitriy/0000-0003-2473-5944; Giulianotti, Marc/0000-0002-2232-3789	National Institutes of Health [1R03DA033985-01, CA098799, 1R01DA031370]; James and Esther King Biomedical Research Program [2KN05]; Multiple Sclerosis National Research Institute; State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033985, R01DA031370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Esther King Biomedical Research Program; Multiple Sclerosis National Research Institute; State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants 1R03DA033985-01 (to D. M.), CA098799 (to G. B. F.), and 1R01DA031370 (to R. A. H.). This work was also supported by James and Esther King Biomedical Research Program Grant 2KN05 (to D. M.), by the Multiple Sclerosis National Research Institute (to G. B. F.), and by the State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development.	Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Bahia MS, 2010, CHEM BIOL DRUG DES, V75, P415, DOI 10.1111/j.1747-0285.2010.00950.x; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Bann JG, 2000, FEBS LETT, V473, P237, DOI 10.1016/S0014-5793(00)01493-9; Baragi VM, 2009, ARTHRITIS RHEUM-US, V60, P2008, DOI 10.1002/art.24629; Becker-Pauly C, 2009, J MOL BIOL, V385, P236, DOI 10.1016/j.jmb.2008.10.062; BRINGMAN TS, 1987, CELL, V48, P429, DOI 10.1016/0092-8674(87)90194-2; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Cole AR, 1999, J BIOL CHEM, V274, P7207, DOI 10.1074/jbc.274.11.7207; Copeland R, 2000, ENZYMES, P289; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Falenski JA, 2010, BIOORGAN MED CHEM, V18, P3703, DOI 10.1016/j.bmc.2010.03.061; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Georgiadis D, 2008, BIOORGAN MED CHEM, V16, P8781, DOI 10.1016/j.bmc.2008.08.058; Gooljarsingh LT, 2008, PROTEIN SCI, V17, P66, DOI 10.1110/ps.073130208; Gurard-Levin ZA, 2008, BIOCHEMISTRY-US, V47, P6242, DOI 10.1021/bi800053v; Hall T, 2009, ARCH BIOCHEM BIOPHYS, V491, P106, DOI 10.1016/j.abb.2009.09.005; Healy EF, 2010, J MOL GRAPH MODEL, V29, P436, DOI 10.1016/j.jmgm.2010.08.006; Hosseini M, 2011, MOL PHARMACOL, V80, P585, DOI 10.1124/mol.111.072280; Houghten RA, 1999, J MED CHEM, V42, P3743, DOI 10.1021/jm990174v; Houghten RA, 2008, J COMB CHEM, V10, P3, DOI 10.1021/cc7001205; Huang A, 2007, BIOORGAN MED CHEM, V15, P6170, DOI 10.1016/j.bmc.2007.06.031; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; Ishii R, 2007, ACTA CRYSTALLOGR F, V63, P637, DOI 10.1107/S1744309107033623; Izaguirre G, 2009, J BIOL CHEM, V284, P1550, DOI 10.1074/jbc.M807340200; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Kataoka H, 2009, J DERMATOL SCI, V56, P148, DOI 10.1016/j.jdermsci.2009.10.002; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Lauer-Fields JL, 2007, J BIOL CHEM, V282, P142, DOI 10.1074/jbc.M605236200; Lauer-Fields JL, 2009, BIOORGAN MED CHEM, V17, P990, DOI 10.1016/j.bmc.2008.03.004; Letavic MA, 2003, BIOORG MED CHEM LETT, V13, P3243, DOI 10.1016/S0960-894X(03)00666-8; Martinez-Irujo JJ, 1998, BIOCHEM J, V329, P689, DOI 10.1042/bj3290689; McManus AM, 1999, BIOCHEMISTRY-US, V38, P705, DOI 10.1021/bi981956d; MELDAL M, 1994, GLYCOCONJUGATE J, V11, P59, DOI 10.1007/BF00731144; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Moss ML, 2008, CURR PHARM BIOTECHNO, V9, P2, DOI 10.2174/138920108783497613; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Moss ML, 2010, COMB CHEM HIGH T SCR, V13, P358; MULLBERG J, 1994, J IMMUNOL, V152, P4958; Murumkar PR, 2010, EXPERT OPIN THER PAT, V20, P31, DOI 10.1517/13543770903465157; Njoroge FG, 2006, BIOORG MED CHEM LETT, V16, P984, DOI 10.1016/j.bmcl.2005.10.090; Otvos L, 2003, MINI-REV MED CHEM, V3, P703, DOI 10.2174/1389557033487809; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Pantke MM, 2001, BIOCHEM J, V356, P43, DOI 10.1042/0264-6021:3560043; Patel IR, 1998, J IMMUNOL, V160, P4570; Pinilla C, 2003, NAT MED, V9, P118, DOI 10.1038/nm0103-118; Prudent R, 2010, BBA-PROTEINS PROTEOM, V1804, P493, DOI 10.1016/j.bbapap.2009.09.003; Roberge M, 2002, BIOCHEM J, V363, P387, DOI 10.1042/0264-6021:3630387; Roberge M, 2001, BIOCHEMISTRY-US, V40, P9522, DOI 10.1021/bi010592d; Roth J, 2011, BIOORG MED CHEM LETT, V21, P7180, DOI 10.1016/j.bmcl.2011.09.077; Rzychon M, 2004, ACTA BIOCHIM POL, V51, P861; Santos RG, 2011, ACS COMB SCI, V13, P337, DOI 10.1021/co100065a; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; Szabova L, 2008, ONCOGENE, V27, P3274, DOI 10.1038/sj.onc.1210982; Tagashira M, 2001, BIOCHEMISTRY-US, V40, P11090, DOI 10.1021/bi010306y; TakakuraYamamoto R, 1996, EUR J BIOCHEM, V235, P431, DOI 10.1111/j.1432-1033.1996.00431.x; Takeda S, 2007, FEBS LETT, V581, P5859, DOI 10.1016/j.febslet.2007.11.062; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Vogel A, 2005, BIOL CHEM, V386, P1253, DOI 10.1515/BC.2005.142; Wang Z, 2011, SHOCK, V35, P141, DOI 10.1097/SHK.0b013e3181ec39cc; Witters L, 2008, CANCER RES, V68, P7083, DOI 10.1158/0008-5472.CAN-08-0739; Wittwer AJ, 2007, BIOCHEMISTRY-US, V46, P6393, DOI 10.1021/bi7000642; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Wormald MR, 2002, CHEM REV, V102, P371, DOI 10.1021/cr990368i; Yegneswaran S, 2007, J THROMB HAEMOST, V5, P2062, DOI 10.1111/j.1538-7836.2007.02712.x; Zhao YH, 2003, J ORG CHEM, V68, P7368, DOI 10.1021/jo034808o	73	44	47	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36473	36487		10.1074/jbc.M112.389114	http://dx.doi.org/10.1074/jbc.M112.389114			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22927435	Green Published, hybrid			2022-12-25	WOS:000310364000067
J	Altemeier, WA; Schlesinger, SY; Buell, CA; Brauer, R; Rapraeger, AC; Parks, WC; Chen, P				Altemeier, William A.; Schlesinger, Saundra Y.; Buell, Catherine A.; Brauer, Rena; Rapraeger, Alan C.; Parks, William C.; Chen, Peter			Transmembrane and Extracellular Domains of Syndecan-1 Have Distinct Functions in Regulating Lung Epithelial Migration and Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; BREAST-CARCINOMA CELLS; INTEGRIN ACTIVATION; CORE PROTEIN; MATRIX; MOUSE; ALPHA(V)BETA(3); ASSOCIATION; SURFACE; REEPITHILIALIZATION	Syndecan-1 is a cell surface proteoglycan that can organize co-receptors into a multimeric complex to transduce intracellular signals. The syndecan-1 core protein has multiple domains that confer distinct cell-and tissue-specific functions. Indeed, the extracellular, transmembrane, and cytoplasmic domains have all been found to regulate specific cellular processes. Our previous work demonstrated that syndecan-1 controls lung epithelial migration and adhesion. Here, we identified the necessary domains of the syndecan-1 core protein that modulate its function in lung epithelial repair. We found that the syndecan-1 transmembrane domain has a regulatory function in controlling focal adhesion disassembly, which in turn controls cell migration speed. In contrast, the extracellular domain facilitates cell adhesion through affinity modulation of alpha(2)beta(1) integrin. These findings highlight the fact that syndecan-1 is a multidimensional cell surface receptor that has several regulatory domains to control various biological processes. In particular, the lung epithelium requires the syndecan-1 transmembrane domain to govern cell migration and is independent from its ability to control cell adhesion via the extracellular domain.	[Altemeier, William A.; Schlesinger, Saundra Y.; Buell, Catherine A.; Brauer, Rena; Parks, William C.; Chen, Peter] Univ Washington, Ctr Lung Biol, Div Pulm & Crit Care Med, Seattle, WA 98109 USA; [Rapraeger, Alan C.] Univ Wisconsin, Dept Human Oncol, Madison, WI 53792 USA	University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison	Chen, P (corresponding author), UW Med S Lake Union, Ctr Lung Biol, 850 Republican St, Seattle, WA 98109 USA.	petechen@uw.edu	Parks, William C./AAH-6786-2021	Altemeier, William/0000-0001-8860-405X; Chen, Peter/0000-0002-5330-1718; Brauer, Rena/0000-0002-5900-4853	National Institutes of Health [HL084396, HL103868, HL086883, HL029594]; American Heart Association; American Lung Association; Cystic Fibrosis Foundation Research Development Program; Mike and Lynn Garvey Cell Imaging Lab at the University of Washington Institute for Stem Cell and Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086883, P01HL029594, R01HL103868, K08HL084396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Lung Association; Cystic Fibrosis Foundation Research Development Program; Mike and Lynn Garvey Cell Imaging Lab at the University of Washington Institute for Stem Cell and Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084396 and HL103868 (to P. C.), HL086883 (to W. A. A.), and HL029594 (to W. C. P.). This work was also supported by an American Heart Association beginning grant-in-aid and the American Lung Association (to P. C.) and by the Cystic Fibrosis Foundation Research Development Program (to W. C. P.).; We thank Dr. Ron Seifert for technical assistance. The imaging studies were supported in part by the Mike and Lynn Garvey Cell Imaging Lab at the University of Washington Institute for Stem Cell and Regenerative Medicine.	Adams JC, 2001, J CELL BIOL, V152, P1169, DOI 10.1083/jcb.152.6.1169; Altemeier W. A., 2012, J CELL SCI IN PRESS; ASUNDI VK, 1995, J BIOL CHEM, V270, P26404, DOI 10.1074/jbc.270.44.26404; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Bode L, 2008, J CLIN INVEST, V118, P229, DOI 10.1172/JCI32335; Burbach BJ, 2004, EXP CELL RES, V300, P234, DOI 10.1016/j.yexcr.2004.07.001; Burbach BJ, 2003, MATRIX BIOL, V22, P163, DOI 10.1016/S0945-053X(03)00009-X; CAREY DJ, 1994, EXP CELL RES, V214, P12, DOI 10.1006/excr.1994.1228; Chakravarti R, 2005, MOL BIOL CELL, V16, P3678, DOI 10.1091/mbc.E04-10-0907; Chen P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006565; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Deramaudt TB, 2011, MOL BIOL CELL, V22, P964, DOI 10.1091/mbc.E10-08-0725; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; KODA JE, 1985, J BIOL CHEM, V260, P8157; Langford JK, 2005, J BIOL CHEM, V280, P3467, DOI 10.1074/jbc.M412451200; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; LIEBERSBACH BF, 1994, J BIOL CHEM, V269, P20013; Liu W, 1998, J BIOL CHEM, V273, P22825, DOI 10.1074/jbc.273.35.22825; McQuade KJ, 2003, J BIOL CHEM, V278, P46607, DOI 10.1074/jbc.M304775200; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Ojeh N, 2008, J INVEST DERMATOL, V128, P26, DOI 10.1038/sj.jid.5700967; Pal-Ghosh S, 2008, EXP EYE RES, V87, P478, DOI 10.1016/j.exer.2008.08.013; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Stepp MA, 2007, J CELL SCI, V120, P2851, DOI 10.1242/jcs.03480; Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yang Y, 2003, J BIOL CHEM, V278, P12888, DOI 10.1074/jbc.M209440200; Zong F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014816	55	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34927	34935		10.1074/jbc.M112.376814	http://dx.doi.org/10.1074/jbc.M112.376814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22936802	Green Published, hybrid			2022-12-25	WOS:000309968000006
J	Aye, Y; Long, MJC; Stubbe, J				Aye, Yimon; Long, Marcus J. C.; Stubbe, JoAnne			Mechanistic Studies of Semicarbazone Triapine Targeting Human Ribonucleotide Reductase in Vitro and in Mammalian Cells TYROSYL RADICAL QUENCHING NOT INVOLVING REACTIVE OXYGEN SPECIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENT IRON CHELATORS; 3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE; DNA-DAMAGE; BIOLOGICAL SAMPLES; ANTITUMOR-ACTIVITY; ESCHERICHIA-COLI; LARGE SUBUNIT; PROTEIN; INHIBITION; HYDROXYUREA	Triapine (R) (3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP)) is a drug in Phase II trials. One of its established cellular targets is the beta(2) subunit of ribonucleotide reductase that requires a diferric-tyrosyl-radical [(Fe-2(III)-Y center dot)(Fe-2(III))] cofactor for de novo DNA biosynthesis. Several mechanisms for 3-AP inhibition of beta(2) have been proposed; one involves direct iron chelation from beta(2), where as a second involves Y center dot destruction by reactive oxygen species formed in situ in the presence of O-2 and reductant by Fe(II)-(3-AP). Inactivation of beta(2) can thus arise from cofactor destruction by loss of iron or Y center dot. In vitro kinetic data on the rates of Fe-55 and Y center dot loss from [(Fe-55(2)III-Y center dot)(Fe-55(2)III)]-beta(2) under aerobic and anaerobic conditions reveal that Y center dot loss alone is sufficient for rapid beta(2) inactivation. Oxyblot (TM) and mass spectrometric analyses of trypsin-digested inhibited beta(2), and lack of Y center dot loss from H2O2 and O-2((center dot) over bar). treatment together preclude reactive oxygen species involvement in Y center dot loss. Three mammalian cell lines treated with 5 mu M 3-AP reveal Y center dot loss and beta(2) inactivation within 30-min of 3-AP-exposure, analyzed by whole-cell EPR and lysate assays, respectively. Selective degradation of apo-over [(Fe-2(III)-Y center dot)(Fe-2(III))]-beta(2) in lysates, similar iron-content in beta(2) immunoprecipitated from 3-AP-treated and untreated [Fe-55]-prelabeled cells, and prolonged (12 h) stability of the inhibited beta(2) are most consistent with Y center dot loss being the predominant mode of inhibition, with beta(2) remaining iron-loaded and stable. A model consistent with in vitro and cell-based biochemical studies is presented in which Fe(II)-(3-AP), which can be cycled with reductant, directly reduces Y center dot of the [(Fe-2(III)-Y center dot)(Fe-2(III))] cofactor of beta(2).	[Aye, Yimon; Stubbe, JoAnne] MIT, Dept Biol, Dept Chem, Cambridge, MA 02139 USA; [Long, Marcus J. C.] Brandeis Univ, Grad Program Biochem & Biophys, Waltham, MA 02454 USA	Massachusetts Institute of Technology (MIT); Brandeis University	Stubbe, J (corresponding author), MIT, Dept Biol, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	stubbe@mit.edu		Long, marcus/0000-0002-0343-9671	National Institutes of Health Grant [GM29595]; Damon Runyon Cancer Research Fellowship [DRG2015-09]; Howard Hughes Medical Institute international student fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029595, R01GM029595] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Fellowship; Howard Hughes Medical Institute international student fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM29595 (to J.S.). This work was also supported by Damon Runyon Cancer Research Fellowship DRG2015-09 (to Y.A.) and a Howard Hughes Medical Institute international student fellowship (to M.J.C.L.).	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; AKERBLOM L, 1981, P NATL ACAD SCI-BIOL, V78, P2159, DOI 10.1073/pnas.78.4.2159; Alvero AB, 2006, J SOC GYNECOL INVEST, V13, P145, DOI 10.1016/j.jsgi.2005.11.004; Aye Y, 2012, CHEM BIOL, V19, P799, DOI 10.1016/j.chembiol.2012.05.015; Aye Y, 2011, P NATL ACAD SCI USA, V108, P9815, DOI 10.1073/pnas.1013274108; Barycki J.J., 2008, REDOX BIOCH, P11; Berg RW, 2002, CURR DRUG TARGETS, V3, P297, DOI 10.2174/1389450023347605; Bou-Abdallah F, 2008, J BIOL INORG CHEM, V13, P15, DOI 10.1007/s00775-007-0304-0; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chaston TB, 2003, CLIN CANCER RES, V9, P402; Christner C, 1999, J MED CHEM, V42, P3615, DOI 10.1021/jm991038t; Cooper CE, 1996, J BIOL CHEM, V271, P20291, DOI 10.1074/jbc.271.34.20291; CORY JG, 1994, BIOCHEM PHARMACOL, V48, P335, DOI 10.1016/0006-2952(94)90105-8; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; DELMAESTRO RF, 1981, MICROVASC RES, V22, P239, DOI 10.1016/0026-2862(81)90095-9; ENGSTROM Y, 1985, J BIOL CHEM, V260, P9114; Enyedy EA, 2011, DALTON T, V40, P5895, DOI 10.1039/c0dt01835j; Enyedy EA, 2010, EUR J INORG CHEM, P1717, DOI 10.1002/ejic.200901174; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; Finch RA, 1999, ADV ENZYME REGUL, V39, P3, DOI 10.1016/S0065-2571(98)00017-X; Finch RA, 2000, BIOCHEM PHARMACOL, V59, P983, DOI 10.1016/S0006-2952(99)00419-0; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; FULLER SD, 1986, J CELL BIOL, V103, P1767, DOI 10.1083/jcb.103.5.1767; Gandhi V., 2006, CANC DRUG DISCOVERY, P153; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Gaudu P, 1996, FEBS LETT, V387, P137, DOI 10.1016/0014-5793(96)00480-2; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hernebring M, 2006, P NATL ACAD SCI USA, V103, P7700, DOI 10.1073/pnas.0510944103; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hsieh YC, 2009, MOL PHARMACOL, V76, P723, DOI 10.1124/mol.109.055772; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; Kolesar JM, 2008, J INORG BIOCHEM, V102, P693, DOI 10.1016/j.jinorgbio.2007.10.013; Kowol CR, 2009, J MED CHEM, V52, P5032, DOI 10.1021/jm900528d; Krakoff I. H., 1975, ANTINEOPLASTIC IMM 2, P789; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; MCCLARTY GA, 1990, J BIOL CHEM, V265, P7539; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Merlot A. M., 2012, ANTIOXID REDOX SIGNA; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Nutting CM, 2009, ANN ONCOL, V20, P1275, DOI 10.1093/annonc/mdn775; NYHOLM S, 1993, BIOCHEMISTRY-US, V32, P11569, DOI 10.1021/bi00094a013; NYHOLM S, 1993, J BIOL CHEM, V268, P26200; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Popovic-Bijelic A, 2011, J INORG BIOCHEM, V105, P1422, DOI 10.1016/j.jinorgbio.2011.07.003; Richardson DR, 2009, J MED CHEM, V52, P1459, DOI 10.1021/jm801585u; ROSE IA, 1967, J BIOL CHEM, V242, P1870; SAHLIN M, 1990, BIOCHEM BIOPH RES CO, V167, P813, DOI 10.1016/0006-291X(90)92098-K; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Shao JM, 2006, MOL CANCER THER, V5, P586, DOI 10.1158/1535-7163.MCT-05-0384; STARGELL LA, 1992, MOL CELL BIOL, V12, P1443, DOI 10.1128/MCB.12.4.1443; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; THELANDER L, 1983, J BIOL CHEM, V258, P4063; Thelander L, 2007, NAT GENET, V39, P703, DOI 10.1038/ng0607-703; Torrents E, 2006, J BIOL CHEM, V281, P25287, DOI 10.1074/jbc.M601794200; Traynor AM, 2010, INVEST NEW DRUG, V28, P91, DOI 10.1007/s10637-009-9230-z; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; Yu Y, 2012, CURR MED CHEM, V19, P2689, DOI 10.2174/092986712800609706; Yu Y, 2006, CLIN CANCER RES, V12, P6876, DOI 10.1158/1078-0432.CCR-06-1954; Zhang Y, 2011, J BIOL CHEM, V286, P41499, DOI 10.1074/jbc.M111.294074; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhu LJ, 2009, BIOCHEM PHARMACOL, V78, P1178, DOI 10.1016/j.bcp.2009.06.103	66	52	53	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35768	35778		10.1074/jbc.M112.396911	http://dx.doi.org/10.1074/jbc.M112.396911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22915594	Green Published, hybrid			2022-12-25	WOS:000309968000087
J	Guan, M; Wang, WB; Liu, XQ; Tong, YM; Liu, Y; Ren, H; Zhu, SY; Dubuisson, J; Baumert, TF; Zhu, YZ; Peng, HR; Aurelian, L; Zhao, P; Qi, ZT				Guan, Mo; Wang, Wenbo; Liu, Xiaoqing; Tong, Yimin; Liu, Yuan; Ren, Hao; Zhu, Shiying; Dubuisson, Jean; Baumert, Thomas F.; Zhu, Yongzhe; Peng, Haoran; Aurelian, Laure; Zhao, Ping; Qi, Zhongtian			Three Different Functional Microdomains in the Hepatitis C Virus Hypervariable Region 1 (HVR1) Mediate Entry and Immune Evasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE GLYCOPROTEIN GP70; B TYPE-I; NEUTRALIZING ANTIBODIES; CELL ENTRY; SEQUENCE EVOLUTION; E2 GLYCOPROTEIN; LOW-DENSITY; INFECTION; RECEPTOR; RESPONSES	High genetic heterogeneity is an important characteristic of hepatitis C virus (HCV) that contributes to its ability to establish persistent infection. The hypervariable region 1 (HVR1) that includes the first 27 amino acid residues of the E2 envelope glycoprotein is the most variable region within the HCV polyprotein. HVR1 plays a major role in both HCV cell entry and immune evasion, but the respective contribution of specific amino acid residues is still unclear. Our mutagenesis analyses of HCV pseudoparticles and cell culture-derived HCV using the H77 isolate indicate that five residues at positions 14, 15, and 25-27 mediate binding of the E2 protein to the scavenger receptor class B, type I receptor, and any residue herein is indispensable for HCV cell entry. The region spanning positions 16-24 contains the sole neutralizing epitope and is dispensable for HCV entry, but it is involved in heparan binding. More importantly, this region is necessary for the enhancement of HCV entry by high density lipoprotein and interferes with virus neutralization by E2-neutralizing antibodies. Residues at positions 1-13 are also dispensable for HCV entry, but they can affect HCV infectivity by modulating binding of the envelope protein to scavenger receptor class B, type I. Mutations occurring at this site may confer resistance to HVR1 antibodies. These findings further our understanding about the mechanisms of HCV cell entry and the significance of HVR1 variation in HCV immune evasion. They have major implications for the development of HCV entry inhibitors and prophylactic vaccines.	[Guan, Mo; Wang, Wenbo; Liu, Xiaoqing; Tong, Yimin; Liu, Yuan; Ren, Hao; Zhu, Shiying; Zhu, Yongzhe; Peng, Haoran; Zhao, Ping; Qi, Zhongtian] Second Mil Med Univ, Dept Microbiol, Shanghai 200433, Peoples R China; [Dubuisson, Jean] Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, CNRS,UMR8204,INSERM,U1019, F-59021 Lille, France; [Baumert, Thomas F.] Univ Strasbourg, Nouvel Hop Civil, Unite Inserm U748, F-67000 Strasbourg, France; [Aurelian, Laure] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	Naval Medical University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University System of Maryland; University of Maryland Baltimore	Zhao, P (corresponding author), Second Mil Med Univ, Dept Microbiol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	pnzhao@163.com; qizt@smmu.edu.cn	Baumert, Thomas/ABF-4718-2020; Dubuisson, Jean/E-6813-2016	Baumert, Thomas/0000-0002-8864-2168; Dubuisson, Jean/0000-0003-1626-7693	973 Programme of China Research Grants [2009CB522501, 2009CB522503]; Important National Science and Technology Special Projects for Prevention and Treatment of Major Infectious Diseases [2012ZX10002003-004-010]; Natural Science Foundation of China [81071364, 31170150]; Science Fund for Creative Research Groups; Shanghai Leading Academic Discipline Project [B901]; French "Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales"; NSFC [30921006]	973 Programme of China Research Grants(National Basic Research Program of China); Important National Science and Technology Special Projects for Prevention and Treatment of Major Infectious Diseases; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Groups(Science Fund for Creative Research Groups); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); French "Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales"(French National Research Agency (ANR)); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by 973 Programme of China Research Grants 2009CB522501 and 2009CB522503, Important National Science and Technology Special Projects for Prevention and Treatment of Major Infectious Diseases Grant 2012ZX10002003-004-010, Natural Science Foundation of China Grants 81071364 and 31170150, Science Fund for Creative Research Groups, NSFC Grant 30921006, and Shanghai Leading Academic Discipline Project B901.; International scholar of the Howard Hughes Medical Institute and supported by the French "Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales."	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Basu A, 2007, J VIROL, V81, P3933, DOI 10.1128/JVI.02622-06; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083; Callens N, 2005, J VIROL, V79, P15331, DOI 10.1128/JVI.79.24.15331-15341.2005; Cao J, 2011, VACCINE, V29, P3714, DOI 10.1016/j.vaccine.2011.02.083; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; De Beeck AO, 2004, J VIROL, V78, P2994, DOI 10.1128/JVI.78.6.2994-3002.2004; Dowd KA, 2009, GASTROENTEROLOGY, V136, P2377, DOI 10.1053/j.gastro.2009.02.080; Dreux M, 2007, J BIOL CHEM, V282, P32357, DOI 10.1074/jbc.M705358200; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Dreux M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000310; Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Flint M, 2000, J VIROL, V74, P702, DOI 10.1128/JVI.74.2.702-709.2000; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Forns X, 2000, P NATL ACAD SCI USA, V97, P13318, DOI 10.1073/pnas.230453597; Goffard A, 2005, J VIROL, V79, P8400, DOI 10.1128/JVI.79.13.8400-8409.2005; Gomez J, 1999, J VIRAL HEPATITIS, V6, P3, DOI 10.1046/j.1365-2893.1999.t01-1-6120131.x; HIJIKATA M, 1991, BIOCHEM BIOPH RES CO, V175, P220, DOI 10.1016/S0006-291X(05)81223-9; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; KATO N, 1993, J VIROL, V67, P3923, DOI 10.1128/JVI.67.7.3923-3930.1993; Kawaguchi K, 2011, J VIROL, V85, P3408, DOI 10.1128/JVI.02554-10; Laskus T, 2004, GASTROENTEROLOGY, V127, P764, DOI 10.1053/j.gastro.2004.06.005; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu L, 2010, J VIROL, V84, P5067, DOI 10.1128/JVI.02265-09; Lucas M, 2003, J GEN VIROL, V84, P545, DOI 10.1099/vir.0.18775-0; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Mondelli MU, 1999, HEPATOLOGY, V30, P537, DOI 10.1002/hep.510300233; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Prentoe J, 2011, J VIROL, V85, P2224, DOI 10.1128/JVI.01594-10; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; SCARSELLI E, 1995, J VIROL, V69, P4407, DOI 10.1128/JVI.69.7.4407-4412.1995; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Tong YM, 2011, J VIROL, V85, P2793, DOI 10.1128/JVI.01818-10; Uebelhoer L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000143; VANDOORN LJ, 1995, J VIROL, V69, P773, DOI 10.1128/JVI.69.2.773-778.1995; Vieyres G, 2011, J GEN VIROL, V92, P494, DOI 10.1099/vir.0.028092-0; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang GP, 2010, J VIROL, V84, P6218, DOI 10.1128/JVI.02271-09; WEINER AJ, 1991, VIROLOGY, V180, P842, DOI 10.1016/0042-6822(91)90104-J; WEINER AJ, 1992, P NATL ACAD SCI USA, V89, P3468, DOI 10.1073/pnas.89.8.3468; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zhang P, 2007, P NATL ACAD SCI USA, V104, P8449, DOI 10.1073/pnas.0703039104; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06; Zibert A, 1997, J VIROL, V71, P4123, DOI 10.1128/JVI.71.5.4123-4127.1997	69	38	42	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35631	35645		10.1074/jbc.M112.382341	http://dx.doi.org/10.1074/jbc.M112.382341			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927442	Green Published, hybrid			2022-12-25	WOS:000309968000075
J	Le Goff, A; Ji, ZL; Leclercq, B; Bourette, RP; Mougel, A; Guerardel, C; de Launoit, Y; Vicogne, J; Goormachtigh, G; Fafeur, V				Le Goff, Arnaud; Ji, Zongling; Leclercq, Berenice; Bourette, Roland P.; Mougel, Alexandra; Guerardel, Cateline; de launoit, Yvan; Vicogne, Jerome; Goormachtigh, Gautier; Fafeur, Veronique			Anti-apoptotic Role of Caspase-cleaved GAB1 Adaptor Protein in Hepatocyte Growth Factor/Scatter Factor-MET Receptor Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE RECEPTOR; EPITHELIAL MORPHOGENESIS; C-MET; DEPENDENT CLEAVAGE; DOCKING PROTEIN; MEDIATED CLEAVAGE; CELL-SURVIVAL; DOMAIN; TRANSDUCTION; RECRUITMENT	The GRB2-associated binder 1 (GAB1) docking/scaffold protein is a key mediator of the MET-tyrosine kinase receptor activated by hepatocyte growth factor/scatter factor (HGF/SF). Activated MET promotes recruitment and tyrosine phosphorylation of GAB1, which in turn recruits multiple proteins and mediates MET signaling leading to cell survival, motility, and morphogenesis. We previously reported that, without its ligand, MET is a functional caspase target during apoptosis, allowing the generation of a p40-MET fragment that amplifies apoptosis. In this study we established that GAB1 is also a functional caspase target by evidencing a caspase-cleaved p35-GAB1 fragment that contains the MET binding domain. GAB1 is cleaved by caspases before MET, and the resulting p35-GAB1 fragment is phosphorylated by MET upon HGF/SF binding and can interact with a subset of GAB1 partners, PI3K, and GRB2 but not with SHP2. This p35-GAB1 fragment favors cell survival by maintaining HGF/SF-induced MET activation of AKT and by hindering p40-MET pro-apoptotic function. These data demonstrate an anti-apoptotic role of caspase-cleaved GAB1 in HGF/SF-MET signaling.	[Le Goff, Arnaud; Ji, Zongling; Leclercq, Berenice; Bourette, Roland P.; Mougel, Alexandra; Guerardel, Cateline; de launoit, Yvan; Vicogne, Jerome; Goormachtigh, Gautier; Fafeur, Veronique] Univ Lille Nord France, Inst Biol Lille, Inst Pasteur Lille, CNRS,UMR 8161,IFR1 42, Lille, France; [Ji, Zongling] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Manchester	Fafeur, V (corresponding author), Univ Lille Nord France, Inst Biol Lille, Inst Pasteur Lille, CNRS,UMR 8161,IFR1 42, Lille, France.	veronique.fafeur@ibl.fr	Bourette, Roland/ABB-3343-2020; Fafeur, Veronique/L-9072-2018	Goormachtigh, Gautier/0000-0003-1736-8269; de Launoit, Yvan/0000-0003-1837-9808; Berenice, Leclercq/0000-0002-0045-4825; Vicogne, Jerome/0000-0001-8360-7497	CNRS; Pasteur Institute of Lille; Universite Lille-Nord de France; INSERM; Fondation de France; FEDER-Region Nord Pas de Calais; Ligue Regionale Contre le Cancer-Comite de l'Aisne; French Ministere de la Recherche; Association pour la Recherche contre le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute of Lille; Universite Lille-Nord de France; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation de France(Fondation de France); FEDER-Region Nord Pas de Calais(Region Hauts-de-France); Ligue Regionale Contre le Cancer-Comite de l'Aisne; French Ministere de la Recherche(Ministry of Research, France); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by CNRS, Pasteur Institute of Lille, Universite Lille-Nord de France and INSERM and by grants from Fondation de France, FEDER-Region Nord Pas de Calais, and the Ligue Regionale Contre le Cancer-Comite de l'Aisne.; Supported by research fellowships from French Ministere de la Recherche and Association pour la Recherche contre le Cancer.	Bachelder RE, 1999, J CELL BIOL, V147, P1063, DOI 10.1083/jcb.147.5.1063; Bachelder RE, 2001, J BIOL CHEM, V276, P34702, DOI 10.1074/jbc.M102806200; Berry DM, 2001, ONCOGENE, V20, P1203, DOI 10.1038/sj.onc.1204218; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000643; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Deheuninck J, 2008, BIOCHEM BIOPH RES CO, V367, P573, DOI 10.1016/j.bbrc.2007.12.177; Deheuninck J, 2009, CELL SIGNAL, V21, P1455, DOI 10.1016/j.cellsig.2009.05.005; Enomoto A, 2003, BIOCHEM BIOPH RES CO, V306, P837, DOI 10.1016/S0006-291X(03)01050-7; Fan SJ, 2001, MOL CELL BIOL, V21, P4968, DOI 10.1128/MCB.21.15.4968-4984.2001; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Foveau B, 2007, CELL DEATH DIFFER, V14, P752, DOI 10.1038/sj.cdd.4402080; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Goormachtigh G, 2011, BIOCHEM BIOPH RES CO, V411, P780, DOI 10.1016/j.bbrc.2011.07.024; Grasset MF, 2010, J LEUKOCYTE BIOL, V87, P127, DOI 10.1189/jlb.0309151; Green KA, 2004, J BIOL CHEM, V279, P25149, DOI 10.1074/jbc.M402395200; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Holgado-Madruga M, 2003, MOL CELL BIOL, V23, P4471, DOI 10.1128/MCB.23.13.4471-4484.2003; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Laszlo B, 2010, FEBS J, V277, P4348, DOI 10.1111/j.1742-4658.2010.07864.x; Lee MW, 2003, ONCOGENE, V22, P6340, DOI 10.1038/sj.onc.1206729; Leroy C, 2006, ANN NY ACAD SCI, V1090, P188, DOI 10.1196/annals.1378.021; Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0; Lock LS, 2003, J BIOL CHEM, V278, P30083, DOI 10.1074/jbc.M302675200; Lock LS, 2002, MOL BIOL CELL, V13, P2132, DOI 10.1091/mbc.02-02-0031; Maroun CR, 1999, J BIOL CHEM, V274, P31719, DOI 10.1074/jbc.274.44.31719; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Mckay MM, 2007, J BIOL CHEM, V282, P26225, DOI 10.1074/jbc.M702692200; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Sarmay G, 2006, IMMUNOL LETT, V104, P76, DOI 10.1016/j.imlet.2005.11.017; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Sun YQ, 2004, MOL CELL BIOL, V24, P1531, DOI 10.1128/MCB.24.4.1531-1539.2004; Tulasne D, 2004, MOL CELL BIOL, V24, P10328, DOI 10.1128/MCB.24.23.10328-10339.2004; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Wee LJK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S14; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Xu J, 2002, J BIOL CHEM, V277, P35561, DOI 10.1074/jbc.M203805200	49	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35382	35396		10.1074/jbc.M112.409797	http://dx.doi.org/10.1074/jbc.M112.409797			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22915589	Green Published, hybrid			2022-12-25	WOS:000309968000046
J	Datta, K; Suman, S; Kallakury, BVS; Fornace, AJ				Datta, Kamal; Suman, Shubhankar; Kallakury, Bhaskar V. S.; Fornace, Albert J., Jr.			Exposure to Heavy Ion Radiation Induces Persistent Oxidative Stress in Mouse Intestine	PLOS ONE			English	Article							NADPH-OXIDASE; DNA-DAMAGE; MITOCHONDRIAL DYSFUNCTION; BIOLOGICAL EFFECTIVENESS; GENOMIC INSTABILITY; ANTIOXIDANT ENZYMES; EPITHELIAL-CELLS; CANCER; EXPRESSION; INJURY	Ionizing radiation-induced oxidative stress is attributed to generation of reactive oxygen species (ROS) due to radiolysis of water molecules and is short lived. Persistent oxidative stress has also been observed after radiation exposure and is implicated in the late effects of radiation. The goal of this study was to determine if long-term oxidative stress in freshly isolated mouse intestinal epithelial cells (IEC) is dependent on radiation quality at a dose relevant to fractionated radiotherapy. Mice (C57BL/6J; 6 to 8 weeks; female) were irradiated with 2 Gy of gamma-rays, a low-linear energy transfer (LET) radiation, and intestinal tissues and IEC were collected 1 year after radiation exposure. Intracellular ROS, mitochondrial function, and antioxidant activity in IEC were studied by flow cytometry and biochemical assays. Oxidative DNA damage, cell death, and mitogenic activity in IEC were assessed by immunohistochemistry. Effects of gamma radiation were compared to Fe-56 radiation (iso-toxic dose: 1.6 Gy; energy: 1000 MeV/nucleon; LET: 148 keV/mm), we used as representative of high-LET radiation, since it's one of the important sources of high Z and high energy (HZE) radiation in cosmic rays. Radiation quality affected the level of persistent oxidative stress with higher elevation of intracellular ROS and mitochondrial superoxide in high-LET Fe-56 radiation compared to unirradiated controls and gamma radiation. NADPH oxidase activity, mitochondrial membrane damage, and loss of mitochondrial membrane potential were greater in Fe-56-irradiated mice. Compared to gamma radiation oxidative DNA damage was higher, cell death ratio was unchanged, and mitotic activity was increased after Fe-56 radiation. Taken together our results indicate that long-term functional dysregulation of mitochondria and increased NADPH oxidase activity are major contributing factors towards heavy ion radiation-induced persistent oxidative stress in IEC with potential for neoplastic transformation.	[Datta, Kamal; Suman, Shubhankar; Fornace, Albert J., Jr.] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cell Biol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Kallakury, Bhaskar V. S.] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Fornace, Albert J., Jr.] King Abdulaziz Univ, Ctr Excellence Genom Med Res CEGMR, Jeddah 21413, Saudi Arabia	Georgetown University; Georgetown University; King Abdulaziz University	Datta, K (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cell Biol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	kd257@georgetown.edu	Fornace, Albert/A-7407-2008; Suman, Shubhankar/H-4610-2011	Fornace, Albert/0000-0001-9695-085X; Suman, Shubhankar/0000-0002-9197-0461	National Aeronautics and Space Administration (NASA) [NNX07AH70G, NNX09AU95G]	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA))	This work is supported in part by National Aeronautics and Space Administration (NASA) Grants NNX07AH70G and NNX09AU95G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Asaithamby A, 2008, RADIAT RES, V169, P437, DOI 10.1667/RR1165.1; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BISSONNETTE R, 1990, J CELL SCI, V95, P247; BRENNER DJ, 1995, RADIAT RES, V142, P61, DOI 10.2307/3578967; Buonanno M, 2011, RADIAT RES, V175, P405, DOI 10.1667/RR2461.1; Clutton SM, 1996, CARCINOGENESIS, V17, P1633, DOI 10.1093/carcin/17.8.1633; Council NR, 1999, HLTH EFF EXP RAD BEI; CUCINOTTA FA, 1994, ADV SPACE RES, V14, P661, DOI 10.1016/0273-1177(94)90523-1; Cucinotta FA, 2001, RADIAT RES, V156, P682, DOI 10.1667/0033-7587(2001)156[0682:SRCRAU]2.0.CO;2; Cui XL, 1997, P NATL ACAD SCI USA, V94, P3771, DOI 10.1073/pnas.94.8.3771; Datta K, 2000, NATL MED J INDIA, V13, P304; Datta K, 2012, INT J RADIAT BIOL, V88, P213, DOI 10.3109/09553002.2012.639434; Datta K, 2011, RADIAT RES, V175, P97, DOI 10.1667/RR2332.1; Dent P, 2003, RADIAT RES, V159, P283, DOI 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO;2; Desai N, 2005, RADIAT RES, V164, P518, DOI 10.1667/RR3431.1; Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X; Dupree-Ellis E, 2000, AM J EPIDEMIOL, V152, P91, DOI 10.1093/aje/152.1.91; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Fornace Albert J Jr, 2002, Mil Med, V167, P13; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Goodhead DT, 1999, J RADIAT RES, V40, P1, DOI 10.1269/jrr.40.S1; GRIBBIN MA, 1993, RADIAT RES, V133, P375, DOI 10.2307/3578225; Hamada N, 2009, J RADIAT RES, V50, P1, DOI 10.1269/jrr.08070; Hayatsu K, 2009, J PHYS SOC JPN, V78, P149, DOI 10.1143/JPSJS.78SA.149; Hickling KC, 2010, TOXICOL PATHOL, V38, P230, DOI 10.1177/0192623309357946; Huigsloot M, 2002, J BIOL CHEM, V277, P35869, DOI 10.1074/jbc.M200378200; Iborra M, 2011, BIOCHEM SOC T, V39, P1102, DOI 10.1042/BST0391102; Jacobson J, 2002, J NEUROCHEM, V82, P224, DOI 10.1046/j.1471-4159.2002.00945.x; Jain Mohit R, 2011, Curr Mol Pharmacol, V4, P106; KATZ R, 1974, PHYS MED BIOL, V19, P413, DOI 10.1088/0031-9155/19/4/001; Keskek M, 2006, J SURG RES, V135, P76, DOI 10.1016/j.jss.2006.03.031; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim GJ, 2006, CANCER RES, V66, P10377, DOI 10.1158/0008-5472.CAN-05-3036; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Leach JK, 2001, CANCER RES, V61, P3894; Lenarczyk M, 2009, RADIAT RES, V171, P164, DOI 10.1667/RR1454.1; Leverkoehne I, 2006, HISTOCHEM CELL BIOL, V126, P239, DOI 10.1007/s00418-006-0164-7; Limoli CL, 2007, RADIAT ENVIRON BIOPH, V46, P167, DOI 10.1007/s00411-006-0077-9; Limoli CL, 1998, CANCER RES, V58, P3712; Macartney KK, 2000, J VIROL, V74, P5597, DOI 10.1128/JVI.74.12.5597-5603.2000; Machella N, 2004, MAR ENVIRON RES, V58, P725, DOI 10.1016/j.marenvres.2004.03.022; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Miro O, 1999, CARCINOGENESIS, V20, P1331, DOI 10.1093/carcin/20.7.1331; Morgan WF, 2003, ONCOGENE, V22, P7094, DOI 10.1038/sj.onc.1206992; Pazhanisamy SK, 2011, MUTAGENESIS, V26, P431, DOI 10.1093/mutage/ger001; Petrosillo G, 2006, FEBS LETT, V580, P6311, DOI 10.1016/j.febslet.2006.10.036; REITZ G, 1993, CLIN INVESTIGATOR, V71, P710; Robbins MEC, 2004, INT J RADIAT BIOL, V80, P251, DOI 10.1080/09553000410001692726; Robbins MEC, 2002, MICRON, V33, P133, DOI 10.1016/S0968-4328(01)00006-3; Roig AI, 2009, RADIAT RES, V171, P33, DOI 10.1667/RR1415.1; Rugo RE, 2004, RADIAT RES, V162, P416, DOI 10.1667/RR3238; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sam F, 2005, J CARD FAIL, V11, P473, DOI 10.1016/j.cardfail.2005.01.007; Schimmerling W, 2010, RADIAT ENVIRON BIOPH, V49, P325, DOI 10.1007/s00411-010-0286-0; Setlow RB, 2003, EMBO REP, V4, P1013, DOI 10.1038/sj.embor.7400016; Setlow RB, 1999, MUTAT RES-FUND MOL M, V430, P169, DOI 10.1016/S0027-5107(99)00127-X; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Skaland I, 2007, MODERN PATHOL, V20, P1307, DOI 10.1038/modpathol.3800972; Stewart LH, 2007, J EMERG MED, V32, P45, DOI 10.1016/j.jemermed.2006.05.031; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Szanto I, 2005, J PATHOL, V207, P164, DOI 10.1002/path.1824; Takahashi A, 2008, J RADIAT RES, V49, P645, DOI 10.1269/jrr.08007; THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trani D, 2010, RADIAT ENVIRON BIOPH, V49, P389, DOI 10.1007/s00411-010-0292-2; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Ward IM, 2005, MOL CELL BIOL, V25, P10079, DOI 10.1128/MCB.25.22.10079-10086.2005; Yano S, 2002, MOL CELL BIOCHEM, V240, P119, DOI 10.1023/A:1020680131754; Yoshida T, 2011, FREE RADICAL RES	72	104	107	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42224	10.1371/journal.pone.0042224	http://dx.doi.org/10.1371/journal.pone.0042224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936983	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500011
J	Garcia, PB; Cai, A; Bates, JG; Nolla, H; Schlissel, MS				Garcia, Patty B.; Cai, Amie; Bates, Jamie G.; Nolla, Hector; Schlissel, Mark S.			miR290-5p/292-5p Activate the Immunoglobulin kappa Locus in B Cell Development	PLOS ONE			English	Article							CHAIN INTRONIC ENHANCER; V(D)J RECOMBINATION; GENE-TRANSCRIPTION; REARRANGEMENT; MICRORNAS; DIFFERENTIATION; LYMPHOCYTES; MECHANISMS; EXPRESSION; ABLATION	Regulated expression of miRNAs influences development in a wide variety of contexts. We report here that miR290-5p (100049710) and miR292-5p (100049711) are induced at the pre-B stage of murine B cell development and that they influence assembly of the Ig kappa light chain gene (243469) by contributing to the activation of germline Ig kappa transcription (kappa GT). We found that upon forced over-expression of miR290-5p/292-5p in Abelson Murine Leukemia Virus (AMuLV) transformed pro-B cells, two known activators of kappa GT, E2A (21423) and NF-kappa B (19697), show increased chromosomal binding to the kappa intronic enhancer. Conversely, knockdown of miR290-5p/292-5p in AMuLV pro-B cells blunts drug-induced activation of kappa GT. Furthermore, miR290-5p/292-5p knockdown also diminishes kappa GT activation, but not Rag1/2 (19373, 19374) expression, in an IL-7 dependent primary pro-B cell culture system. In addition, we identified a deficiency in kappa GT induction in miR290 cluster knockout mice. We hypothesize that increased expression of miR290-5p and miR292-5p contributes to the induction of kappa GT at the pre-B stage of B cell development through increased binding of NF-kappa B and E2A to kappa locus regulatory sequences.	[Garcia, Patty B.; Cai, Amie; Nolla, Hector; Schlissel, Mark S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bates, Jamie G.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	University of California System; University of California Berkeley; Stanford University	Garcia, PB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mark_schlissel@brown.edu			NIH [RO1 HL48702]; NSF; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded in part by NIH RO1 HL48702 (MSS, http://grants.nih.gov/grants/oer.htm) and an NSF Predoctoral Fellowship (PG, http://www.nsfgrfp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cadera EJ, 2009, J EXP MED, V206, P1803, DOI 10.1084/jem.20082815; Chaulk SG, 2011, RNA BIOL, V8, P1105, DOI 10.4161/rna.8.6.17410; CHEN YY, 1994, GENE DEV, V8, P688, DOI 10.1101/gad.8.6.688; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Derudder E, 2009, NAT IMMUNOL, V10, P647, DOI 10.1038/ni.1732; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; Greenbaum S, 2002, P NATL ACAD SCI USA, V99, P15030, DOI 10.1073/pnas.232299999; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Inlay MA, 2004, J EXP MED, V200, P1205, DOI 10.1084/jem.20041135; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; KLUG CA, 1994, GENE DEV, V8, P678, DOI 10.1101/gad.8.6.678; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kuo TC, 2011, MOL CELL BIOL, V31, P2566, DOI 10.1128/MCB.01349-10; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; McDevit DC, 2005, J IMMUNOL, V174, P2834, DOI 10.4049/jimmunol.174.5.2834; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Rizzo M, 2011, PHYSIOL GENOMICS, V43, P1153, DOI 10.1152/physiolgenomics.00064.2011; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; SCHLISSEL MS, 1994, J IMMUNOL, V153, P1645; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shaffer AL, 1997, IMMUNITY, V6, P131, DOI 10.1016/S1074-7613(00)80420-3; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zheng GXY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002054; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	40	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43805	10.1371/journal.pone.0043805	http://dx.doi.org/10.1371/journal.pone.0043805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928038	Green Submitted, Green Published, gold			2022-12-25	WOS:000308224700026
J	Li, XN; He, YQ				Li, Xinna; He, Yongqun			Caspase-2-Dependent Dendritic Cell Death, Maturation, and Priming of T Cells in Response to Brucella abortus Infection	PLOS ONE			English	Article							IFN-GAMMA-PRODUCTION; ANTIGEN PRESENTATION; CYTOKINE PRODUCTION; INTERFERON-GAMMA; ROUGH MUTANTS; IN-VIVO; IMMUNE; APOPTOSIS; SUIS; ACTIVATION	Smooth virulent Brucella abortus strain 2308 (S2308) causes zoonotic brucellosis in cattle and humans. Rough B. abortus strain RB51, derived from S2308, is a live attenuated cattle vaccine strain licensed in the USA and many other countries. Our previous report indicated that RB51, but not S2308, induces a caspase-2-dependent apoptotic and necrotic macrophage cell death. Dendritic cells (DCs) are professional antigen presenting cells critical for bridging innate and adaptive immune responses. In contrast to Brucella-infected macrophages, here we report that S2308 induced higher levels of apoptotic and necrotic cell death in wild type bone marrow-derived DCs (WT BMDCs) than RB51. The RB51 and S2308-induced BMDC cell death was regulated by caspase-2, indicated by the minimal cell death in RB51 and S2308-infected BMDCs isolated from caspase-2 knockout mice (Casp2KO BMDCs). More S2308 bacteria were taken up by Casp2KO BMDCs than wild type BMDCs. Higher levels of S2308 and RB51 cells were found in infected Casp2KO BMDCs compared to infected WT BMDCs at different time points. RB51-infected wild type BMDCs were mature and activated as shown by significantly up-regulated expression of CD40, CD80, CD86, MHC-I, and MHC-II. RB51 induced the production of cytokines TNF-alpha, IL-6, IFN-gamma and IL12/IL23p40 in infected BMDCs. RB51-infected WT BMDCs also stimulated the proliferation of CD4(+) and CD8(+) T cells compared to uninfected WT BMDCs. However, the maturation, activation, and cytokine secretion are significantly impaired in Casp2KO BMDCs infected with RB51 or Salmonella (control). S2308-infected WT and Casp2KO BMDCs were not activated and could not induce cytokine production. These results demonstrated that virulent smooth strain S2308 induced more apoptotic and necrotic dendritic cell death than live attenuated rough vaccine strain RB51; however, RB51, but not its parent strain S2308, induced caspase-2-mediated DC maturation, cytokine production, antigen presentation, and T cell priming.	[Li, Xinna; He, Yongqun] Univ Michigan, Sch Med, Unit Lab Anim Med, Ann Arbor, MI 48109 USA; [Li, Xinna; He, Yongqun] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Li, XN (corresponding author), Univ Michigan, Sch Med, Unit Lab Anim Med, Ann Arbor, MI 48109 USA.	yongqunh@umich.edu		He, Yongqun/0000-0001-9189-9661	Endowment for Basic Science (EBS) bridging fund from the University of Michigan	Endowment for Basic Science (EBS) bridging fund from the University of Michigan	These studies were supported by an Endowment for Basic Science (EBS) bridging fund from the University of Michigan to Y.H. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Banchereau J, 2001, CANCER RES, V61, P6451; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bergner PM, 2006, J IMMUNOL, V176, P2366, DOI 10.4049/jimmunol.176.4.2366; Billard E, 2005, INFECT IMMUN, V73, P8418, DOI 10.1128/IAI.73.12.8418-8424.2005; Billard E, 2008, FEMS IMMUNOL MED MIC, V53, P404, DOI 10.1111/j.1574-695X.2008.00441.x; Billard E, 2007, INFECT IMMUN, V75, P5916, DOI 10.1128/IAI.00931-07; Billard E, 2007, INFECT IMMUN, V75, P4980, DOI 10.1128/IAI.00637-07; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Cao SB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-39; Chase AJ, 2011, J INFECT DIS, V203, P1763, DOI 10.1093/infdis/jir197; Chen F, 2011, INFECT IMMUN, V79, P2460, DOI 10.1128/IAI.00050-11; Chen F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006830; DEBAGUES MPJ, 1994, INFECT IMMUN, V62, P4990; Erfurth SE, 2004, INFECT IMMUN, V72, P7045, DOI 10.1128/IAI.72.12.7045-7054.2004; Fleeton MN, 2004, J EXP MED, V200, P235, DOI 10.1084/jem.20041132; Fong L, 2000, ANNU REV IMMUNOL, V18, P245, DOI 10.1146/annurev.immunol.18.1.245; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760; Haspot F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034795; He YQ, 2001, INFECT IMMUN, V69, P5502, DOI 10.1128/IAI.69.9.5502-5508.2001; Hort GM, 2003, MICROBES INFECT, V5, P95, DOI 10.1016/S1286-4579(02)00076-X; Huang LY, 2001, J IMMUNOL, V167, P1423, DOI 10.4049/jimmunol.167.3.1423; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035; Kalupahana R, 2003, INFECT IMMUN, V71, P6132, DOI 10.1128/IAI.71.11.6132-6140.2003; Ko J, 2002, J IMMUNOL, V168, P2433, DOI 10.4049/jimmunol.168.5.2433; Krumschnabel G, 2009, ONCOGENE, V28, P3093, DOI 10.1038/onc.2009.173; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Langhorne J, 2004, IMMUNOL REV, V201, P35, DOI 10.1111/j.0105-2896.2004.00182.x; Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003; Loof TG, 2008, INFECT IMMUN, V76, P2785, DOI 10.1128/IAI.01680-07; Macedo GC, 2008, J IMMUNOL, V180, P1080, DOI 10.4049/jimmunol.180.2.1080; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Nogueira CV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000478; Paranavitana C, 2005, CYTOKINE, V30, P86, DOI 10.1016/j.cyto.2004.12.009; Pasquevich KA, 2010, J IMMUNOL, V184, P5200, DOI 10.4049/jimmunol.0902209; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Ritter U, 2003, J LEUKOCYTE BIOL, V74, P216, DOI 10.1189/jlb.1202587; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; SantiagoSchwarz F, 1996, STEM CELLS, V14, P225, DOI 10.1002/stem.140225; SCHURIG GG, 1991, VET MICROBIOL, V28, P171, DOI 10.1016/0378-1135(91)90091-S; Schuurhuis DH, 2006, INT ARCH ALLERGY IMM, V140, P53, DOI 10.1159/000092002; Surendran N, 2010, FEMS IMMUNOL MED MIC, V60, P147, DOI 10.1111/j.1574-695X.2010.00729.x; Tam MA, 2008, IMMUNOL REV, V225, P140, DOI 10.1111/j.1600-065X.2008.00679.x; Troy CM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.138pe42; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Zhang XN, 2005, INT J CANCER, V113, P397, DOI 10.1002/ijc.20553; Zhu JG, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00010; Zwerdling A, 2008, MICROBES INFECT, V10, P1346, DOI 10.1016/j.micinf.2008.07.035	55	22	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43512	10.1371/journal.pone.0043512	http://dx.doi.org/10.1371/journal.pone.0043512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927979	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300059
J	Yu, HR; Watt, H; Kesavan, C; Johnson, PJ; Wergedal, JE; Mohan, S				Yu, Hongrun; Watt, Heather; Kesavan, Chandrasekhar; Johnson, Patrick J.; Wergedal, Jon E.; Mohan, Subburaman			Lasting Consequences of Traumatic Events on Behavioral and Skeletal Parameters in a Mouse Model for Post-Traumatic Stress Disorder (PTSD)	PLOS ONE			English	Article							BONE-MINERAL DENSITY; PARTIAL INVERSE AGONIST; FELINE PREDATOR STRESS; GULF-WAR VETERANS; MICE; RECEPTOR; HORMONE; ANXIETY; FG-7142; GROWTH	Background: Post-traumatic stress disorder (PTSD) is an anxiety disorder that not only affects mental health, but may also affect bone health. However, there have been no studies to examine the direct relationship between PTSD and bone. Methodology/Principal Findings: We employed electric shocks in mice to simulate traumatic events that cause PTSD. We also injected the anxiogenic drug FG-7142 prior to electric shocks. Electric shocks created lasting conditioned fear memory in all mice. In young mice, electric shocks elicited not only behavioral response but also skeletal response, and injection of FG-7142 appeared to increase both types of response. For example in behavioral response within the first week, mice shocked alone froze an average of 6.2 sec in 10 sec tests, and mice injected with FG-7142 froze 7.6 sec, both significantly different (P<0.05) from control mice, which only froze 1.3 sec. In skeletal response at week 2, shocks alone reduced 6% bone mineral content (BMC) in total body (P = 0.06), while shocks with FG-7142 injection reduced not only 11% BMC (P<0.05) but also 6% bone mineral density (BMD) (P<0.05). In addition, FG-7142 injection also caused significant reductions of BMC in specific bones such as femur, lumbar vertebra, and tibia at week 3. Strong negative correlations (R-2 = -0.56, P<0.05) and regression (y = 0.2527-0.0037 * x, P<0.01) between freezing behavior and total body BMC in young mice indicated that increased contextual PTSD-like behavior was associated with reduced bone mass acquisition. Conclusions/Significance: This is the first study to document evidence that traumatic events induce lasting consequences on both behavior and skeletal growth, and electric shocks coupled with injection of anxiogenic FG-7142 in young mice can be used as a model to study the effect of PTSD-like symptoms on bone development.	[Yu, Hongrun; Watt, Heather; Kesavan, Chandrasekhar; Johnson, Patrick J.; Wergedal, Jon E.; Mohan, Subburaman] Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA; [Yu, Hongrun; Kesavan, Chandrasekhar; Wergedal, Jon E.; Mohan, Subburaman] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA	Loma Linda University	Yu, HR (corresponding author), Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA.	subburaman.mohan@va.gov			Merit Review Program of the Department of Veterans Affairs	Merit Review Program of the Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Merit Review Program of the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec R, 2004, PHYSIOL BEHAV, V83, P401, DOI 10.1016/j.physbeh.2004.08.029; Adamec R, 2006, PHYSIOL BEHAV, V88, P12, DOI 10.1016/j.physbeh.2006.03.005; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Canalis Ernesto, 2005, Curr Osteoporos Rep, V3, P98, DOI 10.1007/s11914-005-0017-7; Chaki S, 2003, EUR J PHARMACOL, V464, P49, DOI 10.1016/S0014-2999(03)01368-2; Chida Y, 2004, HEPATOLOGY, V39, P1131, DOI 10.1002/hep.20158; Cizza G, 2001, TRENDS ENDOCRIN MET, V12, P198, DOI 10.1016/S1043-2760(01)00407-6; Compston JE, 2002, J CLIN PATHOL, V55, P897, DOI 10.1136/jcp.55.12.897; Dorn LD, 2008, ARCH PEDIAT ADOL MED, V162, P1181, DOI 10.1001/archpedi.162.12.1181; DOROW R, 1983, LANCET, V2, P98; Evans AK, 2007, CNS DRUG REV, V13, P475, DOI 10.1111/j.1527-3458.2007.00025.x; Freemont AJ, 2002, J CLIN PATHOL, V55, P884, DOI 10.1136/jcp.55.12.884; Golier JA, 2007, BIOL PSYCHIAT, V62, P1175, DOI 10.1016/j.biopsych.2007.04.027; Golub Y, 2009, BEHAV BRAIN RES, V205, P544, DOI 10.1016/j.bbr.2009.08.019; Hage WE, 2004, PROG NEURO-PSYCHOPH, V28, P123, DOI 10.1016/j.pnpbp.2003.09.028; Hain RE, 2011, MIL MED, V176, P270, DOI 10.7205/MILMED-D-10-00365; Hammack SE, 2004, BEHAV NEUROSCI, V118, P443, DOI 10.1037/0735-7044.118.2.443; Hebert MA, 2005, J NEUROCHEM, V95, P484, DOI 10.1111/j.1471-4159.2005.03386.x; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; King JA, 2001, BIOL PSYCHIAT, V50, P231, DOI 10.1016/S0006-3223(01)01071-X; Kuljic Blagoje, 2004, Vojnosanit Pregl, V61, P283, DOI 10.2298/VSP0403283K; Kung JC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-29; Laugero KD, 2000, AM J PHYSIOL-ENDOC M, V279, pE44, DOI 10.1152/ajpendo.2000.279.1.E44; LITTLE HJ, 1984, BRIT J PHARMACOL, V83, P951, DOI 10.1111/j.1476-5381.1984.tb16536.x; Louvart N, 2005, PSYCHONEUROENDOCRINO, V30, P316, DOI 10.1016/j.psyneuen.2004.09.003; Ma Y, 2011, ENDOCRINOLOGY, V152, P1412, DOI 10.1210/en.2010-0881; Masinde GL, 2002, CALCIFIED TISSUE INT, V71, P421, DOI 10.1007/s00223-001-1113-z; Mazziotti G, 2006, TRENDS ENDOCRIN MET, V17, P144, DOI 10.1016/j.tem.2006.03.009; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Mirza NR, 2006, J PHARMACOL EXP THER, V316, P1378, DOI 10.1124/jpet.105.094474; Mohan S, 2003, ENDOCRINOLOGY, V144, P929, DOI 10.1210/en.2002-220948; Mohan S, 2005, J ENDOCRINOL, V185, P415, DOI 10.1677/joe.1.06141; Morris P, 2004, PSYCHONEUROENDOCRINO, V29, P269, DOI 10.1016/S0306-4530(03)00027-1; Olson VG, 2011, BIOL PSYCHIAT; Papadopoulos A, 2011, EUR NEUROPSYCHOPHARM, V21, P316, DOI 10.1016/j.euroneuro.2010.05.005; Patel MS, 2007, CALCIFIED TISSUE INT, V80, P337, DOI 10.1007/s00223-007-9015-3; Patterson-Buckendahl P, 2007, STRESS, V10, P163, DOI 10.1080/10253890701317601; Philbert J, 2011, BEHAV BRAIN RES, V221, P149, DOI 10.1016/j.bbr.2011.02.039; Pibiri F, 2008, P NATL ACAD SCI USA, V105, P5567, DOI 10.1073/pnas.0801853105; Rasmussen DD, 2008, PSYCHONEUROENDOCRINO, V33, P282, DOI 10.1016/j.psyneuen.2007.11.010; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; RESNICK HS, 1993, J CONSULT CLIN PSYCH, V61, P984, DOI 10.1037/0022-006X.61.6.984; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Rigo JM, 2002, BRIT J PHARMACOL, V136, P659, DOI 10.1038/sj.bjp.0704766; Sartori SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016849; Sawamura T, 2004, NEUROSCI LETT, V357, P37, DOI 10.1016/j.neulet.2003.12.039; Schwab CL, 2005, TOXICOL SCI, V83, P101, DOI 10.1093/toxsci/kfi014; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Srivastava AK, 2003, BONE, V33, P179, DOI 10.1016/S8756-3282(03)00156-X; Stevenson CW, 2007, SYNAPSE, V61, P646, DOI 10.1002/syn.20414; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Wang W, 2008, NEUROSCI LETT, V441, P237, DOI 10.1016/j.neulet.2008.06.031; Williams LJ, 2011, J AFFECT DISORDERS, V131, P164, DOI 10.1016/j.jad.2010.11.019; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yirmiya R, 2006, P NATL ACAD SCI USA, V103, P16876, DOI 10.1073/pnas.0604234103; Young EA, 2004, ARCH GEN PSYCHIAT, V61, P394, DOI 10.1001/archpsyc.61.4.394; Zhang L, 2006, MED HYPOTHESES, V66, P309, DOI 10.1016/j.mehy.2005.06.034; Zhang XM, 2005, TOHOKU J EXP MED, V206, P203, DOI 10.1620/tjem.206.203	60	13	13	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42684	10.1371/journal.pone.0042684	http://dx.doi.org/10.1371/journal.pone.0042684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927935	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300022
J	Correnti, C; Richardson, V; Sia, AK; Bandaranayake, AD; Ruiz, M; Rahmanto, YS; Kovacevic, Z; Clifton, MC; Holmes, MA; Kaiser, BK; Barasch, J; Raymond, KN; Richardson, DR; Strong, RK				Correnti, Colin; Richardson, Vera; Sia, Allyson K.; Bandaranayake, Ashok D.; Ruiz, Mario; Rahmanto, Yohan Suryo; Kovacevic, Zaklina; Clifton, Matthew C.; Holmes, Margaret A.; Kaiser, Brett K.; Barasch, Jonathan; Raymond, Kenneth N.; Richardson, Des R.; Strong, Roland K.			Siderocalin/Lcn2/NGAL/24p3 Does Not Drive Apoptosis Through Gentisic Acid Mediated Iron Withdrawal in Hematopoietic Cell Lines	PLOS ONE			English	Article							EFFECTIVE ANTIPROLIFERATIVE AGENTS; ISONICOTINOYL HYDRAZONE CLASS; METASTASIS SUPPRESSOR; MOLECULAR TARGETS; GENE-EXPRESSION; IMMUNE-SYSTEM; ENTEROBACTIN; TRANSFERRIN; METABOLISM; IDENTIFICATION	Siderocalin (also lipocalin 2, NGAL or 24p3) binds iron as complexes with specific siderophores, which are low molecular weight, ferric ion-specific chelators. In innate immunity, siderocalin slows the growth of infecting bacteria by sequestering bacterial ferric siderophores. Siderocalin also binds simple catechols, which can serve as siderophores in the damaged urinary tract. Siderocalin has also been proposed to alter cellular iron trafficking, for instance, driving apoptosis through iron efflux via BOCT. An endogenous siderophore composed of gentisic acid (2,5-dihydroxybenzoic acid) substituents was proposed to mediate cellular efflux. However, binding studies reported herein contradict the proposal that gentisic acid forms high-affinity ternary complexes with siderocalin and iron, or that gentisic acid can serve as an endogenous siderophore at neutral pH. We also demonstrate that siderocalin does not induce cellular iron efflux or stimulate apoptosis, questioning the role siderocalin plays in modulating iron metabolism.	[Correnti, Colin; Holmes, Margaret A.; Kaiser, Brett K.; Strong, Roland K.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Richardson, Vera; Rahmanto, Yohan Suryo; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Iron Metab & Chelat Program, Discipline Pathol, Sydney, NSW 2006, Australia; [Richardson, Vera; Rahmanto, Yohan Suryo; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Sia, Allyson K.; Raymond, Kenneth N.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bandaranayake, Ashok D.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Ruiz, Mario] Univ Valladolid, Inst Biol & Genet Mol, UVa CSIC, Valladolid, Spain; [Clifton, Matthew C.] Emerald Biostruct, Bainbridge Isl, WA USA; [Barasch, Jonathan] Columbia Univ, Coll Phys & Surg, New York, NY USA	Fred Hutchinson Cancer Center; University of Sydney; University of Sydney; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Columbia University	Correnti, C (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	d.richardson@sydney.edu.au; rstrong@fhcrc.org	Ruiz, Mario/B-3507-2013; Suryo Rahmanto, Yohan/K-8043-2018; Kovacevic, Zaklina/ABD-9581-2021	Ruiz, Mario/0000-0002-7149-6600; Suryo Rahmanto, Yohan/0000-0003-1453-7872; Kovacevic, Zaklina/0000-0002-4742-4690; Richardson, Des/0000-0002-5506-3274; Richardson, Des/0000-0003-0960-6415	National Institutes of Health [AI117448, AI59432, DK55388, DK58872]; National Institute of Allergy and Infectious Disease Federal Contract [HHSN272200700057C]; Emerald Foundation; March of Dimes; National Health and Medical Research Council of Australia [571123, 512408]; Cancer Institute New South Wales Early Career Development Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059432, R01AI011744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK055388, R01DK058872, R01DK073462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease Federal Contract; Emerald Foundation; March of Dimes(March of Dimes); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Early Career Development Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health grants AI117448 (Dr. Raymond), AI59432 (Dr. Strong), DK55388 and DK58872 (Dr. Barasch), and National Institute of Allergy and Infectious Disease Federal Contract No. HHSN272200700057C (SSGCID); the Emerald Foundation and the March of Dimes (Dr. Barasch); National Health and Medical Research Council of Australia Senior Principal Research Fellowship 571123 and Project grant 512408 (Dr. Richardson); and a Cancer Institute New South Wales Early Career Development Fellowship (Dr. Rahmanto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; Baes C.F., 1976, HYDROLYSIS CATIONS, DOI 10.1002/bbpc.19770810252; Bandaranayake AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr706; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Bennett KM, 2011, MOL CELL BIOCHEM, V352, P143, DOI 10.1007/s11010-011-0748-y; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; BUNDGAARD JR, 1994, BIOCHEM BIOPH RES CO, V202, P1468, DOI 10.1006/bbrc.1994.2096; CASS ME, 1989, J AM CHEM SOC, V111, P1677, DOI 10.1021/ja00187a021; Cohen SM, 1998, J AM CHEM SOC, V120, P6277, DOI 10.1021/ja973442s; Darnell G, 1999, BLOOD, V94, P781, DOI 10.1182/blood.V94.2.781.414k32_781_792; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Fischbach MA, 2006, P NATL ACAD SCI US; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FORD S, 1988, EUR J BIOCHEM, V178, P477, DOI 10.1111/j.1432-1033.1988.tb14473.x; Gans P, 1996, TALANTA, V43, P1739, DOI 10.1016/0039-9140(96)01958-3; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Goetz DH, 2000, BIOCHEMISTRY-US, V39, P1935, DOI 10.1021/bi992215v; Guo K, 2006, J BIOL CHEM, V281, P10291, DOI 10.1074/jbc.M511346200; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hoette TM, 2008, J AM CHEM SOC, V130, P17584, DOI 10.1021/ja8074665; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; KAPLAN J, 1991, J BIOL CHEM, V266, P2997; Kehrer JP, 2010, CELL BIOL TOXICOL, V26, P83, DOI 10.1007/s10565-009-9119-9; KHANOLKAR VD, 1973, INDIAN J CHEM, V11, P286; Kovacevic Z, 2011, CARCINOGENESIS, V32, P732, DOI 10.1093/carcin/bgr046; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; MOORE CH, 1995, J BACTERIOL, V177, P1116, DOI 10.1128/jb.177.4.1116-1118.1995; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Olivieri NF, 1997, BLOOD, V89, P739, DOI 10.1182/blood.V89.3.739; Rahmanto YS, 2007, CARCINOGENESIS, V28, P2172, DOI 10.1093/carcin/bgm096; RAYMOND KN, 1984, TOP CURR CHEM, V123, P49; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; SAKAITANI M, 1990, BIOCHEMISTRY-US, V29, P6789, DOI 10.1021/bi00481a006; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; STURROCK A, 1990, J BIOL CHEM, V265, P3139; Welcher FJ., 1958, ANAL USES ETHYLENEDI; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4	51	35	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43696	10.1371/journal.pone.0043696	http://dx.doi.org/10.1371/journal.pone.0043696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928018	Green Published, Green Submitted, gold			2022-12-25	WOS:000307789700046
J	van Dijk, AE; van Eijsden, M; Stronks, K; Gemke, RJBJ; Vrijkotte, TGM				van Dijk, Aimeee E.; van Eijsden, Manon; Stronks, Karien; Gemke, Reinoud J. B. J.; Vrijkotte, Tanja G. M.			The Association between Prenatal Psychosocial Stress and Blood Pressure in the Child at Age 5-7 Years	PLOS ONE			English	Article							CYTOKINE PRODUCTION; MATERNAL CORTISOL; BIRTH-WEIGHT; HPA AXIS; FETAL; DEXAMETHASONE; RISK; HYPERTENSION; PREGNANCY; EXPOSURE	Objective: Prenatal maternal stress could have permanent effects on the offspring's tissue structure and function, which may predispose to cardiovascular diseases. We investigated whether maternal psychosocial stress is a prenatal factor affecting the blood pressure (BP) of offspring. Study Design: In the Amsterdam Born Children and their Development (ABCD) study, around gestational week 16, depressive symptoms, state-anxiety, pregnancy-related anxiety, parenting daily hassles and job strain were recorded by questionnaire. A cumulative stress score was also calculated (based on 80th percentiles). Systolic and diastolic BP and mean arterial pressure (MAP) were measured in the offspring at age 5-7 years. Inclusion criteria were: no use of antihypertensive medication during pregnancy; singleton birth; no reported cardiovascular problems in the child (N = 2968 included). Results: After adjustment for confounders, the single stress scales were not associated with systolic and diastolic BP, MAP and hypertension (p>0.05). The presence of 3-4 psychosocial stressors prenatally (4%) was associated with 1.5 mmHg higher systolic and diastolic BP (p = 0.046; p = 0.04) and 1.5 mmHg higher MAP in the offspring (p = 0.02) compared to no stressors (46%). The presence of 3-4 stressors did not significantly increase the risk for hypertension (OR 1.8; 95% CI 0.93.4). Associations did not differ between sexes. Bonferroni correction for multiple testing rendered all associations non-significant. Conclusion: The presence of multiple psychosocial stressors during pregnancy was associated with higher systolic and diastolic BP and MAP in the child at age 5-7. Further investigation of maternal prenatal stress may be valuable for later life cardiovascular health.	[van Dijk, Aimeee E.; Stronks, Karien; Vrijkotte, Tanja G. M.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [van Dijk, Aimeee E.; van Eijsden, Manon] Publ Hlth Serv Amsterdam GGD, Dept Epidemiol Documentat & Hlth Promot, Amsterdam, Netherlands; [van Eijsden, Manon] Vrije Univ Amsterdam, Inst Hlth Sci, Amsterdam, Netherlands; [Gemke, Reinoud J. B. J.] Vrije Univ Amsterdam Med Ctr, Dept Pediat, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Dijk, AE (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.e.vandijk@amc.uva.nl		Vrijkotte, Tanja/0000-0003-3641-4048; Stronks, Karien/0000-0002-0921-2232	Netherlands Heart Foundation	Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was supported by the Netherlands Heart Foundation (Nederlandse Hartstichting). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HR, 2010, PEDIATRICS, V126, pE1425, DOI 10.1542/peds.2010-1899; [Anonymous], 1987, CES D NEDERLANDSE VE; BAO WH, 1995, AM J HYPERTENS, V8, P657, DOI 10.1016/0895-7061(95)00116-7; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bekedam DJ, 2002, AM J OBSTET GYNECOL, V187, P1605, DOI 10.1067/mob.2002.127379; Berry LM, 1997, AM J PHYSIOL-REG I, V272, pR1972, DOI 10.1152/ajpregu.1997.272.6.R1972; Breslin MB, 1998, J STEROID BIOCHEM, V67, P369, DOI 10.1016/S0960-0760(98)00138-1; Bruckner TA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-273; Rondo PHC, 2010, EARLY HUM DEV, V86, P127, DOI 10.1016/j.earlhumdev.2010.02.002; Christian LM, 2009, BRAIN BEHAV IMMUN, V23, P750, DOI 10.1016/j.bbi.2009.02.012; Clifton VL, 2004, PLACENTA, V25, pS45, DOI 10.1016/j.placenta.2004.01.004; Cohen G, 2008, CIRCULATION, V118, P1848, DOI 10.1161/CIRCULATIONAHA.108.783902; Coussons-Read ME, 2007, BRAIN BEHAV IMMUN, V21, P343, DOI 10.1016/j.bbi.2006.08.006; Coussons-Read ME, 2005, PSYCHOSOM MED, V67, P625, DOI 10.1097/01.psy.0000170331.74960.ad; CRNIC KA, 1990, CHILD DEV, V61, P1628, DOI 10.2307/1130770; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; de Vries A, 2007, J CLIN INVEST, V117, P1058, DOI 10.1172/JCI30982; Defares P, 1980, PSYCHOLOOG, V15, P460; Diego MA, 2006, PSYCHOSOM MED, V68, P747, DOI 10.1097/01.psy.0000238212.21598.7b; Docherty CC, 2001, AM J PHYSIOL-REG I, V281, pR261, DOI 10.1152/ajpregu.2001.281.1.R261; Dodic M, 2001, CLIN EXP PHARMACOL P, V28, P952, DOI 10.1046/j.1440-1681.2001.03556.x; Dodic M, 2002, HYPERTENSION, V40, P729, DOI 10.1161/01.HYP.0000036455.62159.7E; Doyle LW, 2000, CLIN SCI, V98, P137, DOI 10.1042/CS19990211; Drake AJ, 2007, CLIN SCI, V113, P219, DOI 10.1042/CS20070107; Entringer S, 2008, DEV PSYCHOBIOL, V50, P579, DOI 10.1002/dev.20316; Entringer S, 2011, PSYCHOSOM MED, V73, P469, DOI 10.1097/PSY.0b013e31821fbf9a; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Entringer S, 2009, HORM BEHAV, V55, P292, DOI 10.1016/j.yhbeh.2008.11.006; GILLMAN MW, 1993, J PEDIATR-US, V122, P837, DOI 10.1016/S0022-3476(09)90005-1; Glover V, 2010, NEUROSCI BIOBEHAV R, V35, P17, DOI 10.1016/j.neubiorev.2009.11.008; Glover V, 2009, PSYCHONEUROENDOCRINO, V34, P430, DOI 10.1016/j.psyneuen.2008.10.005; Gluckman PD, 2005, FETAL MATRIX EVOLUTI, P78; Glynn LM, 2001, AM J OBSTET GYNECOL, V184, P637, DOI 10.1067/mob.2001.111066; Goedhart G, 2010, PSYCHOSOM MED, V72, P769, DOI 10.1097/PSY.0b013e3181ee4a62; Groenendaal JH, 1996, DAGELIJKSE BESLOMMER; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Himes KP, 2011, AM J PERINAT, V28, P443, DOI 10.1055/s-0030-1270119; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Holst S, 2002, AUTON NEUROSCI-BASIC, V99, P85, DOI 10.1016/S1566-0702(02)00134-0; Houtman ILD, 1998, OCCUP ENVIRON MED, V55, P73, DOI 10.1136/oem.55.2.73; Huizink AC, 2004, EARLY HUM DEV, V79, P81, DOI 10.1016/j.earlhumdev.2004.04.014; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; KARI MA, 1994, PEDIATRICS, V93, P730; Levitt NS, 1996, NEUROENDOCRINOLOGY, V64, P412, DOI 10.1159/000127146; LOBEL M, 1994, J BEHAV MED, V17, P225, DOI 10.1007/BF01857952; Lu NZ, 2004, ANN NY ACAD SCI, V1024, P102, DOI 10.1196/annals.1321.008; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; MCCORMICK CM, 1995, DEV BRAIN RES, V84, P55, DOI 10.1016/0165-3806(94)00153-Q; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Menghetti E, 1999, J HYPERTENS, V17, P1363, DOI 10.1097/00004872-199917100-00002; Miller DB, 2002, METABOLISM, V51, P5, DOI 10.1053/meta.2002.33184; Molnar J, 2003, J PHYSIOL-LONDON, V547, P61, DOI 10.1113/jphysiol.2002.032565; Molnar J, 2002, AM J PHYSIOL-REG I, V283, pR561, DOI 10.1152/ajpregu.00031.2002; Moritz KM, 2010, PLACENTA, V31, pS40, DOI 10.1016/j.placenta.2010.01.006; Moritz KM, 2002, ENDOCRINOLOGY, V143, P4455, DOI 10.1210/en.2002-220534; Moss TJM, 2001, AM J PHYSIOL-REG I, V281, pR960, DOI 10.1152/ajpregu.2001.281.3.R960; Munkhaugen J, 2008, J HYPERTENS, V26, P1912, DOI 10.1097/HJH.0b013e328308da43; Noorlander CW, 2006, J COMP NEUROL, V499, P924, DOI 10.1002/cne.21162; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; OConnor T., 2011, PSYCHONEUROENDOCRINO; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Ortiz LA, 2001, KIDNEY INT, V59, P1663, DOI 10.1046/j.1523-1755.2001.0590051663.x; Owen D, 2003, ENDOCRINOLOGY, V144, P2775, DOI 10.1210/en.2002-0145; Park MK, 2001, ARCH PEDIAT ADOL MED, V155, P50, DOI 10.1001/archpedi.155.1.50; Paul K, 2008, J NATL MED ASSOC, V100, P540, DOI 10.1016/S0027-9684(15)31300-6; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reynolds RM, 2001, J CLIN ENDOCR METAB, V86, P245, DOI 10.1210/jc.86.1.245; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Rogers LK, 2011, LIFE SCI, V89, P417, DOI 10.1016/j.lfs.2011.07.017; Rondo PHC, 2011, J DEV ORIG HLTH DIS, V2, P56, DOI 10.1017/S2040174410000620; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Spielberger C., 1983, STAI MANUAL; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Tse AC, 2011, PSYCHONEUROENDOCRINO; Van Den Bergh BRH., 1990, PREPERINAT PSYCHOL J, V5, P119; van Dijk AE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-251; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; Wadhwa PD., 2006, PERINATAL PROGRAMMIN, P29; Wintour EM, 2003, J PHYSIOL-LONDON, V549, P929, DOI 10.1113/jphysiol.2003.042408; Woods SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.041	83	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43548	10.1371/journal.pone.0043548	http://dx.doi.org/10.1371/journal.pone.0043548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992PA	22927987	gold, Green Submitted, Green Published			2022-12-25	WOS:000307789700038
J	Vogler, C; Benzie, J; Barber, PH; Erdmann, MV; Ambariyanto; Sheppard, C; Tenggardjaja, K; Gerard, K; Worheide, G				Vogler, Catherine; Benzie, John; Barber, Paul H.; Erdmann, Mark V.; Ambariyanto; Sheppard, Charles; Tenggardjaja, Kimberly; Gerard, Karin; Woerheide, Gert			Phylogeography of the Crown-of-Thorns Starfish in the Indian Ocean	PLOS ONE			English	Article							ACANTHASTER-PLANCI L.; CORAL-REEFS; POPULATION-GENETICS; SPECIES BOUNDARIES; SEQUENCE ALIGNMENT; CIRCULATION; OUTBREAKS; MODEL; BIOGEOGRAPHY; SPECIATION	Background: Understanding the limits and population dynamics of closely related sibling species in the marine realm is particularly relevant in organisms that require management. The crown-of-thorns starfish Acanthaster planci, recently shown to be a species complex of at least four closely related species, is a coral predator infamous for its outbreaks that have devastated reefs throughout much of its Indo-Pacific distribution. Methodology/Principal Findings: In this first Indian Ocean-wide genetic study of a marine organism we investigated the genetic structure and inferred the paleohistory of the two Indian Ocean sister-species of Acanthaster planci using mitochondrial DNA sequence analyses. We suggest that the first of two main diversification events led to the formation of a Southern and Northern Indian Ocean sister-species in the late Pliocene-early Pleistocene. The second led to the formation of two internal clades within each species around the onset of the last interglacial. The subsequent demographic history of the two lineages strongly differed, the Southern Indian Ocean sister-species showing a signature of recent population expansion and hardly any regional structure, whereas the Northern Indian Ocean sister-species apparently maintained a constant size with highly differentiated regional groupings that were asymmetrically connected by gene flow. Conclusions/Significance: Past and present surface circulation patterns in conjunction with ocean primary productivity were identified as the processes most likely to have shaped the genetic structure between and within the two Indian Ocean lineages. This knowledge will help to understand the biological or ecological differences of the two sibling species and therefore aid in developing strategies to manage population outbreaks of this coral predator in the Indian Ocean.	[Vogler, Catherine; Woerheide, Gert] Univ Munich, Dept Geo & Umweltwissensch, Munich, Germany; [Vogler, Catherine; Woerheide, Gert] Univ Munich, GeoBioctr LMU, Munich, Germany; [Benzie, John] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland; [Barber, Paul H.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Erdmann, Mark V.] Indonesia Marine Program, Conservat Int, Bali, Indonesia; [Ambariyanto] Diponegoro Univ, Fac Fisheries & Marine Sci, Semarang, Indonesia; [Sheppard, Charles] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Tenggardjaja, Kimberly] Univ Calif Santa Cruz, Ecol & Evolutionary Biol Dept, Santa Cruz, CA 95064 USA; [Gerard, Karin] Univ Mediterranee, Marine Endoume Stn, Marseille, France; [Woerheide, Gert] Bavarian State Collect Palaeontol & Geol, Munich, Germany	University of Munich; University of Munich; University College Cork; University of California System; University of California Los Angeles; Conservation International - Indonesia; Diponegoro University; University of Warwick; University of California System; University of California Santa Cruz; UDICE-French Research Universities; Aix-Marseille Universite	Vogler, C (corresponding author), Univ Munich, Dept Geo & Umweltwissensch, Munich, Germany.	woerheide@lmu.de	Gerard, Karin/H-6245-2014; Wörheide, Gert/C-1080-2008; Gérard, Karin/AAC-4911-2021; Ambariyanto, Ambariyanto/GQY-4999-2022; Benzie, John A.H./L-6208-2018	Wörheide, Gert/0000-0002-6380-7421; Gérard, Karin/0000-0003-0596-1348; Benzie, John/0000-0001-9599-8683; sheppard, charles/0000-0002-2579-5124	Indonesian government [1187/SU/KS/2006, 04239/SU.3/KS/2006]; Oman Ministry of Environment and Climate Affairs; EU [MEST-CT-2005-020561]; National Science Foundation (NSF) [OCE-0349177]; GIS LAGMAY and Service des Peches (Mayotte); Fujeirah Municipality (UAE)	Indonesian government(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Oman Ministry of Environment and Climate Affairs; EU(European Commission); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); GIS LAGMAY and Service des Peches (Mayotte); Fujeirah Municipality (UAE)	We acknowledge the Indonesian government for permits 1187/SU/KS/2006 and 04239/SU.3/KS/2006, as well as the Oman Ministry of Environment and Climate Affairs and the Fujeirah Municipality (UAE). For logistic and/or financial support, thanks to GIS LAGMAY and Service des Peches (Mayotte), to Five Oceans LLC (Oman) and CORDIO (Kenya). Support for Indonesian data collection came from the US National Science Foundation (Biological Oceanography, OCE-0349177). We also wish to thank Elisabeth Illidge-Evans, Gordon Kirkwood, Emre Turak, Sven Uthicke and Shakil Visram for providing samples, as well as all the institutions and individuals who supported the authors of this study during fieldwork. We thank Oliver Voigt for helpful comments on the manuscript.; This work was funded by the EU Marie-Curie Early Stage Research Training HOTSPOTS MEST-CT-2005-020561 and National Science Foundation (NSF) grant OCE-0349177. GIS LAGMAY and Service des Peches (Mayotte) gave financial support during field work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PH, 2011, CRUSTACEAN ISS, V19, P129; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Benzie JAH, 1999, EVOLUTION, V53, P1782, DOI 10.1111/j.1558-5646.1999.tb04562.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BIRKELAND C, 1990, MAJOR MANAGEMENT PRO; Bonjean F, 2002, J PHYS OCEANOGR, V32, P2938, DOI 10.1175/1520-0485(2002)032<2938:DMAAOT>2.0.CO;2; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Celliers Louis, 2006, Western Indian Ocean Journal of Marine Science, V5, P105; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Fu YX, 1997, GENETICS, V147, P915; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gerard K, 2008, CR BIOL, V331, P137, DOI 10.1016/j.crvi.2007.11.005; Glynn Peter W., 1993, Atoll Research Bulletin, V379, P1; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Houk P, 2007, J OCEANOGR, V63, P149, DOI 10.1007/s10872-007-0013-x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; HUTSON WH, 1980, SCIENCE, V207, P64, DOI 10.1126/science.207.4426.64; Ivanova EV, 2009, GLOBAL THERMOHALINE PALEOCIRCULATION, P1, DOI 10.1007/978-90-481-2415-2; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Lourie SA, 2004, CONSERV BIOL, V18, P1004, DOI 10.1111/j.1523-1739.2004.00137.x; LUCAS JS, 1982, J EXP MAR BIOL ECOL, V65, P173, DOI 10.1016/0022-0981(82)90043-0; Lynch J.D., 1989, P527; Mendonca VM, 2010, ZOOL STUD, V49, P108; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Montaggioni LF, 2005, EARTH-SCI REV, V71, P1, DOI 10.1016/j.earscirev.2005.01.002; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Palumbi SR, 1996, J EXP MAR BIOL ECOL, V203, P75, DOI 10.1016/0022-0981(96)02571-3; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; POLLOCK DE, 1993, B MAR SCI, V53, P937; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Reid DG, 2006, J BIOGEOGR, V33, P990, DOI 10.1111/j.1365-2699.2006.01469.x; Ridgway Tyrone, 2005, Western Indian Ocean Journal of Marine Science, V4, P1; Rousset F, 1997, GENETICS, V145, P1219; Schleyer M, 2004, REEF ENCOUNTER, V23, P25; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Schott FA, 2002, PROG OCEANOGR, V53, P57, DOI 10.1016/S0079-6611(02)00039-3; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Sheppard Charles R.C., 2000, P3; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; VERON JEN, 1995, CORALS SPACE TIME BI; Vogler C, 2008, BIOL LETTERS, V4, P696, DOI 10.1098/rsbl.2008.0454; Wilkinson C., 2008, STATUS CORAL REEFS W; Winter A, 1990, PALEOCEANOGRAPHY, V5, P479, DOI 10.1029/PA005i004p00479; Yamaguchi M., 1973, P369; Yasuda N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-17; Yasuda N, 2009, MOL ECOL, V18, P1574, DOI 10.1111/j.1365-294X.2009.04133.x; Zann LP, 2000, CORAL REEFS INDIAN O, P59	67	43	43	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43499	10.1371/journal.pone.0043499	http://dx.doi.org/10.1371/journal.pone.0043499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927975	Green Submitted, Green Published, gold			2022-12-25	WOS:000307789700036
J	Bateman, RM; Ellis, CG; Suematsu, M; Walley, KR				Bateman, Ryon M.; Ellis, Christopher G.; Suematsu, Makoto; Walley, Keith R.			S-Nitrosoglutathione Acts as a Small Molecule Modulator of Human Fibrin Clot Architecture	PLOS ONE			English	Article							RED-BLOOD-CELLS; NITRIC-OXIDE; PLATELET ACTIVATION; FACTOR-XIII; BETA-CHAIN; PLASMA; NITROSOTHIOLS; NETWORKS; INHIBITION; GLUTATHIONE	Background: Altered fibrin clot architecture is increasingly associated with cardiovascular diseases; yet, little is known about how fibrin networks are affected by small molecules that alter fibrinogen structure. Based on previous evidence that S-nitrosoglutathione (GSNO) alters fibrinogen secondary structure and fibrin polymerization kinetics, we hypothesized that GSNO would alter fibrin microstructure. Methodology/Principal Findings: Accordingly, we treated human platelet-poor plasma with GSNO (0.01-3.75 mM) and imaged thrombin induced fibrin networks using multiphoton microscopy. Using custom designed computer software, we analyzed fibrin microstructure for changes in structural features including fiber density, diameter, branch point density, crossing fibers and void area. We report for the first time that GSNO dose-dependently decreased fibrin density until complete network inhibition was achieved. At low dose GSNO, fiber diameter increased 25%, maintaining clot void volume at approximately 70%. However, at high dose GSNO, abnormal irregularly shaped fibrin clusters with high fluorescence intensity cores were detected and clot void volume increased dramatically. Notwithstanding fibrin clusters, the clot remained stable, as fiber branching was insensitive to GSNO and there was no evidence of fiber motion within the network. Moreover, at the highest GSNO dose tested, we observed for the first time, that GSNO induced formation of fibrin agglomerates. Conclusions/Significance: Taken together, low dose GSNO modulated fibrin microstructure generating coarse fibrin networks with thicker fibers; however, higher doses of GSNO induced abnormal fibrin structures and fibrin agglomerates. Since GSNO maintained clot void volume, while altering fiber diameter it suggests that GSNO may modulate the remodeling or inhibition of fibrin networks over an optimal concentration range.	[Bateman, Ryon M.; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Bateman, Ryon M.; Walley, Keith R.] Univ British Columbia, Heart Lung Inst, Vancouver, BC V5Z 1M9, Canada; [Ellis, Christopher G.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada	Keio University; University of British Columbia; Western University (University of Western Ontario)	Bateman, RM (corresponding author), Keio Univ, Sch Med, Dept Biochem, Tokyo, Japan.	rbateman@z6.keio.jp	Ellis, Christopher G/AAV-2325-2020; Ellis, Christopher G/G-8649-2013; Suematsu, Makoto/O-5762-2018; Suematsu, Makoto/I-8135-2013	Ellis, Christopher G/0000-0002-7760-1846; Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336	Heart and Stroke Foundation of Canada; Michael Smith Foundation for Health Research; MSFHR; Ministry of Education, Culture, Sports, Science and Technology, Japan, Global COE Program for Human Metabolomic Systems Biology	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); MSFHR(Michael Smith Foundation for Health Research); Ministry of Education, Culture, Sports, Science and Technology, Japan, Global COE Program for Human Metabolomic Systems Biology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Heart and Stroke Foundation of Canada (http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.2796497/k.BF8B/Home.htm) and Michael Smith Foundation for Health Research (http://www.msfhr.org/) Fellowships (R. M. B.), MSFHR Distinguished Scholar Award (K. R. W.), and the Ministry of Education, Culture, Sports, Science and Technology, Japan, Global COE Program for Human Metabolomic Systems Biology (M. S., M. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2008, BLOOD, V111, P643, DOI 10.1182/blood-2007-05-091231; Akhter S, 2002, P NATL ACAD SCI USA, V99, P9172, DOI 10.1073/pnas.142136499; Allen BW, 2009, TRENDS MOL MED, V15, P452, DOI 10.1016/j.molmed.2009.08.002; Ariens RAS, 2000, BLOOD, V96, P988, DOI 10.1182/blood.V96.3.988.015k57_988_995; BARADET TC, 1995, BIOPHYS J, V68, P1551, DOI 10.1016/S0006-3495(95)80327-9; Bateman RM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2822882; BLOMBACK B, 1989, BIOCHIM BIOPHYS ACTA, V997, P96, DOI 10.1016/0167-4838(89)90140-4; Bramanti E, 2010, TALANTA, V81, P1295, DOI 10.1016/j.talanta.2010.02.024; CARR ME, 1988, THROMB HAEMOSTASIS, V59, P535; Catani MV, 1998, BIOCHEM BIOPH RES CO, V249, P275, DOI 10.1006/bbrc.1998.9130; Chernysh IN, 2008, BLOOD, V111, P4854, DOI 10.1182/blood-2007-08-105247; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; Cote HCF, 1998, BLOOD, V92, P2195, DOI 10.1182/blood.V92.7.2195.2195_2195_2212; Diesen DL, 2008, CIRC RES, V103, P545, DOI 10.1161/CIRCRESAHA.108.176867; FERRY JD, 1947, J AM CHEM SOC, V69, P388, DOI 10.1021/ja01194a066; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Geer CB, 2008, BIOMACROMOLECULES, V9, P1876, DOI 10.1021/bm800146j; Gersh KC, 2011, BLOOD, V117, P4964, DOI 10.1182/blood-2010-10-310409; Gkaliagkousi E, 2007, CIRC RES, V101, P654, DOI 10.1161/CIRCRESAHA.107.158410; Hogg N, 2000, FREE RADICAL BIO MED, V28, P1478, DOI 10.1016/S0891-5849(00)00248-3; LANGFORD EJ, 1994, LANCET, V344, P1458, DOI 10.1016/S0140-6736(94)90287-9; Langford EJ, 1996, ARTERIOSCL THROM VAS, V16, P51, DOI 10.1161/01.ATV.16.1.51; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Marchi RC, 2004, BLOOD COAGUL FIBRIN, V15, P559, DOI 10.1097/00001721-200410000-00005; MENDELSOHN ME, 1990, J BIOL CHEM, V265, P19028; Mills JD, 2002, CIRCULATION, V106, P1938, DOI 10.1161/01.CIR.0000033221.73082.06; MOSESSON MW, 1989, P NATL ACAD SCI USA, V86, P1113, DOI 10.1073/pnas.86.4.1113; MOSESSON MW, 1993, BLOOD, V82, P1517; OKADA M, 1983, THROMB RES, V29, P269, DOI 10.1016/0049-3848(83)90039-7; Parastatidis I, 2008, J BIOL CHEM, V283, P33846, DOI 10.1074/jbc.M805522200; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; RADOMSKI MW, 1992, BRIT J PHARMACOL, V107, P745, DOI 10.1111/j.1476-5381.1992.tb14517.x; Riba R, 2004, ATHEROSCLEROSIS, V175, P69, DOI 10.1016/j.atherosclerosis.2004.02.008; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Sakharov DV, 1996, J BIOL CHEM, V271, P2133, DOI 10.1074/jbc.271.4.2133; Scott DJA, 2011, ARTERIOSCL THROM VAS, V31, P3004, DOI 10.1161/ATVBAHA.111.236786; SHACTER E, 1995, FREE RADICAL BIO MED, V18, P815, DOI 10.1016/0891-5849(95)93872-4; SHAH GA, 1987, THROMB RES, V45, P257, DOI 10.1016/0049-3848(87)90193-9; SIMON DI, 1993, ARTERIOSCLER THROMB, V13, P791, DOI 10.1161/01.ATV.13.6.791; Sorragi CD, 2011, CELL BIOCHEM FUNCT, V29, P207, DOI 10.1002/cbf.1738; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stamler JS, 2004, CIRC RES, V94, P414, DOI 10.1161/01.RES.0000122071.55721.BC; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; Undas A, 2009, STROKE, V40, P1499, DOI 10.1161/STROKEAHA.108.532812; Vadseth C, 2004, J BIOL CHEM, V279, P8820, DOI 10.1074/jbc.M306101200; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	50	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43660	10.1371/journal.pone.0043660	http://dx.doi.org/10.1371/journal.pone.0043660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916291	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800089
J	Zhang, XF; Dai, DQ; Le, OY; Wu, MY				Zhang, Xiao-Fei; Dai, Dao-Qing; Le Ou-Yang; Wu, Meng-Yun			Exploring Overlapping Functional Units with Various Structure in Protein Interaction Networks	PLOS ONE			English	Article							BIOLOGICAL NETWORKS; SACCHAROMYCES-CEREVISIAE; COMPLEX PREDICTION; GENE ONTOLOGY; MODULES; ALGORITHMS; MODELS; GRAPH; IDENTIFICATION; ORGANIZATION	Revealing functional units in protein-protein interaction (PPI) networks are important for understanding cellular functional organization. Current algorithms for identifying functional units mainly focus on cohesive protein complexes which have more internal interactions than external interactions. Most of these approaches do not handle overlaps among complexes since they usually allow a protein to belong to only one complex. Moreover, recent studies have shown that other non-cohesive structural functional units beyond complexes also exist in PPI networks. Thus previous algorithms that just focus on non-overlapping cohesive complexes are not able to present the biological reality fully. Here, we develop a new regularized sparse random graph model (RSRGM) to explore overlapping and various structural functional units in PPI networks. RSRGM is principally dominated by two model parameters. One is used to define the functional units as groups of proteins that have similar patterns of connections to others, which allows RSRGM to detect non-cohesive structural functional units. The other one is used to represent the degree of proteins belonging to the units, which supports a protein belonging to more than one revealed unit. We also propose a regularizer to control the smoothness between the estimators of these two parameters. Experimental results on four S. cerevisiae PPI networks show that the performance of RSRGM on detecting cohesive complexes and overlapping complexes is superior to that of previous competing algorithms. Moreover, RSRGM has the ability to discover biological significant functional units besides complexes.	[Zhang, Xiao-Fei] Sun Yat Sen Univ, Ctr Comp Vis, Guangzhou 510275, Guangdong, Peoples R China; Sun Yat Sen Univ, Dept Math, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, XF (corresponding author), Sun Yat Sen Univ, Ctr Comp Vis, Guangzhou 510275, Guangdong, Peoples R China.	stsddq@mail.sysu.edu.cn			National Science Foundation of China [90920007, 11171354]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by National Science Foundation of China (90920007, 11171354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Ball B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036103; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Becker E, 2012, BIOINFORMATICS, V28, P84, DOI 10.1093/bioinformatics/btr621; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Cho YR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-265; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gillis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017258; Higham DJ, 2008, BIOINFORMATICS, V24, P1093, DOI 10.1093/bioinformatics/btn079; Jiang P, 2010, BIOINFORMATICS, V26, P1105, DOI 10.1093/bioinformatics/btq078; Jiao QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027646; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuchaiev O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000454; Lee DD, 2001, ADV NEUR IN, V13, P556; Li XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S3; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Luo F, 2007, BIOINFORMATICS, V23, P207, DOI 10.1093/bioinformatics/btl562; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Pinkert S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000659; Qi Y, 2008, BIOINFORMATICS, V24, pI250, DOI 10.1093/bioinformatics/btn164; Ranola JMO, 2010, BIOINFORMATICS, V26, P2004, DOI 10.1093/bioinformatics/btq309; Rhrissorrakrai K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-192; Saul ZM, 2007, BIOINFORMATICS, V23, P2604, DOI 10.1093/bioinformatics/btm370; Schweiger R, 2011, BIOINFORMATICS, V27, pI142, DOI 10.1093/bioinformatics/btr201; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Song JM, 2009, BIOINFORMATICS, V25, P3143, DOI 10.1093/bioinformatics/btp551; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Xie ZP, 2011, BIOINFORMATICS, V27, pI159, DOI 10.1093/bioinformatics/btr212; Zhang XF, 2012, IEEE ACM T COMPUT BI, V9, P857, DOI 10.1109/TCBB.2012.20; Zhang XF, 2012, IEEE ACM T COMPUT BI, V9, P740, DOI 10.1109/TCBB.2011.148	45	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43092	10.1371/journal.pone.0043092	http://dx.doi.org/10.1371/journal.pone.0043092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916212	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800047
J	Petty, A; Myshkin, E; Qin, HN; Guo, H; Miao, H; Tochtrop, GP; Hsieh, JT; Page, P; Liu, LL; Lindner, DJ; Acharya, C; MacKerell, AD; Ficker, E; Song, JX; Wang, BC				Petty, Aaron; Myshkin, Eugene; Qin, Haina; Guo, Hong; Miao, Hui; Tochtrop, Gregory P.; Hsieh, Jer-Tsong; Page, Phillip; Liu, Lili; Lindner, Daniel J.; Acharya, Chayan; MacKerell, Alexander D., Jr.; Ficker, Eckhard; Song, Jianxing; Wang, Bingcheng			A Small Molecule Agonist of EphA2 Receptor Tyrosine Kinase Inhibits Tumor Cell Migration In Vitro and Prostate Cancer Metastasis In Vivo	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; N-15 RELAXATION; EPHRIN-BINDING; PROTEIN; TARGET; ACTIVATION; DYNAMICS; DOMAIN; PHENOXYBENZAMINE; SUPPRESSES	During tumor progression, EphA2 receptor can gain ligand-independent pro-oncogenic functions due to Akt activation and reduced ephrin-A ligand engagement. The effects can be reversed by ligand stimulation, which triggers the intrinsic tumor suppressive signaling pathways of EphA2 including inhibition of PI3/Akt and Ras/ERK pathways. These observations argue for development of small molecule agonists for EphA2 as potential tumor intervention agents. Through virtual screening and cell-based assays, we report here the identification and characterization of doxazosin as a novel small molecule agonist for EphA2 and EphA4, but not for other Eph receptors tested. NMR studies revealed extensive contacts of doxazosin with EphA2/A4, recapitulating both hydrophobic and electrostatic interactions recently found in the EphA2/ephrin-A1 complex. Clinically used as an alpha 1-adrenoreceptor antagonist (Cardura (R)) for treating hypertension and benign prostate hyperplasia, doxazosin activated EphA2 independent of alpha 1-adrenoreceptor. Similar to ephrin-A1, doxazosin inhibited Akt and ERK kinase activities in an EphA2-dependent manner. Treatment with doxazosin triggered EphA2 receptor internalization, and suppressed haptotactic and chemotactic migration of prostate cancer, breast cancer, and glioma cells. Moreover, in an orthotopic xenograft model, doxazosin reduced distal metastasis of human prostate cancer cells and prolonged survival in recipient mice. To our knowledge, doxazosin is the first small molecule agonist of a receptor tyrosine kinase that is capable of inhibiting malignant behaviors in vitro and in vivo.	[Petty, Aaron; Myshkin, Eugene; Guo, Hong; Miao, Hui; Ficker, Eckhard; Wang, Bingcheng] Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Res, Cleveland, OH 44106 USA; [Qin, Haina; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore; [Tochtrop, Gregory P.; Wang, Bingcheng] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA; [Tochtrop, Gregory P.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Hsieh, Jer-Tsong] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Page, Phillip] Reichert Inc, Depew, NY USA; [Liu, Lili] Case Western Reserve Univ, Sch Med, Dept Med, Div Hematol & Oncol,Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Lindner, Daniel J.] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA; [Acharya, Chayan; MacKerell, Alexander D., Jr.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Song, Jianxing] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Wang, Bingcheng] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University; MetroHealth System; National University of Singapore; Case Western Reserve University; Case Western Reserve University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; Case Western Reserve University Hospital; Cleveland Clinic Foundation; University System of Maryland; University of Maryland Baltimore; National University of Singapore; Case Western Reserve University	Petty, A (corresponding author), Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Res, MetroHlth Campus, Cleveland, OH 44106 USA.	bchsj@nus.edu.sg; bxw14@case.edu	MacKerell, Alex/Y-2469-2019; Song, Jianxing/H-8026-2012; MacKerell, Alex/AAA-2560-2020; Qin, Haina/AAB-7486-2020; Lindner, Daniel/ABB-5440-2020	MacKerell, Alex/0000-0001-8287-6804; Haina, Qin/0000-0002-9175-8014; Song, Jianxing/0000-0003-0224-6322	National Institutes of Health [CA155676-01, DK077876, CA152371]; FAMRI; Singapore National Medical Research Council Grants [NMRC/1216/2009]; Ohio Supercomputer Center; NATIONAL CANCER INSTITUTE [R01CA152371, R01CA155676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI; Singapore National Medical Research Council Grants(National Medical Research Council, Singapore); Ohio Supercomputer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from National Institutes of Health to BW (CA155676-01, DK077876), BW and HM (CA152371), and awards to BW from FAMRI and Prayer From Maria Foundations. JS was supported by Singapore National Medical Research Council Grants NMRC/1216/2009. In silico screening was supported by a grant from the Ohio Supercomputer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; [Anonymous], 1997, Cell, V90, P403; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Benning CM, 2002, CANCER RES, V62, P597; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; Chrencik JE, 2006, J BIOL CHEM, V281, P28185, DOI 10.1074/jbc.M605766200; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; CONSTANTINE JW, 1980, N-S ARCH PHARMACOL, V314, P149, DOI 10.1007/BF00504531; Dohn M, 2001, ONCOGENE, V20, P6503, DOI 10.1038/sj.onc.1204816; Duxbury MS, 2004, BIOCHEM BIOPH RES CO, V320, P1096, DOI 10.1016/j.bbrc.2004.06.054; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Guo H, 2006, CANCER RES, V66, P7050, DOI 10.1158/0008-5472.CAN-06-0004; Hall JB, 2003, J BIOMOL NMR, V27, P261, DOI 10.1023/A:1025467918856; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Himanen JP, 2002, ACTA CRYSTALLOGR D, V58, P533, DOI 10.1107/S0907444902000264; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Hui HX, 2008, EUR J CANCER, V44, P160, DOI 10.1016/j.ejca.2007.10.002; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Kyprianou N, 2000, CANCER RES, V60, P4550; LINDBERG RA, 1990, MOL CELL BIOL, V10, P6316, DOI 10.1128/MCB.10.12.6316; Lipinski CA, 2007, J PHARMACOL TOX MET, V44, P235; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Menges CW, 2008, ONCOGENE, V27, P2934, DOI 10.1038/sj.onc.1210957; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miao H, 2012, SEMIN CELL DEV BIOL, V23, P16, DOI 10.1016/j.semcdb.2011.10.013; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Miao H, 2009, INT J BIOCHEM CELL B, V41, P762, DOI 10.1016/j.biocel.2008.07.019; Myshkin E, 2003, J CHEM INF COMP SCI, V43, P1004, DOI 10.1021/ci0256586; NICKERSON M, 1962, ARCH INT PHARMACOD T, V140, P237; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Noblitt LW, 2004, CANCER GENE THER, V11, P757, DOI 10.1038/sj.cgt.7700761; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pienta KJ, 2008, PROSTATE, V68, P629, DOI 10.1002/pros.20726; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Qin HN, 2008, J BIOL CHEM, V283, P29473, DOI 10.1074/jbc.M804114200; Shi JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001084; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; SMYTH DD, 1984, J PHARMACOL EXP THER, V230, P387; Thaker PH, 2004, CLIN CANCER RES, V10, P5145, DOI 10.1158/1078-0432.CCR-03-0589; Visser S, 2010, CELL CYCLE, V9, P3892, DOI 10.4161/cc.9.19.13386; Walker O, 2004, J MAGN RESON, V168, P336, DOI 10.1016/j.jmr.2004.03.019; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Wang BC, 2008, BLOOD, V112, P455, DOI 10.1182/blood-2008-05-152397; Wang BC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002153; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Xie DX, 2010, P NATL ACAD SCI USA, V107, P2485, DOI 10.1073/pnas.0908133107; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yang G, 1997, PROSTATE, V33, P157; Yang NY, 2011, CELL SIGNAL, V23, P201, DOI 10.1016/j.cellsig.2010.09.004; Zelinski DP, 2001, CANCER RES, V61, P2301	61	93	96	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42120	10.1371/journal.pone.0042120	http://dx.doi.org/10.1371/journal.pone.0042120			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916121	Green Published, gold			2022-12-25	WOS:000307823600009
J	Lorente, E; Infantes, S; Abia, D; Barnea, E; Beer, I; Garcia, R; Lasala, F; Jimenez, M; Mir, C; Morreale, A; Admon, A; Lopez, D				Lorente, Elena; Infantes, Susana; Abia, David; Barnea, Eilon; Beer, Ilan; Garcia, Ruth; Lasala, Fatima; Jimenez, Mercedes; Mir, Carmen; Morreale, Antonio; Admon, Arie; Lopez, Daniel			A Viral, Transporter Associated with Antigen Processing (TAP)-independent, High Affinity Ligand with Alternative Interactions Endogenously Presented by the Nonclassical Human Leukocyte Antigen E Class I Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-INFECTED CELLS; NATURAL-KILLER-CELLS; PEPTIDE-BINDING SPECIFICITY; HLA-E EXPRESSION; VACCINIA VIRUS; INHIBITORY RECEPTOR; RECOGNITION; COMPLEX; EPITOPE; IDENTIFICATION	The transporter associated with antigen processing (TAP) enables the flow of viral peptides generated in the cytosol by the proteasome and other proteases to the endoplasmic reticulum, where they complex with nascent human leukocyte antigen (HLA) class I. Later, these peptide-HLA class I complexes can be recognized by CD8(+) lymphocytes. Cancerous cells and infected cells in which TAP is blocked, as well as individuals with unusable TAP complexes, are able to present peptides on HLA class I by generating them through TAP-independent processing pathways. Here, we identify a physiologically processed HLA-E ligand derived from the D8L protein in TAP-deficient vaccinia virus-infected cells. This natural high affinity HLA-E class I ligand uses alternative interactions to the anchor motifs previously described to be presented on nonclassical HLA class I molecules. This octameric peptide was also presented on HLA-Cw1 with similar binding affinity on both classical and nonclassical class I molecules. In addition, this viral peptide inhibits HLA-E-mediated cytolysis by natural killer cells. Comparison between the amino acid sequences of the presenting HLA-E and HLA-Cw1 alleles revealed a shared structural motif in both HLA class molecules, which could be related to their observed similar cross-reactivity affinities. This motif consists of several residues located on the floor of the peptide-binding site. These data expand the role of HLA-E as an antigen-presenting molecule.	[Lopez, Daniel] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Proc Antigen, Majadahonda 28220, Madrid, Spain; [Abia, David; Morreale, Antonio] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Barnea, Eilon; Admon, Arie] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Beer, Ilan] IBM Haifa Res Lab, IL-31905 Haifa, Israel	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Technion Israel Institute of Technology; International Business Machines (IBM)	Lopez, D (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Proc Antigen, Majadahonda 28220, Madrid, Spain.	dlopez@isciii.es	Lorente, Elena/B-1219-2019; López, Daniel/I-2632-2014	Lorente, Elena/0000-0002-2246-6851; López, Daniel/0000-0003-0268-5878; LASALA, FATIMA/0000-0001-8183-1866; Admon, Arie/0000-0003-0504-3950; Abia, David/0000-0003-0401-7590	Ministerio de Ciencia e Innovacion; Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) Foundation; Israel Science Foundation [916/05]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the Ministerio de Ciencia e Innovacion and the Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) Foundation (to D. L.) and Israel Science Foundation Grant 916/05 (to A. A.).	Alzhanova D, 2009, CELL HOST MICROBE, V6, P433, DOI 10.1016/j.chom.2009.09.013; Anandakrishnan R, 2008, J COMPUT BIOL, V15, P165, DOI 10.1089/cmb.2007.0144; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Bertoni R, 1997, J CLIN INVEST, V100, P503, DOI 10.1172/JCI119559; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Carbone E, 1997, J EXP MED, V185, P2053, DOI 10.1084/jem.185.12.2053; Cerundolo V, 2006, SEMIN IMMUNOL, V18, P330, DOI 10.1016/j.smim.2006.07.006; Cooper S, 1996, J EXP MED, V183, P663, DOI 10.1084/jem.183.2.663; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fan QR, 1996, P NATL ACAD SCI USA, V93, P7178, DOI 10.1073/pnas.93.14.7178; FREED ER, 1972, AM J MED, V52, P411, DOI 10.1016/0002-9343(72)90031-9; Goodridge JP, 2010, J IMMUNOL, V184, P6199, DOI 10.4049/jimmunol.1000078; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Griffin BD, 2010, VET MICROBIOL, V143, P89, DOI 10.1016/j.vetmic.2010.02.017; Hickman-Miller HD, 2005, J IMMUNOL, V175, P367, DOI 10.4049/jimmunol.175.1.367; Hoare HL, 2008, J MOL BIOL, V377, P1297, DOI 10.1016/j.jmb.2008.01.098; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Infantes S, 2011, IMMUNOL CELL BIOL, V89, P558, DOI 10.1038/icb.2010.125; Infantes S, 2010, MOL CELL PROTEOMICS, V9, P1533, DOI 10.1074/mcp.M900508-MCP200; Jezek Z, 1988, HUMAN MONKEYPOX; Joosten SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000782; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kennedy R, 2007, REV MED VIROL, V17, P93, DOI 10.1002/rmv.527; Kennedy RB, 2009, VACCINE, V27, pD73, DOI 10.1016/j.vaccine.2009.07.103; Kennedy RB, 2009, CURR OPIN IMMUNOL, V21, P314, DOI 10.1016/j.coi.2009.04.004; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Kondo E, 2004, BLOOD, V103, P630, DOI 10.1182/blood-2003-03-0824; Larsen Mette Voldby, 2006, Current Immunology Reviews, V2, P233; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; LOPEZ D, 1994, J IMMUNOL, V152, P5557; LOPEZ D, 1993, J IMMUNOL, V150, P2675; Lopez D, 2001, J IMMUNOL, V167, P4238, DOI 10.4049/jimmunol.167.8.4238; Lorente E, 2012, J BIOL CHEM, V287, P9990, DOI 10.1074/jbc.M111.314856; Lorente E, 2012, J VIROL, V86, P527, DOI 10.1128/JVI.05737-11; Miller JD, 2003, J IMMUNOL, V171, P1369, DOI 10.4049/jimmunol.171.3.1369; MOSS B, 1991, SCIENCE, V252, P1662, DOI 10.1126/science.2047875; Nattermann J, 2005, ANTIVIR THER, V10, P95; Nattermann J, 2005, AM J PATHOL, V166, P443, DOI 10.1016/S0002-9440(10)62267-5; PARHAM P, 1978, NATURE, V276, P397, DOI 10.1038/276397a0; Pietra G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/907092; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Ravindranath MH, 2011, MOL IMMUNOL, V48, P423, DOI 10.1016/j.molimm.2010.09.011; REDFIELD RR, 1987, NEW ENGL J MED, V316, P673, DOI 10.1056/NEJM198703123161106; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; Sette A, 2005, IMMUNOGENETICS, V57, P53, DOI 10.1007/s00251-004-0749-z; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Ulbrecht M, 1998, J IMMUNOL, V160, P4375; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A	54	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34895	34903		10.1074/jbc.M112.362293	http://dx.doi.org/10.1074/jbc.M112.362293			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927436	hybrid, Green Published			2022-12-25	WOS:000309968000003
J	Schindl, R; Fritsch, R; Jardin, I; Frischauf, I; Kahr, H; Muik, M; Riedl, MC; Groschner, K; Romanin, C				Schindl, Rainer; Fritsch, Reinhard; Jardin, Isaac; Frischauf, Irene; Kahr, Heike; Muik, Martin; Riedl, Maria Christine; Groschner, Klaus; Romanin, Christoph			Canonical Transient Receptor Potential (TRPC) 1 Acts as a Negative Regulator for Vanilloid TRPV6-mediated Ca2+ Influx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DETERMINANTS; OPERATED CHANNEL; HUMAN PLATELETS; FUNCTIONAL-ROLE; CATION CHANNEL; ANKYRIN REPEAT; MAST-CELLS; KNOCK-DOWN; SUBUNIT; STIM1	TRP proteins mostly assemble to homomeric channels but can also heteromerize, preferentially within their subfamilies. The TRPC1 protein is the most versatile member and forms various TRPC channel combinations but also unique channels with the distantly related TRPP2 and TRPV4. We show here a novel cross-family interaction between TRPC1 and TRPV6, a Ca2+ selective member of the vanilloid TRP subfamily. TRPV6 exhibited substantial co-localization and in vivo interaction with TRPC1 in HEK293 cells, however, no interaction was observed with TRPC3, TRPC4, or TRPC5. Ca2+ and Na+ currents of TRPV6-overexpressing HEK293 cells are significantly reduced by co-expression of TRPC1, correlating with a dramatically suppressed plasma membrane targeting of TRPV6. In line with their intracellular retention, remaining currents of TRPC1 and TRPV6 co-expression resemble in current-voltage relationship that of TRPV6. Studying the N-terminal ankyrin like repeat domain, structurally similar in the two proteins, we have found that these cytosolic segments were sufficient to mediate a direct heteromeric interaction. Moreover, the inhibitory role of TRPC1 on TRPV6 influx was also maintained by expression of only its N-terminal ankyrin-like repeat domain. Our experiments provide evidence for a functional interaction of TRPC1 with TRPV6 that negatively regulates Ca2+ influx in HEK293 cells.	[Groschner, Klaus] Graz Univ, Inst Pharmacol & Toxicol, A-8010 Graz, Austria; [Jardin, Isaac] Univ Extremadura, Dept Physiol, Caceres 10003, Spain; [Kahr, Heike] Univ Appl Sci Upper Austria, Sch Engn Enviromental Sci, A-4600 Wels, Austria; [Schindl, Rainer; Fritsch, Reinhard; Frischauf, Irene; Muik, Martin; Riedl, Maria Christine; Romanin, Christoph] Univ Linz, Inst Biophys, A-4020 Linz, Austria	University of Graz; Universidad de Extremadura; Johannes Kepler University Linz	Schindl, R (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Linz Gruberstr 40, A-4020 Linz, Austria.	rainer.schindl@jku.at; christoph.romanin@jku.at	Schindl, Rainer/V-4205-2019; Frischauf, Irene/AAG-2007-2019; Schindl, Rainer/E-3959-2013; Groschner, Klaus/A-2550-2010; Romanin, Christoph/D-5399-2009; Jardin, Isaac/E-8310-2016	Frischauf, Irene/0000-0003-0661-2932; Schindl, Rainer/0000-0003-0896-8887; Groschner, Klaus/0000-0002-8659-377X; Romanin, Christoph/0000-0003-3756-4136; Jardin, Isaac/0000-0003-4575-8264	Austrian Science Foundation [P22747, P21925, P18169, P22565]; MCI fellowship [BES-2008-002875]; Hertha-Firnberg scholarship [T442]; Austrian Science Fund (FWF) [P 22747, P 21925] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); MCI fellowship; Hertha-Firnberg scholarship(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation (to F. W. F.): Project P22747 (to R. S.), Project P21925 (to K. G.), and Project P18169 as well as P22565 (to C. R.).; Supported by MCI fellowship (Ref. BES-2008-002875).; Recipient of a Hertha-Firnberg scholarship (T442).	Alessandri-Haber N, 2009, J NEUROSCI, V29, P6217, DOI 10.1523/JNEUROSCI.0893-09.2009; Alfonso S, 2008, CELL CALCIUM, V43, P375, DOI 10.1016/j.ceca.2007.07.004; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Beech DJ, 2003, CELL CALCIUM, V33, P433, DOI 10.1016/S0143-4160(03)00054-X; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Cheng W, 2010, PROTEIN CELL, V1, P802, DOI 10.1007/s13238-010-0108-9; de Groot T, 2011, J BIOL CHEM, V286, P32132, DOI 10.1074/jbc.M111.226878; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Engelke M, 2002, FEBS LETT, V523, P193, DOI 10.1016/S0014-5793(02)02971-X; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Freichel M, 2005, J PHYSIOL-LONDON, V567, P59, DOI 10.1113/jphysiol.2005.092999; Giamarchi A, 2010, EMBO J, V29, P1176, DOI 10.1038/emboj.2010.18; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jardin I, 2008, J BIOL CHEM, V283, P25296, DOI 10.1074/jbc.M802904200; Jardin I, 2008, BBA-MOL CELL RES, V1783, P84, DOI 10.1016/j.bbamcr.2007.07.007; Jardin I, 2009, BIOCHEM J, V420, P267, DOI 10.1042/BJ20082179; Kahr H, 2004, J PHYSIOL-LONDON, V557, P121, DOI 10.1113/jphysiol.2004.062653; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kobori T, 2009, J BIOL CHEM, V284, P35507, DOI 10.1074/jbc.M109.060228; Lepage PK, 2007, BIOCHEM SOC T, V35, P81, DOI 10.1042/BST0350081; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Ma X, 2010, ARTERIOSCL THROM VAS, V30, P851, DOI 10.1161/ATVBAHA.109.196584; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Mei ZZ, 2009, J MEMBRANE BIOL, V230, P93, DOI 10.1007/s00232-009-9190-4; Nijenhuis T, 2003, J AM SOC NEPHROL, V14, P2731, DOI 10.1097/01.ASN.0000094081.78893.E8; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Rosado JA, 2002, J BIOL CHEM, V277, P42157, DOI 10.1074/jbc.M207320200; Schindl R, 2007, BIOCHEM SOC T, V35, P84, DOI 10.1042/BST0350084; Schindl R, 2002, J BIOL CHEM, V277, P26950, DOI 10.1074/jbc.M203700200; Schindl R, 2008, CELL CALCIUM, V43, P260, DOI 10.1016/j.ceca.2007.05.015; Schoeber JPH, 2009, AM J PHYSIOL-RENAL, V296, pF204, DOI 10.1152/ajprenal.90473.2008; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Vanden Abeele F, 2003, CELL CALCIUM, V33, P357, DOI 10.1016/S0143-4160(03)00049-6; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yu F, 2009, P NATL ACAD SCI USA, V106, P17401, DOI 10.1073/pnas.0904651106	52	36	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35612	35620		10.1074/jbc.M112.400952	http://dx.doi.org/10.1074/jbc.M112.400952			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22932896	Green Published, hybrid			2022-12-25	WOS:000309968000073
J	Yang, C; Wu, J; Sinha, SH; Neveu, JM; Zheng, YG				Yang, Chao; Wu, Jiang; Sinha, Sarmistha H.; Neveu, John M.; Zheng, Yujun George			Autoacetylation of the MYST Lysine Acetyltransferase MOF Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE; NONHISTONE PROTEINS; ACETYLATION; COMPLEXES; TIP60; HMOF; ATM; RECRUITMENT; ACTIVATION; MECHANISMS	The MYST family of histone acetyltransferases (HATs) plays critical roles in diverse cellular processes, such as the epigenetic regulation of gene expression. Lysine autoacetylation of the MYST HATs has recently received considerable attention. Nonetheless, the mechanism and function of the autoacetylation process are not well defined. To better understand the biochemical mechanism of MYST autoacetylation and the impact of autoacetylation on the cognate histone acetylation, we carried out detailed analyses of males-absent-on-the-first (MOF), a key member of the MYST family. A number of mutant MOF proteins were produced with point mutations at several key residues near the active site of the enzyme. Autoradiography and immunoblotting data showed that mutation of these residues affects the autoacetylation activity and HAT activity of MOF by various degrees demonstrating that MOF activity is highly sensitive to the chemical changes in those residues. We produced MOF protein in the deacetylated form by using a nonspecific lysine deacetylase. Interestingly, both the autoacetylation activity and the histone acetylation activity of the deacetylated MOF were found to be very close to that of wild-type MOF, suggesting that autoacetylation of MOF only marginally modulates the enzymatic activity. Also, we found that the autoacetylation rates of MOF and deacetylated MOF were much slower than the cognate substrate acetylation. Thus, autoacetylation does not seem to contribute to the intrinsic enzymatic activity in a significant manner. These data provide new insights into the mechanism and function of MYST HAT autoacetylation.	[Yang, Chao; Wu, Jiang; Sinha, Sarmistha H.; Zheng, Yujun George] Georgia State Univ, Ctr Biotechnol & Drug Design, Dept Chem, Atlanta, GA 30302 USA; [Neveu, John M.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	University System of Georgia; Georgia State University; Harvard University	Zheng, YG (corresponding author), Georgia State Univ, Ctr Biotechnol & Drug Design, Dept Chem, Atlanta, GA 30302 USA.	yzheng@gsu.edu	Wu, Jiang/J-7731-2013; Zheng, Yujun/P-8975-2014	Wu, Jiang/0000-0002-4124-5413; Zheng, Yujun/0000-0001-7116-3067	National Institutes of Health [R01GM086717]; American Heart Association [12GRNT12070056]; Georgia State University Molecular Basis of Disease Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Georgia State University Molecular Basis of Disease Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM086717 (to Y. G. Z.). This work was also supported by American Heart Association Grant 12GRNT12070056 and a Georgia State University Molecular Basis of Disease Fellowship (to C. Y.).	Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Avvakumov N, 2007, ONCOGENE, V26, P5395, DOI 10.1038/sj.onc.1210608; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Feller C, 2012, NUCLEIC ACIDS RES, V40, P1509, DOI 10.1093/nar/gkr869; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Kundu T. K., 2007, CHROMATIN DIS, P233; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Lu L, 2011, CELL RES, V21, P1182, DOI 10.1038/cr.2011.71; Manohar M, 2009, J BIOL CHEM, V284, P23312, DOI 10.1074/jbc.M109.003202; Marmorstein R, 2009, BBA-GENE REGUL MECH, V1789, P58, DOI 10.1016/j.bbagrm.2008.07.009; Peng LR, 2012, MOL CELL BIOL, V32, P2823, DOI 10.1128/MCB.00496-12; Sapountzi V, 2011, CELL MOL LIFE SCI, V68, P1147, DOI 10.1007/s00018-010-0599-9; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Smith KT, 2009, NAT BIOTECHNOL, V27, P917, DOI 10.1038/nbt1009-917; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun BF, 2011, CELL RES, V21, P1262, DOI 10.1038/cr.2011.105; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Yamagata K, 2009, BIOCHEM BIOPH RES CO, V390, P1355, DOI 10.1016/j.bbrc.2009.10.156; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zheng YJ, 2004, METHOD ENZYMOL, V376, P188	37	25	25	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34917	34926		10.1074/jbc.M112.359356	http://dx.doi.org/10.1074/jbc.M112.359356			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22918831	hybrid, Green Published			2022-12-25	WOS:000309968000005
J	Naor, A; Thiaville, PC; Altman-Price, N; Cohen-Or, I; Allers, T; de Crecy-Lagard, V; Gophna, U				Naor, Adit; Thiaville, Patrick C.; Altman-Price, Neta; Cohen-Or, Ifat; Allers, Thorsten; de Crecy-Lagard, Valerie; Gophna, Uri			A Genetic Investigation of the KEOPS Complex in Halophilic Archaea	PLOS ONE			English	Article							TRANSFER-RNA; HALOFERAX-VOLCANII; PROTEIN; YEAST; TRANSCRIPTION; BIOSYNTHESIS; ANTICODON; ADENOSINE; CYTIDINE; ANCIENT	KEOPS is an important cellular complex conserved in Eukarya, with some subunits conserved in Archaea and Bacteria. This complex was recently found to play an essential role in formation of the tRNA modification threonylcarbamoyladenosine (t(6)A), and was previously associated with telomere length maintenance and transcription. KEOPS subunits are conserved in Archaea, especially in the Euryarchaea, where they had been studied in vitro. Here we attempted to delete the genes encoding the four conserved subunits of the KEOPS complex in the euryarchaeote Haloferax volcanii and study their phenotypes in vivo. The fused kae1-bud32 gene was shown to be essential as was cgi121, which is dispensable in yeast. In contrast, pcc1 (encoding the putative dimerizing unit of KEOPS) was not essential in H. volcanii. Deletion of pcc1 led to pleiotropic phenotypes, including decreased growth rate, reduced levels of t(6)A modification, and elevated levels of intracellular glycation products.	[Naor, Adit; Altman-Price, Neta; Cohen-Or, Ifat; Gophna, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Thiaville, Patrick C.; de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Allers, Thorsten] Univ Nottingham, Sch Biol, Queens Med Ctr, Nottingham NG7 2RD, England	Tel Aviv University; State University System of Florida; University of Florida; University of Nottingham	Naor, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	vcrecy@ufl.edu; urigo@tauex.tau.ac.il	de Crecy-Lagard, Valerie/AAN-8995-2020; Gophna, Uri/AAS-8376-2020; Allers, Thorsten/G-5503-2010	Gophna, Uri/0000-0001-5129-5652; Allers, Thorsten/0000-0002-7308-3332	Israel Science Foundation; German-Israeli Project Cooperation (DIP); Federation of the Societies of Biochemistry and Molecular Biology; National Institutes of Health [R01 GM70641]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070641] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); German-Israeli Project Cooperation (DIP); Federation of the Societies of Biochemistry and Molecular Biology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	UG was supported by the Israel Science Foundation and the German-Israeli Project Cooperation (DIP), AN was funded by the Federation of the Societies of Biochemistry and Molecular Biology short term fellowship grant, and VdC by National Institutes of Health (grant no. R01 GM70641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLAH KM, 1991, J BACTERIOL, V173, P5597, DOI 10.1128/jb.173.18.5597-5603.1991; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Bergmiller T, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-118; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Blaby IK, 2010, ARCHAEA, V2010, DOI 10.1155/2010/426239; Chen CC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002258; CLINE SW, 1989, CAN J MICROBIOL, V35, P148, DOI 10.1139/m89-022; Cohen-Or I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017974; Daugeron MC, 2011, NUCL ACIDS RES; de Crecy-Lagard V, 2010, MOL BIOL EVOL, V27, P2062, DOI 10.1093/molbev/msq096; Deutsch C, 2012, J BIOL CHEM, V287, P13666, DOI 10.1074/jbc.M112.344028; Downey M, 2006, CELL, V124, P1155, DOI 10.1016/j.cell.2005.12.044; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Guy CP, 2006, J MOL BIOL, V358, P46, DOI 10.1016/j.jmb.2006.02.010; Hashimoto C, 2011, J BACTERIOL, V193, P6075, DOI 10.1128/JB.05733-11; Hecker A, 2008, EMBO J, V27, P2340, DOI 10.1038/emboj.2008.157; Hecker A, 2007, NUCLEIC ACIDS RES, V35, P6042, DOI 10.1093/nar/gkm554; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; Katz C, 2010, MBIO, V1, DOI 10.1128/mBio.00195-10; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Lin CA, 2010, MOL CELL BIOL, V30, P354, DOI 10.1128/MCB.00754-09; Mandal D, 2010, P NATL ACAD SCI USA, V107, P2872, DOI 10.1073/pnas.0914869107; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; Mehlgarten C, 2010, MOL MICROBIOL, V76, P1082, DOI 10.1111/j.1365-2958.2010.07163.x; Naor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015833; Oberto J, 2009, NUCLEIC ACIDS RES, V37, P5343, DOI 10.1093/nar/gkp557; Peggion C, 2008, FEBS J, V275, P5919, DOI 10.1111/j.1742-4658.2008.06721.x; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; Zalacain M, 2003, J MOL MICROB BIOTECH, V6, P109, DOI 10.1159/000076741	36	18	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43013	10.1371/journal.pone.0043013	http://dx.doi.org/10.1371/journal.pone.0043013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927945	Green Published, gold, Green Submitted			2022-12-25	WOS:000308224700010
J	Su, HM; Lin, TH; Hsu, PC; Chu, CY; Lee, WH; Chen, SC; Lee, CS; Voon, WC; Lai, WT; Sheu, SH				Su, Ho-Ming; Lin, Tsung-Hsien; Hsu, Po-Chao; Chu, Chun-Yuan; Lee, Wen-Hsien; Chen, Szu-Chia; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung			Association of Interarm Systolic Blood Pressure Difference with Atherosclerosis and Left Ventricular Hypertrophy	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ANKLE-BRACHIAL INDEX; PERIPHERAL ARTERIAL-DISEASE; CHRONIC KIDNEY-DISEASE; ARM DIFFERENCES; VASCULAR-DISEASE; PRIMARY-CARE; MORTALITY; PREVALENCE; PREDICTOR	An interarm systolic blood pressure (SBP) difference of 10 mmHg or more have been associated with peripheral artery disease and adverse cardiovascular outcomes. We investigated whether an association exists between this difference and ankle-brachial index (ABI), brachial-ankle pulse wave velocity (baPWV), and echocardiographic parameters. A total of 1120 patients were included in the study. The bilateral arm blood pressures were measured simultaneously by an ABI-form device. The values of ABI and baPWV were also obtained from the same device. Clinical data, ABI < 0.9, baPWV, echocariographic parameters, and an interarm SBP difference >= 10 mmHg were compared and analyzed. We performed two multivariate forward analyses for determining the factors associated with an interarm SBP difference >= 10 mmHg [model 1: significant variables in univariate analysis except left ventricular mass index (LVMI); model 2: significant variables in univariate analysis except ABI < 0.9 and baPWV]. The ABI < 0.9 and high baPWV in model 1 and high LVMI in model 2 were independently associated with an interarm SBP difference >= 10 mmHg. Female, hypertension, and high body mass index were also associated with an interarm SBP difference >= 10 mmHg. Our study demonstrated that ABI < 0.9, high baPWV, and high LVMI were independently associated with an interarm SBP difference of 10 mmHg or more. Detection of an interarm SBP difference may provide a simple method of detecting patients at increased risk of atherosclerosis and left ventricular hypertrophy.	[Su, Ho-Ming; Lin, Tsung-Hsien; Hsu, Po-Chao; Chu, Chun-Yuan; Lee, Wen-Hsien; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol,Div Nephrol, Kaohsiung, Taiwan; [Su, Ho-Ming; Chen, Szu-Chia] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Su, Ho-Ming; Lin, Tsung-Hsien; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Coll Med, Fac Mecicine, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University	Su, HM (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol,Div Nephrol, Kaohsiung, Taiwan.	scarchenone@yahoo.com.tw	蘇, 河名/AAE-9843-2019	Lin, Tsung-Hsien/0000-0002-7226-8730; Su, Ho-Ming/0000-0003-0247-3250; Chu, Chun-Yuan/0000-0001-5550-102X				AVOLIO AP, 1983, CIRCULATION, V68, P50, DOI 10.1161/01.CIR.68.1.50; Bosevski M, 2012, ANGIOLOGY; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Chen SC, 2010, NEPHROLOGY, V15, P294, DOI 10.1111/j.1440-1797.2010.01187.x; Chung CM, 2012, AM J MED SCI; Clark CE, 2007, J HUM HYPERTENS, V21, P633, DOI 10.1038/sj.jhh.1002209; Clark CE, 2006, J HUM HYPERTENS, V20, P923, DOI 10.1038/sj.jhh.1002093; Clark CE, 2002, FAM PRACT, V19, P439, DOI 10.1093/fampra/19.5.439; Clark CE, 2007, FAM PRACT, V24, P420, DOI 10.1093/fampra/cmm035; Clark CE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1327; Clark CE, 2012, LANCET, V379, P905, DOI 10.1016/S0140-6736(11)61710-8; Cyriax EF, 1920, Q J MED, V13, P148, DOI 10.1093/qjmed/os-13.50.148; Dellegrottaglie S, 2011, NEPHROL DIAL TRANSPL, V26, P2891, DOI 10.1093/ndt/gfr186; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; FISHBANE S, 1995, AM J KIDNEY DIS, V25, P34, DOI 10.1016/0272-6386(95)90622-3; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; Fu WC, 2006, NEPHROLOGY, V11, P9, DOI 10.1111/j.1440-1797.2006.00534.x; Hayashi C, 2004, DIABETES RES CLIN PR, V66, P269, DOI 10.1016/j.diabres.2004.03.013; KELLY R, 1989, CIRCULATION, V80, P1652, DOI 10.1161/01.CIR.80.6.1652; Kimura A, 2004, J HYPERTENS, V22, P2277, DOI 10.1097/00004872-200412000-00009; Kitahara T, 2005, AM J KIDNEY DIS, V46, P688, DOI 10.1053/j.ajkd.2005.06.016; Lane D, 2002, J HYPERTENS, V20, P1089, DOI 10.1097/00004872-200206000-00019; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lehmann ED, 1999, LANCET, V354, P528, DOI 10.1016/S0140-6736(99)00179-8; Leskinen Y, 2002, AM J KIDNEY DIS, V40, P472, DOI 10.1053/ajkd.2002.34885; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lohmann FW, 2011, BLOOD PRESS MONIT, V16, P37, DOI 10.1097/MBP.0b013e328343317a; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Newman AB, 1997, J AM GERIATR SOC, V45, P1472, DOI 10.1111/j.1532-5415.1997.tb03198.x; Ono K, 2003, J AM SOC NEPHROL, V14, P1591, DOI 10.1097/01.ASN.0000065547.98258.3D; Orme S, 1999, AGE AGEING, V28, P537, DOI 10.1093/ageing/28.6.537; Pasqualini L, 2012, EUR J INTERN MED, V23, P240, DOI 10.1016/j.ejim.2011.09.004; Roman MJ, 2000, HYPERTENSION, V36, P489, DOI 10.1161/01.HYP.36.4.489; ROMAN MJ, 1995, J AM COLL CARDIOL, V25, P83, DOI 10.1016/0735-1097(94)00316-I; Singer AJ, 1996, ARCH INTERN MED, V156, P2005, DOI 10.1001/archinte.156.17.2005; Sodhi H S, 2007, Kathmandu Univ Med J (KUMJ), V5, P12; Su HM, 2012, ATHEROSCLER IN PRESS; Su HM, 2009, AM J HYPERTENS, V22, P871, DOI 10.1038/ajh.2009.94; Verberk WJ, 2011, AM J HYPERTENS, V24, P1201, DOI 10.1038/ajh.2011.125; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359	43	58	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e41173	10.1371/journal.pone.0041173	http://dx.doi.org/10.1371/journal.pone.0041173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927905	Green Published, gold, Green Submitted			2022-12-25	WOS:000308224700002
J	Hirschhorn, T; Barizilay, L; Smorodinsky, NI; Ehrlich, M				Hirschhorn, Tal; Barizilay, Lior; Smorodinsky, Nechama I.; Ehrlich, Marcelo			Differential Regulation of Smad3 and of the Type II Transforming Growth Factor-beta Receptor in Mitosis: Implications for Signaling	PLOS ONE			English	Article							TGF-BETA; UBIQUITIN LIGASE; CELL-CYCLE; MEDIATED ENDOCYTOSIS; NEGATIVE REGULATION; SPINDLE CHECKPOINT; MITOTIC SPINDLE; DEGRADATION; ACTIVATION; SMURF2	The response to transforming growth factor-beta (TGF-beta) depends on cellular context. This context is changed in mitosis through selective inhibition of vesicle trafficking, reduction in cell volume and the activation of mitotic kinases. We hypothesized that these alterations in cell context may induce a differential regulation of Smads and TGF-beta receptors. We tested this hypothesis in mesenchymal-like ovarian cancer cells, arrested (or not) in mitosis with 2-methoxyestradiol (2ME2). In mitosis, without TGF-beta stimulation, Smad3 was phosphorylated at the C-terminus and linker regions and localized to the mitotic spindle. Phosphorylated Smad3 interacted with the negative regulators of Smad signaling, Smurf2 and Ski, and failed to induce a transcriptional response. Moreover, in cells arrested in mitosis, Smad3 levels were progressively reduced. These phosphorylations and reduction in the levels of Smad3 depended on ERK activation and Mps1 kinase activity, and were abrogated by increasing the volume of cells arrested in mitosis with hypotonic medium. Furthermore, an Mps1-dependent phosphorylation of GFP-Smad3 was also observed upon its over-expression in interphase cells, suggesting a mechanism of negative regulation which counters increases in Smad3 concentration. Arrest in mitosis also induced a block in the clathrin-mediated endocytosis of the type II TGF-beta receptor (T beta RII). Moreover, following the stimulation of mitotic cells with TGF-beta, the proteasome-mediated attenuation of TGF-beta receptor activity, the degradation and clearance of T beta RII from the plasma membrane, and the clearance of the TGF-beta ligand from the medium were compromised, and the C-terminus phosphorylation of Smad3 was prolonged. We propose that the reduction in Smad3 levels, its linker phosphorylation, and its association with negative regulators (observed in mitosis prior to ligand stimulation) represent a signal attenuating mechanism. This mechanism is balanced by the retention of active TGF-beta receptors at the plasma membrane. Together, both mechanisms allow for a regulated cellular response to TGF-beta stimuli in mitosis.	[Hirschhorn, Tal; Barizilay, Lior; Smorodinsky, Nechama I.; Ehrlich, Marcelo] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Smorodinsky, Nechama I.] Tel Aviv Univ, George S Wise Fac Life Sci, Alec & Myra Marmot Hybridoma Unit, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Hirschhorn, T (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	marceloe@post.tau.ac.il		Ehrlich, Marcelo/0000-0002-2352-1808	Israeli Science Foundation (ISF) [1592/11]	Israeli Science Foundation (ISF)(Israel Science Foundation)	The study was funded in part through a grant (1592/11 to ME) of the Israeli Science Foundation (ISF; http://www.isf.org.il/); The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Boucrot E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001477; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Chetrit D, 2011, J BIOL CHEM, V286, P5392, DOI 10.1074/jbc.M110.161851; Clarke DC, 2008, TRENDS CELL BIOL, V18, P430, DOI 10.1016/j.tcb.2008.06.006; Clarke DC, 2009, MOL CELL BIOL, V29, P2443, DOI 10.1128/MCB.01443-08; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Daly AC, 2010, J BIOL CHEM, V285, P6489, DOI 10.1074/jbc.M109.043877; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Dore JJE, 2001, MOL BIOL CELL, V12, P675, DOI 10.1091/mbc.12.3.675; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Ehrlich M, 2011, CELL SIGNAL, V23, P1424, DOI 10.1016/j.cellsig.2011.04.004; Estep AL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001279; Fukuchi M, 2001, MOL BIOL CELL, V12, P1431, DOI 10.1091/mbc.12.5.1431; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Habela CW, 2007, CELL CYCLE, V6, P1613, DOI 10.4161/cc.6.13.4357; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Jin Q, 2007, J BIOL CHEM, V282, P19122, DOI 10.1074/jbc.M609915200; Jin QY, 2009, J CELL PHYSIOL, V221, P707, DOI 10.1002/jcp.21910; Kamath K, 2006, MOL CANCER THER, V5, P2225, DOI 10.1158/1535-7163.MCT-06-0113; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kfir S, 2005, MOL CELL BIOL, V25, P8239, DOI 10.1128/MCB.25.18.8239-8250.2005; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Liu F, 2006, CYTOKINE GROWTH F R, V17, P9, DOI 10.1016/j.cytogfr.2005.09.010; Luo KX, 1997, EMBO J, V16, P1970, DOI 10.1093/emboj/16.8.1970; Marcelain K, 2005, ONCOGENE, V24, P4321, DOI 10.1038/sj.onc.1208631; Matsuura I, 2010, J BIOL CHEM, V285, P1754, DOI 10.1074/jbc.M109.063826; Matsuzaki K, 2011, CARCINOGENESIS, V32, P1578, DOI 10.1093/carcin/bgr172; Meyer C, 2011, J HEPATOL, V55, P369, DOI 10.1016/j.jhep.2010.11.027; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Osmundson EC, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-14; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Penheiter SG, 2010, MOL BIOL CELL, V21, P4009, DOI 10.1091/mbc.E09-12-1019; Petersen M, 2010, ONCOGENE, V29, P1351, DOI 10.1038/onc.2009.426; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schweitzer JK, 2005, J BIOL CHEM, V280, P41628, DOI 10.1074/jbc.M504497200; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Sivan G, 2008, CELL CYCLE, V7, P741, DOI 10.4161/cc.7.6.5596; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; Wartlick O, 2011, NAT REV MOL CELL BIO, V12, P594, DOI 10.1038/nrm3169; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yang Y, 2006, ONCOGENE, V25, P7235, DOI 10.1038/sj.onc.1209712; Zhu SC, 2007, J BIOL CHEM, V282, P18327, DOI 10.1074/jbc.M700636200; Zieba A, 2012, MOL CELLULAR PROTOMI; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898	67	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43459	10.1371/journal.pone.0043459	http://dx.doi.org/10.1371/journal.pone.0043459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927969	gold, Green Published, Green Submitted			2022-12-25	WOS:000308286300053
J	Konopka, KH; Harbers, M; Houghton, A; Kortekaas, R; van Vliet, A; Timmerman, W; den Boer, JA; Struys, MMRF; van Wijhe, M				Konopka, Karl-Heinz; Harbers, Marten; Houghton, Andrea; Kortekaas, Rudie; van Vliet, Andre; Timmerman, Wia; den Boer, Johan A.; Struys, Michel M. R. F.; van Wijhe, Marten			Somatosensory Profiles but Not Numbers of Somatosensory Abnormalities of Neuropathic Pain Patients Correspond with Neuropathic Pain Grading	PLOS ONE			English	Article							MECHANISMS; HYPERALGESIA; NOCICEPTORS; SYMPTOMS; PROTOCOL; INJURY	Due to the lack of a specific diagnostic tool for neuropathic pain, a grading system to categorize pain as 'definite', 'probable', 'possible' and 'unlikely' neuropathic was proposed. Somatosensory abnormalities are common in neuropathic pain and it has been suggested that a greater number of abnormalities would be present in patients with 'probable' and 'definite' grades. To test this hypothesis, we investigated the presence of somatosensory abnormalities by means of Quantitative Sensory Testing (QST) in patients with a clinical diagnosis of neuropathic pain and correlated the number of sensory abnormalities and sensory profiles to the different grades. Of patients who were clinically diagnosed with neuropathic pain, only 60% were graded as 'definite' or 'probable', while 40% were graded as 'possible' or 'unlikely' neuropathic pain. Apparently, there is a mismatch between a clinical neuropathic pain diagnosis and neuropathic pain grading. Contrary to the expectation, patients with 'probable' and 'definite' grades did not have a greater number of abnormalities. Instead, similar numbers of somatosensory abnormalities were identified for each grade. The profiles of sensory signs in 'definite' and 'probable' neuropathic pain were not significantly different, but different from the 'unlikely' grade. This latter difference could be attributed to differences in the prevalence of patients with a mixture of sensory gain and loss and with sensory loss only. The grading system allows a separation of neuropathic and non-neuropathic pain based on profiles but not on the total number of sensory abnormalities. Our findings indicate that patient selection based on grading of neuropathic pain may provide advantages in selecting homogenous groups for clinical research.	[Konopka, Karl-Heinz; Struys, Michel M. R. F.; van Wijhe, Marten] Univ Groningen, Dept Anesthesiol, Pain Management Unit, Univ Med Ctr Groningen, Groningen, Netherlands; [Harbers, Marten; den Boer, Johan A.] Univ Groningen, Dept Psychiat, Univ Med Ctr Groningen, Groningen, Netherlands; [Houghton, Andrea] Merck & Co Inc, West Point, PA USA; [Kortekaas, Rudie] Univ Groningen, Dept Neurosci, Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands; [van Vliet, Andre; Timmerman, Wia] PRA Int, Zuidlaren, Netherlands	University of Groningen; University of Groningen; Merck & Company; University of Groningen	Konopka, KH (corresponding author), Univ Groningen, Dept Anesthesiol, Pain Management Unit, Univ Med Ctr Groningen, Groningen, Netherlands.	k.h.konopka@umcg.nl		Struys, Michel/0000-0003-0421-536X; van Wijhe, Marten/0000-0001-6873-4092	Dutch Top Institute Pharma project [T5-108]	Dutch Top Institute Pharma project	This study was performed within the framework of Dutch Top Institute Pharma project T5-108. Partners in this project include Merck Co., PRA International and UMC Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2000, CLIN J PAIN, V16, pS12, DOI 10.1097/00002508-200006001-00004; Baumgartner U, 2002, PAIN, V96, P141, DOI 10.1016/S0304-3959(01)00438-9; Dworkin RH, 2007, J PAIN, V8, P118, DOI 10.1016/j.jpain.2006.06.005; FAGIUS J, 1981, J NEUROL SCI, V51, P11, DOI 10.1016/0022-510X(81)90056-3; Felix ER, 2009, J REHABIL RES DEV, V46, P69, DOI 10.1682/JRRD.2008.04.0058; Freynhagen R, 2008, PAIN, V135, P65, DOI 10.1016/j.pain.2007.05.004; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; Gierthmuhlen J, 2011, PAIN; Hansson P, 2003, EUR J PAIN, V7, P353, DOI 10.1016/S1090-3801(03)00051-X; Hansson P, 2007, PAIN, V129, P256, DOI 10.1016/j.pain.2007.03.030; Jensen TS, 2001, EUR J PHARMACOL, V429, P1, DOI 10.1016/S0014-2999(01)01302-4; Konopka KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037524; Liu XG, 2000, PAIN, V84, P309, DOI 10.1016/S0304-3959(99)00211-0; Macrae WA, 2008, BRIT J ANAESTH, V101, P77, DOI 10.1093/bja/aen099; Magerl W, 2010, PAIN, V151, P598, DOI 10.1016/j.pain.2010.07.026; Maier C, 2010, PAIN; Moore D.S., 2003, MATH GAZ, V4th, DOI DOI 10.2307/3619120; Ochoa JL, 2005, MUSCLE NERVE, V32, P459, DOI 10.1002/mus.20367; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Scholz J, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000047; Serra J, 2009, PAIN, V147, P46, DOI 10.1016/j.pain.2009.07.028; Shy ME, 2003, NEUROLOGY, V60, P898, DOI 10.1212/01.WNL.0000058546.16985.11; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Treede RD, 2002, PAIN, V98, P235, DOI 10.1016/S0304-3959(02)00203-8; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Uceyler N, 2011, EUR NEUROL REV, V6, P128; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0	30	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43526	10.1371/journal.pone.0043526	http://dx.doi.org/10.1371/journal.pone.0043526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927981	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300061
J	Zamft, BM; Marblestone, AH; Kording, K; Schmidt, D; Martin-Alarcon, D; Tyo, K; Boyden, ES; Church, G				Zamft, Bradley Michael; Marblestone, Adam H.; Kording, Konrad; Schmidt, Daniel; Martin-Alarcon, Daniel; Tyo, Keith; Boyden, Edward S.; Church, George			Measuring Cation Dependent DNA Polymerase Fidelity Landscapes by Deep Sequencing	PLOS ONE			English	Article							Y-FAMILY; IN-VIVO; AMPLIFICATION; MOLECULE; CALCIUM; SYSTEMS; DPO4	High-throughput recording of signals embedded within inaccessible micro-environments is a technological challenge. The ideal recording device would be a nanoscale machine capable of quantitatively transducing a wide range of variables into a molecular recording medium suitable for long-term storage and facile readout in the form of digital data. We have recently proposed such a device, in which cation concentrations modulate the misincorporation rate of a DNA polymerase (DNAP) on a known template, allowing DNA sequences to encode information about the local cation concentration. In this work we quantify the cation sensitivity of DNAP misincorporation rates, making possible the indirect readout of cation concentration by DNA sequencing. Using multiplexed deep sequencing, we quantify the misincorporation properties of two DNA polymerases - Dpo4 and Klenow exo(-) - obtaining the probability and base selectivity of misincorporation at all positions within the template. We find that Dpo4 acts as a DNA recording device for Mn2+ with a misincorporation rate gain of similar to 2%/mM. This modulation of misincorporation rate is selective to the template base: the probability of misincorporation on template T by Dpo4 increases >50-fold over the range tested, while the other template bases are affected less strongly. Furthermore, cation concentrations act as scaling factors for misincorporation: on a given template base, Mn2+ and Mg2+ change the overall misincorporation rate but do not alter the relative frequencies of incoming misincorporated nucleotides. Characterization of the ion dependence of DNAP misincorporation serves as the first step towards repurposing it as a molecular recording device.	[Zamft, Bradley Michael; Church, George] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Marblestone, Adam H.; Church, George] Harvard Univ, Biophys Program, Boston, MA 02115 USA; [Kording, Konrad] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Kording, Konrad] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Kording, Konrad] Northwestern Univ, Dept Appl Math, Chicago, IL 60611 USA; [Schmidt, Daniel; Martin-Alarcon, Daniel; Boyden, Edward S.] MIT, Media Lab, Cambridge, MA 02139 USA; [Schmidt, Daniel; Martin-Alarcon, Daniel; Boyden, Edward S.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Tyo, Keith] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Schmidt, Daniel; Martin-Alarcon, Daniel; Boyden, Edward S.] MIT, McGovern Inst, Cambridge, MA 02139 USA; [Kording, Konrad] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Marblestone, Adam H.] Harvard Univ, Wyss Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Northwestern University; Northwestern University; Northwestern University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwestern University; Massachusetts Institute of Technology (MIT); Shirley Ryan AbilityLab; Harvard University	Zamft, BM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu	Kording, Konrad P/A-1233-2007; Tyo, Keith/AAM-4543-2020; Tyo, Keith/H-6227-2012	Kording, Konrad P/0000-0001-8408-4499; Tyo, Keith/0000-0002-2342-0687; church, george/0000-0001-6232-9969; Marblestone, Adam/0000-0001-9833-9931	Fannie and John Hertz Foundation; Damon Runyon Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; National Institutes of Health (NIH); National Science Foundation; MIT McGovern Institute and Media Lab; New York Stem Cell Foundation Robertson Investigator Award; Human Frontiers Science Program; Paul Allen Distinguished Investigator in Neuroscience Award; Office of Naval Research; NIH Centers of Excellence in Genomic Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER	Fannie and John Hertz Foundation; Damon Runyon Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); MIT McGovern Institute and Media Lab; New York Stem Cell Foundation Robertson Investigator Award; Human Frontiers Science Program(Human Frontier Science Program); Paul Allen Distinguished Investigator in Neuroscience Award; Office of Naval Research(Office of Naval Research); NIH Centers of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Adam Marblestone is supported by the Fannie and John Hertz Foundation. Daniel Schmidt is supported by the Damon Runyon Foundation. Konrad Kording and Keith Tyo are funded in part by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust. Ed Boyden is supported by National Institutes of Health (NIH), National Science Foundation, the MIT McGovern Institute and Media Lab, the New York Stem Cell Foundation Robertson Investigator Award, the Human Frontiers Science Program, and the Paul Allen Distinguished Investigator in Neuroscience Award. Bradley Zamft and George Church acknowledge support from the Office of Naval Research and the NIH Centers of Excellence in Genomic Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar S, 2006, DNA REPAIR, V5, P479, DOI 10.1016/j.dnarep.2006.01.001; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; BARNES WM, 1992, GENE, V112, P29, DOI 10.1016/0378-1119(92)90299-5; Beard WA, 2002, J BIOL CHEM, V277, P47393, DOI 10.1074/jbc.M210036200; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Braman J, 2002, IN VITRO MUTAGENESIS, P259; Broyde S, 2008, TRENDS BIOCHEM SCI, V33, P209, DOI 10.1016/j.tibs.2008.02.004; Bustamante C, 2011, CELL, V144, P480, DOI 10.1016/j.cell.2011.01.033; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Church GM, 2003, US Patent, Patent No. 20030228611; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; Dorjsuren D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp641; ELDEIRY WS, 1984, P NATL ACAD SCI-BIOL, V81, P7378, DOI 10.1073/pnas.81.23.7378; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Irimia A, 2006, BIOCHEMISTRY-US, V45, P5949, DOI 10.1021/bi052511+; Jozwiakowski SK, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp494; KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kording KP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002291; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; MacKay D. J. C., 2003, INFORM THEORY INFERE; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; PROVOST GS, 1993, MUTAT RES, V288, P133; Purves D, 2001, NEUROSCIENCE, P39; Rider TH, 2003, SCIENCE, V301, P213, DOI 10.1126/science.1084920; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Stanley SA, 2012, SCIENCE, V336, P604, DOI 10.1126/science.1216753; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	32	37	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43876	10.1371/journal.pone.0043876	http://dx.doi.org/10.1371/journal.pone.0043876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928047	gold, Green Published, Green Submitted			2022-12-25	WOS:000308286300097
J	Minton, AZ; Phatak, NR; Stankowska, DL; He, SQ; Ma, HY; Mueller, BH; Jiang, M; Luedtke, R; Yang, SH; Brownlee, C; Krishnamoorthy, RR				Minton, Alena Z.; Phatak, Nitasha R.; Stankowska, Dorota L.; He, Shaoqing; Ma, Hai-Ying; Mueller, Brett H.; Jiang, Ming; Luedtke, Robert; Yang, Shaohua; Brownlee, Colby; Krishnamoorthy, Raghu R.			Endothelin B Receptors Contribute to Retinal Ganglion Cell Loss in a Rat Model of Glaucoma	PLOS ONE			English	Article							OPTIC-NERVE DAMAGE; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; AQUEOUS-HUMOR; IN-VIVO; CIRCULATING ENDOTHELIN-1; ET(B) RECEPTORS; GENE-EXPRESSION; AXONAL LOSS; ADULT-RATS	Glaucoma is an optic neuropathy, commonly associated with elevated intraocular pressure (IOP) characterized by optic nerve degeneration, cupping of the optic disc, and loss of retinal ganglion cells which could lead to loss of vision. Endothelin-1 (ET-1) is a 21-amino acid vasoactive peptide that plays a key role in the pathogenesis of glaucoma; however, the receptors mediating these effects have not been defined. In the current study, endothelin B (ETB) receptor expression was assessed in vivo, in the Morrison's ocular hypertension model of glaucoma in rats. Elevation of IOP in Brown Norway rats produced increased expression of ETB receptors in the retina, mainly in retinal ganglion cells (RGCs), nerve fiber layer (NFL), and also in the inner plexiform layer (IPL) and inner nuclear layer (INL). To determine the role of ETB receptors in neurodegeneration, Wistar-Kyoto wild type (WT) and ETB receptor-deficient (KO) rats were subjected to retrograde labeling with Fluoro-Gold (FG), following which IOP was elevated in one eye while the contralateral eye served as control. IOP elevation for 4 weeks in WT rats caused an appreciable loss of RGCs, which was significantly attenuated in KO rats. In addition, degenerative changes in the optic nerve were greatly reduced in KO rats compared to those in WT rats. Taken together, elevated intraocular pressure mediated increase in ETB receptor expression and its activation may contribute to a decrease in RGC survival as seen in glaucoma. These findings raise the possibility of using endothelin receptor antagonists as neuroprotective agents for the treatment of glaucoma.	[Minton, Alena Z.; Phatak, Nitasha R.; Stankowska, Dorota L.; He, Shaoqing; Brownlee, Colby; Krishnamoorthy, Raghu R.] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX USA; [Ma, Hai-Ying; Mueller, Brett H.; Jiang, Ming; Luedtke, Robert; Yang, Shaohua] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Minton, AZ (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX USA.	Raghu.Krishnamoorthy@unthsc.edu	Yang, Shaohua/D-1738-2013; Phatak, Nitasha/ABI-5989-2020	Phatak, Nitasha/0000-0002-2107-985X	National Glaucoma Research grant from the American Health Assistance Foundation (AHAF); National Eye Institute [1RO1EY019952]; NATIONAL EYE INSTITUTE [R01EY019952] Funding Source: NIH RePORTER	National Glaucoma Research grant from the American Health Assistance Foundation (AHAF)(BrightFocus Foundation); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a National Glaucoma Research grant from the American Health Assistance Foundation (AHAF) and by funding from National Eye Institute (1RO1EY019952) to RRK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BEGG IS, 1971, EXP EYE RES, V11, P141; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Cellini M, 1997, ACTA OPHTHALMOL SCAN, V75, P11; Chauhan BC, 2008, CAN J OPHTHALMOL, V43, P356, DOI 10.3129/i08-060; Chauhan BC, 2006, INVEST OPHTH VIS SCI, V47, P634, DOI 10.1167/iovs.05-1206; Chauhan BC, 2004, INVEST OPHTH VIS SCI, V45, P144, DOI 10.1167/iovs.03-0687; Chauhan BC, 2002, INVEST OPHTH VIS SCI, V43, P2969; CHAUHAN BC, 1992, GRAEF ARCH CLIN EXP, V230, P521, DOI 10.1007/BF00181772; Cioffi GA, 1996, J GLAUCOMA, V5, pA12; Cioffi GA, 1999, EUR J OPHTHALMOL, V9, pS34, DOI 10.1177/112067219900901S12; COCKBURN DM, 1983, AM J OPTOM PHYS OPT, V60, P705; DRAGER UC, 1981, INVEST OPHTH VIS SCI, V20, P285; Dupuis J, 1996, J APPL PHYSIOL, V81, P1510, DOI 10.1152/jappl.1996.81.4.1510; FUKURODA T, 1994, BIOCHEM BIOPH RES CO, V199, P1461, DOI 10.1006/bbrc.1994.1395; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Gariepy CE, 1998, J CLIN INVEST, V102, P1092, DOI 10.1172/JCI3702; Good TJ, 2010, EXPERT OPIN THER TAR, V14, P647, DOI 10.1517/14728222.2010.487065; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Hayreh S S, 1971, Trans Ophthalmol Soc U K, V91, P291; HOLLANDER H, 1968, Brain Research, V10, P120, DOI 10.1016/0006-8993(68)90117-0; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Husak PJ, 2000, J VIROL, V74, P10975, DOI 10.1128/JVI.74.23.10975-10983.2000; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kallberg ME, 2002, J GLAUCOMA, V11, P105; Kermer P, 2000, MOL BRAIN RES, V85, P144, DOI 10.1016/S0169-328X(00)00256-4; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Koliakos GG, 2004, BRIT J OPHTHALMOL, V88, P523, DOI 10.1136/bjo.2003.028290; Kong GYX, 2009, J GLAUCOMA, V18, P93, DOI 10.1097/IJG.0b013e318181284f; Krishnamoorthy RR, 2008, CAN J PHYSIOL PHARM, V86, P380, DOI 10.1139/Y08-040; Lau J, 2006, EXP EYE RES, V82, P132, DOI 10.1016/j.exer.2005.06.002; LEE ME, 1990, J CLIN INVEST, V86, P141, DOI 10.1172/JCI114677; LEPPLEWIENHUES A, 1992, CURR EYE RES, V11, P1041, DOI 10.3109/02713689209015075; Levin LA, 1999, SURV OPHTHALMOL, V43, pS98, DOI 10.1016/S0039-6257(99)00027-2; MACCUMBER MW, 1991, ARCH OPHTHALMOL-CHIC, V109, P705, DOI 10.1001/archopht.1991.01080050121041; MACCUMBER MW, 1994, ARCH OPHTHALMOL-CHIC, V112, P1231, DOI 10.1001/archopht.1994.01090210119024; MACCUMBER MW, 1989, P NATL ACAD SCI USA, V86, P7285, DOI 10.1073/pnas.86.18.7285; MACCUMBER MW, 1990, P NATL ACAD SCI USA, V87, P2359, DOI 10.1073/pnas.87.6.2359; McKinnon SJ, 2002, MOL THER, V5, P780, DOI 10.1006/mthe.2002.0608; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; Morrison JC, 1997, EXP EYE RES, V64, P85, DOI 10.1006/exer.1996.0184; Murphy JA, 2010, BRIT J OPHTHALMOL, V94, P1233, DOI 10.1136/bjo.2009.172098; Nie XJ, 1996, REV NEUROSCIENCE, V7, P177; Orgul S, 1996, INVEST OPHTH VIS SCI, V37, P1860; Osborne NN, 2008, PROG BRAIN RES, V173, P339, DOI 10.1016/S0079-6123(08)01124-2; PERRY VH, 1981, NEUROSCIENCE, V6, P931, DOI 10.1016/0306-4522(81)90174-3; Prasanna G, 2005, PHARMACOL RES, V51, P41, DOI 10.1016/j.phrs.2004.04.006; Prasanna G, 2003, MOL CELL BIOCHEM, V253, P71, DOI 10.1023/A:1026005418874; Prasanna G, 2011, EXP EYE RES, V93, P170, DOI 10.1016/j.exer.2010.09.006; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137; QUIGLEY HA, 1995, AUST NZ J OPHTHALMOL, V23, P85, DOI 10.1111/j.1442-9071.1995.tb00135.x; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; QUIGLEY HA, 1982, ARCH OPHTHALMOL-CHIC, V100, P135, DOI 10.1001/archopht.1982.01030030137016; Rao VR, 2007, EXP EYE RES, V84, P1115, DOI 10.1016/j.exer.2007.02.010; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Resch H, 2009, INVEST OPHTH VIS SCI, V50, P358, DOI 10.1167/iovs.08-2460; Rodieck RW, 1973, VERTEBRATE RETINA PR, Vx; Rosenthal R, 2011, BRIT J PHARMACOL, V162, P806, DOI 10.1111/j.1476-5381.2010.01103.x; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Salinas-Navarro M, 2009, VISION RES, V49, P115, DOI 10.1016/j.visres.2008.09.029; SCATCHARD G, 1949, CHEM REV, V44, P7, DOI 10.1021/cr60137a002; Schlamp CL, 2001, MOL VIS, V7, P192; Stitt AW, 1996, CURR EYE RES, V15, P111, DOI 10.3109/02713689609017618; SUGIYAMA T, 1995, SURV OPHTHALMOL, V39, pS49, DOI 10.1016/S0039-6257(05)80073-6; Tao WH, 1998, CURR EYE RES, V17, P31, DOI 10.1076/ceyr.17.1.31.5256; Tezel G, 1997, J GLAUCOMA, V6, P83; Torbidoni V, 2005, EXP EYE RES, V81, P265, DOI 10.1016/j.exer.2004.12.024; Varela HJ, 1997, J GLAUCOMA, V6, P303; Vorwerk CK, 1996, INVEST OPHTH VIS SCI, V37, P1618; Wang L, 2006, ARCH OPHTHALMOL-CHIC, V124, P717, DOI 10.1001/archopht.124.5.717; Wang X, 2009, EXP EYE RES, V88, P378, DOI 10.1016/j.exer.2008.09.009; Watanabe M, 2002, PROG RETIN EYE RES, V21, P529, DOI 10.1016/S1350-9462(02)00037-X; Weishaupt JH, 2003, NEUROBIOL DIS, V13, P124, DOI 10.1016/S0969-9961(03)00032-9; Wollensak G, 1998, CURR EYE RES, V17, P541, DOI 10.1076/ceyr.17.5.541.5187; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yang ZY, 2007, INVEST OPHTH VIS SCI, V48, P5539, DOI 10.1167/iovs.07-0542; Yorio T, 2002, J GLAUCOMA, V11, P259, DOI 10.1097/00061198-200206000-00016	81	47	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43199	10.1371/journal.pone.0043199	http://dx.doi.org/10.1371/journal.pone.0043199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916224	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800053
J	Napoli, N; Zardi, E; Strollo, R; Arigliani, M; Daverio, A; Olearo, F; Tosi, D; Dicuonzo, G; Scarpa, F; Pedone, C; Simo, HHT; Mottini, G; Pozzilli, P				Napoli, Nicola; Zardi, Enrico; Strollo, Rocky; Arigliani, Michele; Daverio, Andrea; Olearo, Flaminia; Tosi, Daniele; Dicuonzo, Giordano; Scarpa, Filomena; Pedone, Claudio; Tegue Simo, Herve Hilaire; Mottini, Giovanni; Pozzilli, Paolo			Increased Carotid Thickness in Subjects with Recently-Diagnosed Diabetes from Rural Cameroon	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; IMPAIRED GLUCOSE-TOLERANCE; ARTERY INTIMA; GLYCEMIC CONTROL; RISK; PROGRESSION; COMPLICATIONS; HYPERTENSION; POPULATION; PREVALENCE	Background: We have recently shown a high prevalence of diabetes and obesity in rural Cameroon, despite an improved lifestyle. Diabetes in rural Africa remains underdiagnosed and its role in increasing risk of atherosclerosis in these populations is unknown. We investigated the prevalence of carotid atherosclerosis and cardiovascular risk factors in a population of subjects with recently-diagnosed diabetes from rural Cameroon. Methodology/Principal Findings: In a case-control study, carotid intima-media thickness (IMT) was measured in 74 subjects with diabetes (diagnosed <2 years), aged 47-85 and 109 controls comparable for age and sex. Subjects were recruited during a health campaign conducted in April 2009. Blood glucose control (HbA1c, fasting blood glucose) and major cardiovascular risk factors (complete lipid panel, blood pressure) were also measured. Mean carotid IMT was higher in subjects with diabetes than healthy controls at each scanned segment (common, internal carotid and bulb) (P < 0.05), except the near wall of the left bulb. Vascular stiffness tended to be higher and pressure-strain elastic modulus of the left carotid was increased in subjects with diabetes than controls (P < 0.05), but distensibility was similar between the two groups. At least one plaque >0.9 mm was found in 4%, 45.9% and 20% of diabetic subjects at the common, bulb or internal carotid, respectively. Only 25% of patients had an HbA1c<7%, while over 41.6% presented with marked hyperglycemia (HbA1c>9%). The prevalence of diabetic subjects with abnormal levels of LDL-cholesterol, triglycerides, HDL-cholesterol or blood pressure was 45%, 16.6%, 15% and 65.7%, respectively. Conclusions: Carotid thickness is increased in subjects with diabetes from a rural area of Cameroon, despite the relatively recent diagnosis. These findings and the high rate of uncontrolled diabetes in this population support the increasing concern of diabetes and cardiovascular diseases in African countries and indicate the need for multifaceted health interventions in urban and rural settings.	[Napoli, Nicola; Dicuonzo, Giordano; Scarpa, Filomena] Campus Biomed Univ Rome, Lab Clin Microbiol, Rome, Italy; [Napoli, Nicola] Washington Univ, Sch Med, Div Bone & Mineral Dis, St Louis, MO USA; [Tegue Simo, Herve Hilaire] Minist Hlth Dist Baham, Baham, Cameroon; [Pozzilli, Paolo] Queen Mary Univ London, Barts & London Sch Med, Ctr Diabet, London, England	University Campus Bio-Medico - Rome Italy; Washington University (WUSTL); University of London; Queen Mary University London	Napoli, N (corresponding author), Campus Biomed Univ Rome, Lab Clin Microbiol, Rome, Italy.	n.napoli@unicampus.it	Zardi, Enrico Maria/Z-1309-2019; Pedone, Claudio/F-9488-2010; Strollo, Rocky/K-5015-2016; Arigliani, Michele/X-3270-2019; Tosi, Daniele/ABC-3656-2020; Napoli, Nicola/K-8242-2016	Pedone, Claudio/0000-0003-1847-9032; Strollo, Rocky/0000-0001-8967-7613; Arigliani, Michele/0000-0002-5366-4594; Tosi, Daniele/0000-0002-4894-206X; Pozzilli, Paolo/0000-0001-5090-636X; Napoli, Nicola/0000-0002-3091-8205	Farmindustria	Farmindustria	The study was funded by an unconditional grant to University Campus Bio-Medico from Farmindustria. Glucometers and strips were kindly offered by Lifescan Italia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard S, 2005, DIABETES CARE, V28, P1158, DOI 10.2337/diacare.28.5.1158; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P969; Cooper RS, 1998, BMJ-BRIT MED J, V316, P614, DOI 10.1136/bmj.316.7131.614; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Distiller LA, 2006, J DIABETES COMPLICAT, V20, P280, DOI 10.1016/j.jdiacomp.2005.07.012; Distiller LA, 2010, METAB SYNDR RELAT D, V8, P539, DOI 10.1089/met.2010.0036; Faeh D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-163; Faeh D, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-32; Fezeu L, 2010, DIABETES RES CLIN PR, V90, P312, DOI 10.1016/j.diabres.2010.06.029; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; International Diabetes Federation, 2009, DIABETES ATLAS; International Diabetes Federation, 1998, ACC INS REP IDF INS; Kengne AP, 2005, CIRCULATION, V112, P3592, DOI 10.1161/CIRCULATIONAHA.105.544312; LAURENT S, 1988, J HYPERTENS, V6, pS182, DOI 10.1097/00004872-198812040-00054; Levitt NS, 2008, HEART, V94, P1376, DOI 10.1136/hrt.2008.147306; Liu YP, 2007, ENDOCRINE, V31, P289, DOI 10.1007/s12020-007-0035-6; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mayosi B, 2007, Cardiovasc J S Afr, V18, P4; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Mbanya JC, 2003, J CARDIOVASC RISK, V10, P97, DOI [10.1097/00043798-200304000-00004, 10.1097/01.hjr.0000060842.48106.78]; Mbanya JCN, 1997, DIABETOLOGIA, V40, P824, DOI 10.1007/s001250050755; Mbanya JC, 2006, LANCET, V368, P1628, DOI 10.1016/S0140-6736(06)69673-6; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Nambuya AP, 1996, QJM-INT J MED, V89, P705; Napoli N, 2007, AM J CLIN NUTR, V85, P1428, DOI 10.1093/ajcn/85.5.1428; Napoli N, 2010, DIABETES-METAB RES, V26, P10, DOI 10.1002/dmrr.1036; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; O'Rourke MF, 2002, AM J HYPERTENS, V15, P426, DOI 10.1016/S0895-7061(01)02319-6; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Reddy KS, 1998, CIRCULATION, V97, P596; Shah AS, 2009, J CLIN ENDOCR METAB, V94, P3740, DOI 10.1210/jc.2008-2039; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shinoda-Tagawa T, 2002, DIABETOLOGIA, V45, P188, DOI 10.1007/s00125-001-0740-2; Skyler JS, 2009, J AM COLL CARDIOL, V53, P298, DOI [10.1016/j.jacc.2008.10.008, 10.2337/dc08-9026]; Stolar M, 2010, AM J MED, V123, pS3, DOI 10.1016/j.amjmed.2009.12.004; Touboul PJ, 2005, CEREBROVASC DIS, V19, P57, DOI 10.1159/000081913; Tsivgoulis G, 2006, STROKE, V37, P1913, DOI 10.1161/01.STR.0000226399.13528.0a; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wagenknecht LE, 1998, DIABETES CARE, V21, P1812, DOI 10.2337/diacare.21.11.1812; Wagenknecht LE, 2003, ARTERIOSCL THROM VAS, V23, P1035, DOI 10.1161/01.ATV.0000072273.67342.6D; Yamasaki Y, 2000, DIABETES CARE, V23, P1310, DOI 10.2337/diacare.23.9.1310; Yokoyama H, 2006, STROKE, V37, P2420, DOI 10.1161/01.STR.0000236632.58323.cd	44	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41316	10.1371/journal.pone.0041316	http://dx.doi.org/10.1371/journal.pone.0041316			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916106	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800010
J	Rocha-Martins, M; Njaine, B; Silveira, MS				Rocha-Martins, Mauricio; Njaine, Brian; Silveira, Mariana S.			Avoiding Pitfalls of Internal Controls: Validation of Reference Genes for Analysis by qRT-PCR and Western Blot throughout Rat Retinal Development	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; REAL-TIME PCR; MESSENGER-RNA LEVELS; REVERSE TRANSCRIPTION; BETA-ACTIN; RELATIVE QUANTIFICATION; EXPRESSION PROFILES; PROGENITOR CELLS; TARGET GENES; SELECTION	Background: Housekeeping genes have been commonly used as reference to normalize gene expression and protein content data because of its presumed constitutive expression. In this paper, we challenge the consensual idea that housekeeping genes are reliable controls for expression studies in the retina through the investigation of a panel of reference genes potentially suitable for analysis of different stages of retinal development. Methodology/Principal Findings: We applied statistical tools on combinations of retinal developmental stages to assess the most stable internal controls for quantitative RT-PCR (qRT-PCR). The stability of expression of seven putative reference genes (Actb, B2m, Gapdh, Hprt1, Mapk1, Ppia and Rn18s) was analyzed using geNorm, BestKeeper and Normfinder software. In addition, several housekeeping genes were tested as loading controls for Western blot in the same sample panel, using Image J. Overall, for qRT-PCR the combination of Gapdh and Mapk1 showed the highest stability for most experimental sets. Actb was downregulated in more mature stages, while Rn18s and Hprt1 showed the highest variability. We normalized the expression of cyclin D1 using various reference genes and demonstrated that spurious results may result from blind selection of internal controls. For Western blot significant variation could be seen among four putative internal controls (bactin, cyclophilin b, alpha-tubulin and lamin A/C), while MAPK1 was stably expressed. Conclusion: Putative housekeeping genes exhibit significant variation in both mRNA and protein content during retinal development. Our results showed that distinct combinations of internal controls fit for each experimental set in the case of qRT-PCR and that MAPK1 is a reliable loading control for Western blot. The results indicate that biased study outcomes may follow the use of reference genes without prior validation for qRT-PCR and Western blot.	[Rocha-Martins, Mauricio; Silveira, Mariana S.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Dept Neurobiol, BR-21941 Rio De Janeiro, Brazil; [Njaine, Brian] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Cell Therapy & Bioengn Dept, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Rocha-Martins, M (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Dept Neurobiol, BR-21941 Rio De Janeiro, Brazil.	silveira@biof.ufrj.br	Silveira, Mariana/M-4865-2013	Silveira, Mariana/0000-0002-0496-1517; Rocha-Martins, Mauricio/0000-0001-6881-6733	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); CNPq; CAEN/International Society for Neurochemistry	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAEN/International Society for Neurochemistry	This study was funded by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), CNPq, and CAEN/International Society for Neurochemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Ayers Duncan, 2007, BMC Vet Res, V3, P7; Barnhill Alison E, 2010, BMC Res Notes, V3, P25, DOI 10.1186/1756-0500-3-25; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; De Gregoris TB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-62; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dijk F, 2004, BRAIN RES, V1026, P194, DOI 10.1016/j.brainres.2004.08.034; Donovan SL, 2005, SEMIN CELL DEV BIOL, V16, P407, DOI 10.1016/j.semcdb.2005.02.012; Donovan SL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-14; Dowling JE, 1987, RETINAL CELLS INFORM; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Egger Denise, 1994, Molecular Biotechnology, V1, P289, DOI 10.1007/BF02921696; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Liu NK, 2006, J NEUROTRAUM, V23, P1794, DOI 10.1089/neu.2006.23.1794; Liu Y, 2010, ACTA PHARMACOL SIN, V31, P10, DOI 10.1038/aps.2009.185; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo Y, 2011, INVEST OPHTH VIS SCI, V52, P7556, DOI 10.1167/iovs.11-7185; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Martins RAP, 2008, GENE DEV, V22, P179, DOI 10.1101/gad.1608008; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Matta BP, 2011, DEV GENES EVOL, V221, P49, DOI 10.1007/s00427-011-0356-6; McNeill B, 2012, MOL CELL NEUROSCI, V49, P333, DOI 10.1016/j.mcn.2011.12.008; Njaine B, 2010, EUR J NEUROSCI, V32, P311, DOI 10.1111/j.1460-9568.2010.07286.x; Petrs-Silva H, 2004, J CELL PHYSIOL, V198, P179, DOI 10.1002/jcp.10404; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Santos ARA, 2008, J NEUROSCI RES, V86, P3684, DOI 10.1002/jnr.21796; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Seol Dongrim, 2011, BMC Res Notes, V4, P162, DOI 10.1186/1756-0500-4-162; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Sindelka R, 2006, DEV DYNAM, V235, P754, DOI 10.1002/dvdy.20665; Sindelka R, 2008, NUCLEIC ACIDS RES, V36, P387, DOI 10.1093/nar/gkm1024; Spinsanti G, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-32; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Trimarchi JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001588; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; van Wijngaarden P, 2007, MOL VIS, V13, P1508; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2012, MOL BIOL REP, V39, P1585, DOI 10.1007/s11033-011-0897-9; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028	48	52	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43028	10.1371/journal.pone.0043028	http://dx.doi.org/10.1371/journal.pone.0043028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916200	Green Submitted, gold, Green Published			2022-12-25	WOS:000307733800043
J	Saur, M; Moeller, V; Kapetanopoulos, K; Braukmann, S; Gebauer, W; Tenzer, S; Markl, J				Saur, Michael; Moeller, Vanessa; Kapetanopoulos, Katharina; Braukmann, Sandra; Gebauer, Wolfgang; Tenzer, Stefan; Markl, Juergen			Acetylcholine-Binding Protein in the Hemolymph of the Planorbid Snail Biomphalaria glabrata Is a Pentagonal Dodecahedron (60 Subunits)	PLOS ONE			English	Article							PARTICLE ELECTRON CRYOMICROSCOPY; RECEPTOR GENE FAMILY; CYS-LOOP RECEPTORS; MOLECULAR-MODEL; QUATERNARY STRUCTURE; NICOTINIC RECEPTORS; CRYSTAL-STRUCTURE; OXYGEN-TRANSPORT; FUNCTIONAL UNITS; CRYOEM STRUCTURE	Nicotinic acetylcholine receptors (nAChR) play important neurophysiological roles and are of considerable medical relevance. They have been studied extensively, greatly facilitated by the gastropod acetylcholine-binding proteins (AChBP) which represent soluble structural and functional homologues of the ligand-binding domain of nAChR. All these proteins are ring-like pentamers. Here we report that AChBP exists in the hemolymph of the planorbid snail Biomphalaria glabrata (vector of the schistosomiasis parasite) as a regular pentagonal dodecahedron, 22 nm in diameter (12 pentamers, 60 active sites). We sequenced and recombinantly expressed two similar to 25 kDa polypeptides (BgAChBP1 and BgAChBP2) with a specific active site, N-glycan site and disulfide bridge variation. We also provide the exon/intron structures. Recombinant BgAChBP1 formed pentamers and dodecahedra, recombinant BgAChBP2 formed pentamers and probably disulfide-bridged di-pentamers, but not dodecahedra. Three-dimensional electron cryo-microscopy (3D-EM) yielded a 3D reconstruction of the dodecahedron with a resolution of 6 angstrom. Homology models of the pentamers docked to the 6 angstrom structure revealed opportunities for chemical bonding at the inter-pentamer interfaces. Definition of the ligand-binding pocket and the gating C-loop in the 6 angstrom structure suggests that 3D-EM might lead to the identification of functional states in the BgAChBP dodecahedron.	[Saur, Michael; Moeller, Vanessa; Kapetanopoulos, Katharina; Braukmann, Sandra; Gebauer, Wolfgang; Markl, Juergen] Johannes Gutenberg Univ Mainz, Inst Zool, D-6500 Mainz, Germany; [Tenzer, Stefan] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, D-6500 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Saur, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Saarstr 21, D-6500 Mainz, Germany.	markl@uni-mainz.de	Tenzer, Stefan/AAE-2180-2020	Tenzer, Stefan/0000-0003-3034-0017; Saur, Michael/0000-0002-6612-6656; Moeller, Arne/0000-0003-1101-5366	DFG (German Research Foundation); Government of Rhineland-Palatinate via the Center of Immunology of the Johannes Gutenberg University in Mainz	DFG (German Research Foundation)(German Research Foundation (DFG)); Government of Rhineland-Palatinate via the Center of Immunology of the Johannes Gutenberg University in Mainz	This work was funded in part by the DFG (German Research Foundation [www.dfg.de]) in the framework of the research training group 1043 "Immunotherapy'' (VM: grant; JM: consumables), and by the Government of Rhineland-Palatinate via the Center of Immunology of the Johannes Gutenberg University in Mainz [www.uni-mainz.de] (ST: financial support of Core Facility "mass spectrometry'', JM: financial support of Core Facility "3D-EM''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2007, ZOOLOGICA SCRIPTA, V36, P13; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amos FF, 2009, BIOMACROMOLECULES, V10, P3298, DOI 10.1021/bm900893f; Babakhani A, 2009, COMPUT BIOL CHEM, V33, P160, DOI 10.1016/j.compbiolchem.2008.12.002; Banks G, 2009, FASEB J, V23, P3030, DOI 10.1096/fj.08-117135; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bourne Y, 2010, P NATL ACAD SCI USA, V107, P6076, DOI 10.1073/pnas.0912372107; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Fornasari MS, 2004, MOL BIOL EVOL, V21, P97, DOI 10.1093/molbev/msg244; Fuschiotti P, 2006, J MOL BIOL, V356, P510, DOI 10.1016/j.jmb.2005.11.048; Gatsogiannis C, 2007, J MOL BIOL, V374, P465, DOI 10.1016/j.jmb.2007.09.036; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Grant T., 2007, THESIS IMPERIAL COLL; Grigorieff N, 2011, CURR OPIN STRUC BIOL, V21, P265, DOI 10.1016/j.sbi.2011.01.008; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2004, J BIOL CHEM, V279, P24197, DOI 10.1074/jbc.M402452200; HARRIS JR, 1994, EUR J BIOCHEM, V225, P521, DOI 10.1111/j.1432-1033.1994.00521.x; HERSKOVITS TT, 1994, COMP BIOCHEM PHYS B, V107, P433, DOI 10.1016/0305-0491(94)90208-9; HERSKOVITS TT, 1990, COMP BIOCHEM PHYS B, V95, P321, DOI 10.1016/0305-0491(90)90083-6; Huang J, 2009, MAR BIOTECHNOL, V11, P596, DOI 10.1007/s10126-008-9176-8; Ilan E, 1986, BIOCHEMISTRY-US, V25, P4; Jaenicke E, 2003, BIOCHEM J, V375, P681, DOI 10.1042/BJ20030726; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P67, DOI 10.1007/s10158-006-0039-6; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; Jorgensen A, 2004, MOL PHYLOGENET EVOL, V32, P778, DOI 10.1016/j.ympev.2004.02.011; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lieb B, 2001, P NATL ACAD SCI USA, V98, P4546, DOI 10.1073/pnas.071049998; Lieb B, 2006, P NATL ACAD SCI USA, V103, P12011, DOI 10.1073/pnas.0601861103; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Maksay Gabor, 2009, Curr Mol Pharmacol, V2, P253; MANGUM CP, 1975, J EXP ZOOL, V191, P279, DOI 10.1002/jez.1401910213; MANGUM CP, 1985, AM J PHYSIOL, V248, pR505, DOI 10.1152/ajpregu.1985.248.5.R505; Markl J, 2009, J MOL BIOL, V392, P362, DOI 10.1016/j.jmb.2009.06.082; McCormack T, 2010, BIOCHEMISTRY-US, V49, P2279, DOI 10.1021/bi902023y; Meissner U, 2007, MICRON, V38, P29, DOI 10.1016/j.micron.2006.04.010; Moeller V, 2011, IUBMB LIFE, V63, P323, DOI 10.1002/iub.453; Page R.D., 2002, CURRENT PROTOCOLS BI, V6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Romanelli MN, 2003, MED RES REV, V23, P393, DOI 10.1002/med.10037; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shao YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-324; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; TERWILLIGER NB, 1976, BIOCHIM BIOPHYS ACTA, V453, P101, DOI 10.1016/0005-2795(76)90254-3; Tsetlin V, 2011, J NEUROCHEM, V116, P734, DOI 10.1111/j.1471-4159.2010.07060.x; TZARTOS SJ, 1991, AUTOIMMUNITY, V8, P259, DOI 10.3109/08916939109007633; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wigand P, 2009, J AGR FOOD CHEM, V57, P4328, DOI 10.1021/jf8034836; WOOD EJ, 1975, BIOCHEM J, V149, P437, DOI 10.1042/bj1490437; Yakel JL, 2010, J PHYSIOL-LONDON, V588, P597, DOI 10.1113/jphysiol.2009.182691	58	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43685	10.1371/journal.pone.0043685	http://dx.doi.org/10.1371/journal.pone.0043685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916297	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800095
J	Thakur, S; Feng, XL; Shi, ZQ; Ganapathy, A; Mishra, MK; Atadja, P; Morris, D; Riabowol, K				Thakur, Satbir; Feng, Xiaolan; Shi, Zhong Qiao; Ganapathy, Amudha; Mishra, Manoj Kumar; Atadja, Peter; Morris, Don; Riabowol, Karl			ING1 and 5-Azacytidine Act Synergistically to Block Breast Cancer Cell Growth	PLOS ONE			English	Article							CANDIDATE TUMOR-SUPPRESSOR; DEACETYLASE INHIBITORS; MESSENGER-RNA; APOPTOSIS; P33(ING1); EXPRESSION; P53; CARCINOMA; GENE; CHEMOSENSITIVITY	Background: Inhibitor of Growth (ING) proteins are epigenetic "readers'' that recognize trimethylated lysine 4 of histone H3 (H3K4Me3) and target histone acetyl transferase (HAT) and histone deacetylase (HDAC) complexes to chromatin. Methods and Principal Findings: Here we asked whether dysregulating two epigenetic pathways with chemical inhibitors showed synergistic effects on breast cancer cell line killing. We also tested whether ING1 could synergize better with chemotherapeutics that target the same epigenetic mechanism such as the HDAC inhibitor LBH589 (Panobinostat) or a different epigenetic mechanism such as 5-azacytidine (5azaC), which inhibits DNA methyl transferases. Simultaneous treatment of breast cancer cell lines with LBH589 and 5azaC did not show significant synergy in killing cells. However, combination treatment of ING1 with either LBH589 or 5azaC did show synergy. The combination of ING1b with 5azaC, which targets two distinct epigenetic mechanisms, was more effective at lower doses and enhanced apoptosis as determined by Annexin V staining and cleavage of caspase 3 and poly-ADP-ribose polymerase (PARP). ING1b plus 5azaC also acted synergistically to increase gamma H2AX staining indicating significant levels of DNA damage were induced. Adenoviral delivery of ING1b with 5azaC also inhibited cancer cell growth in a murine xenograft model and led to tumor regression when viral concentration was optimized in vivo. Conclusions: These data show that targeting distinct epigenetic pathways can be more effective in blocking cancer cell line growth than targeting the same pathway with multiple agents, and that using viral delivery of epigenetic regulators can be more effective in synergizing with a chemical agent than using two chemotherapeutic agents. This study also indicates that the ING1 epigenetic regulator may have additional activities in the cell when expressed at high levels.	[Thakur, Satbir; Feng, Xiaolan; Ganapathy, Amudha; Riabowol, Karl] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Thakur, Satbir; Feng, Xiaolan; Shi, Zhong Qiao; Ganapathy, Amudha; Morris, Don; Riabowol, Karl] So Alberta Canc Res Inst, Calgary, AB, Canada; [Shi, Zhong Qiao; Morris, Don] Univ Calgary, Tom Baker Canc Ctr, Dept Med & Oncol, Calgary, AB, Canada; [Mishra, Manoj Kumar] Univ Calgary, Dept Oncol & Clin Neurosci, Calgary, AB, Canada; [Atadja, Peter] Novartis Inst Biomed Res, Shanghai, Peoples R China	University of Calgary; Tom Baker Cancer Clinic; University of Calgary; University of Calgary; Novartis	Thakur, S (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	karl@ucalgary.ca	Ganapathy, Amudha/ABI-6930-2020; Feng, Xiaolan/J-9997-2019; Mishra, Manoj/A-7105-2018	Mishra, Manoj/0000-0001-9636-4930; Feng, Xiaolan/0000-0002-7333-8198	Alberta Cancer Foundation; Alberta Innovates Health Solutions; Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research	Alberta Cancer Foundation; Alberta Innovates Health Solutions; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This study was supported by grants to DM from the Alberta Cancer Foundation and Alberta Innovates Health Solutions, and to KR from Alberta Innovates Health Solutions and the Canadian Institutes of Health Research. XF is recipient of an Alberta Heritage Foundation for Medical Research Studentship and KR is a Scientist of the Alberta Heritage Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Atadja PW, 2011, PROG DRUG RES, V67, P175, DOI 10.1007/978-3-7643-8989-5_9; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Cheung KJ, 2002, EXP CELL RES, V279, P291, DOI 10.1006/excr.2002.5610; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Eastman A, 1999, SEMIN ONCOL, V26, P7; Garkavtsev I, 2005, CANCER BIOL THER, V4, P48; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Garkavtsev I, 1998, NATURE, V391, P295, DOI 10.1038/34675; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Han XJ, 2008, NAT CELL BIOL, V10, P1333, DOI 10.1038/ncb1792; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Helbing CC, 1997, CANCER RES, V57, P1255; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Kim TY, 2006, EPIGENETICS-US, V1, P14; Kiziltepe T, 2007, MOL CANCER THER, V6, P1718, DOI 10.1158/1535-7163.MCT-07-0010; Kristensen LS, 2009, EUR J PHARMACOL, V625, P131, DOI 10.1016/j.ejphar.2009.10.011; Kuendgen A, 2008, ANN HEMATOL, V87, P601, DOI 10.1007/s00277-008-0477-9; Li ZY, 2010, CANCER BIOTHER RADIO, V25, P427, DOI 10.1089/cbr.2010.0778; Liu Jian-ying, 2003, Zhonghua Bing Li Xue Za Zhi, V32, P48; Loewith R, 2000, MOL CELL BIOL, V20, P3807, DOI 10.1128/MCB.20.11.3807-3816.2000; Maher Stacey K, 2009, Curr Drug Targets, V10, P392; Mandili G, 2012, FEBS J, V279, P2182, DOI 10.1111/j.1742-4658.2012.08602.x; Nagashima M, 2003, ONCOGENE, V22, P343, DOI 10.1038/sj.onc.1206115; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Nouman GS, 2003, J CLIN PATHOL, V56, P507, DOI 10.1136/jcp.56.7.507; Oki Y, 2007, CRIT REV ONCOL HEMAT, V61, P140, DOI 10.1016/j.critrevonc.2006.07.010; Raguz S, 2008, BRIT J CANCER, V99, P387, DOI 10.1038/sj.bjc.6604510; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Sanchez-Abarca LI, 2010, BLOOD, V115, P107, DOI 10.1182/blood-2009-03-210393; Scott M, 2001, J CELL SCI, V114, P3455; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shimada H, 2002, ONCOGENE, V21, P1208, DOI 10.1038/sj.onc.1205176; Shinoura N, 1999, CANCER RES, V59, P5521; Smith KT, 2010, CHEM BIOL, V17, P65, DOI 10.1016/j.chembiol.2009.12.010; Soriano AO, 2007, BLOOD, V110, P2302, DOI 10.1182/blood-2007-03-078576; SZYF M, 1994, TRENDS PHARMACOL SCI, V15, P233, DOI 10.1016/0165-6147(94)90317-4; Tallen G, 2003, ANTICANCER RES, V23, P1631; Thalappilly S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021065; Tokunaga E, 2000, CANCER LETT, V152, P15, DOI 10.1016/S0304-3835(99)00434-6; Toyama T, 1999, ONCOGENE, V18, P5187, DOI 10.1038/sj.onc.1202905; Toyama T, 2003, J STEROID BIOCHEM, V87, P57, DOI 10.1016/S0960-0760(03)00388-1; Toyama Tatsuya, 2004, Breast Cancer, V11, P33, DOI 10.1007/BF02967999; Vieyra D, 2002, CANCER RES, V62, P4445; Wu J C, 1985, Prog Clin Biol Res, V198, P119; Xie Y, 2011, CANCER GENE THER, V18, P176, DOI 10.1038/cgt.2010.67; Xie YF, 2008, CANCER LETT, V271, P105, DOI 10.1016/j.canlet.2008.05.050; Zhang X, 2004, FEBS LETT, V570, P7, DOI 10.1016/j.febslet.2004.06.010; Zhao Y, 2011, CANC LETT; Zhu Jin-Jun, 2004, Ai Zheng, V23, P640; Zhu Y, 2011, CANCER GENE THER, V18, P627, DOI 10.1038/cgt.2011.31; Zhu Z, 2005, WORLD J GASTROENTERO, V11, P1903	53	25	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43671	10.1371/journal.pone.0043671	http://dx.doi.org/10.1371/journal.pone.0043671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916295	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800093
J	Wang, Y; Zhou, GS				Wang, Yu; Zhou, Guangsheng			Light Use Efficiency over Two Temperate Steppes in Inner Mongolia, China	PLOS ONE			English	Article							GROSS PRIMARY PRODUCTION; CARBON-DIOXIDE EXCHANGE; ECOSYSTEM CO2 EXCHANGE; NET ECOSYSTEM; PRIMARY PRODUCTIVITY; TERRESTRIAL BIOSPHERE; SATELLITE; MODIS; RESPIRATION; VARIABILITY	Vegetation light use efficiency (LUE) is a key parameter of Production Efficiency Models (PEMs) for simulating gross primary production (GPP) of vegetation, from regional to global scales. Previous studies suggest that grasslands have the largest inter-site variation of LUE and controlling factors of grassland LUE differ from those of other biomes, since grasslands are usually water-limited ecosystems. Combining eddy covariance flux data with the fraction of photosynthetically active radiation absorbed by the plant canopy from MODIS, we report LUE on a typical steppe and a desert steppe in Inner Mongolia, northern China. Results show that both annual average LUE and maximum LUE were higher on the desert steppe (0.51 and 1.13 g C MJ(-1)) than on the typical steppe (0.34 and 0.88 g C MJ(-1)), despite the higher GPP of the latter. Water availability was the primary limiting factor of LUE at both sites. Evaporative fraction (EF) or the ratio of actual evapotranspiration to potential evapotranspiration (AET/PET) can explain 50-70% of seasonal LUE variations at both sites. However, the slope of linear regression between LUE and EF (or AET/PET) differed significantly between the two sites. LUE increased with the diffuse radiation ratio on the typical steppe; however, such a trend was not found for the desert steppe. Our results suggest that a biome-dependent LUEmax is inappropriate, because of the large inter-site difference of LUEmax within the biome. EF could be a promising down-regulator on grassland LUE for PEMs, but there may be a site-specific relationship between LUE and EF.	[Wang, Yu; Zhou, Guangsheng] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Wang, Yu] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhou, Guangsheng] Chinese Acad Meteorol Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Meteorological Sciences (CAMS)	Wang, Y (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	gszhou@ibcas.ac.cn		Wang, Yu/0000-0003-2085-0064	State Key Development Program of Basic Research [2010CB951303]; Strategic Priority Research Program Climate Change: Carbon Budget and Related Issues of the Chinese Academy of Sciences [XDA05050408]	State Key Development Program of Basic Research; Strategic Priority Research Program Climate Change: Carbon Budget and Related Issues of the Chinese Academy of Sciences	This research was jointly supported by State Key Development Program of Basic Research (2010CB951303) and Strategic Priority Research Program Climate Change: Carbon Budget and Related Issues of the Chinese Academy of Sciences (XDA05050408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Canadell JG, 2000, ECOSYSTEMS, V3, P115, DOI 10.1007/s100210000014; Choudhury BJ, 2001, REMOTE SENS ENVIRON, V75, P1, DOI 10.1016/S0034-4257(00)00151-6; Connolly J, 2009, BIOGEOSCIENCES, V6, P225, DOI 10.5194/bg-6-225-2009; Fang HL, 2012, REMOTE SENS ENVIRON, V119, P43, DOI 10.1016/j.rse.2011.12.006; Fensholt R, 2004, REMOTE SENS ENVIRON, V91, P490, DOI 10.1016/j.rse.2004.04.009; Garbulsky MF, 2010, GLOBAL ECOL BIOGEOGR, V19, P253, DOI 10.1111/j.1466-8238.2009.00504.x; Gilmanov TG, 2007, AGR ECOSYST ENVIRON, V121, P93, DOI 10.1016/j.agee.2006.12.008; Gong Z., 2014, CHINESE SOIL GEOGRAP; Gu LH, 1999, J GEOPHYS RES-ATMOS, V104, P31421, DOI 10.1029/1999JD901068; Gu LH, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001242; Guindin-Garcia N, 2012, AGR FOREST METEOROL, V161, P15, DOI 10.1016/j.agrformet.2012.03.012; Horn JE, 2011, BIOGEOSCIENCES, V8, P999, DOI 10.5194/bg-8-999-2011; Jones MB, 2004, NEW PHYTOL, V164, P423, DOI 10.1111/j.1469-8137.2004.01201.x; Letts MG, 2005, ECOSCIENCE, V12, P53, DOI 10.2980/i1195-6860-12-1-53.1; Li LH, 1998, ACTA BOT SIN, V40, P955; Li SG, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2006JG000349; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; MONTEITH JL, 1972, J APPL ECOL, V9, P747, DOI 10.2307/2401901; Murray S., 2000, PILOT ANAL GLOBAL EC; Myneni R. B., 2003, USERS GUIDE FPAR LAI; Niyogi D, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020915; Nouvellon Y, 2000, AGR FOREST METEOROL, V105, P21, DOI 10.1016/S0168-1923(00)00194-5; Polley HW, 2011, ECOSYSTEMS, V14, P15, DOI 10.1007/s10021-010-9389-3; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Schwalm CR, 2006, AGR FOREST METEOROL, V140, P269, DOI 10.1016/j.agrformet.2006.06.010; Serrano-Ortiz P, 2010, AGR FOREST METEOROL, V150, P321, DOI 10.1016/j.agrformet.2010.01.002; SHABANOV N, 2007, COLLECTION 5 MODIS L; Turner DP, 2009, REMOTE SENS ENVIRON, V113, P1529, DOI 10.1016/j.rse.2009.03.003; Turner DP, 2003, GLOBAL CHANGE BIOL, V9, P383, DOI 10.1046/j.1365-2486.2003.00573.x; Turner DP, 2005, GLOBAL CHANGE BIOL, V11, P666, DOI 10.1111/j.1365-2486.2005.00936.x; Wang HS, 2010, REMOTE SENS ENVIRON, V114, P2248, DOI 10.1016/j.rse.2010.05.001; Wang YL, 2008, AGR FOREST METEOROL, V148, P714, DOI 10.1016/j.agrformet.2008.01.013; World Resources Institute, 2000, WORLD RES 2000 2001, P119; Xiao XM, 2006, IEEE T GEOSCI REMOTE, V44, P1933, DOI 10.1109/TGRS.2006.874796; Xiao XM, 2005, REMOTE SENS ENVIRON, V94, P105, DOI 10.1016/j.rse.2004.08.015; Xiao XM, 2004, REMOTE SENS ENVIRON, V89, P519, DOI 10.1016/j.rse.2003.11.008; Yang FL, 2011, AGR ECOSYST ENVIRON, V142, P318, DOI 10.1016/j.agee.2011.05.032; Yuan H, 2011, REMOTE SENS ENVIRON, V115, P1171, DOI 10.1016/j.rse.2011.01.001; Yuan WP, 2007, AGR FOREST METEOROL, V143, P189, DOI 10.1016/j.agrformet.2006.12.001; Zhang M, 2011, AGR FOREST METEOROL, V151, P803, DOI 10.1016/j.agrformet.2011.01.011	44	11	11	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43614	10.1371/journal.pone.0043614	http://dx.doi.org/10.1371/journal.pone.0043614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916283	Green Published, gold			2022-12-25	WOS:000307733800082
J	Wu, BTF; Dyer, RA; King, DJ; Richardson, KJ; Innis, SM				Wu, Brian T. F.; Dyer, Roger A.; King, D. Janette; Richardson, Kelly J.; Innis, Sheila M.			Early Second Trimester Maternal Plasma Choline and Betaine Are Related to Measures of Early Cognitive Development in Term Infants	PLOS ONE			English	Article							N-3 FATTY-ACIDS; HIPPOCAMPAL PLASTICITY; EMBRYONIC-DEVELOPMENT; PREGNANT-WOMEN; AVAILABILITY; ALTERS; SUPPLEMENTATION; HOMOCYSTEINE; MEMORY; DIMETHYLGLYCINE	Background: The importance of maternal dietary choline for fetal neural development and later cognitive function has been well-documented in experimental studies. Although choline is an essential dietary nutrient for humans, evidence that low maternal choline in pregnancy impacts neurodevelopment in human infants is lacking. We determined potential associations between maternal plasma free choline and its metabolites betaine and dimethylglycine in pregnancy and infant neurodevelopment at 18 months of age. Methodology: This was a prospective study of healthy pregnant women and their full-term, single birth infants. Maternal blood was collected at 16 and 36 weeks of gestation and infant neurodevelopment was assessed at 18 months of age for 154 mother-infant pairs. Maternal plasma choline, betaine, dimethylglycine, methionine, homocysteine, cysteine, total B12, holotranscobalamin and folate were quantified. Infant neurodevelopment was evaluated using the Bayley Scales of Infant Development-III. Multivariate regression, adjusting for covariates that impact development, was used to determine the associations between maternal plasma choline, betaine and dimethylglycine and infant neurodevelopment. Results: The maternal plasma free choline at 16 and 36 weeks gestation was median (interquartile range) 6.70 (5.78-8.03) and 9.40 (8.10-11.3) mu mol/L, respectively. Estimated choline intakes were (mean +/- SD) 383 +/- 98.6 mg/day, and lower than the recommended 450 mg/day. Betaine intakes were 142 +/- 70.2 mg/day. Significant positive associations were found between infant cognitive test scores and maternal plasma free choline (B = 6.054, SE = 2.283, p = 0.009) and betaine (B = 7.350, SE = 1.933, p = 0.0002) at 16 weeks of gestation. Maternal folate, total B12, or holotranscobalamin were not related to infant development. Conclusion: We show that choline status in the first half of pregnancy is associated with cognitive development among healthy term gestation infants. More work is needed on the potential limitation of choline or betaine in the diets of pregnant women.	[Wu, Brian T. F.; Dyer, Roger A.; King, D. Janette; Richardson, Kelly J.; Innis, Sheila M.] Univ British Columbia, Fac Med, Dept Paediat, Nutr & Metab Res Program,Child & Family Res Inst, Vancouver, BC, Canada	Child & Family Research Institute; University of British Columbia	Wu, BTF (corresponding author), Univ British Columbia, Fac Med, Dept Paediat, Nutr & Metab Res Program,Child & Family Res Inst, Vancouver, BC, Canada.	sinnis@mail.ubc.ca			Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was funded by a grant from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Villaca Y, 2011, BEHAV BRAIN RES, V221, P367, DOI 10.1016/j.bbr.2009.12.049; Albright CD, 1999, DEV BRAIN RES, V113, P13, DOI 10.1016/S0165-3806(98)00183-7; Bayley N, 1993, BAYLEY SCALES INFANT; Brown L., 1997, TEST NONVERBAL INTEL; Cheng RK, 2008, LEARN MEMORY, V15, P153, DOI 10.1101/lm.729408; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Depeint F, 2006, CHEM-BIOL INTERACT, V163, P113, DOI 10.1016/j.cbi.2006.05.010; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Friesen RW, 2007, J NUTR, V137, P2641; Glenn MJ, 2008, BRAIN RES, V1237, P110, DOI 10.1016/j.brainres.2008.08.049; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Ilcol Y. Ozarda, 2002, Archives of Physiology and Biochemistry, V110, P393, DOI 10.1076/apab.110.5.393.11832; Ilcol YO, 2005, J NUTR BIOCHEM, V16, P489, DOI 10.1016/j.jnutbio.2005.01.011; Innis SM, 2008, AM J CLIN NUTR, V87, P548, DOI 10.1093/ajcn/87.3.548; Innis SM, 2006, J NUTR, V136, P2226, DOI 10.1093/jn/136.8.2226; Innis SM, 2003, AM J CLIN NUTR, V77, P473, DOI 10.1093/ajcn/77.2.473; Institute of Medicine National Academy of Sciences, 1998, DIET REF INT FOL THI, P390; Kohlmeier M, 2005, P NATL ACAD SCI USA, V102, P16025, DOI 10.1073/pnas.0504285102; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Luka Z, 2009, J BIOL CHEM, V284, P22507, DOI 10.1074/jbc.R109.019273; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Mehedint MG, 2010, FASEB J, V24, P184, DOI 10.1096/fj.09-140145; Molloy AM, 2005, AM J CLIN NUTR, V82, P836, DOI 10.1093/ajcn/82.4.836; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Nijhout HF, 2004, J BIOL CHEM, V279, P55008, DOI 10.1074/jbc.M410818200; Patterson KY., 2008, USDA DATABASE CHOLIN; Signore C, 2008, AM J CLIN NUTR, V87, P896, DOI 10.1093/ajcn/87.4.896; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Velzing-Aarts FV, 2005, AM J CLIN NUTR, V81, P1383; WHO: World Health Organization, 2010, WHO CHILD GROWTH STA; Wong-Goodrich SJE, 2008, BRAIN RES, V1237, P153, DOI 10.1016/j.brainres.2008.08.074; Wu BT, 2012, BR J NUTR IN PRESS; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; Zeisel SH, 2011, SEMIN CELL DEV BIOL, V22, P624, DOI 10.1016/j.semcdb.2011.06.002	39	93	96	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43448	10.1371/journal.pone.0043448	http://dx.doi.org/10.1371/journal.pone.0043448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916264	Green Submitted, gold, Green Published			2022-12-25	WOS:000307733800068
J	Soffler, C; Bosco-Lauth, AM; Aboellail, TA; Marolf, AJ; Bowen, RA				Soffler, Carl; Bosco-Lauth, Angela M.; Aboellail, Tawfik A.; Marolf, Angela J.; Bowen, Richard A.			Development and Characterization of a Caprine Aerosol Infection Model of Melioidosis	PLOS ONE			English	Article							PSEUDOMONAS-PSEUDOMALLEI; BURKHOLDERIA-PSEUDOMALLEI; PULMONARY MELIOIDOSIS; SEPTICEMIC MELIOIDOSIS; DIAGNOSIS; THAILAND; GOATS; EPIDEMIOLOGY; AUSTRALIA; SPECTRUM	Infection with Burkholderia pseudomallei causes the disease melioidosis, which often presents as a serious suppurative infection that is typically fatal without intensive treatment and is a significant emerging infectious disease in Southeast Asia. Despite intensive research there is still much that remains unknown about melioidosis pathogenesis. New animal models of melioidosis are needed to examine novel aspects of pathogenesis as well as for the evaluation of novel therapeutics. The objective of the work presented here was to develop a subacute to chronic caprine model of melioidosis and to characterize the progression of disease with respect to clinical presentation, hematology, clinical microbiology, thoracic radiography, and gross and microscopic pathology. Disease was produced in all animals following an intratracheal aerosol of 10(4) CFU delivered, with variable clinical manifestations indicative of subacute and chronic disease. Bronchointerstitial pneumonia was apparent microscopically by day 2 and radiographically and grossly apparent by day 7 post infection (PI). Early lesions of bronchopneumonia soon progressed to more severe bronchointerstitial pneumonia with pyogranuloma formation. Extrapulmonary dissemination appeared to be a function of pyogranuloma invasion of pulmonary vasculature, which peaked around day 7 PI. Histopathology indicated that leukocytoclastic vasculitis was the central step in dissemination of B. pseudomallei from the lungs as well as in the establishment of new lesions. While higher doses of organism in goats can produce acute fatal disease, the dose investigated and resulting disease had many similarities to human melioidosis and may warrant further development to provide a model for the study of both natural and bioterrorism associated disease.	[Soffler, Carl; Aboellail, Tawfik A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Bosco-Lauth, Angela M.; Bowen, Richard A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Marolf, Angela J.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Soffler, C (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	richard.bowen@colostate.edu	Aboellail, Tawfik/AAB-8990-2019	Aboellail, Tawfik/0000-0003-0989-5333	NIH/NCRR (National Center for Research Resources) Ruth L. Kirschstein Institutional NIH [T32-RR-007072]; NIAID (National Institute of Allergy and Infectious Diseases), NIH [AI065357]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER	NIH/NCRR (National Center for Research Resources) Ruth L. Kirschstein Institutional NIH; NIAID (National Institute of Allergy and Infectious Diseases), NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NCRR (National Center for Research Resources) Ruth L. Kirschstein Institutional NIH T32-RR-007072 and AI065357 from NIAID (National Institute of Allergy and Infectious Diseases), NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAID or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATISOOK K, 1988, Southeast Asian Journal of Tropical Medicine and Public Health, V19, P637; Bateson E M, 1981, Australas Radiol, V25, P239, DOI 10.1111/j.1440-1673.1981.tb02255.x; BRUNDAGE WG, 1968, AM J TROP MED HYG, V17, P183, DOI 10.4269/ajtmh.1968.17.183; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chong V F, 1996, Australas Radiol, V40, P244, DOI 10.1111/j.1440-1673.1996.tb00395.x; Choy JL, 2000, ACTA TROP, V74, P153, DOI 10.1016/S0001-706X(99)00065-0; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; DHIENSIRI T, 1988, RADIOLOGY, V166, P711, DOI 10.1148/radiology.166.3.3340766; EVERETT ED, 1975, AM REV RESPIR DIS, V112, P331; FATIMAH I, 1984, VET REC, V114, P67, DOI 10.1136/vr.114.3.67; Gilad J, 2007, ISR MED ASSOC J, V9, P499; GREENAWALD KA, 1969, AM J CLIN PATHOL, V52, P188; HARRIES EJ, 1948, LANCET, V254, P363; Huisin't Veld D, 2005, AM J TROP MED HYG, V73, P657; IP M, 1995, CHEST, V108, P1420, DOI 10.1378/chest.108.5.1420; Ketai L, 2006, J THORAC IMAG, V21, P265, DOI 10.1097/01.rti.0000213575.01657.4e; LAWS L., 1964, AUSTRALIAN VETERINARY J, V40, P309, DOI 10.1111/j.1751-0813.1964.tb04524.x; LAWS L., 1963, Queensland J. Agric. Sci, V20, P499; LEWIS F. A., 1952, AUSTRALIAN VET JOUR, V28, P145, DOI 10.1111/j.1751-0813.1952.tb05152.x; Lim KS, 2010, CLIN RADIOL, V65, P66, DOI 10.1016/j.crad.2009.08.008; Limmathurotsakul D, 2005, J CLIN MICROBIOL, V43, P2274, DOI 10.1128/JCM.43.5.2274-2276.2005; Limmathurotsakul D, 2011, BR MED B; Limmathurotsakul D, 2012, EMERG INFECT DIS, V18, P325, DOI 10.3201/eid1802.111347; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Limmathurotsakul D, 2009, AM J TROP MED HYG, V81, P335, DOI 10.4269/ajtmh.2009.81.335; Muttarak M, 2009, BRIT J RADIOL, V82, P514, DOI 10.1259/bjr/15785231; NARITA M, 1982, NATL I ANIM HEALTH Q, V22, P170; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; OLDS R. J., 1954, Australian Veterinary Journal, V30, P253, DOI 10.1111/j.1751-0813.1954.tb05416.x; OMAR AR, 1963, J COMP PATHOL THERAP, V73, P359, DOI 10.1016/S0368-1742(63)80038-7; PATTERSON MC, 1967, J AMER MED ASSOC, V200, P447; Pearson T, 2007, INFECT GENET EVOL, V7, P416, DOI 10.1016/j.meegid.2006.12.002; PIGGOTT JA, 1970, ARCH PATHOL, V90, P101; PUTHUCHEARY SD, 1992, T ROY SOC TROP MED H, V86, P683, DOI 10.1016/0035-9203(92)90191-E; Reechaipichitkul Wipa, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P664; RETNASABAPATHY A, 1966, VET REC, V79, P166, DOI 10.1136/vr.79.6.166-a; Simpson AJH, 1999, J CLIN PATHOL, V52, P616, DOI 10.1136/jcp.52.8.616; Sprague LD, 2004, J VET MED B, V51, P305, DOI 10.1111/j.1439-0450.2004.00797.x; Stanton AT, 1925, LANCET, V1, P10; Strauss J M, 1969, Med J Malaya, V24, P94; SUTMO'LLER P., 1957, JOUR AMER VET MED ASSOC, V130, P415; THOMAS AD, 1988, AUST VET J, V65, P43, DOI 10.1111/j.1751-0813.1988.tb07350.x; Titball Richard W, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS111, DOI 10.1016/S0035-9203(08)70026-9; VANDERLUGT JJ, 1995, J S AFR VET ASSOC, V66, P71; Whitmore A, 1912, Ind Med Gaz, V47, P262; WONG KT, 1995, HISTOPATHOLOGY, V26, P51, DOI 10.1111/j.1365-2559.1995.tb00620.x; Wuthiekanun V, 2007, AM J TROP MED HYG, V77, P812, DOI 10.4269/ajtmh.2007.77.812	48	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43207	10.1371/journal.pone.0043207	http://dx.doi.org/10.1371/journal.pone.0043207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916225	Green Published, Green Submitted, gold			2022-12-25	WOS:000307823600060
J	Srinivasaiah, NM; Anand, VD; Vaidyanathan, S; Sinha, A				Srinivasaiah, Nishant M.; Anand, Vijay D.; Vaidyanathan, Srinivas; Sinha, Anindya			Usual Populations, Unusual Individuals: Insights into the Behavior and Management of Asian Elephants in Fragmented Landscapes	PLOS ONE			English	Article							AFRICAN ELEPHANTS; CONSERVATION; RISK; RELATEDNESS; OCCUPANCY; MOVEMENTS; EXPANSION; SIZE	Background: A dearth in understanding the behavior of Asian elephants (Elephas maximus) at the scale of populations and individuals has left important management issues, particularly related to human-elephant conflict (HEC), unresolved. Evaluation of differences in behavior and decision-making among individual elephants across groups in response to changing local ecological settings is essential to fill this gap in knowledge and to improve our approaches towards the management and conservation of elephants. Methodology/Principal Findings: We hypothesized certain behavioral decisions that would be made by Asian elephants as reflected in their residence time and movement rates, time-activity budgets, social interactions and group dynamics in response to resource availability and human disturbance in their habitat. This study is based on 200 h of behavioral observations on 60 individually identified elephants and a 184-km(2) grid-based survey of their natural and anthropogenic habitats within and outside the Bannerghatta National Park, southern India during the dry season. At a general population level, the behavioral decisions appeared to be guided by the gender, age and group-type of the elephants. At the individual level, the observed variation could be explained only by the idiosyncratic behaviors of individuals and that of their associating conspecific individuals. Recursive partitioning classification trees for residence time of individual elephants indicated that the primary decisions were taken by individuals, independently of their above-mentioned biological and ecological attributes. Conclusions/Significance: Decision-making by Asian elephants thus appears to be determined at two levels, that of the population and, more importantly, the individual. Models based on decision-making by individual elephants have the potential to predict conflict in fragmented landscapes that, in turn, could aid in mitigating HEC. Thus, we must target individuals, in addition to populations, in our efforts to manage and conserve this threatened species, particularly in human-dominated landscapes.	[Srinivasaiah, Nishant M.] Tata Inst Fundamental Res, Postgrad Program Wildlife Biol & Conservat, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Anand, Vijay D.] A Rocha India, Bangalore, Karnataka, India; [Vaidyanathan, Srinivas] Fdn Ecol Res Advocacy & Learning, Pondicherry, India; [Sinha, Anindya] Natl Inst Adv Studies, Sch Nat Sci & Engn, Bangalore, Karnataka, India; [Sinha, Anindya] Nat Conservat Fdn, Mysore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Srinivasaiah, NM (corresponding author), Tata Inst Fundamental Res, Postgrad Program Wildlife Biol & Conservat, Natl Ctr Biol Sci, GKVK Campus, Bangalore, Karnataka, India.	msnishant@gmail.com		Vaidyanathan, Srinivas/0000-0003-3642-0309	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by the Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand VD, 2009, 2 ROCH IND; [Anonymous], [No title captured]; Archie EA, 2006, P ROY SOC B-BIOL SCI, V273, P513, DOI 10.1098/rspb.2005.3361; Arivazhagan Chelliya, 2008, Gajah, V29, P11; Bhaskaran N, 1998, THESIS BHARATHIDASAN; Bhaskaran N, 2010, KARNATAKA ELEPHANT C; Blake S, 2004, CONSERV BIOL, V18, P1191, DOI 10.1111/j.1523-1739.2004.01860.x; Buij R, 2007, BIOL CONSERV, V135, P189, DOI 10.1016/j.biocon.2006.10.028; Burke T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002417; Chiyo PI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031382; Chiyo PI, 2011, ANIM BEHAV, V81, P1093, DOI 10.1016/j.anbehav.2011.02.013; Chiyo PI, 2011, BEHAV ECOL, V22, P552, DOI 10.1093/beheco/arr016; Choudhury A, 2008, IUCN 2011 IUCN RED L; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; de Silva Shermin, 2011, BMC Ecology, V11, P17, DOI 10.1186/1472-6785-11-17; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Douglas-Hamilton I, 1972, ECOLOGY BEHAVIOUR AF; Druce HC, 2008, BIOL CONSERV, V141, P3127, DOI 10.1016/j.biocon.2008.09.024; Evans KE, 2008, ANIM BEHAV, V76, P779, DOI 10.1016/j.anbehav.2008.03.019; Fernando P, 2008, MAMM BIOL, V73, P2, DOI 10.1016/j.mambio.2007.07.007; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Gopalakrishna S.P., 2010, Gajah, V33, P47; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; GRASS Development Team, 2007, GRASS 6 2 US MAN; Gubbi S, 2012, BIOL CONSERV, V148, P88, DOI 10.1016/j.biocon.2012.01.046; Hibert F, 2010, BIODIVERS CONSERV, V19, P2003, DOI 10.1007/s10531-010-9822-0; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Loarie SR, 2009, BIOL CONSERV, V142, P3099, DOI 10.1016/j.biocon.2009.08.021; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Martin J, 2010, ECOL APPL, V20, P1173, DOI 10.1890/09-0276.1; Morrison M.L., 1998, WILDLIFE HABITAT REL; Okello MM, 2008, J ARID ENVIRON, V72, P2179, DOI 10.1016/j.jaridenv.2008.07.008; Poole J., 1982, THESIS U CAMBRIDGE C; POOLE JH, 1987, BEHAVIOUR, V102, P283, DOI 10.1163/156853986X00171; Poole Joyce H., 1994, P331; Pretorius Y, 2011, J ANIM ECOL, V80, P875, DOI 10.1111/j.1365-2656.2011.01819.x; Quantum GIS Development Team, 2009, QUANT GIS 1 4 0 GEOG; R Development Core Team, 2009, R FDN STAT COMP; Shannon G, 2009, DIVERS DISTRIB, V15, P776, DOI 10.1111/j.1472-4642.2009.00581.x; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; Sokal R. R., 2012, BIOMETRY; Sukumar R., 2003, LIVING ELEPHANTS EVO; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Vidya TNC, 2005, J ETHOL, V23, P205, DOI 10.1007/s10164-005-0144-8; Whyte IJ, 1993, PACHYDERM, V16, P72; Wittemyer G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1919, DOI 10.1007/s00265-007-0432-0; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Wittemyer G, 2008, P NATL ACAD SCI USA, V105, P19108, DOI 10.1073/pnas.0801744105; Young KD, 2009, AUSTRAL ECOL, V34, P329, DOI 10.1111/j.1442-9993.2009.01934.x; [No title captured]; [No title captured]; [No title captured]; [No title captured]	53	27	28	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42571	10.1371/journal.pone.0042571	http://dx.doi.org/10.1371/journal.pone.0042571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916135	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600016
J	Jayasundar, JJ; Ju, JH; He, LL; Liu, DZ; Meilleur, F; Zhao, JK; Callaway, DJE; Bu, ZM				Jayasundar, Jayant James; Ju, Jeong Ho; He, Lilin; Liu, Dazhi; Meilleur, Flora; Zhao, Jinkui; Callaway, David J. E.; Bu, Zimei			Open Conformation of Ezrin Bound to Phosphatidylinositol 4,5-Bisphosphate and to F-actin Revealed by Neutron Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; EZRIN/RADIXIN/MOESIN ERM PROTEINS; SPIN-ECHO SPECTROSCOPY; SMALL-ANGLE SCATTERING; N-TERMINAL DOMAIN; X-RAY-SCATTERING; NA+/H+ EXCHANGER; BINDING-SITE; PLASMA-MEMBRANE; FERM DOMAIN	Ezrin is a member of the ezrin-radixin-moesin family (ERM) of adapter proteins that are localized at the interface between the cell membrane and the cortical actin cytoskeleton, and they regulate a variety of cellular functions. The structure representing a dormant and closed conformation of an ERM protein has previously been determined by x-ray crystallography. Here, using contrast variation small angle neutron scattering, we reveal the structural changes of the full-length ezrin upon binding to the signaling lipid phosphatidylinositol 4,5-bisphosphate (PIP2) and to F-actin. Ezrin binding to F-actin requires the simultaneous binding of ezrin to PIP2. Once bound to F-actin, the opened ezrin forms more extensive contacts with F-actin than generally depicted, suggesting a possible role of ezrin in regulating the interfacial structure and dynamics between the cell membrane and the underlying actin cytoskeleton. In addition, using gel filtration, we find that the conformational opening of ezrin in response to PIP2 binding is cooperative, but the cooperativity is disrupted by a phospho-mimic mutation S249D in the 4.1-ezrin/radixin/moesin (FERM) domain of ezrin. Using surface plasmon resonance, we show that the S249D mutation weakens the binding affinity and changes the kinetics of 4.1-ERM to PIP2 binding. The study provides the first structural view of the activated ezrin bound to PIP2 and to F-actin.	[Jayasundar, Jayant James; Ju, Jeong Ho; Callaway, David J. E.; Bu, Zimei] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [He, Lilin] Oak Ridge Natl Lab, Ctr Struct Mol Biol, Oak Ridge, TN 37831 USA; [He, Lilin] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA; [He, Lilin; Liu, Dazhi; Meilleur, Flora; Zhao, Jinkui] Oak Ridge Natl Lab, Neutron Sci Directorate, Oak Ridge, TN 37831 USA; [Meilleur, Flora] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA; [Callaway, David J. E.] NYU, Sch Med, New York, NY 10016 USA	City University of New York (CUNY) System; City College of New York (CUNY); United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of North Carolina; North Carolina State University; New York University	Bu, ZM (corresponding author), CUNY City Coll, Dept Chem, Marshak Sci Bldg,Rm 1336,160 Convent Ave, New York, NY 10031 USA.	zbu@ccny.cuny.edu	Zhao, Jinkui/B-7872-2013; Liu, Dazhi/G-2675-2013; He, Lilin/O-4994-2016	Zhao, Jinkui/0000-0002-7756-1952; Liu, Dazhi/0000-0002-7604-6940; He, Lilin/0000-0002-9560-8101; Meilleur, Flora/0000-0001-9313-8989; Jayasundar, Jayant James/0000-0001-9963-9629	National Institutes of Health [5R01HL086496]; National Institutes of Health Grant, NCRR [2G12 RR003060]; Division of Scientific User Facilities, Department of Energy Basic Energy Sciences; Oak Ridge National Laboratory Directed Research and Development Program; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086496] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant, NCRR; Division of Scientific User Facilities, Department of Energy Basic Energy Sciences(United States Department of Energy (DOE)); Oak Ridge National Laboratory Directed Research and Development Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01HL086496 (to Z. B.).; City College of New York was recipient of National Institutes of Health Grant 2G12 RR003060 from the NCRR. The work performed at Oak Ridge National Laboratory was supported by the Division of Scientific User Facilities, Department of Energy Basic Energy Sciences, and the Oak Ridge National Laboratory Directed Research and Development Program. We thank D. M. Engelman for comments on the manuscript.	Alexander RT, 2005, P NATL ACAD SCI USA, V102, P12253, DOI 10.1073/pnas.0409197102; Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Ben-Aissa K, 2012, J BIOL CHEM, V287, P16311, DOI 10.1074/jbc.M111.304881; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bu ZM, 2011, ADV PROTEIN CHEM STR, V83, P163, DOI 10.1016/B978-0-12-381262-9.00005-7; Bu ZM, 1999, BIOPHYS J, V77, P1064, DOI 10.1016/S0006-3495(99)76956-0; Bu ZM, 1998, J APPL CRYSTALLOGR, V31, P533, DOI 10.1107/S0021889897015422; Bu ZM, 2005, P NATL ACAD SCI USA, V102, P17646, DOI 10.1073/pnas.0503388102; Casaletto JB, 2011, P NATL ACAD SCI USA, V108, P11924, DOI 10.1073/pnas.1103418108; Chambers DN, 2005, BIOCHEMISTRY-US, V44, P3926, DOI 10.1021/bi0480382; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Cong Y, 2008, J MOL BIOL, V375, P331, DOI 10.1016/j.jmb.2007.10.027; Dard N, 2004, DEV BIOL, V271, P87, DOI 10.1016/j.ydbio.2004.03.024; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; ENGELMAN DM, 1975, ANNU REV BIOPHYS BIO, V4, P219, DOI 10.1146/annurev.bb.04.060175.001251; Farago B, 2010, BIOPHYS J, V99, P3473, DOI 10.1016/j.bpj.2010.09.058; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Finnerty CM, 2004, J CELL SCI, V117, P1547, DOI 10.1242/jcs.01038; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Glatter O., 1982, SMALL ANGLE XRAY SCA, P33; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hanono A, 2006, J CELL BIOL, V175, P803, DOI 10.1083/jcb.200604046; Heller WT, 2010, ACTA CRYSTALLOGR D, V66, P1213, DOI [10.1107/S0907444910017658, 10.1107/S090744491001]; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Ho DL, 2004, J BIOL CHEM, V279, P39146, DOI 10.1074/jbc.M404565200; Hoeflich KP, 2003, BIOCHEMISTRY-US, V42, P11634, DOI 10.1021/bi0350497; Ishikawa H, 2001, J MOL BIOL, V310, P973, DOI 10.1006/jmbi.2001.4818; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; LaLonde DP, 2009, BIOCHEMISTRY-US, V48, P2261, DOI 10.1021/bi802089k; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li JQ, 2009, J MOL BIOL, V392, P166, DOI 10.1016/j.jmb.2009.07.005; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Liu Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.266pe23; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Mahon MJ, 2009, MOL ENDOCRINOL, V23, P1691, DOI 10.1210/me.2009-0164; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; Niggli V, 2005, ANNU REV CELL DEV BI, V21, P57, DOI 10.1146/annurev.cellbio.21.021704.102317; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; PESTONJAMASP K, 1995, MOL BIOL CELL, V6, P247, DOI 10.1091/mbc.6.3.247; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Roch F, 2010, J CELL SCI, V123, P2057, DOI 10.1242/jcs.064550; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Roy C, 1997, J BIOL CHEM, V272, P20088, DOI 10.1074/jbc.272.32.20088; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Scott JD, 2009, SCI SIGNAL, V2, DOI [10.1126/scisignal.253pc1, 10.1126/scisignal.296eg14, 10.1126/scisignal.266eg4]; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wald FA, 2008, J CELL SCI, V121, P644, DOI 10.1242/jcs.016246; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; WIGNALL GD, 1987, J APPL CRYSTALLOGR, V20, P28, DOI 10.1107/S0021889887087181; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zhao JK, 2010, J APPL CRYSTALLOGR, V43, P1068, DOI 10.1107/S002188981002217X; Zhu L., 2008, COMP STUDY EZRIN PHO; Zwaenepoel I, 2012, MOL BIOL CELL, V23, P1080, DOI 10.1091/mbc.E11-07-0588	92	33	36	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37119	37133		10.1074/jbc.M112.380972	http://dx.doi.org/10.1074/jbc.M112.380972			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22927432	hybrid, Green Published			2022-12-25	WOS:000310588500046
J	Kloft, N; Neukirch, C; von Hoven, G; Bobkiewicz, W; Weis, S; Boller, K; Husmann, M				Kloft, Nicole; Neukirch, Claudia; von Hoven, Gisela; Bobkiewicz, Wiesia; Weis, Silvia; Boller, Klaus; Husmann, Matthias			A Subunit of Eukaryotic Translation Initiation Factor 2 alpha-Phosphatase (CreP/PPP1R15B) Regulates Membrane Traffic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING TOXINS; STAPHYLOCOCCAL ALPHA-HEMOLYSIN; ACTIVATED PROTEIN-KINASE; CAVEOLIN-1 BINDING MOTIF; PLASMA-MEMBRANE; EIF2-ALPHA DEPHOSPHORYLATION; MULTIVESICULAR BODIES; CELLULAR-RESPONSES; GENE-EXPRESSION; VIBRIO-CHOLERAE	The constitutive reverter of eIF2 alpha phosphorylation (CReP)/PPP1r15B targets the catalytic subunit of protein phosphatase 1 (PP1c) to phosphorylated eIF2 alpha (p-eIF2 alpha) to promote its dephosphorylation and translation initiation. Here, we report a novel role and mode of action of CReP. We found that CReP regulates uptake of the pore-forming Staphylococcus aureus alpha-toxin by epithelial cells. This function was independent of PP1c and translation, although p-eIF2 alpha was involved. The latter accumulated at sites of toxin attack and appeared conjointly with alpha-toxin in early endosomes. CReP localized to membranes, interacted with phosphomimetic eIF2 alpha, and, upon overexpression, induced and decorated a population of intracellular vesicles, characterized by accumulation of N-(lissamine rhodamine B sulfonyl) phosphatidylethanolamine (N-Rh-PE), a lipid marker of exosomes and intralumenal vesicles of multivesicular bodies. By truncation analysis, we delineated the CReP vesicle induction/association region, which comprises an amphipathic alpha-helix and is distinct from the PP1c interaction domain. CReP was also required for exocytosis from erythroleukemia cells and thus appears to play a broader role in membrane traffic. In summary, the mammalian traffic machinery co-opts p-eIF2 alpha and CReP, regulators of translation initiation.	[Kloft, Nicole; Neukirch, Claudia; von Hoven, Gisela; Bobkiewicz, Wiesia; Weis, Silvia; Husmann, Matthias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Boller, Klaus] Paul Ehrlich Inst, Dept Immunol, Morphol Sect, D-63225 Langen, Germany	Johannes Gutenberg University of Mainz; Paul Ehrlich Institute	Husmann, M (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Microbiol & Hyg, Hochhaus Augustuspl, D-55131 Mainz, Germany.	husmann@uni-mainz.de	von Hoven, Gisa/AAP-4044-2021		Deutsche Forschungsgemeinschaft [CRC 490]; Project D3	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Project D3	This work was supported by Deutsche Forschungsgemeinschaft, CRC 490, Project D3 (to M. H.). The contributions of G. v. H. were in partial fulfillment of her thesis requirements.	ANTEUNIS A, 1974, CELL TISSUE RES, V149, P497; Apodaca G, 2002, AM J PHYSIOL-RENAL, V282, pF179, DOI 10.1152/ajprenal.2002.282.2.F179; Aroian R, 2007, CURR OPIN MICROBIOL, V10, P57, DOI 10.1016/j.mib.2006.12.008; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Bethani I, 2010, EMBO J, V29, P2677, DOI 10.1038/emboj.2010.175; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Chen CH, 2010, J LASER MICRO NANOEN, V5, P1, DOI 10.2961/jlmn.2010.01.0001; De Filippi L, 2007, CURR GENET, V52, P171, DOI 10.1007/s00294-007-0151-0; Deloche O, 2004, MOL CELL, V13, P357, DOI 10.1016/S1097-2765(04)00008-5; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Freche B, 2007, SEMIN IMMUNOPATHOL, V29, P249, DOI 10.1007/s00281-007-0085-0; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Gonzalez MR, 2011, CELL MICROBIOL, V13, P1026, DOI 10.1111/j.1462-5822.2011.01600.x; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Husmann M, 2006, BIOCHEM BIOPH RES CO, V344, P1128, DOI 10.1016/j.bbrc.2006.03.241; Husmann M, 2009, FEBS LETT, V583, P337, DOI 10.1016/j.febslet.2008.12.028; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Keyel PA, 2011, J CELL SCI, V124, P2414, DOI 10.1242/jcs.076182; Kloft N, 2010, MED MICROBIOL IMMUN, V199, P299, DOI 10.1007/s00430-010-0163-0; Kloft N, 2009, BIOCHEM BIOPH RES CO, V385, P503, DOI 10.1016/j.bbrc.2009.05.121; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Latreille M, 2006, J BIOL CHEM, V281, P26633, DOI 10.1074/jbc.M513556200; Lee H, 2002, J BIOL CHEM, V277, P34556, DOI 10.1074/jbc.M204367200; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Liang XD, 2006, CELL MICROBIOL, V8, P1656, DOI 10.1111/j.1462-5822.2006.00740.x; Los FCO, 2011, CELL HOST MICROBE, V9, P147, DOI 10.1016/j.chom.2011.01.005; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; McNeil PL, 1997, J CELL BIOL, V137, P1, DOI 10.1083/jcb.137.1.1; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; Moskovich O, 2007, J BIOL CHEM, V282, P29977, DOI 10.1074/jbc.M703742200; Munter Sylvia, 2006, Sci STKE, V2006, pre5, DOI 10.1126/stke.3352006re5; Pany S, 2004, BIOCHEM BIOPH RES CO, V322, P29, DOI 10.1016/j.bbrc.2004.07.073; Pany S, 2007, BIOCHEM BIOPH RES CO, V363, P197, DOI 10.1016/j.bbrc.2007.08.132; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; Pilzer D, 2005, INT IMMUNOL, V17, P1239, DOI 10.1093/intimm/dxh300; Saka HA, 2007, AUTOPHAGY, V3, P363, DOI 10.4161/auto.4159; Savina A, 2002, J CELL SCI, V115, P2505; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Sens P, 2008, CURR OPIN CELL BIOL, V20, P476, DOI 10.1016/j.ceb.2008.04.004; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Taylor RC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000166; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Thiery J, 2010, BLOOD, V115, P1582, DOI 10.1182/blood-2009-10-246116; Valeva A, 2000, MOL MICROBIOL, V36, P467, DOI 10.1046/j.1365-2958.2000.01865.x; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; Vidal M, 1997, J CELL SCI, V110, P1867; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Wu CH, 2009, TOXICON, V54, P1183, DOI 10.1016/j.toxicon.2009.02.030; Zhou W, 2011, J BIOL CHEM, V286, P21687, DOI 10.1074/jbc.M110.212787	85	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35299	35317		10.1074/jbc.M112.379883	http://dx.doi.org/10.1074/jbc.M112.379883			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22915583	hybrid, Green Published			2022-12-25	WOS:000309968000039
J	Yu, C; Lou, JZ; Wu, JJ; Pan, LF; Feng, W; Zhang, MJ				Yu, Cong; Lou, Jizhong; Wu, Jingjing; Pan, Lifeng; Feng, Wei; Zhang, Mingjie			Membrane-induced Lever Arm Expansion Allows Myosin VI to Walk with Large and Variable Step Sizes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAND-OVER-HAND; MOLECULAR-DYNAMICS; CELLULAR FUNCTIONS; PROTEIN FUNCTION; ACTIN-FILAMENTS; 3-HELIX BUNDLE; CARGO-BINDING; DOMAIN; MOTOR; DIMERIZATION	Myosin VI, the only known minus-ended actin filament-dependent motor, plays diverse cellular roles both as a processive motor and as a mechanical anchor. Although myosin VI has a short lever arm containing only one "IQ-motif" and a unique insertion for CaM binding, the motor walks with large and variable step sizes of similar to 30-36 nm. Here, we show that the previously predicted coiled-coil domain immediately following the IQ-motifs (referred to as the lever arm extension (LAE)) adopts a stable monomeric, three-helix bundle fold in solution. Importantly, the LAE can undergo reversible, lipid membrane-dependent conformational changes. Upon exposure to lipid membranes, the LAE adopts a partially extended rod shape, and the removal of lipids from the LAE converts it back into the compact helix bundle structure. Molecular dynamics simulations indicate that lipid membrane binding may initiate unfolding and thereby trigger the LAE expansion. This reversible, lipid membrane-dependent expansion of the LAE provides a mechanistic base for myosin VI to walk with large and variable step sizes.	[Lou, Jizhong; Feng, Wei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Lou, Jizhong] Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100101, Peoples R China; [Yu, Cong; Wu, Jingjing; Pan, Lifeng; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Sch Sci, Kowloon, Hong Kong, Peoples R China; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Inst Adv Study, Kowloon, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Feng, W (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	wfeng@ibp.ac.cn; mzhang@ust.hk	yu, cong/V-5140-2018; , 余聪/AAK-9457-2020	yu, cong/0000-0003-2912-6347; Zhang, Mingjie/0000-0001-9404-0190	National Major Basic Research Program of China [2011CB910503]; National Natural Science Foundation of China [31070657, 31190062, 31070827]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-YW-R-154, KSCX2-EW-J-3]; Research Grants Council of Hong Kong [664009, 660709, 663610, HKUST6/CRF/10, SEG_HKUST06, AoE/M-04/04]	National Major Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by National Major Basic Research Program of China Grant 2011CB910503; National Natural Science Foundation of China Grants 31070657, 31190062, and 31070827; Knowledge Innovation Program of the Chinese Academy of Sciences Grants KSCX2-YW-R-154 and KSCX2-EW-J-3; and Research Grants Council of Hong Kong Grants 664009, 660709, 663610, HKUST6/CRF/10, SEG_HKUST06, and AoE/M-04/04 (to M. Z.).	Ahmed ZM, 2003, AM J HUM GENET, V72, P1315, DOI 10.1086/375122; Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Buss F, 2011, P NATL ACAD SCI USA, V108, P5927, DOI 10.1073/pnas.1103086108; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Dunn TA, 2006, AM J PATHOL, V169, P1843, DOI 10.2353/ajpath.2006.060316; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Frank DJ, 2004, CURR OPIN CELL BIOL, V16, P189, DOI 10.1016/j.ceb.2004.02.001; Gao M, 2002, BIOPHYS J, V83, P3435, DOI 10.1016/S0006-3495(02)75343-5; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwaki M, 2006, BIOPHYS J, V90, P3643, DOI 10.1529/biophysj.105.075721; Iwaki M, 2009, NAT CHEM BIOL, V5, P403, DOI 10.1038/nchembio.171; Kay LE, 1997, CURR OPIN STRUC BIOL, V7, P722, DOI 10.1016/S0959-440X(97)80084-X; Kim H, 2010, STRUCTURE, V18, P1443, DOI 10.1016/j.str.2010.09.011; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Liu YX, 2011, BIOPHYS J, V100, P2964, DOI 10.1016/j.bpj.2011.05.010; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Mukherjea M, 2009, MOL CELL, V35, P305, DOI 10.1016/j.molcel.2009.07.010; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Nishikawa S, 2010, CELL, V142, P879, DOI 10.1016/j.cell.2010.08.033; Okten Z, 2004, NAT STRUCT MOL BIOL, V11, P884, DOI 10.1038/nsmb815; Ovchinnikov V, 2011, BIOPHYS J, V101, P2436, DOI 10.1016/j.bpj.2011.09.044; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Shih WM, 2000, CELL, V102, P683, DOI 10.1016/S0092-8674(00)00090-8; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Spudich JA, 2001, NAT REV MOL CELL BIO, V2, P387, DOI 10.1038/35073086; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833; Suveges D, 2009, PROTEINS, V74, P905, DOI 10.1002/prot.22183; Sun YJ, 2007, MOL CELL, V28, P954, DOI 10.1016/j.molcel.2007.10.029; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Sweeney HL, 2010, CELL, V141, P573, DOI 10.1016/j.cell.2010.04.028; Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xiao T, 2002, P NATL ACAD SCI USA, V99, P11151, DOI 10.1073/pnas.172188399; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; Yildiz A, 2004, J BIOL CHEM, V279, P37223, DOI 10.1074/jbc.C400252200; Yoshida H, 2004, P NATL ACAD SCI USA, V101, P8144, DOI 10.1073/pnas.0400400101; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030	61	7	7	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35021	35035		10.1074/jbc.M111.328781	http://dx.doi.org/10.1074/jbc.M111.328781			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22936804	hybrid, Green Published			2022-12-25	WOS:000309968000014
J	Lasek-Nesselquist, E				Lasek-Nesselquist, Erica			A Mitogenomic Re-Evaluation of the Bdelloid Phylogeny and Relationships among the Syndermata	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; DEGENERATE TETRAPLOIDY; PHYLUM ROTIFERA; EVOLUTION; POSITION; TREE; ACCURACY; SEQUENCE; GENE; MICROGNATHOZOA	Molecular and morphological data regarding the relationships among the three classes of Rotifera (Bdelloidea, Seisonidea, and Monogononta) and the phylum Acanthocephala are inconclusive. In particular, Bdelloidea lacks molecular-based phylogenetic appraisal. I obtained coding sequences from the mitochondrial genomes of twelve bdelloids and two monogononts to explore the molecular phylogeny of Bdelloidea and provide insight into the relationships among lineages of Syndermata (Rotifera+Acanthocephala). With additional sequences taken from previously published mitochondrial genomes, the total dataset included nine species of bdelloids, three species of monogononts, and two species of acanthocephalans. A supermatrix of these 10-12 mitochondrial proteins consistently recovered a bdelloid phylogeny that questions the validity of a generally accepted classification scheme despite different methods of inference and various parameter adjustments. Specifically, results showed that neither the family Philodinidae nor the order Philodinida are monophyletic as currently defined. The application of a similar analytical strategy to assess syndermate relationships recovered either a tree with Bdelloidea and Monogononta as sister taxa (Eurotatoria) or Bdelloidea and Acanthocephala as sister taxa (Lemniscea). Both outgroup choice and method of inference affected the topological outcome emphasizing the need for sequences from more closely related outgroups and more sophisticated methods of analysis that can account for the complexity of the data.	Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA	University of Connecticut	Lasek-Nesselquist, E (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA.	elasekness@gmail.com			National Science Foundation [MCB 0923628]; National Institutes of Health [R01AG037960];  [NSF MCB 0923676]; Div Of Molecular and Cellular Bioscience [0923676] Funding Source: National Science Foundation; NATIONAL INSTITUTE ON AGING [R01AG037960] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research expenses and the sole support for this project were provided by funding from the National Science Foundation grant MCB 0923628 awarded to M. Meselson at Harvard University, Boston, MA. Genomic and transcriptome data were generated by funding from the grants NSF MCB 0923676 and National Institutes of Health R01AG037960 awarded to David Mark Welch at the Marine Biological Laboratory, Woods Hole, MA. URLs: http://www.nih.gov/, http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Alhlrichs WH, 1997, ZOOMORPHOLOGY, V117, P41; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45, DOI DOI 10.1.1.23/7465; Cummings MP, 2003, SYST BIOL, V52, P477, DOI 10.1080/10635150390218213; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Fontaneto D, 2011, ZOOL ANZ, V250, P80, DOI 10.1016/j.jcz.2010.11.005; Funch P, 2005, HYDROBIOLOGIA, V546, P11, DOI 10.1007/s10750-005-4093-6; Garcia-Varela M, 2006, MOL PHYLOGENET EVOL, V40, P61, DOI 10.1016/j.ympev.2006.02.010; Garey JR, 1998, AM ZOOL, V38, P907; Garey JR, 1998, HYDROBIOLOGIA, V387, P83, DOI 10.1023/A:1017060902909; Garey JR, 1996, J MOL EVOL, V43, P287, DOI 10.1007/BF02338837; Gazi M, 2012, PARASITOL INT, V61, P307, DOI 10.1016/j.parint.2011.12.001; Giribet G, 2004, CLADISTICS, V20, P1, DOI 10.1111/j.1096-0031.2004.00004.x; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hausdorf B, 2007, MOL BIOL EVOL, V24, P2723, DOI 10.1093/molbev/msm214; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Herlyn H, 2003, MOL PHYLOGENET EVOL, V26, P155, DOI 10.1016/S1055-7903(02)00309-3; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hur JH, 2009, MOL BIOL EVOL, V26, P375, DOI 10.1093/molbev/msn260; Kelchner SA, 2007, TRENDS ECOL EVOL, V22, P87, DOI 10.1016/j.tree.2006.10.004; Kristensen RM, 2000, J MORPHOL, V246, P1; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lorenzen S., 1985, Systematics Association Special Volume Series, P210; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mark Welch D, 2005, HYDROBIOLOGIA, V546, P47, DOI 10.1007/s10750-005-4100-y; Melone G, 1998, HYDROBIOLOGIA, V387, P101, DOI 10.1023/A:1017057619574; Melone G, 1995, HYDROBIOLOGIA, V313, P91, DOI 10.1007/BF00025935; Min GS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-533; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.es.18.110187.001413; Pennak RW, 1989, FRESH WATER INVERTEB; Philippe H, 1998, CURR OPIN GENET DEV, V8, P616, DOI 10.1016/S0959-437X(98)80028-2; Philippe H, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-91; REMANE A, 1929, TIERWELT NORD OSTSEE; RICCI C, 1993, HYDROBIOLOGIA, V255, P495, DOI 10.1007/BF00025879; Ricci C, 1998, HYDROBIOLOGIA, V387, P321, DOI 10.1023/A:1017086425934; Ricci C, 1998, HYDROBIOLOGIA, V387, P93, DOI 10.1023/A:1017091104243; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Segers Hendrik, 2007, Zootaxa, V1564, P1; Segers H, 2008, HYDROBIOLOGIA, V595, P49, DOI 10.1007/s10750-007-9003-7; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sorensen MV, 2006, MOL PHYLOGENET EVOL, V40, P585, DOI 10.1016/j.ympev.2006.04.001; Sorensen MV, 2005, ZOOL STUD, V44, P34; Sorensen MV, 2000, ACTA ZOOL-STOCKHOLM, V81, P9, DOI 10.1046/j.1463-6395.2000.00032.x; Sorensen MV, 2002, J ZOOL SYST EVOL RES, V40, P129, DOI 10.1046/j.1439-0469.2002.00188.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinauer ML, 2005, J MOL EVOL, V60, P706, DOI 10.1007/s00239-004-0159-8; Suga K, 2008, MOL BIOL EVOL, V25, P1129, DOI 10.1093/molbev/msn058; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WALLACE RL, 1989, HYDROBIOLOGIA, V186, P311; Welch DBM, 2008, P NATL ACAD SCI USA, V105, P5145, DOI 10.1073/pnas.0800972105; Welch DBM, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P259, DOI 10.1007/978-90-481-2770-2_13; Welch DBM, 2000, INVERTEBR BIOL, V119, P17; Witek A, 2009, MOL PHYLOGENET EVOL, V53, P1037, DOI 10.1016/j.ympev.2009.07.031; Witek A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-345	72	15	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43554	10.1371/journal.pone.0043554	http://dx.doi.org/10.1371/journal.pone.0043554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927990	gold, Green Published, Green Submitted			2022-12-25	WOS:000308224700018
J	Strodl, MA; Schausberger, P				Strodl, Markus Andreas; Schausberger, Peter			Social Familiarity Reduces Reaction Times and Enhances Survival of Group-Living Predatory Mites under the Risk of Predation	PLOS ONE			English	Article							ANTIPREDATOR BEHAVIOR; LIMITED ATTENTION; PHYTOSEIID MITES; ADULT FEMALES; RECOGNITION; CANNIBALISM; SPECIALIST; EVOLUTION; ACARI	Background: Social familiarity, which is based on the ability to recognise familiar conspecific individuals following prior association, may affect all major life activities of group-living animals such as foraging, reproduction and anti-predator behaviours. A scarcely experimentally tested explanation why social familiarity is beneficial for group-living animals is provided by limited attention theory. Limited attention theory postulates that focusing on a given task, such as inspection and assessment of unfamiliar group members, has cognitive and associated physiological and behavioural costs with respect to the attention paid to other tasks, such as anti-predator vigilance and response. Accordingly, we hypothesised that social familiarity enhances the anti-predator success of group-living predatory mites, Phytoseiulus persimilis, confronted with an intraguild predator, the predatory mite Amblyseius andersoni. Methodology/Principal Findings: We videotaped and analysed the response of two P. persimilis larvae, held in familiar or unfamiliar pairs, to attacks by a gravid A. andersoni female, using the behavioural analyses software EthoVision Pro (R). Familiar larvae were more frequently close together, reacted more quickly to predator attacks, survived more predator encounters and survived longer than unfamiliar larvae. Significance: In line with the predictions of limited attention theory, we suggest that social familiarity improves antipredator behaviours because it allows prey to shift attention to other tasks rather than group member assessment.	[Strodl, Markus Andreas; Schausberger, Peter] Univ Nat Resources & Life Sci, Grp Arthropod Ecol & Behav, Div Plant Protect, Dept Crop Sci, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Strodl, MA (corresponding author), Univ Nat Resources & Life Sci, Grp Arthropod Ecol & Behav, Div Plant Protect, Dept Crop Sci, Vienna, Austria.	markus.strodl@boku.ac.at		Schausberger, Peter/0000-0002-1529-3198	Austrian Science Fund (FWF) [P20743-B17]; Austrian Science Fund (FWF) [P 20743] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financially supported by the Austrian Science Fund (FWF): P20743-B17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCK J, 2005, ANIMAL BEHAV EVOLUTI; Blumstein DT, 2010, BEHAV ECOL, V21, P440, DOI 10.1093/beheco/arq030; Chant D, 1985, SPIDER MITES THEIR B, V1A, P5; CHIVERS DP, 1995, CAN J ZOOL, V73, P955, DOI 10.1139/z95-111; Clark CW, 2003, BEHAV ECOL, V14, P151, DOI 10.1093/beheco/14.2.151; Domenici P, 2011, J EXP BIOL, V214, P2463, DOI 10.1242/jeb.029652; Dukas R, 2002, PHILOS T R SOC B, V357, P1539, DOI 10.1098/rstb.2002.1063; Earley Ryan L., 2010, P285; Griffiths SW, 2004, P ROY SOC B-BIOL SCI, V271, P695, DOI 10.1098/rspb.2003.2648; GRIFFITHS SW, 2006, FISH COGNITION BEHAV, P139; Hojesjo J, 1998, BEHAV ECOL, V9, P445, DOI 10.1093/beheco/9.5.445; Janssen A, 1997, J ANIM ECOL, V66, P223, DOI 10.2307/6024; KELLEY JL, 2006, FISH COGNITION BEHAV, P28; Krause J, 2002, LIVING GROUPS; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; McMurtry JA, 1997, ANNU REV ENTOMOL, V42, P291, DOI 10.1146/annurev.ento.42.1.291; Noldus, 2005, ETHOVISION VID TRACK; Nonacs Peter, 2010, P207; Palphramand KL, 2007, ANIM BEHAV, V74, P429, DOI 10.1016/j.anbehav.2006.10.026; POWELL GVN, 1974, ANIM BEHAV, V22, P501, DOI 10.1016/S0003-3472(74)80049-7; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Sabelis M.W., 1985, P141; Sabelis M.W., 1985, SPIDER MITES THEIR B, P43; Sareen P, 2011, P NATL ACAD SCI USA, V108, P7230, DOI 10.1073/pnas.1102522108; Schausberger P, 1997, EXP APPL ACAROL, V21, P131, DOI 10.1023/A:1018478418010; Schausberger P, 2005, BEHAV ECOL SOCIOBIOL, V58, P53, DOI 10.1007/s00265-004-0898-y; Schausberger P, 2004, ANIM BEHAV, V67, P1031, DOI 10.1016/j.anbehav.2003.10.006; Schausberger P, 2003, EXP APPL ACAROL, V29, P173, DOI 10.1023/A:1025839206394; Schausberger P, 2001, ANIM BEHAV, V61, P459, DOI 10.1006/anbe.2000.1611; Schausberger P, 1999, ENVIRON ENTOMOL, V28, P322, DOI 10.1093/ee/28.2.322; SILLENTULLBERG B, 1988, AM NAT, V132, P723, DOI 10.1086/284884; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Strodl MA, 2012, NATURWISSENSCHAFTEN, V99, P303, DOI 10.1007/s00114-012-0903-7; Utne-Palm AC, 2000, OIKOS, V91, P225, DOI 10.1034/j.1600-0706.2000.910203.x; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; Walzer A, 2006, J INSECT BEHAV, V19, P305, DOI 10.1007/s10905-006-9025-4; Walzer A, 2011, ANIM BEHAV, V81, P177, DOI 10.1016/j.anbehav.2010.09.031; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	40	14	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43590	10.1371/journal.pone.0043590	http://dx.doi.org/10.1371/journal.pone.0043590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927997	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300070
J	Hamdi, Y; Kaddour, H; Vaudry, D; Bahdoudi, S; Douiri, S; Leprince, J; Castel, H; Vaudry, H; Tonon, MC; Amri, M; Masmoudi-Kouki, O				Hamdi, Yosra; Kaddour, Hadhemi; Vaudry, David; Bahdoudi, Seyma; Douiri, Salma; Leprince, Jerome; Castel, Helene; Vaudry, Hubert; Tonon, Marie-Christine; Amri, Mohamed; Masmoudi-Kouki, Olfa			The Octadecaneuropeptide ODN Protects Astrocytes against Hydrogen Peroxide-Induced Apoptosis via a PKA/MAPK-Dependent Mechanism	PLOS ONE			English	Article							DIAZEPAM-BINDING INHIBITOR; CYCLASE-ACTIVATING POLYPEPTIDE; CULTURED RAT ASTROCYTES; STIMULATES ENDOZEPINE RELEASE; CELL-DEATH; OXIDATIVE STRESS; POSSIBLE INVOLVEMENT; RADICAL SCAVENGER; FOCAL ISCHEMIA; UP-REGULATION	Astrocytes synthesize and release endozepines, a family of regulatory peptides, including the octadecaneuropeptide (ODN) an endogenous ligand of both central-type benzodiazepine (CBR) and metabotropic receptors. We have recently shown that ODN exerts a protective effect against hydrogen peroxide (H2O2)-induced oxidative stress in astrocytes. The purpose of the present study was to determine the type of receptor and the transduction pathways involved in the protective effect of ODN in cultured rat astrocytes. We have first observed a protective activity of ODN at very low concentrations that was abrogated by the metabotropic ODN receptor antagonist cyclo(1-8)[DLeu(5)]OP, but not by the CBR antagonist flumazenil. We have also found that the metabotropic ODN receptor is positively coupled to adenylyl cyclase in astrocytes and that the glioprotective action of ODN upon H2O2-induced astrocyte death is PKA- and MEK-dependent, but PLC/PKC-independent. Downstream of PKA, ODN induced ERK phosphorylation, which in turn activated the expression of the anti-apoptotic gene Bcl-2 and blocked the stimulation by H2O2 of the pro-apoptotic gene Bax. The effect of ODN on the Bax/Bcl-2 balance contributed to abolish the deleterious action of H2O2 on mitochondrial membrane integrity and caspase-3 activation. Finally, the inhibitory effect of ODN on caspase-3 activity was shown to be PKA and MEK-dependent. In conclusion, the present results demonstrate that the potent glioprotective action of ODN against oxidative stress involves the metabotropic ODN receptor coupled to the PKA/ERK-kinase pathway to inhibit caspase-3 activation.	[Hamdi, Yosra; Kaddour, Hadhemi; Bahdoudi, Seyma; Douiri, Salma; Amri, Mohamed; Masmoudi-Kouki, Olfa] Univ Tunis El Manar, Fac Sci Tunis, Lab Funct Neurophysiol & Pathol, Dept Biol Sci,Res Unit UR 11ES09, Tunis, Tunisia; [Vaudry, David; Leprince, Jerome; Castel, Helene; Vaudry, Hubert; Tonon, Marie-Christine] Univ Rouen, INSERM, Lab Neuronal & Neuroendocrine Commun & Differenti, U982, Mont St Aignan, France; [Vaudry, David; Leprince, Jerome; Vaudry, Hubert] Int Associated Lab Samuel de Champlain, Mont St Aignan, France; [Vaudry, David; Leprince, Jerome; Vaudry, Hubert] Univ Rouen, Inst Med Res & Innovat IRIB, Reg Platform Cell Imaging Haute Normandie PRIMACE, Mont St Aignan, France	Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Universite de Rouen Normandie	Hamdi, Y (corresponding author), Univ Tunis El Manar, Fac Sci Tunis, Lab Funct Neurophysiol & Pathol, Dept Biol Sci,Res Unit UR 11ES09, Tunis, Tunisia.	hubert.vaudry@univ-rouen.fr; mohamed.amri@fst.rnu.tn	VAUDRY, David/M-1454-2018; castel, helene/B-8675-2009; Leprince, Jerome/N-9083-2017	VAUDRY, David/0000-0003-3567-7452; castel, helene/0000-0002-8972-5555; Amri, Mohamed/0000-0001-5309-7633; Leprince, Jerome/0000-0002-7814-9927	University of Tunis El Manar; France-Tunisia exchange program CMCU-Utique [07G0822]; France-Tunisia exchange program Inserm-DGRS; Research Unit [UR/11ES09]; Inserm-DGRS program [M 10/M]; Inserm [U982]; Institute for Medical Research and Innovation (IRIB); Region Haute-Normandie	University of Tunis El Manar; France-Tunisia exchange program CMCU-Utique; France-Tunisia exchange program Inserm-DGRS; Research Unit; Inserm-DGRS program; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institute for Medical Research and Innovation (IRIB); Region Haute-Normandie(Region Normandie)	The authors wish to thank Mr Samir Elbahi for skillful technical assistance. Y.H. and K.H. were recipients of fellowships from the University of Tunis El Manar and a France-Tunisia exchange program CMCU-Utique. B.S. and S.D. were recipients of fellowships from the University of Tunis El Manar and a France-Tunisia exchange program Inserm-DGRS. This study was supported by the Research Unit UR/11ES09, an Inserm-DGRS program (to M.A. and M.C.T.; grant number M 10/M), Inserm (U982), the Institute for Medical Research and Innovation (IRIB), the Region Haute-Normandie and a France-Tunisia exchange program CMCU-Utique (grant number 07G0822). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi J, 2008, NEUROSCI LETT, V442, P224, DOI 10.1016/j.neulet.2008.07.029; BORMANN J, 1991, NEUROPHARMACOLOGY, V30, P1387, DOI 10.1016/S0028-3908(11)80006-7; Brown DR, 1999, GLIA, V25, P282, DOI 10.1002/(SICI)1098-1136(19990201)25:3<282::AID-GLIA8>3.0.CO;2-N; Burgi B, 1999, J NEUROENDOCRINOL, V11, P85; Burton M, 2005, BIOCHEM J, V392, P299, DOI 10.1042/BJ20050664; Castel H, 2006, J NEUROCHEM, V99, P582, DOI 10.1111/j.1471-4159.2006.04130.x; Chen SH, 2000, GLIA, V31, P249, DOI 10.1002/1098-1136(200009)31:3<249::AID-GLIA60>3.0.CO;2-L; Chen YM, 2001, GLIA, V33, P343, DOI 10.1002/1098-1136(20010315)33:4<343::AID-GLIA1033>3.0.CO;2-H; Choi JH, 2007, EUR J PHARMACOL, V571, P106, DOI 10.1016/j.ejphar.2007.06.042; Compere V, 2010, J MOL ENDOCRINOL, V44, P295, DOI 10.1677/JME-09-0176; Cui M, 2011, GLIA, V59, P641, DOI 10.1002/glia.21134; De Mateos-Verchere JG, 1998, PEPTIDES, V19, P841; de Mateos-Verchere JG, 2001, EUR J PHARMACOL, V414, P225; do Rego JC, 2007, NEUROPSYCHOPHARMACOL, V32, P1641, DOI 10.1038/sj.npp.1301280; Dong EB, 1999, LIFE SCI, V64, P1779, DOI 10.1016/S0024-3205(99)00116-2; Eiden LE, 2008, ANN NY ACAD SCI, V1144, P6, DOI 10.1196/annals.1418.019; Faergeman NJ, 2002, BIOCHEM J, V368, P679, DOI 10.1042/BJ20021413; Feeney CJ, 2008, BRAIN RES, V1198, P1, DOI 10.1016/j.brainres.2007.12.049; FERRARESE C, 1990, NEUROLOGY, V40, P632, DOI 10.1212/WNL.40.4.632; FERRERO P, 1984, NEUROPHARMACOLOGY, V23, P1359, DOI 10.1016/0028-3908(84)90061-3; Gabryel B, 2002, NEUROTOXICOLOGY, V23, P385, DOI 10.1016/S0161-813X(02)00084-0; Gandolfo P, 1999, NEUROPHARMACOLOGY, V38, P725, DOI 10.1016/S0028-3908(98)00231-7; Giffard RG, 2005, GLIA, V50, P299, DOI 10.1002/glia.20167; GUIDOTTI A, 1983, P NATL ACAD SCI-BIOL, V80, P3531, DOI 10.1073/pnas.80.11.3531; Hamdi Y, 2011, J NEUROCHEM, V118, P416, DOI 10.1111/j.1471-4159.2011.07315.x; Hashimoto H, 2003, BIOCHEM BIOPH RES CO, V311, P337, DOI 10.1016/j.bbrc.2003.10.005; Hisano K, 2009, J ANESTH, V23, P363, DOI 10.1007/s00540-009-0766-z; Iwashita A, 2003, J PHARMACOL EXP THER, V307, P961, DOI 10.1124/jpet.103.056572; Jang JH, 2004, J BIOL CHEM, V279, P38779, DOI 10.1074/jbc.M406371200; Juknat AA, 2005, J PINEAL RES, V38, P84, DOI 10.1111/j.1600-079X.2004.00166.x; KAVALIERS M, 1986, BRAIN RES, V383, P343, DOI 10.1016/0006-8993(86)90037-5; Leprince J, 1998, J MED CHEM, V41, P4433, DOI 10.1021/jm980275d; Leprince J, 2001, EUR J BIOCHEM, V268, P6045, DOI 10.1046/j.0014-2956.2001.02533.x; Lesouhaitier O, 2000, ENDOCRINOLOGY, V141, P197, DOI 10.1210/en.141.1.197; Lewerenz J, 2003, J NEUROCHEM, V87, P522, DOI 10.1046/j.1471-4159.2003.02019.x; MALAGON M, 1993, NEUROSCIENCE, V57, P777, DOI 10.1016/0306-4522(93)90023-9; Marino F, 2003, CELL SIGNAL, V15, P511, DOI 10.1016/S0898-6568(02)00134-1; Masmoudi O, 2005, J NEUROCHEM, V94, P561, DOI 10.1111/j.1471-4159.2005.03076.x; Masmoudi O, 2003, FASEB J, V17, P17, DOI 10.1096/fj.02-0317com; Masmoudi-Kouki O, 2011, J NEUROCHEM, V117, P403, DOI 10.1111/j.1471-4159.2011.07185.x; Matsuda K, 2007, NEUROSCIENCE, V150, P425, DOI 10.1016/j.neuroscience.2007.09.012; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; MENTLEIN R, 1994, J NEUROCHEM, V62, P27; PAPADOPOULOS V, 1991, NEUROPHARMACOLOGY, V30, P1417, DOI 10.1016/S0028-3908(11)80011-0; PATTE C, 1995, FEBS LETT, V362, P106, DOI 10.1016/0014-5793(95)00209-R; Rathinam ML, 2006, J NEUROCHEM, V96, P1289, DOI 10.1111/j.1471-4159.2006.03674.x; Rathke-Hartlieb S, 2000, FEBS LETT, V481, P227, DOI 10.1016/S0014-5793(00)02011-1; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Sakurai T, 2003, BRAIN RES, V959, P160, DOI 10.1016/S0006-8993(02)03611-9; Seaborn T, 2011, CURR PHARM DESIGN, V17, P204, DOI 10.2174/138161211795049679; Shin JH, 2009, NEUROSCI RES, V64, P355, DOI 10.1016/j.neures.2009.04.006; SHOYAB M, 1986, J BIOL CHEM, V261, P1968; Stumm R, 2007, J NEUROCHEM, V103, P1666, DOI 10.1111/j.1471-4159.2007.04895.x; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Takuma K, 2000, EUR J PHARMACOL, V399, P1, DOI 10.1016/S0014-2999(00)00334-4; Tokay T, 2005, J NEUROCHEM, V94, P607, DOI 10.1111/j.1471-4159.2005.03102.x; Tokay T, 2008, GLIA, V56, P1380, DOI 10.1002/glia.20705; Tonon MC, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P813, DOI 10.1016/B978-012369442-3/50114-8; TONON MC, 1990, NEUROPEPTIDES, V15, P17, DOI 10.1016/0143-4179(90)90155-R; Vallejo M, 2009, MOL NEUROBIOL, V39, P90, DOI 10.1007/s12035-009-8055-2; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Watts LT, 2005, J NEUROSCI RES, V80, P655, DOI 10.1002/jnr.20502; Yanase H, 2002, ARCH HISTOL CYTOL, V65, P27, DOI 10.1679/aohc.65.27; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819	65	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42498	10.1371/journal.pone.0042498	http://dx.doi.org/10.1371/journal.pone.0042498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927932	Green Published, gold, Green Submitted			2022-12-25	WOS:000307789700012
J	Baydoun, HH; Bai, XT; Shelton, S; Nicot, C				Baydoun, Hicham H.; Bai, Xue Tao; Shelton, Shary; Nicot, Christophe			HTLV-I Tax Increases Genetic Instability by Inducing DNA Double Strand Breaks during DNA Replication and Switching Repair to NHEJ	PLOS ONE			English	Article							T-CELL LEUKEMIA; VIRUS TYPE-1 TAX; NF-KAPPA-B; ANAPHASE-PROMOTING COMPLEX; CYCLE REGULATORY GENES; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; SIGNAL-TRANSDUCTION; CATALYTIC-ACTIVITY; ONCOPROTEIN BINDS	Background: Appropriate responses to damaged DNA are indispensible for preserving genome stability and preventing cancer. Tumor viruses often target DNA repair machinery to achieve transformation. The Human T-cell leukemia virus type I (HTLV-I) is the only known transforming human retrovirus and the etiological agent of Adult T-cell Leukemia (ATLL). Although HTLV-I-transformed leukemic cells have numerous genetic lesions, the precise role of the viral tax gene in this process is not fully understood. Results: Our results show a novel function of HTLV-I oncoprotein Tax as an inducer of genomic DNA double strand breaks (DDSB) during DNA replication. We also found that Tax acts as a potent inhibitor of homologous recombination (HR) DNA repair through the activation of the NF-kB pathway. These results were confirmed using HTLV-I molecular clones expressing Tax at physiological levels in a natural context. We further found that HTLV-I-and Tax-transformed cells are not more susceptible to DNA damaging agents and repair DNA lesions at a rate similar to that of normal cells. Finally, we demonstrated that during S phase, Tax-associated DDSB are preferentially repaired using the error-prone non-homologous end joining (NHEJ) pathway. Conclusions: This study provides new insights in Tax effects on DNA repair and genome instability. Although it may not be self sufficient, the creation of DNA breaks and subsequent abnormal use of the non-conservative NHEJ DNA repair during the S phase in HTLV-I-infected Tax-expressing cells may cooperate with other factors to increase genetic and genome instability and favor transformation.	[Baydoun, Hicham H.; Bai, Xue Tao; Shelton, Shary; Nicot, Christophe] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Baydoun, HH (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	cnicot@kumc.edu			National Cancer Institute [CA106258]; NATIONAL CANCER INSTITUTE [R01CA106258] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (CA106258) to C.N. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 1996, ONCOGENE, V12, P1645; Belgnaoui SM, 2010, J BIOL CHEM, V285, P32897, DOI 10.1074/jbc.M110.146373; Bellon M, 2010, BLOOD, V115, P2441, DOI 10.1182/blood-2009-08-241117; Bentley J, 2004, NUCLEIC ACIDS RES, V32, P5249, DOI 10.1093/nar/gkh842; Bertrand P, 2004, TRENDS GENET, V20, P235, DOI 10.1016/j.tig.2004.04.003; Boxus M, 2012, BLOOD, V119, P151, DOI 10.1182/blood-2011-05-356790; CELIS JE, 1985, P NATL ACAD SCI USA, V82, P3262, DOI 10.1073/pnas.82.10.3262; Chandhasin C, 2008, J VIROL, V82, P6952, DOI 10.1128/JVI.02331-07; Chatrath P, 2006, BRIT J CANCER, V95, P314, DOI 10.1038/sj.bjc.6603262; Cohn MA, 2008, MOL CELL, V32, P306, DOI 10.1016/j.molcel.2008.10.009; Datta A, 2008, ONCOGENE, V27, P1135, DOI 10.1038/sj.onc.1210718; De La Fuente C, 2000, J VIROL, V74, P7270, DOI 10.1128/JVI.74.16.7270-7283.2000; Ducu RI, 2011, VIROLOGY, V416, P1, DOI 10.1016/j.virol.2011.04.012; Franchini G, 2003, ADV CANCER RES, V89, P69, DOI 10.1016/S0065-230X(03)01003-0; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; GESSAIN A, 1985, LANCET, V2, P407; GREEN JE, 1989, NATURE, V341, P72, DOI 10.1038/341072a0; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Guirouilh-Barbat J, 2007, P NATL ACAD SCI USA, V104, P20902, DOI 10.1073/pnas.0708541104; Haller K, 2000, AIDS RES HUM RETROV, V16, P1683, DOI 10.1089/08892220050193146; Haoudi A, 2003, VIROLOGY, V305, P229, DOI 10.1006/viro.2002.1642; Harhaj NS, 2007, J BIOL CHEM, V282, P4185, DOI 10.1074/jbc.M611031200; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Iha H, 2003, ONCOGENE, V22, P8912, DOI 10.1038/sj.onc.1207058; JEANG KT, 1990, SCIENCE, V247, P1082, DOI 10.1126/science.2309119; Kao SY, 1999, J VIROL, V73, P4299, DOI 10.1128/JVI.73.5.4299-4304.1999; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Kehn K, 2005, ONCOGENE, V24, P525, DOI 10.1038/sj.onc.1208105; Kibler KV, 2001, J VIROL, V75, P2161, DOI 10.1128/JVI.75.5.2161-2173.2001; Koike M, 2008, EXP CELL RES, V314, P1061, DOI 10.1016/j.yexcr.2007.11.014; Kuo YL, 2006, EMBO J, V25, P1741, DOI 10.1038/sj.emboj.7601054; Lemasson I, 1998, J BIOL CHEM, V273, P23598, DOI 10.1074/jbc.273.36.23598; Lemoine FJ, 2000, AIDS RES HUM RETROV, V16, P1623, DOI 10.1089/08892220050193056; Liang MH, 2002, J VIROL, V76, P4022, DOI 10.1128/JVI.76.8.4022-4033.2002; Linke SP, 2003, CANCER RES, V63, P2596; Liu BY, 2005, P NATL ACAD SCI USA, V102, P63, DOI 10.1073/pnas.0406424101; Liu BY, 2003, MOL CELL BIOL, V23, P5269, DOI 10.1128/MCB.23.15.5269-5281.2003; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Marriott SJ, 2005, ONCOGENE, V24, P5986, DOI 10.1038/sj.onc.1208976; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Merling R, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-35; Neuveut C, 2002, FRONT BIOSCI-LANDMRK, V7, pD157, DOI 10.2741/neuveut; Nicot C, 2000, ONCOGENE, V19, P2155, DOI 10.1038/sj.onc.1203536; Nicot C, 2001, MOL CELL BIOL, V21, P7391, DOI 10.1128/MCB.21.21.7391-7402.2001; Nutley BP, 2005, BRIT J CANCER, V93, P1011, DOI 10.1038/sj.bjc.6602823; OSAME M, 1987, ANN NEUROL, V21, P117, DOI 10.1002/ana.410210203; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Robek MD, 1999, J VIROL, V73, P4856, DOI 10.1128/JVI.73.6.4856-4865.1999; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; ROY LM, 1991, J CELL BIOL, V113, P507, DOI 10.1083/jcb.113.3.507; SARIN PS, 1983, P NATL ACAD SCI-BIOL, V80, P2370, DOI 10.1073/pnas.80.8.2370; SAWAMI H, 1992, J CELL PHYSIOL, V151, P367, DOI 10.1002/jcp.1041510218; Scott IS, 2003, J PATHOL, V201, P187, DOI 10.1002/path.1444; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Suzuki T, 2000, VIROLOGY, V270, P291, DOI 10.1006/viro.2000.0266; Suzuki T, 1996, EMBO J, V15, P1607, DOI 10.1002/j.1460-2075.1996.tb00505.x; TATEWAKI M, 1995, BLOOD, V86, P3109; Windhofer F, 2008, MUTAT RES-FUND MOL M, V638, P56, DOI 10.1016/j.mrfmmm.2007.08.016; Yamazaki J, 2009, BLOOD, V114, P2709, DOI 10.1182/blood-2008-08-174425; Yang C, 2009, MUTAT RES-FUND MOL M, V660, P66, DOI 10.1016/j.mrfmmm.2008.10.019; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6; YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475; Yoshida M, 2000, AIDS RES HUM RETROV, V16, P1639, DOI 10.1089/08892220050193083	68	40	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42226	10.1371/journal.pone.0042226	http://dx.doi.org/10.1371/journal.pone.0042226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916124	gold, Green Published, Green Submitted			2022-12-25	WOS:000307733800017
J	Bergval, I; Sengstake, S; Brankova, N; Levterova, V; Abadia, E; Tadumaze, N; Bablishvili, N; Akhalaia, M; Tuin, K; Schuitema, A; Panaiotov, S; Bachiyska, E; Kantardjiev, T; de Zwaan, R; Schurch, A; van Soolingen, D; van 't Hoog, A; Cobelens, F; Aspindzelashvili, R; Sola, C; Klatser, P; Anthony, R				Bergval, Indra; Sengstake, Sarah; Brankova, Nadia; Levterova, Viktoria; Abadia, Edgar; Tadumaze, Nino; Bablishvili, Nino; Akhalaia, Maka; Tuin, Kiki; Schuitema, Anja; Panaiotov, Stefan; Bachiyska, Elizabeta; Kantardjiev, Todor; de Zwaan, Rina; Schurch, Anita; van Soolingen, Dick; van 't Hoog, Anja; Cobelens, Frank; Aspindzelashvili, Rusudan; Sola, Christophe; Klatser, Paul; Anthony, Richard			Combined Species Identification, Genotyping, and Drug Resistance Detection of Mycobacterium tuberculosis Cultures by MLPA on a Bead-Based Array	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; RAPID DETECTION; RELATIVE QUANTIFICATION; STRAIN DIFFERENTIATION; DNA POLYMORPHISM; MULTIPLEX ASSAY; MOLECULAR-BASIS; RPOB MUTATIONS; COMPLEX; RIFAMPIN	The population structure of Mycobacterium tuberculosis is typically clonal therefore genotypic lineages can be unequivocally identified by characteristic markers such as mutations or genomic deletions. In addition, drug resistance is mainly mediated by mutations. These issues make multiplexed detection of selected mutations potentially a very powerful tool to characterise Mycobacterium tuberculosis. We used Multiplex Ligation-dependent Probe Amplification (MLPA) to screen for dispersed mutations, which can be successfully applied to Mycobacterium tuberculosis as was previously shown. Here we selected 47 discriminative and informative markers and designed MLPA probes accordingly to allow analysis with a liquid bead array and robust reader (Luminex MAGPIX technology). To validate the bead-based MLPA, we screened a panel of 88 selected strains, previously characterised by other methods with the developed multiplex assay using automated positive and negative calling. In total 3059 characteristics were screened and 3034 (99.2%) were consistent with previous molecular characterizations, of which 2056 (67.2%) were directly supported by other molecular methods, and 978 (32.0%) were consistent with but not directly supported by previous molecular characterizations. Results directly conflicting or inconsistent with previous methods, were obtained for 25 (0.8%) of the characteristics tested. Here we report the validation of the bead-based MLPA and demonstrate its potential to simultaneously identify a range of drug resistance markers, discriminate the species within the Mycobacterium tuberculosis complex, determine the genetic lineage and detect and identify the clinically most relevant non-tuberculous mycobacterial species. The detection of multiple genetic markers in clinically derived Mycobacterium tuberculosis strains with a multiplex assay could reduce the number of TB-dedicated screening methods needed for full characterization. Additionally, as a proportion of the markers screened are specific to certain Mycobacterium tuberculosis lineages each profile can be checked for internal consistency. Strain characterization can allow selection of appropriate treatment and thereby improve treatment outcome and patient management.	[Bergval, Indra; Sengstake, Sarah; Schuitema, Anja; Klatser, Paul; Anthony, Richard] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands; [Brankova, Nadia; Levterova, Viktoria; Panaiotov, Stefan; Bachiyska, Elizabeta; Kantardjiev, Todor] Natl Ctr Infect & Parasit Dis, Sofia, Bulgaria; [Abadia, Edgar; Sola, Christophe] UPS11, CNRS, UMR 8621, Inst Genet & Microbiol, Orsay, France; [Abadia, Edgar] Venezuelan Inst Sci Res, Caracas, Venezuela; [Tadumaze, Nino; Bablishvili, Nino; Akhalaia, Maka; Aspindzelashvili, Rusudan] Natl Ctr TB & Lung Dis, Natl TB Reference Lab, Tbilisi, Georgia; [Tuin, Kiki] MRC Holland, Amsterdam, Netherlands; [de Zwaan, Rina; Schurch, Anita; van Soolingen, Dick] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, TB Reference Lab, NL-3720 BA Bilthoven, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Centre, Univ Lung Ctr Dekkerswald, Dept Microbiol, NL-6525 ED Nijmegen, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Centre, Univ Lung Ctr Dekkerswald, Dept Pulm Dis, NL-6525 ED Nijmegen, Netherlands; [van 't Hoog, Anja; Cobelens, Frank] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	Ministry of Health Bulgaria; National Centre of Infectious & Parasitic Diseases; Centre National de la Recherche Scientifique (CNRS); Venezuelan Institute Science Research; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Radboud University Nijmegen	Bergval, I (corresponding author), Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands.	r.anthony@kit.nl	Sola, Christophe/A-7992-2016; Anthony, Richard/AAP-3406-2020; Panaiotov, Stefan/AAR-6396-2021; Anthony, Richard M/G-5654-2010	Sola, Christophe/0000-0003-4672-2140; Anthony, Richard/0000-0002-0550-5273; Anthony, Richard M/0000-0002-0550-5273; Schurch, Anita/0000-0003-1894-7545; Bachiyska, Elizabeta/0000-0003-2949-5011; Panaiotov, Stefan/0000-0001-9997-5198; Klatser, Paul/0000-0003-2127-9138; Cobelens, Frank/0000-0002-4367-1133; Klatser, Paul/0000-0003-3868-2409	ZonMW [205100005]; FOGARTY INTERNATIONAL CENTER [D43TW007124] Funding Source: NIH RePORTER	ZonMW(Netherlands Organization for Health Research and Development); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was funded by ZonMW project nr. 205100005. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abadia E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-110; Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Ahmed A, 2010, INFECT GENET EVOL, V10, P955, DOI 10.1016/j.meegid.2010.06.002; Alland D, 2003, J BACTERIOL, V185, P3392, DOI 10.1128/JB.185.11.3392-3399.2003; Anthony RM, 2009, INT J TUBERC LUNG D, V13, P1051; Aubry A, 2006, ANTIMICROB AGENTS CH, V50, P104, DOI 10.1128/AAC.50.1.104-112.2006; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bergal IL, 2008, J CLIN MICROBIOL, V46, P689, DOI 10.1128/JCM.01821-07; Brodin P, 2002, INFECT IMMUN, V70, P5568, DOI 10.1128/IAI.70.10.5568-5578.2002; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brown TJ, 2006, J MICROBIOL METH, V65, P294, DOI 10.1016/j.mimet.2005.08.002; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Brzostek A, 2004, INT J TUBERC LUNG D, V8, P1032; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Chuang PC, 2010, INFECT GENET EVOL, V10, P459, DOI 10.1016/j.meegid.2010.03.003; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Cowan LS, 2004, J CLIN MICROBIOL, V42, P474, DOI 10.1128/JCM.42.1.474-477.2004; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Deshpande A, 2010, J MICROBIOL METH, V80, P155, DOI 10.1016/j.mimet.2009.12.001; Devaux I, 2009, EMERG INFECT DIS, V15, P1052, DOI 10.3201/eid1507.080994; Dobner P, 1997, MOL CELL PROBE, V11, P123, DOI 10.1006/mcpr.1996.0086; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Edwards KJ, 2001, J CLIN MICROBIOL, V39, P3350, DOI 10.1128/JCM.39.9.3350-3352.2001; Feuerriegel S, 2009, ANTIMICROB AGENTS CH, V53, P3353, DOI 10.1128/AAC.00050-09; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gegia M, 2008, ANTIMICROB AGENTS CH, V52, P725, DOI 10.1128/AAC.01124-07; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Heep M, 2001, J CLIN MICROBIOL, V39, P107, DOI 10.1128/JCM.39.1.107-110.2001; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; HIGUCHI RG, 1989, NUCLEIC ACIDS RES, V17, P5865, DOI 10.1093/nar/17.14.5865; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1409; Hillemann D, 2005, J CLIN MICROBIOL, V43, P3699, DOI 10.1128/JCM.43.8.3699-3703.2005; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Huard RC, 2006, J BACTERIOL, V188, P4271, DOI 10.1128/JB.01783-05; Jugheli L, 2009, ANTIMICROB AGENTS CH, V53, P5064, DOI 10.1128/AAC.00851-09; Kam KM, 2006, MICROB DRUG RESIST, V12, P7, DOI 10.1089/mdr.2006.12.7; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kontsevaya I, 2011, J CLIN MICROBIOL, V49, P2832, DOI 10.1128/JCM.01889-10; KOX LFF, 1995, J CLIN MICROBIOL, V33, P3225, DOI 10.1128/JCM.33.12.3225-3233.1995; Kroutter EN, 2011, LUM PLAN XMAP M VIEN; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Li J, 1999, ELECTROPHORESIS, V20, P1258, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1258::AID-ELPS1258>3.0.CO;2-V; Luo T, 2012, J CLIN MICROBIOL, V50, P633, DOI 10.1128/JCM.05539-11; Marmiesse M, 2004, MICROBIOL-SGM, V150, P483, DOI 10.1099/mic.0.26662-0; Mijs W, 2002, EUR J CLIN MICROBIOL, V21, P794, DOI 10.1007/s10096-002-0825-y; Mostowy S, 2004, J CLIN MICROBIOL, V42, P3594, DOI 10.1128/jcm.42.8.3594-3599.2004; MUSSER JM, 1995, CLIN MICROBIOL REV, V8, P496, DOI 10.1128/CMR.8.4.496; Nguyen D, 2004, J CLIN MICROBIOL, V42, P2573, DOI 10.1128/JCM.42.6.2573-2580.2004; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; NIKIFOROV TT, 1994, PCR METH APPL, V3, P285; Perdigao J, 2008, MICROB DRUG RESIST, V14, P133, DOI 10.1089/mdr.2008.0798; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Reyes JF, 2012, INFECT GENET EVOL, V12, P811, DOI 10.1016/j.meegid.2011.05.018; Richter E, 2004, J CLIN MICROBIOL, V42, P4303, DOI 10.1128/JCM.42.9.4303-4306.2004; Riska PF, 2000, INT J TUBERC LUNG D, V4, pS4; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schurch AC, 2011, INFECT GENET EVOL, V11, P587, DOI 10.1016/j.meegid.2011.01.009; Schurch AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028365; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Telenti A, 1997, CLIN CHEST MED, V18, P55, DOI 10.1016/S0272-5231(05)70355-5; Terefework Z, 2008, J MICROBIOL METH, V75, P558, DOI 10.1016/j.mimet.2008.08.012; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Tudo G, 2010, J ANTIMICROB CHEMOTH, V65, P2341, DOI 10.1093/jac/dkq322; van der Spuy GD, 2009, INT J TUBERC LUNG D, V13, P419; van Ingen J., 2009, THESIS RADBOUD U NIJ; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; vanSoolingen D, 1997, INT J SYST BACTERIOL, V47, P1236, DOI 10.1099/00207713-47-4-1236; Vo SK, 2010, J CLIN MICROBIOL, V48, P2934, DOI 10.1128/JCM.00201-10; Von Groll A, 2009, ANTIMICROB AGENTS CH, V53, P4498, DOI 10.1128/AAC.00287-09; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0; Zozio T, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-44	81	43	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43240	10.1371/journal.pone.0043240	http://dx.doi.org/10.1371/journal.pone.0043240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916230	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800056
J	Kim, J; Kim, CS; Sohn, E; Lee, YM; Jo, K; Kim, JS				Kim, Junghyun; Kim, Chan-Sik; Sohn, Eunjin; Lee, Yun Mi; Jo, Kyuhyung; Kim, Jin Sook			KIOM-79 Protects AGE-Induced Retinal Pericyte Apoptosis via Inhibition of NF-kappaB Activation In Vitro and In Vivo	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; ENDOTHELIAL GROWTH-FACTOR; GOTO-KAKIZAKI RATS; DIABETIC-RETINOPATHY; HIGH GLUCOSE; SERUM-LEVELS; CELLS; EXPRESSION; MICE; STREPTOZOTOCIN	KIOM-79 is an herbal mixture of parched Puerariae radix, gingered Magnoliae cortex, Glycyrrhizae radix and Euphorbiae radix. In the present study, we determined the efficacy and possible mechanism of KIOM-79 on the advanced glycation end product (AGE)-modified bovine serum albumin (BSA)-induced apoptosis of cultured bovine retinal pericytes and rat retinal pericytes in Zucker diabetic fatty (ZDF) rats. Seven-week-old male ZDF rats were treated with KIOM-79 (50 mg/kg body weight) once a day orally for 13 weeks. KIOM-79 significantly inhibited pericyte apoptosis which were induced by the AGE-BSA treatment. The KIOM-79 treatment markedly suppressed the activation of nuclear factor-kappaB (NF-kappa B) through the inhibition of inhibitory kappa B kinase complex. In addition, the oral administration of KIOM-79 inhibited the changes in retinal vasculature (vascular hyperpermeability, acellular capillary). KIOM-79 strongly inhibited pericyte apoptosis, NF-kappa B activation and the expression of pro-apoptotic Bax and tumor necrosis factor-alpha. Our results suggest that KIOM-79 may exert inhibitory effects on AGE-induced pericyte apoptosis by blocking NF-kappa B activation, thereby ameliorating retinal microvascular dysfunction.	[Kim, Junghyun; Kim, Chan-Sik; Sohn, Eunjin; Lee, Yun Mi; Jo, Kyuhyung; Kim, Jin Sook] Korea Inst Oriental Med, Herbal Med Res Div, Tradit Korean Med Based Herbal Drug Res Grp, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Kim, J (corresponding author), Korea Inst Oriental Med, Herbal Med Res Div, Tradit Korean Med Based Herbal Drug Res Grp, Taejon, South Korea.	jskim@kiom.re.kr			Korea Institute of Oriental Medicine (KIOM) [K12010]	Korea Institute of Oriental Medicine (KIOM)	This research was supported by a grant [K12010] from the Korea Institute of Oriental Medicine (KIOM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA K, 1990, PLANTA MED, V56, P254, DOI 10.1055/s-2006-960950; Alarcon-Aguilara FJ, 1998, J ETHNOPHARMACOL, V61, P101, DOI 10.1016/S0378-8741(98)00020-8; Asnaghi V, 2003, DIABETES, V52, P506, DOI 10.2337/diabetes.52.2.506; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Cacicedo JM, 2005, DIABETES, V54, P1838, DOI 10.2337/diabetes.54.6.1838; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; CAPETANDES A, 1990, INVEST OPHTH VIS SCI, V31, P1738; Chen WC, 2004, PLANTA MED, V70, P113, DOI 10.1055/s-2004-815486; Clements RS, 1998, J DIABETES COMPLICAT, V12, P28, DOI 10.1016/S1056-8727(97)00051-2; Denis U, 2002, FREE RADICAL BIO MED, V33, P236, DOI 10.1016/S0891-5849(02)00879-1; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; ENGERMAN RL, 1989, DIABETES, V38, P1203, DOI 10.2337/diabetes.38.10.1203; Hammes HP, 1999, DIABETOLOGIA, V42, P728, DOI 10.1007/s001250051221; Hernandez-Presa MA, 1999, KIDNEY INT, V55, P209, DOI 10.1046/j.1523-1755.1999.00226.x; Hughes S, 2004, INVEST OPHTH VIS SCI, V45, P2795, DOI 10.1167/iovs.03-1312; Jeon YJ, 2006, J ETHNOPHARMACOL, V108, P38, DOI 10.1016/j.jep.2006.04.007; Kaji Y, 2003, INVEST OPHTH VIS SCI, V44, P521, DOI 10.1167/iovs.02-0268; Kang KA, 2005, BIOL PHARM BULL, V28, P1154, DOI 10.1248/bpb.28.1154; Kang KA, 2007, BIOL PHARM BULL, V30, P852, DOI 10.1248/bpb.30.852; Kasper M, 2000, AM J RESP CELL MOL, V23, P485, DOI 10.1165/ajrcmb.23.4.4117; Kim CS, 2007, J ETHNOPHARMACOL, V111, P240, DOI 10.1016/j.jep.2006.11.023; Kim J, 2006, VET PATHOL, V43, P718, DOI 10.1354/vp.43-5-718; Kim KM, 2010, TOXICOL APPL PHARM, V244, P106, DOI 10.1016/j.taap.2009.12.023; Kim YS, 2007, J ETHNOPHARMACOL, V112, P166, DOI 10.1016/j.jep.2007.02.017; Koga K, 2002, INT J CLIN PHARM RES, V22, P13; Kondo T, 2003, CELL STRUCT FUNCT, V28, P145; Kowluru RA, 2003, FREE RADICAL RES, V37, P1169, DOI 10.1080/10715760310001604189; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lecleire-Collet A, 2005, BRIT J OPHTHALMOL, V89, P1631, DOI 10.1136/bjo.2005.079491; Lee HJ, 2006, CARCINOGENESIS, V27, P2455, DOI 10.1093/carcin/bgl104; Meezan E, 2005, J AGR FOOD CHEM, V53, P8760, DOI 10.1021/jf058105e; Mitsuhashi T, 1997, J IMMUNOL METHODS, V207, P79, DOI 10.1016/S0022-1759(97)00110-5; Miura J, 2003, J DIABETES COMPLICAT, V17, P16, DOI 10.1016/S1056-8727(02)00183-6; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Moore TCB, 2003, INVEST OPHTH VIS SCI, V44, P4457, DOI 10.1167/iovs.02-1063; Podesta F, 2000, AM J PATHOL, V156, P1025, DOI 10.1016/S0002-9440(10)64970-X; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sohn EJ, 2007, LIFE SCI, V80, P468, DOI 10.1016/j.lfs.2006.09.037; Stitt Alan W., 2000, Molecular Cell Biology Research Communications, V3, P380, DOI 10.1006/mcbr.2000.0243; Takii H, 2001, BIOL PHARM BULL, V24, P484, DOI 10.1248/bpb.24.484; Tezel G, 2004, BRAIN RES, V996, P202, DOI 10.1016/j.brainres.2003.10.029; Wang YL, 2007, EYE, V21, P1501, DOI 10.1038/sj.eye.6702716; Yamagishi S, 2002, BIOCHEM BIOPH RES CO, V296, P877, DOI 10.1016/S0006-291X(02)00940-3; Yamagishi S, 2002, BIOCHEM BIOPH RES CO, V290, P973, DOI 10.1006/bbrc.2001.6312; Yamagishi Sho-ichi, 2006, Curr Drug Discov Technol, V3, P83, DOI 10.2174/157016306776637555; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; YAMAGISHI SI, 1995, BIOCHEM BIOPH RES CO, V213, P681, DOI 10.1006/bbrc.1995.2185	49	12	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43591	10.1371/journal.pone.0043591	http://dx.doi.org/10.1371/journal.pone.0043591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916281	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800080
J	Kocalis, HE; Turney, MK; Printz, RL; Laryea, GN; Muglia, LJ; Davies, SS; Stanwood, GD; McGuinness, OP; Niswender, KD				Kocalis, Heidi E.; Turney, Maxine K.; Printz, Richard L.; Laryea, Gloria N.; Muglia, Louis J.; Davies, Sean S.; Stanwood, Gregg D.; McGuinness, Owen P.; Niswender, Kevin D.			Neuron-Specific Deletion of Peroxisome Proliferator-Activated Receptor Delta (PPAR delta) in Mice Leads to Increased Susceptibility to Diet-Induced Obesity	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INSULIN-RESISTANCE; FATTY-ACIDS; TRANSCRIPTIONAL REPRESSION; UNCOUPLING PROTEIN-2; TARGETED DISRUPTION; EXPRESSION; ALPHA; LEPTIN; BRAIN	Central nervous system (CNS) lipid accumulation, inflammation and resistance to adipo-regulatory hormones, such as insulin and leptin, are implicated in the pathogenesis of diet-induced obesity (DIO). Peroxisome proliferator-activated receptors (PPAR alpha, delta, gamma) are nuclear transcription factors that act as environmental fatty acid sensors and regulate genes involved in lipid metabolism and inflammation in response to dietary and endogenous fatty acid ligands. All three PPAR isoforms are expressed in the CNS at different levels. Recent evidence suggests that activation of CNS PPAR alpha and/or PPAR gamma may contribute to weight gain and obesity. PPAR delta is the most abundant isoform in the CNS and is enriched in the hypothalamus, a region of the brain involved in energy homeostasis regulation. Because in peripheral tissues, expression of PPAR delta increases lipid oxidative genes and opposes inflammation, we hypothesized that CNS PPAR delta protects against the development of DIO. Indeed, genetic neuronal deletion using Nes-Cre loxP technology led to elevated fat mass and decreased lean mass on low-fat diet (LFD), accompanied by leptin resistance and hypothalamic inflammation. Impaired regulation of neuropeptide expression, as well as uncoupling protein 2, and abnormal responses to a metabolic challenge, such as fasting, also occur in the absence of neuronal PPAR delta. Consistent with our hypothesis, KO mice gain significantly more fat mass on a high-fat diet (HFD), yet are surprisingly resistant to diet-induced elevations in CNS inflammation and lipid accumulation. We detected evidence of upregulation of PPAR gamma and target genes of both PPARa and PPAR gamma, as well as genes of fatty acid oxidation. Thus, our data reveal a previously underappreciated role for neuronal PPAR delta in the regulation of body composition, feeding responses, and in the regulation of hypothalamic gene expression.	[Kocalis, Heidi E.; Printz, Richard L.; Muglia, Louis J.; McGuinness, Owen P.; Niswender, Kevin D.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Niswender, Kevin D.] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN USA; [Turney, Maxine K.; Niswender, Kevin D.] Vanderbilt Univ, Sch Med, Dept Med, Div Diabet Endocrinol & Metab, Nashville, TN 37212 USA; [Laryea, Gloria N.] Vanderbilt Univ, Neurosci Grad Program, Nashville, TN 37212 USA; [Davies, Sean S.; Stanwood, Gregg D.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Muglia, Louis J.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Kocalis, HE (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	kevin.niswender@vanderbilt.edu		Davies, Sean/0000-0001-9879-8062; Stanwood, Gregg/0000-0001-6005-1203	National Institutes of Health [DK085712, DK069927, DK007563, DK083222]; Vanderbilt Diabetes Research and Training Center (DRTC) [DK20593]; DRTC Mouse Metabolic Phenotyping Center [MMPC DK59637]; Vanderbilt University Translation Pathology Shared Resource Core [5U24 DK059637];  [DK058404]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, P30DK020593, F31DK083222, R01DK069927, P30DK058404, U24DK059637, R01DK085712, U2CDK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH064913, R01MH079010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Diabetes Research and Training Center (DRTC); DRTC Mouse Metabolic Phenotyping Center; Vanderbilt University Translation Pathology Shared Resource Core; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project is supported by National Institutes of Health grants DK085712, DK069927, DK007563 (KDN) and DK083222 (to HK) and partially by DK058404 (KDN), the Vanderbilt Diabetes Research and Training Center (DRTC) (DK20593 to KDN) and the DRTC Mouse Metabolic Phenotyping Center (MMPC DK59637 to KDN). This work was partially supported by resources of the Vanderbilt University Translation Pathology Shared Resource Core (5U24 DK059637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016344; Alvarez-Guardia D, 2011, BBA-MOL CELL BIOL L, V1811, P59, DOI 10.1016/j.bbalip.2010.11.002; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Arsenijevic D, 2006, J CEREBR BLOOD F MET, V26, P433, DOI 10.1038/sj.jcbfm.9600200; Auwerx J, 1996, ATHEROSCLEROSIS, V124, pS29, DOI 10.1016/0021-9150(96)05854-6; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Bright JJ, 2008, PPAR RES, V2008, DOI 10.1155/2008/658520; Bugge A, 2010, PPAR RES, V2010, DOI 10.1155/2010/169506; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Coll T, 2010, ENDOCRINOLOGY, V151, P1560, DOI 10.1210/en.2009-1211; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Degasperi GR, 2008, FEBS LETT, V582, P3103, DOI 10.1016/j.febslet.2008.08.006; Diano S, 2011, NAT MED; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Dunn SE, 2010, J EXP MED, V207, P1599, DOI 10.1084/jem.20091663; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FREDERICH RC, 1995, J CLIN INVEST, V96, P1658, DOI 10.1172/JCI118206; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Georgiadi A, 2010, CIRC RES, V106, P1712, DOI 10.1161/CIRCRESAHA.110.217380; Gustafsson MCU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007046; Haines BA, 2010, J CEREBR BLOOD F MET, V30, P1825, DOI 10.1038/jcbfm.2010.52; Horvath TL, 2003, INT J OBESITY, V27, P433, DOI 10.1038/sj.ijo.0802257; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Kalinin S, 2009, CURR ALZHEIMER RES, V6, P431, DOI 10.2174/156720509789207949; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Konig B, 2009, PPAR RES, V2009, DOI 10.1155/2009/801609; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lee CH, 2006, P NATL ACAD SCI USA, V103, P2434, DOI 10.1073/pnas.0510815103; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Levin BE, 2002, AM J PHYSIOL-REG I, V283, pR941, DOI 10.1152/ajpregu.00245.2002; Li YQ, 2009, J MOL CELL CARDIOL, V47, P536, DOI 10.1016/j.yjmcc.2009.07.001; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; MARON DJ, 1991, CIRCULATION, V84, P2020, DOI 10.1161/01.CIR.84.5.2020; Miyachi H, 2007, CURR MED CHEM, V14, P2335, DOI 10.2174/092986707781745587; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; MORRISON WR, 1964, J LIPID RES, V5, P600; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; OSCAI LB, 1982, AM J PHYSIOL, V242, pR212, DOI 10.1152/ajpregu.1982.242.3.R212; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Porte D, 2002, NUTR REV, V60, pS20, DOI 10.1301/002966402320634797; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Saraswathi V, 2006, J LIPID RES, V47, P1406, DOI 10.1194/jlr.M600159-JLR200; Sasaki T, 2010, ENDOCRINOLOGY, V151, P2556, DOI 10.1210/en.2009-1319; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; Schnegg CI, 2011, PPAR RES, V2011, DOI 10.1155/2011/373560; Schwartz MW, 1998, ENDOCRINOLOGY, V139, P2629, DOI 10.1210/en.139.5.2629; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Speed N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025169; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Woods JW, 2003, BRAIN RES, V975, P10, DOI 10.1016/S0006-8993(03)02515-0; Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081; Wu HT, 2011, HORM METAB RES, V43, P631, DOI 10.1055/s-0031-1280781; Xing GQ, 1995, BIOCHEM BIOPH RES CO, V217, P1015, DOI 10.1006/bbrc.1995.2871; Yessoufou A, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13071	74	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42981	10.1371/journal.pone.0042981	http://dx.doi.org/10.1371/journal.pone.0042981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916190	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800039
J	Stolla, M; Pelisek, J; Von Bruhl, ML; Schafer, A; Barocke, V; Heider, P; Lorenz, M; Tirniceriu, A; Steinhart, A; Bauersachs, J; Bray, PF; Massberg, S; Schulz, C				Stolla, Moritz; Pelisek, Jaroslav; von Bruehl, Marie-Luise; Schaefer, Andreas; Barocke, Verena; Heider, Peter; Lorenz, Michael; Tirniceriu, Anca; Steinhart, Alexander; Bauersachs, Johann; Bray, Paul F.; Massberg, Steffen; Schulz, Christian			Fractalkine Is Expressed in Early and Advanced Atherosclerotic Lesions and Supports Monocyte Recruitment via CX3CR1	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; CORONARY-ARTERY-DISEASE; IN-VIVO; RECEPTOR CX(3)CR1; PLATELET-ADHESION; VASCULAR-LESIONS; UNSTABLE ANGINA; TISSUE FACTOR; AORTIC-WALL; CHEMOKINE	Fractalkine (CX3CL1, FKN) is expressed in the inflamed vascular wall and absence of FKN reduces atherogenesis. Whether FKN is expressed throughout all stages of atherosclerotic disease and whether it directly contributes to monocyte recruitment to atherosclerotic lesions is not known. We collected human atherosclerotic plaque material and blood samples from patients with carotid artery disease undergoing endarterectomy. Plaques were analyzed by immunohistochemistry and qPCR. We found that FKN is expressed at all stages of atherosclerotic lesion formation, and that the number of FKN-expressing cells positively correlates with the number of CX3CR1-positive cells in human carotid artery plaques. In the circulation, soluble FKN levels are significantly elevated in the presence of high-grade (sub-occlusive) stenosis. To determine the role of the FKN-CX3CR1 axis for monocyte adhesion in vivo we then performed intravital videofluorescence microscopy of the carotid artery in ApoE(-/-) mice. Notably, FKN-CX3CR1 interactions are critical for recruitment of circulating monocytes to the injured atherosclerotic vascular wall. Thus, this chemokine dyad could represent an attractive target for anti-atherosclerotic strategies.	[Stolla, Moritz; Bray, Paul F.] Thomas Jefferson Univ, Jefferson Med Coll, Cardeza Fdn, Philadelphia, PA 19107 USA; [Stolla, Moritz; Bray, Paul F.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA; [Pelisek, Jaroslav; Heider, Peter] Tech Univ Munich, Klinikum Rechts Isar, Abt Gefasschirurgie, D-8000 Munich, Germany; [von Bruehl, Marie-Luise; Barocke, Verena; Lorenz, Michael; Tirniceriu, Anca; Steinhart, Alexander; Massberg, Steffen; Schulz, Christian] Tech Univ Munich, Klinikum Rechts Isar, Med Klin, Deutsch Herzzentrum, D-8000 Munich, Germany; [von Bruehl, Marie-Luise; Barocke, Verena; Lorenz, Michael; Tirniceriu, Anca; Steinhart, Alexander; Massberg, Steffen; Schulz, Christian] Munich Heart Alliance, Munich, Germany; [Schaefer, Andreas; Bauersachs, Johann] Hannover Med Sch, Klin Kardiol & Angiol, D-30623 Hannover, Germany	Jefferson University; Jefferson University; Technical University of Munich; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Munich Heart Alliance; Hannover Medical School	Stolla, M (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Cardeza Fdn, Philadelphia, PA 19107 USA.	chrisschulz@mytum.de	Massberg, Steffen/AAN-6054-2021; Schulz, Christian/J-8545-2012; Schäfer, Andreas/AAQ-9512-2021	Schulz, Christian/0000-0003-3878-7833; 	Wilhelm-Vaillant-Stiftung; Technische Universitat Muenchen; German National Academy of Sciences Leopoldina [LPDS 2009-31]; American Heart Association	Wilhelm-Vaillant-Stiftung; Technische Universitat Muenchen; German National Academy of Sciences Leopoldina; American Heart Association(American Heart Association)	The study was supported in by the Wilhelm-Vaillant-Stiftung and grants of the Technische Universitat Muenchen. Christian Schulz is recipient of a fellowship program of the German National Academy of Sciences Leopoldina (LPDS 2009-31). Moritz Stolla is recipient of a fellowship of the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chou J, 2004, BLOOD, V104, P3190, DOI 10.1182/blood-2004-03-0935; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; CROUSE JR, 1993, CIRCULATION, V87, P17; Damas JK, 2005, ARTERIOSCL THROM VAS, V25, P2567, DOI 10.1161/01.ATV.0000190672.36490.7b; Damas JK, 2003, CIRCULATION, V107, P2670, DOI 10.1161/01.CIR.0000070542.18001.87; de Lemos JA, 2003, CIRCULATION, V107, P690, DOI 10.1161/01.CIR.0000049742.68848.99; Dorgham K, 2009, J LEUKOCYTE BIOL, V86, P903, DOI 10.1189/jlb.0308158; Egorina EM, 2005, ARTERIOSCL THROM VAS, V25, P1493, DOI 10.1161/01.ATV.0000168413.29874.d7; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Galkina E, 2007, CIRCULATION, V116, P1801, DOI 10.1161/CIRCULATIONAHA.106.678474; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Greaves DR, 2001, ARTERIOSCL THROM VAS, V21, P923, DOI 10.1161/01.ATV.21.6.923; Hasegawa M, 2005, ANN RHEUM DIS, V64, P21, DOI 10.1136/ard.2003.018705; Ikejima H, 2010, CIRC J, V74, P337, DOI 10.1253/circj.CJ-09-0484; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kerfoot SM, 2003, EUR J IMMUNOL, V33, P729, DOI 10.1002/eji.200323502; Kim KW, 2011, BLOOD; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Lucas AD, 2003, CIRCULATION, V108, P2498, DOI 10.1161/01.CIR.0000097119.57756.EF; Ludwig A, 2007, THROMB HAEMOSTASIS, V97, P694; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Massberg S, 2005, CIRCULATION, V112, P1180, DOI 10.1161/CIRCULATIONAHA.105.539221; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Robinson LA, 2000, J IMMUNOL, V165, P6067, DOI 10.4049/jimmunol.165.11.6067; Robinson LA, 2003, CELL IMMUNOL, V225, P122, DOI 10.1016/j.cellimm.2003.09.010; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulz C, 2011, J THROMB HAEMOST, V9, P1007, DOI 10.1111/j.1538-7836.2011.04235.x; Schulz C, 2008, BASIC RES CARDIOL, V103, P356, DOI 10.1007/s00395-008-0722-3; Schulz C, 2007, CIRCULATION, V116, P764, DOI 10.1161/CIRCULATIONAHA.107.695189; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Umehara H, 2001, IMMUNOL CELL BIOL, V79, P298, DOI 10.1046/j.1440-1711.2001.01004.x; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; WALKER EB, 1982, J IMMUNOL, V128, P852; Wong BWC, 2002, CARDIOVASC PATHOL, V11, P332, DOI 10.1016/S1054-8807(02)00111-4; Yi GW, 2011, CYTOKINE, V53, P320, DOI 10.1016/j.cyto.2010.11.016	51	47	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43572	10.1371/journal.pone.0043572	http://dx.doi.org/10.1371/journal.pone.0043572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916279	Green Submitted, gold, Green Published			2022-12-25	WOS:000307733800078
J	Zhang, K; Han, J; Groesser, T; Fontenay, G; Parvin, B				Zhang, Kai; Han, Ju; Groesser, Torsten; Fontenay, Gerald; Parvin, Bahram			Inference of Causal Networks from Time-Varying Transcriptome Data via Sparse Coding	PLOS ONE			English	Article							GENE-EXPRESSION; SELECTION; DEATH	Temporal analysis of genome-wide data can provide insights into the underlying mechanism of the biological processes in two ways. First, grouping the temporal data provides a richer, more robust representation of the underlying processes that are co-regulated. The net result is a significant dimensional reduction of the genome-wide array data into a smaller set of vocabularies for bioinformatics analysis. Second, the computed set of time-course vocabularies can be interrogated for a potential causal network that can shed light on the underlying interactions. The method is coupled with an experiment for investigating responses to high doses of ionizing radiation with and without a small priming dose. From a computational perspective, inference of a causal network can rapidly become computationally intractable with the increasing number of variables. Additionally, from a bioinformatics perspective, larger networks always hinder interpretation. Therefore, our method focuses on inferring the simplest network that is computationally tractable and interpretable. The method first reduces the number of temporal variables through consensus clustering to reveal a small set of temporal templates. It then enforces simplicity in the network configuration through the sparsity constraint, which is further regularized by requiring continuity between consecutive time points. We present intermediate results for each computational step, and apply our method to a time-course transcriptome dataset for a cell line receiving a challenge dose of ionizing radiation with and without a prior priming dose. Our analyses indicate that (i) the priming dose increases the diversity of the computed templates (e.g., diversity of transcriptome signatures); thus, increasing the network complexity; (ii) as a result of the priming dose, there are a number of unique templates with delayed and oscillatory profiles; and (iii) radiation-induced stress responses are enriched through pathway and subnetwork studies.	[Zhang, Kai; Han, Ju; Groesser, Torsten; Fontenay, Gerald; Parvin, Bahram] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, K (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	B_Parvin@lbl.gov		Groesser, Torsten/0000-0003-3143-1906	U.S. Department of Energy [DE-AC02-05CH11231]; National Cancer Institute [RO1CA140663]; NATIONAL CANCER INSTITUTE [R01CA140663] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Director, Office of Science, Office of Biological and Environmental Research, Radiochemistry and Imaging Instrumentation, Low Dose Radiation program with the U.S. Department of Energy under Contract Nos. DE-AC02-05CH11231, and a grant from the National Cancer Institute (Grant RO1CA140663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ahmed A, 2009, P NATL ACAD SCI USA, V106, P11878, DOI 10.1073/pnas.0901910106; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barcellos-Hoff M, 2005, BJR S27, P123; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Celeux G, 2005, STAT MODEL, V5, P243, DOI 10.1191/1471082X05st096oa; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; Cinquemani E, 2008, BIOINFORMATICS, V24, P2748, DOI 10.1093/bioinformatics/btn527; Das A, 2001, J BIOL CHEM, V276, P3279, DOI 10.1074/jbc.M008454200; Day TK, 2007, INT J RADIAT BIOL, V83, P523, DOI 10.1080/09553000701420582; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Ellis B, 2008, J AM STAT ASSOC, V103, P778, DOI 10.1198/016214508000000193; Fauer A, 2006, BIOINFORMATICS, V22, P124; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Groesser T, 2011, INT J RADIAT BIOL, V87, P696, DOI 10.3109/09553002.2010.549535; Han J, 2010, MICROSCOPY, V241, P315; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Henao R, 2009, BAYESIAN SPARSE FACT, P736; Hill SM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-94; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kou SC, 2006, ANN STAT, V34, P1581, DOI 10.1214/009053606000000515; Li S, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040009, 10.1371/journal.pcbi.0040009.eor]; Lin W, 2011, GENE DEV, V15, P1833; Luan YH, 2003, BIOINFORMATICS, V19, P474, DOI 10.1093/bioinformatics/btg014; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; McBride William H, 2002, Mil Med, V167, P66; Molller-Levet C, 2003, BIOINOFORMATICS, V19, P834; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Nevins J, 1988, CELL GROWTH DIFFER, V9, P585; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Pervan M, 2005, MOL CANCER RES, V3, P381, DOI 10.1158/1541-7786.MCR-05-0032; Prise KM, 2006, OCCUP MED-OXFORD, V56, P156, DOI 10.1093/occmed/kql010; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Robin JM, 1999, IMPOSSIBILITY INFERR; Roy L, 2009, ANN I SUPER SANITA, V45, P272; Tapio S, 2007, RADIAT ENVIRON BIOPH, V46, P1, DOI 10.1007/s00411-006-0078-8; Tenazinha N, 2011, IEEE ACM T COMPUT BI, V8, P943, DOI 10.1109/TCBB.2010.117; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turtoi A, 2008, INT J RADIAT BIOL, V84, P375, DOI 10.1080/09553000802029886; Voy BH, 2006, PLOS COMPUT BIOL, V2, P757, DOI 10.1371/journal.pcbi.0020089; WEICHSELBAUM RR, 1994, INT J RADIAT ONCOL, V30, P229, DOI 10.1016/0360-3016(94)90539-8; Worku D, 2008, ANTICANCER RES, V28, P2135; Yang JY, 2006, INT J ONCOL, V29, P643	46	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42306	10.1371/journal.pone.0042306	http://dx.doi.org/10.1371/journal.pone.0042306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916126	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800018
J	Al-Wadei, HAN; Al-Wadei, MH; Ullah, MF; Schuller, HM				Al-Wadei, Hussein A. N.; Al-Wadei, Mohammed H.; Ullah, Mohammad F.; Schuller, Hildegard M.			Celecoxib and GABA Cooperatively Prevent the Progression of Pancreatic Cancer In Vitro and in Xenograft Models of Stress-Free and Stress-Exposed Mice	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; TOBACCO-SPECIFIC CARCINOGEN; GAMMA-AMINOBUTYRIC-ACID; CELL LUNG-CANCER; CYCLOOXYGENASE-2 EXPRESSION; ARACHIDONIC-ACID; TUMOR-ANGIOGENESIS; HUMAN PROSTATE; BETA-BLOCKERS; BREAST-CANCER	Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis and is associated with high levels of psychological distress. We have shown that beta-adrenergic receptors (beta-ARs), which are activated by stress neurotransmitters, regulate PDAC cells via cyclic AMP (cAMP)-dependent signaling in vitro, that social stress promotes PDAC progression in mouse xenografts and that gamma-aminobutyric acid (GABA) inhibits these responses in vitro and in vivo. The targeted inhibition of stress-induced regulatory pathways may abolish the potentially negative impact of psychological stress on clinical outcomes. Our current data show that chronic exposure of PDAC cell lines Panc-1 (activating point mutations in K-ras) and BXPC-3 (no mutations in K-ras) in vitro to the stress neurotransmitter epinephrine at the concentration (15 nM) previously measured in the serum of mice exposed to social stress significantly increased proliferation and migration. These responses were inhibited in a concentration-dependent manner by celecoxib. The effects of celecoxib alone and in combination with gamma-aminobutyric acid (GABA) on the progression of subcutaneous mouse xenografts from the cell line (BXPC-3) most responsive to epinephrine were then investigated in the presence and absence of social stress. Cancer-stimulating factors (VEGF & prostaglandin E-2 [PGE(2)]) and levels of cAMP were measured by immunoassays in blood and xenograft tissue. Phosphorylation of the signaling proteins ERK, CREB, Src, and AKT was assessed by ELISA assays and Western blotting. Expression of COX-2, 5-lipoxygenase, and p-5-LOX were determined by semi-quantitative Western blotting. Celecoxib alone significantly inhibited xenograft progression and decreased systemic and tumor VEGF, PGE2, and cAMP as well as phosphorylated signaling proteins in stress-exposed and stress-free mice. These responses were significantly enhanced by co-treatment with GABA. The celecoxib-induced downregulation of COX-2 protein and p-5-LOX was also significantly enhanced by GABA under both experimental conditions. Our findings identify the targeted inhibition of stress-induced pathways as a promising area for more effective cancer intervention in pancreatic cancer.	[Al-Wadei, Hussein A. N.; Al-Wadei, Mohammed H.; Ullah, Mohammad F.; Schuller, Hildegard M.] Univ Tennessee, Coll Vet Med, Expt Oncol Lab, Dept Biomed & Diagnost Sci, Knoxville, TN 37901 USA; [Al-Wadei, Hussein A. N.] Sanaa Univ, Dept Prevent Med, Sanaa, Yemen	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Al-Wadei, HAN (corresponding author), Univ Tennessee, Coll Vet Med, Expt Oncol Lab, Dept Biomed & Diagnost Sci, Knoxville, TN 37901 USA.	hmsch@utk.edu	Ullah, Mohammad Fahad/AGH-2871-2022		National Cancer Institute; College of Veterinary Medicine;  [RC1CA144640];  [RO1CA042829]; NATIONAL CANCER INSTITUTE [R01CA042829, RC1CA144640] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); College of Veterinary Medicine; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was financially supported by grants RC1CA144640 and RO1CA042829 with the National Cancer Institute. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Misty Bailey (whose position is fully funded by the College of Veterinary Medicine) for her textual editorial assistance with the manuscript.	Al-Wadei HA, 2009, ANTI-CANCER DRUG, V20, P477, DOI 10.1097/CAD.0b013e32832bd1e3; Al-Wadei HAN, 2012, CANCER PREV RES, V5, P189, DOI 10.1158/1940-6207.CAPR-11-0177; Al-Wadei HAN, 2009, CARCINOGENESIS, V30, P506, DOI 10.1093/carcin/bgp010; Al-Wadei MH, 2012, MOL CANCER RES, V10, P239, DOI 10.1158/1541-7786.MCR-11-0332; Ali S, 2005, MOL CANCER THER, V4, P1943, DOI 10.1158/1535-7163.MCT-05-0065; Almhanna K, 2011, CURR TREAT OPTION ON, V12, P111, DOI 10.1007/s11864-011-0150-8; Askari MDF, 2005, J CANCER RES CLIN, V131, P639, DOI 10.1007/s00432-005-0002-7; Chan G, 1999, CANCER RES, V59, P991; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641; Dempke W, 2001, J CANCER RES CLIN, V127, P411, DOI 10.1007/s004320000225; Ding Xian-Zhong, 2003, Mol Cancer, V2, P10, DOI 10.1186/1476-4598-2-10; Ding XZ, 2001, PANCREATOLOGY, V1, P291, DOI 10.1159/000055827; Elder DJE, 2002, INT J CANCER, V99, P323, DOI 10.1002/ijc.10330; Gately S, 2000, CANCER METAST REV, V19, P19, DOI 10.1023/A:1026575610124; Half E, 2002, CANCER RES, V62, P1676; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Jacobs EJ, 2004, J NATL CANCER I, V96, P524, DOI 10.1093/jnci/djh084; Jendrossek V, 2011, CANC LETT IN PRESS; Khuri FR, 2001, CLIN CANCER RES, V7, P861; Kirschenbaum A, 2000, UROLOGY, V56, P671, DOI 10.1016/S0090-4295(00)00674-9; Kulkarni S, 2001, CLIN CANCER RES, V7, P429; Lefkowitz RJ, 2000, NAT CELL BIOL, V2, pE133, DOI 10.1038/35017152; Lim HY, 2000, CLIN CANCER RES, V6, P519; Liu XL, 2006, ADV ANAT PATHOL, V13, P270, DOI 10.1097/01.pap.0000213046.61941.5c; Longo R, 2008, CRIT REV ONCOL HEMAT, V68, P197, DOI 10.1016/j.critrevonc.2008.03.003; Lowenfels AB, 2005, J CELL BIOCHEM, V95, P649, DOI 10.1002/jcb.20461; Masur K, 2001, CANCER RES, V61, P2866; Melhem-Bertrandt A, 2012, CANCER PREV RES, V5, P147, DOI 10.1158/1940-6207.CAPR-11-0579; Moreno-Smith M, 2010, FUTURE ONCOL, V6, P1863, DOI 10.2217/FON.10.142; Nieto J, 2008, ONCOLOGIST, V13, P562, DOI 10.1634/theoncologist.2007-0181; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; Parsons CM, 2010, ANTICANCER RES, V30, P3279; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; Sapolsky R.M., 1998, WHY ZEBRAS DONT GET; Schernhammer ES, 2004, JNCI-J NATL CANCER I, V96, P22, DOI 10.1093/jnci/djh001; Schmidt C, 1996, Eur J Med Res, V1, P528; Schuller HM, 2008, CANCER-AM CANCER SOC, V112, P767, DOI 10.1002/cncr.23231; Schuller HM, 2012, CARCINOGENESIS, V33, P191, DOI 10.1093/carcin/bgr251; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Schuller HM, 1999, CANCER RES, V59, P4510; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Shields DJ, 2011, ONCOGENE, V30, P2123, DOI 10.1038/onc.2010.589; Shin VY, 2007, TOXICOL SCI, V96, P21, DOI 10.1093/toxsci/kfl118; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Sterlemann V, 2008, HORM BEHAV, V53, P386, DOI 10.1016/j.yhbeh.2007.11.001; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tucker ON, 1999, CANCER RES, V59, P987; Waldner MJ, 2012, EXPERT OPIN THER TAR, V16, P5, DOI 10.1517/14728222.2011.641951; Weddle DL, 2001, CARCINOGENESIS, V22, P473, DOI 10.1093/carcin/22.3.473; Werz O, 2002, J BIOL CHEM, V277, P14793, DOI 10.1074/jbc.M111945200; World Health Organization, 2012, CANC FACT SHEET; Zabora J, 2001, PSYCHO-ONCOL, V10, P19, DOI 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.0.CO;2-6	55	33	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43376	10.1371/journal.pone.0043376	http://dx.doi.org/10.1371/journal.pone.0043376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916251	gold, Green Published			2022-12-25	WOS:000307824300045
J	Eynon, N; Ruiz, JR; Femia, P; Pushkarev, VP; Cieszczyk, P; Maciejewska-Karlowska, A; Sawczuk, M; Dyatlov, DA; Lekontsev, EV; Kulikov, LM; Birk, R; Bishop, DJ; Lucia, A				Eynon, Nir; Ruiz, Jonatan R.; Femia, Pedro; Pushkarev, Vladimir P.; Cieszczyk, Pawel; Maciejewska-Karlowska, Agnieszka; Sawczuk, Marek; Dyatlov, Dmitry A.; Lekontsev, Evgeny V.; Kulikov, Leonid M.; Birk, Ruth; Bishop, David J.; Lucia, Alejandro			The ACTN3 R577X Polymorphism across Three Groups of Elite Male European Athletes	PLOS ONE			English	Article							ALPHA-ACTININ-3 DEFICIENCY; ENDURANCE PERFORMANCE; ASSOCIATION; GENE; GENOTYPE; EXPRESSION; EVOLUTION; STRENGTH; ALLELE; SPEED	The ACTN3 R577X polymorphism (rs1815739) is a strong candidate to influence elite athletic performance. Yet, controversy exists in the literature owing to between-studies differences in the ethnic background and sample size of the cohorts, the latter being usually low, which makes comparisons difficult. In this case: control genetic study we determined the association between elite athletic status and the ACTN3 R577X polymorphism within three cohorts of European Caucasian men, i.e. Spanish, Polish and Russian [ 633 cases (278 elite endurance and 355 power athletes), and 808 non-athletic controls]. The odds ratio (OR) of a power athlete harbouring the XX versus the RR genotype compared with sedentary controls was 0.54 [95% confidence interval (CI): 0.34-0.48; P = 0.006]. We also observed that the OR of an endurance athlete having the XX versus the RR genotype compared with power athletes was 1.88 (95% CI: 1.07-3.31; P = 0.028). In endurance athletes, the OR of a "world-class" competitor having the XX genotype versus the RR+RX genotype was 3.74 (95% CI: 1.08-12.94; P = 0.038) compared with those of a lower ("national") competition level. No association (P>0.1) was noted between the ACTN3 R577X polymorphism and competition level (world-class versus national-level) in power athletes. Our data provide comprehensive support for the influence of the ACTN3 R577X polymorphism on elite athletic performance.	[Eynon, Nir; Bishop, David J.] Victoria Univ, ISEAL, Melbourne, Vic 8001, Australia; [Eynon, Nir; Bishop, David J.] Victoria Univ, Sch Sports & Exercise Sci, Melbourne, Vic 8001, Australia; [Ruiz, Jonatan R.] Univ Granada, Sch Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Ruiz, Jonatan R.] Karolinska Inst, Novum, Unit Prevent Nutr Dept Biosci & Nutr, Huddinge, Sweden; [Femia, Pedro] Univ Granada, Sch Med, Dept Biostat, Granada, Spain; [Pushkarev, Vladimir P.; Dyatlov, Dmitry A.; Lekontsev, Evgeny V.; Kulikov, Leonid M.] Ural State Univ Phys Culture, Ural, Russia; [Cieszczyk, Pawel] Univ Szczecin, Dept Phys Culture & Hlth Promot, Szczecin, Poland; [Maciejewska-Karlowska, Agnieszka; Sawczuk, Marek] Univ Szczecin, Dept Genet, Szczecin, Poland; [Birk, Ruth] Ariel Univ Ctr, Dept Nutr, Fac Hlth Sci, Ariel, Israel; [Lucia, Alejandro] Univ Europea Madrid, Madrid, Spain	Victoria University; Victoria University; University of Granada; Karolinska Institutet; University of Granada; University of Szczecin; University of Szczecin; Ariel University; European University of Madrid	Eynon, N (corresponding author), Victoria Univ, ISEAL, Melbourne, Vic 8001, Australia.	Nir.Eynon@vu.edu.au	RUIZ, JONATAN R/M-1338-2015; Cieszczyk, Pawel/AAG-3328-2022; Sawczuk, Marek/S-3609-2017; Femia, Pedro/C-1367-2011; Lucia, Alejandro/M-2759-2014; Cieszczyk, Pawel/AFK-4645-2022; Bishop, David John/X-9826-2019	RUIZ, JONATAN R/0000-0002-7548-7138; Cieszczyk, Pawel/0000-0002-7735-7580; Femia, Pedro/0000-0002-1746-5619; Lucia, Alejandro/0000-0002-3025-2060; Cieszczyk, Pawel/0000-0002-7735-7580; Bishop, David John/0000-0002-6956-9188; Maciejewska-Skrendo, Agnieszka/0000-0003-4587-2411; birk, ruth/0000-0001-5770-4277; Eynon, Nir/0000-0003-4046-8276; Sawczuk, Marek/0000-0002-5730-5249; Lucia, Alejandro/0000-0002-5565-0997	Consejo Superior de Deportes [001/UPR10/12]; Spanish Ministry of Science and Innovation [RYC-2010-05957]; Fondo de Investigaciones Sanitarias [PS09/00194]; Polish Ministry of Science and Higher Education [404166334]; Ministry of Sport, Tourism and Youth Policy of the Russian Federation	Consejo Superior de Deportes; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Ministry of Sport, Tourism and Youth Policy of the Russian Federation	This work was supported by the Consejo Superior de Deportes (grant #001/UPR10/12), Spanish Ministry of Science and Innovation (RYC-2010-05957), Fondo de Investigaciones Sanitarias (ref. # PS09/00194), the Polish Ministry of Science and Higher Education (grant#404166334), and the Ministry of Sport, Tourism and Youth Policy of the Russian Federation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmetov II, 2010, BRIT J SPORT MED, V44, P649, DOI 10.1136/bjsm.2008.051540; Ahmetov II, 2011, EXP PHYSIOL, V96, P1302, DOI 10.1113/expphysiol.2011.060293; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P191, DOI 10.1001/jama.2008.946; Bishop D, 2000, MED SCI SPORT EXER, V32, P1088, DOI 10.1097/00005768-200006000-00008; Bouchard C, 2011, EXERC SPORT SCI REV, V39, P212, DOI 10.1097/JES.0b013e31822643f6; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Doring FE, 2010, J SPORT SCI, V28, P1355, DOI 10.1080/02640414.2010.507675; Druzhevskaya AM, 2008, EUR J APPL PHYSIOL, V103, P631, DOI 10.1007/s00421-008-0763-1; Eynon N, 2009, INT J SPORTS MED, V30, P695, DOI 10.1055/s-0029-1220731; Eynon N, 2011, J PHYSIOL-LONDON, V589, P3063, DOI 10.1113/jphysiol.2011.207035; Gineviciene V, 2011, MEDICINA-LITHUANIA, V47, P284, DOI 10.3390/medicina47050040; Gomez-Gallego F, 2009, INT J SPORTS MED, V30, P66, DOI 10.1055/s-2008-1038677; Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7; Lucia A, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.034199; MacArthur DG, 2008, HUM MOL GENET, V17, P1076, DOI 10.1093/hmg/ddm380; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; MacArthur DG, 2007, EXERC SPORT SCI REV, V35, P30, DOI 10.1097/JES.0b013e31802d8874; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Muniesa CA, 2010, BRIT J SPORT MED, V44, P898, DOI 10.1136/bjsm.2008.051680; Niemi AK, 2005, EUR J HUM GENET, V13, P965, DOI 10.1038/sj.ejhg.5201438; Norman B, 2009, J APPL PHYSIOL, V106, P959, DOI 10.1152/japplphysiol.91435.2008; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; Papadimitriou ID, 2008, INT J SPORTS MED, V29, P352, DOI 10.1055/s-2007-965339; Roth SM, 2008, EUR J HUM GENET, V16, P391, DOI 10.1038/sj.ejhg.5201964; Ruiz JR, 2011, SCAND J MED SCI SPOR, V21, pE34, DOI 10.1111/j.1600-0838.2010.01134.x; Saunders CJ, 2007, ANN HUM GENET, V71, P777, DOI 10.1111/j.1469-1809.2006.00385.x; Tejedor D, 2005, CLIN CHEM, V51, P1137, DOI 10.1373/clinchem.2004.045203; Vincent B, 2012, ACTA PHYSIOL, V204, P555, DOI 10.1111/j.1748-1716.2011.02366.x; Vincent B, 2007, PHYSIOL GENOMICS, V32, P58, DOI 10.1152/physiolgenomics.00173.2007; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Yang N, 2007, MED SCI SPORT EXER, V39, P1985, DOI 10.1249/mss.0b013e31814844c9	32	59	61	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43132	10.1371/journal.pone.0043132	http://dx.doi.org/10.1371/journal.pone.0043132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916217	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000307824300031
J	Smith, ML				Smith, Michael L.			The Honey Bee Parasite Nosema ceranae: Transmissible via Food Exchange?	PLOS ONE			English	Article							APIS-MELLIFERA; MICROSPORIDIAN PARASITE; COLONY COLLAPSE; INFECTION; EUROPE	Nosema ceranae, a newly introduced parasite of the honey bee, Apis mellifera, is contributing to worldwide colony losses. Other Nosema species, such as N. apis, tend to be associated with increased defecation and spread via a fecal-oral pathway, but because N. ceranae does not induce defecation, it may instead be spread via an oral-oral pathway. Cages that separated older infected bees from young uninfected bees were used to test whether N. ceranae can be spread during food exchange. When cages were separated by one screen, food could be passed between the older bees and the young bees, but when separated by two screens, food could not be passed between the two cages. Young uninfected bees were also kept isolated in cages, as a solitary control. After 4 days of exposure to the older bees, and 10 days to incubate infections, young bees were more likely to be infected in the 1-Screen Test treatment vs. the 2-Screen Test treatment (P = 0.0097). Young bees fed by older bees showed a 13-fold increase in mean infection level relative to young bees not fed by older bees (1-Screen Test 40.8%; 2-Screen Test 3.4%; Solo Control 2.8%). Although fecal-oral transmission is still possible in this experimental design, oral-oral infectivity could help explain the rapid spread of N. ceranae worldwide.	Wageningen Univ, Bees WUR, Wageningen, Netherlands	Wageningen University & Research	Smith, ML (corresponding author), Wageningen Univ, Bees WUR, Wageningen, Netherlands.	mls453@cornell.edu		Smith, Michael/0000-0002-3454-962X	Rotary Ambassadorial Scholarship Program; United States National Science Foundation (NSF)	Rotary Ambassadorial Scholarship Program; United States National Science Foundation (NSF)(National Science Foundation (NSF))	The author would like to thank the Rotary Ambassadorial Scholarship Program for financial support to do research at Wageningen University. This material is based on work supported by a United States National Science Foundation (NSF) Graduate Research Fellowship. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	BAILEY L, 1952, J EXP BIOL, V29, P310; Bailey L, 1955, ANN APPL BIOL, V43, P379, DOI 10.1111/j.1744-7348.1955.tb02488.x; Bourgeois AL, 2010, J INVERTEBR PATHOL, V103, P53, DOI 10.1016/j.jip.2009.10.009; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2009, J EUKARYOT MICROBIOL, V56, P142, DOI 10.1111/j.1550-7408.2008.00374.x; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Free J. B., 1957, British Journal of Animal Behaviour, V5, P41, DOI 10.1016/S0950-5601(57)80023-9; Fries I, 2006, J APICULT RES, V45, P230; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2008, J INVERTEBR PATHOL, V97, P76, DOI 10.1016/j.jip.2007.06.002; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2009, ENV MICROBIOL REP, V1, P495, DOI 10.1111/j.1758-2229.2009.00052.x; Invernizzi C, 2009, J INVERTEBR PATHOL, V101, P150, DOI 10.1016/j.jip.2009.03.006; Kasprzak Sylwia, 2007, Wiadomosci Parazytologiczne, V53, P281; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Larsson R., 1986, Progress in Protistology, V1, P325; Naug D, 2009, APIDOLOGIE, V40, P595, DOI 10.1051/apido/2009039; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; PENG YS, 1986, PHYSIOL ENTOMOL, V11, P433, DOI 10.1111/j.1365-3032.1986.tb00434.x; Winston, 1987, BIOL HONEYBEE	22	89	92	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43319	10.1371/journal.pone.0043319	http://dx.doi.org/10.1371/journal.pone.0043319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916241	Green Submitted, gold, Green Published			2022-12-25	WOS:000307824300039
J	Zhou, R; Wang, SJ; Zhu, XJ				Zhou, Rong; Wang, Shenjun; Zhu, Xuejiang			Prenatal Ethanol Exposure Alters Synaptic Plasticity in the Dorsolateral Striatum of Rat Offspring via Changing the Reactivity of Dopamine Receptor	PLOS ONE			English	Article							LONG-TERM DEPRESSION; ALCOHOL EXPOSURE; ENDOCANNABINOID RELEASE; NEUROMODULATORY ACTIONS; HYPERACTIVITY DISORDER; ATTENTION-DEFICIT; MATERNAL ETHANOL; DORSAL STRIATUM; NERVOUS-SYSTEM; BASAL GANGLIA	Prenatal exposure to high-level ethanol (EtOH) has been reported to produce hyperlocomotion in offspring. Previous studies have demonstrated synaptic plasticity in cortical afferent to the dorsolateral (DL) striatum is involved in the pathogensis of hyperlocomotion. Here, prenatal EtOH-exposed rat offspring were used to investigate whether maternal EtOH exposure affected synaptic plasticity in the DL striatum. We found high-frequency stimulation (HFS) induced a weaker long-term potentiation (LTP) in EtOH rats than that in control rats at postnatal day (PD) 15. The same protocol of HFS induced long-term depression (LTD) in control group but still LTP in EtOH group at PD 30 or PD 40. Furthermore, enhancement of basal synaptic transmission accompanied by the decrease of pair-pulse facilitation (PPF) was observed in PD 30 EtOH offspring. The perfusion with D1-type receptors (D1R) antagonist SCH23390 recovered synaptic transmission and blocked the induction of abnormal LTP in PD 30 EtOH offspring. The perfusion with D2-type receptors (D2R) agonist quinpirole reversed EtOH-induced LTP into D1R- and metabotropic glutamate receptor-dependent LTD. The data provide the functional evidence that prenatal ethanol exposure led to the persistent abnormal synaptic plasticity in the DL striatum via disturbing the balance between D1R and D2R.	[Zhou, Rong; Wang, Shenjun; Zhu, Xuejiang] Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhou, R (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China.	zhou-rong@hotmail.com			National Natural Science Foundation of China [30872725, 81071027, 81000482]; Preclinical Medicine Fund of Nanjing Medical University of China [JX10131801058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Preclinical Medicine Fund of Nanjing Medical University of China	This work was supported by National Natural Science Foundation of China (30872725, 81071027, 81000482) and Preclinical Medicine Fund of Nanjing Medical University of China (JX10131801058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 1997, ALCOHOL, V14, P25, DOI 10.1016/S0741-8329(96)00081-X; Artola A, 1996, J NEUROPHYSIOL, V76, P984, DOI 10.1152/jn.1996.76.2.984; Barbier E, 2009, NEUROSCIENCE, V161, P427, DOI 10.1016/j.neuroscience.2009.03.076; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Bergman H, 1998, TRENDS NEUROSCI, V21, P32, DOI 10.1016/S0166-2236(97)01151-X; Boggan WO, 1996, NEUROTOXICOL TERATOL, V18, P41, DOI 10.1016/0892-0362(95)02027-6; CALABRESI P, 1994, J NEUROSCI, V14, P4871; CALABRESI P, 1992, J NEUROSCI, V12, P4224; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; Calabresi P, 1997, J NEUROSCI, V17, P4536; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Centonze D, 1999, BRAIN RES REV, V31, P1, DOI 10.1016/S0165-0173(99)00018-1; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Charpier S, 1999, NEUROSCIENCE, V91, P1209, DOI 10.1016/S0306-4522(98)00719-2; Choi SK, 1997, J NEUROSCI, V17, P8613; Coles CD, 1997, ALCOHOL CLIN EXP RES, V21, P150, DOI 10.1111/j.1530-0277.1997.tb03743.x; Costa ET, 2000, ALCOHOL CLIN EXP RES, V24, P706, DOI 10.1097/00000374-200005000-00016; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Dang MT, 2012, BEHAV BRAIN RES, V226, P465, DOI 10.1016/j.bbr.2011.10.002; Di Filippo M, 2009, BEHAV BRAIN RES, V199, P108, DOI 10.1016/j.bbr.2008.09.025; Emilien G, 1999, PHARMACOL THERAPEUT, V84, P133, DOI 10.1016/S0163-7258(99)00029-7; FloresHernandez J, 1997, SYNAPSE, V25, P185, DOI 10.1002/(SICI)1098-2396(199702)25:2<185::AID-SYN9>3.0.CO;2-8; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Goodlett CR, 2001, ALCOHOL RES HEALTH, V25, P175; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Guerri C, 1998, ALCOHOL CLIN EXP RES, V22, P304, DOI 10.1111/j.1530-0277.1998.tb03653.x; Hausknecht KA, 2005, BEHAV NEUROSCI, V119, P302, DOI 10.1037/0735-7044.119.1.302; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Levine MS, 1996, SYNAPSE, V24, P65, DOI 10.1002/syn.890240102; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LOVINGER DM, 1993, J NEUROPHYSIOL, V70, P1937, DOI 10.1152/jn.1993.70.5.1937; Marche K, 2011, PSYCHOPHARMACOLOGY, V214, P285, DOI 10.1007/s00213-010-1960-2; MEYER ME, 1993, PHARMACOL BIOCHEM BE, V44, P429, DOI 10.1016/0091-3057(93)90486-D; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; NIO E, 1991, DEV BRAIN RES, V62, P51, DOI 10.1016/0165-3806(91)90189-P; O'Leary CM, 2004, J PAEDIATR CHILD H, V40, P2, DOI 10.1111/j.1440-1754.2004.00280.x; O'Malley KD, 2002, CAN J PSYCHIAT, V47, P349, DOI 10.1177/070674370204700405; Olney JW, 2002, NEUROTOXICOLOGY, V23, P659, DOI 10.1016/S0161-813X(01)00092-4; Partridge JG, 2000, J NEUROPHYSIOL, V84, P1422, DOI 10.1152/jn.2000.84.3.1422; PIERCE DR, 1986, ALCOHOL, V3, P269, DOI 10.1016/0741-8329(86)90036-4; Randall S, 1999, NEUROTOXICOL TERATOL, V21, P587, DOI 10.1016/S0892-0362(99)00017-3; Riley EP, 2005, EXP BIOL MED, V230, P357, DOI 10.1177/15353702-0323006-03; Sobrian SK, 2005, NEUROTOXICOL TERATOL, V27, P73, DOI 10.1016/j.ntt.2004.09.002; STEENAART NAE, 1985, J PHARMACOL METHOD, V14, P199, DOI 10.1016/0160-5402(85)90033-6; Sung KW, 2001, J NEUROPHYSIOL, V86, P2405, DOI 10.1152/jn.2001.86.5.2405; Swanson DJ, 1996, J COMP NEUROL, V364, P104, DOI 10.1002/(SICI)1096-9861(19960101)364:1<104::AID-CNE9>3.0.CO;2-9; Tang KC, 2001, P NATL ACAD SCI USA, V98, P1255, DOI 10.1073/pnas.031374698; Tepper JM, 1998, DEV NEUROSCI-BASEL, V20, P125, DOI 10.1159/000017308; Thomas JD, 2000, NEUROTOXICOL TERATOL, V22, P703, DOI 10.1016/S0892-0362(00)00097-0; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; WALSH JP, 1993, BRAIN RES, V608, P123, DOI 10.1016/0006-8993(93)90782-I; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; WEST JR, 1981, SCIENCE, V211, P957; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Zhou R, 2010, NEUROSCIENCE, V170, P749, DOI 10.1016/j.neuroscience.2010.07.055; Zhou R, 2011, NEUROPHARMACOLOGY, V60, P789, DOI 10.1016/j.neuropharm.2011.01.031	60	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42443	10.1371/journal.pone.0042443	http://dx.doi.org/10.1371/journal.pone.0042443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916128	Green Published, Green Submitted, gold			2022-12-25	WOS:000307824300009
J	Hagiwara, K; Nagamori, S; Umemura, YM; Ohgaki, R; Tanaka, H; Murata, D; Nakagomi, S; Nomura, KH; Kage-Nakadai, E; Mitani, S; Nomura, K; Kanai, Y				Hagiwara, Kohei; Nagamori, Shushi; Umemura, Yasuhiro M.; Ohgaki, Ryuichi; Tanaka, Hidekazu; Murata, Daisuke; Nakagomi, Saya; Nomura, Kazuko H.; Kage-Nakadai, Eriko; Mitani, Shohei; Nomura, Kazuya; Kanai, Yoshikatsu			NRFL-1, the C. elegans NHERF Orthologue, Interacts with Amino Acid Transporter 6 (AAT-6) for Age-Dependent Maintenance of AAT-6 on the Membrane	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; DOMAIN INTERACTION CONTROLS; PROTEIN-KINASE-A; CAENORHABDITIS-ELEGANS; NA+/H+ EXCHANGER; TARGETED DISRUPTION; APICAL MEMBRANE; PDZ DOMAINS; GENE; BINDING	The NHERF (Na+/H+ exchanger regulatory factor) family has been proposed to play a key role in regulating transmembrane protein localization and retention at the plasma membrane. Due to the high homology between the family members, potential functional compensations have been a concern in sorting out the function of individual NHERF numbers. Here, we studied C. elegans NRFL-1 (C01F6.6) (nherf-like protein 1), the sole C. elegans orthologue of the NHERF family, which makes worm a model with low genetic redundancy of NHERF homologues. Integrating bioinformatic knowledge of C. elegans proteins into yeast two-hybrid scheme, we identified NRFL-1 as an interactor of AAT-6, a member of the C. elegans AAT (amino acid transporter) family. A combination of GST pull-down assay, localization study, and co-immunoprecipitation confirmed the binding and characterized the PDZ interaction. AAT-6 localizes to the luminal membrane even in the absence of NRFL-1 when the worm is up to four-day old. A fluorescence recovery after photobleaching (FRAP) analysis suggested that NRFL-1 immobilizes AAT-6 at the luminal membrane. When the nrfl-1 deficient worm is six-day or older, in contrast, the membranous localization of AAT-6 is not observed, whereas AAT-6 tightly localizes to the membrane in worms with NRFL-1. Sorting out the in vivo functions of the C. elegans NHERF protein, we found that NRFL-1, a PDZ-interactor of AAT-6, is responsible for the immobilization and the age-dependent maintenance of AAT-6 on the intestinal luminal membrane.	[Hagiwara, Kohei; Nagamori, Shushi; Umemura, Yasuhiro M.; Ohgaki, Ryuichi; Tanaka, Hidekazu; Nakagomi, Saya; Kanai, Yoshikatsu] Osaka Univ, Div Biosyst Pharmacol, Dept Pharmacol, Grad Sch Med, Osaka, Japan; [Hagiwara, Kohei] Osaka Univ, Sch Med, Osaka, Japan; [Murata, Daisuke] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Murata, Daisuke; Nomura, Kazuko H.; Nomura, Kazuya; Kanai, Yoshikatsu] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan; [Nomura, Kazuko H.; Nomura, Kazuya] Kyushu Univ, Fac Sci, Dept Biol Sci, Fukuoka 812, Japan; [Kage-Nakadai, Eriko; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan	Osaka University; Osaka University; Kyushu University; Japan Science & Technology Agency (JST); Kyushu University; Tokyo Women's Medical University	Hagiwara, K (corresponding author), Osaka Univ, Div Biosyst Pharmacol, Dept Pharmacol, Grad Sch Med, Osaka, Japan.	ykanai@pharma1.med.osaka-u.ac.jp	Nakagomi, Saya/ABE-4676-2020; Nagamori, Shushi/P-4530-2018	Nakagomi, Saya/0000-0002-8272-6192; Nagamori, Shushi/0000-0003-0203-2754; Ohgaki, Ryuichi/0000-0002-6894-7239	Ministry of Education, Culture, Sports, Science and Technology of Japan [17081015]; Japan Society for the Promotion of Science [21390264, 22659052]; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST); Ajinomoto Amino Acid Research Program; Grants-in-Aid for Scientific Research [24591198, 23790334, 12J40095] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ajinomoto Amino Acid Research Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research on Priority Areas of 'Transportsome' from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 17081015 (http://www.mext.go.jp/english/); Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant numbers 21390264 and 22659052) (http://www.mext.go.jp/english/); Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST) (http://www.jst.go.jp/kisoken/crest/en/index.html); and Ajinomoto Amino Acid Research Program (http://www.3arp.ajinomoto.com/). Saya Nakagomi is a research fellow of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altun ZF, 2009, WORMATLAS, DOI [10.3908/wormatlas.1.4, DOI 10.3908/W0RMATLAS.1.4]; Anzai N, 2004, J BIOL CHEM, V279, P45942, DOI 10.1074/jbc.M406724200; Bossinger O, 2004, DEV BIOL, V268, P448, DOI 10.1016/j.ydbio.2004.01.003; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2006, METHOD ENZYMOL, V412, P256, DOI 10.1016/S0076-6879(06)12016-9; Broere N, 2007, J BIOL CHEM, V282, P37575, DOI 10.1074/jbc.M704878200; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FRANCIS GR, 1985, J CELL BIOL, V101, P1532, DOI 10.1083/jcb.101.4.1532; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gloerich M, 2012, NAT CELL BIOL, V14, P793, DOI 10.1038/ncb2537; Gobel V, 2004, DEV CELL, V6, P865, DOI 10.1016/j.devcel.2004.05.018; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Harris BZ, 2001, J CELL SCI, V114, P3219; Hughes SC, 2010, J CELL SCI, V123, P1099, DOI 10.1242/jcs.059469; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kitagawa H, 2007, J BIOL CHEM, V282, P8533, DOI 10.1074/jbc.M611107200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li M, 2010, J BIOL CHEM, V285, P19299, DOI 10.1074/jbc.M109.096081; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Meder D, 2006, P NATL ACAD SCI USA, V103, P329, DOI 10.1073/pnas.0509885103; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miyazaki H, 2005, J AM SOC NEPHROL, V16, P3498, DOI 10.1681/ASN.2005030306; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Nomura KH, 2011, GLYCOBIOLOGY, V21, P834, DOI 10.1093/glycob/cwr019; Noshiro R, 2006, KIDNEY INT, V70, P275, DOI 10.1038/sj.ki.5001522; Portman DS, 2006, C ELEGANS GENE EXPRE; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Samuel ADT, 2003, J NEUROSCI, V23, P373, DOI 10.1523/JNEUROSCI.23-02-00373.2003; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Singh AK, 2009, J CLIN INVEST, V119, P540, DOI 10.1172/JCI35541; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Spradling AC, 1999, GENETICS, V153, P135; Stiernagle T, 2006, MAINTENANCE C ELEGAN; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; Veljkovic E, 2004, J BIOL CHEM, V279, P49268, DOI 10.1074/jbc.M404470200; Veljkovic E, 2004, J BIOL CHEM, V279, P7655, DOI 10.1074/jbc.M309528200; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zachos NC, 2009, J BIOL CHEM, V284, P23708, DOI 10.1074/jbc.M109.012641; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	67	7	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43050	10.1371/journal.pone.0043050	http://dx.doi.org/10.1371/journal.pone.0043050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916205	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600043
J	Schreiter, A; Gore, C; Labuz, D; Fournie-Zaluski, MC; Roques, BP; Stein, C; Machelska, H				Schreiter, Anja; Gore, Carmen; Labuz, Dominika; Fournie-Zaluski, Marie-Claude; Roques, Bernard P.; Stein, Christoph; Machelska, Halina			Pain inhibition by blocking leukocytic and neuronal opioid peptidases in peripheral inflamed tissue	FASEB JOURNAL			English	Article						immune cells; sensory nerves; analgesia	NEUTRAL ENDOPEPTIDASE ENKEPHALINASE; RECEPTORS MEDIATING ANTINOCICEPTION; INFLAMMATORY PAIN; DEGRADING ENZYMES; SYNOVIAL-FLUID; BETA-ENDORPHIN; SPINAL-CORD; RAT-BRAIN; NEUROGENIC INFLAMMATION; CATABOLIZING ENZYMES	Inflammatory pain can be controlled by endogenous opioid peptides. Here we blocked the degradation of opioids in peripheral injured tissue to locally augment this physiological system. In rats with hindpaw inflammation, inhibitors of aminopeptidase N (APN; bestatin) or neutral endopeptidase (NEP; thiorphan), and a dual inhibitor, NH2-CH-Ph-P(O)(OH)CH2-CH-CH2Ph(p-Ph)-CONH-CH-CH3-COOH (P8B), were applied to injured paws. Combined bestatin (1.25-5 mg)/thiorphan (0.2-0.8 mg) or P8B (0.0625-1 mg) alone elevated mechanical nociceptive thresholds to 307 and 227% of vehicle-treated controls, respectively. This analgesia was abolished by antibodies to methionine-enkephalin, leucine-enkephalin, and dynorphin A 1-17, by peripherally restricted and by selective mu-, delta-, and kappa-opioid receptor antagonists. Flow cytometry and photospectrometry revealed expression and metabolic activity of APN and NEP on macrophages, granulocytes, and sciatic nerves from inflamed tissue. Radioimmunoassays showed that inhibition of leukocytic APN and NEP by bestatin (5-500 mu M)/thiorphan (1-100 mu M) combinations or by P8B (1-100 mu M) prevented the degradation of enkephalins. Blockade of neuronal peptidases by bestatin (0.5-10 mM)/thiorphan (0.1-5 mM) or by P8B (0.1-10 mM) additionally hindered dynorphin A 1-17 catabolism. Thus, leukocytes and peripheral nerves are important sources of APN and NEP in inflamed tissue, and their blockade promotes peripheral opioid analgesia.-Schreiter, A., Gore, C., Labuz, D., Fournie-Zaluski, M.-C., Roques, B. P., Stein, C., Machelska, H. Pain inhibition by blocking leukocytic and neuronal opioid peptidases in peripheral inflamed tissue. FASEB J. 26, 5161-5171 (2012). www.fasebj.org	[Schreiter, Anja; Gore, Carmen; Labuz, Dominika; Stein, Christoph; Machelska, Halina] Charite, Klin Anesthesiol & Operat Intensivmed, Free Univ Berlin, D-12203 Berlin, Germany; [Fournie-Zaluski, Marie-Claude; Roques, Bernard P.] Pharmaleads SAS, Paris, France; [Roques, Bernard P.] Univ Paris 05, Paris, France	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; UDICE-French Research Universities; Universite Paris Cite	Machelska, H (corresponding author), Charite, Klin Anesthesiol & Operat Intensivmed, Free Univ Berlin, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany.	halina.machelska@charite.de		Stein, Christoph/0000-0001-5240-6836; Machelska, Halina/0000-0001-6315-2958	Deutsche Forschungsgemeinschaft [MA 2437/2-1, STE 477/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft grants MA 2437/2-1 (H.M.) and STE 477/9-1 (C.S.). The authors declare no conflicts of interest.	Akil H, 1998, DRUG ALCOHOL DEPEN, V51, P127, DOI 10.1016/S0376-8716(98)00071-4; Balog T, 1999, IMMUNOPHARMACOLOGY, V41, P11, DOI 10.1016/S0162-3109(98)00050-2; Balog T, 2001, INT IMMUNOPHARMACOL, V1, P569, DOI 10.1016/S1567-5769(00)00031-X; BARNES K, 1991, NEUROSCIENCE, V44, P245, DOI 10.1016/0306-4522(91)90265-P; BOURGOIN S, 1986, J PHARMACOL EXP THER, V238, P360; Cabot PJ, 1997, J CLIN INVEST, V100, P142, DOI 10.1172/JCI119506; CADONI A, 1993, J NEUROIMMUNOL, V45, P61, DOI 10.1016/0165-5728(93)90164-T; Catheline G, 1998, EUR J PHARMACOL, V357, P171, DOI 10.1016/S0014-2999(98)00597-4; Chen HX, 2000, J MED CHEM, V43, P1398, DOI 10.1021/jm990483l; Chen HX, 1998, P NATL ACAD SCI USA, V95, P12028, DOI 10.1073/pnas.95.20.12028; Coudore-Civiale MA, 2001, BRIT J PHARMACOL, V133, P179, DOI 10.1038/sj.bjp.0704059; Fischer HS, 2002, J MOL NEUROSCI, V18, P129, DOI 10.1385/JMN:18:1-2:129; FOURNIEZALUSKI MC, 1984, EUR J PHARMACOL, V102, P525, DOI 10.1016/0014-2999(84)90575-2; GRAF L, 1985, NEUROPEPTIDES, V6, P13, DOI 10.1016/0143-4179(85)90126-X; HASSAN AHS, 1992, NEUROSCI LETT, V140, P85, DOI 10.1016/0304-3940(92)90688-4; Heinl C, 2011, J NEUROSCI, V31, P16748, DOI 10.1523/JNEUROSCI.3491-11.2011; HERSH LB, 1985, J NEUROCHEM, V44, P1427, DOI 10.1111/j.1471-4159.1985.tb08779.x; HERSH LB, 1984, J NEUROCHEM, V43, P487, DOI 10.1111/j.1471-4159.1984.tb00925.x; IWAMOTO I, 1991, J LEUKOCYTE BIOL, V49, P116, DOI 10.1002/jlb.49.2.116; Kramer HH, 2009, NEUROBIOL DIS, V35, P177, DOI 10.1016/j.nbd.2008.11.002; Kramer HH, 2005, EXP NEUROL, V195, P179, DOI 10.1016/j.expneurol.2005.04.015; Labuz D, 2006, J NEUROSCI, V26, P4350, DOI 10.1523/JNEUROSCI.4349-05.2006; Le Guen S, 2003, PAIN, V104, P139, DOI 10.1016/S0304-3959(02)00486-4; LEE SH, 1994, EUR J PHARMACOL, V264, P61, DOI 10.1016/0014-2999(94)90636-X; Lendeckel U, 2000, ADV EXP MED BIOL, V477, P1; Likar R, 2007, CLIN J PAIN, V23, P136, DOI 10.1097/01.ajp.0000210954.93878.0d; Machelska H, 2003, J NEUROIMMUNOL, V141, P30, DOI 10.1016/S0165-5728(03)00213-3; MALDONADO R, 1994, PAIN, V58, P77, DOI 10.1016/0304-3959(94)90186-4; MATUCCICERINIC M, 1993, RHEUMATOL INT, V13, P1, DOI 10.1007/BF00290326; Mentlein R, 1996, PEPTIDES, V17, P709, DOI 10.1016/0196-9781(96)00066-6; Meynadier J., 1988, PAIN CLINIC, V2, P201; MILLER BC, 1994, REGUL PEPTIDES, V50, P87, DOI 10.1016/0167-0115(94)90194-5; Noble F, 2001, NEUROSCIENCE, V105, P479, DOI 10.1016/S0306-4522(01)00185-3; NOBLE F, 1992, J PHARMACOL EXP THER, V261, P181; Noble F, 2008, PSYCHOPHARMACOLOGY, V196, P327, DOI 10.1007/s00213-007-0964-z; Noble F, 2007, EXPERT OPIN THER TAR, V11, P145, DOI 10.1517/14728222.11.2.145; PARSONS CG, 1990, J PHARMACOL EXP THER, V255, P795; RICH DH, 1984, J MED CHEM, V27, P417, DOI 10.1021/jm00370a001; RIEMANN D, 1993, IMMUNOBIOLOGY, V187, P24, DOI 10.1016/S0171-2985(11)80243-3; Rittner HL, 2001, ANESTHESIOLOGY, V95, P500, DOI 10.1097/00000542-200108000-00036; Roques BP, 2012, NAT REV DRUG DISCOV, V11, P292, DOI 10.1038/nrd3673; ROQUES BP, 1980, NATURE, V288, P286, DOI 10.1038/288286a0; Rougeot C, 2003, P NATL ACAD SCI USA, V100, P8549, DOI 10.1073/pnas.1431850100; SAFAVI A, 1995, J NEUROCHEM, V65, P389; Saria A, 1997, NEUROSCI LETT, V234, P27, DOI 10.1016/S0304-3940(97)00660-5; Simonini G, 2005, RHEUMATOL INT, V25, P336, DOI 10.1007/s00296-004-0447-z; Song BB, 2003, J NEUROSCI, V23, P1847; STEIN C, 1993, LANCET, V342, P321, DOI 10.1016/0140-6736(93)91471-W; STEIN C, 1990, P NATL ACAD SCI USA, V87, P5935, DOI 10.1073/pnas.87.15.5935; STEIN C, 1988, PHARMACOL BIOCHEM BE, V31, P445, DOI 10.1016/0091-3057(88)90372-3; STEIN C, 1989, J PHARMACOL EXP THER, V248, P1269; Stein C, 2011, PHARMACOL REV, V63, P860, DOI 10.1124/pr.110.003145; Thibault K, 2008, EUR J PHARMACOL, V600, P71, DOI 10.1016/j.ejphar.2008.10.004; Thiele DL, 1998, ADV EXP MED BIOL, V437, P291; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; TROWBRIDGE IS, 1991, BIOCHIM BIOPHYS ACTA, V1095, P46, DOI 10.1016/0167-4889(91)90043-W; van Rijn RM, 2010, CURR OPIN PHARMACOL, V10, P73, DOI 10.1016/j.coph.2009.09.007; VANVELDHOVEN P, 1982, FEBS LETT, V138, P76, DOI 10.1016/0014-5793(82)80398-0; WAKSMAN G, 1986, P NATL ACAD SCI USA, V83, P1523, DOI 10.1073/pnas.83.5.1523; Woodcock J, 2009, NEW ENGL J MED, V361, P2105, DOI 10.1056/NEJMp0908913; YAKSH TL, 1991, J PHARMACOL EXP THER, V256, P1033; Zollner C, 2008, J CLIN INVEST, V118, P1065, DOI 10.1172/JCI25911	62	55	55	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					5161	5171		10.1096/fj.12-208678	http://dx.doi.org/10.1096/fj.12-208678			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22923332				2022-12-25	WOS:000311838300036
J	Busch, F; Mobasheri, A; Shayan, P; Lueders, C; Stahlmann, R; Shakibaei, M				Busch, Franziska; Mobasheri, Ali; Shayan, Parviz; Lueders, Cora; Stahlmann, Ralf; Shakibaei, Mehdi			Resveratrol Modulates Interleukin-1 beta-induced Phosphatidylinositol 3-Kinase and Nuclear Factor kappa B Signaling Pathways in Human Tenocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; HIGH-DENSITY COCULTURE; S-PHASE ARREST; IN-VITRO; SACCHAROMYCES-CEREVISIAE; DEPENDENT TRANSCRIPTION; LIFE-SPAN; ACTIVATION; APOPTOSIS; EXPRESSION	Resveratrol, an activator of histone deacetylase Sirt-1, has been proposed to have beneficial health effects due to its antioxidant and anti-inflammatory properties. However, the mechanisms underlying the anti-inflammatory effects of resveratrol and the intracellular signaling pathways involved are poorly understood. An in vitro model of human tenocytes was used to examine the mechanism of resveratrol action on IL-1 beta-mediated inflammatory signaling. Resveratrol suppressed IL-1 beta-induced activation of NF-kappa B and PI3K in a dose- and time-dependent manner. Treatment with resveratrol enhanced the production of matrix components collagen types I and III, tenomodulin, and tenogenic transcription factor scleraxis, whereas it inhibited gene products involved in inflammation and apoptosis. IL-1 beta-induced NF-kappa B and PI3K activation was inhibited by resveratrol or the inhibitors of PI3K ( wortmannin), c-Src ( PP1), and Akt ( SH-5) through inhibition of I kappa B kinase, I kappa B alpha phosphorylation, and inhibition of nuclear translocation of NF-kappa B, suggesting that PI3K signaling pathway may be one of the signaling pathways inhibited by resveratrol to abrogate NF-kappa B activation. Inhibition of PI3K by wortmannin attenuated IL-1 beta-induced Akt and p65 acetylation, suggesting that p65 is a downstream component of PI3K/Akt in these responses. The modulatory effects of resveratrol on IL-1 beta-induced activation of NF-kappa B and PI3K were found to be mediated at least in part by the association between Sirt-1 and scleraxis and deacetylation of NF-kappa B and PI3K. Overall, these results demonstrate that activated Sirt-1 plays an essential role in the anti-inflammatory effects of resveratrol and this may be mediated at least in part through inhibition/deacetylation of PI3K and NF-kappa B.	[Shakibaei, Mehdi] Univ Munich, Inst Anat, Musculoskeletal Res Grp, D-80336 Munich, Germany; [Mobasheri, Ali] Univ Nottingham, Fac Med & Hlth Sci, Sch Vet Med & Sci, Loughborough LE12 5RD, England; [Shayan, Parviz] Investigating Inst Mol Biol Syst Transfer, Tehran 1417863171, Iran; [Lueders, Cora] Lab Tissue Engn, Dept Thorac & Cardiovasc Surg, D-13353 Berlin, Germany; [Stahlmann, Ralf] Charite, Inst Clin Pharmacol & Toxicol, D-13353 Berlin, Germany	University of Munich; University of Nottingham; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Shakibaei, M (corresponding author), Univ Munich, Inst Anat, Musculoskeletal Res Grp, Pettenkoferstr 11, D-80336 Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Mobasheri, Ali/D-5770-2011; Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Mobasheri, Ali/0000-0001-6261-1286; Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506				Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; ALVARES O, 1995, J PERIODONTOL, V66, P552, DOI 10.1902/jop.1995.66.7.552; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BernardBeaubois K, 1997, CELL BIOL TOXICOL, V13, P103, DOI 10.1023/B:CBTO.0000010395.51944.2a; Buhrmann C, 2011, J BIOL CHEM, V286, P28556, DOI 10.1074/jbc.M111.256180; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; Busch F, 2012, J BIOL CHEM, V287, P25770, DOI 10.1074/jbc.M112.355420; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Cheng CY, 2010, BRIT J PHARMACOL, V160, P1595, DOI 10.1111/j.1476-5381.2010.00858.x; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Darieva Z, 2004, J LEUKOCYTE BIOL, V75, P689, DOI 10.1189/jlb.0603280; Das Samarjit, 2007, Inflammation & Allergy Drug Targets, V6, P168, DOI 10.2174/187152807781696464; Estrov Z, 2003, BLOOD, V102, P987, DOI 10.1182/blood-2002-11-3550; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Mattioli B, 2009, FEBS LETT, V583, P1102, DOI 10.1016/j.febslet.2009.02.029; Ozes ON, 1999, NATURE, V401, P82; Pozo-Guisado E, 2005, INT J CANCER, V115, P74, DOI 10.1002/ijc.20856; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Reddy SAG, 2000, J IMMUNOL, V164, P1355, DOI 10.4049/jimmunol.164.3.1355; Riley GP, 2001, J HAND SURG-BRIT EUR, V26, P224, DOI 10.1054/jhsb.2001.0560; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schneider PRA, 2011, J ORTHOP RES, V29, P1351, DOI 10.1002/jor.21400; Schulze-Tanzil G, 2004, HISTOCHEM CELL BIOL, V122, P219, DOI 10.1007/s00418-004-0694-9; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118; SHAKIBAEI M, 1993, HISTOL HISTOPATHOL, V8, P715; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shakibaei M, 2011, J BIOL CHEM, V286, P11492, DOI 10.1074/jbc.M110.198713; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; Squires MS, 2003, BIOCHEM PHARMACOL, V65, P361, DOI 10.1016/S0006-2952(02)01517-4; Sun LP, 2011, EXP CELL RES, V317, P932, DOI 10.1016/j.yexcr.2011.01.025; TEWARI DS, 1994, ARCH ORAL BIOL, V39, P657, DOI 10.1016/0003-9969(94)90091-4; Tseng WP, 2010, J CELL PHYSIOL, V223, P389, DOI 10.1002/jcp.22047; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	51	79	82	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.377028	http://dx.doi.org/10.1074/jbc.M112.377028			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22936809	Green Published, hybrid			2022-12-25	WOS:000310642200039
J	Lin, HC; Lin, JL; Lin-Tan, DT; Ma, HK; Chen, HC				Lin, Hsin-Chiung; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Ma, Hui-Kang; Chen, Hung-Chi			Early Keratectomy in the Treatment of Moderate Fusarium Keratitis	PLOS ONE			English	Article							FUNGAL KERATITIS; MICROBIAL KERATITIS; RISK-FACTORS; PENETRATING KERATOPLASTY; ACANTHAMOEBA-KERATITIS; PRACTICE PATTERNS; CORNEAL ULCERS; MANAGEMENT; SPECTRUM	Purpose: To evaluate the treatment outcomes and costs of early keratectomy in the management of moderate Fusarium keratitis. Methodology/Principal Findings: Consecutive cases of culture proven Fusarium keratitis treated at our hospital between January 2004 to December 2010 were included in this retrospective study. There were 38 cases of moderate keratitis with infiltrates between 3 to 6 mm in diameter and depth of infiltration not exceeding the inner 1/3 of the cornea. After excluding 5 patients with incomplete follow-up data, 13 patients who received early keratectomy within 1 week of admission were compared with a group of 20 patients treated medically. The significance of the association between early keratectomy and visual acuity, progression to perforation, secondary glaucoma and cataract formation, adjuvant therapy, hospitalization days and cost were assessed. There were no differences between the keratectomy and medication groups in regards to age, sex, presence of systemic diseases, and hypopyon formation on presentation. The early keratectomy group had a shorter hospital stay than the medical therapy group. Disease duration was significantly lower in the early keratectomy group (median: 29.0 vs. 54.5 days, P<0.001). Median hospitalization costs per patient were lower with early keratectomy (mean ward fee: 15175.4 vs. 44159.5 NTD, P<0.001; mean donor fee: 0 vs. 900.0 NTD, P<0.001), primarily because of reductions in hospital stay. More patients in the medication group developed perforations than in the keratectomy group (20% vs. 0%, respectively) and the perforation-free rate was higher in those with early keratectomy, but the results were not statistically significant. Conclusions/Significance: Early keratectomy in moderate Fusarium keratitis may reduce length of hospital stay, hospital costs, and perforation rates.	[Lin, Hsin-Chiung; Ma, Hui-Kang; Chen, Hung-Chi] Chang Gung Univ, Chang Gung Mem Hosp, Dept Ophthalmol, Coll Med, Tao Yuan, Taiwan; [Lin, Ja-Liang; Lin-Tan, Dan-Tzu] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lin, HC (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Ophthalmol, Coll Med, Tao Yuan, Taiwan.	hclinn@adm.cgmh.org.tw						Alexandrakis G, 2000, AM J OPHTHALMOL, V129, P571, DOI 10.1016/S0002-9394(99)00449-3; Alfonso E, 2005, MOSBY, V1, P1101; [Anonymous], 2009, J CATARACT REFRACT S, V35, pA4; Bharathi MJ, 2009, INDIAN J MED RES, V130, P749; Bhartiya P, 2007, CLIN EXP OPHTHALMOL, V35, P124, DOI 10.1111/j.1442-9071.2006.01405.x; Chen HC, 2006, CORNEA, V25, P564, DOI 10.1097/01.ico.0000227885.19124.6f; Chen WL, 2001, CORNEA, V20, P141, DOI 10.1097/00003226-200103000-00004; Day S, 2009, BRIT J OPHTHALMOL, V93, P116, DOI 10.1136/bjo.2008.142364; Doczi I, 2004, CLIN MICROBIOL INFEC, V10, P773, DOI 10.1111/j.1469-0691.2004.00909.x; FORSTER RK, 1975, ARCH OPHTHALMOL-CHIC, V93, P1134, DOI 10.1001/archopht.1975.01010020850004; Furlanetto R, 2010, EUR J OPHTHALMOL; Galarreta DJ, 2007, CORNEA, V26, P1082, DOI 10.1097/ICO.0b013e318142bff3; Green M, 2008, CORNEA, V27, P22, DOI 10.1097/ICO.0b013e318156caf2; Gupta G, 2009, CORNEA, V28, P930, DOI 10.1097/ICO.0b013e31819b3213; Hariprasad SM, 2008, BRIT J OPHTHALMOL, V92, P871, DOI 10.1136/bjo.2007.136515; JONES DB, 1981, OPHTHALMOLOGY, V88, P814; Jurkunas U, 2009, CORNEA, V28, P638, DOI 10.1097/ICO.0b013e318191695b; Keay L, 2006, OPHTHALMOLOGY, V113, P109, DOI 10.1016/j.ophtha.2005.08.013; Lin CP, 2005, CORNEA, V24, P262, DOI 10.1097/01.ico.0000148313.78933.68; Lin HC, 2005, INT J CLIN PRACT, V59, P549, DOI 10.1111/j.1368-5031.2005.00399.x; Lin HC, 2009, ACTA OPHTHALMOL, V87, P199, DOI 10.1111/j.1755-3768.2008.01192.x; Loh AR, 2009, CORNEA, V28, P856, DOI 10.1097/ICO.0b013e318199fa77; Meleod S, 1996, OPHTHALMOLOGY, V103, P479; Munir WM, 2007, CORNEA, V26, P621, DOI 10.1097/ICO.0b013e318033e7e1; ROSA RH, 1994, OPHTHALMOLOGY, V101, P1005; Shi WY, 2010, OPHTHALMOLOGY, V117, P890, DOI 10.1016/j.ophtha.2009.10.004; Srinivasan M, 2004, Curr Opin Ophthalmol, V15, P321, DOI 10.1097/00055735-200408000-00008; Tananuvat Napaporn, 2008, Journal of the Medical Association of Thailand, V91, P316; Tanure MAG, 2000, CORNEA, V19, P307, DOI 10.1097/00003226-200005000-00010; Thomas PA, 2003, CLIN MICROBIOL REV, V16, P730, DOI 10.1128/CMR.16.4.730-797.2003; Vajpayee RB, 2000, CORNEA, V19, P52, DOI 10.1097/00003226-200001000-00011; Vemuganti GK, 2002, OPHTHALMOLOGY, V109, P1538, DOI 10.1016/S0161-6420(02)01088-6; Wang LY, 2009, CLIN EXP OPHTHALMOL, V37, P763, DOI 10.1111/j.1442-9071.2009.02155.x; Xie LX, 2002, CORNEA, V21, P33, DOI 10.1097/00003226-200201000-00008; Xie LX, 2001, BRIT J OPHTHALMOL, V85, P1070, DOI 10.1136/bjo.85.9.1070	35	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42126	10.1371/journal.pone.0042126	http://dx.doi.org/10.1371/journal.pone.0042126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936982	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500010
J	Zhan, M; Riordon, DR; Yan, B; Tarasova, YS; Bruweleit, S; Tarasov, KV; Li, RA; Wersto, RP; Boheler, KR				Zhan, Ming; Riordon, Daniel R.; Yan, Bin; Tarasova, Yelena S.; Bruweleit, Sarah; Tarasov, Kirill V.; Li, Ronald A.; Wersto, Robert P.; Boheler, Kenneth R.			The B-MYB Transcriptional Network Guides Cell Cycle Progression and Fate Decisions to Sustain Self-Renewal and the Identity of Pluripotent Stem Cells	PLOS ONE			English	Article							DEVELOPMENTAL REGULATORS; CHROMATIN STATE; POLYCOMB; PHOSPHORYLATION; METHYLATION; GENES; DNA; DIFFERENTIATION; ESTABLISHMENT; COMPLEX	Embryonic stem cells (ESCs) are pluripotent and have unlimited self-renewal capacity. Although pluripotency and differentiation have been examined extensively, the mechanisms responsible for self-renewal are poorly understood and are believed to involve an unusual cell cycle, epigenetic regulators and pluripotency-promoting transcription factors. Here we show that B-MYB, a cell cycle regulated phosphoprotein and transcription factor critical to the formation of inner cell mass, is central to the transcriptional and co-regulatory networks that sustain normal cell cycle progression and self-renewal properties of ESCs. Phenotypically, B-MYB is robustly expressed in ESCs and induced pluripotent stem cells (iPSCs), and it is present predominantly in a hypo-phosphorylated state. Knockdown of B-MYB results in functional cell cycle abnormalities that involve S, G2 and M phases, and reduced expression of critical cell cycle regulators like ccnb1 and plk1. By conducting gene expression profiling on control and B-MYB deficient cells, ChIP-chip experiments, and integrative computational analyses, we unraveled a highly complex B-MYB-mediated transcriptional network that guides ESC self-renewal. The network encompasses critical regulators of all cell cycle phases and epigenetic regulators, pluripotency transcription factors, and differentiation determinants. B-MYB along with E2F1 and c-MYC preferentially co-regulate cell cycle target genes. B-MYB also co-targets genes regulated by OCT4, SOX2 and NANOG that are significantly associated with stem cell differentiation, embryonic development, and epigenetic control. Moreover, loss of B-MYB leads to a breakdown of the transcriptional hierarchy present in ESCs. These results coupled with functional studies demonstrate that B-MYB not only controls and accelerates cell cycle progression in ESCs it contributes to fate decisions and maintenance of pluripotent stem cell identity.	[Zhan, Ming; Yan, Bin] NIA, Bioinformat Unit, NIH, Baltimore, MD 21224 USA; [Riordon, Daniel R.; Tarasova, Yelena S.; Bruweleit, Sarah; Tarasov, Kirill V.; Boheler, Kenneth R.] NIA, Mol Cardiol & Stem Cell Unit, NIH, Baltimore, MD 21224 USA; [Wersto, Robert P.] NIA, Flow Cytometry Unit, NIH, Baltimore, MD 21224 USA; [Zhan, Ming] Cornell Univ, Weill Cornell Med Coll, Methodist Hosp, Res Inst, Houston, TX USA; [Yan, Bin] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Li, Ronald A.; Boheler, Kenneth R.] Univ Hong Kong, Stem Cell & Regenerat Med Consortium, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Hong Kong Baptist University; University of Hong Kong	Zhan, M (corresponding author), Cornell Univ, Weill Cornell Med Coll, Methodist Hosp, Res Inst, Houston, TX USA.	bohelerk@grc.nia.nih.gov		Tarasov, Kirill/0000-0001-7799-4670; /0000-0002-2168-3379	Intramural Research Program of the NIH, National Institute on Aging; Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine (Heidesheim, Germany); NATIONAL INSTITUTE ON AGING [ZIAAG000847, ZICAG000618] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine (Heidesheim, Germany); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in by the Intramural Research Program of the NIH, National Institute on Aging, and by a scholarship (SB) from Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine (Heidesheim, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bessa M, 2001, ONCOGENE, V20, P3376, DOI 10.1038/sj.onc.1204439; Boheler KR, 2009, J CELL PHYSIOL, V221, P10, DOI 10.1002/jcp.21866; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Johnson TK, 1999, J BIOL CHEM, V274, P36741, DOI 10.1074/jbc.274.51.36741; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Knight AS, 2009, ONCOGENE, V28, P1737, DOI 10.1038/onc.2009.22; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Lorvellec M, 2010, STEM CELLS, V28, P1751, DOI 10.1002/stem.496; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mannefeld M, 2009, CANCER RES, V69, P4073, DOI 10.1158/0008-5472.CAN-08-4156; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muller-Tidow C, 2001, BLOOD, V97, P2091, DOI 10.1182/blood.V97.7.2091; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakajima Y, 2007, BIOCHEM BIOPH RES CO, V364, P1050, DOI 10.1016/j.bbrc.2007.10.130; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Petrovas C, 2003, ONCOGENE, V22, P2011, DOI 10.1038/sj.onc.1206231; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Santilli G, 2001, ONCOGENE, V20, P8167, DOI 10.1038/sj.onc.1204943; Schwab R, 2007, BLOOD CELL MOL DIS, V39, P263, DOI 10.1016/j.bcmd.2007.04.006; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Smith K, 2010, REGEN MED, V5, P947, DOI 10.2217/RME.10.79; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003406; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Tarasov KV, 2008, CELLS TISSUES ORGANS, V27, P27; Tarasova YS, 2006, EMBRYONIC STEM CELLS, P130; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yamanaka S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003896; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	77	25	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42350	10.1371/journal.pone.0042350	http://dx.doi.org/10.1371/journal.pone.0042350			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936984	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500012
J	Caspers, S; Heim, S; Lucas, MG; Stephan, E; Fischer, L; Amunts, K; Zilles, K				Caspers, Svenja; Heim, Stefan; Lucas, Marc G.; Stephan, Egon; Fischer, Lorenz; Amunts, Katrin; Zilles, Karl			Dissociated Neural Processing for Decisions in Managers and Non-Managers	PLOS ONE			English	Article							HUMAN PARIETAL OPERCULUM; PREFRONTAL CORTEX; FRONTAL-CORTEX; SYSTEMS; MODEL; MAPS; ACTIVATION; AUTOMATICITY; RATIONALITY; INTEGRATION	Functional neuroimaging studies of decision-making so far mainly focused on decisions under uncertainty or negotiation with other persons. Dual process theory assumes that, in such situations, decision making relies on either a rapid intuitive, automated or a slower rational processing system. However, it still remains elusive how personality factors or professional requirements might modulate the decision process and the underlying neural mechanisms. Since decision making is a key task of managers, we hypothesized that managers, facing higher pressure for frequent and rapid decisions than non-managers, prefer the heuristic, automated decision strategy in contrast to non-managers. Such different strategies may, in turn, rely on different neural systems. We tested managers and non-managers in a functional magnetic resonance imaging study using a forced-choice paradigm on word-pairs. Managers showed subcortical activation in the head of the caudate nucleus, and reduced hemodynamic response within the cortex. In contrast, non-managers revealed the opposite pattern. With the head of the caudate nucleus being an initiating component for process automation, these results supported the initial hypothesis, hinting at automation during decisions in managers. More generally, the findings reveal how different professional requirements might modulate cognitive decision processing.	[Caspers, Svenja; Heim, Stefan; Amunts, Katrin; Zilles, Karl] Res Ctr Julich, Inst Neurosci & Med, Julich, Germany; [Heim, Stefan; Amunts, Katrin; Zilles, Karl] Julich Aachen Res Alliance, BRAIN, Julich, Germany; [Heim, Stefan; Amunts, Katrin] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, D-52062 Aachen, Germany; [Heim, Stefan] Rhein Westfal TH Aachen, Dept Neurol, Sect Neurol Cognit Res, Aachen, Germany; [Lucas, Marc G.; Stephan, Egon] Univ Cologne, Dept Psychol, D-50931 Cologne, Germany; [Lucas, Marc G.] Fernuniv, Dept Business Studies Leadership & Org, Hagen, Germany; [Fischer, Lorenz] Univ Cologne, Inst Econ & Social Psychol, D-50931 Cologne, Germany; [Zilles, Karl] Univ Dusseldorf, C&O Vogt Inst Brain Res, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University; University of Cologne; Fern University Hagen; University of Cologne; Heinrich Heine University Dusseldorf	Caspers, S (corresponding author), Res Ctr Julich, Inst Neurosci & Med, Julich, Germany.	s.caspers@fz-juelich.de	Zilles, Karl/J-9704-2013; Zilles, Karl/Y-3784-2019; Caspers, Svenja/H-9346-2013; Heim, Stefan/G-6348-2013; Amunts, Katrin/I-3470-2013	Zilles, Karl/0000-0001-9296-9959; Zilles, Karl/0000-0002-4705-4175; Caspers, Svenja/0000-0001-5083-4669; Heim, Stefan/0000-0002-5818-8355; Amunts, Katrin/0000-0001-5828-0867	Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model); Helmholtz Alliance for Mental Health in an Aging Society; German Federal Ministry of Education and Research [01GW0613]	Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model); Helmholtz Alliance for Mental Health in an Aging Society; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model, K.Z.), the Helmholtz Alliance for Mental Health in an Aging Society (K.Z., K. A.), and a grant of the German Federal Ministry of Education and Research (No. 01GW0613; K. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashby FG, 2007, PSYCHOL REV, V114, P632, DOI 10.1037/0033-295X.114.3.632; Ashby FG, 2010, J NEUROSCI, V14, P191; Bandettini PA, 2009, ANN NY ACAD SCI, V1156, P260, DOI 10.1111/j.1749-6632.2009.04420.x; Barnard C. I., 1968, FUNCT EXECUTIVE; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; Benhabib J, 2005, GAME ECON BEHAV, V52, P460, DOI 10.1016/j.geb.2004.10.004; Boas DA, 2008, NEUROIMAGE, V40, P1116, DOI 10.1016/j.neuroimage.2007.12.061; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; BOWMAN EH, 1963, MANAGE SCI, V9, P310, DOI 10.1287/mnsc.9.2.310; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Brocas I, 2006, BRAIN HIERARCHICAL O; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Busenitz LW, 1997, J BUS VENTURING, V12, P9, DOI 10.1016/S0883-9026(96)00003-1; Caspers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018451; CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752; Chan RCK, 2001, BRAIN INJURY, V15, P819, DOI 10.1080/02699050119721; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Dane E, 2007, ACAD MANAGE REV, V32, P33, DOI [10.2307/20159279, 10.5465/AMR.2007.23463682]; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dean D, 1974, EXECUTIVE ESP; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Doeller CF, 2006, NEUROIMAGE, V31, P1802, DOI 10.1016/j.neuroimage.2006.02.006; Duden-Das Worterbuch der Synonyme, 2009, DUD WORT SYN; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Eickhoff SB, 2006, CEREB CORTEX, V16, P254, DOI 10.1093/cercor/bhi105; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Fudenberg D, 2006, AM ECON REV, V96, P1449, DOI 10.1257/aer.96.5.1449; Geyer S, 2004, ADV ANATOMY EMBRYOLO, V174; Goldstein DG, 2002, PSYCHOL REV, V109, P75, DOI 10.1037//0033-295X.109.1.75; GRAVES CW, 1970, J HUMANIST PSYCHOL, V10, P131, DOI 10.1177/002216787001000205; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Heim S, 2006, NEUROREPORT, V17, P1097, DOI 10.1097/01.wnr.0000224775.05023.42; Helie S, 2010, ATTEN PERCEPT PSYCHO, V72, P1013, DOI 10.3758/APP.72.4.1013; Hester RL, 2004, J COGNITIVE NEUROSCI, V16, P776, DOI 10.1162/089892904970726; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kompus K, 2009, NEUROSCI LETT, V467, P76, DOI 10.1016/j.neulet.2009.10.005; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Lie CH, 2006, NEUROIMAGE, V30, P1038, DOI 10.1016/j.neuroimage.2005.10.031; Loewenstein G, 2008, ANNU REV PSYCHOL, V59, P647, DOI 10.1146/annurev.psych.59.103006.093710; Loewenstein George, 2004, ANIMAL SPIRITS AFFEC; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Mintzberg, 1973, NATURE MANAGERIAL WO; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Muhammad R, 2006, J COGNITIVE NEUROSCI, V18, P974, DOI 10.1162/jocn.2006.18.6.974; Perlstein WM, 2001, AM J PSYCHIAT, V158, P1105, DOI 10.1176/appi.ajp.158.7.1105; Petty R.E., 1986, COMMUN PERSUATION, P123; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Price CJ, 1999, NEUROIMAGE, V10, P36, DOI 10.1006/nimg.1999.0447; Reyna VF, 2004, CURR DIR PSYCHOL SCI, V13, P60, DOI 10.1111/j.0963-7214.2004.00275.x; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rokeach M., 2008, UNDERSTANDING HUMAN; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Salehnejad R, 2006, RATIONALITY, BOUNDED RATIONALITY AND MICROFOUNDATIONS, P1, DOI 10.1057/9780230625150; Salmi J, 2009, BRAIN RES, V1286, P155, DOI 10.1016/j.brainres.2009.06.083; Salton G, 2000, MANAGERS GUIDE ORG E; Scheperjans F, 2008, CEREB CORTEX, V18, P2141, DOI 10.1093/cercor/bhm241; Scheperjans F, 2008, CEREB CORTEX, V18, P846, DOI 10.1093/cercor/bhm116; SCHWARTZ SH, 1987, J PERS SOC PSYCHOL, V53, P550, DOI 10.1037/0022-3514.53.3.550; Seger CA, 2006, CEREB CORTEX, V16, P1546, DOI 10.1093/cercor/bhj092; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Simon H.A., 1987, ACAD MANAGE PERSPECT, V1, P57, DOI [10.5465/ame.1987.4275905, DOI 10.5465/AME.1987.4275905]; SIMON HA, 1959, AM ECON REV, V49, P253; Stackman RW, 2000, HDB ORG CULTURE CLIM, P37; Teichmann M, 2005, BRAIN, V128, P1155, DOI 10.1093/brain/awh472; Vaughan FE, 1979, AWAKENING INTUITION; Waldschmidt JG, 2011, NEUROIMAGE, V56, P1791, DOI 10.1016/j.neuroimage.2011.02.011; Weiss RH, 1998, TEST BASIC INTELLIGE; WESTCOTT MR, 1961, PSYCHOL REP, V9, P267; Westerhausen R, 2010, NEUROPSYCHOLOGIA, V48, P2075, DOI 10.1016/j.neuropsychologia.2010.03.028; Wu CT, 2007, BRAIN RES, V1134, P187, DOI 10.1016/j.brainres.2006.11.088; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	87	3	3	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43537	10.1371/journal.pone.0043537	http://dx.doi.org/10.1371/journal.pone.0043537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999CI	22927984	Green Submitted, gold, Green Published			2022-12-25	WOS:000308286300064
J	Pineda, SS; Wilson, D; Mattick, JS; King, GF				Pineda, Sandy Steffany; Wilson, David; Mattick, John S.; King, Glenn F.			The Lethal Toxin from Australian Funnel-Web Spiders Is Encoded by an Intronless Gene	PLOS ONE			English	Article							BUTHUS-MARTENSI KARSCH; GATED SODIUM-CHANNEL; VENOM PEPTIDES; GENOMIC DNA; ORNITHOCTONUS-HUWENA; MOLECULAR DIVERSITY; ATRAX-ROBUSTUS; CYSTINE KNOT; NEUROTOXINS; SEQUENCES	Australian funnel-web spiders are generally considered the most dangerous spiders in the world, with envenomations from the Sydney funnel-web spider Atrax robustus resulting in at least 14 human fatalities prior to the introduction of an effective anti-venom in 1980. The clinical envenomation syndrome resulting from bites by Australian funnel-web spiders is due to a single 42-residue peptide known as delta-hexatoxin. This peptide delays the inactivation of voltage-gated sodium channels, which results in spontaneous repetitive firing and prolongation of action potentials, thereby causing massive neurotransmitter release from both somatic and autonomic nerve endings. Here we show that delta-hexatoxin from the Australian funnel-web spider Hadronyche versuta is produced from an intronless gene that encodes a prepropeptide that is post-translationally processed to yield the mature toxin. A limited sampling of genes encoding unrelated venom peptides from this spider indicated that they are all intronless. Thus, in distinct contrast to cone snails and scorpions, whose toxin genes contain introns, spiders may have developed a quite different genetic strategy for evolving their venom peptidome.	[Pineda, Sandy Steffany; Wilson, David; Mattick, John S.; King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Pineda, SS (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	glenn.king@imb.uq.edu.au	King, Glenn F/J-5059-2012; Mattick, John S/I-7789-2012; Wilson, David/Q-9865-2019; Pineda, Sandy S/J-2131-2014; Mattick, John/ABH-6130-2020	King, Glenn F/0000-0002-2308-2200; Mattick, John S/0000-0002-7680-7527; Wilson, David/0000-0001-5047-0711; Pineda, Sandy S/0000-0002-9003-0101; Mattick, John/0000-0002-7680-7527	Australian Research Council [DP1095728]; University of Queensland	Australian Research Council(Australian Research Council); University of Queensland(University of Queensland)	The authors acknowledge financial support from the Australian Research Council (Discovery Grant DP1095728 to G. F. K.). S. S. P. was supported by an International Postgraduate Research Scholarship from The University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Ballweber P, 2002, J BIOL CHEM, V277, P14451, DOI 10.1074/jbc.M111368200; Bazaa A, 2007, J MOL EVOL, V64, P261, DOI 10.1007/s00239-006-0161-4; Bohlen CJ, 2012, TOXICON, V60, P254, DOI 10.1016/j.toxicon.2012.04.336; Cao ZJ, 2006, TOXICON, V47, P348, DOI 10.1016/j.toxicon.2005.11.013; Chang LS, 1997, BIOCHEM BIOPH RES CO, V239, P756, DOI 10.1006/bbrc.1997.7549; Chen J, 2008, CELL MOL LIFE SCI, V65, P2431, DOI 10.1007/s00018-008-8135-x; Diego-Garcia E, 2005, TOXICON, V45, P273, DOI 10.1016/j.toxicon.2004.10.014; Escoubas P, 2000, BIOCHIMIE, V82, P893, DOI 10.1016/S0300-9084(00)01166-4; Escoubas P, 2006, TOXICON, V47, P650, DOI 10.1016/j.toxicon.2006.01.018; Escoubas P, 2007, EXPERT OPIN DRUG DIS, V2, P823, DOI 10.1517/17460441.2.6.823; Fletcher JI, 1997, STRUCTURE, V5, P1525, DOI 10.1016/S0969-2126(97)00301-8; Fujimi TJ, 2003, GENE, V313, P111, DOI 10.1016/S0378-1119(03)00637-1; Goudet C, 2002, TOXICON, V40, P1239, DOI 10.1016/S0041-0101(02)00142-3; Gray MR, 2010, REC AUST MUS, V62, P285, DOI 10.3853/j.0067-1975.62.2010.1556; Gregory TR, 2003, J HERED, V94, P285, DOI 10.1093/jhered/esg070; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Isbister GK, 2004, TOXICON, V43, P477, DOI 10.1016/j.toxicon.2004.02.002; Jiang LP, 2008, PEPTIDES, V29, P1679, DOI 10.1016/j.peptides.2008.06.001; Jiang LP, 2010, COMP BIOCHEM PHYS D, V5, P81, DOI 10.1016/j.cbd.2010.01.001; Kato L, 2012, J IMMUNOL, V188, P3559, DOI 10.4049/jimmunol.1102397; King GF, 2004, TOXICON, V43, P471, DOI 10.1016/j.toxicon.2004.02.001; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; KRAPCHO KJ, 1995, INSECT BIOCHEM MOLEC, V25, P991, DOI 10.1016/0965-1748(95)00029-U; Kuhn-Nentwig L, 2011, ADV INSECT PHYSIOL, V40, P1, DOI 10.1016/B978-0-12-387668-3.00001-5; Lan ZD, 1999, TOXICON, V37, P815, DOI 10.1016/S0041-0101(98)00221-9; Maggio F, 2002, TOXICON, V40, P1355, DOI 10.1016/S0041-0101(02)00154-X; Nicholson GM, 1998, PFLUG ARCH EUR J PHY, V436, P117, DOI 10.1007/s004240050612; Nicholson GM, 2004, TOXICON, V43, P587, DOI 10.1016/j.toxicon.2004.02.006; Olivera BM, 1999, ANN NY ACAD SCI, V870, P223, DOI 10.1111/j.1749-6632.1999.tb08883.x; Pallaghy PK, 1997, FEBS LETT, V419, P191, DOI 10.1016/S0014-5793(97)01452-X; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Platnick, 2011, WORLD SPIDER CATALOG; Qiao P, 2004, ACTA BIOCH BIOPH SIN, V36, P656, DOI 10.1093/abbs/36.10.656; Rasch EM, 2005, J MORPHOL, V265, P209, DOI 10.1002/jmor.10352; Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; Roy SW, 2006, TRENDS GENET, V22, P468, DOI 10.1016/j.tig.2006.07.002; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; Schroeder FC, 2008, P NATL ACAD SCI USA, V105, P14283, DOI 10.1073/pnas.0806840105; Selden PA, 1999, J ARACHNOL, V27, P401; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; Sutherland S, 1981, VENOMOUS CREATURES A; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; Tedford HW, 2004, TOXICON, V43, P601, DOI 10.1016/j.toxicon.2004.02.010; Thompson J.D., 2002, CURRENT PROTOCOLS BI; Vassilevski AA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1505, DOI 10.1134/S0006297909130069; Wang XH, 2001, J BIOL CHEM, V276, P40306, DOI 10.1074/jbc.M105206200; Wen SP, 2005, PEPTIDES, V26, P2412, DOI 10.1016/j.peptides.2005.05.012; Yee JSP, 2004, BIOCHIMIE, V86, P137, DOI 10.1016/j.biochi.2003.11.012	55	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43699	10.1371/journal.pone.0043699	http://dx.doi.org/10.1371/journal.pone.0043699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928020	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000308286300083
J	Wang, DJ; Yang, D; Su, LD; Xie, YJ; Zhou, L; Sun, CL; Wang, Y; Wang, XX; Zhou, L; Shen, Y				Wang, De-Juan; Yang, Dong; Su, Li-Da; Xie, Ya-jun; Zhou, Lin; Sun, Cheng-Long; Wang, Yin; Wang, Xin-Xin; Zhou, Liang; Shen, Ying			Cytosolic Phospholipase A(2) alpha/Arachidonic Acid Signaling Mediates Depolarization-Induced Suppression of Excitation in the Cerebellum	PLOS ONE			English	Article							TERM SYNAPTIC PLASTICITY; MONOACYLGLYCEROL LIPASE; ENDOCANNABINOID RELEASE; RETROGRADE INHIBITION; ANANDAMIDE; DEPRESSION; SYNAPSES; TRIGGERS; 2-ARACHIDONOYLGLYCEROL; BIOSYNTHESIS	Background: Depolarization-induced suppression of excitation (DSE) at parallel fiber-Purkinje cell synapse is an endocannabinoid-mediated short-term retrograde plasticity. Intracellular Ca2+ elevation is critical for the endocannabinoid production and DSE. Nevertheless, how elevated Ca2+ leads to DSE is unclear. Methodology/Principal Findings: We utilized cytosolic phospholipase A(2) alpha (cPLA(2)alpha) knock-out mice and whole-cell patch clamp in cerebellar slices to observed the action of cPLA(2)alpha/arachidonic acid signaling on DSE at parallel fiber-Purkinje cell synapse. Our data showed that DSE was significantly inhibited in cPLA(2)alpha knock-out mice, which was rescued by arachidonic acid. The degradation enzyme of 2-arachidonoylglycerol (2-AG), monoacylglycerol lipase (MAGL), blocked DSE, while another catabolism enzyme for N-arachidonoylethanolamine (AEA), fatty acid amide hydrolase (FAAH), did not affect DSE. These results suggested that 2-AG is responsible for DSE in Purkinje cells. Co-application of paxilline reversed the blockade of DSE by internal K+, indicating that large conductance Ca2+-activated potassium channel (BK) is sufficient to inhibit cPLA(2)alpha/arachidonic acid-mediated DSE. In addition, we showed that the release of 2-AG was independent of soluble NSF attachment protein receptor (SNARE), protein kinase C and protein kinase A. Conclusions/Significance: Our data first showed that cPLA(2)alpha/arachidonic acid/2-AG signaling pathway mediates DSE at parallel fiber-Purkinje cell synapse.	[Wang, De-Juan; Yang, Dong; Xie, Ya-jun; Zhou, Lin; Sun, Cheng-Long; Wang, Xin-Xin; Zhou, Liang; Shen, Ying] Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth,Dept Neurobiol, Hangzhou 310003, Zhejiang, Peoples R China; [Su, Li-Da] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Neurosci Care Unit, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yin] Ningxia Med Univ, Dept Neurobiol, Ctr Sci Technol, Cranial Cerebral Dis Lab, Yinchuan, Peoples R China	Zhejiang University; Zhejiang University; Ningxia Medical University	Wang, DJ (corresponding author), Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth,Dept Neurobiol, Hangzhou 310003, Zhejiang, Peoples R China.	yshen@zju.edu.cn	Xie, Yajun/ABE-8877-2020; Xie, Yajun/AFS-3223-2022; Yang, Dong/AAE-7987-2020; shen, ying/HHS-5635-2022	Xie, Yajun/0000-0003-2988-2708; Yang, Dong/0000-0003-0612-1439; Wang, Dejuan/0000-0002-4877-1213	National Basic Research Program (973) of the Ministry of Science and Technology of China [2009CB94140, 2011CB5044000]; National Foundation of Natural Science of China [30600168, 31070945, 31100780]; National Foundation of Natural Science [30731160616]; Research Grants Council of Hong Kong, China [30731160616]; Ministry of Education of China [NCET-07-0751]; Zhejiang Provincial Foundation of Natural Science of China [R206018]	National Basic Research Program (973) of the Ministry of Science and Technology of China(National Basic Research Program of China); National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); National Foundation of Natural Science(National Natural Science Foundation of China (NSFC)); Research Grants Council of Hong Kong, China(Hong Kong Research Grants Council); Ministry of Education of China(Ministry of Education, China); Zhejiang Provincial Foundation of Natural Science of China	This work was supported by grants from the National Basic Research Program (973) of the Ministry of Science and Technology of China (2009CB94140 and 2011CB5044000), the National Foundation of Natural Science of China (30600168, 31070945 and 31100780), a joint grant from the National Foundation of Natural Science and the Research Grants Council of Hong Kong, China (30731160616), a New Century Talent Award of the Ministry of Education of China (NCET-07-0751) and the Zhejiang Provincial Foundation of Natural Science of China (R206018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Anwar H, 2010, CEREBELLUM; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 1999, BIOCHEM BIOPH RES CO, V256, P377, DOI 10.1006/bbrc.1999.0254; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; Brenowitz SD, 2003, J NEUROSCI, V23, P6373; Brenowitz SD, 2006, J NEUROSCI, V26, P6841, DOI 10.1523/JNEUROSCI.1280-06.2006; Carroll RC, 1998, J NEUROPHYSIOL, V80, P2797, DOI 10.1152/jn.1998.80.5.2797; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Daniel H, 2001, J PHYSIOL-LONDON, V537, P793; Di Marzo V, 1998, FEBS LETT, V436, P449, DOI 10.1016/S0014-5793(98)01175-2; Diana MA, 2004, BRIT J PHARMACOL, V142, P9, DOI 10.1038/sj.bjp.0705726; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Evans JH, 2004, J BIOL CHEM, V279, P6005, DOI 10.1074/jbc.M311246200; Hoggatt J, 2010, LEUKEMIA, V24, P1993, DOI 10.1038/leu.2010.216; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Kalyvas A, 2004, NEURON, V41, P323, DOI 10.1016/S0896-6273(04)00003-0; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Maejima T, 2001, NEUROSCI RES, V40, P205, DOI 10.1016/S0168-0102(01)00241-3; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Malcher-Lopes R, 2008, EUR J PHARMACOL, V583, P322, DOI 10.1016/j.ejphar.2007.12.033; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Pan B, 2009, J PHARMACOL EXP THER, V331, P591, DOI 10.1124/jpet.109.158162; Rancz EA, 2006, J NEUROSCI, V26, P5428, DOI 10.1523/JNEUROSCI.5284-05.2006; Roloff AM, 2010, J NEUROSCI, V30, P3072, DOI 10.1523/JNEUROSCI.4603-09.2010; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Sang N, 2006, J PHYSIOL-LONDON, V572, P735, DOI 10.1113/jphysiol.2006.105569; Shen Y, 2007, P NATL ACAD SCI USA, V104; Shin JH, 2008, P NATL ACAD SCI USA, V105, P746, DOI 10.1073/pnas.0709407105; Smith AJ, 2010, J NEUROSCI, V30, P6116, DOI 10.1523/JNEUROSCI.0170-10.2010; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Straiker A, 2011, BRIT J PHARMACOL, V164, P1672, DOI 10.1111/j.1476-5381.2011.01486.x; Straiker A, 2009, MOL PHARMACOL, V76, P1220, DOI 10.1124/mol.109.059030; Su LD, 2010, ALCOHOL CLIN EXP RES, V34, P1140, DOI 10.1111/j.1530-0277.2010.01190.x; Su LD, 2009, NEUROREPORT, V20, P502, DOI 10.1097/WNR.0b013e328328f397; Sugiura T, 2002, PROSTAG LEUKOTR ESS, V66, P173, DOI 10.1054/plef.2001.0356; Sun CL, 2011, CEREBELLUM, V10, P88, DOI 10.1007/s12311-010-0233-2; Szabo B, 2006, J PHYSIOL-LONDON, V577, P263, DOI 10.1113/jphysiol.2006.119362; Vila A, 2007, BIOCHEMISTRY-US, V46, P9578, DOI 10.1021/bi7005898; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Xiang ZH, 2005, DEV BRAIN RES, V156, P147, DOI 10.1016/j.devbrainres.2005.02.015; Xu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010306; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zhong P, 2011, J PHYSIOL-LONDON, V589, P4847, DOI 10.1113/jphysiol.2011.215509	50	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41499	10.1371/journal.pone.0041499	http://dx.doi.org/10.1371/journal.pone.0041499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927908	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300009
J	Freschauf, LR; McLane, J; Sharma, H; Khine, M				Freschauf, Lauren R.; McLane, Jolie; Sharma, Himanshu; Khine, Michelle			Shrink-Induced Superhydrophobic and Antibacterial Surfaces in Consumer Plastics	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; ESCHERICHIA-COLI; RESISTANCE; ARRAYS	Structurally modified superhydrophobic surfaces have become particularly desirable as stable antibacterial surfaces. Because their self-cleaning and water resistant properties prohibit bacteria growth, structurally modified superhydrophobic surfaces obviate bacterial resistance common with chemical agents, and therefore a robust and stable means to prevent bacteria growth is possible. In this study, we present a rapid fabrication method for creating such superhydrophobic surfaces in consumer hard plastic materials with resulting antibacterial effects. To replace complex fabrication materials and techniques, the initial mold is made with commodity shrink-wrap film and is compatible with large plastic roll-to-roll manufacturing and scale-up techniques. This method involves a purely structural modification free of chemical additives leading to its inherent consistency over time and successive recasting from the same molds. Finally, antibacterial properties are demonstrated in polystyrene (PS), polycarbonate (PC), and polyethylene (PE) by demonstrating the prevention of gram-negative Escherichia coli (E. coli) bacteria growth on our structured plastic surfaces.	[Freschauf, Lauren R.; McLane, Jolie; Khine, Michelle] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA; [Sharma, Himanshu; Khine, Michelle] Univ Calif Irvine, Dept Chem Engn & Mat Sci, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Freschauf, LR (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA.	mkhine@uci.edu			Undergraduate Research Opportunities Program (UROP); Division of Undergraduate Education at the University of California, Irvine [442870-19900]; Integrative Graduate Education and Research Traineeship Program (IGERT); National Science Foundation (NSF) [NSFIGERT DGE 0549479]; Defense Advanced Research Projects Agency (DARPA) N/MEMS S&T Fundamentals Program, Space and Naval Warfare Systems Center Pacific (SPAWAR) [N66001-1-4003]	Undergraduate Research Opportunities Program (UROP); Division of Undergraduate Education at the University of California, Irvine(University of California System); Integrative Graduate Education and Research Traineeship Program (IGERT); National Science Foundation (NSF)(National Science Foundation (NSF)); Defense Advanced Research Projects Agency (DARPA) N/MEMS S&T Fundamentals Program, Space and Naval Warfare Systems Center Pacific (SPAWAR)	This research was supported by the Undergraduate Research Opportunities Program (UROP) sponsored by the Division of Undergraduate Education at the University of California, Irvine (442870-19900) and by the Integrative Graduate Education and Research Traineeship Program (IGERT) sponsored by the National Science Foundation (NSF) (NSFIGERT DGE 0549479). Additional support is due to the Defense Advanced Research Projects Agency (DARPA) N/MEMS S&T Fundamentals Program under grant no. N66001-1-4003 issued by the Space and Naval Warfare Systems Center Pacific (SPAWAR) to the Micro/nano Fluidics Fundamentals Focus (MF3)Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Brooke JS, 2009, J ENVIRON HEALTH, V71, P17; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Cheng YT, 2006, NANOTECHNOLOGY, V17, P1359, DOI 10.1088/0957-4484/17/5/032; Cho KH, 2005, ELECTROCHIM ACTA, V51, P956, DOI 10.1016/j.electacta.2005.04.071; Cortese B, 2008, LANGMUIR, V24, P2712, DOI 10.1021/la702764x; Erbil HY, 2003, SCIENCE, V299, P1377, DOI 10.1126/science.1078365; Flores GE, 2011, PLOS ONE, V6, P11; Fu CC, 2009, ADV MATER, V21, P1; Gaidelyte A, 2006, PLOS ONE, V2, P11; Genzer J, 2000, SCIENCE, V290, P2130, DOI 10.1126/science.290.5499.2130; GETCHELLWHITE SI, 1989, INFECT CONT HOSP EP, V10, P402, DOI 10.1086/646061; Gomez GB, 2010, LANGMUIR, V26, P7248; Goral VN, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/1/017002; Guo SS, 2007, MICROELECTRON ENG, V84, P1673, DOI 10.1016/j.mee.2007.01.190; Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297; Helbig R, 2011, PLOS ONE, V6, P9; Hou SY, 2007, APPL ENVIRON MICROB, V73, P4300, DOI 10.1128/AEM.02633-06; Jokinen V, 2008, ADV MATER, V20, P3453, DOI 10.1002/adma.200800160; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Ma ML, 2006, CURR OPIN COLLOID IN, V11, P193, DOI 10.1016/j.cocis.2006.06.002; Oner D, 2000, LANGMUIR, V16, P7777, DOI 10.1021/la000598o; Padma Srikanth, 2010, Journal of Infection Prevention, V11, P87; PRINGLE JH, 1986, APPL ENVIRON MICROB, V51, P1321, DOI 10.1128/AEM.51.6.1321-1325.1986; Privett BJ, 2011, LANGMUIR, V27, P9597, DOI 10.1021/la201801e; Scott RD, 2008, DIRECT MED COSTS HEA; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Stalder AF, 2010, COLLOID SURFACE A, V364, P72, DOI 10.1016/j.colsurfa.2010.04.040; Temenoff JS, 2008, BIOMATERIALS INTERSE; Vaquette C, 2006, BIO-MED MATER ENG, V16, pS131; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Whitney HM, 2011, PLOS ONE, V6, P3; Wu J, 2010, PLOS ONE, V5, P12, DOI DOI 10.1371/ANNOTATION/F67A90FB-3E4E-4484-BFFE-FCFAFBFE88C7; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xu QF, 2010, ACS NANO, V4, P2201, DOI 10.1021/nn901581j; Yang H, 2008, J COLLOID INTERF SCI, V325, P588, DOI 10.1016/j.jcis.2008.06.034; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]; Zeus Industrial Products Inc, 2005, BIOC PLAST; Zheng LY, 2003, CARBOHYD POLYM, V54, P527, DOI 10.1016/j.carbpol.2003.07.009; Zhu LB, 2005, LANGMUIR, V21, P11208, DOI 10.1021/la051410+	41	90	96	3	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e40987	10.1371/journal.pone.0040987	http://dx.doi.org/10.1371/journal.pone.0040987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916100	gold, Green Published			2022-12-25	WOS:000307733800006
J	Keelan, JA; Mattes, E; Tan, HW; Dinan, A; Newnham, JP; Whitehouse, AJO; Jacoby, P; Hickey, M				Keelan, Jeffrey A.; Mattes, Eugen; Tan, HaiWei; Dinan, Andrew; Newnham, John P.; Whitehouse, Andrew J. O.; Jacoby, Peter; Hickey, Martha			Androgen Concentrations in Umbilical Cord Blood and Their Association with Maternal, Fetal and Obstetric Factors	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; GROWTH-FACTOR-I; FREE TESTOSTERONE; MASS-SPECTROMETRY; STEROID-HORMONES; DEHYDROEPIANDROSTERONE-SULFATE; PREECLAMPTIC PREGNANCIES; CHORIONIC-GONADOTROPIN; SERUM TESTOSTERONE; AMNIOTIC-FLUID	The aim of this study was to measure umbilical blood androgen concentrations in a birth cohort using a highly specific liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay and assesses the effects of sex, labor, and gestational age on fetal androgen levels at birth. We performed a prospective cohort study of androgen concentrations in mixed arterial and venous umbilical cord serum from 803 unselected singleton pregnancies from a general obstetric population in Western Australia. Total testosterone (TT), Delta 4-androstenedione, and dehydroepiandrosterone were extracted from archived cord serum samples and measured using LC-MS/MS. SHBG was measured by ELISA; free testosterone (FT) and bioavailable testosterone (BioT) values were also calculated. Median values for all three androgens were generally lower than previously published values. Levels of TT, FT, BioT, and SHBG were significantly higher in male verses female neonates (P<0.0001), while dehydroepiandrosterone levels were higher in females (P<0.0001). Labor was associated with a significant (similar to 15-26%) decrease in median cord blood TT and FT levels (both sexes combined), but a modest (similar to 16-31%) increase in SHBG, Delta 4-androstenedione, and dehydroepiandrosterone concentrations. TT and FT were significantly negatively correlated with gestational age at delivery, while SHBG, Delta 4-androstenedione, and dehydroepiandrosterone were positively correlated. Antenatal glucocorticoid administration also had a significant effect in the multiple regression models. This is the first study to report umbilical cord androgen levels in a large unselected population of neonates using LC-MS/MS. Our findings suggest that previous studies have over-estimated cord androgen levels, and that fetal, maternal, and obstetric factors influence cord androgen levels differentially. Caution should be exercised when interpreting previously-published data that have not taken all of these factors into account.	[Keelan, Jeffrey A.; Newnham, John P.] Univ Western Australia, Sch Womens & Infants Hlth, King Edward Mem Hosp, Perth, WA 6009, Australia; [Mattes, Eugen; Whitehouse, Andrew J. O.; Jacoby, Peter] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Tan, HaiWei; Dinan, Andrew] CPR Pharma Serv Pty Ltd, BioSA Incubator, Thebarton, SA, Australia; [Hickey, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Womens Hosp, Melbourne, Vic, Australia	King Edward Memorial Hospital; University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Melbourne	Keelan, JA (corresponding author), Univ Western Australia, Sch Womens & Infants Hlth, King Edward Mem Hosp, Perth, WA 6009, Australia.	jeff.keelan@uwa.edu.au	Study, Raine/K-4517-2013; Keelan, JA/G-2170-2011; Whitehouse, Andrew J.O./AGJ-2519-2022; Study, Raine/G-9547-2015	Keelan, JA/0000-0002-5403-6266; Whitehouse, Andrew J.O./0000-0001-8722-1575; Newnham, John/0000-0001-9983-7457; Mattes, Eugen/0000-0003-2708-0445; Hickey, Martha/0000-0002-3941-082X	Rotary Mental Health Australia; Raine Medical Research Foundation at The University of Western Australia (UWA); National Health and Medical Research Council of Australia (NHMRC) [1004065]; Telstra Foundation; Women and Infants Research Foundation; Curtin University; UWA Faculty of Medicine, Dentistry and Health Sciences	Rotary Mental Health Australia; Raine Medical Research Foundation at The University of Western Australia (UWA); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Telstra Foundation; Women and Infants Research Foundation; Curtin University; UWA Faculty of Medicine, Dentistry and Health Sciences	This study was funded by a competitive grant to EM and MH from Rotary Mental Health Australia. The Raine Study is funded by the Raine Medical Research Foundation at The University of Western Australia (UWA), the National Health and Medical Research Council of Australia (NHMRC), the Telstra Foundation, the Women and Infants Research Foundation, Curtin University, and the UWA Faculty of Medicine, Dentistry and Health Sciences. JAK is funded by the Women and Infants Research Foundation; MH is funded by an NHMRC Clinical Career Development Award; and AJOW is funded by a NHMRC Career Development Fellowship (# 1004065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT ED, 1990, ENDOCR REV, V11, P124, DOI 10.1210/edrv-11-1-124; Anderson H, 2010, J CLIN ENDOCR METAB, V95, P2180, DOI 10.1210/jc.2009-2651; ARAI K, 1977, AM J OBSTET GYNECOL, V127, P879, DOI 10.1016/0002-9378(77)90123-5; Auyeung B, 2009, PSYCHOL SCI, V20, P144, DOI 10.1111/j.1467-9280.2009.02279.x; Barry JA, 2010, J OBSTET GYNAECOL, V30, P444, DOI 10.3109/01443615.2010.485254; BERGER NG, 1984, OBSTET GYNECOL, V63, P260; BOLELLI G, 1995, CANCER EPIDEM BIOMAR, V4, P509; BOLTON NJ, 1989, CLIN ENDOCRINOL, V31, P201, DOI 10.1111/j.1365-2265.1989.tb01243.x; Carlsen SM, 2003, SCAND J CLIN LAB INV, V63, P23, DOI 10.1080/00365510310000457; CARTLIDGE PHT, 1986, ARCH DIS CHILD, V61, P657, DOI 10.1136/adc.61.7.657; Chen TH, 2011, CANCER EPIDEM BIOMAR, V20, P324, DOI 10.1158/1055-9965.EPI-10-0857; Clifton VL, 2007, J CHROMATOGR B, V855, P249, DOI 10.1016/j.jchromb.2007.05.041; Demers LM, 2010, MATURITAS, V67, P39, DOI 10.1016/j.maturitas.2010.04.019; Gemer O, 1997, ARCH GYNECOL OBSTET, V259, P139, DOI 10.1007/s004040050148; Hart R, 2010, FERTIL STERIL, V94, P1544, DOI 10.1016/j.fertnstert.2009.12.060; Hickey M, 2009, J CLIN ENDOCR METAB, V94, P3714, DOI 10.1210/jc.2009-0544; Hill M, 2010, J STEROID BIOCHEM, V121, P594, DOI 10.1016/j.jsbmb.2009.10.012; Ingudomnuku E, 2007, HORM BEHAV, V51, P597, DOI 10.1016/j.yhbeh.2007.02.001; Kari MA, 1996, PEDIATR RES, V40, P319, DOI 10.1203/00006450-199608000-00021; Krogh C, 2011, PEDIATRICS, V127, pE197, DOI 10.1542/peds.2010-2127; LAATIKAINEN T, 1980, J CLIN ENDOCR METAB, V50, P489, DOI 10.1210/jcem-50-3-489; Lagiou P, 2011, ANN ONCOL, V22, P1102, DOI 10.1093/annonc/mdq565; LESLIE KK, 1994, PLACENTA, V15, P79, DOI 10.1016/S0143-4004(05)80238-3; Ly LP, 2010, CLIN ENDOCRINOL, V73, P382, DOI 10.1111/j.1365-2265.2010.03804.x; Ly LP, 2005, EUR J ENDOCRINOL, V152, P471, DOI 10.1530/eje.1.01844; Maffeis C, 1999, INT J OBESITY, V23, P943, DOI 10.1038/sj.ijo.0801023; Manikkam M, 2006, ENDOCRINOLOGY, V147, P1997, DOI 10.1210/en.2005-1338; MATHUR RS, 1980, J CLIN ENDOCR METAB, V51, P1235, DOI 10.1210/jcem-51-6-1235; Nagata C, 2007, CANCER SCI, V98, P869, DOI 10.1111/j.1349-7006.2007.00464.x; NORMAN RJ, 1984, BRIT J OBSTET GYNAEC, V91, P776, DOI 10.1111/j.1471-0528.1984.tb04849.x; Procopio M, 2006, EUR ARCH PSY CLIN N, V256, P77, DOI 10.1007/s00406-005-0604-8; Rohrmann S, 2009, CANCER EPIDEM BIOMAR, V18, P1484, DOI 10.1158/1055-9965.EPI-08-0817; Romanowicz Lech, 2009, Atherosclerosis, V204, pe44, DOI 10.1016/j.atherosclerosis.2008.11.008; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; SAKAI LM, 1991, DEV PSYCHOBIOL, V24, P559, DOI 10.1002/dev.420240804; Sartorius G, 2009, ANN CLIN BIOCHEM, V46, P137, DOI 10.1258/acb.2008.008171; SIMMONS D, 1995, J CLIN ENDOCR METAB, V80, P2217, DOI 10.1210/jc.80.7.2217; SIMMONS D, 1994, BIOL NEONATE, V65, P287; Smith LM, 2003, NICOTINE TOB RES, V5, P369, DOI 10.1080/146222031000094196; Soldin OP, 2005, FERTIL STERIL, V84, P701, DOI 10.1016/j.fertnstert.2005.02.045; Stanczyk FZ, 2010, J STEROID BIOCHEM, V121, P491, DOI 10.1016/j.jsbmb.2010.05.001; Stanczyk FZ, 2006, SEMIN REPROD MED, V24, P78, DOI 10.1055/s-2006-939566; Stanczyk FZ, 2004, CLIN CHEM, V50, P2219, DOI 10.1373/clinchem.2004.038505; Stanczyk FZ, 2003, STEROIDS, V68, P1173, DOI 10.1016/j.steroids.2003.08.012; Steier JA, 2002, OBSTET GYNECOL, V100, P552, DOI 10.1016/S0029-7844(02)02088-4; Stroud LR, 2007, PSYCHONEUROENDOCRINO, V32, P140, DOI 10.1016/j.psyneuen.2006.11.008; Troisi R, 2003, CANCER EPIDEM BIOMAR, V12, P452; Troisi R, 2003, CANCER EPIDEM BIOMAR, V12, P1268; Troisi R, 2003, CANCER CAUSE CONTROL, V14, P347, DOI 10.1023/A:1023934518975; Troisi R, 2008, CANCER EPIDEM BIOMAR, V17, P224, DOI 10.1158/1055-9965.EPI-07-0536; van de Beek C, 2004, HORM BEHAV, V46, P663, DOI 10.1016/j.yhbeh.2004.06.010; Varvarigou AA, 2009, J PERINAT MED, V37, P364, DOI 10.1515/JPM.2009.028; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Vicente FB, 2006, CLIN CHEM LAB MED, V44, P70, DOI 10.1515/CCLM.2006.014; Weinstock M, 2010, ISR J PSYCHIATR REL, V47, P36; Whitehouse AJO, 2012, J CHILD PSYCHOL PSYC, V53, P726, DOI 10.1111/j.1469-7610.2011.02523.x; Whitehouse AJO, 2010, PSYCHONEUROENDOCRINO, V35, P1259, DOI 10.1016/j.psyneuen.2010.02.007; ZLOTKIN SH, 1987, CLIN CHEM, V33, P411	58	67	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42827	10.1371/journal.pone.0042827	http://dx.doi.org/10.1371/journal.pone.0042827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916165	gold, Green Published			2022-12-25	WOS:000307733800030
J	Van Brussel, I; Schrijvers, DM; Martinet, W; Pintelon, I; Deschacht, M; Schnorbusch, K; Maes, L; Bosmans, JM; Vrints, CJ; Adriaensen, D; Cos, P; Bult, H				Van Brussel, Ilse; Schrijvers, Dorien M.; Martinet, Wim; Pintelon, Isabel; Deschacht, Maartje; Schnorbusch, Kathy; Maes, Louis; Bosmans, Johan M.; Vrints, Christiaan J.; Adriaensen, Dirk; Cos, Paul; Bult, Hidde			Transcript and Protein Analysis Reveals Better Survival Skills of Monocyte-Derived Dendritic Cells Compared to Monocytes during Oxidative Stress	PLOS ONE			English	Article							T-CELLS; ATHEROSCLEROSIS; DIFFERENTIATION; GLUTATHIONE; PEROXIDASE; ACTIVATION; EXPRESSION; PROTECTION; APOPTOSIS; PITFALLS	Background: Dendritic cells (DCs), professional antigen-presenting cells with the unique ability to initiate primary T-cell responses, are present in atherosclerotic lesions where they are exposed to oxidative stress that generates cytotoxic reactive oxygen species (ROS). A large body of evidence indicates that cell death is a major modulating factor of atherogenesis. We examined antioxidant defence systems of human monocyte-derived (mo)DCs and monocytes in response to oxidative stress. Methods: Oxidative stress was induced by addition of tertiary-butylhydroperoxide (tert-BHP, 30 min). Cellular responses were evaluated using flow cytometry and confocal live cell imaging (both using 5-(and-6)-chloromethyl-2,7-dichlorodihydrofluorescein diacetate, CM-H(2)DCFDA). Viability was assessed by the neutral red assay. Total RNA was extracted for a PCR profiler array. Five genes were selected for confirmation by Taqman gene expression assays, and by immunoblotting or immunohistochemistry for protein levels. Results: Tert-BHP increased CM-H2DCFDA fluorescence and caused cell death. Interestingly, all processes occurred more slowly in moDCs than in monocytes. The mRNA profiler array showed more than 2-fold differential expression of 32 oxidative stress-related genes in unstimulated moDCs, including peroxiredoxin-2 (PRDX2), an enzyme reducing hydrogen peroxide and lipid peroxides. PRDX2 upregulation was confirmed by Taqman assays, immunoblotting and immunohistochemistry. Silencing PRDX2 in moDCs by means of siRNA significantly increased CM-DCF fluorescence and cell death upon tert-BHP-stimulation. Conclusions: Our results indicate that moDCs exhibit higher intracellular antioxidant capacities, making them better equipped to resist oxidative stress than monocytes. Upregulation of PRDX2 is involved in the neutralization of ROS in moDCs. Taken together, this points to better survival skills of DCs in oxidative stress environments, such as atherosclerotic plaques.	[Van Brussel, Ilse; Bosmans, Johan M.; Vrints, Christiaan J.] Univ Antwerp, Lab Cellular & Mol Cardiol, B-2020 Antwerp, Belgium; [Schrijvers, Dorien M.; Martinet, Wim] Univ Antwerp, Lab Physiopharmacol, B-2020 Antwerp, Belgium; [Pintelon, Isabel; Schnorbusch, Kathy; Adriaensen, Dirk] Univ Antwerp, Lab Cell Biol & Histol, B-2020 Antwerp, Belgium; [Deschacht, Maartje; Maes, Louis; Cos, Paul] Univ Antwerp, LMPH, B-2020 Antwerp, Belgium; [Bosmans, Johan M.; Vrints, Christiaan J.] Univ Antwerp Hosp, Dept Cardiol, Antwerp, Belgium; [Bult, Hidde] Univ Antwerp, Pharmacol Lab, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp	Van Brussel, I (corresponding author), Univ Antwerp, Lab Cellular & Mol Cardiol, B-2020 Antwerp, Belgium.	ilse.vanbrussel@ua.ac.be	Bult, Hidde/J-5342-2013; Maes, Louis JRM/A-2384-2017; Martinet, Wim/I-7375-2015; Cos, Paul/L-9717-2015; cos, paul/AAU-3896-2020; Schrijvers, Dorien/I-7535-2013	Maes, Louis JRM/0000-0002-2324-9509; Martinet, Wim/0000-0003-1967-9343; Cos, Paul/0000-0003-4361-8911; cos, paul/0000-0003-4361-8911; Schrijvers, Dorien/0000-0003-0826-4943	University of Antwerp [GOA-BOF 2407]; agency of Innovation by Science and Technology; Fund for Scientific Research (FWO); Flanders (Belgium)	University of Antwerp; agency of Innovation by Science and Technology; Fund for Scientific Research (FWO)(FWO); Flanders (Belgium)	This work was supported by the University of Antwerp (GOA-BOF 2407; http://www.ua.ac.be/main.aspx?c=ONDERZK&n=86348), and the agency of Innovation by Science and Technology (IWT-TBM; http://www.iwt.be/subsidies/tbm). Paul Cos is a postdoctoral researcher awarded by the Fund for Scientific Research (FWO; www.fwo.be) - Flanders (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Berggren MI, 2001, ARCH BIOCHEM BIOPHYS, V392, P103, DOI 10.1006/abbi.2001.2435; BOBRYSHEV YV, 1995, ARCH HISTOL CYTOL, V58, P307, DOI 10.1679/aohc.58.307; Cromheeke KM, 1999, CARDIOVASC RES, V43, P744, DOI 10.1016/S0008-6363(99)00148-0; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Del Prete A, 2008, FREE RADICAL BIO MED, V44, P1443, DOI 10.1016/j.freeradbiomed.2007.12.037; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Funke F, 2011, NEUROIMAGE, V54, P2590, DOI 10.1016/j.neuroimage.2010.11.031; Graf R, 2005, ADV BIOCHEM ENG BIOT, V95, P57, DOI 10.1007/b102210; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Kanupriya D, 2005, MOL CELL BIOCHEM, V275, P1, DOI 10.1007/s11010-005-7637-1; Kockx MM, 2003, ARTERIOSCL THROM VAS, V23, P440, DOI 10.1161/01.ATV.0000057807.28754.7F; Koltsova EK, 2011, TRENDS IMMUNOL, V32, P540, DOI 10.1016/j.it.2011.07.001; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Liu SX, 2001, P NATL ACAD SCI USA, V98, P1643, DOI 10.1073/pnas.031482998; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Manandhar G, 2009, BIOL REPROD, V80, P1168, DOI 10.1095/biolreprod.108.071738; Manthey HD, 2011, THROMB HAEMOSTASIS, V106, P772, DOI 10.1160/TH11-05-0296; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Martin C, 2001, BIOCHEM PHARMACOL, V62, P705, DOI 10.1016/S0006-2952(01)00704-3; Martinet W, 2008, BRIT J PHARMACOL, V154, P1236, DOI 10.1038/bjp.2008.181; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Preynat-Seauve O, 2003, CELL STRESS CHAPERON, V8, P162, DOI 10.1379/1466-1268(2003)008<0162:OSIIEI>2.0.CO;2; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Rivollier A, 2006, MOL CELL PROTEOMICS, V5, P726, DOI 10.1074/mcp.M500262-MCP200; Schwaab V, 1998, MOL REPROD DEV, V51, P362, DOI 10.1002/(SICI)1098-2795(199812)51:4&lt;362::AID-MRD2&gt;3.0.CO;2-L; Thomson MJ, 2007, CARDIOVASC DRUG THER, V21, P195, DOI 10.1007/s10557-007-6027-1; Thoren FB, 2007, J IMMUNOL, V179, P21, DOI 10.4049/jimmunol.179.1.21; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Van Vre EA, 2008, ARTERIOSCL THROM VAS, V28, P511, DOI 10.1161/ATVBAHA.107.157016; Van Vre EA, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/941396; Van Vre EA, 2011, PATHOLOGY, V43, P239, DOI 10.1097/PAT.0b013e328344e266; Wang E, 2005, J MICROSC-OXFORD, V218, P148, DOI 10.1111/j.1365-2818.2005.01473.x; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43357	10.1371/journal.pone.0043357	http://dx.doi.org/10.1371/journal.pone.0043357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916248	Green Published, gold, Green Submitted			2022-12-25	WOS:000307823600072
J	Xu, CJ; Ladouceur, M; Dastani, Z; Richards, JB; Ciampi, A; Greenwood, CMT				Xu, ChangJiang; Ladouceur, Martin; Dastani, Zari; Richards, J. Brent; Ciampi, Antonio; Greenwood, Celia M. T.			Multiple Regression Methods Show Great Potential for Rare Variant Association Tests	PLOS ONE			English	Article							LEAST-SQUARES REGRESSION; GENETIC-VARIANTS; DIMENSION; COMMON	The investigation of associations between rare genetic variants and diseases or phenotypes has two goals. Firstly, the identification of which genes or genomic regions are associated, and secondly, discrimination of associated variants from background noise within each region. Over the last few years, many new methods have been developed which associate genomic regions with phenotypes. However, classical methods for high-dimensional data have received little attention. Here we investigate whether several classical statistical methods for high-dimensional data: ridge regression (RR), principal components regression (PCR), partial least squares regression (PLS), a sparse version of PLS (SPLS), and the LASSO are able to detect associations with rare genetic variants. These approaches have been extensively used in statistics to identify the true associations in data sets containing many predictor variables. Using genetic variants identified in three genes that were Sanger sequenced in 1998 individuals, we simulated continuous phenotypes under several different models, and we show that these feature selection and feature extraction methods can substantially outperform several popular methods for rare variant analysis. Furthermore, these approaches can identify which variants are contributing most to the model fit, and therefore both goals of rare variant analysis can be achieved simultaneously with the use of regression regularization methods. These methods are briefly illustrated with an analysis of adiponectin levels and variants in the ADIPOQ gene.	[Xu, ChangJiang; Ladouceur, Martin; Dastani, Zari; Richards, J. Brent; Greenwood, Celia M. T.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Xu, ChangJiang; Dastani, Zari; Richards, J. Brent; Ciampi, Antonio; Greenwood, Celia M. T.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Ladouceur, Martin] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Richards, J. Brent] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada; [Richards, J. Brent] Kings Coll London, London WC2R 2LS, England; [Greenwood, Celia M. T.] McGill Univ, Dept Oncol, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; University of London; King's College London; McGill University	Xu, CJ (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.	celia.greenwood@mcgill.ca	Richards, J Brent/AAF-4225-2019	Richards, J Brent/0000-0002-3746-9086; Greenwood, Celia/0000-0002-2427-5696	Canadian Institutes for Health Research [MOP-115110]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The authors are indebtted to GlaxoSmithKline for the provision of genotype data used in simulations. We thank GlaxoSmithKline and the co-PIs of the CoLaus study, Gerard Waeber and Peter Vollenweider, for the use of this anonymized resequencing data, and Drs. Matthew R. Nelson and Margaret G. Ehm for their helpful suggestions as well. This work was supported by the Canadian Institutes for Health Research grant number MOP-115110.; This work was supported by the Canadian Institutes for Health Research grant number MOP-115110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Ayers Kristin L, 2011, BMC Proc, V5 Suppl 9, pS92, DOI 10.1186/1753-6561-5-S9-S92; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Biswas S, 2012, BIOMETRICS, V68, P587, DOI 10.1111/j.1541-0420.2011.01680.x; Brennan Jennifer S, 2011, BMC Proc, V5 Suppl 9, pS100, DOI 10.1186/1753-6561-5-S9-S100; Carbonetto P, 2011, BAYESIAN ANAL, V6, P1; Chen Han, 2011, BMC Proc, V5 Suppl 9, pS113, DOI 10.1186/1753-6561-5-S9-S113; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; Dastani Z, 2012, PLOS GENETI IN PRESS; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; FRANK IE, 1993, TECHNOMETRICS, V35, P109, DOI 10.2307/1269656; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gusev A, 2011, AM J HUM GENET, V88, P706, DOI 10.1016/j.ajhg.2011.04.023; Hastie T., 2009, UNSUPERVISED LEARNIN; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Kazma Remi, 2011, BMC Proc, V5 Suppl 9, pS29, DOI 10.1186/1753-6561-5-S9-S29; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Linhart H., 1986, MODEL SELECTION; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Luo L, 2011, GENOME RES, V21, P1099, DOI 10.1101/gr.115998.110; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; MASSY WF, 1965, J AM STAT ASSOC, V60, P234, DOI 10.2307/2283149; McQuarrie A. D, 1998, REGRESSION TIME SERI; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nussbaum R. L., 2007, THOMPSON THOMPSON GE; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; R Development Core Team, 2012, R LANG ENV STAT COMP; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Scholz Markus, 2011, BMC Proc, V5 Suppl 9, pS49, DOI 10.1186/1753-6561-5-S9-S49; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shao J, 1997, STAT SINICA, V7, P221; Song KNM, 2011, PHARMACOGENOMICS; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turkmen Asuman S, 2011, BMC Proc, V5 Suppl 9, pS19, DOI 10.1186/1753-6561-5-S9-S19; Wold H., 1985, ENCY STAT SCI, P581, DOI DOI 10.1002/0471667196; Wold H., 1975, PERSPECTIVES PROBABI, V12, P117, DOI [10.1017/s0021900200047604, DOI 10.1017/S0021900200047604, 10.1017/S0021900200047604]; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhou H, 2010, BIOINFORMATICS, V26, P2375, DOI 10.1093/bioinformatics/btq448; Zhu QQ, 2011, AM J HUM GENET, V88, P458, DOI 10.1016/j.ajhg.2011.03.008	46	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41694	10.1371/journal.pone.0041694	http://dx.doi.org/10.1371/journal.pone.0041694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22916111	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100014
J	Xuan, C; Wang, Q; Han, X; Duan, Y; Li, L; Shi, L; Wang, Y; Shan, L; Yao, Z; Shang, Y				Xuan, C.; Wang, Q.; Han, X.; Duan, Y.; Li, L.; Shi, L.; Wang, Y.; Shan, L.; Yao, Z.; Shang, Y.			RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene	ONCOGENE			English	Article						MDM2; p53; RBB; transcription repressor; NuRD complex	PROTEIN INTERACTION MOTIF; ACUTE PROMYELOCYTIC LEUKEMIA; POZ-DOMAIN; TUMOR-SUPPRESSOR; DOWN-REGULATION; MDM2 GENE; P53; COREPRESSOR; EXPRESSION; PROMOTES	The p53 tumor suppressor is important in many aspects of cell biology. Tight regulation of p53 is thus imperative for maintaining cell homeostasis and preventing tumorigenesis. The stabilization and activity of p53 is primarily regulated by MDM2, which is encoded for by HDM2. However, how the expression and activity of MDM2 is regulated remains largely unknown. Here, we report a novel BTB and BEN domains-containing protein, RBB. We demonstrated that RBB is a novel transcriptional repressor binding specific DNA motif via a homodimer and interacting with the nucleosome remodeling and deacetylase (NuRD) complex. Genome wide transcription target analysis by ChIP sequencing revealed that RBB represses the transcription of a series of functionally important genes including HDM2. We showed that RBB recruits the NuRD complex to the internal promoter of HDM2 and inhibits the expression of MDM2 protein, leading to subsequent stabilization of tumor suppressor p53. Significantly, we showed that RBB suppresses cell proliferation and sensitizes cells to DNA damage-induced apoptosis. Our data indicate that RBB is a novel transcriptional repressor and an important regulator of p53 pathway.	[Xuan, C.; Wang, Q.; Duan, Y.; Li, L.; Shi, L.; Wang, Y.; Shan, L.; Yao, Z.; Shang, Y.] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, Collaborat Innovat Ctr Tianjin Med Epigenet 2011, Tianjin 300070, Peoples R China; [Wang, Q.; Yao, Z.] Tianjin Med Univ, Dept Immunol, Tianjin 300070, Peoples R China; [Han, X.] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China	Tianjin Medical University; Tianjin Medical University; Peking University	Xuan, C (corresponding author), Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	chenghaoxuan@bjmu.edu.cn; yshang@hsc.pku.edu.cn	duan, yang/GZA-6440-2022; Han, Xiao/A-1109-2017	Han, Xiao/0000-0002-5395-4022; Han, Xiao/0000-0002-6024-6286	National Natural Science Foundation of China [81000876, 81130048, 30921062]; Ministry of Science and Technology of China [2011CB504204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants (81000876, 81130048 and 30921062 to YS) from the National Natural Science Foundation of China and grants (973 Program: 2011CB504204 to YS) from the Ministry of Science and Technology of China.	Abhiman S, 2008, BIOINFORMATICS, V24, P458, DOI 10.1093/bioinformatics/btn007; ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Brooks CL, 2004, CELL CYCLE, V3, P895; Brown CY, 1999, ONCOGENE, V18, P5631, DOI 10.1038/sj.onc.1202949; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Davies J, 1999, ONCOGENE, V18, P3643, DOI 10.1038/sj.onc.1202956; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dong S, 1996, P NATL ACAD SCI USA, V93, P3624, DOI 10.1073/pnas.93.8.3624; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Grochola LF, 2010, PANCREAS, V39, P76, DOI 10.1097/MPA.0b013e3181b9f105; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Huynh KD, 2000, GENE DEV, V14, P1810; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Jung CR, 2010, J CLIN INVEST, V120, P4493, DOI 10.1172/JCI42674; JUVEN T, 1993, ONCOGENE, V8, P3411; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; PERRY ME, 1993, P NATL ACAD SCI USA, V90, P11623, DOI 10.1073/pnas.90.24.11623; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Xuan C, 2008, CELL MICROBIOL, V10, P31, DOI 10.1111/j.1462-5822.2007.01011.x; Xuan CH, 2007, J BIOL CHEM, V282, P28800, DOI 10.1074/jbc.M702823200; Yamochi T, 1999, ONCOGENE, V18, P487, DOI 10.1038/sj.onc.1202334	52	13	18	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 8	2013	32	32					3711	3721		10.1038/onc.2012.386	http://dx.doi.org/10.1038/onc.2012.386			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	198EH	22926524				2022-12-25	WOS:000322904400006
J	Bhukhai, K; Suksen, K; Bhummaphan, N; Janjorn, K; Thongon, N; Tantikanlayaporn, D; Piyachaturawat, P; Suksamrarn, A; Chairoungdua, A				Bhukhai, Kanit; Suksen, Kanoknetr; Bhummaphan, Narumol; Janjorn, Keatdamrong; Thongon, Natthakan; Tantikanlayaporn, Duangrat; Piyachaturawat, Pawinee; Suksamrarn, Apichart; Chairoungdua, Arthit			A Phytoestrogen Diarylheptanoid Mediates Estrogen Receptor/Akt/Glycogen Synthase Kinase 3 beta Protein-dependent Activation of the Wnt/beta-Catenin Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; BETA-CATENIN; RECEPTOR ACTIVATOR; BONE LOSS; WNT; TRANSCRIPTION; EXPRESSION; PHOSPHORYLATION; OSTEOBLASTS; SURVIVAL	Estrogen promotes growth in many tissues by activating Wnt/beta-catenin signaling. Recently, ASPP 049, a diarylheptanoid isolated from Curcuma comosa Roxb., has been identified as a phytoestrogen. This investigation determined the involvement of Wnt/beta-catenin signaling in the estrogenic activity of this diarylheptanoid in transfected HEK 293T and in mouse preosteoblastic (MC3T3-E1) cells using a TOPflash luciferase assay and immunofluorescence. ASPP 049 rapidly activated T-cell-specific transcription factor/lymphoid enhancer binding factor-mediated transcription activity and induced beta-catenin accumulation in the nucleus. Interestingly, the effects of ASPP 049 on the transcriptional activity and induction and accumulation of beta-catenin protein in the nucleus of MC3T3-E1 cells were greater compared with estradiol. Activation of beta-catenin in MC3T3-E1cells was inhibited by ICI 182,780, suggesting that an estrogen receptor is required. In addition, ASPP 049 induced phosphorylations at serine 473 of Akt and serine 9 of GSK-3 beta. Moreover, ASPP 049 also induced proliferation and expressions of Wnt target genes Axin2 and Runx2 in MC3T3-E1 cells. In addition, ASPP 049 increased alkaline phosphatase expression, and activity that was abolished by DKK-1, a blocker of the Wnt/beta-catenin receptor. Taken together, these results suggest that ASPP 049 from C. comosa induced osteoblastic cell proliferation and differentiation through ER alpha-, Akt-, and GSK-3 beta-dependent activation of beta-catenin signaling. Our findings provide a scientific rationale for using C. comosa as a dietary supplement to prevent bone loss in postmenopausal women.	[Bhukhai, Kanit; Suksen, Kanoknetr; Janjorn, Keatdamrong; Thongon, Natthakan; Tantikanlayaporn, Duangrat; Piyachaturawat, Pawinee; Chairoungdua, Arthit] Mahidol Univ, Dept Physiol, Fac Sci, Bangkok 10400, Thailand; [Bhummaphan, Narumol; Piyachaturawat, Pawinee; Chairoungdua, Arthit] Mahidol Univ, Toxicol Grad Program, Fac Sci, Bangkok 10400, Thailand; [Bhukhai, Kanit; Bhummaphan, Narumol; Janjorn, Keatdamrong; Thongon, Natthakan; Piyachaturawat, Pawinee; Chairoungdua, Arthit] Mahidol Univ, Res Ctr Transport Prot Med Innovat, Fac Sci, Bangkok 10400, Thailand; [Suksamrarn, Apichart] Ramkhamhang Univ, Dept Chem, Fac Sci, Bangkok 10240, Thailand	Mahidol University; Mahidol University; Mahidol University; Ramkhamhaeng University	Chairoungdua, A (corresponding author), Mahidol Univ, Dept Physiol, Fac Sci, Rama 4 Rd, Bangkok 10400, Thailand.	arthit.chi@mahidol.ac.th	Tantikanlayaporn, Duangrat/AAB-3358-2021; Piyachaturawat, Pawinee/R-5817-2019; Suksamrarn, Apichart/R-8782-2019	Tantikanlayaporn, Duangrat/0000-0002-1197-4957; Thongon, Natthakan/0000-0002-6169-403X	Faculty of Science, Mahidol University; office of the Higher Education Commission; National Research Council of Thailand; Mahidol University under the National Research Universities Initiative (NRU)	Faculty of Science, Mahidol University; office of the Higher Education Commission; National Research Council of Thailand(National Research Council of Thailand (NRCT)); Mahidol University under the National Research Universities Initiative (NRU)	This project was supported by Faculty of Science, Mahidol University, the office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative (NRU), and the National Research Council of Thailand.	Armstrong JL, 2001, J BIOL CHEM, V276, P952, DOI 10.1074/jbc.M004812200; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Chen XW, 2003, J NUTR BIOCHEM, V14, P342, DOI 10.1016/S0955-2863(03)00056-1; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Intapad S, 2009, VASC PHARMACOL, V51, P284, DOI 10.1016/j.vph.2009.07.005; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Liedert A, 2010, BIOCHEM BIOPH RES CO, V394, P755, DOI 10.1016/j.bbrc.2010.03.065; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; McDougall KE, 2003, ENDOCRINOLOGY, V144, P1994, DOI 10.1210/en.2002-0074; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Piyachaturawat P, 1995, ASIA PAC J PHARMACOL, V10, P121; Rubin J, 2002, J CLIN ENDOCR METAB, V87, P4273, DOI 10.1210/jc.2002-020656; SEEMAN E, 1992, J BONE MINER RES, V7, P1467; Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; Suksamrarn A, 2008, BIOORGAN MED CHEM, V16, P6891, DOI 10.1016/j.bmc.2008.05.051; Varea O, 2010, STEROIDS, V75, P565, DOI 10.1016/j.steroids.2009.09.006; Varea O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005153; Wandosell F, 2012, J NEUROENDOCRINOL, V24, P191, DOI 10.1111/j.1365-2826.2011.02186.x; Weerachayaphorn J, 2011, J ETHNOPHARMACOL, V137, P956, DOI 10.1016/j.jep.2011.06.040; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Winuthayanon W, 2009, ENVIRON HEALTH PERSP, V117, P1155, DOI 10.1289/ehp.0900613; Winuthayanon W, 2009, J AGR FOOD CHEM, V57, P840, DOI 10.1021/jf802702c; Wood CE, 2010, CLIN CANCER RES, V16, P946, DOI 10.1158/1078-0432.CCR-09-1541; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786	38	54	64	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36168	36178		10.1074/jbc.M112.344747	http://dx.doi.org/10.1074/jbc.M112.344747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936801	Green Published, hybrid			2022-12-25	WOS:000310364000038
J	Bardai, FH; Price, V; Zaayman, M; Wang, LL; D'Mello, SR				Bardai, Farah H.; Price, Valerie; Zaayman, Marcus; Wang, Lulu; D'Mello, Santosh R.			Histone Deacetylase-1 (HDAC1) Is a Molecular Switch between Neuronal Survival and Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEURODEGENERATIVE DISEASES; GLYCOGEN-SYNTHASE KINASE-3; PROTECTS NEURONS; NERVOUS-SYSTEM; GROWTH-FACTOR; INHIBITION; TOXICITY; MODELS; NEUROPROTECTION; ACTIVATION	Both neuroprotective and neurotoxic roles have previously been described for histone deacetylase-1 (HDAC1). Here we report that HDAC1 expression is elevated in vulnerable brain regions of two mouse models of neurodegeneration, the R6/2 model of Huntington disease and the Ca2+/calmodulin-dependent protein kinase (CaMK)/p25 double-transgenic model of tauopathic degeneration, suggesting a role in promoting neuronal death. Indeed, elevating HDAC1 expression by ectopic expression promotes the death of otherwise healthy cerebellar granule neurons and cortical neurons in culture. The neurotoxic effect of HDAC1 requires interaction and cooperation with HDAC3, which has previously been shown to selectively induce the death of neurons. HDAC1-HDAC3interaction is greatly elevated under conditions of neurodegeneration both in vitro and in vivo. Furthermore, the knockdown of HDAC3 suppresses HDAC1-induced neurotoxicity, and the knockdown of HDAC1 suppresses HDAC3 neurotoxicity. As described previously for HDAC3, the neurotoxic effect of HDAC1 is inhibited by treatment with IGF-1, the expression of Akt, or the inhibition of glycogen synthase kinase 3 beta (GSK3 beta). In addition to HDAC3, HDAC1 has been shown to interact with histone deacetylase-related protein (HDRP), a truncated form of HDAC9, whose expression is down-regulated during neuronal death. In contrast to HDAC3, the interaction between HDRP and HDAC1 protects neurons from death, an effect involving acquisition of the deacetylase activity of HDAC1 by HDRP. We find that elevated HDRP inhibits HDAC1-HDAC3 interaction and prevents the neurotoxic effect of either of these two proteins. Together, our results suggest that HDAC1 is a molecular switch between neuronal survival and death. Its interaction with HDRP promotes neuronal survival, whereas interaction with HDAC3 results in neuronal death.	[Bardai, Farah H.; Price, Valerie; Zaayman, Marcus; Wang, Lulu; D'Mello, Santosh R.] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [D'Mello, Santosh R.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75080 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	D'Mello, SR (corresponding author), Univ Texas Dallas, Dept Mol & Cell Biol, 2601 N Floyd Rd, Richardson, TX 75083 USA.	dmello@utdallas.edu	D'Mello, Santosh/AAO-7192-2020; D'Mello, Santosh/AAM-3644-2020; Zaayman, Marcus/AAM-6528-2021	D'Mello, Santosh/0000-0002-7652-1334; Zaayman, Marcus/0000-0003-1531-8313	National Institutes of Health [NS40408, NS058462]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058462, R01NS040408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS40408 and NS058462 (to S. R. D.).	Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Chen HM, 2008, EUR J NEUROSCI, V28, P2003, DOI 10.1111/j.1460-9568.2008.06491.x; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; D'Mello SR, 2009, DRUG NEWS PERSPECT, V22, P513, DOI [10.1358/dnp.2009.22.9.1437959, 10.1358/dnp.2009.9.1428871]; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Ghosh S, 2004, HUM MOL GENET, V13, P2011, DOI 10.1093/hmg/ddh214; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hernandez F, 2009, MINI-REV MED CHEM, V9, P1024, DOI 10.2174/138955709788922647; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jia HQ, 2012, NEUROBIOL DIS, V46, P351, DOI 10.1016/j.nbd.2012.01.016; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Li Jia Yi, 2005, NeuroRx, V2, P447, DOI 10.1602/neurorx.2.3.447; Ma C, 2011, J BIOL CHEM, V286, P4819, DOI 10.1074/jbc.M110.146860; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Morrison BE, 2007, CELL MOL LIFE SCI, V64, P2258, DOI 10.1007/s00018-007-7035-9; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Sleiman SF, 2009, EXPERT OPIN INV DRUG, V18, P573, DOI [10.1517/13543780902810345, 10.1517/13543780902810345 ]; Tou LQ, 2004, MOL CELL BIOL, V24, P3132, DOI 10.1128/MCB.24.8.3132-3139.2004; Wang LL, 2010, J NEUROSCI RES, V88, P1970, DOI 10.1002/jnr.22352; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	37	101	107	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35444	35453		10.1074/jbc.M112.394544	http://dx.doi.org/10.1074/jbc.M112.394544			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22918830	hybrid, Green Published			2022-12-25	WOS:000309968000054
J	Benabid, R; Wartelle, J; Malleret, L; Guyot, N; Gangloff, S; Lebargy, F; Belaaouaj, A				Benabid, Rym; Wartelle, Julien; Malleret, Laurette; Guyot, Nicolas; Gangloff, Sophie; Lebargy, Francois; Belaaouaj, Azzaq			Neutrophil Elastase Modulates Cytokine Expression CONTRIBUTION TO HOST DEFENSE AGAINST PSEUDOMONAS AERUGINOSA-INDUCED PNEUMONIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; SURFACTANT PROTEIN-D; CYSTIC-FIBROSIS; INNATE IMMUNITY; FACTOR-ALPHA; INFLAMMATORY PROTEIN-2; ALVEOLAR MACROPHAGES; PANCREATIC ELASTASE; LEUKOCYTE ELASTASE	There is accumulating evidence that following bacterial infection, the massive recruitment and activation of the phagocytes, neutrophils, is accompanied with the extracellular release of active neutrophil elastase (NE), a potent serine protease. Using NE-deficient mice in a clinically relevant model of Pseudomonas aeruginosa-induced pneumonia, we provide compelling in vivo evidence that the absence of NE was associated with decreased protein and transcript levels of the proinflammatory cytokines TNF-alpha, MIP-2, and IL-6 in the lungs, coinciding with increased mortality of mutant mice to infection. The implication of NE in the induction of cytokine expression involved at least in part Toll-like receptor 4 (TLR-4). These findings were further confirmed following exposure of cultured macrophages to purified NE. Together, our data suggest strongly for the first time that NE not only plays a direct antibacterial role as it has been previously reported, but released active enzyme can also modulate cytokine expression, which contributes to host protection against P. aeruginosa. In light of our findings, the long held view that considers NE as a prime suspect in P. aeruginosa-associated diseases will need to be carefully reassessed. Also, therapeutic strategies aiming at NE inhibition should take into account the physiologic roles of the enzyme.	[Benabid, Rym; Wartelle, Julien; Malleret, Laurette; Guyot, Nicolas; Lebargy, Francois; Belaaouaj, Azzaq] Inserm Avenir Program, F-51092 Reims, France; [Benabid, Rym; Wartelle, Julien; Malleret, Laurette; Guyot, Nicolas; Gangloff, Sophie; Lebargy, Francois; Belaaouaj, Azzaq] CHU Reims, EA 4303, F-51092 Reims, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Reims	Belaaouaj, A (corresponding author), 45 Rue Cognacq Jay, F-51092 Reims, France.	azzaq.belaaouaj@univ-reims.fr	Bentaher, Abderrazzaq/M-4424-2017; A, Bentaher/F-6531-2018	A, Bentaher/0000-0001-6001-5456; gangloff, sophie/0000-0003-2651-9372	Inserm Avenir Program; Fondation pour la Recherche Medicale; Agence Nationale Recherche; Association Regionale Pour I'Aide aux Insuffisants Respiratoires de Champagne Ardenne; Contrat de Projets Etat-Region	Inserm Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale Recherche(French National Research Agency (ANR)); Association Regionale Pour I'Aide aux Insuffisants Respiratoires de Champagne Ardenne; Contrat de Projets Etat-Region	This work was supported by the Inserm Avenir Program, Fondation pour la Recherche Medicale, Agence Nationale Recherche, Association Regionale Pour I'Aide aux Insuffisants Respiratoires de Champagne Ardenne, and Contrat de Projets Etat-Region.	Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; BELAAOUAJ A, 1995, J BIOL CHEM, V270, P14568, DOI 10.1074/jbc.270.24.14568; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; BIRRER P, 1995, RESPIRATION, V62, P25; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; BURET A, 1994, INFECT IMMUN, V62, P5335, DOI 10.1128/IAI.62.12.5335-5343.1994; Calkins CM, 2002, J SURG RES, V104, P124, DOI 10.1006/jsre.2002.6422; CAMPBELL EJ, 1979, J CLIN INVEST, V64, P824, DOI 10.1172/JCI109530; De Plaen IG, 2006, IMMUNOLOGY, V118, P153, DOI 10.1111/j.1365-2567.2006.02344.x; Delacourt C, 2002, AM J RESP CELL MOL, V26, P290, DOI 10.1165/ajrcmb.26.3.4611; Devaney JM, 2003, FEBS LETT, V544, P129, DOI 10.1016/S0014-5793(03)00482-4; Dichtl Wolfgang, 2000, Molecular Cell Biology Research Communications, V4, P50, DOI 10.1006/mcbr.2000.0256; Ganz T, 1999, P ASSOC AM PHYSICIAN, V111, P390, DOI 10.1111/paa.1999.111.5.390; GOSSELIN D, 1995, INFECT IMMUN, V63, P3272, DOI 10.1128/IAI.63.9.3272-3278.1995; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hietaranta A, 2004, BIOCHEM BIOPH RES CO, V323, P192, DOI 10.1016/j.bbrc.2004.08.077; Hirche TO, 2008, J IMMUNOL, V181, P4945, DOI 10.4049/jimmunol.181.7.4945; Hirche TO, 2005, J IMMUNOL, V174, P1557, DOI 10.4049/jimmunol.174.3.1557; Hirche TO, 2004, J BIOL CHEM, V279, P27688, DOI 10.1074/jbc.M402936200; Hirche TO, 2004, AM J RESP CELL MOL, V30, P576, DOI 10.1165/rcmb.2003-0253OC; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Lee JH, 2003, AM J RESP CRIT CARE, V168, P1462, DOI 10.1164/rccm.200302-303OC; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liou TG, 1995, BIOCHEMISTRY-US, V34, P16171, DOI 10.1021/bi00049a032; Lopez-boado YS, 2004, J IMMUNOL, V172, P509, DOI 10.4049/jimmunol.172.1.509; Mansell A, 2001, FEBS LETT, V508, P313, DOI 10.1016/S0014-5793(01)03077-0; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; Matalon S, 2009, FASEB J, V23, P1415, DOI 10.1096/fj.08-120568; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Moraes TJ, 2003, CRIT CARE MED, V31, pS189, DOI 10.1097/01.CCM.0000057842.90746.1E; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; O'Neill LAJ, 2002, TRENDS IMMUNOL, V23, P296, DOI 10.1016/S1471-4906(02)02222-6; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ramphal R, 2005, J IMMUNOL, V175, P3927, DOI 10.4049/jimmunol.175.6.3927; RAO NV, 1993, AM J RESP CELL MOL, V8, P612, DOI 10.1165/ajrcmb/8.6.612; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Roghanian A, 2006, AM J RESP CRIT CARE, V174, P1189, DOI 10.1164/rccm.200605-632OC; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; SCUDERI P, 1991, CELL IMMUNOL, V135, P299, DOI 10.1016/0008-8749(91)90275-G; Sharma AK, 2007, AM J PHYSIOL-LUNG C, V293, pL105, DOI 10.1152/ajplung.00470.2006; Shibata S, 2010, J ANESTH, V24, P901, DOI 10.1007/s00540-010-1030-2; Standiford TJ, 1996, BIOL SIGNAL, V5, P203; TAMURA Y, 1992, MICROB PATHOGENESIS, V12, P237, DOI 10.1016/0882-4010(92)90058-V; Tsujimoto H, 2005, SHOCK, V23, P39, DOI 10.1097/01.shk.0000145936.31967.d7; Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; Velard F, 2009, ACTA BIOMATER, V5, P1708, DOI 10.1016/j.actbio.2009.01.008; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Weldon S, 2009, J IMMUNOL, V183, P8148, DOI 10.4049/jimmunol.0901716; Williams LA, 2008, MOL IMMUNOL, V45, P2446, DOI 10.1016/j.molimm.2007.12.011; WOLPE SD, 1989, FASEB J, V3, P2565, DOI 10.1096/fasebj.3.14.2687068; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x; ZUCKERFRANKLIN D, 1981, J HISTOCHEM CYTOCHEM, V29, P451, DOI 10.1177/29.3.451	63	54	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34883	34894		10.1074/jbc.M112.361352	http://dx.doi.org/10.1074/jbc.M112.361352			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927440	Green Published, hybrid			2022-12-25	WOS:000309968000002
J	Sugiyama, C; Yamamoto, M; Kotani, T; Kikkawa, F; Murata, Y; Hayashi, Y				Sugiyama, Chisato; Yamamoto, Michiyo; Kotani, Tomomi; Kikkawa, Fumitaka; Murata, Yoshiharu; Hayashi, Yoshitaka			Fertility and Pregnancy-Associated beta-Cell Proliferation in Mice Deficient in Proglucagon-Derived Peptides	PLOS ONE			English	Article							INSULIN-SECRETION; PLACENTAL LACTOGENS; GLUCAGON; RECEPTOR; ISLETS; HYPOGLYCEMIA; HORMONES; GROWTH; MOUSE; MASS	Proglucagon, which is encoded by the glucagon gene (Gcg), is the precursor of several peptide hormones, including glucagon and glucagon-like peptide 1 (GLP-1). Whereas glucagon stimulates hepatic glycogenolysis and gluconeogenesis, GLP-1 stimulates insulin secretion to lower blood glucose and also supports beta-cell proliferation and protection from apoptotic stimuli. Pregnancy is a strong inducer of change in islet function, however the roles of proglucagon-derived peptides in pregnancy are only partially understood. In the present study, we analyzed fertility and pregnancy-associated changes in homozygous glucagon-green fluorescent protein (gfp) knock-in mice (Gcg(gfp/gfp)), which lack all the peptides derived from proglucagon. Female Gcg(gfp/gfp) mice could deliver and raise Gcg(gfp/gfp) pups to weaning and Gcg(gfp/gfp) pups from Gcg(gfp/gfp) dams were viable and fertile. Pregnancy induced beta-cell proliferation in Gcg(gfp/gfp) mice as well as in control mice. However, serum insulin levels in pregnant Gcg(gfp/gfp) females were lower than those in control pregnant females under ad libitum feeding, and blood glucose levels in pregnant Gcg(gfp/gfp) females were higher after gestational day 12. Gcg(gfp/gfp) females showed a decreased pregnancy rate and smaller litter size. The rate of successful breeding was significantly lower in Gcg(gfp/gfp) females and was not improved by experience of breeding. Taken together, proglucagon-derived peptides are not required for pregnancy-associated beta-cell proliferation, however, are required for regulation of blood glucose levels and normal reproductive capacity. Gcg(gfp/gfp) mice may serve as a novel model to analyze the effect of mild hyperglycemia during late gestational periods.	[Sugiyama, Chisato; Yamamoto, Michiyo; Murata, Yoshiharu; Hayashi, Yoshitaka] Nagoya Univ, Environm Med Res Inst, Dept Genet, Nagoya, Aichi 464, Japan; [Sugiyama, Chisato; Kotani, Tomomi; Kikkawa, Fumitaka] Nagoya Univ, Dept Obstet & Gynecol, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Sugiyama, C (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Genet, Nagoya, Aichi 464, Japan.	hayashiy@riem.nagoya-u.ac.jp	Hayashi, Yoshitaka/I-6168-2014; KIKKAWA, Fumitaka/I-7341-2014; Kotani, Tomomi/I-7360-2014	Hayashi, Yoshitaka/0000-0002-7557-4303; Kotani, Tomomi/0000-0002-3082-6116	Japan Society for the Promotion of Science [21659232]; Ministry of Education, Culture, Sports, Science and Technology, Japan [23122507]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (21659232 to Y. H.) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (23122507 to Y. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, BEHAV BRAIN RES, V205, P265, DOI 10.1016/j.bbr.2009.06.035; Ali S, 2011, J CLIN INVEST, V121, P1917, DOI 10.1172/JCI43615; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Dey A, 2005, ENDOCRINOLOGY, V146, P713, DOI 10.1210/en.2004-1118; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; FIELDER PJ, 1987, AM J PHYSIOL, V253, pE40, DOI 10.1152/ajpendo.1987.253.1.E40; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Ijas H, 2010, BJOG, P880; Jones HN, 2007, PLACENTA, V28, P763, DOI 10.1016/j.placenta.2007.05.002; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Lindberg K, 2005, J MOL ENDOCRINOL, V35, P231, DOI 10.1677/jme.1.01840; Mao PZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029343; Miettinen PJ, 2006, DIABETES, V55, P3299, DOI 10.2337/db06-0413; Nasir I, 2005, MOL CELL ENDOCRINOL, V233, P1, DOI 10.1016/j.mce.2005.02.001; Ouhilal S, 2012, AM J PHYSIOL-ENDOC M, V302, pE522, DOI 10.1152/ajpendo.00420.2011; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; PERSSON B, 1993, BAILLIERE CLIN ENDOC, V7, P731, DOI 10.1016/S0950-351X(05)80216-2; Reece E A, 1994, Obstet Gynecol Surv, V49, P64, DOI 10.1097/00006254-199401000-00027; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; SMOAK IW, 1990, AM J OBSTET GYNECOL, V163, P619, DOI 10.1016/0002-9378(90)91213-V; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; ter Braak EWMT, 2002, DIABETES-METAB RES, V18, P96, DOI 10.1002/dmrr.271; Valsamakis G, 2010, EUR J ENDOCRINOL, V162, P897, DOI 10.1530/EJE-10-0047; VANASSCHE FA, 1978, BRIT J OBSTET GYNAEC, V85, P818; Vasavada RC, 2006, INT J BIOCHEM CELL B, V38, P931, DOI 10.1016/j.biocel.2005.08.003; Vuguin PM, 2006, ENDOCRINOLOGY, V147, P3995, DOI 10.1210/en.2005-1410; Watanabe C, 2012, DIABETES, V61, P74, DOI 10.2337/db11-0739	35	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43745	10.1371/journal.pone.0043745	http://dx.doi.org/10.1371/journal.pone.0043745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928026	Green Published, gold, Green Submitted			2022-12-25	WOS:000308224700024
J	Chow, BSM; Chew, EGY; Zhao, CX; Bathgate, RAD; Hewitson, TD; Samuel, CS				Chow, Bryna Suet Man; Chew, Elaine Guo Yan; Zhao, Chongxin; Bathgate, Ross A. D.; Hewitson, Tim D.; Samuel, Chrishan S.			Relaxin Signals through a RXFP1-pERK-nNOS-NO-cGMP-Dependent Pathway to Up-Regulate Matrix Metalloproteinases: The Additional Involvement of iNOS	PLOS ONE			English	Article							NITRIC-OXIDE PATHWAY; SMOOTH-MUSCLE-CELLS; INTERSTITIAL FIBROSIS; TISSUE INHIBITORS; HORMONE RELAXIN; RENAL FIBROSIS; LUNG FIBROSIS; GROWTH; FIBROBLASTS; COLLAGEN	The hormone, relaxin, inhibits aberrant myofibroblast differentiation and collagen deposition by disrupting the TGF-beta 1/Smad2 axis, via its cognate receptor, Relaxin Family Peptide Receptor 1 (RXFP1), extracellular signal-regulated kinase (ERK) 1/2 phosphorylation (pERK) and a neuronal nitric oxide (NO) synthase (nNOS)-NO-cyclic guanosine monophosphate (cGMP)dependent pathway. However, the signalling pathways involved in its additional ability to increase matrix metalloproteinase (MMP) expression and activity remain unknown. This study investigated the extent to which the NO pathway was involved in human gene-2 (H2) relaxin's ability to positively regulate MMP-1 and its rodent orthologue, MMP-13, MMP-2 and MMP-9 (the main collagen-degrading MMPs) in TGF-beta 1-stimulated human dermal fibroblasts and primary renal myofibroblasts isolated from injured rats; by gelatin zymography (media) and Western blotting (cell layer). H2 relaxin (10-100 ng/ml) significantly increased MMP-1 (by similar to 50%), MMP-2 (by similar to 80%) and MMP-9 (by similar to 80%) in TGF-beta 1-stimulated human dermal fibroblasts; and MMP-13 (by similar to 90%), MMP-2 (by similar to 130%) and MMP-9 (by similar to 115%) in rat renal myofibroblasts (all p<0.01 vs untreated cells) over 72 hours. The relaxin-induced up-regulation of these MMPs, however, was significantly blocked by a non-selective NOS inhibitor (L-nitroarginine methyl ester (hydrochloride); L-NAME; 75-100 mu M), and specific inhibitors to nNOS (N-propyl-L-arginine; NPLA; 0.2-2 mu M), iNOS (1400W; 0.5-1 mu M) and guanylyl cyclase (ODQ; 5 mu M) (all p<0.05 vs H2 relaxin alone), but not eNOS (L-N-(1-iminoethyl) ornithine dihydrochloride; L-NIO; 0.5-5 mu M). However, neither of these inhibitors affected basal MMP expression at the concentrations used. Furthermore, of the NOS isoforms expressed in renal myofibroblasts (nNOS and iNOS), H2 relaxin only stimulated nNOS expression, which in turn, was blocked by the ERK1/2 inhibitor (PD98059; 1 mu M). These findings demonstrated that H2 relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to mediate its anti-fibrotic actions, and additionally signals through iNOS to up-regulate MMPs; the latter being suppressed by TGF-beta 1 in myofibroblasts, but released upon H2 relaxin-induced inhibition of the TGF-beta 1/Smad2 axis.	[Chow, Bryna Suet Man; Chew, Elaine Guo Yan; Zhao, Chongxin; Bathgate, Ross A. D.; Samuel, Chrishan S.] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Chow, Bryna Suet Man; Bathgate, Ross A. D.; Samuel, Chrishan S.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Hewitson, Tim D.] Royal Melbourne Hosp, Dept Nephrol, Parkville, Vic 3050, Australia; [Hewitson, Tim D.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Samuel, Chrishan S.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Royal Melbourne Hospital; University of Melbourne; Monash University	Chow, BSM (corresponding author), Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia.	tim.hewitson@mh.org.au; chrishan.samuel@monash.edu	Bathgate, Ross/ABE-6471-2020	Bathgate, Ross/0000-0001-6301-861X; Hewitson, Tim/0000-0002-1994-2423; Chew, Elaine/0000-0001-9763-703X	National Health and Medical Research Council of Australia (NHMRC) [628634]; NHMRC Senior Research Fellowship; National Heart Foundation of Australia/NHMRC; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia/NHMRC(National Health and Medical Research Council (NHMRC) of AustraliaNational Heart Foundation of Australia); Victorian Government's Operational Infrastructure Support Program	This study was supported by a National Health and Medical Research Council of Australia (NHMRC) Project Grant (628634) to Chrishan S. Samuel and Tim D. Hewitson; a NHMRC Senior Research Fellowship to Ross A. D. Bathgate; a National Heart Foundation of Australia/NHMRC R. D. Wright Fellowship to Chrishan S. Samuel; and by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Baccari MC, 2005, ANN NY ACAD SCI, V1041, P308, DOI 10.1196/annals.1282.047; Bani D, 1998, HYPERTENSION, V31, P1240, DOI 10.1161/01.HYP.31.6.1240; Bathgate RAD, 2006, BIOCHEMISTRY-US, V45, P1043, DOI 10.1021/bi052233e; Bathgate RAD, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P679; Becker GJ, 2000, CURR OPIN NEPHROL HY, V9, P133, DOI 10.1097/00041552-200003000-00006; Bennett RG, 2003, BIOCHEM PHARMACOL, V66, P867, DOI 10.1016/S0006-2952(03)00403-9; Bennett RG, 2009, TRANSL RES, V154, P1, DOI 10.1016/j.trsl.2009.03.007; Conrad KP, 2011, AM J PHYSIOL-REG I, V301, pR267, DOI 10.1152/ajpregu.00156.2011; Diamond JR, 1998, SEMIN NEPHROL, V18, P594; Du XJ, 2010, NAT REV CARDIOL, V7, P48, DOI 10.1038/nrcardio.2009.198; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Ferreira VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004845; Filippin LI, 2011, NITRIC OXIDE-BIOL CH, V24, P43, DOI 10.1016/j.niox.2010.11.003; Franchi A, 2002, CANCER-AM CANCER SOC, V95, P1902, DOI 10.1002/cncr.10916; Franklin TJ, 1997, INT J BIOCHEM CELL B, V29, P79, DOI 10.1016/S1357-2725(96)00121-5; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Hewitson TD, 2010, ENDOCRINOLOGY, V151, P4938, DOI 10.1210/en.2010-0286; Hossain MA, 2011, J BIOL CHEM, V286, P37555, DOI 10.1074/jbc.M111.282194; Hossain MA, 2011, BIOCHEMISTRY-US, V50, P1368, DOI 10.1021/bi1013968; Huang XW, 2011, AM J PATHOL, V179, P2751, DOI 10.1016/j.ajpath.2011.08.018; Jeyabalan A, 2007, ADV EXP MED BIOL, V612, P65; JUNQUERO DC, 1992, J PHYSIOL-LONDON, V454, P451, DOI 10.1113/jphysiol.1992.sp019273; Kang EH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3218; Lekgabe ED, 2005, HYPERTENSION, V46, P412, DOI 10.1161/01.HYP.0000171930.00697.2f; Li YY, 2000, CARDIOVASC RES, V46, P214, DOI 10.1016/S0008-6363(00)00003-1; Masini E, 2002, BRIT J PHARMACOL, V137, P337, DOI 10.1038/sj.bjp.0704879; Masterson R, 2004, NEPHROL DIAL TRANSPL, V19, P544, DOI 10.1093/ndt/gfg598; McGuane JT, 2011, ENDOCRINOLOGY, V152, P2786, DOI 10.1210/en.2010-1126; Miyazaki D, 2011, HUM MOL GENET, V20, P1787, DOI 10.1093/hmg/ddr062; MONCADA S, 1991, PHARMACOL REV, V43, P109; Mookerjee I, 2009, FASEB J, V23, P1219, DOI 10.1096/fj.08-120857; Moore XL, 2007, ENDOCRINOLOGY, V148, P1582, DOI 10.1210/en.2006-1324; Mu XD, 2010, AM J PATHOL, V177, P2399, DOI 10.2353/ajpath.2010.091121; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Naqvi T, 2005, ARTHRITIS RES THER, V7, pR1, DOI 10.1186/ar1451; Nistri Silvia, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P101, DOI 10.2174/187152507780363179; Palejwala S, 2001, ENDOCRINOLOGY, V142, P3405, DOI 10.1210/en.142.8.3405; Persichini T, 2006, ANTIOXID REDOX SIGN, V8, P949, DOI 10.1089/ars.2006.8.949; Pini A, 2010, J PHARMACOL EXP THER, V335, P589, DOI 10.1124/jpet.110.170977; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; RODEMANN HP, 1990, P SOC EXP BIOL MED, V195, P57; Royce SG, 2009, ENDOCRINOLOGY, V150, P2692, DOI 10.1210/en.2008-1457; Samuel CS, 2007, CELL MOL LIFE SCI, V64, P1539, DOI 10.1007/s00018-007-6543-y; Samuel CS, 2008, ENDOCRINOLOGY, V149, P3286, DOI 10.1210/en.2008-0250; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Samuel CS, 2002, FASEB J, V16, P121, DOI 10.1096/fj.02-0449fje; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Teichman SL, 2009, HEART FAIL REV, V14, P321, DOI 10.1007/s10741-008-9129-3; Unemori EN, 2000, WOUND REPAIR REGEN, V8, P361, DOI 10.1111/j.1524-475X.2000.00361.x; UNEMORI EN, 1990, J BIOL CHEM, V265, P10681; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; VODOVOTZ Y, 1993, J EXP MED, V178, P605, DOI 10.1084/jem.178.2.605; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P510; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zhang HY, 1999, AM J RESP CELL MOL, V21, P658, DOI 10.1165/ajrcmb.21.6.3720	61	79	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42714	10.1371/journal.pone.0042714	http://dx.doi.org/10.1371/journal.pone.0042714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936987	Green Published, gold			2022-12-25	WOS:000308286300023
J	Pasto, A; Marchesi, M; Diamantini, A; Frasson, C; Curtarello, M; Lago, C; Pilotto, G; Parenti, AR; Esposito, G; Agostini, M; Nitti, D; Amadori, A				Pasto, Anna; Marchesi, Maddalena; Diamantini, Adamo; Frasson, Chiara; Curtarello, Matteo; Lago, Claudia; Pilotto, Giorgia; Parenti, Anna Rosita; Esposito, Giovanni; Agostini, Marco; Nitti, Donato; Amadori, Alberto			PKH26 Staining Defines Distinct Subsets of Normal Human Colon Epithelial Cells at Different Maturation Stages	PLOS ONE			English	Article							CANCER STEM-CELLS; SMALL-INTESTINE; IN-VITRO; MARKERS; POPULATIONS; EXPRESSION; DIVISIONS; SKIN	Background and Aim: Colon crypts are characterized by a hierarchy of cells distributed along the crypt axis. Aim of this paper was to develop an in vitro system for separation of epithelial cell subsets in different maturation stages from normal human colon. Methodology and Major Findings: Dissociated colonic epithelial cells were stained with PKH26, which allows identification of distinct populations based on their proliferation rate, and cultured in vitro in the absence of serum. The cytofluorimetric expression of CK20, Msi-1 and Lgr5 was studied. The mRNA levels of several stemness-associated genes were also compared in cultured cell populations and in three colon crypt populations isolated by microdissection. A PKHpos population survived in culture and formed spheroids; this population included subsets with slow (PKHhigh) and rapid (PKHlow) replicative rates. Molecular analysis revealed higher mRNA levels of both Msi-1 and Lgr-5 in PKHhigh cells; by cytofluorimetric analysis, Msi-1(+)/Lgr5(+) cells were only found within PKHhigh cells, whereas Msi-1(+)/Lgr5(-) cells were also observed in the PKHlow population. As judged by qRT-PCR analysis, the expression of several stemness-associated markers (Bmi-1, EphB2, EpCAM, ALDH1) was highly enriched in Msi-1(+)/Lgr5(+) cells. While CK20 expression was mainly found in PKHlow and PKHneg cells, a small PKHhigh subset co-expressed both CK20 and Msi-1, but not Lgr5; cells with these properties also expressed Mucin, and could be identified in vivo in colon crypts. These results mirrored those found in cells isolated from different crypt portions by microdissection, and based on proliferation rates and marker expression they allowed to define several subsets at different maturation stages: PKHhigh/Lgr5(+)/Msi-1(+)/CK20(-), PKHhigh/Lgr5(-)/Msi-1(+)/CK20(+), PKHlow/Lgr5(-)/Msi-1(+)/Ck20(-), and PKHlow/Lgr5(-)/Msi-1(-)/CK20(+) cells. Conclusions: Our data show the possibility of deriving in vitro, without any selection strategy, several distinct cell subsets of human colon epithelial cells, which recapitulate the phenotypic and molecular profile of cells in a discrete crypt location.	[Pasto, Anna; Marchesi, Maddalena; Diamantini, Adamo; Lago, Claudia; Pilotto, Giorgia; Agostini, Marco; Nitti, Donato; Amadori, Alberto] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Frasson, Chiara] Univ Padua, Dept Pediat, Hematooncol Lab, Padua, Italy; [Curtarello, Matteo; Esposito, Giovanni; Amadori, Alberto] IRCCS Ist Oncol Veneto, Padua, Italy; [Parenti, Anna Rosita] Univ Padua, Dept Diagnost Sci & Special Therapies, Padua, Italy	University of Padua; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua	Pasto, A (corresponding author), Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy.	albido@unipd.it	Curtarello, Matteo/P-8120-2019; agostini, marco/AAC-3408-2019; agostini, marco ma/K-2449-2018; Curtarello, Matteo/K-4021-2016	Curtarello, Matteo/0000-0003-3133-4807; agostini, marco/0000-0001-7578-1233; agostini, marco ma/0000-0001-7578-1233; Curtarello, Matteo/0000-0003-3133-4807; Esposito, Giovanni/0000-0003-1019-6476; , Anna/0000-0002-5783-0668	Associazione Italiana per la Ricerca sul Cancro (AIRC); Ministry of Health; Ministry of Education; PRIN, Regione Veneto	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministry of Health; Ministry of Education; PRIN, Regione Veneto(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC), Ministry of Health, Ministry of Education 60% and PRIN, Regione Veneto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADORI A, 1989, J IMMUNOL, V143, P2146; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Becker L, 2008, THESCIENTIFICWORLDJO, V8, P1168, DOI 10.1100/tsw.2008.148; BJERKNES M, 1981, AM J ANAT, V160, P93, DOI 10.1002/aja.1001600108; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Dangles-Marie V, 2007, J CLIN ONCOL, V25; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Ghisi M, 2011, BLOOD, V117, P7053, DOI 10.1182/blood-2010-12-326629; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; MacNicol AM, 2008, BIOCHEM SOC T, V36, P528, DOI 10.1042/BST0360528; Morrison BJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2111; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Moserle L, 2010, CANCER LETT, V288, P1, DOI 10.1016/j.canlet.2009.05.020; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schulenburg A, 2007, J PATHOL, V213, P152, DOI 10.1002/path.2220; Shaker A, 2010, TRANSL RES, V156, P180, DOI 10.1016/j.trsl.2010.06.003; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Takeda K, 2011, ANTICANCER RES, V31, P263; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	40	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43379	10.1371/journal.pone.0043379	http://dx.doi.org/10.1371/journal.pone.0043379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927961	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300047
J	Peng, H; Wu, YY; Zhang, Y				Peng, Hui; Wu, Yongyan; Zhang, Yong			Efficient Delivery of DNA and Morpholinos into Mouse Preimplantation Embryos by Electroporation	PLOS ONE			English	Article							GENE-TRANSFER; TRANSIENT EXPRESSION; TRANSCRIPTION FACTOR; PLASMID DNA; ZEBRAFISH; SYSTEM; CELLS; RNA; OVO; TRANSFECTION	Mouse preimplantation development is characterized by three major transitions and two lineage segregations. Each transition or lineage segregation entails pronounced changes in the pattern of gene expression. Thus, research into the function of genes with obvious changes in expression pattern will shed light on the molecular basis of preimplantation development. We have described a simplified and effective method-electroporation-of introducing plasmid DNA and morpholinos into mouse preimplantation embryos and verified effectiveness of this approach by testing the procedure on the endogenous gene Oct4. Before electroporation, the zona pellucida was weakened by the treatment of acid Tyrode's solution. Then we optimized the parameters such as voltage, pulse duration, number of pulses and repeats, and applied these parameters to subsequent experiments. Compared with the control groups, the number of apoptotic cells and the expression and localization of OCT3/4 or CDX2 was not significantly changed in blastocysts developed from 1-cell embryos, which were electroporated with pIRES2-AcGFP1-Nuc eukaryotic expression vector or mismatched morpholino oligonucleotides. Furthermore, electroporated plasmid DNA and morpholinos targeting the endogenous gene Oct4 were able to sharply down regulate expression of OCT4 protein and actually cause expected phenotypes in mouse preimplantation embryos. In conclusion, plasmid DNA and morpholinos could be efficient delivered into mouse preimplantation embryos by electroporation and exert their functions, and normal development of preimplantation embryos was not affected.	[Peng, Hui; Wu, Yongyan; Zhang, Yong] NW A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Peng, H (corresponding author), NW A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China.	zhy1956@126.com	Wu, Yongyan/AAH-1471-2019; Zhang, Yong/K-7945-2016	Wu, Yongyan/0000-0003-1669-3860; Zhang, Yong/0000-0001-8642-4071	National Major Project for Production of Transgenic Breeding, People's Republic of China [2011ZX08007-004]	National Major Project for Production of Transgenic Breeding, People's Republic of China	This work was supported by the National Major Project for Production of Transgenic Breeding, People's Republic of China (No. 2011ZX08007-004) (http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu W, 1999, P NATL ACAD SCI USA, V96, P9885, DOI 10.1073/pnas.96.17.9885; Baron S, 2000, J IMMUNOL METHODS, V242, P115, DOI 10.1016/S0022-1759(00)00242-8; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; Buono Russel J., 1992, Molecular Marine Biology and Biotechnology, V1, P271; Cerda GA, 2006, METHODS, V39, P207, DOI 10.1016/j.ymeth.2005.12.009; Coonrod SA, 2001, GENESIS, V30, P198, DOI 10.1002/gene.1065; Das ZC, 2010, CELL REPROGRAM, V12, P95, DOI 10.1089/cell.2009.0068; Eide FF, 2000, FEBS LETT, V486, P29, DOI 10.1016/S0014-5793(00)02124-4; Engstrom PE, 2001, ANTICANCER RES, V21, P1817; Fakhrai H, 1996, P NATL ACAD SCI USA, V93, P2909, DOI 10.1073/pnas.93.7.2909; Foygel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004109; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Gershon E, 2008, DEV BIOL, V313, P1, DOI 10.1016/j.ydbio.2007.08.041; Grabarek JB, 2002, GENESIS, V32, P269, DOI 10.1002/gene.10076; Haraguchi S, 2004, MOL REPROD DEV, V68, P17, DOI 10.1002/mrd.20047; Itasaki N, 1999, NAT CELL BIOL, V1, pE203, DOI 10.1038/70231; Jedrusik A, 2010, DEV BIOL, V344, P66, DOI 10.1016/j.ydbio.2010.04.017; Johnson CW, 2011, DEV BIOL, V357, P269, DOI 10.1016/j.ydbio.2011.06.034; Kamdar K P, 1995, Methods Mol Biol, V48, P239; Kim MH, 2002, BIOCHEM BIOPH RES CO, V296, P1372, DOI 10.1016/S0006-291X(02)02070-3; LAWITTS JA, 1991, J REPROD FERTIL, V91, P543, DOI 10.1530/jrf.0.0910543; Leopold RA, 1996, GENET ANAL-BIOMOL E, V12, P197, DOI 10.1016/1050-3862(96)00136-2; Li HM, 2008, MOL BIOL CELL, V19, P4804, DOI 10.1091/mbc.E08-03-0294; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Mellitzer G, 2002, MECH DEVELOP, V118, P57, DOI 10.1016/S0925-4773(02)00191-0; MONTANO X, 1995, CELL GROWTH DIFFER, V6, P597; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; MULLER F, 1993, FEBS LETT, V324, P27, DOI 10.1016/0014-5793(93)81525-5; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P376, DOI 10.1006/bbrc.1996.5882; Nabti I, 2008, DEV BIOL, V321, P379, DOI 10.1016/j.ydbio.2008.06.036; Nakamura H, 2004, MECH DEVELOP, V121, P1137, DOI 10.1016/j.mod.2004.05.013; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NEMEC L A, 1989, Theriogenology, V31, P233, DOI 10.1016/0093-691X(89)90641-9; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishi T, 1996, CANCER RES, V56, P1050; Osumi N, 2001, METHODS, V24, P35, DOI 10.1006/meth.2001.1154; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161; RICHARDSON JH, 1995, TRENDS BIOTECHNOL, V13, P306, DOI 10.1016/S0167-7799(00)88970-2; Rols MP, 1998, NAT BIOTECHNOL, V16, P168, DOI 10.1038/nbt0298-168; SHEN YM, 1982, MOL CELL BIOL, V2, P1145, DOI 10.1128/MCB.2.9.1145; Smith C, 1992, J Hematother, V1, P155, DOI 10.1089/scd.1.1992.1.155; Su JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023805; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tewari D, 1998, J IMMUNOL, V161, P2642; Timmer J, 2001, GENESIS, V29, P123, DOI 10.1002/gene.1015; Tucker RP, 2001, DEV DYNAM, V222, P115, DOI 10.1002/dvdy.1171; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Wang HH, 2008, DEV BIOL, V318, P112, DOI 10.1016/j.ydbio.2008.03.008; Yamanaka K, 2009, J REPROD DEVELOP, V55, P638, DOI 10.1262/jrd.20245	51	26	28	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43748	10.1371/journal.pone.0043748	http://dx.doi.org/10.1371/journal.pone.0043748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928027	gold, Green Published, Green Submitted			2022-12-25	WOS:000307789700050
J	St Paul, M; Paolucci, S; Barjesteh, N; Wood, RD; Schat, KA; Sharif, S				St Paul, Michael; Paolucci, Sarah; Barjesteh, Neda; Wood, R. Darren; Schat, Karel A.; Sharif, Shayan			Characterization of Chicken Thrombocyte Responses to Toll-Like Receptor Ligands	PLOS ONE			English	Article							DENDRITIC CELLS; ACTIVATED PLATELETS; T-CELLS; EXPRESSION; LIPOPOLYSACCHARIDE; OLIGONUCLEOTIDES; SALMONELLA; INDUCTION; DISTINCT; SUBSETS	Thrombocytes are the avian equivalent to mammalian platelets. In addition to their hemostatic effects, mammalian platelets rely in part on pattern recognition receptors, such as the Toll-like receptors (TLR), to detect the presence of pathogens and signal the release of certain cytokines. Ligands for TLRs include lipopolysaccharide (LPS), which is bound by TLR4, as well as unmethylated CpG DNA motifs, which are bound by TLR9 in mammals and TLR21 in chickens. Similar to mammalian platelets, avian thrombocytes have been shown to express TLR4 and secrete some pro-inflammatory cytokines in response to LPS treatment. However, the full extent of the contributions made by thrombocytes to host immunity has yet to be elucidated. Importantly, the mechanisms by which TLR stimulation may modulate thrombocyte effector functions have not been well characterized. As such, the objective of the present study was to gain further insight into the immunological role of thrombocytes by analyzing their responses to treatment with ligands for TLR4 and TLR21. To this end, we quantified the relative expression of several immune system genes at 1, 3, 8 and 18 hours post-treatment using real-time RT-PCR. Furthermore, production of nitric oxide and phagocytic activity of thrombocytes was measured after their activation with TLR ligands. We found that thrombocytes constitutively express transcripts for both pro-and anti-inflammatory cytokines, in addition to those associated with anti-viral responses and antigen presentation. Moreover, we found that both LPS and CpG oligodeoxynucleotides (ODN) induced robust pro-inflammatory responses in thrombocytes, as characterized by more than 100 fold increase in interleukin (IL)-1 beta, IL-6 and IL-8 transcripts, while only LPS enhanced nitric oxide production and phagocytic capabilities. Future studies may be aimed at examining the responses of thrombocytes to other TLR ligands.	[St Paul, Michael; Paolucci, Sarah; Barjesteh, Neda; Wood, R. Darren; Sharif, Shayan] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada; [Schat, Karel A.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	University of Guelph; Cornell University	St Paul, M (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada.	shayan@uoguelph.ca		St. Paul, Michael/0000-0002-5213-6415	Natural Sciences and Engineering Research Council of Canada; Poultry Industry Council; Ontario Ministry of Agriculture, Food and Rural Affairs	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Poultry Industry Council; Ontario Ministry of Agriculture, Food and Rural Affairs	This research was funded by the Natural Sciences and Engineering Research Council of Canada, Poultry Industry Council, and Ontario Ministry of Agriculture, Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Brown GT, 2011, J IMMUNOL, V186, P5489, DOI 10.4049/jimmunol.1001623; CARLSON HC, 1968, AVIAN DIS, V12, P700, DOI 10.2307/1588457; CHANG CF, 1979, J RETICULOENDOTH SOC, V25, P585; Ciraci C, 2011, DEV COMP IMMUNOL, V35, P392, DOI 10.1016/j.dci.2010.11.012; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Ferdous F, 2008, POULTRY SCI, V87, P61, DOI 10.3382/ps.2007-00356; GRANT RA, 1973, AM J PHYSIOL, V225, P340, DOI 10.1152/ajplegacy.1973.225.2.340; He HQ, 2006, MOL IMMUNOL, V43, P783, DOI 10.1016/j.molimm.2005.07.002; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Iqbal M, 2005, VET IMMUNOL IMMUNOP, V104, P117, DOI 10.1016/j.vetimm.2004.11.003; Karpala AJ, 2011, J INTERF CYTOK RES, V31, P393, DOI 10.1089/jir.2010.0069; Keestra AM, 2010, J IMMUNOL, V185, P460, DOI 10.4049/jimmunol.0901921; Kogut MH, 2005, DEV COMP IMMUNOL, V29, P791, DOI 10.1016/j.dci.2005.02.002; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; KUNICKI TJ, 1985, P NATL ACAD SCI USA, V82, P7319, DOI 10.1073/pnas.82.21.7319; Liang SL, 2006, IUBMB LIFE, V58, P508, DOI 10.1080/15216540600838232; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Ling Y, 2007, EUR J HAEMATOL, V79, P310, DOI 10.1111/j.1600-0609.2007.00917.x; MacKinnon KM, 2009, VET IMMUNOL IMMUNOP, V127, P371, DOI 10.1016/j.vetimm.2008.10.001; Meng SS, 2011, J INTERF CYTOK RES, V31, P533, DOI 10.1089/jir.2010.0123; Moser B, 2006, TRENDS IMMUNOL, V27, P112, DOI 10.1016/j.it.2006.01.002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SALOMONSENJ, 1991, P NATL ACAD SCI USA, V88, P1359, DOI 10.1073/pnas.88.4.1359; Schat KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030960; Scott T, 2008, MOL IMMUNOL, V45, P1001, DOI 10.1016/j.molimm.2007.07.035; Seliger C, 2012, VET IMMUNOL IMMUNOP, V145, P86, DOI 10.1016/j.vetimm.2011.10.010; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Senn JJ, 2005, J PHARMACOL EXP THER, V314, P972, DOI 10.1124/jpet.105.084004; St Paul M, 2011, VET IMMUNOL IMMUNOP, V144, P228, DOI 10.1016/j.vetimm.2011.09.004; Tregaskes CA, 2005, DEV COMP IMMUNOL, V29, P361, DOI 10.1016/j.dci.2004.09.001; Villanueva AI, 2011, DEV COMP IMMUNOL, V35, P28, DOI 10.1016/j.dci.2010.08.001; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; Wigley P, 1999, AVIAN PATHOL, V28, P567, DOI 10.1080/03079459994353; Wu ZG, 2010, IMMUNOLOGY, V129, P133, DOI 10.1111/j.1365-2567.2009.03129.x	36	54	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43381	10.1371/journal.pone.0043381	http://dx.doi.org/10.1371/journal.pone.0043381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916253	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800062
J	Ve, T; Mathisen, K; Helland, R; Karlsen, OA; Fjellbirkeland, A; Rohr, AK; Andersson, KK; Pedersen, RB; Lillehaug, JR; Jensen, HB				Ve, Thomas; Mathisen, Karina; Helland, Ronny; Karlsen, Odd A.; Fjellbirkeland, Anne; Rohr, Asmund K.; Andersson, K. Kristoffer; Pedersen, Rolf-Birger; Lillehaug, Johan R.; Jensen, Harald B.			The Methylococcus capsulatus (Bath) Secreted Protein, MopE*, Binds Both Reduced and Oxidized Copper	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; PARTICULATE METHANE MONOOXYGENASE; STRUCTURAL IMPLICATIONS; METHANOBACTIN; MEMBRANE; SITES; SPECTRA; COMPLEXES; SURFACE; ION	Under copper limiting growth conditions the methanotrophic bacterium Methylococcus capsulatus (Bath) secrets essentially only one protein, MopE*, to the medium. MopE* is a copper-binding protein whose structure has been determined by X-ray crystallography. The structure of MopE* revealed a unique high affinity copper binding site consisting of two histidine imidazoles and one kynurenine, the latter an oxidation product of Trp130. In this study, we demonstrate that the copper ion coordinated by this strong binding site is in the Cu(I) state when MopE* is isolated from the growth medium of M. capsulatus. The conclusion is based on X-ray Near Edge Absorption spectroscopy (XANES), and Electron Paramagnetic Resonance (EPR) studies. EPR analyses demonstrated that MopE*, in addition to the strong copper-binding site, also binds Cu(II) at two weaker binding sites. Both Cu(II) binding sites have properties typical of non-blue type II Cu (II) centres, and the strongest of the two Cu(II) sites is characterised by a relative high hyperfine coupling of copper (A(parallel to) = 20 mT). Immobilized metal affinity chromatography binding studies suggests that residues in the N-terminal part of MopE* are involved in forming binding site(s) for Cu(II) ions. Our results support the hypothesis that MopE plays an important role in copper uptake, possibly making use of both its high (Cu(I) and low Cu(II) affinity properties.	[Ve, Thomas; Karlsen, Odd A.; Fjellbirkeland, Anne; Lillehaug, Johan R.; Jensen, Harald B.] Univ Bergen, Dept Mol Biol, Bergen, Norway; [Mathisen, Karina] Norwegian Univ Sci & Technol, Dept Chem, N-7034 Trondheim, Norway; [Helland, Ronny] Univ Tromso, Fac Sci, Norwegian Struct Biol Ctr, Tromso, Norway; [Rohr, Asmund K.; Andersson, K. Kristoffer] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Pedersen, Rolf-Birger] Univ Bergen, Dept Earth Sci, Ctr Geobiol, Bergen, Norway; [Ve, Thomas] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Bergen; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University of Oslo; University of Bergen; University of Queensland	Ve, T (corresponding author), Univ Bergen, Dept Mol Biol, Bergen, Norway.	harald.jensen@mbi.uib.no	Kjendseth, Åsmund Røhr/O-2543-2016; Ve, Thomas/AEK-1006-2022; Mathisen, Karina/I-3772-2013; Ve, Thomas/F-9820-2011	Kjendseth, Åsmund Røhr/0000-0002-4956-4865; Ve, Thomas/0000-0002-0113-1905; Mathisen, Karina/0000-0001-8199-7559	Functional Genomics Program (FUGE) of the Research Council of Norway (RCN); NRC [101742]; RCN [177661/V30, 214239/F20]; EMBIO program at University of Oslo	Functional Genomics Program (FUGE) of the Research Council of Norway (RCN); NRC(National Research Centre (NRC)); RCN; EMBIO program at University of Oslo	The study was supported by the Functional Genomics Program (FUGE) (www.fuge.no) of the Research Council of Norway (RCN), by NRC Grant 101742 to OAK, by RCN Grant 177661/V30 and 214239/F20 to KKA, and by the EMBIO program at University of Oslo to AKR, by RCN to RH for provision of beam time at the Swiss-Norwegian Beamlines, European Synchrotron Radiation Facility, Grenoble, France, and for travel support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesano F, 2003, P NATL ACAD SCI USA, V100, P3814, DOI 10.1073/pnas.0636904100; Balasubramanian R, 2008, CURR OPIN CHEM BIOL, V12, P245, DOI 10.1016/j.cbpa.2008.01.043; Basu P, 2003, BIOCHEM J, V369, P417, DOI 10.1042/BJ20020823; Boas JF, 2008, EUR BIOPHYS J BIOPHY, V37, P281, DOI 10.1007/s00249-008-0261-8; BROWN GM, 1969, ACTA CRYSTALL B-STRU, VB 25, P676, DOI 10.1107/S0567740869002810; Burns CS, 2002, BIOCHEMISTRY-US, V41, P3991, DOI 10.1021/bi011922x; Cereghetti GM, 2004, J BIOL CHEM, V279, P36497, DOI 10.1074/jbc.M404341200; Choi DW, 2008, J INORG BIOCHEM, V102, P1571, DOI 10.1016/j.jinorgbio.2008.02.003; Choi DW, 2010, J INORG BIOCHEM, V104, P1240, DOI 10.1016/j.jinorgbio.2010.08.002; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; Choi DW, 2005, MICROBIOL-SGM, V151, P3417, DOI 10.1099/mic.0.28169-0; Choi DW, 2006, BIOCHEMISTRY-US, V45, P1442, DOI 10.1021/bi051815t; COOKSEY DA, 1994, FEMS MICROBIOL REV, V14, P381, DOI 10.1016/0168-6445(94)90056-6; DiSpirito AA, 1998, J BACTERIOL, V180, P3606, DOI 10.1128/JB.180.14.3606-3613.1998; Douzou P, 1978, Adv Protein Chem, V32, P77, DOI 10.1016/S0065-3233(08)60575-6; Dudzik CG, 2011, BIOCHEMISTRY-US, V50, P1771, DOI 10.1021/bi101912q; Fee J A, 1978, Methods Enzymol, V49, P512; FISCHER BE, 1979, EUR J BIOCHEM, V94, P523, DOI 10.1111/j.1432-1033.1979.tb12921.x; FITCH MW, 1993, APPL ENVIRON MICROB, V59, P2771, DOI 10.1128/AEM.59.9.2771-2776.1993; Fjellbirkeland A, 1997, ARCH MICROBIOL, V168, P128, DOI 10.1007/s002030050478; Fjellbirkeland A, 2001, ARCH MICROBIOL, V176, P197, DOI 10.1007/s002030100307; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Hatcher LQ, 2008, J PHYS CHEM B, V112, P8160, DOI 10.1021/jp710806s; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; Helland R, 2008, J BIOL CHEM, V283, P13897, DOI 10.1074/jbc.M800340200; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Hureau C, 2008, J BIOL INORG CHEM, V13, P1055, DOI 10.1007/s00775-008-0389-0; Karlsen OA, 2008, MOL MICROBIOL, V70, P15, DOI 10.1111/j.1365-2958.2008.06380.x; Karlsen OA, 2005, FEBS J, V272, P2428, DOI 10.1111/j.1742-4658.2005.04663.x; Karlsen OA, 2005, FEBS J, V272, P6324, DOI 10.1111/j.1742-4658.2005.05020.x; Karlsen OA, 2003, APPL ENVIRON MICROB, V69, P2386, DOI 10.1128/AEM.69.4.2386-2388.2003; Karlsen OA, 2011, FEMS MICROBIOL LETT, V323, P97, DOI 10.1111/j.1574-6968.2011.02365.x; Katterle B, 2002, BIOCHEM J, V363, P677, DOI 10.1042/0264-6021:3630677; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Kim HJ, 2005, BIOCHEMISTRY-US, V44, P5140, DOI 10.1021/bi047367r; Koch KA, 1997, CHEM BIOL, V4, P549, DOI 10.1016/S1074-5521(97)90241-6; LAMBLE G, 1994, J CHEM SOC FARADAY T, V90, P2211, DOI 10.1039/ft9949002211; LEIGH JS, 1971, J PHYS CHEM-US, V75, P1202, DOI 10.1021/j100679a003; Lieberman RL, 2006, INORG CHEM, V45, P8372, DOI 10.1021/ic060739v; Mash HE, 2003, ANAL CHEM, V75, P671, DOI 10.1021/ac0261101; More C, 1999, BIOSPECTROSCOPY, V5, pS3, DOI 10.1002/(SICI)1520-6343(1999)5:5+<S3::AID-BSPY2>3.0.CO;2-P; Murrell JC, 2000, TRENDS MICROBIOL, V8, P221, DOI 10.1016/S0966-842X(00)01739-X; Narindrasorasak S, 2007, BIOCHEMISTRY-US, V46, P3116, DOI 10.1021/bi0620656; Nielsen AK, 1996, MICROBIOL-UK, V142, P1289, DOI 10.1099/13500872-142-5-1289; Nielsen AK, 1997, MOL MICROBIOL, V25, P399, DOI 10.1046/j.1365-2958.1997.4801846.x; PALMER G, 2000, PHYS METHODS BIOINOR, P121; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; RESTORI R, 1986, ACTA CRYSTALLOGR B, V42, P201, DOI 10.1107/S0108768186098336; ROSS RT, 1965, J CHEM PHYS, V42, P3919, DOI 10.1063/1.1695859; Sawada T, 1996, CHEM PHARM BULL, V44, P1009; SCHOLL HJ, 1992, J PHYS CHEM-US, V96, P9684, DOI 10.1021/j100203a023; Semrau JD, 2010, FEMS MICROBIOL REV, V34, P496, DOI 10.1111/j.1574-6976.2010.00212.x; SKOTLAND T, 1980, EUR J BIOCHEM, V103, P5, DOI 10.1111/j.1432-1033.1980.tb04282.x; SOLOMON EI, 1992, CHEM REV, V92, P521, DOI 10.1021/cr00012a003; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Strausak D, 2003, J BIOL CHEM, V278, P20821, DOI 10.1074/jbc.M212437200; Tellez CM, 1998, APPL ENVIRON MICROB, V64, P1115; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Vunnum S, 1997, BIOTECHNOL BIOENG, V54, P373, DOI 10.1002/(SICI)1097-0290(19970520)54:4<373::AID-BIT11>3.0.CO;2-H; Wernimont AK, 2004, J BIOL CHEM, V279, P12269, DOI 10.1074/jbc.M311213200; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P205, DOI 10.1099/00221287-61-2-205; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Zahn JA, 1996, J BACTERIOL, V178, P1018, DOI 10.1128/jb.178.4.1018-1029.1996; Zhang Q, 2003, GENE, V318, P45, DOI 10.1016/S0378-1119(03)00753-4	67	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43146	10.1371/journal.pone.0043146	http://dx.doi.org/10.1371/journal.pone.0043146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916218	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800049
J	Yan, NH; Liao, X; Cai, SP; Lan, CJ; Wang, Y; Zhou, XM; Yin, Y; Yu, WH; Liu, XY				Yan, Naihong; Liao, Xuan; Cai, Su-Ping; Lan, Changjun; Wang, Yun; Zhou, Xiaomin; Yin, Yan; Yu, Wenhan; Liu, Xuyang			A Novel Nonsense Mutation of the GPR143 Gene Identified in a Chinese Pedigree with Ocular Albinism	PLOS ONE			English	Article							LINKED CONGENITAL NYSTAGMUS; OA1 GENE; FAMILY; TYPE-1; DELETION; SYSTEM; TIME	Background: The purpose of this study was to elucidate the molecular basis of ocular albinism type I in a Chinese pedigree. Methodology/Principal Findings: Complete ophthalmologic examinations were performed on 4 patients, 7 carriers and 17 unaffected individuals in this five-generation family. All coding exons of four-point-one (4.1), ezrin, radixin, moesin (FERM) domain-containing 7 (FRMD7) and G protein-coupled receptor 143 (GPR143) genes were amplified by polymerase chain reaction (PCR), sequenced and compared with a reference database. Ocular albinism and nystagmus were found in all patients of this family. Macular hypoplasia was present in the patients including the proband. A novel nonsense hemizygous mutation c.807T>A in the GPR143 gene was identified in four patients and the heterozygous mutation was found in seven asymptomatic individuals. This mutation is a substitution of tyrosine for adenine which leads to a premature stop codon at position 269 (p.Y269X) of GPR143. Conclusions/Significance: This is the first report that p.Y269X mutation of GPR143 gene is responsible for the pathogenesis of familial ocular albinism. These results expand the mutation spectrum of GPR143, and demonstrate the clinical characteristics of ocular albinism type I in Chinese population.	[Yan, Naihong; Liao, Xuan; Wang, Yun; Zhou, Xiaomin; Yin, Yan; Yu, Wenhan] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Ophthalm Labs,Dept Ophthalmol,Translat Neurosci C, Chengdu 610064, Peoples R China; [Liao, Xuan; Lan, Changjun] N Sichuan Med Coll, Dept Ophthalmol, Nanchong, Peoples R China; [Cai, Su-Ping; Liu, Xuyang] Jinan Univ, Shenzhen Eye Hosp, Shenzhen, Peoples R China	Sichuan University; North Sichuan Medical University; Jinan University	Yan, NH (corresponding author), Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Ophthalm Labs,Dept Ophthalmol,Translat Neurosci C, Chengdu 610064, Peoples R China.	xliu1213@yahoo.com.cn		XUAN, LIAO/0000-0003-0097-684X; Yu, Wenhan/0000-0002-0125-4358	National Natural Science Foundation of China (NSFC) [30901635, 81000370]; Research to Prevent Blindness	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by grants from the National Natural Science Foundation of China (NSFC grant no. 30901635 and 81000370), from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSI MT, 1995, NAT GENET, V10, P13, DOI 10.1038/ng0595-13; Camand Olivier, 2003, Ophthalmic Genet, V24, P167, DOI 10.1076/opge.24.3.167.15605; CHARLES SJ, 1993, BRIT J OPHTHALMOL, V77, P222, DOI 10.1136/bjo.77.4.222; CREEL D, 1978, SCIENCE, V201, P931, DOI 10.1126/science.684419; d'Addio M, 2000, HUM MOL GENET, V9, P3011, DOI 10.1093/hmg/9.20.3011; Fang SH, 2008, MOL VIS, V14, P1974; Faugere V, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-1; Ilia M, 1999, J COMP NEUROL, V405, P394, DOI 10.1002/(SICI)1096-9861(19990315)405:3<394::AID-CNE9>3.0.CO;2-Y; Ilia M, 2000, J COMP NEUROL, V420, P437; Kerrison JB, 1999, AM J HUM GENET, V64, P600, DOI 10.1086/302244; Liu JY, 2007, J HUM GENET, V52, P565, DOI 10.1007/s10038-007-0152-3; Lopez VM, 2008, PLOS BIOL, V6, P1861, DOI 10.1371/journal.pbio.0060236; Mayeur H, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-41; ODONNELL FE, 1976, ARCH OPHTHALMOL-CHIC, V94, P1883, DOI 10.1001/archopht.1976.03910040593001; ODONNELL FE, 1978, ARCH OPHTHALMOL-CHIC, V96, P1189, DOI 10.1001/archopht.1978.03910060023005; Oetting WS, 2002, HUM MUTAT, V19, P85, DOI 10.1002/humu.10034; Peng YY, 2009, MOL VIS, V15, P810; Preising M, 2001, BRIT J OPHTHALMOL, V85, P1098, DOI 10.1136/bjo.85.9.1098; Preising MN, 2011, MOL VIS, V17, P939; Rosenberg T, 1998, EUR J HUM GENET, V6, P570, DOI 10.1038/sj.ejhg.5200226; Schiaffino MV, 1999, NAT GENET, V23, P108, DOI 10.1038/12715; SCHIAFFINO MV, 1995, HUM MOL GENET, V4, P2319, DOI 10.1093/hmg/4.12.2319; Schnur RE, 1998, AM J HUM GENET, V62, P800, DOI 10.1086/301776; Schorderet Daniel F, 2007, Hum Mutat, V28, P525, DOI 10.1002/humu.9492; Zhou PT, 2008, MOL VIS, V14, P1015	25	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43177	10.1371/journal.pone.0043177	http://dx.doi.org/10.1371/journal.pone.0043177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916221	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800051
J	El Hage, C; Rappeneau, V; Etievant, A; Morel, AL; Scarna, H; Zimmer, L; Berod, A				El Hage, Cynthia; Rappeneau, Virginie; Etievant, Adeline; Morel, Anne-Laure; Scarna, Helene; Zimmer, Luc; Berod, Anne			Enhanced Anxiety Observed in Cocaine Withdrawn Rats Is Associated with Altered Reactivity of the Dorsomedial Prefrontal Cortex	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; CORTICOTROPIN-RELEASING-FACTOR; VENTRAL TEGMENTAL AREA; PRELIMBIC CORTEX; ACTIVATION PATTERNS; CENTRAL INJECTIONS; RESTRAINT STRESS; EXTENDED ACCESS; FOS EXPRESSION; DRUG-ADDICTION	Discontinuation of drug intake in cocaine abusers commonly produces a variety of adverse withdrawal symptoms among which anxiety and depression-related behavior are prevailing during the initial period of abstinence. The aim of this study was to provide further insight into the neurobiological dysregulations that might contribute to these pathological states. Rats were treated with cocaine or saline for 14 days (20 mg/kg; i.p) and anxiety-related behavior was assessed in different paradigms (elevated plus-maze (EPM), confinement to an open arm of the EPM and shock-probe burying tests) for up to 4 weeks after withdrawal. Depression-like behavior was assessed by the forced swim test and sucrose preference test. Altogether our results demonstrated that cocaine withdrawal induced persistent heightened levels of anxiety that last for at least 28 days but did not affect depression-like behavior. We then used Fos immunohistochemistry to map neuronal activation patterns in withdrawn rats confined to one open arm of an EPM, and a double labeling procedure using Fos immunohistochemistry and in situ hybridization of glutamic acid decarboxylase or vesicular glutamate transporter mRNAs to identify the phenotype of the activated neurons. Our data showed that the exacerbated anxiety observed in cocaine withdrawn rats exposed to an elevated open arm was accompanied by an altered reactivity of the dorsal part of the medial prefrontal cortex (anterior cingulate and dorsal prelimbic cortices), the paraventricular thalamic nucleus and the lateral and anterior areas of the hypothalamus. In the medial prefrontal cortex, we evidenced a negative correlation between Fos expression in its dorsal part and open arm-induced freezing in NaCl-treated rats but not in cocaine withdrawn rats. We also found that more than 65% of activated neurons were glutamatergic projection neurons. The present study provides new insights into the neuroanatomical regions and neuronal cell types that may underlie pathological anxiety during cocaine withdrawal.	[El Hage, Cynthia; Rappeneau, Virginie; Morel, Anne-Laure; Berod, Anne] INSERM, U1028, Lyon Neurosci Res Ctr, Physiopathol Neuronal Network Responsible Sleep W, F-69008 Lyon, France; [El Hage, Cynthia; Rappeneau, Virginie; Morel, Anne-Laure; Berod, Anne] CNRS, UMR5292, Lyon Neurosci Res Ctr, Physiopathol Neuronal Network Responsible Sleep W, Lyon, France; [Zimmer, Luc] INSERM, U1028, Lyon Neurosci Res Ctr, BioRan Pharmaceut & Neurochem Biomarkers Team, F-69008 Lyon, France; [El Hage, Cynthia; Rappeneau, Virginie; Etievant, Adeline; Morel, Anne-Laure; Scarna, Helene; Zimmer, Luc; Berod, Anne] Univ Lyon 1, F-69365 Lyon, France; [Zimmer, Luc] CNRS, UMR5292, Lyon Neurosci Res Ctr, BioRan Pharmaceut & Neurochem Biomarkers Team, Lyon, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	El Hage, C (corresponding author), INSERM, U1028, Lyon Neurosci Res Ctr, Physiopathol Neuronal Network Responsible Sleep W, F-69008 Lyon, France.	anne.berod@univ-lyon1.fr	ZIMMER, Luc/G-6538-2011; ZIMMER, Luc/AAG-1986-2019	ZIMMER, Luc/0000-0002-2805-7098; ZIMMER, Luc/0000-0002-2805-7098; Etievant, Adeline/0000-0002-2577-6724; MOREL, Anne-Laure/0000-0001-7200-1123	Universite Claude Bernard Lyon I, Centre National pour la Recherche Scientifique et la Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie; la Societe Francaise de Pharmacologie et de Therapeutique	Universite Claude Bernard Lyon I, Centre National pour la Recherche Scientifique et la Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie; la Societe Francaise de Pharmacologie et de Therapeutique	This work was supported by several grants from the Universite Claude Bernard Lyon I, Centre National pour la Recherche Scientifique et la Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie. CE was supported by la Societe Francaise de Pharmacologie et de Therapeutique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechet-Souza L, 2009, NEUROSCIENCE, V164, P387, DOI 10.1016/j.neuroscience.2009.08.038; Aujla H, 2008, NEUROPSYCHOPHARMACOL, V33, P1818, DOI 10.1038/sj.npp.1301588; Basso AM, 1999, PSYCHOPHARMACOLOGY, V145, P21, DOI 10.1007/s002130051028; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Bowers MS, 2003, EUR J NEUROSCI, V17, P1273, DOI 10.1046/j.1460-9568.2003.02537.x; Canteras NS, 2010, CURR TOP BEHAV NEURO, V2, P77, DOI 10.1007/7854_2009_7; Chaplin TM, 2010, HUM PSYCHOPHARM CLIN, V25, P368, DOI 10.1002/hup.1127; Chartoff E, 2012, NEUROPHARMACOLOGY, V62, P167, DOI 10.1016/j.neuropharm.2011.06.014; Colussi-Mas J, 2007, EUR J NEUROSCI, V26, P1011, DOI 10.1111/j.1460-9568.2007.05738.x; Contoreggi C, 2003, NEUROENDOCRINOLOGY, V78, P154, DOI 10.1159/000072797; D'Souza MS, 2010, CURR TOP BEHAV NEURO, V3, P119, DOI 10.1007/7854_2009_20; de Visser L, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00109, 10.3389/fnins.2011.00102]; DeVries AC, 1998, BRAIN RES, V786, P39, DOI 10.1016/S0006-8993(97)01328-0; Duncan GE, 1996, BRAIN RES, V713, P79, DOI 10.1016/0006-8993(95)01486-1; Erb S, 2006, PHARMACOL BIOCHEM BE, V85, P206, DOI 10.1016/j.pbb.2006.08.002; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; Etkin A, 2010, CURR TOP BEHAV NEURO, V2, P251, DOI 10.1007/7854_2009_5; Filip M, 2006, BRAIN RES, V1071, P218, DOI 10.1016/j.brainres.2005.11.099; Fox HC, 2005, PSYCHONEUROENDOCRINO, V30, P880, DOI 10.1016/j.psyneuen.2005.05.002; Fox HC, 2008, NEUROPSYCHOPHARMACOL, V33, P796, DOI 10.1038/sj.npp.1301470; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Frankowska M, 2010, EUR J PHARMACOL, V627, P142, DOI 10.1016/j.ejphar.2009.10.049; GAWIN FH, 1991, SCIENCE, V251, P1580, DOI 10.1126/science.2011738; George O, 2008, NEUROPSYCHOPHARMACOL, V33, P2474, DOI 10.1038/sj.npp.1301626; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goussakov I, 2006, EUR J NEUROSCI, V23, P239, DOI 10.1111/j.1460-9568.2005.04538.x; Hall BJ, 2010, NEUROSCI LETT, V474, P84, DOI 10.1016/j.neulet.2010.03.011; HARRIS GC, 1993, PSYCHOPHARMACOLOGY, V113, P131, DOI 10.1007/BF02244345; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Jinks AL, 1997, BRAIN RES, V772, P181, DOI 10.1016/S0006-8993(97)00810-X; JU G, 1989, J COMP NEUROL, V280, P587, DOI 10.1002/cne.902800409; JULIEN JF, 1987, NEUROSCI LETT, V73, P173, DOI 10.1016/0304-3940(87)90013-9; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Kupferschmidt DA, 2012, NEUROSCIENCE, V204, P125, DOI 10.1016/j.neuroscience.2011.07.022; Lejuez CW, 2008, BEHAV RES THER, V46, P811, DOI 10.1016/j.brat.2008.03.010; Leriche M, 2008, NEUROSCIENCE, V153, P259, DOI 10.1016/j.neuroscience.2008.01.069; Li S, 2012, BRAIN STRUCT FUNCT, V217, P257, DOI 10.1007/s00429-011-0360-7; Li YH, 2010, PSYCHOPHARMACOLOGY, V212, P251, DOI 10.1007/s00213-010-1948-y; Makris N, 2004, NEURON, V44, P729, DOI 10.1016/j.neuron.2004.10.027; MARKOU A, 1991, NEUROPSYCHOPHARMACOL, V4, P17; Muigg P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005346; O'Mahony CM, 2010, BEHAV BRAIN RES, V213, P148, DOI 10.1016/j.bbr.2010.04.038; Paine TA, 2002, BEHAV PHARMACOL, V13, P511, DOI 10.1097/00008877-200211000-00001; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perrine SA, 2008, NEUROPHARMACOLOGY, V54, P355, DOI 10.1016/j.neuropharm.2007.10.007; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Perrotti LI, 2005, EUR J NEUROSCI, V21, P2817, DOI 10.1111/j.1460-9568.2005.04110.x; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; PORSOLT RD, 1978, EUR J PHARMACOL, V51, P291, DOI 10.1016/0014-2999(78)90414-4; Radley JJ, 2006, J NEUROSCI, V26, P12967, DOI 10.1523/JNEUROSCI.4297-06.2006; Ren H, 2011, MOL PSYCHIAT; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; RISOLD PY, 1994, J COMP NEUROL, V348, P1, DOI 10.1002/cne.903480102; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Rudoy CA, 2007, PROG NEURO-PSYCHOPH, V31, P1119, DOI 10.1016/j.pnpbp.2007.04.005; Salome N, 2004, BIOL PSYCHIAT, V55, P715, DOI 10.1016/j.biopsych.2003.10.021; Santana N, 2004, CEREB CORTEX, V14, P1100, DOI 10.1093/cercor/bhh070; SARNYAI Z, 1995, BRAIN RES, V675, P89, DOI 10.1016/0006-8993(95)00043-P; Sato SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021783; Shah AA, 2004, BRAIN RES, V996, P31, DOI 10.1016/j.brainres.2003.10.015; SILVEIRA MCL, 1993, BEHAV BRAIN RES, V56, P115, DOI 10.1016/0166-4328(93)90028-O; Singewald N, 2003, BIOL PSYCHIAT, V53, P275, DOI 10.1016/S0006-3223(02)01574-3; Sinha R, 2001, PSYCHOPHARMACOLOGY, V158, P343, DOI 10.1007/s002130100917; Sinha R, 2006, ARCH GEN PSYCHIAT, V63, P324, DOI 10.1001/archpsyc.63.3.324; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Stern CAJ, 2010, NEUROSCIENCE, V170, P214, DOI 10.1016/j.neuroscience.2010.06.080; Tanabe J, 2009, BIOL PSYCHIAT, V65, P160, DOI 10.1016/j.biopsych.2008.07.030; Tavares RF, 2009, J NEUROSCI RES, V87, P2601, DOI 10.1002/jnr.22070; Tomasi D, 2007, PSYCHIAT RES-NEUROIM, V155, P189, DOI 10.1016/j.pscychresns.2007.03.002; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Volkow ND, 2002, NEUROBIOL LEARN MEM, V78, P610, DOI 10.1006/nlme.2002.4099	78	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43535	10.1371/journal.pone.0043535	http://dx.doi.org/10.1371/journal.pone.0043535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916276	Green Published, gold, Green Submitted			2022-12-25	WOS:000307824300054
J	van Dongen, EV; Thielen, JW; Takashima, A; Barth, M; Fernandez, G				van Dongen, Eelco V.; Thielen, Jan-Willem; Takashima, Atsuko; Barth, Markus; Fernandez, Guillen			Sleep Supports Selective Retention of Associative Memories Based on Relevance for Future Utilization	PLOS ONE			English	Article							ENHANCES MEMORY; CONSOLIDATION; CONSEQUENCES; HIPPOCAMPAL	An outstanding question is whether memory consolidation occurs passively or involves active processes that selectively stabilize memories based on future utility. Here, we differentially modulated the expected future relevance of two sets of picture-location associations after learning. Participants first studied two sets of picture-location associations. After a baseline memory test, they were instructed that only one set of associations would be retested after a 14-hour delay. For half of the participants, this test-retest delay contained a night of sleep; for the other half the delay included a normal working day. At retest, participants were re-instructed and against their expectations tested on both sets of associations. Our results show that post-learning instruction about subsequent relevance selectively improves memory retention for specific associative memories. This effect was sleep-dependent; it was present only in the group of subjects for which the test-retest delay contained sleep. Moreover, time spent asleep for participants in this sleep group correlated with retention of relevant but not irrelevant associations; participants who slept longer forgot fewer associations from the relevant category. In contrast, participants that did not sleep forgot more relevant than irrelevant associations across the test-retest delay. In summary, our results indicate that it is possible to modulate the retention of selected memories after learning with simple verbal instructions on their future relevance. The finding that this effect depends on sleep demonstrates this state's active role in memory consolidation and may have utility for educational settings.	[van Dongen, Eelco V.; Thielen, Jan-Willem; Barth, Markus; Fernandez, Guillen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [van Dongen, Eelco V.; Fernandez, Guillen] Radboud Univ Nijmegen Med Ctr, Dept Cognit Neurosci, Nijmegen, Netherlands; [Takashima, Atsuko] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van Dongen, EV (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	e.vandongen@donders.ru.nl	Barth, Markus/B-8446-2008; van Dongen, Eelco V/G-4232-2010; Takashima, Atsuko/E-7880-2012; Fernandez, Guillen/B-3771-2009	Barth, Markus/0000-0002-0520-1843; van Dongen, Eelco V/0000-0002-2031-8759; Takashima, Atsuko/0000-0003-1114-6526; Fernandez, Guillen/0000-0002-5522-0604	Dutch Organization for Scientific Research (NWO) [400-06-110]; European Research Council [2010-AdG 268800 - Neuroschema]	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	Eelco van Dongen was supported by a grant from the Dutch Organization for Scientific Research (NWO, grant no. 400-06-110, http://www.nwo.nl). Guillen Fernandez was supported by a grant from the European Research Council (2010-AdG 268800 - Neuroschema, http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cairney SA, 2011, EXP BRAIN RES, V214, P83, DOI 10.1007/s00221-011-2808-7; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Fischer S, 2009, J EXP PSYCHOL LEARN, V35, P1586, DOI 10.1037/a0017256; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gerstner JR, 2009, J NEUROSCI, V29, P12824, DOI 10.1523/JNEUROSCI.3353-09.2009; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Nieuwenhuis ILC, 2012, CEREB CORTEX, V22, P2622, DOI 10.1093/cercor/bhr338; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Rauchs G, 2011, J NEUROSCI, V31, P2563, DOI 10.1523/JNEUROSCI.3972-10.2011; Robertson EM, 2012, CURR BIOL, V22, pR66, DOI 10.1016/j.cub.2011.11.051; Saletin Jared M, 2012, Front Neurol, V3, P59, DOI 10.3389/fneur.2012.00059; Saletin JM, 2011, CEREB CORTEX, V21, P2534, DOI 10.1093/cercor/bhr034; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Takashima A, 2009, J NEUROSCI, V29, P10087, DOI 10.1523/JNEUROSCI.0799-09.2009; van der Helm E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027421; van Dongen EV, 2011, NEUROIMAGE, V57, P262, DOI 10.1016/j.neuroimage.2011.04.019; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; Winocur G, 2011, J INT NEUROPSYCH SOC, V17, P766, DOI 10.1017/S1355617711000683	28	73	73	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43426	10.1371/journal.pone.0043426	http://dx.doi.org/10.1371/journal.pone.0043426			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916259	Green Published, gold			2022-12-25	WOS:000307824300048
J	Vidal-Infer, A; Roger-Sanchez, C; Daza-Losada, M; Aguilar, MA; Minarro, J; Rodriguez-Arias, M				Vidal-Infer, Antonio; Roger-Sanchez, Concepcion; Daza-Losada, Manuel; Aguilar, Maria A.; Minarro, Jose; Rodriguez-Arias, Marta			Role of the Dopaminergic System in the Acquisition, Expression and Reinstatement of MDMA-Induced Conditioned Place Preference in Adolescent Mice	PLOS ONE			English	Article							FREELY-MOVING RATS; NUCLEUS-ACCUMBENS SHELL; LOCOMOTOR-ACTIVITY; RECEPTOR BLOCKADE; COCAINE-SEEKING; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; BEHAVIORAL SENSITIZATION; ECSTASY USERS; D1 RECEPTORS; DRUG	Background: The rewarding effects of 3,4-methylenedioxy-metamphetamine (MDMA) have been demonstrated in conditioned place preference (CPP) procedures, but the involvement of the dopaminergic system in MDMA-induced CPP and reinstatement is poorly understood. Methodology/Principal Findings: In this study, the effects of the DA D1 antagonist SCH 23390 (0.125 and 0.250 mg/kg), the DA D2 antagonist Haloperidol (0.1 and 0.2 mg/kg), the D2 antagonist Raclopride (0.3 and 0.6 mg/kg) and the dopamine release inhibitor CGS 10746B (3 and 10 mg/kg) on the acquisition, expression and reinstatement of a CPP induced by 10 mg/kg of MDMA were evaluated in adolescent mice. As expected, MDMA significantly increased the time spent in the drug-paired compartment during the post-conditioning (Post-C) test, and a priming dose of 5 mg/kg reinstated the extinguished preference. The higher doses of Haloperidol, Raclopride and CGS 10746B and both doses of SCH 23390 blocked acquisition of the MDMA-induced CPP. However, only Haloperidol blocked expression of the CPP. Reinstatement of the extinguished preference was not affected by any of the drugs studied. Analysis of brain monoamines revealed that the blockade of CPP acquisition was accompanied by an increase in DA concentration in the striatum, with a concomitant decrease in DOPAC and HVA levels. Administration of haloperidol during the Post-C test produced increases in striatal serotonin, DOPAC and HVA concentrations. In mice treated with the higher doses of haloperidol and CGS an increase in SERT concentration in the striatum was detected during acquisition of the CPP, but no changes in DAT were observed. Conclusions/Significance: These results demonstrate that, in adolescent mice, the dopaminergic system is involved in the acquisition and expression of MDMA-induced CPP, but not in its reinstatement.	[Vidal-Infer, Antonio; Roger-Sanchez, Concepcion; Daza-Losada, Manuel; Aguilar, Maria A.; Minarro, Jose; Rodriguez-Arias, Marta] Univ Valencia, Unit Res Psychobiol Drug Dependence, Valencia, Spain	University of Valencia	Vidal-Infer, A (corresponding author), Univ Valencia, Unit Res Psychobiol Drug Dependence, Valencia, Spain.	marta.rodriguez@uv.es	Aguilar, Maria A/D-3416-2011; Roger-Sánchez, Concepción/I-7657-2012; Vidal-Infer, Antonio/D-2314-2015; Rodriguez-Arias, Marta/B-5163-2011; Minarro, Jose/B-4414-2011; Vidal-Infer, Antonio/AAR-6567-2021	Aguilar, Maria A/0000-0002-1935-6619; Roger-Sánchez, Concepción/0000-0002-1442-9751; Vidal-Infer, Antonio/0000-0002-7860-8652; Minarro, Jose/0000-0002-5731-7821; 	Ministerio de Ciencia e Innovacion and Direccion General de Investigacion [PSI2008-00101/PSIC]; Instituto de Salud "Carlos III'' (FIS), RETICS, Red de Trastornos Adictivos [RD06/001/0016]; Generalitat Valenciana, Conselleria de Educacion [PROMETEO/2009/072]; Programa Nacional de formacion de Profesorado Universitario [AP2006-04048]; MICINN, Spain	Ministerio de Ciencia e Innovacion and Direccion General de Investigacion; Instituto de Salud "Carlos III'' (FIS), RETICS, Red de Trastornos Adictivos(Instituto de Salud Carlos III); Generalitat Valenciana, Conselleria de Educacion(Center for Forestry Research & Experimentation (CIEF)); Programa Nacional de formacion de Profesorado Universitario(Spanish Government); MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funding provided by Ministerio de Ciencia e Innovacion and Direccion General de Investigacion (PSI2008-00101/PSIC), Instituto de Salud "Carlos III'' (FIS), RETICS, Red de Trastornos Adictivos (RD06/001/0016); Generalitat Valenciana, Conselleria de Educacion (PROMETEO/2009/072); Programa Nacional de formacion de Profesorado Universitario (AP2006-04048), MICINN, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg M, 2007, NEUROTOXICOL TERATOL, V29, P37, DOI 10.1016/j.ntt.2006.09.002; ACQUAS E, 1989, PSYCHOPHARMACOLOGY, V99, P151, DOI 10.1007/BF00442800; ACQUAS E, 1994, BEHAV PHARMACOL, V5, P555, DOI 10.1097/00008877-199410000-00001; Adams JU, 2001, BEHAV PHARMACOL, V12, P603, DOI 10.1097/00008877-200112000-00004; Aguilar MA, 2009, BRAIN RES REV, V59, P253, DOI 10.1016/j.brainresrev.2008.08.002; ALTAR CA, 1986, LIFE SCI, V39, P699, DOI 10.1016/0024-3205(86)90017-2; Ball KT, 2007, PHARMACOL BIOCHEM BE, V87, P420, DOI 10.1016/j.pbb.2007.05.018; Ball KT, 2003, BRAIN RES, V994, P203, DOI 10.1016/j.brainres.2003.09.037; BENINGER RJ, 1989, ARCH GERONTOL GERIAT, P71; Benturquia N, 2008, BRAIN RES, V1211, P1, DOI 10.1016/j.brainres.2008.03.016; Bilsky EJ, 1998, PHARMACOL BIOCHEM BE, V59, P215, DOI 10.1016/S0091-3057(97)00424-3; BLAHA CD, 1984, EUR J PHARMACOL, V98, P113, DOI 10.1016/0014-2999(84)90115-8; Brennan KA, 2009, BEHAV PHARMACOL, V20, P688, DOI 10.1097/FBP.0b013e328333a28d; BUNNEY BS, 1978, LIFE SCI, V23, P1715, DOI 10.1016/0024-3205(78)90471-X; Cadoni C, 2005, BRAIN RES, V1055, P143, DOI 10.1016/j.brainres.2005.07.002; Caine SB, 2007, J NEUROSCI, V27, P13140, DOI 10.1523/JNEUROSCI.2284-07.2007; CALLAWAY CW, 1992, J PHARMACOL EXP THER, V263, P318; Chen LP, 2010, J NEUROCHEM, V114, P530, DOI 10.1111/j.1471-4159.2010.06775.x; Colado MI, 2004, PSYCHOPHARMACOLOGY, V173, P249, DOI 10.1007/s00213-004-1788-8; Colussi-Mas J, 2008, EUR J NEUROSCI, V28, P1895, DOI 10.1111/j.1460-9568.2008.06467.x; Colussi-Mas J, 2010, INT J NEUROPSYCHOPH, V13, P1315, DOI 10.1017/S1461145710000283; Daniela E, 2004, PHARMACOL BIOCHEM BE, V77, P745, DOI 10.1016/j.pbb.2004.01.008; Daza-Losada M, 2008, EUR J PHARMACOL, V590, P204, DOI 10.1016/j.ejphar.2008.06.025; Daza-Losada M, 2007, NEUROPSYCHOPHARMACOL, V32, P1750, DOI 10.1038/sj.npp.1301309; Daza-Losada M, 2009, ADDICT BIOL, V14, P447, DOI 10.1111/j.1369-1600.2009.00173.x; De Vries TJ, 2002, NEUROPSYCHOPHARMACOL, V26, P18, DOI 10.1016/S0893-133X(01)00293-7; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Do Couto BR, 2011, PHYSIOL BEHAV, V103, P585, DOI 10.1016/j.physbeh.2011.02.012; Do Couto BR, 2005, BRAIN RES BULL, V64, P493, DOI 10.1016/j.brainresbull.2004.10.005; DRAGUNOW M, 1991, EUR J PHARM-MOLEC PH, V206, P255, DOI 10.1016/S0922-4106(05)80027-6; Escobedo I, 2005, BRIT J PHARMACOL, V144, P231, DOI 10.1038/sj.bjp.0706071; Ettenberg A, 1996, PSYCHOPHARMACOLOGY, V124, P205, DOI 10.1007/BF02246658; Fenu S, 2001, J NEUROSCI, V21, P6897, DOI 10.1523/JNEUROSCI.21-17-06897.2001; George J, 2010, DRUG ALCOHOL REV, V29, P243, DOI 10.1111/j.1465-3362.2009.00159.x; GOUGH B, 1991, PHARMACOL BIOCHEM BE, V39, P619, DOI 10.1016/0091-3057(91)90137-Q; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Gudelsky GA, 1996, J NEUROCHEM, V66, P243; HEFFNER TG, 1980, PHARMACOL BIOCHEM BE, V13, P453, DOI 10.1016/0091-3057(80)90254-3; HIRAMATSU M, 1990, NEUROPHARMACOLOGY, V29, P269, DOI 10.1016/0028-3908(90)90012-G; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; IMPERATO A, 1984, J NEUROSCI, V4, P966; Kalivas PW, 1998, NEUROPSYCHOPHARMACOL, V18, P469, DOI 10.1016/S0893-133X(97)00195-4; Kankaanpaa A, 1998, PHARMACOL BIOCHEM BE, V59, P1003, DOI 10.1016/S0091-3057(97)00527-3; Kapur S, 2003, PROG NEURO-PSYCHOPH, V27, P1081, DOI 10.1016/j.pnpbp.2003.09.004; Kehne JH, 1996, NEUROPSYCHOPHARMACOL, V15, P116, DOI 10.1016/0893-133X(95)00160-F; lan Nacional sobre Drogas, 1994, ESTUDES ENCUESTA EST; LAWLEY SI, 1990, PHARMACOL BIOCHEM BE, V36, P531, DOI 10.1016/0091-3057(90)90252-D; Leung KS, 2008, CURR OPIN PSYCHIATR, V21, P234, DOI 10.1097/YCO.0b013e3282f9b1f1; Liao RM, 1998, CHINESE J PHYSIOL, V41, P85; LIDSKY TI, 1993, J PHARMACOL EXP THER, V265, P1193; Liechti ME, 2000, EUR NEUROPSYCHOPHARM, V10, P289, DOI 10.1016/S0924-977X(00)00086-9; Manzanedo C, 2001, BEHAV BRAIN RES, V121, P189, DOI 10.1016/S0166-4328(01)00164-4; Manzanedo C, 2001, BEHAV BRAIN RES, V126, P23, DOI 10.1016/S0166-4328(01)00237-6; Nair SG, 2004, BRAIN RES, V1013, P168, DOI 10.1016/j.brainres.2004.04.007; O'Shea E, 2005, NEUROPSYCHOPHARMACOL, V30, P1312, DOI 10.1038/sj.npp.1300673; Ramos M, 2004, PSYCHOPHARMACOLOGY, V177, P100, DOI 10.1007/s00213-004-1937-0; Ratzenboeck E, 2001, PHARMACOLOGY, V62, P138, DOI 10.1159/000056086; Ribeiro Do Couto B, 2011, ADDICT BIOL IN PRESS; Robledo P, 2004, EUR J NEUROSCI, V20, P853, DOI 10.1111/j.1460-9568.2004.03532.x; Robledo P, 2004, N-S ARCH PHARMACOL, V369, P338, DOI 10.1007/s00210-003-0862-9; Schenk S, 2011, BRIT J PHARMACOL, V162, P1770, DOI 10.1111/j.1476-5381.2010.01193.x; Schenk S, 2003, PSYCHOPHARMACOLOGY, V169, P21, DOI 10.1007/s00213-003-1407-0; Schenk S, 2008, DRUG ALCOHOL DEPEN, V96, P249, DOI 10.1016/j.drugalcdep.2008.03.014; SCHMIDT CJ, 1987, BIOCHEM PHARMACOL, V36, P747, DOI 10.1016/0006-2952(87)90729-5; Schneider M, 2008, ADDICT BIOL, V13, P253, DOI 10.1111/j.1369-1600.2008.00110.x; Sershen H, 2010, BRAIN RES BULL, V81, P120, DOI 10.1016/j.brainresbull.2009.07.015; Shaham Y, 1996, PSYCHOPHARMACOLOGY, V125, P385, DOI 10.1007/BF02246022; Shirayama Y, 2000, EUR J PHARMACOL, V402, P215, DOI 10.1016/S0014-2999(00)00521-5; Simantov R, 2004, LIFE SCI, V74, P803, DOI 10.1016/j.lfs.2003.08.002; Simon VM, 2000, EUR NEUROPSYCHOPHARM, V10, P159, DOI 10.1016/S0924-977X(00)00070-5; SOLOWIJ N, 1992, BRIT J ADDICT, V87, P1161; Trigo JM, 2006, PSYCHOPHARMACOLOGY, V184, P212, DOI 10.1007/s00213-005-0229-7; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Weitemier AZ, 2009, EUR J NEUROSCI, V29, P1015, DOI 10.1111/j.1460-9568.2009.06652.x; WHITE SR, 1994, NEUROSCIENCE, V62, P41, DOI 10.1016/0306-4522(94)90313-1; Xu M, 2000, BRAIN RES, V852, P198, DOI 10.1016/S0006-8993(99)02258-1; YAMAMOTO BK, 1988, EUR J PHARMACOL, V148, P195, DOI 10.1016/0014-2999(88)90564-X	78	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43107	10.1371/journal.pone.0043107	http://dx.doi.org/10.1371/journal.pone.0043107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916213	Green Submitted, Green Published, gold			2022-12-25	WOS:000307824300029
J	Barroso, R; Munoz, LM; Barrondo, S; Vega, B; Holgado, BL; Lucas, P; Baillo, A; Salles, J; Rodriguez-Frade, JM; Mellado, M				Barroso, Ruben; Martinez Munoz, Laura; Barrondo, Sergio; Vega, Beatriz; Holgado, Borja L.; Lucas, Pilar; Baillo, Amparo; Salles, Joan; Rodriguez-Frade, Jose M.; Mellado, Mario			EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5	FASEB JOURNAL			English	Article						modulation of the B-cell response; binding affinity; G alpha(i) activation	B-CELL MIGRATION; CHEMOKINE RECEPTOR; QUANTITATIVE ASSESSMENT; CONFORMATIONAL-CHANGES; OPIOID RECEPTORS; LIVING CELLS; LIGAND; HOMODIMERS; REVEALS; CCR5	B-cell movement into lymphoid follicles depends on the expression of the chemokine receptor CXCR5 and the recently reported Epstein-Barr virus-induced receptor 2 (EBI2). In cooperation with CXCR5, EBI2 helps to position activated B cells in the follicle, although the mechanism is poorly understood. Using human HEK293T cells and fluorescence resonance energy transfer (FRET) techniques, we demonstrate that CXCR5 and EBI2 form homo- and heterodimers. EBI2 expression modulated CXCR5 homodimeric complexes, as indicated by the FRET50 value (CXCR5 homodimer, 0.9851 +/- 0.0784; CXCR5 homodimer+EBI2, 1.7320 +/- 0.4905; P<0.05). HEK293T cells expressing CXCR5/EBI2 and primary activated murine B cells both down-modulated CXCR5-mediated responses, such as Ca2+ flux, cell migration, and MAPK activation; this modulation did not occur when primary B cells were obtained from EBI2(-/-) mice. The mechanism involves a reduction in binding affinity of the ligand (CXCL13) for CXCR5 (K-D: 5.05 x 10(-8) M for CXCR5 alone vs. 1.49 x 10(-7) M for CXCR5/EBI2) and in the efficacy (E-max) of G-protein activation in CXCR5/EBI2-coexpressing cells (42.33 +/- 4.3%; P<0.05). These findings identify CXCR5/EBI2 heterodimers as functional units that contribute to the plasticity of CXCL13-mediated B-cell responses.-Barroso, R., Munoz, L. Martinez., Barrondo, S., Vega, B., Holgado, B. L., Lucas, P., Baillo, A., Salles, J., Rodriguez-Frade J. M., Mellado, M. EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5. FASEB J. 26, 4841-4854 (2012). www.fasebj.org	[Barroso, Ruben; Martinez Munoz, Laura; Vega, Beatriz; Holgado, Borja L.; Lucas, Pilar; Rodriguez-Frade, Jose M.; Mellado, Mario] Univ Autonoma Madrid, CSIC, CNB, Dept Immunol & Oncol, E-28049 Madrid, Spain; [Baillo, Amparo] Univ Autonoma Madrid, Dept Math, E-28049 Madrid, Spain; [Barrondo, Sergio; Salles, Joan] UPV, EHU, Univ Basque Country, Fac Pharm,Dept Pharmacol, Vitoria, Spain; [Barrondo, Sergio; Salles, Joan] Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Mellado, M (corresponding author), Univ Autonoma Madrid, CSIC, CNB, Dept Immunol & Oncol, Darwin 3, E-28049 Madrid, Spain.	mmellado@cnb.csic.es	Barrondo, Sergio/F-2470-2016; Sallés, Joan/ABE-1959-2021; Sallés, Joan/A-7141-2015; Baíllo, Amparo/L-2386-2013; Martínez-Muñoz, Laura/C-2719-2017; Mellado, Mario/M-9893-2014; Sallés, Joan/ABE-2123-2021; Frade, Jose Miguel Rodriguez/K-4266-2014	Barrondo, Sergio/0000-0001-8159-4872; Sallés, Joan/0000-0001-6727-2674; Baíllo, Amparo/0000-0003-1644-3992; Martínez-Muñoz, Laura/0000-0003-3098-279X; Mellado, Mario/0000-0001-6325-1630; Sallés, Joan/0000-0001-6727-2674; Frade, Jose Miguel Rodriguez/0000-0002-7753-1462; Barroso, Ruben/0000-0003-3737-5538	Spanish Ministry of Science and Innovation [SAF 2008-03388, SAF 2011-27370, MTM2010-17366]; RETICS Program [RD08/0075/0010]; Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental; Basque Government [GIC10/147]; European Union [223404]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); RETICS Program; Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental(Instituto de Salud Carlos III); Basque Government(Basque Government); European Union(European Commission)	The authors thank Dr. R. Brink (Garvan Institute of Medical Research, Darlinghurst, NSW, Australia) for the gift of EBI2<SUP>-/-</SUP> mice, L. Gomez for animal handling, and C. Bastos and C. Mark for secretarial and editorial assistance, respectively. This work was supported in part by grants from the Spanish Ministry of Science and Innovation (SAF 2008-03388 and SAF 2011-27370 to M. M.; MTM2010-17366 to A. B.), the RETICS Program (RD08/0075/0010; RIER to M. M.), the Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental (to J.S.), the Basque Government (GIC10/147 to J.S.), and the European Union (FP7-integrated project Masterswitch 223404 to M.M.).	Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Barrondo S, 2009, NEUROPHARMACOLOGY, V56, P455, DOI 10.1016/j.neuropharm.2008.09.018; Berglund MM, 2003, J PHARMACOL EXP THER, V307, P1120, DOI 10.1124/jpet.103.055673; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Burkle A, 2007, BLOOD, V110, P3316, DOI 10.1182/blood-2007-05-089409; Canals M, 2003, J BIOL CHEM, V278, P46741, DOI 10.1074/jbc.M306451200; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Chakera A, 2008, MOL PHARMACOL, V73, P1362, DOI 10.1124/mol.107.040915; Chen CG, 2004, EUR J PHARMACOL, V483, P175, DOI 10.1016/j.ejphar.2003.10.033; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Gatto D, 2011, J IMMUNOL, V187, P4621, DOI 10.4049/jimmunol.1101542; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Kelly LM, 2011, J IMMUNOL, V187, P3026, DOI 10.4049/jimmunol.1101262; Kroeger KM, 2001, J BIOL CHEM, V276, P12736, DOI 10.1074/jbc.M011311200; Latif R, 2001, J BIOL CHEM, V276, P45217, DOI 10.1074/jbc.M103727200; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu CL, 2003, J BIOL CHEM, V278, P50765, DOI 10.1074/jbc.M308996200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Munoz LM, 2009, J IMMUNOL, V183, P7337, DOI 10.4049/jimmunol.0901802; Mellado M., 2008, CURR PROTOC PHARM, V12, P11; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Muller G, 2001, BIOL CHEM, V382, P1387, DOI 10.1515/BC.2001.171; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pello OM, 2008, EUR J IMMUNOL, V38, P537, DOI 10.1002/eji.200737630; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Pfeiffer M, 2003, J BIOL CHEM, V278, P51630, DOI 10.1074/jbc.M307095200; Poncelet P, 1993, METHODS IMMUNOLOGICA, P388; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Sakai T, 2010, MOL BIOL EVOL, V27, P1097, DOI 10.1093/molbev/msp319; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Smith N. J., PHARM REV, V62, P701; Szabo I, 2003, J LEUKOCYTE BIOL, V74, P1074, DOI 10.1189/jlb.0203067; Vega B, 2011, J LEUKOCYTE BIOL, V90, P399, DOI 10.1189/jlb.1010565; Wilson S, 2005, J BIOL CHEM, V280, P28663, DOI 10.1074/jbc.M413475200; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhu WZ, 2005, CIRC RES, V97, P244, DOI 10.1161/01.RES.0000176764.38934.86; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	52	31	33	3	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					4841	4854		10.1096/fj.12-208876	http://dx.doi.org/10.1096/fj.12-208876			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22913878				2022-12-25	WOS:000311838300008
J	Sobhany, M; Kakuta, Y; Sugiura, N; Kimata, K; Negishi, M				Sobhany, Mack; Kakuta, Yoshimitsu; Sugiura, Nobuo; Kimata, Koji; Negishi, Masahiko			The Structural Basis for a Coordinated Reaction Catalyzed by a Bifunctional Glycosyltransferase in Chondroitin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; POLYMERASE; PROTEOGLYCANS; MECHANISM	Bifunctional chondroitin synthase K4CP catalyzes glucuronic acid and N-acetylgalactosamine transfer activities and polymerizes a chondroitin chain. Here we have determined that an N-terminal region (residues 58-134) coordinates two transfer reactions and enables K4CP to catalyze polymerization. When residues 58-107 are deleted, K4CP loses polymerase activity while retaining both transfer activities. Peptide (DWPSDL118)-D-113 within this N-terminal region interacts with C-terminal peptide (YTWEKI682)-Y-677. The deletion of either sequence abolishes glucuronic acid but not N-acetylgalactosamine transfer activity in K4CP. Both donor bindings and transfer activities are lost by mutating (YTWEKI682)-Y-677 to (677)DAWEDI(682). On the other hand, acceptor substrates retain their binding to K4CP mutants. The characteristics of these K4CP mutants highlight different states of the enzyme reaction, providing an underlying structural basis for how these peptides play essential roles in coordinating the two glycosyltransferase activities for K4CP to elongate the chondroitin chain.	[Sobhany, Mack; Negishi, Masahiko] NIEHS, Pharmacogenet Sect, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA; [Kakuta, Yoshimitsu] Kyushu Univ, Fac Agr, Dept Biochem, Fukuoka 8128581, Japan; [Sugiura, Nobuo; Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 4801195, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Kyushu University; Aichi Medical University	Negishi, M (corresponding author), NIEHS, Pharmacogenet Sect, Lab Reprod & Dev Toxicol, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928	National Institutes of Health (Intramural Research Program of NIEHS) [Z01ES1005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040, ZICES102545] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23570176] Funding Source: KAKEN	National Institutes of Health (Intramural Research Program of NIEHS); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01ES1005-01 (Intramural Research Program of NIEHS).	Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Jorpes E, 1935, Biochem J, V29, P1817; Lander AD, 2000, J CELL BIOL, V148, P227, DOI 10.1083/jcb.148.2.227; Negishi M, 2003, BIOCHEM BIOPH RES CO, V303, P393, DOI 10.1016/S0006-291X(03)00356-5; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; PRESS WH, 1989, NUMERICAL RECIPES FO; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Sugiura N, 2008, GLYCOCONJUGATE J, V25, P521, DOI 10.1007/s10719-008-9105-0; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617	13	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36022	36028		10.1074/jbc.M112.375873	http://dx.doi.org/10.1074/jbc.M112.375873			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936799	Green Published, hybrid			2022-12-25	WOS:000310364000024
J	Dogan, J; Schmidt, T; Mu, X; Engstrom, A; Jemth, P				Dogan, Jakob; Schmidt, Tanja; Mu, Xin; Engstrom, Ake; Jemth, Per			Fast Association and Slow Transitions in the Interaction between Two Intrinsically Disordered Protein Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COACTIVATOR BINDING DOMAIN; CONFORMATIONAL SELECTION; UNSTRUCTURED PROTEINS; COMPLEX; CBP; RECRUITMENT; RECOGNITION; MECHANISM; STATE	Proteins that contain long disordered regions are prevalent in the proteome and frequently associated with diseases. However, the mechanisms by which such intrinsically disordered proteins (IDPs) recognize their targets are not well understood. Here, we report the first experimental investigation of the interaction kinetics of the nuclear co-activator binding domain of CREB-binding protein and the activation domain from the p160 transcriptional co-activator for thyroid hormone and retinoid receptors. Both protein domains are intrinsically disordered in the free state and synergistically fold upon binding each other. Using the stopped-flow technique, we found that the binding reaction is fast, with an association rate constant of 3 x 10(7) M-1 s(-1) at 277 K. Mutation of a conserved buried intermolecular salt bridge showed that electrostatics govern the rapid association. Furthermore, upon mutation of the salt bridge or at high salt concentration, an additional kinetic phase was detected (similar to 20 and similar to 40 s(-1), respectively, at 277 K), suggesting that the salt bridge may steer formation of the productive bimolecular complex in an intramolecular step. Finally, we directly measured slow kinetics for the IDP domains (similar to 1 s(-1) at 277 K) related to conformational transitions upon binding. Together, the experiments demonstrate that the interaction involves several steps and accumulation of intermediate states. Our data are consistent with an induced fit mechanism, in agreement with previous simulations. We propose that the slow transitions may be a consequence of the multipartner interactions of IDPs.	[Dogan, Jakob; Schmidt, Tanja; Mu, Xin; Engstrom, Ake; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Uppsala University	Dogan, J (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, BMC Box 582, SE-75123 Uppsala, Sweden.	Jakob.Dogan@imbim.uu.se; Per.Jemth@imbim.uu.se			Swedish Research Council (Natural and Engineering Sciences); Human Frontiers Young Investigator Science Program; Lars Hierta Memorial Foundation	Swedish Research Council (Natural and Engineering Sciences)(Swedish Research Council); Human Frontiers Young Investigator Science Program; Lars Hierta Memorial Foundation	This work was supported by the Swedish Research Council (Natural and Engineering Sciences) and the Human Frontiers Young Investigator Science Program and the Lars Hierta Memorial Foundation.	Chemes LB, 2011, J MOL BIOL, V412, P267, DOI 10.1016/j.jmb.2011.07.015; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ebert MO, 2008, BIOCHEMISTRY-US, V47, P1299, DOI 10.1021/bi701767j; Ganguly D, 2012, MOL BIOSYST, V8, P198, DOI 10.1039/c1mb05156c; Haq SR, 2012, J AM CHEM SOC, V134, P599, DOI 10.1021/ja209341w; Karlsson OA, 2012, J MOL BIOL, V417, P253, DOI 10.1016/j.jmb.2012.01.042; Kjaergaard M, 2010, P NATL ACAD SCI USA, V107, P12535, DOI 10.1073/pnas.1001693107; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Papadakos G, 2012, J MOL BIOL, V418, P269, DOI 10.1016/j.jmb.2012.01.039; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Rezaei-Ghaleh N, 2012, CHEMBIOCHEM, V13, P930, DOI 10.1002/cbic.201200093; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Turjanski AG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000060; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Waters L, 2006, J BIOL CHEM, V281, P14787, DOI 10.1074/jbc.M600237200; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zhang WH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002353	28	66	66	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34316	34324		10.1074/jbc.M112.399436	http://dx.doi.org/10.1074/jbc.M112.399436			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22915588	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000309654200035
J	Risebro, HL; Breton, L; Aird, H; Hooper, A; Hunter, PR				Risebro, Helen L.; Breton, Lynette; Aird, Heather; Hooper, Alan; Hunter, Paul R.			Contaminated Small Drinking Water Supplies and Risk of Infectious Intestinal Disease: A Prospective Cohort Study	PLOS ONE			English	Article							MICROBIOLOGICAL QUALITY; GASTROINTESTINAL ILLNESS; UNITED-KINGDOM; COMMUNITY; CHILDREN; DIARRHEA; ENGLAND; IID2; UK	Background: This study sought to identify whether elevated risk of infectious intestinal disease (IID) exists in contaminated small water supply consumers compared with consumers drinking from small supplies complying with current standards and whether this effect is modified by age. Methodology and Principal Findings: A prospective cohort study of 611 individuals receiving small supplies in England was conducted. Water supplies received sanitary inspection and examination for indicator bacteria and participants maintained a daily record of IID. Regression modeling with generalized estimating equations that included interaction terms between age and indicators of fecal pollution was performed. Crude IID prevalence was 9.3 days with symptoms/1000 person days (95% CI: 8.4, 10.1) and incidence was 3.2 episodes/1000 person days (95% CI, 2.7, 3.7) or 1.2 episodes per person year. Although there was no overall association between IID risk and indicator presence, there was strong interaction between age and indicator presence. In children under ten, relative risk (RR) of IID in those drinking from enterococci contaminated supplies was 4.8 (95% CI: 1.5, 15.3) for incidence and 8.9 (95% CI: 2.8, 27.5) for prevalence. In those aged 10 to 59, IID risk was lower but not statistically significant. Conclusions: Contaminated small water supplies pose a substantial risk of IID to young children who live in homes reliant on these supplies. By contrast older children and adults do not appear to be at increased risk. Health care professionals with responsibility for children living in homes provided by very small water supplies should make parents aware of the risk.	[Risebro, Helen L.; Breton, Lynette; Hunter, Paul R.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Aird, Heather] Norfolk & Norwich Univ Hosp NHS Trust, Food Water & Environm Lab, Norwich, Norfolk, England; [Hooper, Alan] Hereford Cty Hosp, Dept Microbiol & Immunol, Hereford, England	University of East Anglia; Norfolk & Norwich University Hospitals NHS Foundation Trust	Risebro, HL (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	Paul.Hunter@uea.ac.uk	Hunter, Paul/N-9021-2019; Hunter, Paul/A-7172-2008; Risebro, Helen/S-5693-2016	Hunter, Paul/0000-0002-5608-6144; Hunter, Paul/0000-0002-5608-6144; Risebro, Helen/0000-0003-4389-748X	European Commission for the HEALTHY WATER project [FOOD-CT-2006-036306]; Danone Beverages Ltd.	European Commission for the HEALTHY WATER project; Danone Beverages Ltd.	This work was supported by funds from the European Commission for the HEALTHY WATER project (grant number: FOOD-CT-2006-036306). The authors are solely responsible for the content of this publication. It does not represent the opinion of the European Commission. The European Commission is not responsible for any use that might be made of data appearing therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: PRH has been chair of science advisory committee for Suez Environment, Paris and has been funded to attend meetings with Danone Beverages. PRH is chair of the board of directors of the Institute of Public Health and Water Research, Chicago. PRH was chair of Science Advisory Committee for Suez Environment until 2010, and has attended meetings funded by Danone Beverages Ltd. HLR and PRH have completed consultancy work for 1001 Fontaines. The other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Al-Ghamdi MA, 2009, J WATER HEALTH, V7, P380, DOI 10.2166/wh.2009.058; [Anonymous], 2010, PRIV WAT SUPPL; Borchardt MA, 2003, ENVIRON HEALTH PERSP, V111, P742, DOI 10.1289/ehp.5914; Colford JM, 2009, AM J PUBLIC HEALTH, V99, P1988, DOI 10.2105/AJPH.2008.153619; Desinor OY, 2000, ENQUETE MORTALITE IN, V10, P407; European Commission, 1998, OFF J EUR COMMUN L, VL330, P32; FERLEY JP, 1986, REV EPIDEMIOL SANTE, V34, P89; Fewtrell L, 1998, J CHART INST WATER E, V12, P45; Fleisher JM, 2006, MAR POLLUT BULL, V52, P264, DOI 10.1016/j.marpolbul.2005.08.019; Frost FJ, 2005, J INFECT DIS, V191, P809, DOI 10.1086/427561; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hennessy TW, 2008, AM J PUBLIC HEALTH, V98, P2072, DOI 10.2105/AJPH.2007.115618; Hulsmann A., 2005, SMALL SYSTEMS LARGE; Hunter PR, 2004, EMERG INFECT DIS, V10, P1241, DOI 10.3201/eid1007.030582; Kay D, 2007, J WATER HEALTH, V5, P523, DOI 10.2166/wh.2007.042; Marsh David, 1993, JPMA (Journal of the Pakistan Medical Association), V43, P226; O'Brien SJ, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-39; PAYMENT P, 2001, WATER QUALITY GUIDEL; Raina PS, 1999, CAN J PUBLIC HEALTH, V90, P172, DOI 10.1007/BF03404501; Reid DC, 2003, WATER RES, V37, P245, DOI 10.1016/S0043-1354(02)00266-X; Rogan WJ, 2009, PEDIATRICS, V123, pE1123, DOI 10.1542/peds.2009-0752; Rutter M, 2000, EPIDEMIOL INFECT, V124, P417, DOI 10.1017/S0950268899003970; Said B, 2003, EPIDEMIOL INFECT, V130, P469, DOI 10.1017/S0950268803008495; Sethi D, 1999, Commun Dis Public Health, V2, P101; SIGNORINI DF, 1991, BIOMETRIKA, V78, P446; Strauss B, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-8; Swift L, 2004, EUR J EPIDEMIOL, V19, P219, DOI 10.1023/B:EJEP.0000020453.84296.f6; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; UK Biobank Co-ordinating Centre, 2006, UK BIOB REP INT PIL; United States Environmental Protection Agency, 2009, FACTOIDS DRINK WAT G; Yip-Richardson H, 2009, WATER RES, V43, P2159	31	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42762	10.1371/journal.pone.0042762	http://dx.doi.org/10.1371/journal.pone.0042762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936989	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500015
J	Nemeth, E; Kempenaers, B; Matessi, G; Brumm, H				Nemeth, Erwin; Kempenaers, Bart; Matessi, Giuliano; Brumm, Henrik			Rock Sparrow Song Reflects Male Age and Reproductive Success	PLOS ONE			English	Article							SOUND PRESSURE LEVEL; EXTRAPAIR PATERNITY; DAWN SONG; AMPLITUDE REGULATION; FIELD CRICKETS; MALE QUALITY; BIRD SONG; SIGNAL; NOISE; TITS	The evolution of mating signals is closely linked to sexual selection. Acoustic ornaments are often used as secondary sexual traits that signal the quality of the signaller. Here we show that song performance reflects age and reproductive success in the rock sparrow (Petronia petronia). In an Alpine population in south-east France, we recorded the songs of males and assessed their genetic breeding success by microsatellite analysis. In addition to temporal and spectral song features, we also analysed for the first time whether the sound pressure level of bird song reflects reproductive success. Males with higher breeding success sang at a lower rate and with a higher maximum frequency. We found also that older males gained more extra-pair young and had a higher overall breeding success, although they also differed almost significantly by having a higher loss of paternity in their own nests. Older males could be distinguished from yearlings by singing at lower rate and higher amplitudes. Our findings suggest that song rate may be used as a signal of age and together with song pitch as a signal of reproductive success in this species. Alternatively, younger and less successful males might try to compensate their inferior status by increased song rates and lower pitch. Independent of age and quality, high-amplitude songs correlated with paternity loss in the own nest, suggesting that in this species song amplitude is not an indicator of male quality but high-intensity songs may be rather a response to unfaithful social mates.	[Nemeth, Erwin; Kempenaers, Bart; Brumm, Henrik] Max Planck Inst Ornithol, Commun & Social Behav Grp, Seewiesen, Germany; [Nemeth, Erwin] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Matessi, Giuliano] Univ Copenhagen, Dept Biol, Anim Behav Grp, Copenhagen, Denmark	Max Planck Society; University of Vienna; University of Copenhagen	Nemeth, E (corresponding author), Max Planck Inst Ornithol, Commun & Social Behav Grp, Seewiesen, Germany.	enemeth@orn.mpg.de		Kempenaers, Bart/0000-0002-7505-5458; Nemeth, Erwin/0000-0001-9438-1411	Max Planck Society; Deutsche Forschungsgemeinschaft [BR 2309/6-1]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by the Max Planck Society and the Deutsche Forschungsgemeinschaft (award BR 2309/6-1). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson RC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1267, DOI 10.1007/s00265-007-0357-7; Andersson Malte, 1994; Araya-Ajoy YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008137; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Ballentine B, 2009, ANIM BEHAV, V77, P973, DOI 10.1016/j.anbehav.2008.12.027; Botero CA, 2009, ANIM BEHAV, V77, P701, DOI 10.1016/j.anbehav.2008.11.020; Bouwman KM, 2007, ANIM BEHAV, V73, P15, DOI 10.1016/j.anbehav.2006.01.031; Brumm H, 2004, ANIM BEHAV, V67, P281, DOI 10.1016/j.anbehav.2003.06.006; Brumm H, 2011, BEHAV ECOL, V22, P310, DOI 10.1093/beheco/arq205; Brumm H, 2002, ANIM BEHAV, V63, P891, DOI 10.1006/anbe.2001.1968; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Brumm H, 2006, ANIM BEHAV, V72, P699, DOI 10.1016/j.anbehav.2006.01.020; Brumm H, 2011, ANIM BEHAV, V81, P653, DOI 10.1016/j.anbehav.2010.12.015; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Brumm H, 2009, BEHAV ECOL SOCIOBIOL, V63, P1157, DOI 10.1007/s00265-009-0743-4; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Burmeister SS, 2002, ANIM BEHAV, V64, P715, DOI 10.1006/anbe.2002.4012; Byers BE, 2007, BEHAV ECOL, V18, P130, DOI 10.1093/beheco/arl058; CATCHPOLE CK, 1984, NATURE, V312, P563, DOI 10.1038/312563a0; Crawley MJ., 2007, R BOOK; Cynx J, 1998, ANIM BEHAV, V56, P107, DOI 10.1006/anbe.1998.0746; DABELSTEEN T, 1981, Z TIERPSYCHOL, V56, P137; Dabelsteen Torben, 1998, Bioacoustics, V9, P89; de Kort SR, 2009, BEHAV ECOL, V20, P200, DOI 10.1093/beheco/arn135; de Kort SR, 2009, P ROY SOC B-BIOL SCI, V276, P2315, DOI 10.1098/rspb.2009.0127; Fitzsimmons LP, 2011, BEHAVIOUR, V148, P1045, DOI 10.1163/000579511X588812; Forstmeier W, 2004, BEHAV ECOL, V15, P555, DOI 10.1093/beheco/arh051; Garamszegi LZ, 2007, ETHOLOGY, V113, P246, DOI 10.1111/j.1439-0310.2007.01337.x; Garamszegi LZ, 2005, BEHAV ECOL, V16, P580, DOI 10.1093/beheco/ari029; Geberzahn N, 2009, BEHAV ECOL SOCIOBIOL, V64, P193, DOI 10.1007/s00265-009-0836-0; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Geslin T, 2004, BIRD STUDY, V51, P178, DOI 10.1080/00063650409461350; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Grapputo A, 2006, MOL ECOL NOTES, V6, P1070, DOI 10.1111/j.1471-8286.2006.01437.x; Griggio M, 2005, ANIM BEHAV, V69, P1243, DOI 10.1016/j.anbehav.2004.10.004; Griggio M, 2009, J EVOLUTION BIOL, V22, P2077, DOI 10.1111/j.1420-9101.2009.01823.x; Griggio M, 2007, BEHAV ECOL SOCIOBIOL, V61, P423, DOI 10.1007/s00265-006-0270-5; Hofstad E, 2002, CAN J ZOOL, V80, P524, DOI 10.1139/Z02-033; Jacot A, 2007, ETHOLOGY, V113, P615, DOI 10.1111/j.1439-0310.2007.01360.x; Judge KA, 2011, ANIM BEHAV, V81, P185, DOI 10.1016/j.anbehav.2010.09.032; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; Kempenaers B, 1998, ANIM BEHAV, V55, P845, DOI 10.1006/anbe.1997.0667; Kiefer S, 2006, ETHOLOGY, V112, P1217, DOI 10.1111/j.1439-0310.2006.01283.x; Kipper S, 2010, ADV STUD BEHAV, V41, P77, DOI 10.1016/S0065-3454(10)41003-7; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Matessi G, 2005, BEHAVIOUR, V142, P507, DOI 10.1163/1568539054012010; Matessi G, 2007, BEHAVIOUR, V144, P735, DOI 10.1163/156853907781476382; Matessi G, 2009, BEHAVIOUR, V146, P209, DOI 10.1163/156853909X410748; Mundry R, 2009, AM NAT, V173, P119, DOI 10.1086/593303; Murphy MT, 2008, ANIM BEHAV, V75, P1075, DOI 10.1016/j.anbehav.2007.08.020; Nemeth E, 2004, BIOACOUSTICS, V14, P225, DOI 10.1080/09524622.2004.9753527; Patricelli GL, 2008, ANIM BEHAV, V76, P1389, DOI 10.1016/j.anbehav.2008.07.005; Pilastro A, 2003, ANIM BEHAV, V66, P265, DOI 10.1006/anbe.2003.2203; Pilastro A, 2002, ANIM BEHAV, V63, P967, DOI 10.1006/anbe.2002.1987; Poesel A, 2006, ANIM BEHAV, V72, P531, DOI 10.1016/j.anbehav.2005.10.022; Price JJ, 2006, ANIM BEHAV, V71, P799, DOI 10.1016/j.anbehav.2005.05.025; RADESATER T, 1987, ANIM BEHAV, V35, P1645, DOI 10.1016/S0003-3472(87)80057-X; Ripmeester EAP, 2007, ETHOLOGY, V113, P1021, DOI 10.1111/j.1439-0310.2007.01398.x; Ritschard M, 2012, EVOL ECOL, V26, P801, DOI 10.1007/s10682-011-9541-3; Ritschard M, 2011, ANIM BEHAV, V82, P1415, DOI 10.1016/j.anbehav.2011.09.026; Ritschard M, 2010, ANIM BEHAV, V79, P877, DOI 10.1016/j.anbehav.2009.12.038; Ritschard M, 2012, ETHOLOGY, V118, P197, DOI 10.1111/j.1439-0310.2011.01999.x; Rivera-Gutierrez HF, 2010, ANIM BEHAV, V80, P451, DOI 10.1016/j.anbehav.2010.06.002; Scheuber H, 2004, P ROY SOC B-BIOL SCI, V271, P2453, DOI 10.1098/rspb.2004.2907; Schmoll T, 2007, BEHAV ECOL, V18, P1073, DOI 10.1093/beheco/arm082; SEARCY WA, 1984, Z TIERPSYCHOL, V66, P128; Searcy WA, 1996, ETHOLOGY, V102, P187; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Soma M, 2011, BEHAV ECOL, V22, P363, DOI 10.1093/beheco/arq219; Suter SM, 2009, ANIM BEHAV, V77, P473, DOI 10.1016/j.anbehav.2008.11.002; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Vallet E, 1998, ANIM BEHAV, V55, P291, DOI 10.1006/anbe.1997.0631; Verburgt L, 2011, ANIM BEHAV, V81, P19, DOI 10.1016/j.anbehav.2010.09.010; WAGNER WE, 1992, ANIM BEHAV, V44, P449, DOI 10.1016/0003-3472(92)90055-E; Welling PP, 1997, BEHAVIOUR, V134, P891, DOI 10.1163/156853997X00214; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Wyman MT, 2008, ANIM BEHAV, V76, P1625, DOI 10.1016/j.anbehav.2008.05.032	77	35	36	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43259	10.1371/journal.pone.0043259	http://dx.doi.org/10.1371/journal.pone.0043259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927955	Green Submitted, gold, Green Published			2022-12-25	WOS:000308224700013
J	De Marco, L; Manzini, P; Trevisan, M; Gillio-Tos, A; Danielle, F; Balloco, C; Pizzi, A; De Filippo, E; D'Antico, S; Violante, B; Valfre, A; Curti, F; Merletti, F; Richiardi, L				De Marco, Laura; Manzini, Paola; Trevisan, Morena; Gillio-Tos, Anna; Danielle, Franca; Balloco, Cinzia; Pizzi, Alessandra; De Filippo, Eleonora; D'Antico, Sergio; Violante, Beatrice; Valfre, Adriano; Curti, Franco; Merletti, Franco; Richiardi, Lorenzo			Prevalence and Follow-Up of Occult HCV Infection in an Italian Population Free of Clinically Detectable Infectious Liver Disease	PLOS ONE			English	Article							HEPATITIS-C VIRUS; BLOOD MONONUCLEAR-CELLS; MIXED CRYOGLOBULINEMIA; B-VIRUS; PERSISTENCE; COMPARTMENTALIZATION; SERUM; RNA	Background: Occult hepatitis C virus infection (OCI) is a recently described phenomenon characterized by undetectable levels of HCV-RNA in serum/plasma by current laboratory assays, with identifiable levels in peripheral blood mononuclear cells (PBMCs) and/or liver tissue by molecular tests with enhanced sensitivity. Previous results from our group showed an OCI prevalence of 3.3% in a population unselected for hepatic disease. The present study aimed to evaluate OCI prevalence in a larger cohort of infectious liver disease-free (ILDF) subjects. Clinical follow-up of OCI subjects was performed to investigate the natural history of the infection. Methods and Findings: 439 subjects referred to a Turin Blood Bank for phlebotomy therapy were recruited. They included 314 ILDF subjects, 40 HCV-positive subjects and 85 HBV-positive subjects, of whom 7 were active HBV carriers. Six subjects (4/314 ILDF subjects [1.27%] and 2/7 active HBV carriers [28%]) were positive for HCV-RNA in PBMCs, but negative for serological and virological markers of HCV, indicating OCI. HCV genotypes were determined in the PBMCs of 3/6 OCI subjects two had type 1b; the other had type 2a/2c. OCI subjects were followed up for at least 2 years. After 12 months only one OCI persisted, showing a low HCV viral load (3.73x10(1) UI/ml). By the end of follow-up all OCI subjects were negative for HCV. No seroconversion, alteration of liver enzyme levels, or reduction of liver synthesis occurred during follow-up. Conclusions: This study demonstrated the existence of OCI in ILDF subjects, and suggested a high OCI prevalence among active HBV carriers. Follow-up suggested that OCI could be transient, with a trend toward the decrease of HCV viral load to levels undetectable by conventional methods after 12-18 months. Confirmation studies with a longer follow-up period are needed for identification of the OCI clearance or recurrence rates, and to characterize the viruses involved.	[De Marco, Laura; Trevisan, Morena; Gillio-Tos, Anna; Merletti, Franco; Richiardi, Lorenzo] Univ Turin, Canc Epidemiol Unit, CERMS, Turin, Italy; [Manzini, Paola; Danielle, Franca; Balloco, Cinzia; Pizzi, Alessandra; De Filippo, Eleonora; D'Antico, Sergio; Violante, Beatrice; Valfre, Adriano; Curti, Franco] AOU S Giovanni Battista, Blood Bank, Turin, Italy; [Merletti, Franco; Richiardi, Lorenzo] Univ Turin, Ctr Oncol Prevent, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	De Marco, L (corresponding author), Univ Turin, Canc Epidemiol Unit, CERMS, Turin, Italy.	gilliotos.demarco@cpo.it	Trevisan, Morena/J-9088-2016; De Marco, Laura/J-7254-2016; richiardi, lorenzo/J-3480-2018	Trevisan, Morena/0000-0001-7982-7411; De Marco, Laura/0000-0003-2167-9270; richiardi, lorenzo/0000-0003-0316-9402; Gillio-Tos, Anna/0000-0001-6553-5362	Italian Association for Cancer Research; Compagnia di San Paolo/FIRMS (International Foundation for Research in Experimental Medicine); Piedmont Region; Italian Ministry of University and Research (MIUR); European Union; Italian Ministry of Health	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo/FIRMS (International Foundation for Research in Experimental Medicine)(Compagnia di San Paolo); Piedmont Region(Regione Piemonte); Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported in part by the Italian Association for Cancer Research, the Compagnia di San Paolo/FIRMS (International Foundation for Research in Experimental Medicine), the Piedmont Region and the Italian Ministry of University and Research (MIUR), European Union, Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barril G, 2008, J AM SOC NEPHROL, V19, P2288, DOI 10.1681/ASN.2008030293; Bartolome J, 2007, J VIROL, V81, P7710, DOI 10.1128/JVI.02750-06; Bokharaei-Salim F, 2011, J MED VIROL, V83, P989, DOI 10.1002/jmv.22044; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; Carreno V, 2008, REV MED VIROL, V18, P139, DOI 10.1002/rmv.569; Carreno V, 2006, WORLD J GASTROENTERO, V12, P6922, DOI 10.3748/wjg.v12.i43.2000; Casato M, 2003, J VIRAL HEPATITIS, V10, P455, DOI 10.1046/j.1365-2893.2003.00462.x; Castillo I, 2004, J INFECT DIS, V189, P7, DOI 10.1086/380202; Castillo I, 2005, GUT, V54, P682, DOI 10.1136/gut.2004.057281; Castillo I, 2011, LIVER INT, V31, P1519, DOI 10.1111/j.1478-3231.2011.02613.x; Castillo I, 2009, J MED VIROL, V81, P1198, DOI 10.1002/jmv.21483; Coppola N, 2011, HEPATOLOGY, V54, P1487, DOI 10.1002/hep.24436; De Marco L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008128; Di Liberto G, 2006, GASTROENTEROLOGY, V131, P76, DOI 10.1053/j.gastro.2006.04.016; Giannini C, 2006, HEPATOLOGY, V43, P1166, DOI 10.1002/hep.21132; Halfon P, 2008, J CLIN MICROBIOL, V46, P2106, DOI 10.1128/JCM.00345-08; Halfon P, 2009, HEPATOLOGY, V50, P1675, DOI 10.1002/hep.23113; Jamma Shailaja, 2010, Curr Hepat Rep, V9, P260, DOI 10.1007/s11901-010-0060-4; Muazzam Ambreen G, 2011, Genet Vaccines Ther, V9, P14, DOI 10.1186/1479-0556-9-14; Nicot F, 2010, TRANSPL INT, V23, P594, DOI 10.1111/j.1432-2277.2009.01025.x; Pardo M, 2006, ALIMENT PHARM THER, V23, P1153, DOI 10.1111/j.1365-2036.2006.02886.x; Pham TNQ, 2007, J VIRAL HEPATITIS, V14, P537, DOI 10.1111/j.1365-2893.2006.00834.x; Pham TNQ, 2004, J VIROL, V78, P5867, DOI 10.1128/JVI.78.11.5867-5874.2004; Pham TN, 2008, WORLD J GASTROENTERO, V14, P2789, DOI 10.3748/wjg.14.2789; Pham TNQ, 2010, LIVER INT, V30, P502, DOI 10.1111/j.1478-3231.2009.02193.x; Radkowski M, 2005, J INFECT DIS, V191, P1730, DOI 10.1086/429834; Ramirez S, 2009, AM J TRANSPLANT, V9, P1591, DOI 10.1111/j.1600-6143.2009.02666.x; Richiardi L, 2010, CANCER EPIDEMIOL, V34, P709, DOI 10.1016/j.canep.2010.07.014; Roque-Afonso AM, 2005, J VIROL, V79, P6349, DOI 10.1128/JVI.79.10.6349-6357.2005; Welker MW, 2009, HEPATOLOGY, V49, P665, DOI 10.1002/hep.22706	30	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43541	10.1371/journal.pone.0043541	http://dx.doi.org/10.1371/journal.pone.0043541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927986	gold, Green Published			2022-12-25	WOS:000308286300065
J	Kim, KS; Lee, YH				Kim, Kyoung Su; Lee, Yong-Hwan			Gene Expression Profiling during Conidiation in the Rice Blast Pathogen Magnaporthe oryzae	PLOS ONE			English	Article							INFECTION-RELATED MORPHOGENESIS; ASPERGILLUS-NIDULANS; APPRESSORIUM DIFFERENTIATION; TRANSCRIPTION FACTOR; NEUROSPORA-CRASSA; CELL-TYPES; GRISEA; FUNGUS; PROTEIN; SPORULATION	Conidiation of phytopathogenic fungi is a key developmental process that plays a central role in their life cycles and in epidemics. However, there is little information on conidiation-induced molecular changes in the rice blast fungus Magnaporthe oryzae. As a first step to understand conidiogenesis in this fungus, we measured genome-wide gene expression profiles during conidiation using a whole genome oligonucleotide microarray. At a two-fold expression difference, approximately 4.42% and 4.08% of genes were upregulated and downregulated, respectively, during conidiation. The differentially expressed genes were functionally categorized by gene ontology (GO) term analysis, which demonstrated that the gene set encoded proteins that function in metabolism, cell wall biosynthesis, transcription, and molecule transport. To define the events of the complicated process of conidiogenesis, another set of microarray experiments was performed using a deletion mutant for MoHOX2, a stage-specific transcriptional regulator essential for conidial formation, which was expressed de novo in a conidiation-specific manner in M. oryzae. Gene expression profiles were compared between the wild-type and the Delta Mohox2 mutant during conidiation. This analysis defined a common gene set that was upregulated in the wild-type and downregulated in the Delta Mohox2 mutant during conidiation; this gene set is expected to include conidiation-related downstream genes of MoHOX2. We identified several hundred genes that are differentially-expressed during conidiation; our results serve as an important resource for understanding the conidiation, a process in M. oryzae, which is critical for disease development.	[Kim, Kyoung Su] Kangwon Natl Univ, Res Inst Agr & Life Sci, Coll Agr & Life Sci, Dept Appl Biol, Chunchon, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Plant Genom & Breeding Inst, Ctr Fungal Genet Resources, Ctr Fungal Pathogenesis,Dept Agr Biotechnol,Ctr A, Seoul, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Kangwon National University; Seoul National University (SNU); Seoul National University (SNU)	Kim, KS (corresponding author), Kangwon Natl Univ, Res Inst Agr & Life Sci, Coll Agr & Life Sci, Dept Appl Biol, Chunchon, South Korea.	yonglee@snu.ac.kr		Kim, Kyoung Su/0000-0002-0827-0844	Kangwon National University; National Research Foundation of Korea; Korea government [2012-0001149, 2012-0000141]; Technology Development Program for Agriculture and Forestry [309015-04-SB020]; Next-Generation BioGreen 21 Program of Rural Development Administration in Korea [PJ00821201]	Kangwon National University; National Research Foundation of Korea(National Research Foundation of Korea); Korea government(Korean Government); Technology Development Program for Agriculture and Forestry; Next-Generation BioGreen 21 Program of Rural Development Administration in Korea	This work was supported by the 2011 Research Grant from Kangwon National University, the National Research Foundation of Korea grant funded by the Korea government (2012-0001149 and 2012-0000141), the Technology Development Program for Agriculture and Forestry (309015-04-SB020) and the Next-Generation BioGreen 21 Program of Rural Development Administration in Korea (PJ00821201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Choi J, 2009, FUNGAL GENET BIOL, V46, P243, DOI 10.1016/j.fgb.2008.11.010; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Del Sorbo G, 2000, FUNGAL GENET BIOL, V30, P1, DOI 10.1006/fgbi.2000.1206; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Donofrio NM, 2006, FUNGAL GENET BIOL, V43, P605, DOI 10.1016/j.fgb.2006.03.005; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Etienne W, 2004, BIOTECHNIQUES, V36, P618, DOI 10.2144/04364ST02; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; HAMER JE, 1989, GENETICS, V122, P351; Kamakura T, MOL PLANT MICROBE IN, V15, P437; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000757; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Lau GW, 1998, FUNGAL GENET BIOL, V24, P228, DOI 10.1006/fgbi.1998.1053; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; Li D, 2005, GENETICS, V170, P1091, DOI 10.1534/genetics.104.036772; Liu WD, 2010, MOL PLANT MICROBE IN, V23, P366, DOI 10.1094/MPMI-23-4-0366; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Odenbach D, 2007, MOL MICROBIOL, V64, P293, DOI 10.1111/j.1365-2958.2007.05643.x; Oh Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r85; Ou SH, 1985, RICE DIS, P97; Park SY, 2010, PLANT PATHOLOGY J, V26, P313, DOI 10.5423/PPJ.2010.26.4.313; Shi ZX, 1998, MOL PLANT MICROBE IN, V11, P199, DOI 10.1094/MPMI.1998.11.3.199; SPRINGER ML, 1993, BIOESSAYS, V15, P365, DOI 10.1002/bies.950150602; Takano Y, 2003, MOL PLANT PATHOL, V4, P337, DOI [10.1046/j.1364-3703.2003.00182.x, 10.1046/J.1364-3703.2003.00182.X]; Yang J, 2010, MOL PLANT MICROBE IN, V23, P112, DOI 10.1094/MPMI-23-1-0112; Yu JH, 2006, EUKARYOT CELL, V5, P1577, DOI 10.1128/EC.00193-06; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhou ZZ, 2009, MOL PLANT MICROBE IN, V22, P402, DOI 10.1094/MPMI-22-4-0402	33	19	20	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43202	10.1371/journal.pone.0043202	http://dx.doi.org/10.1371/journal.pone.0043202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927950	Green Submitted, Green Published, gold			2022-12-25	WOS:000307789700026
J	Miller, KR; Koide, A; Leung, B; Fitzsimmons, J; Yoder, B; Yuan, H; Jay, M; Sidhu, SS; Koide, S; Collins, EJ				Miller, Keith R.; Koide, Akiko; Leung, Brenda; Fitzsimmons, Jonathan; Yoder, Bryan; Yuan, Hong; Jay, Michael; Sidhu, Sachdev S.; Koide, Shohei; Collins, Edward J.			T Cell Receptor-Like Recognition of Tumor In Vivo by Synthetic Antibody Fragment	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MHC CLASS-I; BREAST-CANCER; METASTATIC MELANOMA; INFILTRATING LYMPHOCYTES; RECOMBINANT ANTIBODIES; RESTRICTED SPECIFICITY; MONOCLONAL-ANTIBODIES; BIOLOGICAL EVALUATION; ESCHERICHIA-COLI	A major difficulty in treating cancer is the inability to differentiate between normal and tumor cells. The immune system differentiates tumor from normal cells by T cell receptor (TCR) binding of tumor-associated peptides bound to Major Histocompatibility Complex (pMHC) molecules. The peptides, derived from the tumor-specific proteins, are presented by MHC proteins, which then serve as cancer markers. The TCR is a difficult protein to use as a recombinant protein because of production issues and has poor affinity for pMHC; therefore, it is not a good choice for use as a tumor identifier outside of the immune system. We constructed a synthetic antibody-fragment (Fab) library in the phage-display format and isolated antibody-fragments that bind pMHC with high affinity and specificity. One Fab, fE75, recognizes our model cancer marker, the Human Epidermal growth factor Receptor 2 (HER2/neu) peptide, E75, bound to the MHC called Human Leukocyte Antigen-A2 (HLA-A2), with nanomolar affinity. The fE75 bound selectively to E75/HLA-A2 positive cancer cell lines in vitro. The fE75 Fab conjugated with Cu-64 selectively accumulated in E75/HLA-A2 positive tumors and not in E75/HLA-A2 negative tumors in an HLA-A2 transgenic mouse as probed using positron emission tomography/computed tomography (PET/CT) imaging. Considering that hundreds to thousands of different peptides bound to HLA-A2 are present on the surface of each cell, the fact that fE75 arrives at the tumor at all shows extraordinary specificity. These antibody fragments have great potential for diagnosis and targeted drug delivery in cancer.	[Koide, Akiko; Leung, Brenda; Koide, Shohei] Univ Chicago, Dept Biochem & Mol Biophys, Chicago, IL 60637 USA; [Miller, Keith R.; Collins, Edward J.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Fitzsimmons, Jonathan; Jay, Michael] Univ N Carolina, Dept Pharmaceut Sci, Chapel Hill, NC USA; [Yoder, Bryan; Yuan, Hong] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Collins, Edward J.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of Chicago; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University of North Carolina; University of North Carolina Chapel Hill	Koide, S (corresponding author), Univ Chicago, Dept Biochem & Mol Biophys, Chicago, IL 60637 USA.	skoide@uchicago.edu; edward_collins@med.unc.edu	, PEP-MX Core/AGV-4051-2022; , UNC Flow Cytometry Core/AGU-9839-2022	Yuan, Hong/0000-0002-0535-3214; Koide, Shohei/0000-0001-5473-4358	National Institutes of Health [AI088081]; NIH [R01-GM072688, P30 AI50410]; University of Chicago Comprehensive Cancer Center; DANA Foundation; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR); University of North Carolina University Cancer Research Fund pilot project award; NCI Center Core Support Grant [P30CA06086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, R21AI088081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Comprehensive Cancer Center; DANA Foundation; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR); University of North Carolina University Cancer Research Fund pilot project award; NCI Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health AI088081 (EJC), NIH R01-GM072688 (AK), the University of Chicago Comprehensive Cancer Center, the DANA Foundation (http://www.dana.org), the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an NIH funded program P30 AI50410 and a University of North Carolina University Cancer Research Fund pilot project award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Ashutosh Tripathy, scientific director of the Macromolecular Interactions Facility at the University of North Carolina at Chapel Hill for his assistance in collecting our SPR data and Drs. Erica Duguid and Chuan He at the University of Chicago for their assistance in oligonucleotide synthesis. We also thank the UNC Flow Cytometry Core Facility, supported in part by an NCI Center Core Support Grant (P30CA06086) to the UNC Lineberger Comprehensive Cancer Center.	ABASTADO JP, 1989, RES IMMUNOL, V140, P581, DOI 10.1016/0923-2494(89)90121-1; Alberti S, 1996, IMMUNOL CELL BIOL, V74, P292, DOI 10.1038/icb.1996.51; Andersen PS, 1996, P NATL ACAD SCI USA, V93, P1820, DOI 10.1073/pnas.93.5.1820; Anikeeva N, 2009, CLIN IMMUNOL, V130, P98, DOI 10.1016/j.clim.2008.08.025; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Boswell CA, 2004, J MED CHEM, V47, P1465, DOI 10.1021/jm030383m; Brossart P, 2000, BLOOD, V96, P3102, DOI 10.1182/blood.V96.9.3102.h8003102_3102_3108; Capala J, 2010, CURR OPIN ONCOL, V22, P559, DOI 10.1097/CCO.0b013e32833f8c3a; CHATZIIOANNOU AF, 2005, P AM THORAC SOC, V2, P510; Chatziioannou Arion F, 2005, Proc Am Thorac Soc, V2, P533, DOI 10.1513/pats.200508-079DS; Clements CS, 2006, CURR OPIN STRUC BIOL, V16, P787, DOI 10.1016/j.sbi.2006.09.004; Cohen CJ, 2003, J IMMUNOL, V170, P4349, DOI 10.4049/jimmunol.170.8.4349; Colcher D, 1998, Q J NUCL MED, V42, P225; Collins EJ, 2008, IMMUNOL RES, V41, P267, DOI 10.1007/s12026-008-8040-2; Denkberg G, 2002, P NATL ACAD SCI USA, V99, P9421, DOI 10.1073/pnas.132285699; Dogan I, 2004, EUR J IMMUNOL, V34, P598, DOI 10.1002/eji.200324721; DUC HT, 1993, INT IMMUNOL, V5, P427, DOI 10.1093/intimm/5.4.427; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Edwards LJ, 2011, IMMUNOL RES, V50, P39, DOI 10.1007/s12026-011-8204-3; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; Engberg J, 1999, IMMUNOTECHNOLOGY, V4, P273; Falkenburg JHF, 2011, BLOOD, V117, P4164, DOI 10.1182/blood-2011-03-335943; Faure F, 1998, CRIT REV IMMUNOL, V18, P77, DOI 10.1615/CritRevImmunol.v18.i1-2.90; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; FISK B, 1995, J EXP MED, V181, P2109, DOI 10.1084/jem.181.6.2109; FROSCHER BG, 1986, J EXP MED, V164, P196, DOI 10.1084/jem.164.1.196; FUJIMORI K, 1989, CANCER RES, V49, P5656; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Gonzalez-Angulo AM, 2007, ADV EXPT MED BIOL; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; Hawkins O, 2011, J IMMUNOL, V186, P6607, DOI 10.4049/jimmunol.1003995; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Heneweer C, 2011, J NUCL MED, V52, P625, DOI 10.2967/jnumed.110.083998; HOLTON OD, 1987, J IMMUNOL, V139, P3041; Homola J, 2006, SPRINGER SER CHEM SE, V4, P1, DOI 10.1007/b100321; Hoogenboom HR, 1998, IMMUNOTECHNOLOGY, V4, P1, DOI 10.1016/S1380-2933(98)00007-4; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Hulsmeyer M, 2005, J BIOL CHEM, V280, P2972, DOI 10.1074/jbc.M411323200; IOANNIDES CG, 1993, CLIN IMMUNOL IMMUNOP, V66, P91, DOI 10.1006/clin.1993.1012; Kaufman J, 1994, Semin Immunol, V6, P411, DOI 10.1006/smim.1994.1050; Kelly MP, 2008, CANCER BIOTHER RADIO, V23, P411, DOI 10.1089/cbr.2007.0450; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; Klechevsky E, 2008, CANCER RES, V68, P6360, DOI 10.1158/0008-5472.CAN-08-0928; Knutson KL, 2002, CLIN CANCER RES, V8, P1014; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Kono K, 2002, CLIN CANCER RES, V8, P3394; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Lane SR, 2010, NUCL MED BIOL, V37, P751, DOI 10.1016/j.nucmedbio.2010.04.016; LE AXT, 1989, J IMMUNOL, V142, P1366; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Lewis MR, 2001, BIOCONJUGATE CHEM, V12, P320, DOI 10.1021/bc0000886; Leyland-Jones B, 2002, LANCET ONCOL, V3, P137, DOI 10.1016/S1470-2045(02)00676-9; Lo BKC, 2003, ANTIBODY ENG; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Lohrisch C, 2008, CLIN BREAST CANCER, V2, P129; Luft T, 2001, J IMMUNOL, V167, P2529, DOI 10.4049/jimmunol.167.5.2529; Mareeva T, 2004, J BIOL CHEM, V279, P44243, DOI 10.1074/jbc.M407021200; Mareeva T, 2008, J BIOL CHEM, V283, P29053, DOI 10.1074/jbc.M804996200; MELIEF CJM, 1992, ADV CANCER RES, V58, P143, DOI 10.1016/S0065-230X(08)60294-8; Michaeli Y, 2009, J IMMUNOL, V182, P6328, DOI 10.4049/jimmunol.0801898; Miles J., 2001, APPL REGRESSION CORR; Mittendorf EA, 2006, CANCER-AM CANCER SOC, V106, P2309, DOI 10.1002/cncr.21849; Mohsin H, 2007, NUCL MED BIOL, V34, P493, DOI 10.1016/j.nucmedbio.2007.03.006; Morgan RA, 2010, CANCER J, V16, P336, DOI 10.1097/PPO.0b013e3181eb3879; Murray JL, 2002, CLIN CANCER RES, V8, P3407; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Neumann F, 2009, IMMUNOL LETT, V125, P86, DOI 10.1016/j.imlet.2009.06.002; Nishimura R, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-131; Orlova A, 2007, CANCER BIOTHER RADIO, V22, P573, DOI 10.1089/cbr.2006.004-U; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Phan GQ, 2001, EXPERT OPIN BIOL TH, V1, P511, DOI 10.1517/14712598.1.3.511; Pinthus JH, 2004, J CLIN INVEST, V114, P1774, DOI 10.1172/JCI200422284; Plaksin D, 1997, J IMMUNOL, V158, P2218; Polakova K, 2000, J IMMUNOL, V165, P5703, DOI 10.4049/jimmunol.165.10.5703; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Reiter Y, 1997, P NATL ACAD SCI USA, V94, P4631, DOI 10.1073/pnas.94.9.4631; ROSENBERG SA, 1988, ANN SURG, V208, P121, DOI 10.1097/00000658-198808000-00001; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; Ross JS, 1998, STEM CELLS, V16, P413, DOI 10.1002/stem.160413; SHIRAI M, 1995, J IMMUNOL, V154, P2733; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Somasundaram R, 2004, CLIN EXP IMMUNOL, V135, P247, DOI 10.1111/j.1365-2249.2003.02366.x; Stewart-Jones G, 2009, P NATL ACAD SCI USA, V106, P5784, DOI 10.1073/pnas.0901425106; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; TAMMINEN WL, 1987, EUR J IMMUNOL, V17, P999, DOI 10.1002/eji.1830170716; Topalian S L, 1990, Important Adv Oncol, P19; Toseland CP, 2005, IMMUNOME RES, V1, P1; Verma B, 2010, J IMMUNOL, V184, P2156, DOI 10.4049/jimmunol.0902414; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; VOSE BM, 1985, SEMIN HEMATOL, V22, P27; Wang LJ, 2009, MOL PHARMACEUT, V6, P231, DOI 10.1021/mp800150r; Weidanz JA, 2006, J IMMUNOL, V177, P5088, DOI 10.4049/jimmunol.177.8.5088; WHITESIDE TL, 1994, IMMUNOL SER, V61, P137; Whitfield-Larry F, 2011, DIABETES, V60, P1726, DOI 10.2337/db10-1287; Willemsen R, 2008, CYTOM PART A, V73A, P1093, DOI 10.1002/cyto.a.20644; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; WULFING C, 1994, J MOL BIOL, V242, P655, DOI 10.1006/jmbi.1994.1615; WYLIE DE, 1982, J EXP MED, V155, P403, DOI 10.1084/jem.155.2.403; Xue SA, 2005, BLOOD, V106, P3062, DOI 10.1182/blood-2005-01-0146; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhu XK, 2010, IMMUNOL CELL BIOL, V88, P667, DOI 10.1038/icb.2010.21	104	50	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43746	10.1371/journal.pone.0043746	http://dx.doi.org/10.1371/journal.pone.0043746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916301	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800099
J	Seto, WK; Wong, DKH; Fung, J; Ip, PPC; Yuen, JCH; Hung, IFN; Lai, CL; Yuen, MF				Seto, Wai-Kay; Wong, Danny Ka-Ho; Fung, James; Ip, Philip P. C.; Yuen, John Chi-Hang; Hung, Ivan Fan-Ngai; Lai, Ching-Lung; Yuen, Man-Fung			High Hepatitis B Surface Antigen Levels Predict Insignificant Fibrosis in Hepatitis B e Antigen Positive Chronic Hepatitis B	PLOS ONE			English	Article							SERUM ALANINE AMINOTRANSFERASE; NATURAL-HISTORY; LIVER HISTOLOGY; HBEAG; DNA; SEVERITY	Introduction: There is no data on the relationship between hepatitis B surface antigen (HBsAg) levels and liver fibrosis in hepatitis B e antigen (HBeAg)-positive patients with chronic hepatitis B (CHB). Methods: Serum HBsAg and HBV DNA levels in HBeAg-positive CHB patients with liver biopsies were analyzed. The upper limit of normal (ULN) of alanine aminotransferase (ALT) was 30 and 19 U/L for men and women respectively. Histologic assessment was based on Ishak fibrosis staging for fibrosis and Knodell histologic activity index (HAI) for necroinflammation. Results: 140 patients (65% male, median age 32.7 years) were recruited. 56 (40%) had ALT <= 2xULN. 72 (51.4%) and 42 (30%) had fibrosis score <= 1 and necroinflammation grading <= 4 respectively. Patients with fibrosis score <= 1, when compared to patients with fibrosis score >1, had significantly higher median HBsAg levels (50,320 and 7,820 IU/mL respectively, p<0.001). Among patients with ALT <= 2xULN, serum HBsAg levels achieved an area under receiver operating characteristic curve of 0.869 in predicting fibrosis score <= 1. HBsAg levels did not accurately predict necroinflammation score. HBsAg >= 25,000 IU/mL was independently associated with fibrosis score <= 1 (p = 0.025, odds ratio 9.042). Using this cut-off HBsAg level in patients with ALT <= 2xULN, positive and negative predictive values for predicting fibrosis score <= 1 were 92.7% and 60.0% respectively. HBV DNA levels had no association with liver histology. Conclusion: Among HBeAg-positive patients with ALT <= 2xULN, high serum HBsAg levels can accurately predict fibrosis score <= 1, and could potentially influence decisions concerning treatment commencement and reduce the need for liver biopsy.	[Seto, Wai-Kay; Wong, Danny Ka-Ho; Fung, James; Yuen, John Chi-Hang; Hung, Ivan Fan-Ngai; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Ip, Philip P. C.] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Seto, WK (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hkucc.hku.hk	Ip, Philip/AAV-5995-2021; Wong, Danny/S-6230-2019; SETO, Wai-Kay/H-4452-2012; Fung, James/AAG-4832-2020; Wong, Danny/H-6819-2016; Hung, Ivan FN/ABD-5916-2021	Ip, Philip/0000-0002-0493-9838; SETO, Wai-Kay/0000-0002-9012-313X; Hung, Ivan FN/0000-0002-1556-2538; Fung, James/0000-0002-1286-8902; Lai, Ching-Lung/0000-0002-5927-2436; /0000-0001-9078-5005				Andreani T, 2007, CLIN GASTROENTEROL H, V5, P636, DOI 10.1016/j.cgh.2007.01.005; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; Chen CJ, 2011, HEPATOLOGY, V54, p881A; Colloredo G, 1999, J VIRAL HEPATITIS, V6, P429, DOI 10.1046/j.1365-2893.1999.00171.x; Fung J, 2008, LIVER INT, V28, P1408, DOI 10.1111/j.1478-3231.2008.01784.x; Fung J, 2011, HEPATOL INT, V5, P868, DOI 10.1007/s12072-011-9288-5; Fung J, 2010, EXPERT REV ANTI-INFE, V8, P717, DOI 10.1586/ERI.10.45; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jaroszewicz J, 2010, J HEPATOL, V52, P514, DOI 10.1016/j.jhep.2010.01.014; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Kumar M, 2008, GASTROENTEROLOGY, V134, P1376, DOI 10.1053/j.gastro.2008.02.075; Lai CL, 2007, ANN INTERN MED, V147, P58, DOI 10.7326/0003-4819-147-1-200707030-00010; Lee JK, 2010, HEPATOLOGY, V51, P1577, DOI 10.1002/hep.23505; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mani H, 2009, HEPATOLOGY, V49, pS61, DOI 10.1002/hep.22930; Martinot-Peignoux M, 2012, J HEPATOL, V56, pS211, DOI 10.1016/S0168-8278(12)60545-5; Moucari R, 2009, HEPATOLOGY, V49, P1151, DOI 10.1002/hep.22744; Myers RP, 2003, J HEPATOL, V39, P222, DOI 10.1016/S0168-8278(03)00171-5; Nguyen T, 2010, J HEPATOL, V52, P508, DOI 10.1016/j.jhep.2010.01.007; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pollicino T, 2012, HEPATOLOGY; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032622; Seto WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023077; Seto WK, 2012, HEPATOLOGY; Sumi H, 2003, HEPATOLOGY, V37, P19, DOI 10.1053/jhep.2003.50036; Tseng TC, 2012, GASTROENTEROLOGY, V142, P1140, DOI 10.1053/j.gastro.2012.02.007; Tseng TC, 2011, GASTROENTEROLOGY, V141, P517, DOI 10.1053/j.gastro.2011.04.046; Wai CT, 2006, LIVER INT, V26, P666, DOI 10.1111/j.1478-3231.2006.01287.x; Wiegand J, 2008, ANTIVIR THER, V13, P547; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136; Yuen MF, 2005, J VIRAL HEPATITIS, V12, P513, DOI 10.1111/j.1365-2893.2005.00629.x; Yuen MF, 2005, ALIMENT PHARM THERAP, V21, P841, DOI 10.1111/j.1365-2036.2005.02410.x; Yuen MF, 2004, AM J GASTROENTEROL, V99, P2032, DOI 10.1111/j.1572-0241.2004.40440.x; Zeng MD, 2005, HEPATOLOGY, V42, P1437, DOI 10.1002/hep.20960	39	60	64	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43087	10.1371/journal.pone.0043087	http://dx.doi.org/10.1371/journal.pone.0043087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916211	Green Submitted, gold, Green Published			2022-12-25	WOS:000307733800046
J	Xu, Y; Wang, YH; Besnard, V; Ikegami, M; Wert, SE; Heffner, C; Murray, SA; Donahue, LR; Whitsett, JA				Xu, Yan; Wang, Yanhua; Besnard, Valerie; Ikegami, Machiko; Wert, Susan E.; Heffner, Caleb; Murray, Stephen A.; Donahue, Leah Rae; Whitsett, Jeffrey A.			Transcriptional Programs Controlling Perinatal Lung Maturation	PLOS ONE			English	Article							NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; DEVELOPING MOUSE LUNG; SURFACTANT PROTEIN-A; PROBE LEVEL DATA; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; STRUCTURAL ASPECTS; EPITHELIAL-CELLS; DOWN-REGULATION	The timing of lung maturation is controlled precisely by complex genetic and cellular programs. Lung immaturity following preterm birth frequently results in Respiratory Distress Syndrome (RDS) and Broncho-Pulmonary Dysplasia (BPD), which are leading causes of mortality and morbidity in preterm infants. Mechanisms synchronizing gestational length and lung maturation remain to be elucidated. In this study, we designed a genome-wide mRNA expression time-course study from E15.5 to Postnatal Day 0 (PN0) using lung RNAs from C57BL/6J (B6) and A/J mice that differ in gestational length by similar to 30 hr (B6, A/J). Comprehensive bioinformatics and functional genomics analyses were used to identify key regulators, bioprocesses and transcriptional networks controlling lung maturation. We identified both temporal and strain dependent gene expression patterns during lung maturation. For time dependent changes, cell adhesion, vasculature development, and lipid metabolism/transport were major bioprocesses induced during the saccular stage of lung development at E16.5-E17.5. CEBPA, PPARG, VEGFA, CAV1 and CDH1 were found to be key signaling and transcriptional regulators of these processes. Innate defense/immune responses were induced at later gestational ages (E18.5-20.5), STAT1, AP1, and EGFR being important regulators of these responses. Expression of RNAs associated with the cell cycle and chromatin assembly was repressed during prenatal lung maturation and was regulated by FOXM1, PLK1, chromobox, and high mobility group families of transcription factors. Strain dependent lung mRNA expression differences peaked at E18.5. At this time, mRNAs regulating surfactant and innate immunity were more abundantly expressed in lungs of B6 (short gestation) than in A/J (long gestation) mice, while expression of genes involved in chromatin assembly and histone modification were expressed at lower levels in B6 than in A/J mice. The present study systemically mapped key regulators, bioprocesses, and transcriptional networks controlling lung maturation, providing the basis for new therapeutic strategies to enhance lung function in preterm infants.	[Xu, Yan; Wang, Yanhua; Besnard, Valerie; Ikegami, Machiko; Wert, Susan E.; Whitsett, Jeffrey A.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45221 USA; [Xu, Yan; Wang, Yanhua; Besnard, Valerie; Ikegami, Machiko; Wert, Susan E.; Whitsett, Jeffrey A.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Sect Neonatol Perinatal & Pulm Biol, Cincinnati, OH USA; [Heffner, Caleb; Murray, Stephen A.; Donahue, Leah Rae] Jackson Lab, Bar Harbor, ME 04609 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Jackson Laboratory	Xu, Y (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45221 USA.	yan.xu@cchmc.org		Heffner, Caleb/0000-0002-2631-6201; Besnard, Valerie/0000-0002-2614-629X; , Yan/0000-0003-2025-027X	March of Dimes [6-FY109-235, HL105433, HL095469]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105433] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by March of Dimes (Dr. Whitsett, Dr. Xu), 6-FY109-235 (Dr. Ikegami), HL105433 (Dr. Xu, Dr. Whitsett, Dr. Ikegami) and HL095469 (Dr. Ikegami, Dr. Xu, Dr. Whitsett). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-415; Arman E, 1999, P NATL ACAD SCI USA, V96, P11895, DOI 10.1073/pnas.96.21.11895; Bachurski CJ, 2003, MOL CELL BIOL, V23, P9014, DOI 10.1128/MCB.23.24.9014-9024.2003; Besnard V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026682; Besnard V, 2009, J BIOL CHEM, V284, P4018, DOI 10.1074/jbc.M805388200; Bonner AE, 2003, J MED GENET, V40, P408, DOI 10.1136/jmg.40.6.408; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Bruno MD, 2000, J BIOL CHEM, V275, P1043, DOI 10.1074/jbc.275.2.1043; Burri PH, 2006, BIOL NEONATE, V89, P313, DOI 10.1159/000092868; BURRI PH, 1984, ANNU REV PHYSIOL, V46, P617, DOI 10.1146/annurev.ph.46.030184.003153; Collins BJ, 2004, SEMIN CANCER BIOL, V14, P357, DOI 10.1016/j.semcancer.2004.04.015; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Cox B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100151; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; Dave V, 2004, J BIOL CHEM, V279, P34578, DOI 10.1074/jbc.M404296200; deFelice M, 2003, J BIOL CHEM, V278, P35574, DOI 10.1074/jbc.M304885200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; DUBIN SB, 1990, CLIN CHEM, V36, P1867; Dziak R, 2003, J BIOL CHEM, V278, P27372, DOI 10.1074/jbc.M301110200; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ferner K, 2009, ANAT REC, V292, P190, DOI 10.1002/ar.20825; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Fu LM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-3; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; FURST DE, 1989, ARTHRITIS RHEUM, V32, P584, DOI 10.1002/anr.1780320512; Garmany TH, 2008, PEDIATR RES, V63, P645, DOI 10.1203/PDR.0b013e31816fdbeb; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Grenache DG, 2006, CLIN BIOCHEM, V39, P1, DOI 10.1016/j.clinbiochem.2005.10.008; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; HAZEN PG, 1977, ARCH DERMATOL, V113, P689, DOI 10.1001/archderm.113.5.689; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Hibbard JU, 2010, JAMA-J AM MED ASSOC, V304, P419, DOI 10.1001/jama.2010.1015; Hiyama A, 2010, J BONE MINER RES, V25, P1179, DOI 10.1359/jbmr.091202; Huqun, 2007, AM J RESP CRIT CARE, V175, P263, DOI 10.1164/rccm.200609-1274OC; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Islam KN, 2006, MOL CELL BIOL, V26, P2901, DOI 10.1128/MCB.26.8.2901-2912.2006; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kho AT, 2009, AM J RESP CELL MOL, V40, P47, DOI 10.1165/rcmb.2008-0048OC; Kimura Y, 2003, J IMMUNOL, V170, P2331, DOI 10.4049/jimmunol.170.5.2331; Kook H, 2003, TRENDS CARDIOVAS MED, V13, P261, DOI 10.1016/S1050-1738(03)00107-5; La Rosa S, 2010, VIRCHOWS ARCH, V457, P497, DOI 10.1007/s00428-010-0954-0; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Lin S, 2008, DEV BIOL, V316, P441, DOI 10.1016/j.ydbio.2008.02.003; Liu C, 2002, J BIOL CHEM, V277, P4519, DOI 10.1074/jbc.M107585200; Londhe VA, 2008, DEV DYNAM, V237, P328, DOI 10.1002/dvdy.21413; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Maina JN, 2002, ADV ANAT EMBRYOL CEL, V163, P1; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Mariani TJ, 2002, AM J RESP CELL MOL, V26, P541, DOI 10.1165/ajrcmb.26.5.2001-00080c; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McCormack FX, 2002, J CLIN INVEST, V109, P707, DOI 10.1172/JCI200215293; McMurtry IF, 2002, AM J PHYSIOL-LUNG C, V282, pL341, DOI 10.1152/ajplung.00445.2001; Metzger DE, 2007, DEV DYNAM, V236, P1175, DOI 10.1002/dvdy.21133; Minoo P, 2007, MOL CELL BIOL, V27, P2155, DOI 10.1128/MCB.01133-06; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Murray SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012418; Naltner A, 2000, J BIOL CHEM, V275, P56, DOI 10.1074/jbc.275.1.56; Nemir M, 2008, J MOL CELL CARDIOL, V45, P495, DOI 10.1016/j.yjmcc.2008.02.273; Nguyen NM, 2002, DEV BIOL, V246, P231, DOI 10.1006/dbio.2002.0658; Ni ZY, 2007, J IMMUNOL, V178, P345, DOI 10.4049/jimmunol.178.1.345; Perl AKT, 1999, CLIN GENET, V56, P14, DOI 10.1034/j.1399-0004.1999.560103.x; Prince LS, 2004, AM J PHYSIOL-LUNG C, V287, pL999, DOI 10.1152/ajplung.00111.2004; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Ray DW, 1996, CANCER RES, V56, P3276; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Salanova B, 2007, J BIOL CHEM, V282, P27960, DOI 10.1074/jbc.M704039200; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shi Wei, 2009, Proc Am Thorac Soc, V6, P558, DOI 10.1513/pats.200905-031RM; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Szdzuy K, 2009, J EXP ZOOL PART B, V312B, P555, DOI 10.1002/jez.b.21228; Taira T, 1999, J BIOL CHEM, V274, P24270, DOI 10.1074/jbc.274.34.24270; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Tirosh I, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.84; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Ueyama T, 2003, MOL CELL BIOL, V23, P9222, DOI 10.1128/MCB.23.24.9222-9232.2003; Wan H, 2005, J BIOL CHEM; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Webster JI, 2004, ANN NY ACAD SCI, V1024, P9, DOI 10.1196/annals.1321.003; White AC, 2006, DEVELOPMENT, V133, P1507, DOI 10.1242/dev.02313; Whitsett JA, 2006, PEDIATR CLIN N AM, V53, P873, DOI 10.1016/j.pcl.2006.08.009; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Xu Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-451; Yang M, 2001, J IMMUNOL, V166, P6885, DOI 10.4049/jimmunol.166.11.6885; Yin Z, 2006, AM J PHYSIOL-LUNG C, V291, pL191, DOI 10.1152/ajplung.00385.2005; Yoshida M, 2001, J IMMUNOL, V166, P7514, DOI 10.4049/jimmunol.166.12.7514	92	41	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e37046	10.1371/journal.pone.0037046	http://dx.doi.org/10.1371/journal.pone.0037046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916088	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800001
J	Borte, S; Janzi, M; Pan-Hammarstrom, Q; von Dobeln, U; Nordvall, L; Winiarski, J; Fasth, A; Hammarstrom, L				Borte, Stephan; Janzi, Magdalena; Pan-Hammarstrom, Qiang; von Dobeln, Ulrika; Nordvall, Lennart; Winiarski, Jacek; Fasth, Anders; Hammarstrom, Lennart			Placental Transfer of Maternally-Derived IgA Precludes the Use of Guthrie Card Eluates as a Screening Tool for Primary Immunodeficiency Diseases	PLOS ONE			English	Article							COMBINED IMMUNE-DEFICIENCY; ADENOSINE-DEAMINASE DEFICIENCY; X-LINKED AGAMMAGLOBULINEMIA; BONE-MARROW-TRANSPLANTATION; COMPLETE DIGEORGE-SYNDROME; STEM-CELL TRANSPLANTATION; ATAXIA-TELANGIECTASIA PATIENTS; ACUTE LYMPHOBLASTIC-LEUKEMIA; EPSTEIN-BARR-VIRUS; PRE-B-CELLS	There is a need for neonatal screening tools to improve the long-term clinical outcome of patients with primary immunodeficiency diseases (PID). Recently, a PCR-based screening method for both TRECs and KRECs using Guthrie card samples has been developed. However, the applicability of these excision circle assays is limited to patients with severe T or B cell lymphopenia (SCID, XLA and A-T), whereas the most common forms of PID are not detected. Absence of serum IgA is seen in a major fraction of patients with immunological defects. As serum IgA in newborns is considered to be of fetal origin, eluates from routinely collected dried blood spot samples might thus be suitable for identification of children with PID. To assess the applicability of such screening assays, stored Guthrie card samples were obtained from 47 patients with various forms of primary immunodeficiency diseases (SCID, XLA, A-T, HIGM and IgAD), 20 individuals with normal serum IgA levels born to IgA-deficient mothers and 51 matched healthy newborns. Surprisingly, normal serum IgA levels were found in all SCID, XLA, A-T and HIGM patients and, additionally, in all those IgAD patients born to IgA-sufficient mothers. Conversely, no serum IgA was found in any of the 16 IgAD patients born by IgA-deficient mothers. Moreover, half of the IgA-sufficient individuals born by IgA-deficient mothers also lacked IgA at birth whereas no IgA-deficient individuals were found among the controls. IgA in neonatal dried blood samples thus appears to be of both maternal and fetal origin and precludes its use as a reliable marker for neonatal screening of primary immunodeficiency diseases.	[Borte, Stephan; Janzi, Magdalena; Pan-Hammarstrom, Qiang; Hammarstrom, Lennart] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Clin Immunol & Transfus Med, Stockholm, Sweden; [Borte, Stephan] Univ Leipzig, Translat Ctr Regenerat Med TRM, Leipzig, Germany; [Borte, Stephan] Hosp St Georg gGmbH Leipzig, Jeffrey Modell Diagnost & Res Ctr Primary Immunod, ImmunoDeficiencyCtr Leipzig IDCL, Leipzig, Germany; [von Dobeln, Ulrika] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Metab Dis, Stockholm, Sweden; [Nordvall, Lennart] Uppsala Univ, Acad Hosp, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Winiarski, Jacek] Karolinska Inst, Karolinska Univ Hosp Huddinge, Div Pediat CLINTEC, Stockholm, Sweden; [Fasth, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Pediat, Gothenburg, Sweden	Karolinska Institutet; Karolinska University Hospital; Leipzig University; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Karolinska Institutet; Karolinska University Hospital; University of Gothenburg	Borte, S (corresponding author), Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Clin Immunol & Transfus Med, Stockholm, Sweden.	stephan.borte@ki.se; lennart.hammarstrom@ki.se	hammarstrom, qiang pan/ABA-4589-2021; Fasth, Anders/I-1109-2019	Fasth, Anders/0000-0002-0033-740X; pan-hammarstrom, qiang/0000-0003-1990-8804	Jeffrey Modell Foundation; Swedish Primary Immunodeficiency Organisation (PIO); Gillbergska Foundation; Karolinska Institutet; Swedish Research Council; European Union [223293]; German Federal Ministry of Education and Research (BMBF) [PtJ-Bio 0315883]; National Research School in Health and Caring Science	Jeffrey Modell Foundation; Swedish Primary Immunodeficiency Organisation (PIO); Gillbergska Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Research School in Health and Caring Science	The herein presented research was supported in part by the Jeffrey Modell Foundation (to S. B. and L. H.), the Swedish Primary Immunodeficiency Organisation (PIO), the Gillbergska Foundation, the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and the Karolinska Institutet, the Swedish Research Council, the European Union (Euro-Gene-Scan, project 223293) and the German Federal Ministry of Education and Research (BMBF, PtJ-Bio 0315883). M.J. was supported by an educational grant from the National Research School in Health and Caring Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAMANOLIS DP, 1979, J NEUROPATH EXP NEUR, V38, P475, DOI 10.1097/00005072-197909000-00003; Akha AAS, 1999, MEDICINE, V78, P370, DOI 10.1097/00005792-199911000-00002; Al-Tamemi S, 2005, PEDIATRICS, V116, pE457, DOI 10.1542/peds.2005-0371; ANDERSSON U, 1980, EUR J IMMUNOL, V10, P888, DOI 10.1002/eji.1830101115; AVRECH OM, 1994, INT ARCH ALLERGY IMM, V103, P160, DOI 10.1159/000236622; Ben-Hur H, 2005, INT J MOL MED, V16, P401; Ben-Hur Herzl, 1997, Human Antibodies, V8, P119; Berlucchi M, 2008, J PEDIATR-US, V153, P293, DOI 10.1016/j.jpeds.2008.03.008; BILLINGTON WD, 1992, BAILLIERE CLIN OB GY, V6, P417, DOI 10.1016/S0950-3552(05)80004-5; Bjerkli IH, 1996, INT J PEDIATR OTORHI, V36, P205, DOI 10.1016/0165-5876(96)01344-4; BORDIGONI P, 1982, LANCET, V2, P293; Borte S, 2012, BLOOD, V119, P2552, DOI 10.1182/blood-2011-08-371021; Borte S, 2011, ANN NY ACAD SCI, V1246, P118, DOI 10.1111/j.1749-6632.2011.06350.x; BORZY MS, 1989, J CLIN IMMUNOL, V9, P386, DOI 10.1007/BF00917103; Butte MJ, 2007, CLIN IMMUNOL, V125, P159, DOI 10.1016/j.clim.2007.06.007; CEDERQVIST LL, 1974, J IMMUNOL, V112, P1605; CEDERQVIST LL, 1978, AM J OBSTET GYNECOL, V131, P520, DOI 10.1016/0002-9378(78)90113-8; CEDERQVIST LL, 1977, AM J OBSTET GYNECOL, V129, P687, DOI 10.1016/0002-9378(77)90653-6; COHEN LE, 1984, J AM ACAD DERMATOL, V10, P431, DOI 10.1016/S0190-9622(84)80089-4; Collard HR, 1999, CLIN IMMUNOL, V91, P156, DOI 10.1006/clim.1999.4691; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; Cossu F, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-76; de Villartay JP, 2005, J CLIN INVEST, V115, P3291, DOI 10.1172/JCI25178; Durandy A, 2005, IMMUNOL REV, V203, P67, DOI 10.1111/j.0105-2896.2005.00222.x; Dvorak CC, 2008, J PEDIAT HEMATOL ONC, V30, P396, DOI 10.1097/MPH.0b013e318168e7a0; Ehl S, 2005, J CLIN INVEST, V115, P3140, DOI 10.1172/JCI25221; FIORILLI M, 1986, J CLIN IMMUNOL, V6, P21, DOI 10.1007/BF00915360; FIORILLI M, 1983, J CLIN IMMUNOL, V3, P135, DOI 10.1007/BF00915484; Forte W C Neves, 2005, Allergol Immunopathol (Madr), V33, P199; FRAIS MA, 1979, J MED GENET, V16, P160, DOI 10.1136/jmg.16.2.160; Fried AJ, 2009, CLIN MICROBIOL REV, V22, P396, DOI 10.1128/CMR.00001-09; Gaspar HB, 2006, MOL THER, V14, P505, DOI 10.1016/j.ymthe.2006.06.007; GATHINGS WE, 1977, EUR J IMMUNOL, V7, P804, DOI 10.1002/eji.1830071112; GATTI RA, 1968, LANCET, V2, P1366; Giliani S, 2006, J PEDIATR-US, V148, P272, DOI 10.1016/j.jpeds.2005.10.004; Giliani S, 2005, IMMUNOL REV, V203, P110, DOI 10.1111/j.0105-2896.2005.00234.x; Ginn Samantha L, 2004, Hum Mutat, V23, P522; GOLDSOBEL AB, 1987, J PEDIATR-US, V111, P40, DOI 10.1016/S0022-3476(87)80339-6; Graziani S, 2008, CLIN IMMUNOL, V128, P322, DOI 10.1016/j.clim.2008.05.012; Gruber TA, 2009, PEDIATR TRANSPLANT, V13, P244, DOI 10.1111/j.1399-3046.2008.00970.x; Gudmundsson KO, 1999, SCAND J IMMUNOL, V50, P21; Gurevich P, 2001, Early Pregnancy, V5, P191; GUSDON JP, 1969, AM J OBSTET GYNECOL, V103, P895, DOI 10.1016/S0002-9378(16)34434-9; Hammarstrom L, 2000, CLIN EXP IMMUNOL, V120, P225, DOI 10.1046/j.1365-2249.2000.01131.x; Hartel C, 2004, KLIN PADIATR, V216, P24, DOI 10.1055/5-2004-817993; HIRSCHHORN R, 1991, AM J HUM GENET, V49, P878; HIRSCHHORN R, 1993, CELL IMMUNOL, V152, P383, DOI 10.1006/cimm.1993.1299; Honig M, 2007, BLOOD, V109, P3595, DOI 10.1182/blood-2006-07-034678; Huang Kuei-Yu, 2001, Journal of Microbiology Immunology and Infection, V34, P71; Huang LH, 2005, ASIAN PAC J ALLERGY, V23, P221; HUMPHREYS MW, 1989, HUM GENET, V83, P79, DOI 10.1007/BF00274154; Hunter HL, 2008, CLIN EXP DERMATOL, V33, P148, DOI 10.1111/j.1365-2230.2007.02582.x; Janda A, 2007, PEDIATR TRANSPLANT, V11, P441, DOI 10.1111/j.1399-3046.2007.00702.x; Janic D, 2007, J PEDIAT HEMATOL ONC, V29, P713, DOI 10.1097/MPH.0b013e31814d67f4; Janzi M, 2009, PLOS ONE, pe5321; Jiang CK, 1997, HUM MOL GENET, V6, P2271, DOI 10.1093/hmg/6.13.2271; Jo EK, 2004, INT J HEMATOL, V80, P332, DOI 10.1532/IJH97.04026; Karaca NE, 2009, CLIN EXP MED, V9, P339, DOI 10.1007/s10238-009-0053-1; Kasasbeh E, 2008, CLIN MOL ALLERGY, V6, P1; Kellermayer R, 2006, J HUM GENET, V51, P495, DOI 10.1007/s10038-006-0386-5; Khumalo NP, 2001, BRIT J DERMATOL, V144, P369, DOI 10.1046/j.1365-2133.2001.04029.x; LANDRETH KS, 1985, J CLIN IMMUNOL, V5, P84, DOI 10.1007/BF00915005; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Malek A, 1996, AM J REPROD IMMUNOL, V36, P248; Malek A, 1998, AM J REPROD IMMUNOL, V40, P347; Markert ML, 1998, J PEDIATR-US, V132, P15, DOI 10.1016/S0022-3476(98)70478-0; Markert ML, 1997, J IMMUNOL, V158, P998; Matsumoto T, 1998, BONE MARROW TRANSPL, V22, P927, DOI 10.1038/sj.bmt.1701475; McDonald PS, 1998, PEDIATR DEVEL PATHOL, V1, P319, DOI 10.1007/s100249900046; Mella P, 2000, CLIN IMMUNOL, V95, P39, DOI 10.1006/clim.2000.4842; MESHRAM CM, 1986, J NEUROL, V233, P304, DOI 10.1007/BF00314163; Meyts I, 2003, PEDIATR ALLERGY IMMU, V14, P330, DOI 10.1034/j.1399-3038.2003.00037.x; Mitsui T, 2006, INT J HEMATOL, V84, P154, DOI 10.1532/IJH97.06095; MITSUYA H, 1981, CLIN IMMUNOL IMMUNOP, V19, P383, DOI 10.1016/0090-1229(81)90081-7; MIYAGI K, 1995, ACTA NEUROCHIR, V135, P87, DOI 10.1007/BF02307420; MIYAWAKI T, 1988, J IMMUNOL, V140, P3887; Moin M, 2007, PEDIATR NEUROL, V37, P21, DOI 10.1016/j.pediatrneurol.2007.03.002; Mustillo P, 2008, PEDIATR BLOOD CANCER, V51, P706, DOI 10.1002/pbc.21651; NELSON DL, 1983, J IMMUNOL, V130, P2629; Noordzij JG, 2009, ARCH DIS CHILD, V94, P448, DOI 10.1136/adc.2008.149351; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; OCHS HD, 1992, BLOOD, V80, P1163; Ohm-Laursen L, 2008, J CLIN IMMUNOL, V28, P588, DOI 10.1007/s10875-008-9210-7; Onodera M, 1998, BLOOD, V91, P30, DOI 10.1182/blood.V91.1.30.30_30_36; Otabor IA, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-29; OXELIUS VA, 1979, CLIN EXP IMMUNOL, V36, P112; Ozdemir O, 2006, ALLERGY ASTHMA PROC, V27, P172; OZER NK, 1985, CLIN EXP IMMUNOL, V61, P118; Ozsahin H, 1997, BLOOD, V89, P2849, DOI 10.1182/blood.V89.8.2849; Palmer K, 2007, J ALLERGY CLIN IMMUN, V120, P423, DOI 10.1016/j.jaci.2007.02.047; Pan-Hammarstrom Q, 2008, EUR J IMMUNOL, V38, P327, DOI 10.1002/eji.200737927; Pasic S, 2009, ACTA PAEDIATR, V98, P1062, DOI 10.1111/j.1651-2227.2009.01250.x; Pirovano S, 2003, IMMUNOL LETT, V86, P93, DOI 10.1016/S0165-2478(02)00291-2; Ponda P, 2006, ANN ALLERG ASTHMA IM, V97, P755, DOI 10.1016/S1081-1206(10)60965-9; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Quan CP, 1998, EUR J IMMUNOL, V28, P4001, DOI 10.1002/(SICI)1521-4141(199812)28:12<4001::AID-IMMU4001>3.3.CO;2-T; Quartier P, 1995, J PEDIAT, V134, P589; QUIE PG, 1990, SEMIN PERINATOL, V14, P2; Ramos JT, 1999, ARCH DIS CHILD, V81, P444, DOI 10.1136/adc.81.5.444; RIVATPERAN L, 1981, CLIN IMMUNOL IMMUNOP, V20, P99, DOI 10.1016/0090-1229(81)90166-5; Roberts JL, 2004, BLOOD, V103, P2009, DOI 10.1182/blood-2003-06-2104; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/ror.0.0040081; Samarghitean Crina, 2007, Immunome Res, V3, P6, DOI 10.1186/1745-7580-3-6; Sanka M, 2007, J ALLERGY CLIN IMMUN, V120, P952, DOI 10.1016/j.jaci.2007.08.013; Sharma LM, 2008, PEDIATR HEMAT ONCOL, V25, P473, DOI 10.1080/08880010802106614; SILBER GM, 1987, CLIN IMMUNOL IMMUNOP, V44, P317, DOI 10.1016/0090-1229(87)90075-4; Sirianni MC, 2006, INT ARCH ALLERGY IMM, V140, P82, DOI 10.1159/000092139; Staples ER, 2008, CLIN EXP IMMUNOL, V153, P214, DOI 10.1111/j.1365-2249.2008.03684.x; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; Strauss KA, 2008, CLIN IMMUNOL, V128, P31, DOI 10.1016/j.clim.2008.02.016; Stray-Pedersen A, 2004, CLIN EXP IMMUNOL, V137, P179, DOI 10.1111/j.1365-2249.2004.02492.x; Tabori U, 2004, CLIN GENET, V65, P322, DOI 10.1111/j.1399-0004.2004.00227.x; Trahair TN, 2008, PEDIATR BLOOD CANCER, V50, P366, DOI 10.1002/pbc.20887; Trimis G G, 2004, J Postgrad Med, V50, P270; TSUKAHARA M, 1986, EUR J PEDIATR, V145, P121, DOI 10.1007/BF00441871; UEDA H, 1980, TOHOKU J EXP MED, V132, P31, DOI 10.1620/tjem.132.31; Usui K, 2001, RESPIR RES, V2, P188, DOI 10.1186/rr56; VANDERMEER JWM, 1993, LANCET, V341, P1439, DOI 10.1016/0140-6736(93)90883-I; Verhagen MMM, 2009, NEUROLOGY, V73, P430, DOI 10.1212/WNL.0b013e3181af33bd; VETRO S W, 1989, Fetal Therapy, V4, P82; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Wada T, 2005, BLOOD, V106, P2099, DOI 10.1182/blood-2005-03-0936; WALDMANN TA, 1983, J CLIN INVEST, V71, P282, DOI 10.1172/JCI110768; Wang LJ, 2004, ASIAN PAC J ALLERGY, V22, P25; Wang Y, 2009, J CLIN IMMUNOL, V29, P352, DOI 10.1007/s10875-008-9262-8; WATANABE A, 1977, TOHOKU J EXP MED, V121, P127, DOI 10.1620/tjem.121.127; WEDGWOOD JF, 1994, MT SINAI J MED, V61, P406; WEINBERG K, 1993, J CLIN INVEST, V92, P596, DOI 10.1172/JCI116626; WILLEMS PJ, 1993, AM J MED GENET, V45, P777, DOI 10.1002/ajmg.1320450624; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x; YING KL, 1981, CANCER GENET CYTOGEN, V4, P311, DOI 10.1016/0165-4608(81)90027-3; YOUNT WJ, 1978, AM J MED, V65, P847, DOI 10.1016/0002-9343(78)90805-7	133	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43419	10.1371/journal.pone.0043419	http://dx.doi.org/10.1371/journal.pone.0043419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916257	Green Submitted, Green Published, gold			2022-12-25	WOS:000307824300046
J	van Helden, SFG; Anthony, EC; Dee, R; Hordijk, PL				van Helden, Suzanne F. G.; Anthony, Eloise C.; Dee, Rob; Hordijk, Peter L.			Rho GTPase Expression in Human Myeloid Cells	PLOS ONE			English	Article							TYPE-2 MACROPHAGES; DENDRITIC CELLS; IN-VIVO; PROTEIN; GENE; OSTEOCLASTS; ACTIVATION; FAMILY; PODOSOMES; ADHESION	Myeloid cells are critical for innate immunity and the initiation of adaptive immunity. Strict regulation of the adhesive and migratory behavior is essential for proper functioning of these cells. Rho GTPases are important regulators of adhesion and migration; however, it is unknown which Rho GTPases are expressed in different myeloid cells. Here, we use a qPCR-based approach to investigate Rho GTPase expression in myeloid cells. We found that the mRNAs encoding Cdc42, RhoQ, Rac1, Rac2, RhoA and RhoC are the most abundant. In addition, RhoG, RhoB, RhoF and RhoV are expressed at low levels or only in specific cell types. More differentiated cells along the monocyte-lineage display lower levels of Cdc42 and RhoV, while RhoC mRNA is more abundant. In addition, the Rho GTPase expression profile changes during dendritic cell maturation with Rac1 being upregulated and Rac2 downregulated. Finally, GM-CSF stimulation, during macrophage and osteoclast differentiation, leads to high expression of Rac2, while M-CSF induces high levels of RhoA, showing that these cytokines induce a distinct pattern. Our data uncover cell type specific modulation of the Rho GTPase expression profile in hematopoietic stem cells and in more differentiated cells of the myeloid lineage.	[van Helden, Suzanne F. G.; Anthony, Eloise C.; Hordijk, Peter L.] Sanquin Res, Dept Mol Cell Biol, Amsterdam, Netherlands; [van Helden, Suzanne F. G.; Anthony, Eloise C.; Hordijk, Peter L.] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Dee, Rob] Sanquin Diagnost, Dept Immunocytol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van Helden, SFG (corresponding author), Sanquin Res, Dept Mol Cell Biol, Amsterdam, Netherlands.	s.vanhelden@sanquin.nl		Hordijk, Peter/0000-0002-3348-078X	Sanquin	Sanquin	This project was funded by Sanquin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Brugger W, 1996, Curr Opin Hematol, V3, P235; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; DALLERY E, 1995, ONCOGENE, V10, P2171; DalleryPrudhomme E, 1997, GENOMICS, V43, P89, DOI 10.1006/geno.1997.4788; de Vries IJM, 2003, CANCER RES, V63, P12; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; Dorn T, 2007, BLOOD, V109, P2346, DOI 10.1182/BLOOD-2006-04-019034; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Foster R, 1996, MOL CELL BIOL, V16, P2689; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Gu Y, 2006, NAT IMMUNOL, V7, P1182, DOI 10.1038/ni1396; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; James DE, 2010, J IMMUNOL, V185, P1265, DOI 10.4049/jimmunol.0902808; Li XY, 2002, MOL CELL BIOL, V22, P1158, DOI 10.1128/MCB.22.4.1158-1171.2002; Linder S, 2000, J CELL SCI, V113, P4165; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mazzolari E, 2009, AM J HEMATOL, V84, P473, DOI 10.1002/ajh.21447; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Nethe M, 2010, J CELL SCI, V123, P4011, DOI 10.1242/jcs.078360; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Permaul P, 2009, IMMUNOL RES, V44, P89, DOI 10.1007/s12026-008-8085-2; Roos D, 1986, Methods Enzymol, V132, P225; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saras J, 2004, EXP CELL RES, V299, P356, DOI 10.1016/j.yexcr.2004.05.029; Schmidt S, 2011, J CELL BIOL, V192, P883, DOI 10.1083/jcb.201007141; Shutes A, 2004, CURR BIOL, V14, P2052, DOI 10.1016/j.cub.2004.11.011; Stenbeck G, 2000, J CELL SCI, V113, P1577; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wheeler AP, 2006, J CELL SCI, V119, P2749, DOI 10.1242/jcs.03024	48	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42563	10.1371/journal.pone.0042563	http://dx.doi.org/10.1371/journal.pone.0042563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916134	Green Published, gold, Green Submitted			2022-12-25	WOS:000307824300011
J	Boyer, S; Toty, C; Jacquet, M; Lemperiere, G; Fontenille, D				Boyer, Sebastien; Toty, Celine; Jacquet, Maxime; Lemperiere, Guy; Fontenille, Didier			Evidence of Multiple Inseminations in the Field in Aedes albopictus	PLOS ONE			English	Article							MICROSATELLITE MARKERS; DIPTERA-CULICIDAE; VECTOR; DENGUE; CHIKUNGUNYA; SURVIVAL; AEGYPTI; POPULATION; DISPERSAL; WOLBACHIA	Studies on the biology and mating behaviour of male mosquitoes are of major importance in a frame of a Sterile Insect Technique which could be used against mosquito vector species. Most particularly, the assumption of possible multiple inseminations in mosquito species must be investigated in order to optimize alternative mosquito control methods (Sterile Insect Techniques with genetically modified mosquitoes, cytoplasmic incompatibility, radiation ... ). The occurrence of multiple insemination events was investigated after 2 field samplings of Aedes albopictus (Diptera: Culicidae) in La Reunion Island using microsatellite markers. Respectively, 14 and 13 females after the first and the second sampling laid eggs. Seven wild females out of the 27 laying females were found with a progeny involving more than one father. This result is important for the new alternative mosquito control methods and raises the importance of pre- and post-copulatory competition.	[Boyer, Sebastien; Toty, Celine; Jacquet, Maxime; Lemperiere, Guy; Fontenille, Didier] Univ Montpellier I, Inst Rech Dev IRD UMR 224, MIVEGEC, Ctr Natl Rech Sci CNRS 5290, Montpellier, France; [Boyer, Sebastien; Toty, Celine; Jacquet, Maxime; Lemperiere, Guy; Fontenille, Didier] Univ Montpellier 2, Inst Rech Dev IRD UMR 224, MIVEGEC, Ctr Natl Rech Sci CNRS 5290, Montpellier, France; [Boyer, Sebastien; Toty, Celine; Jacquet, Maxime; Lemperiere, Guy] Ctr Rech & Veille Malad Emergentes Ocean Indien C, St Clotilde, Reunion, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Boyer, S (corresponding author), Univ Montpellier I, Inst Rech Dev IRD UMR 224, MIVEGEC, Ctr Natl Rech Sci CNRS 5290, Montpellier, France.	sebastien.boyer@ird.fr	FONTENILLE, didier/G-4091-2013	/0000-0001-5073-6217; FONTENILLE, didier/0000-0002-0544-3885; Boyer, Sebastien/0000-0002-2946-586X; Jacquet, Maxime/0000-0003-0690-1232	French Ministry of Health; FEDER Convergence Reunion programme; French Ministry of Health; FEDER Convergence Reunion programme	French Ministry of Health; FEDER Convergence Reunion programme; French Ministry of Health; FEDER Convergence Reunion programme	The IRD Sterile Insect Technique Project was financially supported by the French Ministry of Health and the FEDER Convergence Reunion 2007-2013 programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank Pierre Olivier Maquart for his contribution in the field work. The IRD Sterile Insect Technique Project was financially supported by the French Ministry of Health and the FEDER Convergence Reunion 2007-2013 programme.	Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Alphey N, 2007, J ECON ENTOMOL, V100, P1642, DOI 10.1603/0022-0493(2007)100[1642:MIRBMR]2.0.CO;2; Bellini R, 2010, J MED ENTOMOL, V47, P1082, DOI 10.1603/ME09154; Black WC, 2011, TRENDS PARASITOL, V27, P362, DOI 10.1016/j.pt.2011.04.004; Boyer S, 2011, MED VET ENTOMOL, V25, P454, DOI 10.1111/j.1365-2915.2011.00962.x; BULLINI L, 1976, B ENTOMOL RES, V65, P683, DOI 10.1017/S0007485300006374; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Edwards Keith J., 1998, P22; Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860; FRENCH W. L., 1963, Proceedings. New Jersey Mosquito Extermination Association, V50, P374; Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; GUBLER DJ, 1972, MOSQ NEWS, V32, P219; Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225; Helinski MEH, 2009, ACTA TROP, V109, P64, DOI 10.1016/j.actatropica.2008.10.002; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; HUANG Y-M, 1972, Contributions of the American Entomological Institute, V9, P1; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Lacroix R, 2009, J MED ENTOMOL, V46, P1117, DOI 10.1603/033.046.0519; Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2; Porretta D, 2006, MOL ECOL NOTES, V6, P880, DOI 10.1111/j.1471-8286.2006.01384.x; Ravel S, 2002, ACTA TROP, V82, P39, DOI 10.1016/S0001-706X(02)00028-1; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; SNIJDERS E. P., 1931, American Journal of Tropical Medicine, V11, P171; Tripet F, 2003, AM J TROP MED HYG, V68, P1; VILLARREAL C, 1994, J AM MOSQUITO CONTR, V10, P67; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; YUVAL B, 1994, B ENTOMOL RES, V84, P137, DOI 10.1017/S0007485300032326; ZALOM FG, 1981, MOSQ NEWS, V41, P154	33	30	32	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42040	10.1371/journal.pone.0042040	http://dx.doi.org/10.1371/journal.pone.0042040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916116	gold, Green Published, Green Submitted			2022-12-25	WOS:000307823600007
J	Yang, Y; Wu, J; Demir, A; Castillo-Martin, M; Melamed, RD; Zhang, G; Fukunaga-Kanabis, M; Perez-Lorenzo, R; Zheng, B; Silvers, DN; Brunner, G; Wang, S; Rabadan, R; Cordon-Cardo, C; Celebi, JT				Yang, Y.; Wu, J.; Demir, A.; Castillo-Martin, M.; Melamed, R. D.; Zhang, G.; Fukunaga-Kanabis, M.; Perez-Lorenzo, R.; Zheng, B.; Silvers, D. N.; Brunner, G.; Wang, S.; Rabadan, R.; Cordon-Cardo, C.; Celebi, J. T.			GAB2 induces tumor angiogenesis in NRAS-driven melanoma	ONCOGENE			English	Article						melanoma; angiogenesis; scaffold; adaptor	ADAPTER PROTEINS; CELLS; RAS; AMPLIFICATION; SUSCEPTIBILITY; STIMULATION; BRAF(V600E); ACTIVATION; MIGRATION; ONCOGENE	GAB2 is a scaffold protein with diverse upstream and downstream effectors. MAPK and PI3K signaling pathways are known effectors of GAB2. It is amplified and overexpressed in a variety of human tumors including melanoma. Here we show a previously undescribed role for GAB2 in NRAS-driven melanoma. Specifically, we found that GAB2 is co-expressed with mutant NRAS in melanoma cell lines and tumor samples and its expression correlated with metastatic potential. Co-expression of GAB2(WT) and NRAS(G12D) in melanocytes and in melanoma cells increased anchorage-independent growth by providing GAB2-expressing cells a survival advantage through upregulation of BCL-2 family of anti-apoptotic factors. Of note, collaboration of GAB2 with mutant NRAS enhanced tumorigenesis in vivo and led to an increased vessel density with strong CD34 and VEGFR2 activity. We found that GAB2 facilitiated an angiogenic switch by upregulating HIF-1 alpha and VEGF levels. This angiogenic response was significantly suppressed with the MEK inhibitor PD325901. These data suggest that GAB2-mediated signaling cascades collaborate with NRAS-driven downstream activation for conferring an aggressive phenotype in melanoma. Second, we show that GAB2/NRAS signaling axis is non-linear and non-redundant in melanocytes and melanoma, and thus are acting independent of each other. Finally, we establish a link between GAB2 and angiogenesis in melanoma for the first time. In conclusion, our findings provide evidence that GAB2 is a novel regulator of tumor angiogenesis in NRAS-driven melanoma through regulation of HIF-1 alpha and VEGF expressions mediated by RAS-RAF-MEK-ERK signaling.	[Yang, Y.; Wu, J.; Demir, A.; Perez-Lorenzo, R.; Zheng, B.; Silvers, D. N.; Celebi, J. T.] Columbia Univ, Dept Dermatol, New York, NY 10032 USA; [Castillo-Martin, M.; Cordon-Cardo, C.] Mt Sinai Sch Med, Dept Pathol, New York, NY USA; [Melamed, R. D.; Rabadan, R.] Columbia Univ, Dept Bioinformat, New York, NY 10032 USA; [Zhang, G.; Fukunaga-Kanabis, M.] Wistar Inst Anat & Biol, Melanoma Res Ctr, Philadelphia, PA 19104 USA; [Perez-Lorenzo, R.; Zheng, B.; Silvers, D. N.] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Brunner, G.] Fachklin Hornheide, Dept Canc Res, Munster, Germany; [Wang, S.] Columbia Univ, Dept Biostat, New York, NY 10032 USA	Columbia University; Icahn School of Medicine at Mount Sinai; Columbia University; The Wistar Institute; Columbia University; Columbia University	Celebi, JT (corresponding author), Columbia Univ, Dept Dermatol, 1150 St,St Nicholas Ave,Room 318, New York, NY 10032 USA.	jt165@columbia.edu	Zhang, Gao/D-3471-2017; DEMIR, AHU/A-5650-2015; Castillo-Martin, Mireia/H-6152-2013; Rabadan, Raul/AAZ-7367-2020	DEMIR, AHU/0000-0001-9276-6318; Zheng, Bin/0000-0002-0998-7177; Perez-Lorenzo, Rolando/0000-0002-9355-9617; Melamed, Rachel/0000-0003-3089-9806; Rabadan, Raul/0000-0001-7946-9255	NIH/NCI [RO1 CA138678]; Dow Foundation; Neuberger Dorothy Rodbell Cohen Foundation; NATIONAL CANCER INSTITUTE [R01CA138678, U54CA121852] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dow Foundation; Neuberger Dorothy Rodbell Cohen Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by grants from the NIH/NCI RO1 CA138678 to JTC, the Dow Foundation to JTC and the Neuberger Dorothy Rodbell Cohen Foundation to JTC. We appreciate the technical assistance of Ruzhen Chen, Tasneem Fatima, Yan Lu, Rong Du and Tingting Wu. We are grateful to the following Shared Resources of the Herbert Irving Comprehensive Cancer Center, Pathology Shared Resource, Flow Cytometry Shared Resource, and Confocal & Microscopy Shared Resource, as well as to the Department of Dermatology's Skin Diseases Research Center Cell Culture Core and Division of Dermatopathology.	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Bennett HL, 2008, ONCOGENE, V27, P2693, DOI 10.1038/sj.onc.1210928; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Berking C, 2004, CANCER RES, V64, P807, DOI 10.1158/0008-5472.CAN-03-3438; Bocanegra M, 2010, ONCOGENE, V29, P774, DOI 10.1038/onc.2009.364; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Caron C, 2009, CELL SIGNAL, V21, P943, DOI 10.1016/j.cellsig.2009.02.004; Chernoff KA, 2009, CLIN CANCER RES, V15, P4288, DOI 10.1158/1078-0432.CCR-09-0280; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; D'Alessio A, 2007, CELL SIGNAL, V19, P1193, DOI 10.1016/j.cellsig.2006.12.011; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dickson PV, 2011, SURG ONCOL CLIN N AM, V20, P1, DOI 10.1016/j.soc.2010.09.007; Dufraine J, 2008, ONCOGENE, V27, P5132, DOI 10.1038/onc.2008.227; Gerhardt Holger, 2008, P68, DOI 10.1007/978-0-387-78632-2_6; Gershenwald JE, 2010, ANN SURG ONCOL, V17, P1475, DOI 10.1245/s10434-010-0986-3; Ghosh Papia, 2009, Expert Rev Dermatol, V4, P131, DOI 10.1586/edm.09.2; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Horst B, 2009, AM J PATHOL, V174, P1524, DOI 10.2353/ajpath.2009.080543; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kameda H, 2006, CLIN EXP IMMUNOL, V144, P335, DOI 10.1111/j.1365-2249.2006.03067.x; Ke Y, 2007, ONCOGENE, V26, P4951, DOI 10.1038/sj.onc.1210315; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kranenburg O, 2004, BBA-REV CANCER, V1654, P23, DOI 10.1016/j.bbcan.2003.09.004; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Lock LS, 2002, MOL BIOL CELL, V13, P2132, DOI 10.1091/mbc.02-02-0031; Lu Y, 2011, P NATL ACAD SCI USA, V108, P2957, DOI 10.1073/pnas.1009395108; Mao YW, 2005, J CELL BIOL, V170, P305, DOI 10.1083/jcb.200505061; Meng SS, 2005, BIOCHEM J, V391, P143, DOI 10.1042/BJ20050229; Milagre C, 2010, CANCER RES, V70, P5549, DOI 10.1158/0008-5472.CAN-09-4254; Mishra PJ, 2010, ONCOGENE, V29, P2449, DOI 10.1038/onc.2009.521; Monsel G, 2010, ONCOGENE, V29, P227, DOI 10.1038/onc.2009.320; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Petti C, 2006, CANCER RES, V66, P6503, DOI 10.1158/0008-5472.CAN-05-4671; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Sun JM, 2008, J BIOL CHEM, V283, P27444, DOI 10.1074/jbc.M709703200; Tsatsanis C, 2004, ANN NY ACAD SCI, V1028, P168, DOI 10.1196/annals.1322.019; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wozniak A, 2012, CRIT REV ONCOL HEMAT, V82, P200, DOI 10.1016/j.critrevonc.2011.05.003; Zatkova A, 2006, GENE CHROMOSOME CANC, V45, P798, DOI 10.1002/gcc.20344	53	17	18	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 1	2013	32	31					3627	3637		10.1038/onc.2012.367	http://dx.doi.org/10.1038/onc.2012.367			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	194MW	22926523	hybrid, Green Accepted			2022-12-25	WOS:000322638400007
J	Benowitz, KM; Brodie, ED; Formica, VA				Benowitz, Kyle M.; Brodie, Edmund D., III; Formica, Vincent A.			Morphological Correlates of a Combat Performance Trait in the Forked Fungus Beetle, Bolitotherus cornutus	PLOS ONE			English	Article							BODY-SIZE; INDIVIDUAL-DIFFERENCES; ANTIPREDATOR BEHAVIOR; SEXUAL-DIMORPHISM; SELECTION; COLEOPTERA; EVOLUTION; CONSISTENCY; FITNESS	Combat traits are thought to have arisen due to intense male-male competition for access to females. While large and elaborate weapons used in attacking other males have often been the focus of sexual selection studies, defensive traits (both morphological and performance) have received less attention. However, if defensive traits help males restrict access to females, their role in the process of sexual selection could also be important. Here we examine the morphological correlates of grip strength, a defensive combat trait involved in mate guarding, in the tenebrionid beetle Bolitotherus cornutus. We found that grip strength was repeatable and differed between the sexes. However, these differences in performance were largely explained by body size and a non-additive interaction between size and leg length that differed between males and females. Our results suggest that leg size and body size interact as part of an integrated suite of defensive combat traits.	[Benowitz, Kyle M.; Brodie, Edmund D., III] Univ Virginia, Dept Biol, Mt Lake Biol Stn, Charlottesville, VA 22903 USA; [Formica, Vincent A.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	University of Virginia; Swarthmore College	Benowitz, KM (corresponding author), Univ Virginia, Dept Biol, Mt Lake Biol Stn, Charlottesville, VA 22903 USA.	vince.formica@gmail.com	Brodie, Edmund D/B-2335-2013		National Science Foundation [IOS-1027251]; Mountain Lake Biological Station REU Program (National Science Foundation) [DBI-0453380]	National Science Foundation(National Science Foundation (NSF)); Mountain Lake Biological Station REU Program (National Science Foundation)	Funding was provided by the National Science Foundation IOS-1027251 to EDB and the Mountain Lake Biological Station REU Program (National Science Foundation DBI-0453380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; BOAKE CRB, 1989, EVOL ECOL, V3, P173, DOI 10.1007/BF02270919; Brodie ED, 1999, ANIM BEHAV, V57, P445, DOI 10.1006/anbe.1998.0990; BRODIE ED, 1993, ANIM BEHAV, V45, P851, DOI 10.1006/anbe.1993.1106; CONNER J, 1988, EVOLUTION, V42, P736, DOI 10.1111/j.1558-5646.1988.tb02492.x; CONNER J, 1989, EVOLUTION, V43, P1378, DOI 10.1111/j.1558-5646.1989.tb02589.x; CONNER JF, 1995, ETHOL ECOL EVOL, V7, P277, DOI 10.1080/08927014.1995.9522958; Darwin C., 1874, DESCENT MAN SELECTIO; Eberhard WG, 2000, P ROY SOC B-BIOL SCI, V267, P1129, DOI 10.1098/rspb.2000.1118; Emlen DJ, 1996, EVOLUTION, V50, P1219, DOI [10.1111/j.1558-5646.1996.tb02362.x, 10.2307/2410662]; Emlen DJ, 2007, P NATL ACAD SCI USA, V104, P8661, DOI 10.1073/pnas.0701209104; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Formica VA, 2011, EVOLUTION, V65, P2771, DOI 10.1111/j.1558-5646.2011.01340.x; Herrel A, 2010, BIOL J LINN SOC, V100, P287, DOI 10.1111/j.1095-8312.2010.01433.x; Husak JF, 2009, BIOL J LINN SOC, V96, P840, DOI 10.1111/j.1095-8312.2008.01176.x; Kingsolver JG, 2003, INTEGR COMP BIOL, V43, P361, DOI 10.1093/icb/43.3.361; Kingsolver JG, 2003, INTEGR COMP BIOL, V43, P470, DOI 10.1093/icb/43.3.470; Knell RJ, 2010, P ROY SOC B-BIOL SCI, V277, P2347, DOI 10.1098/rspb.2010.0257; Kruuk LEB, 2002, EVOLUTION, V56, P1683, DOI 10.1111/j.0014-3820.2002.tb01480.x; Lailvaux SP, 2005, FUNCT ECOL, V19, P632, DOI 10.1111/j.1365-2435.2005.01024.x; LILES M. PFERRER, 1956, OHIO JOUR SCI, V56, P329; PACE ANNE E., 1967, OCCAS PAP MUS ZOOL UNIV MICH, V653, P1; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SHUSTER SM, 2003, MG BEH ECOL, pR7; Wellborn GA, 2000, AM MIDL NAT, V143, P212, DOI 10.1674/0003-0031(2000)143[0212:SOASDT]2.0.CO;2; Wikelski M, 2003, INTEGR COMP BIOL, V43, P376, DOI 10.1093/icb/43.3.376	28	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42738	10.1371/journal.pone.0042738	http://dx.doi.org/10.1371/journal.pone.0042738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916153	Green Published, gold			2022-12-25	WOS:000307823600027
J	Bonthuis, M; van Stralen, KJ; Verrina, E; Edefonti, A; Molchanova, EA; Hokken-Koelega, ACS; Schaefer, F; Jager, KJ				Bonthuis, Marjolein; van Stralen, Karlijn J.; Verrina, Enrico; Edefonti, Alberto; Molchanova, Elena A.; Hokken-Koelega, Anita C. S.; Schaefer, Franz; Jager, Kitty J.			Use of National and International Growth Charts for Studying Height in European Children: Development of Up-To-Date European Height-For-Age Charts	PLOS ONE			English	Article							BODY-MASS INDEX; PUBERTAL DEVELOPMENT; REFERENCE VALUES; HORMONE THERAPY; SECULAR CHANGES; WEIGHT; REFERENCES; UK; STANDARDS; COUNTRIES	Background: Growth charts based on data collected in different populations and time periods are key tools to assess children's linear growth. We analyzed the impact of geographic factors and the secular trend on height-for-age charts currently used in European populations, developed up-to-date European growth charts, and studied the effect of using different charts in a sample of growth retarded children. Methods and Findings: In an international survey we obtained 18 unique national height-for-age charts from 28 European countries and compared them with charts from the World Health Organization (WHO), Euro-Growth reference, and Centers of Disease Control and Prevention (CDC). As an example, we obtained height data from 3,534 children with end-stage renal disease (ESRD) from 13 countries via the ESPN/ERA-EDTA registry, a patient group generally suffering from growth retardation. National growth charts showed a clear secular trend in height (mean height increased on average 0.6 cm/decade) and a North-South height gradient in Europe. For countries without a recent (>1990) national growth chart novel European growth charts were constructed from Northern and Southern European reference populations, reflecting geographic height differences in mean final height of 3.9 cm in boys and 3.8 cm in girls. Mean height SDS of 2- to 17-year-old ESRD patients calculated from recent national or derived European growth charts (-1.91, 95% CI: -1.97 to -1.85) was significantly lower than when using CDC or WHO growth charts (-1.55, 95% CI: -1.61 to -1.49) (P<0.0001). Conclusion: Differences between height-for-age charts may reflect true population differences, but are also strongly affected by the secular trend in height. The choice of reference charts substantially affects the clinical decision whether a child is considered short-for-age. Therefore, we advocate using recent national or European height-for-age charts derived from recent national data when monitoring growth of healthy and diseased European children.	[Bonthuis, Marjolein; van Stralen, Karlijn J.; Jager, Kitty J.] Univ Amsterdam, Acad Med Ctr, European Dialysis & Transplant Assoc Registry,Dep, European Soc Pediat Nephrol,European Renal Assoc, NL-1105 AZ Amsterdam, Netherlands; [Verrina, Enrico] Gaslini Childrens Hosp, Genoa, Italy; [Edefonti, Alberto] Fdn Ca Granda IRCCS Osped Maggiore Policlin, Milan, Italy; [Molchanova, Elena A.] Russian Childrens Clin Hosp, Dept Kidney Transplantat, Moscow, Russia; [Hokken-Koelega, Anita C. S.] Erasmus Univ, Sophia Childrens Hosp, Subdivis Endocrinol, Dept Paediat,Med Ctr, Rotterdam, Netherlands; [Schaefer, Franz] Univ Childrens Hosp, Heidelberg, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Ca Granda Ospedale Maggiore Policlinico; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Bonthuis, M (corresponding author), Univ Amsterdam, Acad Med Ctr, European Dialysis & Transplant Assoc Registry,Dep, European Soc Pediat Nephrol,European Renal Assoc, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	k.j.vanstralen@amc.uva.nl	Schaefer, Franz/G-4365-2010; Verrina, Enrico/AAA-7317-2020; Edefonti, Alberto/I-6964-2015	Edefonti, Alberto/0000-0003-3106-4915; van Stralen, Karlijn/0000-0002-3243-2970; Verrina, Enrico Eugenio/0000-0002-5178-1949	ESPN; ERA; EDTA; NephroQUEST project; European Union [2006114]; Amgen	ESPN; ERA; EDTA; NephroQUEST project; European Union(European Commission); Amgen(Amgen)	The European Society for Pediatric Nephrology (ESPN)/European Renal Association (ERA)-European Dialysis and Transplant Association (EDTA) registry is funded by ESPN, the ERA and EDTA and the NephroQUEST project. The NephroQUEST project has received funding from the European Union in the framework of the Public Health Program (project number 2006114). Amgen has provided an unrestricted educational grant to assist the ESPN in the financial support of the Registry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Amgen awarded a (sic) 10,000 grant to the European Society for Pediatric Nephrology (ESPN) to assist the start of the ESPN/ERA-EDTA Registry. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andersen E, 1982, Ugeskr Laeger, V144, P1760; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bocca-Tjeertes IF, 2012, J PEDIAT; Butte NF, 2007, J NUTR, V137, P153, DOI 10.1093/jn/137.1.153; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Carrascosa Lezcano A, 2008, An Pediatr (Barc), V68, P552; Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883; Chiotis D., 2003, ANN CLIN PAEDIAT U A, V50, P136; Cole TJ, 2003, ECON HUM BIOL, V1, P161, DOI 10.1016/S1570-677X(02)00033-3; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Cole TJ, 2000, P NUTR SOC, V59, P317, DOI 10.1017/S0029665100000355; Council of the European Union, 2006, 2733 EMPL SOC POL HL; Danubio ME, 2008, J ANTHROPOL SCI, V86, P91; De Onis M, 2004, J PEDIATR-US, V144, P461, DOI 10.1016/j.jpeds.2003.12.034; de Onis M, 2004, FOOD NUTR BULL, V25, pS89; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; Foote JM, 2011, J PEDIATR NURS, V26, P312, DOI 10.1016/j.pedn.2010.09.002; Foster BJ, 2004, AM J CLIN NUTR, V80, P801, DOI 10.1093/ajcn/80.4.801; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Fredriks AM, 2004, ACTA PAEDIATR, V93, P817, DOI 10.1111/j.1651-2227.2004.tb03024.x; Fredriks AM, 2003, EUR J PEDIATR, V162, P788, DOI 10.1007/s00431-003-1292-x; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Garza C, 2006, ACTA PAEDIATR, V95, P56, DOI 10.1080/08035320500495514; Gohlke B, 2009, DTSCH ARZTEBL INT, V106, P377, DOI 10.3238/arztebl.2009.0377; Grummer-Strawn Laurence M., 2010, Morbidity and Mortality Weekly Report, V59, P1; Grunberg H, 1998, TARTU; Haas JD, 2006, FOOD NUTR BULL, V27, pS212, DOI 10.1177/15648265060274S505; Haschke F, 2000, J PEDIATR GASTR NUTR, V31, pS14, DOI 10.1097/00005176-200007001-00003; Hauspie RC, 1997, ACTA PAEDIATR, V86, P20; Hermanussen M, 2012, ACTA PAEDIATR, V101, P78, DOI 10.1111/j.1651-2227.2011.02415.x; Hermanussen M, 2010, ANN HUM BIOL, V37, P57, DOI 10.3109/03014460903173379; Hughes IP, 2010, CLIN ENDOCRINOL, V73, P760, DOI 10.1111/j.1365-2265.2010.03874.x; Johnson T S, 1999, Pediatr Nurs, V25, P13; Joubert K, 2006, GYERMEKGYOGYASZAT, V5, P517; Juliusson PB, 2011, ARCH DIS CHILD, V96, P916, DOI 10.1136/adc.2009.166157; Juliusson Petur B, 2009, Tidsskr Nor Laegeforen, V129, P281, DOI 10.4045/tidsskr.09.32473; Kirk J, 2012, ARCH DIS CHILD, V97, P63, DOI 10.1136/adc.2010.186205; Kobzova J., 2004, Central European Journal of Public Health, V12, P126; Kuczmarski R J, 2000, Adv Data, P1; Kuczmarski Robert J, 2002, Vital Health Stat 11, P1; Larnkjaer A, 2006, ACTA PAEDIATR, V95, P754, DOI 10.1080/08035250500527323; Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x; Mazurin AV, 1985, PROPEDEUTICS CHILD D; MJONES S, 1987, ANN HUM BIOL, V14, P337, DOI 10.1080/03014468700009121; National Kidney Foundation, 2009, AM J KIDNEY DIS S, V53, pS1; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Prader A, 1989, Helv Paediatr Acta Suppl, V52, P1; Redlefsen T, 2007, ANTHROPOL ANZ, V65, P263, DOI 10.1127/anthranz/65/2007/263; Richmond E, 2010, ENDOCR DEV, V18, P92, DOI 10.1159/000316130; Roelants M, 2009, ANN HUM BIOL, V36, P680, DOI 10.3109/03014460903049074; Rosario AS, 2011, ANN HUM BIOL, V38, P121, DOI 10.3109/03014460.2010.521193; SCHMIDT IM, 1995, ANN HUM BIOL, V22, P57, DOI 10.1080/03014469500003702; Sempe M., 1979, AUXOLOGIE METHODE SE; SORVA R, 1990, ACTA PAEDIATR SCAND, V79, P490, DOI 10.1111/j.1651-2227.1990.tb11502.x; SORVA R, 1990, ACTA PAEDIATR SCAND, V79, P498, DOI 10.1111/j.1651-2227.1990.tb11503.x; Tutkuviene J, 2005, ACTA MED LITUANICA, V12, P9; van Buuren S, 2008, ARCH DIS CHILD, V93, P549, DOI 10.1136/adc.2007.136010; van't Hof MA, 2000, J PEDIATR GASTR NUTR, V31, pS3, DOI 10.1097/00005176-200007001-00002; WHO, 2006, WHO CHILD GROWTH STA; Wikland KA, 2002, ACTA PAEDIATR, V91, P739, DOI 10.1080/08035250213216; World Health Organization, 1995, WHO TECHN REP SER, V854, P161; Wright C, 2008, ARCH DIS CHILD, V93, P566, DOI 10.1136/adc.2007.126854; Wright CM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1140; Ziegler EE, 2010, NESTLE NUTR WORKS SE, V65, P197, DOI 10.1159/000281166	65	73	75	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42506	10.1371/journal.pone.0042506	http://dx.doi.org/10.1371/journal.pone.0042506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916131	Green Published, gold, Green Submitted			2022-12-25	WOS:000307823600014
J	Kaindl, T; Rieger, H; Kaschel, LM; Engel, U; Schmaus, A; Sleeman, J; Tanaka, M				Kaindl, Thomas; Rieger, Harden; Kaschel, Lisa-Mareike; Engel, Ulrike; Schmaus, Anja; Sleeman, Jonathan; Tanaka, Motomu			Spatio-Temporal Patterns of Pancreatic Cancer Cells Expressing CD44 Isoforms on Supported Membranes Displaying Hyaluronic Acid Oligomers Arrays	PLOS ONE			English	Article							PROSTATE-CANCER; BINDING; VARIANT; PROTEINS; METASTASIS; ADHESION; SURFACE	In this paper, we designed a quantitative model of biological membranes by the deposition of planar lipid membranes on solid substrates (called supported membranes), and immobilized biotinylated oligomers of hyaluronic acid (oligo-HA, 6-8 disaccharide units in length) to the membrane surface via neutravidin cross-linkers. By controlling the self-assembly of biotinylated lipid anchors, the mean distance between the oligo-HA molecules on the membrane could be controlled to nm accuracy. The adhesion and motility of pancreatic adenocarcinoma cells expressing different splice variants of the HA-binding cell surface receptor CD44 on these surfaces were investigated quantitatively. The combination of label-free, time-lapse imaging of living cells and statistical analysis suggests that the static morphology (global shape and cytoskeleton remodeling) of cells, their stochastic morphological dynamics, and the probability of directed motion reflect the metastatic behaviour of the cancer cells.	[Kaindl, Thomas; Rieger, Harden; Kaschel, Lisa-Mareike; Tanaka, Motomu] Heidelberg Univ, Inst Phys Chem, D-6900 Heidelberg, Germany; [Schmaus, Anja; Sleeman, Jonathan; Tanaka, Motomu] Karlsruhe Inst Technol, Inst Tox & Genet, Karlsruhe, Germany; [Sleeman, Jonathan] Heidelberg Univ, Ctr Biomed & Med Technol Mannheim CBTM, Med Fac Mannheim, D-6800 Mannheim, Germany; [Engel, Ulrike] Heidelberg Univ, BIOQUANT, Nikon Imaging Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; Nikon Corporation; Ruprecht Karls University Heidelberg	Kaindl, T (corresponding author), Heidelberg Univ, Inst Phys Chem, Neuenheimer Feld 253, D-6900 Heidelberg, Germany.	sleeman@medma.uni-heidelberg.de; tanaka@uni-heidelberg.de	Engel, Ulrike/AAO-7719-2020; Tanaka, Motomu/S-5949-2016; Sleeman, Jonathan P/H-2515-2013; Engel, Ulrike/E-5456-2014	Engel, Ulrike/0000-0002-6953-6845; Tanaka, Motomu/0000-0003-3663-9554; Sleeman, Jonathan P/0000-0003-1718-7687; 	Helmholtz Association	Helmholtz Association(Helmholtz Association)	This work was supported by Helmholtz Association within the framework of "BioInterface'' program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTOLAZZI A, 1994, J EXP MED, V180, P53, DOI 10.1084/jem.180.1.53; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Enegd B, 2002, NEUROSURGERY, V50, P1311, DOI 10.1097/00006123-200206000-00023; Fieber C, 2004, J CELL SCI, V117, P359, DOI 10.1242/jcs.00831; Gao AC, 1998, CANCER RES, V58, P2350; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hiraiwa T, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/20001; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; KERN W, 1970, RCA REV, V31, P187; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Limozin L, 2009, CHEMPHYSCHEM, V10, P2752, DOI 10.1002/cphc.200900601; Lipowsky R., 1995, P521; Maeda YT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003734; MATZKU S, 1989, CANCER RES, V49, P1294; McHardy LM, 2005, MOL CANCER THER, V4, P772, DOI 10.1158/1535-7163.MCT-04-0310; Misra S, 2011, FEBS J, V278, P1429, DOI 10.1111/j.1742-4658.2011.08071.x; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; RADLER J, 1993, J PHYS II, V3, P727; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Sherman L, 1996, CURR TOP MICROBIOL, V213, P249; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Sleeman JP, 2007, CLIN EXP METASTAS, V24, P707, DOI 10.1007/s10585-007-9122-6; Sleeman JP, 1996, CANCER RES, V56, P3134; Sleeman JP, 1997, J BIOL CHEM, V272, P31837, DOI 10.1074/jbc.272.50.31837; Stern R, 2005, PATHOL BIOL, V53, P372, DOI 10.1016/j.patbio.2004.12.021; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; SY MS, 1991, J EXP MED, V174, P859, DOI 10.1084/jem.174.4.859; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164; Tanaka M, 2007, LANGMUIR, V23, P5638, DOI 10.1021/la0628219; Termeer C, 2003, TRENDS IMMUNOL, V24, P112, DOI 10.1016/S1471-4906(03)00029-2; TOLG C, 1993, NUCLEIC ACIDS RES, V21, P1225, DOI 10.1093/nar/21.5.1225; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; YANG BH, 1995, ANAL BIOCHEM, V228, P299, DOI 10.1006/abio.1995.1354; ZHANG LR, 1995, CANCER RES, V55, P428; Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5	41	22	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42991	10.1371/journal.pone.0042991	http://dx.doi.org/10.1371/journal.pone.0042991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916191	gold, Green Published, Green Submitted			2022-12-25	WOS:000307500800035
J	Chatain, N; Ziegler, P; Fahrenkamp, D; Jost, E; Moriggl, R; Schmitz-Van de Leur, H; Muller-Newen, G				Chatain, N.; Ziegler, P.; Fahrenkamp, D.; Jost, E.; Moriggl, R.; Schmitz-Van de Leur, H.; Mueller-Newen, G.			Src family kinases mediate cytoplasmic retention of activated STAT5 in BCR-ABL-positive cells	ONCOGENE			English	Article						CML; BCR-ABL; STAT5; Src; inhibitors	CHRONIC MYELOID-LEUKEMIA; DNA-BINDING ACTIVITY; SIGNAL TRANSDUCERS; CONSTITUTIVE ACTIVATION; LYMPHOBLASTIC-LEUKEMIA; PHOSPHORYLATED STAT5; TRANSCRIPTION STAT; INHIBITS APOPTOSIS; TYROSINE KINASE; SURVIVAL	Persistent activation of the Abl tyrosine kinase in the BCR-ABL fusion protein is the major cause of chronic myeloid leukemia (CML). Among many other substrates BCR-ABL phosphorylates STAT5 and Src family kinases (SFK). Activated pSTAT5 is essential for initial transformation and maintenance of the disease. Cytokine-induced phosphorylation on tyrosine 694 typically leads to nuclear accumulation of pSTAT5 and target gene expression. We verified that in BCR-ABL-positive progenitor cells from a CML patient and in K562 cells pSTAT5 is cytoplasmic. However, upon ectopic expression of BCR-ABL p210 in non-myeloid cells, co-transfected STAT5A is phosphorylated on Y694 and localized in the nucleus arguing for an additional factor mediating cytoplasmic retention in CML cells. Expression of the SFK v-Src, Hck or Lyn together with STAT5A results in phosphorylation on Y694 and cytoplasmic retention. Upon coexpression of BCR-ABL and individual SFK the cytoplasmic retention of activated STAT5A mediated by v-Src and Hck but not Lyn is dominant over nuclear translocation induced by BCR-ABL. Cytoplasmic retention depends on the kinase activity of SFK and is mediated through the interaction of the SH2 domain of STAT5A with the SFK. Interestingly, nuclear accumulation of STAT5A as a result of activation by FLT3-ITD, an oncogene found in acute myeloid leukemia, cannot be prevented by coexpression of SFK. Importantly, inhibition of SFK in K562 cells restored nuclear accumulation of pSTAT5A, enhanced STAT5 target gene expression and increased colony formation. Thus, SFK mediate cytoplasmic retention of pSTAT5A in BCR-ABL-positive cells. Cytoplasmic pSTAT5A in CML cells might balance the controversial functions of STAT5 in cellular senescence and differentiation versus G(1)/S progression and survival.	[Chatain, N.; Fahrenkamp, D.; Schmitz-Van de Leur, H.; Mueller-Newen, G.] Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, D-52074 Aachen, NRW, Germany; [Ziegler, P.; Jost, E.] Rhein Westfal TH Aachen, Klin Onkol Hamatol & Stammzelltransplantat, D-52074 Aachen, NRW, Germany; [Moriggl, R.] Ludwig Boltzmann Inst Canc Res LBI CR, Vienna, Austria	RWTH Aachen University; RWTH Aachen University; Ludwig Boltzmann Institute	Muller-Newen, G (corresponding author), Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, Pauwelsstr 30, D-52074 Aachen, NRW, Germany.	mueller-newen@rwth-aachen.de	Moriggl, Richard/H-8118-2019	Moriggl, Richard/0000-0003-0918-9463	Deutsche Forschungsgemeinschaft (DFG) [SFB 542]; Austrian Science Funds (FWF) [SFB F28]; IZKF Aachen (Interdisciplinary Center for Clinical Research within the Faculty of Medicine at RWTH Aachen University); Austrian Science Fund (FWF) [F 2807] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); IZKF Aachen (Interdisciplinary Center for Clinical Research within the Faculty of Medicine at RWTH Aachen University); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The research project was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, SFB 542, projects B12 and Z1 to GMN), the Austrian Science Funds (FWF, SFB F28 to RM) and the core facility confocal microscopy of the IZKF Aachen (Interdisciplinary Center for Clinical Research within the Faculty of Medicine at RWTH Aachen University). We would like to thank Frank-D Bohmer, Tim Brummendorf, Michael Huber, Isabelle Maridonneau-Parini, Fred Schaper and Veronika Sexl for their critical discussion and helping us with plasmid constructs.	Baumgartner C, 2009, AM J PATHOL, V175, P2416, DOI 10.2353/ajpath.2009.080953; Bunting KD, 2007, BLOOD, V110, P2775, DOI 10.1182/blood-2007-05-090969; Bunting KD, 2007, FRONT BIOSCI-LANDMRK, V12, P2807, DOI 10.2741/2274; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Cortes JE, 2011, BLOOD, V118, P4567, DOI 10.1182/blood-2011-05-355594; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Ferbeyre G, 2011, BBA-REV CANCER, V1815, P104, DOI 10.1016/j.bbcan.2010.10.004; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Harir N, 2007, BLOOD, V109, P1678, DOI 10.1182/blood-2006-01-029918; Heltemes-Harris LM, 2011, ANN NY ACAD SCI, V1217, P18, DOI 10.1111/j.1749-6632.2010.05907.x; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Herrmann A, 2007, J CELL SCI, V120, P3249, DOI 10.1242/jcs.03482; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Kazansky AV, 1999, J BIOL CHEM, V274, P22484, DOI 10.1074/jbc.274.32.22484; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Li G, 2010, LEUKEMIA, V24, P1397, DOI 10.1038/leu.2010.131; Li GQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009152; Li SG, 2005, EXPERT OPIN THER TAR, V9, P329, DOI 10.1517/14728222.9.2.329; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Lilly M, 1997, CANCER RES, V57, P5348; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Mallette FA, 2010, ANN NY ACAD SCI, V1197, P142, DOI 10.1111/j.1749-6632.2010.05192.x; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Nyga R, 2005, BIOCHEM J, V390, P359, DOI 10.1042/BJ20041523; Okutani Y, 2001, ONCOGENE, V20, P6643, DOI 10.1038/sj.onc.1204807; Ozawa Y, 2008, LEUKEMIA RES, V32, P893, DOI 10.1016/j.leukres.2007.11.032; Poincloux R, 2007, J CELL PHYSIOL, V213, P212, DOI 10.1002/jcp.21112; Schenone S, 2010, EXPERT OPIN INV DRUG, V19, P931, DOI 10.1517/13543784.2010.499898; Schmidt-Arras D, 2009, BLOOD, V113, P3568, DOI 10.1182/blood-2007-10-121426; Shiotsu Y, 2009, BLOOD, V114, P1607, DOI 10.1182/blood-2009-01-199307; Shuai K, 1996, ONCOGENE, V13, P247; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Stanglmaier M, 2003, LEUKEMIA, V17, P283, DOI 10.1038/sj.leu.2402778; Tatton L, 2003, J BIOL CHEM, V278, P4847, DOI 10.1074/jbc.M209321200; Vogt M, 2011, J CELL SCI, V124, P900, DOI 10.1242/jcs.072520; Walz C, 2012, BLOOD, V119, P3550, DOI 10.1182/blood-2011-12-397554; Warmuth M, 2003, BLOOD, V101, P664, DOI 10.1182/blood-2002-01-0288; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Ziegler P, 2007, CURR PROTOC TOXICOL	48	24	24	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 1	2013	32	31					3587	3597		10.1038/onc.2012.369	http://dx.doi.org/10.1038/onc.2012.369			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	194MW	22926520				2022-12-25	WOS:000322638400003
J	Millonig, G; Ganzleben, I; Peccerella, T; Casanovas, G; Brodziak-Jarosz, L; Breitkopf-Heinlein, K; Dick, TP; Seitz, HK; Muckenthaler, MU; Mueller, S				Millonig, Gunda; Ganzleben, Ingo; Peccerella, Teresa; Casanovas, Guillem; Brodziak-Jarosz, Lidia; Breitkopf-Heinlein, Katja; Dick, Tobias P.; Seitz, Helmut-Karl; Muckenthaler, Martina U.; Mueller, Sebastian			Sustained Submicromolar H2O2 Levels Induce Hepcidin via Signal Transducer and Activator of Transcription 3 (STAT3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; HYDROGEN-PEROXIDE; TRANSGENIC MICE; IRON OVERLOAD; INFLAMMATION; EXPRESSION; PATHWAY; ANEMIA; IL-6; CATALASE	The peptide hormone hepcidin regulates mammalian iron homeostasis by blocking ferroportin-mediated iron export from macrophages and the duodenum. During inflammation, hepcidin is strongly induced by interleukin 6, eventually leading to the anemia of chronic disease. Here we show that hepatoma cells and primary hepatocytes strongly up-regulate hepcidin when exposed to low concentrations of H2O2 (0.3-6 mu M), concentrations that are comparable with levels of H2O2 released by inflammatory cells. In contrast, bolus treatment of H2O2 has no effect at low concentrations and even suppresses hepcidin at concentrations of > 50 mu M. H2O2 treatment synergistically stimulates hepcidin promoter activity in combination with recombinant interleukin-6 or bone morphogenetic protein-6 and in a manner that requires a functional STAT3-responsive element. The H2O2-mediated hepcidin induction requires STAT3 phosphorylation and is effectively blocked by siRNA-mediated STAT3 silencing, overexpression of SOCS3 (suppressor of cytokine signaling 3), and antioxidants such as N-acetylcysteine. Glycoprotein 130 (gp130) is required for H2O2 responsiveness, and Janus kinase 1 (JAK1) is required for adequate basal signaling, whereas Janus kinase 2 (JAK2) is dispensable upstream of STAT3. Importantly, hepcidin levels are also increased by intracellular H2O2 released from the respiratory chain in the presence of rotenone or antimycin A. Our results suggest a novel mechanism of hepcidin regulation by nanomolar levels of sustained H2O2. Thus, similar to cytokines, H2O2 provides an important regulatory link between inflammation and iron metabolism.	[Millonig, Gunda; Ganzleben, Ingo; Peccerella, Teresa; Seitz, Helmut-Karl; Mueller, Sebastian] Heidelberg Univ, Alcohol Res Ctr, D-69120 Heidelberg, Germany; [Millonig, Gunda; Ganzleben, Ingo; Peccerella, Teresa; Seitz, Helmut-Karl; Mueller, Sebastian] Salem Med Ctr, D-69120 Heidelberg, Germany; [Casanovas, Guillem; Muckenthaler, Martina U.] Heidelberg Univ, Dept Pediat Oncol Hematol Immunol & Pulmonol, D-69120 Heidelberg, Germany; [Casanovas, Guillem; Muckenthaler, Martina U.] Heidelberg Univ, Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Brodziak-Jarosz, Lidia; Dick, Tobias P.] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Redox Regulat, D-69120 Heidelberg, Germany; [Breitkopf-Heinlein, Katja] Heidelberg Univ, Fac Med Mannheim, Med Clin, D-68167 Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Millonig, G (corresponding author), Heidelberg Univ, Alcohol Res Ctr, D-69120 Heidelberg, Germany.	gunda.millonig@uni-heidelberg.de; sebastian.mueller@urz.uni-heidelberg.de		Muckenthaler, Martina/0000-0002-3778-510X; Casanovas, Guillem/0000-0002-1791-041X	Dietmar Hopp-Stiftung; Manfred Lautenschlager-Stiftung; Olympia-Morata-Fellowship from the University of Heidelberg; YAEL Foundation; European Community's Seventh Framework Programme (FP7) [215009]; Dietmar Hopp Stiftung; eRARE-BMBF (HMA-IRON); Network HepatoSys/Virtual Liver grant	Dietmar Hopp-Stiftung; Manfred Lautenschlager-Stiftung; Olympia-Morata-Fellowship from the University of Heidelberg; YAEL Foundation; European Community's Seventh Framework Programme (FP7); Dietmar Hopp Stiftung; eRARE-BMBF (HMA-IRON); Network HepatoSys/Virtual Liver grant	This work was supported in part by the Dietmar Hopp-Stiftung and the Manfred Lautenschlager-Stiftung.; Supported by an Olympia-Morata-Fellowship from the University of Heidelberg and a research grant from the YAEL Foundation. To whom correspondence may be addressed. Tel.: 49-6221-483-201; Fax: 49-6221-483494; E-mail: gunda.millonig@uni-heidelberg.de.; Supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 215009.; Supported by the Dietmar Hopp Stiftung, eRARE-BMBF (HMA-IRON), and the Network HepatoSys/Virtual Liver grant.	Andriopoulos B, 2007, J BIOL CHEM, V282, P20301, DOI 10.1074/jbc.M702463200; Bagu ET, 2011, J MOL ENDOCRINOL, V47, P299, DOI 10.1530/JME-11-0060; BelAiba RS, 2004, BIOL CHEM, V385, P249, DOI 10.1515/BC.2004.019; BOVERIS A, 1971, BIOCHIM BIOPHYS ACTA, V245, P1, DOI 10.1016/0005-2728(71)90002-8; CARTWRIGHT GE, 1946, SCIENCE, V103, P72, DOI 10.1126/science.103.2664.72; Casanovas G, 2009, J MOL MED, V87, P471, DOI 10.1007/s00109-009-0447-2; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; de Oliveira-Marques V, 2007, J IMMUNOL, V178, P3893, DOI 10.4049/jimmunol.178.6.3893; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Falzacappa MVV, 2008, J MOL MED, V86, P531, DOI 10.1007/s00109-008-0313-7; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Franke K, 2004, ANTIOXID REDOX SIGN, V6, P721, DOI 10.1089/1523086041361613; Ganz T, 2002, ISRAEL MED ASSOC J, V4, P1043; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Harrison-Findik DD, 2006, J BIOL CHEM, V281, P22974, DOI 10.1074/jbc.M602098200; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Ikemura M, 2010, MOL PHARMACEUT, V7, P2069, DOI 10.1021/mp100110c; Island M. L., 2004, BIOCHEM J, V437, P477; Klebanoff SJ., 1988, INFLAMMATION BASIC P, P391; LITWIN JA, 1987, AM J PATHOL, V128, P141; LIVINGSTON JN, 1977, J BIOL CHEM, V252, P560; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; MARTINS EAL, 1995, ARCH BIOCHEM BIOPHYS, V316, P128, DOI 10.1006/abbi.1995.1019; Millonig G, 2009, FREE RADICAL BIO MED, V46, P182, DOI 10.1016/j.freeradbiomed.2008.09.043; Miura K, 2008, HEPATOLOGY, V48, P1420, DOI 10.1002/hep.22486; Moirand R, 1997, LANCET, V349, P95, DOI 10.1016/S0140-6736(96)06034-5; Moritz RL, 2001, J BIOL CHEM, V276, P8244, DOI 10.1074/jbc.M009979200; Mueller S, 1997, ANAL BIOCHEM, V245, P55, DOI 10.1006/abio.1996.9939; Mueller S, 2000, FREE RADICAL BIO MED, V29, P410, DOI 10.1016/S0891-5849(00)00261-6; MUELLER S, 1995, J BIOLUM CHEMILUM, V10, P229, DOI 10.1002/bio.1170100406; Mueller S, 2009, ADV MED SCI-POLAND, V54, P121, DOI 10.2478/v10039-009-0042-3; Mueller S, 2002, METHOD ENZYMOL, V348, P324, DOI 10.1016/S0076-6879(02)48651-X; Mueller S, 2001, J BIOL CHEM, V276, P23192, DOI 10.1074/jbc.M100654200; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Mutze S, 2003, J BIOL CHEM, V278, P40542, DOI 10.1074/jbc.M307159200; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nishina S, 2008, GASTROENTEROLOGY, V134, P226, DOI 10.1053/j.gastro.2007.10.011; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Riva A, 2008, WORLD J GASTROENTERO, V14, P4745, DOI 10.3748/wjg.14.4745; Roy CN, 2004, NAT GENET, V36, P481, DOI 10.1038/ng1350; Schieffer B, 2000, CIRC RES, V87, P1195, DOI 10.1161/01.RES.87.12.1195; TEST ST, 1984, J BIOL CHEM, V259, P399; Truksa J, 2007, BLOOD CELL MOL DIS, V39, P255, DOI 10.1016/j.bcmd.2007.06.014	47	56	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37472	37482		10.1074/jbc.M112.358911	http://dx.doi.org/10.1074/jbc.M112.358911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22932892	Green Published, hybrid			2022-12-25	WOS:000310588500076
J	Ferreras, C; Rushton, G; Cole, CL; Babur, M; Telfer, BA; van Kuppevelt, TH; Gardiner, JM; Williams, KJ; Jayson, GC; Avizienyte, E				Ferreras, Cristina; Rushton, Graham; Cole, Claire L.; Babur, Muhammad; Telfer, Brian A.; van Kuppevelt, Toin H.; Gardiner, John M.; Williams, Kaye J.; Jayson, Gordon C.; Avizienyte, Egle			Endothelial Heparan Sulfate 6-O-Sulfation Levels Regulate Angiogenic Responses of Endothelial Cells to Fibroblast Growth Factor 2 and Vascular Endothelial Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR ANGIOGENESIS; METASTASIS; SEQUENCE; BINDING; VEGF; FGF; PROTEOGLYCANS; SPECIFICITY; EXPRESSION	Fibroblast growth factor 2 (FGF2) and vascular endothelial growth factor 165 (VEGF(165)) are potent pro-angiogenic growth factors that play a pivotal role in tumor angiogenesis. The activity of these growth factors is regulated by heparan sulfate (HS), which is essential for the formation of FGF2/FGF receptor (FGFR) and VEGF(165)/VEGF receptor signaling complexes. However, the structural characteristics of HS that determine activation or inhibition of such complexes are only partially defined. Here we show that ovarian tumor endothelium displays high levels of HS sequences that harbor glucosamine 6-O-sulfates when compared with normal ovarian vasculature where these sequences are also detected in perivascular area. Reduced HS 6-O-sulfotransferase 1 (HS6ST-1) or 6-O-sulfotransferase 2 (HS6ST-2) expression in endothelial cells impacts upon the prevalence of HS 6-O-sulfate moieties in HS sequences, which consist of repeating short, highly sulfated S domains interspersed by transitional N-acetylated/N-sulfated domains. 1-40% reduction in 6-O-sulfates significantly compromises FGF2- and VEGF(165)-induced endothelial cell sprouting and tube formation in vitro and FGF2-dependent angiogenesis in vivo. Moreover, HS on wild-type neighboring endothelial or smooth muscle cells fails to restore endothelial cell sprouting and tube formation. The affinity of FGF2 for HS with reduced 6-O-sulfation is preserved, although FGFR1 activation is inhibited correlating with reduced receptor internalization. These data show that 6-O-sulfate moieties in endothelial HS are of major importance in regulating FGF2- and VEGF(165)-dependent endothelial cell functions in vitro and in vivo and highlight HS6ST-1 and HS6ST-2 as potential targets of novel antiangiogenic agents.	[Ferreras, Cristina; Rushton, Graham; Cole, Claire L.; Jayson, Gordon C.; Avizienyte, Egle] Univ Manchester, Sch Canc & Enabling Sci, Translat Angiogenesis Grp, Manchester M20 4BX, Lancs, England; [Babur, Muhammad; Telfer, Brian A.; Williams, Kaye J.] Univ Manchester, Sch Pharm & Pharmaceut Sci, Hypoxia & Therapeut Grp, Manchester M13 9PT, Lancs, England; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Fac Sci, NL-6500 HB Nijmegen, Netherlands; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Biochem 280, NL-6500 HB Nijmegen, Netherlands; [Gardiner, John M.] Univ Manchester, Sch Chem, Manchester Interdisciplinary Bioctr, Manchester M17DN, Lancs, England	University of Manchester; University of Manchester; Radboud University Nijmegen; Radboud University Nijmegen; University of Manchester	Avizienyte, E (corresponding author), Univ Manchester, Sch Canc & Enabling Sci, Translat Angiogenesis Grp, Manchester M20 4BX, Lancs, England.	eavizienyte@picr.man.ac.uk	van Kuppevelt, A.H.M.S.M./L-4463-2015; williams, kaye/HHN-5342-2022; Gardiner, John M/Q-7268-2017; Jayson, Gordon C/O-8224-2015	Gardiner, John M/0000-0003-1827-6817; Jayson, Gordon C/0000-0002-8515-8944; Telfer, Brian/0000-0003-1857-5120	Cancer Research United Kingdom Project Grant [C2075/A11994]; Medical Research Council Developmental Pathway Funding Scheme [G0902173/1]; Cancer Research UK [11994] Funding Source: researchfish	Cancer Research United Kingdom Project Grant; Medical Research Council Developmental Pathway Funding Scheme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research United Kingdom Project Grant C2075/A11994 and Medical Research Council Developmental Pathway Funding Scheme G0902173/1.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Backen AC, 2007, BRIT J CANCER, V96, P1544, DOI 10.1038/sj.bjc.6603747; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Boilly B, 2000, CYTOKINE GROWTH F R, V11, P295, DOI 10.1016/S1359-6101(00)00014-9; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cole CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011644; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; HISCOCK DRR, 1995, BBA-GEN SUBJECTS, V1244, P104, DOI 10.1016/0304-4165(94)00206-D; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jastrebova N, 2010, J BIOL CHEM, V285, P26842, DOI 10.1074/jbc.M109.093542; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; LYON M, 1994, J BIOL CHEM, V269, P11216; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; MACCHIARINI P, 1992, LANCET, V340, P145, DOI 10.1016/0140-6736(92)93217-B; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Paley PJ, 1997, CANCER, V80, P98, DOI 10.1002/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Properzi F, 2008, EUR J NEUROSCI, V27, P593, DOI 10.1111/j.1460-9568.2008.06042.x; PYE DA, 1995, BBA-MOL CELL RES, V1266, P235, DOI 10.1016/0167-4889(95)00012-H; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Stringer SE, 2006, BIOCHEM SOC T, V34, P451, DOI 10.1042/BST0340451; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Thompson SM, 2009, J BIOL CHEM, V284, P35621, DOI 10.1074/jbc.M109.009712; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WEIDNER N, 1993, AM J PATHOL, V143, P401; Whitworth MK, 2005, CLIN CANCER RES, V11, P4282, DOI 10.1158/1078-0432.CCR-04-1386	39	53	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36132	36146		10.1074/jbc.M112.384875	http://dx.doi.org/10.1074/jbc.M112.384875			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22927437	hybrid, Green Published			2022-12-25	WOS:000310364000035
J	Stoneham, CA; Hollinshead, M; Hajitou, A				Stoneham, Charlotte A.; Hollinshead, Michael; Hajitou, Amin			Clathrin-mediated Endocytosis and Subsequent Endo-Lysosomal Trafficking of Adeno-associated Virus/Phage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOVIRAL PENTON BASE; VIRUS ENTRY; IN-VIVO; INTERNALIZATION; VECTORS; ALPHA; RGD; INHIBITOR; RECEPTORS; INTEGRINS	Adeno-associated virus/phage (AAVP) is a gene delivery vector constructed as a hybrid between adeno-associated virus and filamentous phage. Tumor targeting following systemic administration has previously been demonstrated in several in vivo cancer models, with tumor specificity achieved through display of an alpha(v) integrin-targeting ligand on the capsid. However, high titers of AAVP are required for transduction of large numbers of mammalian cells. This study is the first to investigate the mechanisms involved in entry and intracellular trafficking of AAVP. Using a combination of flow cytometry, confocal, and electron microscopy techniques, together with pharmacological agents, RNAi and dominant negative mutants, we have demonstrated that targeted AAVP endocytosis is both dynamin and clathrin-dependent. Following entry, the majority of AAVP particles are sequestered by the endosomal-lysosomal degradative pathway. Finally, we have demonstrated that disruption of this pathway leads to improved transgene expression by AAVP, thus demonstrating that escape from the late endosomes/lysosomes is a critical step for improving gene delivery by AAVP. These findings have important implications for the rational design of improved AAVP and RGD-targeted vectors.	[Stoneham, Charlotte A.; Hajitou, Amin] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Brain Sci, Ctr Neuroinflammat & Neurodegenerat, London W12 0NN, England; [Hollinshead, Michael] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Virol Sect, London W2 1PG, England	Imperial College London; Imperial College London	Hajitou, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Brain Sci, Ctr Neuroinflammat & Neurodegenerat, Hammersmith Hosp Campus,160 Cane Rd, London W12 0NN, England.	a.hajitou@imperial.ac.uk		Stoneham, Charlotte/0000-0003-3729-6936; Hajitou, Amin/0000-0003-1119-5686	UK Medical Research Council (MRC) [G0701159]; Leverhulme Trust [RF/2/RFG/2009/0114]; Medical Research Council; Medical Research Council [G0701159] Funding Source: researchfish; MRC [G0701159] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leverhulme Trust(Leverhulme Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by Grant G0701159 from the UK Medical Research Council (MRC), and Research Fellowship RF/2/RFG/2009/0114 from The Leverhulme Trust.; Supported by a Medical Research Council Doctoral Training Grant.	Bhattacharyya S, 2010, VIROLOGY, V401, P18, DOI 10.1016/j.virol.2010.02.015; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Di Giovine M, 2001, VIROLOGY, V282, P102, DOI 10.1006/viro.2000.0809; FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811; FOX G, 1989, J GEN VIROL, V70, P625, DOI 10.1099/0022-1317-70-3-625; Greber UF, 2002, CELL MOL LIFE SCI, V59, P608, DOI 10.1007/s00018-002-8453-3; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Hajitou A, 2007, NAT PROTOC, V2, P523, DOI 10.1038/nprot.2007.51; HART SL, 1994, J BIOL CHEM, V269, P12468; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hollinshead M, 1999, J VIROL, V73, P1503, DOI 10.1128/JVI.73.2.1503-1517.1999; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Ivanenkov VV, 1999, BBA-MOL CELL RES, V1448, P450, DOI 10.1016/S0167-4889(98)00162-1; Larocca D, 1998, HUM GENE THER, V9, P2393, DOI 10.1089/hum.1998.9.16-2393; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Meier O, 2004, J GENE MED, V6, pS152, DOI 10.1002/jgm.553; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Michelfelder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005122; NGAHA EO, 1982, COMP BIOCHEM PHYS C, V73, P109, DOI 10.1016/0306-4492(82)90176-9; Paoloni MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004972; Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542; Piersanti S, 2004, J MOL MED, V82, P467, DOI 10.1007/s00109-004-0543-2; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; ROIVAINEN M, 1991, J VIROL, V65, P4735, DOI 10.1128/JVI.65.9.4735-4740.1991; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; Trepel M, 2009, MOL CANCER THER, V8, P2383, DOI 10.1158/1535-7163.MCT-09-0110; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Verma IM, 2005, ANNU REV BIOCHEM, V74, P711, DOI 10.1146/annurev.biochem.74.050304.091637; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; ZACHER AN, 1980, GENE, V9, P127, DOI 10.1016/0378-1119(80)90171-7	38	45	49	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35849	35859		10.1074/jbc.M112.369389	http://dx.doi.org/10.1074/jbc.M112.369389			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22915587	Green Published, hybrid			2022-12-25	WOS:000310364000008
J	Minder, P; Bayha, E; Becker-Pauly, C; Sterchi, EE				Minder, Petra; Bayha, Elke; Becker-Pauly, Christoph; Sterchi, Erwin E.			Meprin alpha Transactivates the Epidermal Growth Factor Receptor (EGFR) via Ligand Shedding, thereby Enhancing Colorectal Cancer Cell Proliferation and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBENZOIC ACID HYDROLASE; HUMAN SMALL-INTESTINE; METALLOPROTEASE MEPRIN; PABA-PEPTIDE; BETA-SUBUNIT; DIFFERENTIAL EXPRESSION; CONVERTING-ENZYME; TGF-ALPHA; ACTIVATION; MEMBRANE	Meprin alpha, an astacin-type metalloprotease is overexpressed in colorectal cancer cells and is secreted in a non-polarized fashion, leading to the accumulation of meprin alpha in the tumor stroma. The transition from normal colonocytes to colorectal cancer correlates with increased meprin alpha activity at primary tumor sites. A role for meprin alpha in invasion and metastatic dissemination is supported by its pro-angiogenic and pro-migratory activity. In the present study, we provide evidence for a meprin alpha-mediated transactivation of the EGFR signaling pathway and suggest that this mechanism is involved in colorectal cancer progression. Using alkaline phosphatase-tagged EGFR ligands and an ELISA assay, we demonstrate that meprin alpha is capable of shedding epidermal growth factor (EGF) and transforming growth factor-alpha (TGF alpha) from the plasma membrane. Shedding was abrogated using actinonin, an inhibitor for meprin alpha. The physiological effects of meprin alpha-mediated shedding of EGF and TGF alpha were investigated with human colorectal adenocarcinoma cells (Caco-2). Proteolytically active meprin alpha leads to an increase in EGFR and ERK1/2 phosphorylation and subsequently enhances cell proliferation and migration. In conclusion, the implication of meprin alpha in the EGFR/MAPK signaling pathway indicates a role of meprin alpha in colorectal cancer progression.	[Minder, Petra; Bayha, Elke; Sterchi, Erwin E.] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Becker-Pauly, Christoph] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany	University of Bern; University of Kiel	Sterchi, EE (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buehlstr 28, CH-3012 Bern, Switzerland.	erwin.sterchi@ibmm.unibe.ch	Becker-Pauly, Christoph/B-7569-2011		Swiss National Science Foundation [31003A 125212/1]; Deutsche Forschungsgemeinschaft (DFG) [BE 4086/1-2, SFB877]; Cluster of Excellence "Inflammation at Interfaces"	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was supported by Swiss National Science Foundation Grant 31003A 125212/1 and by the Deutsche Forschungsgemeinschaft (DFG) Grant BE 4086/1-2 and SFB877 (project A9), and the Cluster of Excellence "Inflammation at Interfaces" (to C. B. P.).	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Anoopkumar-Dukie S, 2005, BRIT J RADIOL, V78, P945, DOI 10.1259/bjr/54004230; Barrett AJ, 2001, J STRUCT BIOL, V134, P95, DOI 10.1006/jsbi.2000.4332; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; CHOUDRY Y, 1991, BIOCHEM J, V280, P57, DOI 10.1042/bj2800057; CIARDIELLO F, 1991, P NATL ACAD SCI USA, V88, P7792, DOI 10.1073/pnas.88.17.7792; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; COHEN STANLEY, 1965, DEVELOP BIOL, V12, P394, DOI 10.1016/0012-1606(65)90005-9; Crouch SP, 1993, J IMMUNOL METHODS, V1, P81; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DUMERMUTH E, 1993, FEBS LETT, V335, P367, DOI 10.1016/0014-5793(93)80421-P; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Eldering JA, 1997, EUR J BIOCHEM, V247, P920, DOI 10.1111/j.1432-1033.1997.00920.x; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; GRUNBERG J, 1993, FEBS LETT, V335, P376, DOI 10.1016/0014-5793(93)80422-Q; Half E, 2004, INT J CANCER, V108, P540, DOI 10.1002/ijc.11599; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hedrich J, 2010, BIOCHEMISTRY-US, V49, P8599, DOI 10.1021/bi1004238; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Huguenin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002153; Ishmael FT, 2001, J BIOL CHEM, V276, P23207, DOI 10.1074/jbc.M102654200; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Jefferson T., 2012, CELL MOL LI IN PRESS; KENNY AJ, 1987, BIOCHEM J, V245, P515, DOI 10.1042/bj2450515; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Lottaz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026450; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; MARCHAND P, 1994, J BIOL CHEM, V269, P15388; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Rosmann S, 2002, J BIOL CHEM, V277, P40650, DOI 10.1074/jbc.M206203200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; SHING Y, 1993, SCIENCE, V259, P1604, DOI 10.1126/science.8456283; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; STERCHI EE, 1988, ARCH BIOCHEM BIOPHYS, V265, P105, DOI 10.1016/0003-9861(88)90376-1; STERCHI EE, 1982, CLIN SCI, V62, P557, DOI 10.1042/cs0620557; Strachan L, 2001, J BIOL CHEM, V276, P18265, DOI 10.1074/jbc.M006935200; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Tampellini M, 2007, VIRCHOWS ARCH, V450, P321, DOI 10.1007/s00428-007-0370-2; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Tousseyn Thomas, 2006, Birth Defects Research, V78, P24, DOI 10.1002/bdrc.20066; TOYODA H, 1995, J BIOL CHEM, V270, P7495, DOI 10.1074/jbc.270.13.7495; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yarom N, 2011, DISCOV MED, V11, P95; YASUI W, 1988, CANCER RES, V48, P137	62	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35201	35211		10.1074/jbc.M112.368910	http://dx.doi.org/10.1074/jbc.M112.368910			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22923609	Green Published, hybrid			2022-12-25	WOS:000309968000030
J	Stengel, R; Rivera-Milla, E; Sahoo, N; Ebert, C; Bollig, F; Heinemann, SH; Schonherr, R; Englert, C				Stengel, Rayk; Rivera-Milla, Eric; Sahoo, Nirakar; Ebert, Christina; Bollig, Frank; Heinemann, Stefan H.; Schoenherr, Roland; Englert, Christoph			Kcnh1 Voltage-gated Potassium Channels Are Essential for Early Zebrafish Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-QT SYNDROME; HUMAN ETHER; FUNCTIONAL EXPRESSION; K+ CHANNELS; GENE; INHIBITION; PROLIFERATION; VERTEBRATE; CLONING; HERG	The Kcnh1 gene encodes a voltage-gated potassium channel highly expressed in neurons and involved in tumor cell proliferation, yet its physiological roles remain unclear. We have used the zebrafish as a model to analyze Kcnh1 function in vitro and in vivo. We found that the kcnh1 gene is duplicated in teleost fish (i.e. kcnh1a and kcnh1b) and that both genes are maternally expressed during early development. In adult zebrafish, kcnh1a and kcnh1b have distinct expression patterns but share expression in brain and testis. Heterologous expression of both genes in Xenopus oocytes revealed a strong conservation of characteristic functional properties between human and fish channels, including a unique sensitivity to intracellular Ca2+/calmodulin and modulation of voltage-dependent gating by extracellular Mg2+. Using a morpholino antisense approach, we demonstrate a strong kcnh1 loss-of-function phenotype in developing zebrafish, characterized by growth retardation, delayed hind-brain formation, and embryonic lethality. This late phenotype was preceded by transcriptional up-regulation of known cell-cycle inhibitors (p21, p27, cdh2) and down-regulation of pro-proliferative factors, including cyclin D1, at 70% epiboly. These results reveal an unanticipated basic activity of kcnh1 that is crucial for early embryonic development and patterning.	[Stengel, Rayk; Sahoo, Nirakar; Heinemann, Stefan H.; Schoenherr, Roland] Jena Univ Hosp, Ctr Mol Biomed, Dept Biophys, D-07745 Jena, Germany; [Stengel, Rayk; Sahoo, Nirakar; Heinemann, Stefan H.; Schoenherr, Roland] Univ Jena, D-07745 Jena, Germany; [Rivera-Milla, Eric; Ebert, Christina; Bollig, Frank; Englert, Christoph] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Schonherr, R (corresponding author), Jena Univ Hosp, Ctr Mol Biomed, Dept Biophys, Hans Knoll Str 2, D-07745 Jena, Germany.	Roland.Schoenherr@uni-jena.de	Schönherr, Roland/K-8713-2013	Schönherr, Roland/0000-0003-0633-0775; Heinemann, Stefan H./0000-0002-4144-0251; Englert, Christoph/0000-0002-5931-3189; Sahoo, Nirakar/0000-0003-0669-3840	Deutsche Forschungsgemeinschaft [SFB 604]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (SFB 604) (to C. E. and to S. H. H.).	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Arnaout R, 2007, P NATL ACAD SCI USA, V104, P11316, DOI 10.1073/pnas.0702724104; Bijlenga P, 1998, J PHYSIOL-LONDON, V512, P317, DOI 10.1111/j.1469-7793.1998.317be.x; Borowiec AS, 2011, BBA-MOL CELL RES, V1813, P723, DOI 10.1016/j.bbamcr.2011.01.025; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; Chalasani K, 2011, MOL BIOL CELL, V22, P1505, DOI 10.1091/mbc.E10-08-0675; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019257; Force A, 1999, GENETICS, V151, P1531; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; Hassel D, 2008, CIRCULATION, V117, P866, DOI 10.1161/CIRCULATIONAHA.107.752220; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; KAPLAN WD, 1969, GENETICS, V61, P399; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kohn M, 2006, TRENDS GENET, V22, P203, DOI 10.1016/j.tig.2006.02.008; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; Langheinrich U, 2003, TOXICOL APPL PHARM, V193, P370, DOI 10.1016/j.taap.2003.07.012; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Ludwig J, 2000, MOL CELL NEUROSCI, V16, P59, DOI 10.1006/mcne.2000.0851; Martin S, 2008, NEUROSCIENCE, V155, P833, DOI 10.1016/j.neuroscience.2008.05.019; McCurley AT, 2010, J EXP NEUROSCI, V4, P17; Milan DJ, 2003, CIRCULATION, V107, P1355, DOI 10.1161/01.CIR.0000061912.88753.87; Mittelstadt S. W., 2008, Journal of Pharmacological and Toxicological Methods, V57, P100, DOI 10.1016/j.vascn.2007.10.004; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; Ohno S., 1970, P1; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pelegri F, 2003, DEV DYNAM, V228, P535, DOI 10.1002/dvdy.10390; Reifers F, 1998, DEVELOPMENT, V125, P2381; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Scholz EP, 2009, BIOCHEM BIOPH RES CO, V381, P159, DOI 10.1016/j.bbrc.2009.02.042; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Schonherr R, 2002, NEURON, V35, P935, DOI 10.1016/S0896-6273(02)00869-3; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Silverman WR, 2000, J GEN PHYSIOL, V116, P663, DOI 10.1085/jgp.116.5.663; Spitzner M, 2007, FASEB J, V21, P35, DOI 10.1096/fj.06-6200com; Starkus JG, 2003, PFLUG ARCH EUR J PHY, V447, P44, DOI 10.1007/s00424-003-1121-0; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Thisse B, 2001, ZFIN DIRECT DATA SUB; Venkatesh B, 2003, CURR OPIN GENET DEV, V13, P588, DOI 10.1016/j.gde.2003.09.001; Wang MH, 2004, BIOCHEM BIOPH RES CO, V324, P971, DOI 10.1016/j.bbrc.2004.09.162; Webb SE, 2007, CLIN EXP PHARMACOL P, V34, P897, DOI 10.1111/j.1440-1681.2007.04709.x; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Wimmers S, 2001, PFLUG ARCH EUR J PHY, V441, P450, DOI 10.1007/s004240000467; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	56	20	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35565	35575		10.1074/jbc.M112.363978	http://dx.doi.org/10.1074/jbc.M112.363978			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927438	Green Published, hybrid			2022-12-25	WOS:000309968000069
J	Binder, A; Nakajima, S; Kloft, M; Muller, C; Samek, W; Brefeld, U; Muller, KR; Kawanabe, M				Binder, Alexander; Nakajima, Shinichi; Kloft, Marius; Mueller, Christina; Samek, Wojciech; Brefeld, Ulf; Mueller, Klaus-Robert; Kawanabe, Motoaki			Insights from Classifying Visual Concepts with Multiple Kernel Learning	PLOS ONE			English	Article							MACHINES; FEATURES	Combining information from various image features has become a standard technique in concept recognition tasks. However, the optimal way of fusing the resulting kernel functions is usually unknown in practical applications. Multiple kernel learning (MKL) techniques allow to determine an optimal linear combination of such similarity matrices. Classical approaches to MKL promote sparse mixtures. Unfortunately, 1-norm regularized MKL variants are often observed to be outperformed by an unweighted sum kernel. The main contributions of this paper are the following: we apply a recently developed non-sparse MKL variant to state-of-the-art concept recognition tasks from the application domain of computer vision. We provide insights on benefits and limits of non-sparse MKL and compare it against its direct competitors, the sum-kernel SVM and sparse MKL. We report empirical results for the PASCAL VOC 2009 Classification and ImageCLEF2010 Photo Annotation challenge data sets. Data sets (kernel matrices) as well as further information are available at http://doc.ml.tuberlin.de/image_mkl/(Accessed 2012 Jun 25).	[Binder, Alexander; Kloft, Marius; Mueller, Christina; Samek, Wojciech; Mueller, Klaus-Robert] Berlin Inst Technol, Machine Learning Grp, Berlin, Germany; [Binder, Alexander; Samek, Wojciech] Fraunhofer Inst FIRST, Berlin, Germany; [Nakajima, Shinichi] Nikon Inc, Opt Res Lab, Tokyo, Japan; [Brefeld, Ulf] Univ Bonn, Knowledge Discovery & Machine Learning Grp, Bonn, Germany; [Brefeld, Ulf] Zalando GmbH, Berlin, Germany; [Mueller, Klaus-Robert] Bernstein Focus Neurotechnol Berlin, Berlin, Germany; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Kawanabe, Motoaki] ATR Res, Kyoto, Japan	Technical University of Berlin; Fraunhofer Gesellschaft; Nikon Corporation; University of Bonn; Korea University	Binder, A (corresponding author), Berlin Inst Technol, Machine Learning Grp, Berlin, Germany.	alexander.binder@tu-berlin.de	Samek, Wojciech/C-5107-2014; Mueller, Klaus-Robert/Y-3547-2019; Samek, Wojciech/AAZ-2156-2021; Muller, Klaus R/C-3196-2013	Mueller, Klaus-Robert/0000-0002-3861-7685; Samek, Wojciech/0000-0002-6283-3265; Binder, Alexander/0000-0001-9605-6209	Federal Ministry of Economics and Technology of Germany (BMWi) under the project THESEUS [FKZ 01MQ07018]; Federal Ministry of Education and Research of Germany (BMBF) under the project REMIND [FKZ 01-IS07007A]; German National Science Foundation (DFG) [GA 1615/1-1, MU 987/6-1, RA 1894/1-1]; FP7-ICT program of the European Community, under the PASCAL2 Network of Excellence [ICT-216886]; German Academic Exchange Service (DAAD); World Class University Program through the National Research Foundation of Korea; Korean Ministry of Education, Science, and Technology [R31-10008]	Federal Ministry of Economics and Technology of Germany (BMWi) under the project THESEUS; Federal Ministry of Education and Research of Germany (BMBF) under the project REMIND(Federal Ministry of Education & Research (BMBF)); German National Science Foundation (DFG)(German Research Foundation (DFG)); FP7-ICT program of the European Community, under the PASCAL2 Network of Excellence; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); World Class University Program through the National Research Foundation of Korea(National Research Foundation of Korea); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by the Federal Ministry of Economics and Technology of Germany (BMWi) under the project THESEUS (FKZ 01MQ07018), by Federal Ministry of Education and Research of Germany (BMBF) under the project REMIND (FKZ 01-IS07007A), by the German National Science Foundation (DFG) under references GA 1615/1-1, MU 987/6-1 and RA 1894/1-1 and by the FP7-ICT program of the European Community, under the PASCAL2 Network of Excellence (ICT-216886). Marius Kloft acknowledges a scholarship by the German Academic Exchange Service (DAAD). This work was also supported by the World Class University Program through the National Research Foundation of Korea funded by the Korean Ministry of Education, Science, and Technology, under Grant R31-10008. Part of this work was done while KRM was at the Institute of Pure and Applied Mathematics, University of California Los Angeles, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, LEARNING KERNELS; Bach F, 2004, INT C MACH LEARN; Binder A, 2010, LECT NOTES COMPUT SC, V6242, P269, DOI 10.1007/978-3-642-15751-6_33; Binder A, 2012, INT J COMPUT VISION, V99, P281, DOI 10.1007/s11263-010-0417-8; Bosch A., 2007, P 6 ACM INT C IM VID, V5, P401, DOI [10.1145/1282280.1282340, DOI 10.1145/1282280, DOI 10.1145/1282280.1282340]; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Cai D., 2007, P INT C DAT MIN ICDM; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Cao LL, 2009, IEEE I CONF COMP VIS, P1095, DOI 10.1109/ICCV.2009.5459401; Chapelle O, 1999, IEEE T NEURAL NETWOR, V10, P1055, DOI 10.1109/72.788646; Chapelle O., 2008, P NIPS WORKSH KERN L; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cortes C., 2008, P NIPS WORKSH KERN L; Cortes C., 2010, ICML, P239; Cortes C., 2009, P INT C UNC ART INT; Csurka G., 2004, WORKSH STAT LEARN CO, V1, P1, DOI DOI 10.1234/12345678; Dalal N., 2005, IEEE COMPUTER SOC C, DOI [DOI 10.1109/CVPR.2005.177, 10.1109/CVPR.2005.177]; Everingham M, 2009, PASCAL VISUAL OBJECT; Everingham M, 2010, INT J COMPUT VISION, V88, P303, DOI 10.1007/s11263-009-0275-4; Galleguillos C, 2010, PROC CVPR IEEE, P113, DOI 10.1109/CVPR.2010.5540223; Gehler Peter Vincent, 2009, 2009 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2836, DOI 10.1109/CVPRW.2009.5206592; Gehler P, 2009, IEEE I CONF COMP VIS, P221, DOI 10.1109/ICCV.2009.5459169; Gonen M, 2010, P 20 IAPR INT C PATT; Gonen M, 2011, J MACH LEARN RES, V12, P2211; Jaakkola TS, 1999, ADV NEUR IN, V11, P487; Kloft M, 2008, P NIPS WORKSH KERN L; Kloft M, 2011, J MACH LEARN RES, V12, P953; Kumar A, 2007, IEEE I CONF COMP VIS, P1855; Lampert CH, 2011, ADV NEURAL INFORM PR, P289; Lampert CH, 2008, LECT NOTES COMPUT SC, V5096, P31, DOI 10.1007/978-3-540-69321-5_4; Lanckriet GRG, 2004, J MACH LEARN RES, V5, P27; Lazebnik S., 2006, P IEEE INT C COMP VI, V2, P2169, DOI DOI 10.1109/CVPR.2006.68; Li FF, 2006, IEEE T PATTERN ANAL, V28, P594, DOI 10.1109/TPAMI.2006.79; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Marius K., 2009, NIPS, P997; Marszalek M., LEARNING REPRESENTAT; Mika S, 2003, IEEE T PATTERN ANAL, V25, P623, DOI 10.1109/TPAMI.2003.1195996; Mika S., 1999, Neural Networks for Signal Processing IX: Proceedings of the 1999 IEEE Signal Processing Society Workshop (Cat. No.98TH8468), P41, DOI 10.1109/NNSP.1999.788121; Moosmann F, 2006, ADV NEURAL INFORM PR; Moosmann F, 2008, IEEE T PATTERN ANAL, V30, P1632, DOI 10.1109/TPAMI.2007.70822; Nowak S., 2010, CLEF NOTEBOOK PAPERS; Orabona F, 2010, PROC CVPR IEEE, P787, DOI 10.1109/CVPR.2010.5540137; Rakotomamonjy A., 2007, P 24 INT C MACH LEAR, V227, P775, DOI DOI 10.1145/1273496.1273594; Rakotomamonjy A, 2008, J MACH LEARN RES, V9, P2491; Smeaton A. F., 2006, MIR 2006 P 8 ACM INT, DOI [DOI 10.1145/1178677.1178722, 10.1145/1178677.1178722]; Sonnenburg S., 2010, J MACHINE LEARNING R; Sonnenburg S, 2006, J MACH LEARN RES, V7, P1531; van de Sande KEA, 2010, IEEE T PAT ANAL MACH; van de Sande KEA, 2011, IEEE I CONF COMP VIS, P1879, DOI 10.1109/ICCV.2011.6126456; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Vapnik V., 1998, STAT LEARNING THEORY; Varma M., 2009, ICML; Vedaldi A, 2009, IEEE I CONF COMP VIS, P606, DOI 10.1109/ICCV.2009.5459183; Yan F, 2010, PROC CVPR IEEE, P3626, DOI 10.1109/CVPR.2010.5539916; Yan F, 2009, IEEE DATA MINING, P1064, DOI 10.1109/ICDM.2009.84; Yang JJ, 2009, IEEE I CONF COMP VIS, P436, DOI 10.1109/ICCV.2009.5459172; Zhang J, 2007, INT J COMPUT VISION, V73, P213, DOI 10.1007/s11263-006-9794-4; Zien A, 2000, BIOINFORMATICS, V16, P799, DOI 10.1093/bioinformatics/16.9.799; Zien A., 2007, P 24 INT C MACH LEAR, P1191, DOI DOI 10.1145/1273496.1273646	62	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e38897	10.1371/journal.pone.0038897	http://dx.doi.org/10.1371/journal.pone.0038897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936970	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500003
J	Lennertz, RC; Kossyreva, EA; Smith, AK; Stucky, CL				Lennertz, Richard C.; Kossyreva, Elena A.; Smith, Amanda K.; Stucky, Cheryl L.			TRPA1 Mediates Mechanical Sensitization in Nociceptors during Inflammation	PLOS ONE			English	Article							CUTANEOUS SENSORY NEURONS; ION-CHANNEL TRPA1; PERIPHERAL INFLAMMATION; NEUROGENIC INFLAMMATION; CAPSAICIN RECEPTOR; SPINAL NEURONS; INFLAMED RATS; TRPV1; PAIN; HYPERALGESIA	Inflammation is a part of the body's natural response to tissue injury which initiates the healing process. Unfortunately, inflammation is frequently painful and leads to hypersensitivity to mechanical stimuli, which is difficult to treat clinically. While it is well established that altered sensory processing in the spinal cord contributes to mechanical hypersensitivity (central sensitization), it is still debated whether primary afferent neurons become sensitized to mechanical stimuli after tissue inflammation. We induced inflammation in C57BL/6 mice via intraplantar injection of Complete Freund's Adjuvant. Cutaneous C fibers exhibited increased action potential firing to suprathreshold mechanical stimuli. We found that abnormal responses to intense mechanical stimuli were completely suppressed by acute incubation of the receptive terminals with the TRPA1 inhibitor, HC-030031. Further, elevated responses were predominantly exhibited by a specific subgroup of C fibers, which we determined to be C-Mechano Cold sensitive fibers. Thus, in the presence of HC-030031, C fiber mechanical responses in inflamed mice were not different than responses in saline-injected controls. We also demonstrate that injection of the HC-030031 compound into the hind paw of inflamed mice alleviates behavioral mechanical hyperalgesia without affecting heat hyperalgesia. Further, we pharmacologically anesthetized the TRPA1-expressing fibers in vivo by co-injecting the membrane-impermeable sodium channel inhibitor QX-314 and the TRPA1 agonist cinnamaldehyde into the hind paw. This approach also alleviated behavioral mechanical hyperalgesia in inflamed mice but left heat hypersensitivity intact. Our findings indicate that C-Mechano Cold sensitive fibers exhibit enhanced firing to suprathreshold mechanical stimuli in a TRPA1-dependent manner during inflammation, and that input from these fibers drives mechanical hyperalgesia in inflamed mice.	[Lennertz, Richard C.; Kossyreva, Elena A.; Smith, Amanda K.; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Lennertz, RC (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	cstucky@mcw.edu			National Institutes of Health [NS40538, NS070711]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070711, R01NS040538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health grants NS40538 and NS070711 to CLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew D, 1999, J NEUROPHYSIOL, V82, P2649, DOI 10.1152/jn.1999.82.5.2649; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Bishop T, 2010, PAIN, V150, P141, DOI 10.1016/j.pain.2010.04.018; Breese NM, 2005, PAIN, V115, P37, DOI 10.1016/j.pain.2005.02.010; Brierley SM, 2011, J PHYSIOL-LONDON, V589, P3575, DOI 10.1113/jphysiol.2011.206789; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; COOPER B, 1991, J NEUROPHYSIOL, V66, P1280, DOI 10.1152/jn.1991.66.4.1280; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Elitt CM, 2006, J NEUROSCI, V26, P8578, DOI 10.1523/JNEUROSCI.2185-06.2006; Garcia-Anoveros J., 2007, V179, P347; Ghilardi JR, 2005, J NEUROSCI, V25, P3126, DOI 10.1523/JNEUROSCI.3815-04.2005; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hillery CA, 2011, BLOOD, V118, P3376, DOI 10.1182/blood-2010-12-327429; HYLDEN JLK, 1989, PAIN, V37, P229, DOI 10.1016/0304-3959(89)90135-8; Kanai Y, 2005, NEUROPHARMACOLOGY, V49, P977, DOI 10.1016/j.neuropharm.2005.05.003; Kerstein PC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-19; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; KOCHER L, 1987, PAIN, V29, P363, DOI 10.1016/0304-3959(87)90051-0; Koerber HR, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-58; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Malin S, 2011, J NEUROSCI, V31, P10516, DOI 10.1523/JNEUROSCI.2992-10.2011; McGaraughty S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-14; McGaraughty S, 2008, J NEUROPHYSIOL, V100, P3158, DOI 10.1152/jn.90768.2008; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; REEH PW, 1986, BRAIN RES, V384, P42, DOI 10.1016/0006-8993(86)91217-5; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; Sisignano M, 2012, J NEUROSCI, V32, P6364, DOI 10.1523/JNEUROSCI.5793-11.2012; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Vilceanu D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012177; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Wei H, 2012, ANESTHESIOLOGY, V117, P137, DOI 10.1097/ALN.0b013e31825adb0e; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	46	108	108	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43597	10.1371/journal.pone.0043597	http://dx.doi.org/10.1371/journal.pone.0043597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927999	Green Published, gold, Green Submitted			2022-12-25	WOS:000308224700019
J	Seet, WT; Maarof, M; Anuar, KK; Chua, KH; Irfan, AWA; Ng, MH; Aminuddin, BS; Ruszymah, BHI				Seet, Wan Tai; Maarof, Manira; Anuar, Khairoji Khairul; Chua, Kien-Hui; Irfan, Abdul Wahab Ahmad; Ng, Min Hwei; Aminuddin, Bin Saim; Ruszymah, Bt Hj Idrus			Shelf-Life Evaluation of Bilayered Human Skin Equivalent, MyDerm (TM)	PLOS ONE			English	Article							CLINICAL-EVALUATION; ARTIFICIAL SKIN; IN-VITRO; FIBROBLASTS; APLIGRAF; EFFICACY; DESIGN; MATRIX	Skin plays an important role in defense against infection and other harmful biological agents. Due to its fragile structure, skin can be easily damaged by heat, chemicals, traumatic injuries and diseases. An autologous bilayered human skin equivalent, MyDerm (TM), was engineered to provide a living skin substitute to treat critical skin loss. However, one of the disadvantages of living skin substitute is its short shelf-life, hence limiting its distribution worldwide. The aim of this study was to evaluate the shelf-life of MyDerm (TM) through assessment of cell morphology, cell viability, population doubling time and functional gene expression levels before transplantation. Skin samples were digested with 0.6% Collagenase Type I followed by epithelial cells dissociation with TrypLE Select. Dermal fibroblasts and keratinocytes were culture-expanded to obtain sufficient cells for MyDerm (TM) construction. MyDerm (TM) was constructed with plasma-fibrin as temporary biomaterial and evaluated at 0, 24, 48 and 72 hours after storage at 4 degrees C for its shelf-life determination. The morphology of skin cells derived from MyDerm (TM) remained unchanged across storage times. Cells harvested from MyDerm (TM) after storage appeared in good viability (90.5%+/- 2.7% to 94.9%+/- 1.6%) and had short population doubling time (58.4 +/- 8.7 to 76.9 +/- 19 hours). The modest drop in cell viability and increased in population doubling time at longer storage duration did not demonstrate a significant difference. Gene expression for CK10, CK14 and COL III were also comparable between different storage times. In conclusion, MyDerm (TM) can be stored in basal medium at 4 degrees C for at least 72 hours before transplantation without compromising its functionality.	[Seet, Wan Tai; Maarof, Manira; Anuar, Khairoji Khairul; Chua, Kien-Hui; Irfan, Abdul Wahab Ahmad; Ng, Min Hwei; Aminuddin, Bin Saim; Ruszymah, Bt Hj Idrus] Univ Kebangsaan Malaysia, Med Ctr, Tissue Engn Ctr, Kuala Lumpur, Malaysia; [Chua, Kien-Hui; Ruszymah, Bt Hj Idrus] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia; [Aminuddin, Bin Saim] Ampang Puteri Specialist Hosp, Ear Nose & Throat Consultant Clin, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Seet, WT (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Tissue Engn Ctr, Kuala Lumpur, Malaysia.	ruszyidrus@gmail.com	Ng, Angela Min Hwei/ABC-6726-2020; Maarof, Manira/AAT-3191-2020; Seet, Wan Tai/AAT-3208-2020; chua, kienhui kh/M-7245-2017	Ng, Angela Min Hwei/0000-0002-5791-639X; Kien Hui, Chua/0000-0002-2595-5087; Maarof, Manira/0000-0002-2154-7852; Seet, Wan Tai/0000-0003-3788-6602	Malaysian Technology Development Corporation (MTDC) [UKM-MTDC-BF-0001-2008]; Universiti Kebangsaan Malaysia	Malaysian Technology Development Corporation (MTDC); Universiti Kebangsaan Malaysia	This study is made possible by a grant from Malaysian Technology Development Corporation (MTDC), grant number UKM-MTDC-BF-0001-2008, Universiti Kebangsaan Malaysia (http://www.mtdc.com.my/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3; Bar-Meir E, 2006, ISR MED ASSOC J, V8, P188; BERNSTAM L I, 1990, Journal of Dermatological Science, V1, P173, DOI 10.1016/0923-1811(90)90129-2; Cheng W, 2011, AFR J BIOTECHNOL, V10, P2524; Coulomb B, 1998, PLAST RECONSTR SURG, V101, P1891, DOI 10.1097/00006534-199806000-00018; Dinh TL, 2006, PLAST RECONSTR SURG, V117, p152S, DOI 10.1097/01.prs.0000222534.79915.d3; Edmonds M, 2009, INT J LOW EXTR WOUND, V8, P11, DOI 10.1177/1534734609331597; Furukawa K, 1998, CYTOTECHNOLOGY, V26, P153, DOI 10.1023/A:1007934216507; HANSBROUGH JF, 1992, SURGERY, V111, P438; HANSBROUGH JF, 1994, SURGERY, V115, P633; HARRIGER M D, 1992, Journal of Burn Care and Rehabilitation, V13, P187, DOI 10.1097/00004630-199203000-00002; Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800; Kumar RJ, 2004, ANZ J SURG, V74, P622, DOI 10.1111/j.1445-1433.2004.03106.x; LEVINE JF, 1985, J CELL BIOL, V100, P1415, DOI 10.1083/jcb.100.5.1415; Lewis M. P., 2006, PHARM TECHNOLOGY EUR, P50; MacNeil S, 2008, MATER TODAY, V11, P26, DOI 10.1016/S1369-7021(08)70087-7; Marston WA, 2003, DIABETES CARE, V26, P1701, DOI 10.2337/diacare.26.6.1701; Mast B.A., 1999, SKIN WOUND HEALING B; Mazlyzam AL, 2007, BURNS, V33, P355, DOI 10.1016/j.burns.2006.08.022; Mazlyzam AL, 2008, ARCH MED RES, V39, P743, DOI 10.1016/j.arcmed.2008.09.001; Moiemen NS, 2006, PLAST RECONSTR SURG, V117, p160S, DOI 10.1097/01.prs.0000222609.40461.68; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; PURKIS PE, 1990, J CELL SCI, V97, P39; Schon M, 1996, BRIT J DERMATOL, V135, P696; Schurr MJ, 2009, J TRAUMA, V66, P866, DOI 10.1097/TA.0b013e31819849d6; Shakespeare P, 2001, BURNS, V27, P517, DOI 10.1016/S0305-4179(01)00017-1; TAVIS MJ, 1980, BURNS, V7, P123, DOI 10.1016/0305-4179(80)90038-8; THIVOLET J, 1986, TRANSPLANTATION, V42, P274, DOI 10.1097/00007890-198609000-00010; Tilden E, 2010, FACTS ORGAN DONATION; Wainwright David, 1996, Journal of Burn Care and Rehabilitation, V17, P124, DOI 10.1097/00004630-199603000-00006; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108; YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203	33	40	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e40978	10.1371/journal.pone.0040978	http://dx.doi.org/10.1371/journal.pone.0040978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927903	gold, Green Published, Green Submitted			2022-12-25	WOS:000308224700001
J	Wang, PP; Xie, DY; Liang, XJ; Peng, L; Zhang, GL; Ye, YN; Xie, C; Gao, ZL				Wang, Pei-pei; Xie, Dong-ying; Liang, Xu-jing; Peng, Liang; Zhang, Geng-lin; Ye, Yi-nong; Xie, Chan; Gao, Zhi-liang			HGF and Direct Mesenchymal Stem Cells Contact Synergize to Inhibit Hepatic Stellate Cells Activation through TLR4/NF-kB Pathway	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; BONE-MARROW-CELLS; LIVER FIBROSIS; TRANSPLANTATION; EXPRESSION; CIRRHOSIS; TERM	Aims: Bone marrow-derived mesenchymal stem cells (BMSCs) can reduce liver fibrosis. Apart from the paracrine mechanism by which the antifibrotic effects of BMSCs inhibit activated hepatic stellate cells (HSCs), the effects of direct interplay and juxtacrine signaling between the two cell types are poorly understood. The purpose of this study was to explore the underlying mechanisms by which BMSCs modulate the function of activated HSCs. Methods: We used BMSCs directly and indirectly co-culture system with HSCs to evaluate the anti-fibrosis effect of BMSCs. Cell proliferation and activation were examined in the presence of BMSCs and HGF. c-met was knockdown in HSCs to evaluate the effect of HGF secreted by BMSCs. The TLR4 and Myeloid differentiation primary response gene 88(MyD88) mRNA levels and the NF-kB pathway activation were determined by real-time PCR and western blotting analyses. The effect of BMSCs on HSCs activation was investigated in vitro in either MyD88 silencing or overexpression in HSCs. Liver fibrosis in rats fed CCl4 with and without BMSCs supplementation was compared. Histopathological examinations and serum biochemical tests were compared between the two groups. Results: BMSCs remarkably inhibited the proliferation and activation of HSCs by interfering with LPS-TLR4 pathway through a cell-cell contact mode that was partially mediated by HGF secretion. The NF-kB pathway is involved in HSCs activation inhibition by BMSCs. MyD88 over expression reduced the BMSC inhibition of NF-kB luciferase activation. BMSCs protected liver fibrosis in vivo. Conclusion: BMSCs modulate HSCs in vitro via TLR4/MyD88/NF-kB signaling pathway through cell-cell contact and secreting HGF. BMSCs have therapeutic effects on cirrhosis rats. Our results provide new insights into the treatment of hepatic fibrosis with BMSCs.	[Wang, Pei-pei; Xie, Dong-ying; Peng, Liang; Zhang, Geng-lin; Xie, Chan; Gao, Zhi-liang] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Xu-jing] Jinan Univ, Affiliated Hosp 1, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Ye, Yi-nong] First Peoples Hosp Foshan City, Dept Infect Dis, Foshan, Guangdong, Peoples R China; [Wang, Pei-pei; Xie, Dong-ying; Xie, Chan; Gao, Zhi-liang] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Jinan University; Sun Yat Sen University	Wang, PP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China.	happyxiechan@gmail.com; gaozl@yahoo.com.cn			Natural Science Foundation of China [81101864/H1617]; Baiyang liver cirrhosis grand [2010-004]; Fundamental Research Funds for the Central Universities [09 ykzs07, 10 ykzs04]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Baiyang liver cirrhosis grand; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Grant Support: The Natural Science Foundation of China (No. 81101864/H1617), Baiyang liver cirrhosis grand (No. 2010-004), the Fundamental Research Funds for the Central Universities (09 ykzs07,10 ykzs04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baertschiger RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006657; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Brun P, 2005, AM J PHYSIOL-GASTR L, V289, pG571, DOI 10.1152/ajpgi.00537.2004; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Gaia S, 2006, J HEPATOL, V45, P13, DOI 10.1016/j.jhep.2006.02.018; GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334; Gordon MY, 2006, STEM CELLS, V24, P1822, DOI 10.1634/stemcells.2005-0629; GRINKO I, 1995, J HEPATOL, V23, P449, DOI 10.1016/0168-8278(95)80204-5; Guo JS, 2009, HEPATOLOGY, V49, P960, DOI 10.1002/hep.22697; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; LIN RS, 1995, J HEPATOL, V22, P165, DOI 10.1016/0168-8278(95)80424-2; Liu YB, 2006, J SURG RES, V136, P336, DOI 10.1016/j.jss.2006.07.037; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NOLAN JP, 1978, GASTROENTEROLOGY, V75, P445; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Payne C, 2007, HEPATOLOGY, V46, p710A; Peng L, 2011, HEPATOLOGY, V54, P820, DOI 10.1002/hep.24434; ROOS F, 1992, ENDOCRINOLOGY, V131, P2540, DOI 10.1210/en.131.6.2540; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Sakaida Isao, 2005, Medical Molecular Morphology, V38, P197, DOI 10.1007/s00795-005-0298-z; Schiff ER, 2011, CLIN GASTROENTEROL H, V9, P274, DOI 10.1016/j.cgh.2010.11.040; Schwabe RF, 2001, J IMMUNOL, V166, P6812, DOI 10.4049/jimmunol.166.11.6812; Soares JB, 2010, HEPATOL INT, V4, P659, DOI 10.1007/s12072-010-9219-x; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Xie C, 2009, CELL BIOL INT, V33, P493, DOI 10.1016/j.cellbi.2009.01.006	30	24	31	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43408	10.1371/journal.pone.0043408	http://dx.doi.org/10.1371/journal.pone.0043408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927965	Green Submitted, gold, Green Published			2022-12-25	WOS:000308224700014
J	Greene, JM; Chin, EN; Budde, ML; Lhost, JJ; Hines, PJ; Burwitz, BJ; Broman, KW; Nelson, JE; Friedrich, TC; O'Connor, DH				Greene, Justin M.; Chin, Emily N.; Budde, Melisa L.; Lhost, Jennifer J.; Hines, Paul J.; Burwitz, Benjamin J.; Broman, Karl W.; Nelson, Jennifer E.; Friedrich, Thomas C.; O'Connor, David H.			Ex Vivo SIV-Specific CD8 T Cell Responses in Heterozygous Animals Are Primarily Directed against Peptides Presented by a Single MHC Haplotype	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MAURITIAN CYNOMOLGUS MACAQUES; PLASMA VIRAL LOAD; CLASS-I ALLELES; RHESUS MACAQUES; SIVMAC239 REPLICATION; RELATIVE DOMINANCE; IMMUNE-RESPONSES; INFECTION	The presence of certain MHC class I alleles is correlated with remarkable control of HIV and SIV, indicating that specific CD8 T cell responses can effectively reduce viral replication. It remains unclear whether epitopic breadth is an important feature of this control. Previous studies have suggested that individuals heterozygous at the MHC class I loci survive longer and/or progress more slowly than those who are homozygous at these loci, perhaps due to increased breadth of the CD8 T cell response. We used Mauritian cynomolgus macaques with defined MHC haplotypes and viral inhibition assays to directly compare CD8 T cell efficacy in MHC-heterozygous and homozygous individuals. Surprisingly, we found that cells from heterozygotes suppress viral replication most effectively on target cells from animals homozygous for only one of two potential haplotypes. The same heterozygous effector cells did not effectively inhibit viral replication as effectively on the target cells homozygous for the other haplotype. These results indicate that the greater potential breadth of CD8 T cell responses present in heterozygous animals does not necessarily lead to greater antiviral efficacy and suggest that SIV-specific CD8 T cell responses in heterozygous animals have a skewed focus toward epitopes restricted by a single haplotype.	[Greene, Justin M.; Lhost, Jennifer J.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Chin, Emily N.; O'Connor, David H.] Univ Wisconsin, Dept Cellular & Mol Biol, Madison, WI USA; [Budde, Melisa L.; Hines, Paul J.; Burwitz, Benjamin J.; Nelson, Jennifer E.; Friedrich, Thomas C.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Broman, Karl W.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Greene, JM (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.	david.h.oconnor@gmail.com		o'connor, david/0000-0003-2139-470X; Friedrich, Thomas/0000-0001-9831-6895; Broman, Karl/0000-0002-4914-6671	National Institutes of Health [R01 AI084787, R01 AI077376-04A1, R33 AI082880-03]; National Center for Research Resources [RR000167]; Office of Research Infrastructure Programs (ORIP) [P51OD011106]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, C06RR015459, P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI082880, R01AI084787, R01AI077376] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was made possible in part by National Institutes of Health grants R01 AI084787, R01 AI077376-04A1, and R33 AI082880-03; and it was supported by National Center for Research Resources grant RR000167 and the Office of Research Infrastructure Programs (ORIP) grant P51OD011106. The research was conducted, in part, at a facility constructed with support from Research Facilities Improvement Program grants RR15459-01 and RR020141-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Budde ML, 2012, J VIROL; BUDDE ML, 2011, J VIROL; Burwitz BJ, 2009, J VIROL, V83, P6011, DOI 10.1128/JVI.00199-09; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Cline AN, 2005, J MED PRIMATOL, V34, P303; Day CL, 2001, J VIROL, V75, P6279, DOI 10.1128/JVI.75.14.6279-6291.2001; Day EB, 2011, J IMMUNOL, V186, P6319, DOI 10.4049/jimmunol.1000883; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Greene JM, 2010, J VIROL, V84, P3362, DOI 10.1128/JVI.02028-09; Hollsberg P, 2002, SCAND J IMMUNOL, V55, P189, DOI 10.1046/j.0300-9475.2001.01043.x; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kotturi MF, 2008, J IMMUNOL, V181, P2124, DOI 10.4049/jimmunol.181.3.2124; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lacey SF, 2003, HUM IMMUNOL, V64, P440, DOI 10.1016/S0198-8859(03)00028-4; Levy JA, 2003, TRENDS IMMUNOL, V24, P628, DOI 10.1016/j.it.2003.10.005; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111; Maness NJ, 2008, J VIROL, V82, P5245, DOI 10.1128/JVI.00292-08; Maness NJ, 2010, J IMMUNOL, V184, P67, DOI 10.4049/jimmunol.0903118; McClelland EE, 2003, INFECT IMMUN, V71, P2079, DOI 10.1128/IAI.71.4.2079-2086.2003; Mee ET, 2010, TISSUE ANTIGENS, V76, P223, DOI 10.1111/j.1399-0039.2010.01500.x; Metzner KJ, 2000, J EXP MED, V191, P1921, DOI 10.1084/jem.191.11.1921; O'Connor SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000524; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Penn DJ, 2002, ETHOLOGY, V108, P1, DOI 10.1046/j.1439-0310.2002.00768.x; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; REIMANN KA, 1994, J VIROL, V68, P2362, DOI 10.1128/JVI.68.4.2362-2370.1994; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Saah AJ, 1998, AIDS, V12, P2107, DOI 10.1097/00002030-199816000-00005; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Smith MZ, 2005, J VIROL, V79, P684, DOI 10.1128/JVI.79.2.684-695.2005; Stebbings R, 2005, J VIROL, V79, P12264, DOI 10.1128/JVI.79.19.12264-12272.2005; Tourdot S, 2002, J IMMUNOL, V169, P5615, DOI 10.4049/jimmunol.169.10.5615; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; YASUTOMI Y, 1993, J VIROL, V67, P1707, DOI 10.1128/JVI.67.3.1707-1711.1993; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yewdell JW, 2005, IMMUNOL REV, V207, P8	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43690	10.1371/journal.pone.0043690	http://dx.doi.org/10.1371/journal.pone.0043690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928016	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300081
J	Poell, JB; van Haastert, RJ; de Gunst, T; Schultz, IJ; Gommans, WM; Verheul, M; Cerisoli, F; van Noort, PI; Prevost, GP; Schaapveld, RQJ; Cuppen, E				Poell, Jos B.; van Haastert, Rick J.; de Gunst, Thijs; Schultz, Iman J.; Gommans, Willemijn M.; Verheul, Mark; Cerisoli, Francesco; van Noort, Paula I.; Prevost, Gregoire P.; Schaapveld, Roel Q. J.; Cuppen, Edwin			A Functional Screen Identifies Specific MicroRNAs Capable of Inhibiting Human Melanoma Cell Viability	PLOS ONE			English	Article							LINEAGE SURVIVAL; PROTEIN; KINASE; MIR-16; MITF; BRAF; RNA; DIFFERENTIATION; METASTASIS; RESISTANCE	Malignant melanoma is an aggressive form of skin cancer with poor prognosis. Despite improvements in awareness and prevention of this disease, its incidence is rapidly increasing. MicroRNAs (miRNAs) are a class of small RNA molecules that regulate cellular processes by repressing messenger RNAs (mRNAs) with partially complementary target sites. Several miRNAs have already been shown to attenuate cancer phenotypes, by limiting proliferation, invasiveness, tumor angiogenesis, and stemness. Here, we employed a genome-scale lentiviral human miRNA expression library to systematically survey which miRNAs are able to decrease A375 melanoma cell viability. We highlight the strongest inhibitors of melanoma cell proliferation, including the miR-15/16, miR-141/200a and miR-96/182 families of miRNAs and miR-203. Ectopic expression of these miRNAs resulted in long-term inhibition of melanoma cell expansion, both in vitro and in vivo. We show specifically miR-16, miR-497, miR-96 and miR-182 are efficient effectors when introduced as synthetic miRNAs in several melanoma cell lines. Our study provides a comprehensive interrogation of miRNAs that interfere with melanoma cell proliferation and viability, and offers a selection of miRNAs that are especially promising candidates for application in melanoma therapy.	[Poell, Jos B.; Cuppen, Edwin] Canc Genom Ctr, Hubrecht Inst, Univ Med Ctr Utrecht, Utrecht, Netherlands; [van Haastert, Rick J.; de Gunst, Thijs; Schultz, Iman J.; Gommans, Willemijn M.; Verheul, Mark; Cerisoli, Francesco; van Noort, Paula I.; Prevost, Gregoire P.; Schaapveld, Roel Q. J.; Cuppen, Edwin] InteRNA Technol BV, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Poell, JB (corresponding author), Canc Genom Ctr, Hubrecht Inst, Univ Med Ctr Utrecht, Utrecht, Netherlands.	e.cuppen@hubrecht.eu	Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Poell, Jos/0000-0003-1776-3779	Cancer Genomics Center through Netherlands Genomics Initiative	Cancer Genomics Center through Netherlands Genomics Initiative	This work was financially supported by the Cancer Genomics Center through grants from the Netherlands Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Broderick JA, 2011, RNA; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cohen C, 2002, CLIN CANCER RES, V8, P3728; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Glud M, 2011, MELANOMA RES, V21, P253, DOI 10.1097/CMR.0b013e328345333b; Gommans WM, 2012, METHODS MOL BIOL, V786, P167, DOI 10.1007/978-1-61779-292-2_10; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Huynh C, 2011, ONCOGENE, V30, P1481, DOI 10.1038/onc.2010.523; Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mckenzie JA, 2012, ANTICANCER RES, V32, P397; Mueller DW, 2011, INT J CANCER, V129, P1064, DOI 10.1002/ijc.25768; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Noguchi S, 2012, J BIOL CHEM, V287, P11769, DOI 10.1074/jbc.M111.325027; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Poell JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-546; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rigel DS, 2000, CA-CANCER J CLIN, V50, P215, DOI 10.3322/canjclin.50.4.215; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sala E, 2008, MOL CANCER RES, V6, P751, DOI 10.1158/1541-7786.MCR-07-2001; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sharma A, 2006, CANCER RES, V66, P8200, DOI 10.1158/0008-5472.CAN-06-0809; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	47	45	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43569	10.1371/journal.pone.0043569	http://dx.doi.org/10.1371/journal.pone.0043569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927992	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300066
J	Rodriguez-Martinez, G; Molina-Hernandez, A; Velasco, I				Rodriguez-Martinez, Griselda; Molina-Hernandez, Anayansi; Velasco, Ivan			Activin A Promotes Neuronal Differentiation of Cerebrocortical Neural Progenitor Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; STEM-CELLS; DOPAMINERGIC-NEURONS; SELF-RENEWAL; IN-VIVO; SURVIVAL; CNS; NEUROGENESIS; INDUCTION; SMAD	Background: Activin A is a protein that participates principally in reproductive functions. In the adult brain, Activin is neuroprotective, but its role in brain development is still elusive. Methodology/Principal Findings: We studied if Activin A influences proliferation, differentiation or survival in rat cerebrocortical neural progenitor cells (NPC). After stimulation of NPC with Activin A, phosphorylation and nuclear translocation of Smad 2/3 were induced. In proliferating NPC, Activin produced a significant decrease in cell area and also a discrete increase in the number of neurons in the presence of the mitogen Fibroblast Growth Factor 2. The percentages of cells incorporating BrdU, or positive for the undifferentiated NPC markers Nestin and Sox2, were unchanged after incubation with Activin. In differentiating conditions, continuous treatment with Activin A significantly increased the number of neurons without affecting astroglial differentiation or causing apoptotic death. In cells cultured by extended periods, Activin treatment produced further increases in the proportion of neurons, excluding premature cell cycle exit. In clonal assays, Activin significantly increased neuronal numbers per colony, supporting an instructive role. Activin-induced neurogenesis was dependent on activation of its receptors, since incubation with the type I receptor inhibitor SB431542 or the ligand-trap Follistatin prevented neuronal differentiation. Interestingly, SB431542 or Follistatin by themselves abolished neurogenesis and increased astrogliogenesis, to a similar extent to that induced by Bone Morphogenetic Protein (BMP) 4. Co-incubation of these Activin inhibitors with the BMP antagonist Dorsomorphin restored neuronal and astrocytic differentiation to control levels. Conclusions: Our results show an instructive neuronal effect of Activin A in cortical NPC in vitro, pointing out to a relevant role of this cytokine in the specification of NPC towards a neuronal phenotype.	[Rodriguez-Martinez, Griselda; Molina-Hernandez, Anayansi; Velasco, Ivan] Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Rodriguez-Martinez, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City 04510, DF, Mexico.	ivelasco@ifc.unam.mx	Velasco, Ivan/AAE-4249-2019; Velasco, Iván/D-3593-2014	Velasco, Ivan/0000-0002-8953-6578; Velasco, Iván/0000-0002-8953-6578; Rodriguez-Martinez, Griselda/0000-0002-3727-6743	PAPIIT (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica) from Universidad Nacional Autonoma de Mexico [IN224207, IN224210]; CONACYT	PAPIIT (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica) from Universidad Nacional Autonoma de Mexico; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by PAPIIT (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica) grants IN224207 and IN224210 from Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Raquel Martinez-Mendez, Diana Alatriste-Gonzalez and Dr. Rodrigo Lopez-Gonzalez for excellent technical assistance, and also to Dr. Marina Macias-Silva and Dr. Jesus Chimal-Monroy for advice during the elaboration of the experiments and the preparation of the manuscript. The authors also thank t o M. Sc. Elli Marinopoulou for the advices given during the writing of the manuscript. G. R.-M. received a CONACYT Ph.D. fellowship. This work represents a partial fulfillment of G. R.-M. Ph.D. program in Biomedical Sciences at Universidad Nacional Autonoma de Mexico.	Abdipranoto-Cowley A, 2009, STEM CELLS, V27, P1330, DOI 10.1002/stem.80; Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; ANDREASSON K, 1995, NEUROSCIENCE, V69, P781, DOI 10.1016/0306-4522(95)00245-E; Briones-Orta MA, 2006, BIOCHEM BIOPH RES CO, V341, P889, DOI 10.1016/j.bbrc.2006.01.041; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Funaba M, 1997, J NEUROENDOCRINOL, V9, P105, DOI 10.1046/j.1365-2826.1997.00558.x; Gajavelli S, 2004, EXP NEUROL, V188, P205, DOI 10.1016/j.expneurol.2004.03.026; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; HASHIMOTO M, 1990, BIOCHEM BIOPH RES CO, V173, P193, DOI 10.1016/S0006-291X(05)81040-X; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Iwahori Y, 1997, BRAIN RES, V760, P52, DOI 10.1016/S0006-8993(97)00275-8; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Kupershmidt L, 2007, J NEUROCHEM, V103, P962, DOI 10.1111/j.1471-4159.2007.04785.x; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lopez-Gonzalez R, 2011, IUBMB LIFE, V63, P930, DOI 10.1002/iub.560; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Massague J, 2000, GENE DEV, V14, P627; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massirer KB, 2010, WILEY INTERDISCIP RE, V3, P107; MATHEWS LS, 1993, RECEPTOR, V3, P173; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; Misumi S, 2008, EUR J NEUROSCI, V28, P1049, DOI 10.1111/j.1460-9568.2008.06420.x; Molina-Hernandez A, 2008, J NEUROCHEM, V106, P706, DOI 10.1111/j.1471-4159.2008.05424.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mujtaba T, 1998, DEV BIOL, V200, P1, DOI 10.1006/dbio.1998.8913; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Rodriguez-Rivera NS, 2009, INT J DEV BIOL, V53, P947, DOI 10.1387/ijdb.092869nr; Roussa E, 2004, NEUROBIOL DIS, V16, P300, DOI 10.1016/j.nbd.2004.03.006; Roussa E, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0514; Sailer MHM, 2005, J CELL SCI, V118, P5849, DOI 10.1242/jcs.02708; Sekiguchi M, 2009, NEUROSCI LETT, V452, P232, DOI 10.1016/j.neulet.2009.01.074; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegenthaler JA, 2005, J NEUROSCI, V25, P8627, DOI 10.1523/JNEUROSCI.1876-05.2005; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sun YR, 2011, J CELL SCI, V124, P1867, DOI 10.1242/jcs.085506; Suzuki K, 2010, BIOCHEM BIOPH RES CO, V394, P639, DOI 10.1016/j.bbrc.2010.03.039; Tretter YP, 2000, NAT MED, V6, P812, DOI 10.1038/77548; Vale W, 1986, Methods Enzymol, V124, P389; Vazquez-Macias A, 2005, FEBS LETT, V579, P3701, DOI 10.1016/j.febslet.2005.05.057; Vogel T, 2010, CEREB CORTEX, V20, P661, DOI 10.1093/cercor/bhp134; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549	51	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43797	10.1371/journal.pone.0043797	http://dx.doi.org/10.1371/journal.pone.0043797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928036	gold, Green Published, Green Submitted			2022-12-25	WOS:000308286300092
J	Gutierrez, NL; Valencia, SR; Branch, TA; Agnew, DJ; Baum, JK; Bianchi, PL; Cornejo-Donoso, J; Costello, C; Defeo, O; Essington, TE; Hilborn, R; Hoggarth, DD; Larsen, AE; Ninnes, C; Sainsbury, K; Selden, RL; Sistla, S; Smith, ADM; Stern-Pirlot, A; Teck, SJ; Thorson, JT; Williams, NE				Gutierrez, Nicolas L.; Valencia, Sarah R.; Branch, Trevor A.; Agnew, David J.; Baum, Julia K.; Bianchi, Patricia L.; Cornejo-Donoso, Jorge; Costello, Christopher; Defeo, Omar; Essington, Timothy E.; Hilborn, Ray; Hoggarth, Daniel D.; Larsen, Ashley E.; Ninnes, Chris; Sainsbury, Keith; Selden, Rebecca L.; Sistla, Seeta; Smith, Anthony D. M.; Stern-Pirlot, Amanda; Teck, Sarah J.; Thorson, James T.; Williams, Nicholas E.			Eco-Label Conveys Reliable Information on Fish Stock Health to Seafood Consumers	PLOS ONE			English	Article							FISHERIES; IMPACTS; CERTIFICATION; STEWARDSHIP; BIODIVERSITY; BARRIERS	Concerns over fishing impacts on marine populations and ecosystems have intensified the need to improve ocean management. One increasingly popular market-based instrument for ecological stewardship is the use of certification and eco-labeling programs to highlight sustainable fisheries with low environmental impacts. The Marine Stewardship Council (MSC) is the most prominent of these programs. Despite widespread discussions about the rigor of the MSC standards, no comprehensive analysis of the performance of MSC-certified fish stocks has yet been conducted. We compared status and abundance trends of 45 certified stocks with those of 179 uncertified stocks, finding that 74% of certified fisheries were above biomass levels that would produce maximum sustainable yield, compared with only 44% of uncertified fisheries. On average, the biomass of certified stocks increased by 46% over the past 10 years, whereas uncertified fisheries increased by just 9%. As part of the MSC process, fisheries initially go through a confidential pre-assessment process. When certified fisheries are compared with those that decline to pursue full certification after pre-assessment, certified stocks had much lower mean exploitation rates (67% of the rate producing maximum sustainable yield vs. 92% for those declining to pursue certification), allowing for more sustainable harvesting and in many cases biomass rebuilding. From a consumer's point of view this means that MSC-certified seafood is 3-5 times less likely to be subject to harmful fishing than uncertified seafood. Thus, MSC-certification accurately identifies healthy fish stocks and conveys reliable information on stock status to seafood consumers.	[Gutierrez, Nicolas L.; Agnew, David J.; Bianchi, Patricia L.; Hoggarth, Daniel D.; Ninnes, Chris; Stern-Pirlot, Amanda] Marine Stewardship Council, London, England; [Valencia, Sarah R.; Costello, Christopher] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Branch, Trevor A.; Essington, Timothy E.; Hilborn, Ray; Thorson, James T.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Baum, Julia K.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Cornejo-Donoso, Jorge] Univ Calif Santa Barbara, Inst Marine Sci, Interdept Grad Program Marine Sci, Santa Barbara, CA 93106 USA; [Cornejo-Donoso, Jorge] Univ Austral Chile, Ctr Trapananda, Coyhaique, Chile; [Defeo, Omar] Fac Ciencias, UNDECIMAR, Montevideo, Uruguay; [Larsen, Ashley E.; Selden, Rebecca L.; Sistla, Seeta; Teck, Sarah J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Sainsbury, Keith] Univ Tasmania, Tasmanian Aquaculture & Fisheries Inst, Taroona, Tas, Australia; [Smith, Anthony D. M.] CSIRO, Wealth Oceans Flagship, Hobart, Tas, Australia; [Williams, Nicholas E.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of Washington; University of Washington Seattle; University of Victoria; University of California System; University of California Santa Barbara; Universidad Austral de Chile; Universidad de la Republica, Uruguay; University of California System; University of California Santa Barbara; University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California Santa Barbara	Gutierrez, NL (corresponding author), Marine Stewardship Council, London, England.	nicolas.gutierrez@msc.org	Smith, Tony D/A-4017-2012; Thorson, James T/O-7937-2014; Thorson, James T/H-8771-2019; Hilborn, Ray W/D-6332-2013	Thorson, James T/0000-0001-7415-1010; Thorson, James T/0000-0001-7415-1010; Larsen, Ashley/0000-0001-7491-9245; Cornejo-Donoso, Jorge F./0000-0002-4244-2865; Defeo, Omar/0000-0001-8318-528X; Baum, Julia/0000-0002-9827-1612; Selden, Rebecca/0000-0001-7956-5984	National Science Foundation (NSF) [EF-0553768, 1041570]; University of California, Santa Barbara; State of California	National Science Foundation (NSF)(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California	SRV, JCD, AEL, RLS, SS, SJT, and NEW thank the Henry Luce Foundation and the National Center for Ecological Analysis and Synthesis, which is funded by National Science Foundation (NSF) Grant EF-0553768, the University of California, Santa Barbara, and the State of California. TAB was funded by NSF grant 1041570. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branch TA, 2011, CONSERV BIOL, V25, P777, DOI 10.1111/j.1523-1739.2011.01687.x; Crowder LB, 2008, ANNU REV ECOL EVOL S, V39, P259, DOI 10.1146/annurev.ecolsys.39.110707.173406; Dichmont CM, 2010, P NATL ACAD SCI USA, V107, P16, DOI 10.1073/pnas.0912091107; Eero M, 2012, MAR POLICY, V36, P235, DOI 10.1016/j.marpol.2011.05.010; FAO Fisheries Department, 2010, STAT WORLD FISH AQ 2; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Froese R, 2011, FISH FISH, V12, P340, DOI 10.1111/j.1467-2979.2010.00387.x; Gulbrandsen LH, 2009, MAR POLICY, V33, P654, DOI 10.1016/j.marpol.2009.01.002; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hilborn R, 2011, FISH RES, V108, P235, DOI 10.1016/j.fishres.2010.12.030; Hilborn R, 2010, NATURE, V467, P531, DOI 10.1038/467531c; Hilborn R, 2010, FISHERIES, V35, P113, DOI 10.1577/1548-8446-35.3.113; Hilborn R, 2010, MAR POLICY, V34, P193, DOI 10.1016/j.marpol.2009.04.013; Hixon MA, 2007, J EXP MAR BIOL ECOL, V344, P23, DOI 10.1016/j.jembe.2006.12.026; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Ianelli JN, 2010, ASSESSMENT WALLEYE P; ICES, 2011, REP ICES ADV COMM 20; ICES, 2011, REP ICES ADV COMM 20; Jacquet J, 2008, CONSERV BIOL, V22, P832, DOI 10.1111/j.1523-1739.2008.00978.x; Jacquet J, 2010, NATURE, V467, P28, DOI 10.1038/467028a; Jacquet JL, 2007, MAR POLICY, V31, P308, DOI 10.1016/j.marpol.2006.09.003; Mangel M, 2002, B MAR SCI, V70, P763; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Marine Stewardship Council, 2011, MSC CERT REQ V1; Marko PB, 2011, CURR BIOL, V21, pR621, DOI 10.1016/j.cub.2011.07.006; Martin SM, 2012, REV FISH SCI, V20, P61, DOI 10.1080/10641262.2011.654287; Martinsohn JT, 2011, WOODHEAD PUBL FOOD S, P259; Parkes G, 2010, REV FISH SCI, V18, P344, DOI 10.1080/10641262.2010.516374; Perez-Ramirez M, 2012, OCEAN COAST MANAGE, V63, P24, DOI 10.1016/j.ocecoaman.2012.03.009; Perez-Ramirez M, 2012, MAR POLICY, V36, P297, DOI 10.1016/j.marpol.2011.06.013; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Ponte S, 2006, ECOLABELS FISH TRADE, V66; Ponte S., 2008, SEAFOOD ECOLABELLING, P287, DOI [10.1002/9781444301380.ch14, DOI 10.1002/9781444301380.CH14]; Potts T., 2007, Environment, Development and Sustainability, V9, P91, DOI 10.1007/s10668-005-9006-3; Punt A., 2001, CONSERVATION EXPLOIT, P41; Rademeyer RA, 2012, FISHHERIES2012AUGSWG; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; Roheim CA, 2011, J AGR ECON, V62, P655, DOI 10.1111/j.1477-9552.2011.00299.x; Rosenberg AA, 2006, FRONT ECOL ENVIRON, V4, P303, DOI 10.1890/1540-9295(2006)4[303:RUFPAP]2.0.CO;2; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; UNFSA, 1995, AGR IMPL PROV UN CON, P1; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Ward T.J., 2008, SEAFOOD ECOLABELLING, V1st ed.; Ward TJ, 2008, FISH FISH, V9, P169, DOI 10.1111/j.1467-2979.2008.00277.x; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zhou SJ, 2010, P NATL ACAD SCI USA, V107, P9485, DOI 10.1073/pnas.0912771107	47	102	102	1	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43765	10.1371/journal.pone.0043765	http://dx.doi.org/10.1371/journal.pone.0043765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992PA	22928029	Green Published, gold			2022-12-25	WOS:000307789700051
J	Aamir, UB; Badar, N; Mehmood, MR; Nisar, N; Suleman, RM; Shaukat, S; Sharif, S; Kamran, J; Zaidi, SSZ; Kazi, BM; Gubareva, L; Xu, XY; Garten, R; Klimov, A				Aamir, Uzma Bashir; Badar, Nazish; Mehmood, Muhammad Rashid; Nisar, Nadia; Suleman, Rana Muhammad; Shaukat, Shehzad; Sharif, Salman; Kamran, Jaleel; Zaidi, Syed Sohail Zahoor; Kazi, Birjees Mazher; Gubareva, Larisa; Xu, Xiyan; Garten, Rebecca; Klimov, Alexander			Molecular Epidemiology of Influenza A(H1N1)pdm09 Viruses from Pakistan in 2009-2010	PLOS ONE			English	Article							SWINE; H1N1; EMERGENCE	Background: In early 2009, a novel influenza A(H1N1) virus that emerged in Mexico and United States rapidly disseminated worldwide. The spread of this virus caused considerable morbidity with over 18000 recorded deaths. The new virus was found to be a reassortant containing gene segments from human, avian and swine influenza viruses. Methods/Results: The first case of human infection with A(H1N1)pdm09 in Pakistan was detected on 18th June 2009. Since then, 262 laboratory-confirmed cases have been detected during various outbreaks with 29 deaths (as of 31st August 2010). The peak of the epidemic was observed in December with over 51% of total respiratory cases positive for influenza. Representative isolates from Pakistan viruses were sequenced and analyzed antigenically. Sequence analysis of genes coding for surface glycoproteins HA and NA showed high degree of high levels of sequence identity with corresponding genes of regional viruses circulating South East Asia. All tested viruses were sensitive to Oseltamivir in the Neuraminidase Inhibition assays. Conclusions: Influenza A(H1N1) pdm09 viruses from Pakistan form a homogenous group of viruses. Their HA genes belong to clade 7 and show antigenic profile similar to the vaccine strain A/California/07/2009. These isolates do not show any amino acid changes indicative of high pathogenicity and virulence. It is imperative to continue monitoring of these viruses for identification of potential variants of high virulence or drug resistance.	[Aamir, Uzma Bashir; Badar, Nazish; Mehmood, Muhammad Rashid; Nisar, Nadia; Suleman, Rana Muhammad; Shaukat, Shehzad; Sharif, Salman; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Publ Hlth Labs Div, Islamabad, Pakistan; [Gubareva, Larisa; Xu, Xiyan; Garten, Rebecca; Klimov, Alexander] Ctr Dis Control, Influenza Div, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Aamir, UB (corresponding author), Natl Inst Hlth, Dept Virol, Publ Hlth Labs Div, Islamabad, Pakistan.	sohail.zaidi56@gmail.com	Zaidi, Syed Sohail Zahoor/F-7432-2015		NIH-CDC [U50/CCU024406]	NIH-CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institutes of Health (NIH) - USA)	This work was supported under the NIH-CDC cooperative agreement no. U50/CCU024406 for Development Influenza Surveillance Network in Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BR, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-133; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P305; Barr IG, 2010, EURO SURVEILL, V15; Brockwell-Staats C, 2009, INFLUENZA OTHER RESP, V3, P207, DOI 10.1111/j.1750-2659.2009.00096.x; Chang LY, 2009, J FORMOS MED ASSOC, V108, P526, DOI 10.1016/S0929-6646(09)60369-7; Ciblak MA, 2009, EUROSURVEILLANCE, V14, P2; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Gomez J, 2009, EURO SURVEILL, V4; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hayden FG, 2006, NEW ENGL J MED, V354, P785, DOI 10.1056/NEJMp068030; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Nelson Martha, 2009, PLoS Curr, V1, pRRN1126; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; PALMER DF, 1975, IMMUNOLOGY SERIES, V6, P51; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Perez Daniel Roberto, 2009, PLoS Curr, V1, pRRN1011; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Reichert T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-5; Scalera NM, 2009, POSTGRAD MED, V121, P43, DOI 10.3810/pgm.2009.09.2051; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; World Health Organization, 2009, HUM INF PAND H1N1 20; World Health Organization (WHO) CDC Real time RTPCR (rRTPCR), CDC REAL TIM RTPCR R; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034	27	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41866	10.1371/journal.pone.0041866	http://dx.doi.org/10.1371/journal.pone.0041866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916112	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800013
J	Cobo, T; Kacerovsky, M; Palacio, M; Hornychova, H; Hougaard, DM; Skogstrand, K; Jacobsson, B				Cobo, Teresa; Kacerovsky, Marian; Palacio, Montse; Hornychova, Helena; Hougaard, David M.; Skogstrand, Kristin; Jacobsson, Bo			Intra-Amniotic Inflammatory Response in Subgroups of Women with Preterm Prelabor Rupture of the Membranes	PLOS ONE			English	Article							MICROBIAL INVASION; PREMATURE RUPTURE; AMNIOTIC-FLUID; INTRAUTERINE INFECTION; MULTIPLE-PROTEINS; LABOR ANALYSIS; PREDICTION; CHORIOAMNIONITIS; INTERLEUKIN-6; FUNISITIS	Background: To evaluate the influence of microbial invasion of the amniotic cavity (MIAC) and histological chorioamnionitis (HCA) on the magnitude of intra-amniotic inflammatory response in preterm prelabor rupture of membranes (PPROM). Methodology/Principal Finding: A prospective cohort study was performed in 107 women with PPROM between 23.0 and 36.6 weeks of gestational age. Twenty-six proteins were assayed by multiple immunoassay in amniotic fluid. The policy for PPROM in Czech Republic is active, and 90% of the women were delivered within 96 hours of membrane rupture. Histopathological placental findings were evaluated based on the Salafia classification. Data were analyzed in four subgroups of population according to the presence of MIAC and/or HCA. Results were stratified by gestational age at PPROM (< or >= 34.0 weeks). The rates of MIAC and HCA were 44% and 57%, respectively. Regardless of gestational age at PPROM, intra-amniotic inflammatory response was higher when MIAC and HCA were both present. There were no differences in the intra-amniotic inflammatory response between women with MIAC or HCA alone and women without infection. Conclusion: A higher intra-amniotic inflammatory response was identified when both HCA and MIAC were detected.	[Cobo, Teresa; Palacio, Montse] Univ Barcelona, Hosp Clin, Maternal Fetal Med Dept, ICGON, Barcelona, Spain; [Cobo, Teresa; Palacio, Montse] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Fetal & Perinatal Med Res Grp, Barcelona, Spain; [Cobo, Teresa; Palacio, Montse] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Kacerovsky, Marian] Charles Univ Praque, Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Biomed Res Ctr,Dept Obstet & Gynecol, Hradec Kralove, Czech Republic; [Hornychova, Helena] Univ Hosp Hradec Kralove, Fingerlands Dept Pathol, Hradec Kralove, Czech Republic; [Hougaard, David M.; Skogstrand, Kristin] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Jacobsson, Bo] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; [Jacobsson, Bo] Inst Publ Hlth, Oslo, Norway	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Statens Serum Institut; Sahlgrenska University Hospital	Cobo, T (corresponding author), Univ Barcelona, Hosp Clin, Maternal Fetal Med Dept, ICGON, Barcelona, Spain.	tcobo@clinic.ub.es	Jacobsson, Bo/O-8007-2014; Kacerovsky, Marian/ABE-3437-2020; Hornychová, Helena/M-9470-2017; Hougaard, David/AAD-6368-2019; Cobo, Teresa/K-2770-2017; Kacerovsky, Marian/A-7586-2011	Jacobsson, Bo/0000-0001-5079-2374; Hornychová, Helena/0000-0002-2487-1754; Skogstrand, Kristin/0000-0002-0026-3711; Cobo, Teresa/0000-0003-3130-1829; Palacio, Montse/0000-0002-5869-4629; Kacerovsky, Marian/0000-0001-9858-7900	Instituto de Salud Carlos III in Spain [CM09/00213]; Czech Science Foundation [304-09-0494]; Ministry of Health of the Czech Republic [NS 10382-3/2009, MZO 00179906]; Swedish Medical Society [SLS 2008-21198, ALFGBG-2863, ALFGBG-11522]; Spanish government [FISPI10/01308]	Instituto de Salud Carlos III in Spain(Instituto de Salud Carlos III); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Swedish Medical Society; Spanish government(Spanish GovernmentEuropean Commission)	This work was supported by a Rio Hortega grant from Instituto de Salud Carlos III in Spain (CM09/00213); by grants from the Czech Science Foundation (no. 304-09-0494), Ministry of Health of the Czech Republic (NS 10382-3/2009) and by a research project of Ministry of Health of the Czech Republic (MZO 00179906). Additional support came from grants from the Swedish Medical Society (SLS 2008-21198, ALFGBG-2863, ALFGBG-11522) and grants from Spanish government (FISPI10/01308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018; Buhimschi CS, 2007, PEDIATR RES, V61, P318, DOI 10.1203/01.pdr.0000252439.48564.37; Buhimschi IA, 2010, CLIN PERINATOL, V37, P355, DOI 10.1016/j.clp.2010.03.002; Cobo T, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.050; Davies JK, 2000, AM J OBSTET GYNECOL, V183, P1088, DOI 10.1067/mob.2000.108888; Ghidini A, 1998, J Matern Fetal Med, V7, P238; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Holst RM, 2011, BJOG-INT J OBSTET GY, V118, P240, DOI 10.1111/j.1471-0528.2010.02765.x; Holst RM, 2009, OBSTET GYNECOL, V114, P268, DOI 10.1097/AOG.0b013e3181ae6a08; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P423, DOI 10.1034/j.1600-0412.2003.00157.x; Jun JK, 2000, AM J OBSTET GYNECOL, V183, P868, DOI 10.1067/mob.2000.109034; Kacerovsky M, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.004; Kacerovsky M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.028; Kacerovsky M, 2009, NEUROENDOCRINOL LETT, V30, P733; Katzman PJ, 2010, PEDIATR DEVEL PATHOL, V13, P265, DOI 10.2350/09-02-0604-OA.1; Lee SE, 2006, J MATERN-FETAL NEO M, V19, P693, DOI 10.1080/14767050600927353; Menon R, 2011, OBSTET GYNECOL, V118, P121, DOI 10.1097/AOG.0b013e3182204eaa; Park CW, 2009, PLACENTA, V30, P56, DOI 10.1016/j.placenta.2008.09.017; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P839, DOI 10.1016/0002-9378(93)90014-A; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2011, J MATERN-FETAL NEO M, V24, P1444, DOI 10.3109/14767058.2011.591460; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085; Skogstrand K, 2005, CLIN CHEM, V51, P1854, DOI 10.1373/clinchem.2005.052241; Skogstrand K, 2011, METHODS; The czech society of obstetrics and gynecology, 2007, CLIN GUID OBST; Vogel I, 2007, J REPROD IMMUNOL, V75, P133, DOI 10.1016/j.jri.2007.02.008	30	51	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43677	10.1371/journal.pone.0043677	http://dx.doi.org/10.1371/journal.pone.0043677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916296	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800094
J	Gilmour, S; Li, JH; Shibuya, K				Gilmour, Stuart; Li, Jinghua; Shibuya, Kenji			Projecting HIV Transmission in Japan	PLOS ONE			English	Article							RISK BEHAVIORS; MEN; SEX; PREVALENCE; SURVEILLANCE; INFECTION; AUSTRALIA	Background: Little is known about the epidemiology of HIV in Japan, though newly-identified cases amongst men who have sex with men (MSM) show an increasing trend. Predictions of future trends in the HIV epidemic are essential to identify suitable interventions. Methods: A deterministic, compartmental model was developed that incorporated risk groups, disease stages, and treatment and testing parameters. This model was calibrated against current figures on new infections and run over 30 years to identify trends in prevalence amongst MSM, low-risk men and low-risk women. Multivariate sensitivity analysis was used to estimate sensitivity ranges for all outcomes. Results: Without new interventions amongst MSM in Japan, HIV prevalence will climb from its current rate of 2.1% to 10.4% (sensitivity range 7.4% to 18.7%), while HIV prevalence among low-risk men and women will likely decline. With small changes in safer sex behavior and testing rates, HIV prevalence can remain stable or even decline amongst MSM. Conclusions: Japan is at risk of an epidemic of HIV amongst MSM unless significant changes are made to its current public health intervention framework. More research is necessary to understand the key drivers of the epidemic in Japan.	[Gilmour, Stuart; Li, Jinghua; Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan	University of Tokyo	Gilmour, S (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan.	sgilmour@m.u-tokyo.ac.jp		Shibuya, Kenji/0000-0003-2528-7530	Ministry of Health, Labour and Welfare, Japan [08150755]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Research on HIV/AIDS in Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan (No. 08150755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2011, 2010 NAT DRUG STRAT; Bureau PaFS, 2011, HIV ANT TEST BLOOD D; Bureau PaFS, 2011, ANT TEST PUBL HLTH C; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P329; Curran James W, 2011, MMWR Suppl, V60, P64; Foundation KF, 2009, NAT HIV PREV INV STA; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Guy RJ, 2007, MED J AUSTRALIA, V187, P437, DOI 10.5694/j.1326-5377.2007.tb01353.x; Ichikawa S, 2010, COMBINED RES REPORTS; Ichikawa S, 2011, SEX HEALTH, V8, P123, DOI 10.1071/SH10073; Iversen J, 2010, AUSTR NSP SURVEY NAT; Kaneko N, 2007, JAPANESE J NURSING R, V30, P37; Kihara M, 2003, JAIDS-J ACQ IMM DEF, V32, pS55, DOI 10.1097/00126334-200302011-00009; Koerner J, 2011, SURVEY INVESTIGATING; Koerner J, 2011, INTERSECTIONS-GENDER; Koibuchi T, 2011, ANTIHIV TREATMENT GU; Kral AH, 2005, J URBAN HEALTH, V82, pI43, DOI 10.1093/jurban/jti023; Kretzschmar MEE, 2012, AIDS, V26, P247, DOI 10.1097/QAD.0b013e32834e1592; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; MCDONALD AM, 1994, AM J PUBLIC HEALTH, V84, P1923, DOI 10.2105/AJPH.84.12.1923; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Munakata T, 1996, AIDS EDUC PREV, V8, P115; Network APaI, 2011, CLASS REP HIV AIDS I; Oster Alexandra M., 2011, Morbidity and Mortality Weekly Report, V60, P694; Research NCiHEaC, 2010, HIV VIR HEP SEX TRAN; Research NCiHEaC, 1997, HIV AIDS REL DIS AUS; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; UNAIDS, 2005, INT HIV PREV UNAIDS; UNGASS, 2010, JAP 2010 COUNTR PROG; Waller LA, 2003, ECOL MODEL, V164, P49, DOI 10.1016/S0304-3800(03)00011-5; Wand H, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-19; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081	32	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43473	10.1371/journal.pone.0043473	http://dx.doi.org/10.1371/journal.pone.0043473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916268	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800072
J	Liberman, J; Sartelet, H; Flahaut, M; Muhlethaler-Mottet, A; Coulon, A; Nyalendo, C; Vassal, G; Joseph, JM; Gross, N				Liberman, Julie; Sartelet, Herve; Flahaut, Marjorie; Muehlethaler-Mottet, Annick; Coulon, Aurelie; Nyalendo, Carine; Vassal, Gilles; Joseph, Jean-Marc; Gross, Nicole			Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR7; BREAST-CANCER METASTASIS; NEURO-BLASTOMA CELLS; CREST STEM-CELLS; PROSTATE-CANCER; TUMOR-GROWTH; IN-VITRO; SIGNALING PATHWAYS; RETINOIC ACID; EXPRESSION	Neuroblastoma (NB) is a typical childhood and heterogeneous neoplasm for which efficient targeted therapies for high-risk tumors are not yet identified. The chemokine CXCL12, and its receptors CXCR4 and CXCR7 have been involved in tumor progression and dissemination. While CXCR4 expression is associated to undifferentiated tumors and poor prognosis, the role of CXCR7, the recently identified second CXCL12 receptor, has not yet been elucidated in NB. In this report, CXCR7 and CXCL12 expressions were evaluated using a tissue micro-array including 156 primary and 56 metastatic NB tissues. CXCL12 was found to be highly associated to NB vascular and stromal structures. In contrast to CXCR4, CXCR7 expression was low in undifferentiated tumors, while its expression was stronger in matured tissues and specifically associated to differentiated neural tumor cells. As determined by RT-PCR, CXCR7 expression was mainly detected in N-and S-type NB cell lines, and was slightly induced upon NB cell differentiation in vitro. The relative roles of the two CXCL12 receptors were further assessed by overexpressing CXCR7 or CXCR4 receptor alone, or in combination, in the IGR-NB8 and the SH-SY5Y NB cell lines. In vitro functional analyses indicated that, in response to their common ligand, both receptors induced activation of ERK1/2 cascade, but not Akt pathway. CXCR7 strongly reduced in vitro growth, in contrast to CXCR4, and impaired CXCR4/CXCL12-mediated chemotaxis. Subcutaneous implantation of CXCR7-expressing NB cells showed that CXCR7 also significantly reduced in vivo growth. Moreover, CXCR7 affected CXCR4-mediated orthotopic growth in a CXCL12-producing environment. In such model, CXCR7, in association with CXCR4, did not induce NB cell metastatic dissemination. In conclusion, the CXCR7 and CXCR4 receptors revealed specific expression patterns and distinct functional roles in NB. Our data suggest that CXCR7 elicits anti-tumorigenic functions, and may act as a regulator of CXCR4/CXCL12-mediated signaling in NB.	[Liberman, Julie; Flahaut, Marjorie; Muehlethaler-Mottet, Annick; Coulon, Aurelie; Gross, Nicole] Univ Lausanne, Lausanne Univ Hosp CHUV, Dept Pediat, Pediat Oncol Res Unit, Lausanne, Switzerland; [Sartelet, Herve] St Justine Univ Hosp, Dept Pathol, Montreal, PQ, Canada; [Nyalendo, Carine] St Justine Univ Hosp, Dept Mol Med, Montreal, PQ, Canada; [Vassal, Gilles] Inst Gustave Roussy, UPRES UE 3535, Villejuif, France; [Vassal, Gilles] Inst Gustave Roussy, Dept Pediat Oncol, Villejuif, France; [Joseph, Jean-Marc] Univ Lausanne, Univ Lausanne Hosp, Dept Pediat, Div Pediat Surg, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universite de Montreal; Universite de Montreal; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Liberman, J (corresponding author), Univ Lausanne, Lausanne Univ Hosp CHUV, Dept Pediat, Pediat Oncol Res Unit, Lausanne, Switzerland.	Nicole.Gross@chuv.ch	Mühlethaler-Mottet, Annick/H-2848-2019	Mühlethaler-Mottet, Annick/0000-0001-8274-0907	Swiss National Scientific Foundation [31003A-127063]; FORCE Foundation for Children Cancer Research; Hubert Gouin association	Swiss National Scientific Foundation(Swiss National Science Foundation (SNSF)); FORCE Foundation for Children Cancer Research; Hubert Gouin association	This study was supported by grants from the Swiss National Scientific Foundation #31003A-127063, the FORCE Foundation for Children Cancer Research, and the Hubert Gouin association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-12; Airoldi I, 2006, CLIN CANCER RES, V12, P77, DOI 10.1158/1078-0432.CCR-05-1376; Arscott WT, 2009, ONCOGENE, V28, P479, DOI 10.1038/onc.2008.402; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2003, SEMIN IMMUNOL, V15, P49, DOI 10.1016/S1044-5323(02)00127-6; Beleta H, 2009, CANCER, V115, P2792; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; CICCARONE V, 1989, CANCER RES, V49, P219; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; DECAILLOT FM, 2011, J BIOL CHEM; Gerrits H, 2008, GENESIS, V46, P235, DOI 10.1002/dvg.20387; GROSS N, 1987, INT J CANCER, V39, P521, DOI 10.1002/ijc.2910390420; Grymula K, 2010, INT J CANCER, V127, P2554, DOI 10.1002/ijc.25245; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Harunann TN, 2008, JLEUKOCBIOL; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Hawkins OE, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3092; Hernandez L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3074; Infantino S, 2006, J IMMUNOL, V176, P2197, DOI 10.4049/jimmunol.176.4.2197; Joseph JM, 2005, INT J CANCER, V113, P881, DOI 10.1002/ijc.20681; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kim B, 2004, ONCOGENE, V23, P130, DOI 10.1038/sj.onc.1206924; Kollmar O, 2010, INT J CANCER, V126, P1302, DOI 10.1002/ijc.24956; Kryczek I, 2005, CANCER RES, V65, P465; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Li JK, 2008, WORLD J GASTROENTERO, V14, P2308, DOI 10.3748/wjg.14.2308; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Luker KE, 2012, ONCOGENE; Ma M, 2011, CANCER LETT, V312, P1, DOI 10.1016/j.canlet.2011.06.028; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Meier R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001016; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Monnier J, 2011, EUR J CANC; Muhlethaler-Mottet A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-214; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Odemis V, 2011, GLIA; Odemis V, 2010, J CELL SCI, V123, P1081, DOI 10.1242/jcs.062810; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Ross R A, 1994, Prog Clin Biol Res, V385, P253; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Russell HV, 2004, J PEDIATR SURG, V39, P1506, DOI 10.1016/j.jpedsurg.2004.06.019; Schonemeier B, 2008, J COMP NEUROL, V510, P207, DOI 10.1002/cne.21780; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Singh RK, 2011, CANCER RES, V71, P3268, DOI 10.1158/0008-5472.CAN-10-2769; Somasundaram R, 2008, SEMIN CANC BIOL; SUGIMOTO T, 1988, CANCER RES, V48, P2531; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Thelen M, 2010, CURR OPIN PHARMACOL, V10, P38, DOI 10.1016/j.coph.2009.09.004; Thiele CJ, 1999, HUMAN CELL CULTURE, V1, P21; Tiveron MC, 2010, J NEUROIMMUNOL, V224, P72, DOI 10.1016/j.jneuroim.2010.05.011; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Vicari AP, 2002, CYTOKINE GROWTH F R, V13, P143, DOI 10.1016/S1359-6101(01)00033-8; Wang JH, 2005, CELL SIGNAL, V17, P1578, DOI 10.1016/j.cellsig.2005.03.022; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Xu HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027399; Yu SH, 2011, DEV DYNAM, V240, P384, DOI 10.1002/dvdy.22549; Zabel BA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-73; Zeelenberg IS, 2003, CANCER RES, V63, P3833	68	57	60	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43665	10.1371/journal.pone.0043665	http://dx.doi.org/10.1371/journal.pone.0043665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916293	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800091
J	Shu, CC; Wu, VC; Yang, FJ; Pan, SC; Lai, TS; Wang, JY; Wang, JT; Lee, LN				Shu, Chin-Chung; Wu, Vin-Cent; Yang, Feng-Jung; Pan, Sung-Ching; Lai, Tai-Shuan; Wang, Jann-Yuan; Wang, Jann-Tay; Lee, Li-Na			Predictors and Prevalence of Latent Tuberculosis Infection in Patients Receiving Long-Term Hemodialysis and Peritoneal Dialysis	PLOS ONE			English	Article							STAGE RENAL-DISEASE; GAMMA RELEASE ASSAY; CHRONIC KIDNEY-DISEASE; QUANTIFERON-TB GOLD; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; SKIN-TEST; RISK; DIAGNOSIS; ASSOCIATION	Background: Tuberculosis is a common infectious disease in long-term dialysis patients. The prevalence of latent tuberculosis infection (LTBI) in this population is unclear, particularly in those receiving peritoneal dialysis (PD). This study investigated the prevalence of LTBI in patients receiving either hemodialysis (HD) or PD to determine predictors of LTBI and indeterminate results of interferon-gamma release assay. Methods: Patients receiving long-term (>= 3 months) HD or PD from March 2011 to February 2012 in two medical centers were prospectively enrolled. QuantiFERON-Gold in tube (QFT) test was used to determine the status of LTBI after excluding active tuberculosis. The LTBI prevalence was determined in patients receiving different dialysis modes to obtain predictors of LTBI and QFT-indeterminate results. Results: Of 427 patients enrolled (124 PD and 303 HD), 91 (21.3%) were QFT-positive, 316 (74.0%) QFT-negative, and 20 (4.7%) QFT-indeterminate. The prevalence of LTBI was similar in the PD and HD groups. Independent predictors of LTBI were old age (OR: 1.034 [1.013-1.056] per year increment), TB history (OR: 6.467 [1.985-21.066]), and current smoker (OR: 2.675 [1.061-6.747]). Factors associated with indeterminate QFT results were HD (OR: 10.535 [1.336-83.093]), dialysis duration (OR: 1.113 [1.015-1.221] per year increment), anemia (OR: 8.760 [1.014-75.651]), and serum albumin level (OR: 0.244 [0.086-0.693] per 1 g/dL increment). Conclusion: More than one-fifth of dialysis patients have LTBI. The LTBI prevalence is similar in PD and HD patients but is higher in the elderly, current smokers, and those with prior TB history. Such patients require closer follow-up. Repeated or alternative test may be required for malnutrition patients who received long length of HD.	[Shu, Chin-Chung] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Yun Lin County, Taiwan; [Shu, Chin-Chung; Wu, Vin-Cent; Wang, Jann-Yuan; Wang, Jann-Tay] Natl Taiwan Univ, Coll Internal Med, Taipei 10764, Taiwan; [Yang, Feng-Jung] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Taipei 100, Yun Lin County, Taiwan; [Lai, Tai-Shuan] Natl Taiwan Univ Hosp, Dept Internal Med, Bei Hu Branch, Taipei 100, Yun Lin County, Taiwan; [Lee, Li-Na] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Yun Lin County, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Shu, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Yun Lin County, Taiwan.	jywang@ntu.edu.tw	Yang, Feng-Jung/AAK-9946-2020; Yang, Feng-Jung/GYU-9337-2022	Yang, Feng-Jung/0000-0003-1235-1943; PAN, SUNG-CHING/0000-0003-3154-6690; LEE, LI-NA/0000-0002-7654-2450; SHU, CHIN-CHUNG/0000-0003-0311-5148; Lai, Tai-Shuan/0000-0002-0552-372X; WANG, JANN-TAY/0000-0002-0924-3469; WANG, JANN-YUAN/0000-0003-3406-366X; WU, VIN-CENT/0000-0001-7935-0991	Institute of Biotechnology and Medicine Industry in Taiwan	Institute of Biotechnology and Medicine Industry in Taiwan	This study was funded by Institute of Biotechnology and Medicine Industry in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1997, AM J KIDNEY DIS, V30, pS15; Banach DB, 2011, INT J TUBERC LUNG D, V15, P1623, DOI 10.5588/ijtld.11.0017; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; BROCK I, 2004, AM J RESP CRIT CARE, V170, P65; Centers of Disease Control DoH R. O. C. (Taiwan), 2010, CDC ANN REP 2011; Chavers BM, 2007, J AM SOC NEPHROL, V18, P952, DOI 10.1681/ASN.2006040406; Christopoulos AI, 2006, INT UROL NEPHROL, V38, P745, DOI 10.1007/s11255-006-9051-3; Chung WK, 2010, CLIN MICROBIOL INFEC, V16, P960, DOI 10.1111/j.1469-0691.2009.02949.x; de Cal M, 2008, BLOOD PURIFICAT, V26, P249, DOI 10.1159/000122110; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Dobler CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029563; Dyrhol-Riise AM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-57; Fabrizi F, 2012, DIGEST DIS SCI, V57, P1366, DOI 10.1007/s10620-011-1987-1; Fang HC, 2004, INT J TUBERC LUNG D, V8, P92; Hill CJ, 2012, J RENAL CARE, V38, P12, DOI 10.1111/j.1755-6686.2012.00273.x; Jasmer RM, 2000, AM J RESP CRIT CARE, V162, P1648, DOI 10.1164/ajrccm.162.5.2003028; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lange B, 2010, EUR RESPIR J, V35, P1179, DOI 10.1183/09031936.00122109; Lee SSJ, 2009, INFECTION, V37, P96, DOI 10.1007/s15010-008-8082-3; Lee SSJ, 2010, CLIN J AM SOC NEPHRO, V5, P1451, DOI 10.2215/CJN.01790210; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Lukowsky LR, 2012, AM J NEPHROL, V35, P548, DOI 10.1159/000338673; LUNDIN AP, 1979, AM J MED, V67, P597, DOI 10.1016/0002-9343(79)90240-7; Palomar R, 2011, NEFROLOGIA, V31, P169, DOI 10.3265/Nefrologia.pre2011.Jan.10765; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rose DN, 2000, ARCH INTERN MED, V160, P1513, DOI 10.1001/archinte.160.10.1513; Sester M, 2004, KIDNEY INT, V65, P1826, DOI 10.1111/j.1523-1755.2004.00586.x; Shu CC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-48; Shu CC, 2010, MEDICINE, V89, P53, DOI 10.1097/MD.0b013e3181cafcd3; Simsek H, 2010, JPN J INFECT DIS, V63, P99; Smirnoff M, 1998, CHEST, V113, P25, DOI 10.1378/chest.113.1.25; Stevens LA, 2010, ADV CHRONIC KIDNEY D, V17, P293, DOI 10.1053/j.ackd.2010.03.010; Triverio PA, 2009, NEPHROL DIAL TRANSPL, V24, P1952, DOI 10.1093/ndt/gfn748; Vacher-Coponat H, 2008, NEPHROL DIAL TRANSPL, V23, P1406, DOI 10.1093/ndt/gfm596; Venkata RKC, 2007, CLIN NEPHROL, V67, P217; Wang JY, 2012, J INFECTION, V64, P291, DOI 10.1016/j.jinf.2011.11.028; Yu MC, 1999, J FORMOS MED ASSOC, V98, P496	40	29	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42592	10.1371/journal.pone.0042592	http://dx.doi.org/10.1371/journal.pone.0042592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916137	gold, Green Submitted, Green Published			2022-12-25	WOS:000307733800021
J	Glover, KA; Quintela, M; Wennevik, V; Besnier, F; Sorvik, AGE; Skaala, O				Glover, Kevin A.; Quintela, Maria; Wennevik, Vidar; Besnier, Francois; Sorvik, Anne G. E.; Skaala, Oystein			Three Decades of Farmed Escapees in the Wild: A Spatio-Temporal Analysis of Atlantic Salmon Population Genetic Structure throughout Norway	PLOS ONE			English	Article							SALAR L.; LINKAGE DISEQUILIBRIUM; GENOTYPING ERRORS; LOCAL ADAPTATION; NORTH-AMERICAN; MICROSATELLITE MARKERS; ALLELE FREQUENCIES; TEMPORAL VARIATION; FRESH-WATER; DNA MARKERS	Each year, hundreds of thousands of domesticated farmed Atlantic salmon escape into the wild. In Norway, which is the world's largest commercial producer, many native Atlantic salmon populations have experienced large numbers of escapees on the spawning grounds for the past 15-30 years. In order to study the potential genetic impact, we conducted a spatio-temporal analysis of 3049 fish from 21 populations throughout Norway, sampled in the period 1970-2010. Based upon the analysis of 22 microsatellites, individual admixture, F-ST and increased allelic richness revealed temporal genetic changes in six of the populations. These changes were highly significant in four of them. For example, 76% and 100% of the fish comprising the contemporary samples for the rivers Vosso and Opo were excluded from their respective historical samples at P = 0.001. Based upon several genetic parameters, including simulations, genetic drift was excluded as the primary cause of the observed genetic changes. In the remaining 15 populations, some of which had also been exposed to high numbers of escapees, clear genetic changes were not detected. Significant population genetic structuring was observed among the 21 populations in the historical (global F-ST = 0.038) and contemporary data sets (global F-ST = 0.030), although significantly reduced with time (P = 0.008). This reduction was especially distinct when looking at the six populations displaying temporal changes (global F-ST dropped from 0.058 to 0.039, P = 0.006). We draw two main conclusions: 1. The majority of the historical population genetic structure throughout Norway still appears to be retained, suggesting a low to modest overall success of farmed escapees in the wild; 2. Genetic introgression of farmed escapees in native salmon populations has been strongly population-dependent, and it appears to be linked with the density of the native population.	[Glover, Kevin A.; Wennevik, Vidar; Besnier, Francois; Sorvik, Anne G. E.; Skaala, Oystein] Inst Marine Res, Sect Populat Genet & Ecol, N-5024 Bergen, Norway; [Quintela, Maria] Univ A Coruna, Dept Anim Biol Plant Biol & Ecol, La Coruna, Spain	Institute of Marine Research - Norway; Universidade da Coruna	Glover, KA (corresponding author), Inst Marine Res, Sect Populat Genet & Ecol, POB 1870, N-5024 Bergen, Norway.	Kevin.glover@imr.no	Quintela, María/E-2908-2012		Norwegian Minitry of Fisheries	Norwegian Minitry of Fisheries	This study is financed by the Norwegian Minitry of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, VEDLEGGSRAPPORT MERD; [Anonymous], 1992, NOREGS OFISIELLE S C, pC56; [Anonymous], 2011, STATUS NORSKE LAKSEB; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; Araki H, 2010, AQUACULTURE, V308, pS2, DOI 10.1016/j.aquaculture.2010.05.036; Arnaud-Haond S, 2004, MOL ECOL, V13, P2001, DOI 10.1111/j.1365-294X.2004.02188.x; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Besnier F, 2011, AQUACULT ENV INTERAC, V2, P75, DOI 10.3354/aei00032; Bourret V, 2011, HEREDITY, V106, P500, DOI 10.1038/hdy.2010.165; BURI P, 1956, EVOLUTION, V10, P367, DOI 10.1111/j.1558-5646.1956.tb02864.x; Butler JRA, 2005, FISHERIES MANAG ECOL, V12, P149, DOI 10.1111/j.1365-2400.2005.00437.x; Clifford SL, 1998, CAN J FISH AQUAT SCI, V55, P358, DOI 10.1139/cjfas-55-2-358; Clifford SL, 1998, J FISH BIOL, V52, P118, DOI 10.1111/j.1095-8649.1998.tb01557.x; Cornuet JM, 1999, GENETICS, V153, P1989; Crozier WW, 2000, FISHERIES MANAG ECOL, V7, P437, DOI 10.1046/j.1365-2400.2000.00219.x; CROZIER WW, 1993, AQUACULTURE, V113, P19, DOI 10.1016/0044-8486(93)90337-X; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dillane E, 2008, MOL ECOL, V17, P4786, DOI 10.1111/j.1365-294X.2008.03939.x; Dillane E, 2007, FISHERIES MANAG ECOL, V14, P209, DOI 10.1111/j.1365-2400.2007.00544.x; Dionne M, 2008, MOL ECOL, V17, P2382, DOI 10.1111/j.1365-294X.2008.03771.x; Dionne M, 2009, CONSERV GENET, V10, P869, DOI 10.1007/s10592-008-9647-5; Diserud O. H., 2012, 782 NINA; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Ferguson A., 2007, P357, DOI 10.1002/9780470995846.ch12; Fiske P., 2001, NINA OPPDRAGSMELDING, V704, P1; Fiske P, 2006, ICES J MAR SCI, V63, P1182, DOI 10.1016/j.icesjms.2006.04.006; Fleming IA, 1996, J APPL ECOL, V33, P893, DOI 10.2307/2404960; Fleming IA, 1997, BEHAV ECOL, V8, P470, DOI 10.1093/beheco/8.5.470; Fleming IA, 1997, ICES J MAR SCI, V54, P1051, DOI 10.1006/jmsc.1997.0289; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Fraser DJ, 2011, HEREDITY, V106, P404, DOI 10.1038/hdy.2010.167; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Gilbey J, 2005, ICES J MAR SCI, V62, P1609, DOI 10.1016/j.icesjms.2005.07.001; GJEDREM T, 1991, AQUACULTURE, V98, P41, DOI 10.1016/0044-8486(91)90369-I; Glover KA, 2008, ICES J MAR SCI, V65, P912, DOI 10.1093/icesjms/fsn056; Glover KA, 2012, FISH FISH, V13, P313, DOI 10.1111/j.1467-2979.2011.00447.x; Glover KA, 2010, AQUACULT ENV INTERAC, V1, P1, DOI 10.3354/aei00002; Glover KA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-2; Glover KA, 2009, AQUACULTURE, V290, P37, DOI 10.1016/j.aquaculture.2009.01.034; Glover KA, 2009, AQUACULTURE, V286, P203, DOI 10.1016/j.aquaculture.2008.09.023; Glover KA, 2011, AQUAC RES, V42, P1323, DOI 10.1111/j.1365-2109.2010.02720.x; Griffiths AM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-31; Grimholt U, 2002, IMMUNOGENETICS, V54, P570, DOI 10.1007/s00251-002-0499-8; Haag T, 2010, MOL ECOL, V19, P4906, DOI 10.1111/j.1365-294X.2010.04856.x; Haaland OA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-36; Hansen LP, 2006, ICES J MAR SCI, V63, P1211, DOI 10.1016/j.icesjms.2006.04.022; Hansen MM, 2009, MOL ECOL, V18, P2549, DOI 10.1111/j.1365-294X.2009.04198.x; HEGGBERGET TG, 1993, FISH RES, V18, P123, DOI 10.1016/0165-7836(93)90044-8; HINDAR K, 1991, CAN J FISH AQUAT SCI, V48, P945, DOI 10.1139/f91-111; Hindar K, 2006, ICES J MAR SCI, V63, P1234, DOI 10.1016/j.icesjms.2006.04.025; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jonsson B, 2006, ICES J MAR SCI, V63, P1162, DOI 10.1016/j.icesjms.2006.03.004; Joost S, 2008, MOL ECOL RESOUR, V8, P957, DOI 10.1111/j.1755-0998.2008.02162.x; Jorde PE, 2007, GENETICS, V177, P927, DOI 10.1534/genetics.107.075481; Jorde PE, 2012, MOL ECOL RESOUR, V12, P476, DOI 10.1111/j.1755-0998.2011.03111.x; Borrell YJ, 2008, CONSERV GENET, V9, P807, DOI 10.1007/s10592-007-9400-5; Karlsson S, 2011, MOL ECOL RESOUR, V11, P247, DOI 10.1111/j.1755-0998.2010.02959.x; King TL, 2005, MOL ECOL NOTES, V5, P130, DOI 10.1111/j.1471-8286.2005.00860.x; King TL, 2001, MOL ECOL, V10, P807, DOI 10.1046/j.1365-294X.2001.01231.x; Lubieniecki KP, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-105; LUND R A, 1991, Aquaculture and Fisheries Management, V22, P499, DOI 10.1111/j.1365-2109.1991.tb00763.x; LURA H, 1991, AQUACULTURE, V98, P151, DOI 10.1016/0044-8486(91)90380-P; Lura H, 1995, THESIS U BERGEN NORW; Marie AD, 2010, MOL ECOL, V19, P2025, DOI 10.1111/j.1365-294X.2010.04628.x; Martinez-Cruz B, 2007, MOL ECOL, V16, P477, DOI 10.1111/j.1365-294X.2007.03147.x; MCCONNELL SK, 1995, CAN J FISH AQUAT SCI, V52, P1863, DOI 10.1139/f95-779; McGinnity P, 1997, ICES J MAR SCI, V54, P998, DOI 10.1006/jmsc.1997.0286; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Milner NJ, 2003, FISHERIES MANAG ECOL, V10, P403, DOI 10.1111/j.1365-2400.2003.00348.x; MORK J, 1991, AQUACULTURE, V98, P267, DOI 10.1016/0044-8486(91)90391-J; Morris MRJ, 2008, CAN J FISH AQUAT SCI, V65, P2807, DOI 10.1139/F08-181; Naylor R, 2005, BIOSCIENCE, V55, P427, DOI 10.1641/0006-3568(2005)055[0427:FSATRO]2.0.CO;2; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; OReilly PT, 1996, CAN J FISH AQUAT SCI, V53, P2292, DOI 10.1139/cjfas-53-10-2292; Palstra FP, 2010, CAN J FISH AQUAT SCI, V67, P225, DOI 10.1139/F09-176; Parrish DL, 1998, CAN J FISH AQUAT SCI, V55, P281, DOI 10.1139/cjfas-55-S1-281; Paterson S, 2004, MOL ECOL NOTES, V4, P160, DOI 10.1111/j.1471-8286.2004.00598.x; Perrier C, 2011, MOL ECOL, V20, P4231, DOI 10.1111/j.1365-294X.2011.05266.x; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pritchard JK, 2000, GENETICS, V155, P945; Pudovkin AI, 1996, GENETICS, V144, P383; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roberge C, 2006, MOL ECOL, V15, P9, DOI 10.1111/j.1365-294X.2005.02807.x; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Saegrov H, 1997, ICES J MAR SCI, V54, P1166, DOI 10.1016/S1054-3139(97)80023-9; Sanchez JA, 1996, HEREDITY, V77, P423, DOI 10.1038/hdy.1996.162; Sandoval-Castellanos E, 2010, GENET RES, V92, P309, DOI 10.1017/S0016672310000339; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Seeb LW, 2007, FISHERIES, V32, P540, DOI 10.1577/1548-8446(2007)32[540:DOASDD]2.0.CO;2; Skaala O, 2004, AQUACULTURE, V240, P131, DOI 10.1016/j.aquaculture.2004.07.009; Skaala O, 2006, ICES J MAR SCI, V63, P1224, DOI 10.1016/j.icesjms.2006.04.005; SLETTAN A, 1995, ANIM GENET, V26, P281, DOI 10.1111/j.1365-2052.1995.tb03262.x; STABELL OB, 1984, BIOL REV, V59, P333, DOI 10.1111/j.1469-185X.1984.tb00709.x; STAHL G, 1987, POPULATION GENETICS, P121; Stet RJM, 2002, IMMUNOGENETICS, V54, P320, DOI 10.1007/s00251-002-0477-1; Taggart JB, 1995, CAN J FISH AQUAT SCI, V52, P2305, DOI 10.1139/f95-822; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Tatara CP, 2012, ENVIRON BIOL FISH, V94, P7, DOI 10.1007/s10641-011-9906-z; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; Tessier N, 1999, MOL ECOL, V8, P169, DOI 10.1046/j.1365-294X.1999.00547.x; Tonteri A, 2008, MOL ECOL RESOUR, V8, P1486, DOI 10.1111/j.1755-0998.2008.02317.x; Tonteri A, 2009, CAN J FISH AQUAT SCI, V66, P717, DOI 10.1139/F09-010; Vaha JP, 2007, MOL ECOL, V16, P2638, DOI 10.1111/j.1365-294X.2007.03329.x; Vasemagi A, 2005, MOL ECOL NOTES, V5, P282, DOI 10.1111/j.1471-8286.2005.00902.x; Verspoor E, 2005, J FISH BIOL, V67, P3, DOI 10.1111/j.0022-1112.2005.00838.x; Walker AM, 2006, ICES J MAR SCI, V63, P1201, DOI 10.1016/j.icesjms.2006.04.018; Wang JL, 2009, MOL ECOL, V18, P2148, DOI 10.1111/j.1365-294X.2009.04175.x; Wang JL, 2003, GENETICS, V163, P429; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2011, GENETICS, V189, P633, DOI 10.1534/genetics.111.132233; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; WAPLES RS, 1989, EVOLUTION, V43, P1236, DOI 10.2307/2409359; Weir LK, 2004, J ANIM ECOL, V73, P1069, DOI 10.1111/j.0021-8790.2004.00876.x; Wennevik V, 2004, ENVIRON BIOL FISH, V69, P143, DOI 10.1023/B:EBFI.0000022890.15512.29; Whoriskey FG, 2006, ICES J MAR SCI, V63, P1218, DOI 10.1016/j.icesjms.2006.04.002	125	157	159	1	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43129	10.1371/journal.pone.0043129	http://dx.doi.org/10.1371/journal.pone.0043129			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916215	Green Published, gold, Green Submitted			2022-12-25	WOS:000307823600049
J	Li, Y; Shi, ZT; Cai, Y; Feng, Y; Ma, GS; Shen, CX; Li, ZY; Liu, NF				Li, Yang; Shi, Zhengtao; Cai, Yan; Feng, Yi; Ma, Genshan; Shen, Chengxing; Li, Zhiyong; Liu, Naifeng			Impact of Coronary Tortuosity on Coronary Pressure: Numerical Simulation Study	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSM; INTRALUMINAL THROMBUS; FLOW RESERVE; ARTERIES; WALL; PERFUSION; STEADY	Background: Coronary tortuosity (CT) is a common coronary angiographic finding. Whether CT leads to an apparent reduction in coronary pressure distal to the tortuous segment of the coronary artery is still unknown. The purpose of this study is to determine the impact of CT on coronary pressure distribution by numerical simulation. Methods: 21 idealized models were created to investigate the influence of coronary tortuosity angle (CTA) and coronary tortuosity number (CTN) on coronary pressure distribution. A 2D incompressible Newtonian flow was assumed and the computational simulation was performed using finite volume method. CTA of 30 degrees, 60 degrees, 90 degrees, 120 degrees and CTN of 0, 1, 2, 3, 4, 5 were discussed under both steady and pulsatile conditions, and the changes of outlet pressure and inlet velocity during the cardiac cycle were considered. Results: Coronary pressure distribution was affected both by CTA and CTN. We found that the pressure drop between the start and the end of the CT segment decreased with CTA, and the length of the CT segment also declined with CTA. An increase in CTN resulted in an increase in the pressure drop. Conclusions: Compared to no-CT, CT can results in more decrease of coronary blood pressure in dependence on the severity of tortuosity and severe CT may cause myocardial ischemia.	[Li, Yang; Feng, Yi; Ma, Genshan; Liu, Naifeng] Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Shi, Zhengtao; Cai, Yan; Li, Zhiyong] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China; [Shen, Chengxing] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Cardiol, Shanghai 200030, Peoples R China	Southeast University - China; Southeast University - China; Shanghai Jiao Tong University	Li, Y (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	zylicam@gmail.com; liunf@seu.edu.cn	Li, Zhi-Yong/G-9701-2011; Liu, Nai-feng/AAM-7836-2020; Li, Zhi-Yong/G-9701-2011	Li, Zhi-Yong/0000-0002-6814-9165; Li, Zhi-Yong/0000-0003-3039-8833				Bernad Sandor I, 2012, J Clin Med Res, V4, P177, DOI 10.4021/jocmr843w; Finol Ender A, 2002, Comput Methods Biomech Biomed Engin, V5, P319, DOI 10.1080/1025584021000009751; Finol Ender A, 2002, Comput Methods Biomech Biomed Engin, V5, P309, DOI 10.1080/1025584021000009742; Gaibazzi N, 2011, AM J CARDIOL, V108, P973, DOI 10.1016/j.amjcard.2011.05.030; Gaibazzi N, 2011, INT J CARDIOL, V148, P385, DOI 10.1016/j.ijcard.2010.12.001; Groves Samuel S, 2009, W V Med J, V105, P14; HUTCHINS GM, 1977, AM HEART J, V94, P196, DOI 10.1016/S0002-8703(77)80280-9; Jakob M, 1996, CATHETER CARDIO DIAG, V38, P25; Kazi M, 2003, J VASC SURG, V38, P1283, DOI 10.1016/S0741-5214(03)00791-2; Kern MJ, 2006, CIRCULATION, V114, P1321, DOI 10.1161/CIRCULATIONAHA.106.177276; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024232; Li Z., 2006, Journal of Medical Engineering & Technology, V30, P283, DOI 10.1080/03091900500217406; Li ZY, 2008, J VASC SURG, V47, P928, DOI 10.1016/j.jvs.2008.01.006; Meimoun P, 2008, EUR J ECHOCARDIOGR, V9, P449, DOI 10.1093/ejechocard/jen004; Morris L, 2006, MED ENG PHYS, V28, P19, DOI 10.1016/j.medengphy.2005.04.012; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Turgut O, 2007, INT J CARDIOVAS IMAG, V23, P671, DOI 10.1007/s10554-006-9186-4; Turgut O, 2010, INT J CARDIOL, V142, pE38, DOI 10.1016/j.ijcard.2008.11.160; Wang Li-jun, 2008, Zhonghua Wai Ke Za Zhi, V46, P1658; Wieneke H, 2000, J AM COLL CARDIOL, V35, P1713, DOI 10.1016/S0735-1097(00)00639-2; Yu SCM, 1999, J MED ENG TECHNOL, V23, P228, DOI 10.1080/030919099294096; Zegers ES, 2007, NETH HEART J, V15, P191, DOI 10.1007/BF03085979	22	55	60	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42558	10.1371/journal.pone.0042558	http://dx.doi.org/10.1371/journal.pone.0042558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916199	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500800017
J	Lucas, EK; Dougherty, SE; McMeekin, LJ; Trinh, AT; Reid, CS; Cowell, RM				Lucas, Elizabeth K.; Dougherty, Sarah E.; McMeekin, Laura J.; Trinh, Alisa T.; Reid, Courtney S.; Cowell, Rita M.			Developmental Alterations in Motor Coordination and Medium Spiny Neuron Markers in Mice Lacking PGC-1 alpha	PLOS ONE			English	Article							HUNTINGTONS-DISEASE BRAIN; TRANSGENIC MOUSE MODEL; DOPAMINE-RECEPTOR GENE; BASAL GANGLIA; MITOCHONDRIAL DYSFUNCTION; MUTANT HUNTINGTIN; IMMUNOREACTIVE NEURONS; GABAERGIC INTERNEURONS; PARKINSONS-DISEASE; STRIATAL NEURONS	Accumulating evidence implicates the transcriptional coactivator peroxisome proliferator activated receptor gamma coactivator 1 alpha (PGC-1 alpha) in the pathophysiology of Huntington Disease (HD). Adult PGC-1 alpha (-/-) mice exhibit striatal neurodegeneration, and reductions in the expression of PGC-1 alpha have been observed in striatum and muscle of HD patients as well as in animal models of the disease. However, it is unknown whether decreased expression of PGC-1 alpha alone is sufficient to lead to the motor phenotype and striatal pathology characteristic of HD. For the first time, we show that young PGC-1 alpha (-/-) mice exhibit severe rotarod deficits, decreased rearing behavior, and increased occurrence of tremor in addition to the previously described hindlimb clasping. Motor impairment and striatal vacuolation are apparent in PGC-1 alpha (-/-) mice by four weeks of age and do not improve or decline by twelve weeks of age. The behavioral and pathological phenotype of PGC-1 alpha (-/-) mice can be completely recapitulated by conditional nervous system deletion of PGC-1 alpha, indicating that peripheral effects are not responsible for the observed abnormalities. Evaluation of the transcriptional profile of PGC-1 alpha (-/-) striatal neuron populations and comparison to striatal neuron profiles of R6/2 HD mice revealed that PGC-1 alpha deficiency alone is not sufficient to cause the transcriptional changes observed in this HD mouse model. In contrast to R6/2 HD mice, PGC-1 alpha (-/-) mice show increases in the expression of medium spiny neuron (MSN) markers with age, suggesting that the observed behavioral and structural abnormalities are not primarily due to MSN loss, the defining pathological feature of HD. These results indicate that PGC-1 alpha is required for the proper development of motor circuitry and transcriptional homeostasis in MSNs and that developmental disruption of PGC-1 alpha leads to long-term alterations in motor functioning.	[Lucas, Elizabeth K.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Lucas, Elizabeth K.; Dougherty, Sarah E.; McMeekin, Laura J.; Trinh, Alisa T.; Reid, Courtney S.; Cowell, Rita M.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	Icahn School of Medicine at Mount Sinai; University of Alabama System; University of Alabama Birmingham	Lucas, EK (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	rcowell@uab.edu	Cowell, Rita/J-5083-2013	Cowell, Rita/0000-0001-5814-9412; Lucas, Elizabeth/0000-0002-0632-4538	National Institutes of Health (NIH) [5R01NS070009-02, 5MH077955-05]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH077955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070009] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health (NIH) Grants 5R01NS070009-02 (R.M.C.) and 5MH077955-05 (R.M.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Ariano MA, 2002, J NEUROSCI RES, V68, P716, DOI 10.1002/jnr.10272; Berardelli A, 1999, MOVEMENT DISORD, V14, P398, DOI 10.1002/1531-8257(199905)14:3<398::AID-MDS1003>3.0.CO;2-F; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243; Che HV, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-1; Cicchetti F, 2000, BRAIN RES REV, V34, P80, DOI 10.1016/S0165-0173(00)00039-4; Cipriani S, 2008, EXP NEUROL, V213, P163, DOI 10.1016/j.expneurol.2008.05.015; Cowell RM, 2007, J COMP NEUROL, V502, P1, DOI 10.1002/cne.21211; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1985, P NATL ACAD SCI USA, V82, P8780, DOI 10.1073/pnas.82.24.8780; GERFEN CR, 1991, J NEUROSCI, V11, P1016; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Guttenberg ND, 1996, NEUROREPORT, V7, P2119, DOI 10.1097/00001756-199609020-00011; Heng MY, 2008, NEUROBIOL DIS, V32, P1, DOI 10.1016/j.nbd.2008.06.005; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; KITA H, 1988, BRAIN RES, V447, P346, DOI 10.1016/0006-8993(88)91138-9; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; KUBOTA Y, 1993, NEUROREPORT, V5, P205, DOI 10.1097/00001756-199312000-00004; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Lee ST, 2009, ANN NEUROL, V66, P671, DOI 10.1002/ana.21788; LEMOINE C, 1990, P NATL ACAD SCI USA, V87, P230, DOI 10.1073/pnas.87.1.230; LEMOINE C, 1991, P NATL ACAD SCI USA, V88, P4205, DOI 10.1073/pnas.88.10.4205; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lucas EK, 2010, J NEUROSCI, V30, P7227, DOI 10.1523/JNEUROSCI.0698-10.2010; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; Ma D, 2010, J BIOL CHEM, V285, P39087, DOI 10.1074/jbc.M110.151688; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Menalled L, 2000, EXP NEUROL, V162, P328, DOI 10.1006/exnr.1999.7327; Mudo G, 2012, CELL MOL LIFE SCI, V69, P1153, DOI 10.1007/s00018-011-0850-z; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Smith R, 2006, HUM MOL GENET, V15, P3119, DOI 10.1093/hmg/ddl252; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Stoof JC, 1981, NATURE, V294, P366, DOI 10.1038/294366a0; Sun Z, 2002, NEUROBIOL DIS, V11, P369, DOI 10.1006/nbdi.2002.0554; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Taherzadeh-Fard E, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-10; Taylor TN, 2010, BEHAV BRAIN RES, V211, P1, DOI 10.1016/j.bbr.2010.03.004; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; Tsunemi T, 2011, PROG NEUROBIOL; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Walker FO, 2007, SEMIN NEUROL, V27, P143, DOI 10.1055/s-2007-971176; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Weydt P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-3; Xiang ZM, 2011, J NEUROSCI, V31, P9544, DOI 10.1523/JNEUROSCI.1291-11.2011; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	61	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42878	10.1371/journal.pone.0042878	http://dx.doi.org/10.1371/journal.pone.0042878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916173	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500800026
J	Aro, E; Khatri, R; Gerard-O'Riley, R; Mangiavini, L; Myllyharju, J; Schipani, E				Aro, Ellinoora; Khatri, Richa; Gerard-O'Riley, Rita; Mangiavini, Laura; Myllyharju, Johanna; Schipani, Ernestina			Hypoxia-inducible Factor-1 (HIF-1) but Not HIF-2 Is Essential for Hypoxic Induction of Collagen Prolyl 4-Hydroxylases in Primary Newborn Mouse Epiphyseal Growth Plate Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNIT ISOFORM; LIMB BUD MESENCHYME; BACULOVIRUS EXPRESSION; MATRIX SYNTHESIS; GENE-EXPRESSION; HIF-2-ALPHA; HIF-1-ALPHA; CARTILAGE; ERYTHROPOIETIN; PHENOTYPE	Hypoxia-inducible factors (HIFs) are the master regulators of hypoxia-responsive genes. They play a critical role in the survival, development, and differentiation of chondrocytes in the avascular hypoxic fetal growth plate, which is rich in extracellular matrix (ECM) and in its main component, collagens. Several genes involved in the synthesis, maintenance, and degradation of ECM are regulated by HIFs. Collagen prolyl 4-hydroxylases (C-P4Hs) are key enzymes in collagen synthesis because the resulting 4-hydroxyprolines are necessary for the stability of all collagen molecules. The vertebrate C-P4Hs are alpha(2)beta(2) tetramers with three isoforms of the catalytic alpha subunit, yielding C-P4Hs of types I-III. C-P4H-I is the main form in most cells, but C-P4H-II is the major form in chondrocytes. We postulated here that post-translational modification of collagens, particularly 4-hydroxylation of proline residues, could be one of the modalities by which HIF regulates the adaptive responses of chondrocytes in fetal growth plates. To address this hypothesis, we used primary epiphyseal growth plate chondrocytes isolated from newborn mice with conditionally inactivated genes for HIF-1 alpha, HIF-2 alpha, or the von Hippel-Lindau protein. The data obtained showed that C-P4H alpha(I) and alpha(II) mRNA levels were increased in hypoxic chondrocytes in a manner dependent on HIF-1 but not on HIF-2. Furthermore, the increases in the C-P4H mRNA levels were associated with both increased amounts of the C-P4H tetramers and augmented C-P4H activity in hypoxia. The hypoxia inducibility of the C-P4H isoenzymes is thus likely to ensure sufficient C-P4H activity for collagen synthesis occurring in chondrocytes in a hypoxic environment.	[Aro, Ellinoora; Myllyharju, Johanna] Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, FIN-90014 Oulu, Finland; [Aro, Ellinoora; Myllyharju, Johanna] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland; [Khatri, Richa; Gerard-O'Riley, Rita; Mangiavini, Laura; Schipani, Ernestina] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	University of Oulu; University of Oulu; Indiana University System; Indiana University Bloomington	Myllyharju, J (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, Aapistie 7,POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi; eschipan@iupui.edu	Mangiavini, Laura/K-6340-2016	Mangiavini, Laura/0000-0003-1892-1249	National Institutes of Health [R01 AR04819]; Health Science Council [200471, 202469]; Center of Excellence programme, Academy of Finland; S. Juselius Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Science Council; Center of Excellence programme, Academy of Finland; S. Juselius Foundation	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR04819 (to E. S.). This work was also supported by Health Science Council Grants 200471 and 202469 and the Center of Excellence 2012-2017 programme from the Academy of Finland, and the S. Juselius Foundation (to J. M.).	Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; Annunen P, 1998, J BIOL CHEM, V273, P5989, DOI 10.1074/jbc.273.11.5989; Araldi E, 2011, NAT MED, V17, P25, DOI 10.1038/nm0111-25; Araldi E, 2010, BONE, V47, P190, DOI 10.1016/j.bone.2010.04.606; Chandel NS, 2008, CELL DEATH DIFFER, V15, P619, DOI 10.1038/cdd.2008.11; De Spiegelaere W, 2010, MOL CELL BIOCHEM, V337, P287, DOI 10.1007/s11010-009-0310-3; Duval E, 2009, ARTHRITIS RHEUM-US, V60, P3038, DOI 10.1002/art.24851; Egerbacher Monika, 2003, Pediatr Endocrinol Rev, V1, P2; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Fahling M, 2006, J BIOL CHEM, V281, P26089, DOI 10.1074/jbc.M604939200; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Grimmer C, 2006, AM J PATHOL, V169, P491, DOI 10.2353/ajpath.2006.050738; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; HELAAKOSKI T, 1995, P NATL ACAD SCI USA, V92, P4427, DOI 10.1073/pnas.92.10.4427; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hofbauer KH, 2003, EUR J BIOCHEM, V270, P4515, DOI 10.1046/j.1432-1033.2003.03846.x; JUVA K, 1966, ANAL BIOCHEM, V15, P77, DOI 10.1016/0003-2697(66)90249-1; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; Maes C, 2012, J BONE MINER RES, V27, P596, DOI 10.1002/jbmr.1487; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Myllyharju J, 2010, CELL TISSUE RES, V339, P19, DOI 10.1007/s00441-009-0841-7; Myllyharju J, 2009, CURR PHARM DESIGN, V15, P3878, DOI 10.2174/138161209789649457; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Pfander D, 2004, DEVELOPMENT, V131, P2497, DOI 10.1242/dev.01138; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Ratcliffe PJ, 2007, J CLIN INVEST, V117, P862, DOI 10.1172/JCI31750; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Schipani E, 2001, GENE DEV, V15, P2865; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Svoboda KKH, 1998, MICROSC RES TECHNIQ, V43, P111, DOI 10.1002/(SICI)1097-0029(19981015)43:2<111::AID-JEMT4>3.0.CO;2-O; Takahashi Y, 2000, J BIOL CHEM, V275, P14139, DOI 10.1074/jbc.275.19.14139; Thoms BL, 2010, J BIOL CHEM, V285, P20472, DOI 10.1074/jbc.M110.115238; Van den Diepstraten C, 2003, CIRCULATION, V108, P508, DOI 10.1161/01.CIR.0000080883.53863.5C; VUORI K, 1992, P NATL ACAD SCI USA, V89, P7467, DOI 10.1073/pnas.89.16.7467; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153	44	56	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37134	37144		10.1074/jbc.M112.352872	http://dx.doi.org/10.1074/jbc.M112.352872			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22930750	hybrid, Green Published			2022-12-25	WOS:000310588500047
J	Balasubramanian, S; Kanade, S; Han, BS; Eckert, RL				Balasubramanian, Sivaprakasam; Kanade, Santosh; Han, Bingshe; Eckert, Richard L.			A Proteasome Inhibitor-stimulated Nrf1 Protein-dependent Compensatory Increase in Proteasome Subunit Gene Expression Reduces Polycomb Group Protein Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EZH2 HISTONE METHYLTRANSFERASE; SKIN-CANCER CELLS; BMI-1 ONCOPROTEIN; COLORECTAL-CANCER; MULTIPLE-MYELOMA; INK4A-ARF LOCUS; BREAST-CANCER; SULFORAPHANE; PROLIFERATION; MECHANISM	The polycomb group (PcG) proteins, Bmi-1 and Ezh2, are important epigenetic regulators that enhance skin cancer cell survival. We recently showed that Bmi-1 and Ezh2 protein level is reduced by treatment with the dietary chemopreventive agents, sulforaphane and green tea polyphenol, and that this reduction involves ubiquitination of Bmi-1 and Ezh2, suggesting a key role of the proteasome. In the present study, we observe a surprising outcome that Bmi-1 and Ezh2 levels are reduced by treatment with the proteasome inhibitor, MG132. We show that this is associated with a compensatory increase in the level of mRNA encoding proteasome protein subunits in response to MG132 treatment and an increase in proteasome activity. The increase in proteasome subunit level is associated with increased Nrf1 and Nrf2 level. Moreover, knockdown of Nrf1 attenuates the MG132-dependent increase in proteasome subunit expression and restores Bmi-1 and Ezh2 expression. The MG132-dependent loss of Bmi-1 and Ezh2 is associated with reduced cell proliferation, accumulation of cells in G(2), and increased apoptosis. These effects are attenuated by forced expression of Bmi-1, suggesting that PcG proteins, consistent with a prosurvival action, may antagonize the action of MG132. These studies describe a compensatory Nrf1-dependent, and to a lesser extent Nrf2-dependent, increase in proteasome subunit level in proteasome inhibitor-treated cells and confirm that PcG protein levels are regulated by proteasome activity.	[Balasubramanian, Sivaprakasam; Kanade, Santosh; Han, Bingshe; Eckert, Richard L.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Dept Dermatol, Sch Med, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Dept Obstet & Gynecol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Kanade, Santosh/V-7054-2019	Kanade, Santosh/0000-0002-2184-9973	National Institutes of Health [R01 AR053851, R01 CA131074]; NATIONAL CANCER INSTITUTE [R01CA131074, P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR053851 and R01 CA131074 (to R. L. E.).	Ahmad N, 1999, NUTR REV, V57, P78, DOI 10.1111/j.1753-4887.1999.tb06927.x; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Balasubramanian S, 2008, NUTR REV, V66, pS65, DOI 10.1111/j.1753-4887.2008.00071.x; Balasubramanian S, 2011, MOL PHARMACOL, V80, P870, DOI 10.1124/mol.111.072363; Balasubramanian S, 2010, CARCINOGENESIS, V31, P496, DOI 10.1093/carcin/bgp314; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Breuer RHJ, 2004, NEOPLASIA, V6, P736, DOI 10.1593/neo.04160; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Choudhury SR, 2011, CARCINOGENESIS, V32, P1525, DOI 10.1093/carcin/bgr171; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Di Fiore B, 2003, J CELL SCI, V116, P3399, DOI 10.1242/jcs.00624; Dinkova-Kostova AT, 2006, CANCER LETT, V240, P243, DOI 10.1016/j.canlet.2005.09.012; Eckert RL, 2011, J INVEST DERMATOL, V131, P295, DOI 10.1038/jid.2010.318; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Hatano A, 2010, BIOCHEM BIOPH RES CO, V397, P93, DOI 10.1016/j.bbrc.2010.05.074; Jans R, 2008, J INVEST DERMATOL, V128, P517, DOI 10.1038/sj.jid.5701035; Kidani K, 2009, ORAL ONCOL, V45, P39, DOI 10.1016/j.oraloncology.2008.03.016; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Kwak MK, 2007, FREE RADICAL BIO MED, V43, P809, DOI 10.1016/j.freeradbiomed.2007.05.029; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lancet JE, 2011, CLIN CANCER RES, V17, P1140, DOI 10.1158/1078-0432.CCR-10-1878; Laubach J, 2011, ANNU REV MED, V62, P249, DOI 10.1146/annurev-med-070209-175325; Lee K, 2008, J INVEST DERMATOL, V128, P9, DOI 10.1038/sj.jid.5700949; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Ling SCW, 2012, HAEMATOL-HEMATOL J, V97, P64, DOI 10.3324/haematol.2011.043331; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Mimori K, 2005, EJSO-EUR J SURG ONC, V31, P376, DOI 10.1016/j.ejso.2004.11.001; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Myzak MC, 2007, EXP BIOL MED, V232, P227; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sturniolo MT, 2005, ONCOGENE, V24, P2963, DOI 10.1038/sj.onc.1208392; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Weikert S, 2005, INT J MOL MED, V16, P349; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300	48	22	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36179	36189		10.1074/jbc.M112.359281	http://dx.doi.org/10.1074/jbc.M112.359281			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22932898	hybrid, Green Published			2022-12-25	WOS:000310364000039
J	Han, YJ; Agarwal, V; Dodd, D; Kim, J; Bae, B; Mackie, RI; Nair, SK; Cann, IKO				Han, Yejun; Agarwal, Vinayak; Dodd, Dylan; Kim, Jason; Bae, Brian; Mackie, Roderick I.; Nair, Satish K.; Cann, Isaac K. O.			Biochemical and Structural Insights into Xylan Utilization by the Thermophilic Bacterium Caldanaerobius polysaccharolyticus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULE; THERMOANAEROBACTERIUM-POLYSACCHAROLYTICUM; ALPHA-GLUCURONIDASE; BETA-XYLOSIDASE; GEOBACILLUS-STEAROTHERMOPHILUS; THERMOTOGA-MARITIMA; GENE-CLUSTER; CLOSTRIDIUM-THERMOCELLUM; THERMOSTABLE ENZYMES; CRYSTAL-STRUCTURES	Hemicellulose is the next most abundant plant cell wall component after cellulose. The abundance of hemicellulose such as xylan suggests that their hydrolysis and conversion to biofuels can improve the economics of bioenergy production. In an effort to understand xylan hydrolysis at high temperatures, we sequenced the genome of the thermophilic bacterium Caldanaerobius polysaccharolyticus. Analysis of the partial genome sequence revealed a gene cluster that contained both hydrolytic enzymes and also enzymes key to the pentose-phosphate pathway. The hydrolytic enzymes in the gene cluster were demonstrated to convert products from a large endoxylanase (Xyn10A) predicted to anchor to the surface of the bacterium. We further use structural and calorimetric studies to demonstrate that the end products of Xyn10A hydrolysis of xylan are recognized and bound by XBP1, a putative solute-binding protein, likely for transport into the cell. The XBP1 protein showed preference for xylo-oligosaccharides as follows: xylotriose > xylobiose > xylotetraose. To elucidate the structural basis for the oligosaccharide preference, we solved the co-crystal structure of XBP1 complexed with xylotriose to a 1.8-angstrom resolution. Analysis of the biochemical data in the context of the co-crystal structure reveals the molecular underpinnings of oligosaccharide length specificity.	[Agarwal, Vinayak; Bae, Brian; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Han, Yejun; Dodd, Dylan; Kim, Jason; Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA; [Han, Yejun; Dodd, Dylan; Kim, Jason; Mackie, Roderick I.; Nair, Satish K.; Cann, Isaac K. O.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Agarwal, Vinayak; Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Dodd, Dylan; Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Kim, Jason] Univ Illinois, Dept Mol & Cellular Biol, Urbana, IL 61801 USA; [Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nair, SK (corresponding author), Univ Illinois, Dept Biochem, 600 S Matthews Ave, Urbana, IL 61801 USA.	snair@illinois.edu; icann@illinois.edu	Agarwal, Vinayak/L-5688-2017; Nair, Satish/AAY-2510-2021; Han, Yejun/AAC-7411-2019	Dodd, Dylan/0000-0001-6210-6239	Energy Biosciences Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK084726] Funding Source: NIH RePORTER	Energy Biosciences Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Energy Biosciences Institute.	Abboft DW, 2007, J MOL BIOL, V369, P759, DOI 10.1016/j.jmb.2007.03.045; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BABA T, 1994, APPL ENVIRON MICROB, V60, P2252, DOI 10.1128/AEM.60.7.2252-2258.1994; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Blanco A, 1999, MICROBIOL-SGM, V145, P2163, DOI 10.1099/13500872-145-8-2163; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Cann IKO, 1999, J BACTERIOL, V181, P1643, DOI 10.1128/JB.181.5.1643-1651.1999; Cann IKO, 2001, INT J SYST EVOL MICR, V51, P293, DOI 10.1099/00207713-51-2-293; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cuneo MJ, 2006, J MOL BIOL, V362, P259, DOI 10.1016/j.jmb.2006.06.084; Czjzek M, 2005, J MOL BIOL, V353, P838, DOI 10.1016/j.jmb.2005.09.003; de Wet BJM, 2006, ENZYME MICROB TECH, V38, P649, DOI 10.1016/j.enzmictec.2005.07.018; Diez J, 2001, J MOL BIOL, V305, P905, DOI 10.1006/jmbi.2000.4203; Dodd D, 2010, J BACTERIOL, V192, P2335, DOI 10.1128/JB.01654-09; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; Dodd D, 2009, J BACTERIOL, V191, P3328, DOI 10.1128/JB.01628-08; Eneyskaya EV, 2007, ARCH BIOCHEM BIOPHYS, V457, P225, DOI 10.1016/j.abb.2006.10.024; GASPARIC A, 1995, APPL ENVIRON MICROB, V61, P2958, DOI 10.1128/AEM.61.8.2958-2964.1995; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; Higgins MA, 2009, J MOL BIOL, V388, P299, DOI 10.1016/j.jmb.2009.03.012; HURTUBISE Y, 1995, MOL MICROBIOL, V17, P367, DOI 10.1111/j.1365-2958.1995.mmi_17020367.x; Jun HS, 2003, CAN J MICROBIOL, V49, P171, DOI 10.1139/W03-024; King MR, 2002, J AGR FOOD CHEM, V50, P5676, DOI 10.1021/jf0202281; Kurokawa J, 2002, APPL MICROBIOL BIOT, V59, P455, DOI 10.1007/s00253-002-1048-y; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEE YE, 1993, J BACTERIOL, V175, P5890, DOI 10.1128/JB.175.18.5890-5898.1993; Lee YJ, 2008, INT J SYST EVOL MICR, V58, P666, DOI 10.1099/ijs.0.65329-0; Licht A, 2011, J MOL BIOL, V406, P92, DOI 10.1016/j.jmb.2010.11.048; Liebl WG, 2008, J BACTERIOL, V190, P1350, DOI 10.1128/JB.01149-07; LITTLE E, 1994, J MOL EVOL, V39, P631, DOI 10.1007/BF00160409; Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Meissner K, 2000, MOL MICROBIOL, V36, P898, DOI 10.1046/j.1365-2958.2000.01909.x; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Mierzwa M, 2005, PREP BIOCHEM BIOTECH, V35, P243, DOI 10.1081/PB-200065648; Milner Y., 1967, CARBOHYD RES, V4, P359, DOI DOI 10.1016/S0008-6215(00)80191-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy T, 2003, J BIOL CHEM, V278, P20286, DOI 10.1074/jbc.M302205200; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Rohman A, 2007, ACTA CRYSTALLOGR F, V63, P932, DOI 10.1107/S1744309107046015; Ryabova O, 2009, FEBS LETT, V583, P1457, DOI 10.1016/j.febslet.2009.03.057; Selvaraj T, 2010, J MICROBIOL, V48, P856, DOI 10.1007/s12275-010-0285-5; Shallom D, 2004, J BACTERIOL, V186, P6928, DOI 10.1128/JB.186.20.6928-6937.2004; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Shulami S, 1999, J BACTERIOL, V181, P3695, DOI 10.1128/JB.181.12.3695-3704.1999; Shulami S, 2007, APPL ENVIRON MICROB, V73, P874, DOI 10.1128/AEM.02367-06; Szabo L, 2001, J BIOL CHEM, V276, P49061, DOI 10.1074/jbc.M109558200; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vahedi-Faridi A, 2010, J MOL BIOL, V397, P709, DOI 10.1016/j.jmb.2010.01.054; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; WINTERHALTER C, 1995, MOL MICROBIOL, V15, P431, DOI 10.1111/j.1365-2958.1995.tb02257.x; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28; [No title captured]	61	40	42	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34946	34960		10.1074/jbc.M112.391532	http://dx.doi.org/10.1074/jbc.M112.391532			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22918832	Green Published, hybrid			2022-12-25	WOS:000309968000008
J	Korde, AS; Maragos, WF				Korde, Amit S.; Maragos, William F.			Identification of an N-Methyl-D-aspartate Receptor in Isolated Nervous System Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTOR; GLUTAMATE RECEPTORS; SIGNALING PATHWAY; GNRH NEURONS; CALCIUM; EXPRESSION; MEMBRANE; SUBUNIT; APOPTOSIS; MESSENGER	NMDA ionotropic glutamate receptors gate the cytoplasmic influx of calcium, which may, depending on the intensity of the stimulus, subserve either normal synaptic communication or cell death. We demonstrate that when isolated mitochondria are exposed to calcium and NMDA agonists, there is a significant increase in mitochondrial calcium levels. The agonist/antagonist response studies on purified mitochondria suggest the presence of a receptor on mitochondria with features similar to plasma membrane NMDA receptors. Immunogold electron microscopy of hippocampal tissue sections revealed extensive localization of NR2a subunit immunoreactivity on mitochondria. Transient transfection of neuronal GT1-7 cells with an NR1-NR2a NMDA receptor subunit cassette specifically targeting mitochondria resulted in a significant increase in mitochondrial calcium and neuroprotection against glutamate-induced cell death. Mitochondria prepared from GT1-7 cells in which the NR1 subunit of NMDA receptors was silenced demonstrated a decrease in calcium uptake. Our findings are the first to demonstrate that mitochondria express a calcium transport protein that shares characteristics with the NMDA receptor and may play a neuroprotective role.	[Korde, Amit S.; Maragos, William F.] Hunter Holmes McGuire Vet Hosp, Neurol Serv, Richmond, VA 23294 USA; [Maragos, William F.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23298 USA	Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University	Maragos, WF (corresponding author), Hunter Holmes McGuire Vet Hosp, Neurol Serv, Rm 2B-175,1201 Broad Rock Blvd, Richmond, VA 23294 USA.	william.maragos@va.gov		Korde, Amit/0000-0003-0702-290X	National Institutes of Health [NS01941, NS42111]; McGuire Veterans Administration Medical Center; McGuire Research Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McGuire Veterans Administration Medical Center; McGuire Research Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS01941 and NS42111 (to W. F. M.) and McGuire Veterans Administration Medical Center and McGuire Research Institute.	Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Budd SL, 1996, J NEUROCHEM, V67, P2282; Buntinas L, 2001, BBA-BIOENERGETICS, V1504, P248, DOI 10.1016/S0005-2728(00)00254-1; Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021; Chenu C, 1998, BONE, V22, P295, DOI 10.1016/S8756-3282(97)00295-0; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DENTON RM, 1988, J CARDIOVASC PHARM, V12, pS69; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Franconi F, 1998, BRIT J PHARMACOL, V124, P35, DOI 10.1038/sj.bjp.0701790; Genever PG, 1999, J INVEST DERMATOL, V112, P337, DOI 10.1046/j.1523-1747.1999.00509.x; Genever PG, 1999, BLOOD, V93, P2876; GREENAMYRE JT, 1985, J PHARMACOL EXP THER, V233, P254; Gunter TE, 1998, BBA-BIOENERGETICS, V1366, P5, DOI 10.1016/S0005-2728(98)00117-0; HANSFORD RG, 1994, J BIOENERG BIOMEMBR, V26, P495, DOI 10.1007/BF00762734; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HUNTLEY GW, 1994, J NEUROSCI, V14, P3603; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Khodorov B, 1996, FEBS LETT, V393, P135, DOI 10.1016/0014-5793(96)00873-3; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Korde AS, 2007, J NEUROTRAUM, V24, P895, DOI 10.1089/neu.2006.0122; Korde AS, 2005, J NEUROTRAUM, V22, P1142, DOI 10.1089/neu.2005.22.1142; Kraemer R., 1992, MOL MECH BIOENERGETI, P359; Lancelot E, 1998, PROG BRAIN RES, V116, P331, DOI 10.1016/S0079-6123(08)60446-X; LEBOURDELLES B, 1994, J NEUROCHEM, V62, P2091; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Mahesh VB, 1999, NEUROENDOCRINOLOGY, V69, P397, DOI 10.1159/000054442; MARAGOS WF, 1988, J NEUROSCI, V8, P493; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MORHENN VB, 1994, EUR J PHARM-MOLEC PH, V268, P409, DOI 10.1016/0922-4106(94)90066-3; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Patton AJ, 1998, BONE, V22, P645, DOI 10.1016/S8756-3282(98)00061-1; Peng TI, 1998, MOL PHARMACOL, V53, P974; PETRALIA RS, 1994, J NEUROSCI, V14, P667; Purcell WM, 1996, J NEUROIMMUNOL, V65, P49, DOI 10.1016/0165-5728(95)00182-4; Ricchelli F, 2011, BBA-BIOENERGETICS, V1807, P482, DOI 10.1016/j.bbabio.2011.02.012; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Skerry TM, 2001, TRENDS PHARMACOL SCI, V22, P174, DOI 10.1016/S0165-6147(00)01642-4; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; White RJ, 1996, J NEUROSCI, V16, P5688; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	46	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35192	35200		10.1074/jbc.M111.322032	http://dx.doi.org/10.1074/jbc.M111.322032			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22918829	hybrid, Green Published			2022-12-25	WOS:000309968000029
J	Rueger, MA; Keuters, MH; Walberer, M; Braun, R; Klein, R; Sparing, R; Fink, GR; Graf, R; Schroeter, M				Rueger, Maria Adele; Keuters, Meike Hedwig; Walberer, Maureen; Braun, Ramona; Klein, Rebecca; Sparing, Roland; Fink, Gereon Rudolf; Graf, Rudolf; Schroeter, Michael			Multi-Session Transcranial Direct Current Stimulation (tDCS) Elicits Inflammatory and Regenerative Processes in the Rat Brain	PLOS ONE			English	Article							NEURAL STEM-CELLS; NONINVASIVE CORTICAL STIMULATION; CURRENT ELECTRIC-FIELDS; HUMAN MOTOR CORTEX; PROGENITOR CELLS; IN-VIVO; CEREBRAL-CORTEX; ADULT BRAIN; STROKE; MIGRATION	Transcranial direct current stimulation (tDCS) is increasingly being used in human studies as an adjuvant tool to promote recovery of function after stroke. However, its neurobiological effects are still largely unknown. Electric fields are known to influence the migration of various cell types in vitro, but effects in vivo remain to be shown. Hypothesizing that tDCS might elicit the recruitment of cells to the cortex, we here studied the effects of tDCS in the rat brain in vivo. Adult Wistar rats (n = 16) were randomized to either anodal or cathodal stimulation for either 5 or 10 consecutive days (500 mu A, 15 min). Bromodeoxyuridine (BrdU) was given systemically to label dividing cells throughout the experiment. Immunohistochemical analyses ex vivo included stainings for activated microglia and endogenous neural stem cells (NSC). Multi-session tDCS with the chosen parameters did not cause a cortical lesion. An innate immune response with early upregulation of Iba1-positive activated microglia occurred after both cathodal and anodal tDCS. The involvement of adaptive immunity as assessed by ICAM1-immunoreactivity was less pronounced. Most interestingly, only cathodal tDCS increased the number of endogenous NSC in the stimulated cortex. After 10 days of cathodal stimulation, proliferating NSC increased by similar to 60%, with a significant effect of both polarity and number of tDCS sessions on the recruitment of NSC. We demonstrate a pro-inflammatory effect of both cathodal and anodal tDCS, and a polarity-specific migratory effect on endogenous NSC in vivo. Our data suggest that tDCS in human stroke patients might also elicit NSC activation and modulate neuroinflammation.	[Rueger, Maria Adele; Keuters, Meike Hedwig; Walberer, Maureen; Braun, Ramona; Klein, Rebecca; Sparing, Roland; Fink, Gereon Rudolf; Schroeter, Michael] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Braun, Ramona] Univ Hosp Cologne, Ctr Med Expt, Cologne, Germany; [Rueger, Maria Adele; Keuters, Meike Hedwig; Walberer, Maureen; Klein, Rebecca; Graf, Rudolf; Schroeter, Michael] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Fink, Gereon Rudolf] Res Ctr Juelich, Inst Neurosci & Med INM 3, Cognit Neurol Sect, Julich, Germany	University of Cologne; University of Cologne; Max Planck Society; Helmholtz Association; Research Center Julich	Rueger, MA (corresponding author), Univ Hosp Cologne, Dept Neurol, Cologne, Germany.	adele.rueger@uk-koeln.de	Fink, Gereon R./E-1616-2012; Fink, Gereon R./AFW-9377-2022; Keuters, Meike/AAQ-2165-2021	Fink, Gereon R./0000-0002-8230-1856; Fink, Gereon R./0000-0002-8230-1856; Keuters, Meike Hedwig/0000-0003-4216-1024	Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany [143/2011]	Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany	This work was supported by the Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany (143/2011). The authors gratefully acknowledge a personal grant by Mr. U. Eichrodt to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsellis-Theotokis A, 2008, COLD SH Q B, V73, P403, DOI 10.1101/sqb.2008.73.018; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; Antal A, 2004, EUR J NEUROSCI, V19, P2888, DOI 10.1111/j.1460-9568.2004.03367.x; Ariza CA, 2010, STEM CELL REV REP, V6, P585, DOI 10.1007/s12015-010-9171-0; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Babona-Pilipos R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023808; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; BINDMAN LJ, 1962, NATURE, V196, P584, DOI 10.1038/196584a0; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BROWN MJ, 1994, J CELL BIOL, V127, P117, DOI 10.1083/jcb.127.1.117; Butefisch CM, 2004, J NEUROPHYSIOL, V91, P2110, DOI 10.1152/jn.01038.2003; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Feng JF, 2012, STEM CELLS, V30, P349, DOI 10.1002/stem.779; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Li L, 2008, STEM CELLS, V26, P2193, DOI 10.1634/stemcells.2007-1022; Liebetanz D, 2006, NEUROSCI LETT, V398, P85, DOI 10.1016/j.neulet.2005.12.058; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Liebetanz D, 2009, CLIN NEUROPHYSIOL, V120, P1161, DOI 10.1016/j.clinph.2009.01.022; Mabuchi T, 2000, STROKE, V31, P1735, DOI 10.1161/01.STR.31.7.1735; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; Maysami S, 2008, J CEREBR BLOOD F MET, V28, P1104, DOI 10.1038/jcbfm.2008.4; Monti A, 2008, J NEUROL NEUROSUR PS, V79, P451, DOI 10.1136/jnnp.2007.135277; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nishimura KY, 1996, J CELL SCI, V109, P199; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; RAPP B, 1988, EUR BIOPHYS J BIOPHY, V16, P313, DOI 10.1007/BF00254068; Rueger MA, 2010, J NEUROSCI, V30, P6454, DOI 10.1523/JNEUROSCI.6092-09.2010; Ruohonen J, 2012, CLIN NEUROPHYSIOL; Ryu JK, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-39; Schlaug G, 2008, ARCH NEUROL-CHICAGO, V65, P1571, DOI 10.1001/archneur.65.12.1571; Schweid L, 2008, EXP BRAIN RES, V186, P409, DOI 10.1007/s00221-007-1245-0; Song B, 2007, NAT PROTOC, V2, P1479, DOI 10.1038/nprot.2007.205; Sparing R, 2009, BRAIN, V132, P3011, DOI 10.1093/brain/awp154; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Wachter D, 2011, EXP NEUROL, V227, P322, DOI 10.1016/j.expneurol.2010.12.005; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; Zhang JP, 2011, STEM CELL REV REP, V7, P987, DOI 10.1007/s12015-011-9247-5	44	88	91	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43776	10.1371/journal.pone.0043776	http://dx.doi.org/10.1371/journal.pone.0043776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928032	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300088
J	March-Villalba, JA; Martinez-Jabaloyas, JM; Herrero, MJ; Santamaria, J; Alino, SF; Dasi, F				March-Villalba, Jose A.; Martinez-Jabaloyas, Jose M.; Herrero, Maria J.; Santamaria, Jose; Alino, Salvador F.; Dasi, Francisco			Cell-Free Circulating Plasma hTERT mRNA Is a Useful Marker for Prostate Cancer Diagnosis and Is Associated with Poor Prognosis Tumor Characteristics	PLOS ONE			English	Article							REAL-TIME QUANTIFICATION; NUCLEIC-ACIDS; PREVALENCE; BIOMARKERS; MORTALITY; DISEASE	Background: Serum prostate-specific antigen (PSA) is the most widely used marker for diagnosing prostate cancer (PCa). It lacks specificity and predictive value, resulting in inaccurate diagnoses and overtreatment of the disease. The aim of this study was to assess the usefulness of plasma telomerase reverse transcriptase (hTERT) mRNA as a diagnostic and prognostic tool for PCa and its association with clinicopathological parameters of tumors. Principal Findings: Plasma hTERT mRNA levels were determined by qRT-PCR in 105 consecutive patients with elevated PSA levels and in 68 healthy volunteers. The diagnostic accuracy, the efficacy as a prognostic factor of biochemical recurrence and the association with tumor clinicopathological parameters of plasma hTERT mRNA and serum PSA tests were determined using univariate and multivariate analyses. The results show that plasma hTERT mRNA is a non-invasive biomarker for PCa diagnosis that shows higher sensitivity (85% vs. 83%), specificity (90% vs. 47%), positive predictive value (83% vs. 56%), and negative predictive value (92% vs. 77%) than serum PSA. Plasma hTERT mRNA is significantly associated with poor prognosis tumor clinicopathological parameters and is a significant independent predictor of PCa (p<0.0001). Univariate analysis identified plasma hTERT mRNA (but not serum PSA) as a significant prognostic factor of biochemical recurrence. Plasma hTERT mRNA Kaplan-Meier curves confirmed the significant differences between groups and patients with higher levels than the cut-off value showed diminished recurrence-free survival (p = 0.004), whereas no differences were observed with serum PSA (p = 0.38). Multivariate analysis indicated that plasma hTERT mRNA (but not serum PSA) and stage were significantly associated with biochemical recurrence. Conclusions: Overall, these findings indicate that hTERT mRNA is a useful non-invasive tumor marker for the molecular diagnosis of PCa, affording a greater diagnostic and prognostic accuracy than the PSA assay and may be of relevance in the follow-up of the disease.	[March-Villalba, Jose A.; Martinez-Jabaloyas, Jose M.; Santamaria, Jose; Dasi, Francisco] Hosp Clin Univ Valencia, Fdn Invest, Inst Invest INCLIVA, Valencia, Spain; [March-Villalba, Jose A.; Martinez-Jabaloyas, Jose M.; Santamaria, Jose] Hosp Clin Univ Valencia, Urol Unite, Valencia, Spain; [Herrero, Maria J.; Alino, Salvador F.] Univ Valencia, Sch Med, Dept Pharmacol, Valencia, Spain; [Dasi, Francisco] Univ Valencia, Sch Med, Dept Physiol, Valencia, Spain	University of Valencia; University of Valencia	March-Villalba, JA (corresponding author), Hosp Clin Univ Valencia, Fdn Invest, Inst Invest INCLIVA, Valencia, Spain.	Francisco.Dasi@uv.es	Dasi, Francisco/D-1885-2012; Herrero, Maria Jose/M-1649-2014	Dasi, Francisco/0000-0003-2938-2965; Herrero, Maria Jose/0000-0002-6042-4185; Alino Pellicer, Salvador Francisco/0000-0002-7830-8713				Altimari A, 2008, AM J CLIN PATHOL, V129, P756, DOI 10.1309/DBPX1MFNDDJBW1FL; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bjartell A, 2011, ACTA ONCOL, V50, P76, DOI 10.3109/0284186X.2010.531284; Carbonare LD, 2013, UROL ONCOL-SEMIN ORI, V31, P205, DOI 10.1016/j.urolonc.2010.12.017; Dasi F, 2006, ANN NY ACAD SCI, V1075, P204, DOI 10.1196/annals.1368.028; Dasi F, 2001, LAB INVEST, V81, P767, DOI 10.1038/labinvest.3780285; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Gomella LG, 2011, CAN J UROL, V18, P5875; Greene KL, 2009, J UROLOGY, V182, P2232, DOI 10.1016/j.juro.2009.07.093; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; Hoffman RM, 2011, NEW ENGL J MED, V365, P2013, DOI 10.1056/NEJMcp1103642; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lledo S M, 2004, Colorectal Dis, V6, P236, DOI 10.1111/j.1463-1318.2004.00627.x; March-Villalba JA, 2012, EXPERT OPIN BIOL TH, V12, pS69, DOI 10.1517/14712598.2012.685716; Miura N, 2007, ONCOLOGY-BASEL, V72, P45, DOI 10.1159/000111706; Miura N, 2007, ONCOL REP, V17, P541; Miura N, 2006, CANCER SCI, V97, P1366, DOI 10.1111/j.1349-7006.2006.00342.x; Miura N, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-46; Roobol MJ, 2011, ACTA ONCOL, V50, P85, DOI 10.3109/0284186X.2010.524935; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shariat SF, 2011, ACTA ONCOL, V50, P61, DOI 10.3109/0284186X.2010.542174; Silva JM, 2001, CLIN CANCER RES, V7, P2821; Terrin L, 2008, CLIN CANCER RES, V14, P7444, DOI 10.1158/1078-0432.CCR-08-0478; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Tricoli JV, 2004, CLIN CANCER RES, V10, P3943, DOI 10.1158/1078-0432.CCR-03-0200; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209	28	59	67	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43470	10.1371/journal.pone.0043470	http://dx.doi.org/10.1371/journal.pone.0043470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916267	Green Submitted, gold, Green Published			2022-12-25	WOS:000307733800071
J	Pal, S; Saha, C; Hossain, M; Dey, SK; Kumar, GS				Pal, Sandip; Saha, Chabita; Hossain, Maidul; Dey, Subrata Kumar; Kumar, Gopinatha Suresh			Influence of Galloyl Moiety in Interaction of Epicatechin with Bovine Serum Albumin: A Spectroscopic and Thermodynamic Characterization	PLOS ONE			English	Article							STRUCTURE-AFFINITY RELATIONSHIP; DRUG BINDING-SITES; FLUORESCENCE; FLAVONOIDS; QUERCETIN; BSA; PUERARIN; ACID; RING	The health benefits stemming from green tea are well known, but the exact mechanism of its biological activity is not elucidated. Epicatechin (EC) and epicatechin gallate (ECG) are two dietary catechins ubiquitously present in green tea. Serum albumins functionally carry these catechins through the circulatory system and eliminate reactive oxygen species (ROS) induced injury. In the present study ECG is observed to have higher antioxidant activity; which is attributed to the presence of galloyl moiety. The binding affinity of these catechins to bovine serum albumin (BSA) will govern the efficacy of their biological activity. EC and ECG bind with BSA with binding constants 1.0x10(6) M-1 and 6.6x10(7) M-1, respectively. Changes in secondary structure of BSA on interaction with EC and ECG have been identified by circular dichroism (CD) and Fourier transform infrared (FT-IR) spectroscopy. Thermodynamic characterization reveals the binding process to be exothermic, spontaneous and entropy driven. Mixed binding forces (hydrophobic, electrostatic and hydrogen bonding) exist between ECG and BSA. Binding site for EC is primarily site-II in sub-domain IIIA of BSA and for ECG; it is site-I in subdomain IIA. ECG with its high antioxidant activity accompanied by high affinity for BSA could be a model in drug designing.	[Pal, Sandip; Saha, Chabita; Dey, Subrata Kumar] W Bengal Univ Technol, Sch Biotechnol & Biol Sci, Kolkata, India; [Hossain, Maidul; Kumar, Gopinatha Suresh] Indian Inst Chem Biol, CSIR, Div Chem, Biophys Chem Lab, Kolkata, India	Maulana Abul Kalam Azad University of Technology; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Pal, S (corresponding author), W Bengal Univ Technol, Sch Biotechnol & Biol Sci, Kolkata, India.	k.chabita@gmail.com	KUMAR, P. SURESH/AAT-8951-2020; Kumar, Gopinatha Suresh/W-1461-2019; Kumar, Dr Suresh/HHZ-2615-2022; Saha, chabita/AAW-5020-2021; Hossain, Maidul/AAW-7669-2021	KUMAR, P. SURESH/0000-0003-3222-2604; Kumar, Dr Suresh/0000-0002-2539-6553; Hossain, Maidul/0000-0003-1408-2273	National Tea Research Foundation (NTRF), India; Department of Science and Technology, Govt. of India; NTRF, India; Research Associateship of the Council of Scientific and Industrial Research (CSIR), Govt. of India	National Tea Research Foundation (NTRF), India; Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); NTRF, India; Research Associateship of the Council of Scientific and Industrial Research (CSIR), Govt. of India	This work is supported by National Tea Research Foundation (NTRF), India. Dr. Chabita Saha is thankful to Department of Science and Technology, Govt. of India for the financial support. Mr. Sandip Pal, Junior Research Fellow is financially supported by NTRF, India and is thankful to the same. Dr. Maidul Hossain is a recipient of the Research Associateship of the Council of Scientific and Industrial Research (CSIR), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander B, 1999, J PHARMACOL TOXICOL, V41, P55, DOI 10.1016/S1056-8719(98)00038-0; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Chakraborty B, 2009, J LUMIN, V129, P34, DOI 10.1016/j.jlumin.2008.07.012; Cote J, 2010, CRIT REV FOOD SCI, V50, P666, DOI 10.1080/10408390903044107; Forster T., 1965, MODERN QUANTUM CHEM; Ghosh D, 2013, J BIOMOL STRUCT DYN, V31, P331, DOI 10.1080/07391102.2012.698190; Ghosh D, 2012, DNA CELL BIOL, V31, P377, DOI 10.1089/dna.2011.1299; Ghosh S, 2009, NANOSCALE RES LETT, V4, P937, DOI 10.1007/s11671-009-9339-1; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hossain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018333; Jha NS, 2009, THERMOCHIM ACTA, V482, P21, DOI 10.1016/j.tca.2008.10.012; Jiang M, 2004, J MOL STRUCT, V692, P71, DOI 10.1016/j.molstruc.2004.01.003; Kandagal PB, 2006, J PHARMACEUT BIOMED, V41, P393, DOI 10.1016/j.jpba.2005.11.037; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; Li JH, 2008, J MOL STRUCT, V885, P64, DOI 10.1016/j.molstruc.2007.10.020; Liu EH, 2010, MOLECULES, V15, P9092, DOI 10.3390/molecules15129092; Maiti TK, 2006, PROTEINS, V64, P355, DOI 10.1002/prot.20995; Mishra B, 2005, J CHEM SCI, V117, P641, DOI 10.1007/BF02708293; Nair CKK, 2008, MUTAT RES-GEN TOX EN, V650, P48, DOI 10.1016/j.mrgentox.2007.10.001; Natella F, 2010, BIOCHIMIE, V92, P1147, DOI 10.1016/j.biochi.2010.04.019; Norde W, 2000, J BIOTECHNOL, V79, P259, DOI 10.1016/S0168-1656(00)00242-X; Rahmelow K, 1996, ANAL BIOCHEM, V241, P5, DOI 10.1006/abio.1996.0369; Roy A.S., 2010, J BIOPHYS CHEM, V01, P141, DOI [DOI 10.4236/JBPC.2010.13017, 10.4236/jbpc.2010.13017]; Sengupta B, 2002, BIOCHEM BIOPH RES CO, V299, P400, DOI 10.1016/S0006-291X(02)02667-0; Serro AP, 2004, J BIOMED MATER RES A, V70A, P420, DOI 10.1002/jbm.a.30096; Shi J, 2011, REV BRAS FARMACOGN, V21, P594, DOI 10.1590/S0102-695X2011005000118; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; TERAO J, 1994, ARCH BIOCHEM BIOPHYS, V308, P278, DOI 10.1006/abbi.1994.1039; Tian JN, 2004, J PHOTOCH PHOTOBIO B, V74, P39, DOI 10.1016/j.jphotobiol.2004.01.001; Turkmen N, 2006, FOOD CHEM, V99, P835, DOI 10.1016/j.foodchem.2005.08.034; Wang HF, 2000, TRENDS FOOD SCI TECH, V11, P152, DOI 10.1016/S0924-2244(00)00061-3; Wang YQ, 2007, J PHARMACEUT BIOMED, V43, P1869, DOI 10.1016/j.jpba.2007.01.001; WANWIMOLRUK S, 1983, MOL PHARMACOL, V24, P458; Xiao JB, 2008, J AGR FOOD CHEM, V56, P2350, DOI 10.1021/jf7037295; Xiao JB, 2007, J PHARMACEUT BIOMED, V45, P609, DOI 10.1016/j.jpba.2007.08.032; Xiao JB, 2011, MOL NUTR FOOD RES, V55, P310, DOI 10.1002/mnfr.201000208; Xiao JB, 2010, MOL NUTR FOOD RES, V54, pS253, DOI 10.1002/mnfr.200900454; Yang F, 2011, FOOD FUNCT, V2, P137, DOI 10.1039/c0fo00092b; Zhao JY, 2011, ARCH BIOL SCI, V63, P325, DOI 10.2298/ABS1102325Z	41	37	37	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43321	10.1371/journal.pone.0043321	http://dx.doi.org/10.1371/journal.pone.0043321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916242	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800060
J	Sorice, R; Ruggiero, D; Nutile, T; Aversano, M; Husemoen, L; Linneberg, A; Bourgain, C; Leutenegger, AL; Ciullo, M				Sorice, Rossella; Ruggiero, Daniela; Nutile, Teresa; Aversano, Mario; Husemoen, Lotte; Linneberg, Allan; Bourgain, Catherine; Leutenegger, Anne-Louise; Ciullo, Marina			Genetic and Environmental Factors Influencing the Placental Growth Factor (PGF) Variation in Two Populations	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; LINKAGE ANALYSIS; ANGIOGENESIS; EXPRESSION; RISK; NEOVASCULARIZATION; INHIBITION; CARCINOMA; VEGF; REVASCULARIZATION	Placental Growth Factor (PGF) is a key molecule in angiogenesis. Several studies have revealed an important role of PGF primarily in pathological conditions (e.g.: ischaemia, tumour formation, cardiovascular diseases and inflammatory processes) suggesting its use as a potential therapeutic agent. However, to date, no information is available regarding the genetics of PGF variability. Furthermore, even though the effect of environmental factors (e.g.: cigarette smoking) on angiogenesis has been explored, no data on the influence of these factors on PGF levels have been reported so far. Here we have first investigated PGF variability in two cohorts focusing on non-genetic risk factors: a study sample from two isolated villages in the Cilento region, South Italy (N = 871) and a replication sample from the general Danish population (N = 1,812). A significant difference in PGF mean levels was found between the two cohorts. However, in both samples, we observed a strong correlation of PGF levels with ageing and sex, men displaying PGF levels significantly higher than women. Interestingly, smoking was also found to influence the trait in the two populations, although differently. We have then focused on genetic risk factors. The association between five single nucleotide polymorphisms (SNPs) located in the PGF gene and the plasma levels of the protein was investigated. Two polymorphisms (rs11850328 and rs2268614) were associated with the PGF plasma levels in the Cilento sample and these associations were strongly replicated in the Danish sample. These results, for the first time, support the hypothesis of the presence of genetic and environmental factors influencing PGF plasma variability.	[Sorice, Rossella; Ruggiero, Daniela; Nutile, Teresa; Aversano, Mario; Ciullo, Marina] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy; [Husemoen, Lotte; Linneberg, Allan] Res Ctr Prevent & Hlth, Glostrup, Denmark; [Bourgain, Catherine] Univ Paris Sud, INSERM, U669, Villejuif, France; [Leutenegger, Anne-Louise] INSERM, U946, Paris, France	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Sorice, R (corresponding author), CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy.	ciullo@igb.cnr.it	Leutenegger, Anne-Louise/B-5597-2009; ruggiero, daniela/K-5638-2016; Ciullo, Marina/AAE-3041-2020; Bourgain, Catherine/L-1505-2017	Leutenegger, Anne-Louise/0000-0002-1302-4357; ruggiero, daniela/0000-0003-3898-7827; Ciullo, Marina/0000-0002-9621-9984; Linneberg, Allan/0000-0002-0994-0184; Bourgain, Catherine/0000-0002-6761-0140; NUTILE, TERESA/0000-0001-7062-8352	EU [Vasoplus-037254]; Italian Ministry of Universities [FIRB -RBIN064YAT, RBNE08NKH7]; Assessorato Ricerca Regione Campania; Ente Parco Nazionale del Cilento e Vallo di Diano; Fondazione Banco di Napoli	EU(European Commission); Italian Ministry of Universities(Ministry of Education, Universities and Research (MIUR)); Assessorato Ricerca Regione Campania(Regione Campania); Ente Parco Nazionale del Cilento e Vallo di Diano; Fondazione Banco di Napoli	This work was supported by grants from the EU (Vasoplus-037254), the Italian Ministry of Universities (FIRB -RBIN064YAT, RBNE08NKH7), the Assessorato Ricerca Regione Campania, the Ente Parco Nazionale del Cilento e Vallo di Diano and the Fondazione Banco di Napoli to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini A, 2002, CANCER RES, V62, P2749; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Apple FS, 2005, CLIN CHEM, V51, P810, DOI 10.1373/clinchem.2004.046292; Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cassidy A, 2009, ARTERIOSCL THROM VAS, V29, P134, DOI 10.1161/ATVBAHA.108.171066; Colonna V, 2009, EUR J HUM GENET, V17, P1635, DOI 10.1038/ejhg.2009.97; Conklin BS, 2002, AM J PATHOL, V160, P413, DOI 10.1016/S0002-9440(10)64859-6; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; Debette S, 2011, CIRC RES, V109, P554, DOI 10.1161/CIRCRESAHA.111.243790; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Donnini S, 1999, J PATHOL, V189, P66, DOI 10.1002/(SICI)1096-9896(199909)189:1<66::AID-PATH390>3.0.CO;2-X; Ejaz S, 2005, DRUG CHEM TOXICOL, V28, P447, DOI 10.1080/01480540500262862; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Heeschen C, 2004, JAMA-J AM MED ASSOC, V291, P435, DOI 10.1001/jama.291.4.435; Hildebrandt VA, 2001, ENDOCRINOLOGY, V142, P2050, DOI 10.1210/en.142.5.2050; Ho MC, 2007, CANCER LETT, V250, P237, DOI 10.1016/j.canlet.2006.10.005; ISHIJI T, 1992, EMBO J, V11, P2271, DOI 10.1002/j.1460-2075.1992.tb05286.x; Ivnitski-Steele I, 2005, CARDIOVASC TOXICOL, V5, P215, DOI 10.1385/CT:5:2:215; Jacquemin P, 1997, J BIOL CHEM, V272, P12928, DOI 10.1074/jbc.272.20.12928; Kaneko KJ, 1998, DEV GENET, V22, P43, DOI 10.1002/(SICI)1520-6408(1998)22:1&lt;43::AID-DVG5&gt;3.0.CO;2-7; Karumanchi SA, 2008, CURR HYPERTENS REP, V10, P305, DOI 10.1007/s11906-008-0057-3; Khaliq A, 1998, LAB INVEST, V78, P109; Lenderink T, 2006, J AM COLL CARDIOL, V47, P307, DOI 10.1016/j.jacc.2005.08.063; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Odorisio T, 2006, J DERMATOL SCI, V41, P11, DOI 10.1016/j.jdermsci.2005.08.008; Ogge G, 2010, J MATERN-FETAL NEO M, V23, P820, DOI 10.3109/14767050903366119; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Siervo M, 2010, J INTERN MED, V268, P338, DOI 10.1111/j.1365-2796.2010.02255.x; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Suzumori N, 2003, HUM REPROD, V18, P2595, DOI 10.1093/humrep/deg491; TAKAHASHI A, 1994, CANCER RES, V54, P4233; Traglia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007554; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yoo SA, 2009, ARTHRITIS RHEUM-US, V60, P345, DOI 10.1002/art.24289	44	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42537	10.1371/journal.pone.0042537	http://dx.doi.org/10.1371/journal.pone.0042537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916133	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800020
J	Williams, PT				Williams, Paul T.			Distance Walked and Run as Improved Metrics over Time-Based Energy Estimation in Epidemiological Studies and Prevention; Evidence from Medication Use	PLOS ONE			English	Article							VIGOROUS PHYSICAL-ACTIVITY; SELF-REPORT MEASURES; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; OF-SPORTS-MEDICINE; 7-YEAR FOLLOW-UP; WEIGHT-GAIN; CARDIORESPIRATORY FITNESS; WALKING DISTANCE	Purpose: The guideline physical activity levels are prescribed in terms of time, frequency, and intensity (e.g., 30 minutes brisk walking, five days a week or its energy equivalence) and assume that different activities may be combined to meet targeted goals (exchangeability premise). Habitual runners and walkers may quantify exercise in terms of distance (km/day), and for them, the relationship between activity dose and health benefits may be better assessed in terms of distance rather than time. Analyses were therefore performed to test: 1) whether time-based or distance-based estimates of energy expenditure provide the best metric for relating running and walking to hypertensive, high cholesterol, and diabetes medication use (conditions known to be diminished by exercise), and 2) the exchangeability premise. Methods: Logistic regression analyses of medication use (dependent variable) vs. metabolic equivalent hours per day (METhr/d) of running, walking and other exercise (independent variables) using cross-sectional data from the National Runners' (17,201 male, 16,173 female) and Walkers' Health Studies (3,434 male, 12,384 female). Results: Estimated METhr/d of running and walking activity were 38% and 31% greater, respectively, when calculated from self-reported time than distance in men, and 43% and 37% greater in women, respectively. Percent reductions in the odds for hypertension and high cholesterol medication use per METhr/d run or per METhr/d walked were >= 2-fold greater when estimated from reported distance (km/wk) than from time (hr/wk). The per METhr/d odds reduction was significantly greater for the distance-than the time-based estimate for hypertension (runners: P < 10(-5) for males and P = 0.003 for females; walkers: P = 0.03 for males and P < 10(-4) for females), high cholesterol medication use in runners (P < 10(-4) for males and P = 0.02 for females) and male walkers (P = 0.01 for males and P = 0.08 for females) and for diabetes medication use in male runners (P < 10(-3)). Conclusions: Although causality between greater exercise and lower prevalence of hypertension, high cholesterol and diabetes cannot be inferred from these cross-sectional data, the results do suggest that distance-based estimates of METhr/d run or walked provide superior metrics for epidemiological analyses to their traditional time-based estimates.	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Williams, PT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	ptwilliams@lbl.gov			National Institutes of Health (NIH) [HL094717]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094717] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health (NIH) grant HL094717. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; BARANOWSKI T, 1988, RES Q EXERCISE SPORT, V59, P314, DOI 10.1080/02701367.1988.10609379; Bassett DR, 2000, MED SCI SPORT EXER, V32, P1018; Buchowski MS, 1999, OBES RES, V7, P23, DOI 10.1002/j.1550-8528.1999.tb00387.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colley Rachel C, 2011, Health Rep, V22, P7; Duncan GE, 2001, PREV MED, V33, P18, DOI 10.1006/pmed.2001.0847; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; HEATH GW, 1989, AM J PREV MED, V5, P347, DOI 10.1016/S0749-3797(18)31055-9; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; KLESGES RC, 1990, MED SCI SPORT EXER, V22, P690, DOI 10.1249/00005768-199010000-00022; Knuiman MW, 1998, ANN EPIDEMIOL, V8, P56, DOI 10.1016/S1047-2797(97)00107-5; KOPLAN JP, 1995, MED SCI SPORT EXER, V27, P1180; Kushi LH, 1997, JAMA-J AM MED ASSOC, V277, P1287, DOI 10.1001/jama.277.16.1287; LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179; Leitzmann MF, 1998, ANN INTERN MED, V128, P417, DOI 10.7326/0003-4819-128-6-199803150-00001; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM199909093411101; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; Lubin F, 2003, J NUTR, V133, P1180, DOI 10.1093/jn/133.4.1180; Luke A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-387; Mensink GBM, 1996, EPIDEMIOLOGY, V7, P391, DOI 10.1097/00001648-199607000-00009; O'Donovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; RICHARDSON MT, 1994, J CLIN EPIDEMIOL, V47, P271, DOI 10.1016/0895-4356(94)90008-6; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Sarkin JA, 2000, MED SCI SPORT EXER, V32, P149; STEPHENS T, 1985, PUBLIC HEALTH REP, V100, P147; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; Swain DP, 2006, AM J CARDIOL, V97, P141, DOI 10.1016/j.amjcard.2005.07.130; U.S. Department of Health and Human Services, 2008, ODPHP PUBL; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; US Department of Health and Human Services, 1999, PHYS ACT HLTH REP SU; Wannamethee SG, 1998, LANCET, V351, P1603, DOI 10.1016/S0140-6736(97)12355-8; Washburn RA, 2000, RES Q EXERCISE SPORT, V71, pS104, DOI 10.1080/02701367.2000.11082793; Williams PT, 2008, AM J GASTROENTEROL, V103, P2239, DOI 10.1111/j.1572-0241.2008.01944.x; Williams PT, 2008, MED SCI SPORT EXER, V40, P998, DOI 10.1249/MSS.0b013e31816722a9; Williams PT, 2008, AM J CLIN NUTR, V87, P1480, DOI 10.1093/ajcn/87.5.1480; Williams PT, 2008, MED SCI SPORT EXER, V40, P433, DOI 10.1249/MSS.0b013e31815f38f1; Williams PT, 2008, MED SCI SPORT EXER, V40, P296, DOI 10.1249/mss.0b013e31815b6475; Williams PT, 2007, MED SCI SPORT EXER, V39, P1933, DOI 10.1249/mss.0b013e318145b337; Williams PT, 2007, MED SCI SPORT EXER, V39, P801, DOI 10.1249/mss.0b013e31803349b1; Williams PT, 2010, ATHEROSCLEROSIS, V209, P524, DOI 10.1016/j.atherosclerosis.2009.09.018; Williams PT, 2009, MED SCI SPORT EXER, V41, P1566, DOI 10.1249/MSS.0b013e31819e420f; Williams PT, 2009, MED SCI SPORT EXER, V41, P1042, DOI 10.1249/MSS.0b013e318192d02d; Williams PT, 2009, STROKE, V40, P1921, DOI 10.1161/STROKEAHA.108.535427; Williams PT, 2009, INVEST OPHTH VIS SCI, V50, P101, DOI 10.1167/iovs.08-2165; Williams PT, 2009, INVEST OPHTH VIS SCI, V50, P95, DOI 10.1167/iovs.08-1797; Williams PJ, 2005, NATION, V281, P13; Williams PT, 2005, MED SCI SPORT EXER, V37, P1893, DOI 10.1249/01.mss.0000175860.51204.85; Williams PT, 2005, MED SCI SPORT EXER, V37, P1329, DOI 10.1249/01.mss.0000174894.05236.45; Williams PT, 2004, INT J OBESITY, V28, P120, DOI 10.1038/sj.ijo.0802480; Williams PT, 2012, MED SCI SPO IN PRESS; Williams PT, 2012, PLOS ONE IN PRESS; Winzenberg T, 2009, BRIT J GEN PRACT, V59, P850, DOI 10.3399/bjgp09X472818; World Health Organization, 2006, GLOB STRAT DIET PHYS; Yu S, 2003, HEART, V89, P502, DOI 10.1136/heart.89.5.502	60	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41906	10.1371/journal.pone.0041906	http://dx.doi.org/10.1371/journal.pone.0041906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916114	gold, Green Submitted, Green Published			2022-12-25	WOS:000307733800014
J	Farook, MF; DeCuypere, M; Hyland, K; Takumi, T; LeDoux, MS; Reiter, LT				Farook, M. Febin; DeCuypere, Michael; Hyland, Keith; Takumi, Toru; LeDoux, Mark S.; Reiter, Lawrence T.			Altered Serotonin, Dopamine and Norepinepherine Levels in 15q Duplication and Angelman Syndrome Mouse Models	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; UBIQUITIN LIGASE; AUTISM; TRANSPORTER; GENE; BEHAVIOR; UBE3A; MUTATIONS; MICE; INHIBITORS	Childhood neurodevelopmental disorders like Angelman syndrome and autism may be the result of underlying defects in neuronal plasticity and ongoing problems with synaptic signaling. Some of these defects may be due to abnormal monoamine levels in different regions of the brain. Ube3a, a gene that causes Angelman syndrome (AS) when maternally deleted and is associated with autism when maternally duplicated has recently been shown to regulate monoamine synthesis in the Drosophila brain. Therefore, we examined monoamine levels in striatum, ventral midbrain, frontal cerebral cortex, cerebellar cortex and hippocampus in Ube3a deficient and Ube3a duplication animals. We found that serotonin (5HT), a monoamine affected in autism, was elevated in the striatum and cortex of AS mice. Dopamine levels were almost uniformly elevated compared to control littermates in the striatum, midbrain and frontal cortex regardless of genotype in Ube3a deficient and Ube3a duplication animals. In the duplication 15q autism mouse model, paternal but not maternal duplication animals showed a decrease in 5HT levels when compared to their wild type littermates, in accordance with previously published data. However, maternal duplication animals show no significant changes in 5HT levels throughout the brain. These abnormal monoamine levels could be responsible for many of the behavioral abnormalities observed in both AS and autism, but further investigation is required to determine if any of these changes are purely dependent on Ube3a levels in the brain.	[Farook, M. Febin; LeDoux, Mark S.; Reiter, Lawrence T.] UTHSC, Dept Neurol, Memphis, TN USA; [DeCuypere, Michael] UTHSC, Dept Neurosurg, Memphis, TN USA; [Hyland, Keith] Med Neurogenet LCC, Atlanta, GA USA; [Takumi, Toru] Hiroshima Univ, Sch Med, Hiroshima, Japan; [LeDoux, Mark S.; Reiter, Lawrence T.] UTHSC, Dept Anat & Neurobiol, Memphis, TN USA; [Reiter, Lawrence T.] UTHSC, Dept Pediat, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Hiroshima University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Farook, MF (corresponding author), UTHSC, Dept Neurol, Memphis, TN USA.	lreiter@uthsc.edu	Reiter, Lawrence/H-4161-2019; DeCuypere, Michael/GMX-4926-2022	Reiter, Lawrence/0000-0002-4100-2630; DeCuypere, Michael/0000-0002-4598-8644	NIH NINDS [R01NS059902]; Core Research for Evolutional Science; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059902] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Core Research for Evolutional Science(Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH (http://www.nih.gov/) NINDS R01NS059902 to LTR. TT is supported by grants from Core Research for Evolutional Science and Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allensworth M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-7; Anderson GM, 2002, J AM ACAD CHILD PSY, V41, P1513, DOI 10.1097/00004583-200212000-00025; ANDERSON GM, 1984, PSYCHIAT RES, V11, P133, DOI 10.1016/0165-1781(84)90097-0; Ansorge MS, 2008, J NEUROSCI, V28, P199, DOI 10.1523/JNEUROSCI.3973-07.2008; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Bryant JL, 2010, EUR J NEUROSCI, V32, P41, DOI 10.1111/j.1460-9568.2010.07244.x; Cheron G, 2005, NEUROSCIENCE, V130, P631, DOI 10.1016/j.neuroscience.2004.09.013; Chugani DC, 1999, ANN NEUROL, V45, P287, DOI 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; Cook EH, 1997, AM J HUM GENET, V60, P928; Croonenberghs J, 2000, NEUROPSYCHOPHARMACOL, V22, P275, DOI 10.1016/S0893-133X(99)00131-1; Deneris ES, 2012, NAT NEUROSCI, V15, P519, DOI 10.1038/nn.3039; Depienne C, 2009, BIOL PSYCHIAT, V66, P349, DOI 10.1016/j.biopsych.2009.01.025; Devlin B, 2005, MOL PSYCHIATR, V10, P1110, DOI 10.1038/sj.mp.4001724; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Fang P, 1999, HUM MOL GENET, V8, P129, DOI 10.1093/hmg/8.1.129; Ferdousy F, 2011, NEUROBIOL DIS, V41, P669, DOI 10.1016/j.nbd.2010.12.001; Heck DH, 2008, HUM MOL GENET, V17, P2181, DOI 10.1093/hmg/ddn117; Hedlund PB, 2009, PSYCHOPHARMACOLOGY, V206, P345, DOI 10.1007/s00213-009-1626-0; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Holmes A, 2001, NEUROSCI BIOBEHAV R, V25, P261, DOI 10.1016/S0149-7634(01)00012-4; HOWELLS DW, 1987, CLIN CHIM ACTA, V167, P23, DOI 10.1016/0009-8981(87)90081-7; Hranilovic D, 2009, J NEURAL TRANSM, V116, P493, DOI 10.1007/s00702-009-0192-2; Janusonis S, 2006, J NEUROCHEM, V99, P1019, DOI 10.1111/j.1471-4159.2006.04150.x; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kalueff AV, 2010, NEUROSCI BIOBEHAV R, V34, P373, DOI 10.1016/j.neubiorev.2009.08.003; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kolevzon A, 2006, J CLIN PSYCHIAT, V67, P407, DOI 10.4088/JCP.v67n0311; Lam KSL, 2006, RES DEV DISABIL, V27, P254, DOI 10.1016/j.ridd.2005.03.003; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Makkonen I, 2008, DEV MED CHILD NEUROL, V50, P593, DOI 10.1111/j.1469-8749.2008.03027.x; Marazziti D, 2000, PHARMACOPSYCHIATRY, V33, P165, DOI 10.1055/s-2000-7588; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Mukand J, 1996, ARCH PHYS MED REHAB, V77, P1309, DOI 10.1016/S0003-9993(96)90198-7; Nahas Z, 1998, J NEUROPSYCH CLIN N, V10, P453, DOI 10.1176/jnp.10.4.453; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Ohta T, 1999, AM J HUM GENET, V64, P385, DOI 10.1086/302232; Pelc Karine, 2008, Neuropsychiatr Dis Treat, V4, P577; Ramamoorthy Sivapriya, 2008, Nucl Recept Signal, V6, pe006, DOI 10.1621/nrs.06006; Reiter LA, 2006, BIOORG MED CHEM LETT, V16, P5822, DOI 10.1016/j.bmcl.2006.08.066; Robinson WP, 2000, CLIN GENET, V57, P349, DOI 10.1034/j.1399-0004.2000.570505.x; Scoles HA, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-19; Scoppetta M, 2005, Eur Rev Med Pharmacol Sci, V9, P343; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Stecker MM, 2003, CLIN NEUROL NEUROSUR, V105, P183, DOI 10.1016/S0303-8467(03)00005-2; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; Tamada K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015126; TANI Y, 1994, NEUROSCI LETT, V181, P169, DOI 10.1016/0304-3940(94)90586-X; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Veenstra-VanderWeele J, 2012, P NATL ACAD SCI USA, V109, P5469, DOI 10.1073/pnas.1112345109; Williams C A, 1995, Curr Probl Pediatr, V25, P216, DOI 10.1016/S0045-9380(06)80036-8; Williams CA, 2005, BRAIN DEV-JPN, V27, P88, DOI 10.1016/j.braindev.2003.09.014; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327	55	33	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43030	10.1371/journal.pone.0043030	http://dx.doi.org/10.1371/journal.pone.0043030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916201	Green Submitted, gold, Green Published			2022-12-25	WOS:000307824300025
J	Saluja, R; Delin, I; Nilsson, GP; Adner, M				Saluja, Rohit; Delin, Ingrid; Nilsson, Gunnar P.; Adner, Mikael			Fc epsilon R-1-Mediated Mast Cell Reactivity Is Amplified through Prolonged Toll-Like Receptor-Ligand Treatment	PLOS ONE			English	Article							ASTHMA EXACERBATIONS; INNATE IMMUNITY; TLR2; ACTIVATION; CYTOKINES; STIMULATION; INFECTIONS; RESPONSES; VIRUS	Background: Mast cell-derived mediators mediate several of the pathological features of asthma. Microbial infections induce asthma exacerbations in which the contribution of mast cells remains incomprehensible. Principal Findings: In this study we have investigated the characteristic expression pattern of Toll-like receptors (TLRs) 1-9 and the effect of TLR ligand treatment on IgE-receptor mediated mast cell reactivity. For the studies we employed in vitro differentiated connective tissue like mast cells (CTLMC) and mucosal like mast cells (MLMC) from mice. Both phenotypes were treated for 24 h or 96 h with ligands for TLR1/2, TLR2/6, TLR3 and TLR4, before activation with IgE and antigen. Prolonged exposure (96 h) with TLR-ligands promoted mast cell reactivity following IgE-receptor activation. TLR4 activation with LPS generated the most pronounced effect, with an enhanced degranulation and secretion of leukotrienes, cytokines and chemokines, in both CTLMC and MLMC. The effect of LPS was mediated through a Myd88-dependent pathway and the increased effect involved JNK-dependent pathway. Conclusion: We find that prolonged exposure of mast cells to pathogens/TLR-ligands modulates their effector responses by priming them for increased release of several inflammatory mediators when subsequently activated by IgE-receptors. These data suggest that infections might exaggerate the severity of allergic reactions such as in asthma, by enhancing mediator release from mast cells.	[Saluja, Rohit; Nilsson, Gunnar P.] Karolinska Inst, Dept Med, Clin Immunol & Allergy Unit, Stockholm, Sweden; [Delin, Ingrid; Adner, Mikael] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Nilsson, Gunnar P.; Adner, Mikael] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Saluja, R (corresponding author), Karolinska Inst, Dept Med, Clin Immunol & Allergy Unit, Stockholm, Sweden.	Gunnar.P.Nilsson@ki.se		Delin, Ingrid/0000-0003-3716-4589	Swedish Research Council Medicine; Swedish Heart and Lung Foundation; Centre for Allergy Research at Karolinska Institutet; King Gustaf V's 80-years Foundation; Ollie and Elof Ericsson's foundation; Hans von Kantzow's foundation; Ellen, Walter and Lennart Hesselman's foundation	Swedish Research Council Medicine(Swedish Research Council); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Centre for Allergy Research at Karolinska Institutet(Karolinska Institutet); King Gustaf V's 80-years Foundation; Ollie and Elof Ericsson's foundation; Hans von Kantzow's foundation; Ellen, Walter and Lennart Hesselman's foundation	The study was supported by the Swedish Research Council Medicine, The Swedish Heart and Lung Foundation, the Centre for Allergy Research at Karolinska Institutet, King Gustaf V's 80-years Foundation, Ollie and Elof Ericsson's foundation, Hans von Kantzow's foundation, and Ellen, Walter and Lennart Hesselman's foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bachar O, 2004, EUR J IMMUNOL, V34, P1196, DOI 10.1002/eji.200324569; Balzar S, 2011, AM J RESP CRIT CARE, V183, P299, DOI 10.1164/rccm.201002-0295OC; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; Ekoff M, 2007, J IMMUNOL, V178, P4177, DOI 10.4049/jimmunol.178.7.4177; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Fehrenbach K, 2007, MOL IMMUNOL, V44, P2087, DOI 10.1016/j.molimm.2006.09.011; Kasakura K, 2009, INT ARCH ALLERGY IMM, V150, P359, DOI 10.1159/000226237; Kulka M, 2004, J ALLERGY CLIN IMMUN, V114, P174, DOI 10.1016/j.jaci.2004.03.049; Martin RJ, 2006, CLIN CHEST MED, V27, P87, DOI 10.1016/j.ccm.2005.10.004; Matsushima H, 2004, J IMMUNOL, V173, P531, DOI 10.4049/jimmunol.173.1.531; McAlpine SM, 2011, J INNATE IMMUN, V3, P120, DOI 10.1159/000323350; McCurdy JD, 2003, J IMMUNOL, V170, P1625, DOI 10.4049/jimmunol.170.4.1625; McCurdy JD, 2001, J LEUKOCYTE BIOL, V70, P977; Mrabet-Dahbi S, 2009, EXP DERMATOL, V18, P437, DOI 10.1111/j.1600-0625.2009.00878.x; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; Okayama Y, 2007, CURR OPIN IMMUNOL, V19, P687, DOI 10.1016/j.coi.2007.07.018; Poulakou G, 2011, CLIN MICROBIOL INFEC; Qiao HH, 2006, BLOOD, V107, P610, DOI 10.1182/blood-2005-06-2271; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; Roquet A, 1997, AM J RESP CRIT CARE, V155, P1856, DOI 10.1164/ajrccm.155.6.9196086; Selander C, 2009, J IMMUNOL, V182, P4208, DOI 10.4049/jimmunol.0800885; Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; Supajatura V, 2001, J IMMUNOL, V167, P2250, DOI 10.4049/jimmunol.167.4.2250; Varadaradjalou S, 2003, EUR J IMMUNOL, V33, P899, DOI 10.1002/eji.200323830; Yang C, 2012, EXP PHYSL; Yoshioka M, 2007, J ALLERGY CLIN IMMUN, V120, P452, DOI 10.1016/j.jaci.2007.03.027; Zanini A, 2007, J ALLERGY CLIN IMMUN, V120, P329, DOI 10.1016/j.jaci.2007.04.021	31	50	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43547	10.1371/journal.pone.0043547	http://dx.doi.org/10.1371/journal.pone.0043547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916277	gold, Green Published, Green Submitted			2022-12-25	WOS:000307824300055
J	Zhao, XB; Khajo, A; Jarrett, S; Suarez, J; Levitsky, Y; Burger, RM; Jarzecki, AA; Magliozzo, RS				Zhao, Xiangbo; Khajo, Abdelahad; Jarrett, Sanchez; Suarez, Javier; Levitsky, Yan; Burger, Richard M.; Jarzecki, Andrzej A.; Magliozzo, Richard S.			Specific Function of the Met-Tyr-Trp Adduct Radical and Residues Arg-418 and Asp-137 in the Atypical Catalase Reaction of Catalase-Peroxidase KatG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; MYCOBACTERIUM-TUBERCULOSIS; HYDROGEN-PEROXIDE; BURKHOLDERIA-PSEUDOMALLEI; COMPOUND-II; HORSERADISH-PEROXIDASE; ISONIAZID ACTIVATION; CRYSTAL-STRUCTURE; CROSS-LINK; KINETICS	Catalase activity of the dual-function heme enzyme catalase-peroxidase (KatG) depends on several structural elements, including a unique adduct formed from covalently linked side chains of three conserved amino acids (Met-255, Tyr-229, and Trp-107, Mycobacterium tuberculosis KatG numbering) (MYW). Mutagenesis, electron paramagnetic resonance, and optical stopped-flow experiments, along with calculations using density functional theory (DFT) methods revealed the basis of the requirement for a radical on the MYW-adduct, for oxyferrous heme, and for conserved residues Arg-418 and Asp-137 in the rapid catalase reaction. The participation of an oxyferrous heme intermediate (dioxyheme) throughout the pH range of catalase activity is suggested from our finding that carbon monoxide inhibits the activity at both acidic and alkaline pH. In the presence of H2O2, the MYW-adduct radical is formed normally in KatG[D137S] but this mutant is defective in forming dioxyheme and lacks catalase activity. KatG[R418L] is also catalase deficient but exhibits normal formation of the adduct radical and dioxyheme. Both mutants exhibit a coincidence between MYW-adduct radical persistence and H2O2 consumption as a function of time, and enhanced subunit oligomerization during turnover, suggesting that the two mutations disrupting catalase turnover allow increased migration of the MYW-adduct radical to protein surface residues. DFT calculations showed that an interaction between the side chain of residue Arg-418 and Tyr-229 in the MYW-adduct radical favors reaction of the radical with the adjacent dioxyheme intermediate present throughout turnover in WT KatG. Release of molecular oxygen and regeneration of resting enzyme are thereby catalyzed in the last step of a proposed catalase reaction.	[Zhao, Xiangbo; Khajo, Abdelahad; Jarrett, Sanchez; Suarez, Javier; Levitsky, Yan; Burger, Richard M.; Jarzecki, Andrzej A.; Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Khajo, Abdelahad; Suarez, Javier; Jarzecki, Andrzej A.; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Chem, New York, NY 10016 USA; [Khajo, Abdelahad; Suarez, Javier; Jarzecki, Andrzej A.; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Biochem, New York, NY 10016 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System	Magliozzo, RS (corresponding author), CUNY Brooklyn Coll, Dept Chem, 2900 Bedford Ave, Brooklyn, NY 11210 USA.	rmaglioz@brooklyn.cuny.edu			National Institutes of Health [R01-AI060014, 2R56AI060014-06A1]; NSF [CHE-1058116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060014, R56AI060014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008078] Funding Source: NIH RePORTER; Division Of Chemistry [1058116] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI060014 and 2R56AI060014-06A1 (NIAID) and NSF Grant CHE-1058116 (to R. S. M.).	ADEDIRAN SA, 1989, EUR J BIOCHEM, V186, P571, DOI 10.1111/j.1432-1033.1989.tb15246.x; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Carpena X, 2006, BIOCHEMISTRY-US, V45, P5171, DOI 10.1021/bi060017f; Carpena X, 2003, J MOL BIOL, V327, P475, DOI 10.1016/S0022-2836(03)00122-0; Chouchane S, 2003, J BIOL CHEM, V278, P8154, DOI 10.1074/jbc.M208256200; Chouchane S, 2000, BIOCHEMISTRY-US, V39, P9975, DOI 10.1021/bi0005815; Chouchane S, 2002, J BIOL CHEM, V277, P42633, DOI 10.1074/jbc.M207916200; COTTON ML, 1973, CAN J BIOCHEM CELL B, V51, P627, DOI 10.1139/o73-078; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Ghiladi RA, 2005, BIOCHEMISTRY-US, V44, P15093, DOI 10.1021/bi051463q; Ghiladi RA, 2005, J BIOL CHEM, V280, P22651, DOI 10.1074/jbc.M502486200; Glendening E. D., 2001, NBO 5 0; Hillar A, 2000, BIOCHEMISTRY-US, V39, P5868, DOI 10.1021/bi0000059; Jakopitsch C, 2005, J BIOL CHEM, V280, P9037, DOI 10.1074/jbc.M413317200; Jakopitsch C, 2003, BIOCHEMISTRY-US, V42, P5292, DOI 10.1021/bi026944d; Jakopitsch C, 2004, J BIOL CHEM, V279, P46082, DOI 10.1074/jbc.M408399200; Jakopitsch C, 2003, J BIOL CHEM, V278, P20185, DOI 10.1074/jbc.M211625200; Jakopitsch C, 2007, BIOCHEMISTRY-US, V46, P1183, DOI 10.1021/bi062266+; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Johnsson K, 1997, J BIOL CHEM, V272, P2834, DOI 10.1074/jbc.272.5.2834; KEILIN D, 1951, BIOCHEM J, V49, P88, DOI 10.1042/bj0490088; NAKAJIMA R, 1987, J BIOL CHEM, V262, P2576; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Ranguelova K, 2008, BIOCHEMISTRY-US, V47, P11377, DOI 10.1021/bi800952b; Suarez J, 2009, J BIOL CHEM, V284, P7017, DOI 10.1074/jbc.M808106200; Vlasits J, 2007, FEBS LETT, V581, P320, DOI 10.1016/j.febslet.2006.12.037; WILSON TM, 1995, MOL MICROBIOL, V15, P1009, DOI 10.1111/j.1365-2958.1995.tb02276.x; WITTENBERG JB, 1967, J BIOL CHEM, V242, P626; Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834; Yordanov ND, 2000, SPECTROCHIM ACTA A, V56, P373, DOI 10.1016/S1386-1425(99)00248-6; Yu SW, 2003, J BIOL CHEM, V278, P44121, DOI 10.1074/jbc.M304757200; Zhao XB, 2006, BIOCHEMISTRY-US, V45, P4131, DOI 10.1021/bi051967o; Zhao XB, 2010, J AM CHEM SOC, V132, P8268, DOI 10.1021/ja103311e; Zhao XB, 2009, J BIOL CHEM, V284, P7030, DOI 10.1074/jbc.M808107200	36	20	20	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37057	37065		10.1074/jbc.M112.401208	http://dx.doi.org/10.1074/jbc.M112.401208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22918833	Green Published, hybrid			2022-12-25	WOS:000310588500040
J	Liu, YY; Kogai, T; Schultz, JJ; Mody, K; Brent, GA				Liu, Yan-Yun; Kogai, Takahiko; Schultz, James J.; Mody, Kaizeen; Brent, Gregory A.			Thyroid Hormone Receptor Isoform-specific Modification by Small Ubiquitin-like Modifier (SUMO) Modulates Thyroid Hormone-dependent Gene Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA; SUMOYLATION; BINDING; REPRESSOR; PROTEIN; ALPHA	Thyroid hormone receptor (TR) alpha and beta mediate thyroid hormone action at target tissues. TR isoforms have specific roles in development and in adult tissues. The mechanisms underlying TR isoform-specific action, however, are not well understood. We demonstrate that posttranslational modification of TR by conjugation of smallSUMOtoTR alpha and TR beta plays an important role in triiodothyronine (T3) action and TR isoform specificity. TR alpha was sumoylated at lysines 283 and 389, and TR beta at lysines 50, 146, and 443. Sumoylation of TR beta was ligand-dependent, and sumoylation of TR alpha was ligand-independent. TR alpha-SUMO conjugation utilized the E3 ligase PIASx beta and TR beta-SUMO conjugation utilized predominantly PIAS1. SUMO1 and SUMO3 conjugation to TR was important for T3-dependent gene regulation, as demonstrated in transient transfection assay and studies of endogenous gene regulation. The functional role of SUMO1 and SUMO3 in T3 induction in transient expression assays was closely matched to the pattern of TR and cofactor recruitment to thyroid hormone response elements (TREs) as determined by ChIP assays. SUMO1 was required for the T3-induced recruitment of the co-activator CREB-binding protein (CBP) and release of nuclear receptor co-repressor (NCoR) on a TRE but had no significant effect on TR DNA binding. SUMO1 was required for T3-mediated recruitment of NCoR and release of CBP from the TSH beta-negative TRE. SUMO3 was required for T3-stimulated TR binding to the TSH beta-negative TRE and recruitment of NCoR. These findings demonstrate that conjugation of SUMO to TR has a TR-isoform preference and is important for T3-dependent gene induction and repression.	[Liu, Yan-Yun] Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Dept Med, Los Angeles, CA 90073 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Dept Physiol, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90073 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Liu, YY (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Dept Med, Bldg 114,Rm 229,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	yyl@ucla.edu; gbrent@ucla.edu		Liu, Yan-Yun/0000-0003-1946-2275	Veterans Affairs Merit Review Funds	Veterans Affairs Merit Review Funds(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Merit Review Funds.	Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; BRENT GA, 1989, J BIOL CHEM, V264, P178; CARR FE, 1987, J BIOL CHEM, V262, P981; CARR FE, 1994, J BIOL CHEM, V269, P4175; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; DARLING DS, 1989, MOL ENDOCRINOL, V3, P1359, DOI 10.1210/mend-3-9-1359; de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25, DOI 10.1530/eje.0.151u025; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gauthier K, 1999, EMBO J, V18, P623, DOI 10.1093/emboj/18.3.623; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gullberg H, 2002, MOL ENDOCRINOL, V16, P1767, DOI 10.1210/me.2002-0009; Hamard PJ, 2007, NUCLEIC ACIDS RES, V35, P1134, DOI 10.1093/nar/gkl1168; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Lazar MA, 2003, J CLIN INVEST, V112, P497, DOI 10.1172/JCI200319479; Liu G, 2006, BIOCHEM BIOPH RES CO, V349, P360, DOI 10.1016/j.bbrc.2006.08.049; Liu YY, 2011, ENDOCRINOLOGY, V152, P1143, DOI 10.1210/en.2010-0580; Liu YY, 2010, TRENDS ENDOCRIN MET, V21, P166, DOI 10.1016/j.tem.2009.11.004; Liu YY, 2003, J BIOL CHEM, V278, P38913, DOI 10.1074/jbc.M306120200; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; PETTY KJ, 1990, J BIOL CHEM, V265, P7395; Ribeiro MO, 2001, J CLIN INVEST, V108, P97, DOI 10.1172/JCI12584; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Rusch A, 2001, J NEUROSCI, V21, P9792, DOI 10.1523/JNEUROSCI.21-24-09792.2001; Rytinki MM, 2008, J BIOL CHEM, V283, P11586, DOI 10.1074/jbc.M709359200; Sjogren M, 2007, EMBO J, V26, P4535, DOI 10.1038/sj.emboj.7601882; Tian S, 2002, BIOCHEM J, V367, P907, DOI 10.1042/BJ20021085; Tiefenbach J, 2006, MOL BIOL CELL, V17, P1643, DOI 10.1091/mbc.E05-07-0610; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	35	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36499	36508		10.1074/jbc.M112.344317	http://dx.doi.org/10.1074/jbc.M112.344317			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22930759	hybrid, Green Published			2022-12-25	WOS:000310364000069
J	Eidemuller, M; Jacob, P; Lane, RSD; Frost, SE; Zablotska, LB				Eidemueller, Markus; Jacob, Peter; Lane, Rachel S. D.; Frost, Stanley E.; Zablotska, Lydia B.			Lung Cancer Mortality (1950-1999) among Eldorado Uranium Workers: A Comparison of Models of Carcinogenesis and Empirical Excess Risk Models	PLOS ONE			English	Article							RADON DAUGHTER EXPOSURE; ATOMIC-BOMB SURVIVORS; INTERCELLULAR INDUCTION; ALPHA-PARTICLES; 2-STAGE MODEL; SOLID CANCER; MINERS; RADIATION; SMOKING; COHORT	Lung cancer mortality after exposure to radon decay products (RDP) among 16,236 male Eldorado uranium workers was analyzed. Male workers from the Beaverlodge and Port Radium uranium mines and the Port Hope radium and uranium refinery and processing facility who were first employed between 1932 and 1980 were followed up from 1950 to 1999. A total of 618 lung cancer deaths were observed. The analysis compared the results of the biologically-based two-stage clonal expansion (TSCE) model to the empirical excess risk model. The spontaneous clonal expansion rate of pre-malignant cells was reduced at older ages under the assumptions of the TSCE model. Exposure to RDP was associated with increase in the clonal expansion rate during exposure but not afterwards. The increase was stronger for lower exposure rates. A radiation-induced bystander effect could be a possible explanation for such an exposure response. Results on excess risks were compared to a linear dose-response parametric excess risk model with attained age, time since exposure and dose rate as effect modifiers. In all models the excess relative risk decreased with increasing attained age, increasing time since exposure and increasing exposure rate. Large model uncertainties were found in particular for small exposure rates.	[Eidemueller, Markus; Jacob, Peter] Helmholtz Zentrum Munchen, Inst Radiat Protect, Neuherberg, Germany; [Lane, Rachel S. D.] Canadian Nucl Safety Commiss, Radiat & Hlth Sci Div, Directorate Environm & Radiat Protect & Assessmen, Ottawa, ON, Canada; [Frost, Stanley E.] Frost&Frost Consultants, Saskatoon, SK, Canada; [Zablotska, Lydia B.] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of California System; University of California San Francisco	Eidemuller, M (corresponding author), Helmholtz Zentrum Munchen, Inst Radiat Protect, Neuherberg, Germany.	markus.eidemueller@helmholtz-muenchen.de			Canadian Nuclear Safety Commission (CNSC); Government of Saskatchewan; Cameco Corporation; AREVA Resources Canada Inc.; CNSC Research and Support Program; European Network of Excellence DoReMi (Low Dose Research towards Multidisciplinary Integration) [249689]; Cameco Corporation Canada Inc.; NATIONAL CANCER INSTITUTE [K07CA132918] Funding Source: NIH RePORTER	Canadian Nuclear Safety Commission (CNSC); Government of Saskatchewan; Cameco Corporation; AREVA Resources Canada Inc.; CNSC Research and Support Program; European Network of Excellence DoReMi (Low Dose Research towards Multidisciplinary Integration); Cameco Corporation Canada Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Updated Eldorado Study was supported (co-funded) by the Canadian Nuclear Safety Commission (CNSC), the Government of Saskatchewan, Cameco Corporation and AREVA Resources Canada Inc. All data checking, analysis, interpretation and report writing were done independently of the mining companies, which had no part in any aspect of the work of the scientific team of the present study. The CNSC acted as project co-ordinator so all the work was coordinated through the CNSC. The current project (TSCE model) received additional funding from the CNSC Research and Support Program. The current project received funding from the European Network of Excellence DoReMi (Low Dose Research towards Multidisciplinary Integration) under grant agreement no. 249689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was received from the mining companies Cameco Corporation and AREVA Resources Canada Inc. SF is an independent consultant and is associated with Frost&Frost Consultants, Saskatoon. He is a retired Eldorado employee. All funds from the mining companies were given to the CNSC's Research Support Program (RSP). All research activities required the approval of an internal RSP committee. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors..	Al-Zoughool M, 2009, INT J RADIAT BIOL, V85, P57, DOI 10.1080/09553000802635054; Amabile JC, 2009, HEALTH PHYS, V97, P613, DOI 10.1097/01.HP.0000363842.62922.58; Bauer G, 2007, INT J RADIAT BIOL, V83, P873, DOI 10.1080/09553000701727523; BEIR VI, 1999, HLTH EFF EXP RAD; Brenner DJ, 2002, INT J RADIAT BIOL, V78, P593, DOI 10.1080/09553000210121740; Brenner DJ, 2001, RADIAT RES, V155, P402, DOI 10.1667/0033-7587(2001)155[0402:TBEIRO]2.0.CO;2; Canadian Cancer Society's Steering Committee on Cancer Statistics, 2011, CAN CANC STAT; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; DARBY SC, 1995, JNCI-J NATL CANCER I, V87, P378, DOI 10.1093/jnci/87.5.378; Doll R, 2004, BMJ-BRIT MED J, V328, P1529, DOI 10.1136/bmj.328.7455.1529; Eidemuller M, 2010, RADIAT ENVIRON BIOPH, V49, P477, DOI 10.1007/s00411-010-0289-x; Eidemuller M, 2009, MUTAT RES-FUND MOL M, V669, P48, DOI 10.1016/j.mrfmmm.2009.04.009; Harley NH, 1996, ENVIRON INT, V22, pS977; Heidenreich WF, 1997, RISK ANAL, V17, P391, DOI 10.1111/j.1539-6924.1997.tb00878.x; HOWE GR, 1988, AM J EPIDEMIOL, V128, P1364, DOI 10.1093/oxfordjournals.aje.a115089; Howe GR, 1996, RADIAT RES, V146, P37, DOI 10.2307/3579393; HOWE GR, 1986, J NATL CANCER I, V77, P357; HOWE GR, 1987, J NATL CANCER I, V79, P1255; IARC, 1986, MON EV CARC RISKS HU; IARC, 1980, MON EV CARC RISKS CH; IARC, 2002, MON EV CARC RISKS HU; Jacob P, 2007, RADIAT ENVIRON BIOPH, V46, P383, DOI 10.1007/s00411-007-0117-0; Jacob P, 2010, MUTAT RES-FUND MOL M, V687, P34, DOI 10.1016/j.mrfmmm.2010.01.005; Kai M, 1997, RADIAT RES, V148, P348, DOI 10.2307/3579520; Krewski D, 2005, EPIDEMIOLOGY, V16, P137, DOI 10.1097/01.ede.0000152522.80261.e3; LABBE KA, 1991, HEALTH PHYS, V60, P489, DOI 10.1097/00004032-199104000-00002; Lane RSD, 2010, RADIAT RES, V174, P773, DOI 10.1667/RR2237.1; Leuraud K, 2011, RADIAT RES, V176, P375, DOI 10.1667/RR2377.1; Little MP, 2007, CARCINOGENESIS, V28, P479, DOI 10.1093/carcin/bgl173; Luebeck EG, 1999, RADIAT RES, V152, P339, DOI 10.2307/3580219; MOOLGAVKAR SH, 1981, J NATL CANCER I, V66, P1037, DOI 10.1093/jnci/66.6.1037; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; Nagasawa H, 1999, RADIAT RES, V152, P552, DOI 10.2307/3580153; Portess DI, 2007, CANCER RES, V67, P1246, DOI 10.1158/0008-5472.CAN-06-2985; Portier C, 1997, Stat Methods Med Res, V6, P305; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Schnelzer M, 2010, HEALTH PHYS, V98, P20, DOI 10.1097/HP.0b013e3181b8ce81; Schubauer-Berigan MK, 2009, AM J EPIDEMIOL, V169, P718, DOI 10.1093/aje/kwn406; Shao CL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-184; Taeger D, 2009, INT ARCH OCC ENV HEA, V82, P867, DOI 10.1007/s00420-008-0386-1; Tomasek L, 2008, RADIAT PROT DOSIM, V130, P98, DOI 10.1093/rpd/ncn117; Tomasek L, 2011, RADIAT PROT DOSIM, V145, P238, DOI 10.1093/rpd/ncr048; Tomasek L, 2008, RADIAT RES, V169, P125, DOI 10.1667/RR0848.1; Trosko JE, 2005, RADIAT ENVIRON BIOPH, V44, P3, DOI 10.1007/s00411-005-0269-8; van Dillen T, 2011, RADIAT RES, V175, P119, DOI 10.1667/RR2102.1; Villeneuve PJ, 2007, HEALTH PHYS, V92, P157, DOI 10.1097/01.HP.0000239127.43136.89; Walsh L, 2010, HEALTH PHYS, V99, P292, DOI 10.1097/HP.0b013e3181cd669d; Walsh L, 2010, RADIAT RES, V173, P79, DOI 10.1667/RR1803.1; Wu LJ, 1999, P NATL ACAD SCI USA, V96, P4959, DOI 10.1073/pnas.96.9.4959; Zhou HN, 2001, P NATL ACAD SCI USA, V98, P14410, DOI 10.1073/pnas.251524798	50	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e41431	10.1371/journal.pone.0041431	http://dx.doi.org/10.1371/journal.pone.0041431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936975	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500006
J	Choi, YJ; Park, YJ; Park, JY; Jeong, HO; Kim, DH; Ha, YM; Kim, JM; Song, YM; Heo, HS; Yu, BP; Chun, P; Moon, HR; Chung, HY				Choi, Yeon Ja; Park, Yun Jung; Park, Ji Young; Jeong, Hyoung Oh; Kim, Dae Hyun; Ha, Young Mi; Kim, Ji Min; Song, Yu Min; Heo, Hyoung-Sam; Yu, Byung Pal; Chun, Pusoon; Moon, Hyung Ryong; Chung, Hae Young			Inhibitory Effect of mTOR Activator MHY1485 on Autophagy: Suppression of Lysosomal Fusion	PLOS ONE			English	Article							CELL-DEATH; PROTEIN-DEGRADATION; SIGNALING PATHWAYS; ARPE-19 CELLS; GLIOMA-CELLS; CHLOROQUINE; MACROAUTOPHAGY; ACCUMULATION; INDUCTION; TRIAZINES	Autophagy is a major degradative process responsible for the disposal of cytoplasmic proteins and dysfunctional organelles via the lysosomal pathway. During the autophagic process, cells form double-membraned vesicles called autophagosomes that sequester disposable materials in the cytoplasm and finally fuse with lysosomes. In the present study, we investigated the inhibition of autophagy by a synthesized compound, MHY1485, in a culture system by using Ac2F rat hepatocytes. Autophagic flux was measured to evaluate the autophagic activity. Autophagosomes were visualized in Ac2F cells transfected with AdGFP-LC3 by live-cell confocal microscopy. In addition, activity of mTOR, a major regulatory protein of autophagy, was assessed by western blot and docking simulation using AutoDock 4.2. In the result, treatment with MHY1485 suppressed the basal autophagic flux, and this inhibitory effect was clearly confirmed in cells under starvation, a strong physiological inducer of autophagy. The levels of p62 and beclin-1 did not show significant change after treatment with MHY1485. Decreased co-localization of autophagosomes and lysosomes in confocal microscopic images revealed the inhibitory effect of MHY1485 on lysosomal fusion during starvation-induced autophagy. These effects of MHY1485 led to the accumulation of LC3II and enlargement of the autophagosomes in a dose-and time-dependent manner. Furthermore, MHY1485 induced mTOR activation and correspondingly showed a higher docking score than PP242, a well-known ATP-competitive mTOR inhibitor, in docking simulation. In conclusion, MHY1485 has an inhibitory effect on the autophagic process by inhibition of fusion between autophagosomes and lysosomes leading to the accumulation of LC3II protein and enlarged autophagosomes. MHY1485 also induces mTOR activity, providing a possibility for another regulatory mechanism of autophagy by the MHY compound. The significance of this study is the finding of a novel inhibitor of autophagy with an mTOR activating effect.	[Choi, Yeon Ja; Jeong, Hyoung Oh; Kim, Dae Hyun; Ha, Young Mi; Kim, Ji Min; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan, South Korea; [Park, Yun Jung; Park, Ji Young; Song, Yu Min; Moon, Hyung Ryong] Pusan Natl Univ, Coll Pharm, Med Chem Lab, Pusan, South Korea; [Heo, Hyoung-Sam] KRIBB, Plant Syst Engn Ctr, Taejon, South Korea; [Yu, Byung Pal] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Chun, Pusoon] Inje Univ, Coll Pharm, Gimhae, Gyeongnam, South Korea	Pusan National University; Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Texas System; University of Texas Health San Antonio; Inje University	Choi, YJ (corresponding author), Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan, South Korea.	mhr108@pusan.ac.kr; hyjung@pusan.ac.kr			National Research Foundation of Korea (NRF); Korean government (MEST) [2009-0083538]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2009-0083538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, BIOORG MED CHEM LETT, V15, P531, DOI 10.1016/j.bmcl.2004.11.052; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Chen PM, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-10; Cho YS, 2010, ARCH PHARM RES, V33, P1881, DOI 10.1007/s12272-010-1201-6; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hiruma H, 2011, FOLIA HISTOCHEM CYTO, V49, P272, DOI 10.5603/FHC.2011.0038; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Katayama M, 2007, CELL DEATH DIFFER, V14, P548, DOI 10.1038/sj.cdd.4402030; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Kolmakov KA, 2008, J HETEROCYCLIC CHEM, V45, P1215, DOI 10.1002/jhet.5570450446; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Noda T, 2009, CELL DEATH DIFFER, V16, P984, DOI 10.1038/cdd.2009.54; Oh M, 2008, BIOCHEM BIOPH RES CO, V369, P1179, DOI 10.1016/j.bbrc.2008.03.019; Pous C, 2011, NAT CELL BIOL, V13, P342, DOI 10.1038/ncb0411-342; Ramser B, 2009, J INVEST DERMATOL, V129, P2419, DOI 10.1038/jid.2009.80; Richard DJ, 2010, BIOORG MED CHEM LETT, V20, P2654, DOI 10.1016/j.bmcl.2010.02.029; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Salminen A, 2009, TRENDS MOL MED, V15, P217, DOI 10.1016/j.molmed.2009.03.004; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Sturgill TW, 2009, ACS CHEM BIOL, V4, P999, DOI 10.1021/cb900193e; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tanida I, 2010, METHODS MOL BIOL, V648, P193, DOI 10.1007/978-1-60761-756-3_13; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Wang JH, 2011, GASTROENTEROLOGY, V141, P2188, DOI 10.1053/j.gastro.2011.08.005; Wang XM, 2011, J MOL CELL BIOL, V3, P206, DOI 10.1093/jmcb/mjq038; Wang Yao, 2011, Chin J Cancer, V30, P690, DOI 10.5732/cjc.011.10056; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yuk JM, 2012, EXP MOL MED, V44, P99, DOI 10.3858/emm.2012.44.2.032; Zask A, 2010, BIOORG MED CHEM LETT, V20, P2644, DOI 10.1016/j.bmcl.2010.02.045; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	155	159	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43418	10.1371/journal.pone.0043418	http://dx.doi.org/10.1371/journal.pone.0043418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927967	gold, Green Published, Green Submitted			2022-12-25	WOS:000308286300051
J	Fieseler, L; Schmitter, S; Teiserskas, J; Loessner, MJ				Fieseler, Lars; Schmitter, Sibylle; Teiserskas, Justinas; Loessner, Martin J.			Rhamnose-Inducible Gene Expression in Listeria monocytogenes	PLOS ONE			English	Article							ESCHERICHIA-COLI; AUTO-REGULATION; MECHANISM; INFECTION; DELIVERY; VECTOR; CELLS; COMPLEMENTATION; DIFFERENTIATION; CONSTRUCTION	Acid production from rhamnose is a characteristic phenotype of Listeria monocytogenes. We report the identification of the rhamnose transport and utilization operon located at lmo2846 to lmo2851, including the rhamnose-dependent promoter P-rha. Expression of reporter genes under control of P-rha on a single copy integration vector demonstrated its suitability for inducible gene expression in L. monocytogenes. Transcription initiation from P-rha is dose dependent, and a concentration as low as 100 mu M rhamnose was found sufficient for induction. Moreover, P-rha is subject to glucose catabolite repression, which provides additional options for strict control of expression. Infection of human THP1 macrophages revealed that P-rha is repressed in intracellular L. monocytogenes, which is explained by the absence of rhamnose in the cytosol and possible interference by catabolite repression. The P-rha promoter provides a novel and useful tool for triggering gene expression in extracellular L. monocytogenes, whereas intracellular conditions prevent transcription from this promoter.	[Fieseler, Lars; Schmitter, Sibylle; Teiserskas, Justinas; Loessner, Martin J.] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Fieseler, L (corresponding author), Zurich Univ Appl Sci, Inst Food & Beverage Innovat, Wadenswil, Switzerland.	martin.loessner@ethz.ch	Teišerskas, Justinas/AAE-2795-2020; Loessner, Martin J/B-4316-2012	Loessner, Martin J/0000-0002-8162-2631; Teiserskas, Justinas/0000-0002-8314-8865	Feodor-Lynen Research Fellowship of the Alexander von Humboldt Foundation, Bonn, Germany; ETH Zurich	Feodor-Lynen Research Fellowship of the Alexander von Humboldt Foundation, Bonn, Germany; ETH Zurich(ETH Zurich)	LF was financially supported by a Feodor-Lynen Research Fellowship of the Alexander von Humboldt Foundation, Bonn, Germany, and JT was enrolled in the Biology Undergraduate Summer School (BUSS) at ETH Zurich and University of Zurich. This study was funded by resources from ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Allerberger F, 2003, FEMS IMMUNOL MED MIC, V35, P183, DOI 10.1016/S0928-8244(02)00447-9; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bhavsar AP, 2001, APPL ENVIRON MICROB, V67, P403, DOI 10.1128/AEM.67.1.403-410.2001; Bockmann R, 1996, MOL MICROBIOL, V22, P643, DOI 10.1046/j.1365-2958.1996.d01-1722.x; Brewster DR, 1997, ARCH DIS CHILD, V76, P236, DOI 10.1136/adc.76.3.236; Brockstedt DG, 2004, P NATL ACAD SCI USA, V101, P13832, DOI 10.1073/pnas.0406035101; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Dancz CE, 2002, J BACTERIOL, V184, P5935, DOI 10.1128/JB.184.21.5935-5945.2002; Dietrich G, 1998, NAT BIOTECHNOL, V16, P181, DOI 10.1038/nbt0298-181; EGAN SM, 1993, J MOL BIOL, V234, P87, DOI 10.1006/jmbi.1993.1565; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Glaser P, 2001, SCIENCE, V294, P849; Gopal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010349; Graves LM, 2009, INT J SYST EVOL MICR; Grundling A, 2004, P NATL ACAD SCI USA, V101, P12318, DOI 10.1073/pnas.0404924101; Hagens S, 2007, APPL MICROBIOL BIOT, V76, P513, DOI 10.1007/s00253-007-1031-8; Korndorfer IP, 2000, J MOL BIOL, V300, P917, DOI 10.1006/jmbi.2000.3896; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; LEE NL, 1981, P NATL ACAD SCI-BIOL, V78, P752, DOI 10.1073/pnas.78.2.752; MIYADA CG, 1984, P NATL ACAD SCI-BIOL, V81, P4120, DOI 10.1073/pnas.81.13.4120; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Monk IR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-96; MORALEJO P, 1993, J BACTERIOL, V175, P5585, DOI 10.1128/JB.175.17.5585-5594.1993; MUIRY JAR, 1993, BIOCHEM J, V290, P833, DOI 10.1042/bj2900833; PARK SF, 1990, GENE, V94, P129, DOI 10.1016/0378-1119(90)90479-B; Pilgrim S, 2003, GENE THER, V10, P2036, DOI 10.1038/sj.gt.3302105; Prabhu P, 2010, APPL MICROBIOL BIOTE; Shahabi V, 2011, CANCER GENE THER, V18, P53, DOI 10.1038/cgt.2010.48; Soussi N, 2000, INFECT IMMUN, V68, P1498, DOI 10.1128/IAI.68.3.1498-1506.2000; Wallecha A, 2009, CLIN VACCINE IMMUNOL, V16, P96, DOI 10.1128/CVI.00274-08; Wegerer A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-2; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; Xue JF, 2008, APPL ENVIRON MICROB, V74, P7073, DOI 10.1128/AEM.01074-08; Yoshida H, 2010, FEBS J, V277, P1045, DOI 10.1111/j.1742-4658.2009.07548.x; Yoshimura K, 2006, CANCER RES, V66, P1096, DOI 10.1158/0008-5472.CAN-05-2307	37	9	9	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43444	10.1371/journal.pone.0043444	http://dx.doi.org/10.1371/journal.pone.0043444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927968	Green Submitted, Green Published, gold			2022-12-25	WOS:000308286300052
J	Hervera, A; Leanez, S; Negrete, R; Motterlini, R; Pol, O				Hervera, Arnau; Leanez, Sergi; Negrete, Roger; Motterlini, Roberto; Pol, Olga			Carbon Monoxide Reduces Neuropathic Pain and Spinal Microglial Activation by Inhibiting Nitric Oxide Synthesis in Mice	PLOS ONE			English	Article							HEME OXYGENASE-1; TACTILE ALLODYNIA; FORMALIN TEST; UP-REGULATION; NERVE INJURY; RAT; MODEL; MOLECULE; HYPERALGESIA; DEGRADATION	Background: Carbon monoxide (CO) synthesized by heme oxygenase 1 (HO-1) exerts antinociceptive effects during inflammation but its role during neuropathic pain remains unknown. Our objective is to investigate the exact contribution of CO derived from HO-1 in the modulation of neuropathic pain and the mechanisms implicated. Methodology/Principal Findings: We evaluated the antiallodynic and antihyperalgesic effects of CO following sciatic nerve injury in wild type (WT) or inducible nitric oxide synthase knockout (NOS2-KO) mice using two carbon monoxide-releasing molecules (CORM-2 and CORM-3) and an HO-1 inducer (cobalt protoporphyrin IX, CoPP) daily administered from days 10 to 20 after injury. The effects of CORM-2 and CoPP on the expression of HO-1, heme oxygenase 2 (HO-2), neuronal nitric oxide synthase (NOS1) and NOS2 as well as a microglial marker (CD11b/c) were also assessed at day 20 after surgery in WT and NOS2-KO mice. In WT mice, the main neuropathic pain symptoms induced by nerve injury were significantly reduced in a time-dependent manner by treatment with CO-RMs or CoPP. Both CORM-2 and CoPP treatments increased HO-1 expression in WT mice, but only CoPP stimulated HO-1 in NOS2-KO animals. The increased expression of HO-2 induced by nerve injury in WT, but not in NOS2-KO mice, remains unaltered by CORM-2 or CoPP treatments. In contrast, the overexpression of CD11b/c, NOS1 and NOS2 induced by nerve injury in WT, but not in NOS2-KO mice, were significantly decreased by both CORM-2 and CoPP treatments. These data indicate that CO alleviates neuropathic pain through the reduction of spinal microglial activation and NOS1/NOS2 over-expression. Conclusions/Significance: This study reports that an interaction between the CO and nitric oxide (NO) systems is taking place following sciatic nerve injury and reveals that increasing the exogenous (CO-RMs) or endogenous (CoPP) production of CO may represent a novel strategy for the treatment of neuropathic pain.	[Hervera, Arnau; Leanez, Sergi; Negrete, Roger; Pol, Olga] Univ Autonoma Barcelona, Grp Neurofarmacol Mol, Inst Invest Biomed St Pau, E-08193 Barcelona, Spain; [Hervera, Arnau; Leanez, Sergi; Negrete, Roger; Pol, Olga] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Motterlini, Roberto] Univ Paris Est, INSERM, U955, Equipe 3,Fac Med, Creteil, France	Autonomous University of Barcelona; Autonomous University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Hervera, A (corresponding author), Univ Autonoma Barcelona, Grp Neurofarmacol Mol, Inst Invest Biomed St Pau, E-08193 Barcelona, Spain.	opol@santpau.es	Motterlini, Roberto/Q-1890-2019; Motterlini, Roberto/G-2489-2013; abad, Arnau Hervera/V-5435-2017; Pol, Olga/O-2146-2019	Motterlini, Roberto/0000-0003-2684-2612; Motterlini, Roberto/0000-0003-2684-2612; abad, Arnau Hervera/0000-0001-8362-369X; Pol, Olga/0000-0002-4621-8457	Fundacio La Marato de TV3 Barcelona [070810]; Fondo de Investigacion Sanitaria, Madrid, Spain [PS0900968]	Fundacio La Marato de TV3 Barcelona; Fondo de Investigacion Sanitaria, Madrid, Spain(Instituto de Salud Carlos III)	This work was supported by the Fundacio La Marato de TV3 Barcelona [Grant: 070810] and Fondo de Investigacion Sanitaria, Madrid [Grant: PS0900968], Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz MJ, 2000, BRIT J PHARMACOL, V130, P57, DOI 10.1038/sj.bjp.0703281; Bani-Hani Mohamed G, 2006, Pharmacol Rep, V58 Suppl, P132; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; De Alba J, 2006, PAIN, V120, P170, DOI 10.1016/j.pain.2005.10.028; Devesa I, 2005, ARTHRITIS RHEUM-US, V52, P3230, DOI 10.1002/art.21356; Fan WG, 2011, J NEUROSCI RES, V89, P802, DOI 10.1002/jnr.22613; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; Gordh T, 2000, AMINO ACIDS, V19, P373, DOI 10.1007/s007260070068; Guillen MI, 2008, RHEUMATOLOGY, V47, P1323, DOI 10.1093/rheumatology/ken264; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014321; Hervera A, 2010, J PHARMACOL EXP THER, V334, P887, DOI 10.1124/jpet.110.167585; KIM YM, 1995, J BIOL CHEM, V270, P5710, DOI 10.1074/jbc.270.11.5710; Kuboyama K, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-50; LaBuda CJ, 2006, EUR J PAIN, V10, P505, DOI 10.1016/j.ejpain.2005.07.004; Lee SK, 2007, CANCER LETT, V249, P283, DOI 10.1016/j.canlet.2006.09.012; Levy D, 1998, EUR J NEUROSCI, V10, P1846, DOI 10.1046/j.1460-9568.1998.00186.x; Li XQ, 2003, J PAIN, V4, P101, DOI 10.1054/jpai.2003.18; Li XQ, 2000, ANESTH ANALG, V90, P677, DOI 10.1097/00000539-200003000-00031; Maicas N, 2010, EUR J PHARMACOL, V634, P184, DOI 10.1016/j.ejphar.2010.02.028; Megias J, 2009, BIOCHEM PHARMACOL, V77, P1806, DOI 10.1016/j.bcp.2009.03.009; MELLER ST, 1992, NEUROSCIENCE, V50, P7, DOI 10.1016/0306-4522(92)90377-E; Mika J, 2009, EUR J PHARMACOL, V623, P65, DOI 10.1016/j.ejphar.2009.09.030; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Naik AK, 2006, EUR J PHARMACOL, V530, P59, DOI 10.1016/j.ejphar.2005.11.029; Nascimento CGO, 2007, EUR J PHARMACOL, V556, P55, DOI 10.1016/j.ejphar.2006.10.009; Rosa AO, 2008, PAIN, V137, P332, DOI 10.1016/j.pain.2007.09.015; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Schmidtko A, 2008, J NEUROSCI, V28, P8568, DOI 10.1523/JNEUROSCI.2128-08.2008; Steiner AA, 2001, BRIT J PHARMACOL, V132, P1673, DOI 10.1038/sj.bjp.0704014; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Wilkinson WJ, 2011, PURINERG SIGNAL, V7, P57, DOI 10.1007/s11302-010-9213-8	37	61	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43693	10.1371/journal.pone.0043693	http://dx.doi.org/10.1371/journal.pone.0043693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928017	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300082
J	Kaiyala, KJ; Morton, GJ; Thaler, JP; Meek, TH; Tylee, T; Ogimoto, K; Wisse, BE				Kaiyala, Karl J.; Morton, Gregory J.; Thaler, Joshua P.; Meek, Thomas H.; Tylee, Tracy; Ogimoto, Kayoko; Wisse, Brent E.			Acutely Decreased Thermoregulatory Energy Expenditure or Decreased Activity Energy Expenditure Both Acutely Reduce Food Intake in Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; DIET-INDUCED THERMOGENESIS; LOCOMOTOR-ACTIVITY; RUNNING WHEEL; TEMPERATURE; HOMEOSTASIS; OBESITY; LEPTIN; MOUSE; COLD	Despite the suggestion that reduced energy expenditure may be a key contributor to the obesity pandemic, few studies have tested whether acutely reduced energy expenditure is associated with a compensatory reduction in food intake. The homeostatic mechanisms that control food intake and energy expenditure remain controversial and are thought to act over days to weeks. We evaluated food intake in mice using two models of acutely decreased energy expenditure: 1) increasing ambient temperature to thermoneutrality in mice acclimated to standard laboratory temperature or 2) exercise cessation in mice accustomed to wheel running. Increasing ambient temperature (from 21 degrees C to 28 degrees C) rapidly decreased energy expenditure, demonstrating that thermoregulatory energy expenditure contributes to both light cycle (40 +/- 1%) and dark cycle energy expenditure (15 +/- 3%) at normal ambient temperature (21 degrees C). Reducing thermoregulatory energy expenditure acutely decreased food intake primarily during the light cycle (65 +/- 7%), thus conflicting with the delayed compensation model, but did not alter spontaneous activity. Acute exercise cessation decreased energy expenditure only during the dark cycle (14 +/- 2% at 21 degrees C; 21 +/- 4% at 28 degrees C), while food intake was reduced during the dark cycle (0.9 +/- 0.1 g) in mice housed at 28 degrees C, but during the light cycle (0.3 +/- 0.1 g) in mice housed at 21 degrees C. Cumulatively, there was a strong correlation between the change in daily energy expenditure and the change in daily food intake (R-2 = 0.51, p<0.01). We conclude that acutely decreased energy expenditure decreases food intake suggesting that energy intake is regulated by metabolic signals that respond rapidly and accurately to reduced energy expenditure.	[Kaiyala, Karl J.] Univ Washington, Dept Dent, Seattle, WA 98195 USA; [Morton, Gregory J.; Thaler, Joshua P.; Meek, Thomas H.; Tylee, Tracy; Ogimoto, Kayoko; Wisse, Brent E.] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kaiyala, KJ (corresponding author), Univ Washington, Dept Dent, Seattle, WA 98195 USA.	bewisse@u.washington.edu			National Institutes of Health [DK071784]; Clinical Nutrition and Research Unit [P30DK035816]; Diabetes Endocrinology Research Center at the University of Washington [P30DK17047]; Seattle Metabolic Mouse Phenotyping Core (MMPC) [U24 DK076126]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076126, T32DK007247, F32DK097859, R01DK089056, P30DK017047, R01DK074758, P30DK035816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Nutrition and Research Unit; Diabetes Endocrinology Research Center at the University of Washington; Seattle Metabolic Mouse Phenotyping Core (MMPC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health to BEW (DK071784), the Clinical Nutrition and Research Unit (P30DK035816) and the Diabetes Endocrinology Research Center (P30DK17047) at the University of Washington, and the Seattle Metabolic Mouse Phenotyping Core (MMPC, U24 DK076126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; BROBECK JR, 1948, YALE J BIOL MED, V20, P545; Cabanac M, 2001, INT J OBESITY, V25, pS7, DOI 10.1038/sj.ijo.0801904; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Castaneda TR, 2005, J NUTR, V135, P1314, DOI 10.1093/jn/135.5.1314; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; EDHOLM OG, 1955, BRIT J NUTR, V9, P286, DOI 10.1079/BJN19550040; Galgani J, 2008, INT J OBESITY, V32, pS109, DOI 10.1038/ijo.2008.246; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; GIRARDIER L, 1995, J PHYSIOL-LONDON, V488, P779, DOI 10.1113/jphysiol.1995.sp021009; GORDON CJ, 1985, PHYSIOL BEHAV, V34, P687, DOI 10.1016/0031-9384(85)90365-8; HAMILTON CL, 1963, J COMP PHYSIOL PSYCH, V56, P476, DOI 10.1037/h0046241; Harri M, 1999, LAB ANIM SCI, V49, P401; HIMMSHAGEN J, 1978, BIOCHEM BIOPH RES CO, V83, P628, DOI 10.1016/0006-291X(78)91036-7; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; JAKUBCZAK LF, 1976, PHYSIOL BEHAV, V17, P251, DOI 10.1016/0031-9384(76)90073-1; Jung AP, 2010, MED SCI SPORT EXER, V42, P355, DOI 10.1249/MSS.0b013e3181a6d88f; Jurgens HS, 2006, PHYSIOL GENOMICS, V25, P234, DOI 10.1152/physiolgenomics.00252.2005; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Leon LR, 2005, AM J PHYSIOL-REG I, V288, pR197, DOI 10.1152/ajpregu.00046.2004; Levitsky DA, 2005, PHYSIOL BEHAV, V86, P623, DOI 10.1016/j.physbeh.2005.08.053; Lighton JRB, 2008, J EXP BIOL, V211, P563, DOI 10.1242/jeb.010041; Lowell BB, 2003, J BIOL CHEM, V278, P29385, DOI 10.1074/jbc.R300011200; Marrif H, 2005, ENDOCRINOLOGY, V146, P2872, DOI 10.1210/en.2004-1544; Melnyk A, 1997, AM J PHYSIOL-REG I, V272, pR1088, DOI 10.1152/ajpregu.1997.272.4.R1088; Melnyk A, 1998, AM J PHYSIOL-REG I, V274, pR1131, DOI 10.1152/ajpregu.1998.274.4.R1131; Mesaros A, 2008, CELL METAB, V7, P236, DOI 10.1016/j.cmet.2008.01.007; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Morton GJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE392, DOI 10.1152/ajpendo.00546.2010; Murgatroyd PR, 1999, INT J OBESITY, V23, P1269, DOI 10.1038/sj.ijo.0801062; Nehrenberg DL, 2009, OBESITY, V17, P1402, DOI 10.1038/oby.2009.51; Nogueiras R, 2008, ENDOCRINOLOGY, V149, P3009, DOI 10.1210/en.2007-1684; Novak CM, 2007, J NEUROENDOCRINOL, V19, P923, DOI 10.1111/j.1365-2826.2007.01606.x; Novak CM, 2010, HORM BEHAV, V58, P355, DOI 10.1016/j.yhbeh.2010.03.013; Overton JM, 2011, INT J OBES LOND S2, V34, pS53; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; ROTHWELL NJ, 1986, BRIT J NUTR, V56, P123, DOI 10.1079/BJN19860092; Sakkou M, 2007, CELL METAB, V5, P450, DOI 10.1016/j.cmet.2007.05.007; Schwartz MW, 2003, DIABETES, V52, P232, DOI 10.2337/diabetes.52.2.232; Seeley RJ, 1996, AM J PHYSIOL-REG I, V271, pR819, DOI 10.1152/ajpregu.1996.271.3.R819; Sims E A, 1973, Recent Prog Horm Res, V29, P457; Speakman JR, 2011, DIS MODEL MECH, V4, P733, DOI 10.1242/dmm.008698; Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; THORNE A, 1990, ACTA CHIR SCAND, P6; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Uceyler N, 2011, INT J OBES LOND, V34, P701; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wernstedt I, 2006, AM J PHYSIOL-REG I, V291, pR551, DOI 10.1152/ajpregu.00514.2005; Westerterp KR, 2008, INT J OBESITY, V32, P1256, DOI 10.1038/ijo.2008.74; Westerterp KR, 2010, NUTR REV, V68, P148, DOI 10.1111/j.1753-4887.2010.00270.x; Williams TD, 2002, AM J PHYSIOL-REG I, V282, pR1459, DOI 10.1152/ajpregu.00612.2001; Wisse BE, 2006, PEPTIDES, V27, P265, DOI 10.1016/j.peptides.2005.08.020; WRIGHT GL, 1976, J APPL PHYSIOL, V40, P683, DOI 10.1152/jappl.1976.40.5.683; Yu XX, 2002, FASEB J, V16, P155, DOI 10.1096/fj.01-0568com	58	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41473	10.1371/journal.pone.0041473	http://dx.doi.org/10.1371/journal.pone.0041473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936977	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300008
J	Malenke, JR; Magnanou, E; Thomas, K; Dearing, MD				Malenke, Jael R.; Magnanou, Elodie; Thomas, Kirk; Dearing, M. Denise			Cytochrome P450 2B Diversity and Dietary Novelty in the Herbivorous, Desert Woodrat (Neotoma lepida)	PLOS ONE			English	Article							SUBSTRATE RECOGNITION SITES; P4502B4 ACTIVE-SITE; AMINO-ACID; DIRECTED MUTAGENESIS; LARREA-TRIDENTATA; MOLECULAR-BASIS; EVOLUTION; GENE; ENZYMES; SPECIFICITY	Detoxification enzymes play a key role in plant-herbivore interactions, contributing to the on-going evolution of ecosystem functional diversity. Mammalian detoxification systems have been well studied by the medical and pharmacological industries to understand human drug metabolism; however, little is known of the mechanisms employed by wild herbivores to metabolize toxic plant secondary compounds. Using a wild rodent herbivore, the desert woodrat (Neotoma lepida), we investigated genomic structural variation, sequence variability, and expression patterns in a multigene subfamily involved in xenobiotic metabolism, cytochrome P450 2B (CYP2B). We hypothesized that differences in CYP2B expression and sequence diversity could explain differential abilities of woodrat populations to consume native plant toxins. Woodrats from two distinct populations were fed diets supplemented with either juniper (Juniperus osteosperma) or creosote bush (Larrea tridentata), plants consumed by woodrats in their respective desert habitats. We used Southern blot and quantitative PCR to determine that the genomic copy number of CYP2B in both populations was equivalent, and similar in number to known rodent copy number. We compared CYP2B expression patterns and sequence diversity using cloned hepatic CYP2B cDNA. The resulting sequences were very diverse, and clustered into four major clades by amino acid similarity. Sequences from the experimental treatments were distributed non-randomly across a CYP2B tree, indicating unique expression patterns from woodrats on different diets and from different habitats. Furthermore, within each major CYP2B clade, sequences shared a unique combination of amino acid residues at 13 sites throughout the protein known to be important for CYP2B enzyme function, implying differences in the function of each major CYP2B variant. This work is the most comprehensive investigation of the genetic diversity of a detoxification enzyme subfamily in a wild mammalian herbivore, and contributes an initial genetic framework to our understanding of how a wild herbivore responds to critical changes in its diet.	[Malenke, Jael R.; Magnanou, Elodie; Dearing, M. Denise] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Magnanou, Elodie] Univ Paris 06, Lab ARAGO, Banyuls Sur Mer, France; [Magnanou, Elodie] Ctr Natl Rech Sci, Banyuls Sur Mer, France; [Thomas, Kirk] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Utah System of Higher Education; University of Utah	Malenke, JR (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	malenke@biology.utah.edu		Magnanou, Elodie/0000-0002-8375-9682	NSF [IOS 0817527]; Direct For Biological Sciences [0817527] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this project was provided by an NSF (http://www.nsf.gov/) grant (IOS 0817527) to MDD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ADAMS RP, 1981, BIOCHEM SYST ECOL, V9, P93, DOI 10.1016/0305-1978(81)90025-9; Al-Omari A, 2007, J PHARM PRACT, V20, P206, DOI DOI 10.1177/0897190007304821; Babik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-390; Baker ME, 2005, INTEGR COMP BIOL, V45, P172, DOI 10.1093/icb/45.1.172; Bodin L, 2005, J BIOMED BIOTECHNOL, P248, DOI 10.1155/JBB.2005.248; Daly AK, 1998, TOXICOL LETT, V103, P143, DOI 10.1016/S0378-4274(98)00299-9; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond A., 2011, GENEIOUS V5 5; El-Merhibi A., 2007, Australasian Journal of Ecotoxicology, V13, P53; GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243; Gonzalez-Duarte R, 2005, HEREDITY, V95, P184, DOI 10.1038/sj.hdy.6800723; GOTOH O, 1992, J BIOL CHEM, V267, P83; GOTOH O, 1994, CYTOCHROME P450, P279; Hahn MW, 2009, J HERED, V100, P605, DOI 10.1093/jhered/esp047; Haley SL, 2008, PHYSIOL BIOCHEM ZOOL, V81, P584, DOI 10.1086/589951; HALPERT JR, 1993, J BIOL CHEM, V268, P4453; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; HASLER JA, 1994, MOL PHARMACOL, V46, P338; HE YA, 1992, BIOCHEMISTRY-US, V31, P9220, DOI 10.1021/bi00153a015; HE YA, 1994, BIOCHEMISTRY-US, V33, P4419, DOI 10.1021/bi00180a040; HE YQ, 1995, CHEM RES TOXICOL, V8, P574, DOI 10.1021/tx00046a011; Hernandez CE, 2006, ARCH BIOCHEM BIOPHYS, V455, P61, DOI 10.1016/j.abb.2006.08.024; Hu SY, 2008, GENETICA, V133, P215, DOI 10.1007/s10709-007-9206-x; Hunter KL, 2001, GLOBAL ECOL BIOGEOGR, V10, P521, DOI 10.1046/j.1466-822X.2001.00254.x; Ingelman-Sundberg M, 1999, TRENDS PHARMACOL SCI, V20, P342, DOI 10.1016/S0165-6147(99)01363-2; Jinno H, 2003, DRUG METAB DISPOS, V31, P398, DOI 10.1124/dmd.31.4.398; KARASOV WH, 1989, PHYSIOL ZOOL, V62, P1351, DOI 10.1086/physzool.62.6.30156217; KEDZIE KM, 1991, J BIOL CHEM, V266, P22515; Kirischian N, 2011, J MOL EVOL, V72, P56, DOI 10.1007/s00239-010-9402-7; KLAASSEN CD, 2001, CARARETT DOULLS TOXI; Kobayashi Y, 1998, BIOCHEMISTRY-US, V37, P6679, DOI 10.1021/bi9731450; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lamb JG, 2001, J CHEM ECOL, V27, P845, DOI 10.1023/A:1010366322299; Lamba JK, 2002, PHARMACOGENETICS, V12, P121, DOI 10.1097/00008571-200203000-00006; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li XC, 2004, P NATL ACAD SCI USA, V101, P2939, DOI 10.1073/pnas.0308691101; Ma Q, 2008, CURR DRUG METAB, V9, P374, DOI 10.2174/138920008784746337; Mabry T.J., 1977, CREOSOTE BUSH BIOL C, P115; Magnanou E, 2009, MOL ECOL, V18, P2401, DOI 10.1111/j.1365-294X.2009.04171.x; Mangione AM, 2004, J CHEM ECOL, V30, P1409, DOI 10.1023/B:JOEC.0000037748.19927.a1; Mangione AM, 2001, J CHEM ECOL, V27, P2559, DOI 10.1023/A:1013639817958; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Muralidhara BK, 2008, J MOL BIOL, V377, P232, DOI 10.1016/j.jmb.2007.12.068; NEBERT DW, 1989, XENOBIOTICA, V19, P1149, DOI 10.3109/00498258909043167; Nelson David R., 2009, Human Genomics, V4, P59; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; NELSON DR, 1987, MOL BIOL EVOL, V4, P572; Ngo S, 2000, COMP BIOCHEM PHYS C, V127, P327, DOI 10.1016/S0742-8413(00)00160-2; Ohta T, 2000, GENE, V259, P45, DOI 10.1016/S0378-1119(00)00428-5; Patton J.L., 2008, EVOLUTIONARY HIST SY, V135; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Sachse C, 1997, AM J HUM GENET, V60, P284; Spatzenegger M, 2001, MOL PHARMACOL, V59, P475, DOI 10.1124/mol.59.3.475; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Stupans I, 1999, COMP BIOCHEM PHYS C, V123, P67, DOI 10.1016/S0742-8413(99)00012-2; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; SZKLARZ GD, 1995, BIOCHEMISTRY-US, V34, P14312, DOI 10.1021/bi00044a008; Szklarz GD, 1996, ARCH BIOCHEM BIOPHYS, V327, P308, DOI 10.1006/abbi.1996.0127; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Van Devender T.R., 1990, PACKRAT MIDDENS LAST, P104; Watanabe T, 2010, PHARMACOGENET GENOM, V20, P459, DOI 10.1097/FPC.0b013e32833bba0e; Wen ZM, 2005, PROTEIN ENG DES SEL, V18, P191, DOI 10.1093/protein/gzi023; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57	70	13	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41510	10.1371/journal.pone.0041510	http://dx.doi.org/10.1371/journal.pone.0041510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927909	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300010
J	Mendu, SK; Bhandage, A; Jin, Z; Birnir, B				Mendu, Suresh K.; Bhandage, Amol; Jin, Zhe; Birnir, Bryndis			Different Subtypes of GABA-A Receptors Are Expressed in Human, Mouse and Rat T Lymphocytes	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; GENE-EXPRESSION; CELL; SUBUNIT; AUTOIMMUNITY; ANESTHETICS; INHIBITION; RESPONSES; EFFECTOR; LIGAND	gamma-aminobutyric acid (GABA) is the most prominent neuroinhibitory transmitter in the brain, where it activates neuronal GABA-A receptors (GABA-A channels) located at synapses and outside of synapses. The GABA-A receptors are primary targets of many clinically useful drugs. In recent years, GABA has been shown to act as an immunomodulatory molecule. We have examined in human, mouse and rat CD4(+) and CD8(+) T cells which subunit isoforms of the GABA-A channels are expressed. The channel physiology and drug specificity is dictated by the GABA-A receptor subtype, which in turn is determined by the subunit isoforms that make the channel. There were 5, 8 and 13 different GABA-A subunit isoforms identified in human, mouse and rat CD4(+) and CD8(+) T cells, respectively. Importantly, the gamma 2 subunit that imposes benzodiazepine sensitivity on the GABA-A receptors, was only detected in the mouse T cells. Immunoblots and immunocytochemistry showed abundant GABA-A channel proteins in the T cells from all three species. GABA-activated whole-cell transient and tonic currents were recorded. The currents were inhibited by picrotoxin, SR95531 and bicuculline, antagonists of GABA-A channels. Clearly, in both humans and rodents T cells, functional GABA-A channels are expressed but the subtypes vary. It is important to bear in mind the interspecies difference when selecting the appropriate animal models to study the physiological role and pharmacological properties of GABA-A channels in CD4(+) and CD8(+) T cells and when selecting drugs aimed at modulating the human T cells function.	[Mendu, Suresh K.; Bhandage, Amol; Jin, Zhe; Birnir, Bryndis] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Mendu, SK (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	bryndis.birnir@neuro.uu.se	Bhandage, Amol/O-1869-2016; Jin, Zhe/C-5150-2008; Bhandage, Amol K./AAY-2435-2020	Bhandage, Amol/0000-0002-7116-0939; Jin, Zhe/0000-0002-4717-1558; Bhandage, Amol K./0000-0002-7116-0939; Birnir, Bryndis/0000-0002-1763-0266; Mendu, Suresh Kumar/0000-0002-6785-0806	Swedish national strategic research initiative EXODIAB (Excellence of Diabetes Research in Sweden); Juvenile Diabetes Research Foundation; Swedish Research Council; Swedish Diabetes Research Foundation; Ernfors Foundation; Uppsala University; EXODIAB; Swedish Association for Medical Research (SSMF)	Swedish national strategic research initiative EXODIAB (Excellence of Diabetes Research in Sweden); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Research Foundation; Ernfors Foundation; Uppsala University; EXODIAB; Swedish Association for Medical Research (SSMF)	Human pancreatic lymph nodes were obtained from The Nordic network for Clinical Islet Transplantation, supported by the Swedish national strategic research initiative EXODIAB (Excellence of Diabetes Research in Sweden) and the Juvenile Diabetes Research Foundation. The authors thank the Swedish Research Council, Swedish Diabetes Research Foundation, The Ernfors Foundation, Uppsala University and EXODIAB for financial support. ZJ held a postdoctoral fellowship sponsored by EXODIAB and The Swedish Association for Medical Research (SSMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakuijala A, 2005, EUR J NEUROSCI, V21, P692, DOI 10.1111/j.1460-9568.2005.03880.x; Alam S, 2006, MOL IMMUNOL, V43, P1432, DOI 10.1016/j.molimm.2005.07.025; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Bhat R, 2009, NEURON, V64, P123, DOI 10.1016/j.neuron.2009.09.015; Birnir B, 1997, J MEMBRANE BIOL, V155, P157, DOI 10.1007/s002329900167; Birnir B, 2007, CURR PHARM DESIGN, V13, P3169, DOI 10.2174/138161207782341330; Bjurstrom H, 2008, J NEUROIMMUNOL, V205, P44, DOI 10.1016/j.jneuroim.2008.08.017; Chiffoleau E, 2007, INT IMMUNOL, V19, P193, DOI 10.1093/intimm/dxl136; Condamine T, 2010, J LEUKOCYTE BIOL, V87, P451, DOI 10.1189/jlb.0609410; Dionisio L, 2011, NEUROPHARMACOLOGY, V60, P513, DOI 10.1016/j.neuropharm.2010.11.007; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; ERDO SL, 1990, J NEUROCHEM, V54, P363, DOI 10.1111/j.1471-4159.1990.tb01882.x; GERBER JC, 1980, BRAIN RES BULL, V5, P341, DOI 10.1016/0361-9230(80)90055-6; Reyes-Garcia MG, 2009, J NEUROIMMUNOL, V216, P20, DOI 10.1016/j.jneuroim.2009.06.024; Halonen LM, 2009, NEUROCHEM INT, V55, P389, DOI 10.1016/j.neuint.2009.04.008; Hillebrands JL, 2006, J IMMUNOL, V177, P7820, DOI 10.4049/jimmunol.177.11.7820; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Jin Z, 2011, AMINO ACIDS; Jin Z, 2012, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00030; Kim MY, 2006, J IMMUNOL, V177, P3074, DOI 10.4049/jimmunol.177.5.3074; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Lupberger J, 2002, MOL CELL PROBE, V16, P25, DOI 10.1006/mcpr.2001.0392; Mendu SK, 2011, MOL IMMUNOL, V48, P399, DOI 10.1016/j.molimm.2010.08.005; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; PETTY F, 1984, J AFFECT DISORDERS, V6, P131, DOI 10.1016/0165-0327(84)90018-1; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; Reyes-Garcia MG, 2007, J NEUROIMMUNOL, V188, P64, DOI 10.1016/j.jneuroim.2007.05.013; Sidorkiewicz M, 2011, EUR J CLIN MICROBIOL; Soltani N, 2011, P NATL ACAD SCI US; Tian J, 1999, J NEUROIMMUNOL, V96, P21, DOI 10.1016/S0165-5728(98)00264-1; Tian JD, 2004, J IMMUNOL, V173, P5298, DOI 10.4049/jimmunol.173.8.5298; WANG TL, 1994, J NEUROSCI, V14, P6524; Wang Y, 2008, J IMMUNOL, V181, P8226, DOI 10.4049/jimmunol.181.12.8226; Wheeler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017152; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4	38	70	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42959	10.1371/journal.pone.0042959	http://dx.doi.org/10.1371/journal.pone.0042959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927941	Green Published, gold			2022-12-25	WOS:000307789700016
J	Seufi, AM; Galal, FH; Hafez, EE				Seufi, AlaaEddeen M.; Galal, Fatma H.; Hafez, Elsayed E.			Characterization of Multisugar-Binding C-Type Lectin (Spli Lec) from a Bacterial-Challenged Cotton Leafworn, Spodoptera littoralis	PLOS ONE			English	Article							MANDUCA-SEXTA; ANTIBACTERIAL ACTIVITY; IMMUNE-RESPONSES; HEMOLYMPH; PURIFICATION; INSECT; LIPOPOLYSACCHARIDE; RECOGNITION; INNATE; CLONING	Background:Various proteins that display carbohydrate-binding activity in a Ca2+-dependent manner are classified into the C-type lectin family. They have one or two C-type carbohydrate-recognition domains (CRDs) composed of 110-130 amino acid residues in common. C-type lectins mediate cell adhesion, non-self recognition, and immuno-protection processes in immune responses and thus play significant roles in clearance of invaders, either as cell surface receptors for microbial carbohydrates or as soluble proteins existing in tissue fluids. The lectin of Spodoptera littoralis is still uncharacterized. Methodology: A single orf encoding a deduced polypeptide consisting of an 18-residue signal peptide and a 291-residue mature peptide, termed SpliLec, was isolated from the haemolymph of the cotton leafworm, S. littoralis, after bacterial challenge using RACE-PCR. Sequence analyses of the data revealed that SpliLec consists of two CRDs. Short-form CRD1 and long-form CRD2 are stabilized by two and three highly conserved disulfide bonds, respectively. SpliLec shares homology with some dipteran lectins suggesting possible common ancestor. The purified SpliLec exhibited a 140-kDa molecular mass with a subunit molecular mass of 35 kDa. The hemagglutination assays of the SpliLec confirmed a thermally stable, multisugar-binding C-type lectin that binds different erythrocytes. The purified SpliLec agglutinated microorganisms and exhibited comparable antimicrobial activity against gram (+) and gram (-) bacteria too. Conclusions: Our results suggested an important role of the SpliLec gene in cell adhesion and non-self recognition. It may cooperate with other AMPs in clearance of invaders of Spodoptera littoralis.	[Seufi, AlaaEddeen M.; Galal, Fatma H.] Cairo Univ, Fac Sci, Dept Entomol, Giza, Egypt; [Hafez, Elsayed E.] City Sci Res & Technol Applicat, ALCADRI, Dept Plant Protect & Mol Diag, New Borg ElArab, Alex, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); City of Scientific Research & Technological Applications (SRTA-City)	Seufi, AM (corresponding author), Cairo Univ, Fac Sci, Dept Entomol, Giza, Egypt.	alaaseufi@yahoo.com	hafez, elsayed/ABG-2456-2021; Seufi, AlaaEddeen/A-8722-2015	hafez, elsayed/0000-0003-4044-5103; Seufi, AlaaEddeen/0000-0002-6261-1873; Galal, Fatma/0000-0002-6819-3422	Cairo University [CU-008-08]	Cairo University(Cairo University)	This work is supported partially by Cairo University grant no. CU-008-08. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayaad Tahany H., 2009, Egyptian Academic Journal of Biological Sciences A Entomology, V2, P55; Basseri HR, 2002, IRAN J PUBLIC HEALTH, V31, P69; BRADLEY RS, 1989, J INSECT PHYSIOL, V35, P353, DOI 10.1016/0022-1910(89)90108-X; CHEN CL, 1993, BIOCHEM J, V294, P181, DOI 10.1042/bj2940181; Clark PM, 2008, J AM CHEM SOC, V130, P11576, DOI 10.1021/ja8030467; DAY AJ, 1994, BIOCHEM SOC T, V22, P83, DOI 10.1042/bst0220083; Drickamer K, 2002, BIOCHEM SOC SYMP, V69, P59; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; DRIF L, 1994, INSECT BIOCHEM MOLEC, V24, P283, DOI 10.1016/0965-1748(94)90008-6; ELDEFRAWI ME, 1964, J ECON ENTOMOL, V57, P591, DOI 10.1093/jee/57.4.591; Eslin P, 2000, J INSECT PHYSIOL, V46, P1161, DOI 10.1016/S0022-1910(99)00227-9; FAVEL A, 1994, PLANTA MED, V60, P50, DOI 10.1055/s-2006-959407; Goh EB, 2005, J BACTERIOL, V187, P4890, DOI 10.1128/JB.187.14.4890-4899.2005; Gul Nursel, 2002, Turkish Journal of Biology, V26, P49; HAPNER KD, 1981, INSECT BIOCHEM, V11, P287, DOI 10.1016/0020-1790(81)90006-8; Haq S, 1996, J BIOL CHEM, V271, P20213, DOI 10.1074/jbc.271.33.20213; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Koizumi N, 1999, FEBS LETT, V443, P139, DOI 10.1016/S0014-5793(98)01701-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LEVINSON HZ, 1969, J INSECT PHYSIOL, V15, P591, DOI 10.1016/0022-1910(69)90257-1; LIANG P, 1993, NUCLEIC ACIDS RES, V21, P3269, DOI 10.1093/nar/21.14.3269; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mello CB, 1999, EXP PARASITOL, V91, P289, DOI 10.1006/expr.1998.4385; NCCLS, 1993, APPR STAND NCCLS PUB; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pendland JC, 1996, CELL TISSUE RES, V285, P57, DOI 10.1007/s004410050620; Pinheiro VB, 2006, CELL MICROBIOL, V8, P545, DOI 10.1111/j.1462-5822.2006.00693.x; Poget SF, 1999, J MOL BIOL, V290, P867, DOI 10.1006/jmbi.1999.2910; Riera AS, 2003, BIOCELL, V27, P37; Santana FA, 2006, AN ACAD BRAS CIENC, V78, P69, DOI 10.1590/S0001-37652006000100008; Santos AFS, 2009, PROCESS BIOCHEM, V44, P504, DOI 10.1016/j.procbio.2009.01.002; Seufi AM, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-47; SHANGARY S, 1995, PHYTOCHEMISTRY, V40, P449, DOI 10.1016/0031-9422(95)00229-Z; SHARON N, 1977, SCI AM, V236, P108, DOI 10.1038/scientificamerican0677-108; Shin SW, 2000, FEBS LETT, V467, P70, DOI 10.1016/S0014-5793(00)01127-3; Soo C, 2002, PLAST RECONSTR SURG, V110, P787, DOI 10.1097/01.PRS.0000019717.64418.E6; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tanji T, 2006, BIOCHEM J, V396, P127, DOI 10.1042/BJ20051921; Tian YY, 2009, DEV COMP IMMUNOL, V33, P772, DOI 10.1016/j.dci.2009.01.002; Varki A, 2009, ESSENTIALS GLYCOBIOL; Vasta GR, 1999, DEV COMP IMMUNOL, V23, P401, DOI 10.1016/S0145-305X(99)00020-8; Wang H, 2007, MOL IMMUNOL, V44, P722, DOI 10.1016/j.molimm.2006.04.015; Wang Q, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-9; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Wilson R, 1999, J IMMUNOL, V162, P1590; Yu XQ, 2006, INSECT MOL BIOL, V15, P119, DOI 10.1111/j.1365-2583.2006.00618.x; Yu XQ, 2005, INSECT BIOCHEM MOLEC, V35, P285, DOI 10.1016/j.ibmb.2005.01.004; Yu XQ, 2003, DEV COMP IMMUNOL, V27, P189, DOI 10.1016/S0145-305X(02)00099-X; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zelensky AN, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-51; Zhu SY, 2000, TOXICON, V38, P1653, DOI 10.1016/S0041-0101(00)00081-7	57	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42795	10.1371/journal.pone.0042795	http://dx.doi.org/10.1371/journal.pone.0042795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916161	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800029
J	Endo, T; Kobayashi, T				Endo, Toyoshi; Kobayashi, Tetsuro			Dominant Negative Effect of Mutated Thyroid Stimulating Hormone Receptor (P556L) Causes Hypothyroidism in C.RF-Tshr(hyt/wild) Mice	PLOS ONE			English	Article							THYROTROPIN RECEPTOR; TSH RECEPTOR; HYT/HYT MOUSE; OLIGOMERIZATION; BINDING; DOMAIN	C.RF-Tshr(hyt/hyt) mice have a mutated thyroid stimulating hormone receptor (P556L-TSHR) and these mice develop severe hypothyroidism. We found that C.RF-Tshr(hyt/wild) heterozygous mice are also in a hypothyroid state. Thyroid glands from C.RF-Tshr(hyt/wild) mice are smaller than those from wild-type mice, and I-125 uptake activities of the former are significantly lower than those in the latter. When TSHR (TSHR(W)) and P556L-TSHR (TSHR(M)) cDNAs were cloned and co-transfected into HEK 293 cells, the cells retained I-125-TSH binding activity, but cAMP response to TSH was decreased to about 20% of HEK 293 cells transfected with TSHR(W) cDNA. When TSHR(W) and TSHR(M) were tagged with eCFP or eYFP, we observed fluorescence resonance energy transfer (FRET) in HEK 293 cells expressing TSHR(W)-eCFP and TSHR(W)-eYFP in the absence of TSH, but not in the presence of TSH. In contrast, we obtained FRET in HEK 293 cells expressing TSHR(W)-eCFP and TSHR (M)-eYFP, regardless of the presence or absence of TSH. These results suggest that P556L TSHR has a dominant negative effect on TSHR(W) by impairing polymer to monomer dissociation, which decreases TSH responsiveness and induces hypothyroidism in C.RF-Tshr(hyt/wild) mice.	[Endo, Toyoshi; Kobayashi, Tetsuro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Chuo City, Yamanashi, Japan	University of Yamanashi	Endo, T (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Chuo City, Yamanashi, Japan.	endot@yamanashi.ac.jp						Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; BEAMER WG, 1981, SCIENCE, V212, P61, DOI 10.1126/science.7209519; Calebiro D, 2005, HUM MOL GENET, V14, P2991, DOI 10.1093/hmg/ddi329; COLLINS WT, 1980, VIRCHOWS ARCH B, V33, P213, DOI 10.1007/BF02899183; Davies T, 2002, J CLIN INVEST, V110, P161, DOI 10.1172/JCI200216234; ENDO T, 1993, BIOCHEM BIOPH RES CO, V190, P774, DOI 10.1006/bbrc.1993.1116; Endo T, 2008, AM J PHYSIOL-ENDOC M, V295, pE514, DOI 10.1152/ajpendo.90433.2008; GU WX, 1995, ENDOCRINOLOGY, V136, P3146, DOI 10.1210/en.136.7.3146; Inoue M, 1998, THYROID, V8, P1059, DOI 10.1089/thy.1998.8.1059; Latif R, 2001, J BIOL CHEM, V276, P45217, DOI 10.1074/jbc.M103727200; Latif R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009449; Marians RC, 2002, P NATL ACAD SCI USA, V99, P15776, DOI 10.1073/pnas.242322099; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; OMALLEY BW, 1995, HEARING RES, V88, P181, DOI 10.1016/0378-5955(95)00111-G; Sprenkle PM, 2001, JARO-J ASSOC RES OTO, V2, P312, DOI 10.1007/s101620010076; STEIN SA, 1994, MOL ENDOCRINOL, V8, P129, DOI 10.1210/me.8.2.129; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686	17	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42358	10.1371/journal.pone.0042358	http://dx.doi.org/10.1371/journal.pone.0042358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916127	Green Submitted, gold, Green Published			2022-12-25	WOS:000307824300008
J	Hirano, K; Sasaki, N; Ichimiya, T; Miura, T; Van Kuppevelt, TH; Nishihara, S				Hirano, Kazumi; Sasaki, Norihiko; Ichimiya, Tomomi; Miura, Taichi; Van Kuppevelt, Toin H.; Nishihara, Shoko			3-O-Sulfated Heparan Sulfate Recognized by the Antibody HS4C3 Contribute to the Differentiation of Mouse Embryonic Stem Cells via Fas Signaling	PLOS ONE			English	Article							SELF-RENEWAL; MEDIATED APOPTOSIS; PLURIPOTENCY; EXPRESSION; MAINTAINS; SURFACE; TERATOCARCINOMA; PROTEOGLYCANS; MAINTENANCE; ACTIVATION	Maintenance of self-renewal and pluripotency in mouse embryonic stem cells (mESCs) is regulated by the balance between several extrinsic signaling pathways. Recently, we demonstrated that heparan sulfate (HS) chains play important roles in the maintenance and differentiation of mESCs by regulating extrinsic signaling. Sulfated HS structures are modified by various sulfotransferases during development. However, the significance of specific HS structures during development remains unclear. Here, we show that 3-O-sulfated HS structures synthesized by HS 3-O-sulfotransferases (3OSTs) and recognized by the antibody HS4C3 increase during differentiation of mESCs. Furthermore, expression of Fas on the cell surface of the differentiated cells also increased. Overexpression of the HS4C3-binding epitope in mESCs induced apoptosis and spontaneous differentiation even in the presence of LIF and serum. These data showed that the HS4C3-binding epitope was required for differentiation of mESCs. Up-regulation of the HS4C3-binding epitope resulted in the recruitment of Fas from the cytoplasm to lipid rafts on the cell surface followed by activation of Fas signaling. Indeed, the HS4C3-binding epitope interacted with a region that included the heparin-binding domain (KLRRRVH) of Fas. Reduced self-renewal capability in cells overexpressing 3OST resulted from the degradation of Nanog by activated caspase-3, which is downstream of Fas signaling, and was rescued by the inhibition of Fas signaling. We also found that knockdown of 3OST and inhibition of Fas signaling reduced the potential for differentiation into the three germ layers during embryoid body formation. This is the first demonstration that activation of Fas signaling is mediated by an increase in the HS4C3-binding epitope and indicates a novel signaling pathway for differentiation in mESCs.	[Hirano, Kazumi; Sasaki, Norihiko; Ichimiya, Tomomi; Miura, Taichi; Nishihara, Shoko] Soka Univ, Fac Engn, Dept Bioinformat, Cell Biol Lab, Hachioji, Tokyo, Japan; [Van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands	Soka University; Radboud University Nijmegen	Hirano, K (corresponding author), Soka Univ, Fac Engn, Dept Bioinformat, Cell Biol Lab, Hachioji, Tokyo, Japan.	shoko@soka.ac.jp	van Kuppevelt, A.H.M.S.M./L-4463-2015; Hirano, Kazumi/R-5290-2019; Hirano, Kazumi/L-7031-2018	Hirano, Kazumi/0000-0001-9717-5904; Hirano, Kazumi/0000-0001-9717-5904; Nishihara, Shoko/0000-0002-1668-2603	Ministry of Education, Culture, Sports, Science and Technology [20370051]; Matching Fund for Private Universities [S0901015]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Matching Fund for Private Universities	This research was partially supported by funds from Ministry of Education, Culture, Sports, Science and Technology, the Grant-in-Aid for Scientific Research (B) to SN, 20370051, 2008-2010, and from Ministry of Education, Culture, Sports, Science and Technology, the Matching Fund for Private Universities, S0901015, 2009-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Brunlid G, 2007, STEM CELLS, V25, P2551, DOI 10.1634/stemcells.2006-0745; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Duval D, 2004, CELL DEATH DIFFER, V11, P331, DOI 10.1038/sj.cdd.4401337; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Ivanov VN, 2003, MOL CELL BIOL, V23, P3623, DOI 10.1128/MCB.23.10.3623-3635.2003; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Kamiyama S, 2006, J BIOL CHEM, V281, P10945, DOI 10.1074/jbc.M508991200; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Ko YG, 1999, J IMMUNOL, V162, P7217; Kraushaar DC, 2010, J BIOL CHEM, V285, P5907, DOI 10.1074/jbc.M109.066837; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Legembre P, 2002, CELL DEATH DIFFER, V9, P329, DOI 10.1038/sj.cdd.4400960; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Mochizuki H, 2008, J BIOL CHEM, V283, P31237, DOI 10.1074/jbc.M801586200; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Sasaki N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008262; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smits NC, 2006, METHOD ENZYMOL, V416, P61, DOI 10.1016/S0076-6879(06)16005-X; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Villena J, 2006, APOPTOSIS, V11, P2065, DOI 10.1007/s10495-006-0193-7; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xia GQ, 2002, J BIOL CHEM, V277, P37912, DOI 10.1074/jbc.M204209200; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	43	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43440	10.1371/journal.pone.0043440	http://dx.doi.org/10.1371/journal.pone.0043440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916262	gold, Green Published			2022-12-25	WOS:000307824300050
J	Lin, LF; Chiu, SP; Wu, MJ; Chen, PY; Yen, JH				Lin, Lian-Fang; Chiu, Szu-Ping; Wu, Ming-Jiuan; Chen, Pei-Yi; Yen, Jui-Hung			Luteolin Induces microRNA-132 Expression and Modulates Neurite Outgrowth in PC12 Cells	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM POTENTIATION; EPIDERMAL-GROWTH-FACTOR; FLAVONOID LUTEOLIN; ADULT HIPPOCAMPUS; INDUCED TOXICITY; MESSENGER-RNAS; CREB; NEURONS; CAMP	Luteolin (3',4',5,7-tetrahydroxyflavone), a food-derived flavonoid, has been reported to exert neurotrophic properties that are associated with its capacity to promote neuronal survival and neurite outgrowth. In this study, we report for the first time that luteolin induces the persistent expression of microRNA-132 (miR-132) in PC12 cells. The correlation between miR-132 knockdown and a decrease in luteolin-mediated neurite outgrowth may indicate a mechanistic link by which miR-132 functions as a mediator for neuritogenesis. Furthermore, we find that luteolin led to the phosphorylation and activation of cAMP response element binding protein (CREB), which is associated with the up-regulation of miR-132 and neurite outgrowth. Moreover, luteolin-induced CREB activation, miR-132 expression and neurite outgrowth were inhibited by adenylate cyclase, protein kinase A (PKA) and MAPK/ERK kinase 1/2 (MEK1/2) inhibitors but not by protein kinase C (PKC) or calcium/calmodulin-dependent protein kinase II (CaMK II) inhibitors. Consistently, we find that luteolin treatment increases ERK phosphorylation and PKA activity in PC12 cells. These results show that luteolin induces the up-regulation of miR-132, which serves as an important regulator for neurotrophic actions, mainly acting through the activation of cAMP/PKA- and ERK-dependent CREB signaling pathways in PC12 cells.	[Lin, Lian-Fang; Chiu, Szu-Ping; Yen, Jui-Hung] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Wu, Ming-Jiuan] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan; [Chen, Pei-Yi] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Chen, Pei-Yi] Buddhist Tzu Chi Gen Hosp, Ctr Med Genet, Hualien, Taiwan	Tzu Chi University; Chia Nan University of Pharmacy & Science; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Lin, LF (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.	imyenjh@mail.tcu.edu.tw		Wu, Ming-Jiuan/0000-0003-3327-828X	National Science Council, Taiwan, ROC [NSC-97-2320-B-320-011-MY3, NSC-99-2320-B-041-005-MY3]; Tzu Chi University [TCMRC-P-100006]	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Tzu Chi University	This study was supported by grant NSC-97-2320-B-320-011-MY3 and NSC-99-2320-B-041-005-MY3 from National Science Council, Taiwan, ROC; and by grant TCMRC-P-100006 from Tzu Chi University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2008, NAT MED, V14, P1036, DOI 10.1038/nm1008-1036; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boss V, 2001, J NEUROSCI, V21, P18, DOI 10.1523/JNEUROSCI.21-01-00018.2001; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng HY, 2010, PHYTOTHER RES, V24, pS102, DOI 10.1002/ptr.2940; Dirscherl K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-3; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gueorguiev VD, 2006, J BIOL CHEM, V281, P10188, DOI 10.1074/jbc.M513806200; Hansen KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015497; Hong JT, 2009, TOXICOL APPL PHARM, V237, P59, DOI 10.1016/j.taap.2009.02.014; Hougee S, 2005, BIOCHEM PHARMACOL, V69, P241, DOI 10.1016/j.bcp.2004.10.002; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lai HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028280; Liao KK, 2012, J AGR FOOD CHEM, V60, P433, DOI 10.1021/jf203290r; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin CW, 2010, J AGR FOOD CHEM, V58, P4477, DOI 10.1021/jf904061x; Liu R, 2009, NEUROSCIENCE, V162, P1232, DOI 10.1016/j.neuroscience.2009.05.009; Loohuis NFMO, 2012, CELL MOL LIFE SCI, V69, P89, DOI 10.1007/s00018-011-0788-1; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; Middleton E, 2000, PHARMACOL REV, V52, P673; Nagase H, 2005, BIOCHEM BIOPH RES CO, V337, P1330, DOI 10.1016/j.bbrc.2005.10.001; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Pavlica S, 2010, LIFE SCI, V86, P79, DOI 10.1016/j.lfs.2009.10.017; Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Reznichenko L, 2005, J NEUROCHEM, V93, P1157, DOI 10.1111/j.1471-4159.2005.03085.x; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Romanova D, 2001, NEOPLASMA, V48, P104; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Seelinger G, 2008, MOLECULES, V13, P2628, DOI 10.3390/molecules13102628; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Spencer JPE, 2007, GENES NUTR, V2, P257, DOI 10.1007/s12263-007-0056-z; Spencer JPE, 2009, ARCH BIOCHEM BIOPHYS, V492, P1, DOI 10.1016/j.abb.2009.10.003; Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3; Su JD, 2012, FREE RADICAL BIO MED, V52, P126, DOI 10.1016/j.freeradbiomed.2011.10.002; Tsai FS, 2007, LIFE SCI, V80, P1692, DOI 10.1016/j.lfs.2007.01.055; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang JY, 2008, J NEUROCHEM, V107, P1544, DOI 10.1111/j.1471-4159.2008.05714.x; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; Wruck CJ, 2007, J NEURAL TRANSM-SUPP, P57; Xu B, 2010, EUR J PHARMACOL, V627, P99, DOI 10.1016/j.ejphar.2009.10.038; Yang DH, 2012, J CELL SCI, V125, P1673, DOI 10.1242/jcs.086421	58	46	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43304	10.1371/journal.pone.0043304	http://dx.doi.org/10.1371/journal.pone.0043304			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916239	Green Published, gold, Green Submitted			2022-12-25	WOS:000307824300038
J	Arulanandam, BP; Chetty, SL; Yu, JJ; Leonard, S; Klose, K; Seshu, J; Cap, A; Valdes, JJ; Chambers, JP				Arulanandam, Bernard P.; Chetty, Senthilnath Lakshmana; Yu, Jieh-Juen; Leonard, Sean; Klose, Karl; Seshu, Janakiram; Cap, Andrew; Valdes, James J.; Chambers, James P.			Francisella DnaK Inhibits Tissue-nonspecific Alkaline Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVE VACCINE STRAIN; TULARENSIS SUBSP NOVICIDA; PROTECTIVE IMMUNITY; ESCHERICHIA-COLI; SERUM COMPONENTS; WHOLE-BLOOD; IN-VIVO; SCHU S4; MICE; CHALLENGE	Following pulmonary infection with Francisella tularensis, we observed an unexpected but significant reduction of alkaline phosphatase, an enzyme normally up-regulated following inflammation. However, no reduction was observed in mice infected with a closely related Gram-negative pneumonic organism (Klebsiella pneumoniae) suggesting the inhibition may be Francisella-specific. In similar fashion to in vivo observations, addition of Francisella lysate to exogenous alkaline phosphatase (tissue-nonspecific isozyme) was inhibitory. Partial purification and subsequent proteomic analysis indicated the inhibitory factor to be the heat shock protein DnaK. Incubation with increasing amounts of anti-DnaK antibody reduced the inhibitory effect in a dose-dependent manner. Furthermore, DnaK contains an adenosine triphosphate binding domain at its N terminus, and addition of adenosine triphosphate enhances dissociation of DnaK with its target protein, e. g. alkaline phosphatase. Addition of adenosine triphosphate resulted in decreased DnaK co-immunoprecipitated with alkaline phosphatase as well as reduction of Francisella-mediated alkaline phosphatase inhibition further supporting the binding of Francisella DnaK to alkaline phosphatase. Release of DnaK via secretion and/or bacterial cell lysis into the extracellular milieu and inhibition of plasma alkaline phosphatase could promote an orchestrated, inflammatory response advantageous to Francisella.	[Arulanandam, Bernard P.; Chetty, Senthilnath Lakshmana; Yu, Jieh-Juen; Leonard, Sean; Klose, Karl; Seshu, Janakiram; Chambers, James P.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Cap, Andrew] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA; [Valdes, James J.] USA, Edgewood Chem Biol Command, Aberdeen Proving Ground, MD 21010 USA	University of Texas System; University of Texas at San Antonio (UTSA); United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM)	Chambers, JP (corresponding author), Univ Texas San Antonio, Dept Biol, 1 UTSA Circle, San Antonio, TX 78249 USA.	james.chambers@UTSA.edu	Arulanandam, Bernard P/O-9501-2014	Lakshmanachetty, Senthilnath/0000-0002-3760-2772	National Institutes of Health [AI057986]; Center of Excellence in Infection Genomics Contract [W911NF-11-1-0136]; San Antonio Life Sciences Institute [14-3300-24]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Infection Genomics Contract; San Antonio Life Sciences Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant AI057986, Center of Excellence in Infection Genomics Contract W911NF-11-1-0136, and San Antonio Life Sciences Institute Grant 14-3300-24.	Beumer C, 2003, J PHARMACOL EXP THER, V307, P737, DOI 10.1124/jpet.103.056606; BUCHBERGER A, 1994, NAT STRUCT BIOL, V1, P95, DOI 10.1038/nsb0294-95; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chen WX, 2004, MICROB PATHOGENESIS, V37, P185, DOI 10.1016/j.micpath.2004.06.010; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Coburn SP, 1998, J CLIN ENDOCR METAB, V83, P3951, DOI 10.1210/jc.83.11.3951; Cong Y, 2009, VACCINE, V27, P5554, DOI 10.1016/j.vaccine.2009.07.034; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P39, DOI 10.1016/S0882-4010(02)00194-8; Dreisbach VC, 2000, INFECT IMMUN, V68, P1988, DOI 10.1128/IAI.68.4.1988-1996.2000; EDELSON JD, 1988, AM REV RESPIR DIS, V138, P1268, DOI 10.1164/ajrccm/138.5.1268; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; FERNLEY HN, 1969, BIOCHEM J, V111, P187, DOI 10.1042/bj1110187; Fossati G, 2003, J BACTERIOL, V185, P4256, DOI 10.1128/JB.185.14.4256-4267.2003; Fraley CD, 2007, P NATL ACAD SCI USA, V104, P3526, DOI 10.1073/pnas.0609733104; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HAMBLETON P, 1977, BRIT J EXP PATHOL, V58, P644; HAMBLETON P, 1978, BRIT J EXP PATHOL, V59, P630; Havlasova J, 2002, PROTEOMICS, V2, P857, DOI 10.1002/1615-9861(200207)2:7<857::AID-PROT857>3.0.CO;2-L; Jeffery CJ, 2005, MASS SPECTROM REV, V24, P772, DOI 10.1002/mas.20041; KELLER JA, 1988, MOL MICROBIOL, V2, P31, DOI 10.1111/j.1365-2958.1988.tb00004.x; Konecna K, 2010, PROTEOMICS, V10, P4501, DOI 10.1002/pmic.201000248; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawlor MS, 2005, MOL MICROBIOL, V58, P1054, DOI 10.1111/j.1365-2958.2005.04918.x; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; OHKUBO A, 1974, J BIOL CHEM, V249, P7174; Pierson T, 2011, J PROTEOME RES, V10, P954, DOI 10.1021/pr1009756; Poelstra K, 1997, LAB INVEST, V76, P319; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Ray HJ, 2009, CLIN VACCINE IMMUNOL, V16, P444, DOI 10.1128/CVI.00405-08; Richards MI, 2008, J MED MICROBIOL, V57, P1183, DOI 10.1099/jmm.0.2008/001826-0; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; STRAUS DB, 1988, GENE DEV, V2, P1851, DOI 10.1101/gad.2.12b.1851; TARNVIK A, 1989, REV INFECT DIS, V11, P440; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Twenhafel NA, 2009, VET PATHOL, V46, P698, DOI 10.1354/vp.08-VP-0302-T-AM; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Vanet A, 1998, INFECT IMMUN, V66, P1023, DOI 10.1128/IAI.66.3.1023-1027.1998; Verweij WR, 2004, SHOCK, V22, P174, DOI 10.1097/01.shk.0000132485.05049.8a; VOLLER A, 1976, BRIT J EXP PATHOL, V57, P243; Xu Q, 2002, LIVER, V22, P8, DOI 10.1034/j.1600-0676.2002.220102.x; Yu JJ, 2008, EUR J CLIN MICROBIOL, V27, P323, DOI 10.1007/s10096-007-0434-x	44	5	5	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37185	37194		10.1074/jbc.M112.404400	http://dx.doi.org/10.1074/jbc.M112.404400			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22923614	Green Published, hybrid			2022-12-25	WOS:000310588500052
J	Epstein, LF; Chen, H; Emkey, R; Whittington, DA				Epstein, Linda F.; Chen, Hao; Emkey, Renee; Whittington, Douglas A.			The R1275Q Neuroblastoma Mutant and Certain ATP-competitive Inhibitors Stabilize Alternative Activation Loop Conformations of Anaplastic Lymphoma Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; NON-HODGKINS-LYMPHOMA; FACTOR-I RECEPTOR; CRYSTAL-STRUCTURE; EXPERIMENTAL-MODELS; ANTITUMOR-ACTIVITY; ALK KINASE; CHROMOSOMAL TRANSLOCATION; PROTEIN-KINASES; LUNG-CANCER	Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that, when genetically altered by mutation, amplification, chromosomal translocation or inversion, has been shown to play an oncogenic role in certain cancers. Small molecule inhibitors targeting the kinase activity of ALK have proven to be effective therapies in certain ALK-driven malignancies and one such inhibitor, crizotinib, is now approved for the treatment of EML4-ALK-driven, non-small cell lung cancer. In neuroblastoma, activating point mutations in the ALK kinase domain can drive disease progression, with the two most common mutations being F1174L and R1275Q. We report here crystal structures of the ALK kinase domain containing the F1174L and R1275Q mutations. Also included are crystal structures of ALK in complex with novel small molecule ALK inhibitors, including a classic type II inhibitor, that stabilize previously unobserved conformations of the ALK activation loop. Collectively, these structures illustrate a different series of activation loop conformations than has been observed in previous ALK crystal structures and provide insight into the activating nature of the R1275Q mutation. The novel active site topologies presented here may also aid the structure-based drug design of a new generation of ALK inhibitors.	[Epstein, Linda F.; Chen, Hao; Emkey, Renee; Whittington, Douglas A.] Amgen Inc, Dept Mol Struct & Characterizat, Cambridge, MA 02142 USA	Amgen	Whittington, DA (corresponding author), 360 Binney St, Cambridge, MA 02142 USA.	dwhittin@amgen.com			Office of Science, Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-05CH11231]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC0206CH11357]; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan	We thank John Robinson for N-terminal sequencing and Michele Potashman and Marian C. Bryan for the synthesis of compounds 1 and 2, respectively. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences of the United States Department of Energy under Contract DE-AC02-05CH11231. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC0206CH11357. Research performed at the Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Arber DA, 1996, HUM PATHOL, V27, P590, DOI 10.1016/S0046-8177(96)90167-7; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Bossi RT, 2010, BIOCHEMISTRY-US, V49, P6813, DOI 10.1021/bi1005514; Bresler SC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002950; Bryan MC, 2012, J MED CHEM, V55, P1698, DOI 10.1021/jm201565s; Camidge DR, 2012, NAT REV CLIN ONCOL, V9, P268, DOI 10.1038/nrclinonc.2012.43; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheng MG, 2012, MOL CANCER THER, V11, P670, DOI 10.1158/1535-7163.MCT-11-0776; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Donella-Deana A, 2005, BIOCHEMISTRY-US, V44, P8533, DOI 10.1021/bi0472954; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Drew AE, 2011, J BIOMOL SCREEN, V16, P164, DOI 10.1177/1087057110394657; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Du XL, 2007, J MOL MED, V85, P863, DOI 10.1007/s00109-007-0159-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Grande E, 2011, MOL CANCER THER, V10, P569, DOI 10.1158/1535-7163.MCT-10-0615; Griffin CA, 1999, CANCER RES, V59, P2776; Heuckmann JM, 2011, CLIN CANCER RES, V17, P7394, DOI 10.1158/1078-0432.CCR-11-1648; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Janoueix-Lerosey I, 2010, ONCOGENE, V29, P1566, DOI 10.1038/onc.2009.518; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jazii FR, 2006, WORLD J GASTROENTERO, V12, P7104, DOI 10.3748/wjg.v12.i44.7104; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kinoshita K, 2011, J MED CHEM, V54, P6286, DOI 10.1021/jm200652u; Kuefer MU, 1997, BLOOD, V90, P2901, DOI 10.1182/blood.V90.8.2901; Lange K, 2003, ONCOGENE, V22, P517, DOI 10.1038/sj.onc.1206076; Laurent C, 2009, J CLIN ONCOL, V27, P4211, DOI 10.1200/JCO.2008.21.5020; Lawrence B, 2000, AM J PATHOL, V157, P377, DOI 10.1016/S0002-9440(10)64550-6; Lee CC, 2010, BIOCHEM J, V430, P425, DOI 10.1042/BJ20100609; Lewis RT, 2012, J MED CHEM, V55, P6523, DOI 10.1021/jm3005866; Lietha D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003800; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Mazot P, 2011, ONCOGENE, V30, P2017, DOI 10.1038/onc.2010.595; McTigue MA, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-2327; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Munshi S, 2002, J BIOL CHEM, V277, P38797, DOI 10.1074/jbc.M205580200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ott GR, 2011, J MED CHEM, V54, P6328, DOI 10.1021/jm200758k; Ott GR, 2010, ACS MED CHEM LETT, V1, P493, DOI 10.1021/ml100158s; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Potashman MH, 2007, J MED CHEM, V50, P4351, DOI 10.1021/jm070034i; Pulford K, 1997, BLOOD, V89, P1394, DOI 10.1182/blood.V89.4.1394; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sabbatini P, 2009, MOL CANCER THER, V8, P2811, DOI 10.1158/1535-7163.MCT-09-0423; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Sasaki T, 2010, CANCER RES, V70, P10038, DOI 10.1158/0008-5472.CAN-10-2956; Schonherr C, 2011, BIOCHEM J, V440, P405, DOI 10.1042/BJ20101796; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Westwood I, 2009, J MOL BIOL, V386, P476, DOI 10.1016/j.jmb.2008.12.033; Wood AC, 2009, J CLIN ONCOL, V27	63	33	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37447	37457		10.1074/jbc.M112.391425	http://dx.doi.org/10.1074/jbc.M112.391425			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22932897	hybrid, Green Published			2022-12-25	WOS:000310588500074
J	Jaspers, MHJ; Nolde, K; Behr, M; Joo, SH; Plessmann, U; Nikolov, M; Urlaub, H; Schuh, R				Jaspers, Martin H. J.; Nolde, Kai; Behr, Matthias; Joo, Seol-hee; Plessmann, Uwe; Nikolov, Miroslav; Urlaub, Henning; Schuh, Reinhard			The Claudin Megatrachea Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEPTATE JUNCTION ORGANIZATION; TUBE-SIZE; TIGHT JUNCTIONS; NA+/K+ ATPASE; DROSOPHILA; ENDOCYTOSIS; BINDING; MATRIX; MORPHOGENESIS; LOCALIZATION	Claudins are integral transmembrane components of the tight junctions forming trans-epithelial barriers in many organs, such as the nervous system, lung, and epidermis. In Drosophila three claudins have been identified that are required for forming the tight junctions analogous structure, the septate junctions (SJs). The lack of claudins results in a disruption of SJ integrity leading to a breakdown of the trans-epithelial barrier and to disturbed epithelial morphogenesis. However, little is known about claudin partners for transport mechanisms and membrane organization. Here we present a comprehensive analysis of the claudin proteome in Drosophila by combining biochemical and physiological approaches. Using specific antibodies against the claudin Megatrachea for immunoprecipitation and mass spectrometry, we identified 142 proteins associated with Megatrachea in embryos. The Megatrachea interacting proteins were analyzed in vivo by tissue-specific knockdown of the corresponding genes using RNA interference. We identified known and novel putative SJ components, such as the gene product of CG3921. Furthermore, our data suggest that the control of secretion processes specific to SJs and dependent on Sec61p may involve Megatrachea interaction with Sec61 subunits. Also, our findings suggest that clathrin-coated vesicles may regulate Megatrachea turnover at the plasma membrane similar to human claudins. As claudins are conserved both in structure and function, our findings offer novel candidate proteins involved in the claudin interactome of vertebrates and invertebrates.	[Schuh, Reinhard] Max Planck Inst Biophys Chem, Res Grp Mol Organogenesis, D-37077 Gottingen, Germany; [Plessmann, Uwe; Nikolov, Miroslav; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Dept Clin Chem, D-37075 Gottingen, Germany; [Behr, Matthias] Univ Bonn, Life & Med Sci Inst, D-53115 Bonn, Germany	Max Planck Society; Max Planck Society; University of Gottingen; University of Bonn	Schuh, R (corresponding author), Max Planck Inst Biophys Chem, Res Grp Mol Organogenesis, D-37077 Gottingen, Germany.	rschuh@gwdg.de	Behr, Matthias/K-6505-2019	Behr, Matthias/0000-0001-9869-1257	Max-Planck-Society [MPIbpc Abt.11020]; Deutsche Forschungsgemeinschaft [SFB645]; Ph.D. program "Molecular Biology," International Max Planck Research School at the Georg August University Gottingen	Max-Planck-Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ph.D. program "Molecular Biology," International Max Planck Research School at the Georg August University Gottingen	This work was supported by the Max-Planck-Society (MPIbpc Abt.11020).; Supported by the Deutsche Forschungsgemeinschaft (SFB645).; Supported by a fellowship from the Ph.D. program "Molecular Biology," International Max Planck Research School at the Georg August University Gottingen.	Affolter M, 2000, CURR OPIN CELL BIOL, V12, P731, DOI 10.1016/S0955-0674(00)00160-5; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; BAZINET C, 1993, GENETICS, V134, P1119; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Behr M, 2007, NAT CELL BIOL, V9, P847, DOI 10.1038/ncb1611; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodu V, 2006, GENE DEV, V20, P1817, DOI 10.1101/gad.375706; Daugherty BL, 2004, AM J PHYSIOL-LUNG C, V287, pL1266, DOI 10.1152/ajplung.00423.2003; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Faivre-Sarrailh C, 2004, DEVELOPMENT, V131, P4931, DOI 10.1242/dev.01372; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Fox DT, 2005, DEVELOPMENT, V132, P4819, DOI 10.1242/dev.02056; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Hijazi A, 2009, DEVELOPMENT, V136, P2199, DOI 10.1242/dev.033845; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Ivanov AI, 2004, NOVART FDN SYMP, V263, P124; IVANOV AI, 2004, NOVART FDN SYMP, V263, P211; Ivanov Andrei I, 2004, Novartis Found Symp, V263, P115; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Llimargas M, 2004, DEVELOPMENT, V131, P181, DOI 10.1242/dev.00917; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Nelson KS, 2010, GENETICS, V185, P831, DOI 10.1534/genetics.110.114959; Nilton A, 2010, DEVELOPMENT, V137, P2427, DOI 10.1242/dev.052605; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Paul SM, 2007, DEVELOPMENT, V134, P147, DOI 10.1242/dev.02710; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Petkau G, 2012, J BIOL CHEM, V287, P21396, DOI 10.1074/jbc.M112.359984; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Tiklova K, 2010, NAT CELL BIOL, V12, P1071, DOI 10.1038/ncb2111; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wingen C, 2009, GENE EXPR PATTERNS, V9, P549, DOI 10.1016/j.gep.2009.06.007; Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134; Zhang C. X., 2000, DROSOPHILA PROTOCOLS, P563	53	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36756	36765		10.1074/jbc.M112.399410	http://dx.doi.org/10.1074/jbc.M112.399410			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22930751	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000310588500013
J	Shiozaki, A; Shen-Tu, G; Bai, XH; Iitaka, D; De Falco, V; Santoro, M; Keshavjee, S; Liu, MY				Shiozaki, Atsushi; Shen-Tu, Grace; Bai, Xiaohui; Iitaka, Daisuke; De Falco, Valentina; Santoro, Massimo; Keshavjee, Shaf; Liu, Mingyao			XB130 Mediates Cancer Cell Proliferation and Survival through Multiple Signaling Events Downstream of Akt	PLOS ONE			English	Article							PROTEIN-KINASE B; FORKHEAD TRANSCRIPTION FACTOR; LUNG EPITHELIAL-CELLS; THYROID-CARCINOMA; ADAPTER PROTEIN; IN-VIVO; PHOSPHORYLATION; ACTIVATION; EXPRESSION; APOPTOSIS	XB130, a novel adaptor protein, mediates RET/PTC chromosome rearrangement-related thyroid cancer cell proliferation and survival through phosphatidyl-inositol-3-kinase (PI3K)/Akt pathway. Recently, XB130 was found in different cancer cells in the absence of RET/PTC. To determine whether RET/PTC is required of XB130-related cancer cell proliferation and survival, WRO thyroid cancer cells (with RET/PTC mutation) and A549 lung cancer cells (without RET/PTC) were treated with XB130 siRNA, and multiple Akt down-stream signals were examined. Knocking-down of XB130 inhibited G(1)-S phase progression, and induced spontaneous apoptosis and enhanced intrinsic and extrinsic apoptotic stimulus-induced cell death. Knocking-down of XB130 reduced phosphorylation of p21Cip1/WAF1, p27Kip1, FOXO3a and GSK3 beta, increased p21Cip1/WAF1protein levels and cleavages of caspase-8 and-9. However, the phosphorylation of FOXO1 and the protein levels of p53 were not affected by XB130 siRNA. We also found XB130 can be phosphorylated by multiple protein tyrosine kinases. These results indicate that XB130 is a substrate of multiple protein tyrosine kinases, and it can regulate cell proliferation and survival through modulating selected down-stream signals of PI3K/Akt pathway. XB130 could be involved in growth and survival of different cancer cells.	[Shiozaki, Atsushi; Shen-Tu, Grace; Bai, Xiaohui; Iitaka, Daisuke; Keshavjee, Shaf; Liu, Mingyao] Univ Hlth Network, Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Toronto, ON, Canada; [Keshavjee, Shaf; Liu, Mingyao] Univ Toronto, Fac Med, Dept Surg, Toronto, ON M5S 1A1, Canada; [Keshavjee, Shaf; Liu, Mingyao] CNR G Salvatore, Dipartimento Biol & Patol Cellulare & Mol, Ist Endocrinol & Oncol Sperimentale, Naples, Italy	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Shiozaki, A (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Toronto, ON, Canada.	mingyao.liu@utoronto.ca	DE FALCO, VALENTINA/C-2061-2015	DE FALCO, VALENTINA/0000-0002-8972-7921; Keshavjee, Shaf/0000-0003-4547-8094; Liu, Mingyao/0000-0002-9188-8417	Canadian Institutes of Health Research [MOP-13270, MOP-42546]; Uehara Memorial Foundation; International Society of Heart and Lung Transplantation; Associazione Italiana Ricerca sul Cancro (AIRC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Uehara Memorial Foundation(Uehara Memorial Foundation); International Society of Heart and Lung Transplantation; Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by operating grants (MOP-13270 and MOP-42546) from Canadian Institutes of Health Research, Research Fellowship Awards from Uehara Memorial Foundation and International Society of Heart and Lung Transplantation for Dr. Atsushi Shiozaki and by Associazione Italiana Ricerca sul Cancro (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Balogh K, 2011, ONCOGENE; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; Bernassola F, 1999, CELL DEATH DIFFER, V6, P652, DOI 10.1038/sj.cdd.4400537; Brognard J, 2001, CANCER RES, V61, P3986; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fung SY, 2011, BIOMATERIALS, V32, P4000, DOI 10.1016/j.biomaterials.2011.02.005; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200; Iavarone C, 2006, J BIOL CHEM, V281, P10567, DOI 10.1074/jbc.M513397200; Keane MM, 1996, CANCER RES, V56, P4791; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu W, 2005, MOL ENDOCRINOL, V19, P2349, DOI 10.1210/me.2005-0117; Liu W, 2002, AM J PATHOL, V160, P511, DOI 10.1016/S0002-9440(10)64870-5; Lodyga M, 2002, AM J PHYSIOL-LUNG C, V283, pL265, DOI 10.1152/ajplung.00492.2001; Lodyga M, 2009, ONCOGENE, V28, P937, DOI 10.1038/onc.2008.447; Lodyga M, 2010, J CELL SCI, V123, P4156, DOI 10.1242/jcs.071050; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Massion PP, 2004, AM J RESP CRIT CARE, V170, P1088, DOI 10.1164/rccm.200404-487OC; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Moore SM, 1998, CANCER RES, V58, P5239; Mura M, 2006, CRIT CARE, V10, DOI 10.1186/cc5042; NOGUCHI PD, 1981, CYTOMETRY, V1, P390, DOI 10.1002/cyto.990010607; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Ping B, 2006, INT J ONCOL, V29, P1103; Razzini G, 2000, FASEB J, V14, P1179, DOI 10.1096/fasebj.14.9.1179; Ringel MD, 2001, CANCER RES, V61, P6105; Rokhlin OW, 2002, PROSTATE, V52, P1, DOI 10.1002/pros.10074; ROMANO A, 1994, ONCOGENE, V9, P2923; Santarpia L, 2010, CANCER-AM CANCER SOC, V116, P2974, DOI 10.1002/cncr.25061; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038049; Shiozaki Atsushi, 2011, J Clin Bioinforma, V1, P10, DOI 10.1186/2043-9113-1-10; Shiozaki A, 2011, AM J PATHOL, V178, P391, DOI 10.1016/j.ajpath.2010.11.024; Stiles BL, 2009, ADV DRUG DELIVER REV, V61, P1276, DOI 10.1016/j.addr.2009.07.017; Tang PS, 2008, AM J PHYSIOL-LUNG C, V294, pL632, DOI 10.1152/ajplung.00262.2007; Tang PS, 2006, J CELL PHYSIOL, V209, P457, DOI 10.1002/jcp.20751; Tartari CJ, 2011, AM J CANCER RES, V1, P716; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yamanaka D, 2012, MOL ENDOCRINOL, V26, P1043, DOI 10.1210/me.2011-1349; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	56	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43646	10.1371/journal.pone.0043646	http://dx.doi.org/10.1371/journal.pone.0043646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928011	gold, Green Published, Green Submitted			2022-12-25	WOS:000308224700021
J	Wang, J; Guo, JS; Wu, S; Feng, HQ; Sun, SJ; Pan, J; Zhang, J; Beebe, SJ				Wang, Jing; Guo, Jinsong; Wu, Shan; Feng, Hongqing; Sun, Shujun; Pan, Jie; Zhang, Jue; Beebe, Stephen J.			Synergistic Effects of Nanosecond Pulsed Electric Fields Combined with Low Concentration of Gemcitabine on Human Oral Squamous Cell Carcinoma In Vitro	PLOS ONE			English	Article							ELECTROPORATION THERAPY; INDUCE APOPTOSIS; HEAD; CALCIUM; MECHANISMS; DEATH; DRUG; TRANSLOCATION; RESISTANCE; SURVIVAL	Treatment of cancer often involves uses of multiple therapeutic strategies with different mechanisms of action. In this study we investigated combinations of nanosecond pulsed electric fields (nsPEF) with low concentrations of gemcitabine on human oral cancer cells. Cells (Cal-27) were treated with pulse parameters (20 pulses, 100 ns in duration, intensities of 10, 30 and 60 kV/cm) and then cultured in medium with 0.01 mu g/ml gemcitabine. Proliferation, apoptosis/necrosis, invasion and morphology of those cells were examined using MTT, flow cytometry, clonogenics, transwell migration and TEM assay. Results show that combination treatments of gemcitabine and nsPEFs exhibited significant synergistic activities versus individual treatments for inhibiting oral cancer cell proliferation and inducing apoptosis and necrosis. However, there was no apparent synergism for cell invasion. By this we demonstrated synergistic inhibition of Cal-27 cells in vitro by nsPEFs and gemcitabine. Synergistic behavior indicates that these two treatments have different sites of action and combination treatment allows reduced doses of gemcitabine and lower nsPEF conditions, which may provide better treatment for patients than either treatment alone while reducing systemic toxicities.	[Wang, Jing; Guo, Jinsong] Lanzhou Univ, Dept Oral Med, Sch Stomatol, Lanzhou, Gansu, Peoples R China; [Guo, Jinsong; Wu, Shan; Feng, Hongqing; Zhang, Jue] Peking Univ, Coll Engn, Beijing 100871, Peoples R China; [Sun, Shujun; Zhang, Jue] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Pan, Jie] Peking Univ, Sch Stomatol, Dept Gen Dent, Beijing 100871, Peoples R China; [Beebe, Stephen J.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA	Lanzhou University; Peking University; Peking University; Peking University; Old Dominion University	Wang, J (corresponding author), Lanzhou Univ, Dept Oral Med, Sch Stomatol, Lanzhou, Gansu, Peoples R China.	panjie72@sina.com; sbeebe@odu.edu	Feng, Hongqing/I-5222-2019; Zhang, Jue/N-7594-2013; Zhang, Jue/E-2067-2014	Feng, Hongqing/0000-0003-2767-3080; Guo, Jinsong/0000-0002-7379-4708	Gansu Chinese Medicine Funds [GZK-2011-78]; Fundamental Research Funds for the Central Universities [lzujbky-2012-159]; Mr. Fran Reidy, Bioelectrics Inc.	Gansu Chinese Medicine Funds; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Mr. Fran Reidy, Bioelectrics Inc.	This work was supported by Gansu Chinese Medicine Funds (GZK-2011-78), Fundamental Research Funds for the Central Universities (lzujbky-2012-159), and Mr. Fran Reidy, Bioelectrics Inc. The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript. In addition, Mr. Reidy and Bioelectric Inc. have not pre-reviewed or seen the data presented in this manuscript.	Beebe SJ, 2004, PHYSIOL MEAS, V25, P1077, DOI 10.1088/0967-3334/25/4/023; Beebe SJ, 2003, DNA CELL BIOL, V22, P785, DOI 10.1089/104454903322624993; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Beebe SJ, 2002, IEEE T PLASMA SCI, V30, P286, DOI 10.1109/TPS.2002.1003872; Beebe Stephen J, 2010, Cancers (Basel), V2, P1731, DOI 10.3390/cancers2031731; Boyl P, 2008, WORLD CANC REPORT; BRAAKHUIS BJM, 1991, CANCER RES, V51, P211; Buescher ES, 2004, IEEE T PLASMA SCI, V32, P1563, DOI 10.1109/TPS.2004.832643; Burian M, 2003, ACTA OTO-LARYNGOL, V123, P264, DOI 10.1080/00016480310001114; Carmichael J, 1995, BRIT J CANCER, V8, P21; Chen X, 2012, TECHNOL CANCER RES T, V11, P83, DOI 10.7785/tcrt.2012.500237; Chen XH, 2010, PIGM CELL MELANOMA R, V23, P554, DOI 10.1111/j.1755-148X.2010.00704.x; Chen YW, 2011, MOL BIOSYST, V7, P3065, DOI 10.1039/c1mb05125c; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Dev SB, 2000, IEEE T PLASMA SCI, V28, P206, DOI 10.1109/27.842905; Eguchi Y, 1997, CANCER RES, V57, P1835; Ford WE, 2010, ARCH BIOCHEM BIOPHYS, V497, P82, DOI 10.1016/j.abb.2010.03.008; Frey W, 2006, BIOPHYS J, V90, P3608, DOI 10.1529/biophysj.105.072777; Galmarini Carlos Maria, 2004, BMC Pharmacology, V4, P8, DOI 10.1186/1471-2210-4-8; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Gowrishankar TR, 2006, BIOCHEM BIOPH RES CO, V349, P643, DOI 10.1016/j.bbrc.2006.08.097; Hall EH, 2007, APOPTOSIS, V12, P1721, DOI 10.1007/s10495-007-0083-7; Heller LC, 2011, CLINICAL ASPECTS OF ELECTROPORATION, P159, DOI 10.1007/978-1-4419-8363-3_14; Hofmann GA, 1999, IEEE T BIO-MED ENG, V46, P752, DOI 10.1109/10.764952; Hu Q, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031902; HUANG P, 1995, SEMIN ONCOL, V22, P19; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Landstrom FJ, 2010, DERMATOL SURG, V36, P1245, DOI 10.1111/j.1524-4725.2010.01617.x; Lawrence TS, 2001, CLIN CANCER RES, V7, P314; LeBlanc AK, 2004, VET RADIOL ULTRASOUN, V45, P466, DOI 10.1111/j.1740-8261.2004.04080.x; Mir Lluis M., 2008, V423, P3, DOI 10.1007/978-1-59745-194-9_1; Mir LM, 1999, ADV DRUG DELIVER REV, V35, P107, DOI 10.1016/S0169-409X(98)00066-0; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; OKINO M, 1987, JPN J CANCER RES, V78, P1319; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Panesar K, 2011, US PHARM, V36, P7; Pauwels B, 2005, ONCOLOGIST, V10, P34, DOI 10.1634/theoncologist.10-1-34; Petersen PE, 2009, ORAL ONCOL, V45, P454, DOI 10.1016/j.oraloncology.2008.05.023; PLUNKETT W, 1995, SEMIN ONCOL, V22, P3; PRAUSNITZ MR, 1993, P NATL ACAD SCI USA, V90, P10504, DOI 10.1073/pnas.90.22.10504; Ren W, 2012, BIOCHEM BIOPH RES CO, V421, P808, DOI 10.1016/j.bbrc.2012.04.094; Ren W, 2011, APOPTOSIS, V16, P382, DOI 10.1007/s10495-010-0572-y; Rhodus N, 2007, INSIDE DENT, V3, P1; Schoenbach KH, 2004, P IEEE, V92, P1122, DOI 10.1109/JPROC.2004.829009; Spielmann M, 2001, ONCOLOGY-BASEL, V60, P303, DOI 10.1159/000058524; Stacey M, 2003, MUTAT RES-GEN TOX EN, V542, P65, DOI 10.1016/j.mrgentox.2003.08.006; Sun C, 2004, C P IEEE ENG MED BIO, V7, P5005; Ueno H, 2007, BRIT J CANCER, V97, P145, DOI 10.1038/sj.bjc.6603860; Vernier PT, 2006, PHYS BIOL, V3, P233, DOI 10.1088/1478-3975/3/4/001; Vernier PT, 2011, IEEE ENG MED BIO, P743, DOI 10.1109/IEMBS.2011.6090169; Vernier PT, 2003, IEEE T DIELECT EL IN, V10, P795, DOI 10.1109/TDEI.2003.1237329; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; White JA, 2004, J BIOL CHEM, V279, P22964, DOI 10.1074/jbc.M311135200; Wu Y, 2009, CLIN THER, V31, P2416, DOI 10.1016/j.clinthera.2009.11.020	55	60	70	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43213	10.1371/journal.pone.0043213	http://dx.doi.org/10.1371/journal.pone.0043213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927951	Green Published, Green Submitted, gold			2022-12-25	WOS:000308224700012
J	Shahsavar, A; Kastrup, JS; Nielsen, EO; Kristensen, JL; Gajhede, M; Balle, T				Shahsavar, Azadeh; Kastrup, Jette S.; Nielsen, Elsebet O.; Kristensen, Jesper L.; Gajhede, Michael; Balle, Thomas			Crystal Structure of Lymnaea stagnalis AChBP Complexed with the Potent nAChR Antagonist DH beta E Suggests a Unique Mode of Antagonism	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; BINDING-PROTEIN; COMPETITIVE ANTAGONIST; DETERMINANTS; AGONISTS; DIVERSITY	Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels that belong to the Cys-loop receptor superfamily. These receptors are allosteric proteins that exist in different conformational states, including resting (closed), activated (open), and desensitized (closed) states. The acetylcholine binding protein (AChBP) is a structural homologue of the extracellular ligand-binding domain of nAChRs. In previous studies, the degree of the C-loop radial extension of AChBP has been assigned to different conformational states of nAChRs. It has been suggested that a closed C-loop is preferred for the active conformation of nAChRs in complex with agonists whereas an open C-loop reflects an antagonist-bound (closed) state. In this work, we have determined the crystal structure of AChBP from the water snail Lymnaea stagnalis (Ls) in complex with dihydro-beta-erythroidine (DH beta E), which is a potent competitive antagonist of nAChRs. The structure reveals that binding of DH beta E to AChBP imposes closure of the C-loop as agonists, but also a shift perpendicular to previously observed C-loop movements. These observations suggest that DH beta E may antagonize the receptor via a different mechanism compared to prototypical antagonists and toxins.	[Shahsavar, Azadeh; Kastrup, Jette S.; Kristensen, Jesper L.; Gajhede, Michael; Balle, Thomas] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Nielsen, Elsebet O.] NeuroSearch AS, Ballerup, Denmark	University of Copenhagen	Shahsavar, A (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark.	thomas.balle@sydney.edu.au	Kristensen, Jesper/AAP-4439-2021; Kristensen, Jesper/E-3581-2010	Kristensen, Jesper/0000-0002-5613-1267; Kristensen, Jesper/0000-0002-5613-1267; Shahsavar, Azadeh/0000-0001-5405-597X; Gajhede, Michael/0000-0001-9864-2287; Kastrup, Jette Sandholm/0000-0003-2654-1510; Balle, Thomas/0000-0002-0233-8350	Danscatt; Novo Nordisk Foundation; Danish Research Agency for Science Technology and Innovation	Danscatt; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Agency for Science Technology and Innovation	This work was supported by Danscatt, The Novo Nordisk Foundation, and The Danish Research Agency for Science Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; [Anonymous], 2011, MACROMODEL VERS 9 9; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; Bourne Y, 2010, P NATL ACAD SCI USA, V107, P6076, DOI 10.1073/pnas.0912372107; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brams M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001034; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; CHANGEUX JP, 1984, SCIENCE, V225, P1335, DOI 10.1126/science.6382611; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DECKER MW, 1995, EUR J PHARMACOL, V280, P79, DOI 10.1016/0014-2999(95)00191-M; DECKER MW, 1995, LIFE SCI, V56, P545, DOI 10.1016/0024-3205(94)00488-E; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Harvey SC, 1996, J NEUROSCI, V16, P3798; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; Iturriaga-Vasquez P, 2010, MOL PHARMACOL, V78, P366, DOI 10.1124/mol.110.065490; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Marks MJ, 1999, J PHARMACOL EXP THER, V289, P1090; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGehee DS, 1999, ANN NY ACAD SCI, V868, P565, DOI 10.1111/j.1749-6632.1999.tb11330.x; Papke RL, 2008, NEUROPHARMACOLOGY, V54, P1189, DOI 10.1016/j.neuropharm.2008.03.010; Rohde LAH, 2012, J BIOL CHEM, V287, P4248, DOI 10.1074/jbc.M111.292243; Schrodinger LLC, 2011, MAESTR VERS 9 2; Talley TT, 2008, P NATL ACAD SCI USA, V105, P7606, DOI 10.1073/pnas.0802197105	32	39	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e40757	10.1371/journal.pone.0040757	http://dx.doi.org/10.1371/journal.pone.0040757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927902	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300004
J	Siam, R; Mustafa, GA; Sharaf, H; Moustafa, A; Ramadan, AR; Antunes, A; Bajic, VB; Stingl, U; Marsis, NGR; Coolen, MJL; Sogin, M; Ferreira, AJS; El Dorry, H				Siam, Rania; Mustafa, Ghada A.; Sharaf, Hazem; Moustafa, Ahmed; Ramadan, Adham R.; Antunes, Andre; Bajic, Vladimir B.; Stingl, Uli; Marsis, Nardine G. R.; Coolen, Marco J. L.; Sogin, Mitchell; Ferreira, Ari J. S.; El Dorry, Hamza			Unique Prokaryotic Consortia in Geochemically Distinct Sediments from Red Sea Atlantis II and Discovery Deep Brine Pools	PLOS ONE			English	Article							METALLIFEROUS SEDIMENTS; MICROBIAL COMMUNITIES; SEAWATER INTERFACE; METHANE; DIVERSITY; KEBRIT; OXIDATION; SEQUENCE; ARCHAEA; SHABAN	The seafloor is a unique environment, which allows insights into how geochemical processes affect the diversity of biological life. Among its diverse ecosystems are deep-sea brine pools - water bodies characterized by a unique combination of extreme conditions. The 'polyextremophiles' that constitute the microbial assemblage of these deep hot brines have not been comprehensively studied. We report a comparative taxonomic analysis of the prokaryotic communities of the sediments directly below the Red Sea brine pools, namely, Atlantis II, Discovery, Chain Deep, and an adjacent brine-influenced site. Analyses of sediment samples and high-throughput pyrosequencing of PCR-amplified environmental 16S ribosomal RNA genes (16S rDNA) revealed that one sulfur (S)-rich Atlantis II and one nitrogen (N)-rich Discovery Deep section contained distinct microbial populations that differed from those found in the other sediment samples examined. Proteobacteria, Actinobacteria, Cyanobacteria, Deferribacteres, and Euryarchaeota were the most abundant bacterial and archaeal phyla in both the S-and N-rich sections. Relative abundance-based hierarchical clustering of the 16S rDNA pyrotags assigned to major taxonomic groups allowed us to categorize the archaeal and bacterial communities into three major and distinct groups; group I was unique to the S-rich Atlantis II section (ATII-1), group II was characteristic for the N-rich Discovery sample (DD-1), and group III reflected the composition of the remaining sediments. Many of the groups detected in the S-rich Atlantis II section are likely to play a dominant role in the cycling of methane and sulfur due to their phylogenetic affiliations with bacteria and archaea involved in anaerobic methane oxidation and sulfate reduction.	[Siam, Rania; Mustafa, Ghada A.; Sharaf, Hazem; Moustafa, Ahmed; Marsis, Nardine G. R.; Ferreira, Ari J. S.; El Dorry, Hamza] Amer Univ Cairo, Biotechnol Grad Program, Cairo, Egypt; [Siam, Rania; Moustafa, Ahmed; Ferreira, Ari J. S.; El Dorry, Hamza] Amer Univ Cairo, Dept Biol, Cairo, Egypt; [Siam, Rania; Mustafa, Ghada A.; El Dorry, Hamza] Amer Univ Cairo, Sci & Technol Res Ctr, Cairo, Egypt; [Ramadan, Adham R.] Amer Univ Cairo, Dept Chem, Cairo, Egypt; [Antunes, Andre; Stingl, Uli] KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Bajic, Vladimir B.] KAUST, CBRC, Thuwal, Saudi Arabia; [Coolen, Marco J. L.] Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA; [Sogin, Mitchell] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA USA	Egyptian Knowledge Bank (EKB); American University Cairo; Egyptian Knowledge Bank (EKB); American University Cairo; Egyptian Knowledge Bank (EKB); American University Cairo; Egyptian Knowledge Bank (EKB); American University Cairo; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Woods Hole Oceanographic Institution; Marine Biological Laboratory - Woods Hole	Siam, R (corresponding author), Amer Univ Cairo, Biotechnol Grad Program, Cairo, Egypt.	rsiam@aucegypt.edu	Sogin, Mitchell/AAE-7186-2019; Moustafa, Ahmed/C-5234-2009; Moustafa, Ahmed/AAZ-3991-2020; Stingl, Uli/H-1191-2014; Coolen, Marco J. L./B-8263-2015; Sharaf, Hazem/ABG-5995-2021; Antunes, André/A-8711-2012; Ferreira, Ari J S/C-2266-2015; Bajic, Vladimir/D-2810-2009	Moustafa, Ahmed/0000-0002-0111-3555; Moustafa, Ahmed/0000-0002-0111-3555; Stingl, Uli/0000-0002-0684-2597; Coolen, Marco J. L./0000-0002-0417-920X; Sharaf, Hazem/0000-0002-6728-1631; Antunes, André/0000-0001-7668-9842; Ferreira, Ari J S/0000-0002-7526-5543; Bajic, Vladimir/0000-0001-5435-4750	King Abdullah University for Science and Technology Global Collaborative Partners (GCR) program; Division Of Ocean Sciences [0825020] Funding Source: National Science Foundation	King Abdullah University for Science and Technology Global Collaborative Partners (GCR) program; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by King Abdullah University for Science and Technology Global Collaborative Partners (GCR) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Antunes A, 2011, ENV MICROBIOL REP, V3, P416, DOI 10.1111/j.1758-2229.2011.00264.x; BACKER H, 1972, NATURE-PHYS SCI, V240, P153, DOI 10.1038/physci240153a0; Bertram C, 2011, RESOUR POLICY, V36, P315, DOI 10.1016/j.resourpol.2011.09.001; Bower A, 2009, WOODS HOLE OCEANOGRA; DANIELSSON LG, 1980, GEOCHIM COSMOCHIM AC, V44, P2051, DOI 10.1016/0016-7037(80)90203-3; Eder W, 2002, ENVIRON MICROBIOL, V4, P758, DOI 10.1046/j.1462-2920.2002.00351.x; Eder W, 2001, APPL ENVIRON MICROB, V67, P3077, DOI 10.1128/AEM.67.7.3077-3085.2001; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faber E, 1998, ORG GEOCHEM, V29, P363, DOI 10.1016/S0146-6380(98)00155-7; FIALA G, 1990, ARCH MICROBIOL, V154, P120, DOI 10.1007/BF00423320; Hartmann M, 1998, MAR GEOL, V144, P311, DOI 10.1016/S0025-3227(97)00055-8; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Kendall MM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P244, DOI 10.1007/0-387-30743-5_12; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lio P, 1998, GENOME RES, V8, P1233, DOI 10.1101/gr.8.12.1233; Lliros M, 2010, APPL ENVIRON MICROB, V76, P6853, DOI 10.1128/AEM.02864-09; Lloyd KG, 2011, ENVIRON MICROBIOL, V13, P2548, DOI 10.1111/j.1462-2920.2011.02526.x; Lloyd KG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008738; MILLER AR, 1966, GEOCHIM COSMOCHIM AC, V30, P341, DOI 10.1016/0016-7037(66)90007-X; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Pratscher J, 2011, PNAS, P1; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qian PY, 2011, ISME J, V5, P507, DOI 10.1038/ismej.2010.112; Reeburgh W. S., 1993, P1; Ryan WBF, 2011, RED SEA; Schmidt M, 2003, CHEM GEOL, V200, P359, DOI 10.1016/S0009-2541(03)00206-7; Singh SK, 2010, RES MICROBIOL, V161, P177, DOI 10.1016/j.resmic.2010.01.008; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Takacs CD, 2001, FEMS MICROBIOL ECOL, V35, P123, DOI 10.1016/S0168-6496(00)00119-7; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Wang Y, 2011, INT CONF ACOUST SPEE, P1, DOI 10.1109/PLASMA.2011.5993071; Winckler G, 2000, GEOCHIM COSMOCHIM AC, V64, P1567, DOI 10.1016/S0016-7037(99)00441-X; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	35	35	36	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42872	10.1371/journal.pone.0042872	http://dx.doi.org/10.1371/journal.pone.0042872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916172	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800034
J	Zhang, H; Yu, H; Wang, X; Zheng, WW; Yang, B; Pi, JB; He, GS; Qu, WD				Zhang, Hao; Yu, Huan; Wang, Xia; Zheng, Weiwei; Yang, Bei; Pi, Jingbo; He, Gengsheng; Qu, Weidong			(S)-alpha-Chlorohydrin Inhibits Protein Tyrosine Phosphorylation through Blocking Cyclic AMP - Protein Kinase A Pathway in Spermatozoa	PLOS ONE			English	Article							SOLUBLE ADENYLYL-CYCLASE; MOUSE SPERM CAPACITATION; ALPHA-CHLOROHYDRIN; BOAR SPERM; IN-VITRO; HYPERACTIVATED MOTILITY; ANTIFERTILITY COMPOUNDS; MAMMALIAN SPERMATOZOA; ACROSOME REACTION; RAT SPERM	alpha-Chlorohydrin is a common contaminant in food. Its (S)-isomer, (S)-alpha-chlorohydrin (SACH), is known for causing infertility in animals by inhibiting glycolysis of spermatozoa. The aim of present work was to examine the relationship between SACH and protein tyrosine phosphorylation (PTP), which plays a critical role in regulating mammalian sperm capacitation. In vitro exposure of SACH 50 mu M to isolated rat epididymal sperm inhibited PTP. Sperm-specific glyceraldehyde 3-phosphate dehydrogenase (GAPDS) activities, the intracellular adenosine 5'-triphosphate (ATP) levels, 3'-5'-cyclic adenosine monophosphate (cAMP) levels and phosphorylation of protein kinase A (PKA) substrates in rat sperm were diminished dramatically, indicating that both glycolysis and the cAMP/PKA signaling pathway were impaired by SACH. The inhibition of both PTP and phosphorylation of PKA substrates by SACH could be restored by addition of cAMP analog dibutyryl-cAMP (dbcAMP) and phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX). Moreover, addition of glycerol protected glycolysis, ATP levels, phosphorylation of PKA substrates and PTP against the influence of SACH. These results suggested SACH inhibited PTP through blocking cAMP/PKA pathway in sperm, and PTP inhibition may play a role in infertility associated with SACH.	[Zhang, Hao; Wang, Xia; Zheng, Weiwei; He, Gengsheng; Qu, Weidong] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Dept Environm Hlth,Sch Publ Hlth, Shanghai 200433, Peoples R China; [Yu, Huan] Fudan Univ, Dept Neurol, Huashan Hosp, Shanghai 200433, Peoples R China; [Yang, Bei; Pi, Jingbo] Hamner Inst Hlth Sci, Inst Chem Safety Sci, Res Triangle Pk, NC USA; [Yang, Bei] China Med Univ, Dept Histol & Embryol, Basic Med Coll, Shenyang, Peoples R China	Fudan University; Fudan University; The Hamner Institutes for Health Sciences; China Medical University	Zhang, H (corresponding author), Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Dept Environm Hlth,Sch Publ Hlth, Shanghai 200433, Peoples R China.	gshe@shmu.edu.cn; wdqu@fudan.edu.cn	PI, JINGBO/GWC-2514-2022	PI, JINGBO/0000-0003-0227-8041	National Natural Science Fund [30571539, 30972438]; Shanghai Rising Star program [03QD14011]; Shanghai Municipal Health Bureau Leading Academic Discipline Project [08GWD14]; Dawn Scholarship Project [07SG01]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Shanghai Rising Star program; Shanghai Municipal Health Bureau Leading Academic Discipline Project; Dawn Scholarship Project	This research was supported by grants from the National Natural Science Fund (No. 30571539 and 30972438), Shanghai Rising Star program (No. 03QD14011), Shanghai Municipal Health Bureau Leading Academic Discipline Project (No. 08GWD14), and Dawn Scholarship Project (No. 07SG01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 1998, BIOL REPROD, V58, P186, DOI 10.1095/biolreprod58.1.186; Arcelay E, 2008, INT J DEV BIOL, V52, P463, DOI 10.1387/ijdb.072555ea; Baer I, 2010, ANAL BIOANAL CHEM, V396, P443, DOI 10.1007/s00216-009-3177-y; Bailey JL, 2005, THERIOGENOLOGY, V63, P599, DOI 10.1016/j.theriogenology.2004.09.034; Bone W, 2000, INT J ANDROL, V23, P284; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Buffone MG, 2009, J ANDROL, V30, P552, DOI 10.2164/jandrol.108.006551; Burton KA, 2007, PHYSIOLOGY, V22, P40, DOI 10.1152/physiol.00034.2006; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; COONEY SJ, 1988, J REPROD FERTIL, V82, P309; COOPER TG, 1981, J REPROD FERTIL, V61, P163, DOI 10.1530/jrf.0.0610163; Crews C, 2001, FOOD ADDIT CONTAM, V18, P271, DOI 10.1080/02652030010021512; Duan C, 2003, CYTOGENET GENOME RES, V103, P352, DOI 10.1159/000076824; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; FORD WCL, 1986, J REPROD FERTIL, V77, P537; FORD WCL, 1977, J REPROD FERTIL, V51, P105; Frayne J, 2009, J BIOL CHEM, V284, P22703, DOI 10.1074/jbc.M109.004648; Hamlet CG, 2002, FOOD ADDIT CONTAM A, V19, P619, DOI 10.1080/02652030210132391; Hamlet CG, 2011, EUR J LIPID SCI TECH, V113, P279, DOI 10.1002/ejlt.201000480; Harrison RAP, 2004, MOL REPROD DEV, V67, P337, DOI 10.1002/mrd.20028; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Ho HC, 2003, BIOL REPROD, V68, P1590, DOI 10.1095/biolreprod.102.011320; HOPPE PC, 1976, BIOL REPROD, V15, P39, DOI 10.1095/biolreprod15.1.39; Hung PH, 2008, BIOL REPROD, V79, P367, DOI 10.1095/biolreprod.107.066357; Jelks K, 2001, REPROD TOXICOL, V15, P11; JEULIN C, 1992, CELL MOTIL CYTOSKEL, V21, P210, DOI 10.1002/cm.970210305; JOHNSON LA, 1972, J ANIM SCI, V34, P241; JONES AR, 1969, NATURE, V224, P83, DOI 10.1038/224083a0; Jones AR, 1998, J REPROD FERTIL, P227; JONES AR, 1983, AUST J BIOL SCI, V36, P333; Jones AR, 1999, INT J ANDROL, V22, P130; JONES AR, 1992, J REPROD FERTIL, V94, P129, DOI 10.1530/jrf.0.0940129; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kaneto M, 2008, MOL REPROD DEV, V75, P1045, DOI 10.1002/mrd.20839; KIRTON KT, 1970, J REPROD FERTIL, V21, P275; Kota V, 2009, PROTEOMICS, V9, P1809, DOI 10.1002/pmic.200800519; Krapf D, 2010, J BIOL CHEM, V285, P7977, DOI 10.1074/jbc.M109.085845; KREIDER JL, 1970, J ANIM SCI, V31, P95, DOI 10.2527/jas1970.31195x; Lin CY, 2009, REPROD TOXICOL, V28, P75, DOI 10.1016/j.reprotox.2009.03.005; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Liu DY, 2006, HUM REPROD, V21, P1002, DOI 10.1093/humrep/dei435; Macarthur R, 2000, FOOD ADDIT CONTAM, V17, P903, DOI 10.1080/026520300750038072; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Mohanarao GJ, 2011, ANIM REPROD SCI, V123, P40, DOI 10.1016/j.anireprosci.2010.11.013; MOHRI H, 1967, J REPROD FERTIL, V14, P179, DOI 10.1530/jrf.0.0140179; Morgan DJ, 2008, P NATL ACAD SCI USA, V105, P20740, DOI 10.1073/pnas.0810971105; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Naaby-Hansen S, 2002, DEV BIOL, V242, P236, DOI 10.1006/dbio.2001.0527; Nascimento JM, 2008, J CELL PHYSIOL, V217, P745, DOI 10.1002/jcp.21549; Naz Rajesh K, 2004, Reprod Biol Endocrinol, V2, P75, DOI 10.1186/1477-7827-2-75; Nienow AM, 2009, CHEMOSPHERE, V75, P1015, DOI 10.1016/j.chemosphere.2009.01.053; NIWA K, 1978, J REPROD FERTIL, V53, P267, DOI 10.1530/jrf.0.0530267; O'Flaherty C, 2004, MOL HUM REPROD, V10, P355, DOI 10.1093/molehr/gah046; Reece P, 2005, ORIGIN FORMATION 3 M; Roberts KP, 2003, BIOL REPROD, V69, P572, DOI 10.1095/biolreprod.102.013771; Salicioni Ana M, 2007, Soc Reprod Fertil Suppl, V65, P245; Samojlik E, 1970, Biol Reprod, V2, P299, DOI 10.1095/biolreprod2.2.299; Schilter B, 2011, EUR J LIPID SCI TECH, V113, P309, DOI 10.1002/ejlt.201000311; Sepideh Jabbari, 2009, J Reprod Infertil, V10, P185; Signorelli J, 2012, CELL TISSUE IN PRESS; Siva AB, 2006, REPROD TOXICOL, V22, P702, DOI 10.1016/j.reprotox.2006.04.013; Sommer D, 2002, ARCH BIOCHEM BIOPHYS, V404, P271, DOI 10.1016/S0003-9861(02)00242-4; STENGEL D, 1984, ANN NY ACAD SCI, V438, P18, DOI 10.1111/j.1749-6632.1984.tb38272.x; STEVENSON D, 1984, INT J ANDROL, V7, P79, DOI 10.1111/j.1365-2605.1984.tb00762.x; Terrell KA, 2011, BIOL REPROD, V84, P1198, DOI 10.1095/biolreprod.110.090225; Travis AJ, 2001, J BIOL CHEM, V276, P7630, DOI 10.1074/jbc.M006217200; Urner F, 2003, REPRODUCTION, V125, P17, DOI 10.1530/rep.0.1250017; Urner F, 2001, BIOL REPROD, V64, P1350, DOI 10.1095/biolreprod64.5.1350; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; WARD WS, 1991, BIOL REPROD, V44, P569, DOI 10.1095/biolreprod44.4.569; Weisshaar R, 2008, EUR J LIPID SCI TECH, V110, P671, DOI 10.1002/ejlt.200800154; Welch JE, 2000, J ANDROL, V21, P328; WHISLER RL, 1995, ARCH BIOCHEM BIOPHYS, V319, P23, DOI 10.1006/abbi.1995.1263; Williams AC, 2001, J ANDROL, V22, P680; Wong KO, 2006, FOOD CONTROL, V17, P408, DOI 10.1016/j.foodcont.2005.01.010	76	15	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43004	10.1371/journal.pone.0043004	http://dx.doi.org/10.1371/journal.pone.0043004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916194	Green Submitted, gold, Green Published			2022-12-25	WOS:000307733800040
J	Hayakawa, T; Sugawara, T; Go, Y; Udono, T; Hirai, H; Imai, H				Hayakawa, Takashi; Sugawara, Tohru; Go, Yasuhiro; Udono, Toshifumi; Hirai, Hirohisa; Imai, Hiroo			Eco-Geographical Diversification of Bitter Taste Receptor Genes (TAS2Rs) among Subspecies of Chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							WILD CHIMPANZEES; MAHALE MOUNTAINS; HAPLOTYPE RECONSTRUCTION; VERNONIA-AMYGDALINA; STATISTICAL-METHOD; NATIONAL-PARK; SENSITIVITY; EVOLUTION; FAMILY; ALLELES	Chimpanzees (Pan troglodytes) have region-specific difference in dietary repertoires from East to West across tropical Africa. Such differences may result from different genetic backgrounds in addition to cultural variations. We analyzed the sequences of all bitter taste receptor genes (cTAS2Rs) in a total of 59 chimpanzees, including 4 putative subspecies. We identified genetic variations including single-nucleotide variations (SNVs), insertions and deletions (indels), gene-conversion variations, and copy-number variations (CNVs) in cTAS2Rs. Approximately two-thirds of all cTAS2R haplotypes in the amino acid sequence were unique to each subspecies. We analyzed the evolutionary backgrounds of natural selection behind such diversification. Our previous study concluded that diversification of cTAS2Rs in western chimpanzees (P. t. verus) may have resulted from balancing selection. In contrast, the present study found that purifying selection dominates as the evolutionary form of diversification of the so-called human cluster of cTAS2Rs in eastern chimpanzees (P. t. schweinfurthii) and that the other cTAS2Rs were under no obvious selection as a whole. Such marked diversification of cTAS2Rs with different evolutionary backgrounds among subspecies of chimpanzees probably reflects their subspecies-specific dietary repertoires.	[Hayakawa, Takashi; Sugawara, Tohru; Go, Yasuhiro; Hirai, Hirohisa; Imai, Hiroo] Kyoto Univ, Primate Res Inst, Dept Cellular & Mol Biol, Mol Biol Sect, Inuyama, Aichi 484, Japan; [Hayakawa, Takashi] Japan Soc Promot Sci, Tokyo, Japan; [Udono, Toshifumi] Kyoto Univ, Wildlife Res Ctr, Kumamoto, Japan	Kyoto University; Japan Society for the Promotion of Science; Kyoto University	Hayakawa, T (corresponding author), Kyoto Univ, Primate Res Inst, Dept Cellular & Mol Biol, Mol Biol Sect, Inuyama, Aichi 484, Japan.	imai.hiroo.5m@kyoto-u.ac.jp	Imai, Hiroo/AAP-2393-2020; Hayakawa, Takashi/U-9518-2018; Go, Yasuhiro/AAD-3313-2020; Sugawara, Tohru/W-5304-2019	Imai, Hiroo/0000-0003-0729-0322; Hayakawa, Takashi/0000-0002-1037-0350; Go, Yasuhiro/0000-0003-4581-0325; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21370109, 22247036, 22247037, 22650053, 22770233, 24370096, 24405018, 244270, A06]; Environment Research and Technology Development Fund from the Ministry of the Environment of Japan [D-1007]; Inamori Foundation; Takeda Foundation for Science; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research [22247037, 24650234] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Environment Research and Technology Development Fund from the Ministry of the Environment of Japan; Inamori Foundation; Takeda Foundation for Science; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by Grants-in-Aid for Scientific Research (21370109, 22247036, 22247037, 22650053, 22770233, 24370096, 24405018, 244270, and Global COE Program A06) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Environment Research and Technology Development Fund (D-1007) from the Ministry of the Environment of Japan, and grants from the Inamori Foundation to YG and from the Takeda Foundation for Science and the Suzuken Memorial Foundation to HI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Betran E, 1997, GENETICS, V146, P89; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Campbell MC, 2012, MOL BIOL EVOL, V29, P1141, DOI 10.1093/molbev/msr293; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; CHIARELLI B., 1963, FOLIA PRIMATOLOGICA [BASEL], V1, P88, DOI 10.1159/000165784; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Fisher RA, 1939, NATURE, V144, P750, DOI 10.1038/144750a0; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Gonder MK, 1997, NATURE, V388, P337, DOI 10.1038/41005; Groves CP, 2001, PRIMATE TAXONOMY; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; HUFFMAN MA, 1989, PRIMATES, V30, P51, DOI 10.1007/BF02381210; Huffman MA, 2003, P NUTR SOC, V62, P371, DOI 10.1079/PNS2003257; Imai H, 2012, BIOL LETT IN PRESS; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim U, 2005, HUM MUTAT, V26, P199, DOI 10.1002/humu.20203; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; KOSHIMIZU K, 1993, INT J PRIMATOL, V14, P345, DOI 10.1007/BF02192637; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P408, DOI 10.1098/rspb.2010.1112; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MCGREW WC, 1988, AM J PRIMATOL, V16, P213, DOI 10.1002/ajp.1350160304; Meyerhof W, 2011, FLAVOUR FRAG J, V26, P260, DOI 10.1002/ffj.2041; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nishida, 2012, CHIMPANZEES LAKESHOR; NISHIDA T, 1983, J HUM EVOL, V12, P467, DOI 10.1016/S0047-2484(83)80142-0; Nishida T, 2000, CURR ANTHROPOL, V41, P431, DOI 10.1086/300149; Nishida T., 1983, AFR STUD MONOGR, V3, P109, DOI DOI 10.14989/67987; Oates JF, 2009, PRIMATES, V50, P78, DOI 10.1007/s10329-008-0116-z; OHIGASHI H, 1994, J CHEM ECOL, V20, P541, DOI 10.1007/BF02059596; Pronin AN, 2007, CURR BIOL, V17, P1403, DOI 10.1016/j.cub.2007.07.046; Roudnitzky N, 2011, HUM MOL GENET, V20, P3437, DOI 10.1093/hmg/ddr252; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Snyder LH, 1931, SCIENCE, V74, P151, DOI 10.1126/science.74.1910.151; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sugawara T, 2011, MOL BIOL EVOL, V28, P921, DOI 10.1093/molbev/msq279; SUGIYAMA Y, 1987, PRIMATES, V28, P133, DOI 10.1007/BF02382192; Sugiyama Yukimaru, 1992, African Study Monographs, V13, P127; Suzuki N, 2010, PRIMATES, V51, P285, DOI 10.1007/s10329-010-0209-3; TAJIMA F, 1989, GENETICS, V123, P585; van Lawick-Goodall J., 1968, Animal Behaviour Monographs, V1, P161; Wegmann D, 2010, MOL BIOL EVOL, V27, P1425, DOI 10.1093/molbev/msq028; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wooding S, 2006, NATURE, V440, P930, DOI 10.1038/nature04655; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743	60	18	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43277	10.1371/journal.pone.0043277	http://dx.doi.org/10.1371/journal.pone.0043277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916235	Green Submitted, gold, Green Published			2022-12-25	WOS:000307824300036
J	Jonker, FAM; Calis, JCJ; van Hensbroek, MB; Phiri, K; Geskus, RB; Brabin, BJ; Leenstra, T				Jonker, Femkje A. M.; Calis, Job C. J.; van Hensbroek, Michael Boele; Phiri, Kamija; Geskus, Ronald B.; Brabin, Bernard J.; Leenstra, Tjalling			Iron Status Predicts Malaria Risk in Malawian Preschool Children	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; SEVERE ANEMIA; FOLIC-ACID; DEFICIENCY; SUPPLEMENTATION; INFECTION; IMPACT; CHILDHOOD; MORTALITY; PATTERNS	Introduction: Iron deficiency is highly prevalent in pre-school children in developing countries and an important health problem in sub-Saharan Africa. A debate exists on the possible protective effect of iron deficiency against malaria and other infections; yet consensus is lacking due to limited data. Recent studies have focused on the risks of iron supplementation but the effect of an individual's iron status on malaria risk remains unclear. Studies of iron status in areas with a high burden of infections often are exposed to bias. The aim of this study was to assess the predictive value of baseline iron status for malaria risk explicitly taking potential biases into account. Methods and materials: We prospectively assessed the relationship between baseline iron deficiency (serum ferritin <30 mu g/L) and malaria risk in a cohort of 727 Malawian preschool children during a year of follow-up. Data were analyzed using marginal structural Cox regression models and confounders were selected using causal graph theory. Sensitivity of results to bias resulting from misclassification of iron status by concurrent inflammation and to bias from unmeasured confounding were assessed using modern causal inference methods. Results and Conclusions: The overall incidence of malaria parasitemia and clinical malaria was 1.9 (95%CI 1.8-2.0) and 0.7 (95%CI 0.6-0.8) events per person-year, respectively. Children with iron deficiency at baseline had a lower incidence of malaria parasitemia and clinical malaria during a year of follow-up; adjusted hazard ratio's 0.55 (95%-CI: 0.41-0.74) and 0.49 (95%-CI: 0.33-0.73), respectively. Our results suggest that iron deficiency protects against malaria parasitemia and clinical malaria in young children. Therefore the clinical importance of treating iron deficiency in a pre-school child should be weighed carefully against potential harms. In malaria endemic areas treatment of iron deficiency in children requires sustained prevention of malaria.	[Jonker, Femkje A. M.; Calis, Job C. J.; van Hensbroek, Michael Boele; Brabin, Bernard J.] Univ Amsterdam, Acad Med Ctr, Global Child Hlth Grp, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Phiri, Kamija] Coll Med, Dept Community Hlth, Blantyre, Malawi; [Geskus, Ronald B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Brabin, Bernard J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Leenstra, Tjalling] Univ Amsterdam, Acad Med Ctr, Div Internal Med, Ctr Trop Med & Travel Med,Dept Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Leenstra, Tjalling] Netherlands Minist Def, The Hague, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Malawi; University of Amsterdam; Academic Medical Center Amsterdam; Liverpool School of Tropical Medicine; University of Liverpool; University of Amsterdam; Academic Medical Center Amsterdam	Jonker, FAM (corresponding author), Univ Amsterdam, Acad Med Ctr, Global Child Hlth Grp, Emma Childrens Hosp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	femkje.jonker@live.nl	Brabin, Bernard/AAJ-7389-2020	Boele van Hensbroek, Michael/0000-0003-1907-5427; Phiri, Kamija/0000-0003-1753-2727; Brabin, Bernard/0000-0001-6860-2508	Wellcome Trust [064722]; Nutricia Research Foundation; Ter Meulen Fund of the Royal Netherlands Academy of Arts and Sciences; Dr. P.C. Flu Foundation; JANIVO Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Nutricia Research Foundation(Danone Nutricia); Ter Meulen Fund of the Royal Netherlands Academy of Arts and Sciences; Dr. P.C. Flu Foundation; JANIVO Foundation	This study was supported by a grant (064722) from the Wellcome Trust and by independent grants from the Nutricia Research Foundation, the Ter Meulen Fund of the Royal Netherlands Academy of Arts and Sciences, the Dr. P.C. Flu Foundation and JANIVO Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, B WORLD HEALTH ORGAN, V64, P929; [Anonymous], 2000, WHOFCHCSH001; Barry AE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008326; Beesley R, 2000, T ROY SOC TROP MED H, V94, P295, DOI 10.1016/S0035-9203(00)90329-8; Brumback BA, 2004, STAT MED, V23, P749, DOI 10.1002/sim.1657; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Carter JY, 2005, AM J TROP MED HYG, V73, P166, DOI 10.4269/ajtmh.2005.73.166; Cercamondi CI, 2010, AM J CLIN NUTR, V92, P1385, DOI 10.3945/ajcn.2010.30051; COENEN JLLM, 1991, CLIN CHEM, V37, P560; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Denic S, 2007, NUTRITION, V23, P603, DOI 10.1016/j.nut.2007.05.002; Doherty CP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002133; Doherty CP, 2002, J PEDIATR GASTR NUTR, V34, P346, DOI 10.1097/00005176-200204000-00004; English M, 2006, LANCET, V367, P90, DOI 10.1016/S0140-6736(06)67939-7; Franchini M, 2008, HEPATOL INT, V2, P335, DOI 10.1007/s12072-008-9076-z; Gangaidzo IT, 2001, J INFECT DIS, V184, P936, DOI 10.1086/323203; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gwamaka M, 2012, CLIN INFECT DIS, V54, P1137, DOI 10.1093/cid/cis010; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Iannotti LL, 2006, AM J CLIN NUTR, V84, P1261, DOI 10.1093/ajcn/84.6.1261; Iolascon A, 2009, HAEMATOL-HEMATOL J, V94, P395, DOI 10.3324/haematol.13619; Iron Deficiency Project Advisory Service, 163660 IR DEF PROJ A; Jonker FAM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001555; Kabyemela ER, 2008, J INFECT DIS, V198, P163, DOI 10.1086/589512; Klungsoyr O, 2009, LIFETIME DATA ANAL, V15, P278, DOI 10.1007/s10985-008-9109-x; Lash TL, 2000, EPIDEMIOLOGY, V11, P544, DOI 10.1097/00001648-200009000-00010; Matsuzaki-Moriya C, 2011, EUR J IMMUNOL, V41, P1365, DOI 10.1002/eji.201040942; Mebrahtu T, 2004, J NUTR, V134, P3037, DOI 10.1093/jn/134.11.3037; Molyneux EM, 2003, ARCH DIS CHILD, V88, P1112, DOI 10.1136/adc.88.12.1112; MURAKAWA H, 1987, BLOOD, V69, P1464; MURRAY MJ, 1978, BRIT MED J, V2, P1113, DOI 10.1136/bmj.2.6145.1113; Mutero CM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-21; Nweneka CV, 2010, T ROY SOC TROP MED H, V104, P175, DOI 10.1016/j.trstmh.2009.08.007; Nyakeriga AM, 2004, J INFECT DIS, V190, P439, DOI 10.1086/422331; Okebe JU, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006589.pub3; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; Pearl J, 2000, ART SCI CAUSE EFFECT, P331; Phiri KS, 2009, J CLIN PATHOL, V62, P1103, DOI 10.1136/jcp.2009.066498; Phiri KS, 2009, J CLIN PATHOL, V62, P685, DOI 10.1136/jcp.2009.064451; Raiten DJ, 2011, INT J VITAM NUTR RES, V81, P57, DOI 10.1024/0300-9831/a000051; Richard SA, 2006, AM J TROP MED HYG, V75, P126, DOI 10.4269/ajtmh.2006.75.1.0750126; Robins JM, 1999, STAT MODELS EPIDEMIO, P1; Rowe AK, 2011, AM J PUBLIC HEALTH, V101, P2333, DOI 10.2105/AJPH.2010.300068; Rubin DB, 1987, HDB STAT MODELING SO; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; SLUTSKER L, 1994, T ROY SOC TROP MED H, V88, P548, DOI 10.1016/0035-9203(94)90157-0; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Smith JL, 2010, TROP MED INT HEALTH, V15, P776, DOI 10.1111/j.1365-3156.2010.02542.x; Sullivan AD, 1996, PARASITOLOGY, V112, P285, DOI 10.1017/S003118200006580X; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Trey JE, 1995, CRIT REV ONCOL HEMAT, V21, P1, DOI 10.1016/1040-8428(94)00141-3; Van Buuren S., 2011, MICE MULTIVARIATE IM; van der Wal WM, 2011, J STAT SOFTW, V43, P1; Wander K, 2009, AM J HUM BIOL, V21, P172, DOI 10.1002/ajhb.20839; Weinberg ED, 1996, BIOMETALS, V9, P393; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; WHO, 2007, CONCL REC WHO CONS P	61	54	55	38	222	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42670	10.1371/journal.pone.0042670	http://dx.doi.org/10.1371/journal.pone.0042670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916146	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000307824300014
J	Schneider, T; Herzig, A; Koinig, KA; Sommaruga, R				Schneider, Tobias; Herzig, Alois; Koinig, Karin A.; Sommaruga, Ruben			Copepods in Turbid Shallow Soda Lakes Accumulate Unexpected High Levels of Carotenoids	PLOS ONE			English	Article							FRESH-WATER ZOOPLANKTON; ULTRAVIOLET-RADIATION; AMINO-ACIDS; PHOTOPROTECTIVE COMPOUNDS; UV-RADIATION; ADAPTIVE SIGNIFICANCE; DIAPTOMUS COPEPODA; PIGMENTATION; PHYTOPLANKTON; PROTECTION	Carotenoids are protective pigments present in many aquatic organisms that reduce the photooxidative stress induced by short-wavelenght solar radiation, yet increase their susceptibility to predators. Arctodiaptomus spinosus, a calanoid copepod typically found in many fishless shallow soda lakes, shows large between-lake differences in pigmentation. Here, we attribute these differences to the environmental state of these ecosystems, namely, 'dark water' lakes with submersed vegetation and turbid 'white' lakes lacking macrophytes. Copepod carotenoid concentration in the turbid 'white' lakes was significantly (about 20-fold) higher than in the 'dark water' ones, although the latter systems were characterized by higher transparency. In addition, males had on a dry weight basis around three times higher carotenoid concentrations than females. Mycosporine-like amino acids (direct UV screening substances) were found in all cases, but in low concentration. The environmental conditions in these ecosystems were largely shaped by the presence/absence of submersed macrophytes Thus, in the turbid lakes, the strong wind-driven mixis allows for copepods to be brought to the surface and being exposed to solar radiation, whereas in 'dark water' ones, macrophytes reduce water turbulence and additionally provide shelter. Our results explain the counter-intuitive notion of strong red pigmentation in copepods from a turbid ecosystem and suggest that factors other than high UV transparency favor carotenoid accumulation in zooplankton.	[Herzig, Alois] Biol Res Stn Neusiedler See, Illmitz, Austria; [Schneider, Tobias; Sommaruga, Ruben] Univ Innsbruck, Inst Ecol, Lab Aquat Photobiol & Plankton Ecol, A-6020 Innsbruck, Austria	University of Innsbruck	Schneider, T (corresponding author), Univ Quebec Chicoutimi, Dept Sci Fondamentales, Saguenay, PQ, Canada.	ruben.sommaruga@uibk.ac.at	Koinig, Karin/F-2542-2013; Sommaruga, Ruben/P-6626-2019; Sommaruga, Ruben/E-5335-2011	Koinig, Karin/0000-0002-3659-4934; Sommaruga, Ruben/0000-0002-1055-2461; Sommaruga, Ruben/0000-0002-1055-2461; Schneider, Tobias/0000-0002-4793-4762	Institute of Ecology; University of Innsbruck; Biological Research Station Neusiedler See	Institute of Ecology; University of Innsbruck; Biological Research Station Neusiedler See	Funding was provided by the Institute of Ecology, University of Innsbruck and the Biological Research Station Neusiedler See. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2004, LIMNOL OCEANOGR, V49, P225, DOI 10.4319/lo.2004.49.1.0225; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andersson M, 2003, MAR ECOL PROG SER, V254, P213, DOI 10.3354/meps254213; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; BYRON ER, 1982, ECOLOGY, V63, P1871, DOI 10.2307/1940127; BYRON ER, 1981, P NATL ACAD SCI-BIOL, V78, P1765, DOI 10.1073/pnas.78.3.1765; Cerbin S, 2003, HYDROBIOLOGIA, V491, P111, DOI 10.1023/A:1024491011742; CHEESMAN DF, 1967, BIOL REV, V42, P131, DOI 10.1111/j.1469-185X.1967.tb01343.x; Cockell CS, 1999, BIOL REV, V74, P311, DOI 10.1017/S0006323199005356; Eiler A, 2003, MICROB ECOL, V46, P43, DOI 10.1007/s00248-002-2041-9; Einsle U, 1993, CRUSTACEA COPEPODA C, P208; Garcia PE, 2008, J PLANKTON RES, V30, P817, DOI 10.1093/plankt/fbn041; Gaviria S., 1998, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V100, P539; HAIRSTON NG, 1976, P NATL ACAD SCI USA, V73, P971, DOI 10.1073/pnas.73.3.971; HAIRSTON NG, 1979, LIMNOL OCEANOGR, V24, P15, DOI 10.4319/lo.1979.24.1.0015; HAIRSTON NG, 1979, LIMNOL OCEANOGR, V24, P38, DOI 10.4319/lo.1979.24.1.0038; HAIRSTON NG, 1981, HYDROBIOLOGIA, V81-2, P151, DOI 10.1007/BF00048712; Hansson LA, 2004, ECOLOGY, V85, P1005, DOI 10.1890/02-0525; Hansson LA, 2007, ECOLOGY, V88, P1932, DOI 10.1890/06-2038.1; HERZIG A, 1974, OECOLOGIA, V15, P127, DOI 10.1007/BF00345741; HESSEN D O, 1990, Aqua Fennica, V20, P165; Hylander S, 2009, LIMNOL OCEANOGR, V54, P1883, DOI 10.4319/lo.2009.54.6.1883; Krachler R., 2000, BURGENLANDISCHE HEIM, V62, P3; KRINSKY NI, 1979, PURE APPL CHEM, V51, P649, DOI 10.1351/pac197951030649; Laurion I, 2002, AQUAT MICROB ECOL, V26, P283, DOI 10.3354/ame026283; Lee KW, 2012, COMP BIOCHEM PHYS A, V161, P145, DOI 10.1016/j.cbpa.2011.10.019; Leech DM, 2003, COMP SER PHOTOCHEM, V1, P455; LOFFLER H., 1957, VERH ZOO BOT GES WIE, V97, P27; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Lotocka M, 2004, J PLANKTON RES, V26, P159, DOI 10.1093/plankt/fbh021; Meerhoff M., 2009, ENCY INLAND WATERS, V2, P645, DOI DOI 10.1016/B978-012370626-3.00041-7; Miralto A, 1996, J PLANKTON RES, V18, P1033, DOI 10.1093/plankt/18.6.1033; Moeller RE, 2005, LIMNOL OCEANOGR, V50, P427, DOI 10.4319/lo.2005.50.2.0427; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; Nemeth B, 2009, HYDROBIOLOGIA, V632, P91; Oren A, 2007, FEMS MICROBIOL LETT, V269, P1, DOI 10.1111/j.1574-6968.2007.00650.x; Persaud AD, 2007, FRESHWATER BIOL, V52, P2121, DOI 10.1111/j.1365-2427.2007.01833.x; Rautio Milla, 2010, Freshwater Reviews, V3, P105, DOI 10.1608/FRJ-3.2.157; Rhode SC, 2001, NATURE, V412, P69, DOI 10.1038/35083567; Scheffer M., 2004, ECOLOGY SHALLOW LAKE; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Sommaruga R, 2010, HYDROBIOLOGIA, V648, P143, DOI 10.1007/s10750-010-0141-y; Tartarotti B, 2001, LIMNOL OCEANOGR, V46, P1546, DOI 10.4319/lo.2001.46.6.1546; Tartarotti B, 2006, LIMNOL OCEANOGR, V51, P1530, DOI 10.4319/lo.2006.51.3.1530; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Trenzado CE, 2009, COMP BIOCHEM PHYS C, V149, P440, DOI 10.1016/j.cbpc.2008.10.105; Van der Veen IT, 2005, J EVOLUTION BIOL, V18, P992, DOI 10.1111/j.1420-9101.2005.00903.x; Wolfram G, 1999, HYDROBIOLOGIA, V408, P193, DOI 10.1023/A:1017011414599; Zagarese HE, 1998, J PLANKTON RES, V20, P1423, DOI 10.1093/plankt/20.8.1423	49	11	11	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43063	10.1371/journal.pone.0043063	http://dx.doi.org/10.1371/journal.pone.0043063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916208	Green Published, Green Submitted, gold			2022-12-25	WOS:000307824300028
J	Wang, WZ; Li, F; Wang, KZ; Cheng, B; Guo, X				Wang, Weizhuo; Li, Fang; Wang, Kunzheng; Cheng, Bin; Guo, Xiong			PAPSS2 Promotes Alkaline Phosphates Activity and Mineralization of Osteoblastic MC3T3-E1 Cells by Crosstalk and Smads Signal Pathways	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SPONDYLOEPIMETAPHYSEAL DYSPLASIA; GENE-EXPRESSION; ENDEMIC OSTEOARTHRITIS; ARTICULAR-CARTILAGE; MOLECULAR-BIOLOGY; DIFFERENTIATION; BONE; DISEASE; MOUSE	Several studies have indicated that PAPSS2 (3'-phosphoadenosine-5'-phosphosulfate synthetase 2) activity is important to normal skeletal development. Mouse PAPSS2 is predominantly expressed during the formation of the skeleton and cartilaginous elements of the mouse embryo and in newborn mice. However, the role and mechanism of PAPSS2 in bone formation remains largely unidentified. By analyzing the expression pattern of the PAPSS2 gene, we have found that PAPSS2 is expressed in bone tissue and bone formation. PAPSS2 transcripts increase during osteoblast differentiation and are in less level in RANKL-induced osteoclast like cells. By using lentivirus-mediated RNA interference (RNAi) technology, we knocked down PAPSS2 expression in MC3T3-E1 osteoblast. Silencing of PAPSS2 expression significantly decreases ALP activity and cell mineralization, inhibits expression of osteoblast marker osteopontin (OPN) and collagen I. Conversely, overexpression of PAPSS2 promotes the MC3T3-E1 to differentiate into osteoblast and mineralization. Moreover, compared to that in the control cells, the mRNA level and protein expression of phosphorylated Smad 2/3, which is a key transcriptional factor in the Smad osteoblast differentiation pathway, showed significant decreases in PAPSS2-silenced cells and increases in PAPSS2-overexpression cells. These results suggest that PAPSS2 might regulate osteoblast ALP activity and cell mineralization, probably through Smads signal pathways.	[Wang, Weizhuo; Wang, Kunzheng; Cheng, Bin] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Orthoped Surg, Xian, Shaanxi, Peoples R China; [Li, Fang] Fourth Mil Univ, Sch Stomatol, Dept Prosthodont, Xian, Shaanxi, Peoples R China; [Guo, Xiong] Xi An Jiao Tong Univ, Key Lab Environm & Gene Related Dis, Minist Educ, Fac Publ Hlth,Coll Med, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Air Force Military Medical University; Xi'an Jiaotong University	Wang, WZ (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Orthoped Surg, Xian, Shaanxi, Peoples R China.	wangweizhuo@mail.xjtu.edu.cn		Wang, Kunzheng/0000-0002-1981-4237	Natural Scientific Fund of China [81001225]; Xian Jiaotong University, China; Xian Jiaotong University, US [08143004]; Fundamental Research Funds for the Central Universities [08140003]	Natural Scientific Fund of China; Xian Jiaotong University, China(Xi'an Jiaotong University); Xian Jiaotong University, US; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This project was supported by the Natural Scientific Fund of China (81001225), the international Co-operative Fund in Xian Jiaotong University, China and US (08143004), and the Fundamental Research Funds for the Central Universities (08140003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 1998, AM J MED GENET, V78, P468; Apte UM, 2005, TOXICOL APPL PHARM, V207, P25, DOI 10.1016/j.taap.2004.12.018; Beckmann M P, 2000, SCIENCE, V77, P34; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Ford-Hutchinson AF, 2005, OSTEOARTHR CARTILAGE, V13, P418, DOI 10.1016/j.joca.2004.12.011; Fukunishi N, 2010, NEOPLASIA, V12, P969, DOI 10.1593/neo.101054; Genevieve D, 2005, EUR J HUM GENET, V13, P541, DOI 10.1038/sj.ejhg.5201339; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Ikeda T, 2001, J HUM GENET, V46, P538, DOI 10.1007/s100380170036; Kaji H, 2006, HORM METAB RES, V38, P740, DOI 10.1055/s-2006-955085; Kaji H, 2008, HORM METAB RES, V40, P746, DOI 10.1055/s-0028-1082051; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Ma WJ, 2011, PROTEOMICS, V11, P2881, DOI 10.1002/pmic.201000636; MATSUI M, 1994, INT J BIOCHEM, V26, P1237; MERRY K, 1993, J CELL SCI, V104, P1013; Noordam C, 2009, NEW ENGL J MED, V360, P2310, DOI 10.1056/NEJMoa0810489; Ovchinnikov D, 2009, COLD SPRING HARB PRO, V2009, DOI [10.1101/pdb. prot5170, DOI 10.1101/PDB.PROT5170]; Ozcaka O, 2011, INFLAMMATION; Ozeki K, 2008, J MATER SCI-MATER M, V19, P1753, DOI 10.1007/s10856-007-3288-y; Pessah M, 2001, P NATL ACAD SCI USA, V98, P6198, DOI 10.1073/pnas.101579798; Ramaswamy G, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3762; Reinholz GG, 2000, CANCER RES, V60, P6001; Rossi A, 1996, J BIOL CHEM, V271, P18456, DOI 10.1074/jbc.271.31.18456; RUNGBY J, 1993, HISTOCHEM J, V25, P446, DOI 10.1007/BF00157809; Schneider GB, 1999, BONE, V24, P321, DOI 10.1016/S8756-3282(99)00007-1; Shinto O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-652; Sowa H, 2002, J BONE MINER RES, V17, P1190, DOI 10.1359/jbmr.2002.17.7.1190; Sowa H, 2003, J BIOL CHEM, V278, P52240, DOI 10.1074/jbc.M302566200; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Steenhard BM, 2010, AM J PATHOL, V177, P84, DOI 10.2353/ajpath.2010.090767; Stelzer C, 2007, DEV DYNAM, V236, P1313, DOI 10.1002/dvdy.21137; Su JL, 2010, J BIOL CHEM, V285, P31325, DOI 10.1074/jbc.M109.087122; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; Venkatachalam KV, 2003, IUBMB LIFE, V55, P1, DOI 10.1080/1521654031000072148; Wan M, 2001, J BIOL CHEM, V276, P10119, DOI 10.1074/jbc.M006918200; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028439; Wang WZ, 2009, OSTEOARTHR CARTILAGE, V17, P83, DOI 10.1016/j.joca.2008.05.008; Wang WZ, 2008, J RHEUMATOL, V35, P696; Wang Yuntao, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P68; Weller NJ, 2007, HLTH AG LONG 3 INT C, Vxv; Wrana JL, 1998, MINER ELECTROL METAB, V24, P120, DOI 10.1159/000057359; Xu ZH, 2002, PHARMACOGENETICS, V12, P11, DOI 10.1097/00008571-200201000-00003; Yamakawa K, 2003, J RHEUMATOL, V30, P1032; Yang SY, 2007, GENE DEV, V21, P1803, DOI 10.1101/gad.1544107; Zheng Qixin, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P674; Zheng ZH, 2009, J BIOMED MATER RES A, V89A, P453, DOI 10.1002/jbm.a.31979	47	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43475	10.1371/journal.pone.0043475	http://dx.doi.org/10.1371/journal.pone.0043475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916269	Green Submitted, Green Published, gold			2022-12-25	WOS:000307824300051
J	Yamanaka, W; Takeshita, T; Shibata, Y; Matsuo, K; Eshima, N; Yokoyama, T; Yamashita, Y				Yamanaka, Wataru; Takeshita, Toru; Shibata, Yukie; Matsuo, Kazuki; Eshima, Nobuoki; Yokoyama, Takeshi; Yamashita, Yoshihisa			Compositional Stability of a Salivary Bacterial Population against Supragingival Microbiota Shift following Periodontal Therapy	PLOS ONE			English	Article							FLORA	Supragingival plaque is permanently in contact with saliva. However, the extent to which the microbiota contributes to the salivary bacterial population remains unclear. We compared the compositional shift in the salivary bacterial population with that in supragingival plaque following periodontal therapy. Samples were collected from 19 patients with periodontitis before and after periodontal therapy (mean sample collection interval, 25.8+/-2.6 months), and their bacterial composition was investigated using barcoded pyrosequencing analysis of the 16S rRNA gene. Phylogenetic community analysis using the UniFrac distance metric revealed that the overall bacterial community composition of saliva is distinct from that of supragingival plaque, both pre- and post-therapy. Temporal variation following therapy in the salivary bacterial population was significantly smaller than in the plaque microbiota, and the post-therapy saliva sample was significantly more similar to that pre-therapy from the same individual than to those from other subjects. Following periodontal therapy, microbial richness and biodiversity were significantly decreased in the plaque microbiota, but not in the salivary bacterial population. The operational taxonomic units whose relative abundances changed significantly after therapy were not common to the two microbiotae. These results reveal the compositional stability of salivary bacterial populations against shifts in the supragingival microbiota, suggesting that the effect of the supragingival plaque microbiota on salivary bacterial population composition is limited.	[Yamanaka, Wataru; Takeshita, Toru; Shibata, Yukie; Matsuo, Kazuki; Yamashita, Yoshihisa] Kyushu Univ, Sect Prevent & Publ Hlth Dent, Div Oral Hlth Growth & Dev, Fac Dent Sci, Fukuoka 812, Japan; [Matsuo, Kazuki; Yokoyama, Takeshi] Kyushu Univ, Sect Dent Anesthesiol, Div Maxillofacial Diagnost & Surg Sci, Fac Dent Sci, Fukuoka 812, Japan; [Eshima, Nobuoki] Oita Univ, Fac Med, Dept Biostat, Yufu City, Oita, Japan	Kyushu University; Kyushu University; Oita University	Yamanaka, W (corresponding author), Kyushu Univ, Sect Prevent & Publ Hlth Dent, Div Oral Hlth Growth & Dev, Fac Dent Sci, Fukuoka 812, Japan.	yoshi@dent.kyushu-u.ac.jp	Takeshita, Toru/AAT-2321-2021		Ministry of Education, Culture, Sports, Science and Technology of Japan [23792517, 20192403]; Grants-in-Aid for Scientific Research [22500260, 23659986] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported by Grants-in Aid for Young Scientist 23792517 (T. T.) and by Grants-in Aid for Scientific Research 20192403 (Y.Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Farrell JJ, 2012, GUT, V61, P582, DOI 10.1136/gutjnl-2011-300784; Goodson JM, 2009, J DENT RES, V88, P519, DOI 10.1177/0022034509338353; Gura T, 2008, NAT MED, V14, P706, DOI 10.1038/nm0708-706; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Paju S, 2009, J CLIN MICROBIOL, V47, P235, DOI 10.1128/JCM.01824-08; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; R Development Core Team, 2007, R LANG ENV STAT COMP; Rasiah IA, 2005, ARCH ORAL BIOL, V50, P779, DOI 10.1016/j.archoralbio.2005.02.001; Sakamoto M, 2003, J MED MICROBIOL, V52, P79, DOI 10.1099/jmm.0.04991-0; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; Takeshita T, 2007, ORAL MICROBIOL IMMUN, V22, P419, DOI 10.1111/j.1399-302X.2007.00384.x; Takeshita T, 2011, APPL ENVIRON MICROB, V77, P6739, DOI 10.1128/AEM.00651-11; Takeshita T, 2010, APPL ENVIRON MICROB, V76, P2806, DOI 10.1128/AEM.02304-09; Takeshita T, 2009, ISME J, V3, P65, DOI 10.1038/ismej.2008.91; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	29	46	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42806	10.1371/journal.pone.0042806	http://dx.doi.org/10.1371/journal.pone.0042806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916162	Green Published, Green Submitted, gold			2022-12-25	WOS:000307824300017
J	Yin, ZY; Fan, LN; Wei, LP; Gao, HK; Zhang, RQ; Tao, L; Cao, F; Wang, HC				Yin, Zhiyong; Fan, Linni; Wei, Liping; Gao, Haokao; Zhang, Rongqing; Tao, Ling; Cao, Feng; Wang, Haichang			FTY720 Protects Cardiac Microvessels of Diabetes: A Critical Role of S1P1/3 in Diabetic Heart Disease	PLOS ONE			English	Article							SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATOR; SPHINGOSINE 1-PHOSPHATE RECEPTORS; ENDOTHELIAL GROWTH-FACTOR; MICROVASCULAR DISEASE; THERAPEUTIC ANGIOGENESIS; LYMPHOCYTE EGRESS; COUPLED RECEPTORS; ISCHEMIC DISEASE; MICE; PREVENTION	Background: Diabetes is associated with an increased risk of cardiac microvascular disease. The mechanisms by which this damage occurs are unknown. However, research suggests that signaling through the sphingosine-1-phosphates receptor 1 and 3 (S1P1/3) by FTY720, a sphiongolipid drug that is structually similar to SIP, may play a role in the treatment on cardiac microvascular dysfunction in diabetes. We hypothesized that FTY720 might exert the cardioprotective effects of S1P1 and S1P3 viaprotein kinase C-beta (PKC beta II) signaling pathway. Methodology/Principal Findings: Transthoracic echocardiography was performed to detect the change of cardiac function. Scanning and transmission electron microscope with lanthanum tracer were used to determine microvascular ultrastructure and permeability in vivo. Apoptosis was detected by TUNEL and CD31 dual labeling in paraffin-embedded sections. Laser capture miscrodissection was used to assess cardiac micovascular endothelial cells (CMECs) in vivo. RT-PCR and Western blot analysis were used to determine the mRNA levels and protein expression of S1P1, S1P3, and PKC beta II. In the diabetic rats vs. controls, cardiac capillaries showed significantly higher density; CD31 positive endothelial cells were significantly reduced; the apoptosis index of cardiac endothlial cells was significantly higher. And FTY720 could increase the expressional level of S1P1 and boost S1P3 trasnslocation from membrane to nuclear, then ameliorate cardiac microvascular barrier impairment and pathologic angiogenesis induced by diabetes. In addition, overexpression of PKC beta II significantly decreased the protective effect of FTY720. Conclusions: Our study represents that the deregulation of S1P1 and S1P3 is an important signalresponsible for cardiac microvascular dysfunction in diabetes. FTY720 might be competent to serve as a potential therapeutic approach for diabetic heart disease through ameliorating cardiac microvascular barrier impairment and pathologic angiogenesis, which might be partly dependent on PKC beta II-mediated signaling pathway.	[Yin, Zhiyong; Gao, Haokao; Zhang, Rongqing; Tao, Ling; Cao, Feng; Wang, Haichang] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Fan, Linni] Fourth Mil Med Univ, Dept Pathol, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Wei, Liping] Tianjin Union Med Ctr, Dept Cardiol, Tianjin, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Yin, ZY (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China.	wanghc@fmmu.edu.cn	wei, li/GSD-3630-2022; 黎, 伟/GXM-4040-2022					Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Berdyshev EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016571; Bertoni AG, 2004, DIABETES CARE, V27, P699, DOI 10.2337/diacare.27.3.699; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; BISHOP MA, 1985, CELL TISSUE RES, V239, P131, DOI 10.1007/BF00214912; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Del Bo R, 2006, IMMUNOGENETICS, V58, P107, DOI 10.1007/s00251-006-0089-2; Del Canizo Gomez F. J., 2011, ENDOCRINOL NUTR, V58, P163, DOI DOI 10.1016/J.ENDONU.2011.01.006; Dragun D, 2004, TRANSPL P, V36, p544S, DOI 10.1016/j.transproceed.2003.12.048; Egom EEA, 2010, J MOL CELL CARDIOL, V48, P406, DOI 10.1016/j.yjmcc.2009.10.009; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; Flores-Le Roux JA, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-39; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Hofmann U, 2010, BRIT J PHARMACOL, V160, P1243, DOI 10.1111/j.1476-5381.2010.00767.x; Kendall MR, 2008, DIABETES OBES METAB, V10, P802, DOI 10.1111/j.1463-1326.2008.00910.x; Keul P, 2011, CIRC RES, V108, P314, DOI 10.1161/CIRCRESAHA.110.235028; Laakso M, 2011, DIABETES CARE, V34, pS145, DOI 10.2337/dc11-s209; Li CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032380; Liao JJ, 2007, J BIOL CHEM, V282, P1964, DOI 10.1074/jbc.M608597200; Liesz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021312; Lim HS, 2005, ATHEROSCLEROSIS, V180, P113, DOI 10.1016/j.atherosclerosis.2004.11.004; Liu LS, 2007, MICROSURG, V27, P300, DOI 10.1002/micr.20360; Liu Y, 2011, ANTIOXID REDOX SIGN, V15, P1769, DOI 10.1089/ars.2010.3764; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA; Machado DE, 2008, FERTIL STERIL, V90, P148, DOI 10.1016/j.fertnstert.2007.05.076; Maki T, 2005, TRANSPLANTATION, V79, P1051, DOI 10.1097/01.TP.0000161220.87548.EE; Maki T, 2002, TRANSPLANTATION, V74, P1684, DOI 10.1097/01.TP.0000038969.72218.0F; Marcovecchio ML, 2011, PEDIATR NEPHROL, V26, P365, DOI 10.1007/s00467-010-1624-9; Martinet W, 2004, J PATHOL, V202, P382, DOI 10.1002/path.1525; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; NISHIDA M, 1993, AM J PHYSIOL, V264, pH639, DOI 10.1152/ajpheart.1993.264.2.H639; Penaranda C, 2010, DIABETES, V59, P1461, DOI 10.2337/db09-1129; Popovic J, 2004, PEDIATR DIABETES, V5, P3, DOI 10.1111/j.1399-543X.2004.00036.x; Raposo C, 2007, BRAIN RES, V1149, P18, DOI 10.1016/j.brainres.2007.02.086; Retnakaran R, 2008, LANCET, V371, P1790, DOI 10.1016/S0140-6736(08)60767-9; Rosenson RS, 2011, ATHEROSCLEROSIS, V218, P13, DOI 10.1016/j.atherosclerosis.2011.06.029; Ryu J, 2008, CARDIOVASC RES, V78, P333, DOI 10.1093/cvr/cvm067; Skyler JS, 2009, CIRCULATION, V119, P351, DOI 10.1161/CIRCULATIONAHA.108.191305; Verli FD, 2008, SCANNING, V30, P414, DOI 10.1002/sca.20122; Waeber C, 2004, DRUG NEWS PERSPECT, V17, P365, DOI 10.1358/dnp.2004.17.6.829028; Walter DH, 2007, ARTERIOSCL THROM VAS, V27, P275, DOI 10.1161/01.ATV.0000254669.12675.70; Wei LP, 2010, MICROVASC RES, V80, P158, DOI 10.1016/j.mvr.2010.01.003; Wei LP, 2010, APOPTOSIS, V15, P488, DOI 10.1007/s10495-009-0439-2; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36; Zhao ZS, 2012, J BIOL CHEM, V287, P5562, DOI 10.1074/jbc.M111.305359	49	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42900	10.1371/journal.pone.0042900	http://dx.doi.org/10.1371/journal.pone.0042900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916176	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500800028
J	Yokogawa, M; Kobashigawa, Y; Yoshida, N; Ogura, K; Harada, K; Inagaki, F				Yokogawa, Mariko; Kobashigawa, Yoshihiro; Yoshida, Naoki; Ogura, Kenji; Harada, Kohsuke; Inagaki, Fuyuhiko			NMR Analyses of the Interaction between the FYVE Domain of Early Endosome Antigen 1 (EEA1) and Phosphoinositide Embedded in a Lipid Bilayer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE; PX DOMAIN; DODECYLPHOSPHOCHOLINE MICELLES; MEMBRANE INSERTION; CRYSTAL-STRUCTURE; CROSS-SATURATION; PROTEIN; NANODISCS; MECHANISM; RESIDUES	Phosphoinositides (PIs) are crucial lipid components of membranes and are involved in a number of cellular processes through interactions with their effector proteins. Recently, we have established a lipid-protein nanoscale bilayer (nanodisc) containing PIs, hereafter referred to as PI-nanodisc and demonstrated that it could be used for both qualitative and quantitative evaluations of protein-membrane interactions. Here, we report further NMR analyses for obtaining structural insights at the residue-specific level between PI-binding effector protein and PI-nanodisc, using the FYVE domain of early endosome antigen 1 (EEA1), denoted as EEA1 FYVE, and PI(3)P-nanodisc as a model system. We performed a combination of the NMR analyses including chemical shift perturbation, transferred cross-saturation, and paramagnetic relaxation enhancement experiments. These enabled an identification of the interaction surface, structural change, and relative orientation of EEA1 FYVE to the PI(3) P-incorporated lipid bilayer, substantiating that NMR analyses of protein-membrane interactions using nanodisc makes it possible to show the residue-specific interactions in the lipid bilayer environment.	[Inagaki, Fuyuhiko] Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Yoshida, Naoki; Harada, Kohsuke] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University; Hokkaido University	Inagaki, F (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Kita21 Nishi11, Sapporo, Hokkaido 0010021, Japan.	finagaki@pharm.hokudai.ac.jp			Japan Society for the Promotion of Science through its Funding Program for World Leading Innovative R&D on Science and Technology; Japan Society for the Promotion of Science through the Targeted Proteins Research Program; Grants-in-Aid for Scientific Research [24121701, 22570109] Funding Source: KAKEN	Japan Society for the Promotion of Science through its Funding Program for World Leading Innovative R&D on Science and Technology; Japan Society for the Promotion of Science through the Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science through its Funding Program for World Leading Innovative R&D on Science and Technology and the Targeted Proteins Research Program.	Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; Hong M, 2011, PROTEIN SCI, V20, P641, DOI 10.1002/pro.600; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Jung HH, 2010, BIOPHYS J, V99, P638, DOI 10.1016/j.bpj.2010.04.061; Kami Keiichiro, 2009, V462, P291, DOI 10.1007/978-1-60327-115-8_20; Kobashigawa Y, 2011, ANAL BIOCHEM, V410, P77, DOI 10.1016/j.ab.2010.11.021; Kobashigawa Y, 2009, J BIOMOL NMR, V43, P145, DOI 10.1007/s10858-008-9296-5; KOHDA D, 1992, BIOCHEMISTRY-US, V31, P677, DOI 10.1021/bi00118a007; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Kutateladze TG, 2004, J BIOL CHEM, V279, P3050, DOI 10.1074/jbc.M309007200; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Lee SA, 2006, J BIOL CHEM, V281, P37091, DOI 10.1074/jbc.M608610200; Malkova S, 2005, BIOPHYS J, V89, P1861, DOI 10.1529/biophysj.105.061515; Malmberg NJ, 2005, ANNU REV BIOPH BIOM, V34, P71, DOI 10.1146/annurev.biophys.34.040204.144534; Matsuda T, 2004, J MOL RECOGNIT, V17, P41, DOI 10.1002/jmr.656; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Nakamura T, 2005, BIOPHYS J, V89, P4051, DOI 10.1529/biophysj.105.066910; Nishida N, 2011, METHODS MOL BIOL, V757, P129, DOI 10.1007/978-1-61779-166-6_10; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Sankaran VG, 2001, BIOCHEMISTRY-US, V40, P8581, DOI 10.1021/bi010425d; Shimada I, 2005, METHOD ENZYMOL, V394, P483, DOI 10.1016/S0076-6879(05)94020-2; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Stampoulis P., 2012, J BIOL CHEM; Takeuchi K, 2004, J BIOL CHEM, V279, P4981, DOI 10.1074/jbc.M307815200; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5; Zhou CZ, 2003, J BIOL CHEM, V278, P50371, DOI 10.1074/jbc.M304392200	35	25	25	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34936	34945		10.1074/jbc.M112.398255	http://dx.doi.org/10.1074/jbc.M112.398255			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22915584	Green Published, hybrid			2022-12-25	WOS:000309968000007
J	Elnakish, MT; Hassona, MDH; Alhaj, MA; Moldovan, L; Janssen, PML; Khan, M; Hassanain, HH				Elnakish, Mohammad T.; Hassona, Mohamed D. H.; Alhaj, Mazin A.; Moldovan, Leni; Janssen, Paul M. L.; Khan, Mahmood; Hassanain, Hamdy H.			Rac-Induced Left Ventricular Dilation in Thyroxin-Treated ZmRacD Transgenic Mice: Role of Cardiomyocyte Apoptosis and Myocardial Fibrosis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CARDIAC-HYPERTROPHY; OXIDATIVE STRESS; HEART-FAILURE; INDUCED CARDIOTOXICITY; SYSTOLIC FUNCTION; CELLULAR BASIS; CARVEDILOL; PRAVASTATIN; ACTIVATION	The pathways inducing the critical transition from compensated hypertrophy to cardiac dilation and failure remain poorly understood. The goal of our study is to determine the role of Rac-induced signaling in this transition process. Our previous results showed that Thyroxin (T4) treatment resulted in increased myocardial Rac expression in wild-type mice and a higher level of expression in Zea maize RacD (ZmRacD) transgenic mice. Our current results showed that T4 treatment induced physiologic cardiac hypertrophy in wild-type mice, as demonstrated by echocardiography and histopathology analyses. This was associated with significant increases in myocardial Rac-GTP, superoxide and ERK1/2 activities. Conversely, echocardiography and histopathology analyses showed that T4 treatment induced dilated cardiomyopathy along with compensatory cardiac hypertrophy in ZmRacD mice. These were linked with further increases in myocardial Rac-GTP, superoxide and ERK1/2 activities. Additionally, there were significant increases in caspase-8 expression and caspase-3 activity. However, there was a significant decrease in p38-MAPK activity. Interestingly, inhibition of myocardial Rac-GTP activity and superoxide generation with pravastatin and carvedilol, respectively, attenuated all functional, structural, and molecular changes associated with the T4-induced cardiomyopathy in ZmRacD mice except the compensatory cardiac hypertrophy. Taken together, T4-induced ZmRacD is a novel mouse model of dilated cardiomyopathy that shares many characteristics with the human disease phenotype. To our knowledge, this is the first study to show graded Rac-mediated O-2 center dot(-) results in cardiac phenotype shift in-vivo. Moreover, Rac-mediated O-2 center dot(-) generation, cardiomyocyte apoptosis, and myocardial fibrosis seem to play a pivotal role in the transition from cardiac hypertrophy to cardiac dilation and failure. Targeting Rac signaling could represent valuable therapeutic strategy not only in saving the failing myocardium but also to prevent this transition process.	[Elnakish, Mohammad T.; Hassona, Mohamed D. H.; Alhaj, Mazin A.; Hassanain, Hamdy H.] Ohio State Univ, Dept Anesthesiol, Columbus, OH 43210 USA; [Elnakish, Mohammad T.; Hassona, Mohamed D. H.; Alhaj, Mazin A.; Moldovan, Leni; Janssen, Paul M. L.; Khan, Mahmood; Hassanain, Hamdy H.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Elnakish, Mohammad T.; Janssen, Paul M. L.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Moldovan, Leni] Ohio State Univ, Dept Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Khan, Mahmood] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University; Ohio State University; Ohio State University	Elnakish, MT (corresponding author), Ohio State Univ, Dept Anesthesiol, Columbus, OH 43210 USA.	dr.hamdyhassanain@gmail.com	Janssen, Paul ML/E-3307-2011	Moldovan, Leni/0000-0003-1967-2408; Khan, Mahmood/0000-0003-3430-374X; Akcelrud, Leni/0000-0003-2498-1678; Janssen, Paul/0000-0002-9682-3014	Department of Anesthesiology, The Ohio State University; The Egyptian Government	Department of Anesthesiology, The Ohio State University; The Egyptian Government	This work was supported by Startup fund, Department of Anesthesiology, The Ohio State University. Mohammad T. Elnakish was supported by a scholarship from The Egyptian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 2002, CYTOKINE, V18, P179, DOI 10.1006/cyto.2001.1007; Araujo ASR, 2008, J MOL ENDOCRINOL, V41, P423, DOI 10.1677/JME-08-0024; Arozal W, 2010, TOXICOLOGY, V274, P18, DOI 10.1016/j.tox.2010.05.003; Balakumar P, 2006, BASIC CLIN PHARMACOL, V99, P418, DOI 10.1111/j.1742-7843.2006.pto_569.x; BELTRAMI CA, 1995, J MOL CELL CARDIOL, V27, P291, DOI 10.1016/S0022-2828(08)80028-4; Berenji K, 2005, AM J PHYSIOL-HEART C, V289, pH8, DOI 10.1152/ajpheart.01303.2004; Brower GL, 2001, AM J PHYSIOL-HEART C, V280, pH674, DOI 10.1152/ajpheart.2001.280.2.H674; Carlson DL, 2005, CRIT CARE MED, V33, P1021, DOI 10.1097/01.CCM.0000163398.79679.66; Cheng CF, 2008, APOPTOSIS, V13, P883, DOI 10.1007/s10495-008-0214-9; Chua S, 2008, INT HEART J, V49, P605, DOI 10.1536/ihj.49.605; Communal C, 2002, J CARD FAIL, V8, P86, DOI 10.1054/jcaf.2002.32755; Corradi D, 2009, CIRCULATION, V120, pE38, DOI 10.1161/CIRCULATIONAHA.108.840660; Araujo ASD, 2010, J CARDIOVASC PHARM, V56, P513, DOI 10.1097/FJC.0b013e3181f50a70; Diwan A, 2007, PHYSIOLOGY, V22, P56, DOI 10.1152/physiol.00033.2006; Dong Y, 2006, J CARDIOTHORAC REN R, V1, P123; Dorn GW, 2009, NAT REV CARDIOL, V6, P283, DOI 10.1038/nrcardio.2009.12; Elnakish MT, 2011, AM J PHYSIOL-HEART C, V301, pH868, DOI 10.1152/ajpheart.00807.2010; Fentzke RC, 1998, J CLIN INVEST, V101, P2415, DOI 10.1172/JCI2950; Feuerstein GZ, 1996, EUR HEART J, V17, P24, DOI 10.1093/eurheartj/17.suppl_B.24; FLORINI JR, 1973, J GERONTOL, V28, P293, DOI 10.1093/geronj/28.3.293; Freeman K, 2001, AM J PHYSIOL-HEART C, V280, pH151, DOI 10.1152/ajpheart.2001.280.1.H151; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Hassona MDH, 2011, J CARDIOVASC PHARM, V57, P550, DOI 10.1097/FJC.0b013e318212b1c2; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Helms SA, 2010, INT J BIOL SCI, V6, P475; Ichihara S, 2006, CARDIOVASC RES, V69, P726, DOI 10.1016/j.cardiores.2005.08.001; Klein L, 2003, AM J CARDIOL, V91, p18F, DOI 10.1016/S0002-9149(02)03336-2; KORECKY B, 1978, AM J PHYSIOL, V234, pH123, DOI 10.1152/ajpheart.1978.234.2.H123; Kuzman JA, 2005, J MOL CELL CARDIOL, V39, P251, DOI 10.1016/j.yjmcc.2005.03.020; Kuzman JA, 2007, ENDOCRINOLOGY, V148, P3477, DOI 10.1210/en.2007-0099; Lemke LE, 2001, J MOL CELL CARDIOL, V33, P1527, DOI 10.1006/jmcc.2001.1415; Lezoualc'h F, 2008, J MOL CELL CARDIOL, V44, P623, DOI 10.1016/j.yjmcc.2008.01.011; Li B, 2006, INT J CARDIOL, V111, P247, DOI 10.1016/j.ijcard.2005.08.065; Lips DJ, 2003, EUR HEART J, V24, P883, DOI 10.1016/S0195-668X(02)00829-1; Lu XR, 2006, CRIT CARE MED, V34, P484, DOI 10.1097/01.CCM.0000199079.64231.C1; Maack C, 2003, CIRCULATION, V108, P1567, DOI 10.1161/01.CIR.0000091084.46500.BB; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Nakamura K, 2011, PHARMACEUTICALS, V4, P1088, DOI 10.3390/ph4081088; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Ojamaa K, 2010, VASC PHARMACOL, V52, P113, DOI 10.1016/j.vph.2009.11.008; Palazzuoli A, 2002, EUR J HEART FAIL, V4, P765, DOI 10.1016/S1388-9842(02)00114-9; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Philipp S, 2004, EUR J HEART FAIL, V6, P845, DOI 10.1016/j.ejheart.2004.01.014; Pierres C, 2009, CONCENTRATED LIQUID; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Samuel MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017143; Schaefer WH, 1998, DRUG METAB DISPOS, V26, P958; Selvetella G, 2004, CARDIOVASC RES, V63, P373, DOI 10.1016/j.cardiores.2004.04.031; Siwik DA, 1999, CIRC RES, V85, P147, DOI 10.1161/01.RES.85.2.147; Sussman MA, 2000, J CLIN INVEST, V105, P875, DOI 10.1172/JCI8497; Tenhunen O, 2006, FASEB J, V20, P1907, DOI 10.1096/fj.05-5618fje; Watanabe K, 2000, BRIT J PHARMACOL, V130, P1489, DOI 10.1038/sj.bjp.0703450; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Worou ME, 2011, CARDIOVASC RES, V91, P320, DOI 10.1093/cvr/cvr072; Xu Z, 2008, J CARDIOVASC PHARM, V51, P62, DOI 10.1097/FJC.0b013e31815bb629; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yaoita H, 2002, CIRCULATION, V105, P975, DOI 10.1161/hc0802.104503; YOKOYAMA T, 1993, J CLIN INVEST, V92, P2303, DOI 10.1172/JCI116834; Zhao H, 2008, HYPERTENS RES, V31, P1977, DOI 10.1291/hypres.31.1977; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	61	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42500	10.1371/journal.pone.0042500	http://dx.doi.org/10.1371/journal.pone.0042500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936985	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500013
J	Folco, EG; Lee, CS; Dufu, K; Yamazaki, T; Reed, R				Folco, Eric G.; Lee, Chung-Sheng; Dufu, Kobina; Yamazaki, Tomohiro; Reed, Robin			The Proteins PDIP3 and ZC11A Associate with the Human TREX Complex in an ATP-Dependent Manner and Function in mRNA Export	PLOS ONE			English	Article							UAP56	The conserved TREX complex, which contains UAP56, Aly, CIP29, and the multi-subunit THO complex, functions in mRNA export. Recently, several putative new components of the human TREX complex were identified by mass spectrometry. Here, we investigated the function of two of these, PDIP3 and ZC11A. Our data indicate that both of these proteins are components of a common TREX complex and function in mRNA export. Recently, we found that both CIP29 and Aly associate with the DEAD box helicase UAP56 and with the TREX complex in an ATP-dependent manner. We now show that this is also the case for PDIP3 and ZC11A. Thus, together with previous work, our data indicate that the TREX complex participates in multiple ATP-dependent interactions.	[Folco, Eric G.; Lee, Chung-Sheng; Dufu, Kobina; Yamazaki, Tomohiro; Reed, Robin] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Harvard University; Harvard Medical School	Folco, EG (corresponding author), Inst Albert Bonniot, INSERM U823, Grenoble, France.	rreed@hms.harvard.edu	Folco, Eric/M-2665-2013	Dufu, Kobina/0000-0001-5450-4157	NIH [GM043375]; Toyobo Biotechnology Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM043375, R01GM043375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Toyobo Biotechnology Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH grant (GM043375) to RR. TY is supported by a grant-in-aid from Toyobo Biotechnology Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Dias AP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1103; Dufu K, 2010, GENE DEV, V24, P2043, DOI 10.1101/gad.1898610; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Hautbergue GM, 2009, CURR BIOL, V19, P1918, DOI 10.1016/j.cub.2009.09.041; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Jimeno S, 2006, MOL CELL BIOL, V26, P4387, DOI 10.1128/MCB.00234-06; Kapadia F, 2006, GENE, V384, P37, DOI 10.1016/j.gene.2006.07.010; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Okada M, 2008, P NATL ACAD SCI USA, V105, P8649, DOI 10.1073/pnas.0802533105; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Strasser K, 2002, NATURE, V28, P28; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	18	33	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43804	10.1371/journal.pone.0043804	http://dx.doi.org/10.1371/journal.pone.0043804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928037	gold, Green Published			2022-12-25	WOS:000308224700025
J	Bruder, JM; Pfeiffer, ZA; Ciriello, JM; Horrigan, DM; Wicks, NL; Flaherty, B; Oancea, E				Bruder, Jan M.; Pfeiffer, Zachary A.; Ciriello, Jonathan M.; Horrigan, Diana M.; Wicks, Nadine L.; Flaherty, Benjamin; Oancea, Elena			Melanosomal Dynamics Assessed with a Live-Cell Fluorescent Melanosomal Marker	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEM; SKIN PIGMENTATION; MYOSIN-VA; MELANIN TRANSFER; OCULAR ALBINISM; MEMBRANE DYNAMICS; MODEL SYSTEM; IN-VITRO; MELANOCYTES; PROTEIN	Melanocytes present in skin and other organs synthesize and store melanin pigment within membrane-delimited organelles called melanosomes. Exposure of human skin to ultraviolet radiation (UV) stimulates melanin production in melanosomes, followed by transfer of melanosomes from melanocytes to neighboring keratinocytes. Melanosomal function is critical for protecting skin against UV radiation, but the mechanisms underlying melanosomal movement and transfer are not well understood. Here we report a novel fluorescent melanosomal marker, which we used to measure real-time melanosomal dynamics in live human epidermal melanocytes (HEMs) and transfer in melanocyte-keratinocyte co-cultures. A fluorescent fusion protein of Ocular Albinism 1 (OA1) localized to melanosomes in both B16-F1 cells and HEMs, and its expression did not significantly alter melanosomal distribution. Live-cell tracking of OA1-GFP-tagged melanosomes revealed a bimodal kinetic profile, with melanosomes exhibiting combinations of slow and fast movement. We also found that exposure to UV radiation increased the fraction of melanosomes exhibiting fast versus slow movement. In addition, using OA1-GFP in live co-cultures, we monitored melanosomal transfer using time-lapse microscopy. These results highlight OA1-GFP as a specific and effective melanosomal marker for live-cell studies, reveal new aspects of melanosomal dynamics and transfer, and are relevant to understanding the skin's physiological response to UV radiation.	[Bruder, Jan M.; Pfeiffer, Zachary A.; Ciriello, Jonathan M.; Horrigan, Diana M.; Wicks, Nadine L.; Flaherty, Benjamin; Oancea, Elena] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University	Bruder, JM (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany.	elena_oancea@brown.edu	Bruder, Jan/AGN-4025-2022; Bruder, Jan/AAM-4165-2021	Bruder, Jan/0000-0003-3126-0625; Bruder, Jan/0000-0003-3126-0625				Abdel-Malek ZA, 2010, PIGM CELL MELANOMA R, V23, P171, DOI 10.1111/j.1755-148X.2010.00679.x; Ando H, 2009, PIGMENT CELL MELANOM; Aspengren S, 2009, INT REV CEL MOL BIO, V272, P245, DOI 10.1016/S1937-6448(08)01606-7; Beaumont KA, 2011, TRAFFIC, V12, P627, DOI 10.1111/j.1600-0854.2011.01172.x; Berens W, 2005, PIGM CELL RES, V18, P370, DOI 10.1111/j.1600-0749.2005.00263.x; Bharti K, 2006, PIGM CELL RES, V19, P380, DOI 10.1111/j.1600-0749.2006.00318.x; Boissy RE, 2003, EXP DERMATOL, V12, P5, DOI 10.1034/j.1600-0625.12.s2.1.x; Brito FC, 2008, PIGM CELL MELANOMA R, V21, P464, DOI 10.1111/j.1755-148X.2008.00459.x; Desnos C, 2003, J CELL BIOL, V163, P559, DOI 10.1083/jcb.200302157; Ebanks JP, 2009, INT J MOL SCI, V10, P4066, DOI 10.3390/ijms10094066; FITZPATRICK T B, 1963, Dermatol Wochenschr, V147, P481; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; GOLDGEIER MH, 1984, J INVEST DERMATOL, V82, P235, DOI 10.1111/1523-1747.ep12260111; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; HILDING DA, 1977, ACTA OTO-LARYNGOL, V84, P24, DOI 10.3109/00016487709123939; Hume AN, 2007, J CELL SCI, V120, P3111, DOI 10.1242/jcs.010207; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; Innamorati G, 2006, PIGM CELL RES, V19, P125, DOI 10.1111/j.1600-0749.2006.00292.x; Lavado A, 2006, FRONT BIOSCI-LANDMRK, V11, P743, DOI 10.2741/1832; Lee CW, 2008, MOL BIOL CELL, V19, P150, DOI 10.1091/mbc.E07-05-0515; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lopez VM, 2008, PLOS BIOL, V6, P1861, DOI 10.1371/journal.pbio.0060236; Lubeck RP, 2008, EXP DERMATOL, V17, P228; Mahmoud BH, 2010, J INVEST DERMATOL, V130, P2092, DOI 10.1038/jid.2010.95; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Meng S, 2008, BIOPHYS J, V95, P4396, DOI 10.1529/biophysj.108.135756; Minwalla L, 2001, J INVEST DERMATOL, V117, P341, DOI 10.1046/j.0022-202x.2001.01411.x; Minwalla L, 2001, PIGM CELL RES, V14, P185, DOI 10.1034/j.1600-0749.2001.140308.x; MOTTAZ JH, 1967, J INVEST DERMATOL, V49, P605, DOI 10.1038/jid.1967.187; Nordlund J. J., 1998, PIGMENTARY SYSTEM; OKAZAKI K, 1976, J INVEST DERMATOL, V67, P541, DOI 10.1111/1523-1747.ep12664554; Palmisano I, 2008, HUM MOL GENET; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Ross MJ, 2006, J AM SOC NEPHROL, V17, P996, DOI 10.1681/ASN.2005070692; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schiaffino MV, 1999, NAT GENET, V23, P108, DOI 10.1038/12715; Schiaffino MV, 2005, PIGM CELL RES, V18, P227, DOI 10.1111/j.1600-0749.2005.00240.x; Scott G, 2002, J CELL SCI, V115, P1441; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Seiberg M, 2001, PIGM CELL RES, V14, P236, DOI 10.1034/j.1600-0749.2001.140402.x; SEIJI M, 1963, NATURE, V197, P1082, DOI 10.1038/1971082a0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHEETZ MP, 1989, NATURE, V340, P284, DOI 10.1038/340284a0; Singh SK, 2010, FASEB J; Singh SK, 2008, EXP DERMATOL, V17, P418, DOI 10.1111/j.1600-0625.2008.00702.x; Singh SK, 2010, FASEB J, V24, P3756, DOI 10.1096/fj.10-159046; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Sone M, 2007, EXP EYE RES, V85, P806, DOI 10.1016/j.exer.2007.08.016; Spitz, 2004, GEN CLIN GUID GEN SK; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; SWIFT JA, 1964, NATURE, V203, P976, DOI 10.1038/203976b0; Tachibana M, 1999, PIGM CELL RES, V12, P344, DOI 10.1111/j.1600-0749.1999.tb00518.x; Toriello HV, 2011, ADV OTO-RHINO-LARYNG, V70, P50, DOI 10.1159/000322471; Van den Bossche K, 2006, TRAFFIC, V7, P769, DOI 10.1111/j.1600-0854.2006.00425.x; Van Gele M, 2009, PIGM CELL MELANOMA R, V22, P268, DOI 10.1111/j.1755-148X.2009.00558.x; Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667; Wicks NL, 2011, CURR BIOL; Wu XF, 2001, J CELL SCI, V114, P1091; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yajima I, 2008, PIGM CELL MELANOMA R, V21, P471, DOI 10.1111/j.1755-148X.2008.00483.x; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; YAMAMOTO O, 1994, PIGM CELL RES, V7, P158, DOI 10.1111/j.1600-0749.1994.tb00044.x; Yoshida Y, 2007, FASEB J, V21, P2829, DOI 10.1096/fj.06-6845com; Zecca L, 2002, J NEURAL TRANSM, V109, P663, DOI 10.1007/s007020200055	69	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43465	10.1371/journal.pone.0043465	http://dx.doi.org/10.1371/journal.pone.0043465			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927970	Green Submitted, Green Published, gold			2022-12-25	WOS:000308286300054
J	D'Alvise, PW; Lillebo, S; Prol-Garcia, MJ; Wergeland, HI; Nielsen, KF; Bergh, O; Gram, L				D'Alvise, Paul W.; Lillebo, Siril; Prol-Garcia, Maria J.; Wergeland, Heidrun I.; Nielsen, Kristian F.; Bergh, Oivind; Gram, Lone			Phaeobacter gallaeciensis Reduces Vibrio anguillarum in Cultures of Microalgae and Rotifers, and Prevents Vibriosis in Cod Larvae	PLOS ONE			English	Article							TROPODITHIETIC ACID BIOSYNTHESIS; ALGA ULVA-AUSTRALIS; GADUS-MORHUA; LISTONELLA-ANGUILLARUM; BRACHIONUS-PLICATILIS; PROBIOTIC BACTERIA; RAINBOW-TROUT; PATHOGENIC BACTERIA; MARINE LARVICULTURE; INHIBITORY-ACTIVITY	Phaeobacter gallaeciensis can antagonize fish-pathogenic bacteria in vitro, and the purpose of this study was to evaluate the organism as a probiont for marine fish larvae and their feed cultures. An in vivo mechanism of action of the antagonistic probiotic bacterium is suggested using a non-antagonistic mutant. P. gallaeciensis was readily established in axenic cultures of the two microalgae Tetraselmis suecica and Nannochloropsis oculata, and of the rotifer Brachionus plicatilis. P. gallaeciensis reached densities of 10(7) cfu/ml and did not adversely affect growth of algae or rotifers. Vibrio anguillarum was significantly reduced by wild-type P. gallaeciensis, when introduced into these cultures. A P. gallaeciensis mutant that did not produce the antibacterial compound tropodithietic acid (TDA) did not reduce V. anguillarum numbers, suggesting that production of the antibacterial compound is important for the antagonistic properties of P. gallaeciensis. The ability of P. gallaeciensis to protect fish larvae from vibriosis was determined in a bath challenge experiment using a multidish system with 1 larva per well. Unchallenged larvae reached 40% accumulated mortality which increased to 100% when infected with V. anguillarum. P. gallaeciensis reduced the mortality of challenged cod larvae (Gadus morhua) to 10%, significantly below the levels of both the challenged and the unchallenged larvae. The TDA mutant reduced mortality of the cod larvae in some of the replicates, although to a much lesser extent than the wild type. It is concluded that P. gallaeciensis is a promising probiont in marine larviculture and that TDA production likely contributes to its probiotic effect.	[D'Alvise, Paul W.; Prol-Garcia, Maria J.; Gram, Lone] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark; [Lillebo, Siril; Wergeland, Heidrun I.] Univ Bergen, Dept Biol, Bergen, Norway; [Nielsen, Kristian F.] Tech Univ Denmark, Dept Syst Biol, Ctr Microbiol Biotechnol, DK-2800 Lyngby, Denmark; [Bergh, Oivind] Inst Marine Res, N-5024 Bergen, Norway	Technical University of Denmark; University of Bergen; Technical University of Denmark; Institute of Marine Research - Norway	D'Alvise, PW (corresponding author), Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark.	gram@food.dtu.dk	Nielsen, Kristian Fog/C-7233-2011; Bergh, Øivind/AIE-3508-2022	Nielsen, Kristian Fog/0000-0002-5848-0911; Bergh, Øivind/0000-0002-9849-025X; Gram, Lone/0000-0002-1076-5723	Danish Research Council for Technology and Production [09-066524]	Danish Research Council for Technology and Production	This study was funded by the Danish Research Council for Technology and Production to the project 09-066524 (Bioactive bacterial biofilm surfaces in aquaculture - disease prevention without antibiotics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcazar JL, 2006, VET MICROBIOL, V114, P173, DOI 10.1016/j.vetmic.2006.01.009; BAO Y, 1991, GENE, V109, P167, DOI 10.1016/0378-1119(91)90604-A; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P7263, DOI 10.1128/AEM.71.11.7263-7270.2005; Bruhn JB, 2007, APPL ENVIRON MICROB, V73, P442, DOI 10.1128/AEM.02238-06; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Carnevali O, 2004, AQUACULT INT, V12, P377, DOI 10.1023/B:AQUI.0000042141.85977.bb; Conceicao LEC, 2010, AQUAC RES, V41, P613, DOI 10.1111/j.1365-2109.2009.02242.x; Croxatto A, 2007, ENVIRON MICROBIOL, V9, P370, DOI 10.1111/j.1462-2920.2006.01147.x; D'Alvise PW, 2010, APPL ENVIRON MICROB, V76, P2366, DOI 10.1128/AEM.02717-09; Dimitroglou A, 2011, FISH SHELLFISH IMMUN, V30, P1, DOI 10.1016/j.fsi.2010.08.009; Douillet PA, 1999, AQUACULTURE, V170, P113, DOI 10.1016/S0044-8486(98)00398-6; Eddy SD, 2002, AQUACULTURE, V211, P9, DOI 10.1016/S0044-8486(01)00882-1; Gatesoupe FJ, 2002, AQUACULTURE, V212, P347, DOI 10.1016/S0044-8486(02)00138-2; Geng HF, 2008, APPL ENVIRON MICROB, V74, P1535, DOI 10.1128/AEM.02339-07; Geng HF, 2010, J BACTERIOL, V192, P4377, DOI 10.1128/JB.00410-10; Gram L, 2010, MAR BIOTECHNOL, V12, P439, DOI 10.1007/s10126-009-9233-y; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HANSEN PJ, 1989, MAR ECOL PROG SER, V53, P105, DOI 10.3354/meps053105; Harzevili ARS, 1997, AQUACULT INT, V5, P183; Hjelm M, 2004, SYST APPL MICROBIOL, V27, P360, DOI 10.1078/0723-2020-00256; Irianto A, 2002, J FISH DIS, V25, P633, DOI 10.1046/j.1365-2761.2002.00422.x; Kesarcodi-Watson A, 2008, AQUACULTURE, V274, P1, DOI 10.1016/j.aquaculture.2007.11.019; Lambertsen L, 2004, ENVIRON MICROBIOL, V6, P726, DOI 10.1111/j.1462-2920.2004.00605.x; MANGORJENSEN A, 1987, FISH PHYSIOL BIOCHEM, V3, P99, DOI 10.1007/BF02183004; Marques A, 2005, APPL ENVIRON MICROB, V71, P4307, DOI 10.1128/AEM.71.8.4307-4317.2005; Marques A, 2006, AQUACULTURE, V258, P116, DOI 10.1016/j.aquaculture.2006.04.021; Martens T, 2006, INT J SYST EVOL MICR, V56, P1293, DOI 10.1099/ijs.0.63724-0; Martinez-Diaz SF, 2003, AQUACULT INT, V11, P95, DOI 10.1023/A:1024117109362; Munro PD, 1999, AQUACULTURE, V170, P229, DOI 10.1016/S0044-8486(98)00419-0; MUNRO PD, 1995, APPL ENVIRON MICROB, V61, P4425, DOI 10.1128/AEM.61.12.4425-4428.1995; NAAS KE, 1992, AQUACULTURE, V105, P143, DOI 10.1016/0044-8486(92)90126-6; NORQVIST A, 1990, INFECT IMMUN, V58, P3731, DOI 10.1128/IAI.58.11.3731-3736.1990; NORQVIST A, 1989, APPL ENVIRON MICROB, V55, P1400, DOI 10.1128/AEM.55.6.1400-1405.1989; Olafsen JA, 2001, AQUACULTURE, V200, P223, DOI 10.1016/S0044-8486(01)00702-5; Perez-Sanchez T, 2011, FISH SHELLFISH IMMUN, V31, P196, DOI 10.1016/j.fsi.2011.05.005; Picchietti S, 2007, FISH SHELLFISH IMMUN, V22, P57, DOI 10.1016/j.fsi.2006.03.009; Planas M, 2006, AQUACULTURE, V255, P323, DOI 10.1016/j.aquaculture.2005.11.039; Planas M, 2004, AQUACULTURE, V240, P313, DOI 10.1016/j.aquaculture.2004.07.016; Porsby CH, 2008, APPL ENVIRON MICROB, V74, P7356, DOI 10.1128/AEM.01738-08; Porsby CH, 2011, ANTIMICROB AGENTS CH, V55, P1332, DOI 10.1128/AAC.01222-10; Prado S, 2009, INT MICROBIOL, V12, P107, DOI 10.2436/20.1501.01.87; Prol MJ, 2009, J APPL MICROBIOL, V106, P1292, DOI 10.1111/j.1365-2672.2008.04096.x; Rao D, 2005, APPL ENVIRON MICROB, V71, P1729, DOI 10.1128/AEM.71.4.1729-1736.2005; Rao D, 2007, APPL ENVIRON MICROB, V73, P7844, DOI 10.1128/AEM.01543-07; Rao D, 2006, APPL ENVIRON MICROB, V72, P5547, DOI 10.1128/AEM.00449-06; Reid HI, 2009, AQUACULTURE, V288, P36, DOI 10.1016/j.aquaculture.2008.11.022; Rollo A, 2006, FISH PHYSIOL BIOCHEM, V32, P167, DOI 10.1007/s10695-006-0009-2; Ruiz-Ponte C, 1998, INT J SYST BACTERIOL, V48, P537, DOI 10.1099/00207713-48-2-537; Salvesen I, 2000, AQUACULT INT, V8, P275, DOI 10.1023/A:1009200926452; Samuelsen OB, 2004, AQUACULTURE, V235, P27, DOI 10.1016/S0044-8486(03)00446-0; Sandlund N, 2008, DIS AQUAT ORGAN, V81, P203, DOI 10.3354/dao01934; Sandlund N, 2010, DIS AQUAT ORGAN, V89, P29, DOI 10.3354/dao02176; Seljestokken B, 2006, J FISH DIS, V29, P737, DOI 10.1111/j.1365-2761.2006.00773.x; Seyedsayamdost MR, 2011, NAT CHEM, V3, P331, DOI 10.1038/NCHEM.1002; Skjermo J, 1999, AQUACULTURE, V177, P333, DOI 10.1016/S0044-8486(99)00096-4; Skjermo J, 1997, AQUACULT INT, V5, P13, DOI 10.1007/BF02764784; Sobecky PA, 1997, APPL ENVIRON MICROB, V63, P888, DOI 10.1128/AEM.63.3.888-895.1997; Tinh NTN, 2008, MAR BIOTECHNOL, V10, P1, DOI 10.1007/s10126-007-9054-9; Tinh NTN, 2006, AQUACULTURE, V253, P421, DOI 10.1016/j.aquaculture.2005.09.006; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Vik-Mo FT, 2005, DIS AQUAT ORGAN, V67, P87, DOI 10.3354/dao067087; Vine NG, 2006, FEMS MICROBIOL REV, V30, P404, DOI 10.1111/j.1574-6976.2006.00017.x; Wang YB, 2008, AQUACULTURE, V281, P1, DOI 10.1016/j.aquaculture.2008.06.002; Wietz M, 2010, AQUAT MICROB ECOL, V61, P179, DOI 10.3354/ame01443	65	81	83	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43996	10.1371/journal.pone.0043996	http://dx.doi.org/10.1371/journal.pone.0043996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928051	gold, Green Published			2022-12-25	WOS:000308286300100
J	Saussine, A; Tazi, A; Feuillet, S; Rybojad, M; Juillard, C; Bergeron, A; Dessirier, V; Bouhidel, F; Janin, A; Bensussan, A; Bagot, M; Bouaziz, JD				Saussine, Anne; Tazi, Abdellatif; Feuillet, Severine; Rybojad, Michel; Juillard, Caroline; Bergeron, Anne; Dessirier, Valerie; Bouhidel, Fatiha; Janin, Anne; Bensussan, Armand; Bagot, Martine; Bouaziz, Jean-David			Active Chronic Sarcoidosis is Characterized by Increased Transitional Blood B Cells, Increased IL-10-Producing Regulatory B Cells and High BAFF Levels	PLOS ONE			English	Article							LYMPHOCYTE STIMULATOR; PULMONARY SARCOIDOSIS; T-CELLS; MICE; SCLEROSIS; RITUXIMAB; DISEASES; CD4(+)	Background: Sarcoidosis is a multisystemic disease of unknown etiology characterized by a disproportionate Th1 granulomatous immune response in the organs involved. Plasmatic hypergammaglobulinemia and B cell accumulation in granulomatous lesions suggest the possible role of humoral immune responses in the pathogenesis of sarcoidosis. The purpose of this study is to describe B cell peripheral compartment in sarcoidosis. Methodology/Principal Findings: We analyzed blood B cell subsets and BAFF levels in 33 patients with chronic sarcoidosis (active sarcoidosis n = 18; inactive sarcoidosis n = 15) and 18 healthy donors. Active chronic sarcoidosis patients had significantly less circulating memory B cells (p<0.01), more transitional (p<0.01) and increased numbers of IL-10-producing regulatory B cells (p<0.05) compared with healthy donors and patients with inactive sarcoidosis. BAFF serum levels were significantly higher in patients with active sarcoidosis (p<0.01 versus healthy donors and inactive sarcoidosis patients) and strongly correlated with serum hypergammaglobulinemia (r = 0.53, p<0.01) and angiotensin converting enzyme levels (r = 0.61, p =< 0.01). Conclusions/Significance: These data show that there is an altered B cell homeostasis in active sarcoidosis and suggest BAFF antagonist drugs as potential new treatments of this disease.	[Saussine, Anne; Dessirier, Valerie; Bensussan, Armand; Bagot, Martine; Bouaziz, Jean-David] INSERM, U976, Paris, France; [Saussine, Anne; Dessirier, Valerie; Bensussan, Armand; Bagot, Martine; Bouaziz, Jean-David] Univ Paris Diderot, Lab Immunol Dermatol & Oncol, UMR S 976, Paris, France; [Saussine, Anne; Rybojad, Michel; Juillard, Caroline; Bagot, Martine; Bouaziz, Jean-David] Hop St Louis, Serv Dermatol, F-75475 Paris, France; [Tazi, Abdellatif; Feuillet, Severine; Bergeron, Anne] Hop St Louis, Serv Pneumol, Paris, France; [Tazi, Abdellatif; Feuillet, Severine; Bergeron, Anne] Univ Paris Diderot, AP HP, Paris, France; [Bouhidel, Fatiha; Janin, Anne] Hop St Louis, Serv Anatomopathol, Paris, France; [Bouhidel, Fatiha; Janin, Anne] Univ Paris Diderot Sorbonne Paris Cite, Lab Pahol, UMR S 728, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Saussine, A (corresponding author), INSERM, U976, Paris, France.	Armand.Bensussan@inserm.fr; jean-david.bouaziz@sls.aphp.fr		Bensussan, Armand/0000-0002-0409-2497; Bergeron, Anne/0000-0003-2156-254X	Bourse du Fonds d'Etudes et de Recherche du Corps Medical de l'AP-HP, Societe francaise de Dermatologie (SFD), Societe francaise de Recherche Dermatologique (SRD), Legs Poix	Bourse du Fonds d'Etudes et de Recherche du Corps Medical de l'AP-HP, Societe francaise de Dermatologie (SFD), Societe francaise de Recherche Dermatologique (SRD), Legs Poix	Bourse du Fonds d'Etudes et de Recherche du Corps Medical de l'AP-HP, Societe francaise de Dermatologie (SFD), Societe francaise de Recherche Dermatologique (SRD), Legs Poix. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, EUR RESP J, V7, P624; [Anonymous], 1999, AM J RESP CRIT CARE, V160, P736; Baumer I, 1997, AM J RESP CELL MOL, V16, P171; Belkhou A, 2008, JOINT BONE SPINE, V75, P511, DOI 10.1016/j.jbspin.2008.01.025; Bergeron A, 1997, J IMMUNOL, V159, P3034; Bertheau P, 1998, J CLIN PATHOL, V51, P370, DOI 10.1136/jcp.51.5.370; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Bouaziz J-D, 2012, CURRENT MOL MED; Bouaziz JD, 2010, EUR J IMMUNOL; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; Boudouin SV, 1994, SARCOIDOSIS OTHER GR, P573; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Dasilva V, 2010, JOINT BONE SPINE, V77, P82, DOI 10.1016/j.jbspin.2009.11.005; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; FAZEL SB, 1992, THORAX, V47, P964, DOI 10.1136/thx.47.11.964; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Gottenberg JE, 2005, ANN RHEUM DIS, V64, P913, DOI 10.1136/ard.2004.029694; HUNNINGHAKE GW, 1981, J CLIN INVEST, V67, P86, DOI 10.1172/JCI110036; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Landolt-Marticorena C, 2011, J RHEUMATOL, V38, P642, DOI 10.3899/jrheum.100214; Lee NS, 2011, CLIN VACCINE IMMUNOL, V18, P1306, DOI 10.1128/CVI.05118-11; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Matsushita T, 2006, ARTHRITIS RHEUM-US, V54, P192, DOI 10.1002/art.21526; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Medoff BD, 2005, ANN NY ACAD SCI, V1062, P220, DOI 10.1196/annals.1358.026; Miyara M, 2006, J EXP MED, V203, P359, DOI 10.1084/jem.20050648; Mizoguchi A, 1997, J EXP MED, V186, P1749, DOI 10.1084/jem.186.10.1749; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; QUISMORIO FP, 1977, BRIT J DERMATOL, V97, P635, DOI 10.1111/j.1365-2133.1977.tb14270.x; Wahlstrom J, 2001, AM J RESP CRIT CARE, V163, P115, DOI 10.1164/ajrccm.163.1.9906071; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6; Zissel G, 2010, SEMIN RESP CRIT CARE, V31, P390, DOI 10.1055/s-0030-1262208	37	62	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43588	10.1371/journal.pone.0043588	http://dx.doi.org/10.1371/journal.pone.0043588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927996	Green Submitted, Green Published, gold			2022-12-25	WOS:000308286300069
J	Spronk, M; Vogel, EK; Jonkman, LM				Spronk, Marjolein; Vogel, Edward K.; Jonkman, Lisa M.			Electrophysiological Evidence for Immature Processing Capacity and Filtering in Visuospatial Working Memory in Adolescents	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; IRRELEVANT INFORMATION; INDIVIDUAL-DIFFERENCES; FLUID INTELLIGENCE; NEURAL MECHANISMS; SPATIAL ATTENTION; STORAGE CAPACITY; PARIETAL CORTEX; CHILDHOOD	The present study investigated the development of visuospatial working memory (VSWM) capacity and the efficiency of filtering in VSWM in adolescence. To this end, a group of IQ-matched adults and adolescents performed a VSWM change detection task with manipulations of WM-load and distraction, while performance and electrophysiological contralateral delay activity (CDA) were measured. The CDA is a lateralized ERP marker of the number of targets and distracters that are selectively encoded/maintained in WM from one hemifield of the memory display. Significantly lower VSWM-capacity (Cowan's K) was found in adolescents than adults, and adolescents' WM performance (in terms of accuracy and speed) also suffered more from the presence of distracters. Distracter-related CDA responses were partly indicative of higher distracter encoding/maintenance in WM in adolescents and were positively correlated with performance measures of distracter interference. This correlation suggests that the higher interference of distracters on WM performance in adolescents was caused by an inability to block distracters from processing and maintenance in WM. The lower visuospatial WM-capacity (K) in adolescents in the high load (3 items) condition was accompanied by a trend (p<.10) towards higher CDA amplitudes in adolescents than adults, whereas CDA amplitudes in the low load (1 item) condition were comparable between adolescents and adults. These findings point to immaturity of frontal-parietal WM-attention networks that support visuospatial WM processing in adolescence.	[Spronk, Marjolein; Jonkman, Lisa M.] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Vogel, Edward K.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	Maastricht University; University of Oregon	Spronk, M (corresponding author), Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands.	marjoleinspronk@gmail.com	Vogel, Edward K/AAW-9466-2021		Netherlands Organization of Scientific Research (NWO) [400-05-132]	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Netherlands Organization of Scientific Research (NWO), Open Competition programme, grant number 400-05-132 awarded to L. M. Jonkman (http://www.nwo.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 1991, MANUAL SELF REPORT 1; Achenbach TM, 2003, MANUAL ASEBA ADULT F; ANDERER P, 1992, PSYCHIAT RES-NEUROIM, V45, P79, DOI 10.1016/0925-4927(92)90002-L; [Anonymous], 1991, MANUAL CHILD BEHAV C; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Brisson B, 2007, PSYCHOPHYSIOLOGY, V44, P323, DOI 10.1111/j.1469-8986.2007.00503.x; Bunge SA, 2007, CURR OPIN NEUROBIOL, V17, P243, DOI 10.1016/j.conb.2007.02.005; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Cowan N, 2006, TRENDS COGN SCI, V10, P139, DOI 10.1016/j.tics.2006.02.001; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N, 2010, DEVELOPMENTAL SCI, V13, P120, DOI 10.1111/j.1467-7687.2009.00864.x; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Delvenne JF, 2011, PSYCHOPHYSIOLOGY, V48, P333, DOI 10.1111/j.1469-8986.2010.01079.x; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; Emrich SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008042; Fukuda K, 2010, PSYCHON B REV, V17, P673, DOI 10.3758/17.5.673; Fukuda K, 2009, J NEUROSCI, V29, P8726, DOI 10.1523/JNEUROSCI.2145-09.2009; Gao ZF, 2009, J VISION, V9, DOI 10.1167/9.7.17; Gathercole SE, 1999, TRENDS COGN SCI, V3, P410, DOI 10.1016/S1364-6613(99)01388-1; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 2006, J CHILD PSYCHOL PSYC, V47, P4, DOI 10.1111/j.1469-7610.2005.01446.x; Grimault S, 2009, HUM BRAIN MAPP, V30, P3378, DOI 10.1002/hbm.20759; Hill BD, 2010, J CLIN EXP NEUROPSYC, V32, P315, DOI 10.1080/13803390903032529; HITCH GJ, 1989, MEM COGNITION, V17, P175, DOI 10.3758/BF03197067; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Jeyakumar SLE, 2004, EDUC PSYCHOL MEAS, V64, P71, DOI 10.1177/0013164403258407; Jost K, 2011, CEREB CORTEX, V21, P1147, DOI 10.1093/cercor/bhq185; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Kwon H, 2002, P NATL ACAD SCI USA, V99, P13336, DOI 10.1073/pnas.162486399; Lee EY, 2010, BRAIN, V133, P2677, DOI 10.1093/brain/awq197; Linden DEJ, 2003, NEUROIMAGE, V20, P1518, DOI 10.1016/j.neuroimage.2003.07.021; Luciana M, 2005, CHILD DEV, V76, P697, DOI 10.1111/j.1467-8624.2005.00872.x; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Riggs KJ, 2006, J EXP CHILD PSYCHOL, V95, P18, DOI 10.1016/j.jecp.2006.03.009; Robitaille N, 2007, BRAIN RES, V1185, P158, DOI 10.1016/j.brainres.2007.09.004; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Sander MC, 2011, CONTRALATERAL DELAY; Schleepen TMJ, 2010, DEV NEUROPSYCHOL, V35, P37, DOI 10.1080/87565640903325733; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Spreen O, 1998, COMPENDIUM NEUROPSYC; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Van Leijenhorst L, 2007, CHILD DEV, V78, P987, DOI 10.1111/j.1467-8624.2007.01045.x; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D., 1997, WECHSLER ADULT INTEL; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009	55	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42262	10.1371/journal.pone.0042262	http://dx.doi.org/10.1371/journal.pone.0042262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999CI	22927923	Green Submitted, gold, Green Published			2022-12-25	WOS:000308286300019
J	Fortington, LV; Geertzen, JHB; Bosmans, JC; Dijkstra, PU				Fortington, Lauren V.; Geertzen, Jan H. B.; Bosmans, Joline C.; Dijkstra, Pieter U.			Bias in Amputation Research; Impact of Subjects Missed from a Prospective Study	PLOS ONE			English	Article							PHANTOM-LIMB PAIN; AMPUTEES; HEALTH	For research findings to be generalized, a sample must be representative of the actual population of interest. Lower limb amputation is most frequently performed in older patients with vascular disease, a population that is often underrepresented in research. The aim of this study was to explore the impact of selection bias by comparing characteristics from a sample included in a prospective study of phantom pain with the actual population who underwent amputation. Only 27% of all potential patients were referred during the first year of the prospective study. The referred patients were 8 years younger (p<0.001) and less likely to have had amputation because of a vascular condition, diabetes or infection (p = 0.003) than those not referred. There was also a significant difference in one year survival between the groups; 67% of referred patients survived compared with just 40% of non-referred patients (p = 0.004). The biased population in the phantom pain study may have resulted in an underestimation of phantom pain in the original study and subsequent protective factors should be considered within the context of the younger population reported. Selection bias is common in amputation research, and research methods to minimize its impact must be given greater attention.	[Fortington, Lauren V.; Geertzen, Jan H. B.; Bosmans, Joline C.; Dijkstra, Pieter U.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, NL-9713 AV Groningen, Netherlands; [Dijkstra, Pieter U.] Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen	Fortington, LV (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, NL-9713 AV Groningen, Netherlands.	l.v.fortington@umcg.nl	Fortington, Lauren/E-9002-2015	Fortington, Lauren/0000-0003-2760-9249	OIM Foundation, Assen; Beatrixoord Foundation North Netherlands, Haren	OIM Foundation, Assen; Beatrixoord Foundation North Netherlands, Haren	This study was funded in part by grants provided by the OIM Foundation, Assen and the Beatrixoord Foundation North Netherlands, Haren. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACH S, 1988, PAIN, V33, P297, DOI 10.1016/0304-3959(88)90288-6; Bosmans JC, 2010, J REHABIL RES DEV, V47, P457, DOI 10.1682/JRRD.2009.06.0078; Bosmans JC, 2010, CLIN REHABIL, V24, P444, DOI 10.1177/0269215509360645; Casale R, 2009, J REHABIL MED, V41, P418, DOI 10.2340/16501977-0353; Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Dijkstra PU, 2002, J PAIN SYMPTOM MANAG, V24, P578, DOI 10.1016/S0885-3924(02)00538-9; Ehde DM, 2000, ARCH PHYS MED REHAB, V81, P1039, DOI 10.1053/apmr.2000.7583; Euser SM, 2008, EPIDEMIOLOGY, V19, P440, DOI 10.1097/EDE.0b013e31816a1d31; Fletcher B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000496; Flor H, 2002, LANCET NEUROL, V1, P182, DOI 10.1016/S1474-4422(02)00074-1; Geertzen JHB, 2005, DISABIL REHABIL, V27, P101, DOI 10.1080/09638280400009345; Halbert J, 2002, CLIN J PAIN, V18, P84, DOI 10.1097/00002508-200203000-00003; Hardy SE, 2009, J AM GERIATR SOC, V57, P722, DOI 10.1111/j.1532-5415.2008.02168.x; Hernan MA, 2008, EPIDEMIOLOGY, V19, P448, DOI 10.1097/EDE.0b013e31816bbe14; Hirsh AT, 2010, J PAIN, V11, P79, DOI 10.1016/j.jpain.2009.06.004; JAHANGIRI M, 1994, ANN ROY COLL SURG, V76, P324; JENSEN TS, 1985, PAIN, V21, P267, DOI 10.1016/0304-3959(85)90090-9; Miller WC, 2002, PHYS THER, V82, P856, DOI 10.1093/ptj/82.9.856; Nikolajsen L, 2001, BRIT J ANAESTH, V87, P107, DOI 10.1093/bja/87.1.107; O'Neill BF, 2009, DISABIL REHABIL, V31, P1083, DOI 10.1080/09638280802509579; Patrick K, 2011, PAIN MED, V12, P794, DOI 10.1111/j.1526-4637.2011.01105.x; Rayegani SM, 2010, JPO, V22, P162, DOI DOI 10.1097/JP0.0B013E3181EB3C8C; Richardson C, 2006, CLIN J PAIN, V22, P353, DOI 10.1097/01.ajp.0000177793.01415.bd; Subedi B, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/864605; Unwin J, 2009, CLIN REHABIL, V23, P1044, DOI 10.1177/0269215509339001; van der Schans CP, 2002, J PAIN SYMPTOM MANAG, V24, P429, DOI 10.1016/S0885-3924(02)00511-0; Wolff A, 2011, PAIN PRACT, V11, P403, DOI 10.1111/j.1533-2500.2011.00454.x	27	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43629	10.1371/journal.pone.0043629	http://dx.doi.org/10.1371/journal.pone.0043629			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	991WJ	22916286	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800085
J	Fuller, JC; Jackson, RM; Edwards, TA; Wilson, AJ; Shirts, MR				Fuller, Jonathan C.; Jackson, Richard M.; Edwards, Thomas A.; Wilson, Andrew J.; Shirts, Michael R.			Modeling of Arylamide Helix Mimetics in the p53 Peptide Binding Site of hDM2 Suggests Parallel and Anti-Parallel Conformations Are Both Stable	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; AB-INITIO; MOLECULAR SIMULATION; FREE-ENERGIES; MDM2 BINDING; FORCE-FIELDS; RECOGNITION; ANTAGONISTS; FOLDAMERS; DYNAMICS	The design of novel alpha-helix mimetic inhibitors of protein-protein interactions is of interest to pharmaceuticals and chemical genetics researchers as these inhibitors provide a chemical scaffold presenting side chains in the same geometry as an alpha-helix. This conformational arrangement allows the design of high affinity inhibitors mimicking known peptide sequences binding specific protein substrates. We show that GAFF and AutoDock potentials do not properly capture the conformational preferences of alpha-helix mimetics based on arylamide oligomers and identify alternate parameters matching solution NMR data and suitable for molecular dynamics simulation of arylamide compounds. Results from both docking and molecular dynamics simulations are consistent with the arylamides binding in the p53 peptide binding pocket. Simulations of arylamides in the p53 binding pocket of hDM2 are consistent with binding, exhibiting similar structural dynamics in the pocket as simulations of known hDM2 binders Nutlin-2 and a benzodiazepinedione compound. Arylamide conformations converge towards the same region of the binding pocket on the 20 ns time scale, and most, though not all dihedrals in the binding pocket are well sampled on this timescale. We show that there are two putative classes of binding modes for arylamide compounds supported equally by the modeling evidence. In the first, the arylamide compound lies parallel to the observed p53 helix. In the second class, not previously identified or proposed, the arylamide compound lies anti-parallel to the p53 helix.	[Fuller, Jonathan C.; Jackson, Richard M.; Edwards, Thomas A.; Wilson, Andrew J.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Fuller, Jonathan C.; Shirts, Michael R.] Univ Virginia, Dept Chem Engn, Charlottesville, VA USA; [Wilson, Andrew J.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Virginia; University of Leeds	Fuller, JC (corresponding author), Heidelberg Inst Theoret Studies, Heidelberg, Germany.	michael.shirts@virginia.edu	; Andrew, Wilson/P-1545-2014	Fuller, Jonathan/0000-0001-8801-149X; Andrew, Wilson/0000-0001-9852-6366; edwards, thomas/0000-0002-1467-3674	Biotechnology and Biological Sciences Research Council (BBSRC); Collaborative Computational Project for Biomolecular Simulation (CCPB); European Research Council [ERC-StG-240324]; Yorkshire Cancer Research [L348]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Collaborative Computational Project for Biomolecular Simulation (CCPB); European Research Council(European Research Council (ERC)European Commission); Yorkshire Cancer Research	The authors thank the Biotechnology and Biological Sciences Research Council (BBSRC) for funding JCF in the form of a PhD studentship and the Collaborative Computational Project for Biomolecular Simulation (CCPB) in the form of a USPA Travel award for visiting the University of Virginia. AJW and TAE acknowledge the financial support of the European Research Council [ERC-StG-240324]. AJW, TAE and RJM acknowledge the financial support of Yorkshire Cancer Research [L348]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; Bottger V, 1996, ONCOGENE, V13, P2141; Campbell F, 2010, ORG BIOMOL CHEM, V8, P2344, DOI 10.1039/c001164a; Carotti A, 2009, PROTEINS, V77, P524, DOI 10.1002/prot.22464; Case D., 2004, AMBER; Dickens MP, 2010, SEMIN CANCER BIOL, V20, P10, DOI 10.1016/j.semcancer.2009.10.003; Ding K, 2005, J AM CHEM SOC, V127, P10130, DOI 10.1021/ja051147z; Edwards TA, 2011, AMINO ACIDS, V41, P743, DOI 10.1007/s00726-011-0880-8; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Fry DC, 2004, J BIOMOL NMR, V30, P163, DOI 10.1023/B:JNMR.0000048856.84603.9b; Fuller JC, 2012, J PHYS CHEM B, V116, P10856, DOI 10.1021/jp209041x; Fuller JC, 2009, DRUG DISCOV TODAY, V14, P155, DOI 10.1016/j.drudis.2008.10.009; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Harker EA, 2009, BIOORGAN MED CHEM, V17, P2038, DOI 10.1016/j.bmc.2009.01.039; Henchey LK, 2010, CHEMBIOCHEM, V11, P2104, DOI 10.1002/cbic.201000378; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Kalid O, 2009, J CHEM INF MODEL, V49, P865, DOI 10.1021/ci800352c; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Laue ED, ACPYPE ANTECHA UNPUB; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu ZW, 2011, J COMPUT CHEM, V32, P1846, DOI 10.1002/jcc.21767; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Mobley DL, 2007, J CHEM THEORY COMPUT, V3, P1231, DOI 10.1021/ct700032n; Mobley DL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221683; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plante J, 2008, ORG BIOMOL CHEM, V6, P138, DOI 10.1039/b712606a; Plante JP, 2009, CHEM COMMUN, P5091, DOI 10.1039/b908207g; Pophristic V, 2006, J PHYS CHEM B, V110, P3517, DOI 10.1021/jp054306+; Prabhakaran P, 2012, TETRAHEDRON, V68, P4485, DOI 10.1016/j.tet.2011.11.078; Sadowsky JD, 2007, J AM CHEM SOC, V129, P139, DOI 10.1021/ja0662523; Shaginian A, 2009, J AM CHEM SOC, V131, P5564, DOI 10.1021/ja810025g; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vemparala S, 2006, J COMPUT CHEM, V27, P693, DOI 10.1002/jcc.20382; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Yuan Y, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-16; Zhong HZ, 2005, PROTEINS, V58, P222, DOI 10.1002/prot.20275	49	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43253	10.1371/journal.pone.0043253	http://dx.doi.org/10.1371/journal.pone.0043253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916232	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800057
J	Birkenfeld, AL; Boschmann, M; Engeli, S; Moro, C; Arafat, AM; Luft, FC; Jordan, J				Birkenfeld, Andreas L.; Boschmann, Michael; Engeli, Stefan; Moro, Cedric; Arafat, Ayman M.; Luft, Friedrich C.; Jordan, Jens			Atrial Natriuretic Peptide and Adiponectin Interactions in Man	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; LIPID MOBILIZATION; HUMAN ADIPOCYTES; ADIPOSE-TISSUE; ASSOCIATION; EXPRESSION; HUMANS; RISK; GENE	Reduced circulating natriuretic peptide concentrations are independently associated with insulin resistance and type 2 diabetes, while increased natriuretic peptide levels appear to be protective. Observations in vitro and in heart failure patients suggest that atrial natriuretic peptide (ANP) promotes adiponectin release, an adipokine with insulin sensitizing properties. We tested the hypothesis that ANP acutely raises adiponectin levels in 12 healthy men. We infused ANP intravenously over 135 minutes while collecting venous blood and adipose tissue microdialysates at baseline and at the end of ANP-infusion. We obtained blood samples at identical time-points without ANP infusion in 7 age and BMI matched men. With infusion, venous ANP concentrations increased similar to 10 fold. Systemic and adipose tissue glycerol concentrations increased 70% and 80%, respectively (P<0.01). ANP infusion increased total adiponectin 14 +/- 5% and high molecular-weight (HMW)-adiponectin 13 +/- 5% (P<0.05). Adiponectin did not change in the control group (P<0.05 vs. infusion). ANP-induced changes in HMW adiponectin and adipose tissue lipolysis were directly correlated with each other, possibly suggesting a common mechanism. Our data show that ANP acutely increases systemic total and HMW-adiponectin concentrations in healthy subjects. Our study could have implications for the physiological regulation of adiponectin and for disease states associated with altered natriuretic peptide availability.	[Birkenfeld, Andreas L.; Arafat, Ayman M.] Charite Univ Sch Med Berlin, CCR, Dept Endocrinol Diabet & Nutr, Berlin, Germany; [Birkenfeld, Andreas L.; Boschmann, Michael; Luft, Friedrich C.] Expt & Clin Res Ctr, Berlin, Germany; [Moro, Cedric] Univ Toulouse 3, Inst Metab & Cardiovasc Dis, Inserm UMR1048, F-31062 Toulouse, France; [Engeli, Stefan; Jordan, Jens] Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Hannover Medical School	Birkenfeld, AL (corresponding author), Charite Univ Sch Med Berlin, CCR, Dept Endocrinol Diabet & Nutr, Berlin, Germany.	jordan.jens@mh-hannover.de	Moro, Cedric/N-5754-2017; Birkenfeld, Andreas L./U-3954-2019	Birkenfeld, Andreas L./0000-0003-1407-9023; Arafat, Ayman/0000-0003-3069-8385; Luft, Friedrich/0000-0002-8635-1199; Moro, Cedric/0000-0003-4294-0597	Deutsche Forschungsgemeinschaft [BI 1292/4-1, JO 284/5-2]; collaborative research grant of the European Commission (SICA-HF, FP7) [241558]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); collaborative research grant of the European Commission (SICA-HF, FP7)	Our work was supported in part by a grant from the Deutsche Forschungsgemeinschaft to ALB (BI 1292/4-1), JJ (JO 284/5-2) and a collaborative research grant of the European Commission (SICA-HF, FP7 241558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkenfeld AL, 2005, J CLIN ENDOCR METAB, V90, P3622, DOI 10.1210/jc.2004-1953; Birkenfeld AL, 2006, J CLIN ENDOCR METAB, V91, P5069, DOI 10.1210/jc.2006-1084; Birkenfeld AL, 2011, HYPERTENSION, V57, pE4, DOI 10.1161/HYPERTENSIONAHA.110.165159; Birkenfeld AL, 2008, DIABETES, V57, P3199, DOI 10.2337/db08-0649; Brunner-La Rocca HP, 2001, J AM COLL CARDIOL, V37, P1221, DOI 10.1016/S0735-1097(01)01172-X; Fasshauer M, 2001, FEBS LETT, V507, P142, DOI 10.1016/S0014-5793(01)02960-X; Halberg N, 2009, DIABETES, V58, P1961, DOI 10.2337/db08-1750; Khan AM, 2011, J CLIN ENDOCR METAB, V96, P3242, DOI 10.1210/jc.2011-1182; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Lafontan M, 2008, TRENDS ENDOCRIN MET, V19, P130, DOI 10.1016/j.tem.2007.11.006; Magnusson M, 2011, J CLIN ENDOCRINOL ME; Meirhaeghe A, 2007, HUM MOL GENET, V16, P1343, DOI 10.1093/hmg/ddm084; Miyashita K, 2009, DIABETES, V58, P2880, DOI 10.2337/db09-0393; Nakatsuji H, 2010, BIOCHEM BIOPH RES CO, V392, P100, DOI 10.1016/j.bbrc.2010.01.008; Ohara T, 2011, J CARDIOL, V58, P181, DOI 10.1016/j.jjcc.2011.06.010; Polak J, 2011, J AM COLL CARDIOL, V58, P1119, DOI 10.1016/j.jacc.2011.05.042; Sarzani R, 1996, J ENDOCRINOL INVEST, V19, P581; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Souza SC, 2011, BIOCHEM BIOPH RES CO, V410, P398, DOI 10.1016/j.bbrc.2011.05.143; Tsukamoto O, 2009, J AM COLL CARDIOL, V53, P2070, DOI 10.1016/j.jacc.2009.02.038; Wang TJ, 2007, CIRCULATION, V115, P1345, DOI 10.1161/CIRCULATIONAHA.106.655142	21	64	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43238	10.1371/journal.pone.0043238	http://dx.doi.org/10.1371/journal.pone.0043238			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916229	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000307824300033
J	Calvo, R; Zheng, YH; Kumar, S; Olgiati, A; Berkman, L				Calvo, Rocio; Zheng, Yuhui; Kumar, Santosh; Olgiati, Analia; Berkman, Lisa			Well-Being and Social Capital on Planet Earth: Cross-National Evidence from 142 Countries	PLOS ONE			English	Article							HAPPINESS; HEALTH; LIFE; TRUST; HAPPY	High levels of social trust and social support are associated with life satisfaction around the world. However, it is not known whether this association extends to other indicators of social capital and of subjective well-being globally. We examine associations between three measures of social capital and three indicators of subjective well-being in 142 low-, middle- dand high-income countries. Furthermore, we explore whether positive and negative feelings mirror each other or if they are separate constructs that behave differently in relation to social capital. Data comes from the Gallup World Poll, an international cross-sectional comparable survey conducted yearly from 2005 to 2009 for those 15 years of age and over. The poll represents 95% of the world's population. Social capital was measured with self-reports of access to support from relatives and friends, of volunteering to an organization in the past month, and of trusting others. Subjective well-being was measured with self-reports of life satisfaction, positive affect, and negative affect. We first estimate random coefficient (multi-level) models and then use multivariate (individual-level) Ordinary Least Square (OLS) regression to model subjective well-being as a function of social support, volunteering and social trust, controlling for age, gender, education, marital status, household income and religiosity. We found that having somebody to count on in case of need and reporting high levels of social trust are associated with better life evaluations and more positive feelings and an absence of negative feelings in most countries around the world. Associations, however, are stronger for high- and middle-income countries. Volunteering is also associated with better life evaluations and a higher frequency of positive emotions. There is not an association, however, between volunteering and experiencing negative feelings, except for low-income countries. Finally, we present evidence that the two affective components of subjective well-being behave differently in relation to different indicators of social capital and social support across countries.	[Calvo, Rocio] Boston Coll, Dept Global Practice, Grad Sch Social Work, Chestnut Hill, MA 02167 USA; [Calvo, Rocio; Zheng, Yuhui; Olgiati, Analia; Berkman, Lisa] Harvard Ctr Populat & Dev Studies, Cambridge, MA USA; [Kumar, Santosh] Univ Washington, Sch Publ Hlth, Inst Hlth Metr & Evaluat, Dept Global Hlth, Seattle, WA 98195 USA; [Berkman, Lisa] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Berkman, Lisa] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Berkman, Lisa] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Boston College; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Calvo, R (corresponding author), Boston Coll, Dept Global Practice, Grad Sch Social Work, Chestnut Hill, MA 02167 USA.	lberkman@hsph.harvard.edu	Calvo, Rocio/V-5499-2019; Calvo, Rocío/AAF-8428-2020	Calvo, Rocío/0000-0002-6303-9215	Bell postdoctoral fellowship	Bell postdoctoral fellowship	YZ, RC, SK and AO were supported by the Bell postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjornskov C, 2003, KYKLOS, V56, P3, DOI 10.1111/1467-6435.00207; Blanchflower DG, 2008, J HEALTH ECON, V27, P218, DOI 10.1016/j.jhealeco.2007.06.002; Blanchflower DG, 2004, J PUBLIC ECON, V88, P1359, DOI 10.1016/S0047-2727(02)00168-8; Bourdieu P, 1993, SOCIOLOGY QUESTION, P143; Brockmann H, 2009, J HAPPINESS STUD, V10, P387, DOI 10.1007/s10902-008-9095-4; Cramm JM, 2012, SOC INDIC RES, V105, P581, DOI 10.1007/s11205-011-9790-0; Cramm JM, 2010, J HEALTH PSYCHOL, V15, P1012, DOI 10.1177/1359105310367833; Delhey J, 2011, AM SOCIOL REV, V76, P786, DOI 10.1177/0003122411420817; Delhey J, 2010, SOC INDIC RES, V97, P65, DOI 10.1007/s11205-009-9558-y; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Diener E, 2009, WELL BEING PUBLIC PO, P67; Diener E., 2009, PSIHOL TEME, V18, P213; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Diener E, 2010, J PERS SOC PSYCHOL, V99, P52, DOI 10.1037/a0018066; EASTERLIN RA, 1995, J ECON BEHAV ORGAN, V27, P35, DOI 10.1016/0167-2681(95)00003-B; Easterlin RA., 1974, NATIONS HOUSEHOLDS E, V89, P89; Fischer J. A., 2009, 16619 MPRA; Gallup, 2012, WORLDW RES METH COD; Gallup, 2008, STAT WORLD 2008 ANN; Han S, 2013, SOC INDIC RES, V111, P185, DOI 10.1007/s11205-011-9990-7; Handy F, 2010, NONPROF VOLUNT SEC Q, V39, P498, DOI 10.1177/0899764009344353; Helliwell J., 2013, WORLD HAPPINESS REPO; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Helliwell JF, 2008, 14507 NBER; Helliwell JF, 2010, CAN J ECON, V43, P729, DOI 10.1111/j.1540-5982.2010.01592.x; Helliwell JF, 2009, STAT SCI INTERDISC R, V5, P3; Helliwell JohnF., 2010, INT DIFFERENCES WELL, P291, DOI [DOI 10.1093/ACPR0F:0S0/9780199732739.003.0010, DOI 10.1093/ACPROF:OSO/9780199732739.003.0010]; Hooghe M, 2011, SOC INDIC RES, V100, P17, DOI 10.1007/s11205-010-9600-0; Inglehart R, 2000, WASH QUART, V23, P215, DOI 10.1162/016366000560665; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kumar S, 2012, SOC SCI MED, V74, P696, DOI 10.1016/j.socscimed.2011.11.017; Layard R, 2010, SCIENCE, V327, P534, DOI 10.1126/science.1186315; Lucas RE, 1996, J PERS SOC PSYCHOL, V71, P616, DOI 10.1037/0022-3514.71.3.616; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Maddala G.S., 1986, LTD DEPENDENT QUALIT; Maslow A.H., 1954, MOTIVATION PERSONALI; McMahan EA, 2011, SOC INDIC RES, V103, P93, DOI 10.1007/s11205-010-9698-0; Oishi Shigehiro., 2010, INT DIFFERENCES WELL, P34, DOI DOI 10.1093/ACPROF:OSO/9780199732739.003.0003; Oswald AJ, 2010, SCIENCE, V327, P576, DOI 10.1126/science.1180606; Park N, 2004, ANN AM ACAD POLIT SS, V591, P25, DOI 10.1177/0002716203260078; Piliavin JA, 2008, COOPERATION POLITICA; Putnam RD, 1993, MAKING DEMOCRACY WOR, p[xv, 258]; Putnam Robert, 1996, AMERICAN PROSPECT, P66; Ram R, 2010, J HAPPINESS STUD, V11, P409, DOI 10.1007/s10902-009-9148-3; Reeskens T, 2008, SOC INDIC RES, V85, P515, DOI 10.1007/s11205-007-9100-z; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Schimmack U., 2008, SCI SUBJECTIVE WELL, P97, DOI DOI 10.5860/CHOICE.45-5867; Sheldon K. M., 2011, OXFORD HDB HAPPINESS; Steptoe A, 2005, NEUROBIOL AGING, V26, pS108, DOI 10.1016/j.neurobiolaging.2005.08.016; Stevenson B., 2008, BROOKINGS PAPERS EC, P88; Tay L, 2011, J PERS SOC PSYCHOL, V101, P354, DOI 10.1037/a0023779; Thoits PA, 2001, J HEALTH SOC BEHAV, V42, P115, DOI 10.2307/3090173; Tov W, 2009, SOC INDIC RES SER, V37, P155, DOI 10.1007/978-90-481-2350-6_7; Tshililo AR, 2009, NURSING HLTH SCI; Wang S., 2010, 15911 NBER; Wills-Herrera E., 2011, Journal of Socio-Economics, V40, P88, DOI 10.1016/j.socec.2010.08.002; Winkelmann R, 2009, J HAPPINESS STUD, V10, P421, DOI 10.1007/s10902-008-9097-2; Yamaoka K, 2008, SOC SCI MED, V66, P885, DOI 10.1016/j.socscimed.2007.10.024; Yip W, 2007, SOC SCI MED, V64, P35, DOI 10.1016/j.socscimed.2006.08.027; Ziemek S., 2006, J SOCIO-ECON, V35, P532, DOI [10.1016/j.socec.2005.11.064, DOI 10.1016/J.SOCEC.2005.11.064, DOI 10.1016/J.S0CEC.2005.11.064]	62	49	50	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42793	10.1371/journal.pone.0042793	http://dx.doi.org/10.1371/journal.pone.0042793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AG	22916160	Green Published, Green Submitted, gold			2022-12-25	WOS:000307823600028
J	Twiner, MJ; Flewelling, LJ; Fire, SE; Bowen-Stevens, SR; Gaydos, JK; Johnson, CK; Landsberg, JH; Leighfield, TA; Mase-Guthrie, B; Schwacke, L; Van Dolah, FM; Wang, ZH; Rowles, TK				Twiner, Michael J.; Flewelling, Leanne J.; Fire, Spencer E.; Bowen-Stevens, Sabrina R.; Gaydos, Joseph K.; Johnson, Christine K.; Landsberg, Jan H.; Leighfield, Tod A.; Mase-Guthrie, Blair; Schwacke, Lori; Van Dolah, Frances M.; Wang, Zhihong; Rowles, Teresa K.			Comparative Analysis of Three Brevetoxin-Associated Bottlenose Dolphin (Tursiops truncatus) Mortality Events in the Florida Panhandle Region (USA)	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; FORMERLY GYMNODINIUM-BREVE; SENSITIVE SODIUM-CHANNELS; GULF-OF-MEXICO; DOMOIC ACID; RED-TIDE; KARENIA-BREVIS; SARASOTA BAY; SEA LIONS; EXPOSURE	In the Florida Panhandle region, bottlenose dolphins (Tursiops truncatus) have been highly susceptible to large-scale unusual mortality events (UMEs) that may have been the result of exposure to blooms of the dinoflagellate Karenia brevis and its neurotoxin, brevetoxin (PbTx). Between 1999 and 2006, three bottlenose dolphin UMEs occurred in the Florida Panhandle region. The primary objective of this study was to determine if these mortality events were due to brevetoxicosis. Analysis of over 850 samples from 105 bottlenose dolphins and associated prey items were analyzed for algal toxins and have provided details on tissue distribution, pathways of trophic transfer, and spatial-temporal trends for each mortality event. In 1999/2000, 152 dolphins died following extensive K. brevis blooms and brevetoxin was detected in 52% of animals tested at concentrations up to 500 ng/g. In 2004, 105 bottlenose dolphins died in the absence of an identifiable K. brevis bloom; however, 100% of the tested animals were positive for brevetoxin at concentrations up to 29,126 ng/mL. Dolphin stomach contents frequently consisted of brevetoxin-contaminated menhaden. In addition, another potentially toxigenic algal species, Pseudo-nitzschia, was present and low levels of the neurotoxin domoic acid (DA) were detected in nearly all tested animals (89%). In 2005/2006, 90 bottlenose dolphins died that were initially coincident with high densities of K. brevis. Most (93%) of the tested animals were positive for brevetoxin at concentrations up to 2,724 ng/mL. No DA was detected in these animals despite the presence of an intense DA-producing Pseudo-nitzschia bloom. In contrast to the absence or very low levels of brevetoxins measured in live dolphins, and those stranding in the absence of a K. brevis bloom, these data, taken together with the absence of any other obvious pathology, provide strong evidence that brevetoxin was the causative agent involved in these bottlenose dolphin mortality events.	[Twiner, Michael J.; Fire, Spencer E.; Leighfield, Tod A.; Van Dolah, Frances M.; Wang, Zhihong] NOAA, Marine Biotoxins Program, Natl Ocean Serv, Charleston, SC USA; [Twiner, Michael J.] Univ Michigan, Dept Nat Sci, Dearborn, MI 48128 USA; [Flewelling, Leanne J.; Landsberg, Jan H.] Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commiss, St Petersburg, FL USA; [Bowen-Stevens, Sabrina R.] Natl Ocean & Atmospher Adm Fisheries, SE Fisheries Sci Ctr, Panama City Lab, Panama City, FL USA; [Bowen-Stevens, Sabrina R.; Mase-Guthrie, Blair] NOAA, Natl Marine Fisheries Serv, SE Fisheries Sci Ctr, Miami, FL USA; [Gaydos, Joseph K.; Johnson, Christine K.] Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA; [Schwacke, Lori] NOAA, Natl Ocean Serv, Cooperat Ctr Marine Anim Hlth, Hollings Marine Lab, Charleston, SC USA; [Rowles, Teresa K.] Natl Ocean & Atmospher Adm Fisheries, Cooperat Ctr Marine Anim Hlth, Silver Spring, MD USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; University of Michigan System; University of Michigan; Florida Fish & Wildlife Conservation Commission; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Davis; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Oceanic Atmospheric Admin (NOAA) - USA	Twiner, MJ (corresponding author), NOAA, Marine Biotoxins Program, Natl Ocean Serv, Charleston, SC USA.	mtwiner@umd.umich.edu	Fire, Spencer/P-6040-2014	Fire, Spencer/0000-0002-1657-790X; Gaydos, Joseph/0000-0001-6599-8797	National Oceanographic and Atmospheric Administration Marine Biotoxins Program; state of Florida; National Oceanographic and Atmospheric Administration Center for Sponsored Coastal Ocean Research Harmful Algal Bloom Event Response Fund	National Oceanographic and Atmospheric Administration Marine Biotoxins Program; state of Florida; National Oceanographic and Atmospheric Administration Center for Sponsored Coastal Ocean Research Harmful Algal Bloom Event Response Fund	This work was supported by the National Oceanographic and Atmospheric Administration Marine Biotoxins Program, the state of Florida, and the National Oceanographic and Atmospheric Administration Center for Sponsored Coastal Ocean Research Harmful Algal Bloom Event Response Fund (2004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON D, 2000, WHOI20002011; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; [Anonymous], 2000, P AM ASS ZOO VET INT; APHA, 1970, SUBC LAB METH EX SHE; ASAI S, 1984, J ALLERGY CLIN IMMUN, V73, P824, DOI 10.1016/0091-6749(84)90454-8; BADEN DG, 1984, SEAFOOD TOXINS, P359; Baden DG, 1996, MR148 NAT I ENV HLTH; Bargu S, 2002, MAR ECOL PROG SER, V237, P209, DOI 10.3354/meps237209; Barros N.B., 1990, P309; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; Benson JM, 2006, TOXICON, V48, P1018, DOI 10.1016/j.toxicon.2006.08.008; Blanco J, 2002, AQUAT TOXICOL, V60, P111, DOI 10.1016/S0166-445X(01)00274-0; Bossart GD, 1998, TOXICOL PATHOL, V26, P276, DOI 10.1177/019262339802600214; Bowen-Stevens SR, 2011, DIET BOTTLENOSE DOLP; CATTERALL WA, 1981, MOL PHARMACOL, V19, P345; CATTET M, 1993, TOXICON, V31, P1483, DOI 10.1016/0041-0101(93)90214-4; DICKEY RW, 1992, TOXICON, V30, P355, DOI 10.1016/0041-0101(92)90877-8; Fairey ER, 2001, ENVIRON HEALTH PERSP, V109, P717, DOI 10.2307/3454789; Ferdin ME, 2002, TOXICON, V40, P1259, DOI 10.1016/S0041-0101(02)00129-0; Fernandez S, 1998, FISH B-NOAA, V96, P357; Fire SE, 2011, COOCCURRENCE MULTIPL; Fire SE, 2008, MAR ECOL PROG SER, V368, P283, DOI 10.3354/meps07643; Fire SE, 2008, MAR MAMMAL SCI, V24, P831, DOI 10.1111/j.1748-7692.2008.00221.x; Fire SE, 2007, MAR BIOL, V152, P827, DOI 10.1007/s00227-007-0733-x; Flaherty KE, 2011, ESTUAR COAST, V34, P417, DOI 10.1007/s12237-010-9350-x; Flewelling L.J., 2008, VECTORS BREVETOXINS; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; FRYXELL G.A., 1990, BEIH NOVA HEDWIGIA, V100, P171; FWC, 2008, FLOR MAN TRICH MAN L, P52; Gannon DP, 2009, MAR ECOL PROG SER, V378, P171, DOI 10.3354/meps07853; Gaydos JK, 2006, NMFSOPR32 NOAA, P46; GUNTER G, 1948, ECOL MONOGR, V18, P309, DOI 10.2307/1948575; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hampson David R., 1998, Natural Toxins, V6, P153, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<153::AID-NT16>3.0.CO;2-1; HUANG JMC, 1984, J PHARMACOL EXP THER, V229, P615; IRVINE AB, 1981, FISH B-NOAA, V79, P671; Kirkpatrick B, 2004, HARMFUL ALGAE, V3, P99, DOI 10.1016/j.hal.2003.08.005; Landsberg JH, 2009, HARMFUL ALGAE, V8, P598, DOI 10.1016/j.hal.2008.11.010; Landsberg JH, 2000, S HARMF MAR ALG US M, P44; Lefebvre KA, 1999, NAT TOXINS, V7, P85, DOI 10.1002/(SICI)1522-7189(199905/06)7:3<85::AID-NT39>3.0.CO;2-Q; Liefer JD, 2009, HARMFUL ALGAE, V8, P706, DOI 10.1016/j.hal.2009.02.003; LIN YY, 1981, J AM CHEM SOC, V103, P6773, DOI 10.1021/ja00412a053; Maucher JM, 2007, ENVIRON SCI TECHNOL, V41, P563, DOI 10.1021/es0612605; Maucher JM, 2005, ENVIRON HEALTH PERSP, V113, P461, DOI 10.1289/ehp.7649; McFARREN E. F., 1965, TOXICON, V3, P111, DOI 10.1016/0041-0101(65)90005-X; Naar J, 2002, ENVIRON HEALTH PERSP, V110, P179, DOI 10.1289/ehp.02110179; Naar JP, 2007, TOXICON, V50, P707, DOI 10.1016/j.toxicon.2007.06.005; NOAA, 2007, INT REP BOTTL DOLPH; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Pan YL, 2001, MAR ECOL PROG SER, V220, P83, DOI 10.3354/meps220083; Parsons ML, 1999, J PHYCOL, V35, P1368, DOI 10.1046/j.1529-8817.1999.3561368.x; Pierce R, 2008, CONT SHELF RES, V28, P45, DOI 10.1016/j.csr.2007.04.012; PIERCE RH, 1992, B ENVIRON CONTAM TOX, V49, P479; Plakas SM, 2004, TOXICON, V44, P677, DOI 10.1016/j.toxicon.2004.07.027; POLI MA, 1995, J AOAC INT, V78, P538; Poli MA, 2000, TOXICON, V38, P981, DOI 10.1016/S0041-0101(99)00191-9; POLI MA, 1986, MOL PHARMACOL, V30, P129; QUILLIAM MA, 1989, ANAL CHEM, V61, pA1053, DOI 10.1021/ac00193a745; Radwan FFY, 2006, TOXICOL SCI, V89, P57, DOI 10.1093/toxsci/kfj013; Radwan FFY, 2005, TOXICOL SCI, V85, P839, DOI 10.1093/toxsci/kfi138; Ramsdell John S., 2008, P519; READ AJ, 1993, J ZOOL, V231, P107, DOI 10.1111/j.1469-7998.1993.tb05356.x; Rossini GP, 2010, EXPERIENTIA SUPPL, V100, P65; Roth PB, 2007, TOXICON, V50, P1175, DOI 10.1016/j.toxicon.2007.08.003; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Schwacke LH, 2012, P ROY SOC B-BIOL SCI, V279, P48, DOI 10.1098/rspb.2011.0665; Schwacke LH, 2010, ENVIRON RES, V110, P548, DOI 10.1016/j.envres.2010.05.003; Shea D, 1997, ELECTROPHORESIS, V18, P277, DOI 10.1002/elps.1150180216; STEIDINGER K, 1972, MARINE PHARMACOGNOSY, P179; Steidinger K.A., 1999, HARMFUL MICROALGAE A; Steidinger KA, 2008, NOVA HEDWIGIA, P269; Steidinger Karen A., 1998, NATO ASI Series Series G Ecological Sciences, V41, P133; Twiner MJ, 2007, ANAL BIOCHEM, V369, P128, DOI 10.1016/j.ab.2007.06.031; Twiner MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017394; Van Dolah FM, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P85; Van Dolah FM, 2003, N P TOX ENV, P247; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Wang ZH, 2004, TOXICON, V43, P455, DOI 10.1016/j.toxicon.2004.02.017; Wang ZH, 2007, J CHROMATOGR A, V1163, P169, DOI 10.1016/j.chroma.2007.06.054; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; WOODCOCK AH, 1948, J MAR RES, V7, P56; Woofter R, 2003, ENVIRON HEALTH PERSP, V111, P1595, DOI 10.1289/ehp.6166; WORK TM, 1993, J ZOO WILDLIFE MED, V24, P54	84	43	47	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42974	10.1371/journal.pone.0042974	http://dx.doi.org/10.1371/journal.pone.0042974			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916189	Green Submitted, gold, Green Published			2022-12-25	WOS:000307823600036
J	Veeregowda, DH; Busscher, HJ; Vissink, A; Jager, DJ; Sharma, PK; van der Mei, HC				Veeregowda, Deepak H.; Busscher, Henk J.; Vissink, Arjan; Jager, Derk-Jan; Sharma, Prashant K.; van der Mei, Henny C.			Role of Structure and Glycosylation of Adsorbed Protein Films in Biolubrication	PLOS ONE			English	Article							QUALITY-OF-LIFE; HUMAN-SALIVA; TEAR FILM; LUBRICATION; SURFACES; FORCES; MUCIN; ADSORPTION; PRESSURES; FRICTION	Water forms the basis of lubrication in the human body, but is unable to provide sufficient lubrication without additives. The importance of biolubrication becomes evident upon aging and disease, particularly under conditions that affect secretion or composition of body fluids. Insufficient biolubrication, may impede proper speech, mastication and swallowing, underlie excessive friction and wear of articulating cartilage surfaces in hips and knees, cause vaginal dryness, and result in dry, irritated eyes. Currently, our understanding of biolubrication is insufficient to design effective therapeutics to restore biolubrication. Aim of this study was to establish the role of structure and glycosylation of adsorbed protein films in biolubrication, taking the oral cavity as a model and making use of its dynamics with daily perturbations due to different glandular secretions, speech, drinking and eating, and tooth brushing. Using different surface analytical techniques (a quartz crystal microbalance with dissipation monitoring, colloidal probe atomic force microscopy, contact angle measurements and X-ray photo-electron spectroscopy), we demonstrated that adsorbed salivary conditioning films in vitro are more lubricious when their hydrophilicity and degree of glycosylation increase, meanwhile decreasing their structural softness. High-molecular-weight, glycosylated proteins adsorbing in loops and trains, are described as necessary scaffolds impeding removal of water during loading of articulating surfaces. Comparing in vitro and in vivo water contact angles measured intra-orally, these findings were extrapolated to the in vivo situation. Accordingly, lubricating properties of teeth, as perceived in 20 volunteers comprising of equal numbers of male and female subjects, could be related with structural softness and glycosylation of adsorbed protein films on tooth surfaces. Summarizing, biolubrication is due to a combination of structure and glycosylation of adsorbed protein films, providing an important clue to design effective therapeutics to restore biolubrication in patients with insufficient biolubrication.	[Veeregowda, Deepak H.; Busscher, Henk J.; Sharma, Prashant K.; van der Mei, Henny C.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands; [Vissink, Arjan; Jager, Derk-Jan] Univ Med Ctr Groningen, Dept Oral Maxillofacial Surg, NL-9713 AV Groningen, Netherlands; [Veeregowda, Deepak H.; Busscher, Henk J.; Vissink, Arjan; Jager, Derk-Jan; Sharma, Prashant K.; van der Mei, Henny C.] Univ Groningen, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Veeregowda, DH (corresponding author), Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.	p.k.sharma@umcg.nl	Jager, Derk Jan/W-1045-2019; Busscher, Henk/AAU-2113-2020; Jager, Derk-Jan/H-5737-2012	Jager, Derk Jan/0000-0002-3006-2128; Busscher, Henk/0000-0002-3644-5533; Sharma, Prashant/0000-0002-8342-8939				ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90, DOI 10.1128/AEM.46.1.90-97.1983; Akpek EK, 2011, OPHTHALMOLOGY, V118, P1242, DOI 10.1016/j.ophtha.2010.12.016; Bongaerts JHH, 2007, TRIBOL LETT, V27, P277, DOI 10.1007/s11249-007-9232-y; Busscher Henk J., 2002, Journal of Clinical Dentistry, V13, P38; Chen M, 2009, SCIENCE, V323, P1698, DOI 10.1126/science.1169399; Coles JM, 2010, CURR OPIN COLLOID IN, V15, P406, DOI 10.1016/j.cocis.2010.07.002; Davidson HJ, 2004, VET OPHTHALMOL, V7, P71, DOI 10.1111/j.1463-5224.2004.00325.x; Dejak B, 2003, J PROSTHET DENT, V90, P591, DOI 10.1016/j.prosdent.2003.08.009; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Hahnel S, 2009, SUPPORT CARE CANCER, V17, P1331, DOI 10.1007/s00520-009-0671-x; Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271; Iwasaki LR, 2003, AM J ORTHOD DENTOFAC, V123, P408, DOI 10.1067/mod.2003.61; Jones CS, 2004, BRIT DENT J, V196, P42, DOI 10.1038/sj.bdj.4810881; Klein J, 2006, P I MECH ENG J-J ENG, V220, P691, DOI 10.1243/13506501JET143; KLEIN J, 1993, MACROMOLECULES, V26, P5552, DOI 10.1021/ma00073a004; Lee S, 2008, SCIENCE, V319, P575, DOI 10.1126/science.1153273; Mariotti A, 2007, XPHARM COMPREHENSIVE, P1; McGlone R E, 1972, Cleft Palate J, V9, P229; Meijer JM, 2009, RHEUMATOLOGY, V48, P1077, DOI 10.1093/rheumatology/kep141; Morrell KC, 2005, P NATL ACAD SCI USA, V102, P14819, DOI 10.1073/pnas.0507117102; NAVAZESH M, 1982, J DENT RES, V61, P1158, DOI 10.1177/00220345820610100901; PEASE CT, 1993, BRIT J RHEUMATOL, V32, P609; Perdok JF, 1991, BIOFOULING, V3, P209; Pettersson T, 2008, LANGMUIR, V24, P3336, DOI 10.1021/la703229n; Pettersson T, 2008, J COLLOID INTERF SCI, V324, P246, DOI 10.1016/j.jcis.2008.04.055; Pettersson T, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2779215; Pramanik R, 2010, EUR J ORAL SCI, V118, P245, DOI 10.1111/j.1600-0722.2010.00728.x; Pratt-Terpstra HI, 1991, BIOFOULING, V3, P199; Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Schipper R, 2007, J CHROMATOGR B, V847, P45, DOI 10.1016/j.jchromb.2006.10.005; Schoofs N, 2003, JOGNN, V32, P589, DOI 10.1177/0884217503257142; SHARMA A, 1993, BIOPHYS CHEM, V47, P87, DOI 10.1016/0301-4622(93)80036-I; Stewart CM, 2008, J AM DENT ASSOC, V139, P291, DOI 10.14219/jada.archive.2008.0158; Svendsen IE, 2008, J COLLOID INTERF SCI, V321, P52, DOI 10.1016/j.jcis.2008.01.041; van der Mei HC, 2012, CLIN ORAL INVEST, V16, P109, DOI 10.1007/s00784-011-0514-2; Veerman ECI, 1996, EUR J ORAL SCI, V104, P346, DOI 10.1111/j.1600-0722.1996.tb00090.x; VISSINK A, 1986, J DENT RES, V65, P1121, DOI 10.1177/00220345860650090301; Vroman L, 2008, COLLOID SURFACE B, V62, P1, DOI 10.1016/j.colsurfb.2007.11.017; Walz A, 2006, PROTEOMICS, V6, P1631, DOI 10.1002/pmic.200500125; WATANABE S, 1990, J DENT RES, V69, P1150, DOI 10.1177/00220345900690050601; Weisenhorn A. L., 1993, Nanotechnology, V4, P106, DOI 10.1088/0957-4484/4/2/006; Yakubov GE, 2009, LANGMUIR, V25, P2313, DOI 10.1021/la8018666; Zappone B, 2007, BIOPHYS J, V92, P1693, DOI 10.1529/biophysj.106.088799	45	33	33	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42600	10.1371/journal.pone.0042600	http://dx.doi.org/10.1371/journal.pone.0042600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916138	Green Published, Green Submitted, gold			2022-12-25	WOS:000307823600018
J	Ribeiro, HV; Zunino, L; Lenzi, EK; Santoro, PA; Mendes, RS				Ribeiro, Haroldo V.; Zunino, Luciano; Lenzi, Ervin K.; Santoro, Perseu A.; Mendes, Renio S.			Complexity-Entropy Causality Plane as a Complexity Measure for Two-Dimensional Patterns	PLOS ONE			English	Article							PERMUTATION ENTROPY	Complexity measures are essential to understand complex systems and there are numerous definitions to analyze one-dimensional data. However, extensions of these approaches to two or higher-dimensional data, such as images, are much less common. Here, we reduce this gap by applying the ideas of the permutation entropy combined with a relative entropic index. We build up a numerical procedure that can be easily implemented to evaluate the complexity of two or higher-dimensional patterns. We work out this method in different scenarios where numerical experiments and empirical data were taken into account. Specifically, we have applied the method to i) fractal landscapes generated numerically where we compare our measures with the Hurst exponent; ii) liquid crystal textures where nematic-isotropic-nematic phase transitions were properly identified; iii) 12 characteristic textures of liquid crystals where the different values show that the method can distinguish different phases; iv) and Ising surfaces where our method identified the critical temperature and also proved to be stable.	[Ribeiro, Haroldo V.; Lenzi, Ervin K.; Santoro, Perseu A.; Mendes, Renio S.] Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil; [Ribeiro, Haroldo V.; Lenzi, Ervin K.; Santoro, Perseu A.; Mendes, Renio S.] Univ Estadual Maringa, Natl Inst Sci & Technol Complex Syst, Maringa, Parana, Brazil; [Zunino, Luciano] CONICET La Plata CIC, Ctr Invest Opt, CC 3, Gonnet, Argentina; [Zunino, Luciano] Univ Nacl La Plata, Fac Ingn, Dept Ciencias Basicas, La Plata, Argentina	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Centro de Investigaciones Opticas (CIOP); National University of La Plata	Ribeiro, HV (corresponding author), Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil.	hvr@dfi.uem.br	Ribeiro, Haroldo Valentin/C-8614-2012; Zunino, Luciano/AAX-9198-2021; Mendes, Renio/F-9261-2017; Lenzi, Ervin Kaminski/N-1767-2019	Ribeiro, Haroldo Valentin/0000-0002-9532-5195; Lenzi, Ervin Kaminski/0000-0003-3853-1790; Zunino, Luciano/0000-0002-2852-3263	agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Consejo Nacional de Investigaciones Cientificas y Tecnicas; CAPES [5678-11-0]	agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work has been supported by the agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Consejo Nacional de Investigaciones Cientificas y Tecnicas. HVR also thank the financial support of CAPES (Grant 5678-11-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrienko YA, 2000, EUR PHYS J B, V15, P539, DOI 10.1007/s100510051157; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Barreiro M, 2011, CHAOS, V21, DOI 10.1063/1.3545273; BOON JP, 1995, CHAOS, V5, P501, DOI 10.1063/1.166145; Brito AF, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031130; Brito AF, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046106; Cai ZJ, 2006, INT J BIFURCAT CHAOS, V16, P3235, DOI 10.1142/S0218127406016756; Canovas JS, 2011, PHYSICA D, V240, P1199, DOI 10.1016/j.physd.2011.04.010; Consolini G, 2009, ASTRON ASTROPHYS, V506, P1381, DOI 10.1051/0004-6361/200811074; Feldman DP, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051104; FOURNIER A, 1982, COMMUN ACM, V25, P371, DOI 10.1145/358523.358553; GRASSBERGER P, 1986, INT J THEOR PHYS, V25, P907, DOI 10.1007/BF00668821; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Khader M, 2011, IEEE T INF TECHNOL B, V15, P681, DOI 10.1109/TITB.2011.2159806; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lamberti PW, 2004, PHYSICA A, V334, P119, DOI 10.1016/j.physa.2003.11.005; Li XL, 2010, NEUROIMAGE, V52, P497, DOI 10.1016/j.neuroimage.2010.05.003; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; LopezRuiz R, 1995, PHYS LETT A, V209, P321, DOI 10.1016/0375-9601(95)00867-5; Lovallo M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/03/P03029; Lyapunov A. M., 1992, GEN PROBLEM STABILIT; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Martin MT, 2006, PHYSICA A, V369, P439, DOI 10.1016/j.physa.2005.11.053; Masoller C, 2011, PHILOS T R SOC A, V369, P425, DOI 10.1098/rsta.2010.0281; Mendes RS, 2008, ECOGRAPHY, V31, P450, DOI 10.1111/j.0906-7590.2008.05469.x; Nicolaou N, 2011, CLIN EEG NEUROSCI, V42, P24, DOI 10.1177/155005941104200107; Nicolaou N, 2012, EXPERT SYST APPL, V39, P202, DOI 10.1016/j.eswa.2011.07.008; Ouyang GX, 2010, CLIN NEUROPHYSIOL, V121, P694, DOI 10.1016/j.clinph.2009.12.030; Parrott L, 2005, ECOL COMPLEX, V2, P175, DOI 10.1016/j.ecocom.2004.11.004; Parrott L, 2010, ECOL INDIC, V10, P1069, DOI 10.1016/j.ecolind.2010.03.014; Ribeiro HV, 2012, PHYSICA A, V391, P2421, DOI 10.1016/j.physa.2011.12.009; Rosso OA, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061114; Rosso OA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154102; SCHWARZ U, 1993, ASTRON ASTROPHYS, V277, P215; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Su ZY, 2006, PHYSICA D, V221, P188, DOI 10.1016/j.physd.2006.08.001; YU LJ, 1980, PHYS REV LETT, V45, P1000, DOI 10.1103/PhysRevLett.45.1000	40	46	47	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e40689	10.1371/journal.pone.0040689	http://dx.doi.org/10.1371/journal.pone.0040689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916097	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500800003
J	Ansari, KI; Kasiri, S; Mandal, SS				Ansari, K. I.; Kasiri, S.; Mandal, S. S.			Histone methylase MLL1 has critical roles in tumor growth and angiogenesis and its knockdown suppresses tumor growth in vivo	ONCOGENE			English	Article						MLL1; histone methylase; xenograft; antisense; hypoxia; tumor supression	CPG-BINDING-PROTEIN; METHYLTRANSFERASE ACTIVITY; CANCER XENOGRAFTS; GENE-EXPRESSION; CHROMATIN; LEUKEMIA; INHIBITION; ANTISENSE; TRITHORAX; HYPOXIA	Mixed lineage leukemias (MLLs) are human histone H3 lysine-4-specific methyl transferases that have critical roles in gene expression, epigenetics and cancer. Herein, we demonstrated that antisense-mediated knockdown of MLL1 induced cell-cycle arrest and apoptosis in cultured cells. Intriguingly, application of MLL1 antisense specifically knocked down MLL1 in vivo and suppressed the growth of xenografted cervical tumor implanted in nude mouse. MLL1 knockdown downregulated various growth and angiogenic factors, such as HIF1 alpha, VEGF and CD31, in tumor tissue affecting tumor growth. MLL1 is overexpressed along the line of vascular network and localized adjacent to endothelial cell layer expressing CD31, indicating potential roles of MLL1 in vasculogenesis. MLL1 is also overexpressed in the hypoxic regions along with HIF1 alpha. Overall, our studies demonstrated that MLL1 is a key factor in hypoxia signaling, vasculogenesis and tumor growth, and its depletion suppresses tumor growth in vivo, indicating its potential in novel cancer therapy.	[Ansari, K. I.; Kasiri, S.; Mandal, S. S.] Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington	Mandal, SS (corresponding author), Univ Texas Arlington, Dept Chem & Biochem, 700 Planetarium Pl, Arlington, TX 76019 USA.	smandal@uta.edu		Mandal, Subhrangsu/0000-0001-8495-9881	NIH [1R15 ES019129-01, 2R15 CA113747-02]; NSF [0821969]; NATIONAL CANCER INSTITUTE [R15CA113747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES019129] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Linda Perrotti and Samara Morris-Bobzean for their technical assistance with tissue sectioning and Mandal lab members for discussion. Mandal research is supported by grants from NIH (1R15 ES019129-01, 2R15 CA113747-02) and NSF (0821969).	Ansari KI, 2008, BBA-GENE REGUL MECH, V1779, P66, DOI 10.1016/j.bbagrm.2007.11.006; Ansari KI, 2011, J MOL BIOL, V411, P334, DOI 10.1016/j.jmb.2011.05.050; Ansari KI, 2011, BIOCHEMISTRY-US, V50, P3517, DOI 10.1021/bi102037t; Ansari KI, 2010, FEBS J, V277, P1790, DOI 10.1111/j.1742-4658.2010.07606.x; Ansari KI, 2009, FEBS J, V276, P3299, DOI 10.1111/j.1742-4658.2009.07055.x; Ansari KI, 2009, J INORG BIOCHEM, V103, P818, DOI 10.1016/j.jinorgbio.2009.02.004; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bromleigh VC, 2000, GENE DEV, V14, P2581, DOI 10.1101/gad.817100; Canaani E, 2004, BRIT J CANCER, V90, P756, DOI 10.1038/sj.bjc.6601639; Corey DR, 2002, ONCOGENE, V21, P631, DOI 10.1038/sj.onc.1205063; Crawford BD, 2006, ACS CHEM BIOL, V1, P495, DOI 10.1021/cb600367v; Cuthbert G, 2000, LEUKEMIA, V14, P1885, DOI 10.1038/sj.leu.2401919; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Deng LW, 2004, P NATL ACAD SCI USA, V101, P757, DOI 10.1073/pnas.2036345100; Diehl F, 2007, BLOOD, V109, P1472, DOI 10.1182/blood-2006-08-039651; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Gleave ME, 2005, NAT REV CANCER, V5, P468, DOI 10.1038/nrc1631; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Halatsch ME, 2006, CANCER TREAT REV, V32, P74, DOI 10.1016/j.ctrv.2006.01.003; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Hendriksen EM, 2009, MICROVASC RES, V77, P96, DOI 10.1016/j.mvr.2008.11.002; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hess JL, 1997, BLOOD, V90, P1799, DOI 10.1182/blood.V90.5.1799; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Joaquin M, 2012, EMBO J, V31, P2952, DOI 10.1038/emboj.2012.122; Kang CS, 2006, CANCER GENE THER, V13, P530, DOI 10.1038/sj.cgt.7700932; Kurdistani SK, 2011, PROG DRUG RES, V67, P91, DOI 10.1007/978-3-7643-8989-5_5; Lee JS, 2008, CANCER LETT, V267, P189, DOI 10.1016/j.canlet.2008.03.013; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Lee JH, 2002, J BIOL CHEM, V277, P42259, DOI 10.1074/jbc.M205054200; Lee K, 2007, PHARMACOL THERAPEUT, V113, P229, DOI 10.1016/j.pharmthera.2006.08.001; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu H, 2010, NATURE, V467, P343, DOI 10.1038/nature09350; Lu B, 2004, CANCER RES, V64, P2840, DOI 10.1158/0008-5472.CAN-03-3547; Mishra BP, 2009, FEBS J, V276, P1629, DOI 10.1111/j.1742-4658.2009.06895.x; Monti Elena, 2011, Curr Mol Pharmacol, V4, P62; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Paulussen ADC, 2011, HUM MUTAT, V32, pE2018, DOI 10.1002/humu.21416; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Saigo K, 2008, HUM MUTAT, V29, P703, DOI 10.1002/humu.20701; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Sims RJ, 2004, NAT CELL BIOL, V6, P685, DOI 10.1038/ncb0804-685; Singhal SS, 2007, CANCER RES, V67, P4382, DOI 10.1158/0008-5472.CAN-06-4124; Travers J, 2011, NAT CHEM BIOL, V7, P663, DOI 10.1038/nchembio.661; Wang D, 2008, BIOTECH HISTOCHEM, V83, P179, DOI 10.1080/10520290802451085; Wang H, 2002, INT J ONCOL, V21, P73; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wang XX, 2011, PATHOL ONCOL RES, V17, P429, DOI 10.1007/s12253-010-9316-0; Watanabe Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023320; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	59	46	47	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 11	2013	32	28					3359	3370		10.1038/onc.2012.352	http://dx.doi.org/10.1038/onc.2012.352			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	180TM	22926525	Green Accepted, Bronze			2022-12-25	WOS:000321620200006
J	Stadtmueller, BM; Kish-Trier, E; Ferrell, K; Petersen, CN; Robinson, H; Myszka, DG; Eckert, DM; Formosa, T; Hill, CP				Stadtmueller, Beth M.; Kish-Trier, Erik; Ferrell, Katherine; Petersen, Charisse N.; Robinson, Howard; Myszka, David G.; Eckert, Debra M.; Formosa, Tim; Hill, Christopher P.			Structure of a Proteasome Pba1-Pba2 Complex IMPLICATIONS FOR PROTEASOME ASSEMBLY, ACTIVATION, AND BIOLOGICAL FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; YEAST; GATE; MECHANISMS; SUBSTRATE; REVEALS; TERMINI; SYSTEM; UMP1P	The 20S proteasome is an essential, 28-subunit protease that sequesters proteolytic sites within a central chamber, thereby repressing substrate degradation until proteasome activators open the entrance/exit gate. Two established activators, Blm10 and PAN/19S, induce gate opening by binding to the pockets between proteasome alpha-subunits using C-terminal HbYX (hydrophobic-tyrosine-any residue) motifs. Equivalent HbYX motifs have been identified in Pba1 and Pba2, which function in proteasome assembly. Here, we demonstrate that Pba1-Pba2 proteins form a stable heterodimer that utilizes its HbYX motifs to bind mature 20S proteasomes in vitro and that the Pba1-Pba2 HbYX motifs are important for a physiological function of proteasomes, the maintenance of mitochondrial function. Other factors that contribute to proteasome assembly or function also act in the maintenance of mitochondrial function and display complex genetic interactions with one another, possibly revealing an unexpected pathway of mitochondrial regulation involving the Pba1-Pba2 proteasome interaction. Our determination of a proteasome Pba1-Pba2 crystal structure reveals a Pba1 HbYX interaction that is superimposable with those of known activators, a Pba2 HbYX interaction that is different from those reported previously, and a gate structure that is disrupted but not sufficiently open to allow entry of even small peptides. These findings extend understanding of proteasome interactions with HbYX motifs and suggest multiple roles for Pba1-Pba2 interactions throughout proteasome assembly and function.	[Stadtmueller, Beth M.; Kish-Trier, Erik; Ferrell, Katherine; Petersen, Charisse N.; Myszka, David G.; Eckert, Debra M.; Formosa, Tim; Hill, Christopher P.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Brookhaven National Laboratory	Hill, CP (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	chris@biochem.utah.edu		Petersen, Charisse/0000-0003-4045-2610; Stadtmueller, Beth/0000-0003-0637-3206; Formosa, Tim/0000-0002-8477-2483	National Institutes of Health Grant [RO1 GM59135]; Postdoctoral Fellowship National Institutes of Health Multidisciplinary Cancer Research Training Program (MCRTP) [T32CA092347]; National Center for Research Resources; United States Department of Energy, Office of Basic Energy Sciences; National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099195, R01GM059135] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Postdoctoral Fellowship National Institutes of Health Multidisciplinary Cancer Research Training Program (MCRTP); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1 GM59135 (to C. P. H.).; Supported by Postdoctoral Fellowship National Institutes of Health T32CA092347 Multidisciplinary Cancer Research Training Program (MCRTP).; We thank William Alexander, Zaily Connell, and Ira Baci for technical assistance. We thank Mark Hochstrasser and Andrew Kusmierczyk for insightful discussions and for providing Pba1 and Pba2 template DNA that was used to generate the expression vector used in these studies. Data collection at the National Synchrotron Light Source was funded by the National Center for Research Resources. Operations of the National Synchrotron Light Source are supported by the United States Department of Energy, Office of Basic Energy Sciences, and by the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bader M, 2011, CELL, V145, P371, DOI 10.1016/j.cell.2011.03.021; Braun HA, 2005, J BIOL CHEM, V280, P28394, DOI 10.1074/jbc.M502453200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forster A, 2003, EMBO J, V22, P4356, DOI 10.1093/emboj/cdg436; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Malc E, 2009, MUTAT RES-FUND MOL M, V669, P95, DOI 10.1016/j.mrfmmm.2009.05.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Rinaldi T, 2008, MOL BIOL CELL, V19, P1022, DOI 10.1091/mbc.E07-07-0717; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Sasaki K, 2010, MOL CELL BIOL, V30, P3864, DOI 10.1128/MCB.00216-10; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smulski PA, 2009, STRUCTURE, V17, P1137, DOI 10.1016/j.str.2009.06.011; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tian G, 2011, NAT STRUCT MOL BIOL, V18, P1259, DOI 10.1038/nsmb.2147; Yashiroda H, 2008, NAT STRUCT MOL BIOL, V15, P228, DOI 10.1038/nsmb.1386	41	37	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37371	37382		10.1074/jbc.M112.367003	http://dx.doi.org/10.1074/jbc.M112.367003			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22930756	hybrid, Green Published			2022-12-25	WOS:000310588500068
J	Chen, JX; Winarski, KL; Myerburg, MM; Pitt, BR; Sheng, SH				Chen, Jingxin; Winarski, Katie L.; Myerburg, Mike M.; Pitt, Bruce R.; Sheng, Shaohu			Probing the Structural Basis of Zn2+ Regulation of the Epithelial Na+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; SELF-INHIBITION; GAMMA-SUBUNIT; HISTIDINE-RESIDUES; ION CHANNELS; EXTRACELLULAR DOMAINS; PULMONARY TOXICITY; ALPHA-SUBUNIT; ENAC; ACTIVATION	Extracellular Zn2+ activates the epithelial Na+ channel (ENaC) by relieving Na+ self-inhibition. However, a biphasic Zn2+ dose response was observed, suggesting that Zn2+ has dual effects on the channel (i.e. activating and inhibitory). To investigate the structural basis for this biphasic effect of Zn2+, we examined the effects of mutating the 10 extracellular His residues of mouse gamma ENaC. Four mutations within the finger subdomain (gamma H193A, gamma H200A, gamma H202A, and gamma H239A) significantly reduced the maximal Zn2+ activation of the channel. Whereas gamma H193A, gamma H200A, and gamma H202A reduced the apparent affinity of the Zn2+ activating site, gamma H239A diminished Na+ self-inhibition and thus concealed the activating effects of Zn2+. Mutation of a His residue within the palm subdomain (gamma H88A) abolished the low-affinity Zn2+ inhibitory effect. Based on structural homology with acid-sensing ion channel 1, gamma Asp(516) was predicted to be in close proximity to gamma His(88). Ala substitution of the residue (gamma 516A) blunted the inhibitory effect of Zn2+. Our results suggest that external Zn2+ regulates ENaC activity by binding to multiple extracellular sites within the gamma-subunit, including (i) a high-affinity stimulatory site within the finger subdomain involving His(193), His(200), and His(202) and (ii) a low-affinity Zn2+ inhibitory site within the palm subdomain that includes His(88) and Asp(516).	[Sheng, Shaohu] Univ Pittsburgh, Renal Electrolyte Div, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; [Pitt, Bruce R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sheng, SH (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Sch Med, Dept Med, S929 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	shaohu@pitt.edu	Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702	National Institutes of Health [R01 ES014701, K08 HL087932, P30 DK079307]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES014701, K08 HL087932, and P30 DK079307.	Adamson IYR, 1999, TOXICOL APPL PHARM, V157, P43, DOI 10.1006/taap.1999.8658; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Busst CJ, 2011, HYPERTENSION, V58, P1073, DOI 10.1161/HYPERTENSIONAHA.111.176370; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; HARRISON NL, 1994, NEUROPHARMACOLOGY, V33, P935, DOI 10.1016/0028-3908(94)90152-X; Harvey RJ, 1999, J PHYSIOL-LONDON, V520, P53, DOI 10.1111/j.1469-7793.1999.00053.x; Horisberger JD., 2004, NEPHRON PHYSIOL, V96, P37, DOI [10.1159/000076406, DOI 10.1159/000076406]; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Molina R, 2011, BBA-BIOMEMBRANES, V1808, P1818, DOI 10.1016/j.bbamem.2011.03.004; Pratt JH, 2005, J AM SOC NEPHROL, V16, P3154, DOI 10.1681/ASN.2005050460; Prieditis H, 2002, EXP LUNG RES, V28, P563, DOI 10.1080/01902140290096782; Qadri YJ, 2012, AM J PHYSIOL-CELL PH, V302, pC943, DOI 10.1152/ajpcell.00019.2012; Restrepo-Angulo I, 2010, J APPL TOXICOL, V30, P497, DOI 10.1002/jat.1556; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; SHENG S, 2007, SELDIN GIEBISCHS KID, P743; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Soundararajan R, 2010, J BIOL CHEM, V285, P30363, DOI 10.1074/jbc.R110.155341; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; St Croix Claudette M, 2005, Proc Am Thorac Soc, V2, P236, DOI 10.1513/pats.200501-007AC; Stewart AP, 2011, J BIOL CHEM, V286, P31944, DOI 10.1074/jbc.M111.275289; VANDRIESSCHE W, 1985, PHYSIOL REV, V65, P833, DOI 10.1152/physrev.1985.65.4.833; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF236, DOI 10.1152/ajprenal.00002.2007	50	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35589	35598		10.1074/jbc.M112.394734	http://dx.doi.org/10.1074/jbc.M112.394734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22930753	Green Published, hybrid			2022-12-25	WOS:000309968000071
J	Cohen, I; Birnbaum, RY; Leibson, K; Taube, R; Sivan, S; Birk, OS				Cohen, Idan; Birnbaum, Ramon Y.; Leibson, Keren; Taube, Ran; Sivan, Sara; Birk, Ohad S.			ZNF750 Is Expressed in Differentiated Keratinocytes and Regulates Epidermal Late Differentiation Genes	PLOS ONE			English	Article							PROTEIN; DERMATITIS; CELLS	Disrupted skin barrier due to altered keratinocyte differentiation is common in pathologic conditions such as atopic dermatitis, ichthyosis and psoriasis. However, the molecular cascades governing keratinocyte terminal differentiation are poorly understood. We have previously demonstrated that a dominant mutation in ZNF750 leads to a clinical phenotype reminiscent of psoriasis and seborrheic dermatitis. Here we show that ZNF750 is a nuclear protein bearing a functional C-terminal nuclear localization signal. ZNF750 was specifically expressed in the epidermal suprabasal layers and its expression was augmented during differentiation, both in human skin and in-vitro, peaking in the granular layer. Silencing of ZNF750 in Ca2+-induced HaCaT keratinocytes led to morphologically apparent arrest in the progression of late differentiation, as well as diminished apoptosis and sustained proliferation. ZNF750 knockdown cells presented with markedly reduced expression of epidermal late differentiation markers, including gene subsets of epidermal differentiation complex and skin barrier formation such as FLG, LOR, SPINK5, ALOX12B and DSG1, known to be mutated in various human skin diseases. Furthermore, overexpression of ZNF750 in undifferentiated cells induced terminal differentiation genes. Thus, ZNF750 is a regulator of keratinocyte terminal differentiation and with its downstream targets can serve in future elucidation of therapeutics for common diseases of skin barrier.	[Cohen, Idan; Leibson, Keren; Sivan, Sara; Birk, Ohad S.] Ben Gurion Univ Negev, Morris Kahn Lab Human Genet, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Cohen, Idan; Leibson, Keren; Taube, Ran; Sivan, Sara; Birk, Ohad S.] Ben Gurion Univ Negev, Dept Mol Genet & Virol, IL-84105 Beer Sheva, Israel; [Birnbaum, Ramon Y.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Birnbaum, Ramon Y.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Birk, Ohad S.] Soroka Med Ctr, Genet Inst, IL-84101 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ben Gurion University; Soroka Medical Center	Cohen, I (corresponding author), Ben Gurion Univ Negev, Morris Kahn Lab Human Genet, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.	obirk@bgu.ac.il		Birnbaum, Ramon/0000-0002-3792-1095; Taube, Ran/0000-0002-2062-4537; Cohen, Idan/0000-0002-5524-2344; Birk, Ohad/0000-0003-1430-1296	Israel Science Foundation (ISF); Morris Kahn Family Foundation	Israel Science Foundation (ISF)(Israel Science Foundation); Morris Kahn Family Foundation	This study was funded through a grant of the Israel Science Foundation (ISF) and through the generosity of the Morris Kahn Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birnbaum RY, 2006, NAT GENET, V38, P749, DOI 10.1038/ng1813; Birnbaum RY, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-167; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Descargues P, 2008, EMBO J, V27, P2639, DOI 10.1038/emboj.2008.196; Deyrieux AF, 2007, CYTOTECHNOLOGY, V54, P77, DOI 10.1007/s10616-007-9076-1; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; Du LP, 2006, TOXICOL APPL PHARM, V213, P135, DOI 10.1016/j.taap.2005.10.003; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hoffjan S, 2007, BRIT J DERMATOL, V157, P441, DOI 10.1111/j.1365-2133.2007.07999.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalinin A, 2001, J CELL SCI, V114, P3069; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; STEVEN AC, 1994, J CELL SCI, V107, P693; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	26	31	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42628	10.1371/journal.pone.0042628	http://dx.doi.org/10.1371/journal.pone.0042628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936986	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500014
J	Kim, YI; Park, JE; Kwon, KH; Hong, CY; Yi, AK				Kim, Young-In; Park, Jeoung-Eun; Kwon, Ki Han; Hong, Cheol Yi; Yi, Ae-Kyung			Interleukin-1 Receptor-Associated Kinase 2-and Protein Kinase D1-Dependent Regulation of IRAK-Monocyte Expression by CpG DNA	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; SIGNALING PATHWAYS; ADAPTER PROTEIN; CROSS-TOLERANCE; BACTERIAL-DNA; LIVER-INJURY; MICE LACKING; ACTIVATION; INDUCTION	As a part of the negative feedback mechanism, CpG DNA induces IRAK-M expression in monocytic cells. In the present study we investigated a biochemical signaling pathway and the transcription factors responsible for CpG DNA-mediated Irak-m gene expression. CpG DNA-induced Irak-m expression did not require new protein synthesis and was regulated at the transcriptional level through an endosomal pH-sensitive TLR9/MyD88 signaling pathway. Over-expression of the dominant negative (DN) form of or gene-specific knockdown of signaling modulators in the TLR9 pathway demonstrated that IRAK4, IRAK1, IRAK2, and PKD1 are required for Irak-m transcription induced by CpG DNA. Over-expression of DN-IRAK1 only partially, but significantly, inhibited CpG DNA-induced Irak-m promoter activity. While IRAK1 was critical for the initial phase, IRAK2 was required for the late phase of TLR9 signaling by sustaining activation of PKD1 that leads to activation of NF-kappa B and MAPKs. Irak-m promoter-luciferase reporters with alterations in the predicted cis-acting transcriptional regulatory elements revealed that the NF-kappa B consensus site in the Irak-m promoter region is absolutely required for Irak-m gene expression. AP-1 and CREB binding sites also contributed to the optimal Irak-m expression by CpG DNA. Collectively, our results demonstrate that IRAK2 plays a key role in the TLR9-mediated transcriptional regulation of Irak-m expression by sustaining activation of PKD1 and NF-kappa B.	[Kim, Young-In; Park, Jeoung-Eun; Kwon, Ki Han; Yi, Ae-Kyung] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA; [Kim, Young-In; Park, Jeoung-Eun; Kwon, Ki Han; Yi, Ae-Kyung] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Hong, Cheol Yi] Chonnam Natl Univ, Specialized Res Ctr Canc Immunotherapy, Jeonnam, South Korea; [Yi, Ae-Kyung] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; Chonnam National University; University of Tennessee System; University of Tennessee Health Science Center	Kim, YI (corresponding author), Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA.	ayi@uthsc.edu			Children's Foundation Research Center at Le Bonheur Children's Medical Center; NIH [AI053137]; Le Bonheur Children's Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053137] Funding Source: NIH RePORTER	Children's Foundation Research Center at Le Bonheur Children's Medical Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Le Bonheur Children's Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AKY was supported by the Children's Foundation Research Center at Le Bonheur Children's Medical Center and a grant from NIH (AI053137). YIK and JEP were supported by grants from Le Bonheur Children's Medical Center. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, the Children's Foundation of Memphis, or Le Bonheur Children's Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Dalpke AH, 2005, IMMUNOLOGY, V116, P203, DOI 10.1111/j.1365-2567.2005.02211.x; Dalpke AH, 2001, J IMMUNOL, V166, P7082, DOI 10.4049/jimmunol.166.12.7082; del Fresno C, 2005, J IMMUNOL, V174, P3032, DOI 10.4049/jimmunol.174.5.3032; Flannery SM, 2011, J BIOL CHEM, V286, P23688, DOI 10.1074/jbc.M111.248351; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kim YI, 2008, J BIOL CHEM, V283, P15258, DOI 10.1074/jbc.M709549200; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lenert P, 2003, ANTISENSE NUCLEIC A, V13, P143, DOI 10.1089/108729003768247600; Li CH, 2006, J LEUKOCYTE BIOL, V79, P867, DOI 10.1189/jlb.0905505; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 1999, MOL CELL BIOL, V19, P4643; Lye E, 2004, J BIOL CHEM, V279, P40653, DOI 10.1074/jbc.M402666200; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Park JE, 2008, J IMMUNOL, V181, P2044, DOI 10.4049/jimmunol.181.3.2044; Park JE, 2009, J IMMUNOL, V182, P6316, DOI 10.4049/jimmunol.0804239; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Sly LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2836, DOI 10.2741/2276; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Thomas JA, 1999, J IMMUNOL, V163, P978; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Yeo SJ, 2003, J BIOL CHEM, V278, P22563, DOI 10.1074/jbc.M302076200; Yeo SJ, 2003, J IMMUNOL, V170, P1052, DOI 10.4049/jimmunol.170.2.1052; Yi AK, 2006, J BIOL CHEM, V281, P15001, DOI 10.1074/jbc.M601337200; Yi AK, 1998, J IMMUNOL, V160, P1240; Yi AK, 2003, INT IMMUNOL, V15, P577, DOI 10.1093/intimm/dxg058; Yi AK, 1998, J IMMUNOL, V161, P4493; Yi AK, 1996, J IMMUNOL, V156, P558; Yi AK, 2001, INT IMMUNOL, V13, P1391, DOI 10.1093/intimm/13.11.1391; Yi AK, 2002, J IMMUNOL, V168, P4711, DOI 10.4049/jimmunol.168.9.4711	49	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43970	10.1371/journal.pone.0043970	http://dx.doi.org/10.1371/journal.pone.0043970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928050	Green Published, Green Submitted, gold			2022-12-25	WOS:000308224700030
J	Lohberger, B; Rinner, B; Stuendl, N; Absenger, M; Liegl-Atzwanger, B; Walzer, SM; Windhager, R; Leithner, A				Lohberger, Birgit; Rinner, Beate; Stuendl, Nicole; Absenger, Markus; Liegl-Atzwanger, Bernadette; Walzer, Sonja M.; Windhager, Reinhard; Leithner, Andreas			Aldehyde Dehydrogenase 1, a Potential Marker for Cancer Stem Cells in Human Sarcoma	PLOS ONE			English	Article							TUMOR-GROWTH; IDENTIFICATION; PREDICTOR; PARADIGM; ALDH1	Tumors contain a small population of cancer stem cells (CSC) proposed to be responsible for tumor maintenance and relapse. Aldehyde dehydrogenase 1 (ALDH1) activity has been used as a functional stem cell marker to isolate CSCs in different cancer types. This study used the Aldefluor (R) assay and fluorescence-activated cell sorting (FACS) analysis to isolate ALDH1(high) cells from five human sarcoma cell lines and one primary chordoma cell line. ALDH1(high) cells range from 0.3% (MUG-Chor1) to 4.1% (SW-1353) of gated cells. Immunohistochemical staining, analysis of the clone formation efficiency, and xCELLigence microelectronic sensor technology revealed that ALDH1(high) cells from all sarcoma cell lines have an increased proliferation rate compared to ALDH1(low) cells. By investigating of important regulators of stem cell biology, real-time RT-PCR data showed an increased expression of c-Myc, beta-catenin, and SOX-2 in the ALDH1(high) population and a significant higher level of ABCG2. Statistical analysis of data demonstrated that ALDH1(high) cells of SW-982 and SW-1353 showed higher resistance to commonly used chemotherapeutic agents like doxorubicin, epirubicin, and cisplatin than ALDH1(low) cells. This study demonstrates that in different sarcoma cell lines, high ALDH1 activity can be used to identify a subpopulation of cells characterized by a significantly higher proliferation rate, increased colony forming, increased expression of ABC transporter genes and stemness markers compared to control cells. In addition, enhanced drug resistance was demonstrated.	[Lohberger, Birgit; Stuendl, Nicole; Leithner, Andreas] Med Univ Graz, Dept Orthopaed Surg, Graz, Austria; [Rinner, Beate; Absenger, Markus] Med Univ Graz, Med Res Ctr, Graz, Austria; [Liegl-Atzwanger, Bernadette] Med Univ Graz, Inst Pathol, Graz, Austria; [Walzer, Sonja M.; Windhager, Reinhard] Med Univ Vienna, Dept Orthopaed Surg, Vienna, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Vienna	Lohberger, B (corresponding author), Med Univ Graz, Dept Orthopaed Surg, Graz, Austria.	birgit.lohberger@medunigraz.at		Windhager, Reinhard/0000-0002-6321-1804; Walzer, Sonja Maria/0000-0002-9056-4330	Medical University of Graz (START grant); OENB grant [14356]; "EccoCell" grant	Medical University of Graz (START grant); OENB grant; "EccoCell" grant	Financial support by the Medical University of Graz (START grant), OENB grant (#14356) and "EccoCell" grant is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2009, EXPERT OPIN DRUG MET, V5, P1529, DOI 10.1517/17425250903228834; Awad O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013943; Balicki D, 2007, CELL STEM CELL, V1, P485, DOI 10.1016/j.stem.2007.10.015; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Croker AK, 2012, BREAST CANCER RES TR, V133, P75, DOI 10.1007/s10549-011-1692-y; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Gangemi R, 2009, CURR MED CHEM, V16, P1688, DOI 10.2174/092986709788186147; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hajj M, 2004, ONCOGENE, V23, P7274; Hellsten R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022118; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Moreb JS, 2008, CURR STEM CELL RES T, V3, P237, DOI 10.2174/157488808786734006; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rinner B, 2012, INT J ONCOL, V40, P443, DOI 10.3892/ijo.2011.1235; Santagata S, 2007, AM J SURG PATHOL, V31, P836, DOI 10.1097/PAS.0b013e31802e708a; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Wang L, 2011, INT J CANCER, V128, P294, DOI 10.1002/ijc.25331; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Yang M, 2010, BIOCHEM BIOPH RES CO, V391, P1062, DOI 10.1016/j.bbrc.2009.12.020	37	69	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43664	10.1371/journal.pone.0043664	http://dx.doi.org/10.1371/journal.pone.0043664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928012	Green Submitted, gold, Green Published			2022-12-25	WOS:000308224700022
J	Usuyama, M; Ushida, C; Shingai, R				Usuyama, Mamoru; Ushida, Chisato; Shingai, Ryuzo			A Model of the Intracellular Response of an Olfactory Neuron in Caenorhabditis elegans to Odor Stimulation	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNEL; PROTEIN; CA2+	We developed a mathematical model of a hypothetical neuronal signal transduction pathway to better understand olfactory perception in Caenorhabditis elegans. This worm has only three pairs of olfactory receptor neurons. Intracellular Ca2+ decreases in one pair of olfactory neurons in C. elegans, the AWC neurons, following application of an attractive odor and there is a transient increase in intracellular Ca2+ following removal of odor. The magnitude of this increase is positively correlated with the duration of odor stimulation. Additionally, this Ca2+ transient is induced by a cGMP second messenger system. We identified likely candidates for the signal transduction molecules functioning in this system based on available gene expression and physiological data from AWCs. Our model incorporated a G-protein-coupled odor receptor, a G-protein, a guanylate cyclase as the G-protein effector, and a single phosphodiesterase. Additionally, a cyclic-nucleotidegated ion channel and a voltage-gated ion channel that mediated calcium influx were incorporated into the model. We posited that, upon odor stimulation, guanylate cyclase was suppressed by the G-protein and that, upon cessation of the stimulus, the G-protein-induced suppression ceased and cGMP synthesis was restored. A key element of our model was a Ca2+-dependent negative feedback loop that ensured that the calcium increases were transient. Two guanylate cyclase-activating proteins acted on the effector guanylate cyclase to negatively regulate cGMP signaling and the resulting calcium influx. Our model was able to closely replicate in silico three important features of the calcium dynamics of AWCs. Specifically, in our simulations, [Ca2+] increased rapidly and reached its peak within 10 s after the odor stimulus was removed, peak [Ca2+] increased with longer odor exposure, and [Ca2+] decreased during a second stimulus that closely followed an initial stimulus. However, application of random background signal ('noise') showed that certain components of the pathway were particularly sensitive to this noise.	[Usuyama, Mamoru; Shingai, Ryuzo] Iwate Univ, Fac Engn, Lab Biosci, Morioka, Iwate 020, Japan; [Ushida, Chisato] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 020, Japan; [Ushida, Chisato] Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori, Japan; [Ushida, Chisato] Hirosaki Univ, RNA Res Ctr, Hirosaki, Aomori, Japan	Iwate University; Iwate University; Hirosaki University; Hirosaki University	Usuyama, M (corresponding author), Iwate Univ, Fac Engn, Lab Biosci, Morioka, Iwate 020, Japan.	shingai@iwate-u.ac.jp			MEXT KAKENHI [20115004]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supporter by MEXT KAKENHI Grant Number 20115004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manscript.	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Biron D, 2008, P NATL ACAD SCI USA, V105, P11002, DOI 10.1073/pnas.0805004105; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Dougherty DP, 2005, P NATL ACAD SCI USA, V102, P10415, DOI 10.1073/pnas.0504099102; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; Hatt H, 2004, CHEM BIODIVERS, V1, P1857, DOI 10.1002/cbdv.200490142; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Kotera J, 2004, J BIOL CHEM, V279, P4366, DOI 10.1074/jbc.M308471200; Kwon HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004260; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Mathews EA, 2003, J NEUROSCI, V23, P6537; Mellem JE, 2008, NAT NEUROSCI, V11, P865, DOI 10.1038/nn.2131; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P731, DOI 10.1113/jphysiol.1988.sp016943; Nickell WT, 2002, J MEMBRANE BIOL, V189, P55, DOI 10.1007/s00232-002-1004-x; O'Halloran DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031614; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1	24	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e42907	10.1371/journal.pone.0042907	http://dx.doi.org/10.1371/journal.pone.0042907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927938	Green Published, gold			2022-12-25	WOS:000308224700008
J	Cabral, EV; Vieira, LD; Silva, PA; Nascimento, WS; Aires, RS; Oliveira, FST; Luzardo, R; Vieyra, A; Paixao, ADO				Cabral, Edjair V.; Vieira-Filho, Leucio D.; Silva, Paulo A.; Nascimento, Williams S.; Aires, Regina S.; Oliveira, Fabiana S. T.; Luzardo, Ricardo; Vieyra, Adalberto; Paixao, Ana D. O.			Perinatal Na+ Overload Programs Raised Renal Proximal Na+ Transport and Enalapril-Sensitive Alterations of Ang II Signaling Pathways during Adulthood	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; PROTEIN-KINASE-A; OXIDATIVE STRESS; BLOOD-PRESSURE; DIETARY SALT; PLASMA-MEMBRANE; KIDNEY; HYPERTENSION; ATPASE; RATS	Background: High Na+ intake is a reality in nowadays and is frequently accompanied by renal and cardiovascular alterations. In this study, renal mechanisms underlying perinatal Na+ overload-programmed alterations in Na+ transporters and the renin/angiotensin system (RAS) were investigated, together with effects of short-term treatment with enalapril in terms of reprogramming molecular alterations in kidney. Methodology/Principal Findings: Male adult Wistar rats were obtained from dams maintained throughout pregnancy and lactation on a standard diet and drinking water (control) or 0.17 M NaCl (saline group). Enalapril (100 mg/l), an angiotensin converting enzyme inhibitor, was administered for three weeks after weaning. Ninety day old offspring from dams that drank saline presented with proximal tubules exhibiting increased (Na++ K+) ATPase expression and activity. Ouabain-insensitive Na+-ATPase activity remained unchanged but its response to angiotensin II (Ang II) was lost. PKC, PKA, renal thiobarbituric acid reactive substances (TBARS), macrophage infiltration and collagen deposition markedly increased, and AT(2) receptor expression decreased while AT(1) expression was unaltered. Early treatment with enalapril reduced expression and activity of (Na++ K+) ATPase, partially recovered the response of Na+-ATPase to Ang II, and reduced PKC and PKA activities independently of whether offspring were exposed to high perinatal Na+ or not. In addition, treatment with enalapril per se reduced AT(2) receptor expression, and increased TBARS, macrophage infiltration and collagen deposition. The perinatally Na+-overloaded offspring presented high numbers of Ang II-positive cortical cells, and significantly lower circulating Ang I, indicating that programming/reprogramming impacted systemic and local RAS. Conclusions/Significance: Maternal Na+ overload programmed alterations in renal Na+ transporters and in its regulation, as well as severe structural lesions in adult offspring. Enalapril was beneficial predominantly through its influence on Na+ pumping activities in adult offspring. However, side effects including down-regulation of PKA, PKC and AT(2) receptors and increased TBARS could impair renal function in later life.	[Cabral, Edjair V.; Vieira-Filho, Leucio D.; Nascimento, Williams S.; Aires, Regina S.; Oliveira, Fabiana S. T.; Paixao, Ana D. O.] Univ Fed Pernambuco, Dept Physiol & Pharmacol, Recife, PE, Brazil; [Silva, Paulo A.; Luzardo, Ricardo; Vieyra, Adalberto] Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, BR-21941 Rio De Janeiro, Brazil; [Cabral, Edjair V.; Vieira-Filho, Leucio D.; Silva, Paulo A.; Luzardo, Ricardo; Vieyra, Adalberto; Paixao, Ana D. O.] Natl Inst Sci & Technol Struct Biol & Bioimaging, Rio De Janeiro, Brazil	Universidade Federal de Pernambuco; Universidade Federal do Rio de Janeiro	Cabral, EV (corresponding author), Univ Fed Pernambuco, Dept Physiol & Pharmacol, Recife, PE, Brazil.	adpaixao@ufpe.br		Vieira, Leucio/0000-0002-6041-1720; Aires, Regina/0000-0002-1881-8957; Nascimento de Siqueira, Williams/0000-0001-6073-5875	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Institutos Nacionais de Ciencia e Tecnologia, Brazil	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Institutos Nacionais de Ciencia e Tecnologia, Brazil	This work has been funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Institutos Nacionais de Ciencia e Tecnologia, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil I, 2005, ACTA HISTOCHEM, V107, P291, DOI 10.1016/j.acthis.2005.06.011; Axelband F, 2009, REGUL PEPTIDES, V155, P81, DOI 10.1016/j.regpep.2009.03.014; Balbi APC, 2004, PEDIATR NEPHROL, V19, P1212, DOI 10.1007/s00467-004-1586-x; Banday AA, 2007, J AM SOC NEPHROL, V18, P1446, DOI 10.1681/ASN.2006121373; Beltowski J, 2007, CLIN EXP HYPERTENS, V29, P189, DOI 10.1080/10641960701361585; Bertorello A, 1988, Prog Clin Biol Res, V268B, P353; Boesch DM, 2001, AM J PHYSIOL-REG I, V281, pR861, DOI 10.1152/ajpregu.2001.281.3.R861; Buege J A, 1978, Methods Enzymol, V52, P302; Cabral LMP, 2007, J BIOL CHEM, V282, P24599, DOI 10.1074/jbc.M701669200; Cardoso HD, 2009, PEDIATR NEPHROL, V24, P1959, DOI 10.1007/s00467-009-1247-1; Carranza ML, 1998, J PHYSIOL-LONDON, V511, P235, DOI 10.1111/j.1469-7793.1998.235bi.x; Caruso-Neves C, 2000, BBA-BIOMEMBRANES, V1468, P107, DOI 10.1016/S0005-2736(00)00248-0; Chabrashvili T, 2003, AM J PHYSIOL-REG I, V285, pR117, DOI 10.1152/ajpregu.00476.2002; Contreras RJ, 2000, PHYSIOL BEHAV, V71, P173, DOI 10.1016/S0031-9384(00)00331-0; da Silva AA, 2003, NUTR METAB CARDIOVAS, V13, P133, DOI 10.1016/S0939-4753(03)80172-2; Feraille E, 2000, MOL BIOL CELL, V11, P39, DOI 10.1091/mbc.11.1.39; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; Finch JL, 2012, AM J PHYSIOL-RENAL, V302, pF141, DOI 10.1152/ajprenal.00293.2011; FRIBERG P, 1994, KIDNEY INT, V45, P485, DOI 10.1038/ki.1994.63; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Lara LS, 2012, AM J PHYSIOL-RENAL, V302, pF85, DOI 10.1152/ajprenal.00351.2011; Lara LS, 2010, ARCH BIOCHEM BIOPHYS, V496, P117, DOI 10.1016/j.abb.2010.02.005; Laube GF, 2007, ARCH DIS CHILD-FETAL, V92, P402, DOI 10.1136/adc.2006.101717; Li XC, 2011, KIDNEY INT, V80, P620, DOI 10.1038/ki.2011.161; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maia JCC, 1993, LAB MANUAL, P146; Manning J, 2005, AM J PHYSIOL-REG I, V288, pR80, DOI 10.1152/ajpregu.00309.2004; Manning RD, 2005, AM J NEPHROL, V25, P311, DOI 10.1159/000086411; Matos André Costa, 2003, Arq. Bras. Cardiol., V81, P297; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Miura K, 2009, PEDIATR NEPHROL, V24, P1235, DOI 10.1007/s00467-008-1091-8; Naito T, 2010, AM J PHYSIOL-RENAL, V298, pF683, DOI 10.1152/ajprenal.00503.2009; PROVERBIO F, 1981, BIOCHIM BIOPHYS ACTA, V646, P99, DOI 10.1016/0005-2736(81)90276-5; Quan A, 2006, EARLY HUM DEV, V82, P23, DOI 10.1016/j.earlhumdev.2005.11.001; Queiroz-Madeira EP, 2010, BBA-BIOMEMBRANES, V1798, P360, DOI 10.1016/j.bbamem.2009.06.018; Rangel LBA, 2005, REGUL PEPTIDES, V127, P177, DOI 10.1016/j.regpep.2004.12.007; Rocafull MA, 2011, BBA-BIOMEMBRANES, V1808, P1684, DOI 10.1016/j.bbamem.2011.02.010; Rodriguez-Iturbe B, 2004, AM J PHYSIOL-RENAL, V286, pF606, DOI 10.1152/ajprenal.00269.2003; Sanchez SI, 2008, EUR J PHARMACOL, V588, P114, DOI 10.1016/j.ejphar.2008.04.014; Marin ECS, 2008, RENAL FAILURE, V30, P547, DOI 10.1080/08860220802060448; Thomson SC, 2006, J CLIN INVEST, V116, P1110, DOI 10.1172/JCI26092; Tian N, 2007, AM J PHYSIOL-HEART C, V293, pH3388, DOI 10.1152/ajpheart.00981.2007; Tonkiss J, 1998, HYPERTENSION, V32, P108, DOI 10.1161/01.HYP.32.1.108; TUFROMCREDDIE A, 1995, AM J PHYSIOL-RENAL, V269, pF110, DOI 10.1152/ajprenal.1995.269.1.F110; Vehaskari VM, 2007, PEDIATR NEPHROL, V22, P490, DOI 10.1007/s00467-006-0353-6; Vieira LD, 2011, PEDIATR NEPHROL, V26, P2019, DOI 10.1007/s00467-011-1908-8; Vieira LD, 2011, ARCH BIOCHEM BIOPHYS, V505, P91, DOI 10.1016/j.abb.2010.09.025; VIEYRA A, 1986, J BIOL CHEM, V261, P4247; Wang CT, 2003, J HYPERTENS, V21, P353, DOI 10.1097/00004872-200302000-00027; Wang ZC, 2011, KIDNEY INT, V79, P300, DOI 10.1038/ki.2010.326; WHITTEMB.G, 1970, PFLUG ARCH EUR J PHY, V316, P1, DOI 10.1007/BF00587893; Yang LE, 2008, AM J PHYSIOL-RENAL, V295, pF1003, DOI 10.1152/ajprenal.90235.2008; Zhang LN, 2008, FUND CLIN PHARMACOL, V22, P615, DOI 10.1111/j.1472-8206.2008.00620.x	53	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43791	10.1371/journal.pone.0043791	http://dx.doi.org/10.1371/journal.pone.0043791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928034	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300090
J	Chege, D; Chai, YJ; Huibner, S; Kain, T; Wachihi, C; Kimani, M; Barasa, S; McKinnon, LR; Muriuki, FK; Kariri, A; Jaoko, W; Anzala, O; Kimani, J; Ball, TB; Plummer, FA; Kaul, R				Chege, Duncan; Chai, Yijie; Huibner, Sanja; Kain, Taylor; Wachihi, Charles; Kimani, Makubo; Barasa, Samson; McKinnon, Lyle R.; Muriuki, Festus K.; Kariri, Anthony; Jaoko, Walter; Anzala, Omu; Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.; Kaul, Rupert			Blunted IL17/IL22 and Pro-Inflammatory Cytokine Responses in the Genital Tract and Blood of HIV-Exposed, Seronegative Female Sex Workers in Kenya	PLOS ONE			English	Article							CD4(+) T-CELLS; REAL-TIME PCR; IMMUNODEFICIENCY VIRUS-INFECTION; MESSENGER-RNA EXPRESSION; TH17 CELLS; INTEGRIN ALPHA(4)BETA(7); SUSCEPTIBILITY; RESISTANCE; TRANSMISSION; PROTEIN	Background: Identifying the immune correlates of reduced susceptibility to HIV remains a key goal for the HIV vaccine field, and individuals who are HIV-exposed, seronegative (HESN) may offer important clues. Reduced systemic immune activation has been described in HESN individuals. Conversely, pro-inflammatory T cell subsets, particularly CD4+ T cells producing the cytokine IL17 (Th17 cells), may represent a highly susceptible target for HIV infection after sexual exposure. Therefore, we characterized the cellular pro-inflammatory and IL17/IL22 cytokine immune milieu in the genital mucosa and blood of HESN female sex workers (FSWs). Methods and Results: Blinded lab personnel characterized basal and mitogen-induced gene and cytokine immune responses in the cervix and blood of HESN FSWs (n = 116) and non-FSW controls (n = 17) using qPCR and ELISA. IL17 and IL22 production was significantly reduced in both the cervix and blood of HESNs, both in resting cells and after mitogen stimulation. In addition, HESN participants demonstrated blunted production of both pro-inflammatory cytokines and beta-chemokines. Discussion and Conclusions: We conclude that HIV exposure without infection was associated with blunted IL17/IL22 and pro-inflammatory responses, both systemically and at the site of mucosal HIV exposure. It will be important for further studies to examine the causal nature of the association and to define the cell subsets responsible for these differences.	[Chege, Duncan; Chai, Yijie; Huibner, Sanja; Kain, Taylor; McKinnon, Lyle R.; Kaul, Rupert] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada; [Wachihi, Charles; Kimani, Makubo; Barasa, Samson; McKinnon, Lyle R.; Muriuki, Festus K.; Kariri, Anthony; Jaoko, Walter; Anzala, Omu; Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.; Kaul, Rupert] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Ball, T. Blake; Plummer, Francis A.] Publ Hlth Agcy Canada, Lab HIV Immunol, Natl HIV & Retrovirol Labs, Winnipeg, MB, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Nairobi; University of Manitoba; University of Manitoba; Public Health Agency of Canada	Chege, D (corresponding author), Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada.	duncan.chege@utoronto.ca; rupert.kaul@utoronto.ca	Jaoko, Walter/AAN-5048-2020; Kain, Taylor/ABF-9338-2021	McKinnon, Lyle/0000-0002-7157-0700; Jaoko, Walter/0000-0002-7134-6581; Kain, Taylor/0000-0002-9680-6679; barasa, samson/0000-0002-4929-0737; Kaul, Rupert/0000-0002-1586-4093	Bill and Melinda Gates Foundation; Canadian Institutes of Health Research through the Grand Challenges in Global Health Initiative [37873]; Banting and Best CIHR scholarship; Canadian Research Chair Program	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canadian Institutes of Health Research through the Grand Challenges in Global Health Initiative(Canadian Institutes of Health Research (CIHR)); Banting and Best CIHR scholarship(Canadian Institutes of Health Research (CIHR)); Canadian Research Chair Program(Canada Research Chairs)	This work was in part supported by the Bill and Melinda Gates Foundation and the Canadian Institutes of Health Research through the Grand Challenges in Global Health Initiative (grant #37873); The Banting and Best CIHR scholarship (DC salary) and the Canadian Research Chair Program (RK salary support). The funders had no role in study design, data collection, analysis and decision to publish, or preparation of the manuscript.	Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Aujla SJ, 2009, J MOL MED, V87, P451, DOI 10.1007/s00109-009-0448-1; Baltzer H, 2009, CURR HIV RES, V7, P504, DOI 10.2174/157016209789346336; Begaud E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-35; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Cecchinato V, 2010, CURR OPIN HIV AIDS, V5, P141, DOI 10.1097/COH.0b013e32833653ec; Chege D, 2011, AIDS, V25, P741, DOI 10.1097/QAD.0b013e328344cefb; Chege D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013077; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Cohen J, 2009, SCIENCE, V326, P1476, DOI 10.1126/science.326.5959.1476; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; DAWOOD MR, 1992, J CLIN MICROBIOL, V30, P2279, DOI 10.1128/JCM.30.9.2279-2283.1992; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hirbod T, 2008, AIDS, V22, P727, DOI 10.1097/QAD.0b013e3282f56b64; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Horton RE, 2010, J INFECT DIS, V202, pS377, DOI 10.1086/655971; Horton RE, 2009, AIDS RES HUM RETROV, V25, P83, DOI 10.1089/aid.2008.0207; Iqbal SM, 2005, J INFECT DIS, V192, P728, DOI 10.1086/432482; Jennes W, 2006, CLIN EXP IMMUNOL, V143, P435, DOI 10.1111/j.1365-2249.2006.03017.x; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Kaul R, 2011, SEX TRANSM INFECT, V87, P125, DOI 10.1136/sti.2009.040931; Kaul R, 2002, J ACQ IMMUN DEF SYND, V30, P69, DOI 10.1097/00042560-200205010-00009; Kaul R, 2001, IMMUNOL LETT, V79, P3, DOI 10.1016/S0165-2478(01)00260-7; Kim CJ, 2011, MUCOSAL IMM IN PRESS; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; Lajoie J, 2012, MUCOSAL IMMUNOLOGY; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Listvanova S, 2003, J IMMUNOL METHODS, V281, P27, DOI 10.1016/S0022-1759(03)00267-9; Lundgren A, 2012, VACCINE, V30, P3897, DOI 10.1016/j.vaccine.2012.03.082; Macal M, 2008, MUCOSAL IMMUNOL, V1, P475, DOI 10.1038/mi.2008.35; McKinnon LR, 2011, CURRENT OPI IN PRESS; McKinnon LR, 2012, CURR OPIN HIV AIDS, V7, P195, DOI 10.1097/COH.0b013e3283504941; McKinnon LR, 2011, J IMMUNOL, V187, P6032, DOI 10.4049/jimmunol.1101836; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Nazli A, 2011, POSSIBLE PROTE UNPUB; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Piacentini L, 2008, VACCINE, V26, P3002, DOI 10.1016/j.vaccine.2007.11.062; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Rebbapragada A, 2008, J ACQUIR IMMUNE DEFI; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Roberts L, 2011, CROI 2011 BOST MASS; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Stordeur P, 2002, J IMMUNOL METHODS, V259, P55, DOI 10.1016/S0022-1759(01)00489-6; UNAIDS, 2009, AIDS EPIDEMIC UPDATE; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl400; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	58	41	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43670	10.1371/journal.pone.0043670	http://dx.doi.org/10.1371/journal.pone.0043670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928014	Green Submitted, Green Published, gold			2022-12-25	WOS:000308286300080
J	Zhang, XT; Meng, J; Wang, ZY				Zhang, XinTian; Meng, Jun; Wang, Zhao-Yi			A Switch Role of Src in the Biphasic EGF Signaling of ER-Negative Breast Cancer Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; C-SRC; ADAPTER PROTEIN; PHOSPHORYLATION; PROLIFERATION; EXPRESSION; APOPTOSIS; ARREST; HEAD	It is well established that epidermal growth factor (EGF) is a potent mitogen in cells expressing EGF receptor (EGFR). However, a body of evidence indicated that the effects of mitogenic EGF signaling exhibit a non-monotonic, or biphasic dose response curve; EGF at low concentrations elicits a mitogenic signaling pathway to stimulate cell proliferation while at high concentrations, EGF inhibits cell growth. However, the molecular mechanism underlying this paradoxical effect of EGF on cell proliferation remains largely unknown. Here, we investigated the molecular mechanisms underlying the biphasic EGF signaling in ER-negative breast cancer MDA-MB-231 and MDA-MB-436 cells, both of which express endogenous EGFR. We found that EGF at low concentrations induced the phosphorylation of the Src-Y416 residue, an event to activate Src, while at high concentrations allowed Src-Y527 phosphorylation that inactivates Src. EGF at 10 ng/ml also induced phosphorylation of the MAPK/ERK and activated cyclin D1 promoter activity through the Src/EGFR/STAT5 pathways but not at a higher concentration (500 ng/ml). Our results thus demonstrated that Src functions as a switch of EGF signaling depending on concentrations of EGF.	[Zhang, XinTian; Meng, Jun; Wang, Zhao-Yi] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	Creighton University	Zhang, XT (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA.	zywang@creighton.edu		Migliaccio, Antimo/0000-0002-4197-2055	National Institutes of Health grant [DK070016]; Nebraska Tobacco Settlement Biomedical Research Program Awards [LB-595]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070016] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Program Awards; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant DK070016 and Nebraska Tobacco Settlement Biomedical Research Program Awards (LB-595). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biscardi JS, 1998, MOL CARCINOGEN, V21, P261, DOI 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Cao L, 2000, J CELL BIOCHEM, V77, P569, DOI 10.1002/(SICI)1097-4644(20000615)77:4<569::AID-JCB5>3.0.CO;2-K; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; Chen XY, 2004, ONCOGENE, V23, P1854, DOI 10.1038/sj.onc.1207308; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; FAN Z, 1995, J CELL BIOL, V131, P235, DOI 10.1083/jcb.131.1.235; GILL GN, 1981, NATURE, V293, P305, DOI 10.1038/293305a0; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; Jakus J, 1996, ONCOGENE, V12, P2369; KAWAMOTO T, 1984, J BIOL CHEM, V259, P7761; KEARSLEY JH, 1990, BRIT J CANCER, V61, P821, DOI 10.1038/bjc.1990.184; KONGER RL, 1993, J CELL PHYSIOL, V156, P515, DOI 10.1002/jcp.1041560310; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; OZANNE B, 1986, J PATHOL, V149, P9, DOI 10.1002/path.1711490104; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Sato K, 2003, GENES CELLS, V8, P995, DOI 10.1046/j.1356-9597.2003.00691.x; Sato K, 2002, J BIOL CHEM, V277, P29568, DOI 10.1074/jbc.M203179200; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; STANTON P, 1994, BRIT J CANCER, V70, P427, DOI 10.1038/bjc.1994.322; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Yamashita H, 2003, ONCOGENE, V22, P1638, DOI 10.1038/sj.onc.1206277; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	27	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e41613	10.1371/journal.pone.0041613	http://dx.doi.org/10.1371/journal.pone.0041613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927910	Green Published, Green Submitted, gold			2022-12-25	WOS:000307789700004
J	Dawicki-McKenna, JM; Goldman, YE; Ostap, EM				Dawicki-McKenna, Jennine M.; Goldman, Yale E.; Ostap, E. Michael			Sites of Glucose Transporter-4 Vesicle Fusion with the Plasma Membrane Correlate Spatially with Microtubules	PLOS ONE			English	Article							RAT ADIPOSE-CELLS; REGULATABLE GLUCOSE TRANSPORTER; 3T3-L1 ADIPOCYTES; GLUT4 TRANSLOCATION; SUBCELLULAR TRAFFICKING; FLUORESCENT PROTEINS; AMINOPEPTIDASE VP165; INSULIN ACTION; MYOSIN MYO1C; MUSCLE-CELLS	In adipocytes, vesicles containing glucose transporter-4 (GLUT4) redistribute from intracellular stores to the cell periphery in response to insulin stimulation. Vesicles then fuse with the plasma membrane, facilitating glucose transport into the cell. To gain insight into the details of microtubule involvement, we examined the spatial organization and dynamics of microtubules in relation to GLUT4 vesicle trafficking in living 3T3-L1 adipocytes using total internal reflection fluorescence (TIRF) microscopy. Insulin stimulated an increase in microtubule density and curvature within the TIRF-illuminated region of the cell. The high degree of curvature and abrupt displacements of microtubules indicate that substantial forces act on microtubules. The time course of the microtubule density increase precedes that of the increase in intensity of fluorescently-tagged GLUT4 in this same region of the cell. In addition, portions of the microtubules are highly curved and are pulled closer to the cell cortex, as confirmed by Parallax microscopy. Microtubule disruption delayed and modestly reduced GLUT4 accumulation at the plasma membrane. Quantitative analysis revealed that fusions of GLUT4-containing vesicles with the plasma membrane, detected using insulin-regulated aminopeptidase with a pH-sensitive GFP tag (pHluorin), preferentially occur near microtubules. Interestingly, long-distance vesicle movement along microtubules visible at the cell surface prior to fusion does not appear to account for this proximity. We conclude that microtubules may be important in providing spatial information for GLUT4 vesicle fusion.	[Dawicki-McKenna, Jennine M.; Goldman, Yale E.; Ostap, E. Michael] Univ Penn, Perelman Sch Med, Pennsylvania Muscle Inst, Philadelphia, PA 19104 USA; [Dawicki-McKenna, Jennine M.; Goldman, Yale E.; Ostap, E. Michael] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Ostap, EM (corresponding author), Univ Penn, Perelman Sch Med, Pennsylvania Muscle Inst, Philadelphia, PA 19104 USA.	ostap@mail.med.upenn.edu		Dawicki McKenna, Jennine/0000-0002-1293-640X	National Institutes of Health [GM07229]; American Heart Association; NIH [P01 GM087253]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229, P01GM087253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JMDM was supported by a training grant from the National Institutes of Health (GM07229) and a pre-doctoral fellowship from the American Heart Association. This work was also supported through a program project grant from the NIH (P01 GM087253) to YEG and EMO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Chen Y, 2008, FEBS J, V275, P705, DOI 10.1111/j.1742-4658.2007.06232.x; Chung LTK, 2010, BIOCHEM BIOPH RES CO, V391, P995, DOI 10.1016/j.bbrc.2009.12.004; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; Emoto M, 2001, J BIOL CHEM, V276, P10677, DOI 10.1074/jbc.M010785200; Eyster CA, 2009, VITAM HORM, V80, P193, DOI 10.1016/S0083-6729(08)00608-0; Eyster CA, 2006, J BIOL CHEM, V281, P39719, DOI 10.1074/jbc.M607101200; Faire K, 1999, J CELL SCI, V112, P4243; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Fujita H, 2010, MOL BIOL CELL, V21, P2721, DOI 10.1091/mbc.E10-01-0029; Fulcher FK, 2008, EXP CELL RES, V314, P3264, DOI 10.1016/j.yexcr.2008.08.007; Garza LA, 2000, J BIOL CHEM, V275, P2560, DOI 10.1074/jbc.275.4.2560; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Huang J, 2005, J BIOL CHEM, V280, P42300, DOI 10.1074/jbc.M510920200; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Imamura T, 2003, MOL CELL BIOL, V23, P4892, DOI 10.1128/MCB.23.14.4892-4900.2003; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; JHUN BH, 1992, J BIOL CHEM, V267, P17710; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; Jolly AL, 2010, P NATL ACAD SCI USA, V107, P12151, DOI 10.1073/pnas.1004736107; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Khandani A, 2007, J LEUKOCYTE BIOL, V82, P417, DOI 10.1189/jlb.0706469; Lalioti VS, 2009, J CELL PHYSIOL, V218, P416, DOI 10.1002/jcp.21614; Liu LB, 2003, J BIOL CHEM, V278, P30157, DOI 10.1074/jbc.M301511200; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Lizunov VA, 2009, J BIOL CHEM, V284, P7914, DOI 10.1074/jbc.M806460200; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Malide D, 1997, FEBS LETT, V409, P461, DOI 10.1016/S0014-5793(97)00563-2; Malide D, 2000, J CELL SCI, V113, P4203; Martin S, 1997, J CELL SCI, V110, P2281; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mentlik AN, 2010, MOL BIOL CELL, V21, P2241, DOI 10.1091/mbc.E09-11-0930; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Molero JC, 2001, J BIOL CHEM, V276, P43829, DOI 10.1074/jbc.M105452200; Olson AL, 2003, ENDOCRINOLOGY, V144, P5030, DOI 10.1210/en.2003-0609; Olson AL, 2001, J BIOL CHEM, V276, P10706, DOI 10.1074/jbc.M007610200; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Ross SA, 1996, J BIOL CHEM, V271, P3328, DOI 10.1074/jbc.271.6.3328; SATOH S, 1993, J BIOL CHEM, V268, P17820; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Sumitani S, 1997, ENDOCRINOLOGY, V138, P1029, DOI 10.1210/en.138.3.1029; Sun Y, 2009, NANO LETT, V9, P2676, DOI 10.1021/nl901129j; Thurmond DC, 2001, MOL MEMBR BIOL, V18, P237; Toyoda T, 2011, J BIOL CHEM, V286, P4133, DOI 10.1074/jbc.M110.174938; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; YANG J, 1993, J BIOL CHEM, V268, P4600; Yoshizaki T, 2007, MOL CELL BIOL, V27, P5172, DOI 10.1128/MCB.02298-06; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723; [No title captured]	61	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43662	10.1371/journal.pone.0043662	http://dx.doi.org/10.1371/journal.pone.0043662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916292	gold, Green Published, Green Submitted			2022-12-25	WOS:000307733800090
J	Hideyama, T; Teramoto, S; Hachiga, K; Yamashita, T; Kwak, S				Hideyama, Takuto; Teramoto, Sayaka; Hachiga, Kosuke; Yamashita, Takenari; Kwak, Shin			Co-Occurrence of TDP-43 Mislocalization with Reduced Activity of an RNA Editing Enzyme, ADAR2, in Aged Mouse Motor Neurons	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; RECEPTOR SUBUNITS GLUR2; LOW RELATIVE ABUNDANCE; MOTONEURONS IN-VIVO; MESSENGER-RNA; SYSTEMATIC VARIATIONS; DEATH; BISTABILITY; PARVALBUMIN	TDP-43 pathology in spinal motor neurons is a neuropathological hallmark of sporadic amyotrophic lateral sclerosis (ALS) and has recently been shown to be closely associated with the downregulation of an RNA editing enzyme called adenosine deaminase acting on RNA 2 (ADAR2) in the motor neurons of sporadic ALS patients. Because TDP-43 pathology is found more frequently in the brains of elderly patients, we investigated the age-related changes in the TDP-43 localization and ADAR2 activity in mouse motor neurons. We found that ADAR2 was developmentally upregulated, and its mRNA expression level was progressively decreased in the spinal cords of aged mice. Motor neurons normally exhibit nuclear ADAR2 and TDP-43 immunoreactivity, whereas fast fatigable motor neurons in aged mice demonstrated a loss of ADAR2 and abnormal TDP-43 localization. Importantly, these motor neurons expressed significant amounts of the Q/R site-unedited AMPA receptor subunit 2 (GluA2) mRNA. Because expression of unedited GluA2 has been demonstrated as a lethality-causing molecular abnormality observed in the motor neurons, these results suggest that age-related decreases in ADAR2 activity play a mechanistic role in aging and serve as one of risk factors for ALS.	[Hideyama, Takuto; Teramoto, Sayaka; Yamashita, Takenari; Kwak, Shin] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Hideyama, Takuto; Teramoto, Sayaka; Hachiga, Kosuke; Yamashita, Takenari; Kwak, Shin] Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo, Japan; [Hideyama, Takuto] Univ Tokyo, Div Hlth Promot, Bunkyo Ku, Tokyo, Japan; [Teramoto, Sayaka; Yamashita, Takenari; Kwak, Shin] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo, Japan; [Kwak, Shin] Int Univ Hlth & Welf, Clin Res Ctr Med, Ichikawa, Chiba, Japan	Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; University of Tokyo; International University of Health & Welfare	Hideyama, T (corresponding author), Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan.	kwak-tky@umin.ac.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan ALS (Amyotrophic Lateral Sclerosis) Association; Nakabayashi Trust For ALS Research; Grants-in-Aid for Scientific Research [23790978] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan ALS (Amyotrophic Lateral Sclerosis) Association; Nakabayashi Trust For ALS Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Health, Labor (SK), and Welfare of Japan and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (SK), and Research Grants from Japan ALS (Amyotrophic Lateral Sclerosis) Association and from The Nakabayashi Trust For ALS Research (TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 2010, ACTA NEUROPATHOL, V120, P75, DOI 10.1007/s00401-010-0678-x; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Atsuta N, 2009, J NEUROL SCI, V276, P163, DOI 10.1016/j.jns.2008.09.024; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Cotel F, 2009, J NEUROSCI, V29, P2748, DOI 10.1523/JNEUROSCI.3462-08.2009; DENGLER R, 1990, MUSCLE NERVE, V13, P545, DOI 10.1002/mus.880130612; HASHIZUME K, 1988, J COMP NEUROL, V269, P425, DOI 10.1002/cne.902690309; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Hideyama T, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00033; Hideyama T, 2010, J NEUROSCI, V30, P11917, DOI 10.1523/JNEUROSCI.2021-10.2010; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hirofuji C, 2000, NEUROREPORT, V11, P823, DOI 10.1097/00001756-200003200-00033; INCE P, 1993, NEUROPATH APPL NEURO, V19, P291, DOI 10.1111/j.1365-2990.1993.tb00443.x; Kadhiresan VA, 1996, J PHYSIOL-LONDON, V493, P543, DOI 10.1113/jphysiol.1996.sp021402; KANDA K, 1989, J NEUROPHYSIOL, V61, P737, DOI 10.1152/jn.1989.61.4.737; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kawahara Y, 2004, DEV BRAIN RES, V148, P151, DOI 10.1016/j.devbrainres.2003.11.008; Kawahara Y, 2003, EUR J NEUROSCI, V18, P23, DOI 10.1046/j.1460-9568.2003.02718.x; Kawahara Y, 2003, J NEUROCHEM, V85, P680, DOI 10.1046/j.1471-4159.2003.01703.x; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; Kwak S, 2008, RNA BIOL, V5, P193, DOI 10.4161/rna.6925; Lee RH, 1998, J NEUROPHYSIOL, V80, P572, DOI 10.1152/jn.1998.80.2.572; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nicholas A, 2010, MECH AGEING DEV, V131, P445, DOI 10.1016/j.mad.2010.06.001; Nishimoto Y, 2008, NEUROSCI RES, V61, P201, DOI 10.1016/j.neures.2008.02.009; PASCHEN W, 1995, J NEUROSCI METH, V56, P21, DOI 10.1016/0165-0270(94)00085-U; PASCHEN W, 1994, J NEUROCHEM, V63, P1596, DOI 10.1046/j.1471-4159.1994.63051596.x; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; STURROCK RR, 1988, J ANAT, V160, P189; STURROCK RR, 1991, J ANAT, V174, P125; Takuma H, 1999, ANN NEUROL, V46, P806, DOI 10.1002/1531-8249(199912)46:6<806::AID-ANA2>3.0.CO;2-S; Van den Bosch L, 2002, EXP NEUROL, V174, P150, DOI 10.1006/exnr.2001.7858; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147	37	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43469	10.1371/journal.pone.0043469	http://dx.doi.org/10.1371/journal.pone.0043469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916266	Green Submitted, gold, Green Published			2022-12-25	WOS:000307733800070
J	Kim, H; Jones, KE				Kim, Hojeong; Jones, Kelvin E.			The Retrograde Frequency Response of Passive Dendritic Trees Constrains the Nonlinear Firing Behaviour of a Reduced Neuron Model	PLOS ONE			English	Article							MOTONEURONS IN-VIVO; PERSISTENT INWARD CURRENTS; MOUSE SPINAL MOTONEURONS; PLATEAU POTENTIALS; CALCIUM CURRENTS; SYSTEMATIC VARIATIONS; ELECTRICAL-PROPERTIES; COMPARTMENTAL MODEL; VARIABLE-THRESHOLD; LUMBAR MOTONEURONS	Our goal was to investigate how the propagation of alternating signals (i.e. AC), like action potentials, into the dendrites influenced nonlinear firing behaviour of motor neurons using a systematically reduced neuron model. A recently developed reduced modeling approach using only steady-current (i.e. DC) signaling was analytically expanded to retain features of the frequency-response analysis carried out in multicompartment anatomically reconstructed models. Bifurcation analysis of the extended model showed that the typically overlooked parameter of AC amplitude attenuation was positively correlated with the current threshold for the activation of a plateau potential in the dendrite. Within the multiparameter space map of the reduced model the region demonstrating "fully-bistable'' firing was bounded by directional DC attenuation values that were negatively correlated to AC attenuation. Based on these results we conclude that analytically derived reduced models of dendritic trees should be fit on DC and AC signaling, as both are important biophysical parameters governing the nonlinear firing behaviour of motor neurons.	[Kim, Hojeong; Jones, Kelvin E.] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Jones, Kelvin E.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Jones, Kelvin E.] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Kim, H (corresponding author), Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada.	hojeong@ualberta.ca	Jones, Kelvin/AAJ-6112-2021; Jones, Kelvin/AFW-5002-2022; Jones, Kelvin/M-6487-2019	Jones, Kelvin/0000-0003-4764-7031; 	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The study was supported by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Ballou EW, 2006, J NEUROSCI METH, V156, P257, DOI 10.1016/j.jneumeth.2006.03.014; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bennett DJ, 2001, J NEUROPHYSIOL, V86, P1955, DOI 10.1152/jn.2001.86.4.1955; Booth V, 1997, J NEUROPHYSIOL, V78, P3371, DOI 10.1152/jn.1997.78.6.3371; Booth V, 1995, J COMPUT NEUROSCI, V2, P299, DOI 10.1007/BF00961442; Bui TV, 2006, J NEUROPHYSIOL, V95, P225, DOI 10.1152/jn.00646.2005; Burke RE, 1999, PROG BRAIN RES, V123, P167, DOI 10.1016/S0079-6123(08)62854-X; Carlin KP, 2000, EUR J NEUROSCI, V12, P1635, DOI 10.1046/j.1460-9568.2000.00055.x; Carlin KP, 2000, EUR J NEUROSCI, V12, P1624, DOI 10.1046/j.1460-9568.2000.00050.x; Carnevale N. T., 2005, NEURON BOOK, pXIX; Carnevale NT, 1997, J NEUROPHYSIOL, V78, P703, DOI 10.1152/jn.1997.78.2.703; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P291, DOI 10.1113/jphysiol.1955.sp005411; CULLHEIM S, 1987, J COMP NEUROL, V255, P82, DOI 10.1002/cne.902550107; CULLHEIM S, 1987, J COMP NEUROL, V255, P68, DOI 10.1002/cne.902550106; Doiron B, 2002, J COMPUT NEUROSCI, V12, P5, DOI 10.1023/A:1014921628797; ElBasiouny SM, 2005, J NEUROPHYSIOL, V94, P3961, DOI 10.1152/jn.00391.2005; Grande G, 2007, J NEUROPHYSIOL, V97, P4023, DOI 10.1152/jn.00044.2007; Gutman A. M., 1991, International Journal of Neural Systems, V1, P291, DOI 10.1142/S0129065791000339; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Heckman CJ, 2005, MUSCLE NERVE, V31, P135, DOI 10.1002/mus.20261; Heckman CJ, 2003, TRENDS NEUROSCI, V26, P688, DOI 10.1016/j.tins.2003.10.002; Hendrickson EB, 2011, J COMPUT NEUROSCI, V30, P301, DOI 10.1007/s10827-010-0258-z; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V398, P591, DOI 10.1113/jphysiol.1988.sp017059; HOUNSGAARD J, 1989, J PHYSIOL-LONDON, V414, P265, DOI 10.1113/jphysiol.1989.sp017687; HOUNSGAARD J, 1985, EXP BRAIN RES, V57, P422; HOUNSGAARD J, 1984, EXP BRAIN RES, V55, P391; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V398, P575, DOI 10.1113/jphysiol.1988.sp017058; Izhikevich EM, 2007, DYNAMICAL SYSTEMS NE, p[xvi, 441]; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; Jones KE, 2000, NEUROCOMPUTING, V32, P173, DOI 10.1016/S0925-2312(00)00160-0; Kim H, 2011, J COMPUT NEUROSCI, V30, P659, DOI 10.1007/s10827-010-0284-x; Kim H, 2009, J COMPUT NEUROSCI, V27, P321, DOI 10.1007/s10827-009-0145-7; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lee RH, 1998, J NEUROPHYSIOL, V80, P572, DOI 10.1152/jn.1998.80.2.572; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Lee RH, 1999, J NEUROPHYSIOL, V81, P2164, DOI 10.1152/jn.1999.81.5.2164; Lee RH, 1999, J NEUROPHYSIOL, V82, P2518, DOI 10.1152/jn.1999.82.5.2518; Lee RH, 2000, J NEUROSCI, V20, P6734, DOI 10.1523/JNEUROSCI.20-17-06734.2000; Li YR, 2003, J NEUROPHYSIOL, V90, P857, DOI 10.1152/jn.00236.2003; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MCCOMAS AJ, 1995, MUSCLE NERVE, V18, P369, DOI 10.1002/mus.880180402; Meehan CF, 2010, J NEUROPHYSIOL, V103, P2599, DOI 10.1152/jn.00668.2009; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Phillips CL, 2000, FEEDBACK CONTROL SYS, pxiii; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; POWERS RK, 1993, J NEUROPHYSIOL, V70, P246, DOI 10.1152/jn.1993.70.1.246; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; SCHWINDT PC, 1980, J NEUROPHYSIOL, V44, P827, DOI 10.1152/jn.1980.44.4.827; SCHWINDT PC, 1980, J NEUROPHYSIOL, V43, P1700, DOI 10.1152/jn.1980.43.6.1700; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 2008, DENDRITES, pxv; Svirskis G, 1997, J NEUROPHYSIOL, V78, P1740, DOI 10.1152/jn.1997.78.3.1740; ZADOR AM, 1995, J NEUROSCI, V15, P1669, DOI 10.1523/JNEUROSCI.15-03-01669.1995; ZENGEL JE, 1985, J NEUROPHYSIOL, V53, P1323, DOI 10.1152/jn.1985.53.5.1323	57	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43654	10.1371/journal.pone.0043654	http://dx.doi.org/10.1371/journal.pone.0043654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916290	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800088
J	Lamsoul, I; Erard, M; van der Ven, PFM; Lutz, PG				Lamsoul, Isabelle; Erard, Monique; van der Ven, Peter F. M.; Lutz, Pierre G.			Filamins but Not Janus Kinases Are Substrates of the ASB2 alpha Cullin-Ring E3 Ubiquitin Ligase in Hematopoietic Cells	PLOS ONE			English	Article							MYELOID-LEUKEMIA CELLS; PROTEASOMAL DEGRADATION; CRYSTAL-STRUCTURE; DIFFERENTIATION; COMPLEX; REGULATOR; PROTEINS; ADHESION; PATHWAY; ASB2	The ASB2 alpha protein is the specificity subunit of an E3 ubiquitin ligase complex involved in hematopoietic differentiation and is proposed to exert its effects by regulating the turnover of specific proteins. Three ASB2 alpha substrates have been described so far: the actin-binding protein filamins, the Mixed Lineage Leukemia protein, and the Janus kinases 2 and 3. To determine the degradation of which substrate drives ASB2 alpha biological effects is crucial for the understanding of ASB2 alpha functions in hematopoiesis. Here, we show that neither endogenous nor exogenously expressed ASB2 alpha induces degradation of JAK proteins in hematopoietic cells. Furthermore, we performed molecular modeling to generate the first structural model of an E3 ubiquitin ligase complex of an ASB protein bound to one of its substrates.	[Lamsoul, Isabelle; Erard, Monique; Lutz, Pierre G.] CNRS, IPBS, F-31077 Toulouse, France; [Lamsoul, Isabelle; Erard, Monique; Lutz, Pierre G.] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [van der Ven, Peter F. M.] Univ Bonn, Dept Mol Cell Biol, Inst Cell Biol, Bonn, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Bonn	Lamsoul, I (corresponding author), CNRS, IPBS, 205 Route Narbonne,BP64182, F-31077 Toulouse, France.	Pierre.Lutz@ipbs.fr	Lutz, Pierre/B-8822-2009	Lutz, Pierre/0000-0003-0590-9101; Lamsoul, Isabelle/0000-0002-7769-5627; van der Ven, Peter/0000-0002-9750-8913	Centre National de la Recherche Scientifique; Universite Paul Sabatier; Comite Leucemie de la Fondation de France; Comite Midi-Pyrenees de la Ligue contre le Cancer; Lady TATA Foundation	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Sabatier; Comite Leucemie de la Fondation de France(Fondation de France); Comite Midi-Pyrenees de la Ligue contre le Cancer; Lady TATA Foundation	This work was supported by Centre National de la Recherche Scientifique and Universite Paul Sabatier and by grants to PGL from the Comite Leucemie de la Fondation de France and from the Comite Midi-Pyrenees de la Ligue contre le Cancer. I. Lamsoul was supported by fellowships from the Lady TATA Foundation and the Comite Leucemie de la Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello NF, 2009, CELL DEATH DIFFER, V16, P921, DOI 10.1038/cdd.2009.27; Biethahn S, 1999, EXP HEMATOL, V27, P885, DOI 10.1016/S0301-472X(99)00017-X; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Burande CF, 2009, MOL CELL PROTEOMICS, V8, P1719, DOI 10.1074/mcp.M800410-MCP200; Guibal FC, 2002, J BIOL CHEM, V277, P218, DOI 10.1074/jbc.M108476200; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Kohroki J, 2001, FEBS LETT, V505, P223, DOI 10.1016/S0014-5793(01)02829-0; Lamsoul I, 2011, J BIOL CHEM, V286, P30571, DOI 10.1074/jbc.M111.220921; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Moog-Lutz C, 2003, BLOOD, V102, P3371, DOI 10.1182/blood-2002-11-3462; Nie L, 2011, CELL RES, V21, P754, DOI 10.1038/cr.2010.165; Okumura F, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00010; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Spicuglia S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024176; Wang JY, 2012, BLOOD, V119, P1151, DOI 10.1182/blood-2011-06-362079; Wu W, 2011, J BIOL CHEM, V286, P41153, DOI 10.1074/jbc.M111.273755; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	20	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43798	10.1371/journal.pone.0043798	http://dx.doi.org/10.1371/journal.pone.0043798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916308	gold, Green Submitted, Green Published			2022-12-25	WOS:000307733800105
J	Ostermann, E; Tuddenham, L; Macquin, C; Alsaleh, G; Schreiber-Becker, J; Tanguy, M; Bahram, S; Pfeffer, S; Georgel, P				Ostermann, Eleonore; Tuddenham, Lee; Macquin, Cecile; Alsaleh, Ghada; Schreiber-Becker, Julie; Tanguy, Melanie; Bahram, Seiamak; Pfeffer, Sebastien; Georgel, Philippe			Deregulation of Type I IFN-Dependent Genes Correlates with Increased Susceptibility to Cytomegalovirus Acute Infection of Dicer Mutant Mice	PLOS ONE			English	Article							MICRORNAS TARGET; RECOGNITION; DEFENSE; IDENTIFICATION; PREDICTION; RESPONSES; VIRUSES; IMPACT; LIGAND; RNAS	Regulation of gene expression by microRNAs (miRNAs) is now considered as an essential mechanism for cell development and homeostasis. Indeed, numerous studies have reported that modulating their expression, maturation, or activity can affect cell survival, identity or activation. In particular, miRNAs are key players in the tight regulation of signaling cascades, and as such, they appear as perfectly suited immunomodulators. Several immune-related processes, including inflammation, have recently been demonstrated to require specific miRNAs. In addition, the discovery of herpesvirus-encoded miRNAs has reinforced this assumption. To decipher the potential roles of miRNAs in innate antiviral immune response, we developed an in vivo model based on the inoculation of mouse cytomegalovirus (MCMV) in mice. Furthermore, we exploited a mouse line carrying a hypomorphic mutation in the Dicer gene to visualize the impact of impaired miRNA biogenesis upon the anti-MCMV response. Our data indicate that miRNAs are important actors in mounting an efficient response against herpesviruses. We suggest that a rapid and transient interferon response following viral infection requires miRNA-dependent repressor release. In addition, our in vivo efforts identified several miRNA targets, thus providing a conceptual framework for future analyzes on the regulation of specific actors involved in the Type I interferon pathway.	[Ostermann, Eleonore; Macquin, Cecile; Bahram, Seiamak; Georgel, Philippe] Univ Strasbourg, EA 4438, Lab Immunogenet Mol Humaine, Strasbourg, France; [Tuddenham, Lee; Schreiber-Becker, Julie; Tanguy, Melanie; Pfeffer, Sebastien] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN, Strasbourg, France; [Alsaleh, Ghada] Univ Strasbourg, EA 4438, Lab Physiopathol Arthrites, Illkirch Graffenstaden, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ostermann, E (corresponding author), Univ Strasbourg, EA 4438, Lab Immunogenet Mol Humaine, Strasbourg, France.	s.pfeffer@ibmc-cnrs.unistra.fr; pgeorgel@unistra.fr	georgel, philippe/P-5676-2016; Pfeffer, Sebastien/A-6512-2010; Pfeffer, Sébastien/H-3212-2019; Bahram, Seiamak/GZA-7150-2022	georgel, philippe/0000-0001-6853-7080; Pfeffer, Sebastien/0000-0002-8458-348X; Pfeffer, Sébastien/0000-0002-8458-348X; Bahram, Seiamak/0000-0002-6928-9952; Ostermann, Eleonore/0000-0002-7539-2155; Tanguy, Melanie/0000-0003-4862-0981; alsaleh, ghada/0000-0002-4211-3420	Agence Nationale de la Recherche (ANR) [ANR-08-MIEN-005-01 DICERPATHO]; Association pour la Recherche sur le Cancer	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by Agence Nationale de la Recherche (ANR) (ANR-08-MIEN-005-01 DICERPATHO) to PG and SP. MT was funded by a fellowship from the Association pour la Recherche sur le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barenboim M, 2010, HUM MUTAT, V31, P1223, DOI 10.1002/humu.21349; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Cicin-Sain L, 2005, J VIROL, V79, P9492, DOI 10.1128/JVI.79.15.9492-9502.2005; Dai RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014302; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kemp C, 2009, CURR OPIN IMMUNOL, V21, P3, DOI 10.1016/j.coi.2009.01.007; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Muller S, 2007, IMMUNITY, V27, P1, DOI 10.1016/j.immuni.2007.07.003; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Rolli V, 2007, FEBS LETT, V581, P394, DOI 10.1016/j.febslet.2006.12.047; Seo GJ, 2008, J VIROL, V82, P9823, DOI 10.1128/JVI.01144-08; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Stark TJ, 2012, J VIROL, V86, P226, DOI 10.1128/JVI.05903-11; Suffert G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002405; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tolfvenstam T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-209; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Tuddenham L, 2012, J VIROL, V86, P1638, DOI 10.1128/JVI.05911-11; Wies E, 2009, J BIOL CHEM, V284, P8525, DOI 10.1074/jbc.M809252200; Ye JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020681; Zucchini N, 2008, J IMMUNOL, V180, P5799, DOI 10.4049/jimmunol.180.9.5799	42	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43744	10.1371/journal.pone.0043744	http://dx.doi.org/10.1371/journal.pone.0043744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916300	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800098
J	Zabini, D; Nagaraj, C; Stacher, E; Lang, IM; Nierlich, P; Klepetko, W; Heinemann, A; Olschewski, H; Balint, Z; Olschewski, A				Zabini, Diana; Nagaraj, Chandran; Stacher, Elvira; Lang, Irene M.; Nierlich, Patrick; Klepetko, Walter; Heinemann, Akos; Olschewski, Horst; Balint, Zoltan; Olschewski, Andrea			Angiostatic Factors in the Pulmonary Endarterectomy Material from Chronic Thromboembolic Pulmonary Hypertension Patients Cause Endothelial Dysfunction	PLOS ONE			English	Article							INTERFERON-INDUCIBLE PROTEIN-10; CHEMOKINE RECEPTOR CXCR3; PROGENITOR CELLS; T-LYMPHOCYTES; IN-VIVO; ANGIOGENESIS; EXPRESSION; GROWTH; NEOVASCULARIZATION; PLATELET-FACTOR-4	Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease with persistent thrombotic occlusion or stenosis of the large pulmonary arteries resulting in pulmonary hypertension. Surgical removal of the neointimal layer of these vessels together with the non-resolved thrombus consisting of organized collagen-rich fibrotic areas with partly recanalized regions is the treatment of choice (pulmonary endarterectomy, PEA). The present study investigates endothelial cells isolated from such material as well as factors present in the surgical PEA material, which may contribute to impairment of recanalization and thrombus non-resolution. We observed muscularized vessels and non-muscularized vessels in the PEA material. The isolated endothelial cells from the PEA material showed significantly different calcium homeostasis as compared to pulmonary artery endothelial cells (hPAECs) from normal controls. In the supernatant (ELISA) as well as on the tissue level (histochemical staining) of the PEA material, platelet factor 4 (PF4), collagen type I and interferon-gamma-inducible 10 kD protein (IP-10) were detected. CXCR3, the receptor for PF4 and IP-10, was particularly elevated in the distal parts of the PEA material as compared to human control lung (RT-PCR). PF4, collagen type I and IP-10 caused significant changes in calcium homeostasis and affected the cell proliferation, migration and vessel formation in hPAECs. The presence of angiostatic factors like PF4, collagen type I and IP-10, as recovered from the surgical PEA material from CTEPH patients, may lead to changes in calcium homeostasis and endothelial dysfunction.	[Zabini, Diana; Nagaraj, Chandran; Balint, Zoltan; Olschewski, Andrea] Med Univ Graz, Dept Anesthesia & Intens Care Med, Graz, Austria; [Stacher, Elvira] Med Univ Graz, Inst Pathol, Graz, Austria; [Lang, Irene M.] Med Univ Vienna, Div Cardiol, Dept Internal Med 2, Vienna, Austria; [Nierlich, Patrick; Klepetko, Walter] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Heinemann, Akos] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria; [Olschewski, Horst] Med Univ Graz, Div Pulmonol, Dept Internal Med, Graz, Austria; [Nagaraj, Chandran; Balint, Zoltan; Olschewski, Andrea] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Vienna; Medical University of Vienna; Medical University of Graz; Medical University of Graz; Ludwig Boltzmann Institute	Zabini, D (corresponding author), Med Univ Graz, Dept Anesthesia & Intens Care Med, Graz, Austria.	zoltan.balint@lvr.lbg.ac.at	Olschewski, Horst/L-3547-2019; Chandran, Nagaraj/AAP-2007-2020; Bálint, Zoltán/AAJ-3080-2020	Olschewski, Horst/0000-0002-2834-7466; Chandran, Nagaraj/0000-0003-3825-8587; Olschewski, Andrea/0000-0002-8189-3634; Balint, Zoltan/0000-0001-8598-2784; Lang, Irene/0000-0003-0485-2692	Medical University of Graz; EU [LSHM-CT-2005-018725]; Austrian-Hungarian Joint Grant [AT-4/2009]; Austrian Science Fund (FWF) [P 22521] Funding Source: researchfish	Medical University of Graz; EU(European Commission); Austrian-Hungarian Joint Grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded by the Medical University of Graz (PhD Program Molecular Medicine) to DZ and CN, EU FP6 "PULMOTENSION'' (LSHM-CT-2005-018725) to AO, HO, IML and WK, and Austrian-Hungarian Joint Grant AT-4/2009 to AO and ZB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo AL, 1996, ANN NY ACAD SCI, V795, P158, DOI 10.1111/j.1749-6632.1996.tb52664.x; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; Bodnar RJ, 2009, J CELL SCI, V122, P2064, DOI 10.1242/jcs.048793; Bonderman D, 2008, ARTERIOSCL THROM VAS, V28, P678, DOI 10.1161/ATVBAHA.107.156000; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; Dartevelle P, 2004, EUR RESPIR J, V23, P637, DOI 10.1183/09031936.04.00079704; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; De S, 2005, P NATL ACAD SCI USA, V102, P7589, DOI 10.1073/pnas.0502935102; Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721; DIBLE JH, 1958, J PATHOL BACTERIOL, V75, P1, DOI 10.1002/path.1700750102; Distler JHW, 2003, Q J NUCL MED, V47, P149; Ellis CA, 1999, J BIOL CHEM, V274, P13718, DOI 10.1074/jbc.274.19.13718; FILES JC, 1981, BLOOD, V58, P607; Firth AL, 2010, AM J PHYSIOL-CELL PH, V298, pC1217, DOI 10.1152/ajpcell.00416.2009; Firth AL, 2009, AM J PHYSIOL-LUNG C, V296, pL979, DOI 10.1152/ajplung.90412.2008; FUKAMI MH, 2001, HEMOSTASIS THROMBOSI, P561; GARCIA JGN, 1993, J CELL PHYSIOL, V156, P541, DOI 10.1002/jcp.1041560313; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Herve P, 2006, J APPL PHYSIOL, V100, P1101, DOI 10.1152/japplphysiol.01554.2005; Hofer E, 2007, THROMB HAEMOSTASIS, V97, P355, DOI 10.1160/TH06-08-0470; Hosokawa K, 2011, INT HEART J, V52, P377, DOI 10.1536/ihj.52.377; Hou YH, 2006, EXP HEMATOL, V34, P1125, DOI 10.1016/j.exphem.2006.05.021; Humbert M, 2010, EUR RESPIR REV, V19, P59, DOI 10.1183/09059180.00007309; Ji WDR, 1998, FASEB J, V12, P1731, DOI 10.1096/fasebj.12.15.1731; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Kimura H, 2001, AM J RESP CRIT CARE, V164, P319, DOI 10.1164/ajrccm.164.2.2006154; LANG IM, 1994, CIRCULATION, V89, P2715, DOI 10.1161/01.CIR.89.6.2715; Lang I, 2010, BRIT J HAEMATOL, V149, P478, DOI 10.1111/j.1365-2141.2010.08142.x; Lang IM, 2008, CURR OPIN CARDIOL, V23, P555, DOI 10.1097/HCO.0b013e328311f254; Lang IM, 2009, REV ESP CARDIOL, V62, P120, DOI 10.1016/S0300-8932(09)70153-8; LUSTER AD, 1995, J EXP MED, V182, P219, DOI 10.1084/jem.182.1.219; Maruoka M, 2012, INT J CARDIOL, V159, P119, DOI 10.1016/j.ijcard.2011.02.037; Mayer Eckhard, 2006, Proc Am Thorac Soc, V3, P589, DOI 10.1513/pats.200605-120LR; McGuinness CL, 2001, THROMB HAEMOSTASIS, V85, P1018, DOI 10.1055/s-0037-1615957; Morris TA, 2006, AM J RESP CRIT CARE, V173, P1270, DOI 10.1164/rccm.200506-916OC; MOSER KM, 1993, CHEST, V103, P685, DOI 10.1378/chest.103.3.685; Mueller A, 2008, J LEUKOCYTE BIOL, V83, P875, DOI 10.1189/jlb.1006645; Ogawa A, 2009, AM J PHYSIOL-LUNG C, V297, pL666, DOI 10.1152/ajplung.90548.2008; Perollet C, 1998, BLOOD, V91, P3289, DOI 10.1182/blood.V91.9.3289.3289_3289_3299; Ribatti D, 2009, LEUKEMIA RES, V33, P638, DOI 10.1016/j.leukres.2008.11.019; Romagnani P, 2001, J CLIN INVEST, V107, P53, DOI 10.1172/JCI9775; Sacks RS, 2006, SEMIN THORAC CARDIOV, V18, P265, DOI 10.1053/j.semtcvs.2006.09.004; Sakao S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-109; Sevitt S, 1970, J PATHOL, V100, pPi; Singh I, 2003, CIRCULATION, V107, P869, DOI 10.1161/01.CIR.0000050149.22928.39; Struyf S, 2011, BLOOD, V117, P480, DOI 10.1182/blood-2009-11-253591; Suntharalingam J, 2008, EUR RESPIR J, V31, P736, DOI 10.1183/09031936.00055107; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Undas A, 2009, BLOOD, V114, P4272, DOI 10.1182/blood-2009-05-222380; van Weering HRJ, 2010, BRAIN BEHAV IMMUN, V24, P768, DOI 10.1016/j.bbi.2009.04.007; Wakefield TW, 1999, J VASC SURG, V30, P885, DOI 10.1016/S0741-5214(99)70013-3; Wolf M, 2000, EUR RESPIR J, V15, P395, DOI 10.1034/j.1399-3003.2000.15b28.x; Wynants M, 2012, EUR RESPIR J, V40, P886, DOI 10.1183/09031936.00197511; Yang LJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-261; Yao WJ, 2009, AM J PHYSIOL-LUNG C, V296, pL870, DOI 10.1152/ajplung.90413.2008; Yi ES, 2000, AM J RESP CRIT CARE, V162, P1577, DOI 10.1164/ajrccm.162.4.9912131; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101	61	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43793	10.1371/journal.pone.0043793	http://dx.doi.org/10.1371/journal.pone.0043793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916307	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800104
J	Gao, LX; Tang, SQ; Zhuge, LQ; Nie, M; Zhu, Z; Li, B; Yang, J				Gao, Lexuan; Tang, Shaoqing; Zhuge, Liqiong; Nie, Ming; Zhu, Zhu; Li, Bo; Yang, Ji			Spatial Genetic Structure in Natural Populations of Phragmites australis in a Mosaic of Saline Habitats in the Yellow River Delta, China	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; SALT TOLERANCE; RELATIVE IMPORTANCE; OSMOTIC ADJUSTMENT; LOCAL ADAPTATION; CANDIDATE LOCI; CLIMATE-CHANGE; WORLD-WIDE; SCALE; DIVERSITY	Determination of spatial genetic structure (SGS) in natural populations is important for both theoretical aspects of evolutionary genetics and their application in species conservation and ecological restoration. In this study, we examined genetic diversity within and among the natural populations of a cosmopolitan grass Phragmites australis (common reed) in the Yellow River Delta (YRD), China, where a mosaic of habitat patches varying in soil salinity was detected. We demonstrated that, despite their close geographic proximity, the common reed populations in the YRD significantly diverged at six microsatellite loci, exhibiting a strong association of genetic variation with habitat heterogeneity. Genetic distances among populations were best explained as a function of environmental difference, rather than geographical distance. Although the level of genetic divergence among populations was relatively low (F'(ST) = 0.073), weak but significant genetic differentiation, as well as the concordance between ecological and genetic landscapes, suggests spatial structuring of genotypes in relation to patchy habitats. These findings not only provided insights into the population dynamics of common reed in changing environments, but also demonstrated the feasibility of using habitat patches in a mosaic landscape as test systems to identify appropriate genetic sources for ecological restoration.	[Gao, Lexuan; Zhu, Zhu; Li, Bo; Yang, Ji] Fudan Univ, Ctr Evolutionary Biol, Shanghai 200433, Peoples R China; [Gao, Lexuan; Zhu, Zhu; Li, Bo; Yang, Ji] Fudan Univ, Inst Biodivers Sci, Shanghai 200433, Peoples R China; [Tang, Shaoqing; Zhuge, Liqiong] Guangxi Normal Univ, Coll Life Sci, Guilin, Peoples R China; [Nie, Ming; Yang, Ji] Nanchang Univ, Ctr Watershed Ecol, Nanchang, Peoples R China	Fudan University; Fudan University; Guangxi Normal University; Nanchang University	Gao, LX (corresponding author), Fudan Univ, Ctr Evolutionary Biol, Shanghai 200433, Peoples R China.	zzhu@fudan.edu.cn	Li, Bo/B-8016-2010; Nie, Ming/F-1880-2010; Li, Bo/AAA-8968-2020; Nie, Ming/F-1880-2010	Li, Bo/0000-0002-0439-5666; Nie, Ming/0000-0003-0702-8009; Li, Bo/0000-0002-7294-6888; Nie, Ming/0000-0003-3898-5389	National Basic Research Program of China [2006CB403305]; National Natural Science Foundation of China [91131901]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2006CB403305) and the National Natural Science Foundation of China (91131901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2006, MAR ECOL PROG SER, V309, P117, DOI 10.3354/meps309117; Bascompte J, 2002, AM NAT, V159, P128, DOI 10.1086/324793; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Becher SA, 2000, THEOR APPL GENET, V101, P643, DOI 10.1007/s001220051526; Bell DJ, 2009, BOTANY, V87, P932, DOI 10.1139/B09-058; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Bond NR, 2000, J ANIM ECOL, V69, P608, DOI 10.1046/j.1365-2656.2000.00420.x; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Brown BL, 2007, HYDROBIOLOGIA, V586, P93, DOI 10.1007/s10750-006-0531-3; Buckley J, 2012, MOL ECOL, V21, P267, DOI 10.1111/j.1365-294X.2011.05388.x; Burdick DM, 2001, ENVIRON EXP BOT, V46, P247, DOI 10.1016/S0098-8472(01)00099-5; Capelle J, 2005, J EVOLUTION BIOL, V18, P1445, DOI 10.1111/j.1420-9101.2005.00951.x; [陈小英 Chen Xiaoying], 2005, [海洋科学进展, Advances in Marine Science], V23, P438; Colling G, 2010, PLANT SYST EVOL, V287, P99, DOI 10.1007/s00606-010-0298-x; Cureton AN, 2006, J APPL ECOL, V43, P1203, DOI 10.1111/j.1365-2664.2006.01236.x; Curn V, 2007, AQUAT BOT, V86, P321, DOI 10.1016/j.aquabot.2006.11.010; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Edmonds CA, 2004, P NATL ACAD SCI USA, V101, P975, DOI 10.1073/pnas.0308064100; Engloner AI, 2009, FLORA, V204, P331, DOI 10.1016/j.flora.2008.05.001; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; FAHRIG L, 1992, THEOR POPUL BIOL, V41, P300, DOI 10.1016/0040-5809(92)90031-N; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fang HL, 2005, ENVIRON MANAGE, V35, P72, DOI 10.1007/s00267-004-3066-2; Feng SZL, 2006, HYDROGRAPHIC SURVEYI, V26, P38; Flather CH, 2002, AM NAT, V159, P40, DOI 10.1086/324120; Garnier-Gere PH, 2001, CONSERV BIOL, V15, P1632, DOI 10.1046/j.1523-1739.2001.00180.x; Gonzales E, 2010, J HERED, V101, P133, DOI 10.1093/jhered/esp101; Guldbrandtsen B, 2000, J HERED, V91, P178, DOI 10.1093/jhered/91.2.178; Guo WH, 2003, BIOCHEM SYST ECOL, V31, P1093, DOI 10.1016/S0305-1978(03)00032-2; Guo XX, 2008, J MOL EVOL, V67, P497, DOI 10.1007/s00239-008-9166-5; Hallatschek O, 2008, THEOR POPUL BIOL, V73, P158, DOI 10.1016/j.tpb.2007.08.008; Hancock AM, 2010, PHILOS T R SOC B, V365, P2459, DOI 10.1098/rstb.2010.0032; Hansen DL, 2007, AQUAT BOT, V86, P269, DOI 10.1016/j.aquabot.2006.11.005; Hargeby A, 2004, EVOLUTION, V58, P81; Hie Qiang, 2008, Yingyong Shengtai Xuebao, V19, P969; Holsinger K.E., 2007, HICKORY PACKAGE ANAL; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Joost S, 2008, MOL ECOL RESOUR, V8, P957, DOI 10.1111/j.1755-0998.2008.02162.x; Kalisz S, 2001, EVOLUTION, V55, P1560, DOI 10.1111/j.0014-3820.2001.tb00675.x; Keller BEM, 2000, AQUAT BOT, V66, P195, DOI 10.1016/S0304-3770(99)00077-7; Kettle CJ, 2011, PERSPECT PLANT ECOL, V13, P45, DOI 10.1016/j.ppees.2010.11.002; Kirk H, 2011, AM J BOT, V98, P1180, DOI 10.3732/ajb.1000278; Koppitz H, 1999, AQUAT BOT, V64, P209, DOI 10.1016/S0304-3770(99)00051-0; Korpelainen H, 2011, EVOL ECOL, V25, P45, DOI 10.1007/s10682-010-9378-1; Lambertini C, 2008, AQUAT BOT, V88, P160, DOI 10.1016/j.aquabot.2007.10.002; Li M, 2009, ANN APPL BIOL, V154, P43, DOI 10.1111/j.1744-7348.2008.00269.x; MANTEL N, 1967, CANCER RES, V27, P209; MATOH T, 1988, PHYSIOL PLANTARUM, V72, P8, DOI 10.1111/j.1399-3054.1988.tb06615.x; Mauchamp A, 2001, AQUAT BOT, V70, P39, DOI 10.1016/S0304-3770(00)00140-6; McCairns RJS, 2008, MOL ECOL, V17, P3901, DOI 10.1111/j.1365-294X.2008.03884.x; McCormick MK, 2010, WETLANDS, V30, P67, DOI 10.1007/s13157-009-0007-0; MILLIMAN JD, 1983, J GEOL, V91, P1, DOI 10.1086/628741; Nie M, 2010, J HAZARD MATER, V174, P156, DOI 10.1016/j.jhazmat.2009.09.030; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Obbard DJ, 2006, HEREDITY, V97, P296, DOI 10.1038/sj.hdy.6800862; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Parisod C, 2010, ANN BOT-LONDON, V105, P655, DOI 10.1093/aob/mcq014; Paul J, 2011, HYDROBIOLOGIA, V665, P107, DOI 10.1007/s10750-011-0608-5; Pfeifer M, 2006, FOLIA GEOBOT, V41, P3, DOI 10.1007/BF02805258; Pritchard JK, 2000, GENETICS, V155, P945; Richards LA., 1954, DIAGNOSIS IMPROVEMEN; Rohlf F. J., 1998, NTSYS PC NUMERICAL T; Sagnard F, 2011, TREE GENET GENOMES, V7, P37, DOI 10.1007/s11295-010-0313-y; Saltonstall K, 2003, ESTUARIES, V26, P444, DOI 10.1007/BF02823721; Saltonstall K, 2003, MOL ECOL, V12, P1689, DOI 10.1046/j.1365-294X.2003.01849.x; Saltonstall K, 2010, INVAS PLANT SCI MANA, V3, P495, DOI 10.1614/IPSM-09-053.1; Sambatti JBM, 2006, EVOLUTION, V60, P696, DOI 10.1111/j.0014-3820.2006.tb01149.x; Schlotterer C, 2004, P ROY SOC B-BIOL SCI, V271, P869, DOI 10.1098/rspb.2003.2662; Slatkin M, 2012, GENETICS, V191, P171, DOI 10.1534/genetics.112.139022; Spies B., 2005, SALINITY MAPPING MET; Sun JK, 2011, PLANT SOIL ENVIRON, V57, P139, DOI 10.17221/227/2010-PSE; Suzuki RO, 2005, ANN BOT-LONDON, V96, P1009, DOI 10.1093/aob/mci253; TAYLOR CE, 1976, GENETICS, V83, P887; Troupin D, 2006, MOL ECOL, V15, P3617, DOI 10.1111/j.1365-294X.2006.03047.x; Van Dongen S, 1998, HEREDITY, V80, P92, DOI 10.1046/j.1365-2540.1998.00278.x; Vasquez EA, 2006, AM J BOT, V93, P1784, DOI 10.3732/ajb.93.12.1784; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Volis S, 2010, HEREDITY, V105, P384, DOI 10.1038/hdy.2009.168; Wang W., 2007, YELLOW RIVER, V29, p[27, 32]; [王兆印 WANG Zhaoyin], 2006, [泥沙研究, Journal of Sediment Research], P76; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; Williams BL, 2003, MOL ECOL, V12, P11, DOI 10.1046/j.1365-294X.2003.01700.x; Yao RongJiang, 2006, Transactions of the Chinese Society of Agricultural Engineering, V22, P61; Zhang TT, 2010, INT ARCH PHOTOGRAMM, V38, P947; Zhao KF, 1999, ESTUAR COAST SHELF S, V49, P37, DOI 10.1016/S0272-7714(99)80006-7; Zhao Y., 1995, YELLOW RIVER DELTA N	90	21	26	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43334	10.1371/journal.pone.0043334	http://dx.doi.org/10.1371/journal.pone.0043334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916244	Green Published, gold, Green Submitted			2022-12-25	WOS:000307824300040
J	Takarada, T; Kodama, A; Hotta, S; Mieda, M; Shimba, S; Hinoi, E; Yoneda, Y				Takarada, Takeshi; Kodama, Ayumi; Hotta, Shogo; Mieda, Michihiro; Shimba, Shigeki; Hinoi, Eiichi; Yoneda, Yukio			Clock Genes Influence Gene Expression in Growth Plate and Endochondral Ossification in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCADIAN CLOCK; INDIAN HEDGEHOG; CHONDROGENIC DIFFERENTIATION; PROTEIN; KINASE; BMAL1; PROLIFERATION; TRANSCRIPTION; INTERFERENCE; OSCILLATIONS	We have previously shown transient promotion by parathyroid hormone of Period-1 (Per1) expression in cultured chondrocytes. Here we show the modulation by clock genes of chondrogenic differentiation through gene transactivation of the master regulator of chondrogenesis Indian hedgehog (IHH) in chondrocytes of the growth plate. Several clock genes were expressed with oscillatory rhythmicity in cultured chondrocytes and rib growth plate in mice, whereas chondrogenesis was markedly inhibited in stable transfectants of Per1 in chondrocytic ATDC5 cells and in rib growth plate chondrocytes from mice deficient of brain and muscle aryl hydrocarbon receptor nuclear translocator-like (BMAL1). Ihh promoter activity was regulated by different clock gene products, with clear circadian rhythmicity in expression profiles of Ihh in the growth plate. In BMAL1-null mice, a predominant decrease was seen in Ihh expression in the growth plate with a smaller body size than in wild-type mice. BMAL1 deficit led to disruption of the rhythmic expression profiles of both Per1 and Ihh in the growth plate. A clear rhythmicity was seen with Ihh expression in ATDC5 cells exposed to dexamethasone. In young mice defective of BMAL1 exclusively in chondrocytes, similar abnormalities were found in bone growth and Ihh expression. These results suggest that endochondral ossification is under the regulation of particular clock gene products expressed in chondrocytes during postnatal skeletogenesis through a mechanism relevant to the rhythmic Ihh expression.	[Takarada, Takeshi; Kodama, Ayumi; Hotta, Shogo; Hinoi, Eiichi; Yoneda, Yukio] Kanazawa Univ, Grad Sch, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa 9201192, Japan; [Mieda, Michihiro] Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa 9208640, Japan; [Shimba, Shigeki] Nihon Univ, Coll Pharm, Dept Hlth Sci, Chiba 2748555, Japan	Kanazawa University; Kanazawa University; Nihon University	Yoneda, Y (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Mol Pharmacol Lab, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	yyoneda@p.kanazawa-u.ac.jp	Yoneda, Yukio/ABI-1864-2020	Yoneda, Yukio/0000-0002-4624-177X; Takarada, Takeshi/0000-0002-2363-7704; Mieda, Michihiro/0000-0002-2451-7034	Ministry of Education, Culture, Sports, Science and Technology, Japan [20790250]; Foundation of Growth Science, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation of Growth Science, Japan	This work was supported in part by Grant-in-aid for Scientific Research 20790250 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T. T.) and by a Research Grant from Foundation of Growth Science, Japan (to T. T.).	Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262; Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; Deckelbaum RA, 2002, J CELL SCI, V115, P3015; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Hinoi E, 2006, J BIOL CHEM, V281, P23632, DOI 10.1074/jbc.M512362200; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Muhlbauer E, 2004, FEBS LETT, V564, P91, DOI 10.1016/S0014-5793(04)00322-9; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Noonan KJ, 2004, J PEDIATR ORTHOPED, V24, P726, DOI 10.1097/01241398-200411000-00024; Okamura H, 2010, ADV DRUG DELIVER REV, V62, P876, DOI 10.1016/j.addr.2010.06.004; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takarada T, 2008, J CELL PHYSIOL, V215, P320, DOI 10.1002/jcp.21310; Takarada T, 2007, EUR J PHARMACOL, V575, P1, DOI 10.1016/j.ejphar.2007.07.041; Takarada T, 2009, BONE, V45, P568, DOI 10.1016/j.bone.2009.05.004; Takarada T, 2009, J CELL PHYSIOL, V220, P756, DOI 10.1002/jcp.21821; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Yamaguchi S, 2000, CURR BIOL, V10, P873, DOI 10.1016/S0960-9822(00)00602-3; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young ME, 2001, CIRC RES, V89, P1199, DOI 10.1161/hh2401.100741	36	74	77	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36081	36095		10.1074/jbc.M112.408963	http://dx.doi.org/10.1074/jbc.M112.408963			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936800	hybrid, Green Published			2022-12-25	WOS:000310364000030
J	Wen, LB; He, KW; Xiao, Q; Yu, ZY; Mao, AH; Ni, YX; Zhang, XH; Li, B; Wang, XM; Guo, RL; Zhou, JM; Lv, LX; Jiang, JY				Wen, Libin; He, Kongwang; Xiao, Qi; Yu, Zhengyu; Mao, Aihua; Ni, Yanxiu; Zhang, Xuehan; Li, Bin; Wang, Xiaomin; Guo, Rongli; Zhou, Junming; Lv, Lixin; Jiang, Jieyuan			A Novel Porcine Circovirus-Like Agent P1 Is Associated with Wasting Syndromes in Pigs	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; TYPE-2 PCV2; SYNDROME PMWS; EXPERIMENTAL INFECTIONS; NEPHROPATHY SYNDROME; WEANED PIGS; DISEASE; LESIONS; DNA; IDENTIFICATION	A novel porcine pathogen tentatively named P1, which was obtained from the sera of the pigs exhibiting clinical signs of postweaning multisystemic wasting syndrome (PMWS) experimentally caused the classical clinic signs and pathologic lesions of the disease in pigs by direct in vivo injection with P1 DNA plasmids. Twenty colostrum-fed (CF) pigs that were free of PCV2 and P1 at 1 month of age were randomly designated equally to two groups. Group 1 pigs were each injected with 400 mu g of the cloned P1 plasmid DNA into the superficial inguinal lymph nodes and Group 2 were injected with same amount of the empty pSK vector DNA and served as controls. Viremias were positively detected in 8 of 10 P1 infected pigs from 14-21 days post-inoculation (dpi). The 8 infected animals showed pallor of skin and diarrhea. Gross lesions in the pigs euthanized on 35 dpi were similarly characterized by encephalemia, haemorrhage of the bladder mucosa, haemorrhage of the superficial inguinal lymph nodes, lung atrophy and haemorrhage. Histopathological lesions were arteriectasis and telangiectasia of the cavitas subarachnoidealis, interstitial pneumonia, mild atrophy of the cardiac muscle cells, histiocytic hyperplasia of the follicles in the tonsils, and haemorrhage of the inguinal lymph nodes. P1 DNA and antigens were confirmed by PCR and immunohistochemistry in the tissues and organs of the infected pigs, including the pancreas, bladders, testicles/ovaries, brains, lungs and liver. There were no obvious clinical signs and pathological lesions in the control pigs. This study demonstrated that P1 infection is one of the important pathologic agents on pig farms.	[Wen, Libin; He, Kongwang; Xiao, Qi; Yu, Zhengyu; Mao, Aihua; Ni, Yanxiu; Zhang, Xuehan; Li, Bin; Wang, Xiaomin; Guo, Rongli; Zhou, Junming; Lv, Lixin; Jiang, Jieyuan] Jiangsu Acad Agr Sci, Natl Ctr Engn Res Vet Bioprod, Inst Vet Med, Key Lab Vet Biol Engn & Technol,Minist Agr, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Wen, LB (corresponding author), Jiangsu Acad Agr Sci, Natl Ctr Engn Res Vet Bioprod, Inst Vet Med, Key Lab Vet Biol Engn & Technol,Minist Agr, Nanjing, Jiangsu, Peoples R China.	kwh2003@yeah.net			National Natural Science Foundation of China [30972184]; Fund for Independent Innovation of Agricultural Sciences in Jiangsu province [CX(11)2060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for Independent Innovation of Agricultural Sciences in Jiangsu province	This work was supported by a grant from the National Natural Science Foundation of China (30972184) and Fund for Independent Innovation of Agricultural Sciences in Jiangsu province (CX(11)2060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan G, 1998, VET REC, V142, P467; Allan GM, 2004, VET MICROBIOL, V98, P165, DOI 10.1016/j.vetmic.2003.10.009; Allan GM, 1999, J COMP PATHOL, V121, P1, DOI 10.1053/jcpa.1998.0295; Allan GM, 1998, J VET DIAGN INVEST, V10, P3, DOI 10.1177/104063879801000102; ALLAN GM, 1995, VET MICROBIOL, V44, P49, DOI 10.1016/0378-1135(94)00136-K; Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; Balasch M, 1999, J COMP PATHOL, V121, P139, DOI 10.1053/jcpa.1999.0310; Borel N, 2001, SCHWEIZ ARCH TIERH, V143, P249; Celer V, 2002, J VET MED B, V49, P155, DOI 10.1046/j.1439-0450.2002.00547.x; Choi C, 2000, J VET DIAGN INVEST, V12, P151, DOI 10.1177/104063870001200209; DULAC GC, 1989, CAN J VET RES, V53, P431; EDWARDS S, 1994, VET REC, V134, P680, DOI 10.1136/vr.134.26.680; Ellis J, 1998, CAN VET J, V39, P44; Fenaux M, 2002, J VIROL, V76, P541, DOI 10.1128/JVI.76.2.541-551.2002; Hamel AL, 1998, J VIROL, V72, P5262, DOI 10.1128/JVI.72.6.5262-5267.1998; Harding JCS, 1997, SWINE HEALTH PROD, V5, P201; Harding JCS, 1998, SWINE HEALTH PROD, V6, P249; Harms PA, 1999, P 7 ANN IOW SWIN DIS, P43; Hines R. K., 1995, Swine Health and Production, V3, P71; Jemersic L, 2004, RES VET SCI, V77, P171, DOI 10.1016/j.rvsc.2004.04.003; Kennedy S, 1998, VET REC, V142, P495; Kiupel M, 1998, VET PATHOL, V35, P303, DOI 10.1177/030098589803500411; Larochelle R, 1999, VET REC, V145, P140, DOI 10.1136/vr.145.5.140; Lukert P, 1995, VIRUS TAXONOMY, P166; Magar R, 2000, J COMP PATHOL, V123, P258, DOI 10.1053/jcpa.2000.0413; Maldonado J, 2004, J VET MED SCI, V66, P533, DOI 10.1292/jvms.66.533; Mankertz A, 2000, VIRUS RES, V66, P65, DOI 10.1016/S0168-1702(99)00122-7; Mankertz A, 1998, J GEN VIROL, V79, P381, DOI 10.1099/0022-1317-79-2-381; Mankertz A, 1997, J VIROL, V71, P2562, DOI 10.1128/JVI.71.3.2562-2566.1997; Meehan BM, 1998, J GEN VIROL, V79, P2171, DOI 10.1099/0022-1317-79-9-2171; Morozov I, 1998, J CLIN MICROBIOL, V36, P2535, DOI 10.1128/JCM.36.9.2535-2541.1998; Nayar GPS, 1999, CAN VET J, V40, P277; Onuki A, 1999, J VET MED SCI, V61, P1119, DOI 10.1292/jvms.61.1119; Opriessnig T, 2006, VET PATHOL, V43, P281, DOI 10.1354/vp.43-3-281; Pesch S, 2000, P INT PIG VET SOC C, V16, P581; Pogranichnyy RM, 2000, VIRAL IMMUNOL, V13, P143, DOI 10.1089/vim.2000.13.143; Roca M, 2004, J GEN VIROL, V85, P1259, DOI 10.1099/vir.0.79836-0; Rosell C, 2000, VET REC, V146, P40, DOI 10.1136/vr.146.2.40; Saoulidis K, 2002, J VET MED B, V49, P202, DOI 10.1046/j.1439-0450.2002.00480.x; Sarradell J., 2004, Rev. argent. microbiol., V36, P118; Segales J, 2004, VET MICROBIOL, V98, P137, DOI 10.1016/j.vetmic.2003.10.006; Spillane P, 1998, VET REC, V143, P511; Terregino C, 2001, VET REC, V149, P340; THACKER B, 2000, PIG PROG, P16; TISCHER I, 1995, ARCH VIROL, V140, P1427, DOI 10.1007/BF01322669; TISCHER I, 1986, ARCH VIROL, V91, P271, DOI 10.1007/BF01314286; TISCHER I, 1974, ZBL BAKT-INT J MED M, V226, P153; TISCHER I, 1982, NATURE, V295, P64, DOI 10.1038/295064a0; Tomas A, 2008, VET MICROBIOL, V132, P260, DOI 10.1016/j.vetmic.2008.05.023; Toplak I, 2004, VET REC, V155, P178, DOI 10.1136/vr.155.6.178; Wallgren P, 2004, VET QUART, V26, P170, DOI 10.1080/01652176.2004.9695179; Wellenberg GJ, 2000, VET QUART, V22, P167, DOI 10.1080/01652176.2000.9695049; Wen L, 2012, ACTA AGR BOREALI SIN, V27, P42; Wen LB, 2012, J VIROL, V86, P5963, DOI 10.1128/JVI.00494-12; Wen LB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-543; Wen LB, 2012, J VIROL, V86, P639, DOI 10.1128/JVI.06469-11; West KH, 1999, J VET DIAGN INVEST, V11, P530, DOI 10.1177/104063879901100608; Yang Zong-Zhao, 2007, Journal of Zhejiang University-Science B, V8, P162, DOI 10.1631/jzus.2007.B0162	58	26	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e41565	10.1371/journal.pone.0041565	http://dx.doi.org/10.1371/journal.pone.0041565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936978	gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500007
J	Huang, HL; Lee, HY; Tsai, AC; Peng, CY; Lai, MJ; Wang, JC; Pan, SL; Teng, CM; Liou, JP				Huang, Han-Lin; Lee, Hsueh-Yun; Tsai, An-Chi; Peng, Chieh-Yu; Lai, Mei-Jung; Wang, Jing-Chi; Pan, Shiow-Lin; Teng, Che-Ming; Liou, Jing-Ping			Anticancer Activity of MPT0E028, a Novel Potent Histone Deacetylase Inhibitor, in Human Colorectal Cancer HCT116 Cells In Vitro and In Vivo	PLOS ONE			English	Article							MEDIATED APOPTOSIS; HDAC INHIBITORS; LEUKEMIA-CELLS; COLON-CANCER; EXPRESSION; AGENTS; ANGIOGENESIS; THERAPY; ARREST; GROWTH	Recently, histone deacetylase (HDAC) inhibitors have emerged as a promising class of drugs for treatment of cancers, especially subcutaneous T-cell lymphoma. In this study, we demonstrated that MPT0E028, a novel N-hydroxyacrylamide-derived HDAC inhibitor, inhibited human colorectal cancer HCT116 cell growth in vitro and in vivo. The results of NCI-60 screening showed that MPT0E028 inhibited proliferation in both solid and hematological tumor cell lines at micromolar concentrations, and was especially potent in HCT116 cells. MPT0E028 had a stronger apoptotic activity and inhibited HDACs activity more potently than SAHA, the first therapeutic HDAC inhibitor proved by FDA. In vivo murine model, the growth of HCT116 tumor xenograft was delayed and inhibited after treatment with MPT0E028 in a dose-dependent manner. Based on in vivo study, MPT0E028 showed stronger anti-cancer efficacy than SAHA. No significant body weight difference or other adverse effects were observed in both MPT0E028-and SAHA-treated groups. Taken together, our results demonstrate that MPT0E028 has several properties and is potential as a promising anti-cancer therapeutic drug.	[Huang, Han-Lin; Teng, Che-Ming] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Lee, Hsueh-Yun; Lai, Mei-Jung; Liou, Jing-Ping] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan; [Tsai, An-Chi; Wang, Jing-Chi; Pan, Shiow-Lin] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan Town, Miaoli County, Taiwan; [Pan, Shiow-Lin] Taipei Med Univ, Dept Pharmacol, Taipei, Taiwan; [Peng, Chieh-Yu] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan	National Taiwan University; Taipei Medical University; National Health Research Institutes - Taiwan; Taipei Medical University; China Medical University Taiwan	Huang, HL (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	apan0826@nhri.org.tw; cmteng@ntu.edu.tw; jpl@tmu.edu.tw	Pan, Shiow-Lin/C-1372-2010	TENG, CHE-MING/0000-0002-9719-7334	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by a grant from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beumer JH, 2010, CURR CLIN PHARMACOL, V5, P196, DOI 10.2174/157488410791498770; Chang JY, 2006, J MED CHEM, V49, P6656, DOI 10.1021/jm061076u; Chang JY, 2010, MEDCHEMCOMM, V1, P152, DOI 10.1039/c0md00052c; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Darvas K, 2010, INT J CANCER, V127, P1384, DOI 10.1002/ijc.25170; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Hassig CA, 2008, MOL CANCER THER, V7, P1054, DOI 10.1158/1535-7163.MCT-07-2347; Jazirehi AR, 2010, ANTI-CANCER DRUG, V21, P805, DOI 10.1097/CAD.0b013e32833dad91; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Khosravi-Far R, 2007, HISTONE DEACETYLASE, P261; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Martinez-Iglesias O, 2008, CLIN TRANSL ONCOL, V10, P395, DOI 10.1007/s12094-008-0221-x; Nakagawa M, 2007, ONCOL REP, V18, P769; Nishioka C, 2008, LEUKEMIA, V22, P2159, DOI 10.1038/leu.2008.243; Paris M, 2008, J MED CHEM, V51, P1505, DOI 10.1021/jm7011408; Paull K, 1995, CANC CHEMOTHERAPEUTI; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Srivastava RK, 2010, MOL CANCER THER, V9, P3254, DOI 10.1158/1535-7163.MCT-10-0582; Takai N, 2007, CURR MED CHEM, V14, P2548, DOI 10.2174/092986707782023299; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tsapis M, 2007, INT J BIOCHEM CELL B, V39, P1500, DOI 10.1016/j.biocel.2007.03.009; Venugopal B, 2011, CURR MED CHEM, V18, P1658, DOI 10.2174/092986711795471284; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X; Zopf S, 2007, INT J ONCOL, V31, P1391	25	25	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43645	10.1371/journal.pone.0043645	http://dx.doi.org/10.1371/journal.pone.0043645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928010	gold, Green Submitted, Green Published			2022-12-25	WOS:000308286300078
J	Li, SK; Lu, XF; Xue, YP; Lei, JY; Zheng, T; Wang, C				Li, Shangkun; Lu, Xiaofeng; Xue, Yanpeng; Lei, Junyu; Zheng, Tian; Wang, Ce			Fabrication of Polypyrrole/Graphene Oxide Composite Nanosheets and Their Applications for Cr(VI) Removal in Aqueous Solution	PLOS ONE			English	Article							HEXAVALENT CHROMIUM; GRAPHENE; POLYANILINE; REDUCTION; ION; ADSORPTION; SULFATE; GROWTH	In this paper, we report on the simple, reliable synthesis of polypyrrole (PPy)/graphene oxide (GO) composite nanosheets by using sacrificial-template polymerization method. Herein, MnO2 nanoslices were chosen as a sacrificial-template to deposit PPy, which served as the oxidant as well. During the polymerization of pyrrole on surface of GO nanosheets, MnO2 component was consumed incessantly. As a result, the PPy growing on the surface of GO nanosheets has the morphology just like the MnO2 nanoslices. This method can provide the fabrication of PPy nanostructures more easily than conventional route due to its independence of removing template, which usually is a complex and tedious experimental process. The as-prepared PPy/GO composite nanosheets exhibited an enhanced properties for Cr(VI) ions removal in aqueous solution based on the synergy effect. The adsorption capacity of the PPy/GO composite nanosheets is about two times as large as that of conventional PPy nanoparticles. We believe that our findings can open a new and effective avenue to improve the adsorption performance in removing heavy metal ions from waste water.	[Li, Shangkun; Lu, Xiaofeng; Xue, Yanpeng; Lei, Junyu; Zheng, Tian; Wang, Ce] Jilin Univ, Coll Chem, Alan G MacDiarmid Inst, Changchun 130023, Peoples R China	Jilin University	Li, SK (corresponding author), Jilin Univ, Coll Chem, Alan G MacDiarmid Inst, Changchun 130023, Peoples R China.	xflu@jlu.edu.cn		Zheng, Tian/0000-0002-3019-9618; Li, Shangkun/0000-0002-0247-2883	National 973 Project [S2009061009]; National Natural Science Foundation of China [20904015, 50973038]; Jilin Science and Technology Department project [20100101, 201115014]; State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Dong Hua University	National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Science and Technology Department project; State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Dong Hua University	This work was supported by the research grants from the National 973 Project (S2009061009), the National Natural Science Foundation of China (20904015,50973038), Jilin Science and Technology Department project (20100101, 201115014) and State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Dong Hua University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandkumar J, 2009, J HAZARD MATER, V168, P633, DOI 10.1016/j.jhazmat.2009.02.136; Ansari R, 2007, REACT FUNCT POLYM, V67, P367, DOI 10.1016/j.reactfunctpolym.2007.02.001; Bhaumik M, 2012, CHEM ENG J, V181, P323, DOI 10.1016/j.cej.2011.11.088; Bhaumik M, 2011, J HAZARD MATER, V190, P381, DOI 10.1016/j.jhazmat.2011.03.062; Bora C, 2012, POLYMER, V53, P923, DOI 10.1016/j.polymer.2011.12.054; Chen Y, 2007, MATER RES BULL, V42, P1935, DOI 10.1016/j.materresbull.2006.12.005; Cote LJ, 2009, J AM CHEM SOC, V131, P1043, DOI 10.1021/ja806262m; Dai TY, 2006, NANOTECHNOLOGY, V17, P3028, DOI 10.1088/0957-4484/17/12/036; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Golder AK, 2007, SEP SCI TECHNOL, V42, P2177, DOI 10.1080/01496390701446464; Gupta S, 2006, P INT S 59 ANN SESS, P27; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043; Huang LM, 2006, ELECTROCHIM ACTA, V52, P1058, DOI 10.1016/j.electacta.2006.06.040; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Kampalanonwat P, 2010, ACS APPL MATER INTER, V2, P3619, DOI 10.1021/am1008024; Khalil LB, 1998, APPL CATAL B-ENVIRON, V17, P267, DOI 10.1016/S0926-3373(98)00020-4; Konwer S, 2011, J ELECTRON MATER, V40, P2248, DOI 10.1007/s11664-011-1749-z; Kovtyukhova NI, 1992, RUSS J INORG CHEM, V37, P566; Lalvani SB, 1998, CARBON, V36, P1219, DOI 10.1016/S0008-6223(98)00102-X; Lee HT, 2006, J POLYM SCI POL CHEM, V44, P2724, DOI 10.1002/pola.21385; Leonavicius K, 2011, LANGMUIR, V27, P10970, DOI 10.1021/la201962a; Liu AR, 2010, J PHYS CHEM C, V114, P22783, DOI 10.1021/jp108826e; Liu SY, 2012, APPL SURF SCI, V258, P5299, DOI 10.1016/j.apsusc.2012.02.023; Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060; Pugazhenthi G, 2005, J MEMBRANE SCI, V254, P229, DOI 10.1016/j.memsci.2005.01.011; Qin G, 2005, ENVIRON SCI TECHNOL, V39, P6321, DOI 10.1021/es050486p; Rao CNR, 2009, ANGEW CHEM INT EDIT, V48, P7752, DOI 10.1002/anie.200901678; Schmuhl R, 2001, WATER SA, V27, P1; Shchukin DG, 2006, J AM CHEM SOC, V128, P4560, DOI 10.1021/ja061028z; Shevchenko N, 2008, ENVIRON SCI TECHNOL, V42, P6922, DOI 10.1021/es800677b; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Tan CK, 2000, SENSOR ACTUAT B-CHEM, V71, P184, DOI 10.1016/S0925-4005(00)00615-8; TRIVEDI DC, 1993, SYNTHETIC MET, V59, P267, DOI 10.1016/0379-6779(93)91036-2; Wang YQ, 2012, J MATER CHEM, V22, P9034, DOI 10.1039/c2jm30440f; Wang YY, 2005, POLYM ADVAN TECHNOL, V16, P344, DOI 10.1002/pat.589; WEI C, 1993, J ELECTROCHEM SOC, V140, pL60, DOI 10.1149/1.2056247; Wu ZS, 2010, ACS NANO, V4, P5835, DOI 10.1021/nn101754k; Xue YK, 2010, CLIM DYNAM, V35, P1, DOI 10.1007/s00382-010-0831-1; Yang CH, 2007, POLYMER, V48, P3237, DOI 10.1016/j.polymer.2007.04.013; Yao TJ, 2009, J COLLOID INTERF SCI, V338, P573, DOI 10.1016/j.jcis.2009.05.001; Zhang S, 2011, ACS APPL MATER INTER, V3, P3633, DOI 10.1021/am200839m; ZHAO H, 1994, REACT POLYM, V23, P213, DOI 10.1016/0923-1137(94)90023-X; Zhou YF, 2011, WATER AIR SOIL POLL, V215, P631, DOI 10.1007/s11270-010-0505-y	44	114	124	2	225	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43328	10.1371/journal.pone.0043328	http://dx.doi.org/10.1371/journal.pone.0043328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927957	Green Published, gold			2022-12-25	WOS:000308286300042
J	Maeda, A; Leung, MKK; Conroy, L; Chen, YH; Bu, JC; Lindsay, PE; Mintzberg, S; Virtanen, C; Tsao, J; Winegarden, NA; Wang, YC; Morikawa, L; Vitkin, IA; Jaffray, DA; Hill, RP; DaCosta, RS				Maeda, Azusa; Leung, Michael K. K.; Conroy, Leigh; Chen, Yonghong; Bu, Jiachuan; Lindsay, Patricia E.; Mintzberg, Shani; Virtanen, Carl; Tsao, Julissa; Winegarden, Neil A.; Wang, Yanchun; Morikawa, Lily; Vitkin, I. Alex; Jaffray, David A.; Hill, Richard P.; DaCosta, Ralph S.			In Vivo Optical Imaging of Tumor and Microvascular Response to Ionizing Radiation	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; RADIOCHROMIC FILM; BLOOD-VESSELS; ANGIOGENESIS; IRRADIATION; THERAPY; CANCER; MICROENVIRONMENT; RADIOTHERAPY	Radiotherapy is a widely used cancer treatment. However, understanding how ionizing radiation affects tumor cells and their vasculature, particularly at cellular, subcellular, genetic, and protein levels, has been limited by an inability to visualize the response of these interdependent components within solid tumors over time and in vivo. Here we describe a new preclinical experimental platform combining intravital multimodal optical microscopy for cellular-level longitudinal imaging, a small animal x-ray microirradiator for reproducible spatially-localized millimeter-scale irradiations, and laser-capture microdissection of ex vivo tissues for transcriptomic profiling. Using this platform, we have developed new methods that exploit the power of optically-enabled microscopic imaging techniques to reveal the important role of the tumor microvasculature in radiation response of tumors. Furthermore, we demonstrate the potential of this preclinical platform to study quantitatively - with cellular and sub-cellular details - the spatio-temporal dynamics of the biological response of solid tumors to ionizing radiation in vivo.	[Maeda, Azusa; Leung, Michael K. K.; Conroy, Leigh; Chen, Yonghong; Bu, Jiachuan; Mintzberg, Shani; Virtanen, Carl; Tsao, Julissa; Winegarden, Neil A.; Vitkin, I. Alex; Jaffray, David A.; Hill, Richard P.; DaCosta, Ralph S.] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Maeda, Azusa; Leung, Michael K. K.; Conroy, Leigh; Chen, Yonghong; Bu, Jiachuan; Mintzberg, Shani; Virtanen, Carl; Tsao, Julissa; Winegarden, Neil A.; Vitkin, I. Alex; Jaffray, David A.; Hill, Richard P.; DaCosta, Ralph S.] Princess Margaret Hosp, Campbell Family Inst Canc Res, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Maeda, Azusa; Leung, Michael K. K.; Conroy, Leigh; Vitkin, I. Alex; Jaffray, David A.; Hill, Richard P.; DaCosta, Ralph S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Lindsay, Patricia E.; Vitkin, I. Alex; Jaffray, David A.; Hill, Richard P.] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Jaffray, David A.; DaCosta, Ralph S.] STTARR Innovat Ctr, Radiat Med Program, Toronto, ON, Canada; [Mintzberg, Shani; Virtanen, Carl; Tsao, Julissa; Winegarden, Neil A.] Univ Hlth Network Microarray Ctr, Toronto, ON, Canada; [Wang, Yanchun; Morikawa, Lily] Mt Sinai Hosp, Ctr Modelling Human Dis, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Maeda, A (corresponding author), Ontario Canc Inst, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	rdacosta@uhnres.utoronto.ca	Vitkin, Alex/I-8166-2012	Vitkin, Alex/0000-0001-5495-8888; Hill, Richard Peter/0000-0001-5331-8045; Winegarden, Neil/0000-0001-5964-5899; Conroy, Leigh/0000-0003-0055-3660; Jaffray, David/0000-0001-7378-7543	Canadian Institutes of Health Research [192131]; Cancer Care Ontario Research Chair in Cancer Imaging; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Care Ontario Research Chair in Cancer Imaging; Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This work was funded by a Canadian Institutes of Health Research operating grant (#192131) and a Cancer Care Ontario Research Chair in Cancer Imaging to RSD. This research was also funded, in part, by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER D B, 1991, Eye (London), V5, P239; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bussink J, 2000, RADIAT RES, V153, P398, DOI 10.1667/0033-7587(2000)153[0398:CIBPAH]2.0.CO;2; Butson MJ, 2005, PHYS MED BIOL, V50, pN135, DOI 10.1088/0031-9155/50/13/N02; Cairns RA, 2004, CLIN EXP METASTAS, V21, P275, DOI 10.1023/B:CLIN.0000037729.75981.9e; Choi P, 2008, ARCH OTOLARYNGOL, V134, P539, DOI 10.1001/archotol.134.5.539; Clarkson R, 2011, MED PHYS, V38, P845, DOI 10.1118/1.3533947; Devic S, 2005, MED PHYS, V32, P2245, DOI 10.1118/1.1929253; di Tomaso E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005123; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gaugler M-H, 2005, BRIT J RADIOL, V78, P100, DOI [10.1259/bjr/24511652, DOI 10.1259/BJR/24511652]; Gaugler MH, 2004, J THROMB HAEMOST, V2, P2020, DOI 10.1111/j.1538-7836.2004.00951.x; Gervaz P, 2009, CURR MOL MED, V9, P273, DOI 10.2174/156652409787847164; Hayashi T, 2008, PFLUG ARCH EUR J PHY, V456, P1239, DOI 10.1007/s00424-008-0466-9; HERMAN IM, 1985, J CELL BIOL, V101, P43, DOI 10.1083/jcb.101.1.43; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Kawamoto A, 2012, ONCOL REP, V27, P51, DOI 10.3892/or.2011.1485; Kim DWN, 2006, J ULTRAS MED, V25, P1507, DOI 10.7863/jum.2006.25.12.1507; Kufe D, 2003, CANCER BIOL THER, V2, P326, DOI 10.4161/cbt.2.4.495; Li ML, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-5; Manti L, 2010, MUTAT RES-REV MUTAT, V704, P115, DOI 10.1016/j.mrrev.2010.03.005; Mariampillai A, 2008, OPT LETT, V33, P1530, DOI 10.1364/OL.33.001530; Mariampillai A, 2010, OPT LETT, V35, P1257, DOI 10.1364/OL.35.001257; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Mounzer RH, 2010, BLOOD, V116, P2173, DOI 10.1182/blood-2009-12-256065; Mouthon MA, 2003, RADIAT RES, V160, P593, DOI 10.1667/3068; O'Reilly MS, 2006, SEMIN RADIAT ONCOL, V16, P45, DOI 10.1016/j.semradonc.2005.08.006; OWEN JB, 1992, INT J RADIAT ONCOL, V24, P983, DOI 10.1016/0360-3016(92)90483-X; Quarmby S, 1999, INT J CANCER, V82, P385, DOI 10.1002/(SICI)1097-0215(19990730)82:3<385::AID-IJC12>3.0.CO;2-5; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rink A, 2005, MED PHYS, V32, P2510, DOI 10.1118/1.1951447; Sabatasso S, 2011, INT J RADIAT ONCOL, V80, P1522, DOI 10.1016/j.ijrobp.2011.03.018; Sckell A, 2001, METH MOLEC MED, V46, P95, DOI 10.1385/1-59259-143-4:095; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Shiao SL, 2010, J MAMMARY GLAND BIOL, V15, P411, DOI 10.1007/s10911-010-9194-9; Sonveaux P, 2003, CANCER RES, V63, P1012; Timke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-134; Tipton K, 2011, ANN INTERN MED, V154, P737, DOI 10.7326/0003-4819-154-11-201106070-00343; Tsai JH, 2005, CANCER BIOL THER, V4, P1395, DOI 10.4161/cbt.4.12.2331; Tsukamoto H, 2007, GYNECOL ONCOL, V107, P500, DOI 10.1016/j.ygyno.2007.08.058; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971; VERHEIJ M, 1994, RADIAT RES, V137, P202, DOI 10.2307/3578813; Wachsberger P, 2003, CLIN CANCER RES, V9, P1957; Wang JR, 2007, WORLD J GASTROENTERO, V13, P3047, DOI 10.3748/wjg.v13.i22.3047; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Zheng HC, 2006, ANTICANCER RES, V26, P3579	55	38	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42133	10.1371/journal.pone.0042133	http://dx.doi.org/10.1371/journal.pone.0042133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927920	Green Submitted, gold, Green Published			2022-12-25	WOS:000308286300017
J	Shuo, T; Koshikawa, N; Hoshino, D; Minegishi, T; Ao-Kondo, H; Oyama, M; Sekiya, S; Iwamoto, S; Tanaka, K; Seiki, M				Shuo, Takuya; Koshikawa, Naohiko; Hoshino, Daisuke; Minegishi, Tomoko; Ao-Kondo, Hiroko; Oyama, Masaaki; Sekiya, Sadanori; Iwamoto, Shinichi; Tanaka, Koichi; Seiki, Motoharu			Detection of the Heterogeneous O-Glycosylation Profile of MT1-MMP Expressed in Cancer Cells by a Simple MALDI-MS Method	PLOS ONE			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; MASS-SPECTROMETRY; MEMBRANE; PROTEINS; GLYCANS; SURFACE; COLON; DRUG	Background: Glycosylation is an important and universal post-translational modification for many proteins, and regulates protein functions. However, simple and rapid methods to analyze glycans on individual proteins have not been available until recently. Methods/Principal Findings: A new technique to analyze glycopeptides in a highly sensitive manner by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) using the liquid matrix 3AQ/CHCA was developed recently and we optimized this technique to analyze a small amount of transmembrane protein separated by SDS-PAGE. We used the MALDI-MS method to evaluate glycosylation status of membrane-type 1 matrix metalloproteinase (MT1-MMP). O-glycosylation of MT1-MMP is reported to modulate its protease activity and thereby to affect cancer cell invasion. MT1-MMP expressed in human fibrosarcoma HT1080 cells was immunoprecipitated and resolved by SDS-PAGE. After in-gel tryptic digestion of the protein, a single droplet of the digest was applied directly to the liquid matrix on a MALDI target plate. Concentration of hydrophilic glycopeptides within the central area occurred due to gradual evaporation of the sample solution, whereas nonglycosylated hydrophobic peptides remained at the periphery. This specific separation and concentration of the glycopeptides enabled comprehensive analysis of the MT1-MMP O-glycosylation. Conclusions/Significance: We demonstrate, for the first time, heterogeneous O-glycosylation profile of a protein by a whole protein analysis using MALDI-MS. Since cancer cells are reported to have altered glycosylation of proteins, this easy-to-use method for glycopeptide analysis opens up the possibility to identify specific glycosylation patterns of proteins that can be used as new biomarkers for malignant tumors.	[Shuo, Takuya; Koshikawa, Naohiko; Hoshino, Daisuke; Minegishi, Tomoko; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan; [Ao-Kondo, Hiroko; Oyama, Masaaki] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan; [Sekiya, Sadanori; Iwamoto, Shinichi; Tanaka, Koichi] Shimadzu Co Ltd, Koichi Tanaka Mass Spectrometry Res Lab, Nakagyo Ku, Kyoto, Japan	University of Tokyo; University of Tokyo; Shimadzu Corporation	Shuo, T (corresponding author), Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan.	mseiki@ims.u-tokyo.ac.jp	Sekiya, Sadanori/AAT-9089-2021; Seiki, Motoharu/K-9443-2015; Koshikawa, Naohiko/S-7306-2017	Koshikawa, Naohiko/0000-0002-4539-888X; Oyama, Masaaki/0000-0001-6478-3735	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22700375, 22220014]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Young Scientists (B) [22700375] (to TS), a Grant-in-Aid for Scientific Research (S) [22220014] (to MS) and Global COE Program "Center of Education and Research for the Advanced Genome - Based Medicine - For personalized medicine and the control of worldwide infectious diseases'' (to TS and MS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HJ, 2009, CURR OPIN CHEM BIOL, V13, P421, DOI 10.1016/j.cbpa.2009.07.022; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Itoh Y, 1999, J BIOL CHEM, V274, P34260, DOI 10.1074/jbc.274.48.34260; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Iwai T, 2005, P NATL ACAD SCI USA, V102, P4572, DOI 10.1073/pnas.0407983102; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kim S, 2010, BBA-MOL CELL RES, V1803, P1287, DOI 10.1016/j.bbamcr.2010.06.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu CH, 2011, J PHARMACEUT BIOMED, V54, P27, DOI 10.1016/j.jpba.2010.07.044; Ludwig T, 2008, J BIOL CHEM, V283, P35410, DOI 10.1074/jbc.M801816200; North SJ, 2009, CURR OPIN STRUC BIOL, V19, P498, DOI 10.1016/j.sbi.2009.05.005; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Remacle AG, 2006, J BIOL CHEM, V281, P16897, DOI 10.1074/jbc.M600295200; Rozanov DV, 2004, J BIOL CHEM, V279, P46551, DOI 10.1074/jbc.M405284200; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sekiya S, 2012, RAPID COMMUN MASS SP, V26, P693, DOI 10.1002/rcm.6148; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STAHL B, 1991, ANAL CHEM, V63, P1463, DOI 10.1021/ac00014a022; Tanaka K, 1988, RAPID COMMUN MASS SP, V2, P151, DOI [10.1002/RCM.1290020802, DOI 10.1002/RCM.1290020802, 10.1002/rcm.1290020802]; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Wada Y, 2010, MOL CELL PROTEOMICS, V9, P719, DOI 10.1074/mcp.M900450-MCP200; Wu YI, 2004, J BIOL CHEM, V279, P8278, DOI 10.1074/jbc.M311870200	27	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43751	10.1371/journal.pone.0043751	http://dx.doi.org/10.1371/journal.pone.0043751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928028	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300086
J	Thi, EP; Lambertz, U; Reiner, NE				Thi, Emily P.; Lambertz, Ulrike; Reiner, Neil E.			Class IA Phosphatidylinositol 3-Kinase p110 alpha Regulates Phagosome Maturation	PLOS ONE			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; MYCOBACTERIUM-TUBERCULOSIS PHAGOSOME; HOPS TETHERING COMPLEX; RAB5 EFFECTOR EEA1; HUMAN MACROPHAGES; MEMBRANE-FUSION; CATHEPSIN-D; LYSOSOMAL PROTEINS; ENDOCYTIC PATHWAY; ENDOSOME FUSION	Of the various phosphatidylinositol 3- kinases (PI3Ks), only the class III enzyme Vps34 has been shown to regulate phagosome maturation. During studies of phagosome maturation in THP-1 cells deficient in class IA PI3K p110 alpha, we discovered that this PI3K isoform is required for vacuole maturation to progress beyond acquisition of Rab7 leading to delivery of lysosomal markers. Bead phagosomes from THP-1 cells acquired p110 alpha and contained PI3P and PI(3,4,5) P3; however, p110 alpha and PI(3,4,5) P3 levels in phagosomes from p110 alpha knockdown cells were decreased. Phagosomes from p110 alpha knock down cells showed normal acquisition of both Rab5 and EEA-1, but were markedly deficient in the lysosomal markers LAMP-1 and LAMP-2, and the lysosomal hydrolase, beta-galactosidase. Phagosomes from p110 alpha deficient cells also displayed impaired fusion with Texas Red dextran-loaded lysosomes. Despite lacking lysosomal components, phagosomes from p110 alpha deficient cells recruited normal levels of Rab7, Rab-interacting lysosomal protein (RILP) and homotypic vacuole fusion and protein sorting (HOPs) components Vps41 and Vps16. The latter observations demonstrated that phagosomal Rab7 was active and capable of recruiting effectors involved in membrane fusion. Nevertheless, active Rab7 was not sufficient to bring about the delivery of lysosomal proteins to the maturing vacuole, which is shown for the first time to be dependent on a class I PI3K.	[Thi, Emily P.; Lambertz, Ulrike; Reiner, Neil E.] Univ British Columbia, Dept Med, Expt Med Program, Div Infect Dis, Vancouver, BC, Canada; [Thi, Emily P.; Lambertz, Ulrike; Reiner, Neil E.] Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC, Canada	University of British Columbia; Vancouver Coastal Health Research Institute	Thi, EP (corresponding author), Univ British Columbia, Dept Med, Expt Med Program, Div Infect Dis, Vancouver, BC, Canada.	ethan@mail.ubc.ca			Canadian Institutes of Health Research [MOP-84582]; Canada Graduate Scholarship Doctoral Award [CGD-87892]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Graduate Scholarship Doctoral Award	Funding provided by a Canadian Institutes of Health Research grant (MOP-84582) to N.R. and a Canada Graduate Scholarship Doctoral Award (CGD-87892) to E.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999; Atlashkin V, 2003, MOL CELL BIOL, V23, P5198, DOI 10.1128/MCB.23.15.5198-5207.2003; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; BERMUDEZ LE, 1991, INFECT IMMUN, V59, P1697, DOI 10.1128/IAI.59.5.1697-1702.1991; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Bohdanowicz M, 2010, J CELL BIOL, V191, P999, DOI 10.1083/jcb.201004005; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Bringer MA, 2006, CELL MICROBIOL, V8, P471, DOI 10.1111/j.1462-5822.2005.00639.x; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Clague MJ, 2009, EXP CELL RES, V315, P1627, DOI 10.1016/j.yexcr.2008.10.005; Clague MJ, 1999, BIOCHEM SOC T, V27, P662, DOI 10.1042/bst0270662; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; Falasca M, 2009, BBA-MOL CELL RES, V1793, P1795, DOI 10.1016/j.bbamcr.2009.10.003; Fortier A, 2007, CELL MICROBIOL, V9, P910, DOI 10.1111/j.1462-5822.2006.00839.x; Fratti RA, 2002, J BIOL CHEM, V277, P17320, DOI 10.1074/jbc.M200335200; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; GIESELMANN V, 1985, J BIOL CHEM, V260, P3215; Hmama Z, 2004, J CELL SCI, V117, P2131, DOI 10.1242/jcs.01072; Hoffmann E, 2010, EUR J CELL BIOL, V89, P693, DOI 10.1016/j.ejcb.2010.04.006; Howe D, 2010, INFECT IMMUN, V78, P3465, DOI 10.1128/IAI.00406-10; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Huynh KK, 2008, J BIOL CHEM, V283, P35745, DOI 10.1074/jbc.M806232200; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Jovic M, 2009, MOL BIOL CELL, V20, P2731, DOI 10.1091/mbc.E08-11-1102; Karlsson K, 1998, J BIOL CHEM, V273, P18966, DOI 10.1074/jbc.273.30.18966; KOSTER A, 1993, EMBO J, V12, P5219, DOI 10.1002/j.1460-2075.1993.tb06217.x; Laage R, 2001, MOL BIOL CELL, V12, P3375, DOI 10.1091/mbc.12.11.3375; LaGrassa TJ, 2005, J CELL BIOL, V168, P401, DOI 10.1083/jcb.200407141; Lawe DC, 2003, MOL BIOL CELL, V14, P2935, DOI 10.1091/mbc.E02-09-0591; Lee JS, 2004, J BIOL CHEM, V279, P9379, DOI 10.1074/jbc.M310638200; Lu L, 2009, BIOSCIENCE REP, V29, P261, DOI 10.1042/BSR20090043; LUDWIG T, 1994, EMBO J, V13, P3430, DOI 10.1002/j.1460-2075.1994.tb06648.x; LUKACS GL, 1992, J BIOL CHEM, V267, P14568; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2009, BIOCHEM SOC T, V37, P1019, DOI 10.1042/BST0371019; Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; Malik ZA, 2001, J IMMUNOL, V166, P3392, DOI 10.4049/jimmunol.166.5.3392; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Mills IG, 2001, J CELL SCI, V114, P1959; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; POHLMANN R, 1995, J BIOL CHEM, V270, P27311, DOI 10.1074/jbc.270.45.27311; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Purdy GE, 2005, CELL MICROBIOL, V7, P1627, DOI 10.1111/j.1462-5822.2005.00580.x; Robinson N, 2008, TRAFFIC, V9, P1936, DOI 10.1111/j.1600-0854.2008.00804.x; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Seeger EM, 2010, FEMS MICROBIOL LETT, V307, P113, DOI 10.1111/j.1574-6968.2010.01976.x; Seto S, 2011, TRAFFIC; Seto S, 2009, BIOCHEM BIOPH RES CO, V387, P272, DOI 10.1016/j.bbrc.2009.06.152; Shaw JD, 2003, TRAFFIC, V4, P479, DOI 10.1034/j.1600-0854.2003.t01-1-00106.x; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; STOKES RW, 1993, J IMMUNOL, V151, P7067; Sun Jim, 2009, V531, P57, DOI 10.1007/978-1-59745-396-7_5; Tsang AW, 2000, J LEUKOCYTE BIOL, V68, P487; Ullrich HJ, 1999, EUR J CELL BIOL, V78, P739, DOI 10.1016/S0171-9335(99)80042-9; Utermoehlen O, 2010, INNATE IMMUN; Verhage M, 2009, P NATL ACAD SCI USA, V106, P19745, DOI 10.1073/pnas.0911425106; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Villeneuve C, 2005, J LIPID RES, V46, P475, DOI 10.1194/jlr.M400308-JLR200; Vinet AF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000628; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/NCHEMBIO.386, 10.1038/nchembio.386]; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Xu H, 2010, J BIOL CHEM; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099	92	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43668	10.1371/journal.pone.0043668	http://dx.doi.org/10.1371/journal.pone.0043668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928013	Green Submitted, Green Published, gold			2022-12-25	WOS:000308286300079
J	Uyeki, TM; Nguyen, DC; Rowe, T; Lu, XH; Hu-Primmer, J; Huynh, LP; Hang, NLK; Katz, JM				Uyeki, Timothy M.; Nguyen, Doan C.; Rowe, Thomas; Lu, Xiuhua; Hu-Primmer, Jean; Huynh, Lien P.; Hang, Nguyen L. K.; Katz, Jacqueline M.			Seroprevalence of Antibodies to Avian Influenza A (H5) and A (H9) Viruses among Market Poultry Workers, Hanoi, Vietnam, 2001	PLOS ONE			English	Article							HIGHLY PATHOGENIC H5N1; HONG-KONG; HUMAN INFECTION; RISK-FACTORS; CHINA; ILLNESS; VACCINE	Background: The frequency of avian influenza A virus infections among poultry workers is not well understood. Methods: A seroprevalence study of market poultry workers and persons without occupational poultry exposure was conducted during 2001 in Hanoi, Vietnam. Sera were tested for avian influenza H5 and H9 antibodies by microneutralization and Western blot assays. Results: Seroprevalence of H5 and H9 antibodies was 4% and 3% in poultry workers and 1% and 3.5% in non-poultry workers, respectively. Conclusions: Seroprevalence of H5 and H9 antibodies was low among Hanoi market poultry workers in 2001, but can serve as a baseline for additional studies.	[Uyeki, Timothy M.; Rowe, Thomas; Lu, Xiuhua; Hu-Primmer, Jean; Katz, Jacqueline M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA; [Nguyen, Doan C.; Huynh, Lien P.; Hang, Nguyen L. K.] Natl Inst Hyg & Epidemiol, Dept Virol, Minist Hlth, Hanoi, Vietnam	Centers for Disease Control & Prevention - USA; National Institute of Hygiene & Epidemiology (NIHE)	Uyeki, TM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA.	tuyeki@cdc.gov	Rowe, Thomas/AAW-4899-2020		Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Centers for Disease Control and Prevention (CDC). CDC staff were involved in study design, data collection and analysis, preparation of the manuscript, and decision to publish. No other external funding was received.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P93; Atmar RL, 2011, VACCINE, V29, P8066, DOI 10.1016/j.vaccine.2011.08.044; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Buchy P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010864; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Chen Y, 2011, CLIN MICROBIOL INFEC, V17, P1347, DOI 10.1111/j.1469-0691.2011.03538.x; Cheng VCC, 2011, J INFECTION, V62, P394, DOI 10.1016/j.jinf.2011.02.007; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; FAO Food and Agriculture Organization of the United Nations, 2011, APPR CONTR PREV EL H; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Hadipour MM, 2011, ASIAN J ANIM VET ADV, V6, P196, DOI 10.3923/ajava.2011.196.200; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Li Chuan-hua, 2004, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V18, P213; Liu Yang, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1111; Lu CT, 2008, INT J ARTIF INTELL T, V17, P1; Nguyen DC, 2005, J VIROL, V79, P4201, DOI 10.1128/JVI.79.7.4201-4212.2005; Pawar SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036374; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Shinya K, 2005, J VIROL, V79, P9926, DOI 10.1128/JVI.79.15.9926-9932.2005; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Uyeki TM, 2002, EMERG INFECT DIS, V8, P154, DOI 10.3201/eid0802.010148; Wan XF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003462; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; *WHO, 2006, WHO CAS DEF HUM INF; WHO, 2012, CUM NUMB CONF HUM CA; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206	29	55	58	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43948	10.1371/journal.pone.0043948	http://dx.doi.org/10.1371/journal.pone.0043948			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928049	Green Published, gold, Green Submitted			2022-12-25	WOS:000307789700054
J	Chabot, AA; Hobson, KA; Van Wilgenburg, SL; McQuat, GJ; Lougheed, SC				Chabot, Amy A.; Hobson, Keith A.; Van Wilgenburg, Steven L.; McQuat, Gregory J.; Lougheed, Stephen C.			Advances in Linking Wintering Migrant Birds to Their Breeding-Ground Origins Using Combined Analyses of Genetic and Stable Isotope Markers	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION ANALYSIS; DELTA-D; NEOTROPICAL MIGRANT; MITOCHONDRIAL-DNA; MICROSATELLITE VARIATION; POPULATION-STRUCTURE; DISPERSAL DISTANCES; NORTHERN PINTAIL; MIGRATORY BIRDS; NATAL DISPERSAL	An enduring problem in avian ecology and conservation is linking breeding and wintering grounds of migratory species. As migratory species and populations vary in the degree to which individuals from distinct breeding locales mix on stop-over sites and wintering grounds, establishing migratory connectivity informs our understanding of population demography and species management. We present a new Bayesian approach for inferring breeding grounds of wintering birds of unknown origins in North America. We incorporate prior information from analysis of genetic markers into geographic origin assignment based upon stable-hydrogen isotope analysis of feathers (delta H-2(f)), using the Loggerhead Shrike (Lanius ludovicianus). Likely geographic origins derived from analyses of DNA microsatellites were used as priors for Bayesian analyses in which birds were assigned to a breeding-ground origin using their delta H-2(f) values. As with most applications of Bayesian methods, our approach greatly improved the results (i.e. decreased the size of the potential area of origin). Area of origin decreased by 3 to 5-fold on average, but ranged up to a 10-fold improvement. We recommend this approach in future studies of migratory connectivity and suggest that our methodology could be applied more broadly to the study of dispersal, sources of productivity of migratory populations, and a range of evolutionary phenomena.	[Chabot, Amy A.; Lougheed, Stephen C.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Hobson, Keith A.; Van Wilgenburg, Steven L.] Environm Canada, Saskatoon, SK, Canada; [McQuat, Gregory J.] Queens Univ, Dept Geog, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Environment & Climate Change Canada; Queens University - Canada	Chabot, AA (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	steve.lougheed@queensu.ca	Hobson, Keith/Q-9306-2019	Van Wilgenburg, Steven/0000-0002-6742-4567	Environment Canada's Canadian Wildlife Service, Environment Canada's Strategic Technologies Application of Genomics in the Environment Research Fund; Endangered Species Recovery Fund through the World Wildlife Fund of Canada; Interdepartmental Recovery Fund; Natural Sciences and Engineering Research Council; Ontario Ministry of Training, Colleges and Universities (Ontario Graduate Scholarship); Queen's University (Duncan and Urlla Carmichael Fellowship); Wildlife Preservation Canada	Environment Canada's Canadian Wildlife Service, Environment Canada's Strategic Technologies Application of Genomics in the Environment Research Fund; Endangered Species Recovery Fund through the World Wildlife Fund of Canada; Interdepartmental Recovery Fund; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Training, Colleges and Universities (Ontario Graduate Scholarship); Queen's University (Duncan and Urlla Carmichael Fellowship); Wildlife Preservation Canada	Funding was provided by Environment Canada's Canadian Wildlife Service, Environment Canada's Strategic Technologies Application of Genomics in the Environment Research Fund, the Endangered Species Recovery Fund through the World Wildlife Fund of Canada, the Interdepartmental Recovery Fund, the Natural Sciences and Engineering Research Council (grant to Lougheed and Post Graduate Scholarship to Chabot), the Ontario Ministry of Training, Colleges and Universities (Ontario Graduate Scholarship to Chabot), Queen's University (Duncan and Urlla Carmichael Fellowship to Chabot) and Wildlife Preservation Canada. Additional funding for stable isotope work was provided by an operating grant to Hobson by Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley P, 2010, AVIAN CONSERV ECOL, V5; Avise J.C., 2004, MOL MARKERS NATURAL; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Bairlein F, 2001, ARDEA, V89, P7; Barr KR, 2008, MOL ECOL, V17, P3628, DOI 10.1111/j.1365-294X.2008.03868.x; BERLANGA H., 2010, SAVING OUR SHARED BI; Bock CE, 2004, FRONT ECOL ENVIRON, V2, P403, DOI 10.2307/3868428; Boulet Marylene, 2006, Ornithological Monographs, V61, P29, DOI 10.1642/0078-6594(2006)61[29:IAOGSI]2.0.CO;2; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Brawn JD, 1996, CONDOR, V98, P547; Brewer AD, 2000, CANADIAN ATLAS BIRDS, V1; Bulgin NL, 2003, MOL ECOL, V12, P831, DOI 10.1046/j.1365-294X.2003.01774.x; Chabot AA, 2011, THESIS QUEENS U; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Clark RG, 2006, CAN J ZOOL, V84, P1395, DOI 10.1139/Z06-135; Clegg SM, 2003, MOL ECOL, V12, P819, DOI 10.1046/j.1365-294X.2003.01757.x; Coulton DW, 2010, WATERBIRDS, V33, P10, DOI 10.1675/063.033.0102; Coxon A, 2011, CONSERV GENET RESOUR, V4, P503; Craig Susan H., 1997, North American Bird Bander, V22, P124; Esler D, 2000, CONSERV BIOL, V14, P366, DOI 10.1046/j.1523-1739.2000.98147.x; Faaborg J, 2010, ECOL APPL, V20, P398, DOI 10.1890/09-0397.1; Gibbs HL, 2000, MOL ECOL, V9, P2137, DOI 10.1046/j.1365-294X.2000.01136.x; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Grimmer J, 2010, POLIT ANAL, V18, P1, DOI [10.1093/pan/mpp034, 10.1093/pan/mpq027]; Gunnarsson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035679; HANSKI I, 1997, METAPOPULATION BIOL; Hansson B, 2000, MOL ECOL, V9, P1529, DOI 10.1046/j.1365-294x.2000.01028.x; Hebert CE, 2005, WILDLIFE SOC B, V33, P92, DOI 10.2193/0091-7648(2005)33[92:FSIIWN]2.0.CO;2; Henaux V, 2011, METHODS ECOL EVOL, V2, P489, DOI 10.1111/j.2041-210X.2011.00107.x; Hijmans R. J., 2011, GEOGRAPHIC ANAL MODE; Hobson KA, 2005, DIVERS DISTRIB, V11, P157, DOI 10.1111/j.1366-9516.2005.00149.x; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 2008, TERR ECOL SER, V2, P45, DOI 10.1016/S1936-7961(07)00003-6; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hobson KA, 2009, J RAPTOR RES, V43, P325, DOI 10.3356/JRR-08-74.1; Hobson KA, 2009, J GEOCHEM EXPLOR, V102, P63, DOI 10.1016/j.gexplo.2009.02.002; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Howell S. N, 1997, IDENTIFICATION GUIDE; Kelly JF, 2005, ECOL APPL, V15, P1487, DOI 10.1890/04-1704; Kimura M, 2002, MOL ECOL, V11, P1605, DOI 10.1046/j.1365-294X.2002.01551.x; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Losos JB, 1997, NATURE, V387, P70, DOI 10.1038/387070a0; Lott CA, 2006, AUK, V123, P822, DOI 10.1642/0004-8038(2006)123[822:AGATET]2.0.CO;2; Lovette IJ, 2004, CONSERV BIOL, V18, P156, DOI 10.1111/j.1523-1739.2004.00239.x; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; MILLER ALDEN H., 1928, UNIV CALIFORNIA PUBL ZOOL, V30, P393; Mundy NI, 1997, P ROY SOC B-BIOL SCI, V264, P869, DOI 10.1098/rspb.1997.0121; Norris D. Ryan, 2006, Ornithological Monographs, V61, P14; Oyler-McCance SJ, 2007, CONSERV GENET, V8, P1339, DOI 10.1007/s10592-006-9282-y; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Pearce JM, 2000, J WILDLIFE MANAGE, V64, P863, DOI 10.2307/3802757; Perez GE, 2006, THESIS U SASKATCHEWA; Perez GE, 2006, CONDOR, V108, P877, DOI 10.1650/0010-5422(2006)108[877:IEOIMI]2.0.CO;2; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2022, R LANG ENV STAT COMP; Ramos MA, 1980, MIGRANT BIRDS NEOTRO; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; RICH T, 2006, BIRDING, V38, P30; Royle JA, 2004, ECOL APPL, V14, P1780; Ruegg KC, 2002, P ROY SOC B-BIOL SCI, V269, P1375, DOI 10.1098/rspb.2002.2032; Smith Thomas B., 2005, P222; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; TAYLOR LR, 1977, NATURE, V265, P415, DOI 10.1038/265415a0; Temple HJ, 2006, MOL ECOL, V15, P3449, DOI 10.1111/j.1365-294X.2006.03006.x; Tiedemann R, 2004, MOL ECOL, V13, P1481, DOI 10.1111/j.1365-294X.2004.02168.x; Tsuji Y, 2009, J CLIN PHARM THER, V34, P465, DOI 10.1111/j.1365-2710.2008.01015.x; Van Wilgenburg Steven L., 2012, Endangered Species Research, V16, P17, DOI 10.3354/esr00383; Van Wilgenburg SL, 2011, ECOL APPL, V21, P1340, DOI 10.1890/09-2047.1; VICKERY PD, 1992, AUK, V109, P706, DOI 10.2307/4088146; Walters JR, 2000, CONDOR, V102, P479, DOI 10.1650/0010-5422(2000)102[0479:DBAOF]2.0.CO;2; Wassenaar L. I., 2003, ISOT ENVIRON HEALT S, V39, P1; Wassenaar LI, 2008, TERR ECOL SER, V2, P21, DOI 10.1016/S1936-7961(07)00002-4; Webster Michael S., 2005, P199; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wenink PW, 1996, AUK, V113, P744, DOI 10.2307/4088854; Wennerberg L, 2001, MOL ECOL, V10, P1111, DOI 10.1046/j.1365-294X.2001.01256.x; Wilson GA, 2003, GENETICS, V163, P1177; Winkler DW, 2005, J ANIM ECOL, V74, P1080, DOI 10.1111/j.1365-2656.2005.01007.x; WRIGHT S, 1946, GENETICS, V31, P39; Wright S, 1943, GENETICS, V28, P114; Wunder WB, 2009, UNDERSTANDING MOVEME; Zhan XW, 2006, IEEE T GEOSCI REMOTE, V44, P1534, DOI 10.1109/TGRS.2005.863319; Zhou HF, 2008, STAT MED, V27, P5907, DOI 10.1002/sim.3409	87	58	63	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43627	10.1371/journal.pone.0043627	http://dx.doi.org/10.1371/journal.pone.0043627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916285	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800084
J	Iyer, P; Lalane, R; Morris, C; Challa, P; Vann, R; Rao, PV				Iyer, Padma; Lalane, Robert, III; Morris, Corey; Challa, Pratap; Vann, Robin; Rao, Ponugoti Vasantha			Autotaxin-Lysophosphatidic Acid Axis Is a Novel Molecular Target for Lowering Intraocular Pressure	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INCREASES OUTFLOW RESISTANCE; HUMAN AQUEOUS-HUMOR; TRABECULAR MESHWORK; EXTRACELLULAR-MATRIX; LYSOPHOSPHOLIPASE-D; INCREASED LEVEL; EYES; MODULATION; FACILITY	Primary open-angle glaucoma is the second leading cause of blindness in the United States and is commonly associated with elevated intraocular pressure (IOP) resulting from diminished aqueous humor (AH) drainage through the trabecular pathway. Developing effective therapies for increased IOP in glaucoma patients requires identification and characterization of molecular mechanisms that regulate IOP and AH outflow. This study describes the identification and role of autotaxin (ATX), a secretory protein and a major source for extracellular lysophosphatidic acid (LPA), in regulation of IOP in a rabbit model. Quantitative proteomics analysis identified ATX as an abundant protein in both human AH derived from non-glaucoma subjects and in AH from different animal species. The lysophospholipase D (LysoPLD) activity of ATX was found to be significantly elevated (by similar to 1.8 fold; n = 20) in AH derived from human primary open angle glaucoma patients as compared to AH derived from age-matched cataract control patients. Immunoblotting analysis of conditioned media derived from primary cultures of human trabecular meshwork (HTM) cells has confirmed secretion of ATX and the ability of cyclic mechanical stretch of TM cells to increase the levels of secreted ATX. Topical application of a small molecular chemical inhibitor of ATX (S32826), which inhibited AH LysoPLD activity in vitro (by >90%), led to a dose-dependent and significant decrease of IOP in Dutch-Belted rabbits. Single intracameral injection of S32826 (similar to 2 mu M) led to significant reduction of IOP in rabbits, with the ocular hypotensive response lasting for more than 48 hrs. Suppression of ATX expression in HTM cells using small-interfering RNA (siRNA) caused a decrease in actin stress fibers and myosin light chain phosphorylation. Collectively, these observations indicate that the ATX-LPA axis represents a potential therapeutic target for lowering IOP in glaucoma patients.	[Iyer, Padma; Lalane, Robert, III; Morris, Corey; Challa, Pratap; Vann, Robin; Rao, Ponugoti Vasantha] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27710 USA; [Rao, Ponugoti Vasantha] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA	Duke University; Duke University	Iyer, P (corresponding author), Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27710 USA.	rao00011@mc.duke.edu	Vann, Robin/AAU-7051-2020	Vann, Robin/0000-0002-8209-4746	National Eye Institute, National Institutes of Health [RO1 EY18950, EY18950]	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, National Institutes of Health grants RO1 EY18950 and EY18950 ARRA stimulus supplement to PVR. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Chowdhury UR, 2010, INVEST OPHTH VIS SCI, V51, P4921, DOI 10.1167/iovs.10-5531; Chudgar SM, 2006, MOL VIS, V12, P1117; Clair T, 2003, CANCER RES, V63, P5446; Clark AF, 2009, EXP EYE RES, V88, P752, DOI 10.1016/j.exer.2008.10.004; Ederer F, 2000, ARCH OPHTHALMOL-CHIC, V118, P1639; Fautsch MP, 2006, INVEST OPHTH VIS SCI, V47, P213, DOI 10.1167/iovs.05-0334; Ferry G, 2008, J PHARMACOL EXP THER, V327, P809, DOI 10.1124/jpet.108.141911; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Giganti A, 2008, J BIOL CHEM, V283, P7776, DOI 10.1074/jbc.M708705200; Gijsbers R, 2003, FEBS LETT, V538, P60, DOI 10.1016/S0014-5793(03)00133-9; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Howell KG, 2010, J GLAUCOMA, V19, P569, DOI 10.1097/IJG.0b013e3181d13020; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; Knepper PA, 2002, INVEST OPHTH VIS SCI, V43, P133; Kumar J, 2011, J CELL BIOCHEM, V112, P600, DOI 10.1002/jcb.22950; Lee AJ, 2011, EXPERT OPIN EMERG DR, V16, P137, DOI 10.1517/14728214.2011.521631; Liton PB, 2005, BIOCHEM BIOPH RES CO, V337, P1229, DOI 10.1016/j.bbrc.2005.09.182; Lutjen-Drecoll E, 1999, PROG RETIN EYE RES, V18, P91, DOI 10.1016/S1350-9462(98)00011-1; MacKay EO, 2008, VET OPHTHALMOL, V11, P177, DOI 10.1111/j.1463-5224.2008.00617.x; Maddala R, 2011, DEV BIOL, V357, P179, DOI 10.1016/j.ydbio.2011.06.036; Mettu PS, 2004, INVEST OPHTH VIS SCI, V45, P2263, DOI 10.1167/iovs.03-0960; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Moolenaar WH, 2011, NAT REV MOL CELL BIO, V12, P674, DOI 10.1038/nrm3188; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Pattabiraman PP, 2012, AM J PHYSIOL-CELL PH, V302, pC979, DOI 10.1152/ajpcell.00396.2011; Pattabiraman PP, 2010, AM J PHYSIOL-CELL PH, V298, pC749, DOI 10.1152/ajpcell.00317.2009; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rao PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Sample PA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1136, DOI 10.1001/archophthalmol.2009.187; Shepard AR, 2010, INVEST OPHTH VIS SCI, V51, P2067, DOI 10.1167/iovs.09-4567; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Stamer WD, 2009, EXP EYE RES, V89, P980, DOI 10.1016/j.exer.2009.08.008; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Tamm ER, 2007, SURV OPHTHALMOL, V52, pS101, DOI 10.1016/j.survophthal.2007.08.002; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Toris CB, 2010, CURR MOL MED, V10, P824; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wiederholt M, 2000, PROG RETIN EYE RES, V19, P271, DOI 10.1016/S1350-9462(99)00015-4	47	48	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42627	10.1371/journal.pone.0042627	http://dx.doi.org/10.1371/journal.pone.0042627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916143	Green Submitted, gold, Green Published			2022-12-25	WOS:000307733800023
J	Rangam, G; Schmitz, KM; Cobb, AJA; Petersen-Mahrt, SK				Rangam, Gopinath; Schmitz, Kerstin-Maike; Cobb, Alexander J. A.; Petersen-Mahrt, Svend K.			AID Enzymatic Activity Is Inversely Proportional to the Size of Cytosine C5 Orbital Cloud	PLOS ONE			English	Article							THYMINE-DNA GLYCOSYLASE; MAMMALIAN DNA; DEMETHYLATION; 5-METHYLCYTOSINE; DEAMINASE; 5-CARBOXYLCYTOSINE; EXCISION; TET1; MICE	Activation induced deaminase (AID) deaminates cytosine to uracil, which is required for a functional humoral immune system. Previous work demonstrated, that AID also deaminates 5-methylcytosine (5 mC). Recently, a novel vertebrate modification (5-hydroxymethylcytosine - 5 hmC) has been implicated in functioning in epigenetic reprogramming, yet no molecular pathway explaining the removal of 5 hmC has been identified. AID has been suggested to deaminate 5 hmC, with the 5 hmU product being repaired by base excision repair pathways back to cytosine. Here we demonstrate that AID's enzymatic activity is inversely proportional to the electron cloud size of C5-cytosine - H > F > methyl >> hydroxymethyl. This makes AID an unlikely candidate to be part of 5 hmC removal.	[Rangam, Gopinath; Schmitz, Kerstin-Maike; Petersen-Mahrt, Svend K.] Fdn Ist FIRC Oncol Mol, DNA Editing Immun & Epigenet, Milan, Italy; [Rangam, Gopinath; Petersen-Mahrt, Svend K.] London Res Inst, Clare Hall Labs, DNA Editing Lab, S Mimms, Herts, England; [Cobb, Alexander J. A.] Univ Reading, Sch Pharm, Reading, Berks, England	IFOM - FIRC Institute of Molecular Oncology; University of Reading	Rangam, G (corresponding author), Fdn Ist FIRC Oncol Mol, DNA Editing Immun & Epigenet, Milan, Italy.	svend.petersen-mahrt@ifom.eu	Cobb, Alexander/Q-5702-2016; Rangam, Gopinath/J-8832-2019	Cobb, Alexander/0000-0002-3397-9636; Rangam, Gopinath/0000-0001-5081-5804	Fondazione Istituto FIRC di Oncologia Molecolare (IFOM-FIRC), Milan, Italy; London Research Institute / Cancer Research United Kingdom, United Kingdom; Cancer Research United Kingdom; IFOM-FIRC; Marie-Curie post-doc fellowship [274627]	Fondazione Istituto FIRC di Oncologia Molecolare (IFOM-FIRC), Milan, Italy; London Research Institute / Cancer Research United Kingdom, United Kingdom; Cancer Research United Kingdom(Cancer Research UK); IFOM-FIRC; Marie-Curie post-doc fellowship	SKPM was supported by, Fondazione Istituto FIRC di Oncologia Molecolare (IFOM-FIRC), Milan, Italy and the London Research Institute / Cancer Research United Kingdom, United Kingdom core lab funding - (facilities, materials, and salary). GR was supported by post-doctoral fellowship from Cancer Research United Kingdom and IFOM-FIRC core funding (salary). KMS was supported by Marie-Curie post-doc fellowship #274627 (materials and salary). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Coker HA, 2007, DNA REPAIR, V6, P235, DOI 10.1016/j.dnarep.2006.10.001; Coker HA, 2006, METHOD ENZYMOL, V408, P156, DOI 10.1016/S0076-6879(06)08010-4; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hashimoto H, 2012, NUCL ACIDS RES; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Kemmerich K., 2012, NUCL ACIDS RES; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Mol CD, 2002, J MOL BIOL, V315, P373, DOI 10.1006/jmbi.2001.5264; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Nabel CS, 2012, NATURE CHEM IN PRESS; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Zhao YH, 2003, J ORG CHEM, V68, P7368, DOI 10.1021/jo034808o	22	54	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43279	10.1371/journal.pone.0043279	http://dx.doi.org/10.1371/journal.pone.0043279			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916236	Green Accepted, Green Published, gold			2022-12-25	WOS:000307733800058
J	Bark, SJ; Wegrzyn, J; Taupenot, L; Ziegler, M; O'Connor, DT; Ma, Q; Smoot, M; Ideker, T; Hook, V				Bark, Steven J.; Wegrzyn, Jill; Taupenot, Laurent; Ziegler, Michael; O'Connor, Daniel T.; Ma, Qi; Smoot, Michael; Ideker, Trey; Hook, Vivian			The Protein Architecture of Human Secretory Vesicles Reveals Differential Regulation of Signaling Molecule Secretion by Protein Kinases	PLOS ONE			English	Article							CATECHOLAMINE STORAGE-VESICLES; CLATHRIN-COATED VESICLES; TANDEM MASS-SPECTRA; LARGE DENSE-CORE; CHROMAFFIN GRANULES; BIOLOGICAL NETWORKS; PROTEOMIC ANALYSIS; BETA-SECRETASE; SYSTEMS BIOLOGY; ADRENAL-MEDULLA	Secretory vesicles are required for release of chemical messengers to mediate intercellular signaling among human biological systems. It is necessary to define the organization of the protein architecture of the 'human' dense core secretory vesicles (DCSV) to understand mechanisms for secretion of signaling molecules essential for cellular regulatory processes. This study, therefore, conducted extensive quantitative proteomics and systems biology analyses of human DCSV purified from human pheochromocytoma. Over 600 human DCSV proteins were identified with quantitative evaluation of over 300 proteins, revealing that most proteins participate in producing peptide hormones and neurotransmitters, enzymes, and the secretory machinery. Systems biology analyses provided a model of interacting DCSV proteins, generating hypotheses for differential intracellular protein kinases A and C signaling pathways. Activation of cellular PKA and PKC pathways resulted in differential secretion of neuropeptides, catecholamines, and beta-amyloid of Alzheimer's disease for mediating cell-cell communication. This is the first study to define a model of the protein architecture of human DCSV for human disease and health.	[Bark, Steven J.; Wegrzyn, Jill; Hook, Vivian] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Taupenot, Laurent; Ziegler, Michael; O'Connor, Daniel T.; Smoot, Michael; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ma, Qi] Univ Calif San Diego, Grad Program Bioinformat & Syst Biol, La Jolla, CA 92093 USA; [Hook, Vivian] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Hook, Vivian] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Bark, SJ (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	stevenjbark@central.uh.edu; vhook@ucsd.edu	Wegrzyn, Jill/H-3745-2019; Ma, Qi/C-9716-2015; Ziegler, Michael/L-4728-2019	Wegrzyn, Jill/0000-0001-5923-0888; Ma, Qi/0000-0002-8705-4460; Taupenot, Laurent/0000-0003-2316-3825; Ideker, Trey/0000-0002-1708-8454	National Institutes of Health (NIH) [R01DA04271, PO1HL58120, R01MH077305, K01DA023065, P41RR031228, R01GM070743, P01HL58120]; Alzheimer's Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR031228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA023065, R01DA004271] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors appreciate support of this research by grants from the National Institutes of Health (NIH) (R01DA04271, PO1HL58120, R01MH077305) and the Alzheimer's Association to V. Hook, NIH grant K01DA023065 to S. Bark, NIH grants P41RR031228 and R01GM070743 to T. Ideker, and NIH grant P01HL58120 to D. T. O'Connor. The grant agencies' websites are: http://www.nih.gov/ and http://www.alz.org/. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of this manuscript.	Andreyev AY, 2010, MOL CELL PROTEOMICS, V9, P388, DOI 10.1074/mcp.M900432-MCP200; Bark SJ, 2007, J PROTEOME RES, V6, P4511, DOI 10.1021/pr070294o; Bark SJ, 2009, ANAL BIOCHEM, V389, P18, DOI 10.1016/j.ab.2009.03.010; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; CHIDGEY MAJ, 1993, BIOESSAYS, V15, P317, DOI 10.1002/bies.950150505; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Efthimiopoulos S, 1998, J NEUROCHEM, V71, P2365; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; GAINER H, 1985, NEUROENDOCRINOLOGY, V40, P171, DOI 10.1159/000124070; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Gauthier DJ, 2008, PROTEOMICS, V8, P3848, DOI 10.1002/pmic.200700969; Geer LY, J PROTEOME RES, V3, P958; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Goel G, 2007, INT J TOXICOL, V26, P279, DOI 10.1080/10915810701464641; Gorelick F, 2008, J GASTROEN HEPATOL, V23, pS37, DOI 10.1111/j.1440-1746.2007.05282.x; GRATZL M, 1981, BIOCHIM BIOPHYS ACTA, V649, P355, DOI 10.1016/0005-2736(81)90425-9; Gross J. H., 2004, MASS SPECTROMETRY; Gupta N, 2010, J PROTEOME RES, V9, P5065, DOI 10.1021/pr100358b; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Hook V, 2008, ANNU REV PHARMACOL, V48, P393, DOI 10.1146/annurev.pharmtox.48.113006.094812; Hook V, 2008, NEUROPEPTIDES, V42, P503, DOI 10.1016/j.npep.2008.05.001; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; HOOK VYH, 1984, FEBS LETT, V172, P212, DOI 10.1016/0014-5793(84)81128-X; Hook VYH, 2002, J NEUROCHEM, V81, P237; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Jayapandian M, 2007, NUCLEIC ACIDS RES, V35, pD566, DOI 10.1093/nar/gkl859; Jethwaney D, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-12; KELLY R B, 1991, Current Opinion in Cell Biology, V3, P654, DOI 10.1016/0955-0674(91)90037-Y; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kim T, 2006, PHYSIOLOGY, V21, P124, DOI 10.1152/physiol.00043.2005; Lodish H., 2004, MOL CELL BIOL, P701; OCONNOR DT, 1984, J BIOL CHEM, V259, P3237; OCONNOR DT, 1983, J CLIN ENDOCR METAB, V56, P582, DOI 10.1210/jcem-56-3-582; PARMER RJ, 1988, J HYPERTENS, V6, P187, DOI 10.1097/00004872-198803000-00002; Parmer RJ, 1997, J BIOL CHEM, V272, P1976, DOI 10.1074/jbc.272.3.1976; Rindler MJ, 2007, J PROTEOME RES, V6, P2978, DOI 10.1021/pr0607029; Scott MS, 2005, PLOS COMPUT BIOL, V1, P518, DOI 10.1371/journal.pcbi.0010066; SEAMON KB, 1983, J MED CHEM, V26, P436, DOI 10.1021/jm00357a021; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel GJ, 1999, BASIC NEUROCHEMISTRY, P191; SMITH AD, 1967, BIOCHEM J, V103, P480, DOI 10.1042/bj1030480; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Suderman M, 2007, BIOINFORMATICS, V23, P2651, DOI 10.1093/bioinformatics/btm401; SUIZDAK G, 2003, EXPANDING ROLE MASS; Takahashi M, 2003, J PHARMACOL SCI, V93, P41, DOI 10.1254/jphs.93.41; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tarcea VG, 2009, NUCLEIC ACIDS RES, V37, pD642, DOI 10.1093/nar/gkn722; Wegrzyn J, 2007, J PROTEOME RES, V6, P1652, DOI 10.1021/pr060503p; Wegrzyn JL, 2010, J PROTEOME RES, V9, P5002, DOI 10.1021/pr1003104; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Winkler H, 1998, CELL MOL NEUROBIOL, V18, P193, DOI 10.1023/A:1022516919932; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; Yasothornsrikul S, 1998, J NEUROCHEM, V70, P153; Yin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028679; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	66	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e41134	10.1371/journal.pone.0041134	http://dx.doi.org/10.1371/journal.pone.0041134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916103	Green Submitted, Green Published, gold			2022-12-25	WOS:000307824300005
J	Gradin, VB; Waiter, G; Kumar, P; Stickle, C; Milders, M; Matthews, K; Reid, I; Hall, J; Steele, JD				Gradin, Victoria B.; Waiter, Gordon; Kumar, Poornima; Stickle, Catriona; Milders, Maarten; Matthews, Keith; Reid, Ian; Hall, Jeremy; Steele, J. Douglas			Abnormal Neural Responses to Social Exclusion in Schizophrenia	PLOS ONE			English	Article							PREFRONTAL CORTEX; MENTAL-ILLNESS; SELF-ESTEEM; FMRI; METAANALYSIS; ATTRIBUTION; PERSPECTIVE; REJECTION; PSYCHOSIS; OSTRACISM	Social exclusion is an influential concept in politics, mental health and social psychology. Studies on healthy subjects have implicated the medial prefrontal cortex (mPFC), a region involved in emotional and social information processing, in neural responses to social exclusion. Impairments in social interactions are common in schizophrenia and are associated with reduced quality of life. Core symptoms such as delusions usually have a social content. However little is known about the neural underpinnings of social abnormalities. The aim of this study was to investigate the neural substrates of social exclusion in schizophrenia. Patients with schizophrenia and healthy controls underwent fMRI while participating in a popular social exclusion paradigm. This task involves passing a 'ball' between the participant and two cartoon representations of other subjects. The extent of social exclusion (ball not being passed to the participant) was parametrically varied throughout the task. Replicating previous findings, increasing social exclusion activated the mPFC in controls. In contrast, patients with schizophrenia failed to modulate mPFC responses with increasing exclusion. Furthermore, the blunted response to exclusion correlated with increased severity of positive symptoms. These data support the hypothesis that the neural response to social exclusion differs in schizophrenia, highlighting the mPFC as a potential substrate of impaired social interactions.	[Gradin, Victoria B.; Matthews, Keith; Steele, J. Douglas] Univ Dundee, Med Res Inst, Dundee, Scotland; [Waiter, Gordon] Univ Aberdeen, Biomed Imaging Ctr, Aberdeen, Scotland; [Kumar, Poornima] Univ Oxford, Dept Psychiat, Oxford, England; [Stickle, Catriona; Reid, Ian] Univ Aberdeen, Inst Mental Hlth, Aberdeen, Scotland; [Milders, Maarten] Univ Aberdeen, Dept Psychol, Aberdeen, Scotland; [Hall, Jeremy] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland	University of Dundee; University of Aberdeen; University of Oxford; University of Aberdeen; University of Aberdeen; University of Edinburgh	Gradin, VB (corresponding author), Univ Dundee, Med Res Inst, Dundee, Scotland.	v.gradin@dundee.ac.uk	Waiter, Gordon/AAA-1141-2020; Steele, Douglas/AAB-9889-2019; Steele, J Douglas/A-8972-2017; Milders, Maarten/GWD-1508-2022; Kumar, Poornima/ABF-3826-2020	Steele, Douglas/0000-0002-9822-8753; Steele, J Douglas/0000-0002-9822-8753; Waiter, Gordon/0000-0002-5313-9845; Matthews, Keith/0000-0002-4478-5888; Hall, Jeremy/0000-0002-0403-3278	Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE); Miller McKenzie Trust; Chief Scientist Office, Scotland; Medical Research Council [G0801418B] Funding Source: researchfish	Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE); Miller McKenzie Trust; Chief Scientist Office, Scotland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	VBG was supported by a studentship from Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE). The Miller McKenzie Trust and Chief Scientist Office, Scotland, funded scanning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Angermeyer MC, 2003, ACTA PSYCHIAT SCAND, V108, P304, DOI 10.1034/j.1600-0447.2003.00150.x; BAZIRE S, 2001, PSYCHOTROPIC DRUG DI; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Bolling DZ, 2011, NEUROIMAGE, V54, P2462, DOI 10.1016/j.neuroimage.2010.10.049; Bora E, 2009, SCHIZOPHR RES, V109, P1, DOI 10.1016/j.schres.2008.12.020; Brune M, 2007, SCHIZOPHR RES, V92, P151, DOI 10.1016/J.SCHRES.2007.01.006; Brune M, 2010, PSYCHIAT RES; Brunet-Gouet E, 2006, PSYCHIAT RES-NEUROIM, V148, P75, DOI 10.1016/j.pscychresns.2006.05.001; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; Edwards J, 2002, CLIN PSYCHOL REV, V22, P789, DOI 10.1016/S0272-7358(02)00130-7; Eisenberger NI, 2007, EMOTION, V7, P745, DOI 10.1037/1528-3542.7.4.745; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Goto Y, 2007, INTEGRATING NEUROBIO; Gunther Moor B, 2011, NEUROIMAGE; Huxley P, 2003, BRIT J PSYCHIAT, V182, P289, DOI 10.1192/bjp.182.4.289; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kohler CG, 2010, SCHIZOPHRENIA BULL, V36, P1009, DOI 10.1093/schbul/sbn192; Kumar P, 2009, HUM BRAIN MAPP, V30, P1421, DOI 10.1002/hbm.20611; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Masten CL, 2009, SOC COGN AFFECT NEUR, V4, P143, DOI 10.1093/scan/nsp007; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Perry Y, 2010, BR J CLIN PSYCHOL; Romaniuk L, 2010, ARCH GEN PSYCHIAT, V67, P1246, DOI 10.1001/archgenpsychiatry.2010.169; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sebastian C. L., 2010, NEUROIMAGE; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Spielberger C. D., 1983, MIND GARDEN; Steele JD, 2004, NEUROIMAGE, V21, P868, DOI 10.1016/j.neuroimage.2003.09.066; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006	45	26	27	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42608	10.1371/journal.pone.0042608	http://dx.doi.org/10.1371/journal.pone.0042608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AN	22916139	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000307824300012
J	Kanamarlapudi, V; Owens, SE; Saha, K; Pope, RJ; Mundell, SJ				Kanamarlapudi, Venkateswarlu; Owens, Sian E.; Saha, Keya; Pope, Robert J.; Mundell, Stuart J.			ARF6-Dependent Regulation of P2Y Receptor Traffic and Function in Human Platelets	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; PROTEIN-COUPLED RECEPTOR; GTPASE-ACTIVATING PROTEIN; BINDING PROTEIN; GOLGI MEMBRANES; ARF PROTEINS; ENDOCYTOSIS; CENTAURIN-ALPHA(1); INTERNALIZATION; CLATHRIN	Adenosine diphosphate (ADP) is a critical regulator of platelet activation, mediating its actions through two G protein-coupled receptors, the P2Y(1) and P2Y(12) purinoceptors. Recently, we demonstrated that P2Y(1) and P2Y(12) purinoceptor activities are rapidly and reversibly modulated in human platelets, revealing that the underlying mechanism requires receptor internalization and subsequent trafficking as an essential part of this process. In this study we investigated the role of the small GTP-binding protein ADP ribosylation factor 6 (ARF6) in the internalization and function of P2Y(1) and P2Y(12) purinoceptors in human platelets. ARF6 has been implicated in the internalization of a number of GPCRs, although its precise molecular mechanism in this process remains unclear. In this study we show that activation of either P2Y(1) or P2Y(12) purinoceptors can stimulate ARF6 activity. Further blockade of ARF6 function either in cell lines or human platelets blocks P2Y purinoceptor internalization. This blockade of receptor internalization attenuates receptor resensitization. Furthermore, we demonstrate that Nm23-H1, a nucleoside diphosphate (NDP) kinase regulated by ARF6 which facilitates dynamin-dependent fission of coated vesicles during endocytosis, is also required for P2Y purinoceptor internalization. These data describe a novel function of ARF6 in the internalization of P2Y purinoceptors and demonstrate the integral importance of this small GTPase upon platelet ADP receptor function.	[Kanamarlapudi, Venkateswarlu; Owens, Sian E.; Saha, Keya] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales; [Pope, Robert J.; Mundell, Stuart J.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	Swansea University; University of Bristol	Kanamarlapudi, V (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales.	s.j.mundell@bristol.ac.uk	Kanamarlapudi, Venkateswarlu/A-9864-2011	Kanamarlapudi, Venkateswarlu/0000-0002-8739-1483; Owens, Sian-Eleri/0000-0003-1806-5235; Mundell, Stuart/0000-0001-7754-3271	BBSRC UK (Biotechnology and Biological Sciences Research Council); MRC UK; British Heart Foundation Senior Research Fellowship; MRC [G0401232, G1000432] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C515455/2] Funding Source: researchfish; British Heart Foundation [FS/11/49/28751] Funding Source: researchfish; Medical Research Council [G0401232, G1000432] Funding Source: researchfish	BBSRC UK (Biotechnology and Biological Sciences Research Council); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation Senior Research Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by funding from BBSRC UK (Biotechnology and Biological Sciences Research Council) (to VK), MRC UK (to VK) and a British Heart Foundation Senior Research Fellowship (to SJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOMAN AL, 1995, TRENDS BIOCHEM SCI, V20, P147, DOI 10.1016/S0968-0004(00)88991-4; Choi W, 2006, BLOOD, V107, P3145, DOI 10.1182/blood-2005-09-3563; Conery AR, 2010, P NATL ACAD SCI USA, V107, P15461, DOI 10.1073/pnas.1010633107; Cosemans JMEM, 2006, BLOOD, V108, P3045, DOI 10.1182/blood-2006-03-006338; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; El Annan J, 2004, AM J PHYSIOL-CELL PH, V286, pC768, DOI 10.1152/ajpcell.00250.2003; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Goto S, 2006, J AM COLL CARDIOL, V47, P155, DOI 10.1016/j.jacc.2005.08.055; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; Hsu T, 2006, J BIOL CHEM, V281, P12069, DOI 10.1074/jbc.M511621200; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Kanamarlapudi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037954; Kanamarlapudi V, 2012, J BIOL CHEM, V287, P20443, DOI 10.1074/jbc.M112.362087; Karim ZA, 2008, J BIOL CHEM, V283, P11995, DOI 10.1074/jbc.M800146200; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Kunapuli SP, 2003, CURR PHARM DESIGN, V9, P2303, DOI 10.2174/1381612033453947; Lawrence J, 2005, MOL PHARMACOL, V67, P1822, DOI 10.1124/mol.105.011338; Mukherjee S, 2000, P NATL ACAD SCI USA, V97, P5901, DOI 10.1073/pnas.100127097; Mundell SJ, 2008, J THROMB HAEMOST, V6, P1393, DOI 10.1111/j.1538-7836.2008.03039.x; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Poupart ME, 2007, CELL SIGNAL, V19, P2370, DOI 10.1016/j.cellsig.2007.07.015; Rochdi MD, 2004, J BIOL CHEM, V279, P18981, DOI 10.1074/jbc.M312621200; Smyth SS, 2009, ARTERIOSCL THROM VAS, V29, P449, DOI 10.1161/ATVBAHA.108.176388; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Venkateswarlu K, 2005, J CELL SCI, V118, P2471, DOI 10.1242/jcs.02369; Venkateswarlu K, 2004, J BIOL CHEM, V279, P6205, DOI 10.1074/jbc.C300482200; Venkateswarlu K, 2003, J BIOL CHEM, V278, P43460, DOI 10.1074/jbc.M304078200	37	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43532	10.1371/journal.pone.0043532	http://dx.doi.org/10.1371/journal.pone.0043532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916275	gold, Green Published, Green Submitted			2022-12-25	WOS:000307824300053
J	Shin, SC; Kim, SJ; Lee, JK; Ahn, DH; Kim, MG; Lee, H; Lee, J; Kim, BK; Park, H				Shin, Seung Chul; Kim, Su Jin; Lee, Jong Kyu; Ahn, Do Hwan; Kim, Min Gyu; Lee, Hyoungseok; Lee, Jungeun; Kim, Bum-Keun; Park, Hyun			Transcriptomics and Comparative Analysis of Three Antarctic Notothenioid Fishes	PLOS ONE			English	Article							EXPRESSION; GENE; EVOLUTION; BLOOD; NEUROGLOBIN; MYOGLOBIN; REMNANTS; ICEFISH; HSP70	For the past 10 to 13 million years, Antarctic notothenioid fish have undergone extraordinary periods of evolution and have adapted to a cold and highly oxygenated Antarctic marine environment. While these species are considered an attractive model with which to study physiology and evolutionary adaptation, they are poorly characterized at the molecular level, and sequence information is lacking. The transcriptomes of the Antarctic fishes Notothenia coriiceps, Chaenocephalus aceratus, and Pleuragramma antarcticum were obtained by 454 FLX Titanium sequencing of a normalized cDNA library. More than 1,900,000 reads were assembled in a total of 71,539 contigs. Overall, 40% of the contigs were annotated based on similarity to known protein or nucleotide sequences, and more than 50% of the predicted transcripts were validated as full-length or putative full-length cDNAs. These three Antarctic fishes shared 663 genes expressed in the brain and 1,557 genes expressed in the liver. In addition, these cold-adapted fish expressed more Ub-conjugated proteins compared to temperate fish; Ub-conjugated proteins are involved in maintaining proteins in their native state in the cold and thermally stable Antarctic environments. Our transcriptome analysis of Antarctic notothenioid fish provides an archive for future studies in molecular mechanisms of fundamental genetic questions, and can be used in evolution studies comparing other fish.	[Shin, Seung Chul; Lee, Jong Kyu; Ahn, Do Hwan; Kim, Min Gyu; Lee, Hyoungseok; Lee, Jungeun; Park, Hyun] Korea Polar Res Inst, Inchon, South Korea; [Kim, Su Jin] Korea Univ, Coll Life Sci & Biotechnol, Seoul, South Korea; [Ahn, Do Hwan; Park, Hyun] Univ Sci & Technol, Taejon, South Korea; [Kim, Bum-Keun] Korea Food Res Inst, Songnam, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Korea University; Korea Food Research Institute (KFRI)	Shin, SC (corresponding author), Korea Polar Res Inst, Inchon, South Korea.	hpark@kopri.re.kr		Kim, Bum-Keun/0000-0002-9752-741X; Lee, Hyoungseok/0000-0002-5831-6345	Functional Genomics on Polar Organisms grant [PE12020]; Korea Polar Research Institute (KOPRI)	Functional Genomics on Polar Organisms grant; Korea Polar Research Institute (KOPRI)(Korea Polar Research Institute of Marine Research Placement (KOPRI))	This work was supported by a Functional Genomics on Polar Organisms grant (PE12020) funded by the Korea Polar Research Institute (KOPRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber C, 2009, NATURE, V458, P9; Albertson RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-4; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; BARBER DL, 1981, J FISH BIOL, V19, P11, DOI 10.1111/j.1095-8649.1981.tb05807.x; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Chen ZZ, 2008, P NATL ACAD SCI USA, V105, P12944, DOI 10.1073/pnas.0802432105; Cheng CHC, 2009, IUBMB LIFE, V61, P184, DOI 10.1002/iub.138; Cheng CHC, 1999, NATURE, V401, P443, DOI 10.1038/46721; COCCA E, 1995, P NATL ACAD SCI USA, V92, P1817, DOI 10.1073/pnas.92.6.1817; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Detrich HW, 2010, J EXP ZOOL PART B, V314B, P369, DOI 10.1002/jez.b.21341; Detrich HW, 2000, HEMOGLOBIN FUNCTION IN VERTEBRATES, P39; di Prisco G, 2002, GENE, V295, P185, DOI 10.1016/S0378-1119(02)00691-1; Eastman Joseph T., 1998, P3; Eastman JT, 2005, POLAR BIOL, V28, P93, DOI 10.1007/s00300-004-0667-4; Eastman JT, 2000, ANTARCT SCI, V12, P276, DOI 10.1017/S0954102000000341; Eastman JT, 1993, ANTARCTIC FISH BIOL; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hofmann GE, 2000, J EXP BIOL, V203, P2331; JAENICKE R, 1990, PHILOS T R SOC B, V326, P535, DOI 10.1098/rstb.1990.0030; Li SZ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r115; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Moylan TJ, 2000, J EXP BIOL, V203, P1277; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Parkinson John, 2009, V533, P1, DOI 10.1007/978-1-60327-136-3_1; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; Place S, 2005, POLAR BIOL, V28, P261, DOI 10.1007/s00300-004-0697-y; Place SP, 2004, AM J PHYSIOL-REG I, V287, pR429, DOI 10.1152/ajpregu.00223.2004; RUUD JT, 1954, NATURE, V173, P848, DOI 10.1038/173848a0; Sidell BD, 1997, P NATL ACAD SCI USA, V94, P3420, DOI 10.1073/pnas.94.7.3420; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vacchi M, 2012, POLAR BIOL, V35, P1573, DOI 10.1007/s00300-012-1199-y; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Zhao YQ, 1998, J BIOL CHEM, V273, P14745, DOI 10.1074/jbc.273.24.14745	38	56	58	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43762	10.1371/journal.pone.0043762	http://dx.doi.org/10.1371/journal.pone.0043762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916302	Green Published, Green Submitted, gold			2022-12-25	WOS:000307824300057
J	Holl, EK; Roney, KE; Allen, IC; Steinbach, E; Arthur, JC; Buntzman, A; Plevy, S; Frelinger, J; Ting, JPY				Holl, Eda K.; Roney, Kelly E.; Allen, Irving C.; Steinbach, Erin; Arthur, Janelle C.; Buntzman, Adam; Plevy, Scott; Frelinger, Jeffrey; Ting, Jenny P. -Y.			Plexin-B2 and Plexin-D1 in Dendritic Cells: Expression and IL-12/IL-23p40 Production	PLOS ONE			English	Article							IV SEMAPHORIN CD100; NONREDUNDANT ROLES; IMMUNE-RESPONSES; B-CELL; FAMILY; GROWTH; RECEPTORS; GUIDANCE; SYSTEM; SEMA4A	Plexins are a family of genes (A,B,C, and D) that are expressed in many organ systems. Plexins expressed in the immune system have been implicated in cell movement and cell-cell interaction during the course of an immune response. In this study, the expression pattern of Plexin-B2 and Plexin-D1 in dendritic cells (DCs), which are central in immune activation, was investigated. Plexin-B2 and Plexin-D1 are reciprocally expressed in myeloid and plasmacytoid DC populations. Plasmacytoid DCs have high Plexin-B2 but low Plexin-D1, while the opposite is true of myeloid DCs. Expression of Plexin-B2 and Plexin-D1 is modulated upon activation of DCs by TLR ligands, TNF alpha, and anti-CD40, again in a reciprocal fashion. Semaphorin3E, a ligand for Plexin-D1 and Plexin-B2, is expressed by T cells, and interestingly, is dramatically higher on Th2 cells and on DCs. The expression of Plexins and their ligands on DCs and T cells suggest functional relevance. To explore this, we utilized chimeric mice lacking Plxnb2 or Plxnd1. Absence of Plexin-B2 and Plexin-D1 on DCs did not affect the ability of these cells to upregulate costimulatory molecules or the ability of these cells to activate antigen specific T cells. Additionally, Plexin-B2 and Plexin-D1 were dispensable for chemokine-directed in-vitro migration of DCs towards key DC chemokines, CXCL12 and CCL19. However, the absence of either Plexin-B2 or Plexin-D1 on DCs leads to constitutive expression of IL-12/IL-23p40. This is the first report to show an association between Plexin-B2 and Plexin-D1 with the negative regulation of IL-12/IL-23p40 in DCs. This work also shows the presence of Plexin-B2 and Plexin-D1 on mouse DC subpopulations, and indicates that these two proteins play a role in IL-12/IL-23p40 production that is likely to impact the immune response.	[Holl, Eda K.; Roney, Kelly E.; Arthur, Janelle C.; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Holl, Eda K.; Roney, Kelly E.; Allen, Irving C.; Arthur, Janelle C.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Steinbach, Erin; Plevy, Scott] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Buntzman, Adam; Frelinger, Jeffrey] Univ Arizona, Dept Immunobiol, Tucson, AZ USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Arizona	Holl, EK (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.	jenny_ting@med.unc.edu	Frelinger, Jeffrey A/F-2448-2014	Frelinger, Jeffrey A/0000-0002-2503-6267; Buntzman, Adam/0000-0003-1067-4618; Steinbach, Erin/0000-0002-6165-8928; Allen, Irving/0000-0001-9573-5250; Arthur, Janelle/0000-0002-4796-0207	University of North Carolina Developmental Biology Training Program Grant [HD046369]; National Institutes of Health Grant [AI29564]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI029564, R37AI029564, R01AI029564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK089692, K01DK092355] Funding Source: NIH RePORTER	University of North Carolina Developmental Biology Training Program Grant; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by University of North Carolina Developmental Biology Training Program Grant HD046369 (to E.K.H.) and National Institutes of Health Grant AI29564 (to J.P. and Y.T.). The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Choi YI, 2008, IMMUNITY; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Delaire S, 1998, CELL MOL LIFE SCI, V54, P1265, DOI 10.1007/s000180050252; Friedel RH, 2007, J NEUROSCI, V27, P3921, DOI 10.1523/JNEUROSCI.4710-06.2007; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Granziero L, 2003, BLOOD, V101, P1962, DOI 10.1182/blood-2002-05-1339; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Hanahan D, 1998, CURR OPIN IMMUNOL, V10, P656, DOI 10.1016/S0952-7915(98)80085-X; Holl EK, 2011, J IMMUNOL, V186, P5603, DOI 10.4049/jimmunol.1003464; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kumanogoh A, 2005, IMMUNITY, V22, P305, DOI 10.1016/j.immuni.2005.01.014; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Lamont RE, 2009, DEV BIOL, V331, P199, DOI 10.1016/j.ydbio.2009.04.037; Masuda K, 2004, GENES CELLS, V9, P821, DOI 10.1111/j.1365-2443.2004.00766.x; Mizui M, 2009, J CLIN IMMUNOL, V29, P1, DOI 10.1007/s10875-008-9263-7; O'Connor BP, 2008, P NATL ACAD SCI USA, V105, P13015, DOI 10.1073/pnas.0803386105; Sakurai A, 2010, MOL CELL BIOL; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Smith EP, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-30; Takamatsu H, 2010, NAT IMMUNOL, V11, P594, DOI 10.1038/ni.1885; Takamatsu H, 2010, CELL MOL IMMUNOL, V7, P83, DOI 10.1038/cmi.2009.111; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Toyofuku T, 2007, EMBO J, V26, P1373, DOI 10.1038/sj.emboj.7601589; Van Der Zwaag B, 2002, DEV DYNAM, V225, P336, DOI 10.1002/dvdy.10159; van Deventer HW, 2002, J IMMUNOL, V169, P1634, DOI 10.4049/jimmunol.169.3.1634; Walzer T, 2005, INT IMMUNOL, V17, P943, DOI 10.1093/intimm/dxh274; Walzer T, 2005, J IMMUNOL, V174, P51, DOI 10.4049/jimmunol.174.1.51; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Yamamoto M, 2008, INT IMMUNOL, V20, P413, DOI 10.1093/intimm/dxn006; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Yu D, 2008, IMMUNOL CELL BIOL, V86, P3, DOI 10.1038/sj.icb.7100123; Yukawa K, 2010, INT J MOL MED, V25, P225, DOI 10.3892/ijmm_00000334; Zielonka M, 2010, EXP CELL RES	41	32	34	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43333	10.1371/journal.pone.0043333	http://dx.doi.org/10.1371/journal.pone.0043333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916243	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600069
J	Liu, X; Sano, T; Guan, YS; Nagata, S; Hoffmann, JA; Fukuyama, H				Liu, Xi; Sano, Teruyuki; Guan, Yongsheng; Nagata, Shigekazu; Hoffmann, Jules A.; Fukuyama, Hidehiro			Drosophila EYA Regulates the Immune Response against DNA through an Evolutionarily Conserved Threonine Phosphatase Motif	PLOS ONE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; BRANCHIOOTORENAL BOR SYNDROME; INDEPENDENT GENE INDUCTION; ABSENT MUTANTS REVEALS; EYES ABSENT; RETINAL DETERMINATION; MAMMALIAN DNA; INNATE IMMUNITY; HOST-DEFENSE; SINE-OCULIS	Innate immune responses against DNA are essential to counter both pathogen infections and tissue damages. Mammalian EYAs were recently shown to play a role in regulating the innate immune responses against DNA. Here, we demonstrate that the unique Drosophila eya gene is also involved in the response specific to DNA. Haploinsufficiency of eya in mutants deficient for lysosomal DNase activity (DNaseII) reduces antimicrobial peptide gene expression, a hallmark for immune responses in flies. Like the mammalian orthologues, Drosophila EYA features a N-terminal threonine and C-terminal tyrosine phosphatase domain. Through the generation of a series of mutant EYA fly strains, we show that the threonine phosphatase domain, but not the tyrosine phosphatase domain, is responsible for the innate immune response against DNA. A similar role for the threonine phosphatase domain in mammalian EYA4 had been surmised on the basis of in vitro studies. Furthermore EYA associates with IKK beta and full-length RELISH, and the induction of the IMD pathway-dependent antimicrobial peptide gene is independent of SO. Our data provide the first in vivo demonstration for the immune function of EYA and point to their conserved immune function in response to endogenous DNA, throughout evolution.	[Liu, Xi; Guan, Yongsheng; Fukuyama, Hidehiro] Inst Biol Mol & Cellulaire, INSERM Equipe Avenir, CNRS UPR9022, F-67084 Strasbourg, France; [Liu, Xi; Hoffmann, Jules A.] Univ Strasbourg, Strasbourg, France; [Sano, Teruyuki; Nagata, Shigekazu] Kyoto Univ, Dept Med Chem, Grad Sch Med, Kyoto, Japan; [Sano, Teruyuki; Nagata, Shigekazu] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kyoto, Japan; [Sano, Teruyuki; Nagata, Shigekazu] Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Kyoto, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Liu, X (corresponding author), Inst Biol Mol & Cellulaire, INSERM Equipe Avenir, CNRS UPR9022, F-67084 Strasbourg, France.	snagata@mfour.med.kyoto-u.ac.jp; h.fukuyama@unistra.fr	Fukuyama, Hidehiro/N-5276-2018; Fukuyama, Hidehiro/AAY-6256-2021; Nagata, Shigekazu/AAG-3203-2019	Fukuyama, Hidehiro/0000-0002-6457-0630; Fukuyama, Hidehiro/0000-0002-6457-0630; Nagata, Shigekazu/0000-0001-9758-8426	Avenir; Institut National de la Sante et de la Recherche Medicale, France; Chinese Scholarship Council, China; Solution Oriented Research for Science and Technology; Japan Science and Technology Agency, Japan; Centre National de la Recherche Scientifique, France; Grants-in-Aid for Scientific Research [22000013] Funding Source: KAKEN	Avenir; Institut National de la Sante et de la Recherche Medicale, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Chinese Scholarship Council, China(China Scholarship Council); Solution Oriented Research for Science and Technology; Japan Science and Technology Agency, Japan(Japan Science & Technology Agency (JST)); Centre National de la Recherche Scientifique, France(Centre National de la Recherche Scientifique (CNRS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding provided by Avenir, Institut National de la Sante et de la Recherche Medicale, France (HF), Chinese Scholarship Council, China (XL), Solution Oriented Research for Science and Technology, Japan Science and Technology Agency, Japan (SN) and Centre National de la Recherche Scientifique, France (HF and JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Bui QT, 2000, GENETICS, V155, P709; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Erturk-Hasdemir D, 2009, P NATL ACAD SCI USA, V106, P9779, DOI 10.1073/pnas.0812022106; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hsiao FC, 2001, DEV CELL, V1, P51, DOI 10.1016/S1534-5807(01)00011-9; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jenic J, 2007, ANNU REV BIOCHEM, V76, P513, DOI 10.1146/annurev.biochem.76.052705.164916; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kenyon KL, 2005, DEV BIOL, V286, P158, DOI 10.1016/j.ydbio.2005.07.017; Kumar S, 1998, HUM MUTAT, V11, P443, DOI 10.1002/(SICI)1098-1004(1998)11:6<443::AID-HUMU4>3.3.CO;2-J; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morillo SA, 2012, DEV BIOL, V365, P267, DOI 10.1016/j.ydbio.2012.02.030; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Okabe Y, 2008, EUR J IMMUNOL, V38, P3150, DOI 10.1002/eji.200838559; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Silver SJ, 2003, MOL CELL BIOL, V23, P5989, DOI 10.1128/MCB.23.17.5989-5999.2003; Soker T, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-118; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zimmerman JE, 2000, GENETICS, V154, P237	55	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42725	10.1371/journal.pone.0042725	http://dx.doi.org/10.1371/journal.pone.0042725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916150	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600024
J	Basit, F; Humphreys, R; Fulda, S				Basit, Farhan; Humphreys, Robin; Fulda, Simone			RIP1 Protein-dependent Assembly of a Cytosolic Cell Death Complex Is Required for Inhibitor of Apoptosis (IAP) Inhibitor-mediated Sensitization to Lexatumumab-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; DRUG-INDUCED APOPTOSIS; KAPPA-B ACTIVATION; TESTING STAGE 1; CANCER-CELLS; ALPHA; ANTAGONISTS; XIAP; RIPOPTOSOME; CASPASE-8	Searching for new strategies to trigger apoptosis in rhabdomyosarcoma (RMS), we investigated the effect of two novel classes of apoptosis-targeting agents, i.e. monoclonal antibodies against TNF-related apoptosis-inducing ligand (TRAIL) receptor 1 (mapatumumab) and TRAIL receptor 2 (lexatumumab) and small-molecule inhibitors of inhibitor of apoptosis (IAP) proteins. Here, we report that IAP inhibitors synergized with lexatumumab, but not with mapatumumab, to reduce cell viability and to induce apoptosis in several RMS cell lines in a highly synergistic manner (combination index <0.1). Cotreatment-induced apoptosis was accompanied by enhanced activation of caspase-8, -9, and -3; loss of mitochondrial membrane potential; and caspase-dependent apoptosis. In addition, IAP inhibitor and lexatumumab cooperated to stimulate the assembly of a cytosolic complex containing RIP1, FADD, and caspase-8. Importantly, knockdown of RIP1 by RNA interference prevented the formation of the RIP1.FADD.caspase-8 complex and inhibited subsequent activation of caspase-8, -9, and -3; loss of mitochondrial membrane potential; and apoptosis upon treatment with IAP inhibitor and lexatumumab. In addition, RIP1 silencing rescued clonogenic survival of cells treated with the combination of lexatumumab and IAP inhibitor, thus underscoring the critical role of RIP1 in cotreatment-induced apoptosis. By comparison, the TNF alpha-blocking antibody Enbrel had no effect on IAP inhibitor/lexatumumab-induced apoptosis, indicating that an autocrine TNF alpha loop is dispensable. By demonstrating that IAP inhibitors and lexatumumab synergistically trigger apoptosis in a RIP1-dependent but TNF alpha-independent manner in RMS cells, our findings substantially advance our understanding of IAP inhibitor-mediated regulation of TRAIL-induced cell death.	[Basit, Farhan; Fulda, Simone] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Germany; [Humphreys, Robin] Human Genome Sci Inc, Oncol Res Dept, Rockville, MD 20850 USA	Goethe University Frankfurt; GlaxoSmithKline; Human Genome Sciences Inc	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3A, D-60528 Frankfurt, Germany.	simone.fulda@kgu.de		Fulda, Simone/0000-0002-0459-6417	Deutsche Krebshilfe; Federal Minisrty of Education and Research [01GM0871, 01GM1104C]	Deutsche Krebshilfe(Deutsche Krebshilfe); Federal Minisrty of Education and Research	This work was supported in part by grants from the Deutsche Krebshilfe and the Federal Minisrty of Education and Research (01GM0871 and 01GM1104C) (to S.F.).	Abhari B. A., 2012, ONCOGENE IN PRESS; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; CHAO B, 2006, Patent No. 2005024700; Chou TC, 1991, SYNERGISM ANTAGONISM, P61; Dagher R, 1999, Oncologist, V4, P34; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Fakler M, 2009, BLOOD, V113, P1710, DOI 10.1182/blood-2007-09-114314; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Fox NL, 2010, EXPERT OPIN BIOL TH, V10, P1, DOI 10.1517/14712590903319656; Fulda S, 1997, CANCER RES, V57, P3823; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Hayes-Jordan A, 2009, CURR OPIN PEDIATR, V21, P373, DOI 10.1097/MOP.0b013e32832b4171; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Houghton PJ, 2012, PEDIATR BLOOD CANCER, V58, P636, DOI 10.1002/pbc.23167; Humphreys RC, 2008, ADV EXP MED BIOL, V615, P127, DOI 10.1007/978-1-4020-6554-5_7; Kang ZG, 2011, CLIN CANCER RES, V17, P3181, DOI 10.1158/1078-0432.CCR-10-2874; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Loder S, 2012, LEUKEMIA, V26, P1020, DOI 10.1038/leu.2011.353; Loeder S, 2009, CANCER RES, V69, P8977, DOI 10.1158/0008-5472.CAN-09-2604; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Smith MA, 2010, PEDIATR BLOOD CANCER, V54, P307, DOI 10.1002/pbc.22188; Stadel D, 2010, CLIN CANCER RES, V16, P5734, DOI 10.1158/1078-0432.CCR-10-0985; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; van Noesel MM, 2003, GENE CHROMOSOME CANC, V38, P226, DOI 10.1002/gcc.10278; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036	38	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38767	38777		10.1074/jbc.M112.398966	http://dx.doi.org/10.1074/jbc.M112.398966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22927431	Green Published, hybrid			2022-12-25	WOS:000310982800034
J	Ardanuy, C; Marimon, JM; Calatayud, L; Gimenez, M; Alonso, M; Grau, I; Pallares, R; Perez-Trallero, E; Linares, J				Ardanuy, Carmen; Maria Marimon, Jose; Calatayud, Laura; Gimenez, Montserrat; Alonso, Marta; Grau, Immaculada; Pallares, Roman; Perez-Trallero, Emilio; Linares, Josefina			Epidemiology of Invasive Pneumococcal Disease in Older People in Spain (2007-2009): Implications for Future Vaccination Strategies	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE SEROTYPES; CONJUGATE VACCINE; ANTIMICROBIAL RESISTANCE; TEMPORAL TRENDS; DRUG-RESISTANT; UNITED-STATES; EMERGENCE; 19A; REPLACEMENT; CHILDREN	Background: Recently, the 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended for adults. We analyzed the epidemiology of invasive pneumococcal disease (IPD) in older adults in Spain before PCV13 introduction. Methodology/Principal Findings: IPD episodes, defined as clinical findings together with an invasive pneumococcal isolate, were prospectively collected from patients aged over 65 years in three hospitals in Spain from 2007 to 2009. A total of 335 IPD episodes were collected. Pneumonia was the main clinical syndrome, while chronic obstructive pulmonary disease, diabetes mellitus and cancer were the main underlying diseases. Pneumococcal isolates were serotyped and the molecular typing was performed by PFGE/MLST. PCV13 serotypes accounted for 59.3% of isolates, the most prevalent being serotypes 19A (15.1%), 3 (9.6%), 7F (7.5%), 14 (6.9%) and 1 (5.4%). The most frequent non-PCV13 serotypes were serotypes 16F (4.5%), 22F (3.6%), 24F (3.3%) and 6C (2.1%). The most common genotypes were CC230 (8.5%, serotypes 19A and 24F), CC156 (8.2%, serotypes 9V and 14), ST191 (7.9%, serotype 7F), CC260 (6.6%, serotype 3), ST306 (5.2%, serotype 1), CC30 (4.6%, serotype 16F) and ST433 (3.6%, serotype 22F). Comparing the 335 IPD isolates to 174 invasive pneumococci collected at the same hospitals in 1999-2000, PCV7 serotypes decreased (45.4% vs 18.4%, p<0.001), non-PCV7 serotypes included in PCV13 increased (26.4% vs 41.0%, p = 0.001) and two non-PCV13 serotypes increased (serotype 6C 0% vs 2.1%, p = 0.05; serotype 24F 0.6% vs 3.3%, p = 0.04,). Conclusion: In our older adult population two serotypes (19A and 3) included in PCV13 accounted for about a quarter of IPD episodes in people >= 65 years. Non-PCV13 emerging serotypes should be carefully monitored in future surveillance studies.	[Ardanuy, Carmen; Calatayud, Laura; Linares, Josefina] Univ Barcelona, Dept Microbiol, Hosp Univ Bellvitge, IDIBELL, Barcelona, Spain; [Ardanuy, Carmen; Maria Marimon, Jose; Calatayud, Laura; Gimenez, Montserrat; Alonso, Marta; Grau, Immaculada; Pallares, Roman; Perez-Trallero, Emilio; Linares, Josefina] CIBER Enfermedades Resp CIBERES ISCII, Madrid, Spain; [Maria Marimon, Jose; Alonso, Marta; Perez-Trallero, Emilio] Hosp Univ Donostia, Dept Microbiol, Donostia San Sebastian, Spain; [Gimenez, Montserrat] Hosp Badalona Germans Trias & Pujol, Dept Microbiol, Barcelona, Spain; [Grau, Immaculada; Pallares, Roman] Univ Barcelona, Dept Infect Dis, Hosp Univ Bellvitge, IDIBELL, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Germans Trias i Pujol; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Ardanuy, C (corresponding author), Univ Barcelona, Dept Microbiol, Hosp Univ Bellvitge, IDIBELL, Barcelona, Spain.	c.ardanuy@bellvitgehospital.cat	PALLARES, Roman/B-5710-2008; MARIMON, JOSE MARIA/AAM-5581-2021; Ardanuy, Carmen/C-4463-2015; Liñares, Josefina/N-9450-2014	PALLARES, Roman/0000-0003-3262-8508; MARIMON, JOSE MARIA/0000-0002-2787-7094; Grau, Imma/0000-0002-3040-8184; Ardanuy, Carmen/0000-0003-0225-607X; Gimenez, Montserrat/0000-0001-8841-810X; Alonso, Marta/0000-0002-8909-4968	Fondo de Investigaciones Sanitarias [PI081922, PI090104, PI1000127, PI11/0763]; Basque Government [2009/111012]; CIBER de Enfermedades Respiratorias (CIBERES)	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Basque Government(Basque Government); CIBER de Enfermedades Respiratorias (CIBERES)	This work was supported by grants from the "Fondo de Investigaciones Sanitarias" (PI081922, PI090104, PI1000127, and PI11/0763), the Basque Government 2009/111012 and by CIBER de Enfermedades Respiratorias (CIBERES), a project run by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews N, 2012, 8 INT S PNEUM PNEUM; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Calatayud L, 2010, J CLIN MICROBIOL, V48, P1310, DOI 10.1128/JCM.01868-09; Choi EH, 2008, EMERG INFECT DIS, V14, P275, DOI 10.3201/eid1402.070807; Clinical and Laboratory Standard Institute, 2009, M7A8 CLSINCCLS, V29; Clinical Laboratory Standard Institute, 2011, M100S21 CLSINCCLS, V31; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Fenoll A, 1997, J CLIN MICROBIOL, V35, P764, DOI 10.1128/JCM.35.3.764-766.1997; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Grall N, 2011, EUR J CLIN MICROBIOL, V30, P1511, DOI 10.1007/s10096-011-1251-9; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Marimon JM, 2010, J MICROBIOL METH, V80, P274, DOI 10.1016/j.mimet.2010.01.011; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Nuorti J. P., 2010, Morbidity and Mortality Weekly Report, V59, P1102; Obando I, 2008, EMERG INFECT DIS, V14, P1390, DOI 10.3201/eid1409.071094; Pantosti A, 2002, CLIN INFECT DIS, V35, P205, DOI 10.1086/341250; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Perez-Trallero E, 2009, EUR J CLIN MICROBIOL, V28, P731, DOI 10.1007/s10096-008-0693-1; Picazo J, 2012, 8 INT S PNEUM PNEUM; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; van der Linden M., 2012, 8 INT S PNEUM PNEUM; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	33	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43619	10.1371/journal.pone.0043619	http://dx.doi.org/10.1371/journal.pone.0043619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928005	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300075
J	Nagarkatti, R; Bist, V; Sun, S; de Araujo, FF; Nakhasi, HL; Debrabant, A				Nagarkatti, Rana; Bist, Vaibhav; Sun, Sirena; de Araujo, Fernanda Fortes; Nakhasi, Hira L.; Debrabant, Alain			Development of an Aptamer-Based Concentration Method for the Detection of Trypanosoma cruzi in Blood	PLOS ONE			English	Article							IN-VITRO SELECTION; CHAGAS-DISEASE PATIENTS; RNA APTAMERS; AFRICAN TRYPANOSOMES; PCR; POLYMERASE; SURFACE; ASSAY; LIGANDS; SAMPLES	Trypanosoma cruzi, a blood-borne parasite, is the etiological agent of Chagas disease. T. cruzi trypomastigotes, the infectious life cycle stage, can be detected in blood of infected individuals using PCR-based methods. However, soon after a natural infection, or during the chronic phase of Chagas disease, the number of parasites in blood may be very low and thus difficult to detect by PCR. To facilitate PCR-based detection methods, a parasite concentration approach was explored. A whole cell SELEX strategy was utilized to develop serum stable RNA aptamers that bind to live T. cruzi trypomastigotes. These aptamers bound to the parasite with high affinities (8-25 nM range). The highest affinity aptamer, Apt68, also demonstrated high specificity as it did not interact with the insect stage epimastigotes of T. cruzi nor with other related trypanosomatid parasites, L. donovani and T. brucei, suggesting that the target of Apt68 was expressed only on T. cruzi trypomastigotes. Biotinylated Apt68, immobilized on a solid phase, was able to capture live parasites. These captured parasites were visible microscopically, as large motile aggregates, formed when the aptamer coated paramagnetic beads bound to the surface of the trypomastigotes. Additionally, Apt68 was also able to capture and aggregate trypomastigotes from several isolates of the two major genotypes of the parasite. Using a magnet, these parasite-bead aggregates could be purified from parasite-spiked whole blood samples, even at concentrations as low as 5 parasites in 15 ml of whole blood, as detected by a real-time PCR assay. Our results show that aptamers can be used as pathogen specific ligands to capture and facilitate PCR-based detection of T. cruzi in blood.	[Nagarkatti, Rana; Bist, Vaibhav; Sun, Sirena; de Araujo, Fernanda Fortes; Nakhasi, Hira L.; Debrabant, Alain] US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Nagarkatti, R (corresponding author), US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	alain.debrabant@fda.hhs.gov			FDA under FDA Critical Path Initiative	FDA under FDA Critical Path Initiative	This work was supported by FDA internal funding under the FDA Critical Path Initiative. No external funding sources were used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS NW, 1987, EXP PARASITOL, V64, P474, DOI 10.1016/0014-4894(87)90062-2; Bern C, 2008, CURR OPIN INFECT DIS, V21, P476, DOI 10.1097/QCO.0b013e32830ef5b6; Bern C, 2011, ADV PARASIT, V75, P19, DOI 10.1016/B978-0-12-385863-4.00002-2; Brasil PEAA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-337; Britto CC, 2009, MEM I OSWALDO CRUZ, V104, P122, DOI 10.1590/S0074-02762009000900018; Cordero EM, 2009, J PROTEOME RES, V8, P3642, DOI 10.1021/pr800887u; Debrabant A, 2000, J BIOL CHEM, V275, P16366, DOI 10.1074/jbc.M908725199; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; DIAZ C, 1992, AM J TROP MED HYG, V46, P616, DOI 10.4269/ajtmh.1992.46.616; Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419; FAUCHER JF, 1995, PARASITOL RES, V81, P441, DOI 10.1007/BF00931508; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Gorlin J, 2008, TRANSFUSION, V48, P531, DOI 10.1111/j.1537-2995.2007.01566.x; Guthrie JW, 2006, METHODS, V38, P324, DOI 10.1016/j.ymeth.2006.01.001; Homann M, 1999, NUCLEIC ACIDS RES, V27, P2006, DOI 10.1093/nar/27.9.2006; Huang FQ, 2008, NAT PROTOC, V3, P1848, DOI 10.1038/nprot.2008.185; Huang Y, 1997, BIOCHEMISTRY-US, V36, P8231, DOI 10.1021/bi962674l; Jhaveri SD, 2001, CURR PROTOC NUCL ACI; Keefe AD, 2008, CURR OPIN CHEM BIOL, V12, P448, DOI 10.1016/j.cbpa.2008.06.028; Lescure FX, 2010, LANCET INFECT DIS, V10, P556, DOI 10.1016/S1473-3099(10)70098-0; LINGNER J, 1993, NUCLEIC ACIDS RES, V21, P2917, DOI 10.1093/nar/21.12.2917; Lorger M, 2003, EUKARYOT CELL, V2, P84, DOI 10.1128/EC.2.1.84-94.2003; Marro ML, 2006, BIOCHEM BIOPH RES CO, V349, P270, DOI 10.1016/j.bbrc.2006.08.029; Martin JA, 2011, MOL BIOSYST, V7, P1720, DOI 10.1039/c0mb00311e; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Padilla R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf138; Andreu GLP, 2009, ARZNEIMITTELFORSCH, V59, P207; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Schijman AG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000931; Shamah SM, 2008, ACCOUNTS CHEM RES, V41, P130, DOI 10.1021/ar700142z; Takemura K, 2006, EXP BIOL MED, V231, P204; Teixeira ARL, 2006, POSTGRAD MED J, V82, P788, DOI 10.1136/pgmj.2006.047357; Torres-Chavolla E, 2009, BIOSENS BIOELECTRON, V24, P3175, DOI 10.1016/j.bios.2008.11.010; Ulrich H, 2002, J BIOL CHEM, V277, P20756, DOI 10.1074/jbc.M111859200; Vant-Hull B., 2000, CURR PROTOC NUCL ACI; VOLLER A, 1977, T ROY SOC TROP MED H, V71, P431, DOI 10.1016/0035-9203(77)90046-3; Zuker M, 1994, Methods Mol Biol, V25, P267; Zulantay I, 2011, J ANTIMICROB CHEMOTH, V66, P2224, DOI 10.1093/jac/dkr313	40	35	39	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43533	10.1371/journal.pone.0043533	http://dx.doi.org/10.1371/journal.pone.0043533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927983	gold, Green Published, Green Submitted			2022-12-25	WOS:000308286300063
J	Fagundo, AB; de la Torre, R; Jimenez-Murcia, S; Aguera, Z; Granero, R; Tarrega, S; Botella, C; Banos, R; Fernandez-Real, JM; Rodriguez, R; Forcano, L; Fruhbeck, G; Gomez-Ambrosi, J; Tinahones, FJ; Fernandez-Garcia, JC; Casanueva, FF; Fernandez-Aranda, F				Fagundo, Ana B.; de la Torre, Rafael; Jimenez-Murcia, Susana; Agueera, Zaida; Granero, Roser; Tarrega, Salome; Botella, Cristina; Banos, Rosa; Fernandez-Real, Jose M.; Rodriguez, Roser; Forcano, Laura; Fruehbeck, Gema; Gomez-Ambrosi, Javier; Tinahones, Francisco J.; Fernandez-Garcia, Jose C.; Casanueva, Felipe F.; Fernandez-Aranda, Fernando			Executive Functions Profile in Extreme Eating/Weight Conditions: From Anorexia Nervosa to Obesity	PLOS ONE			English	Article							IOWA-GAMBLING-TASK; EATING-DISORDERS; DECISION-MAKING; COGNITIVE FUNCTION; SHARED RISK; OVERWEIGHT; BULIMIA; UNDERWEIGHT; ADDICTION; DEFICITS	Background: Extreme weight conditions (EWC) groups along a continuum may share some biological risk factors and intermediate neurocognitive phenotypes. A core cognitive trait in EWC appears to be executive dysfunction, with a focus on decision making, response inhibition and cognitive flexibility. Differences between individuals in these areas are likely to contribute to the differences in vulnerability to EWC. The aim of the study was to investigate whether there is a common pattern of executive dysfunction in EWC while comparing anorexia nervosa patients (AN), obese subjects (OB) and healthy eating/weight controls (HC). Methods: Thirty five AN patients, fifty two OB and one hundred thirty seven HC were compared using the Wisconsin Card Sorting Test (WCST); Stroop Color and Word Test (SCWT); and Iowa Gambling Task (IGT). All participants were female, aged between 18 and 60 years. Results: There was a significant difference in IGT score (F(1.79); p<.001), with AN and OB groups showing the poorest performance compared to HC. On the WCST, AN and OB made significantly more errors than controls (F(25.73); p<.001), and had significantly fewer correct responses (F(2.71); p<.001). Post hoc analysis revealed that the two clinical groups were not significantly different from each other. Finally, OB showed a significant reduced performance in the inhibition response measured with the Stroop test (F(5.11); p<.001) compared with both AN and HC. Conclusions: These findings suggest that EWC subjects (namely AN and OB) have similar dysfunctional executive profile that may play a role in the development and maintenance of such disorders.	[Fagundo, Ana B.; Jimenez-Murcia, Susana; Fernandez-Aranda, Fernando] Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain; [de la Torre, Rafael; Jimenez-Murcia, Susana; Agueera, Zaida; Granero, Roser; Tarrega, Salome; Botella, Cristina; Banos, Rosa; Fernandez-Real, Jose M.; Rodriguez, Roser; Forcano, Laura; Fruehbeck, Gema; Gomez-Ambrosi, Javier; Tinahones, Francisco J.; Fernandez-Garcia, Jose C.; Casanueva, Felipe F.; Fernandez-Aranda, Fernando] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Madrid, Spain; [de la Torre, Rafael] IMIM Hosp Mar Res Inst, Neurosci Res Program, Human Pharmacol & Clin Neurosci Res Grp, Barcelona, Spain; [Jimenez-Murcia, Susana; Fernandez-Aranda, Fernando] Univ Barcelona, Sch Med, Dept Clin Sci, E-08007 Barcelona, Spain; [Granero, Roser; Tarrega, Salome] Univ Autonoma Barcelona, Dept Psicobiol & Metodol, Lab Estadist Aplicada, Barcelona, Spain; [Botella, Cristina] Univ Jaume 1, Dept Basic Psychol Clin & Psychobiol, Castellon de La Plana, Spain; [Banos, Rosa] Univ Valencia, Dept Pyschol Personal Evaluat & Treatment, E-46003 Valencia, Spain; [Fernandez-Real, Jose M.; Rodriguez, Roser] Hosp Dr Josep Trueta, Inst Invest Biomed Girona IdlBGi, Serv Diabet Endocrinol & Nutr, Girona, Spain; [Fruehbeck, Gema; Gomez-Ambrosi, Javier] Univ Navarra, Dept Endocrinol, E-31080 Pamplona, Spain; [Tinahones, Francisco J.; Fernandez-Garcia, Jose C.] Hosp Clin Univ Virgen de Victoria, Serv Diabet Endocrinol & Nutr, Malaga, Spain; [Casanueva, Felipe F.] Univ Santiago de Compostela, Complejo Hosp U de Santiago, Div Endocrine, Santiago De Compostela, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Barcelona; Autonomous University of Barcelona; Universitat Jaume I; University of Valencia; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; University of Navarra; Universidade de Santiago de Compostela	Fagundo, AB (corresponding author), Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain.	ffernandez@bellvitgehospital.cat	García, José Carlos Fernández/X-3910-2019; Fernandez-Aranda, Fernando/L-9762-2014; Fernández-Real, Jose Manuel/AGH-3599-2022; Tárrega, Salomé/D-8876-2011; AGÜERA, ZAIDA/K-9771-2014; Granero, Roser/S-3529-2019; de la Torre, Rafael/D-3561-2018; Tinahones, Francisco José/AAB-2882-2020; Botella, Cristina/F-9230-2010; Fernandez-Garcia, Jose Carlos/B-5312-2013; FORCANO, LAURA/AAP-1933-2020; Larrea, Salomé Tárrega/AAE-2684-2020; BAÑOS, ROSA MARIA/C-6077-2011; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Gómez-Ambrosi, Javier/D-2984-2017; García, José Carlos Fernández/B-3723-2013; Granero, Roser/F-9492-2016; JIMENEZ-MURCIA, SUSANA/L-9786-2014; Gamazo, Laura Forcano/B-1154-2017	García, José Carlos Fernández/0000-0003-2308-2865; Fernandez-Aranda, Fernando/0000-0002-2968-9898; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Tárrega, Salomé/0000-0002-5820-6795; AGÜERA, ZAIDA/0000-0003-4453-4939; de la Torre, Rafael/0000-0002-6765-1866; Botella, Cristina/0000-0001-8783-6959; Fernandez-Garcia, Jose Carlos/0000-0003-2229-8488; FORCANO, LAURA/0000-0002-8478-1451; Larrea, Salomé Tárrega/0000-0002-5820-6795; BAÑOS, ROSA MARIA/0000-0003-0626-7665; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Gómez-Ambrosi, Javier/0000-0001-5601-1604; García, José Carlos Fernández/0000-0003-2308-2865; Granero, Roser/0000-0001-6308-3198; JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; Gamazo, Laura Forcano/0000-0002-8478-1451; Fagundo, Ana Beatriz/0000-0003-1703-9457; Tinahones, Francisco J/0000-0001-6871-4403	Fondo de Investigacion Sanitaria -FIS [PI081714, PI11/210]; AGAUR [2009SGR1554, 2009SGR718]; Ministerio de Ciencia e Innovacion Subprograma Juan de la Cierva [JCI-2011-09248]; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn); CIBER Salud Mental (CIBERsam); initiative of ISCIII	Fondo de Investigacion Sanitaria -FIS(Instituto de Salud Carlos III); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Ministerio de Ciencia e Innovacion Subprograma Juan de la Cierva(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn); CIBER Salud Mental (CIBERsam); initiative of ISCIII	Financial support was received from Fondo de Investigacion Sanitaria -FIS (PI081714; PI11/210) and AGAUR (2009SGR1554, 2009SGR718); Ministerio de Ciencia e Innovacion Subprograma Juan de la Cierva (JCI-2011-09248); CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn) and CIBER Salud Mental (CIBERsam), are an initiative of ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna C, 2010, NEUROTOX RES, V18, P416, DOI 10.1007/s12640-010-9194-y; Altamirano LJ, 2010, PSYCHOL SCI, V21, P1377, DOI 10.1177/0956797610381505; Anderluh MB, 2003, AM J PSYCHIAT, V160, P242, DOI 10.1176/appi.ajp.160.2.242; APA, 2000, DSM 4 TR DIAGN STAT; Avena NM, 2008, NEUROSCIENCE, V156, P865, DOI 10.1016/j.neuroscience.2008.08.017; Avena NM, 2011, NEUROPHARMACOLOGY; Bayless John D, 2002, Ann Clin Psychiatry, V14, P203, DOI 10.1023/A:1021905916252; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Boeka AG, 2006, J INT NEUROPSYCH SOC, V12, P741, DOI 10.1017/S1355617706060887; Bosanac P, 2007, INT J EAT DISORDER, V40, P613, DOI 10.1002/eat.20412; Brogan A, 2010, J INT NEUROPSYCH SOC, V16, P711, DOI 10.1017/S1355617710000354; Bulik CM, 2003, AM J PSYCHIAT, V160, P366, DOI 10.1176/appi.ajp.160.2.366; Bulik CM, 2003, INT J EAT DISORDER, V33, P293, DOI 10.1002/eat.10140; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Carter FA, 2012, APPETITE; Casper RC, 2008, PSYCHOPHARMACOLOGY, V199, P313, DOI 10.1007/s00213-008-1102-2; Cavedini P, 2006, PSYCHIAT RES, V145, P179, DOI 10.1016/j.psychres.2004.12.014; Cohen JI, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000175; Danner UN, 2012, EUR EAT DISORD REV, V20, pe56, DOI 10.1002/erv.1098; Davis C, 2009, APPETITE, V53, P1, DOI 10.1016/j.appet.2009.05.018; Derogatis L, 1990, SCL 90 R BIBLIOGRAPH; Eddy KT, 2011, AM J PSYCHIAT, V168, P1139, DOI 10.1176/appi.ajp.2011.11071125; Fassino S, 2002, INT J EAT DISORDER, V31, P274, DOI 10.1002/eat.10028; Figlewicz DP, 2011, AM J PHYSIOL-REG I, V300, pR876, DOI 10.1152/ajpregu.00655.2010; First M. D., 1996, USERS GUIDE STRUCTUR; Garner DM, 1991, EATING DISORDER INVE; Gillberg IC, 2010, J CLIN EXP NEUROPSYC, V32, P358, DOI 10.1080/13803390903066857; Golden C.J., 1978, STROOP COLOR WORD TE; Goldschmidt AB, 2008, BEHAV RES THER, V46, P777, DOI 10.1016/j.brat.2008.03.004; Goldschmidt AB, 2008, OBESITY, V16, P257, DOI 10.1038/oby.2007.48; Goossens L, 2009, EUR EAT DISORD REV, V17, P68, DOI 10.1002/erv.892; Grunwald M, 2001, INT J EAT DISORDER, V29, P417, DOI 10.1002/eat.1038; Haines J, 2006, HEALTH EDUC RES, V21, P770, DOI 10.1093/her/cyl094; Haines J, 2010, ARCH PEDIAT ADOL MED, V164, P336, DOI 10.1001/archpediatrics.2010.19; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Heaton, 1981, WISCONSIN CARD SORTI; Hill AJ, 2007, OBES REV, V8, P151, DOI 10.1111/j.1467-789X.2007.00335.x; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Jauregui-Lobera I, 2012, NEUROPSYCH DIS TREAT, V8, P1, DOI 10.2147/NDT.S27302; Jauregui-Lobera I, 2011, NEUROPSYCH DIS TREAT, V7, P577, DOI 10.2147/NDT.S25186; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; Lauer CJ, 1999, J PSYCHIATR RES, V33, P129, DOI 10.1016/S0022-3956(98)00020-X; Lee EB, 2011, ANN NY ACAD SCI, V1243, P15, DOI 10.1111/j.1749-6632.2011.06274.x; Lena SM, 2004, NEUROPSYCHOL REV, V14, P99, DOI 10.1023/B:NERV.0000028081.40907.de; Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836; Loeb C, 2012, EAT DISORD, V20, P173, DOI 10.1080/10640266.2012.654063; Lopez C, 2008, INT J EAT DISORDER, V41, P143, DOI 10.1002/eat.20478; Maayan L, 2011, OBESITY, V19, P1382, DOI 10.1038/oby.2011.15; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mobbs O, 2010, PATIENT EDUC COUNS, V79, P372, DOI 10.1016/j.pec.2010.03.003; Moser DJ, 2003, INT J EAT DISORDER, V33, P64, DOI 10.1002/eat.10108; Narita K, 2009, BIOL PSYCHIAT, V65, P992, DOI 10.1016/j.biopsych.2008.10.006; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pieters G, 2003, J PSYCHIATR RES, V37, P501, DOI 10.1016/S0022-3956(03)00067-0; Pignatti R, 2006, Eat Weight Disord, V11, P126; Qiu CX, 2010, J ALZHEIMERS DIS, V20, P689, DOI 10.3233/JAD-2010-091663; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Roberts ME, 2007, PSYCHOL MED, V37, P1075, DOI 10.1017/S0033291707009877; Roemmich JN, 2011, EAT BEHAV, V12, P309, DOI 10.1016/j.eatbeh.2011.07.003; Rose M, 2012, EUR EAT DISORD REV, V20, P32, DOI 10.1002/erv.1095; Rothemund Y, 2011, NEUROSCIENCE, V197, P242, DOI 10.1016/j.neuroscience.2011.09.016; Rubia K, 2011, BIOL PSYCHIAT, V69, pE69, DOI 10.1016/j.biopsych.2010.09.023; Siervo M, 2011, OBES REV, V12, P968, DOI 10.1111/j.1467-789X.2011.00903.x; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Steinglass JE, 2006, J INT NEUROPSYCH SOC, V12, P431, DOI 10.1017/S1355617706060528; Tchanturia K, 2005, INT J EAT DISORDER, V37, pS72, DOI 10.1002/eat.20119; Tchanturia Kate, 2007, Ann Gen Psychiatry, V6, P14, DOI 10.1186/1744-859X-6-14; Tchanturia K, 2007, J INT NEUROPSYCH SOC, V13, P635, DOI 10.1017/S1355617707070798; Tchanturia K, 2012, EUR EAT DISORD REV, V20, P169, DOI 10.1002/erv.1154; Van Den Eynde F, 2009, CHILD ADOL PSYCH CL, V18, P95, DOI 10.1016/j.chc.2008.07.016; Villarejo C, 2012, EUR EAT DISORD REV, V20, P250, DOI 10.1002/erv.2166; Volkow N. D., 2011, CURR TOP BEHAV NEURO; Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wilbertz G, 2012, NEUROIMAGE, V60, P353, DOI 10.1016/j.neuroimage.2011.12.011; Williamson DA, 2002, AM J PSYCHIAT, V159, P412, DOI 10.1176/appi.ajp.159.3.412; Wilsdon A, 2006, J PSYCHIATR RES, V40, P746, DOI 10.1016/j.jpsychires.2005.10.006; Wilson GT, 2010, EUR EAT DISORD REV, V18, P341, DOI 10.1002/erv.1048; Zelazo P. D., 2007, HDB EMOTION REGULATI, P135; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212	81	153	154	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43382	10.1371/journal.pone.0043382	http://dx.doi.org/10.1371/journal.pone.0043382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992PA	22927962	Green Published, Green Submitted, gold			2022-12-25	WOS:000307789700032
J	Horne, AW; Brown, JK; Tong, S; Kaitu'u-Lino, T				Horne, Andrew W.; Brown, Jeremy K.; Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha			Evaluation of ADAM-12 as a Diagnostic Biomarker of Ectopic Pregnancy in Women with a Pregnancy of Unknown Location	PLOS ONE			English	Article							MANAGEMENT	Background: Ectopic pregnancy (EP) remains the most life-threatening acute condition in modern gynaecology. It remains difficult to diagnose early and accurately. Women often present at emergency departments in early pregnancy with a 'pregnancy of unknown location' (PUL) and diagnosis/exclusion of EP is challenging due to a lack of reliable biomarkers. Recent studies suggest that serum levels of a disintegrin and metalloprotease protein-12 (ADAM-12) can be used differentiate EP from viable intrauterine pregnancy (VIUP). Here we describe a prospective study evaluating the performance of ADAM-12 in differentiating EP from the full spectrum of alternative PUL outcomes in an independent patient cohort. Methodology/Principal Findings: Sera were collected from 120 patients at their first clinical presentation with a PUL and assayed for ADAM-12 by ELISA. Patients were categorized according to final pregnancy outcomes. Serum ADAM-12 concentrations were increased in women with histologically-confirmed EP (median 442 pg/mL; 25%-75% percentile 232783 pg/mL) compared to women with VIUP (256 pg/mL; 168-442 pg/mL) or miscarriage (192 pg/mL; 133-476 pg/mL). Serum ADAM-12 did not differentiate histologically-confirmed EP from spontaneously resolving PUL (srPUL) (416 pg/mL; 154-608 pg/mL). The diagnostic potential of ADAM-12 was only significant when 'ambiguous' PUL outcomes were excluded from the analysis (AROC = 0.6633; P = 0.03901). Conclusions/Significance: When measured in isolation, ADAM-12 levels had limited value as a diagnostic biomarker for EP in our patient cohort. The development of a reliable serum biomarker-based test for EP remains an ongoing challenge.	[Horne, Andrew W.; Brown, Jeremy K.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha] Mercy Hosp Women, Translat Obstet Grp, Heidelberg, Vic, Australia	University of Edinburgh	Horne, AW (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	andrew.horne@ed.ac.uk		Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737; Tong, Stephen/0000-0002-2319-0586; Horne, Andrew/0000-0002-9656-493X	Australian National Health and Medical Research Council [1008276, 606611]; United Kingdom Medical Research Council (MRC) [G0802808]; MRC [G1002033, G0802808] Funding Source: UKRI; Medical Research Council [G0802808, G1002033] Funding Source: researchfish	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the Australian National Health and Medical Research Council (#1008276; #606611) and by the United Kingdom Medical Research Council (MRC G0802808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart K, 2011, EXPERT REV MOL DIAGN, V11, P759, DOI [10.1586/erm.11.72, 10.1586/ERM.11.72]; Barnhart K, 2011, FERTIL STERIL, V95, P857, DOI 10.1016/j.fertnstert.2010.09.006; Condous G, 2004, HUM REPROD, V19, P1900, DOI 10.1093/humrep/deh341; Horne AW, 2010, ACTA OBSTET GYN SCAN, V89, P299, DOI 10.3109/00016340903568191; Jurkovic D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3397; Kirk E, 2007, HUM REPROD, V22, P2824, DOI 10.1093/humrep/dem283; Laigaard J, 2006, PRENATAL DIAG, V26, P973, DOI 10.1002/pd.1540; Rausch ME, 2011, FERTIL STERIL, V95, P1373, DOI 10.1016/j.fertnstert.2010.12.040; Sahraravand M, 2011, PLACENTA, V32, P999, DOI 10.1016/j.placenta.2011.10.005; Sivalingam VN, 2011, J FAM PLAN REPROD H, V37, P231, DOI 10.1136/jfprhc-2011-0073; Torring N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-129; Wedderburn CJ, 2010, HUM REPROD, V25, P328, DOI 10.1093/humrep/dep397; Wiwanitkit V, 2011, FERTIL STERIL, V95, pE21, DOI 10.1016/j.fertnstert.2011.02.027	13	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e41442	10.1371/journal.pone.0041442	http://dx.doi.org/10.1371/journal.pone.0041442			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927907	Green Published, gold			2022-12-25	WOS:000307789700003
J	O'Rorke, R; Lavery, S; Chow, S; Takeyama, H; Tsai, P; Beckley, LE; Thompson, PA; Waite, AM; Jeffs, AG				O'Rorke, Richard; Lavery, Shane; Chow, Seinen; Takeyama, Haruko; Tsai, Peter; Beckley, Lynnath E.; Thompson, Peter A.; Waite, Anya M.; Jeffs, Andrew G.			Determining the Diet of Larvae of Western Rock Lobster (Panulirus cygnus) Using High-Throughput DNA Sequencing Techniques	PLOS ONE			English	Article							PHYLLOSOMA LARVAE; JASUS-EDWARDSII; COLONIAL RADIOLARIAN; MOLECULAR ANALYSIS; SAGITTA GAZELLAE; STAGE PHYLLOSOMA; LEEUWIN CURRENT; FECAL PELLETS; PREY DNA; SP-NOV	The Western Australian rock lobster fishery has been both a highly productive and sustainable fishery. However, a recent dramatic and unexplained decline in post-larval recruitment threatens this sustainability. Our lack of knowledge of key processes in lobster larval ecology, such as their position in the food web, limits our ability to determine what underpins this decline. The present study uses a high-throughput amplicon sequencing approach on DNA obtained from the hepatopancreas of larvae to discover significant prey items. Two short regions of the 18S rRNA gene were amplified under the presence of lobster specific PNA to prevent lobster amplification and to improve prey amplification. In the resulting sequences either little prey was recovered, indicating that the larval gut was empty, or there was a high number of reads originating from multiple zooplankton taxa. The most abundant reads included colonial Radiolaria, Thaliacea, Actinopterygii, Hydrozoa and Sagittoidea, which supports the hypothesis that the larvae feed on multiple groups of mostly transparent gelatinous zooplankton. This hypothesis has prevailed as it has been tentatively inferred from the physiology of larvae, captive feeding trials and co-occurrence in situ. However, these prey have not been observed in the larval gut as traditional microscopic techniques cannot discern between transparent and gelatinous prey items in the gut. High-throughput amplicon sequencing of gut DNA has enabled us to classify these otherwise undetectable prey. The dominance of the colonial radiolarians among the gut contents is intriguing in that this group has been historically difficult to quantify in the water column, which may explain why they have not been connected to larval diet previously. Our results indicate that a PCR based technique is a very successful approach to identify the most abundant taxa in the natural diet of lobster larvae.	[O'Rorke, Richard; Lavery, Shane; Jeffs, Andrew G.] Univ Auckland, Leigh Marine Lab, Warkworth, New Zealand; [Lavery, Shane; Tsai, Peter] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Chow, Seinen] Natl Res Inst Fisheries Sci, Yokosuka, Kanagawa, Japan; [Takeyama, Haruko] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan; [Beckley, Lynnath E.] Murdoch Univ, Sch Environm Sci, Murdoch, WA 6150, Australia; [Thompson, Peter A.] Australian Commonwealth Sci Ind & Res Org, Hobart, Tas, Australia; [Waite, Anya M.] Univ Western Australia, Sch Environm Syst Engn, Crawley, WA, Australia; [Waite, Anya M.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia	University of Auckland; University of Auckland; Japan Fisheries Research & Education Agency (FRA); Waseda University; Murdoch University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Western Australia	O'Rorke, R (corresponding author), Univ Auckland, Leigh Marine Lab, Warkworth, New Zealand.	roro002@aucklanduni.ac.nz	Waite, Anya M/A-5492-2015; O'Rorke, Richard/C-9281-2011; Jeffs, Andrew G/D-9474-2012; Thompson, Peter A/A-2361-2012; Lavery, Shane/AFX-7929-2022	Waite, Anya M/0000-0003-2965-0296; O'Rorke, Richard/0000-0002-9304-2677; Thompson, Peter A/0000-0002-9504-5433; Lavery, Shane/0000-0003-3038-292X; Tsai, Peter/0000-0002-9930-9029; Jeffs, Andrew/0000-0002-8504-1949	Fisheries Research and Development Council Australia under FRDC PROJECT [2010/047]; Australian Marine National Facility [SS05-2010]; Fisheries WA	Fisheries Research and Development Council Australia under FRDC PROJECT; Australian Marine National Facility; Fisheries WA	The experimental component of this project was funded by a grant from the Fisheries Research and Development Council Australia (http://www.frdc.com.au/) under FRDC PROJECT NUMBER: 2010/047, and ship time was provided by the Australian Marine National Facility under grant SS05-2010 (http://www.csiro.au/Organisation-Structure/National-Facilities/Marine-National-Facility.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Captain, crew and scientific team of R. V. Southern Surveyor voyage 2010-05. Liam Williams of the University of Auckland CGP (now a part of NZGL) for his knowledgeable input into the sequencing process. Nick Caputi and Fisheries WA for their support and advice.	ABARES, 2011, AUSTR FISH STAT 2010; Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; ANGEL DL, 1991, SYMBIOSIS, V10, P195; Armougom F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-576; Baier CT, 1997, MAR ECOL PROG SER, V146, P37, DOI 10.3354/meps146037; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Blankenship LE, 2005, MOL ECOL, V14, P891, DOI 10.1111/j.1365-294X.2005.02448.x; Braine SJ, 1979, ILLUSTRATED KEY NOTE, P1; Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39; Brown R. S., 2009, W ROCK LOBSTER LOW P, P1; Budowle B, 2009, FORENS SCI INT-GEN S, V2, P551, DOI 10.1016/j.fsigss.2009.08.082; Caputi N, 2001, MAR FRESHWATER RES, V52, P1167, DOI 10.1071/MF01180; Caputi N, 2008, FISH OCEANOGR, V17, P147, DOI 10.1111/j.1365-2419.2008.00471.x; Chariton AA, 2010, FRONT ECOL ENVIRON, V8, P233, DOI 10.1890/090115; Chow S, 2011, MAR BIOTECHNOL, V13, P305, DOI 10.1007/s10126-010-9301-3; Cox SL, 2004, MAR FRESHWATER RES, V55, P145, DOI 10.1071/MF03175; Cox SL, 2003, REV FISH SCI, V11, P89, DOI 10.1080/713610924; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Dennett MR, 2002, J PLANKTON RES, V24, P797, DOI 10.1093/plankt/24.8.797; Dilling L, 1998, MAR ECOL PROG SER, V170, P189, DOI 10.3354/meps170189; DILLING L, 1993, MAR ECOL PROG SER, V92, P51, DOI 10.3354/meps092051; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Froneman PW, 1998, POLAR BIOL, V19, P242, DOI 10.1007/s003000050241; Gast RJ, 2004, APPL ENVIRON MICROB, V70, P2028, DOI 10.1128/AEM.70.4.2028-2037.2004; Giesecke R, 2010, POLAR BIOL, V33, P293, DOI 10.1007/s00300-009-0704-4; Hardy CM, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04411.x; Harwood JD, 2008, ENVIRON ENTOMOL, V37, P990, DOI 10.1603/0046-225X(2008)37[990:ASNSAP]2.0.CO;2; HERRNKIND W, 1976, B MAR SCI, V26, P110; Holland SM, 2009, ANAL RAREFACTION 2 0; Janssen J, 2009, J MAR BIOL ASSOC UK, V61, P917; Jeffs AG, 2004, COMP BIOCHEM PHYS B, V137, P487, DOI 10.1016/j.cbpc.2004.02.003; Jeffs AG, 2001, MAR FRESHWATER RES, V52, P1211, DOI 10.1071/MF01182; JEFFS AG, 2001, P INT S LOBST HLTH M, P64; Jeffs Andrew, 2007, Bulletin of Fisheries Research Agency, P9; Johnston DJ, 2004, COMP BIOCHEM PHYS B, V138, P137, DOI 10.1016/j.cbpc.2004.02.013; Johnston M, 2008, J CRUSTACEAN BIOL, V28, P46, DOI 10.1651/06-2814R.1; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Larsen JB, 2005, MAR BIOL, V146, P1119, DOI 10.1007/s00227-004-1524-2; LEMMENS JWTJ, 1994, J MORPHOL, V220, P271, DOI 10.1002/jmor.1052200306; Limbourn AJ, 2009, MAR FRESHWATER RES, V60, P810, DOI 10.1071/MF08244; Limbourn AJ, 2009, COMP BIOCHEM PHYS B, V152, P292, DOI 10.1016/j.cbpb.2008.12.009; McWilliam PS, 2007, REV FISH BIOL FISHER, V17, P615, DOI 10.1007/s11160-007-9067-5; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mitchell J, 1971, FOOD PREFERENCES FEE, P110; Mochioka N, 1996, MAR BIOL, V125, P447; NISHIDA S, 1990, J CRUSTACEAN BIOL, V10, P293, DOI 10.2307/1548488; O'Rorke R, 2012, MOL ECOL RESOUR, V12, P5, DOI 10.1111/j.1755-0998.2011.03091.x; ORUM H, 1993, NUCLEIC ACIDS RES, V21, P5332, DOI 10.1093/nar/21.23.5332; Pawlowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018169; PEARCE AF, 1988, J CONSEIL, V45, P13; Phillips BF, 2006, COMP BIOCHEM PHYS B, V143, P219, DOI 10.1016/j.cbpb.2005.11.009; PHILLIPS BF, 1979, AUST J MAR FRESH RES, V30, P773; Phillips BF, 2009, REV FISH BIOL FISHER, V19, P193, DOI 10.1007/s11160-008-9099-5; Phleger CF, 2001, MAR FRESHWATER RES, V52, P1475, DOI 10.1071/MF01071; POMEROY LR, 1984, B MAR SCI, V35, P426; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Prokopowich CD, 2003, GENOME, V46, P48, DOI [10.1139/g02-103, 10.1139/G02-103]; RITZ DA, 1972, MAR BIOL, V13, P309, DOI 10.1007/BF00348078; Roche, 2010, GS JUN SYST GUID AMP; Roche, 2011, TECHN B GS FLX SYST; Saunders MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036580; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Shojima Y., 1963, Bulletin of the Japanese Society of Scientific Fisheries, V29, P349; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Stemmann L, 2008, ICES J MAR SCI, V65, P433, DOI 10.1093/icesjms/fsn010; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Suzuki N, 2008, MAR BIOTECHNOL, V10, P49, DOI 10.1007/s10126-007-9038-9; Suzuki N, 2006, FISHERIES SCI, V72, P342, DOI 10.1111/j.1444-2906.2006.01155.x; Suzuki Nobuaki, 2007, Bulletin of Fisheries Research Agency, P1; SWANBERG NR, 1981, DEEP-SEA RES, V28, P1033, DOI 10.1016/0198-0149(81)90016-9; SWANBERG NR, 1980, DEEP-SEA RES, V27, P715, DOI 10.1016/0198-0149(80)90024-2; Terahara T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025715; THOMAS LR, 1963, NATURE, V198, P208, DOI 10.1038/198208a0; TIPPER JC, 1979, PALEOBIOLOGY, V5, P423, DOI 10.1017/S0094837300016924; Tong LJ, 1997, MAR FRESHWATER RES, V48, P935, DOI 10.1071/MF97073; Turner JT, 2002, AQUAT MICROB ECOL, V27, P57, DOI 10.3354/ame027057; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; van Oorschot Roland Ah, 2010, Investig Genet, V1, P14, DOI 10.1186/2041-2223-1-14; VANDERAUWERA G, 1994, FEBS LETT, V338, P133, DOI 10.1016/0014-5793(94)80350-1; Vestheim H, 2011, METHODS MOL BIOL, V687, P265, DOI 10.1007/978-1-60761-944-4_19; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Waite AM, 2007, DEEP-SEA RES PT II, V54, P1055, DOI 10.1016/j.dsr2.2006.12.010; Wilkin JL., 2011, LIMNOLOGY OCEANOGRAP, V1, P163, DOI [10.1215/21573698-1504363, DOI 10.1215/21573698-1504363]; Zettler LAA, 1999, MAR MICROPALEONTOL, V36, P67, DOI 10.1016/S0377-8398(98)00028-0	92	74	76	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42757	10.1371/journal.pone.0042757	http://dx.doi.org/10.1371/journal.pone.0042757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927937	Green Published, gold			2022-12-25	WOS:000307789700015
J	Shi, YY; Wu, XB; Huang, ZY; Wang, ZL; Yan, WY; Zeng, ZJ				Shi, Yuan Yuan; Wu, Xiao Bo; Huang, Zachary Y.; Wang, Zi Long; Yan, Wei Yu; Zeng, Zhi Jiang			Epigenetic Modification of Gene Expression in Honey Bees by Heterospecific Gland Secretions	PLOS ONE			English	Article							DIVISION-OF-LABOR; APIS-MELLIFERA; NEUREXIN-I; MICRORNAS; TRANSCRIPTOMES; NEUROLIGINS; BIOGENESIS; MECHANISMS; GENOMICS; QUEEN	Background: In the honey bee (Apis mellifera), queen and workers have different behavior and reproductive capacity despite possessing the same genome. The primary substance that leads to this differentiation is royal jelly (RJ), which contains a range of proteins, amino acids, vitamins and nucleic acids. MicroRNA (miRNA) has been found to play an important role in regulating the expression of protein-coding genes and cell biology. In this study, we characterized the miRNAs in RJ from two honey bee sister species and determined their possible effect on transcriptome in one species. Methodology/Principal Findings: We sequenced the miRNAs in RJ either from A. mellifera (RJM) or A. cerana (RJC). We then determined the global transcriptomes of adult A. mellifera developed from larvae fed either with RJM (mRJM) or RJC (mRJC). Finally we analyzed the target genes of those miRNA that are species specific or differentially expressed in the two honey bee species. We show that there were differences in miRNA between RJM and RJC, and that transcriptomes of adult A. mellifera were affected by the two types of RJ. A high proportion (23.3%) of the affected genes were target genes of differential miRNAs. Conclusion: We show for the first time that there are differences in miRNAs in RJ between A. mellifera and A. cerana. Further, the differences in transcriptomes of bees reared from these two RJs might be related to miRNA differences of the two species. This study provides the first evidence that heterospecific royal jelly can modify gene expression in honey bees through an epigenetic mechanism.	[Shi, Yuan Yuan; Wu, Xiao Bo; Wang, Zi Long; Yan, Wei Yu; Zeng, Zhi Jiang] Jiangxi Agr Univ, Honeybee Res Inst, Nanchang, Jiangxi, Peoples R China; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Huang, Zachary Y.] Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA	Jiangxi Agricultural University; Michigan State University; Michigan State University	Shi, YY (corresponding author), Jiangxi Agr Univ, Honeybee Res Inst, Nanchang, Jiangxi, Peoples R China.	bees1965@sina.com	Huang, Zachary/D-5485-2011; Wang, Zhiquan/HHS-6768-2022	Huang, Zachary/0000-0001-5354-5547; 	Earmarked Fund for China Agriculture Research System [CARS-45-KXJ12]; National Natural Science Foundation of China [31060327]; Doctoral Fund of Ministry of Education of China [20103603110003]	Earmarked Fund for China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported by the Earmarked Fund for China Agriculture Research System (No. CARS-45-KXJ12), the National Natural Science Foundation of China (No. 31060327) and Doctoral Fund of Ministry of Education of China (No. 20103603110003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; [Anonymous], BIOGEOGRAPHY TAXONOM, DOI DOI 10.1007/978-3-642-72649-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behura SK, 2010, INSECT MOL BIOL, V19, P431, DOI 10.1111/j.1365-2583.2010.01010.x; Behura SK, 2007, INSECT BIOCHEM MOLEC, V37, P3, DOI 10.1016/j.ibmb.2006.10.006; Biswas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009133; Biswas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003542; Blum MS, 2000, J CHEM ECOL, V26, P801, DOI 10.1023/A:1005476405192; Chen X, 2010, INSECT MOL BIOL, V19, P799, DOI 10.1111/j.1365-2583.2010.01039.x; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Chittka A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000532; de Azevedo SV, 2008, J INSECT PHYSIOL, V54, P1064, DOI 10.1016/j.jinsphys.2008.04.009; Drapeau MD, 2006, GENOME RES, V16, P1385, DOI 10.1101/gr.5012006; Fang Y, 2010, J PROTEOME RES, V9, P2207, DOI 10.1021/pr900979h; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Greenberg JK, 2012, GENES BRAIN BEHAV, DOI [10.1111/j.1601-183X.2012.00782-x, DOI 10.1111/J.1601-183X.2012.00782-X]; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Guo XQ, 2010, DEV MOL MECH QUEEN W; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hepburn HR, 2011, HONEYBEES OF ASIA, P1, DOI 10.1007/978-3-642-16422-4; Hori S, 2011, APIDOLOGIE, V42, P89, DOI 10.1051/apido/2010032; Jung-Hoffmann I., 1966, BIENENFORSCH, V8, P296; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kucharski R., 2007, Invertebrate Neuroscience, V7, P99, DOI 10.1007/s10158-007-0045-3; Laubinger S, 2010, P NATL ACAD SCI USA, V107, P17466, DOI 10.1073/pnas.1012891107; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu F, 2012, INSECT MOL BIOL, V21, P297, DOI 10.1111/j.1365-2583.2012.01135.x; Maleszka R, 2008, EPIGENETICS-US, V3, P188, DOI 10.4161/epi.3.4.6697; Matsuura H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-228; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Odronitz F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-173; Oldroyd BP, 2006, ASIAN HONEY HEES BIO; Ragan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005745; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; Robinson GE, 2002, AM NAT, V160, pS160, DOI 10.1086/342901; Schwander T, 2010, TRENDS ECOL EVOL, V25, P275, DOI 10.1016/j.tree.2009.12.001; SEELEY TD, 1989, AM SCI, V77, P546; Shi YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018808; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Tan K, 2012, J COMP PHYSIOL A, V198, P319, DOI 10.1007/s00359-012-0710-9; Tautz J, 2008, BUZZ BEES; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Viuda-Martos M, 2008, J FOOD SCI, V73, pR117, DOI 10.1111/j.1750-3841.2008.00966.x; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; WEAVER N, 1966, ANNU REV ENTOMOL, V11, P79, DOI 10.1146/annurev.en.11.010166.000455; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Winston M.L., 1991, BIOL HONEY BEE; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yang GH, 1983, APIS CERANA; Zeng Z.-J, 2009, AGRICULTURE; Zeng ZhiJiang, 2006, Indian Bee Journal, V68, P18	53	18	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43727	10.1371/journal.pone.0043727	http://dx.doi.org/10.1371/journal.pone.0043727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928024	Green Published, Green Submitted, gold			2022-12-25	WOS:000307789700049
J	Shin, H; Lee, JH; Kim, H; Choi, Y; Heu, S; Ryu, S				Shin, Hakdong; Lee, Ju-Hoon; Kim, Hyeryen; Choi, Younho; Heu, Sunggi; Ryu, Sangryeol			Receptor Diversity and Host Interaction of Bacteriophages Infecting Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; LYTIC BACTERIOPHAGES; PHAGE; RESISTANCE; BACTERIA; IDENTIFICATION; THERAPY; BINDING; GENES	Background: Salmonella enterica subspecies enterica serovar Typhimurium is a Gram-negative pathogen causing salmonellosis. Salmonella Typhimurium-targeting bacteriophages have been proposed as an alternative biocontrol agent to antibiotics. To further understand infection and interaction mechanisms between the host strains and the bacteriophages, the receptor diversity of these phages needs to be elucidated. Methodology/Principal Findings: Twenty-five Salmonella phages were isolated and their receptors were identified by screening a Tn5 random mutant library of S. Typhimurium SL1344. Among them, three types of receptors were identified flagella (11 phages), vitamin B-12 uptake outer membrane protein, BtuB (7 phages) and lipopolysaccharide-related O-antigen (7 phages). TEM observation revealed that the phages using flagella (group F) or BtuB (group B) as a receptor belong to Siphoviridae family, and the phages using O-antigen of LPS as a receptor (group L) belong to Podoviridae family. Interestingly, while some of group F phages (F-I) target FliC host receptor, others (F-II) target both FliC and FljB receptors, suggesting that two subgroups are present in group F phages. Cross-resistance assay of group B and L revealed that group L phages could not infect group B phage-resistant strains and reversely group B phages could not infect group L SPN9TCW-resistant strain. Conclusions/Significance: In this report, three receptor groups of 25 newly isolated S. Typhimurium-targeting phages were determined. Among them, two subgroups of group F phages interact with their host receptors in different manner. In addition, the host receptors of group B or group L SPN9TCW phages hinder other group phage infection, probably due to interaction between receptors of their groups. This study provides novel insights into phage-host receptor interaction for Salmonella phages and will inform development of optimal phage therapy for protection against Salmonella.	[Shin, Hakdong; Kim, Hyeryen; Choi, Younho; Ryu, Sangryeol] Seoul Natl Univ, Dept Food & Anim Biotechnol, Dept Agr Biotechnol, Seoul, South Korea; [Shin, Hakdong; Kim, Hyeryen; Choi, Younho; Ryu, Sangryeol] Seoul Natl Univ, Ctr Agr Biomat, Seoul, South Korea; [Lee, Ju-Hoon] Kyung Hee Univ, Dept Food Sci & Biotechnol, Yongin, South Korea; [Heu, Sunggi] Rural Dev Adm, Natl Acad Agr Sci, Microbial Safety Div, Suwon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; Rural Development Administration (RDA)	Shin, H (corresponding author), Seoul Natl Univ, Dept Food & Anim Biotechnol, Dept Agr Biotechnol, Seoul, South Korea.	sangryu@snu.ac.kr	Lee, Ju-Hoon/AAK-7256-2020; Choi, Younho/Y-7282-2019	Choi, Younho/0000-0003-4719-3279; Shin, Hakdong/0000-0001-7615-9809	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [20090078983]; Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (No. 20090078983) and the Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 1987, VIRUSES PROKARYOTES, V1; Anany H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-242; Andreatti RL, 2007, POULTRY SCI, V86, P1904, DOI 10.1093/ps/86.9.1904; Atterbury RJ, 2007, APPL ENVIRON MICROB, V73, P4543, DOI 10.1128/AEM.00049-07; Berngruber TW, 2010, J VIROL, V84, P10200, DOI 10.1128/JVI.00865-10; Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005; Cairns BJ, 2008, ANTIMICROB AGENTS CH, V52, P4344, DOI 10.1128/AAC.00574-08; Cann A.J., 1993, PRINCIPLES MOL VIROL, P173; Carey-Smith GV, 2006, FEMS MICROBIOL LETT, V258, P182, DOI 10.1111/j.1574-6968.2006.00217.x; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; *CDC, 2008, SALM SURV ANN SUMM 2; CDC (Centers for Disease Control and Prevention), 2007, CDC ANN REP 2005; CHAN RK, 1972, VIROLOGY, V50, P883, DOI 10.1016/0042-6822(72)90442-4; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chang JT, 2010, J MOL BIOL, V402, P731, DOI 10.1016/j.jmb.2010.07.058; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Erickson M, 2009, FEMS MICROBIOL LETT, V294, P37, DOI 10.1111/j.1574-6968.2009.01554.x; Ernst RK, 2001, MICROBES INFECT, V3, P1327, DOI 10.1016/S1286-4579(01)01494-0; Fauquet CM, 2005, VIRUS TAXONOMY CLASS; Garcia P, 2008, LETT APPL MICROBIOL, V47, P479, DOI 10.1111/j.1472-765X.2008.02458.x; Greer GG, 2005, J FOOD PROTECT, V68, P1102, DOI 10.4315/0362-028X-68.5.1102; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; HELLER K, 1982, J VIROL, V41, P222, DOI 10.1128/JVI.41.1.222-227.1982; Higgins JP, 2008, AVIAN DIS, V52, P139, DOI 10.1637/8017-050807-ResNote; HILL C, 1989, APPL ENVIRON MICROB, V55, P2416, DOI 10.1128/AEM.55.9.2416-2419.1989; Ho TD, 2001, J BACTERIOL, V183, P1495, DOI 10.1128/JB.183.4.1495-1498.2001; HOFER B, 1995, J BACTERIOL, V177, P3080, DOI 10.1128/jb.177.11.3080-3086.1995; Hong J, 2008, FEMS MICROBIOL LETT, V289, P202, DOI 10.1111/j.1574-6968.2008.01397.x; Hudson JA, 2005, J FOOD PROTECT, V68, P426, DOI 10.4315/0362-028X-68.2.426; Hwang S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022300; ISRAEL V, 1972, J VIROL, V10, P1152, DOI 10.1128/JVI.10.6.1152-1158.1972; Jiang SC, 1998, APPL ENVIRON MICROB, V64, P535; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; KAGAWA H, 1984, J BACTERIOL, V157, P649, DOI 10.1128/JB.157.2.649-654.1984; Kim M, 2011, APPL ENVIRON MICROB, V77, P2042, DOI 10.1128/AEM.02504-10; Kropinski AM, 2007, VIROLOGY, V369, P234, DOI 10.1016/j.virol.2007.07.027; KRUGER DH, 1981, MICROBIOL REV, V45, P9; Kutsukake K, 2006, J BACTERIOL, V188, P950, DOI 10.1128/JB.188.3.950-957.2006; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lee JH, 2011, J VIROL, V85, P13470, DOI 10.1128/JVI.06344-11; Mahichi F, 2009, FEMS MICROBIOL LETT, V295, P211, DOI 10.1111/j.1574-6968.2009.01588.x; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McLaughlin MR, 2008, CURR MICROBIOL, V56, P208, DOI 10.1007/s00284-007-9057-9; McLaughlin MR, 2006, J ENVIRON QUAL, V35, P522, DOI 10.2134/jeq2005.0080; MEAD PS, 1999, FOOD RELATED ILLNESS; O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x; O'Flynn G, 2006, J APPL MICROBIOL, V101, P251, DOI 10.1111/j.1365-2672.2005.02792.x; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; Park M, 2012, APPL ENVIRON MICROB, V78, P58, DOI 10.1128/AEM.06231-11; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Pickard D, 2010, J BACTERIOL, V192, P5746, DOI 10.1128/JB.00659-10; Poppe C, 1998, CAN VET J, V39, P559; Ricci V, 2010, APPL ENVIRON MICROB, V76, P1704, DOI 10.1128/AEM.02681-09; Salgado CJ, 2004, VIRUS GENES, V29, P87, DOI 10.1023/B:VIRU.0000032792.86188.fb; Samuel ADT, 1999, P NATL ACAD SCI USA, V96, P9863, DOI 10.1073/pnas.96.17.9863; Santos SB, 2011, J VIROL, V85, P11265, DOI 10.1128/JVI.01769-10; SCHADE SYLVIA Z., 1967, J VIROL, V1, P599; Serwer Philip, 2009, V501, P55, DOI 10.1007/978-1-60327-164-6_6; Shin H, 2012, J VIROL, V86, P1284, DOI 10.1128/JVI.06696-11; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Villafane R, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-227; Wang JB, 2005, VIROLOGY, V332, P45, DOI 10.1016/j.virol.2004.10.049; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Ye J, 2010, J FOOD PROTECT, V73, P9, DOI 10.4315/0362-028X-73.1.9; Zhang JY, 2010, FOODBORNE PATHOG DIS, V7, P1415, DOI 10.1089/fpd.2010.0621; Zhang X, 1997, INFECT IMMUN, V65, P5381, DOI 10.1128/IAI.65.12.5381-5387.1997	70	70	72	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43392	10.1371/journal.pone.0043392	http://dx.doi.org/10.1371/journal.pone.0043392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927964	gold, Green Published, Green Submitted			2022-12-25	WOS:000307789700034
J	Zhang, W; Niu, YQ; Xiong, Y; Zhao, M; Yu, RW; Liu, J				Zhang, Wen; Niu, Yanqing; Xiong, Yi; Zhao, Meng; Yu, Rongwei; Liu, Juan			Computational Prediction of Conformational B-Cell Epitopes from Antigen Primary Structures by Ensemble Learning	PLOS ONE			English	Article							BINDING RESIDUES; PROTEINS; SERVER; SITES; ALGORITHM; SELECTION; TOOL; SVM	Motivation: The conformational B-cell epitopes are the specific sites on the antigens that have immune functions. The identification of conformational B-cell epitopes is of great importance to immunologists for facilitating the design of peptide-based vaccines. As an attempt to narrow the search for experimental validation, various computational models have been developed for the epitope prediction by using antigen structures. However, the application of these models is undermined by the limited number of available antigen structures. In contrast to the most of available structure-based methods, we here attempt to accurately predict conformational B-cell epitopes from antigen sequences. Methods: In this paper, we explore various sequence-derived features, which have been observed to be associated with the location of epitopes or ever used in the similar tasks. These features are evaluated and ranked by their discriminative performance on the benchmark datasets. From the perspective of information science, the combination of various features can usually lead to better results than the individual features. In order to build the robust model, we adopt the ensemble learning approach to incorporate various features, and develop the ensemble model to predict conformational epitopes from antigen sequences. Results: Evaluated by the leave-one-out cross validation, the proposed method gives out the mean AUC scores of 0.687 and 0.651 on two datasets respectively compiled from the bound structures and unbound structures. When compared with publicly available servers by using the independent dataset, our method yields better or comparable performance. The results demonstrate the proposed method is useful for the sequence-based conformational epitope prediction. Availability: The web server and datasets are freely available at http://bcell.whu.edu.cn.	[Zhang, Wen; Xiong, Yi; Zhao, Meng; Yu, Rongwei; Liu, Juan] Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China; [Niu, Yanqing] S Cent Univ Nationalities, Sch Math & Stat, Wuhan, Peoples R China; [Yu, Rongwei] Minist Educ, Key Lab Aerosp Informat Secur & Trust Comp, Wuhan, Peoples R China	Wuhan University; South Central Minzu University	Zhang, W (corresponding author), Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China.	zhangwen@whu.edu.cn	Xiong, Yi/F-7377-2012; Zhang, Wen/W-7471-2019	Xiong, Yi/0000-0003-2910-6725; Zhang, Wen/0000-0001-5221-2628	National Science Foundation of China [60970063, 61103126]; Ph.D. Programs Foundation of Ministry of Education of China [20090141110026, 20100141120049]; Program for New Century Excellent Talents in University [NCET-10-0644]; Natural Science Foundation of Hubei Province [2011CDB454]; Fundamental Research Funds for the Central Universities of China [6081007, 3101054]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work is supported by the National Science Foundation of China (60970063, 61103126, http://www.nsfc.gov.cn/), the Ph.D. Programs Foundation of Ministry of Education of China (20090141110026, 20100141120049, http://www.moe.gov.cn/), Program for New Century Excellent Talents in University (NCET-10-0644, http://www.moe.gov.cn/), Natural Science Foundation of Hubei Province (No. 2011CDB454, http://www.hbstd.gov.cn/) and the Fundamental Research Funds for the Central Universities of China (6081007, 3101054, http://kfy.whu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2009, BIOINFORMATICS, V25, pI313, DOI 10.1093/bioinformatics/btp191; Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Deng L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-426; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Enshell-Seijffers D, 2003, J MOL BIOL, V334, P87, DOI 10.1016/j.jmb.2003.09.002; Flower DR., 2007, IMMUNOINFORMATICS PR; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hu JJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-342; Jain A, 2005, PATTERN RECOGN, V38, P2270, DOI 10.1016/j.patcog.2005.01.012; Jain P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-364; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Kumar M, 2011, J MOL RECOGNIT, V24, P303, DOI 10.1002/jmr.1061; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381; Liang SD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-302; Liu R., 2011, J PROTEOM BIOINFORM, V4, P10; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Netzer M, 2009, BIOINFORMATICS, V25, P941, DOI 10.1093/bioinformatics/btp093; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; PONNUSWAMY PK, 1980, BIOCHIM BIOPHYS ACTA, V623, P301, DOI 10.1016/0005-2795(80)90258-5; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Riddick G, 2011, BIOINFORMATICS, V27, P220, DOI 10.1093/bioinformatics/btq628; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Sikic M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000278; Sollner J, 2006, J MOL RECOGNIT, V19, P200, DOI 10.1002/jmr.771; Sun J, 2009, NUCLEIC ACIDS RES, V37, pW612, DOI 10.1093/nar/gkp417; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Van Regenmortel MHV, 2001, VACCINE, V19, P2369, DOI 10.1016/S0264-410X(00)00456-4; VANREGENMORTEL MHV, 1989, PHILOS T ROY SOC B, V323, P451; WALTER G, 1986, J IMMUNOL METHODS, V88, P149, DOI 10.1016/0022-1759(86)90001-3; Wu JS, 2009, BIOINFORMATICS, V25, P30, DOI 10.1093/bioinformatics/btn583; Xiong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028440; Xiong Y, 2011, PROTEINS, V79, P509, DOI 10.1002/prot.22898; Zhang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-341	49	48	48	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43575	10.1371/journal.pone.0043575	http://dx.doi.org/10.1371/journal.pone.0043575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927994	gold, Green Published			2022-12-25	WOS:000307789700041
J	Bhatt, SP; Nigam, P; Misra, A; Guleria, R; Luthra, K; Jain, SK; Pasha, MAQ				Bhatt, Surya Prakash; Nigam, Priyanka; Misra, Anoop; Guleria, Randeep; Luthra, Kalpana; Jain, S. K.; Pasha, M. A. Qadar			Association of the Myostatin Gene with Obesity, Abdominal Obesity and Low Lean Body Mass and in Non-Diabetic Asian Indians in North India	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; METABOLIC SYNDROME; INSULIN-RESISTANCE; FAT; SENSITIVITY; MICE; MEN; MUTATIONS; LEPTIN; MALES	Background: To determine the association of the A55T and K153R polymorphisms of the Myostatin gene with obesity, abdominal obesity and lean body mass (LBM) in Asian Indians in north India. Materials and Methods: A total of 335 subjects (238 men and 97 women) were assessed for anthropometry, % body fat (BF), LBM and biochemical parameters. Associations of Myostatin gene polymorphisms were evaluated with anthropometric, body composition and biochemical parameters. In A55T polymorphism, BMI (p = 0.04), suprailiac skinfold (p = 0.05), total skinfold (p = 0.008), % BF (p = 0.002) and total fat mass (p = 0.003) were highest and % LBM (p = 0.03) and total LBM (Kg) were lowest (p = 0.04) in subjects with Thr/Thr genotype as compared to other genotypes. Association analysis of K153R polymorphism showed that subjects with R/R genotype had significantly higher BMI (p = 0.05), waist circumference (p = 0.04), % BF (p = 0.04) and total fat mass (p = 0.03), and lower % LBM (p = 0.02) and total LBM [(Kg), (p = 0.04)] as compared to other genotypes. Using a multivariate logistic regression model after adjusting for age and sex, subjects with Thr/Thr genotype of A55T showed high risk for high % BF (OR, 3.92, 95% CI: 2.61-12.41), truncal subcutaneous adiposity (OR, 2.9, 95% CI: 1.57-6.60)] and low LBM (OR, 0.64, 95% CI: 0.33-0.89) whereas R/R genotype of K153R showed high risk of obesity (BMI; OR, 3.2, 95% CI: 1.2-12.9; % BF, OR, 3.6, 95% CI: 1.04-12.4), abdominal obesity (OR, 2.12, 95% CI: 2.71-14.23) and low LBM (OR, 0.61, 95% CI: 0.29-0.79). Conclusions/Significance: We report that variants of Myostatin gene predispose to obesity, abdominal obesity and low lean body mass in Asian Indians in north India.	[Bhatt, Surya Prakash] All India Inst Med Sci, Dept Med, New Delhi 110029, India; [Bhatt, Surya Prakash; Guleria, Randeep] All India Inst Med Sci, Dept Pulm Med & Sleep Disorders, New Delhi, India; [Bhatt, Surya Prakash; Luthra, Kalpana] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Nigam, Priyanka; Misra, Anoop] Diabet Fdn India, New Delhi, India; [Nigam, Priyanka; Misra, Anoop] Natl Diabet Obes & Cholesterol Fdn N DOC, New Delhi, India; [Misra, Anoop] Fortis C DOC Ctr Excellence Diabet Metab Dis & En, New Delhi, India; [Jain, S. K.] Jamia Hamdard, Dept Biotechnol, New Delhi, India; [Pasha, M. A. Qadar] Inst Genom & Integrat Biol, Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Jamia Hamdard University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Bhatt, SP (corresponding author), All India Inst Med Sci, Dept Med, New Delhi 110029, India.	anoopmisra@metabolicresearchindia.com	Bhatt, Surya/K-5263-2019; Bhatt, Surya Prakash/X-5941-2018	Bhatt, Surya/0000-0001-9489-9747; Bhatt, Surya Prakash/0000-0001-9489-9747	Indian Council of Medical Research, Government of India [5/9/70/2008-RHM]	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This study was fully supported by a grant from the Indian Council of Medical Research (No. 5/9/70/2008-RHM) Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; Choi SJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE1031, DOI 10.1152/ajpendo.00656.2010; Chowdhury B, 1996, METABOLISM, V45, P634, DOI 10.1016/S0026-0495(96)90036-0; Ferrell RE, 1999, GENOMICS, V62, P203, DOI 10.1006/geno.1999.5984; Ge XJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE90, DOI 10.1152/ajpendo.00113.2012; Goel K, 2010, HEART, V96, P579, DOI 10.1136/hrt.2009.183236; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Gonzalez-Freire M, 2010, AGE, V32, P405, DOI 10.1007/s11357-010-9139-7; Gu ZL, 2004, SCI CHINA SER C, V47, P25, DOI 10.1360/02yc0201; Han DS, 2011, CLIN ENDOCRINOL, V75, P857, DOI 10.1111/j.1365-2265.2011.04120.x; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; John I, 1991, NUCL ACIDS RES, V19; Jorgensen JOL, 2010, PEDIATR NEPHROL, V25, P705, DOI 10.1007/s00467-009-1334-3; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McFarlane C, 2011, AM J PHYSL CELL PHYS, V301; McPherron, 2012, J CLIN INVEST, V109, P595; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Misra A, 2009, J Assoc Physicians India, V57, P163; Misra A, 2001, INT J OBESITY, V25, P1722, DOI 10.1038/sj.ijo.0801748; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Misra A, 2008, DIABETES CARE, V31, P1282, DOI 10.2337/dc07-2316; Nishiyama A, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-19; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Rios R, 2002, AM J PHYSIOL-CELL PH, V282, pC993, DOI 10.1152/ajpcell.00372.2001; Santiago C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016323; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Seibert MJ, 2001, J AM GERIATR SOC, V49, P1093, DOI 10.1046/j.1532-5415.2001.49214.x; Siriett V, 2006, J CELL PHYSIOL, V209, P866, DOI 10.1002/jcp.20778; Thomis MAI, 2004, EUR J APPL PHYSIOL, V92, P267, DOI 10.1007/s00421-004-1093-6; Unni US, 2009, EUR J CLIN NUTR, V63, P1206, DOI 10.1038/ejcn.2009.32; Vikram NK, 2006, INDIAN J MED RES, V124, P677; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219; Zhang C, 2012, DIABETOLOGIA, V55, P183, DOI 10.1007/s00125-011-2304-4	37	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e40977	10.1371/journal.pone.0040977	http://dx.doi.org/10.1371/journal.pone.0040977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916099	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800005
J	Kaplan, F; Zhao, W; Richards, JT; Wheeler, RM; Guy, CL; Levine, LH				Kaplan, Fatma; Zhao, Wei; Richards, Jeffrey T.; Wheeler, Raymond M.; Guy, Charles L.; Levine, Lanfang H.			Transcriptional and Metabolic Insights into the Differential Physiological Responses of Arabidopsis to Optimal and Supraoptimal Atmospheric CO2	PLOS ONE			English	Article							ELEVATED CO2; GENE-EXPRESSION; PHOTOSYNTHETIC ACCLIMATION; STOMATAL CONDUCTANCE; SIGNAL-TRANSDUCTION; RISING CO2; GROWTH; SUGAR; PLANTS; CARBON	Background: In tightly closed human habitats such as space stations, locations near volcano vents and closed culture vessels, atmospheric CO2 concentration may be 10 to 20 times greater than Earth's current ambient levels. It is known that super-elevated (SE) CO2 (>1,200 mu mol mol(-1)) induces physiological responses different from that of moderately elevated CO2 (up to 1,200 mu mol mol(-1)), but little is known about the molecular responses of plants to supra-optimal [CO2]. Methodology/Principal Findings: To understand the underlying molecular causes for differential physiological responses, metabolite and transcript profiles were analyzed in aerial tissue of Arabidopsis plants, which were grown under ambient atmospheric CO2 (400 mmol mol(-1)), elevated CO2 (1,200 mmol mol(-1)) and SE CO2 (4,000 mu mol mol(-1)), at two developmental stages early and late vegetative stage. Transcript and metabolite profiling revealed very different responses to elevated versus SE [CO2]. The transcript profiles of SE CO2 treated plants were closer to that of the control. Development stage had a clear effect on plant molecular response to elevated and SE [CO2]. Photosynthetic acclimation in terms of down-regulation of photosynthetic gene expression was observed in response to elevated [CO2], but not that of SE [CO2] providing the first molecular evidence that there appears to be a fundamental disparity in the way plants respond to elevated and SE [CO2]. Although starch accumulation was induced by both elevated and SE [CO2], the increase was less at the late vegetative stage and accompanied by higher soluble sugar content suggesting an increased starch breakdown to meet sink strength resulting from the rapid growth demand. Furthermore, many of the elevated and SE CO2-responsive genes found in the present study are also regulated by plant hormone and stress. Conclusions/Significance: This study provides new insights into plant acclimation to elevated and SE [CO2] during development and how this relates to stress, sugar and hormone signaling.	[Kaplan, Fatma] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Zhao, Wei] MedImmune LLC, Gaithersburg, MD USA; [Richards, Jeffrey T.; Levine, Lanfang H.] Enterprise Advisory Serv Inc, QinetiQ N Amer Engn Serv Contract ESC, Sustainable Syst Appl Res, Kennedy Space Ctr, Kennedy Space Ctr, FL USA; [Wheeler, Raymond M.] NASA, Engn Directorate, Kennedy Space Ctr, Kennedy Space Ctr, FL USA; [Guy, Charles L.] Univ Florida, Inst Food & Agr Sci, Dept Environm Hort, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA	United States Department of Agriculture (USDA); AstraZeneca; Medimmune; National Aeronautics & Space Administration (NASA); State University System of Florida; University of Florida	Kaplan, F (corresponding author), Res LLC, Gainesville, FL USA.	fkaplan@ufl.edu; lanfang.h.levine@nasa.gov	Kaplan, Fatma/AAJ-7666-2020	Kaplan, Fatma/0000-0002-9565-0211				Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Ainsworth EA, 2006, PLANT PHYSIOL, V142, P135, DOI 10.1104/pp.106.086256; Asselbergh B, 2008, MOL PLANT MICROBE IN, V21, P709, DOI 10.1094/MPMI-21-6-0709; Berkel N. van, 1984, Acta Horticulturae, P101; BOWES G, 1993, ANNU REV PLANT PHYS, V44, P309, DOI 10.1146/annurev.pp.44.060193.001521; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Browse J, 2008, PLANT PHYSIOL, V146, P832, DOI 10.1104/pp.107.115683; Caldana C, 2011, PLANT J, V67, P869, DOI 10.1111/j.1365-313X.2011.04640.x; Cheng SH, 1998, PLANT PHYSIOL, V116, P715, DOI 10.1104/pp.116.2.715; Choudhury Ananyo, 2008, In Silico Biol, V8, P511; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Druart N, 2006, FUNCT PLANT BIOL, V33, P121, DOI 10.1071/FP05139; EHRET DL, 1985, CAN J BOT, V63, P2015, DOI 10.1139/b85-281; Estiarte M, 1999, PHYSIOL PLANTARUM, V105, P423, DOI 10.1034/j.1399-3054.1999.105306.x; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; Grimmer C, 1999, PLANT CELL ENVIRON, V22, P1275, DOI 10.1046/j.1365-3040.1999.00481.x; Grotenhuis T, 1997, ADV SPACE RES, V20, P1901, DOI 10.1016/S0273-1177(97)00858-2; Gupta P, 2005, NEW PHYTOL, V167, P129, DOI 10.1111/j.1469-8137.2005.01422.x; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Jung C, 2007, PLANT CELL REP, V26, P1053, DOI 10.1007/s00299-007-0311-1; Kanani Harin, 2010, BMC Syst Biol, V4, P177, DOI 10.1186/1752-0509-4-177; Kaplan F, 2005, PLANT J, V44, P730, DOI 10.1111/j.1365-313X.2005.02565.x; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; KIMBALL BA, 1993, VEGETATIO, V104, P65, DOI 10.1007/BF00048145; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; LaDeau SL, 2001, SCIENCE, V292, P95, DOI 10.1126/science.1057547; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Leakey ADB, 2009, P NATL ACAD SCI USA, V106, P3597, DOI 10.1073/pnas.0810955106; Levine LH, 2008, ADV SPACE RES, V42, P1917, DOI 10.1016/j.asr.2008.07.014; Levine LH, 2009, J PLANT PHYSIOL, V166, P903, DOI 10.1016/j.jplph.2008.11.006; Li PH, 2008, PLANT CELL ENVIRON, V31, P1673, DOI 10.1111/j.1365-3040.2008.01874.x; Li PH, 2006, PLANT MOL BIOL, V62, P593, DOI 10.1007/s11103-006-9041-y; Loreti E, 2008, NEW PHYTOL, V179, P1004, DOI 10.1111/j.1469-8137.2008.02511.x; Ludewig F, 1998, FEBS LETT, V429, P147, DOI 10.1016/S0014-5793(98)00580-8; Ludewig F, 2000, FEBS LETT, V479, P19, DOI 10.1016/S0014-5793(00)01873-1; Mackowiak CL, 1996, J PLANT PHYSIOL, V149, P205, DOI 10.1016/S0176-1617(96)80196-9; Majeau N, 1996, PLANT PHYSIOL, V112, P569, DOI 10.1104/pp.112.2.569; Miyazaki S, 2004, FIELD CROP RES, V90, P47, DOI 10.1016/j.fcr.2004.07.010; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Moore BD, 1998, PLANT CELL ENVIRON, V21, P905, DOI 10.1046/j.1365-3040.1998.00324.x; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; NIE GY, 1995, PLANT PHYSIOL, V108, P975, DOI 10.1104/pp.108.3.975; Nikiforova VJ, 2004, J EXP BOT, V55, P1861, DOI 10.1093/jxb/erh177; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Penuelas J, 1996, J EXP BOT, V47, P1463, DOI 10.1093/jxb/47.9.1463; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Prins A, 2011, PLANT CELL ENVIRON, V34, P314, DOI 10.1111/j.1365-3040.2010.02245.x; Rogers A, 2002, PLANT CELL ENVIRON, V25, P851, DOI 10.1046/j.1365-3040.2002.00868.x; Roitsch T, 1999, CURR OPIN PLANT BIOL, V2, P198, DOI 10.1016/S1369-5266(99)80036-3; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rook F, 2001, PLANT J, V26, P421, DOI 10.1046/j.1365-313X.2001.2641043.x; Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Taylor G, 2005, NEW PHYTOL, V167, P143, DOI 10.1111/j.1469-8137.2005.01450.x; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; TRIPP KE, 1991, J AM SOC HORTIC SCI, V116, P876, DOI 10.21273/JASHS.116.5.876; Urban O, 2003, PHOTOSYNTHETICA, V41, P9, DOI 10.1023/A:1025891825050; Wagner C, 2003, PHYTOCHEMISTRY, V62, P887, DOI 10.1016/S0031-9422(02)00703-3; Wheeler RM, 1999, ANN BOT-LONDON, V83, P243, DOI 10.1006/anbo.1998.0813; WHEELER RM, 1993, J PLANT PHYSIOL, V142, P173, DOI 10.1016/S0176-1617(11)80959-4	65	48	49	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43583	10.1371/journal.pone.0043583	http://dx.doi.org/10.1371/journal.pone.0043583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916280	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800079
J	Lahut, S; Omur, O; Uyan, O; Agim, ZS; Ozoguz, A; Parman, Y; Deymeer, F; Oflazer, P; Koc, F; Ozcelik, H; Auburger, G; Basak, AN				Lahut, Suna; Omur, Ozgur; Uyan, Ozgun; Agim, Zeynep Sena; Ozoguz, Aslihan; Parman, Yesim; Deymeer, Feza; Oflazer, Piraye; Koc, Filiz; Ozcelik, Hilmi; Auburger, Georg; Basak, A. Nazli			ATXN2 and Its Neighbouring Gene SH2B3 Are Associated with Increased ALS Risk in the Turkish Population	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; LENGTH POLYGLUTAMINE EXPANSIONS; GENOME-WIDE ASSOCIATION; HEXANUCLEOTIDE REPEAT; ATAXIN-2; MUTATIONS; SCA2; SUSCEPTIBILITY; PATHOGENESIS; DISEASE	Expansions of the polyglutamine (polyQ) domain (>= 34) in Ataxin-2 (ATXN2) are the primary cause of spinocerebellar ataxia type 2 (SCA2). Recent studies reported that intermediate-length (27-33) expansions increase the risk of Amyotrophic Lateral Sclerosis (ALS) in 1-4% of cases in diverse populations. This study investigates the Turkish population with respect to ALS risk, genotyping 158 sporadic, 78 familial patients and 420 neurologically healthy controls. We re-assessed the effect of ATXN2 expansions and extended the analysis for the first time to cover the ATXN2 locus with 18 Single Nucleotide Polymorphisms (SNPs) and their haplotypes. In accordance with other studies, our results confirmed that 31-32 polyQ repeats in the ATXN2 gene are associated with risk of developing ALS in 1.7% of the Turkish ALS cohort (p = 0.0172). Additionally, a significant association of a 136 kb haplotype block across the ATXN2 and SH2B3 genes was found in 19.4% of a subset of our ALS cohort and in 10.1% of the controls (p = 0.0057, OR: 2.23). ATXN2 and SH2B3 encode proteins that both interact with growth receptor tyrosine kinases. Our novel observations suggest that genotyping of SNPs at this locus may be useful for the study of ALS risk in a high percentage of individuals and that ATXN2 and SH2B3 variants may interact in modulating the disease pathway.	[Lahut, Suna; Omur, Ozgur; Uyan, Ozgun; Agim, Zeynep Sena; Ozoguz, Aslihan; Basak, A. Nazli] Bogazici Univ, Mol Biol & Genet Dept, Neurodegenerat Res Lab, Istanbul, Turkey; [Parman, Yesim; Deymeer, Feza; Oflazer, Piraye] Istanbul Univ, Istanbul Med Sch, Dept Neurol, Istanbul, Turkey; [Koc, Filiz] Cukurova Univ, Sch Med, Dept Neurol, Adana, Turkey; [Ozcelik, Hilmi] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada; [Auburger, Georg] Goethe Univ Frankfurt, Frankfurt, Germany	Bogazici University; Istanbul University; Cukurova University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Goethe University Frankfurt	Lahut, S (corresponding author), Bogazici Univ, Mol Biol & Genet Dept, Neurodegenerat Res Lab, Istanbul, Turkey.	basak@boun.edu.tr	Agim, Zeynep Sena/L-8142-2019; Koc, Filiz/A-9125-2017	Agim, Zeynep Sena/0000-0002-8699-9884; , Piraye/0000-0001-8202-5313	Suna and Inan Kirac Foundation; Bogazici University; Deutsche Forschungsgemeinschaft [AU96/13-1]	Suna and Inan Kirac Foundation; Bogazici University(Bogazici University); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding provided by Suna and Inan Kirac Foundation (http://en.kiraca.com.tr/Corp-Responsibility/detail_kiracfoundation.aspx?SectionID=C2%2bWE3 CIWXkxHtpw8lqgFA%3d%3d&ContentId=faQeVeZudHFv1A4ACnP5uA%3d%3d), Bogazici University Research Funds (http://www.arastirma.boun.edu.tr/arastirma.php?a_I=tr&p=130) and Deutsche Forschungsgemeinschaft(AU96/13-1) (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2001, BIOCHEM SOC T, V29, P529, DOI 10.1042/BST0290529; Alcina A, 2010, GENES IMMUN, V11, P439, DOI 10.1038/gene.2010.30; Auburger Georg W J, 2012, Handb Clin Neurol, V103, P423, DOI 10.1016/B978-0-444-51892-7.00026-7; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Chen YP, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.015; Choudhry S, 2001, HUM MOL GENET, V10, P2437, DOI 10.1093/hmg/10.21.2437; Colombrita C, 2011, ARCH ITAL BIOL, V149, P83, DOI 10.4449/aib.v149i1.1261; Corrado L, 2011, HUM GENET, V130, P575, DOI 10.1007/s00439-011-1000-2; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Daoud H, 2011, ARCH NEUROL-CHICAGO, V68, P739, DOI 10.1001/archneurol.2011.111; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Devalliere J, 2011, BIOCHEM PHARMACOL, V82, P1391, DOI 10.1016/j.bcp.2011.06.023; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gispert S, 2012, NEUROBIOL DIS, V45, P356, DOI 10.1016/j.nbd.2011.08.021; Gwinn-Hardy KA, 2000, NEUROLOGY, V54, P504, DOI 10.1212/WNL.54.2.504; Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162; Huynh DP, 2007, EXP NEUROL, V203, P531, DOI 10.1016/j.expneurol.2006.09.009; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lastres-Becker I, 2008, CEREBELLUM, V7, P115, DOI 10.1007/s12311-008-0019-y; Lee JK, 2010, STAT BIOINFORMATICS, P293; Lee T, 2011, NEUROLOGY, V76, P2062, DOI 10.1212/WNL.0b013e31821f4447; Lee T, 2011, HUM MOL GENET, V20, P1697, DOI 10.1093/hmg/ddr045; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Nonis D, 2008, CELL SIGNAL, V20, P1725, DOI 10.1016/j.cellsig.2008.05.018; O'Brien KB, 2002, J BIOL CHEM, V277, P8673, DOI 10.1074/jbc.M109165200; Pang JT, 2002, BRAIN, V125, P656, DOI 10.1093/brain/awf060; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ralser M, 2005, HUM MOL GENET, V14, P2893, DOI 10.1093/hmg/ddi321; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Ross OA, 2011, HUM MOL GENET, V20, P3207, DOI 10.1093/hmg/ddr227; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Soraru G, 2011, NEUROLOGY, V76, P2030, DOI 10.1212/WNL.0b013e31821e557a; Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029; Takaki S, 2000, IMMUNITY, V13, P599, DOI 10.1016/S1074-7613(00)00060-1; Van Damme P, 2011, NEUROLOGY, V76, P2066, DOI 10.1212/WNL.0b013e31821f445b; van de Loo S, 2009, EXP NEUROL, V215, P110, DOI 10.1016/j.expneurol.2008.09.020; van Es MA, 2009, NAT GENET, V41, P1083, DOI 10.1038/ng.442; Van Langenhove T, 2011, NEUROBIOL AGING; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026433; Yu ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017951	48	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42956	10.1371/journal.pone.0042956	http://dx.doi.org/10.1371/journal.pone.0042956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916186	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800038
J	Lopez, S; Buil, A; Souto, JC; Casademont, J; Blangero, J; Martinez-Perez, A; Fontcuberta, J; Lathrop, M; Almasy, L; Soria, JM				Lopez, Sonia; Buil, Alfonso; Carlos Souto, Juan; Casademont, Jordi; Blangero, John; Martinez-Perez, Angel; Fontcuberta, Jordi; Lathrop, Mark; Almasy, Laura; Manuel Soria, Jose			Sex-Specific Regulation of Mitochondrial DNA Levels: Genome-Wide Linkage Analysis to Identify Quantitative Trait Loci	PLOS ONE			English	Article							COPY NUMBER; OXIDATIVE STRESS; HEPATOCELLULAR-CARCINOMA; GENETIC-DETERMINANTS; DEPLETION SYNDROME; CANCER RISK; D-LOOP; DISEASE; CELLS; PHENOTYPES	Altered mitochondrial DNA (mtDNA) levels have been associated with common diseases in humans. We investigated the genetic mechanism that controls mtDNA levels using genome-wide linkage analyses in families from the Genetic Analysis of Idiopathic Thrombophilia Project (GAIT). We measure mtDNA levels by quantitative real-time PCR in 386 subjects from 21 extended Spanish families. A variance component linkage method using 485 microsatellites was conducted to evaluate linkage and to detect quantitative trait loci (QTLs) involved in the control of mtDNA levels. The heritalibility of mtDNA levels was 0.33 (p = 1.82e-05). We identified a QTL on Chromosome 2 (LOD = 2.21) using all of the subjects, independently on their sex. When females and males were analysed separately, three QTLs were identified. Females showed the same QTL on Chromosome 2 (LOD = 3.09), indicating that the QTL identified in the analysis using all of the subjects was a strong female QTL, and another one on Chromosome 3 (LOD = 2.67), whereas in males a QTL was identified on Chromosome 1 (LOD = 2.81). These QTLs were fine-mapped to find associations with mtDNA levels. The most significant SNP association was for the rs10888838 on Chromosome 1 in males. This SNP mapped to the gene MRPL37, involved in mitochondrial protein translation. The rs2140855 on Chromosome 2 showed association in the analysis using all of the subjects. It was near the gene CMPK2, which encodes a mitochondrial enzyme of the salvage pathway of deoxyribonucleotide synthesis. Our results provide evidence of a sex-specific genetic mechanism for the control of mtDNA levels and provide a framework to identify new genes that influence mtDNA levels.	[Lopez, Sonia; Buil, Alfonso; Martinez-Perez, Angel; Manuel Soria, Jose] Hosp Santa Creu & Sant Pau, Inst Biomed Res, Unit Genom Complex Dis, Barcelona, Spain; [Carlos Souto, Juan; Fontcuberta, Jordi] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Haematol, Haemostasis & Thrombosis Unit, E-08193 Barcelona, Spain; [Casademont, Jordi] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Internal Med, E-08193 Barcelona, Spain; [Blangero, John; Almasy, Laura] Texas Biomed Res Inst, Dept Populat Genet, San Antonio, TX USA; [Lathrop, Mark] Ctr Natl Genotypage, Inst Genom, Evry, France	Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Texas Biomedical Research Institute; CEA; UDICE-French Research Universities; Universite Paris Saclay	Lopez, S (corresponding author), Hosp Santa Creu & Sant Pau, Inst Biomed Res, Unit Genom Complex Dis, Barcelona, Spain.	jsoria@santpau.cat	Martinez-Perez, Angel/AAC-4339-2019; Almasy, Laura/V-3156-2019; Casademont, Jordi/GPK-8669-2022; Blangero, John/ABA-7175-2021; Lopez, Sonia/AAC-8830-2019; Soria Fernández, José Manuel/AAD-6761-2019; Casademont, Jordi/A-6828-2010	Martinez-Perez, Angel/0000-0002-5934-1454; Casademont, Jordi/0000-0002-8100-1827; Lopez, Sonia/0000-0002-5023-5153; Soria Fernández, José Manuel/0000-0002-6226-4293; Casademont, Jordi/0000-0002-8100-1827; Buil, Alfonso/0000-0002-3097-1014	Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria [PI-11/00184, PI-08/0420, PI-08/0756, RECAVA-RD06/0014]; Ministerio de Ciencia e Innovacion [SAF2008/01859]; Agencia de Gestio d'ajuts Universitaris i de Recerca [SGR 2009-1240]; "Contratos Posdoctorales de Perfeccionamiento Sara Borrell" from 'Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria' (ISCIII-FIS)	Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Agencia de Gestio d'ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); "Contratos Posdoctorales de Perfeccionamiento Sara Borrell" from 'Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria' (ISCIII-FIS)	This work was supported by the 'Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria' [PI-11/00184, PI-08/0420, PI-08/0756, RECAVA-RD06/0014]; the 'Ministerio de Ciencia e Innovacion' [SAF2008/01859]; and the 'Agencia de Gestio d'ajuts Universitaris i de Recerca' [SGR 2009-1240]. SL was supported by "Contratos Posdoctorales de Perfeccionamiento Sara Borrell" from 'Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria' (ISCIII-FIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blangero J, 2000, GENET EPIDEMIOL, V19, pS8, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI2>3.0.CO;2-Y; Boehnke M, 1984, Prog Clin Biol Res, V147, P173; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Burhans WC, 2007, NUCLEIC ACIDS RES, V35, P7545, DOI 10.1093/nar/gkm1059; Carter AM, 1997, ARTERIOSCL THROM VAS, V17, P589, DOI 10.1161/01.ATV.17.3.589; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chiu YF, 2010, HUM GENET, V128, P501, DOI 10.1007/s00439-010-0877-5; Colom B, 2007, CELL PHYSIOL BIOCHEM, V19, P205, DOI 10.1159/000099208; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; Cote HCF, 2011, MITOCHONDRION, V11, P520, DOI 10.1016/j.mito.2011.01.011; Curran JE, 2007, HUM MOL GENET, V16, P1504, DOI 10.1093/hmg/ddm101; Czarnecka AM, 2010, ONCOL REP, V23, P531, DOI 10.3892/or_00000666; Dalakas MC, 2001, LAB INVEST, V81, P1537, DOI 10.1038/labinvest.3780367; Dyke B, 1995, 2 SW FDN BIOM RES DE; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129; Gavrilova-Jordan LP, 2007, SEMIN REPROD MED, V25, P154, DOI 10.1055/s-2007-973428; Giordano C, 2011, ESTROGENS AMELIORATE; Guevara R, 2009, FREE RADICAL BIO MED, V46, P169, DOI 10.1016/j.freeradbiomed.2008.09.035; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045; Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003; Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936; Kushnareva Y, 2010, ANN NY ACAD SCI, V1201, P50, DOI 10.1111/j.1749-6632.2010.05633.x; Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu CS, 2005, ANN NY ACAD SCI, V1042, P70, DOI 10.1196/annals.1338.008; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Marti R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294; Mattingly KA, 2008, MOL ENDOCRINOL, V22, P609, DOI 10.1210/me.2007-0029; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Psarra AMG, 2008, IUBMB LIFE, V60, P210, DOI 10.1002/iub.37; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Seda O, 2008, HYPERTENSION, V51, P1156, DOI 10.1161/HYPERTENSIONAHA.107.105247; Simpkins JW, 2008, MOL CELL ENDOCRINOL, V290, P51, DOI 10.1016/j.mce.2008.04.013; Song GJ, 2008, FERTIL STERIL, V90, P2238, DOI 10.1016/j.fertnstert.2007.10.059; Soria JM, 2002, AM J HUM GENET, V70, P567, DOI 10.1086/339259; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang Y, 2005, GYNECOL ONCOL, V98, P104, DOI 10.1016/j.ygyno.2005.04.015; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Xu YJ, 2008, J BIOL CHEM, V283, P1563, DOI 10.1074/jbc.M707997200; Yamada S, 2006, EJSO-EUR J SURG ONC, V32, P303, DOI 10.1016/j.ejso.2006.01.002; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955; Yu XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001530; Zhang RX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-130	57	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42711	10.1371/journal.pone.0042711	http://dx.doi.org/10.1371/journal.pone.0042711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916149	Green Submitted, gold, Green Published			2022-12-25	WOS:000307733800024
J	Morone, S; Lo-Buono, N; Parrotta, R; Giacomino, A; Nacci, G; Brusco, A; Larionov, A; Ostano, P; Mello-Grand, M; Chiorino, G; Ortolan, E; Funaro, A				Morone, Simona; Lo-Buono, Nicola; Parrotta, Rossella; Giacomino, Alice; Nacci, Giulia; Brusco, Alfredo; Larionov, Alexey; Ostano, Paola; Mello-Grand, Maurizia; Chiorino, Giovanna; Ortolan, Erika; Funaro, Ada			Overexpression of CD157 Contributes to Epithelial Ovarian Cancer Progression by Promoting Mesenchymal Differentiation	PLOS ONE			English	Article							CELL-ADHESION; TRANSITIONS; EXPRESSION; GROWTH; METALLOPROTEINASES; BIOINFORMATICS; RESISTANCE; MIGRATION; BIOLOGY; ANOIKIS	Epithelial ovarian carcinoma (EOC) is an aggressive tumor often diagnosed at an advanced stage, when there is little or no prospect of cure. Despite advances in surgical and chemotherapeutic strategies, only marginal improvements in patient outcome have been obtained. Hence, unraveling the biological mechanisms underpinning EOC progression is critical for improving patients' survival. Recently, we reported that CD157 (an ectoenzyme regulating leukocyte diapedesis) is expressed in EOC and that high expression of the molecule is negatively correlated with the disease outcome in patients. Here, we demonstrate that forced overexpression of CD157 in OVCAR-3, TOV-21G, A2780 and OV-90 ovarian cancer cell lines promotes morphological and phenotypic changes characterized by disruption of intercellular junctions, downregulation of epithelial markers and upregulation of mesenchymal ones. These changes in cell shape and phenotype bring to reduced sensitivity to anoikis, increased anchorage-independent growth, cell motility and mesothelial invasion. Conversely, knockdown of CD157 in OV-90 and OC314 cells reverts the mesenchymal phenotype and reduces the cells' migratory potential. Transcriptome profiling analysis highlighted 378 significantly differentially expressed genes, representing the signature of CD157-overexpressing OVCAR-3 and OV-90 cells. The modulation of selected genes translates into alteration of protein expression that give cells a highly malignant phenotype. The overall picture deduced from the analysis of the modulated transcripts is that high expression of CD157 strengthens a number of biological processes favoring tumor progression (including development and cell motility), and weakens several biological processes hindering tumor progression (such as apoptosis, cell death and response to stress). Together, these findings implicate CD157 in the progression of EOC to metastatic disease and suggest that CD157 may represent a valuable therapeutic target.	[Morone, Simona; Lo-Buono, Nicola; Parrotta, Rossella; Giacomino, Alice; Nacci, Giulia; Brusco, Alfredo; Larionov, Alexey; Ortolan, Erika; Funaro, Ada] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Ostano, Paola; Mello-Grand, Maurizia; Chiorino, Giovanna] Fdn Edo & Elvo Tempia Valenta, Lab Canc Genom, Biella, Italy; [Ortolan, Erika; Funaro, Ada] Univ Turin, Res Ctr Expt Med CeRMS, Turin, Italy	University of Turin; University of Turin	Morone, S (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Turin, Italy.	erika.ortolan@unito.it; ada.funaro@unito.it	Ostano, Paola/K-1979-2018; Lo Buono, Nicola/F-4817-2013; Chiorino, Giovanna/K-5037-2016; Brusco, Alfredo/A-1811-2013; Funaro, Ada/AAC-3203-2019	Ostano, Paola/0000-0002-4000-2954; Lo Buono, Nicola/0000-0001-5538-6869; Chiorino, Giovanna/0000-0002-9502-6400; Brusco, Alfredo/0000-0002-8318-7231; Funaro, Ada/0000-0001-6341-1817; ORTOLAN, Erika/0000-0003-2287-9020; Larionov, Alexey/0000-0001-6902-8878	Italian Association for Cancer Research (AIRC) [MFAG6312, IG 11602]; Italian Ministry for University and Scientific Research; International Foundation for Research in Experimental Medicine	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry for University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); International Foundation for Research in Experimental Medicine	Supported by grants from the Italian Association for Cancer Research (AIRC, MFAG6312 and IG 11602 to EO), from the Italian Ministry for University and Scientific Research (PRIN and 60% Projects to AF) and from the International Foundation for Research in Experimental Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175; Alarmo EL, 2009, CANCER LETT, V275, P35, DOI 10.1016/j.canlet.2008.09.028; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chauhan SC, 2009, CANCER RES, V69, P765, DOI 10.1158/0008-5472.CAN-08-0587; Chikh A, 2011, EMBO J, V30, P4261, DOI 10.1038/emboj.2011.302; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; Davidson B, 2002, MOL CELL ENDOCRINOL, V187, P39, DOI 10.1016/S0303-7207(01)00709-2; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Funaro A, 2009, FRONT BIOSCI-LANDMRK, V14, P929, DOI 10.2741/3287; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GOLDSTEIN SC, 1993, TISSUE ANTIGENS, V41, P214, DOI 10.1111/j.1399-0039.1993.tb02007.x; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; HAMILTON TC, 1987, CANCER, V60, P2054, DOI 10.1002/1097-0142(19901015)60:8+<2054::AID-CNCR2820601518>3.0.CO;2-0; HAMILTON TC, 1983, CANCER RES, V43, P5379; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ishihara K, 2000, CHEM IMMUNOL, V75, P235; ITO A, 1995, BRIT J CANCER, V71, P1039, DOI 10.1038/bjc.1995.200; KAISHO T, 1994, P NATL ACAD SCI USA, V91, P5325, DOI 10.1073/pnas.91.12.5325; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kenny HA, 2009, CELL CYCLE, V8, P683, DOI 10.4161/cc.8.5.7703; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kwon Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018872; Lancaster JM, 2006, INT J GYNECOL CANCER, V16, P1733, DOI 10.1111/j.1525-1438.2006.00660.x; Lavagno L, 2007, J BIOL REG HOMEOS AG, V21, P5; Legrand C, 2001, EXP CELL RES, V264, P326, DOI 10.1006/excr.2000.5125; Liang F, 2001, FEBS LETT, V506, P207, DOI 10.1016/S0014-5793(01)02912-X; Lo Buono N, 2011, J BIOL CHEM, V286, P18681, DOI 10.1074/jbc.M111.227876; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Ortolan E, 2010, JNCI-J NATL CANCER I, V102, P1160, DOI 10.1093/jnci/djq256; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sasaki CY, 2000, CANCER RES, V60, P7057; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Slack-Davis JK, 2009, CANCER RES, V69, P1469, DOI 10.1158/0008-5472.CAN-08-2678; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Tang MKS, 2010, NEOPLASIA, V12, P128, DOI 10.1593/neo.91438; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Ween MP, 2011, INT J MOL SCI, V12, P1009, DOI 10.3390/ijms12021009; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang SX, 2005, CANCER RES, V65, P5769, DOI 10.1158/0008-5472.CAN-05-0289; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zeechini S, 2008, CANCER RES, V68, P1110, DOI 10.1158/0008-5472.CAN-07-2897; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zietarska M, 2007, MOL CARCINOGEN, V46, P872, DOI 10.1002/mc.20315	53	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43649	10.1371/journal.pone.0043649	http://dx.doi.org/10.1371/journal.pone.0043649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916288	gold, Green Published, Green Submitted			2022-12-25	WOS:000307733800087
J	Zwerling, A; Cojocariu, M; McIntosh, F; Pietrangelo, F; Behr, MA; Schwartzman, K; Benedetti, A; Dendukuri, N; Menzies, D; Pai, M				Zwerling, Alice; Cojocariu, Mihaela; McIntosh, Fiona; Pietrangelo, Filomena; Behr, Marcel A.; Schwartzman, Kevin; Benedetti, Andrea; Dendukuri, Nandini; Menzies, Dick; Pai, Madhukar			TB Screening in Canadian Health Care Workers Using Interferon-Gamma Release Assays	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; WITHIN-SUBJECT VARIABILITY; CELL ASSAYS; TESTS; DIAGNOSIS; RISK	Background: While many North American healthcare institutions are switching from Tuberculin Skin Test (TST) to Interferon-gamma release assays (IGRAs), there is relatively limited data on association between occupational tuberculosis (TB) risk factors and test positivity and/or patterns of test discordance. Methods: We recruited a cohort of Canadian health care workers (HCWs) in Montreal, and performed both TST and QuantiFERON-TB Gold In Tube (QFT) tests, and assessed risk factors and occupational exposure. Results: In a cross-sectional analysis of baseline results, the prevalence of TST positivity using the 10 mm cut-off was 5.7% (22/388, 95% CI: 3.6-8.5%), while QFT positivity was 6.2% (24/388, 95% CI: 4-9.1%). Overall agreement between the tests was poor (kappa = 0.26), and 8.3% of HCWs had discordant test results, most frequently TST2/QFT+ (17/388, 4.4%). TST positivity was associated with total years worked in health care, non-occupational exposure to TB and BCG vaccination received after infancy or on multiple occasions. QFT positivity was associated with having worked as a HCW in a foreign country. Conclusions: Our results suggest that LTBI prevalence as measured by either the TST or the QFT is low in this HCW population. Of concern is the high frequency of unexplainable test discordance, namely: TST-/QFT+ subjects, and the lack of any association between QFT positivity and clear-cut recent TB exposure. If these discordant results are indeed false positives, the use of QFT in lieu of TST in low TB incidence settings could result in overtreatment of uninfected individuals.	[Zwerling, Alice; Behr, Marcel A.; Benedetti, Andrea; Dendukuri, Nandini; Menzies, Dick; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Zwerling, Alice; Cojocariu, Mihaela; Behr, Marcel A.; Schwartzman, Kevin; Benedetti, Andrea; Menzies, Dick; Pai, Madhukar] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Behr, Marcel A.; Schwartzman, Kevin; Menzies, Dick] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada; [Pietrangelo, Filomena] McGill Univ, Dept Occupat Hlth & Safety, Ctr Hlth, Montreal, PQ, Canada; [Cojocariu, Mihaela; McIntosh, Fiona] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Zwerling, A (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	madhukar.pai@mcgill.ca	Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X	Canadian Institutes of Health Research (CIHR) [81362]; Fonds de recherche du Quebec-Sante	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health Research (CIHR) grant 81362. AZ received a doctoral fellowship from CIHR, and MP received a New Investigator Award from CIHR. MP also received a salary award from Fonds de recherche du Quebec-Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Can Commun Dis Rep, V36, P1, DOI [10.14745/ccdr.v36i00as2, 10.14745/ccdr.v36i00a05, 10.14745/ccdr.v36i00as3]; [Anonymous], 2008, Canada Communicable Disease Report, V34, P1; Chan ED, 2008, CURR OPIN INFECT DIS, V21, P587, DOI 10.1097/QCO.0b013e328319bce6; Ciaschetti A, 2007, G Ital Med Lav Ergon, V29, P406; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Cummings KJ, 2009, INFECT CONT HOSP EP, V30, P1123, DOI 10.1086/644754; DORMAN S, 2009, AM J RESP CRIT CARE, pA1010; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Joshi R, 2011, EUR RESPIR J, V38, P1475, DOI 10.1183/09031936.00014611; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Long R., 2007, CANADIAN TUBERCULOSI, V6th; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Mirtskhulava V, 2008, INT J TUBERC LUNG D, V12, P513; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Reichman L.B., 2000, TUBERCULOSIS COMPREH; Ringshausen FC, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-6; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; SSSQ, 2009, EP TUB QUEB 2004 200; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	30	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43014	10.1371/journal.pone.0043014	http://dx.doi.org/10.1371/journal.pone.0043014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916197	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800041
J	Wang, XY; Keefe, KM; Jensen-Taubman, SM; Yang, DL; Yan, K; Linnoila, RI				Wang, Xiao-Yang; Keefe, Kathleen M.; Jensen-Taubman, Sandra M.; Yang, Danlei; Yan, Kai; Linnoila, R. Ilona			Novel Method for Isolation of Murine Clara Cell Secretory Protein-Expressing Cells with Traces of Stemness	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; MOUSE LUNG; BRONCHIOLAR EPITHELIUM; IDENTIFICATION; DIFFERENTIATION; PROLIFERATION; DEFICIENCY; EXPOSURE; RENEWAL; NUMBER	Clara cells are non-ciliated, secretory bronchiolar epithelial cells that serve to detoxify harmful inhaled substances. Clara cells also function as stem/progenitor cells for repair in the bronchioles. Clara cell secretory protein (CCSP) is specifically expressed in pulmonary Clara cells and is widely used as a Clara cell marker. In addition CCSP promoter is commonly used to direct gene expression into the lung in transgenic models. The discovery of CCSP immunoreactivity in plasma membranes of airway lining cells prompted us to explore the possibility of enriching Clara cells by flow cytometry. We established a novel and simple method for the isolation of CCSP-expressing cell Clara cells using a combination of mechanical and enzymatic dissociation followed by flow cytometry sorting technology. We showed that similar to 25% of dissociated cells from whole lung expressed CCSP. In the resulting preparation, up to 98% of cells expressed CCSP. Notably, we found that several common stem cell markers including CD44, CD133, Sca-1 and Sox2 were expressed in CCSP+ cells. Moreover, CCSP+ cells were able to form spheroid colonies in vitro with 0.97 parts per thousand efficiency. Parallel studies in vivo confirmed that a small population of CCSP- expressing cells in mouse airways also demonstrates stem cell-like properties such as label retention and harboring rare bronchioalveolar stem cells (BASCs) in terminal bronchioles (TBs). We conclude that CCSP+ cells exhibit a number of stem cell-like features including stem cell marker expression, bronchosphere colony formation and self-renewal ability. Clara cell isolation by flow cytometry sorting is a useful method for investigating the function of primary Clara cells in stem cell research and mouse models.	[Wang, Xiao-Yang; Keefe, Kathleen M.; Jensen-Taubman, Sandra M.; Yang, Danlei; Yan, Kai; Linnoila, R. Ilona] NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, XY (corresponding author), NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	xiaoyangwang@gmail.com; Linnoila@mail.nih.gov			National Cancer Institute at the National Institutes of Health	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Intramural Research Program of the National Cancer Institute at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELINSKY SA, 1995, IN VITRO CELL DEV-AN, V31, P361; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Boers JE, 1998, AM J RESP CRIT CARE, V157, P2000, DOI 10.1164/ajrccm.157.6.9707011; Boers JE, 1999, AM J RESP CRIT CARE, V159, P1585, DOI 10.1164/ajrccm.159.5.9806044; CHICHESTER CH, 1991, AM J RESP CELL MOL, V4, P179, DOI 10.1165/ajrcmb/4.2.179; Coppens JT, 2007, AM J PHYSIOL-LUNG C, V292, pL1155, DOI 10.1152/ajplung.00454.2006; Dai XL, 2006, EXP BIOL MED, V231, P746; Dave V, 2008, AM J RESP CELL MOL, V38, P337, DOI 10.1165/rcmb.2007-0182OC; DEVEREUX TR, 1980, IN VITRO CELL DEV B, V16, P958; EVANS MJ, 1976, LAB INVEST, V35, P246; Fernandez-Gonzalez R, 2010, METHODS MOL BIOL, V621, P1, DOI 10.1007/978-1-60761-063-2_1; Germano D, 2009, AM J RESP CRIT CARE, V179, P939, DOI 10.1164/rccm.200809-1390OC; HACKETT BP, 1992, AM J PHYSIOL, V262, pL399, DOI 10.1152/ajplung.1992.262.4.L399; Hegab AE, 2010, STEM CELLS DEV, V19, P523, DOI 10.1089/scd.2009.0287; Heijink IH, 2010, EUR RESPIR J, V35, P894, DOI 10.1183/09031936.00065809; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Jensen-Taubman S, 2010, TOXICOL SCI, V117, P238, DOI 10.1093/toxsci/kfq177; Katavolos P, 2009, VET PATHOL, V46, P604, DOI 10.1354/vp.08-VP-0255-B-FL; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Ling TY, 2006, P NATL ACAD SCI USA, V103, P9530, DOI 10.1073/pnas.0510232103; Linnoila RI, 2000, ANN NY ACAD SCI, V923, P249; MARTIN J, 1990, BIOCHEM SOC T, V18, P664, DOI 10.1042/bst0180664; MASSEY TE, 1987, CAN J PHYSIOL PHARM, V65, P2368, DOI 10.1139/y87-375; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; MONTEFORT S, 1993, EUR RESPIR J, V6, P1257; OREFFO VIC, 1990, ENVIRON HEALTH PERSP, V85, P51, DOI 10.2307/3430665; Potten CS, 2002, J CELL SCI, V115, P2381; SINGH G, 1988, J HISTOCHEM CYTOCHEM, V36, P73, DOI 10.1177/36.1.3275712; Stripp BR, 2002, AM J RESP CELL MOL, V27, P170, DOI 10.1165/ajrcmb.27.2.200200270c; Stripp BR, 1996, AM J PHYSIOL-LUNG C, V271, pL656, DOI 10.1152/ajplung.1996.271.4.L656; Stripp BR, 2000, ANN NY ACAD SCI, V923, P202; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Tompkins DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008248; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; WALKER SR, 1989, EXP LUNG RES, V15, P553, DOI 10.3109/01902148909069618; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Wang XY, 2007, LAB INVEST, V87, P527, DOI 10.1038/labinvest.3700552; Wong AP, 2009, CYTOTHERAPY, V11, P676, DOI 10.3109/14653240903313974; Wong AP, 2009, J CLIN INVEST, V119, P336, DOI 10.1172/JCI36882; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	41	12	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43008	10.1371/journal.pone.0043008	http://dx.doi.org/10.1371/journal.pone.0043008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916196	gold, Green Submitted, Green Published			2022-12-25	WOS:000307824300024
J	Hermann, GJ; Scavarda, E; Weis, AM; Saxton, DS; Thomas, LL; Salesky, R; Somhegyi, H; Curtin, TP; Barrett, A; Foster, OK; Vine, A; Erlich, K; Kwan, E; Rabbitts, BM; Warren, K				Hermann, Greg J.; Scavarda, Emily; Weis, Allison M.; Saxton, Daniel S.; Thomas, Laura L.; Salesky, Rebecca; Somhegyi, Hannah; Curtin, Thomas P.; Barrett, Alec; Foster, Olivia K.; Vine, Annalise; Erlich, Katherine; Kwan, Elizabeth; Rabbitts, Beverley M.; Warren, Kaila			C. elegans BLOC-1 Functions in Trafficking to Lysosome-Related Gut Granules	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; PROTEIN SECONDARY STRUCTURE; CAENORHABDITIS-ELEGANS; ORGANELLE BIOGENESIS; INTESTINAL-CELLS; SYNDROME GENES; COMPLEX; AP-3; MELANOSOMES; PREDICTION	The human disease Hermansky-Pudlak syndrome results from defective biogenesis of lysosome-related organelles (LROs) and can be caused by mutations in subunits of the BLOC-1 complex. Here we show that C. elegans glo-2 and snpn-1, despite relatively low levels of amino acid identity, encode Pallidin and Snapin BLOC-1 subunit homologues, respectively. BLOC-1 subunit interactions involving Pallidin and Snapin were conserved for GLO-2 and SNPN-1. Mutations in glo-2 and snpn-1, or RNAi targeting 5 other BLOC-1 subunit homologues in a genetic background sensitized for glo-2 function, led to defects in the biogenesis of lysosome-related gut granules. These results indicate that the BLOC-1 complex is conserved in C. elegans. To address the function of C. elegans BLOC-1, we assessed the intracellular sorting of CDF-2::GFP, LMP-1, and PGP-2 to gut granules. We validated their utility by analyzing their mislocalization in intestinal cells lacking the function of AP-3, which participates in an evolutionarily conserved sorting pathway to LROs. BLOC-1(-) intestinal cells missorted gut granule cargo to the plasma membrane and conventional lysosomes and did not have obviously altered function or morphology of organelles composing the conventional lysosome protein sorting pathway. Double mutant analysis and comparison of AP-3(-) and BLOC-1(-) phenotypes revealed that BLOC-1 has some functions independent of the AP-3 adaptor complex in trafficking to gut granules. We discuss similarities and differences of BLOC-1 activity in the biogenesis of gut granules as compared to mammalian melanosomes, where BLOC-1 has been most extensively studied for its role in sorting to LROs. Our work opens up the opportunity to address the function of this poorly understood complex in cell and organismal physiology using the genetic approaches available in C. elegans.	[Hermann, Greg J.; Scavarda, Emily; Weis, Allison M.; Saxton, Daniel S.; Salesky, Rebecca; Somhegyi, Hannah; Warren, Kaila] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA; [Hermann, Greg J.; Thomas, Laura L.; Curtin, Thomas P.; Barrett, Alec; Foster, Olivia K.; Vine, Annalise; Erlich, Katherine; Kwan, Elizabeth; Rabbitts, Beverley M.] Lewis & Clark Coll, Program Biochem & Mol Biol, Portland, OR 97219 USA		Hermann, GJ (corresponding author), Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA.	hermann@lclark.edu	Hermann, Greg/AAA-7862-2020; Rabbitts, Beverley M./W-1376-2019; Weis, Allison/O-8184-2016	Hermann, Greg/0000-0002-0278-6356; Rabbitts, Beverley M./0000-0002-0896-6024; Foster, Olivia/0000-0001-7782-7995; Kwan, Elizabeth/0000-0002-5858-7110; Weis, Allison/0000-0001-9991-1661	National Science Foundation [MCB-0716280, MCB-1120835]; Howard Hughes Medical Institute; James F. and Marion L. Miller Foundation; John S. Rogers Summer Research Program; Direct For Biological Sciences [0922613, 1120835] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); James F. and Marion L. Miller Foundation; John S. Rogers Summer Research Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation (MCB-0716280 and MCB-1120835), the Howard Hughes Medical Institute, the James F. and Marion L. Miller Foundation and the John S. Rogers Summer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MA, 2011, GENOME RES, V21, P255, DOI 10.1101/gr.113811.110; Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Audhya A, 2007, J CELL BIOL, V178, P1309, DOI 10.1083/jcb.20070113920070911c; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BOSSINGER O, 1992, DEVELOPMENT, V114, P317; Britton C, 2004, J CELL SCI, V117, P5133, DOI 10.1242/jcs.01387; Caldwell GA, 2006, INTEGRATED GENOMICS; Campbell EM, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-40; Cheli VT, 2010, TRAFFIC, V11, P579, DOI 10.1111/j.1600-0854.2010.01044.x; Cheli VT, 2010, HUM MOL GENET, V19, P861, DOI 10.1093/hmg/ddp555; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Cherqui S, 2001, J BIOL CHEM, V276, P13314, DOI 10.1074/jbc.M010562200; Ciciotte SL, 2003, BLOOD, V101, P4402, DOI 10.1182/blood-2003-01-0020; CLOKEY GV, 1986, MECH AGEING DEV, V35, P79, DOI 10.1016/0047-6374(86)90068-0; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cullinane AR, 2011, AM J HUM GENET, V88, P778, DOI 10.1016/j.ajhg.2011.05.009; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Currie E, 2007, GENETICS, V177, P1569, DOI 10.1534/genetics.107.080689; Davis DE, 2009, GENETICS, V182, P1015, DOI 10.1534/genetics.109.103614; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Docampo R, 2011, CELL CALCIUM, V50, P113, DOI 10.1016/j.ceca.2011.05.012; Elowitz MB, 1997, CURR BIOL, V7, P809, DOI 10.1016/S0960-9822(06)00342-3; Falcon-Perez JM, 2002, PIGM CELL RES, V15, P82, DOI 10.1034/j.1600-0749.2002.1r082.x; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Fujii T, 2010, INSECT MOL BIOL, V19, P659, DOI 10.1111/j.1365-2583.2010.01020.x; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Gengyo-Ando K, 2007, EMBO REP, V8, P152, DOI 10.1038/sj.embor.7400882; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Hadwiger G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010161; Hayes MJ, 2011, TRAFFIC, V12, P260, DOI 10.1111/j.1600-0854.2010.01151.x; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; HOWELL AM, 1990, GENETICS, V126, P583; Huang LP, 1999, NAT GENET, V23, P329, DOI 10.1038/15507; Huang PM, 2007, GENOME RES, V17, P1478, DOI 10.1101/gr.6824707; Huizing M, 2001, MOL BIOL CELL, V12, P2075, DOI 10.1091/mbc.12.7.2075; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; James P, 1996, GENETICS, V144, P1425; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Kontani K, 2005, DEV CELL, V8, P787, DOI 10.1016/j.devcel.2005.02.018; Kostich M, 2000, J CELL SCI, V113, P2595; LAUFER JS, 1980, CELL, V19, P569, DOI 10.1016/S0092-8674(80)80033-X; Lee HH, 2012, J BIOL CHEM, V287, P5882, DOI 10.1074/jbc.M111.325746; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Levitte S, 2010, FEBS J, V277, P1420, DOI 10.1111/j.1742-4658.2010.07573.x; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; Mahoney TR, 2008, P NATL ACAD SCI USA, V105, P16350, DOI 10.1073/pnas.0803617105; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; Mullin AP, 2011, MOL NEUROBIOL, V44, P53, DOI 10.1007/s12035-011-8183-3; Newell-Litwa K, 2009, MOL BIOL CELL, V20, P1441, DOI 10.1091/mbc.E08-05-0456; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498; Przybylski D, 2002, PROTEINS, V46, P197, DOI 10.1002/prot.10029; Rabbitts BM, 2008, GENETICS, V180, P857, DOI 10.1534/genetics.108.093534; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Salazar G, 2004, MOL BIOL CELL, V15, P575, DOI 10.1091/mbc.E03-06-0401; Salazar G, 2004, J BIOL CHEM, V279, P25430, DOI 10.1074/jbc.M402331200; Salazar G, 2009, J BIOL CHEM, V284, P1790, DOI 10.1074/jbc.M805991200; Schaheen L, 2006, DEV BIOL, V293, P382, DOI 10.1016/j.ydbio.2006.02.008; Schroeder LK, 2007, MOL BIOL CELL, V18, P995, DOI 10.1091/mbc.E06-08-0685; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; SHARROCK WJ, 1983, DEV BIOL, V96, P182, DOI 10.1016/0012-1606(83)90321-4; Sitaram A, 2012, PHYSIOLOGY, V27, P85, DOI 10.1152/physiol.00043.2011; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Stiernagle T, 2006, WORMBOOK, DOI DOI 10.1895/WORM-BOOK.1.101.1; Tanizawa H, 2008, CHEM BIOINFORMATICS, V8, P96, DOI DOI 10.1273/CBIJ.8.96; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Yang Q, 2012, TRAFFIC; Yang W, 2000, J CELL SCI, V113, P4077; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061	93	23	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43043	10.1371/journal.pone.0043043	http://dx.doi.org/10.1371/journal.pone.0043043			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916203	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600041
J	Maes, M; Rimon, A; Kozachkov-Magrisso, L; Friedler, A; Padan, E				Maes, Michal; Rimon, Abraham; Kozachkov-Magrisso, Lena; Friedler, Assaf; Padan, Etana			Revealing the Ligand Binding Site of NhaA Na+/H+ Antiporter and Its pH Dependence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRUCTURAL INTERACTIONS; EVOLUTIONARY ORIGINS; TRANSMEMBRANE DOMAIN; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; MODEL-STRUCTURE; ION-TRANSPORT; ALKALINE PH; MEMBRANE	pH and Na+ homeostasis in all cells requires Na+/H+ antiporters. In most cases, their activity is tightly pH-regulated. NhaA, the main antiporter of Escherichia coli, has homologues in all biological kingdoms. The crystal structure of NhaA provided insights into the mechanism of action and pH regulation of an antiporter. However, the active site of NhaA remained elusive because neither Na+ nor Li+, the NhaA ligands, were observed in the structure. Using isothermal titration calorimetry, we show that purified NhaA binds Li+ in detergent micelles. This interaction is driven by an increase in enthalpy (Delta H of -8000 +/- 300 cal/mol and Delta S of -15.2 cal/mol/degree at 283 K), involves a single binding site per NhaA molecule, and is highly specific and drastically dependent on pH; Li+ binding was observed only at pH 8.5. Combining mutational analysis with the isothermal titration calorimetry measurements revealed that Asp-163, Asp-164, Thr-132, and Asp-133 form the Li+ binding site, whereas Lys-300 plays an important role in pH regulation of the antiporter.	[Maes, Michal; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, Alexander Silberman Inst Life Sci, Fac Sci, IL-91904 Jerusalem, Israel; [Rimon, Abraham; Kozachkov-Magrisso, Lena; Padan, Etana] Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silberman Inst Life Sci, Fac Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Friedler, A (corresponding author), Hebrew Univ Jerusalem, Inst Chem, Alexander Silberman Inst Life Sci, Fac Sci, Safra Campus, IL-91904 Jerusalem, Israel.	assaf.friedler@mail.huji.ac.il; etana@vms.huji.ac.il		Maes, Michal/0000-0002-7406-3982	European Drug Initiative on Channels and Transporters (EDICT) Grant EU FP 7; United State-Israel Binational Science Foundation (BSF) [501/03-16.2]; Israel Science Foundation [284/12]; European Research Council under the European Community Seventh Framework Programme [203413]	European Drug Initiative on Channels and Transporters (EDICT) Grant EU FP 7; United State-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); European Research Council under the European Community Seventh Framework Programme	This work was supported in part by European Drug Initiative on Channels and Transporters (EDICT) Grant EU FP 7, United State-Israel Binational Science Foundation (BSF) Grant 501/03-16.2, and Israel Science Foundation Grant 284/12 (to E. P.).; Supported by a starting grant from the European Research Council under the European Community Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement 203413. To whom correspondence may be addressed. Tel.: 972-2-6585746; Fax: 972-2-6585345; E-mail: assaf.friedler@mail.huji.ac.il.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Fliegel L, 2008, J MOL CELL CARDIOL, V44, P228, DOI 10.1016/j.yjmcc.2007.11.016; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; Gerchman Y, 1999, J BIOL CHEM, V274, P24617, DOI 10.1074/jbc.274.35.24617; Gerchman Y, 2001, BIOCHEMISTRY-US, V40, P3403, DOI 10.1021/bi002669o; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; Herz K, 2009, J BIOL CHEM, V284, P6337, DOI 10.1074/jbc.M807720200; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Inoue S, 2001, J BIOCHEM, V129, P569, DOI 10.1093/oxfordjournals.jbchem.a002892; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kuwabara N, 2006, BIOCHEMISTRY-US, V45, P14834, DOI 10.1021/bi061048d; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Nie YL, 2006, J BIOL CHEM, V281, P35779, DOI 10.1074/jbc.M607232200; Noumi T, 1997, J BIOCHEM-TOKYO, V121, P661; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PADAN E, 1993, J BIOENERG BIOMEMBR, V25, P647; PADAN E, 1989, J BIOL CHEM, V264, P20297; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; PINNER E, 1993, J BIOL CHEM, V268, P1729; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; Rothman A., 1997, THESIS HEBREW U JERU; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; Schushan M, 2012, J BIOL CHEM, V287, P18249, DOI 10.1074/jbc.M111.336446; Schushan M, 2010, J MOL BIOL, V396, P1181, DOI 10.1016/j.jmb.2009.12.055; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Tsuboi Y, 2003, J BIOL CHEM, V278, P21467, DOI 10.1074/jbc.M301932200; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558; Xiang MH, 2007, P NATL ACAD SCI USA, V104, P18677, DOI 10.1073/pnas.0707120104; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	45	43	43	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.391128	http://dx.doi.org/10.1074/jbc.M112.391128			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22915592	hybrid, Green Published			2022-12-25	WOS:000310642200048
J	Gregory, AD; Hale, P; Perlmutter, DH; Houghton, AM				Gregory, Alyssa D.; Hale, Pamela; Perlmutter, David H.; Houghton, A. McGarry			Clathrin Pit-mediated Endocytosis of Neutrophil Elastase and Cathepsin G by Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-LEUKOCYTE ELASTASE; COMPLEX SEC RECEPTOR; PHYSIOLOGICAL FUNCTIONS; NONOXIDATIVE MECHANISM; MEASLES-VIRUS; LUNG INJURY; DEGRADATION; MICE; EMPHYSEMA; MUTANTS	Neutrophil elastase (NE) is a neutrophil-derived serine proteinase with broad substrate specificity. We have recently demonstrated that NE is capable of entering tumor cell endosomes and processing novel intracellular substrates. In the current study, we sought to determine the mechanism by which NE enters tumor cells. Our results show that NE enters into early endosomal antigen-1(+) endosomes in a dynamin- and clathrin-dependent but flotillin-1- and caveolin-1-independent fashion. Cathepsin G (but not proteinase-3) also enters tumor endosomes via the same mechanism. We utilized I-125-labeled NE to demonstrate that NE binds to the surface of cancer cells. Incubation of radiolabeled NE with lung cancer cells displays a dissociation constant (K-d) of 284 nM. Because NE is known to bind to heparan sulfate-and chondroitin sulfate-containing proteoglycans, we treated cells with glycanases to remove these confounding factors, which did not significantly diminish cell surface binding or endosomal entry. Thus, NE and CG bind to the surface of cancer cells, presumably to a cell surface receptor, and subsequently undergo clathrin pit-mediated endocytosis.	[Houghton, A. McGarry] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Gregory, Alyssa D.; Houghton, A. McGarry] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; [Hale, Pamela; Perlmutter, David H.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15261 USA; [Houghton, A. McGarry] Univ Washington, Div Pulm & Crit Care, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle	Houghton, AM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave N,POB 19024,D4-100, Seattle, WA 98109 USA.	houghton@fhcrc.org			National Institutes of Health through NHLBI [R01HL108979]; NHLBI [5T32HL007563]; American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007563, R01HL108979] Funding Source: NIH RePORTER	National Institutes of Health through NHLBI; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL108979 through the NHLBI (to A. M. H.) and 5T32HL007563-24 through the NHLBI (to A. D. G.). This work was also supported by an American Lung Association senior research award (to A. D. G.).	BAUGH RJ, 1976, BIOCHEMISTRY-US, V15, P836, DOI 10.1021/bi00649a017; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Buchholz CJ, 1997, J BIOL CHEM, V272, P22072, DOI 10.1074/jbc.272.35.22072; Campbell EJ, 2007, J BIOL CHEM, V282, P14645, DOI 10.1074/jbc.M608346200; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; Erlenhoefer C, 2001, J VIROL, V75, P4499, DOI 10.1128/JVI.75.10.4499-4505.2001; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; JOSLIN G, 1992, J CLIN INVEST, V90, P1150, DOI 10.1172/JCI115934; Kaynar AM, 2008, AM J RESP CELL MOL, V39, P53, DOI 10.1165/rcmb.2007-0315OC; Kohri K, 2002, AM J PHYSIOL-LUNG C, V283, pL531, DOI 10.1152/ajplung.00455.2001; Lane AA, 2003, CELL, V115, P305, DOI 10.1016/S0092-8674(03)00852-3; Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040; Liou TG, 1996, J IMMUNOL, V157, P2624; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Metz HE, 2011, CLIN CANCER RES, V17, P206, DOI 10.1158/1078-0432.CCR-10-0434; Mittendorf EA, 2012, CANCER RES, V72, P3153, DOI 10.1158/0008-5472.CAN-11-4135; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; PERLMUTTER DH, 1990, J BIOL CHEM, V265, P16713; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; SENIOR RM, 1977, AM REV RESPIR DIS, V116, P469, DOI 10.1164/arrd.1977.116.3.469; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a	30	39	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35341	35350		10.1074/jbc.M112.385617	http://dx.doi.org/10.1074/jbc.M112.385617			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22915586	Green Published, hybrid			2022-12-25	WOS:000309968000043
J	LeGoff, J; Rousset, D; Abou-Jaoude, G; Scemla, A; Ribaud, P; Mercier-Delarue, S; Caro, V; Enouf, V; Simon, F; Molina, JM; van der Werf, S				LeGoff, Jerome; Rousset, Dominique; Abou-Jaoude, Georges; Scemla, Anne; Ribaud, Patricia; Mercier-Delarue, Severine; Caro, Valerie; Enouf, Vincent; Simon, Francois; Molina, Jean-Michel; van der Werf, Sylvie			I223R Mutation in Influenza A(H1N1) pdm09 Neuraminidase Confers Reduced Susceptibility to Oseltamivir and Zanamivir and Enhanced Resistance with H275Y	PLOS ONE			English	Article							A H1N1 VIRUS; IMMUNOCOMPROMISED CHILD; INFECTION; INHIBITORS; SURVEILLANCE; TRANSMISSION; GENERATION; RECOVERY	Background: Resistance of pandemic A(H1N1) 2009 (H1N1pdm09) virus to neuraminidase inhibitors (NAIs) has remained limited. A new mutation I223R in the neuraminidase (NA) of H1N1pdm09 virus has been reported along with H275Y in immunocompromised patients. The aim of this study was to determine the impact of I223R on oseltamivir and zanamivir susceptibility. Methods: The NA enzymatic characteristics and susceptibility to NAIs of viruses harbouring the mutations I223R and H275Y alone or in combination were analyzed on viruses produced by reverse genetics and on clinical isolates collected from an immunocompromised patient with sustained influenza H1N1pdm09 virus shedding and treated by oseltamivir (days 0-15) and zanamivir (days 15-25 and 70-80). Results: Compared with the wild type, the NA of recombinant viruses and clinical isolates with H275Y or I223R mutations had about two-fold reduced affinity for the substrate. The H275Y and I223R isolates showed decreased susceptibility to oseltamivir (246-fold) and oseltamivir and zanamivir (8.9- and 4.9-fold), respectively. Reverse genetics assays confirmed these results and further showed that the double mutation H275Y and I223R conferred enhanced levels of resistance to oseltamivir and zanamivir (6195- and 15.2-fold). In the patient, six days after initiation of oseltamivir therapy, the mutation H275Y conferring oseltamivir resistance and the I223R mutation were detected in the NA. Mutations were detected concomitantly from day 6-69 but molecular cloning did not show any variant harbouring both mutations. Despite cessation of NAI treatment, the mutation I223R persisted along with additional mutations in the NA and the hemagglutinin. Conclusions: Reduced susceptibility to both oseltamivir and zanamivir was conferred by the I223R mutation which potentiated resistance to both NAIs when associated with the H275Y mutation in the NA. Concomitant emergence of the I223R and H275Y mutations under oseltamivir treatment underlines the importance of close monitoring of treated patients especially those immunocompromised.	[LeGoff, Jerome; Simon, Francois; van der Werf, Sylvie] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [LeGoff, Jerome; Mercier-Delarue, Severine; Simon, Francois] Hop St Louis, Microbiol Lab, Assistance Publ Hop Paris, Paris, France; [LeGoff, Jerome; Mercier-Delarue, Severine; Simon, Francois] Inserm, U941, Paris, France; [Rousset, Dominique; Abou-Jaoude, Georges; Enouf, Vincent; van der Werf, Sylvie] Ctr Natl Reference Virus Influenzae Reg Nord, Inst Pasteur, Dept Virol, Unite Genet Mol Virus ARN, Paris, France; [Rousset, Dominique; Abou-Jaoude, Georges; Enouf, Vincent; van der Werf, Sylvie] CNRS, URA3015, Paris, France; [Scemla, Anne; Molina, Jean-Michel] Hop St Louis, Dept Infect Dis, Paris, France; [Ribaud, Patricia] Hop St Louis, Serv Hematol Greffe, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	LeGoff, J (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.	sylvie.van-der-werf@pasteur.fr	LeGoff, jerome/AAP-7880-2021; le goff, jerome/B-3447-2016; Rousset, Dominique/S-5400-2019; ENOUF, Vincent/H-6494-2017	le goff, jerome/0000-0001-7111-1865; Rousset, Dominique/0000-0002-1473-3147; ENOUF, Vincent/0000-0001-7609-4742; van der WERF, Sylvie/0000-0002-1148-4456	Institut Pasteur; Institut de Veille Sanitaire; Centre National de la Recherche Scientifique [URA3015]; University Paris Diderot Paris 7, Assistance Publique-Hopitaux de Paris; European Community under the project "European Management Platform for Emerging and Re-emerging Infectious disease Entities'' EC [223498]; United States Department of Health and Human Services	Institut Pasteur(European Commission); Institut de Veille Sanitaire; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Paris Diderot Paris 7, Assistance Publique-Hopitaux de Paris; European Community under the project "European Management Platform for Emerging and Re-emerging Infectious disease Entities'' EC; United States Department of Health and Human Services	This work was supported by the Institut Pasteur, funding from the Institut de Veille Sanitaire to the National Influenza Center (Northern-France), the Centre National de la Recherche Scientifique [URA3015], the University Paris Diderot Paris 7, Assistance Publique-Hopitaux de Paris and the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "European Management Platform for Emerging and Re-emerging Infectious disease Entities'' EC [grant agreement number 223498]. GAJ was supported by a grant from the United States Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2004, ANTIVIR THER, V9, P577; Aoki FY, 2007, ANTIVIR THER, V12, P603; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; CDC, 2011, SEAS INFL WEEKL REP; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P969; Chan P.A., 2010, CLIN MICROBIOL INFEC; Chen HL, 2009, EMERG INFECT DIS, V15, P1970, DOI 10.3201/eid1512.091057; Da Dalt L, 2010, EMERG INFECT DIS, V16, P1813, DOI 10.3201/eid1611.100789; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; Deyde VM, 2010, ANTIMICROB AGENTS CH, V54, P1102, DOI 10.1128/AAC.01417-09; Dulek DE, 2010, CLIN INFECT DIS, V50, P1493, DOI 10.1086/652655; Eshaghi A, 2011, EMERG INFECT DIS, V17, P1472, DOI 10.3201/eid1708.102004; Esposito S, 2010, J CLIN VIROL, V48, P62, DOI 10.1016/j.jcv.2010.02.019; Gaur AH, 2010, NEW ENGL J MED, V362, P88, DOI 10.1056/NEJMc0910893; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Harvala H, 2010, EURO SURVEILL, V15; Holmes EC, 2010, SCIENCE, V328, P1243, DOI 10.1126/science.1190994; Hurt AC, 2010, ANTIVIRAL RES; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Ison MG, 2006, J INFECT DIS, V193, P760, DOI 10.1086/500465; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Moore C, 2011, J INFECT DIS, V203, P18, DOI 10.1093/infdis/jiq007; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Nguyen HT, 2010, CLIN INFECT DIS, V51, P983, DOI 10.1086/656439; Peng AW, 2000, ANTIMICROB AGENTS CH, V44, P1974, DOI 10.1128/AAC.44.7.1974-1976.2000; Pizzorno A, 2012, ANTIMICROB AGENTS CH, V56, P1208, DOI 10.1128/AAC.05994-11; Pizzorno A, 2011, J INFECT DIS, V203, P25, DOI 10.1093/infdis/jiq010; Rameix-Welti MA, 2006, ANTIMICROB AGENTS CH, V50, P3809, DOI 10.1128/AAC.00645-06; Rameix-Welti MA, 2011, ANTIVIRAL T IN PRESS, V16; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; REED L. J., 1938, AMER JOUR HYG, V27, P493; Renaud C, 2011, EMERG INFECT DIS, V17, P653, DOI 10.3201/eid1704.101429; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Tramontana AR, 2010, EMERG INFECT DIS, V16, P1068, DOI 10.3201/eid1607.091691; van der Vries E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002276; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; WHO, 2011, WER, V45, P497; World Health Organization, 2009, WHO INF LAB DIAGN PA	46	39	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e37095	10.1371/journal.pone.0037095	http://dx.doi.org/10.1371/journal.pone.0037095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936969	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500002
J	Chang, TH; Chen, SR; Yu, CY; Lin, YS; Chen, YS; Kubota, T; Matsuoka, M; Lin, YL				Chang, Tsung-Hsien; Chen, Siang-Ru; Yu, Chia-Yi; Lin, You-Sheng; Chen, Yao-Shen; Kubota, Toru; Matsuoka, Mayumi; Lin, Yi-Ling			Dengue Virus Serotype 2 Blocks Extracellular Signal-Regulated Kinase and Nuclear Factor-kappa B Activation to Downregulate Cytokine Production	PLOS ONE			English	Article							PREEXISTING ENHANCING ANTIBODIES; I INTERFERON INDUCTION; DENDRITIC CELLS; DEPENDENT ENHANCEMENT; INNATE IMMUNITY; INFECTION; PROTEIN; MACROPHAGES; MECHANISMS; INHIBITION	Background: Dengue virus (DENV) infection is the most common mosquito-borne viral disease threatening human health around the world. Type I interferon (IFN) and cytokine production are crucial in the innate immune system. We previously reported that DENV serotype 2 (DENV-2) induced low levels of interferon regulatory factor 3 and NF-kappa B activation, thus leading to reduced production of IFN-beta in the early phase of infection. Here, we determined whether DENV infection not only hampers type I IFN activation but also cytokine production triggered by Toll-like receptor (TLR) signaling. Methodology/Principal Findings: We used quantitative RT-PCR and found that only low levels of IFN-beta and inflammatory cytokines such as interleukin 10 (IL-10), IL-12 and tumor necrosis factor alpha (TNF alpha) mRNA were detected in DENV-2-infected bone-marrow-derived dendritic cells. Furthermore, DENV-2 infection repressed cytokine production triggered by TLR signaling. To elucidate the molecular mechanisms underlying this suppression event, we measured NF-kappa B activation by p65 nuclear translocation and luciferase reporter assay and found that NF-kappa B activation triggered by TLR ligands was blocked by DENV-2 infection. As well, extracellular signal-regulated kinase (ERK) activity was suppressed by DENV-2 infection. Conclusions/Significance: To downregulate the host innate immunity, DENV-2 by itself is a weak inducer of type I IFN and cytokines, furthermore DENV-2 can also block the TLR-triggered ERK-NF-kappa B activation and cytokine production.	[Chang, Tsung-Hsien; Chen, Siang-Ru; Lin, You-Sheng] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Yu, Chia-Yi; Lin, Yi-Ling] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lin, You-Sheng] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Dept Internal Med, Infect Dis Sect, Kaohsiung, Taiwan; [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Microbiol Sect, Dept Pathol & Lab Med, Kaohsiung, Taiwan; [Matsuoka, Mayumi] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Kubota, Toru] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan	Kaohsiung Veterans General Hospital; Academia Sinica - Taiwan; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Chang, TH (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan.	changth@vghks.gov.tw; yll@ibms.sinica.edu.tw	Chang, Tsung-Hsien/AAG-9384-2019; Lin, Yi-Ling/N-7128-2018	Chang, Tsung-Hsien/0000-0003-4806-7864; Lin, Yi-Ling/0000-0002-1838-6410; Yu, Chia-Yi/0000-0002-7567-6481	Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan [VGHKS99-122, VGHKS100-104]; Academia Sinica, Taipei, Taiwan	Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; Academia Sinica, Taipei, Taiwan(Academia Sinica - Taiwan)	This work was supported by grants (VGHKS99-122, VGHKS100-104) from the Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan (http://www.vghks.gov.tw/English/), and from Academia Sinica, Taipei, Taiwan (http://www.ibms.sinica.edu.tw/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; Chanteux H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-71; Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0; Chase AJ, 2011, J INFECT DIS, V203, P1763, DOI 10.1093/infdis/jir197; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; Chen RF, 2005, FEMS IMMUNOL MED MIC, V44, P43, DOI 10.1016/j.femsim.2004.11.012; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Choi SH, 2006, MOL CELL BIOL, V26, P3048, DOI 10.1128/MCB.26.8.3048-3059.2006; Cyktor JC, 2011, INFECT IMMUN, V79, P2964, DOI 10.1128/IAI.00047-11; Dai JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-468; Fang XN, 2007, J MED VIROL, V79, P1431, DOI 10.1002/jmv.20953; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kwan WH, 2005, J VIROL, V79, P7291, DOI 10.1128/JVI.79.12.7291-7299.2005; Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Liang ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023346; Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728; Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Modhiran N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000924; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moreno-Altamirano MMB, 2007, INTERVIROLOGY, V50, P237, DOI 10.1159/000100567; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10; Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Sariol CA, 2007, CLIN VACCINE IMMUNOL, V14, P756, DOI 10.1128/CVI.00052-07; Schuhmann KM, 2011, J VIROL, V85, P3162, DOI 10.1128/JVI.02342-10; Su HL, 2001, VIROLOGY, V282, P141, DOI 10.1006/viro.2000.0820; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018; Van Vliet K, 2009, MICROBIOL MOL BIOL R, V73, P730, DOI 10.1128/MMBR.00026-09; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132; Wati S, 2007, J VIROL, V81, P10161, DOI 10.1128/JVI.00313-07; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553; Zheng Z, 2011, J IMMUNOL	55	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41635	10.1371/journal.pone.0041635	http://dx.doi.org/10.1371/journal.pone.0041635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927911	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300011
J	Kestens, Y; Lebel, A; Chaix, B; Clary, C; Daniel, M; Pampalon, R; Theriault, M; Subramanian, SVP				Kestens, Yan; Lebel, Alexandre; Chaix, Basile; Clary, Christelle; Daniel, Mark; Pampalon, Robert; Theriault, Marius; Subramanian, S. V. P.			Association between Activity Space Exposure to Food Establishments and Individual Risk of Overweight	PLOS ONE			English	Article							GEOGRAPHIC LIFE ENVIRONMENTS; PHYSICAL-ACTIVITY; NEIGHBORHOOD; HEALTH; LEVEL; RESTAURANTS; CONSUMPTION; DISPARITIES; DISEASE; QUEBEC	Objective: Environmental exposure to food sources may underpin area level differences in individual risk for overweight. Place of residence is generally used to assess neighbourhood exposure. Yet, because people are mobile, multiple exposures should be accounted for to assess the relation between food environments and overweight. Unfortunately, mobility data is often missing from health surveys. We hereby test the feasibility of linking travel survey data with food listings to derive food store exposure predictors of overweight among health survey participants. Methods: Food environment exposure measures accounting for non-residential activity places (activity spaces) were computed and modelled in Montreal and Quebec City, Canada, using travel surveys and food store listings. Models were then used to predict activity space food exposures for 5,578 participants of the Canadian Community Health Survey. These food exposure estimates, accounting for daily mobility, were used to model self-reported overweight in a multilevel framework. Median Odd Ratios were used to assess the proportion of between-neighborhood variance explained by such food exposure predictors. Results: Estimates of food environment exposure accounting for both residential and non-residential destinations were significantly and more strongly associated with overweight than residential-only measures of exposure for men. For women, residential exposures were more strongly associated with overweight than non-residential exposures. In Montreal, adjusted models showed men in the highest quartile of exposure to food stores were at lesser risk of being overweight considering exposure to restaurants (OR = 0.36 [0.21-0.62]), fast food outlets (0.48 [0.30-0.79]), or corner stores (0.52 [0.35-0.78]). Conversely, men experiencing the highest proportion of restaurants being fast-food outlets were at higher risk of being overweight (2.07 [1.25-3.42]). Women experiencing higher residential exposures were at lower risk of overweight. Conclusion: Using residential neighbourhood food exposure measures may underestimate true exposure and observed associations. Using mobility data offers potential for deriving activity space exposure estimates in epidemiological models.	[Kestens, Yan] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [Kestens, Yan; Lebel, Alexandre; Clary, Christelle] Montreal Univ Hosp Res Ctr, CRCHUM, Montreal, PQ, Canada; [Lebel, Alexandre; Subramanian, S. V. P.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Daniel, Mark] Univ S Australia, Samson Inst Hlth Res, Adelaide, SA 5001, Australia; [Chaix, Basile] Univ Paris 06, INSERM, Paris, France; [Pampalon, Robert] Quebec Natl Inst Publ Hlth, INSPQ, Quebec City, PQ, Canada; [Theriault, Marius] ESAD, Quebec City, PQ, Canada	Universite de Montreal; Universite de Montreal; Harvard University; Harvard T.H. Chan School of Public Health; University of South Australia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut national de sante publique du Quebec (INSPQ)	Kestens, Y (corresponding author), Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada.	yan.kestens@umontreal.ca	Chaix, Basile/B-8625-2014; Daniel, Mark/A-1151-2009; Kestens, Yan/D-1631-2012	Kestens, Yan/0000-0003-2619-5750; Lebel, Alexandre/0000-0001-6774-7633; Daniel, Mark/0000-0001-9112-134X	Centre Lea Roback; Canadian Institutes of Health Research [MOP-106420]; Fonds de Recherche du Quebec - Sante (FRQ-S)	Centre Lea Roback; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec - Sante (FRQ-S)	This work was supported by the Centre Lea Roback and by the Canadian Institutes of Health Research (Grant #MOP-106420). YK is supported by an investigator award from Fonds de Recherche du Quebec - Sante (FRQ-S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence Metropolitaine de Transport, 2009, ENQ OR DEST 2008 MOB; Akhtar-Danesh N, 2008, OPEN MED, V2, pe83; Apparicio P, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-4; Auld J, 2010, RESULTS UTRACS INTER; Auld J, 2009, TRANSP LETT, V1, P59, DOI 10.3328/TL.2009.01.01.59-79; Bertrand L, 2008, CAN J PUBLIC HEALTH, V99, P6, DOI 10.1007/BF03403732; Blazquez Gil G, 2012, INT J DISTRIB SENS N, V2012, P15; Boone-Heinonen J, 2011, ARCH INTERN MED, V171, P1162, DOI 10.1001/archinternmed.2011.283; Brown C, 2011, BROWNS EC DAMAGES NE, V8, P13; BRUNSDON C, 1995, COMPUT GEOSCI-UK, V21, P877, DOI 10.1016/0098-3004(95)00020-9; Carlos HA, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-39; Chaix B, 2005, J EPIDEMIOL COMMUN H, V59, P517, DOI 10.1136/jech.2004.025478; Chaix B, 2012, AM J PREV M IN PRESS; Chaix B, 2009, ANNU REV PUBL HEALTH, V30, P81, DOI 10.1146/annurev.publhealth.031308.100158; Charalambous H, 2011, P AM MATH SOC, V139, P2383, DOI 10.1090/S0002-9939-2010-10677-9; Chung CJ, 1999, J CONSUM AFF, V33, P276, DOI 10.1111/j.1745-6606.1999.tb00071.x; Cummins S, 2007, INT J EPIDEMIOL, V36, P355, DOI 10.1093/ije/dym033; Curone D, 2010, IEEE T INF TECHNOL B, V14, P1098, DOI 10.1109/TITB.2010.2050696; Daniel M, 2010, EUR J EPIDEMIOL, V25, P711, DOI 10.1007/s10654-010-9499-4; Davis B, 2009, AM J PUBLIC HEALTH, V99, P505, DOI 10.2105/AJPH.2008.137638; Doherty ST, 2006, INTERNET BASED PROMP; Flamm M, 2006, CONCEPT PERSONAL NET; Fleischhacker SE, 2011, OBES REV, V12, pe460, DOI 10.1111/j.1467-789X.2010.00715.x; Frank LD, 2005, AM J PREV MED, V28, P117, DOI 10.1016/j.amepre.2004.11.001; Fraser LK, 2010, INT J ENV RES PUB HE, V7, P2290, DOI 10.3390/ijerph7052290; Gordon-Larsen P, 2011, HEALTH PLACE, V17, P1235, DOI 10.1016/j.healthplace.2011.07.011; Hagerstrand T, 1963, DEPLACEMENTS HUMAINS, P61; Holsten JE, 2009, PUBLIC HEALTH NUTR, V12, P397, DOI 10.1017/S1368980008002267; Inagami S, 2007, SOC SCI MED, V65, P1779, DOI 10.1016/j.socscimed.2007.05.051; Jeffery RW, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-2; Kelly P, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-44; Kerr J, 2011, AM J PREV MED, V41, P532, DOI 10.1016/j.amepre.2011.07.017; Kestens Y, 2010, HEALTH PLACE, V16, P1094, DOI 10.1016/j.healthplace.2010.06.016; Kestens Y, 2010, AM J PREV MED, V39, P33, DOI 10.1016/j.amepre.2010.03.014; Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x; Lebel A, 2009, CAN J PUBLIC HEALTH, V100, P18, DOI 10.1007/BF03405486; Lebel A, 2012, J OBES, V2012, DOI 10.1155/2012/912645; Marshall K, 2006, PERSPECTIVES LABOUR, V7; Matthews SA, 2008, AM J PREV MED, V34, P257, DOI 10.1016/j.amepre.2007.12.001; Matthews SA, 2011, SOC DISPAR H H CARE, P35, DOI 10.1007/978-1-4419-7482-2_3; McKinnon RA, 2009, AM J PREV MED, V36, pS124, DOI 10.1016/j.amepre.2009.01.012; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; Oliver LN, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-41; Paez A, 2010, URBAN STUD, V47, P1415, DOI 10.1177/0042098009353626; Paquet C, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-58; Patrick K, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.3.e23; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Pouliot N, 2009, PUBLIC HEALTH NUTR, V12, P2051, DOI 10.1017/S1368980009005369; Roux AVD, 2003, AM J EPIDEMIOL, V157, P315, DOI 10.1093/aje/kwf207; Scully M, 2009, PUBLIC HEALTH NUTR, V12, P105, DOI 10.1017/S1368980008002012; Setton E, 2011, J EXPO SCI ENV EPID, V21, P42, DOI 10.1038/jes.2010.14; Shields Margot, 2008, Health Rep, V19, P61; Shohaimi S, 2004, J EPIDEMIOL COMMUN H, V58, P686, DOI 10.1136/jech.2003.008490; Silverman B.W., 1986, DENSITY ESTIMATION S; Stovel K, 2004, SOCIOL METHOD RES, V32, P559, DOI 10.1177/0049124103262683; Vallee J, 2011, SOC SCI MED, V73, P1133, DOI 10.1016/j.socscimed.2011.08.009; Vallee J, 2010, HEALTH PLACE, V16, P838, DOI 10.1016/j.healthplace.2010.04.009; Yang J, 2010, ADV PATTERN RECOGNIT, P185, DOI 10.1007/978-1-84996-507-1_8; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246; Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001	61	98	98	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41418	10.1371/journal.pone.0041418	http://dx.doi.org/10.1371/journal.pone.0041418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999CI	22936974	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000308286300006
J	Stebbeds, WJD; Lunec, J; Larcombe, LD				Stebbeds, William J. D.; Lunec, Joseph; Larcombe, Lee D.			An In Silico Study of the Differential Effect of Oxidation on Two Biologically Relevant G-Quadruplexes: Possible Implications in Oncogene Expression	PLOS ONE			English	Article							C-MYC; GENE-EXPRESSION; DNA; STABILITY; SEQUENCES; 8-OXOGUANINE; KINETICS; DAMAGE	G-quadruplex structures, formed from guanine rich sequences, have previously been shown to be involved in various physiological processes including cancer-related gene expression. Furthermore, G-quadruplexes have been found in several oncogene promoter regions, and have been shown to play a role in the regulation of gene expression. The mutagenic properties of oxidative stress on DNA have been widely studied, as has the association with carcinogenesis. Guanine is the most susceptible nucleotide to oxidation, and as such, G-rich sequences that form G-quadruplexes can be viewed as potential "hot-spots" for DNA oxidation. We propose that oxidation may destabilise the G-quadruplex structure, leading to its unfolding into the duplex structure, affecting gene expression. This would imply a possible mechanism by which oxidation may impact on oncogene expression. This work investigates the effect of oxidation on two biologically relevant G-quadruplex structures through 500 ns molecular dynamics simulations on those found in the promoter regions of the c-Kit and c-Myc oncogenes. The results show oxidation having a detrimental effect on stability of the structure, substantially destabilising the c-Kit quadruplex, and with a more attenuated effect on the c-Myc quadruplex. Results are suggestive of a novel route for oxidation-mediated oncogenesis and may have wider implications for genome stability.	[Stebbeds, William J. D.; Lunec, Joseph; Larcombe, Lee D.] Cranfield Univ, Cranfield Hlth, Cranfield MK43 0AL, Beds, England	Cranfield University	Stebbeds, WJD (corresponding author), Cranfield Univ, Cranfield Hlth, Cranfield MK43 0AL, Beds, England.	w.j.stebbeds@cranfield.ac.uk		Larcombe, Lee/0000-0003-3150-6445				Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Bejugam M, 2007, J AM CHEM SOC, V129, P12926, DOI 10.1021/ja075881p; Briede JJ, 2010, TOXICOL SCI, V114, P193, DOI 10.1093/toxsci/kfp309; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; Dexheimer TS, 2006, RSC BIOMOL SCI, P180; Ghosh A, 2009, J BIOL CHEM, V284, P31074, DOI 10.1074/jbc.M109.027532; Grand CL, 2002, MOL CANCER THER, V1, P565; Gros J, 2007, NUCLEIC ACIDS RES, V35, P3064, DOI 10.1093/nar/gkm111; Guedin A, 2009, NUCLEIC ACIDS RES, V37, P5559, DOI 10.1093/nar/gkp563; Haider S, 2010, METHODS MOL BIOL, V608, P17, DOI 10.1007/978-1-59745-363-9_2; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103; Kawanishi S, 1999, BIOCHEMISTRY-US, V38, P16733, DOI 10.1021/bi990890z; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Kumar N, 2008, NUCLEIC ACIDS RES, V36, P4433, DOI 10.1093/nar/gkn402; Kuryavyi V, 2010, NUCLEIC ACIDS RES, V38, P6757, DOI 10.1093/nar/gkq558; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Pelengaris S, 2000, CURR OPIN GENET DEV, V10, P100, DOI 10.1016/S0959-437X(99)00046-5; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Shafer RH, 2001, BIOPOLYMERS, V56, P209, DOI 10.1002/1097-0282(2000/2001)56:3<209::AID-BIP10018>3.0.CO;2-Y; Sherer EC, 1999, J AM CHEM SOC, V121, P5981, DOI 10.1021/ja983715z; Singh V, 2011, CHEM-EUR J, V17, P10838, DOI 10.1002/chem.201100284; Takabayashi F, 2004, GERONTOLOGY, V50, P57, DOI 10.1159/000075556; Vorlickova M, 2012, FEBS J, V279, P29, DOI 10.1111/j.1742-4658.2011.08396.x; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wu Y, 2009, CELL MOL LIFE SCI, V66, P1209, DOI 10.1007/s00018-008-8580-6; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07	37	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43735	10.1371/journal.pone.0043735	http://dx.doi.org/10.1371/journal.pone.0043735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928025	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300085
J	Stoto, MA				Stoto, Michael A.			The Effectiveness of US Public Health Surveillance Systems for Situational Awareness during the 2009 H1N1 Pandemic: A Retrospective Analysis	PLOS ONE			English	Article							INFLUENZA-A H1N1; UNITED-STATES; APRIL; FLU; EPIDEMIOLOGY; RATES	Background: The 2009 H1N1 outbreak provides an opportunity to learn about the strengths and weaknesses of current U. S. public health surveillance systems and to identify implications for measuring public health emergency preparedness. Methodology/Principal Findings: We adopted a "triangulation" approach in which multiple contemporary data sources, each with different expected biases, are compared to identify time patterns that are likely to reflect biases versus those that are more likely to be indicative of actual infection rates. This approach is grounded in the understanding that surveillance data are the result of a series of decisions made by patients, health care providers, and public health professionals about seeking and providing health care and about reporting cases to health authorities. Although limited by the lack of a gold standard, this analysis suggests that children and young adults are over-represented in many pH1N1 surveillance systems, especially in the spring wave. In addition, the nearly two-month delay between the Northeast and the South in the Fall peak in some surveillance data seems to at least partially reflect regional differences in concerns about pH1N1rather than real differences in pH1N1 infection rates. Conclusions/Significance: Although the extent of the biases suggested by this analysis cannot be known precisely, the analysis identifies underlying problems with surveillance systems - in particular their dependence on patient and provider behavior, which is influenced by a changing information environment - that could limit situational awareness in future public health emergencies. To improve situational awareness in future health emergencies, population-based surveillance systems such as telephone surveys of representative population samples and seroprevalence surveys in well-defined population cohorts are needed.	Georgetown Univ, Dept Hlth Syst Adm, Sch Nursing & Hlth Syst Adm, Washington, DC 20007 USA	Georgetown University	Stoto, MA (corresponding author), Georgetown Univ, Dept Hlth Syst Adm, Sch Nursing & Hlth Syst Adm, Washington, DC 20007 USA.	stotom@georgetown.edu			United States Centers for Disease Control and Prevention (CDC) [5P01TP000307-01]	United States Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This article was developed with funding support awarded to the Harvard School of Public Health under cooperative agreements with the United States Centers for Disease Control and Prevention (CDC) grant number 5P01TP000307-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Brammer L, 2011, CLIN INFECT DIS, V52, pS27, DOI 10.1093/cid/ciq009; Brown D, 2009, WASHINGTON POST; Casalegno JS, 2011, EUROSURVEILLANCE, V16, P18; Centers for Disease Control and Prevention, 2009, 2009 H1N1 VACC REC; Centers for Disease Control and Prevention, 2010, CDC GUID STAT LOC PU; Centers for Disease Control and Prevention, 2009, 2008 2009 INFL SEAS; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P37; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Centers for Disease Control and Prevention (CDC), 2009, UPD CDC EST 2009 H1N; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Cordova-Villalobos Jose A, 2009, Health Res Policy Syst, V7, P21, DOI 10.1186/1478-4505-7-21; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Farley T, 2009, 2009 NEW YORK CIT DE; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Gilson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001079; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Government Accountability Office (2010) Public health information technology, 2010, GAO1199; Hadler JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011677; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; Hodge JG, 2009, BIOSECUR BIOTERROR, V7, P45, DOI 10.1089/bsp.2009.0006; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Keramarou M, 2011, EUROSURVEILLANCE, V16, P17; Kok J, 2011, LANCET INFECT DIS, V11, P423, DOI 10.1016/S1473-3099(11)70120-7; Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; McDonnell WM, 2012, AM J EMERG MED, V30, P275, DOI 10.1016/j.ajem.2010.11.027; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Noyes KA, 2011, J PUBLIC HEALTH MAN, V17, P12, DOI 10.1097/PHH.0b013e3181fb0050; Office of Public Health Preparedness and Response (OPHPR), 2010, 2010 REP PUBL HLTH P; Pandemic Influenza Preparedness Team, 2011, UK INFL PAND PREP ST; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Stoto MA, 2005, TR285DHHS RAND; Stoto MA, 2008, GEORGETOWN LAW J, V96, P703; Swerdlow DL, 2011, CLIN INFECT DIS, V52, pS1, DOI 10.1093/cid/ciq005; THACKER SB, 1988, EPIDEMIOL REV, V10, P164, DOI 10.1093/oxfordjournals.epirev.a036021; Trust for America's Health (TFAH), 2010, READ NOT 2010 PROT P; U.S. Department of Health and Human Services, INT IMPL GUID NAT HL; U.S. Department of Health and Human Services, NAT HLTH SEC STRAT U; U.S. Government Accountability Office, 2010, GAO10645; Zhang Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-591	46	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e40984	10.1371/journal.pone.0040984	http://dx.doi.org/10.1371/journal.pone.0040984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927904	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300005
J	Ghisolfi, L; Keates, AC; Hu, XW; Lee, DK; Li, CJ				Ghisolfi, Laura; Keates, Andrew C.; Hu, Xingwang; Lee, Dong-ki; Li, Chiang J.			Ionizing Radiation Induces Stemness in Cancer Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; INDUCED GENOMIC INSTABILITY; ACUTE MYELOID-LEUKEMIA; SIDE-POPULATION; SELF-RENEWAL; MULTIDRUG-RESISTANCE; MELANOMA-CELLS; DIFFERENTIATION; GROWTH; CARCINOGENESIS	The cancer stem cell (CSC) model posits the presence of a small number of CSCs in the heterogeneous cancer cell population that are ultimately responsible for tumor initiation, as well as cancer recurrence and metastasis. CSCs have been isolated from a variety of human cancers and are able to generate a hierarchical and heterogeneous cancer cell population. CSCs are also resistant to conventional chemo-and radio-therapies. Here we report that ionizing radiation can induce stem cell-like properties in heterogeneous cancer cells. Exposure of non-stem cancer cells to ionizing radiation enhanced spherogenesis, and this was accompanied by upregulation of the pluripotency genes Sox2 and Oct3/4. Knockdown of Sox2 or Oct3/4 inhibited radiation-induced spherogenesis and increased cellular sensitivity to radiation. These data demonstrate that ionizing radiation can activate stemness pathways in heterogeneous cancer cells, resulting in the enrichment of a CSC subpopulation with higher resistance to radiotherapy.	[Ghisolfi, Laura; Keates, Andrew C.; Hu, Xingwang; Li, Chiang J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Skip Ackerman Ctr Mol Therapeut,Div Gastroenterol, Boston, MA 02215 USA; [Lee, Dong-ki] Sungkyunkwan Univ, Dept Chem, Global Res Lab RNAi Med, Suwon, South Korea	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Sungkyunkwan University (SKKU)	Ghisolfi, L (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Skip Ackerman Ctr Mol Therapeut,Div Gastroenterol, Boston, MA 02215 USA.	cli@bidmc.harvard.edu	Hu, Xingwang/ABG-6400-2021; Ghisolfi, Laura/I-8609-2012	Hu, Xingwang/0000-0002-2320-3279	Skip Ackerman Center for Molecular Therapeutics Fund; Global Research Laboratory Award (Ministry of Education Science and Technology, Korea)	Skip Ackerman Center for Molecular Therapeutics Fund; Global Research Laboratory Award (Ministry of Education Science and Technology, Korea)	This study was supported by Skip Ackerman Center for Molecular Therapeutics Fund and Global Research Laboratory Award (Ministry of Education Science and Technology, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Atlasi Y, 2007, INT J CANCER, V120, P1598, DOI 10.1002/ijc.22508; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Blagosklonny MV, 2007, CANCER BIOL THER, V6, P1684, DOI 10.4161/cbt.6.11.5167; Blagosklonny MV, 2006, LEUKEMIA, V20, P385, DOI 10.1038/sj.leu.2404075; Boman BM, 2007, CLIN PHARMACOL THER, V81, P893, DOI 10.1038/sj.clpt.6100202; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bussolati B, 2009, J CELL MOL MED, V13, P309, DOI 10.1111/j.1582-4934.2008.00338.x; Chen JS, 2006, LARYNGOSCOPE, V116, P401, DOI 10.1097/01.mlg.0000195075.14093.fb; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Collins CA, 2005, CELL CYCLE, V4, P1338, DOI 10.4161/cc.4.10.2114; Debeb BG, 2009, J MAMMARY GLAND BIOL, V14, P11, DOI 10.1007/s10911-009-9114-z; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gregory CA, 2005, EXP CELL RES, V306, P330, DOI 10.1016/j.yexcr.2005.03.018; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Haraguchi Naotsugu, 2006, Hum Cell, V19, P24, DOI 10.1111/j.1749-0774.2005.00004.x; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kaup S, 2006, MUTAT RES-FUND MOL M, V597, P87, DOI 10.1016/j.mrfmmm.2005.06.032; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Little JB, 2000, CARCINOGENESIS, V21, P397, DOI 10.1093/carcin/21.3.397; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Madjd Zahra, 2009, Cancer Immun, V9, P4; Martin LP, 2008, CLIN CANCER RES, V14, P1291, DOI 10.1158/1078-0432.CCR-07-2238; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Morgan WF, 2005, P NATL ACAD SCI USA, V102, P14127, DOI 10.1073/pnas.0507119102; Morgan WF, 2007, MUTAT RES-FUND MOL M, V616, P159, DOI 10.1016/j.mrfmmm.2006.11.009; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Mothersill C, 2003, ONCOGENE, V22, P7028, DOI 10.1038/sj.onc.1206882; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; POSTE G, 1982, Invasion and Metastasis, V2, P137; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Robinson SN, 2005, BONE MARROW TRANSPL, V35, P807, DOI 10.1038/sj.bmt.1704881; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; SELL S, 1994, LAB INVEST, V70, P6; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith LE, 2003, HEALTH PHYS, V85, P23, DOI 10.1097/00004032-200307000-00006; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trosko JE, 1998, ENVIRON HEALTH PERSP, V106, P331, DOI 10.2307/3433935; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wicha MS, 2006, CLIN CANCER RES, V12, P5606, DOI 10.1158/1078-0432.CCR-06-1537; WOODRUFF MFA, 1983, BRIT J CANCER, V47, P589, DOI 10.1038/bjc.1983.96; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt1211; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zobalova R, 2008, BIOCHEM BIOPH RES CO, V373, P567, DOI 10.1016/j.bbrc.2008.06.073	75	152	160	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43628	10.1371/journal.pone.0043628	http://dx.doi.org/10.1371/journal.pone.0043628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928007	Green Submitted, gold, Green Published			2022-12-25	WOS:000307789700043
J	Guo, FG; Lei, JX; Sun, YC; Chi, YH; Ge, F; Patil, BS; Koiwa, H; Zeng, RS; Zhu-Salzman, K				Guo, Fengguang; Lei, Jiaxin; Sun, Yucheng; Chi, Yong Hun; Ge, Feng; Patil, Bhimanagouda S.; Koiwa, Hisashi; Zeng, Rensen; Zhu-Salzman, Keyan			Antagonistic Regulation, Yet Synergistic Defense: Effect of Bergapten and Protease Inhibitor on Development of Cowpea Bruchid Callosobruchus maculatus	PLOS ONE			English	Article							DEPRESSARIA-PASTINACELLA; IMMUNE HOMEOSTASIS; SPODOPTERA-EXIGUA; INSECT HERBIVORES; COUNTER-DEFENSE; SOYACYSTATIN-N; PLANT; DROSOPHILA; FURANOCOUMARINS; EXPRESSION	The furanocoumarin compound bergapten is a plant secondary metabolite that has anti-insect function. When incorporated into artificial diet, it retarded cowpea bruchid development, decreased fecundity, and caused mortality at a sufficient dose. cDNA microarray analysis indicated that cowpea bruchid altered expression of 543 midgut genes in response to dietary bergapten. Among these bergapten-regulated genes, 225 have known functions; for instance, those encoding proteins related to nutrient transport and metabolism, development, detoxification, defense and various cellular functions. Such differential gene regulation presumably facilitates the bruchids' countering the negative effect of dietary bergapten. Many genes did not have homology (E-value cutoff 10(-6)) with known genes in a BLASTX search (206), or had homology only with genes of unknown function (112). Interestingly, when compared with the transcriptomic profile of cowpea bruchids treated with dietary soybean cysteine protease inhibitor N (scN), 195 out of 200 coregulated midgut genes are oppositely regulated by the two compounds. Simultaneous administration of bergapten and scN attenuated magnitude of change in selected oppositely-regulated genes, as well as led to synergistic delay in insect development. Therefore, targeting insect vulnerable sites that may compromise each other's counter-defensive response has the potential to increase the efficacy of the anti-insect molecules.	[Guo, Fengguang; Lei, Jiaxin; Sun, Yucheng; Chi, Yong Hun; Zhu-Salzman, Keyan] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Sun, Yucheng; Ge, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest & Rodent, Beijing, Peoples R China; [Patil, Bhimanagouda S.; Koiwa, Hisashi] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA; [Patil, Bhimanagouda S.; Koiwa, Hisashi; Zhu-Salzman, Keyan] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, College Stn, TX USA; [Zeng, Rensen] S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China	Texas A&M University System; Texas A&M University College Station; Chinese Academy of Sciences; Institute of Zoology, CAS; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; South China Agricultural University	Guo, FG (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA.	ksalzman@tamu.edu	Guo, Fengguang/M-4482-2019; Zeng, Ren-sen/AAI-2067-2020; Guo, Fengguang/E-1728-2018; Lei, Jiaxin/AAK-8479-2021; Koiwa, Hisashi/AAO-6512-2020; Patil, Bhimu S/C-7620-2013; Koiwa, Hisashi/AAA-8182-2019	Guo, Fengguang/0000-0002-3742-7214; Koiwa, Hisashi/0000-0002-7421-340X; Patil, Bhimu S/0000-0001-7189-0432; Sun, Yucheng/0000-0003-2353-0218; Zeng, Rensen/0000-0002-6435-3054	United States Department of Agriculture (USDA) AFRI [2007-35607-17887]; USDA Cooperative State Research, Education and Extension Service [2009-34402-19831, 2010-34402-20875]; National Natural Science Foundation of China [31028018]	United States Department of Agriculture (USDA) AFRI(United States Department of Agriculture (USDA)); USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the United States Department of Agriculture (USDA) AFRI grant# 2007-35607-17887, USDA Cooperative State Research, Education and Extension Service, grants# 2009-34402-19831 and 2010-34402-20875, as well as National Natural Science Foundation of China (31028018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JE, 2007, INSECT MOL BIOL, V16, P295, DOI 10.1111/j.1365-2583.2007.00726.x; Ahn JE, 2004, INSECT MOL BIOL, V13, P649, DOI 10.1111/j.0962-1075.2004.00523.x; Ahn JE, 2009, J INSECT PHYSIOL, V55, P678, DOI 10.1016/j.jinsphys.2009.04.016; Amirhusin B, 2004, J ECON ENTOMOL, V97, P2095, DOI 10.1603/0022-0493-97.6.2095; Amirhusin B, 2007, J INSECT PHYSIOL, V53, P734, DOI 10.1016/j.jinsphys.2007.03.008; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; AUCOIN R, 1995, ARCH INSECT BIOCHEM, V29, P211, DOI 10.1002/arch.940290210; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Ben Amor T, 2000, INSECT BIOCHEM MOLEC, V30, P915, DOI 10.1016/S0965-1748(00)00072-2; BERENBAUM M, 1978, SCIENCE, V201, P532, DOI 10.1126/science.201.4355.532; BERENBAUM M, 1995, ARCH INSECT BIOCHEM, V29, P119, DOI 10.1002/arch.940290204; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; Bown DP, 1997, INSECT BIOCHEM MOLEC, V27, P625, DOI 10.1016/S0965-1748(97)00043-X; Chi YH, 2009, INSECT MOL BIOL, V18, P97, DOI 10.1111/j.1365-2583.2008.00854.x; Chi YH, 2011, J INSECT PHYSIOL, V57, P220, DOI 10.1016/j.jinsphys.2010.11.011; Cianfrogna JA, 2002, J CHEM ECOL, V28, P1365, DOI 10.1023/A:1016244402019; Daimon T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002486; Danielson PB, 1997, P NATL ACAD SCI USA, V94, P10797, DOI 10.1073/pnas.94.20.10797; Davies SA, 2012, J INSECT PHYSIOL, V58, P488, DOI 10.1016/j.jinsphys.2012.01.008; De Leo F, 1998, PLANT PHYSIOL, V118, P997, DOI 10.1104/pp.118.3.997; DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104; DIAWARA MM, 1993, J CHEM ECOL, V19, P2473, DOI 10.1007/BF00980684; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hoffmann JA, 1997, TRENDS CELL BIOL, V7, P309, DOI 10.1016/S0962-8924(97)01087-8; Huang YF, 2011, J INSECT PHYSIOL, V57, P1033, DOI 10.1016/j.jinsphys.2011.05.001; IVIE GW, 1983, SCIENCE, V221, P374, DOI 10.1126/science.221.4608.374; JONGSMA MA, 1995, P NATL ACAD SCI USA, V92, P8041, DOI 10.1073/pnas.92.17.8041; Kim BY, 2008, COMP BIOCHEM PHYS B, V149, P183, DOI 10.1016/j.cbpb.2007.09.007; Koiwa H, 2000, FEBS LETT, V471, P67, DOI 10.1016/S0014-5793(00)01368-5; Koiwa H, 1997, TRENDS PLANT SCI, V2, P379, DOI 10.1016/S1360-1385(97)90052-2; Koo YD, 2008, INSECT MOL BIOL, V17, P235, DOI 10.1111/j.1365-2583.2008.00799.x; LEE KW, 1991, INSECT BIOCHEM, V21, P353, DOI 10.1016/0020-1790(91)90001-U; Leulier F, 2009, NAT IMMUNOL, V10, P936, DOI 10.1038/ni0909-936; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu YL, 2004, INSECT BIOCHEM MOLEC, V34, P1069, DOI 10.1016/j.ibmb.2004.06.010; MICHAUD D, 1995, ARCH BIOCHEM BIOPHYS, V322, P469, DOI 10.1006/abbi.1995.1490; Nitao JK, 2003, J CHEM ECOL, V29, P671, DOI 10.1023/A:1022872704016; Pan CY, 2009, PESTIC BIOCHEM PHYS, V93, P105, DOI 10.1016/j.pestbp.2008.12.003; Peroutka R, 2007, J SCI FOOD AGR, V87, P2152, DOI 10.1002/jsfa.2979; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Schuler MA, 1996, PLANT PHYSIOL, V112, P1411, DOI 10.1104/pp.112.4.1411; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Scott JG, 1996, INSECT BIOCHEM MOLEC, V26, P645, DOI 10.1016/S0965-1748(96)00008-2; Simon A, 2008, ANTIMICROB AGENTS CH, V52, P1407, DOI 10.1128/AAC.00155-07; Stergiopoulos K, 2009, PHYSIOL GENOMICS, V37, P1, DOI 10.1152/physiolgenomics.90360.2008; Stevens JL, 2000, INSECT BIOCHEM MOLEC, V30, P559, DOI 10.1016/S0965-1748(00)00024-2; Stevenson PC, 2003, PHYTOCHEMISTRY, V63, P41, DOI 10.1016/S0031-9422(02)00748-3; VOGEL H, 2011, BMC GENOMICS, V12; Wen ZM, 2003, INSECT BIOCHEM MOLEC, V33, P937, DOI 10.1016/S0965-1748(03)00100-0; Zhu-Salzman K, 2003, INSECT MOL BIOL, V12, P135, DOI 10.1046/j.1365-2583.2003.00395.x; Zhu-Salzman K., 2006, ENCY PEST MANAGEMENT, P1	53	14	15	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e41877	10.1371/journal.pone.0041877	http://dx.doi.org/10.1371/journal.pone.0041877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927917	Green Published, gold, Green Submitted			2022-12-25	WOS:000307789700006
J	Henning, T; Weigend, M				Henning, Tilo; Weigend, Maximilian			Total Control - Pollen Presentation and Floral Longevity in Loasaceae (Blazing Star Family) Are Modulated by Light, Temperature and Pollinator Visitation Rates	PLOS ONE			English	Article							NECTAR; MOVEMENTS; DISPERSAL; EVOLUTION; RESPONSES; FLOWERS; PLANTS	Stamen movements can be understood as a mechanism influencing pollen presentation and increasing outbreeding success of hermaphroditic flowers via optimized male function. In this study we experimentally analyzed the factors regulating autonomous and thigmonastic (triggered by flower visitors) stamen movements in eight species of Loasaceae. Both types of stamen movements are positively influenced by light and temperature and come to a virtual standstill in the dark and at low temperatures (12 degrees C). Pollen presentation is thus discontinued during periods where pollinators are not active. Overall stamen presentation increases with increasing flower age. Contrary to expectation, no geometrical correlation between the floral scale stimulated and the stamen fascicle reacting exists, indicating that the stimulus is transmitted over the receptacle and stamen maturation dictates which and how many stamens react. Thigmonastic stamen presentation is dramatically accelerated compared to autonomous movement (3-37 times), indicating that the rate of stamen maturation can be adjusted to different visitation schedules. Flowers can react relatively uniformly down to stimulation intervals of 10-15 min., consistently presenting comparable numbers of stamens in the flower c. 5 min. after the stimulus and can thus keep the amount of pollen presented relatively constant even under very high visitation frequencies of 4-6 visits/h. Thigmonastic pollen presentation dramatically reduces the overall duration of the staminate phase (to 1/3rd in Nasa macrothyrsa). Similarly, the carpellate phase is dramatically reduced after pollination, down to 1 d from 4 d. Overall flower longevity is reduced by more than 2/3rds under high visitation rates (<3 d versus 10 d under visitor exclusion) and depleted and pollinated flowers are rapidly removed from the pool. Complex floral behaviour in Loasaceae thus permits a near-total control over pollen dispensation schedules and floral longevity of the individual flower by an extraordinary fine-tuning to both biotic and abiotic factors.	[Henning, Tilo] Free Univ Berlin, Inst Biol Morphol & Systemat Phanerogamen, Berlin, Germany; [Weigend, Maximilian] Univ Bonn, Nees Inst Biodiversitat Pflanzen, Bonn, Germany	Free University of Berlin; University of Bonn	Henning, T (corresponding author), Free Univ Berlin, Inst Biol Morphol & Systemat Phanerogamen, Berlin, Germany.	tilo.henning@fu-berlin.de	Weigend, Maximilian/F-7989-2014	Weigend, Maximilian/0000-0003-0813-6650; Henning, Tilo/0000-0003-1929-3264	NaFoG (Elsa Neumann Stipendium des Landes Berlin); botconsult GmbH	NaFoG (Elsa Neumann Stipendium des Landes Berlin); botconsult GmbH	Funds provided by NaFoG (Elsa Neumann Stipendium des Landes Berlin, http://www.fu-berlin.de/en/forschung/service/foerderung/nachwuchsfoerder/nachwuchs/nafoeg.html, PhD study of the first author), and botconsult GmbH (http://www.botconsult.de/) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2006, ANN BOT-LONDON, V98, P503, DOI 10.1093/aob/mcl136; [Anonymous], ERGEBNISSE WELTWEITE; Ashman T. L., 1996, FLORAL BIOL STUDIES, P112, DOI DOI 10.1007/978-1-4613-1165-2_5; Biernaskie JM, 2002, OIKOS, V98, P98, DOI 10.1034/j.1600-0706.2002.980110.x; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Castellanos MC, 2006, AM NAT, V167, P288, DOI 10.1086/498854; CRESSWELL JE, 1990, OECOLOGIA, V82, P450, DOI 10.1007/BF00319785; Dafni A, 2000, PLANT SYST EVOL, V222, P113, DOI 10.1007/BF00984098; Darwin C., 1875, MOVEMENTS HABITS CLI; Dostert Nicolas, 1999, Harvard Papers in Botany, V4, P439; GRANT V, 1979, PLANT SYST EVOL, V132, P313, DOI 10.1007/BF00982393; HARDER LD, 1994, EVOL ECOL, V8, P542, DOI 10.1007/BF01238257; HARDER LD, 1989, AM NAT, V133, P323, DOI 10.1086/284922; Harter B, 1995, APIDOLOGIE, V26, P356; Henning T, 2009, BOT J LINN SOC, V161, P278, DOI 10.1111/j.1095-8339.2009.01006.x; Irwin RE, 1998, OECOLOGIA, V116, P519, DOI 10.1007/s004420050617; JAFFE MJ, 1977, BOT GAZ, V138, P438, DOI 10.1086/336946; Jersakova J, 2006, OECOLOGIA, V147, P60, DOI 10.1007/s00442-005-0254-6; Johnson SD, 2004, P ROY SOC B-BIOL SCI, V271, P803, DOI 10.1098/rspb.2003.2659; LeBuhn G, 1998, EVOL ECOL, V12, P111, DOI 10.1023/A:1006563108498; LEBUHN G, 1994, AM MIDL NAT, V131, P257, DOI 10.2307/2426251; Linnaeus C., 1745, FLORA SUECICA, DOI 10.5962/bhl.title.714; LLOYD DG, 1982, EVOLUTION, V36, P903, DOI 10.1111/j.1558-5646.1982.tb05462.x; MOURE J. S., 1951, DUSENIA, V2, P25; Pinheiro J., 2011, NLME LINEAR NONLINEA; PRIMACK RB, 1985, ANNU REV ECOL SYST, V16, P15, DOI 10.1146/annurev.es.16.110185.000311; SATTER RL, 1973, PLANT PHYSIOL, V52, P202, DOI 10.1104/pp.52.3.202; SATTER RL, 1981, ANNU REV PLANT PHYS, V32, P83, DOI 10.1146/annurev.pp.32.060181.000503; Schlindwein C, 1997, BOT ACTA, V110, P177, DOI 10.1111/j.1438-8677.1997.tb00626.x; Schlindwein C, 1997, PLANT SYST EVOL, V204, P179, DOI 10.1007/BF00989204; Schlindwein C., 1992, C LAT AM ZOOL 12 C B, P73; Scott R, 1903, ANN BOT-LONDON, V17, P761, DOI 10.1093/oxfordjournals.aob.a088942; SIBOAKA T, 1969, ANN REV PLANT PHYSIO, V20, P165; SMITH A P, 1974, Biotropica, V6, P263, DOI 10.2307/2989670; Thomson J, 2003, AM NAT, V162, pS1, DOI 10.1086/378683; URBAN I, 1886, JB BOTANISCHEN GARTE, V4, P364; Urban I., 1892, BER DEUT BOT GES, V10, P259; vanDoorn WG, 1997, J EXP BOT, V48, P1615, DOI 10.1093/jexbot/48.314.1615; WEBB CJ, 1987, ANN MO BOT GARD, V74, P51, DOI 10.2307/2399261; WEBER A., 1993, VERH ZOOL BOT GES OS, V130, P99; Weigend M, 2010, BIOL J LINN SOC, V100, P124, DOI 10.1111/j.1095-8312.2010.01419.x; Weintraub M, 1952, N PHYTOL, V3, P357, DOI [10.1111/j.1469-8137.1952.tb05196.x, DOI 10.1111/J.1469-8137.1952.TB05196.X]; WILLMER PG, 1983, ECOL ENTOMOL, V8, P455, DOI 10.1111/j.1365-2311.1983.tb00524.x; WITTMANN D., 1995, BIOCIENCIAS, V3, P19; Zuur Alain F., 2009, P1	45	16	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41121	10.1371/journal.pone.0041121	http://dx.doi.org/10.1371/journal.pone.0041121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916102	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800008
J	Kleinschmidt, MA; de Graaf, P; van Teeffelen, HAAM; Timmers, HTM				Kleinschmidt, Markus A.; de Graaf, Petra; van Teeffelen, Hetty A. A. M.; Timmers, H. Th Marc			Cell Cycle Regulation by the PRMT6 Arginine Methyltransferase through Repression of Cyclin-Dependent Kinase Inhibitors	PLOS ONE			English	Article							PREMATURE SENESCENCE; H3K4 TRIMETHYLATION; GENE-EXPRESSION; HISTONE H3R2; METHYLATION; PROTEIN; P21; BINDING; TARGET; PROLIFERATION	PRMT6 belongs to the family of Protein Arginine Methyltransferase (PRMT) enzymes that catalyze the methylation of guanidino nitrogens of arginine residues. PRMT6 has been shown to modify the tail of histone H3, but the in vivo function of PRMT6 is largely unknown. Here, we show that PRMT6 regulates cell cycle progression. Knockdown of PRMT6 expression in the human osteosarcoma cell line U2OS results in an accumulation of cells at the G2 checkpoint. Loss of PRMT6 coincides with upregulation of p21 and p27, two members of the CIP/KIP family of cyclin-dependent kinase (CDK) inhibitors. Gene expression and promoter analysis show that p21 and p27 are direct targets of PRMT6, which involves methylation of arginine-2 of histone H3. Our findings imply arginine methylation of histones by PRMT6 in cell cycle regulation.	[Kleinschmidt, Markus A.] Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands; Univ Med Ctr Utrecht, Netherlands Prote Ctr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Kleinschmidt, MA (corresponding author), Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands.	h.t.m.timmers@umcutrecht.nl		de Graaf, Petra/0000-0002-3183-8901	NWO-TOP [700.57.302]; Netherlands Proteomics Center	NWO-TOP(Netherlands Organization for Scientific Research (NWO)); Netherlands Proteomics Center	This work was financially supported by grants from NWO-TOP (#700.57.302) and Netherlands Proteomics Center to HTMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fujiwara T, 2006, MOL CELL BIOL, V26, P2273, DOI 10.1128/MCB.26.6.2273-2285.2006; Gillespie David A F, 2006, Subcell Biochem, V40, P355; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Harrison MJ, 2010, NUCLEIC ACIDS RES, V38, P2201, DOI 10.1093/nar/gkp1203; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Invernizzi CF, 2007, AIDS, V21, P795, DOI 10.1097/QAD.0b013e32803277ae; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kim C, 2010, BBA-GEN SUBJECTS, V1800, P977, DOI 10.1016/j.bbagen.2010.06.004; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Kleinschmidt MA, 2008, NUCLEIC ACIDS RES, V36, P3202, DOI 10.1093/nar/gkn166; Kottemann MC, 2009, DNA REPAIR, V8, P944, DOI 10.1016/j.dnarep.2009.06.001; Lee YH, 2012, PROTEIN ARGININE MET, DOI [10.1089/scd.2011.0330, DOI 10.1089/SCD.2011.0330]; Lim Y, 2008, J BIOCHEM, V144, P523, DOI 10.1093/jb/mvn097; Mainprize TG, 2001, J NEURO-ONCOL, V51, P205, DOI 10.1023/A:1010671908204; Mannefeld M, 2009, CANCER RES, V69, P4073, DOI 10.1158/0008-5472.CAN-08-4156; Michaud-Levesque J, 2009, J BIOL CHEM, V284, P21338, DOI 10.1074/jbc.M109.005322; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Polotskaia A, 2007, CELL CYCLE, V6, P2524, DOI 10.4161/cc.6.20.4799; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Smits VAJ, 2000, J BIOL CHEM, V275, P30638, DOI 10.1074/jbc.M005437200; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; Wagner S, 2006, J BIOL CHEM, V281, P27242, DOI 10.1074/jbc.M605172200; Waldmann T, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-11; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Wu Q, 2009, STEM CELLS, V27, P2637, DOI 10.1002/stem.131; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Yoshimatsu M, 2011, INT J CANCER, V128, P562, DOI 10.1002/ijc.25366; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	42	49	62	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e41446	10.1371/journal.pone.0041446	http://dx.doi.org/10.1371/journal.pone.0041446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916108	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800011
J	Naish, KR; Harris, G				Naish, Katherine R.; Harris, Gillian			Food Intake Is Influenced by Sensory Sensitivity	PLOS ONE			English	Article							REWARD DEFICIENCY SYNDROME; INDIVIDUAL-DIFFERENCES; PALATABILITY; CHILDREN; OBESITY; CHOCOLATE; APPETITE; ANXIETY	Wide availability of highly palatable foods is often blamed for the rising incidence of obesity. As palatability is largely determined by the sensory properties of food, this study investigated how sensitivity to these properties affects how much we eat. Forty females were classified as either high or low in sensory sensitivity based on their scores on a self-report measure of sensory processing (the Adult Sensory Profile), and their intake of chocolate during the experiment was measured. Food intake was significantly higher for high-sensitivity compared to low-sensitivity individuals. Furthermore, individual scores of sensory sensitivity were positively correlated with self-reported emotional eating. These data could indicate that individuals who are more sensitive to the sensory properties of food have a heightened perception of palatability, which, in turn, leads to a greater food intake.	[Naish, Katherine R.; Harris, Gillian] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Naish, KR (corresponding author), Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England.	k.r.naish@pgr.reading.ac.uk	Naish, Katherine/N-6436-2014	Naish, Katherine/0000-0002-8939-8945	University of Birmingham's School of Psychology	University of Birmingham's School of Psychology	The work was not supported by any external sources of funding. Minimal funding (e.g., for printing costs and test materials) was provided by the University of Birmingham's School of Psychology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Blum K, 1996, AM SCI, V84, P132; Blum K, 2006, ADV THER, V23, P1040, DOI 10.1007/BF02850224; Brown C.E., 2002, ADOLESCENT ADULT SEN; Bruinsma K, 1999, J AM DIET ASSOC, V99, P1249, DOI 10.1016/S0002-8223(99)00307-7; Chou SY, 2004, J HEALTH ECON, V23, P565, DOI 10.1016/j.jhealeco.2003.10.003; Coulthard H, 2009, APPETITE, V52, P410, DOI 10.1016/j.appet.2008.11.015; Davis C, 2008, APPETITE, V50, P43, DOI 10.1016/j.appet.2007.05.007; Davis C, 2007, APPETITE, V48, P12, DOI 10.1016/j.appet.2006.05.016; DREWNOWSKI A, 1995, AM J CLIN NUTR, V62, P1081, DOI 10.1093/ajcn/62.5.1081S; Dunn W, 1997, INFANT YOUNG CHILD, V9, P23, DOI 10.1097/00001163-199704000-00005; Dunn W, 1999, SENSORY PROFILE USER; Farrow CV, 2012, APPETITE, V58, P842, DOI 10.1016/j.appet.2012.01.017; Franken IHA, 2005, APPETITE, V45, P198, DOI 10.1016/j.appet.2005.04.004; HYDE RJ, 1993, APPETITE, V21, P1, DOI 10.1006/appe.1993.1032; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Liss M, 2008, PERS INDIV DIFFER, V45, P255, DOI 10.1016/j.paid.2008.04.009; Rolls ET, 2007, P NUTR SOC, V66, P96, DOI 10.1017/S0029665107005332; ROZIN P, 1991, APPETITE, V17, P199, DOI 10.1016/0195-6663(91)90022-K; SHACHAM S, 1983, J PERS ASSESS, V47, P305, DOI 10.1207/s15327752jpa4703_14; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Yeomans MR, 1997, APPETITE, V29, P61, DOI 10.1006/appe.1997.0092; Yeomans MR, 1998, P NUTR SOC, V57, P609, DOI 10.1079/PNS19980089	23	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43622	10.1371/journal.pone.0043622	http://dx.doi.org/10.1371/journal.pone.0043622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	991WJ	22916284	gold, Green Published, Green Submitted			2022-12-25	WOS:000307733800083
J	Zapater, P; Gomez-Hurtado, I; Peiro, G; Gonzalez-Navajas, JM; Garcia, I; Gimenez, P; Moratalla, A; Such, J; Frances, R				Zapater, Pedro; Gomez-Hurtado, Isabel; Peiro, Gloria; Manuel Gonzalez-Navajas, Jose; Garcia, Irma; Gimenez, Paula; Moratalla, Alba; Such, Jose; Frances, Ruben			Beta-Adrenergic Receptor 1 Selective Antagonism Inhibits Norepinephrine-Mediated TNF-Alpha Downregulation in Experimental Liver Cirrhosis	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; SPONTANEOUS BACTERIAL PERITONITIS; CARBON-TETRACHLORIDE; TRANSLOCATION; ASCITES; RATS; NORADRENALINE; INFLAMMATION; ADRENORECEPTOR; FIBROGENESIS	Background: Bacterial translocation is a frequent event in cirrhosis leading to an increased inflammatory response. Splanchnic adrenergic system hyperactivation has been related with increased bacterial translocation. We aim at evaluating the interacting mechanism between hepatic norepinephrine and inflammation during liver damage in the presence of bacterial-DNA. Animals and Methods: Forty-six mice were included in a 16-week protocol of CCl4-induced cirrhosis. Laparotomies were performed at weeks 6, 10, 13 and 16. A second set of forty mice injected with a single intraperitoneal dose of CCl4 was treated with saline, 6-hydroxidopamine, Nebivolol or Butoxamine. After 5 days, mice received E. coli-DNA intraperitoneally. Laparotomies were performed 24 hours later. Liver bacterial-DNA, norepinephrine, TNF-alpha, IL-6 and beta-adrenergic receptor levels were measured. Results: Bacterial-DNA translocation was more frequent in CCl4-treated animals compared with controls, and increased as fibrosis progressed. Liver norepinephrine and pro-inflammatory cytokines were significantly higher in mice with vs without bacterial-DNA (319.7 +/- 120.6 vs 120.7 +/- 68.6 pg/g for norepinephrine, 38.4 +/- 6.1 vs 29.7 +/- 4.2 pg/g for TNF-alpha, 41.8 +/- 7.4 vs 28.7 +/- 4.3 pg/g for IL-6). Only beta-adrenergic receptor-1 was significantly increased in treated vs control animals (34.6 +/- 7.3 vs 12.5 +/- 5.3, p = 0.01) and correlated with TNF-alpha, IL-6 and norepinephrine hepatic levels in animals with bacterial-DNA. In the second set of mice, cytokine levels were increased in 6-hydroxidopamine and Nebivolol (beta-adrenergic receptor-1 antagonist) treated mice compared with saline. Butoxamine (beta-adrenergic receptor-2 antagonist) didn't inhibit liver norepinephrine modulation of pro-inflammatory cytokines. Conclusions: Beta-adrenergic receptor-1 mediates liver norepinephrine modulation of the pro-inflammatory response in CCl4-treated mice with bacterial-DNA.	[Zapater, Pedro; Gomez-Hurtado, Isabel; Manuel Gonzalez-Navajas, Jose; Garcia, Irma; Gimenez, Paula; Moratalla, Alba; Such, Jose; Frances, Ruben] Inst Salud Carlos III, Biomed Res Ctr Network, Area Hepat & Digest Disorders CIBERehd, Madrid, Spain; [Zapater, Pedro] Hosp Gen Univ, Serv Farmacol Clin, Alicante, Spain; [Gomez-Hurtado, Isabel; Manuel Gonzalez-Navajas, Jose; Garcia, Irma; Gimenez, Paula; Moratalla, Alba; Such, Jose; Frances, Ruben] Hosp Gen Univ, Unidad Hepat, Alicante, Spain; [Peiro, Gloria] Hosp Gen Univ, Unidad Invest, Alicante, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; General University Hospital of Alicante; General University Hospital of Alicante; General University Hospital of Alicante	Zapater, P (corresponding author), Inst Salud Carlos III, Biomed Res Ctr Network, Area Hepat & Digest Disorders CIBERehd, Madrid, Spain.	frances_rub@gva.es	Zapater, Pedro/H-7277-2017; Francés, Rubén/V-4120-2019; Zapater, Pedro/H-8450-2019; GARCIA-MARTINEZ, IRMA/Q-4763-2018; González-Navajas, Jose Manuel/AAB-1575-2019; Gomez-Hurtado, Isabel/AAA-5815-2019	Zapater, Pedro/0000-0001-7927-858X; Francés, Rubén/0000-0001-5105-1201; Zapater, Pedro/0000-0001-7927-858X; GARCIA-MARTINEZ, IRMA/0000-0002-8828-6888; González-Navajas, Jose Manuel/0000-0002-1591-939X; Gomez-Hurtado, Isabel/0000-0003-4305-9427	Instituto de Salud Carlos III, Madrid, Spain [CP05/0005, PI10/0340, PI11/0962]; Conselleria de Sanitat, Generalitat Valenciana, Spain [AP-026/09, AP-162/11]; Fundacion FCVI-HGUA, Alicante, Spain [C-6/11]; Diputacion Provincial de Alicante, Alicante, Spain	Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Conselleria de Sanitat, Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); Fundacion FCVI-HGUA, Alicante, Spain; Diputacion Provincial de Alicante, Alicante, Spain	This work has been supported by grants CP05/0005, PI10/0340 and PI11/0962 from Instituto de Salud Carlos III, Madrid, Spain; AP-026/09 and AP-162/11 from Conselleria de Sanitat, Generalitat Valenciana, Spain; C-6/11 from Fundacion FCVI-HGUA, Alicante, Spain; and Diputacion Provincial de Alicante, Alicante, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BERG RD, 1992, J MED, V23, P217; Dubuisson L, 2002, HEPATOLOGY, V35, P325, DOI 10.1053/jhep.2002.31166; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Frances R, 2007, J HEPATOL, V46, P797, DOI 10.1016/j.jhep.2006.11.018; Garcia JJ, 2003, MOL CELL BIOCHEM, V254, P305; Garcia JJ, 2003, MOL CELL BIOCHEM, V254, P299, DOI 10.1023/A:1027345820519; Garcia-Tsao G, 2001, J HEPATOL, V34, P150, DOI 10.1016/S0168-8278(00)00006-4; Gomez-Hurtado I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023037; Gonzalez-Suarez B, 2006, EUR J GASTROEN HEPAT, V18, P49, DOI 10.1097/00042737-200601000-00009; Guarner C, 2005, EUR J GASTROEN HEPAT, V17, P27, DOI 10.1097/00042737-200501000-00006; Guarner C, 1997, J HEPATOL, V26, P1372, DOI 10.1016/S0168-8278(97)80474-6; Guarner C, 2006, HEPATOLOGY, V44, P633, DOI 10.1002/hep.21286; Henriksen JH, 1998, J HEPATOL, V29, P328, DOI 10.1016/S0168-8278(98)80022-6; HENRIKSEN JH, 1984, GUT, V25, P1034, DOI 10.1136/gut.25.10.1034; HSU CT, 1995, J AUTONOM NERV SYST, V51, P135, DOI 10.1016/0165-1838(94)00124-3; HSU CT, 1992, J AUTONOM NERV SYST, V37, P163, DOI 10.1016/0165-1838(92)90038-I; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kershenobich S.D., 2003, ANN HEPATOL, V2, P159; Marra F, 2002, FRONT BIOSCI, V7, pD1899, DOI 10.2741/marra; Mori K, 2011, INTENS CARE MED, V37, P1849, DOI 10.1007/s00134-011-2326-x; Oben JA, 2004, GUT, V53, P438, DOI 10.1136/gut.2003.026658; Perez-Paramo M, 2000, HEPATOLOGY, V31, P43, DOI 10.1002/hep.510310109; Pritchard MT, 2010, J HEPATOL, V53, P655, DOI 10.1016/j.jhep.2010.04.017; Senzolo M, 2009, LIVER INT, V29, P1189, DOI 10.1111/j.1478-3231.2009.02038.x; Serste T, 2010, HEPATOLOGY, V52, P1017, DOI 10.1002/hep.23775; Shilov JI, 2003, IMMUNOL LETT, V86, P229, DOI 10.1016/S0165-2478(03)00027-0; Straub RH, 2005, J INFECT DIS, V192, P560, DOI 10.1086/432134; Such J, 2002, HEPATOLOGY, V36, P135, DOI 10.1053/jhep.2002.33715; Ubeda M, 2010, HEPATOLOGY, V52, P2086, DOI 10.1002/hep.23961; VANDERPOLL T, 1994, INFECT IMMUN, V62, P2046, DOI 10.1128/IAI.62.5.2046-2050.1994; Walker-Brown J, 2009, SHOCK, V32, P541, DOI 10.1097/SHK.0b013e3181a6eda2; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Wong F, 2012, NAT REV GASTRO HEPAT, V9, P382, DOI 10.1038/nrgastro.2012.96; Worlicek M, 2010, GUT, V59, P1127, DOI 10.1136/gut.2009.185413	35	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43371	10.1371/journal.pone.0043371	http://dx.doi.org/10.1371/journal.pone.0043371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916250	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800061
J	Lasky, T; Greenspan, J; Ernst, FR; Gonzalez, L				Lasky, Tamar; Greenspan, Jay; Ernst, Frank R.; Gonzalez, Liliana			Pediatric Vancomycin Use in 421 Hospitals in the United States, 2008	PLOS ONE			English	Article							INFECTIOUS-DISEASES-SOCIETY; AMERICA	Background: Recommendations to prevent the spread of vancomycin resistance have been in place since 1995 and include guidelines for inpatient pediatric use of vancomycin. The emergence of large databases allows us to describe variation in pediatric vancomycin across hospitals. We analyzed a database with hospitalizations for children under 18 at 421 hospitals in 2008. Methodology/Principal Findings: The Premier hospital 2008 database, consisting of records for 877,201 pediatric hospitalizations in 421 hospitals, was analyzed. Stratified analyses and logistic mixed effects models were used to calculate the probability of vancomycin use while considering random effects of hospital variation, hospital fixed effects and patient effects, and the hierarchical structure of the data. Most hospitals (221) had fewer than 10 hospitalizations with vancomycin use in the study period, and 47 hospitals reported no vancomycin use in 17,271 pediatric hospitalizations. At the other end of the continuum, 21 hospitals (5.6% of hospitals) each had over 200 hospitalizations with vancomycin use, and together, accounted for more than 50% of the pediatric hospitalizations with vancomycin use. The mixed effects modeling showed hospital variation in the probability of vancomycin use that was statistically significant after controlling for teaching status, urban or rural location, size, region of the country, patient ethnic group, payor status, and APR-mortality and severity codes. Conclusions/Significance: The number and percentage of pediatric hospitalizations with vancomycin use varied greatly across hospitals and was not explained by hospital or patient characteristics in our logistic models. Public health efforts to reduce vancomycin use should be intensified at hospitals with highest use.	[Lasky, Tamar] MIE Resources, Kingston, RI USA; [Greenspan, Jay] Thomas Jefferson Univ, Nemours Childrens Clin, Wilmington, DE USA; [Ernst, Frank R.] Premier Healthcare Alliance, Premier Res Serv, Clin & Outcomes Res, Charlotte, NC USA; [Gonzalez, Liliana] Univ Rhode Isl, Kingston, RI 02881 USA	Jefferson University; University of Rhode Island	Lasky, T (corresponding author), MIE Resources, Kingston, RI USA.	tlasky@mie-epi.com	Ernst, Frank/AAT-9230-2021; Lasky, Tamar/AAR-3410-2021		AHRQ grant "Measuring Pediatric Inpatient Use" [R03 HS017998]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS017998] Funding Source: NIH RePORTER	AHRQ grant "Measuring Pediatric Inpatient Use"; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Funded by AHRQ grant R03 HS017998 "Measuring Pediatric Inpatient Use" to Tamar Lasky, Principal Investigator, http://www.ahrq.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, MMWR Recomm Rep, V44, P1; [Anonymous], 2008, PREM PERSP DAT; Bolon MK, 2005, INFECT CONT HOSP EP, V26, P47, DOI 10.1086/502486; Bowman SM, 2005, JAMA-J AM MED ASSOC, V294, P2611, DOI 10.1001/jama.294.20.2611; Center for Disease Control and Prevention, 2002, 12 STEP PROGR PREV A; Dai J., 2006, SAS C P W US SAS SOF; Di Pentima M, 2010, PEDIAT INFECT DIS J; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; Grohskopf LA, 2005, PEDIATR INFECT DIS J, V24, P766, DOI 10.1097/01.inf.0000178064.55193.1c; Halsey NA, 1997, PEDIATRICS, V99, P289, DOI 10.1542/peds.99.2.289; Hersh AL, 2009, INFECT CONT HOSP EP, V30, P1211, DOI 10.1086/648088; Hopkins HA, 2000, INFECT CONT HOSP EP, V21, P48, DOI 10.1086/501698; Hughes J., 2008, MORT MEAS M CAMBR MA; Keyserling HL, 2003, PEDIATRICS, V112, pE104, DOI 10.1542/peds.112.2.e104; KUEHN BM, 2011, JAMA-J AM MED ASSOC, V306, P2661; Leung KM, 1998, AM J PUBLIC HEALTH, V88, P377, DOI 10.2105/AJPH.88.3.377; Li J, 2006, SAS C P W US SAS SOF; Pakyz AL, 2009, INFECT CONT HOSP EP, V30, P600, DOI 10.1086/597545; Patel S, 2009, POWER, V153, P12; Rybak MJ, 2009, PHARMACOTHERAPY, V29, P1275, DOI 10.1592/phco.29.11.1275; SAS Institute Inc, 2009, SAS GRAPH 9 2 STATIS; SAS Institute Inc, 2009, BAS SAS 9 2 PROC GUI; Schabenberger O.., 2005, INTRO GLIMMIX PROCED; Shah SS, 1999, AM J INFECT CONTROL, V27, P482, DOI 10.1016/S0196-6553(99)70025-8; Shlaes DM, 1997, INFECT CONT HOSP EP, V18, P275; Titus A, 2011, NATL ANTIBIOTIC USE; Weiss PF, 2009, J PEDIAT, V155; WENNBERG JE, 2004, HLTH AFF MILLWOOD S, pVAR5	28	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43258	10.1371/journal.pone.0043258	http://dx.doi.org/10.1371/journal.pone.0043258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916234	Green Published, Green Submitted, gold			2022-12-25	WOS:000307824300035
J	Stark, JH; Cummings, DAT; Ermentrout, B; Ostroff, S; Sharma, R; Stebbins, S; Burke, DS; Wisniewski, SR				Stark, James H.; Cummings, Derek A. T.; Ermentrout, Bard; Ostroff, Stephen; Sharma, Ravi; Stebbins, Samuel; Burke, Donald S.; Wisniewski, Stephen R.			Local Variations in Spatial Synchrony of Influenza Epidemics	PLOS ONE			English	Article							UNITED-STATES; MEASLES METAPOPULATION; TRAVELING-WAVES; DYNAMICS; HIERARCHIES; VACCINATION; PATTERNS; JAPAN	Background: Understanding the mechanism of influenza spread across multiple geographic scales is not complete. While the mechanism of dissemination across regions and states of the United States has been described, understanding the determinants of dissemination between counties has not been elucidated. The paucity of high resolution spatial-temporal influenza incidence data to evaluate disease structure is often not available. Methodology and Findings: We report on the underlying relationship between the spread of influenza and human movement between counties of one state. Significant synchrony in the timing of epidemics exists across the entire state and decay with distance (regional correlation = 62%). Synchrony as a function of population size display evidence of hierarchical spread with more synchronized epidemics occurring among the most populated counties. A gravity model describing movement between two populations is a stronger predictor of influenza spread than adult movement to and from workplaces suggesting that non-routine and leisure travel drive local epidemics. Conclusions: These findings highlight the complex nature of influenza spread across multiple geographic scales.	[Stark, James H.] New York City Dept Hlth & Mental Hyg, Div Epidemiol, New York, NY USA; [Cummings, Derek A. T.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ermentrout, Bard] Univ Pittsburgh, Dept Math, Sch Arts & Sci, Pittsburgh, PA 15260 USA; [Ostroff, Stephen] Penn Dept Hlth, Bur Epidemiol, Harrisburg, PA 17108 USA; [Sharma, Ravi] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA; [Stebbins, Samuel; Burke, Donald S.; Wisniewski, Stephen R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	New York City Department of Health & Mental Hygiene; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Stark, JH (corresponding author), New York City Dept Hlth & Mental Hyg, Div Epidemiol, New York, NY USA.	jstark@health.nyc.gov	Stark, James/A-2895-2019	Stark, James/0000-0002-0728-876X; Wisniewski, Stephen/0000-0002-3877-9860; /0000-0002-5704-8094	National Institute of General Medical Sciences [U01 GM070708-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070708] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of General Medical Sciences (U01 GM070708-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Bharti N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001941; Bjornstad ON, 1999, ECOLOGY, V80, P622, DOI 10.2307/176640; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; Centers for Disease Control and Prevention, BEHAV RISK FACT SURV; CLIFF A, 1993, MEASLES HIST GEOGRAP; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Erlander Sven, 1990, GRAVITY MODEL TRANSP, V3; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Grassly NC, 2005, NATURE, V433, P417, DOI 10.1038/nature03072; Greene SK, 2006, AM J EPIDEMIOL, V163, P316, DOI 10.1093/aje/kwj040; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Grenfell BT, 1998, ECOL LETT, V1, P63; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jia HM, 2006, AM J PREV MED, V31, P275, DOI 10.1016/j.amepre.2006.06.005; Legendre P., 1998, NUMERICAL ECOLOGY, V24; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Mathews J. H., 2004, NUMERICAL METHODS US; Merrill RM, 2009, MED SCI MONITOR, V15, pPH92; Proff R, 2009, EMERG INFECT DIS, V15, P892, DOI 10.3201/eid1506.081645; Sakai T, 2004, EMERG INFECT DIS, V10, P1822, DOI 10.3201/eid1010.040147; Stark JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034245; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Vora A, 2008, EPIDEMIOL INFECT, V136, P713, DOI 10.1017/S0950268807009193; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	28	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43528	10.1371/journal.pone.0043528	http://dx.doi.org/10.1371/journal.pone.0043528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916274	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000307824300052
J	Antonsson, A; Bialasiewicz, S; Rockett, RJ; Jacob, K; Bennett, IC; Sloots, TP				Antonsson, Annika; Bialasiewicz, Seweryn; Rockett, Rebecca J.; Jacob, Kevin; Bennett, Ian C.; Sloots, Theo P.			Exploring the Prevalence of Ten Polyomaviruses and Two Herpes Viruses in Breast Cancer	PLOS ONE			English	Article							MERKEL CELL POLYOMAVIRUS; EPSTEIN-BARR-VIRUS; QUANTITATIVE PCR ASSAYS; PERIPHERAL-BLOOD; REAL-TIME; LYMPHOTROPIC POLYOMAVIRUS; MOLECULAR-BIOLOGY; DNA; CARCINOMA; SKIN	Several different viruses have been proposed to play a role in breast carcinogenesis. The aim of this study was to investigate the prevalence of a subset of viruses in breast cancer tissue. We investigated the prevalence of 12 DNA viruses: EBV and CMV from the Herpesviridae family and SV40, BKV, JCV, MCV, WUV, KIV, LPV, HPyV6, HPyV7, and TSV from the Polyomaviridae family in 54 fresh frozen breast tumour specimens. Relevant clinical data and basic lifestyle data were available for all patients. The tissue samples were DNA extracted and real-time PCR assays were used for viral detection. The highest prevalence, 10% (5/54), was found for EBV. MCV, HPyV6, and HPyV7 were detected in single patient samples (2% each), while WUV, KIV, JCV, BKV, LPV, SV40, TSV and CMV were not detected in the 54 breast cancer specimens analysed here. Further investigations are needed to elucidate the potential role of viruses, and particularly EBV, in breast carcinogenesis.	[Antonsson, Annika] Queensland Inst Med Res, Dept Populat Hlth, Brisbane, Qld 4006, Australia; [Bialasiewicz, Seweryn; Rockett, Rebecca J.; Jacob, Kevin; Sloots, Theo P.] Sir Albert Sakzewski Virus Res Ctr, Queensland Childrens Med Res Inst, Queensland Paediat Infect Dis Lab, Queensland Childrens Hlth Serv, Brisbane, Qld, Australia; [Bennett, Ian C.] Princess Alexandra Hosp, Breast & Endocrine Unit, Dept Surg, Brisbane, Qld 4102, Australia	QIMR Berghofer Medical Research Institute	Antonsson, A (corresponding author), Queensland Inst Med Res, Dept Populat Hlth, Brisbane, Qld 4006, Australia.	annika.antonsson@qimr.edu.au	Antonsson, Annika/A-2725-2015; Bialasiewicz, Seweryn/F-1414-2010; Bennett, Ian/G-3058-2013; Sloots, Theo P/E-6118-2011	Antonsson, Annika/0000-0002-7383-8416; Bialasiewicz, Seweryn/0000-0001-9474-6943; Bennett, Ian/0000-0002-5951-9291; Bennett, Ian/0000-0002-3634-9680	QCMRI Program Grant [5006]; Garnett Passe and Rodney Williams Memorial Foundation	QCMRI Program Grant; Garnett Passe and Rodney Williams Memorial Foundation	This study was funded by the QCMRI Program Grant 5006 (Queensland Children's Medical Research Institute). http://www.qcmri.org.au/Funding/Programs.aspx. Annika Antonsson is supported by a fellowship from the Garnett Passe and Rodney Williams Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Amarante MK, 2009, J CANCER RES CLIN, V135, P329, DOI 10.1007/s00432-008-0511-2; Antonsson A, 2011, J MED VIROL, V83, P2157, DOI 10.1002/jmv.22223; Bialasiewicz S, 2009, EMERG INFECT DIS, V15, P492, DOI 10.3201/eid1503.081067; Boldorini R, 2005, ACTA CYTOL, V49, P235, DOI 10.1159/000326143; Campeau PM, 2008, HUM GENET, V124, P31, DOI 10.1007/s00439-008-0529-1; Cox B, 2010, BRIT J CANCER, V102, P1665, DOI 10.1038/sj.bjc.6605675; Delbue S, 2008, J CLIN MICROBIOL, V46, P2461, DOI 10.1128/JCM.00381-08; Delbue S, 2010, J CLIN VIROL, V47, P156, DOI 10.1016/j.jcv.2009.11.029; DORRIES K, 1994, VIROLOGY, V198, P59, DOI 10.1006/viro.1994.1008; Dorries K, 1998, DEV BIOLOGICALS, V94, P71; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FERRANTE P, 1995, J MED VIROL, V47, P219, DOI 10.1002/jmv.1890470306; Foulongne V, 2010, BRIT J DERMATOL, V162, P59, DOI 10.1111/j.1365-2133.2009.09381.x; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Hachana M, 2009, BREAST CANCER RES TR, V113, P43, DOI 10.1007/s10549-008-9901-z; Hachana M, 2011, BREAST CANC RES TREA; Hirsch HH, 2001, J INFECT DIS, V184, P1494, DOI 10.1086/324425; Khan G, 2011, EXP MOL PATHOL, V91, P466, DOI 10.1016/j.yexmp.2011.04.018; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Lawson James S, 2010, Cancers (Basel), V2, P752, DOI 10.3390/cancers2020752; Lawson JS, 2006, FUTURE MICROBIOL, V1, P33, DOI 10.2217/17460913.1.1.33; ONORATO IM, 1985, REV INFECT DIS, V7, P479; Pal A, 2006, J VIROL METHODS, V135, P32, DOI 10.1016/j.jviromet.2006.01.018; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Sastre-Garau X, 2009, J PATHOL, V218, P48, DOI 10.1002/path.2532; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; Watzinger F, 2004, J CLIN MICROBIOL, V42, P5189, DOI 10.1128/JCM.42.11.5189-5198.2004; Weigelt B, 2009, NAT REV CLIN ONCOL, V6, P718, DOI 10.1038/nrclinonc.2009.166; ZURHAUSEN H, 1979, MED MICROBIOL IMMUN, V167, P137, DOI 10.1007/BF02121180	32	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e39842	10.1371/journal.pone.0039842	http://dx.doi.org/10.1371/journal.pone.0039842			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916092	gold, Green Published, Green Submitted			2022-12-25	WOS:000307823600002
J	Melzer, D; Gates, P; Osborn, NJ; Henley, WE; Cipelli, R; Young, A; Money, C; McCormack, P; Schofield, P; Mosedale, D; Grainger, D; Galloway, TS				Melzer, David; Gates, Phil; Osborn, Nicholas J.; Henley, William E.; Cipelli, Ricardo; Young, Anita; Money, Cathryn; McCormack, Paul; Schofield, Peter; Mosedale, David; Grainger, David; Galloway, Tamara S.			Urinary Bisphenol A Concentration and Angiography-Defined Coronary Artery Stenosis	PLOS ONE			English	Article							ENDOTHELIAL SHEAR-STRESS; NATURAL-HISTORY; IN-VIVO; ATHEROSCLEROSIS; EXPOSURE; DISEASE; ADULTS; WOMEN; RISK; ASSOCIATION	Background: Bisphenol A is widely used in food and drinks packaging. There is evidence of associations between raised urinary bisphenol A (uBPA) and increased incidence of reported cardiovascular diagnoses. Methodology/Principal Findings: To estimate associations between BPA exposure and angiographically graded coronary atherosclerosis. 591 patients participating in The Metabonomics and Genomics in Coronary Artery Disease (MaGiCAD) study in Cambridgeshire UK, comparing urinary BPA (uBPA) with grades of severity of coronary artery disease (CAD) on angiography. Linear models were adjusted for BMI, occupational social class and diabetes status. Severe (one to three vessel) CAD was present in 385 patients, 86 had intermediate disease (n = 86) and 120 had normal coronary arteries. The (unadjusted) median uBPA concentration was 1.28 ng/mL with normal coronary arteries, and 1.53 ng/mL with severe CAD. Compared to those with normal coronary arteries, uBPA concentration was significantly higher in those with severe CAD (OR per uBPA SD = 5.96 ng/ml OR = 1.43, CI 1.03 to 1.98, p = 0.033), and near significant for intermediate disease (OR = 1.69, CI 0.98 to 2.94, p = 0.061). There was no significant uBPA difference between patients with severe CAD (needing surgery) and the remaining groups combined. Conclusions/Significance: BPA exposure was higher in those with severe coronary artery stenoses compared to those with no vessel disease. Larger studies are needed to estimate true dose response relationships. The mechanisms underlying the association remain to be established.	[Melzer, David; Gates, Phil] Univ Exeter, Epidemiol & Publ Hlth Grp, Peninsula Coll Med & Dent, Exeter, Devon, England; [Cipelli, Ricardo; Galloway, Tamara S.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Henley, William E.] Univ Plymouth, Sch Math & Stat, Plymouth PL4 8AA, Devon, England; [Young, Anita; Money, Cathryn; McCormack, Paul] Brixham Environm Lab, Brixham, England; [Osborn, Nicholas J.] Univ Exeter, Peninsula Coll Med & Dent, European Ctr Environm & Human Hlth, Truro, England; [Mosedale, David; Grainger, David] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Schofield, Peter] Papworth Hosp NHS Fdn Trust, Cambridge, England	University of Exeter; University of Plymouth; University of Exeter; University of Plymouth; University of Exeter; University of Plymouth; University of Cambridge; Papworth Hospital	Melzer, D (corresponding author), Univ Exeter, Epidemiol & Publ Hlth Grp, Peninsula Coll Med & Dent, Exeter, Devon, England.	david.melzer@pms.ac.uk	Osborne, Nicholas/D-2086-2011	Osborne, Nicholas/0000-0002-6700-2284	University of Exeter; Peninsula Clinical Research facility; British Heart Foundation [PG/09/097]; British Heart Foundation [PG/09/097/28118] Funding Source: researchfish	University of Exeter; Peninsula Clinical Research facility; British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	David Melzer and Tamara Galloway's work on BPA has been supported by unrestricted funds from the University of Exeter (www.exeter.ac.uk), the Peninsula Clinical Research facility (www.peninsulacrf.org) and by grant funding from the British Heart Foundation (www.bhf.org.uk - grant reference PG/09/097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Asano S, 2010, BRIT J PHARMACOL, V160, P160, DOI 10.1111/j.1476-5381.2010.00687.x; Biedermann S, 2010, ANAL BIOANAL CHEM, V398, P571, DOI 10.1007/s00216-010-3936-9; Bindhumol V, 2003, TOXICOLOGY, V188, P117, DOI 10.1016/S0300-483X(03)00056-8; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; Carwile JL, 2011, ENV RES; Chatzizisis YS, 2008, CIRCULATION, V117, P993, DOI 10.1161/CIRCULATIONAHA.107.695254; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Elsby R, 2001, J PHARMACOL EXP THER, V297, P103; FRANCESCONI RP, 1987, J APPL PHYSIOL, V62, P1271, DOI 10.1152/jappl.1987.62.3.1271; Galloway T, 2010, ENV HLTH PERSPECT, P118; Hong YC, 2009, TOXICOL LETT, V184, P139, DOI 10.1016/j.toxlet.2008.11.001; Koskinas KC, 2010, CIRCULATION, V121, P2092, DOI 10.1161/CIRCULATIONAHA.109.901678; Lakind JS, 2011, J EXPO SCI ENV EPID, V21, P272, DOI 10.1038/jes.2010.9; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lind PM, 2011, ATHEROSCLEROSIS, V218, P207, DOI 10.1016/j.atherosclerosis.2011.05.001; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Mastin JP, 2005, CARDIOVASC TOXICOL, V5, P91, DOI 10.1385/CT:5:2:091; Melzer D, 2012, CIRCULATION, V125, P1482, DOI 10.1161/CIRCULATIONAHA.111.069153; Melzer D, 2011, ENVIRON HEALTH PERSP, V119, P1788, DOI 10.1289/ehp.1103809; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Miller MR, 2009, ENVIRON HEALTH PERSP, V117, P611, DOI 10.1289/ehp.0800235; Mosedale DE, 2004, IRTL REV, V2, P11; Nepomnaschy PA, 2009, ENVIRON RES, V109, P734, DOI 10.1016/j.envres.2009.04.004; Ning G, 2011, ANN INTERN MED, V155, P368, DOI 10.7326/0003-4819-155-6-201109200-00005; RINGQVIST I, 1983, J CLIN INVEST, V71, P1854, DOI 10.1172/JCI110941; Ritter SK, 2011, CHEM ENG NEWS, V89, P14; Sieli PT, 2011, ENVIRON HEALTH PERSP, V119, P1260, DOI 10.1289/ehp.1003385; Simeonova PP, 2004, TOXICOL APPL PHARM, V198, P444, DOI 10.1016/j.taap.2003.10.018; Simeonova PP, 2003, ENVIRON HEALTH PERSP, V111, P1744, DOI 10.1289/ehp.6332; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121; Valverde MA, 1999, SCIENCE, V285, P1929, DOI 10.1126/science.285.5435.1929; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; WHO, 2010, WHOHSEFOS111 UN FAO; Wohlin M, 2009, ATHEROSCLEROSIS, V205, P486, DOI 10.1016/j.atherosclerosis.2009.01.032; Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014; Zalko D, 2011, CHEMOSPHERE, V82, P424, DOI 10.1016/j.chemosphere.2010.09.058	42	73	78	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43378	10.1371/journal.pone.0043378	http://dx.doi.org/10.1371/journal.pone.0043378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916252	Green Published, gold			2022-12-25	WOS:000307823600076
J	Wasser, SK; Hayward, LS; Hartman, J; Booth, RK; Broms, K; Berg, J; Seely, E; Lewis, L; Smith, H				Wasser, Samuel K.; Hayward, Lisa S.; Hartman, Jennifer; Booth, Rebecca K.; Broms, Kristin; Berg, Jodi; Seely, Elizabeth; Lewis, Lyle; Smith, Heath			Using Detection Dogs to Conduct Simultaneous Surveys of Northern Spotted (Strix occidentalis caurina) and Barred Owls (Strix varia)	PLOS ONE			English	Article							HABITAT SELECTION; RATES; DISTURBANCE; MANAGEMENT; QUALITY; ALBERTA; RANGE; DNA	State and federal actions to conserve northern spotted owl (Strix occidentalis caurina) habitat are largely initiated by establishing habitat occupancy. Northern spotted owl occupancy is typically assessed by eliciting their response to simulated conspecific vocalizations. However, proximity of barred owls (Strix varia)-a significant threat to northern spotted owls-can suppress northern spotted owl responsiveness to vocalization surveys and hence their probability of detection. We developed a survey method to simultaneously detect both species that does not require vocalization. Detection dogs (Canis familiaris) located owl pellets accumulated under roost sites, within search areas selected using habitat association maps. We compared success of detection dog surveys to vocalization surveys slightly modified from the U.S. Fish and Wildlife Service's Draft 2010 Survey Protocol. Seventeen 2 km 62 km polygons were each surveyed multiple times in an area where northern spotted owls were known to nest prior to 1997 and barred owl density was thought to be low. Mitochondrial DNA was used to confirm species from pellets detected by dogs. Spotted owl and barred owl detection probabilities were significantly higher for dog than vocalization surveys. For spotted owls, this difference increased with number of site visits. Cumulative detection probabilities of northern spotted owls were 29% after session 1, 62% after session 2, and 87% after session 3 for dog surveys, compared to 25% after session 1, increasing to 59% by session 6 for vocalization surveys. Mean detection probability for barred owls was 20.1% for dog surveys and 7.3% for vocal surveys. Results suggest that detection dog surveys can complement vocalization surveys by providing a reliable method for establishing occupancy of both northern spotted and barred owl without requiring owl vocalization. This helps meet objectives of Recovery Actions 24 and 25 of the Revised Recovery Plan for the Northern Spotted Owl.	[Wasser, Samuel K.; Hayward, Lisa S.; Hartman, Jennifer; Booth, Rebecca K.; Berg, Jodi; Seely, Elizabeth; Smith, Heath] Univ Washington, Ctr Conservat Biol, Dept Biol, Seattle, WA 98195 USA; [Lewis, Lyle] US Fish & Wildlife Serv, Vancouver, WA USA	University of Washington; University of Washington Seattle; United States Department of the Interior; US Fish & Wildlife Service	Wasser, SK (corresponding author), Univ Washington, Ctr Conservat Biol, Dept Biol, Seattle, WA 98195 USA.	wassers@uw.edu	Wasser, Samuel K/I-5542-2015		USFWS [10100-0-J001MOD4]; Seattle Audubon; Washington Forest Law Center; Wilburforce Foundation; Endangered Species and Habitat Conservation; Red Bluff Fish and Wildlife Office	USFWS(US Fish & Wildlife Service); Seattle Audubon; Washington Forest Law Center; Wilburforce Foundation; Endangered Species and Habitat Conservation; Red Bluff Fish and Wildlife Office	This research was funded by a grant from the USF&WS grant # 10100-0-J001MOD4, Seattle Audubon (http://www.seattleaudubon.org/sas/), the Washington Forest Law Center (http://wflc.org/), and the Wilburforce Foundation (http://www.wilburforce.org/). The Assistant Project Leader, Endangered Species and Habitat Conservation, Red Bluff Fish and Wildlife Office provided partial funding and participated in the design and implementation of this study. However, as indicated by the disclaimer in the manuscript, The findings and conclusions in this article are those of the author(s) and do not necessarily represent the views of the U.S. Fish and Wildlife Service. No other funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RG, 2006, WILDLIFE MONOGR, P1; Ball MC, 2007, CONSERV GENET, V8, P577, DOI 10.1007/s10592-006-9193-y; BLAKESLEY JA, 1992, J WILDLIFE MANAGE, V56, P388, DOI 10.2307/3808840; Boulanger J, 2002, URSUS, V13, P137; Carroll C, 2008, CONSERV BIOL, V22, P1026, DOI 10.1111/j.1523-1739.2008.00931.x; Crozier ML, 2006, CONDOR, V108, P760, DOI 10.1650/0010-5422(2006)108[760:DTPOBO]2.0.CO;2; Forsman ED, 1983, PNW162 USDA FOR SERV, P8; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; Franklin Alan B., 1996, Studies in Avian Biology, V17, P12; Gutierrez RJ, 2007, BIOL INVASIONS, V9, P181, DOI 10.1007/s10530-006-9025-5; Hamer TE, 2007, CONDOR, V109, P750, DOI 10.1650/0010-5422(2007)109[750:HRAAHS]2.0.CO;2; Harrison RL, 2006, WILDLIFE SOC B, V34, P548, DOI 10.2193/0091-7648(2006)34[548:ACOSMF]2.0.CO;2; Hayward LS, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00199.1; MacKay Paula, 2008, P183; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mazur KM, 2000, BIRDS N AM; Olson GS, 2005, J WILDLIFE MANAGE, V69, P918, DOI 10.2193/0022-541X(2005)069[0918:MOSODF]2.0.CO;2; Olson GS, 2004, J WILDLIFE MANAGE, V68, P1039, DOI 10.2193/0022-541X(2004)068[1039:MDPONS]2.0.CO;2; Reid JA, 1999, WILDLIFE SOC B, V27, P986; Singleton PH, 2010, J WILDLIFE MANAGE, V74, P285, DOI 10.2193/2008-548; Smith DA, 2003, ANIM CONSERV, V6, P339, DOI 10.1017/S136794300300341X; Thomas JW, 1990, CONSERVATION STRATEG; U.S. Fish and Wildlife Service, 2010, DRAFT PROT SURV PROP; United States Fish and Wildlife Service, 2011, PROT SURV PROP MAN A; *US FISH WILDL SER, 2011, REV REC PLAN NO SPOT; Vynne C, 2011, CONSERV BIOL, V25, P154, DOI 10.1111/j.1523-1739.2010.01581.x; Wasser SK, 2008, NAT HIST, V117, P48; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Wasser SK, 2005, ANN NY ACAD SCI, V1046, P109, DOI 10.1196/annals.1343.010; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Wiens JD, 2011, J WILDLIFE MANAGE, V75, P531, DOI 10.1002/jwmg.82; Zabel CJ, 2003, ECOL APPL, V13, P1027, DOI 10.1890/02-5084	33	17	19	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42892	10.1371/journal.pone.0042892	http://dx.doi.org/10.1371/journal.pone.0042892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916175	gold, Green Published, Green Submitted			2022-12-25	WOS:000307823600032
J	Ebrahimi, KH; Hagedoorn, PL; Hagen, WR				Ebrahimi, Kourosh Honarmand; Hagedoorn, Peter-Leon; Hagen, Wilfred R.			A Synthetic Peptide with the Putative Iron Binding Motif of Amyloid Precursor Protein (APP) Does Not Catalytically Oxidize Iron	PLOS ONE			English	Article							HUMAN H-CHAIN; PYROCOCCUS-FURIOSUS FERRITIN; SITE-DIRECTED MUTAGENESIS; HUMAN-SERUM TRANSFERRIN; ALZHEIMERS-DISEASE; CORE FORMATION; FERROXIDASE KINETICS; OXIDASE ACTIVITY; HORSE SPLEEN; HUMAN-LIVER	The beta-amyloid precursor protein (APP), which is a key player in Alzheimer's disease, was recently reported to possess an Fe(II) binding site within its E2 domain which exhibits ferroxidase activity [Duce et al. 2010, Cell 142: 857]. The putative ligands of this site were compared to those in the ferroxidase site of ferritin. The activity was indirectly measured using transferrin, which scavenges the Fe(III) product of the reaction. A 22-residue synthetic peptide, named FD1, with the putative ferroxidase site of APP, and the E2 domain of APP were each reported to exhibit 40% of the ferroxidase activity of APP and of ceruloplasmin. It was also claimed that the ferroxidase activity of APP is inhibited by Zn(II) just as in ferritin. We measured the ferroxidase activity indirectly (i) by the incorporation of the Fe(III) product of the ferroxidase reaction into transferrin and directly (ii) by monitoring consumption of the substrate molecular oxygen. The results with the FD1 peptide were compared to the established ferroxidase activities of human H-chain ferritin and of ceruloplasmin. For FD1 we observed no activity above the background of non-enzymatic Fe(II) oxidation by molecular oxygen. Zn(II) binds to transferrin and diminishes its Fe(III) incorporation capacity and rate but it does not specifically bind to a putative ferroxidase site of FD1. Based on these results, and on comparison of the putative ligands of the ferroxidase site of APP with those of ferritin, we conclude that the previously reported results for ferroxidase activity of FD1 and - by implication - of APP should be re-evaluated.	[Ebrahimi, Kourosh Honarmand; Hagedoorn, Peter-Leon; Hagen, Wilfred R.] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands	Delft University of Technology	Ebrahimi, KH (corresponding author), Delft Univ Technol, Dept Biotechnol, Delft, Netherlands.	w.r.hagen@tudelft.nl	Ebrahimi, Kourosh Honarmand/X-4579-2019; Hagedoorn, Peter-Leon/C-8535-2014; Hagen, Wilfred R./H-8918-2017	Ebrahimi, Kourosh Honarmand/0000-0001-6628-944X; Hagedoorn, Peter-Leon/0000-0001-6342-2022; Hagen, Wilfred R./0000-0002-1609-6671	Dutch National Research School Combination - Catalysis Controlled by Chemical Design (NRSC-Catalysis)	Dutch National Research School Combination - Catalysis Controlled by Chemical Design (NRSC-Catalysis)	This work was supported by a research grant from the Dutch National Research School Combination - Catalysis Controlled by Chemical Design (NRSC-Catalysis). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo KM, 2011, J BIOL CHEM, V286, P8252, DOI 10.1074/jbc.M110.128512; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; BAKKER GR, 1986, J BIOL CHEM, V261, P3182; Bou-Abdallah F, 2004, BIOCHEMISTRY-US, V43, P4332, DOI 10.1021/bi0498813; Bou-Abdallah F, 2003, J BIOL INORG CHEM, V8, P489, DOI 10.1007/s00775-003-0455-6; Bou-Abdallah F, 2002, BIOCHEM J, V364, P57, DOI 10.1042/bj3640057; Bou-Abdallah F, 2010, BBA-GEN SUBJECTS, V1800, P719, DOI 10.1016/j.bbagen.2010.03.021; Bou-Abdallah F, 2008, J AM CHEM SOC, V130, P17801, DOI 10.1021/ja8054035; Cho HH, 2010, J BIOL CHEM, V285, P31217, DOI 10.1074/jbc.M110.149161; Dahms SO, 2012, J MOL BIOL, V416, P438, DOI 10.1016/j.jmb.2011.12.057; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Ebrahimi KH, 2010, J BIOL INORG CHEM, V15, P1243, DOI 10.1007/s00775-010-0682-6; Ebrahimi KH, 2009, J BIOL INORG CHEM, V14, P1265, DOI 10.1007/s00775-009-0571-z; HARRIS WR, 1988, J INORG BIOCHEM, V33, P211, DOI 10.1016/0162-0134(88)80050-3; HARRIS WR, 1983, BIOCHEMISTRY-US, V22, P3920, DOI 10.1021/bi00285a030; Hung YH, 2010, J BIOL INORG CHEM, V15, P61, DOI 10.1007/s00775-009-0600-y; Kong GKW, 2007, J MOL BIOL, V367, P148, DOI 10.1016/j.jmb.2006.12.041; LEVI S, 1988, J BIOL CHEM, V263, P18086; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; OSAKI S, 1966, J BIOL CHEM, V241, P5053; OSAKI S, 1966, J BIOL CHEM, V241, P2746; Pouvreau LAM, 2008, METHOD ENZYMOL, V436, P97, DOI 10.1016/S0076-6879(08)36006-6; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; Snow CL, 2011, J INORG BIOCHEM, V105, P972, DOI 10.1016/j.jinorgbio.2011.04.003; SUN S, 1992, J BIOL CHEM, V267, P25160; SUN SJ, 1993, BIOCHEMISTRY-US, V32, P9362, DOI 10.1021/bi00087a015; Tabner Brian J, 2010, Int J Alzheimers Dis, V2011, P546380, DOI 10.4061/2011/546380; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Tinoco AD, 2005, J AM CHEM SOC, V127, P11218, DOI 10.1021/ja052768v; TREFFRY A, 1993, BIOCHEM J, V296, P721, DOI 10.1042/bj2960721; Treffry A, 1998, J BIOL INORG CHEM, V3, P682, DOI 10.1007/s007750050282; TREFFRY A, 1995, BIOCHEMISTRY-US, V34, P15204, DOI 10.1021/bi00046a028; Venkataramani V, 2010, J BIOL CHEM, V285, P10678, DOI 10.1074/jbc.M109.057836; Wan L, 2012, J ALZHEIMERS DIS, V30, P523, DOI 10.3233/JAD-2012-111169; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Watthanawisuth N., 2011, IEEE DEFENSE SCI RES, P1, DOI DOI 10.4061/2011/971021; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Zhao GH, 2003, BIOCHEMISTRY-US, V42, P3142, DOI 10.1021/bi027357v; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	41	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e40287	10.1371/journal.pone.0040287	http://dx.doi.org/10.1371/journal.pone.0040287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916096	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500800002
J	Zalamea, PC; Heuret, P; Sarmiento, C; Rodriguez, M; Berthouly, A; Guitet, S; Nicolini, E; Delnatte, C; Barthelemy, D; Stevenson, PR				Zalamea, Paul-Camilo; Heuret, Patrick; Sarmiento, Carolina; Rodriguez, Manuel; Berthouly, Anne; Guitet, Stephane; Nicolini, Eric; Delnatte, Cesar; Barthelemy, Daniel; Stevenson, Pablo R.			The Genus Cecropia: A Biological Clock to Estimate the Age of Recently Disturbed Areas in the Neotropics	PLOS ONE			English	Article							FORESTS; TREES; PATTERNS; RATES	Forest successional processes following disturbance take decades to play out, even in tropical forests. Nonetheless, records of vegetation change in this ecosystem are scarce, increasing the importance of the chronosequence approach to study forest recovery. However, this approach requires accurate dating of secondary forests, which until now was a difficult and/or expensive task. Cecropia is a widespread and abundant pioneer tree genus of the Neotropics. Here we propose and validate a rapid and straightforward method to estimate the age of secondary forest patches based on morphological observations of Cecropia trees. We found that Cecropia-inferred ages were highly correlated with known ages of the forest. We also demonstrate that Cecropia can be used to accurately date disturbances and propose twenty-one species distributed all over the geographical range of the genus as potential secondary forest chronometer species. Our method is limited in applicability by the maximal longevity of Cecropia individuals. Although the oldest chronosequence used in this study was 20 years old, we argue that at least for the first four decades after disturbance, the method described in this study provides very accurate estimations of secondary forest ages. The age of pioneer trees provides not only information needed to calculate the recovery of carbon stocks that would help to improve forest management, but also provides information needed to characterize the initial floristic composition and the rates of species remigration into secondary forest. Our contribution shows how successional studies can be reliably and inexpensively extended without the need to obtain forest ages based on expensive or potentially inaccurate data across the Neotropics.	[Zalamea, Paul-Camilo] IRD, UMR AMAP Bot & Bioinformat Architecture Plantes, Montpellier, France; [Zalamea, Paul-Camilo; Sarmiento, Carolina; Rodriguez, Manuel; Stevenson, Pablo R.] Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia; [Heuret, Patrick; Berthouly, Anne] INRA, UMR ECOFOG Ecol Forets Guyane, Kourou, French Guiana; [Heuret, Patrick; Delnatte, Cesar] Museum Hist Nat, Aix En Provence, France; [Sarmiento, Carolina; Nicolini, Eric] CIRAD, UMR AMAP Bot & Bioinformat Architecture Plantes, Montpellier, France; [Guitet, Stephane] DTRD, Off Natl Forets, Cayenne, French Guiana; [Guitet, Stephane; Barthelemy, Daniel] INRA, UMR AMAP Bot & Bioinformat Architecture Plantes, F-34060 Montpellier, France; [Barthelemy, Daniel] CIRAD, BIOS Direct, Montpellier, France	CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidad de los Andes (Colombia); INRAE; Museum National d'Histoire Naturelle (MNHN); CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; CIRAD	Zalamea, PC (corresponding author), Smithsonian Trop Res Inst, Ancon, Panama.	camilozalamea@gmail.com	Sarmiento, Carolina/ABF-3966-2020; HEURET, Patrick/GNH-3499-2022; Guitet, Stéphane/F-5616-2016	Sarmiento, Carolina/0000-0002-8575-7170; Guitet, Stéphane/0000-0003-2374-4240; Zalamea, Paul-Camilo/0000-0002-0987-4164; barthelemy, Daniel/0000-0003-3187-2517	Ecos-Nord-Colciencias and Paris 13 University grant [C08A01]; Institut de Recherche pour le Developpement (France)	Ecos-Nord-Colciencias and Paris 13 University grant; Institut de Recherche pour le Developpement (France)	This research was supported by an Ecos-Nord-Colciencias and Paris 13 University grant (C08A01), and the Institut de Recherche pour le Developpement (France) doctoral grant to PCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bawa KS, 1997, NATURE, V386, P562, DOI 10.1038/386562a0; Berg CC, 2005, FLORA NEOTROPICA MON, V94, P1, DOI DOI 10.2307/4393938; Brienen RJW, 2009, BIOTROPICA, V41, P186, DOI 10.1111/j.1744-7429.2008.00462.x; BROKAW NVL, 1987, J ECOL, V75, P9, DOI 10.2307/2260533; Chambers JQ, 1998, NATURE, V391, P135, DOI 10.1038/34325; Chazdon RL, 2007, PHILOS T R SOC B, V362, P273, DOI 10.1098/rstb.2006.1990; CONDIT R, 1993, FOREST ECOL MANAG, V62, P123, DOI 10.1016/0378-1127(93)90046-P; ESRI, 2008, ARCMAP 9 3; Heuret P, 2002, AM J BOT, V89, P1180, DOI 10.3732/ajb.89.7.1180; KORNING J, 1994, J TROP ECOL, V10, P151, DOI 10.1017/S026646740000780X; Laurance WF, 2004, FOREST ECOL MANAG, V190, P131, DOI 10.1016/j.foreco.2003.09.011; Laurance WF, 2007, TRENDS ECOL EVOL, V22, P65, DOI 10.1016/j.tree.2006.09.014; Lugo AE, 2009, BIOTROPICA, V41, P589, DOI 10.1111/j.1744-7429.2009.00550.x; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Martinez-Ramos M, 1998, TRENDS PLANT SCI, V3, P400, DOI 10.1016/S1360-1385(98)01313-2; Martinez-Ramos M, 1999, TRENDS PLANT SCI, V4, P386, DOI 10.1016/S1360-1385(99)01478-8; Mesquita RCG, 2001, J ECOL, V89, P528, DOI 10.1046/j.1365-2745.2001.00583.x; Neeff T, 2006, ECOSYSTEMS, V9, P609, DOI 10.1007/s10021-006-0001-9; Norden N, 2009, ECOL LETT, V12, P385, DOI 10.1111/j.1461-0248.2009.01292.x; PINHEIRO J., 2009, NLME LINEAR NONLINEA; R Core Team, 2016, R FDN STAT COMP; Sanchez-Azofeifa GA, 2009, ECOL APPL, V19, P480, DOI 10.1890/08-1149.1; Terborgh J, 1997, J TROP ECOL, V13, P833, DOI 10.1017/S0266467400011020; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009; Zalamea P-C, 2010, THESIS U MONTPELLIER; Zalamea PC, 2008, AM J BOT, V95, P263, DOI 10.3732/ajb.95.3.263; Zalamea PC, 2011, P ROY SOC B-BIOL SCI, V278, P2437, DOI 10.1098/rspb.2010.2259	27	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42643	10.1371/journal.pone.0042643	http://dx.doi.org/10.1371/journal.pone.0042643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22916144	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900053
J	Schlessinger, A; Wittwer, MB; Dahlin, A; Khuri, N; Bonomi, M; Fan, H; Giacomini, KM; Sali, A				Schlessinger, Avner; Wittwer, Matthias B.; Dahlin, Amber; Khuri, Natalia; Bonomi, Massimiliano; Fan, Hao; Giacomini, Kathleen M.; Sali, Andrej			High Selectivity of the gamma-Aminobutyric Acid Transporter 2 (GAT-2, SLC6A13) Revealed by Structure-based Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN-I; 5-AMINOLEVULINIC ACID; ALTERNATING ACCESS; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; SODIUM; SUBSTRATE; MECHANISM; DISCOVERY; DYNAMICS	The solute carrier 6 (SLC6) is a family of ion-dependent transporters that mediate uptake into the cell of osmolytes such as neurotransmitters and amino acids. Four SLC6 members transport GABA, a key neurotransmitter that triggers inhibitory signaling pathways via various receptors (e. g., GABA(A)). The GABA transporters (GATs) regulate the concentration of GABA available for signaling and are thus targeted by a variety of anticonvulsant and relaxant drugs. Here, we characterize GAT-2, a transporter that plays a role in peripheral GABAergic mechanisms, by constructing comparative structural models based on crystallographic structures of the leucine transporter LeuT. Models of GAT-2 in two different conformations were constructed and experimentally validated, using site-directed mutagenesis. Computational screening of 594,166 compounds including drugs, metabolites, and fragment-like molecules from the ZINC database revealed distinct ligands for the two GAT-2 models. 31 small molecules, including high scoring compounds and molecules chemically related to known and predicted GAT-2 ligands, were experimentally tested in inhibition assays. Twelve ligands were found, six of which were chemically novel (e. g., homotaurine). Our results suggest that GAT-2 is a high selectivity/low affinity transporter that is resistant to inhibition by typical GABAergic inhibitors. Finally, we compared the binding site of GAT-2 with those of other SLC6 members, including the norepinephrine transporter and other GATs, to identify ligand specificity determinants for this family. Our combined approach may be useful for characterizing interactions between small molecules and other membrane proteins, as well as for describing substrate specificities in other protein families.	[Schlessinger, Avner; Wittwer, Matthias B.; Dahlin, Amber; Khuri, Natalia; Bonomi, Massimiliano; Fan, Hao; Giacomini, Kathleen M.; Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Schlessinger, Avner; Khuri, Natalia; Bonomi, Massimiliano; Fan, Hao; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Giacomini, KM (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Bioengn & Therapeut Sci, 1550 4th St,Box 2911, San Francisco, CA 94143 USA.	kathy.giacomini@ucsf.edu; sali@salilab.org	Giacomini, Kathleen/AEF-2452-2022; Wittwer, Matthias/AFY-6872-2022; Wittwer, Matthias/F-7679-2011	Bonomi, Massimiliano/0000-0002-7321-0004	National Institutes of Health [R01 GM54762, U54 GM093342, P01 GM71790, U54 GM074929, U01 GM61390, R25 CA112355, F32 GM088991]; Swiss National Science Foundation [PBBSP3-133384]; Hewlett Packard; IBM; NetApps; Intel; Ron Conway; Mike Homer; NATIONAL CANCER INSTITUTE [R25CA112355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM088991, R01GM054762, U01GM061390, U54GM074929, P01GM071790, U54GM093342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hewlett Packard; IBM(International Business Machines (IBM)); NetApps; Intel(Intel Corporation); Ron Conway; Mike Homer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM54762, U54 GM093342, and P01 GM71790 (to A. S.); U54 GM074929 and U01 GM61390 (to A. S. and K. M. G.); R25 CA112355 (to A. D.); and F32 GM088991 (to A. Sc.). This work was also supported by Swiss National Science Foundation Grant for Prospective Researchers PBBSP3-133384 (to M. B. W.). We also acknowledge funding for computing hardware from Hewlett Packard, IBM, NetApps, Intel, Ron Conway, and Mike Homer.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Albers JW, 2004, MUSCLE NERVE, V30, P410, DOI 10.1002/mus.20137; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bednarczyk D, 2010, ANAL BIOCHEM, V405, P50, DOI 10.1016/j.ab.2010.06.012; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Carr RAE, 2005, DRUG DISCOV TODAY, V10, P987, DOI 10.1016/S1359-6446(05)03511-7; Carter LP, 2009, PHARMACOL THERAPEUT, V121, P100, DOI 10.1016/j.pharmthera.2008.10.003; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Christiansen B, 2007, J BIOL CHEM, V282, P19331, DOI 10.1074/jbc.M702111200; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; ERDO SL, 1990, J NEUROCHEM, V54, P363, DOI 10.1111/j.1471-4159.1990.tb01882.x; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fan H, 2009, J CHEM INF MODEL, V49, P2512, DOI 10.1021/ci9003706; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Fukuda H, 2005, INT J BIOCHEM CELL B, V37, P272, DOI 10.1016/j.biocel.2004.04.018; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Garbutt JC, 2010, ALCOHOL CLIN EXP RES, V34, P1849, DOI 10.1111/j.1530-0277.2010.01273.x; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Hahn MK, 2007, ANNU REV PHARMACOL, V47, P401, DOI 10.1146/annurev.pharmtox.47.120505.105242; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Lindberg RLP, 1999, J CLIN INVEST, V103, P1127, DOI 10.1172/JCI5986; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lorber DM, 2005, CURR TOP MED CHEM, V5, P739, DOI 10.2174/1568026054637683; Madsen KK, 2010, PHARMACOL THERAPEUT, V125, P394, DOI 10.1016/j.pharmthera.2009.11.007; Melamed N, 2004, MOL PHARMACOL, V65, P1452, DOI 10.1124/mol.65.6.1452; MORETTI MB, 1995, INT J BIOCHEM CELL B, V27, P169, DOI 10.1016/1357-2725(95)00002-7; Musiol R, 2011, CURR PHARM DESIGN, V17, P3548, DOI 10.2174/138161211798194549; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Nakashita M, 1997, NEUROSCI RES, V29, P87, DOI 10.1016/S0168-0102(97)00072-2; Nyola A, 2010, CURR OPIN STRUC BIOL, V20, P415, DOI 10.1016/j.sbi.2010.05.007; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlessinger A, 2011, P NATL ACAD SCI USA, V108, P15810, DOI 10.1073/pnas.1106030108; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Steinbeck C, 2006, CURR PHARM DESIGN, V12, P2111, DOI 10.2174/138161206777585274; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Warr W, 2009, J COMPUT AID MOL DES, V23, P195, DOI 10.1007/s10822-009-9260-9; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057	73	40	41	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.388157	http://dx.doi.org/10.1074/jbc.M112.388157			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22932902	hybrid, Green Published			2022-12-25	WOS:000310642200014
J	Fang, WB; Jokar, I; Zou, A; Lambert, D; Dendukuri, P; Cheng, N				Fang, Wei Bin; Jokar, Iman; Zou, An; Lambert, Diana; Dendukuri, Prasanthi; Cheng, Nikki			CCL2/CCR2 Chemokine Signaling Coordinates Survival and Motility of Breast Cancer Cells through Smad3 Protein- and p42/44 Mitogen-activated Protein Kinase (MAPK)-dependent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SMOOTH MUSCLE ACTIN; TGF-BETA; PROSTATE-CANCER; MAP KINASE; IMMUNOHISTOCHEMICAL EXPRESSION; PROGNOSTIC-SIGNIFICANCE; MACROPHAGE RECRUITMENT; INDUCED APOPTOSIS; ONCOGENE PRODUCT	Increased cell motility and survival are important hallmarks of metastatic tumor cells. However, the mechanisms that regulate the interplay between these cellular processes remain poorly understood. In these studies, we demonstrate that CCL2, a chemokine well known for regulating immune cell migration, plays an important role in signaling to breast cancer cells. We report that in a panel of mouse and human breast cancer cell lines CCL2 enhanced cell migration and survival associated with increased phosphorylation of Smad3 and p42/44MAPK proteins. The G protein-coupled receptor CCR2 was found to be elevated in breast cancers, correlating with CCL2 expression. RNA interference of CCR2 expression in breast cancer cells significantly inhibited CCL2-induced migration, survival, and phosphorylation of Smad3 and p42/44MAPK proteins. Disruption of Smad3 expression in mammary carcinoma cells blocked CCL2-induced cell survival and migration and partially reduced p42/44MAPK phosphorylation. Ablation of MAPK phosphorylation in Smad3-deficient cells with the MEK inhibitor U0126 further reduced cell survival but not migration. These data indicate that Smad3 signaling through MEK-p42/44MAPK regulates CCL2-induced cell motility and survival, whereas CCL2 induction of MEK-p42/44MAPK signaling independent of Smad3 functions as an alternative mechanism for cell survival. Furthermore, we show that CCL2-induced Smad3 signaling through MEK-p42/44MAPK regulates expression and activity of Rho GTPase to mediate CCL2-induced breast cancer cell motility and survival. With these studies, we characterize an important role for CCL2/CCR2 chemokine signaling in regulating the intrinsic relationships between breast cancer cell motility and survival with implications on the metastatic process.	[Fang, Wei Bin; Jokar, Iman; Zou, An; Lambert, Diana; Dendukuri, Prasanthi; Cheng, Nikki] Univ Kansas, Dept Pathol & Lab Med, Med Ctr, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Cheng, N (corresponding author), Univ Kansas, Dept Pathol & Lab Med, Med Ctr, 3901 Rainbow Blvd,MS 3003, Kansas City, KS 66160 USA.	ncheng@kumc.edu			National Institutes of Health from the NCI [R00 CA127357-03]; United States Department of Health and Human Services; Kansas Bioscience Authority; NATIONAL CANCER INSTITUTE [R00CA127357] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Health and Human Services; Kansas Bioscience Authority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R00 CA127357-03 from the NCI and United States Department of Health and Human Services (to N. C.). This work was also supported by funds from the Kansas Bioscience Authority (to N. C.).	Amar S, 2009, BREAST CANCER RES TR, V114, P413, DOI 10.1007/s10549-008-0032-3; [Anonymous], 1978, BIOCH VIRUSES, P21; Araki S, 2010, J CLIN INVEST, V120, P290, DOI 10.1172/JCI39194; Arefieva TI, 2005, CYTOKINE, V31, P439, DOI 10.1016/j.cyto.2005.06.016; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Blanc C, 2000, CANCER RES, V60, P4386; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Buxton ILO, 2008, CIRC RES, V102, P151, DOI 10.1161/CIRCRESAHA.107.170217; CAMERON DA, 1994, BRIT J CANCER, V70, P120, DOI 10.1038/bjc.1994.259; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Cheng N, 2007, CANCER RES, V67, P4869, DOI 10.1158/0008-5472.CAN-06-3381; Choi Kyu Hun, 2000, Korean Journal of Internal Medicine, V15, P218; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Dawson J, 2003, EXPERT OPIN THER TAR, V7, P35; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; DIXON RA, 1981, ANTIMICROB AGENTS CH, V20, P321, DOI 10.1128/AAC.20.3.321; Duchene J, 2002, J BIOL CHEM, V277, P40375, DOI 10.1074/jbc.M202744200; El Mouedden M, 2000, TOXICOL SCI, V56, P229, DOI 10.1093/toxsci/56.1.229; ERNST CA, 1994, J IMMUNOL, V152, P3541; ERSKINE RJ, 1992, AM J VET RES, V53, P375; Fang WB, 2011, CLIN EXP METASTAS, V28, P351, DOI 10.1007/s10585-011-9373-0; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Florio T, 2000, J PHYSIOL-PARIS, V94, P239, DOI 10.1016/S0928-4257(00)00214-X; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Fujisawa K, 1996, J BIOL CHEM, V271, P23022, DOI 10.1074/jbc.271.38.23022; Gangur V, 2002, VET IMMUNOL IMMUNOP, V86, P127, DOI 10.1016/S0165-2427(02)00018-1; Ghellal A, 2000, ANTICANCER RES, V20, P4413; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Guo L, 2007, INT J BIOL MARKER, V22, P1; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hembruff SL, 2010, NEOPLASIA, V12, P425, DOI 10.1593/neo.10200; Herrera A. C., 2012, CANC IMMUNO IN PRESS; HOSHINO Y, 1995, EXP HEMATOL, V23, P1035; Hotta K, 1996, BIOCHEM BIOPH RES CO, V225, P69, DOI 10.1006/bbrc.1996.1132; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Ikushima H, 2012, CELL TISSUE RES, V347, P37, DOI 10.1007/s00441-011-1179-5; Iwata H, 2011, JPN J CLIN ONCOL, V41, P867, DOI 10.1093/jjco/hyr081; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Johnson Z, 2004, BIOCHEM SOC T, V32, P366, DOI 10.1042/BST0320366; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Juan SH, 2007, NEPHROL DIAL TRANSPL, V22, P732, DOI 10.1093/ndt/gfl699; KAHN T, 1972, LANCET, V1, P498; Kondoh K, 2005, CHROMOSOMA, V114, P86, DOI 10.1007/s00412-005-0341-9; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Koumoundourou D, 2007, ANTICANCER RES, V27, P2613; Laing KJ, 2004, DEV COMP IMMUNOL, V28, P443, DOI 10.1016/j.dci.2003.09.006; Lang HN, 1997, HEARING RES, V111, P177, DOI 10.1016/S0378-5955(97)00098-1; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Lebrecht A, 2004, TUMOR BIOL, V25, P14, DOI 10.1159/000077718; Lentsch AB, 2002, FASEB J, V16, P1093, DOI 10.1096/fj.02-0066hyp; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Loberg RD, 2007, J CELL BIOCHEM, V101, P1292, DOI 10.1002/jcb.21252; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Lu Y, 2007, J CELL BIOCHEM, V101, P676, DOI 10.1002/jcb.21220; Lu Y, 2009, CLIN EXP METASTAS, V26, P161, DOI 10.1007/s10585-008-9226-7; Maglione JE, 2001, CANCER RES, V61, P8298; Mantovani A, 2011, EUR J IMMUNOL, V41, P2522, DOI 10.1002/eji.201141894; Mao LM, 2005, J BIOL CHEM, V280, P12602, DOI 10.1074/jbc.M411709200; Mazzoni E, 2003, MOL CANCER RES, V1, P776; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; MEDINA D, 2000, METHODS MAMMARY GLAN, P137; Mellado M, 1998, J IMMUNOL, V161, P805; MIZUKAMI Y, 1990, ANTICANCER RES, V10, P1115; MIZUKAMI Y, 1991, ANTICANCER RES, V11, P1485; Moon A, 2000, INT J CANCER, V85, P176, DOI 10.1002/(SICI)1097-0215(20000115)85:2<176::AID-IJC5>3.0.CO;2-E; Moore-Smith L, 2011, J MAMMARY GLAND BIOL, V16, P89, DOI 10.1007/s10911-011-9216-2; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Okamoto S, 1996, ANTICANCER RES, V16, P2699; PAAPE MJ, 1990, AM J VET RES, V51, P1055; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Pilat MJP, 1998, ANTICANCER RES, V18, P2575; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qin BY, 2002, GENE DEV, V16, P1950, DOI 10.1101/gad.1002002; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Qualls JE, 2011, CURR TOP DEV BIOL, V94, P309, DOI 10.1016/B978-0-12-380916-2.00010-3; Richardsen Elin, 2012, BMC Res Notes, V5, P110, DOI 10.1186/1756-0500-5-110; Riggins GJ, 1997, CANCER RES, V57, P2578; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roca H, 2009, NEOPLASIA, V11, P1309, DOI 10.1593/neo.09936; Ross KR, 2007, CELL SIGNAL, V19, P923, DOI 10.1016/j.cellsig.2006.11.008; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Samanta D, 2012, FRONT BIOSCI-LANDMRK, V17, P1281, DOI 10.2741/3986; Schuh JoAnn C L, 2004, Toxicol Pathol, V32 Suppl 1, P53, DOI 10.1080/01926230490424770; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Soung YH, 2008, HUM PATHOL, V39, P895, DOI 10.1016/j.humpath.2007.10.015; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Talmadge JE, 2011, SEMIN CANCER BIOL, V21, P131, DOI 10.1016/j.semcancer.2010.12.002; Tamiolakis D, 2002, EUR J GYNAECOL ONCOL, V23, P469; Tian F, 2003, CANCER RES, V63, P8284; TSUKAMOTO H, 1992, J INVEST DERMATOL, V98, P116, DOI 10.1111/1523-1747.ep12496020; Tylaska LA, 2002, CYTOKINE, V18, P184, DOI 10.1006/cyto.2002.1031; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; Xia MD, 2009, EXPERT OPIN THER PAT, V19, P295, DOI 10.1517/13543770902755129; YAMASHIRO S, 1994, AM J PATHOL, V145, P856; Yanagisawa K, 1998, ONCOGENE, V17, P1743, DOI 10.1038/sj.onc.1202052; Youngs SJ, 1997, INT J CANCER, V71, P257, DOI 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhao SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023262; Zoli W, 2005, BREAST CANCER RES, V7, pR681, DOI 10.1186/bcr1274	108	133	137	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36593	36608		10.1074/jbc.M112.365999	http://dx.doi.org/10.1074/jbc.M112.365999			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22927430	Green Published, hybrid			2022-12-25	WOS:000310364000079
J	Varfaj, F; Lampe, JN; de Montellano, PRO				Varfaj, Fatbardha; Lampe, Jed N.; de Montellano, Paul R. Ortiz			Role of Cysteine Residues in Heme Binding to Human Heme Oxygenase-2 Elucidated by Two-dimensional NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-GEL DIGESTION; CARBON-MONOXIDE; PROTEIN; SEQUENCE; GENE; YEAST; PURIFICATION; EXPRESSION; DOMAINS; CLONING	Human heme oxygenases 1 and 2 (HO-1 and HO-2) degrade heme in the presence of oxygen and NADPH-cytochrome P450 reductase, producing ferrous iron, CO, and biliverdin. HO-1 is an inducible enzyme, but HO-2 is constitutively expressed in selected tissues and is involved in signaling and regulatory processes. HO-2 has three cysteine residues that have been proposed to modulate the affinity for heme, whereas HO-1 has none. Here we use site-specific mutagenesis and two-dimensional NMR of L-[3-C-13] cysteine-labeled proteins to determine the redox state of the individual cysteines in HO-2 and assess their roles in binding of heme. The results indicate that in the apoprotein, Cys(282) and Cys(265) are in the oxidized state, probably in an intramolecular disulfide bond. The addition of a reducing agent converts them to the reduced, free thiol state. Two-dimensional NMR of site-specific mutants reveals that the redox state of Cys(265) and Cys(282) varies with the presence or absence of other Cys residues, indicating that the microenvironments of the Cys residues are mutually interdependent. Cys(265) appears to be in a relatively hydrophilic, oxidizable environment compared with Cys(127) and Cys(282). Chemical shift data indicate that none of the cysteines stably coordinates to the heme iron atom. In the oxidized state of the apoprotein, heme is bound 2.5-fold more tightly than in the reduced state. This small difference in heme affinity between the oxidized and reduced states of the protein is much less than previously reported, suggesting that it is not a significant factor in the physiological regulation of cellular heme levels.	[Varfaj, Fatbardha; Lampe, Jed N.; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, 600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu	Lampe, Jed N./J-8930-2019	Lampe, Jed N./0000-0003-0794-2263	National Institutes of Health [DK30297]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK30297.	Bianchetti CM, 2007, J BIOL CHEM, V282, P37624, DOI 10.1074/jbc.M707396200; CHEN JJ, 1991, P NATL ACAD SCI USA, V88, P7729, DOI 10.1073/pnas.88.17.7729; CREUSOT F, 1988, J MOL BIOL, V204, P263, DOI 10.1016/0022-2836(88)90574-8; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dierks EA, 1998, BIOCHEMISTRY-US, V37, P1839, DOI 10.1021/bi972458s; DRYGAS ME, 1989, J BIOL CHEM, V264, P17897; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; Gardner JD, 2010, J BIOL INORG CHEM, V15, P1117, DOI 10.1007/s00775-010-0672-8; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Jiang YY, 2009, J INORG BIOCHEM, V103, P316, DOI 10.1016/j.jinorgbio.2008.11.002; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P178; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Lightning LK, 2001, J BIOL CHEM, V276, P10612, DOI 10.1074/jbc.M010349200; Moore BA, 2005, CRIT CARE MED, V33, P1317, DOI 10.1097/01.CCM.0000166349.76514.40; Mossner E, 2000, FEBS LETT, V477, P21, DOI 10.1016/S0014-5793(00)01738-5; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Rafie-Kolpin M, 2000, J BIOL CHEM, V275, P5171, DOI 10.1074/jbc.275.7.5171; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Steiner H, 1996, J BIOL CHEM, V271, P32605, DOI 10.1074/jbc.271.51.32605; TRAKSHEL GM, 1986, J BIOL CHEM, V261, P1131; TRIGGSRAINE BL, 1988, J BACTERIOL, V170, P4415, DOI 10.1128/jb.170.9.4415-4419.1988; Wehrli F.W., 1976, INTERPRETATION CARBO; WILKS A, 1993, J BIOL CHEM, V268, P22357; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; YOSHIDA T, 1978, J BIOL CHEM, V253, P4224; Zakhary R, 1997, P NATL ACAD SCI USA, V94, P14848, DOI 10.1073/pnas.94.26.14848	31	23	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35181	35191		10.1074/jbc.M112.378042	http://dx.doi.org/10.1074/jbc.M112.378042			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22923613	Green Published, hybrid			2022-12-25	WOS:000309968000028
J	Bergmann, G; Graichen, F; Dymke, J; Rohlmann, A; Duda, GN; Damm, P				Bergmann, Georg; Graichen, Friedmar; Dymke, Joern; Rohlmann, Antonius; Duda, Georg N.; Damm, Philipp			High-Tech Hip Implant for Wireless Temperature Measurements In Vivo	PLOS ONE			English	Article							TELEMETRY SYSTEM; ORTHOPEDIC IMPLANTS; JOINT SIMULATOR; SYNOVIAL-FLUIDS; WEAR; PROSTHESES; REPLACEMENTS; FORCES; LOADS; BONE	When walking long distances, hip prostheses heat up due to friction. The influence of articulating materials and lubricating properties of synovia on the final temperatures, as well as any potential biological consequences, are unknown. Such knowledge is essential for optimizing implant materials, identifying patients who are possibly at risk of implant loosening, and proving the concepts of current joint simulators. An instrumented hip implant with telemetric data transfer was developed to measure the implant temperatures in vivo. A clinical study with 100 patients is planned to measure the implant temperatures for different combinations of head and cup materials during walking. This study will answer the question of whether patients with synovia with poor lubricating properties may be at risk for thermally induced bone necrosis and subsequent implant failure. The study will also deliver the different friction properties of various implant materials and prove the significance of wear simulator tests. A clinically successful titanium hip endoprosthesis was modified to house the electronics inside its hollow neck. The electronics are powered by an external induction coil fixed around the joint. A temperature sensor inside the implant triggers a timer circuit, which produces an inductive pulse train with temperature-dependent intervals. This signal is detected by a giant magnetoresistive sensor fixed near the external energy coil. The implant temperature is measured with an accuracy of 0.1 degrees C in a range between 20 degrees C and 58 degrees C and at a sampling rate of 2-10 Hz. This rate could be considerably increased for measuring other data, such as implant strain or vibration. The employed technique of transmitting data from inside of a closed titanium implant by low frequency magnetic pulses eliminates the need to use an electrical feedthrough and an antenna outside of the implant. It enables the design of mechanically safe and simple instrumented implants.	[Bergmann, Georg; Graichen, Friedmar; Dymke, Joern; Rohlmann, Antonius; Duda, Georg N.; Damm, Philipp] Charite, Julius Wolff Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bergmann, G (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	friedmar.graichen@charite.de	Rohlmann, Antonius/E-4778-2011; Duda, Georg N/H-2085-2016	Rohlmann, Antonius/0000-0002-0083-2793; Duda, Georg N/0000-0001-7605-3908; Damm, Philipp/0000-0001-8471-7284				[Anonymous], 1995, ISO72068; [Anonymous], 2010, ISO72064; [Anonymous], 1992, ISO72066; Bergmann G, 2001, J BIOMECH, V34, P421, DOI 10.1016/S0021-9290(00)00188-3; Bergmann G, 2001, J BIOMECH, V34, P429, DOI 10.1016/S0021-9290(00)00234-7; BERGMANN G, 1988, J BIOMECH, V21, P169, DOI 10.1016/0021-9290(88)90009-7; Brockett C, 2007, J BIOMED MATER RES B, V81B, P508, DOI 10.1002/jbm.b.30691; BROWN RH, 1982, J BIOMECH, V15, P815, DOI 10.1016/0021-9290(82)90046-X; Chikama H, 1985, Nihon Seikeigeka Gakkai Zasshi, V59, P559; Drewniak EI, 2009, J BIOMECH, V42, P1996, DOI 10.1016/j.jbiomech.2009.05.024; Fam H, 2007, BIORHEOLOGY, V44, P59; Fialho JC, 2007, J BIOMECH, V40, P2358, DOI 10.1016/j.jbiomech.2006.12.005; GRAICHEN F, 1991, J BIOMED ENG, V13, P370, DOI 10.1016/0141-5425(91)90016-Z; Graichen F, 1999, J BIOMECH, V32, P1113, DOI 10.1016/S0021-9290(99)00110-4; Graichen F, 2007, IEEE T BIO-MED ENG, V54, P253, DOI 10.1109/TBME.2006.886857; Gronkiewicz K, 2009, J PHYSIOL PHARMACOL, V60, P123; Holland HJ, 2012, P MIKROSYTEM TECHN K, P437; Karrholm J, 2010, ACTA ORTHOP, V81, P3, DOI 10.3109/17453671003635918; LEON SA, 1993, INT J HYPERTHER, V9, P77, DOI 10.3109/02656739309061480; Li S, 1999, J ORTHOP RES, V17, P891, DOI 10.1002/jor.1100170614; Liao YS, 1999, J BIOMED MATER RES, V48, P465; Lu Z, 1997, P I MECH ENG H, V211, P101, DOI 10.1243/0954411971534728; Marschner U, 2009, SENSOR ACTUAT A-PHYS, V156, P145, DOI 10.1016/j.sna.2009.08.025; MORITZ AR, 1947, AM J PATHOL, V23, P695; Moss C, 2010, P 3 INT S APPL SCI B, P1; Moss Ch., 2009, P SOMSED 09, V1, P97; Moss SG, 1998, RADIOLOGY, V208, P43, DOI 10.1148/radiology.208.1.9646791; Pritchett JW, 2006, CLIN ORTHOP RELAT R, P195, DOI 10.1097/01.blo.0000183739.50869.bb; Puers R, 2000, SENSOR ACTUAT A-PHYS, V85, P42, DOI 10.1016/S0924-4247(00)00320-4; Rainer F, 1980, Acta Med Austriaca, V7, P92; Rocchi M, 2007, P I MECH ENG H, V221, P561, DOI 10.1243/09544119JEIM137; Schneider E, 2001, J BIOMECH, V34, P849, DOI 10.1016/S0021-9290(01)00037-9; Smith SL, 2001, P I MECH ENG H, V215, P61, DOI 10.1243/0954411011533535; Streicher R M, 1996, Proc Inst Mech Eng H, V210, P223, DOI 10.1243/PIME_PROC_1996_210_416_02; SWANN DA, 1984, ARTHRITIS RHEUM, V27, P552, DOI 10.1002/art.1780270511; Taylor SJG, 1997, J BIOMECH, V30, P225, DOI 10.1016/S0021-9290(96)00141-8; TEPIC S, 1985, J ORTHOPAED RES, V3, P516, DOI 10.1002/jor.1100030416; Williams S, 2008, J BONE JOINT SURG AM, V90A, P111, DOI 10.2106/JBJS.H.00485; Yoshida K, 2009, CLIN ORAL IMPLAN RES, V20, P782, DOI 10.1111/j.1600-0501.2008.01654.x	39	33	36	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43489	10.1371/journal.pone.0043489	http://dx.doi.org/10.1371/journal.pone.0043489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927973	Green Submitted, Green Published, gold			2022-12-25	WOS:000308286300055
J	Kruger, C; Kumar, KG; Mynatt, RL; Volaufova, J; Richards, BK				Kruger, Claudia; Kumar, K. Ganesh; Mynatt, Randall L.; Volaufova, Julia; Richards, Brenda K.			Brain Transcriptional Responses to High-Fat Diet in Acads-Deficient Mice Reveal Energy Sensing Pathways	PLOS ONE			English	Article							AMPHETAMINE-REGULATED TRANSCRIPT; COA DEHYDROGENASE-DEFICIENCY; ACID BETA-OXIDATION; BALB CBYJ MICE; BALB/CBYJ MOUSE; FOOD-INTAKE; HYPOTHALAMIC NUCLEI; ORGANIC ACIDURIA; INDUCED OBESITY; MESSENGER-RNA	Background: How signals from fatty acid metabolism are translated into changes in food intake remains unclear. Previously we reported that mice with a genetic inactivation of Acads (acyl-coenzyme A dehydrogenase, short-chain), the enzyme responsible for mitochondrial beta-oxidation of C4-C6 short-chain fatty acids (SCFAs), shift consumption away from fat and toward carbohydrate when offered a choice between diets. In the current study, we sought to indentify candidate genes and pathways underlying the effects of SCFA oxidation deficiency on food intake in Acads-/- mice. Methodology/Principal Findings: We performed a transcriptional analysis of gene expression in brain tissue of Acads-/- and Acads+/+ mice fed either a high-fat (HF) or low-fat (LF) diet for 2 d. Ingenuity Pathway Analysis revealed three top-scoring pathways significantly modified by genotype or diet: oxidative phosphorylation, mitochondrial dysfunction, and CREB signaling in neurons. A comparison of statistically significant responses in HF Acads-/- vs. HF Acads+/+ (3917) and Acads+/+ HF vs. LF Acads+/+ (3879) revealed 2551 genes or approximately 65% in common between the two experimental comparisons. All but one of these genes were expressed in opposite direction with similar magnitude, demonstrating that HF-fed Acads-deficient mice display transcriptional responses that strongly resemble those of Acads+/+ mice fed LF diet. Intriguingly, genes involved in both AMP-kinase regulation and the neural control of food intake followed this pattern. Quantitative RT-PCR in hypothalamus confirmed the dysregulation of genes in these pathways. Western blotting showed an increase in hypothalamic AMP-kinase in Acads-/- mice and HF diet increased, a key protein in an energy-sensing cascade that responds to depletion of ATP. Conclusions: Our results suggest that the decreased beta-oxidation of short-chain fatty acids in Acads-deficient mice fed HF diet produces a state of energy deficiency in the brain and that AMP-kinase may be the cellular energy-sensing mechanism linking fatty acid oxidation to feeding behavior in this model.	[Kruger, Claudia; Kumar, K. Ganesh; Mynatt, Randall L.; Richards, Brenda K.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA; [Volaufova, Julia] Louisiana State Univ, Sch Publ Hlth, Hlth Sci Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Kruger, C (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA.	richarbk@pbrc.edu	Mynatt, Randall L/N-1980-2017	Mynatt, Randall L/0000-0003-4399-0019	National Institutes of Health [DK-53113]; NORC Center [P30 DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, R01DK053113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health Grant DK-53113 to B. K. Smith Richards and partially supported by NORC Center Grant P30 DK072476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CR, 2001, ENDOCRINOLOGY, V142, P3457, DOI 10.1210/en.142.8.3457; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; AMENDT BA, 1992, PEDIATR RES, V31, P552, DOI 10.1203/00006450-199206000-00003; Asnicar MA, 2001, ENDOCRINOLOGY, V142, P4394, DOI 10.1210/en.142.10.4394; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; He MA, 2011, MOL GENET METAB, V102, P418, DOI 10.1016/j.ymgme.2010.12.005; HINSDALE ME, 1993, GENOMICS, V16, P605, DOI 10.1006/geno.1993.1237; Hou J, 2010, CLIN EXP PHARMACOL P, V37, P989, DOI 10.1111/j.1440-1681.2010.05423.x; Iijima K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008498; Kelly CL, 1996, MAMM GENOME, V7, P262, DOI 10.1007/s003359900078; Lopaschuk GD, 2010, PHARMACOL REV, V62, P237, DOI 10.1124/pr.109.002428; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; QURESHI IA, 1993, BIOCHEM MED METAB B, V50, P145, DOI 10.1006/bmmb.1993.1056; REICHMANN H, 1988, J NEUROCHEM, V51, P339, DOI 10.1111/j.1471-4159.1988.tb01044.x; Reue K, 1996, MAMM GENOME, V7, P694, DOI 10.1007/s003359900208; Richards BKS, 2004, AM J PHYSIOL-REG I, V286, pR311, DOI 10.1152/ajpregu.00488.2003; Ronnett GV, 2009, J NEUROCHEM, V109, P17, DOI 10.1111/j.1471-4159.2009.05916.x; SCHARRER E, 1986, AM J PHYSIOL, V250, P1003, DOI 10.1152/ajpregu.1986.250.6.R1003; SCHIFFER SP, 1989, BIOCHEM GENET, V27, P47, DOI 10.1007/BF00563017; Schreurs M, 2010, OBES REV, V11, P380, DOI 10.1111/j.1467-789X.2009.00642.x; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Smith KL, 2008, OBESITY, V16, P2239, DOI 10.1038/oby.2008.366; Spitzer J J, 1973, Physiologist, V16, P55; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; Tyni T, 2004, PEDIATR RES, V56, P744, DOI 10.1203/01.PDR.0000141967.52759.83; WAHBE VG, 1961, COMP BIOCHEM PHYSIOL, V3, P199, DOI 10.1016/0010-406X(61)90055-X; Wolfgang MJ, 2006, ANNU REV NUTR, V26, P23, DOI 10.1146/annurev.nutr.25.050304.092532; WOOD PA, 1989, PEDIATR RES, V25, P38, DOI 10.1203/00006450-198901000-00010; Wood PA, 1999, ADV EXP MED BIOL, V466, P395; Young PT, 1967, HDB PHYSL 6, V1; Ziotopoulou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE838, DOI 10.1152/ajpendo.2000.279.4.E838	37	8	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41709	10.1371/journal.pone.0041709	http://dx.doi.org/10.1371/journal.pone.0041709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936979	gold, Green Published, Green Submitted			2022-12-25	WOS:000308286300013
J	van Tilborg, AAG; Kompier, LC; Lurkin, I; Poort, R; El Bouazzaoui, S; van der Keur, K; Zuiverloon, T; Dyrskjot, L; Orntoft, TF; Roobol, MJ; Zwarthoff, EC				van Tilborg, Angela A. G.; Kompier, Lucie C.; Lurkin, Irene; Poort, Ricardo; El Bouazzaoui, Samira; van der Keur, Kirstin; Zuiverloon, Tahlita; Dyrskjot, Lars; Orntoft, Torben F.; Roobol, Monique J.; Zwarthoff, Ellen C.			Selection of Microsatellite Markers for Bladder Cancer Diagnosis without the Need for Corresponding Blood	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; VOIDED URINE; MUTATION ANALYSIS; COPY NUMBER; CHROMOSOME-9; TUMORS; SURVEILLANCE; CYTOLOGY; FGFR3; DNA	Microsatellite markers are used for loss-of-heterozygosity, allelic imbalance and clonality analyses in cancers. Usually, tumor DNA is compared to corresponding normal DNA. However, normal DNA is not always available and can display aberrant allele ratios due to copy number variations in the genome. Moreover, stutter peaks may complicate the analysis. To use microsatellite markers for diagnosis of recurrent bladder cancer, we aimed to select markers without stutter peaks and a constant ratio between alleles, thereby avoiding the need for a control DNA sample. We investigated 49 microsatellite markers with tri- and tetranucleotide repeats in regions commonly lost in bladder cancer. Based on analysis of 50 blood DNAs the 12 best performing markers were selected with few stutter peaks and a constant ratio between peaks heights. Per marker upper and lower cut off values for allele ratios were determined. LOH of the markers was observed in 59/104 tumor DNAs. We then determined the sensitivity of the marker panel for detection of recurrent bladder cancer by assaying 102 urine samples of these patients. Sensitivity was 63% when patients were stratified for LOH in their primary tumors. We demonstrate that up-front selection of microsatellite markers obliterates the need for a corresponding blood sample. For diagnosis of bladder cancer recurrences in urine this significantly reduces costs. Moreover, this approach facilitates retrospective analysis of archival tumor samples for allelic imbalance.	[van Tilborg, Angela A. G.; Kompier, Lucie C.; Lurkin, Irene; Poort, Ricardo; El Bouazzaoui, Samira; van der Keur, Kirstin; Zuiverloon, Tahlita; Zwarthoff, Ellen C.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Dyrskjot, Lars; Orntoft, Torben F.] Aarhus Univ Hosp, Dept Clin Biochem, Skejby, Denmark; [Roobol, Monique J.] Erasmus MC, Dept Urol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Aarhus University; Erasmus University Rotterdam; Erasmus MC	van Tilborg, AAG (corresponding author), Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	e.zwarthoff@erasmusmc.nl	Dyrskjot, Lars/H-4922-2012; van Tilborg, Angela/M-5704-2015	van Tilborg, Angela/0000-0003-3968-5345; Dyrskjot, Lars/0000-0001-7061-9851	European Community [201663]; Dutch Cancer Society [EMCR 2007-3863]	European Community(European Commission); Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by European Community Seventh Framework program FP7/2007-2012, grant agreement no 201663; Dutch Cancer Society grant no. EMCR 2007-3863. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist DA, 2008, ANN INTERN MED, V149, P441, DOI 10.7326/0003-4819-149-7-200810070-00004; Babjuk M, 2008, EUR UROL; Bartoletti R, 2005, ONCOL REP, V13, P531; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; CAIRNS P, 1993, ONCOGENE, V8, P1083; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Carozzi FM, 2010, LUNG CANCER, V68, P216, DOI 10.1016/j.lungcan.2009.06.015; de Bekker-Grob EW, 2009, BJU INT, V104, P41, DOI 10.1111/j.1464-410X.2008.08323.x; Frigerio S, 2007, INT J CANCER, V121, P329, DOI 10.1002/ijc.22690; Junker K, 2006, CYTOGENET GENOME RES, V114, P279, DOI 10.1159/000094214; Koed K, 2005, CANCER RES, V65, P34; Kompier LC, 2008, J PATHOL; Mao L, 1996, SCIENCE, V271, P659, DOI 10.1126/science.271.5249.659; MATSUYAMA H, 1994, CANCER GENET CYTOGEN, V77, P118, DOI 10.1016/0165-4608(94)90226-7; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Placer J, 2002, EUR UROL, V42, P547, DOI 10.1016/S0302-2838(02)00448-7; Roobol MJ, 2010, UROL ONCOL-SEMIN ORI, V28, P686, DOI 10.1016/j.urolonc.2009.12.002; Sieben NLG, 2000, HUM PATHOL, V31, P1414, DOI 10.1053/hupa.2000.20381; Simon R, 2001, CANCER RES, V61, P4514; Soloway MS, 2003, J UROLOGY, V170, P438, DOI 10.1097/01.ju.0000076621.71247.6c; Steiner G, 1997, NAT MED, V3, P621, DOI 10.1038/nm0697-621; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Talwar R, 2007, UROLOGY, V70, P267, DOI 10.1016/j.urology.2007.03.070; TSAI YC, 1990, CANCER RES, V50, P44; van der Aa MN, 2008, EUR UROL; van Oers JMM, 2005, CLIN CANCER RES, V11, P7743, DOI 10.1158/1078-0432.CCR-05-1045; van Rhijn BWG, 2001, CANCER, V92, P768, DOI 10.1002/1097-0142(20010815)92:4<768::AID-CNCR1381>3.0.CO;2-C; van Rhijn BWG, 2005, EUR UROL, V47, P736, DOI 10.1016/j.eururo.2005.03.014; van Rhijn BWG, 2003, CLIN CANCER RES, V9, P257; van Tilborg AAG, 2000, HUM MOL GENET, V9, P2973, DOI 10.1093/hmg/9.20.2973; Van Tilborg AAG, 1998, INT J CANCER, V75, P9, DOI 10.1002/(SICI)1097-0215(19980105)75:1<9::AID-IJC2>3.3.CO;2-I; Wild PJ, 2009, CANCER EPIDEM BIOMAR, V18, P1798, DOI 10.1158/1055-9965.EPI-09-0099; Zuiverloon TCM, 2010, CLIN CANCER RES, V16, P3011, DOI 10.1158/1078-0432.CCR-09-3013; Zuiverloon TC, 2011, J UROL; Zwarthoff EC, 2008, SCAND J UROL NEPHROL, V42, P147, DOI 10.1080/03008880802283953	35	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43345	10.1371/journal.pone.0043345	http://dx.doi.org/10.1371/journal.pone.0043345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927958	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300044
J	Ceccom, J; Cosledan, F; Halley, H; Frances, B; Lassalle, JM; Meunier, B				Ceccom, Johnatan; Cosledan, Frederic; Halley, Helene; Frances, Bernard; Lassalle, Jean Michel; Meunier, Bernard			Copper Chelator Induced Efficient Episodic Memory Recovery in a Non-Transgenic Alzheimer's Mouse Model	PLOS ONE			English	Article							AMYLOID-BETA TOXICITY; A-BETA; NEURODEGENERATIVE DISEASES; OLIGOMERS; STRATEGY; AGENTS; NEUROPROTECTION; INVOLVEMENT; NEUROPATHY; MEMANTINE	Alzheimer's disease (AD) is a neurodegenerative syndrom involving many different biological parameters, including the accumulation of copper metal ions in Ab amyloid peptides due to a perturbation of copper circulation and homeostasis within the brain. Copper-containing amyloids activated by endogenous reductants are able to generate an oxidative stress that is involved in the toxicity of abnormal amyloids and contribute to the progressive loss of neurons in AD. Since only few drugs are currently available for the treatment of AD, we decided to design small molecules able to interact with copper and we evaluated these drug-candidates with non-transgenic mice, since AD is mainly an aging disease, not related to genetic disorders. We created a memory deficit mouse model by a single icv injection of A beta(1-42) peptide, in order to mimic the early stage of the disease and the key role of amyloid oligomers in AD. No memory deficit was observed in the control mice with the antisense A beta(42-1) peptide. Here we report the capacity of a new copper- specific chelating agent, a bis-8-aminoquinoline PA1637, to fully reverse the deficit of episodic memory after three weeks of treatment by oral route on non-transgenic amyloid-impaired mice. Clioquinol and memantine have been used as comparators to validate this fast and efficient mouse model.	[Ceccom, Johnatan; Halley, Helene; Frances, Bernard; Lassalle, Jean Michel] Univ Toulouse, UPS, Ctr Rech Cognit Anim, Toulouse, France; [Halley, Helene; Frances, Bernard; Lassalle, Jean Michel] CNRS, Ctr Rech Cognit Anim, Toulouse, France; [Cosledan, Frederic; Meunier, Bernard] Palumed, Castanet Tolosan, France; [Meunier, Bernard] CNRS, Chim Coordinat Lab, F-31077 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Ceccom, J (corresponding author), Univ Toulouse, UPS, Ctr Rech Cognit Anim, Toulouse, France.	lassalle@cict.fr; bmeunier@lcc-toulouse.fr	MEUNIER, Bernard/J-4879-2013	MEUNIER, Bernard/0000-0003-2200-7142	UPS; CNRS; Region Midi-Pyrenees and Palumed	UPS; CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Midi-Pyrenees and Palumed(Region Occitanie)	This work was supported by UPS, CNRS, the Region Midi-Pyrenees and Palumed. Frederic Cosledan (full-time employee of Palumed) and Bernard Meunier (full-time employee of Palumed up to January 2011 and now full-time employee of the CNRS) participated to the study design, the analysis and the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017669; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Arbiser JL, 1998, MOL MED, V4, P665, DOI 10.1007/BF03401927; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; BLANCHARD RJ, 1968, J COMP PHYSIOL PSYCH, V66, P603, DOI 10.1037/h0026511; Boldron C, 2005, CHEMBIOCHEM, V6, P1976, DOI 10.1002/cbic.200500220; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Daumas S, 2005, LEARN MEMORY, V12, P375, DOI 10.1101/lm.81905; Deraeve C, 2005, French Patent Application, Patent No. 0508351; Deraeve C, 2008, CHEM-EUR J, V14, P682, DOI 10.1002/chem.200701024; Deraeve C, 2007, NEW J CHEM, V31, P193, DOI 10.1039/b616085a; Deraeve C, 2008, EUR J INORG CHEM, P5622, DOI 10.1002/ejic.200800924; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Feaga HA, 2011, INORG CHEM, V50, P1614, DOI 10.1021/ic100967s; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Jhoo JH, 2004, BEHAV BRAIN RES, V155, P185, DOI 10.1016/j.bbr.2004.04.012; Kitazawa M, 2009, J NEUROCHEM, V108, P1550, DOI 10.1111/j.1471-4159.2009.05901.x; LeDoux J E, 1992, Curr Opin Neurobiol, V2, P191, DOI 10.1016/0959-4388(92)90011-9; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Martin P, 1988, MEASURING BEHAV INTR; Meloni G, 2008, NAT CHEM BIOL, V4, P366, DOI 10.1038/nchembio.89; Miguel-Hidalgo JJ, 2002, BRAIN RES, V958, P210, DOI 10.1016/S0006-8993(02)03731-9; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Perrone L, 2010, CHEMBIOCHEM, V11, P110, DOI 10.1002/cbic.200900474; Quinn JF, 2010, J ALZHEIMERS DIS, V21, P903, DOI 10.3233/JAD-2010-100408; Quinn JF, 2009, EXPERT REV NEUROTHER, V9, P631, DOI 10.1586/ERN.09.27; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Sanokawa-Akakura R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008626; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; Scott LE, 2009, CHEM REV, V109, P4885, DOI 10.1021/cr9000176; Squitti R, 2009, CURR ALZHEIMER RES, V6, P476, DOI 10.2174/156720509790147133; Tateishi J, 2000, NEUROPATHOLOGY, V20, pS20; Van Dam D, 2006, NAT REV DRUG DISCOV, V5, P956, DOI 10.1038/nrd2075; Yan JJ, 2001, BRIT J PHARMACOL, V133, P89, DOI 10.1038/sj.bjp.0704047; Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004	42	73	73	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43105	10.1371/journal.pone.0043105	http://dx.doi.org/10.1371/journal.pone.0043105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927947	Green Published, Green Submitted, gold			2022-12-25	WOS:000307789700023
J	Dornbierer, M; Stadelmann, M; Sourdon, J; Gahl, B; Cook, S; Carrel, TP; Tevaearai, HT; Longnus, SL				Dornbierer, Monika; Stadelmann, Mathieu; Sourdon, Joevin; Gahl, Brigitta; Cook, Stephane; Carrel, Thierry P.; Tevaearai, Hendrik T.; Longnus, Sarah L.			Early Reperfusion Hemodynamics Predict Recovery in Rat Hearts: A Potential Approach towards Evaluating Cardiac Grafts from Non-Heart-Beating Donors	PLOS ONE			English	Article							ISCHEMIC HEARTS; TRANSPLANTATION; PROCUREMENT; VIABILITY; DONATION; DEATH	Aims: Cardiac grafts from non-heartbeating donors (NHBDs) could significantly increase organ availability and reduce waiting-list mortality. Reluctance to exploit hearts from NHBDs arises from obligatory delays in procurement leading to periods of warm ischemia and possible subsequent contractile dysfunction. Means for early prediction of graft suitability prior to transplantation are thus required for development of heart transplantation programs with NHBDs. Methods and Results: Hearts (n = 31) isolated from male Wistar rats were perfused with modified Krebs-Henseleit buffer aerobically for 20 min, followed by global, no-flow ischemia (32 degrees C) for 30, 50, 55 or 60 min. Reperfusion was unloaded for 20 min, and then loaded, in working-mode, for 40 min. Left ventricular (LV) pressure was monitored using a micro-tip pressure catheter introduced via the mitral valve. Several hemodynamic parameters measured during early, unloaded reperfusion correlated significantly with LV work after 60 min reperfusion (p<0.001). Coronary flow and the production of lactate and lactate dehydrogenase (LDH) also correlated significantly with outcomes after 60 min reperfusion (p<0.05). Based on early reperfusion hemodynamic measures, a composite, weighted predictive parameter, incorporating heart rate (HR), developed pressure (DP) and end-diastolic pressure, was generated and evaluated against the HR-DP product after 60 min of reperfusion. Effective discriminating ability for this novel parameter was observed for four HR*DP cut-off values, particularly for >= 20 * 10(3) mmHg*beats*min(-1) (p<0.01). Conclusion: Upon reperfusion of a NHBD heart, early evaluation, at the time of organ procurement, of cardiac hemodynamic parameters, as well as easily accessible markers of metabolism and necrosis seem to accurately predict subsequent contractile recovery and could thus potentially be of use in guiding the decision of accepting the ischemic heart for transplantation.	[Dornbierer, Monika; Stadelmann, Mathieu; Sourdon, Joevin; Gahl, Brigitta; Carrel, Thierry P.; Tevaearai, Hendrik T.; Longnus, Sarah L.] Univ Hosp Bern, Inselspital, Dept Cardiovasc Med, CH-3010 Bern, Switzerland; [Dornbierer, Monika; Stadelmann, Mathieu; Sourdon, Joevin; Gahl, Brigitta; Carrel, Thierry P.; Tevaearai, Hendrik T.; Longnus, Sarah L.] Univ Bern, Bern, Switzerland; [Stadelmann, Mathieu; Cook, Stephane] Univ & Hosp, Fribourg, Switzerland; [Sourdon, Joevin] Univ Auvergne, Inst Technol, Clermont Ferrand, France	University of Bern; University Hospital of Bern; University of Bern; Universite Clermont Auvergne (UCA); Universite de Montpellier	Dornbierer, M (corresponding author), Univ Hosp Bern, Inselspital, Dept Cardiovasc Med, CH-3010 Bern, Switzerland.	hendrik.tevaearai@insel.ch	Carrel, Thierry/AAI-5910-2021; Longnus, Sarah/M-1122-2019	Longnus, Sarah/0000-0001-8489-917X	University of Berne's Department of Clinical Research; Olga Mayenfisch Foundation	University of Berne's Department of Clinical Research; Olga Mayenfisch Foundation	This work was supported by a Grant-in-Aid from the University of Berne's Department of Clinical Research and a Research Grant from the Olga Mayenfisch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2009, J HEART LUNG TRANSPL, V28, P290, DOI 10.1016/j.healun.2008.12.014; Almond CSD, 2009, CIRCULATION, V119, P717, DOI 10.1161/CIRCULATIONAHA.108.815712; BARNARD C N, 1967, South African Medical Journal, V41, P1271; Boucek MM, 2008, NEW ENGL J MED, V359, P709, DOI 10.1056/NEJMoa0800660; Collins MJ, 2007, J HEART LUNG TRANSPL, V26, P376, DOI 10.1016/j.healun.2006.12.013; Doenst T, 1998, MOL CELL BIOCHEM, V180, P153, DOI 10.1023/A:1006863728395; Doig CJ, 2003, CAN J ANAESTH, V50, P1069, DOI 10.1007/BF03018376; Ferrera R, 2006, TRANSPL P, V38, P2283, DOI 10.1016/j.transproceed.2006.06.124; FERRERA R, 1995, CIRCULATION, V91, P257, DOI 10.1161/01.CIR.91.2.257; GUNDRY SR, 1992, ANN THORAC SURG, V53, P772, DOI 10.1016/0003-4975(92)91433-A; Hirota M, 2006, J HEART LUNG TRANSPL, V25, P339, DOI 10.1016/j.healun.2005.09.014; Kato G, 2006, GEN THORAC CARDIOVAS, V54, P511, DOI 10.1007/s11748-006-0051-0; Koogler T, 1998, PEDIATRICS, V101, P1049, DOI 10.1542/peds.101.6.1049; LOPASCHUK GD, 1993, J PHARMACOL EXP THER, V264, P135; MACKERSIE RC, 1991, ANN SURG, V213, P143, DOI 10.1097/00000658-199102000-00009; Manno EM, 2005, NEUROCRIT CARE, V3, P111, DOI 10.1385/NCC:3:2:111; Martin J, 1999, J HEART LUNG TRANSPL, V18, P597, DOI 10.1016/S1053-2498(98)00017-5; NEELY JR, 1967, AM J PHYSIOL, V212, P804; Osaki S, 2010, EUR J CARDIO-THORAC, V37, P74, DOI 10.1016/j.ejcts.2009.07.005; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Singhal AK, 2005, J HEART LUNG TRANSPL, V24, P1657, DOI 10.1016/j.healun.2004.11.043; Suehiro K, 2001, ANN THORAC SURG, V71, P278, DOI 10.1016/S0003-4975(00)01939-1; Whetstine L, 2002, CRIT CARE, V6, P192, DOI 10.1186/cc1487; Wood KE, 2007, CURR OPIN ANESTHESIO, V20, P97, DOI 10.1097/ACO.0b013e3280895ac8	24	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43642	10.1371/journal.pone.0043642	http://dx.doi.org/10.1371/journal.pone.0043642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928009	Green Published, Green Submitted, gold			2022-12-25	WOS:000307789700044
J	Labrenz, F; Themann, M; Wascher, E; Beste, C; Pfleiderer, B				Labrenz, Franziska; Themann, Maria; Wascher, Edmund; Beste, Christian; Pfleiderer, Bettina			Neural Correlates of Individual Performance Differences in Resolving Perceptual Conflict	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SELECTIVE VISUAL-ATTENTION; ANTERIOR CINGULATE CORTEX; INFERIOR TEMPORAL CORTEX; MEDIAL PREFRONTAL CORTEX; TOP-DOWN; ORBITOFRONTAL CORTEX; BUNDESENS THEORY; COVERT SHIFTS; BOTTOM-UP	Attentional mechanisms are a crucial prerequisite to organize behavior. Most situations may be characterized by a 'competition' between salient, but irrelevant stimuli and less salient, relevant stimuli. In such situations top-down and bottom-up mechanisms interact with each other. In the present fMRI study, we examined how interindividual differences in resolving situations of perceptual conflict are reflected in brain networks mediating attentional selection. Doing so, we employed a change detection task in which subjects had to detect luminance changes in the presence and absence of competing distractors. The results show that good performers presented increased activation in the orbitofrontal cortex (BA 11), anterior cingulate (BA 25), inferior parietal lobule (BA 40) and visual areas V2 and V3 but decreased activation in BA 39. This suggests that areas mediating top-down attentional control are stronger activated in this group. Increased activity in visual areas reflects distinct neuronal enhancement relating to selective attentional mechanisms in order to solve the perceptual conflict. Opposed to good performers, brain areas activated by poor performers comprised the left inferior parietal lobule (BA 39) and fronto-parietal and visual regions were continuously deactivated, suggesting that poor performers perceive stronger conflict than good performers. Moreover, the suppression of neural activation in visual areas might indicate a strategy of poor performers to inhibit the processing of the irrelevant non-target feature. These results indicate that high sensitivity in perceptual areas and increased attentional control led to less conflict in stimulus processing and consequently to higher performance in competitive attentional selection.	[Labrenz, Franziska; Beste, Christian] Ruhr Univ Bochum, Inst Cognit Neurosci Biopsychol, Bochum, Germany; [Wascher, Edmund] IFADO Leibniz Res Ctr, Dortmund, Germany; [Themann, Maria; Pfleiderer, Bettina] Univ Munster, Dept Clin Radiol, Munster, Germany	Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); University of Munster	Labrenz, F (corresponding author), Ruhr Univ Bochum, Inst Cognit Neurosci Biopsychol, Univ Str 150, Bochum, Germany.	franziska.labrenz@rub.de	Labrenz, Franziska/AAQ-7131-2020; Wascher, Edmund/N-6848-2019; Wascher, Edmund/B-8457-2019; Labrenz, Franziska/ABC-9386-2021	Wascher, Edmund/0000-0003-3616-9767; Labrenz, Franziska/0000-0001-7284-3451	Deutsche Forschungsgemeinschaft [BE 4045/6-1, PF 244/13]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/index.jsp) BE 4045/6-1 (to C.B.) and PF 244/13 (to B.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBAS H, 1988, J COMP NEUROL, V276, P313, DOI 10.1002/cne.902760302; Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2012, EUR J NEUROSCI, V35, P1124, DOI 10.1111/j.1460-9568.2012.07990.x; Beste C, 2011, CURR BIOL, V21, P876, DOI 10.1016/j.cub.2011.03.065; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Chadick JZ, 2011, NAT NEUROSCI, V14, P830, DOI 10.1038/nn.2823; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Fishburn P. C., 1970, PUBLICATIONS OPERATI, V18; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gruska A, 2010, HDB INDIVIDUAL DIFFE; Hahn B, 2006, NEUROIMAGE, V32, P842, DOI 10.1016/j.neuroimage.2006.04.177; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Hilimire MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012677; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Hung J, 2005, J NEUROSCI, V25, P9602, DOI 10.1523/JNEUROSCI.0879-05.2005; Hung J, 2011, J NEUROSCI, V31, P15904, DOI 10.1523/JNEUROSCI.2626-11.2011; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Kastner Sabine, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P483, DOI 10.3758/CABN.4.4.483; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; MILLER EK, 1993, BRAIN RES, V616, P25, DOI 10.1016/0006-8993(93)90187-R; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perry RJ, 2000, BRAIN, V123, P2273, DOI 10.1093/brain/123.11.2273; Poghosyan V, 2005, EUR J NEUROSCI, V22, P225, DOI 10.1111/j.1460-9568.2005.04181.x; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Preacher KJ, 2005, PSYCHOL METHODS, V10, P178, DOI 10.1037/1082-989X.10.2.178; Prevost C, 2010, J NEUROSCI, V30, P14080, DOI 10.1523/JNEUROSCI.2752-10.2010; Proulx MJ, 2008, PSYCHOL RES-PSYCH FO, V72, P106, DOI 10.1007/s00426-006-0077-z; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Schreij D, 2008, PERCEPT PSYCHOPHYS, V70, P208, DOI 10.3758/PP.70.2.208; Serences JT, 2006, TRENDS COGN SCI, V10, P38, DOI 10.1016/j.tics.2005.11.008; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Stokes M, 2009, P NATL ACAD SCI USA, V106, P19569, DOI 10.1073/pnas.0905306106; Talairach J., 1988, COPLANAR STEREOTAXIC; Theeuwes J, 2004, PSYCHON B REV, V11, P65, DOI 10.3758/BF03206462; Treue S, 2007, NEURON, V55, P174, DOI 10.1016/j.neuron.2007.07.005; Walton ME, 2006, NEURAL NETWORKS, V19, P1302, DOI 10.1016/j.neunet.2006.03.005; Ward B, 2002, DECONVULATION ANAL F; Wascher E, 2010, J NEUROPHYSIOL, V103, P1057, DOI 10.1152/jn.00376.2009; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; Windischberger C, 2002, COGNITIVE BRAIN RES, V13, P129, DOI 10.1016/S0926-6410(01)00101-X; Yantis S, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P73; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257; Zenon A, 2010, J COGNITIVE NEUROSCI, V22, P918, DOI 10.1162/jocn.2009.21233	77	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42849	10.1371/journal.pone.0042849	http://dx.doi.org/10.1371/journal.pone.0042849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916169	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800033
J	Madeira, A; da Silva, CL; dos Santos, F; Camafeita, E; Cabral, JMS; Sa-Correia, I				Madeira, Andreia; da Silva, Claudia L.; dos Santos, Francisco; Camafeita, Emilio; Cabral, Joaquim M. S.; Sa-Correia, Isabel			Human Mesenchymal Stem Cell Expression Program upon Extended Ex-Vivo Cultivation, as Revealed by 2-DE-Based Quantitative Proteomics	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; STROMAL CELLS; PROTEINS; APOPTOSIS; VIMENTIN; ADHESION; THERAPY; STRESS; PROLIFERATION; TRANSCRIPTION	Human mesenchymal stem cells (MSC) have been on the focus of intense clinical-oriented research due to their multilineage differentiation potential and immunomodulatory properties. However, to reach the clinically meaningful cell numbers for cellular therapy and tissue engineering applications, MSC ex-vivo expansion is mandatory but sequential cell passaging results in loss of proliferative, clonogenic and differentiation potential. To get clues into the molecular mechanisms underlying cellular senescence resulting from extended ex-vivo cultivation of bone marrow (BM) MSC, we explored a two-dimensional gel electrophoresis (2-DE) based quantitative proteomics to compare the expression programs of Passage 3 cells (P3), commonly used in clinical studies with expanded MSC, and Passage 7 (P7) cells, which already demonstrated significant signs of culture-induced senescence. Proteins of the functional categories "Structural components and cellular cytoskeleton" and "Folding and stress response proteins" are less abundant in P7 cells, compared to P3, while proteins involved in "Energy metabolism", "Cell cycle regulation and aging" and "Apoptosis" are more abundant. The large number of multiple size and charge isoforms with an altered content that were identified in this study in P7 versus P3, namely the cytoskeleton components beta-actin (7 forms) and vimentin (24 forms), also emphasizes the importance of post-transcriptional modification upon long-term cultivation. The differential protein expression registered suggests that cellular senescence occurring during ex-vivo expansion of BM MSC is associated with the impairment of cytoskeleton remodeling and/or organization and the repair of damaged proteins resulting from cell exposure to culture stress. The genome-wide expression approach used in this study has proven useful for getting mechanistic insights into the observed decrease on the proliferative and clonogenic potential of P7 versus P3 cells and paves the way to set up a proteome profiling strategy for quality control to assure safe and clinically effective expanded MSC.	[Madeira, Andreia; da Silva, Claudia L.; dos Santos, Francisco; Cabral, Joaquim M. S.; Sa-Correia, Isabel] Inst Super Tecn, Ctr Biol & Chem Engn, IBB, Lisbon, Portugal; [Madeira, Andreia; da Silva, Claudia L.; dos Santos, Francisco; Cabral, Joaquim M. S.; Sa-Correia, Isabel] Univ Tecn Lisboa, Inst Super Tecn, Dept Bioengn, Lisbon, Portugal; [Camafeita, Emilio] CNIC, Unidad Prote, Madrid, Spain	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Madeira, A (corresponding author), Inst Super Tecn, Ctr Biol & Chem Engn, IBB, Lisbon, Portugal.	isacorreia@ist.utl.pt	da Silva, Claudia L./K-6104-2012; Cabral, Joaquim M S/G-2052-2010; Sá-Correia, Isabel/H-4054-2011; Santos, Francisco F dos/N-9832-2016; Madeira, Andreia S/B-4962-2012	da Silva, Claudia L./0000-0002-1091-7651; Cabral, Joaquim M S/0000-0002-2405-5845; Sá-Correia, Isabel/0000-0003-2208-5183; Santos, Francisco F dos/0000-0002-2046-2742; 	Portuguese Foundation for Science and Technology (FCT) [PEst-OE/EQB/LA0023/2011, PTDC/EQU-EQU/114231/2009, SFRH/BD/37012/2007, SFRH/BD/38719/2007]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work was funded by the Portuguese Foundation for Science and Technology (FCT) (PEst-OE/EQB/LA0023/2011_research lines: Systems and Synthetic Biology and Stem Cell Engineering and Regenerative Medicine; PTDC/EQU-EQU/114231/2009; and PhD fellowships SFRH/BD/37012/2007 to Dr. Madeira and SFRH/BD/38719/2007 to Dr. dos Santos. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alldridge LC, 2003, EXP CELL RES, V290, P93, DOI 10.1016/S0014-4827(03)00310-0; Aravind L, 1998, PROTEIN SCI, V7, P1250, DOI 10.1002/pro.5560070521; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chowdhury I, 2007, ENDOCRINOLOGY, V148, P206, DOI 10.1210/en.2006-0187; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; DellOrco RT, 1996, EXP GERONTOL, V31, P245, DOI 10.1016/0531-5565(95)02009-8; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; dos Santos F, 2011, METHODS MOL BIOL, V698, P189, DOI 10.1007/978-1-60761-999-4_15; Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987; Eibes G, 2010, J BIOTECHNOL, V146, P194, DOI 10.1016/j.jbiotec.2010.02.015; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Feldmann RE, 2005, ELECTROPHORESIS, V26, P2749, DOI 10.1002/elps.200410406; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Huang HL, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-36; Ishitani R, 1996, J NEUROCHEM, V66, P928; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Izzo MW, 1999, J BIOL CHEM, V274, P19498, DOI 10.1074/jbc.274.27.19498; KAPISZEWSKA M, 1991, INT J RADIAT BIOL, V60, P635, DOI 10.1080/09553009114552461; Kasper G, 2009, STEM CELLS, V27, P1288, DOI 10.1002/stem.49; Kim JS, 2011, EXP GERONTOL, V46, P500, DOI 10.1016/j.exger.2011.02.012; Kim J, 2009, ARCH PHARM RES, V32, P117, DOI 10.1007/s12272-009-1125-1; Kindas-Mugge I, 1998, ANTICANCER RES, V18, P413; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Levchenko A, 2005, NAT BIOTECHNOL, V23, P828, DOI 10.1038/nbt0705-828; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Madeira A, 2011, PROTEOMICS, V11, P1313, DOI 10.1002/pmic.201000457; Martin I, 2011, TISSUE ENG PT A, V17, P2221, DOI [10.1089/ten.tea.2011.0131, 10.1089/ten.TEA.2011.0131]; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rattan SIS, 2005, IUBMB LIFE, V57, P297, DOI 10.1080/15216540500092195; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Sa-Correia I, 2010, EXPERT REV PROTEOMIC, V7, P943, DOI 10.1586/EPR.10.76; Santos PM, 2009, PROTEOMICS, V9, P5101, DOI 10.1002/pmic.200900325; Santos PM, 2009, PROTEOMICS, V9, P657, DOI 10.1002/pmic.200800452; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; SUNAGA K, 1995, NEUROSCI LETT, V200, P133, DOI 10.1016/0304-3940(95)12098-O; Tsukahara F, 2000, MOL PHARMACOL, V58, P1257, DOI 10.1124/mol.58.6.1257; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Tyndall A, 2009, BONE MARROW TRANSPL, V43, P821, DOI 10.1038/bmt.2009.63; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Zhou ZL, 2010, MOL BIOL REP, V37, P2407, DOI 10.1007/s11033-009-9751-8	65	46	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43523	10.1371/journal.pone.0043523	http://dx.doi.org/10.1371/journal.pone.0043523			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916271	Green Submitted, gold, Green Published			2022-12-25	WOS:000307733800074
J	Nelis, LC				Nelis, Lisa Castillo			Life Form and Life History Explain Variation in Population Processes in a Grassland Community Invaded by Exotic Plants and Mammals	PLOS ONE			English	Article							DYNAMICS; RECRUITMENT; INVASIONS; TRAITS	The existence of general characteristics of plant invasiveness is still debated. One reason we may not have found these characteristics is because we do not yet understand how processes underlying population dynamics contribute to community composition in invaded communities. Here I modify Ricker stock-recruitment models to parameterize processes important to community dynamics in an invaded grassland community: immigration, maximum intrinsic growth rate, self-regulation, and limitation by other species. I then used the parameterized models in a multi-species stochastic simulation to determine how processes affected long-term community dynamics. By parameterizing the models using the frequency of the 18 most common species in the grassland, I determined that life history and life form are stronger predictors of underlying processes than is native status. Immigration maintains exotic annual grasses and the dominant native perennial grass in the community. Growth rate maintains other perennial species. While the model mirrors the frequency of native species well, exotic species have lower observed than parameterized frequencies, suggesting that they are not reaching their potential frequency. These results, combined with results from past research, suggest that disturbance may be key to maintaining exotic species in the community. Here I showed that a continuous modified Ricker model fit discrete grassland frequency data well. This allowed me to model the dominant species in the community simultaneously and gain insight into the processes that determine community composition.	[Nelis, Lisa Castillo] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA	University of Chicago	Nelis, LC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	lnelis@stanford.edu			National Science Foundation (NSF) [011780, 10456110, 0452687, 0708462]; ARCS (Achievement Rewards for College Scientists) Foundation Chicago; University of Chicago Hinds Fund; Sigma Xi; Rotary One; Southeast Chicago Rotary Club	National Science Foundation (NSF)(National Science Foundation (NSF)); ARCS (Achievement Rewards for College Scientists) Foundation Chicago; University of Chicago Hinds Fund; Sigma Xi; Rotary One; Southeast Chicago Rotary Club	The majority of funding was provided by the National Science Foundation (NSF; www.nsf.gov) Minority Postdoctoral Fellowship, Doctoral Dissertation Improvement Grant, Dissertation Enhancement Grant, Graduate Research Fellowship, and grants: 011780, 10456110, 0452687, and 0708462. Additional funding was provided by the ARCS (Achievement Rewards for College Scientists) Foundation Chicago, (http://www.arcsfoundation.org/chicago/), The University of Chicago Hinds Fund (http://evbio.uchicago.edu/), Sigma Xi (http://www.sigmaxi.org/), Rotary One (http://www.rotaryone.org/), Southeast Chicago Rotary Club (http://www.rccse.org/), and personal funds. With the exception of the author who contributed personal funds to this research, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckley HL, 2010, J ECOL, V98, P645, DOI 10.1111/j.1365-2745.2010.01650.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Castilla J. C., 1987, ISLAS OCEANICAS CHIL, P15; Colwell RK, 2013, ESTIMATES STAT ESTIM; DENNIS B, 1994, ECOL MONOGR, V64, P205, DOI 10.2307/2937041; Greimler Josef, 2002, Pacific Science, V56, P263, DOI 10.1353/psc.2002.0022; Grime J. P., 2001, PLANT STRATEGIES VEG; Haberle SG, 2003, J BIOGEOGR, V30, P239, DOI 10.1046/j.1365-2699.2003.00780.x; Hulme PE, 2011, TRENDS ECOL EVOL, V26, P318, DOI 10.1016/j.tree.2011.03.018; ILES TC, 1994, NETH J SEA RES, V32, P399, DOI 10.1016/0077-7579(94)90017-5; Lamarque LJ, 2011, BIOL INVASIONS, V13, P1969, DOI 10.1007/s10530-011-0015-x; Lande R., 2003, OXFORD SERIES ECOLOG; Laska MS, 1998, ECOLOGY, V79, P461, DOI 10.2307/176946; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McGhee JD, 2008, J WILDLIFE MANAGE, V72, P196, DOI 10.2193/2006-484; Meiners SJ, 2007, ECOLOGY, V88, P1098, DOI 10.1890/06-1505; Nelis LC, 2012, OECOLOGIA, DOI [10.1007/s00442-00012-02265-00444, DOI 10.1007/S00442-00012-02265-00444]; Nelis LC, 2008, THESIS U CHICAGO CHI; Nelis LC, 2010, P R SOC B, V277, P539, DOI 10.1098/rspb.2009.1564; Poulsen JR, 2007, AM NAT, V170, P167, DOI 10.1086/518945; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Skottsberg C, 1920, NATURAL HIST J FERNA, DOI 10.5962/bhl.title.41367; Thompson K, 2011, TRENDS ECOL EVOL, V26, P319, DOI 10.1016/j.tree.2011.03.020; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; van Kleunen M, 2011, TRENDS ECOL EVOL, V26, P317, DOI 10.1016/j.tree.2011.03.019; Zunino S, 1989, MUSEO NATURAL HIST N, V316, P8	26	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42906	10.1371/journal.pone.0042906	http://dx.doi.org/10.1371/journal.pone.0042906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916178	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800035
J	Pan, QF; Wang, Q; Yuan, F; Xing, SH; Zhao, JY; Choi, YH; Verpoorte, R; Tian, YS; Wang, GF; Tang, KX				Pan, Qifang; Wang, Quan; Yuan, Fang; Xing, Shihai; Zhao, Jingya; Choi, Young Hae; Verpoorte, Robert; Tian, Yuesheng; Wang, Guofeng; Tang, Kexuan			Overexpression of ORCA3 and G10H in Catharanthus roseus Plants Regulated Alkaloid Biosynthesis and Metabolism Revealed by NMR-Metabolomics	PLOS ONE			English	Article							STRICTOSIDINE SYNTHASE; CELL-CULTURES; HAIRY ROOTS; GERANIOL 10-HYDROXYLASE; MULTIVARIATE-ANALYSIS; H-1-NMR SPECTROSCOPY; PHENOLIC-COMPOUNDS; TISSUE-CULTURES; EXPRESSION; PATHWAY	In order to improve the production of the anticancer dimeric indole alkaloids in Catharanthuse roseus, much research has been dedicated to culturing cell lines, hairy roots, and efforts to elucidate the regulation of the monoterpenoid indole alkaloid (MIA) biosynthesis. In this study, the ORCA3 (Octadecanoid-derivative Responsive Catharanthus AP2-domain) gene alone or integrated with the G10H (geraniol 10-hydroxylase) gene were first introduced into C. roseus plants. Transgenic C. roseus plants overexpressing ORCA3 alone (OR lines), or co-overexpressing G10H and ORCA3 (GO lines) were obtained by genetic modification. ORCA3 overexpression induced an increase of AS, TDC, STR and D4H transcripts but did not affect CRMYC2 and G10H transcription. G10H transcripts showed a significant increase under G10H and ORCA3 co-overexpression. ORCA3 and G10H overexpression significantly increased the accumulation of strictosidine, vindoline, catharanthine and ajmalicine but had limited effects on anhydrovinblastine and vinblastine levels. NMR-based metabolomics confirmed the higher accumulation of monomeric indole alkaloids in OR and GO lines. Multivariate data analysis of H-1 NMR spectra showed change of amino acid, organic acid, sugar and phenylpropanoid levels in both OR and GO lines compared to the controls. The result indicated that enhancement of MIA biosynthesis by ORCA3 and G10H overexpression might affect other metabolic pathways in the plant metabolism of C. roseus.	[Pan, Qifang; Wang, Quan; Yuan, Fang; Xing, Shihai; Zhao, Jingya; Tian, Yuesheng; Wang, Guofeng; Tang, Kexuan] Shanghai Jiao Tong Univ, Fudan SJTU Nottingham Plant Biotechnol R&D Ctr, SJTU Cornell Inst Sustainable Agr & Biotechnol, Plant Biotechnol Res Ctr,Sch Agr & Biol, Shanghai 200030, Peoples R China; [Pan, Qifang; Choi, Young Hae; Verpoorte, Robert] Leiden Univ, Nat Prod Lab, Inst Biol Leiden, Leiden, Netherlands	Shanghai Jiao Tong University; Leiden University; Leiden University - Excl LUMC	Pan, QF (corresponding author), Shanghai Jiao Tong Univ, Fudan SJTU Nottingham Plant Biotechnol R&D Ctr, SJTU Cornell Inst Sustainable Agr & Biotechnol, Plant Biotechnol Res Ctr,Sch Agr & Biol, Shanghai 200030, Peoples R China.	kxtang1@yahoo.com	Verpoorte, Robert/Y-4363-2019; Tang, Kexuan/E-3555-2013; Choi, Young Hae/O-7886-2016	Tang, Kexuan/0000-0002-8748-9624; Choi, Young Hae/0000-0003-1484-1700; Verpoorte, Robert/0000-0001-6180-1424	China National High-Tech "863" Program [2011AA100605]; Shanghai Science and Technology Committee [08391911800]; Shanghai Leading Academic Discipline Project [B209]	China National High-Tech "863" Program(National High Technology Research and Development Program of China); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was funded by China National High-Tech "863" Program (grant number 2011AA100605), Shanghai Science and Technology Committee (grant number 08391911800), and Shanghai Leading Academic Discipline Project (project number B209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi BH, 2007, PLANT CELL REP, V26, P1367, DOI 10.1007/s00299-007-0344-5; [Anonymous], 1997, ALAKLOIDS; Burlat V, 2004, PLANT J, V38, P131, DOI 10.1111/j.1365-313X.2004.02030.x; Canel C, 1998, PLANTA, V205, P414, DOI 10.1007/s004250050338; Charlton A, 2004, PLANT BIOTECHNOL J, V2, P27, DOI 10.1046/j.1467-7652.2003.00045.x; Choi HK, 2004, PHYTOCHEMISTRY, V65, P857, DOI 10.1016/j.phytochem.2004.01.019; Choi YH, 2004, PLANT PHYSIOL, V135, P2398, DOI 10.1104/pp.104.041012; Choi YH, 2006, J NAT PROD, V69, P742, DOI 10.1021/np050535b; Chung IM, 2007, BIOTECHNOL PROGR, V23, P327, DOI 10.1021/bp060258e; Collu G, 2001, FEBS LETT, V508, P215, DOI 10.1016/S0014-5793(01)03045-9; El-Sayed Magdi, 2007, Phytochemistry Reviews, V6, P277, DOI 10.1007/s11101-006-9047-8; Guirimand G, 2009, PLANT CELL REP, V28, P1215, DOI 10.1007/s00299-009-0722-2; Hisiger Steve, 2007, Phytochemistry Reviews, V6, P207, DOI 10.1007/s11101-006-9036-y; Hoekenga Owen A, 2008, J Biomol Tech, V19, P159; Hughes EH, 2004, BIOTECHNOL BIOENG, V86, P718, DOI 10.1002/bit.20081; Jaggi M, 2011, APPL MICROBIOL BIOT, V90, P1005, DOI 10.1007/s00253-011-3131-8; Kim HK, 2010, PHYTOCHEMISTRY, V71, P773, DOI 10.1016/j.phytochem.2010.02.001; Kumar S, 2012, PROTOPLASMA, V249, P423, DOI 10.1007/s00709-011-0294-1; KUTCHAN TM, 1995, PLANT CELL, V7, P1059, DOI 10.2307/3870057; Liu DH, 2011, AFR J BIOTECHNOL, V10, P3260; Magnotta M, 2007, PHYTOCHEMISTRY, V68, P1922, DOI 10.1016/j.phytochem.2007.04.037; Mahroug S, 2006, PLANTA, V223, P1191, DOI 10.1007/s00425-005-0167-y; Mattoo AK, 2006, PLANT PHYSIOL, V142, P1759, DOI 10.1104/pp.106.084400; MORENO PRH, 1995, PLANT CELL TISS ORG, V42, P1, DOI 10.1007/BF00037677; Murata J, 2005, PLANT J, V44, P581, DOI 10.1111/j.1365-313X.2005.02557.x; Murata J, 2008, PLANT CELL, V20, P524, DOI 10.1105/tpc.107.056630; Mustafa Natali Rianika, 2007, Phytochemistry Reviews, V6, P243, DOI 10.1007/s11101-006-9039-8; Noteborn HPJM, 2000, J BIOTECHNOL, V77, P103, DOI 10.1016/S0168-1656(99)00210-2; OKeefe BR, 1997, J NAT PROD, V60, P261, DOI 10.1021/np960703n; Oudin Audrey, 2007, Phytochemistry Reviews, V6, P259, DOI 10.1007/s11101-006-9054-9; Pan QF, 2010, PLANT GROWTH REGUL, V60, P133, DOI 10.1007/s10725-009-9429-1; Pauw B, 2004, J BIOL CHEM, V279, P52940, DOI 10.1074/jbc.M404391200; Pearce HL, 2005, ADV ENZYME REGUL, V45, P229, DOI 10.1016/j.advenzreg.2005.02.017; Peebles CAM, 2011, METAB ENG, V13, P234, DOI 10.1016/j.ymben.2010.11.005; Peebles CAM, 2009, METAB ENG, V11, P76, DOI 10.1016/j.ymben.2008.09.002; Pomahacova B, 2009, J PLANT PHYSIOL, V166, P1405, DOI 10.1016/j.jplph.2009.02.015; Ren YF, 2009, J GENET GENOMICS, V36, P621, DOI 10.1016/S1673-8527(08)60154-X; ROTHSTEIN SJ, 1987, P NATL ACAD SCI USA, V84, P8439, DOI 10.1073/pnas.84.23.8439; Roytrakul Sittiruk, 2007, Phytochemistry Reviews, V6, P383, DOI 10.1007/s11101-006-9022-4; Siberil Y, 2001, PLANT MOL BIOL, V45, P477, DOI 10.1023/A:1010650906695; St-Pierre B, 1999, PLANT CELL, V11, P887, DOI 10.1105/tpc.11.5.887; Suttipanta N, 2007, BBA-GENE STRUCT EXPR, V1769, P139, DOI 10.1016/j.bbaexp.2007.01.006; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; van der Heijden R, 2004, CURR MED CHEM, V11, P607; VANDERHEIJDEN R, 1989, PLANT CELL TISS ORG, V18, P231, DOI 10.1007/BF00043397; VANDERKROL AR, 1988, NATURE, V333, P866, DOI 10.1038/333866a0; Wang CT, 2010, PLANT CELL REP, V29, P887, DOI 10.1007/s00299-010-0874-0; Wang Q, 2010, PLANT CELL REP, V29, P185, DOI 10.1007/s00299-009-0811-2; Ward JL, 2003, PHYTOCHEMISTRY, V62, P949, DOI 10.1016/S0031-9422(02)00705-7; Whitmer S, 2002, PLANT CELL TISS ORG, V69, P85, DOI 10.1023/A:1015090224398; Xu MJ, 2007, SCI CHINA SER C, V50, P234, DOI 10.1007/s11427-007-0030-4; Yang SO, 2009, BIOSCI BIOTECH BIOCH, V73, P2032, DOI 10.1271/bbb.90240; Zarate Rafael, 2007, Phytochemistry Reviews, V6, P475, DOI 10.1007/s11101-006-9020-6; Zhang HT, 2011, PLANT J, V67, P61, DOI 10.1111/j.1365-313X.2011.04575.x; Zhao Jian, 2007, Phytochemistry Reviews, V6, P435, DOI 10.1007/s11101-006-9050-0; Zhou ML, 2011, APPL MICROBIOL BIOT, V90, P1229, DOI 10.1007/s00253-011-3228-0; Zhou ML, 2010, APPL MICROBIOL BIOT, V88, P737, DOI 10.1007/s00253-010-2822-x	57	73	85	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43038	10.1371/journal.pone.0043038	http://dx.doi.org/10.1371/journal.pone.0043038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916202	Green Published, Green Submitted, gold			2022-12-25	WOS:000307733800044
J	Stern, RF; Andersen, RA; Jameson, I; Kupper, FC; Coffroth, MA; Vaulot, D; Le Gall, F; Veron, B; Brand, JJ; Skelton, H; Kasai, F; Lilly, EL; Keeling, PJ				Stern, Rowena F.; Andersen, Robert A.; Jameson, Ian; Kuepper, Frithjof C.; Coffroth, Mary-Alice; Vaulot, Daniel; Le Gall, Florence; Veron, Benoit; Brand, Jerry J.; Skelton, Hayley; Kasai, Fumai; Lilly, Emily L.; Keeling, Patrick J.			Evaluating the Ribosomal Internal Transcribed Spacer (ITS) as a Candidate Dinoflagellate Barcode Marker	PLOS ONE			English	Article							SP-NOV; MOLECULAR PHYLOGENY; GENETIC DIVERSITY; LIFE-CYCLE; DINOPHYCEAE; DNA; SYMBIODINIUM; EVOLUTION; COMPLEX; GENUS	Background: DNA barcoding offers an efficient way to determine species identification and to measure biodiversity. For dinoflagellates, an ancient alveolate group of about 2000 described extant species, DNA barcoding studies have revealed large amounts of unrecognized species diversity, most of which is not represented in culture collections. To date, two mitochondrial gene markers, Cytochrome Oxidase I (COI) and Cytochrome b oxidase (COB), have been used to assess DNA barcoding in dinoflagellates, and both failed to amplify all taxa and suffered from low resolution. Nevertheless, both genes yielded many examples of morphospecies showing cryptic speciation and morphologically distinct named species being genetically similar, highlighting the need for a common marker. For example, a large number of cultured Symbiodinium strains have neither taxonomic identification, nor a common measure of diversity that can be used to compare this genus to other dinoflagellates. Methodology/Principal Findings: The purpose of this study was to evaluate the Internal Transcribed Spacer units 1 and 2 (ITS) of the rDNA operon, as a high resolution marker for distinguishing species dinoflagellates in culture. In our study, from 78 different species, the ITS barcode clearly differentiated species from genera and could identify 96% of strains to a known species or sub-genus grouping. 8.3% showed evidence of being cryptic species. A quarter of strains identified had no previous species identification. The greatest levels of hidden biodiversity came from Scrippsiella and the Pfiesteriaceae family, whilst Heterocapsa strains showed a high level of mismatch to their given species name. Conclusions/Significance: The ITS marker was successful in confirming species, revealing hidden diversity in culture collections. This marker, however, may have limited use for environmental barcoding due to paralogues, the potential for unidentifiable chimaeras and priming across taxa. In these cases ITS would serve well in combination with other markers or for specific taxon studies.	[Stern, Rowena F.] Sir Alister Hardy Fdn Ocean Sci, The Laboratory, Plymouth, Devon, England; [Andersen, Robert A.] Provasoli Guillard Natl Ctr Culture Marine Phytop, W Boothbay Harbor, ME USA; [Jameson, Ian] Commonwealth Sci & Ind Res Org Marine & Atmospher, Australian Natl Algae Culture Collect, Hobart, Tas, Australia; [Kuepper, Frithjof C.] Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Coffroth, Mary-Alice] SUNY Buffalo, Dept Geol, Buffalo, NY 14260 USA; [Veron, Benoit] Univ Caen Basse Normandie, Algobank Caen, Caen, France; [Vaulot, Daniel; Le Gall, Florence] Roscoff Culture Collect, Stn Biol Roscoff, Roscoff, France; [Brand, Jerry J.] Univ Texas Austin, Sch Biol Sci, Sect MCD Biol, Austin, TX 78712 USA; [Skelton, Hayley] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Kasai, Fumai] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Lilly, Emily L.] Virginia Mil Inst, Dept Biol, Lexington, VA 24450 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); UHI Millennium Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Universite de Caen Normandie; UDICE-French Research Universities; Sorbonne Universite; University of Texas System; University of Texas Austin; University of Connecticut; National Institute for Environmental Studies - Japan; University of British Columbia	Stern, RF (corresponding author), Sir Alister Hardy Fdn Ocean Sci, The Laboratory, Plymouth, Devon, England.	rost@sahfos.ac.uk	Brand, JJ/GQR-2139-2022; Véron, Benoît/I-2942-2012; Vaulot, Daniel/T-6649-2019; /AAY-2080-2020	Véron, Benoît/0000-0002-8434-8981; Vaulot, Daniel/0000-0002-0717-5685; /0000-0002-1365-9723; Keeling, Patrick/0000-0002-7644-0745; Kuepper, Frithjof/0000-0003-1273-7109	Genome Canada; United Kingdom Natural Environment Research Council [Oceans 2025 NF3, MGF 154]; National Science Foundation [OCE 04-24994, OCE-09-26822]	Genome Canada(Genome Canada); United Kingdom Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Science Foundation(National Science Foundation (NSF))	This project was funded by Genome Canada. The authors would also like to acknowledge the United Kingdom Natural Environment Research Council for funding the CCAP (Oceans 2025 NF3 and MGF 154) and National Science Foundation grants OCE 04-24994 and OCE-09-26822 for funding Symbiodinium analysis by MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1996, J PHYCOL, V32, P424, DOI 10.1111/j.0022-3646.1996.00424.x; Al-Kandari MA, 2011, HARMFUL ALGAE, V10, P636, DOI 10.1016/j.hal.2011.04.017; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P185, DOI 10.1016/j.ejop.2004.01.002; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; Dodge J.D., 1982, P1; Ferrell J, 2008, EVALUATION DNA BARCO; FREUDENTHAL HD, 1962, J PROTOZOOL, V9, P45, DOI 10.1111/j.1550-7408.1962.tb02579.x; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; GERBI SA, 1986, BIOSYSTEMS, V19, P247, DOI 10.1016/0303-2647(86)90001-8; GHAZAROSSIAN VE, 1974, BIOCHEM BIOPH RES CO, V59, P1219, DOI 10.1016/0006-291X(74)90444-6; Giacobbe MG, 2000, PHYCOLOGIA, V39, P177, DOI 10.2216/i0031-8884-39-3-177.1; Gile GH, 2010, J PHYCOL, V46, P743, DOI 10.1111/j.1529-8817.2010.00851.x; Gottschling M, 2005, MOL PHYLOGENET EVOL, V36, P444, DOI 10.1016/j.ympev.2005.03.036; Hansen G, 2000, J PHYCOL, V36, P394, DOI 10.1046/j.1529-8817.2000.99172.x; HANSEN G, 1995, PHYCOLOGIA, V34, P166, DOI 10.2216/i0031-8884-34-2-166.1; Hansen G, 2009, J PHYCOL, V45, P251, DOI 10.1111/j.1529-8817.2008.00621.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoef-Emden Kerstin, 2007, Protist, V158, P135, DOI 10.1016/j.protis.2007.02.001; Hunter RL, 2007, J PHYCOL, V43, P120, DOI 10.1111/j.1529-8817.2006.00309.x; Iwataki M, 2004, PHYCOLOGIA, V43, P394, DOI 10.2216/i0031-8884-43-4-394.1; Jeong HJ, 2005, J EUKARYOT MICROBIOL, V52, P382, DOI 10.1111/j.1550-7408.2005.00051.x; John U, 2005, J PLANKTON RES, V27, P199, DOI 10.1093/plankt/fbh160; Jorgensen MF, 2004, J PHYCOL, V40, P351, DOI 10.1111/j.1529-8817.2004.03131.x; Joseph N, 1999, NUCLEIC ACIDS RES, V27, P4533, DOI 10.1093/nar/27.23.4533; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029013; Lakeman MB, 2009, HARMFUL ALGAE, V8, P746, DOI 10.1016/j.hal.2008.11.011; Leander BS, 2004, J PHYCOL, V40, P341, DOI 10.1111/j.1529-8817.2004.03129.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li HC, 2008, J MED MICROBIOL, V57, P592, DOI 10.1099/jmm.0.47607-0; Lilly EL, 2007, J PHYCOL, V43, P1329, DOI 10.1111/j.1529-8817.2007.00420.x; Lin S, 2009, APPL ENVIRON MICROB, V75, P1279, DOI 10.1128/AEM.01578-08; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; Litaker RW, 2005, J PHYCOL, V41, P643, DOI 10.1111/j.1529-8817.2005.00075.x; Lowe CD, 2010, PROTIST, V161, P212, DOI 10.1016/j.protis.2009.11.003; Maddison DR, 2005, MACCLADE; Mason PL, 2007, J PHYCOL, V43, P799, DOI 10.1111/j.1529-8817.2007.00370.x; Matsuyama Y, 1996, HARMFUL TOXIC ALGAL, P247; McLachlin J, 1997, PHYCOLOGIA, V36, P48; Montresor M, 2003, PHYCOLOGIA, V42, P56, DOI 10.2216/i0031-8884-42-1-56.1; Morado JF, 2005, SPECIES IDENTITY LIF; Morill LC, 1981, J PLANKTON RES, V3, P53; Murray S, 2009, PROTIST, V160, P245, DOI 10.1016/j.protis.2008.12.004; Nguyen HDT, 2008, PERSOONIA, V21, P57, DOI 10.3767/003158508X361334; Park TG, 2007, APPL ENVIRON MICROB, V73, P2552, DOI 10.1128/AEM.02389-06; Penna A, 2005, MAR BIOL, V148, P13, DOI 10.1007/s00227-005-0067-5; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Pochon X, 2010, J PHYCOL, V46, P53, DOI 10.1111/j.1529-8817.2009.00797.x; ROWAN R, 1992, P NATL ACAD SCI USA, V89, P3639, DOI 10.1073/pnas.89.8.3639; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Santos SR, 2003, MAR BIOTECHNOL, V5, P130, DOI 10.1007/s10126-002-0076-9; Santos SR, 2001, J PHYCOL, V37, P900, DOI 10.1046/j.1529-8817.2001.00194.x; Santos SR, 2002, MOL PHYLOGENET EVOL, V23, P97, DOI 10.1016/S1055-7903(02)00010-6; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Scholin CA, 1995, PHYCOLOGIA, V34, P472, DOI 10.2216/i0031-8884-34-6-472.1; Shankle AM, 2004, J PHYCOL, V40, P239, DOI 10.1111/j.1529-8817.2004.03021.x; Sherwood AR, 2007, J PHYCOL, V43, P605, DOI 10.1111/j.1529-8817.2007.00341.x; SILVA ES, 1995, PHYCOLOGIA, V34, P396, DOI 10.2216/i0031-8884-34-5-396.1; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Steidinger KA, 1996, J PHYCOL, V32, P157, DOI 10.1111/j.0022-3646.1996.00157.x; Steidinger Karen A., 1997, P387, DOI 10.1016/B978-012693018-4/50005-7; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor DL, 1974, SYMBIOSIS SEA, P245; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; TAYLOR FJR, 1975, ENVIRON LETT, V9, P103, DOI 10.1080/00139307509435840; Thornhill DJ, 2008, J PHYCOL, V44, P1126, DOI 10.1111/j.1529-8817.2008.00567.x; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Touzet N, 2007, APPL ENVIRON MICROB, V73, P3333, DOI 10.1128/AEM.02161-06; Trench R.K., 1997, P1275; TRENCH RK, 1987, J PHYCOL, V23, P469, DOI 10.1111/j.1529-8817.1987.tb02534.x; White T., 1990, PCR PROTOCOLS GUIDE, P315; Zhang H, 2007, J MOL EVOL, V65, P463, DOI 10.1007/s00239-007-9038-4	81	75	81	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42780	10.1371/journal.pone.0042780	http://dx.doi.org/10.1371/journal.pone.0042780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916158	Green Published, Green Submitted, gold			2022-12-25	WOS:000307824300016
J	Zhang, L; Yin, S; Tan, WL; Xiao, D; Weng, YC; Wang, WJ; Li, TT; Shi, JW; Shuai, LF; Li, HW; Zhou, JH; Allain, JP; Li, CY				Zhang, Ling; Yin, Sen; Tan, Wanlong; Xiao, Dong; Weng, Yunceng; Wang, Wenjing; Li, Tingting; Shi, Junwen; Shuai, Lifang; Li, Hongwei; Zhou, Jianhua; Allain, Jean-Pierre; Li, Chengyao			Recombinant Interferon-gamma Lentivirus Co-Infection Inhibits Adenovirus Replication Ex Vivo	PLOS ONE			English	Article							GB-VIRUS-C; IN-VIVO; RHESUS MACAQUES; GENE DELIVERY; IFN-GAMMA; HIV-1; EXPRESSION; VECTORS; INFECTION; CELLS	Recombinant interferon-gamma (IFN gamma) production in cultured lentivirus (LV) was explored for inhibition of target virus in cells co-infected with adenovirus type 5 (Ad5). The ability of three different promoters of CMV, EF1 alpha and Ubiquitin initiating the enhanced green fluorescence protein (GFP) activities within lentiviruses was systematically assessed in various cell lines, which showed that certain cell lines selected the most favorable promoter driving a high level of transgenic expression. Recombinant IFN gamma lentivirus carrying CMV promoter (LV-CMV-IFN gamma) was generated to co-infect 293A cells with a viral surrogate of recombinant GFP Ad5 in parallel with LV-CMV-GFP control. The best morphologic conditions were observed from the two lentiviruses co-infected cells, while single adenovirus infected cells underwent clear pathologic changes. Viral load of adenoviruses from LV-CMV-IFN gamma or LV-CMV-GFP co-infected cell cultures was significantly lower than that from adenovirus alone infected cells (P = 0.005-0.041), and the reduction of adenoviral load in the co-infected cells was 86% and 61%, respectively. Ad5 viral load from LV-CMV-IFN gamma co-infected cells was significantly lower than that from LV-CMV-GFP co-infection (P = 0.032), which suggested that IFN gamma rather than GFP could further enhance the inhibition of Ad5 replication in the recombinant lentivirus co-infected cells. The results suggest that LV-CMV-IFN gamma co-infection could significantly inhibit the target virus replication and might be a potential approach for alternative therapy of severe viral diseases.	[Zhang, Ling; Yin, Sen; Weng, Yunceng; Wang, Wenjing; Li, Tingting; Li, Hongwei; Allain, Jean-Pierre; Li, Chengyao] So Med Univ, Dept Transfus Med, Guangzhou, Guangdong, Peoples R China; [Xiao, Dong; Shi, Junwen] So Med Univ, Inst Oncol, Guangzhou, Guangdong, Peoples R China; [Tan, Wanlong] So Med Univ, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Shuai, Lifang] Guangzhou Mil Ctr Dis Control, Guangzhou, Guangdong, Peoples R China; [Zhou, Jianhua] Chinese Acad Agr Sci, Harbin Vet Res Inst, Lab Lentiviruses & Horse Dis, Harbin, Peoples R China; [Allain, Jean-Pierre] Univ Cambridge, Dept Hematol, Cambridge, England	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; University of Cambridge	Zhang, L (corresponding author), So Med Univ, Dept Transfus Med, Guangzhou, Guangdong, Peoples R China.	chengyaoli@hotmail.com	Weng, Yunceng/AAV-9980-2020		S&T Grand Special Program [2012ZX10001008, 2009ZX10004-305]; National Basic Research Program of China (973 Program) [2010CB530204, 2009CB522507]; National Natural Science Foundation of China [31100657, 81071348]; Guangdong Provincial Science and Technology Foundation [8151051501000014, 2010B060500010]	S&T Grand Special Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Foundation	This work was supported by the grants from S&T Grand Special Program (No. 2012ZX10001008 and 2009ZX10004-305), National Basic Research Program of China (973 Program No. 2010CB530204 and 2009CB522507), National Natural Science Foundation of China (No. 31100657 and 81071348) and Guangdong Provincial Science and Technology Foundation (No. 8151051501000014 and 2010B060500010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 1999, J VIROL, V73, P7671, DOI 10.1128/JVI.73.9.7671-7677.1999; Brule F, 2007, BIOCHEM PHARMACOL, V74, P898, DOI 10.1016/j.bcp.2007.06.036; Bukovsky AA, 1999, J VIROL, V73, P7087, DOI 10.1128/JVI.73.8.7087-7092.1999; Cao SB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-48; Corbeau P, 1998, VIROLOGY, V243, P268, DOI 10.1006/viro.1998.9089; Dale CJ, 2000, J MED PRIMATOL, V29, P240, DOI 10.1034/j.1600-0684.2000.290317.x; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Fischetti L, 2004, AIDS, V18, P1208, DOI 10.1097/00002030-200405210-00017; Frese M, 2002, HEPATOLOGY, V35, P694, DOI 10.1053/jhep.2002.31770; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Giavedoni L, 1997, J VIROL, V71, P866, DOI 10.1128/JVI.71.2.866-872.1997; Gorry PR, 2007, JAIDS-J ACQ IMM DEF, V46, P390, DOI 10.1097/QAI.0b013e31815aba08; Hoglund S, 1997, VIROLOGY, V233, P271, DOI 10.1006/viro.1997.8585; Iidal T, 2004, ARCH VIROL, V149, P743, DOI 10.1007/s00705-003-0229-z; Kaiser J, 2008, SCIENCE, V320, P30, DOI 10.1126/science.320.5872.30; Kim JJ, 2001, VACCINE, V19, P2496, DOI 10.1016/S0264-410X(00)00479-5; Kim SY, 2002, J BIOTECHNOL, V93, P183, DOI 10.1016/S0168-1656(01)00388-1; Klimatcheva E, 2001, MOL THER, V3, P928, DOI 10.1006/mthe.2001.0344; Li CY, 2006, AIDS, V20, P379, DOI 10.1097/01.aids.0000200536.79360.03; Li HW, 2005, BIOCHEM BIOPH RES CO, V336, P29, DOI 10.1016/j.bbrc.2005.08.035; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nattermann J, 2003, AIDS, V17, P1457, DOI 10.1097/00002030-200307040-00006; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Scherer LJ, 2011, HUM MOL GENET, V20, pR100, DOI 10.1093/hmg/ddr160; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Xiang JH, 2004, LANCET, V363, P2040, DOI 10.1016/S0140-6736(04)16453-2; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Younes HM, 2002, J PHARM SCI-US, V91, P2, DOI 10.1002/jps.10007; Zeng LB, 2006, J GENE MED, V8, P18, DOI 10.1002/jgm.825	32	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e42455	10.1371/journal.pone.0042455	http://dx.doi.org/10.1371/journal.pone.0042455			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916129	Green Submitted, gold, Green Published			2022-12-25	WOS:000307824300010
J	Basappa; Sugahara, K; Thimmaiah, KN; Bid, HK; Houghton, PJ; Rangappa, KS				Basappa; Sugahara, Kazuyuki; Thimmaiah, Kuntebommanahalli N.; Bid, Hemant K.; Houghton, Peter J.; Rangappa, Kanchugarakoppal S.			Anti-Tumor Activity of a Novel HS-Mimetic-Vascular Endothelial Growth Factor Binding Small Molecule	PLOS ONE			English	Article							TUMOR-GROWTH; INHIBITORS; HEPARIN; TRANSFORMATION; METASTASIS; DOMAIN; AGENTS	The angiogenic process is controlled by variety of factors of which the vascular endothelial growth factor (VEGF) pathway plays a major role. A series of heparan sulfate mimetic small molecules targeting VEGF/VEGFR pathway has been synthesized. Among them, compound 8 (2-butyl-5-chloro-3-(4-nitro-benzyl)-3H-imidazole-4-carbaldehyde) was identified as a significant binding molecule for the heparin-binding domain of VEGF, determined by high-throughput-surface plasmon resonance assay. The data predicted strong binding of compound 8 with VEGF which may prevent the binding of VEGF to its receptor. We compared the structure of compound 8 with heparan sulfate (HS), which have in common the functional ionic groups such as sulfate, nitro and carbaldehyde that can be located in similar positions of the disaccharide structure of HS. Molecular docking studies predicted that compound 8 binds at the heparin binding domain of VEGF through strong hydrogen bonding with Lys-30 and Gln-20 amino acid residues, and consistent with the prediction, compound 8 inhibited binding of VEGF to immobilized heparin. In vitro studies showed that compound 8 inhibits the VEGF-induced proliferation migration and tube formation of mouse vascular endothelial cells, and finally the invasion of a murine osteosarcoma cell line (LM8G7) which secrets high levels of VEGF. In vivo, these effects produce significant decrease of tumor burden in an experimental model of liver metastasis. Collectively, these data indicate that compound 8 may prevent tumor growth through a direct effect on tumor cell proliferation and by inhibition of endothelial cell migration and angiogenesis mediated by VEGF. In conclusion, compound 8 may normalize the tumor vasculature and microenvironment in tumors probably by inhibiting the binding of VEGF to its receptor.	[Basappa; Sugahara, Kazuyuki] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan; [Thimmaiah, Kuntebommanahalli N.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Bid, Hemant K.; Houghton, Peter J.] Nationwide Childrens Hosp, Ctr Childhood Canc, Columbus, OH USA; [Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India; [Basappa] Singapore MIT Alliance Res & Technol, Singapore, Singapore; [Basappa] Bangalore Univ, Dept Chem, Bangalore 560056, Karnataka, India	Hokkaido University; St Jude Children's Research Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Mysore; Singapore-MIT Alliance for Research & Technology Centre (SMART); Bangalore University	Basappa (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan.	rangappaks@gmail.com	Houghton, Peter/E-3265-2011	Basappa, Basappa/0000-0002-8844-468X	INSA (Indian National Science Academy)-JSPS (Japan Society for the Promotion of Science) program; Future Drug Discovery and Medical Care Innovation Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); JSPS; VGST from government of Karnataka; USPHS award [CA23099]; NATIONAL CANCER INSTITUTE [P01CA023099] Funding Source: NIH RePORTER	INSA (Indian National Science Academy)-JSPS (Japan Society for the Promotion of Science) program; Future Drug Discovery and Medical Care Innovation Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); VGST from government of Karnataka; USPHS award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the INSA (Indian National Science Academy)-JSPS (Japan Society for the Promotion of Science) program between India (to K.S.R.) and Japan (to K.S.), Future Drug Discovery and Medical Care Innovation Program (K. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), and a Grant-in-aid (19-07194) from JSPS, VGST from government of Karnataka (B.) and USPHS award CA23099 (P.J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 1998, INT J CANCER, V76, P418, DOI 10.1002/(SICI)1097-0215(19980504)76:3<418::AID-IJC21>3.3.CO;2-E; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Basappa, 2010, CANCER LETT, V297, P231, DOI 10.1016/j.canlet.2010.05.016; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; BENEZRA M, 1992, CANCER RES, V52, P5656; CIOMEI M, 1994, BIOCHEM PHARMACOL, V47, P295, DOI 10.1016/0006-2952(94)90020-5; Compain P, 2001, BIOORGAN MED CHEM, V9, P3077, DOI 10.1016/S0968-0896(01)00176-6; CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F; Dawson MI, 2008, J MED CHEM, V51, P5650, DOI 10.1021/jm800456k; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1987, NATURE, V329, P671, DOI 10.1038/329671a0; Gallos JK, 2003, CURR ORG CHEM, V7, P397, DOI 10.2174/1385272033372734; Gaonkar SL, 2009, MED CHEM RES, V18, P221, DOI 10.1007/s00044-008-9121-4; Goss PE, 1995, CLIN CANCER RES, V1, P935; HORI A, 1991, CANCER RES, V51, P6180; Ishida K, 2004, CHEM BIOL, V11, P367, DOI 10.1016/j.chembiol.2004.02.015; Jarvis A, 2010, J MED CHEM, V53, P2215, DOI 10.1021/jm901755g; Kavitha BCV, 2004, BIOORG MED CHEM LETT, V14, P3279, DOI 10.1016/j.bmcl.2004.03.098; Kavitha CV, 2005, J CHEM CRYSTALLOGR, V35, P957, DOI 10.1007/s10870-005-5249-y; Lee CM, 2002, CANCER RES, V62, P4282; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Perion R, 2005, TETRAHEDRON, V61, P9118, DOI 10.1016/j.tet.2005.07.033; Priya BS, 2005, BIOORGAN MED CHEM, V13, P2623, DOI 10.1016/j.bmc.2005.01.026; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Saito A, 2008, CHEM-ASIAN J, V3, P1607, DOI 10.1002/asia.200800099; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Slee DH, 2001, J MED CHEM, V44, P2094, DOI 10.1021/jm000508c; SOLA F, 1995, CANCER CHEMOTH PHARM, V36, P217, DOI 10.1007/BF00685849; STEIN CA, 1993, CANCER RES, V53, P2239; Tiligada E., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P553; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; WELLSTEIN A, 1991, JNCI-J NATL CANCER I, V83, P716, DOI 10.1093/jnci/83.10.716; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s	36	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e39444	10.1371/journal.pone.0039444	http://dx.doi.org/10.1371/journal.pone.0039444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916091	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000307823600001
J	Sandvik, GK; Tomter, AB; Bergan, J; Zoppellaro, G; Barra, AL; Rohr, AK; Kolberg, M; Ellefsen, S; Andersson, KK; Nilsson, GE				Sandvik, Guro K.; Tomter, Ane B.; Bergan, Jonas; Zoppellaro, Giorgio; Barra, Anne-Laure; Rohr, Asmund K.; Kolberg, Matthias; Ellefsen, Stian; Andersson, K. Kristoffer; Nilsson, Goeran E.			Studies of Ribonucleotide Reductase in Crucian Carp-An Oxygen Dependent Enzyme in an Anoxia Tolerant Vertebrate	PLOS ONE			English	Article							HIGH-FIELD EPR; MAGNETIC CIRCULAR-DICHROISM; HERPES-SIMPLEX-VIRUS; HIGH-FREQUENCY EPR; CELL-CYCLE; DNA-DAMAGE; TYROSYL RADICALS; BIFERROUS SITE; IRON CENTER; PROTEIN R2	The enzyme ribonucleotide reductase (RNR) catalyzes the conversion of ribonucleotides to deoxyribonucleotides, the precursors for DNA. RNR requires a thiyl radical to activate the substrate. In RNR of eukaryotes (class Ia RNR), this radical originates from a tyrosyl radical formed in reaction with oxygen (O-2) and a ferrous di-iron center in RNR. The crucian carp (Carassius carassius) is one of very few vertebrates that can tolerate several months completely without oxygen (anoxia), a trait that enables this fish to survive under the ice in small ponds that become anoxic during the winter. Previous studies have found indications of cell division in this fish after 7 days of anoxia. This appears nearly impossible, as DNA synthesis requires the production of new deoxyribonucleotides and therefore active RNR. We have here characterized RNR in crucian carp, to search for adaptations to anoxia. We report the full-length sequences of two paralogs of each of the RNR subunits (R1i, R1ii, R2i, R2ii, p53R2i and p53R2ii), obtained by cloning and sequencing. The mRNA levels of these subunits were measured with quantitative PCR and were generally well maintained in hypoxia and anoxia in heart and brain. We also report maintained or increased mRNA levels of the cell division markers proliferating cell nuclear antigen (PCNA), brain derived neurotrophic factor (BDNF) and Ki67 in anoxic hearts and brains. Electron paramagnetic resonance (EPR) measurements on in vitro expressed crucian carp R2 and p53R2 proteins gave spectra similar to mammalian RNRs, including previously unpublished human and mouse p53R2 EPR spectra. However, the radicals in crucian carp RNR small subunits, especially in the p53R2ii subunit, were very stable at 0 degrees C. A long half-life of the tyrosyl radical during wintertime anoxia could allow for continued cell division in crucian carp.	[Sandvik, Guro K.; Tomter, Ane B.; Bergan, Jonas; Zoppellaro, Giorgio; Rohr, Asmund K.; Kolberg, Matthias; Andersson, K. Kristoffer; Nilsson, Goeran E.] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Barra, Anne-Laure] CNRS, UPR 3228, LNCMI G, Lab Natl Champs Magnet Intenses, Grenoble, France; [Ellefsen, Stian] Lillehammer Univ Coll, Lillehammer, Norway	University of Oslo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Inland Norway University of Applied Sciences	Sandvik, GK (corresponding author), Univ Oslo, Dept Mol Biosci, Oslo, Norway.	g.k.sandvik@imbv.uio.no	Kolberg, Matthias/G-2784-2011; Kolberg, Matthias/AAY-3478-2021; Nilsson, Göran Erik/Q-6129-2019; Kjendseth, Åsmund Røhr/O-2543-2016; Zoppellaro, Giorgio/F-8453-2012; Nilsson, Goran E/K-7668-2012	Kolberg, Matthias/0000-0001-8288-5364; Kjendseth, Åsmund Røhr/0000-0002-4956-4865; Zoppellaro, Giorgio/0000-0003-2304-2564; Nilsson, Goran E/0000-0002-3195-3053; Bergan, Jonas/0000-0003-4267-8904	European Community [PIEF-GA-2009235237]; Research Council of Norway [177661/V30, 214239/F20, 186406/V40]; Norwegian Cancer Society [539012]	European Community(European Commission); Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by the PEOPLE Marie Curie Actions Intra-European Fellowship within the 7th European Community Framework Programme (PIEF-GA-2009235237 to GZ), the Research Council of Norway (http://www.rcn.no) (Grants 177661/V30 and 214239/F20 to KKA; 186406/V40 to GEN), and the Norwegian Cancer Society (http://www.kreftforeningen.no) (539012 to KKA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 1996, J AM CHEM SOC, V118, P895, DOI 10.1021/ja9529192; AMELLEM O, 1994, BRIT J CANCER, V70, P857, DOI 10.1038/bjc.1994.411; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Andersson K. K., 1995, ADV INORG CHEM, V43, P359; Andersson KK, 2003, J BIOL INORG CHEM, V8, P235, DOI 10.1007/s00775-002-0429-0; Andersson KK, 2002, SPECTROCHIM ACTA A, V58, P1101, DOI 10.1016/S1386-1425(01)00700-4; Andersson KK, 2008, ROBONUCLEOTIDE REDUC; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atta M, 1996, J BIOL INORG CHEM, V1, P210, DOI 10.1007/s007750050045; ATTA M, 1994, J AM CHEM SOC, V116, P6429, DOI 10.1021/ja00093a051; Bennati M, 2005, BIOL CHEM, V386, P1007, DOI 10.1515/BC.2005.117; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; BLAZKA P., 1958, PHYSIOL ZOOL, V31, P117; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Brischwein K, 1997, EUR J BIOCHEM, V244, P286, DOI 10.1111/j.1432-1033.1997.00286.x; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chimploy K, 2000, J BIOL CHEM, V275, P39267, DOI 10.1074/jbc.M006233200; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Douglas RM, 2003, J APPL PHYSIOL, V94, P2068, DOI 10.1152/japplphysiol.01029.2002; Eisch AJ, 2007, CURR PHARM BIOTECHNO, V8, P147; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Ellefsen S, 2008, ANAL BIOCHEM, V376, P83, DOI 10.1016/j.ab.2008.01.028; Ellefsen S, 2008, PHYSIOL GENOMICS, V35, P5, DOI 10.1152/physiolgenomics.90221.2008; Engstrom M, 2000, J PHYS CHEM A, V104, P5149, DOI 10.1021/jp0006633; ENGSTROM Y, 1985, J BIOL CHEM, V260, P9114; Evans H, 2008, PHYSIOL GENOMICS, V35, P18, DOI 10.1152/physiolgenomics.90266.2008; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; GERFEN GJ, 1993, J AM CHEM SOC, V115, P6420, DOI 10.1021/ja00067a071; Graslund A, 2007, APPL MAGN RESON, V31, P447, DOI 10.1007/BF03166595; Graslund A, 1996, ANNU REV BIOPH BIOM, V25, P259; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hoganson CW, 1996, J AM CHEM SOC, V118, P4672, DOI 10.1021/ja953979a; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3209, DOI 10.1073/pnas.0536684100; JOHANSSON D, 1995, J EXP BIOL, V198, P853; JOHNSTON IA, 1983, J EXP BIOL, V104, P73; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kauppi B, 1996, J MOL BIOL, V262, P706, DOI 10.1006/jmbi.1996.0546; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Leggatt RA, 2003, REV FISH BIOL FISHER, V13, P237, DOI 10.1023/B:RFBF.0000033049.00668.fe; Lendzian F, 2005, BBA-BIOENERGETICS, V1707, P67, DOI 10.1016/j.bbabio.2004.02.011; Leung AYH, 2005, HISTOCHEM CELL BIOL, V124, P105, DOI 10.1007/s00418-005-0003-2; Lu B, 2004, NEURON GLIA BIOL, V1, P377, DOI 10.1017/S1740925X05000232; MAGNUSSON KE, 1976, BIOTECHNOL BIOENG, V18, P865, DOI 10.1002/bit.260180608; Mathews CZ, 1996, MOL MAR BIOL BIOTECH, V5, P284; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Nilsson GE, 2001, NEWS PHYSIOL SCI, V16, P217; NILSSON GE, 1990, J EXP BIOL, V150, P295; NYHOLM S, 1993, J BIOL CHEM, V268, P26200; Ohno S., 1970, EVOLUTION GENE DUPLI; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reichard P, 1997, TRENDS BIOCHEM SCI, V22, P81, DOI 10.1016/S0968-0004(97)01003-7; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; ROSS W, 1995, J CLIN PATHOL-CL MOL, V48, pM113; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schmidt PP, 1996, J BIOL CHEM, V271, P23615, DOI 10.1074/jbc.271.39.23615; Semenza GL, 2011, AM J PHYSIOL-CELL PH, V301, pC550, DOI 10.1152/ajpcell.00176.2011; Shang HQ, 2011, GENE, V475, P30, DOI 10.1016/j.gene.2010.12.008; Sjoberg BM, 1997, STRUCT BOND, V88, P139; Smith RW, 1996, AM J PHYSIOL-REG I, V271, pR897, DOI 10.1152/ajpregu.1996.271.4.R897; Sollid J, 2005, AM J PHYSIOL-REG I, V289, pR1196, DOI 10.1152/ajpregu.00267.2005; Stecyk JAW, 2004, SCIENCE, V306, P77, DOI 10.1126/science.1100763; Strand KR, 2004, J BIOL CHEM, V279, P46794, DOI 10.1074/jbc.M407346200; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; SYMONS MCR, 1978, ANN REP PROGR CHEM A, V75, P117, DOI 10.1039/pr9787500117; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; THELANDER L, 1983, BIOCHEM BIOPH RES CO, V110, P859, DOI 10.1016/0006-291X(83)91040-9; Tomter AB, 2008, BIOCHEMISTRY-US, V47, P11300, DOI 10.1021/bi801212f; Tomter AB, 2013, COORDIN CHEM REV, V257, P3, DOI 10.1016/j.ccr.2012.05.021; Tomter AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025022; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; UN S, 1995, J AM CHEM SOC, V117, P10713, DOI 10.1021/ja00148a013; Uppsten M, 2006, J MOL BIOL, V359, P365, DOI 10.1016/j.jmb.2006.03.035; van Dam PJ, 1998, J AM CHEM SOC, V120, P5080, DOI 10.1021/ja9737127; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Vornanen M, 2011, NATURWISSENSCHAFTEN, V98, P225, DOI 10.1007/s00114-011-0764-5; Vornanen M, 2009, FISH PHYSIOL, V27, P397, DOI 10.1016/S1546-5098(08)00009-5; Wei PP, 2006, BIOCHEMISTRY-US, V45, P14043, DOI 10.1021/bi061127p; Zupanc GKH, 2009, SEMIN CELL DEV BIOL, V20, P683, DOI 10.1016/j.semcdb.2008.12.001	86	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42784	10.1371/journal.pone.0042784	http://dx.doi.org/10.1371/journal.pone.0042784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916159	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500800022
J	Vrentas, CE; Greenlee, JJ; Tatum, TL; Nicholson, EM				Vrentas, Catherine E.; Greenlee, Justin J.; Tatum, Trudy L.; Nicholson, Eric M.			Relationships between PrPSc Stability and Incubation Time for United States Scrapie Isolates in a Natural Host System	PLOS ONE			English	Article							SHEEP PRION PROTEIN; CONFORMATIONAL STABILITY; SUFFOLK SHEEP; TRANSMISSION; GENOTYPE; STRAINS	Transmissible spongiform encephalopathies (TSEs), including scrapie in sheep (Ovis aries), are fatal neurodegenerative diseases caused by the misfolding of the cellular prion protein (PrPC) into a a-rich conformer (PrPSc) that accumulates into higher-order structures in the brain and other tissues. Distinct strains of TSEs exist, characterized by different pathologic profiles upon passage into rodents and representing distinct conformations of PrPSc. One biochemical method of distinguishing strains is the stability of PrPSc as determined by unfolding in guanidine hydrochloride (GdnHCl), which is tightly and positively correlated with the incubation time of disease upon passage into mice. Here, we utilize a rapid, protease-free version of the stability assay to characterize naturally occurring scrapie samples, including a fast-acting scrapie inoculum for which incubation time is highly dependent on the amino acid at codon 136 of the prion protein. We utilize the stability methodology to identify the presence of two distinct isolates in the inoculum, and compare isolate properties to those of a host-stabilized reference scrapie isolate (NADC 13-7) in order to assess the stability/incubation time correlation in a natural host system. We demonstrate the utility of the stability methodology in characterizing TSE isolates throughout serial passage in livestock, which is applicable to a range of natural host systems, including strains of bovine spongiform encephalopathy and chronic wasting disease.	[Vrentas, Catherine E.; Greenlee, Justin J.; Tatum, Trudy L.; Nicholson, Eric M.] USDA ARS, Natl Anim Dis Ctr, Ames, IA 50010 USA	United States Department of Agriculture (USDA)	Vrentas, CE (corresponding author), USDA ARS, Natl Anim Dis Ctr, POB 70, Ames, IA 50010 USA.	eric.nicholson@ars.usda.gov	Greenlee, Justin/Y-5732-2019	Greenlee, Justin/0000-0003-2202-3054	U.S. Department of Agriculture, Agriculture Research Service	U.S. Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded in its entirety by congressionally appropriated funds to the U.S. Department of Agriculture, Agriculture Research Service. The funders of the work did not influence study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Bett C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002522; Bossers A, 1997, P NATL ACAD SCI USA, V94, P4931, DOI 10.1073/pnas.94.10.4931; BRUCE ME, 1989, NEUROSCI LETT, V102, P1, DOI 10.1016/0304-3940(89)90298-X; Bulgin MS, 2007, JAVMA-J AM VET MED A, V230, P1158, DOI 10.2460/javma.230.8.1158; Bulgin MS, 2006, AM J VET RES, V67, P498, DOI 10.2460/ajvr.67.3.498; Choi YP, 2010, J VIROL, V84, P12030, DOI 10.1128/JVI.01057-10; Detwiler LA, 2003, REV SCI TECH OIE, V22, P121, DOI 10.20506/rst.22.1.1386; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Hamir AN, 2009, VET PATHOL, V46, P1205, DOI 10.1354/vp.08-VP-0258-H-FL; Hamir AN, 2009, VET PATHOL, V46, P39, DOI 10.1354/vp.46-1-39; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Harnir AN, 2008, CAN J VET RES, V72, P63; HECKER R, 1992, GENE DEV, V6, P1213, DOI 10.1101/gad.6.7.1213; Jacobs JG, 2011, J VIROL, V85, P12537, DOI 10.1128/JVI.00448-11; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; ORourke KI, 1997, J GEN VIROL, V78, P975, DOI 10.1099/0022-1317-78-4-975; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Pirisinu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012723; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rezaei H, 2002, J MOL BIOL, V322, P799, DOI 10.1016/S0022-2836(02)00856-2; Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sajnani G, 2007, PLOS PATHOG, V8; Sun Y, 2008, J MOL BIOL, V376, P1155, DOI 10.1016/j.jmb.2007.12.053; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Thackray AM, 2008, J VIROL, V82, P11197, DOI 10.1128/JVI.01454-08; Thackray AM, 2012, EXP MOL PATHOL, V92, P167, DOI 10.1016/j.yexmp.2011.11.004; Tranulis MA, 2002, APMIS, V110, P33, DOI 10.1034/j.1600-0463.2002.100105.x; Wemheuer WM, 2009, AM J PATHOL, V175, P2566, DOI 10.2353/ajpath.2009.090623; Zampieri M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000420	35	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43060	10.1371/journal.pone.0043060	http://dx.doi.org/10.1371/journal.pone.0043060			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916207	gold, Green Submitted, Green Published			2022-12-25	WOS:000307500800040
J	Ramanujam, R; Xu, YS; Hao, L; Naqvi, NI				Ramanujam, Ravikrishna; Xu Yishi; Hao Liu; Naqvi, Naweed I.			Structure-Function Analysis of Rgs1 in Magnaporthe oryzae: Role of DEP Domains in Subcellular Targeting	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEINS; SACCHAROMYCES-CEREVISIAE; ALPHA-SUBUNITS; CRYPTOCOCCUS-NEOFORMANS; APPRESSORIUM FORMATION; HYDROPHOBIN SYNTHESIS; ASEXUAL SPORULATION; REGULATES PHEROMONE; STRESS-RESPONSE; GRISEA	Background: Rgs1, a prototypical Regulator of G protein Signaling, negatively modulates the cyclic AMP pathway thereby influencing various aspects of asexual development and pathogenesis in the rice-blast fungus Magnaporthe oryzae. Rgs1 possesses tandem DEP motifs (termed DEP-A and DEP-B; for Dishevelled, Egl-10, Pleckstrin) at the N-terminus, and a G alpha-GTP interacting RGS catalytic core domain at the C-terminus. In this study, we focused on gaining further insights into the mechanisms of Rgs1 regulation and subcellular localization by characterizing the role(s) of the individual domains and the full-length protein during asexual development and pathogenesis in Magnaporthe. Methodology/Principal Findings: Utilizing western blot analysis and specific antisera against the N- and C-terminal halves of Rgs1, we identify and report the in vivo endoproteolytic processing/cleavage of full-length Rgs1 that yields an N-terminal DEP and a RGS core domain. Independent expression of the resultant DEP-DEP half (N-Rgs1) or RGS core (C-Rgs1) fragments, failed to complement the rgs1 Delta defects in colony morphology, aerial hyphal growth, surface hydrophobicity, conidiation, appressorium formation and infection. Interestingly, the full-length Rgs1-mCherry, as well as the tagged N-terminal DEP domains (individually or in conjunction) localized to distinct punctate vesicular structures in the cytosol, while the catalytic RGS core motif was predominantly vacuolar. Conclusions/Significance: Based on our data from sequence alignments, immuno-blot and microscopic analysis, we propose that the post-translational proteolytic processing of Rgs1 and the vacuolar sequestration of the catalytic RGS domain represents an important means of down regulating Rgs1 function and thus forming an additional and alternative means of regulating G protein signaling in Magnaporthe. We further hypothesize the prevalence of analogous mechanisms functioning in other filamentous fungi. Furthermore, we conclusively assign a specific vesicular/membrane targeting function for the N-terminal DEP domains of Rgs1 in the rice-blast fungus.	[Ramanujam, Ravikrishna; Xu Yishi; Naqvi, Naweed I.] Temasek Life Sci Lab, Fungal Pathobiol Grp, Singapore, Singapore; [Ramanujam, Ravikrishna; Naqvi, Naweed I.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Hao Liu] Tianjin Univ Sci & Technol, MOE Key Lab Ind Fermentat Microbiol, Coll Biotechnol, Tianjin, Peoples R China; [Naqvi, Naweed I.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Tianjin University Science & Technology; National University of Singapore	Ramanujam, R (corresponding author), Temasek Life Sci Lab, Fungal Pathobiol Grp, Singapore, Singapore.	naweed@tll.org.sg	Naqvi, Naweed/CAG-5662-2022	Naqvi, Naweed/0000-0002-3619-4906	Temasek Life Sciences Laboratory (Singapore); National Natural Science Foundation of China [NSFC31170134]; maging Facility at TLL	Temasek Life Sciences Laboratory (Singapore)(National University of Singapore); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); maging Facility at TLL	This work was funded by intramural research grants from the Temasek Life Sciences Laboratory (Singapore). HL acknowledges grants from the project National Natural Science Foundation of China NSFC31170134. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Fungal Patho-Biology Group for helpful discussions and suggestions. We gratefully acknowledge support from the Imaging Facility at TLL.	Adachi K, 1998, PLANT CELL, V10, P1361, DOI 10.1105/tpc.10.8.1361; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker LG, 2005, THESIS; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bosch DE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002553; Burchett SA, 2002, J BIOL CHEM, V277, P22156, DOI 10.1074/jbc.M202254200; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; DIETZEL C, 1987, MOL CELL BIOL, V7, P4169, DOI 10.1128/MCB.7.12.4169; Dignard D, 2006, EUKARYOT CELL, V5, P192, DOI 10.1128/EC.5.1.192-202.2006; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dohlman HG, 1998, SEMIN CELL DEV BIOL, V9, P135, DOI 10.1006/scdb.1998.0218; Fang WG, 2007, MICROBIOL-SGM, V153, P1017, DOI 10.1099/mic.0.2006/002105-0; Han KH, 2004, MOL MICROBIOL, V53, P529, DOI 10.1111/j.1365-2958.2004.04163.x; Hoffman GA, 2000, J BIOL CHEM, V275, P37533, DOI 10.1074/jbc.M005751200; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; LEE BN, 1994, MOL MICROBIOL, V14, P323, DOI 10.1111/j.1365-2958.1994.tb01293.x; LEE YH, 1993, PLANT CELL, V5, P693, DOI 10.1105/tpc.5.6.693; Liu H., 2006, THESIS; Liu H, 2007, EMBO J, V26, P690, DOI 10.1038/sj.emboj.7601536; Liu SH, 1997, MOL PLANT MICROBE IN, V10, P1075, DOI 10.1094/MPMI.1997.10.9.1075; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; Mukherjee M, 2011, MOL PLANT PATHOL, V12, P479, DOI 10.1111/j.1364-3703.2010.00686.x; Nishimura M, 2003, MOL MICROBIOL, V50, P231, DOI 10.1046/j.1365-2958.2003.03676.x; Pereira PS, 2001, GENES CELLS, V6, P789, DOI 10.1046/j.1365-2443.2001.00465.x; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Ramanujam R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000897; Sambrook J., 2002, MOL CLONING LAB MANU; Segers GC, 2004, EUKARYOT CELL, V3, P1454, DOI 10.1128/EC.3.6.1454-1463.2004; Shen G, 2008, EUKARYOT CELL, V7, P1540, DOI 10.1128/EC.00154-08; Shoji JY, 2006, EUKARYOT CELL, V5, P411, DOI 10.1128/EC.5.2.411-421.2006; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Talbot NJ, 1996, PLANT CELL, V8, P985, DOI 10.1105/tpc.8.6.985; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Watson P, 1999, MOL MICROBIOL, V33, P623, DOI 10.1046/j.1365-2958.1999.01510.x; Xue CY, 2008, MOL MICROBIOL, V70, P379, DOI 10.1111/j.1365-2958.2008.06417.x; Zhang HF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002450	48	17	18	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41084	10.1371/journal.pone.0041084	http://dx.doi.org/10.1371/journal.pone.0041084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22927898	Green Published, gold			2022-12-25	WOS:000306956300049
J	Robson, A; Harris, LK; Innes, BA; Lash, GE; Aljunaidy, MM; Aplin, JD; Baker, PN; Robson, SC; Bulmer, JN				Robson, Andrew; Harris, Lynda K.; Innes, Barbara A.; Lash, Gendie E.; Aljunaidy, Mais M.; Aplin, John D.; Baker, Philip N.; Robson, Stephen C.; Bulmer, Judith N.			Uterine natural killer cells initiate spiral artery remodeling in human pregnancy	FASEB JOURNAL			English	Article						angiogenic growth factors; proteases; vascular smooth muscle cells	GROWTH-FACTOR; TROPHOBLAST INVASION; EXTRAVILLOUS TROPHOBLAST; GRANULATED LYMPHOCYTES; CARDIOVASCULAR-DISEASE; MATERNAL ARTERIES; SMOOTH-MUSCLE; IN-VITRO; EXPRESSION; FACTS	Uterine spiral artery remodeling is required for successful human pregnancy; impaired remodeling is associated with pregnancy complications, including late miscarriage, preeclampsia, and fetal growth restriction. The molecular triggers of remodeling are not known, but it is now clear that there are "trophoblast-independent" and "trophoblast-dependent" stages. Uterine natural killer (uNK) cells are abundant in decidualized endometrium in early pregnancy; they surround spiral arteries and secrete a range of angiogenic growth factors. We hypothesized that uNK cells mediate the initial stages of spiral artery remodeling. uNK cells and extravillous trophoblast (EVT) cells were isolated from early pregnancy decidua and placenta. Chorionic plate arteries from full-term placentas and spiral arteries from nonpregnant myometrium were cultured with angiogenic growth factors or conditioned medium (CM) from uNK cells or EVT or uNK cell/EVT cocultures. In both vessel models, uNK cell CM induced disruption of vascular smooth muscle cells (VSMCs) and breakdown of extracellular matrix components. Angiopoietin (Ang)-1, Ang-2, interferon-gamma, and VEGF-C also disrupted VSMC integrity with an Ang-2 inhibitor abrogating the effect of uNK cell CM. These results provide compelling evidence that uNK cells contribute to the early stages of spiral artery remodeling; failure of this process could contribute to pregnancy pathology.-Robson, A., Harris, L. K., Innes, B. A., Lash, G. E., Aljunaidy, M. M., Aplin, J. D., Baker, P. N., Robson, S. C., Bulmer, J. N. Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. FASEB J. 26, 4876-4885 (2012). www.fasebj.org	[Robson, Andrew; Innes, Barbara A.; Lash, Gendie E.; Robson, Stephen C.; Bulmer, Judith N.] Newcastle Univ, Inst Cellular Med, Reprod & Vasc Biol Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Harris, Lynda K.; Aljunaidy, Mais M.; Aplin, John D.; Baker, Philip N.] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Baker, Philip N.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada	Newcastle University - UK; University of Manchester; University of Alberta	Bulmer, JN (corresponding author), Newcastle Univ, Inst Cellular Med, Reprod & Vasc Biol Grp, 3rd Floor,William Leech Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	judith.bulmer@ncl.ac.uk	Lash, Gendie/AAI-4116-2021; Harris, Lynda K/I-2628-2019; Aplin, John/AET-4363-2022	Harris, Lynda K/0000-0001-7709-5202; Baker, Philip/0000-0002-4592-6427; Lash, Gendie/0000-0002-3606-1361; Aplin, John/0000-0001-8777-9261	UK Biotechnology and Biological Sciences Research Council [BB/E016790/1]; Biotechnology and Biological Sciences Research Council [BB/E016790/1] Funding Source: researchfish; BBSRC [BB/E016790/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Amgen (Thousand Oaks, CA, USA) for the peptibody AMG 386 neutralizing antibody and the research midwives team at the Royal Victoria Infirmary for help in obtaining consent and collecting samples. The authors also thank all the women who donated tissues to be used for these studies. This work was supported by a grant from the UK Biotechnology and Biological Sciences Research Council (BB/E016790/1). Author contributions: A. R. performed experiments and wrote the manuscript; L. K. H. performed experiments and wrote the manuscript; B. A. I. performed experiments; G. E. L. designed the study and wrote the manuscript; M. M. A. performed experiments; J.D.A. designed the study and wrote the manuscript; P.N.B. designed the study; S. C. R. designed the study and collected samples; J.N.B. designed the study and wrote the manuscript.	Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Ball E, 2006, J PATHOL, V208, P535, DOI 10.1002/path.1927; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; BULMER JN, 1991, HUM REPROD, V6, P791, DOI 10.1093/oxfordjournals.humrep.a137430; Cartwright JE, 1999, BRIT J PHARMACOL, V128, P181, DOI 10.1038/sj.bjp.0702757; Cartwright JE, 2002, PLACENTA, V23, P232, DOI 10.1053/plac.2001.0760; Choy MY, 1998, HUM REPROD, V13, P2941, DOI 10.1093/humrep/13.10.2941; Craven CM, 1998, PLACENTA, V19, P241, DOI 10.1016/S0143-4004(98)90055-8; Crocker IP, 2005, J PATHOL, V206, P476, DOI 10.1002/path.1801; Distler JHW, 2003, Q J NUCL MED, V47, P149; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gastrich MD, 2010, J MATERN-FETAL NEO M, V23, P751, DOI 10.3109/14767058.2010.481316; Geelhoed JJM, 2010, EUR J EPIDEMIOL, V25, P677, DOI 10.1007/s10654-010-9510-0; Guimond MJ, 1998, J EXP MED, V187, P217, DOI 10.1084/jem.187.2.217; Harris LK, 2010, AM J PATHOL, V177, P2103, DOI 10.2353/ajpath.2010.100182; Kam EPY, 1999, HUM REPROD, V14, P2131, DOI 10.1093/humrep/14.8.2131; Lash GE, 2010, PLACENTA, V31, pS87, DOI 10.1016/j.placenta.2009.12.022; Lash GE, 2010, PLACENTA, V31, P545, DOI 10.1016/j.placenta.2010.02.020; Lash GE, 2011, HUM REPROD, V26, P2289, DOI 10.1093/humrep/der198; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Leonard S, 2006, PLACENTA, V27, pS40, DOI 10.1016/j.placenta.2005.11.007; Li XF, 2001, J CLIN ENDOCR METAB, V86, P1823, DOI 10.1210/jc.86.4.1823; Lyall F, 2002, PLACENTA, V23, P555, DOI 10.1053/plac.2002.0850; Naruse K, 2009, HUM REPROD, V24, P553, DOI 10.1093/humrep/den408; Nuyt AM, 2009, CURR OPIN NEPHROL HY, V18, P144, DOI 10.1097/MNH.0b013e328326092c; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Sweeney M, 2006, PLACENTA, V27, P635, DOI 10.1016/j.placenta.2005.05.010; van der Heijden OWH, 2005, BIOL REPROD, V73, P1289, DOI 10.1095/biolreprod.105.044438; van Weel V, 2007, ARTERIOSCL THROM VAS, V27, P2310, DOI 10.1161/ATVBAHA.107.151407; Vassiliadou N, 1998, IMMUNOLOGY, V94, P368, DOI 10.1046/j.1365-2567.1998.00497.x; Whitman SC, 2004, ARTERIOSCL THROM VAS, V24, P1049, DOI 10.1161/01.ATV.0000124923.95545.2c	33	206	222	0	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					4876	4885		10.1096/fj.12-210310	http://dx.doi.org/10.1096/fj.12-210310			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22919072	Green Submitted			2022-12-25	WOS:000311838300011
J	Dickson, AM; Anderson, JR; Barnhart, MD; Sokoloski, KJ; Oko, L; Opyrchal, M; Galanis, E; Wilusz, CJ; Morrison, TE; Wilusz, J				Dickson, Alexa M.; Anderson, John R.; Barnhart, Michael D.; Sokoloski, Kevin J.; Oko, Lauren; Opyrchal, Mateusz; Galanis, Evanthia; Wilusz, Carol J.; Morrison, Thomas E.; Wilusz, Jeffrey			Dephosphorylation of HuR Protein during Alphavirus Infection Is Associated with HuR Relocalization to the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA-BINDING; HNRNP A1 INTERACTS; SINDBIS-VIRUS; NUCLEAR IMPORT; PHOSPHORYLATION; MOSQUITO; POLYADENYLATION; TRANSCRIPTS; EXPRESSION; LIGANDS	We have demonstrated previously that the cellular HuR protein binds U-rich elements in the 3' untranslated region (UTR) of Sindbis virus RNA and relocalizes from the nucleus to the cytoplasm upon Sindbis virus infection in 293T cells. In this study, we show that two alphaviruses, Ross River virus and Chikungunya virus, lack the conserved high-affinity U-rich HuR binding element in their 3' UTRs but still maintain the ability to interact with HuR with nanomolar affinities through alternative binding elements. The relocalization of HuR protein occurs during Sindbis infection of multiple mammalian cell types as well as during infections with three other alphaviruses. Interestingly, the relocalization of HuR is not a general cellular reaction to viral infection, as HuR protein remained largely nuclear during infections with dengue and measles virus. Relocalization of HuR in a Sindbis infection required viral gene expression, was independent of the presence of a high-affinity U-rich HuR binding site in the 3' UTR of the virus, and was associated with an alteration in the phosphorylation state of HuR. Sindbis virus-induced HuR relocalization was mechanistically distinct from the movement of HuR observed during a cellular stress response, as there was no accumulation of caspase-mediated HuR cleavage products. Collectively, these data indicate that virus-induced HuR relocalization to the cytoplasm is specific to alphavirus infections and is associated with distinct posttranslational modifications of this RNA-binding protein.	[Dickson, Alexa M.; Anderson, John R.; Barnhart, Michael D.; Sokoloski, Kevin J.; Wilusz, Carol J.; Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Parasitol, Ft Collins, CO 80523 USA; [Oko, Lauren; Morrison, Thomas E.] Univ Colorado, Dept Microbiol, Sch Med, Aurora, CO 80045 USA; [Opyrchal, Mateusz; Galanis, Evanthia] Mayo Clin, Dept Oncol, Div Med Oncol, Rochester, MN 55905 USA; [Sokoloski, Kevin J.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus; Mayo Clinic; Indiana University System; Indiana University Bloomington	Wilusz, J (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Parasitol, Ft Collins, CO 80523 USA.	jeffrey.wilusz@colostate.edu	Wilusz, Carol/F-7241-2017; Wilusz, Carol/AAC-2901-2021		National Institutes of Health [AI063434]; NIAID, National Institutes of Health through the Rocky Mountain Regional Center of Excellence [U54 AI-065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357, R01AI063434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, National Institutes of Health through the Rocky Mountain Regional Center of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported, in whole or in part, by National Institutes of Health Grant AI063434 and NIAID, National Institutes of Health award U54 AI-065357 through the Rocky Mountain Regional Center of Excellence (to J.W.).	Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; BARTON DJ, 1988, J VIROL, V62, P3597, DOI 10.1128/JVI.62.10.3597-3602.1988; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Burnham AJ, 2007, VIROLOGY, V367, P212, DOI 10.1016/j.virol.2007.05.008; Doller A, 2011, CARCINOGENESIS, V32, P676, DOI 10.1093/carcin/bgr024; Doller A, 2010, MOL CELL BIOL, V30, P1397, DOI 10.1128/MCB.01373-09; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Epis MR, 2011, J BIOL CHEM, V286, P41442, DOI 10.1074/jbc.M111.301481; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Garneau NL, 2008, J VIROL, V82, P880, DOI 10.1128/JVI.01205-07; Gui HX, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-59; Guttinger S, 2004, P NATL ACAD SCI USA, V101, P2918, DOI 10.1073/pnas.0400342101; Hardy RW, 2005, J VIROL, V79, P4630, DOI 10.1128/JVI.79.8.4630-4639.2005; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]; Jupille H. J., 2011, VIROLOGY, V178, P32; Kim HS, 2011, NUCLEIC ACIDS RES, V39, P1117, DOI 10.1093/nar/gkq837; Kim HH, 2008, CELL CYCLE, V7, P3371; Kim HH, 2008, CELL CYCLE, V7, P3124, DOI 10.4161/cc.7.20.6884; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kim HH, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/981487; Li ZH, 2011, RNA BIOL, V8, P305, DOI 10.4161/rna.8.2.15391; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Liu L, 2009, MOL BIOL CELL, V20, P4885, DOI 10.1091/mbc.E09-07-0550; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; PARDIGON N, 1993, J VIROL, V67, P5003, DOI 10.1128/JVI.67.8.5003-5011.1993; Pardigon N, 1996, J VIROL, V70, P1173, DOI 10.1128/JVI.70.2.1173-1181.1996; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; Rivas-Aravena A, 2009, VIROLOGY, V392, P178, DOI 10.1016/j.virol.2009.06.050; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Sokoloski KJ, 2010, CELL HOST MICROBE, V8, P196, DOI 10.1016/j.chom.2010.07.003; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; von Roretz C, 2010, J BIOL CHEM, V285, P16806, DOI 10.1074/jbc.M109.087320; Weaver SC, 1997, J VIROL, V71, P613, DOI 10.1128/JVI.71.1.613-623.1997; WILUSZ J, 1988, CELL, V52, P221, DOI 10.1016/0092-8674(88)90510-7; Yu TX, 2011, NUCLEIC ACIDS RES, V39, P8472, DOI 10.1093/nar/gkr567; Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023; Zhou HL, 2011, P NATL ACAD SCI USA, V108, pE627, DOI 10.1073/pnas.1103344108; Zhu H, 2007, J BIOL CHEM, V282, P2203, DOI 10.1074/jbc.M609349200	41	46	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36229	36238		10.1074/jbc.M112.371203	http://dx.doi.org/10.1074/jbc.M112.371203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22915590	Green Published, hybrid			2022-12-25	WOS:000310364000044
J	Vallese, F; Berto, P; Ruzzene, M; Cendron, L; Sarno, S; De Rosa, E; Giacometti, GM; Costantini, P				Vallese, Francesca; Berto, Paola; Ruzzene, Maria; Cendron, Laura; Sarno, Stefania; De Rosa, Edith; Giacometti, Giorgio M.; Costantini, Paola			Biochemical Analysis of the Interactions between the Proteins Involved in the [FeFe]-Hydrogenase Maturation Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-CLUSTER; FEFE HYDROGENASE; SCAFFOLD PROTEIN; HYDF; INSIGHTS; ACTIVATION; ENZYMES	[FeFe]-hydrogenases are iron-sulfur proteins characterized by a complex active site, the H-cluster, whose assembly requires three conserved maturases. HydE and HydG are radical S-adenosylmethionine enzymes that chemically modify a H-cluster precursor on HydF, a GTPase with a dual role of scaffold on which this precursor is synthesized, and carrier to transfer it to the hydrogenase. Coordinate structural and functional relationships between HydF and the two other maturases are crucial for the H-cluster assembly. However, to date only qualitative analysis of this protein network have been provided. In this work we showed that the interactions of HydE and HydG with HydF are distinct events, likely occurring in a precise functional order driven by different kinetic properties, independently of the HydF GTPase activity, which is instead involved in the dissociation of the maturases from the scaffold. We also found that HydF is able to interact with the hydrogenase only when co-expressed with the two other maturases, indicating that under these conditions it harbors per se all the structural elements needed to transfer the H-cluster precursor, thus completing the maturation process. These results open new working perspectives aimed at improving the knowledge of how these complex metalloenzymes are biosynthesized.	[Vallese, Francesca; Cendron, Laura; Giacometti, Giorgio M.; Costantini, Paola] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Berto, Paola; Ruzzene, Maria; Sarno, Stefania; De Rosa, Edith] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy	University of Padua; University of Padua	Costantini, P (corresponding author), Univ Padua, Dept Biol, Viale G Colombo 3, I-35131 Padua, Italy.	paola.costantini@unipd.it	cendron, Laura/A-5202-2014	Cendron, Laura/0000-0002-0125-0461; Ruzzene, Maria/0000-0001-8712-8151	Ministero delle Politiche Agricole e Forestali; Fondazione Cassa di Risparmio di Padova e Rovigo	Ministero delle Politiche Agricole e Forestali; Fondazione Cassa di Risparmio di Padova e Rovigo(Fondazione Cariparo)	This work was supported by Ministero delle Politiche Agricole e Forestali Grant (to G. M. G.).; Recipient of a Ph.D. fellowship from the Fondazione Cassa di Risparmio di Padova e Rovigo.	Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Cendron L, 2011, J BIOL CHEM, V286, P43944, DOI 10.1074/jbc.M111.281956; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Duffus BR, 2012, BBA-PROTEINS PROTEOM, V1824, P1254, DOI 10.1016/j.bbapap.2012.01.002; Fontecilla-Camps JC, 2009, NATURE, V460, P814, DOI 10.1038/nature08299; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; McGlynn SE, 2007, J BIOL INORG CHEM, V12, P443, DOI 10.1007/s00775-007-0224-z; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Mulder DW, 2009, BIOCHEMISTRY-US, V48, P6240, DOI 10.1021/bi9000563; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Nicolet Y, 2012, J BIOL CHEM, V287, P13532, DOI 10.1074/jbc.R111.310797; Peters JW, 2012, ANNU REV BIOCHEM, V81, P429, DOI 10.1146/annurev-biochem-052610-094911; Peters JW, 2006, FEBS LETT, V580, P363, DOI 10.1016/j.febslet.2005.12.040; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Ruzzene M, 1999, FEBS LETT, V461, P32, DOI 10.1016/S0014-5793(99)01409-X; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107	25	25	25	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36544	36555		10.1074/jbc.M112.388900	http://dx.doi.org/10.1074/jbc.M112.388900			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22932901	hybrid, Green Published			2022-12-25	WOS:000310364000075
J	Apte, SH; Groves, PL; Skwarczynski, M; Fujita, Y; Chang, CH; Toth, I; Doolan, DL				Apte, Simon H.; Groves, Penny L.; Skwarczynski, Mariusz; Fujita, Yoshio; Chang, Chenghung; Toth, Istvan; Doolan, Denise L.			Vaccination with Lipid Core Peptides Fails to Induce Epitope-Specific T Cell Responses but Confers Non-Specific Protective Immunity in a Malaria Model	PLOS ONE			English	Article							YOELII CIRCUMSPOROZOITE PROTEIN; SYNTHETIC LIPOPEPTIDE VACCINE; GROUP-A STREPTOCOCCUS; LIVER-STAGE ANTIGEN; PLASMODIUM-FALCIPARUM; IN-VIVO; DELIVERY-SYSTEM; CD4 HELP; LYMPHOCYTE RESPONSES; INFECTED HEPATOCYTES	Vaccines against many pathogens for which conventional approaches have failed remain an unmet public health priority. Synthetic peptide-based vaccines offer an attractive alternative to whole protein and whole organism vaccines, particularly for complex pathogens that cause chronic infection. Previously, we have reported a promising lipid core peptide (LCP) vaccine delivery system that incorporates the antigen, carrier, and adjuvant in a single molecular entity. LCP vaccines have been used to deliver several peptide subunit-based vaccine candidates and induced high titre functional antibodies and protected against Group A streptococcus in mice. Herein, we have evaluated whether LCP constructs incorporating defined CD4(+) and/or CD8(+) T cell epitopes could induce epitope-specific T cell responses and protect against pathogen challenge in a rodent malaria model. We show that LCP vaccines failed to induce an expansion of antigen-specific CD8(+) T cells following primary immunization or by boosting. We further demonstrated that the LCP vaccines induced a non-specific type 2 polarized cytokine response, rather than an epitope-specific canonical CD8(+) T cell type 1 response. Cytotoxic responses of unknown specificity were also induced. These non-specific responses were able to protect against parasite challenge. These data demonstrate that vaccination with lipid core peptides fails to induce canonical epitope-specific T cell responses, at least in our rodent model, but can nonetheless confer non-specific protective immunity against Plasmodium parasite challenge.	[Apte, Simon H.; Groves, Penny L.; Doolan, Denise L.] Queensland Inst Med Res, Infect Dis Programme, Herston, Qld 4006, Australia; [Skwarczynski, Mariusz; Fujita, Yoshio; Chang, Chenghung; Toth, Istvan] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Toth, Istvan] Univ Queensland, Sch Pharm, St Lucia, Qld, Australia; [Doolan, Denise L.] Univ Queensland, Sch Med, Herston, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; University of Queensland	Apte, SH (corresponding author), Queensland Inst Med Res, Infect Dis Programme, Bramston Terrace, Herston, Qld 4006, Australia.	Denise.Doolan@qimr.edu.au	Apte, Simon/R-8794-2019; Toth, Istvan/C-1965-2013; Apte, Simon/H-2798-2016; Doolan, Denise L/F-1969-2015; Skwarczynski, Mariusz/A-6707-2009	Apte, Simon/0000-0003-3105-0820; Toth, Istvan/0000-0002-4572-397X; Apte, Simon/0000-0003-3105-0820; Skwarczynski, Mariusz/0000-0001-7257-807X; Doolan, Denise/0000-0001-7354-8817	NHMRC Program [496600]; Pfizer Australia Senior Research Fellowship; Grants-in-Aid for Scientific Research [23790144] Funding Source: KAKEN	NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia); Pfizer Australia Senior Research Fellowship(PfizerPfizer Australia); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by NHMRC Program Grant 496600. DLD was supported by a Pfizer Australia Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal ABM, 2008, J MED CHEM, V51, P167, DOI 10.1021/jm701091d; AICHELE P, 1990, J EXP MED, V171, P1815, DOI 10.1084/jem.171.5.1815; Alexander J, 1998, IMMUNOL RES, V18, P79, DOI 10.1007/BF02788751; ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; An LL, 1997, J VIROL, V71, P2292, DOI 10.1128/JVI.71.3.2292-2302.1997; Anders RF, 2010, HUM VACCINES, V6, P39, DOI 10.4161/hv.6.1.10712; [Anonymous], 2008, WORLD MAL REP 2008; Apte SH, 2011, INT J PARASITOL, V41, P1285, DOI 10.1016/j.ijpara.2011.07.010; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Benmohamed L, 2000, VACCINE, V18, P2843, DOI 10.1016/S0264-410X(00)00068-2; BenMohamed L, 2002, EUR J IMMUNOL, V32, P2274, DOI 10.1002/1521-4141(200208)32:8<2274::AID-IMMU2274>3.0.CO;2-C; BenMohamed L, 1997, EUR J IMMUNOL, V27, P1242, DOI 10.1002/eji.1830270528; BenMohamed L, 2002, LANCET INFECT DIS, V2, P425, DOI 10.1016/S1473-3099(02)00318-3; Bour H, 1998, J IMMUNOL, V160, P5522; Bourgeois C, 2003, EUR J IMMUNOL, V33, P3225, DOI 10.1002/eji.200324576; Brown Lorena E., 2005, Current Drug Delivery, V2, P383, DOI 10.2174/156720105774370258; Daubersies P, 2000, NAT MED, V6, P1258, DOI 10.1038/81366; DERES K, 1989, NATURE, V342, P561, DOI 10.1038/342561a0; Dobano C, 2007, MOL IMMUNOL, V44, P2235, DOI 10.1016/j.molimm.2006.11.003; Dobano C, 2008, OPEN VACCINE J, V1, P27; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; Doolan DL, 2006, CURR MOL MED, V6, P169, DOI 10.2174/156652406776055249; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Franke ED, 1997, J IMMUNOL, V159, P3424; Franke ED, 2000, INFECT IMMUN, V68, P3403, DOI 10.1128/IAI.68.6.3403-3411.2000; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Godoy-Ramirez K, 2005, CYTOM PART A, V68A, P71, DOI 10.1002/cyto.a.20189; Goldszmid RS, 2010, CURR OPIN IMMUNOL, V22, P118, DOI 10.1016/j.coi.2010.01.017; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; GRILLOT D, 1990, EUR J IMMUNOL, V20, P1215, DOI 10.1002/eji.1830200604; Hayman WA, 2002, IMMUNOL CELL BIOL, V80, P178, DOI 10.1046/j.1440-1711.2002.01067.x; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Holtappels R, 2008, J VIROL, V82, P5781, DOI 10.1128/JVI.00155-08; HOPP TP, 1984, MOL IMMUNOL, V21, P13, DOI 10.1016/0161-5890(84)90084-1; Ishioka GY, 1999, J IMMUNOL, V162, P3915; Iwasaki A, 1998, CANCER IMMUNOL IMMUN, V45, P273, DOI 10.1007/s002620050443; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720; Kloverpris H, 2009, AIDS, V23, P1329, DOI 10.1097/QAD.0b013e32832d9b00; Livingston BD, 1999, J IMMUNOL, V162, P3088; Martinez X, 2003, VIROLOGY, V305, P428, DOI 10.1006/viro.2002.1775; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mauduit M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007717; Moyle PM, 2008, CURR MED CHEM, V15, P506, DOI 10.2174/092986708783503249; Moyle PM, 2007, J MED CHEM, V50, P4721, DOI 10.1021/jm070287b; Moyle PM, 2006, INT J PEPT RES THER, V12, P317, DOI 10.1007/s10989-006-9021-8; Olive C, 2003, INFECT IMMUN, V71, P2373, DOI 10.1128/IAI.71.5.2373-2383.2003; Olive C, 2006, J INFECT DIS, V193, P1666, DOI 10.1086/504266; Oukka M, 1996, J IMMUNOL, V157, P3039; Patarroyo ME, 2008, ACCOUNTS CHEM RES, V41, P377, DOI 10.1021/ar700120t; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; Phillipps KSM, 2009, IMMUNOLOGY, V128, pe582, DOI 10.1111/j.1365-2567.2008.03038.x; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; RENIA L, 1991, P NATL ACAD SCI USA, V88, P7963, DOI 10.1073/pnas.88.18.7963; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Ruckwardt TJ, 2010, J IMMUNOL, V185, P4673, DOI 10.4049/jimmunol.1001606; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; SCHILD H, 1991, EUR J IMMUNOL, V21, P2649, DOI 10.1002/eji.1830211102; SCHILD H, 1991, J EXP MED, V174, P1665, DOI 10.1084/jem.174.6.1665; Schofield L., 1988, Vaccines 88. New chemical and genetic approaches to vaccination: prevention of AIDS and other viral, bacterial and parasitic diseases., P71; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; SEDEGAH M, 1990, B WORLD HEALTH ORGAN, V68, P109; Sedegah M, 1998, P NATL ACAD SCI USA, V95, P7648, DOI 10.1073/pnas.95.13.7648; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P9866, DOI 10.1073/pnas.91.21.9866; SEDEGAH M, 1992, VACCINE, V10, P578, DOI 10.1016/0264-410X(92)90436-N; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Skwarczynski M, 2012, LIPO PEPTIDES SACCHA; Skwarczynski M, 2011, METHODS MOL BIOL, V751, P297, DOI 10.1007/978-1-61779-151-2_18; Skwarczynski M, 2010, ANGEW CHEM INT EDIT, V49, P5742, DOI 10.1002/anie.201002221; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Thomson SA, 1996, J IMMUNOL, V157, P822; TOTH I, 1993, TETRAHEDRON LETT, V34, P3925, DOI 10.1016/S0040-4039(00)79265-3; van den Hoorn T, 2011, CURR OPIN IMMUNOL, V23, P88, DOI 10.1016/j.coi.2010.11.002; vanderMost RG, 1996, J IMMUNOL, V157, P5543; WEISS WR, 1990, B WORLD HEALTH ORGAN, V68, P99; WEISS WR, 1992, J IMMUNOL, V149, P2103; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; White K, 2004, IMMUNOL CELL BIOL, V82, P517, DOI 10.1111/j.0818-9641.2004.01269.x; Witney AA, 2001, MOL BIOCHEM PARASIT, V118, P233, DOI 10.1016/S0166-6851(01)00372-3; Yewdell JW, 2010, CURR OPIN IMMUNOL, V22, P402, DOI 10.1016/j.coi.2010.04.002; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Zaman Mehfuz, 2010, Current Drug Delivery, V7, P118; Zaman M, 2010, VACCINE, V28, P2243, DOI 10.1016/j.vaccine.2009.12.046; Zhan YF, 2000, J IMMUNOL, V165, P3612, DOI 10.4049/jimmunol.165.7.3612; ZHONG GM, 1993, J IMMUNOL, V151, P3728; Zhong W, 2009, AUST J CHEM, V62, P956, DOI 10.1071/CH09149; Zhu XM, 2004, EUR J IMMUNOL, V34, P3102, DOI 10.1002/eji.200425166	92	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e40928	10.1371/journal.pone.0040928	http://dx.doi.org/10.1371/journal.pone.0040928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936972	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000308225500004
J	Iwasaki, M; Piao, JY; Kimura, A; Sato, S; Inose, H; Ochi, H; Asou, Y; Shinomiya, K; Okawa, A; Takeda, S				Iwasaki, Makiko; Piao, Jinying; Kimura, Ayako; Sato, Shingo; Inose, Hiroyuki; Ochi, Hiroki; Asou, Yoshinori; Shinomiya, Kenichi; Okawa, Atsushi; Takeda, Shu			Runx2 Haploinsufficiency Ameliorates the Development of Ossification of the Posterior Longitudinal Ligament	PLOS ONE			English	Article							SPINAL LIGAMENT; CHONDROCYTE DIFFERENTIATION; CBFA1; ASSOCIATION; CELLS; POLYMORPHISM; EXPRESSION; PROTEINS; GENE	Ossification of the Posterior Longitudinal Ligament (OPLL) is a disease that is characterized by the ectopic calcification of the ligament; however, the pathogenesis of OPLL remains to be investigated. We attempted to identify the in vivo role of Runx2, a master regulator of osteoblast differentiation and skeletal mineralization, in the pathogenesis of OPLL. The expression of Runx2 in the ligament was examined using in situ hybridization and immunohistochemistry and by monitoring the activity of a LacZ gene that was inserted into the Runx2 gene locus. To investigate the functional role of Runx2, we studied ENPP1(ttw/ttw) mice, a mouse model of OPLL, that were crossed with heterozygous Runx2 mice to decrease the expression of Runx2, and we performed histological and quantitative radiological analyses using 3D-micro CT. Runx2 was expressed in the ligament of wild-type mice. The induction of Runx2 expression preceded the development of ectopic calcification in the OPLL-like region of the ENPP1(ttw/ttw) mice. Runx2 haploinsufficiency ameliorated the development of ectopic calcification in the ENPP1(ttw/ttw) mice. Collectively, this study demonstrated that Runx2 is expressed in an OPLL-like region, and its elevation is a prerequisite for developing the complete OPLL-like phenotype in a mouse model of OPLL.	[Iwasaki, Makiko; Piao, Jinying; Sato, Shingo; Inose, Hiroyuki; Asou, Yoshinori; Shinomiya, Kenichi; Okawa, Atsushi] Tokyo Med & Dent Univ, Dept Orthoped Surg, Tokyo, Japan; [Kimura, Ayako; Ochi, Hiroki] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo, Japan; [Takeda, Shu] Keio Univ, Sch Med, Dept Internal Med, Sect Nephrol Endocrinol & Metab, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Keio University	Iwasaki, M (corresponding author), Tokyo Med & Dent Univ, Dept Orthoped Surg, Tokyo, Japan.	shu-tky@umin.ac.jp		INOSE, HIROYUKI/0000-0003-4195-2545	Funding Program for Next Generation World-Leading Researchers (NEXT Program); Japan Society for the Promotion of Science; Global Center of Excellence Program from Ministry of Education, Culture, Sports, Science	Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence Program from Ministry of Education, Culture, Sports, Science	The work was supported by Funding Program for Next Generation World-Leading Researchers (NEXT Program), grant-in-aid for scientific research from the Japan Society for the Promotion of Science and a grant for Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Horikoshi T, 2006, HUM GENET, V119, P611, DOI 10.1007/s00439-006-0170-9; Ikeda R, 2005, J BIOL CHEM, V280, P8523, DOI 10.1074/jbc.M409442200; Inamasu J, 2006, NEUROSURGERY, V58, P1027, DOI 10.1227/01.NEU.0000215867.87770.73; Iwasaki K, 2004, CALCIFIED TISSUE INT, V74, P448, DOI 10.1007/s00223-002-0021-1; Kamiya M, 2001, SPINE, V26, P1264, DOI 10.1097/00007632-200106010-00017; Kim DH, 2011, CYTOKINE, V55, P343, DOI 10.1016/j.cyto.2011.05.016; Kimura A, 2010, DEVELOPMENT, V137, P1159, DOI 10.1242/dev.045005; Kishiya M, 2008, J PHARMACOL SCI, V106, P404, DOI 10.1254/jphs.FP0072043; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Kong QQ, 2007, SPINE, V32, P2834, DOI 10.1097/BRS.0b013e31815b761c; Liu Y, 2010, CLIN ORTHOP RELAT R, V468, P3333, DOI 10.1007/s11999-010-1511-5; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ren Y, 2011, J ORTHOP RES; Sakou T, 2000, J Orthop Sci, V5, P310, DOI 10.1007/s007760050169; Sato S, 2008, ARTHRITIS RHEUM, V58, P2764, DOI 10.1002/art.23805; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Tanaka H, 2001, RHEUMATOLOGY, V40, P1163, DOI 10.1093/rheumatology/40.10.1163; Tanno M, 2003, BONE, V33, P475, DOI 10.1016/S8756-3282(03)00204-7; YASUI N, 1983, CALCIFIED TISSUE INT, V35, P159, DOI 10.1007/BF02405024; Yoshizawa T, 2004, MOL CELL BIOL, V24, P3460, DOI 10.1128/MCB.24.8.3460-3472.2004	22	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43372	10.1371/journal.pone.0043372	http://dx.doi.org/10.1371/journal.pone.0043372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927960	Green Submitted, Green Published, gold			2022-12-25	WOS:000307789700031
J	Li, CC; Wu, TS; Huang, CF; Jang, LT; Liu, YT; You, ST; Liou, GG; Lee, FJS				Li, Chun-Chun; Wu, Tsung-Sheng; Huang, Chun-Fang; Jang, Li-Ting; Liu, Yu-Tsan; You, Shu-Ting; Liou, Gunn-Guang; Lee, Fang-Jen S.			GTP-Binding-Defective ARL4D Alters Mitochondrial Morphology and Membrane Potential	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; SMALL G-PROTEINS; PLASMA-MEMBRANE; ARF FAMILY; CELL-DEATH; ENDOPLASMIC-RETICULUM; NUCLEOTIDE EXCHANGE; SAR PROTEINS; DOMAIN; TRANSPORT	ARL4D, ARL4A, and ARL4C are closely related members of the ADP-ribosylation factor/ARF-like protein (ARF/ARL) family of GTPases. All three ARL4 proteins contain nuclear localization signals (NLSs) at their C-termini and are primarily found at the plasma membrane, but they are also present in the nucleus and cytoplasm. ARF function and localization depends on their controlled binding and hydrolysis of GTP. Here we show that GTP-binding-defective ARL4D is targeted to the mitochondria, where it affects mitochondrial morphology and function. We found that a portion of endogenous ARL4D and the GTP-binding-defective ARL4D mutant ARL4D(T35N) reside in the mitochondria. The N-terminal myristoylation of ARL4D(T35N) was required for its localization to mitochondria. The localization of ARL4D(T35N) to the mitochondria reduced the mitochondrial membrane potential (Delta Psi m) and caused mitochondrial fragmentation. Furthermore, the C-terminal NLS region of ARL4D(T35N) was required for its effect on the mitochondria. This study is the first to demonstrate that the dysfunctional GTP-binding-defective ARL4D is targeted to mitochondria, where it subsequently alters mitochondrial morphology and membrane potential.	[Li, Chun-Chun; Wu, Tsung-Sheng; Huang, Chun-Fang; Jang, Li-Ting; Liu, Yu-Tsan; You, Shu-Ting; Lee, Fang-Jen S.] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan; [Jang, Li-Ting; Lee, Fang-Jen S.] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Liou, Gunn-Guang] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Li, CC (corresponding author), Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan.	fangjen@ntu.edu.tw	Liou, Gunn‐Guang/AAI-9787-2020; Liou, Gan-Guang/E-3976-2010	Li, Chun-Chun/0000-0002-3601-838X; LEE, FANG-JEN/0000-0002-2167-2426; Liou, Gan-Guang/0000-0002-2619-8516	National Science Council, Taiwan [NSC 97-3112-B-002-016, NSC-1002325-B-022-028]; National Taiwan University Hospital [99P21-1]; Yung-Shin Biomedical Research Fund [YSP-86-019]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); Yung-Shin Biomedical Research Fund	This work was supported by grants from the National Science Council, Taiwan (NSC 97-3112-B-002-016, NSC-1002325-B-022-028), National Taiwan University Hospital (99P21-1), and the Yung-Shin Biomedical Research Fund (YSP-86-019) to F.-J.S. Lee. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009944; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Briere JJ, 2004, BBA-BIOENERGETICS, V1659, P172, DOI 10.1016/j.bbabio.2004.07.002; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Derby MC, 2004, J CELL SCI, V117, P5865, DOI 10.1242/jcs.01497; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Grimm S, 2007, APOPTOSIS, V12, P841, DOI 10.1007/s10495-007-0747-3; Hall B, 2008, ANAL BIOCHEM, V374, P243, DOI 10.1016/j.ab.2007.11.032; Harroun TA, 2005, BBA-BIOMEMBRANES, V1668, P138, DOI 10.1016/j.bbamem.2004.12.003; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Jacobs S, 1999, FEBS LETT, V456, P384, DOI 10.1016/S0014-5793(99)00759-0; Jian X, 2010, MODIFICATIONS C TERM; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; KAHN RA, 1992, J BIOL CHEM, V267, P13039; Katayama T, 2004, CELL MOL NEUROBIOL, V24, P137, DOI 10.1023/B:CEMN.0000012719.12015.ec; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Lin CY, 2000, J BIOL CHEM, V275, P37815, DOI 10.1074/jbc.M002470200; Lin CY, 2002, J CELL SCI, V115, P4433, DOI 10.1242/jcs.00123; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; MOORE KJM, 1993, BIOCHEMISTRY-US, V32, P7451, DOI 10.1021/bi00080a016; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pacheco-Rodriguez G, 1998, J BIOL CHEM, V273, P26543, DOI 10.1074/jbc.273.41.26543; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Vitale N, 1998, J BIOL CHEM, V273, P2553, DOI 10.1074/jbc.273.5.2553; Webster P, 2008, METHOD CELL BIOL, V88, P45, DOI 10.1016/S0091-679X(08)00403-2; Zhang JY, 2003, J BIOL CHEM, V278, P7459, DOI 10.1074/jbc.M207976200; Zhou J, 2007, J BIOL CHEM, V282, P7482, DOI 10.1074/jbc.M608289200	41	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43552	10.1371/journal.pone.0043552	http://dx.doi.org/10.1371/journal.pone.0043552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927989	Green Submitted, Green Published, gold			2022-12-25	WOS:000307789700039
J	Sun, L; Yau, HY; Wong, WY; Li, RA; Huang, Y; Yao, XQ				Sun, Lei; Yau, Ho-Yan; Wong, Wei-Yan; Li, Ronald A.; Huang, Yu; Yao, Xiaoqiang			Role of TRPM2 in H2O2-Induced Cell Apoptosis in Endothelial Cells	PLOS ONE			English	Article							PEROXIDE-INDUCED TOXICITY; KAPPA-B ACTIVATION; HYDROGEN-PEROXIDE; ADP-RIBOSE; OXIDATIVE STRESS; CATION CHANNEL; ION-CHANNEL; INOSITOL 1,4,5-TRISPHOSPHATE; CALCIUM INFLUX; CA2+ INFLUX	Melastatin-like transient receptor potential channel 2 (TRPM2) is an oxidant-sensitive and cationic non-selective channel that is expressed in mammalian vascular endothelium. Here we investigated the functional role of TRPM2 channels in hydrogen peroxide (H2O2)-induced cytosolic Ca2+([Ca2+](i)) elavation, whole-cell current increase, and apoptotic cell death in murine heart microvessel endothelial cell line H5V. A TRPM2 blocking antibody (TM2E3), which targets the E3 region near the ion permeation pore of TRPM2, was developed. Treatment of H5V cells with TM2E3 reduced the [Ca2+](i) rise and whole-cell current change in response to H2O2. Suppressing TRPM2 expression using TRPM2-specific short hairpin RNA (shRNA) had similar inhibitory effect. H2O2-induced apoptotic cell death in H5V cells was examined using MTT assay, DNA ladder formation analysis, and DAPI-based nuclear DNA condensation assay. Based on these assays, TM2E3 and TRPM2-specific shRNA both showed protective effect against H2O2-induced apoptotic cell death. TM2E3 and TRPM2-specific shRNA also protect the cells from tumor necrosis factor (TNF)-alpha-induced cell death in MTT assay. In contrast, overexpression of TRPM2 in H5V cells resulted in an increased response in [Ca2+](i) and whole-cell currents to H2O2. TRPM2 overexpression also aggravated the H2O2-induced apoptotic cell death. Downstream pathways following TRPM2 activation was examined. Results showed that TRPM2 activity stimulated caspase-8, caspase-9 and caspase-3. These findings strongly suggest that TRPM2 channel mediates cellular Ca2+ overload in response to H2O2 and contribute to oxidant-induced apoptotic cell death in vascular endothelial cells. Down-regulating endogenous TRPM2 could be a means to protect the vascular endothelial cells from apoptotic cell death.	[Sun, Lei; Yau, Ho-Yan; Wong, Wei-Yan; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Sun, Lei; Yau, Ho-Yan; Wong, Wei-Yan; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Li, Ronald A.] Univ Hong Kong, Stem Cell & Regenerat Med Consortium, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong	Sun, L (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.	yao2068@cuhk.edu.hk	Huang, Yu/K-2866-2017; Yao, Xiaoqiang/I-5413-2016	Huang, Yu/0000-0002-1277-6784; Yao, Xiaoqiang/0000-0002-0687-8186	Hong Kong RGC [CUHK477408, CUHK479109, CUHK478710]; Chinese University of Hong Kong; National Science Foundation of China [31171100]	Hong Kong RGC(Hong Kong Research Grants Council); Chinese University of Hong Kong(Chinese University of Hong Kong); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants CUHK477408, CUHK479109, and CUHK478710 from Hong Kong RGC, Strategic Investment Scheme C and Group Research Grant from Chinese University of Hong Kong, and National Science Foundation of China grant 31171100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Brown RC, 2008, MICROCIRCULATION, V15, P359, DOI 10.1080/10739680701762656; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; DOAN TN, 1994, BIOCHEM J, V297, P209, DOI 10.1042/bj2970209; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Graham S, 2006, J BIOL CHEM, V285, P23466; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Hu QH, 2000, J BIOL CHEM, V275, P15749, DOI 10.1074/jbc.M000381200; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kouoh F, 1999, FARMACO, V54, P695, DOI 10.1016/S0014-827X(99)00082-8; Leung PC, 2006, J VASC RES, V43, P367, DOI 10.1159/000094096; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Marasa BS, 2006, BIOCHEM J, V397, P77, DOI 10.1042/BJ20060124; Naziroglu M, 2008, NEUROCHEM RES, V33, P1256, DOI 10.1007/s11064-007-9577-5; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Poteser M, 2006, J BIOL CHEM, V281, P13588, DOI 10.1074/jbc.M512205200; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schwerdt G, 2005, TOXICOL SCI, V85, P735, DOI 10.1093/toxsci/kfi117; Smith MA, 2003, J PHYSIOL-LONDON, V547, P417, DOI 10.1113/jphysiol.2002.034561; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Telo P, 1998, J BIOL CHEM, V273, P17565, DOI 10.1074/jbc.273.28.17565; Urayama K, 2007, FASEB J, V21, P2980, DOI 10.1096/fj.07-8116com; Waxman AB, 2003, AM J RESP CELL MOL, V29, P513, DOI 10.1165/rcmb.2002-0044OC; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200; Zhang WY, 2006, AM J PHYSIOL-CELL PH, V290, pC1146, DOI 10.1152/ajpcell.00205.2005; Zheng Y, 2005, REDOX REP, V10, P29, DOI 10.1179/135100005X21660	42	52	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43186	10.1371/journal.pone.0043186	http://dx.doi.org/10.1371/journal.pone.0043186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916222	gold, Green Submitted, Green Published			2022-12-25	WOS:000307733800052
J	Hamasaki, T; Suzuki, H; Shirohzu, H; Matsumoto, T; D'Alessandro-Gabazza, CN; Gil-Bernabe, P; Boveda-Ruiz, D; Naito, M; Kobayashi, T; Toda, M; Mizutani, T; Taguchi, O; Morser, J; Eguchi, Y; Kuroda, M; Ochiya, T; Hayashi, H; Gabazza, EC; Ohgi, T				Hamasaki, Tomohiro; Suzuki, Hiroshi; Shirohzu, Hisao; Matsumoto, Takahiro; D'Alessandro-Gabazza, Corina N.; Gil-Bernabe, Paloma; Boveda-Ruiz, Daniel; Naito, Masahiro; Kobayashi, Tetsu; Toda, Masaaki; Mizutani, Takayuki; Taguchi, Osamu; Morser, John; Eguchi, Yutaka; Kuroda, Masahiko; Ochiya, Takahiro; Hayashi, Hirotake; Gabazza, Esteban C.; Ohgi, Tadaaki			Efficacy of a Novel Class of RNA Interference Therapeutic Agents	PLOS ONE			English	Article							ACUTE LUNG INJURY; PULMONARY-FIBROSIS; DISEASE; SIRNA; BETA	RNA interference (RNAi) is being widely used in functional gene research and is an important tool for drug discovery. However, canonical double-stranded short interfering RNAs are unstable and induce undesirable adverse effects, and thus there is no currently RNAi-based therapy in the clinic. We have developed a novel class of RNAi agents, and evaluated their effectiveness in vitro and in mouse models of acute lung injury (ALI) and pulmonary fibrosis. The novel class of RNAi agents (nkRNA (R), PnkRNA (TM)) were synthesized on solid phase as single-stranded RNAs that, following synthesis, self-anneal into a unique helical structure containing a central stem and two loops. They are resistant to degradation and suppress their target genes. nkRNA and PnkRNA directed against TGF-beta 1mRNA ameliorate outcomes and induce no off-target effects in three animal models of lung disease. The results of this study support the pathological relevance of TGF-beta 1 in lung diseases, and suggest the potential usefulness of these novel RNAi agents for therapeutic application.	[Hamasaki, Tomohiro; Suzuki, Hiroshi; Shirohzu, Hisao; Matsumoto, Takahiro; Mizutani, Takayuki; Hayashi, Hirotake; Gabazza, Esteban C.; Ohgi, Tadaaki] BONAC Corp, BIO Factory 4F, Kurume, Fukuoka, Japan; [Matsumoto, Takahiro; D'Alessandro-Gabazza, Corina N.; Gil-Bernabe, Paloma; Boveda-Ruiz, Daniel; Toda, Masaaki; Gabazza, Esteban C.] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie, Japan; [D'Alessandro-Gabazza, Corina N.; Naito, Masahiro; Kobayashi, Tetsu; Taguchi, Osamu] Mie Univ, Grad Sch Med, Dept Pulm & Crit Care Med, Tsu, Mie, Japan; [Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Tokyo 104, Japan; [Mizutani, Takayuki; Kuroda, Masahiko] Tokyo Med Univ, Dept Mol Pathol, Tokyo, Japan; [Eguchi, Yutaka] Osaka Univ, Grad Sch Med, Mol Genet Lab, Dept Med Genet, Osaka, Japan; [Morser, John] Stanford Univ, Div Hematol, Sch Med, Stanford, CA 94305 USA	Mie University; Mie University; National Cancer Center - Japan; Tokyo Medical University; Osaka University; Stanford University	Hamasaki, T (corresponding author), BONAC Corp, BIO Factory 4F, Kurume, Fukuoka, Japan.	gabazza@doc.medic.mie-u.ac.jp; ohgi@bonac.co.jp	Ochiya, Takahiro/AAH-7585-2019	Gabazza, Esteban/0000-0001-5748-1499	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Center of Excellence Grant from Mie University; Grants-in-Aid for Scientific Research [23659626] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center of Excellence Grant from Mie University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Center of Excellence Grant from Mie University. No additional external funding received for this study. The funders were not involved in study design, data analysis, decision to publish, or preparation of the manuscript.	Abe Hiroshi, 2009, Nucleic Acids Symp Ser (Oxf), P65, DOI 10.1093/nass/nrp033; Abe N, 2007, J AM CHEM SOC, V129, P15108, DOI 10.1021/ja0754453; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Chernolovskaya EL, CURR OPIN MOL THER, V12, P158; D'Alessandro-Gabazza CN, 2012, AM J RESP CELL MOL, V46, P397, DOI 10.1165/rcmb.2011-0158OC; De Fougerolles AR, 2008, HUM GENE THER, V19, P125, DOI 10.1089/hum.2008.928; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kedmi R, 2009, NANOMEDICINE-UK, V4, P853, DOI 10.2217/NNM.09.74; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Lares MR, TRENDS BIOTECHNOL, V28, P570; Lu Q, 2006, J APPL PHYSIOL, V101, P375, DOI 10.1152/japplphysiol.01515.2005; Madtes DK, 1998, AM J RESP CRIT CARE, V158, P424, DOI 10.1164/ajrccm.158.2.9711112; Matthay MA, ANN REV PATHOL, V6, P147; Pecot CV, NAT REV CANC, V11, P59; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Sledz CA, 2005, BLOOD, V106, P787, DOI 10.1182/blood-2004-12-4643; Takagi T, 2009, J THROMB HAEMOST, V7, P2053, DOI 10.1111/j.1538-7836.2009.03642.x; Watts JK, J PATHOL, V226, P365; Willis BC, 2003, AM J PHYSIOL-LUNG C, V285, pL1192, DOI 10.1152/ajplung.00379.2002; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	25	29	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42655	10.1371/journal.pone.0042655	http://dx.doi.org/10.1371/journal.pone.0042655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916145	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600021
J	Frisan, T; Coppotelli, G; Dryselius, R; Masucci, MG				Frisan, Teresa; Coppotelli, Giuseppe; Dryselius, Rikard; Masucci, Maria G.			Ubiquitin C-terminal hydrolase-L1 interacts with adhesion complexes and promotes cell migration, survival, and anchorage independent growth	FASEB JOURNAL			English	Article						adherens junction; anoikis; DUB; UCH-L1	GENE-PRODUCT 9.5; PROTEIN; UCH-L1; L1; PGP9.5; DEGRADATION; EXPRESSION; DYNAMICS; CLEAVAGE; INVASION	Ubiquitin C-terminal hydrolase-L1 (UCH-L1) is a deubiquitinating enzyme of unknown function that is highly expressed in neurons and overexpressed in several human cancers. UCH-L1 has been implicated in the regulation of phenotypic properties associated with malignant cell growth but the underlying mechanisms have not been elucidated. By comparing cells expressing catalytically active or inactive versions of UCH-L1, we found that the active enzyme enhances cell adhesion, spreading, and migration; inhibits anoikis; and promotes anchorage independent growth. UCH-L1 accumulates at the motile edge of the cell membrane during the initial phases of adhesion, colocalizes with focal adhesion kinase (FAK), p120-catenin, and vinculin, and enhances the formation of focal adhesions, which correlates with enhanced FAK activation. The involvement of UCH-L1 in the regulation of focal adhesions and adherens junctions is supported by coimmunoprecipitation with key components of these complexes, including FAK, paxillin, p120-catenin, beta-catenin, and vinculin. UCH-L1 stabilizes focal adhesion signaling in the absence of adhesion, as assessed by reduced caspase-dependent cleavage of FAK following cell detachment and sustained activity of the AKT signaling pathway. These findings offer new insights on the molecular interactions through which the deubiquitinating enzyme regulates the survival, proliferation, and metastatic potential of malignant cells.-Frisan, T., Coppotelli, G., Dryselius, R., Masucci, M. G. Ubiquitin C-terminal hydrolase-L1 interacts with adhesion complexes and promotes cell migration, survival, and anchorage independent growth. FASEB J. 26, 5060-5070 (2012). www.fasebj.org	[Frisan, Teresa; Coppotelli, Giuseppe; Dryselius, Rikard; Masucci, Maria G.] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Frisan, T (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Box 285, S-17177 Stockholm, Sweden.	teresa.frisan@ki.se; maria.masucci@ki.se	Frisan, Teresa/H-8444-2019; Masucci, Maria/AAC-6666-2019	Frisan, Teresa/0000-0002-1209-0942; Masucci, Maria/0000-0002-5541-2809	Swedish Research Council; Swedish Cancer Society; Karolinska Institute; European Community [LSHC-CT-2005-018704]; AkeWiberg Foundation; Magnus Bergvall Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute(Karolinska Institutet); European Community(European Commission); AkeWiberg Foundation; Magnus Bergvall Foundation	This work was supported by grants awarded by the Swedish Research Council, the Swedish Cancer Society, and the Karolinska Institute to M. G. M. and T. F.; the European Community Integrated Project on Infection and Cancer (INCA), Project LSHC-CT-2005-018704 to M. G. M.; and the AkeWiberg and Magnus Bergvall Foundations to T.F. T.F. is a fellow of the Swedish Cancer Society.	Aumuller G, 1999, PROSTATE, V38, P261; Basseres E, 2010, CELL MICROBIOL, V12, P1622, DOI 10.1111/j.1462-5822.2010.01495.x; Bheda A, 2010, CELL CYCLE, V9, P980, DOI 10.4161/cc.9.5.10934; Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006764; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Buus R, 2009, CURR BIOL, V19, P1463, DOI 10.1016/j.cub.2009.07.040; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen FJ, 2010, P NATL ACAD SCI USA, V107, P1636, DOI 10.1073/pnas.0911516107; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Ciechanover A, 2004, BBA-MOL CELL RES, V1695, P3, DOI 10.1016/j.bbamcr.2004.09.018; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; D'Andrea V, 1997, G Chir, V18, P521; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; Didier C, 2003, MOL CELL BIOL, V23, P5331, DOI 10.1128/MCB.23.15.5331-5345.2003; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Huang C, 2010, CELL ADHES MIGR, V4, P10, DOI 10.4161/cam.4.1.9834; Hussain S, 2010, LEUKEMIA, V24, P1641, DOI 10.1038/leu.2010.138; Jang MJ, 2011, CANCER LETT, V302, P128, DOI 10.1016/j.canlet.2011.01.006; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim HJ, 2009, ONCOGENE, V28, P117, DOI 10.1038/onc.2008.364; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Liu ZH, 2009, P NATL ACAD SCI USA, V106, P4635, DOI 10.1073/pnas.0806474106; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Naze P, 2002, NEUROSCI LETT, V328, P1, DOI 10.1016/S0304-3940(02)00231-8; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Rolen U, 2009, J CELL MOL MED, V13, P1666, DOI 10.1111/j.1582-4934.2008.00501.x; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Sasaki H, 2001, JPN J CLIN ONCOL, V31, P532, DOI 10.1093/jjco/hye113; SCHUMACHER U, 1994, DNA CELL BIOL, V13, P839, DOI 10.1089/dna.1994.13.839; Sekine Y, 2007, J IMMUNOL, V179, P2397, DOI 10.4049/jimmunol.179.4.2397; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Tezel E, 2000, CLIN CANCER RES, V6, P4764; van de Water B, 1999, J BIOL CHEM, V274, P13328, DOI 10.1074/jbc.274.19.13328; Vasudevan KM, 2011, CURR TOP MICROBIOL, V347, P105, DOI 10.1007/82_2010_66; Yamazaki T, 2002, CLIN CANCER RES, V8, P192; Yanagisawa TY, 1998, TOHOKU J EXP MED, V184, P229; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	45	20	23	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					5060	5070		10.1096/fj.12-211946	http://dx.doi.org/10.1096/fj.12-211946			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22932395				2022-12-25	WOS:000311838300027
J	Jackson, MI; Cao, J; Zeng, HW; Uthus, E; Combs, GF				Jackson, Matthew I.; Cao, Jay; Zeng, Huawei; Uthus, Eric; Combs, Gerald F., Jr.			S-Adenosylmethionine-dependent Protein Methylation Is Required for Expression of Selenoprotein P and Gluconeogenic Enzymes in HepG2 Human Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE METHYLATION; COACTIVATOR PGC-1-ALPHA; INSULIN-RESISTANCE; METABOLIC SYNDROME; METHIONINE; LIVER; INHIBITION; SUPPLEMENTATION; POLYMORPHISMS; ASSOCIATION	Cellular methylation processes enable expression of gluconeogenic enzymes and metabolism of the nutrient selenium. Selenium status has been proposed to relate to type II diabetes risk, and plasma levels of selenoprotein P (SEPP1) have been positively correlated with insulin resistance. Increased expression of gluconeogenic enzymes glucose-6-phosphatase (G6PC) and phosphoenolpyruvate carboxykinase 1 (PCK1) has negative consequences for blood glucose management in type II diabetics. Transcriptional regulation of SEPP1 is directed by the same transcription factors that control the expression of G6PC and PCK1, and these factors are activated by methylation of arginine residues. We sought to determine whether expression of SEPP1 and the aforementioned glucoconeogenic enzymes are regulated by protein methylation, the levels of which are reliant upon adequate S-adenosylmethionine (SAM) and inhibited by S-adenosylhomocysteine (SAH). We treated a human hepatocyte cell line, HepG2, with inhibitors of adenosylhomocysteine hydrolase (AHCY) known to increase concentration of SAH before analysis of G6PC, PCK1, and SEPP1 expression. Increasing SAH decreased 1) the SAM/SAH ratio, 2) protein-arginine methylation, and 3) expression of SEPP1, G6PC, and PCK1 transcripts. Furthermore, hormone-dependent induction of gluconeogenic enzymes was reduced by inhibition of protein methylation. When protein-arginine methyltransferase 1 expression was reduced by siRNA treatment, G6PC expression was inhibited. These findings demonstrate that hepatocellular SAM-dependent protein methylation is required for both SEPP1 and gluconeogenic enzyme expression and that inhibition of protein arginine methylation might provide a route to therapeutic interventions in type II diabetes.	[Jackson, Matthew I.; Cao, Jay; Zeng, Huawei; Uthus, Eric; Combs, Gerald F., Jr.] ARS, Grand Forks Human Nutr Res Ctr, USDA, Grand Forks, ND 58203 USA	United States Department of Agriculture (USDA)	Jackson, MI (corresponding author), ARS, Grand Forks Human Nutr Res Ctr, USDA, 2420 2nd Ave S, Grand Forks, ND 58203 USA.	matthew.jackson@ars.usda.gov		Jackson, Matthew/0000-0001-7535-1831				Andrade-Cetto A, 2010, J ETHNOPHARMACOL, V130, P93, DOI 10.1016/j.jep.2010.04.016; Arora P, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-95; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Barres R, 2011, AM J CLIN NUTR, V93, p897S, DOI 10.3945/ajcn.110.001933; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Chen AR, 2010, CLIN INVEST MED, V33, pE290, DOI 10.25011/cim.v33i5.14354; Choi D., 2012, HEPATOLOGY IN PRESS; Combs GF, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-75; COWARD JK, 1977, J MED CHEM, V20, P500, DOI 10.1021/jm00214a008; Frelut ML, 2011, INT J PEDIATR OBES, V6, pE312, DOI 10.3109/17477166.2010.486835; INGROSSO D, 1991, ADV EXP MED BIOL, V307, P263; Iwasaki H, 2008, BIOCHEM BIOPH RES CO, V372, P314, DOI 10.1016/j.bbrc.2008.05.051; Iwasaki H, 2007, BIOCHEM BIOPH RES CO, V364, P1015, DOI 10.1016/j.bbrc.2007.10.113; Iwasaki H, 2009, LIFE SCI, V85, P161, DOI 10.1016/j.lfs.2009.05.007; Kalhan SC, 2011, CLIN SCI, V121, P179, DOI 10.1042/CS20110060; Krones-Herzig A, 2006, J BIOL CHEM, V281, P3025, DOI 10.1074/jbc.M509770200; Laclaustra M, 2009, ENVIRON HEALTH PERSP, V117, P1409, DOI 10.1289/ehp.0900704; Lee JH, 2011, DIABETES RES CLIN PR, V94, P111, DOI 10.1016/j.diabres.2011.07.005; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Ohta Y, 2008, TOXICOL APPL PHARM, V226, P169, DOI 10.1016/j.taap.2007.09.011; Rock C, 2009, BIOMETALS, V22, P995, DOI 10.1007/s10534-009-9251-2; Sack JS, 2011, BIOCHEM J, V436, P331, DOI 10.1042/BJ20102161; Song ZY, 2005, BBA-MOL CELL RES, V1743, P205, DOI 10.1016/j.bbamcr.2004.12.001; Speckmann B, 2008, HEPATOLOGY, V48, P1998, DOI 10.1002/hep.22526; Steinbrenner H, 2011, J CLIN BIOCHEM NUTR, V48, P40, DOI 10.3164/jcbn.11-002FR; Stoytcheva ZR, 2009, BBA-GEN SUBJECTS, V1790, P1429, DOI 10.1016/j.bbagen.2009.05.012; Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175; Tanaka H, 2010, EUR J PHARMACOL, V645, P185, DOI 10.1016/j.ejphar.2010.07.018; TANDON SK, 1986, BIOCHEM PHARMACOL, V35, P2763, DOI 10.1016/0006-2952(86)90187-5; Tchantchou F, 2008, J ALZHEIMERS DIS, V14, P323; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; van Driel LMJW, 2009, J NUTR, V139, P2315, DOI 10.3945/jn.109.109710; Vasilopoulos Y, 2011, GENET TEST MOL BIOMA, V15, P613, DOI 10.1089/gtmb.2010.0256; WAGNER J, 1984, ANAL BIOCHEM, V140, P108, DOI 10.1016/0003-2697(84)90140-4; Wang X, 2011, MINI-REV MED CHEM, V11, P1082, DOI 10.2174/138955711797247761; Williams KT, 2012, DIABETES-METAB RES, V28, P123, DOI 10.1002/dmrr.1281; Wortham M, 2008, DIGEST DIS SCI, V53, P2761, DOI 10.1007/s10620-007-0193-7; Xia YM, 2010, AM J CLIN NUTR, V92, P525, DOI 10.3945/ajcn.2010.29642; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yamagishi S, 2008, CURR PHARM DESIGN, V14, P2613, DOI 10.2174/138161208786071326; Yasui K, 2011, J MED FOOD, V14, P930, DOI 10.1089/jmf.2010.1396; Yun K. U., 2012, EUR J NUTR IN PRESS	45	19	21	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36455	36464		10.1074/jbc.M112.412932	http://dx.doi.org/10.1074/jbc.M112.412932			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22932905	hybrid, Green Published			2022-12-25	WOS:000310364000065
J	Wang, XF; Wang, SZ; Lu, YB; Gibson, MP; Liu, Y; Yuan, BZ; Feng, JQ; Qin, CL				Wang, Xiaofang; Wang, Suzhen; Lu, Yongbo; Gibson, Monica P.; Liu, Ying; Yuan, Baozhi; Feng, Jian Q.; Qin, Chunlin			FAM20C Plays an Essential Role in the Formation of Murine Teeth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTIN MATRIX PROTEIN-1; AMELOGENESIS IMPERFECTA; MICE DISPLAY; ENAMEL DEFECTS; SIALOPHOSPHOPROTEIN; MINERALIZATION; EXPRESSION; LEADS; DENTINOGENESIS; MATURATION	FAM20Cis highly expressed in bone and tooth. Previously, we showed that Fam20C conditional knock-out (KO) mice manifest hypophosphatemic rickets, which highlights the crucial roles of this molecule in promoting bone formation and mediating phosphate homeostasis. In this study, we characterized the dentin, enamel, and cementum of Sox2-Cre-mediated Fam20C KO mice. The KO mice exhibited small malformed teeth, severe enamel defects, very thin dentin, less cementum than normal, and overall hypomineralization in the dental mineralized tissues. In situ hybridization and immunohistochemistry analyses revealed remarkable down-regulation of dentin matrix protein 1 (DMP1) and dentin sialophosphoprotein in odontoblasts, along with a sharply reduced expression of ameloblastin and amelotin in ameloblasts. Collectively, these data indicate that FAM20Cis essential to the differentiation and mineralization of dental tissues through the regulation of molecules critical to the differentiation of tooth-formative cells.	[Wang, Xiaofang; Wang, Suzhen; Lu, Yongbo; Gibson, Monica P.; Liu, Ying; Feng, Jian Q.; Qin, Chunlin] Texas A&M Hlth Sci Ctr Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA; [Yuan, Baozhi] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Yuan, Baozhi] William S Middleton Mem Vet Adm Med Ctr, Dept Vet Affairs, Ctr Geriatr Res Educ & Clin, Madison, WI 53705 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Qin, CL (corresponding author), Texas A&M Hlth Sci Ctr Baylor Coll Dent, Dept Biomed Sci, 3302 Gaston Ave, Dallas, TX 75246 USA.	cqin@bcd.tamhsc.edu		Wang, Xiaofang/0000-0002-7370-7192; Lu, Yongbo/0000-0003-3692-1736	National Institutes of Health [DE005092]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027032, R56AR027032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE005092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE005092 (to C. Q.).	An Chunying, 2010, Kobe J Med Sci, V55, pE82; Caterina JJ, 2002, J BIOL CHEM, V277, P49598, DOI 10.1074/jbc.M209100200; Chen L, 2011, CLIN EXP PHARMACOL P, V38, P395, DOI 10.1111/j.1440-1681.2011.05526.x; Du Y, 2002, EXP HEMATOL, V30, P649, DOI 10.1016/S0301-472X(02)00817-2; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hao JJ, 2007, J BIOL CHEM, V282, P15357, DOI 10.1074/jbc.M701547200; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Huang BZ, 2008, EUR J ORAL SCI, V116, P104, DOI 10.1111/j.1600-0722.2008.00522.x; Huang XF, 2010, J BONE MINER RES, V25, P1167, DOI 10.1359/jbmr.091103; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Liu F, 2010, J DENT RES, V89, P909, DOI 10.1177/0022034510370090; Moffatt P, 2006, BIOCHEM J, V399, P37, DOI 10.1042/BJ20060662; Moses KD, 2006, EUR J ORAL SCI, V114, P216, DOI 10.1111/j.1600-0722.2006.00353.x; Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; O'Sullivan J, 2011, AM J HUM GENET, V88, P616, DOI 10.1016/j.ajhg.2011.04.005; Prasad M, 2010, CONNECT TISSUE RES, V51, P404, DOI 10.3109/03008200903329789; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; Simpson MA, 2007, AM J HUM GENET, V81, P906, DOI 10.1086/522240; Sire JY, 2007, CELLS TISSUES ORGANS, V186, P25, DOI 10.1159/000102679; Smith CE, 2011, EUR J ORAL SCI, V119, P125, DOI 10.1111/j.1600-0722.2011.00871.x; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Sun Y, 2010, J BIOL CHEM, V285, P31713, DOI 10.1074/jbc.M110.137059; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; WANG XF, 2010, HEALTH TECHNOL ASSES, V14, P957, DOI DOI 10.1369/JHC.2010.9565651; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Yokohama-Tamaki T, 2006, DEVELOPMENT, V133, P1359, DOI 10.1242/dev.02307; Zeichner-David M, 2003, DEV DYNAM, V228, P651, DOI 10.1002/dvdy.10404	37	49	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35934	35942		10.1074/jbc.M112.386862	http://dx.doi.org/10.1074/jbc.M112.386862			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936805	Green Published, hybrid			2022-12-25	WOS:000310364000015
J	Gong, K; Chen, C; Zhan, Y; Chen, Y; Huang, ZB; Li, WH				Gong, Ke; Chen, Chao; Zhan, Yao; Chen, Yan; Huang, Zebo; Li, Wenhua			Autophagy-related Gene 7 (ATG7) and Reactive Oxygen Species/Extracellular Signal-regulated Kinase Regulate Tetrandrine-induced Autophagy in Human Hepatocellular Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; CYTOCHROME-C; APOPTOSIS; DEATH; ACTIVATION; PATHWAY; MITOCHONDRIA; THERAPY; GROWTH; PERMEABILIZATION	Tetrandrine, a bisbenzylisoquinoline alkaloid isolated from the broadly used Chinese medicinal herb Stephaniae tetrandrae, exhibits potent antitumor effects and has the potential to be used as a cancer chemotherapeutic agent. We previously reported that high concentrations of tetrandrine induce apoptosis in liver cancer cells. Here, we found that in human hepatocellular carcinoma (HCC) cells, a low dose of tetrandrine (5 mu M) induced the expression of LC3-II, resulted in the formation of acidic autophagolysosome vacuoles (AVOs), and caused a punctate fluorescence pattern with the GFP-LC3 protein, which all are markers for cellular autophagy. Tetrandrine induced the production of intracellular reactive oxygen species (ROS), and treatment with ROS scavengers significantly abrogated the tetrandrine-induced autophagy. These results suggest that the generation of ROS plays an important role in promoting tetrandrine-induced autophagy. Tetrandrine-induced mitochondrial dysfunction resulted in ROS accumulation and autophagy. ROS generation activated the ERK MAP kinase, and the ERK signaling pathway at least partially contributed to tetrandrine-induced autophagy in HCC cells. Moreover, we found that tetrandrine transcriptionally regulated the expression of autophagy related gene 7 (ATG7), which promoted tetrandrine-induced autophagy. In addition to in vitro studies, similar results were also observed in vivo, where tetrandrine caused the accumulation of ROS and induced cell autophagy in a tumor xenograft model. Interestingly, tetrandrine treatment also induced autophagy in a ROS-dependent manner in C. elegans muscle cells. Therefore, these findings suggest that tetrandrine is a potent autophagy agonist and may be a promising clinical chemotherapeutic agent.	[Gong, Ke; Chen, Chao; Zhan, Yao; Li, Wenhua] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Chen, Yan; Huang, Zebo] Wuhan Univ, Coll Pharm, Wuhan 430071, Peoples R China	Wuhan University; Wuhan University	Li, WH (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	whli@whu.edu.cn	Huang, Zebo/AAF-2382-2019	Huang, Zebo/0000-0003-2431-3741	National Basic Research Program of China [2010CB529800]; National Nature Science Foundation of China [81273540]; Chinese 111 project [B06018]; major scientific and technological special project for "Significant Creation of New Drugs" [2011ZX09102-001-32, 2011ZX09401-302-4]	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 project(Ministry of Education, China - 111 Project); major scientific and technological special project for "Significant Creation of New Drugs"	This work was supported by National Basic Research Program of China Grant 2010CB529800, National Nature Science Foundation of China Grant 81273540, The Chinese 111 project (B06018), and the major scientific and technological special project for "Significant Creation of New Drugs" Grants 2011ZX09102-001-32 and 2011ZX09401-302-4.	Allan LA, 2009, FEBS J, V276, P6063, DOI 10.1111/j.1742-4658.2009.07330.x; Amelio I, 2011, BIOCHEM BIOPH RES CO, V414, P277, DOI 10.1016/j.bbrc.2011.09.080; Balague C, 2000, BLOOD, V95, P820, DOI 10.1182/blood.V95.3.820.003k32_820_828; Balmanno K, 2009, INT J CANCER, V125, P2332, DOI 10.1002/ijc.24604; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Burscha W, 2008, TOXICOLOGY, V254, P147, DOI 10.1016/j.tox.2008.07.048; Caroppi P, 2009, CURR MED CHEM, V16, P4058, DOI 10.2174/092986709789378206; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Chen Y, 2009, INT J CANCER, V124, P2260, DOI 10.1002/ijc.24208; Cheng TH, 2001, J MOL CELL CARDIOL, V33, P1805, DOI 10.1006/jmcc.2001.1444; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; Gailhouste L, 2010, INT J CANCER, V126, P1367, DOI 10.1002/ijc.24950; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gong K, 2011, FREE RADICAL BIO MED, V51, P2259, DOI 10.1016/j.freeradbiomed.2011.09.018; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Grimm S, 2007, APOPTOSIS, V12, P841, DOI 10.1007/s10495-007-0747-3; Gutierrez-Uzquiza A, 2012, J BIOL CHEM, V287, P2632, DOI 10.1074/jbc.M111.323709; Ibanez A, 2009, BIOCHEM J, V422, P161, DOI 10.1042/BJ20082118; Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8; Jang BC, 2004, BIOCHEM PHARMACOL, V67, P1819, DOI 10.1016/j.bcp.2004.01.018; Jiang M, 2010, AUTOPHAGY, V6, P175, DOI 10.4161/auto.6.1.10700; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kuo CC, 2011, FREE RADICAL BIO MED, V51, P2195, DOI 10.1016/j.freeradbiomed.2011.09.023; Lee JH, 2002, INT J ONCOL, V21, P1239; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Lin ML, 2010, CANCER LETT, V291, P46, DOI 10.1016/j.canlet.2009.09.016; Lin ST, 2008, MOL CELL BIOCHEM, V315, P41, DOI 10.1007/s11010-008-9787-4; Liu CY, 2011, INT J CANCER, V129, P1519, DOI 10.1002/ijc.25817; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Pang LH, 1997, BIOCHEM PHARMACOL, V53, P773, DOI 10.1016/S0006-2952(96)00817-9; Park KR, 2011, CANCER LETT, V312, P178, DOI 10.1016/j.canlet.2011.08.001; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Quinsay MN, 2010, J MOL CELL CARDIOL, V48, P1146, DOI 10.1016/j.yjmcc.2009.12.004; Rosato RR, 2003, CANCER BIOL THER, V2, P30; Rygiel TP, 2008, J CELL SCI, V121, P1183, DOI 10.1242/jcs.017194; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shen YC, 2001, MOL PHARMACOL, V60, P1083, DOI 10.1124/mol.60.5.1083; Stipanuk MH, 2009, NUTR REV, V67, P677, DOI 10.1111/j.1753-4887.2009.00252.x; Sung BK, 2010, J BIOL CHEM, V285, P35418, DOI 10.1074/jbc.M110.172767; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Wu JM, 2010, CANCER LETT, V287, P187, DOI 10.1016/j.canlet.2009.06.009; Xie CM, 2011, FREE RADICAL BIO MED, V51, P1365, DOI 10.1016/j.freeradbiomed.2011.06.016; Yue ZY, 2008, AUTOPHAGY, V4, P94, DOI 10.4161/auto.5202; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang M, 2011, FREE RADICAL BIO MED, V50, P1252, DOI 10.1016/j.freeradbiomed.2011.02.031	57	100	110	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35576	35588		10.1074/jbc.M112.370585	http://dx.doi.org/10.1074/jbc.M112.370585			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927446	Green Published, hybrid			2022-12-25	WOS:000309968000070
J	Rossi, F; Bellini, G; Alisi, A; Alterio, A; Maione, S; Perrone, L; Locatelli, F; del Giudice, EM; Nobili, V				Rossi, Francesca; Bellini, Giulia; Alisi, Anna; Alterio, Arianna; Maione, Sabatino; Perrone, Laura; Locatelli, Franco; del Giudice, Emanuele Miraglia; Nobili, Valerio			Cannabinoid Receptor Type 2 Functional Variant Influences Liver Damage in Children with Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							CB2 HEPATOPROTECTIVE PROPERTIES; GLN63ARG POLYMORPHISM; INSULIN-RESISTANCE; OBESE CHILDREN; STEATOHEPATITIS; INFLAMMATION; ASSOCIATION; HIGHLIGHT; INDEXES; CELLS	Non-alcoholic fatty liver disease (NAFLD) comprises a spectrum of disease ranging from simple steatosis to inflammatory steatohepatitis (NASH) with different degrees of fibrosis that can ultimately progress to cirrhosis. Accumulating evidence suggests the involvement of the endocannabinoid-system in liver disease and related complications. In particular, hepatoprotective properties for Cannabinoid Receptor type 2 (CB2) have been shown both through experimental murine models of liver injury and association study between a CB2 functional variant, Q63R, and liver enzymes in Italian obese children with steatosis. Here, in order to clarify the role of CB2 in severity of childhood NAFLD, we have investigated the association of the CB2 Q63R variant, with histological parameters of liver disease severity in 118 Italian children with histologically-proven NAFLD. CB2 Q63R genotype was assigned performing a TaqMan assay and a general linear model analysis was used to evaluate the association between the polymorphism and the histological parameters of liver damage. We have found that whereas CB2 Q63R variant is not associated with steatosis or fibrosis, it is associated with the severity of the inflammation (p = 0.002) and the presence of NASH (p = 0.02). Our findings suggest a critical role for CB2 Q63R variant in modulating hepatic inflammation state in obese children and in the consequent increased predisposition of these patients to liver damage.	[Rossi, Francesca; Perrone, Laura; del Giudice, Emanuele Miraglia] Univ Naples 2, Dept Pediat, Naples, Italy; [Bellini, Giulia; Maione, Sabatino] Univ Naples 2, Dept Expt Med, Naples, Italy; [Rossi, Francesca; Locatelli, Franco] Bambino Gesu Childrens Hosp & Res Inst, Dept Haematol Oncol, Rome, Italy; [Alisi, Anna; Alterio, Arianna; Nobili, Valerio] Bambino Gesu Childrens Hosp & Res Inst, Liver Unit, Rome, Italy; [Locatelli, Franco] Univ Pavia, I-27100 Pavia, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Pavia	Rossi, F (corresponding author), Univ Naples 2, Dept Pediat, Naples, Italy.	fra.rossi76@libero.it	Nobili, Valerio/K-8670-2018; Alisi, Anna/A-6469-2010; del Giudice, Emanuele Muraglia/AAC-2824-2019	Alisi, Anna/0000-0001-7241-6329; Maione, Sabatino/0000-0003-3850-6704; Perrone, Laura/0000-0002-8647-3938; Alterio, Arianna/0000-0002-8561-1868; Rossi, Francesca/0000-0003-2879-6277; nobili, valerio/0000-0002-4570-3979				Al-Serri A, 2012, J HEPATOL, V56, P448, DOI 10.1016/j.jhep.2011.05.029; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Barshop NJ, 2008, ALIMENT PHARM THER, V28, P13, DOI 10.1111/j.1365-2036.2008.03703.x; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Carrasquer A, 2010, PHARMACOGENET GENOM, V20, P157, DOI 10.1097/FPC.0b013e3283367c6b; Cencioni MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008688; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Correa F, 2010, GLIA, V58, P135, DOI 10.1002/glia.20907; de Alwis NMW, 2007, SEMIN LIVER DIS, V27, P44, DOI 10.1055/s-2006-960170; del Giudice EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027933; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; Dunn Winston, 2008, Curr Gastroenterol Rep, V10, P67, DOI 10.1007/s11894-008-0011-1; Hegde VL, 2008, MOL PHARMACOL, V74, P20, DOI 10.1124/mol.108.047035; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Larter CZ, 2010, J GASTROEN HEPATOL, V25, P672, DOI 10.1111/j.1440-1746.2010.06253.x; Lotersztajn S, 2011, HEPATOLOGY, V54, P1102, DOI 10.1002/hep.24476; Manco M, 2008, INT J OBESITY, V32, P381, DOI 10.1038/sj.ijo.0803711; Patel KD, 2010, CURR MED CHEM, V17, P1394, DOI 10.2174/092986710790980041; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rossi F, 2011, HEPATOLOGY, V54, P1102, DOI 10.1002/hep.24440; Schwimmer JB, 2009, GASTROENTEROLOGY, V136, P1585, DOI 10.1053/j.gastro.2009.01.050; Sipe JC, 2005, J LEUKOCYTE BIOL, V78, P231, DOI 10.1189/jlb.0205111; Tam J, 2011, HEPATOLOGY, V53, P346, DOI 10.1002/hep.24077; Teixeira-Clerc F, 2010, HEPATOLOGY, V52, P1046, DOI 10.1002/hep.23779; Valenti L, 2010, HEPATOLOGY, V52, P1274, DOI 10.1002/hep.23823; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; WANG P, 1994, J IMMUNOL, V153, P811	32	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e42259	10.1371/journal.pone.0042259	http://dx.doi.org/10.1371/journal.pone.0042259			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927922	Green Published, Green Submitted, gold			2022-12-25	WOS:000308224700004
J	Dahlstrom, O; Backe, S; Ekberg, J; Janson, S; Timpka, T				Dahlstrom, Orjan; Backe, Stefan; Ekberg, Joakim; Janson, Staffan; Timpka, Toomas			Is "Football for All" Safe for All? Cross-Sectional Study of Disparities as Determinants of 1-Year Injury Prevalence in Youth Football Programs	PLOS ONE			English	Article							BODY-MASS INDEX; SOCCER; HEALTH; RISK; OVERWEIGHT; ATHLETE	Background: Football (soccer) is endorsed as a health-promoting physical activity worldwide. When football programs are introduced as part of general health promotion programs, equal access and limitation of pre-participation disparities with regard to injury risk are important. The aim of this study was to explore if disparity with regard to parents' educational level, player body mass index (BMI), and self-reported health are determinants of football injury in community-based football programs, separately or in interaction with age or gender. Methodology/Principal Findings: Four community football clubs with 1230 youth players agreed to participate in the cross-sectional study during the 2006 season. The study constructs (parents' educational level, player BMI, and self-reported health) were operationalized into questionnaire items. The 1-year prevalence of football injury was defined as the primary outcome measure. Data were collected via a postal survey and analyzed using a series of hierarchical statistical computations investigating associations with the primary outcome measure and interactions between the study variables. The survey was returned by 827 (67.2%) youth players. The 1-year injury prevalence increased with age. For youths with parents with higher formal education, boys reported more injuries and girls reported fewer injuries than expected; for youths with lower educated parents there was a tendency towards the opposite pattern. Youths reporting injuries had higher standardized BMI compared with youths not reporting injuries. Children not reporting full health were slightly overrepresented among those reporting injuries and underrepresented for those reporting no injury. Conclusion: Pre-participation disparities in terms of parents' educational level, through interaction with gender, BMI, and self-reported general health are associated with increased injury risk in community-based youth football. When introduced as a general health promotion, football associations should adjust community-based youth programs to accommodate children and adolescents with increased pre-participation injury risk.	[Dahlstrom, Orjan; Ekberg, Joakim; Timpka, Toomas] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Dahlstrom, Orjan; Timpka, Toomas] Swedish Inst Disabil Res, Linnaeus Ctr HEAD, Linkoping, Sweden; [Dahlstrom, Orjan] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Backe, Stefan; Janson, Staffan] Karlstad Univ, Div Publ Hlth Sci, Karlstad, Sweden; [Backe, Stefan; Timpka, Toomas] Skovde Univ, Sch Life Sci, Dept Publ Hlth, Skovde, Sweden	Linkoping University; Linkoping University; Karlstad University	Dahlstrom, O (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.	orjan.dahlstrom@liu.se	Timpka, Toomas/E-8065-2018	Dahlstrom, Orjan/0000-0002-3955-0443	Swedish National Centre for Research in Sports (CIF) [2007/82]	Swedish National Centre for Research in Sports (CIF)	The study was supported by a grant (2007/82) from the Swedish National Centre for Research in Sports (CIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Bazelmans C, 2004, EUR J EPIDEMIOL, V19, P1037, DOI 10.1007/s10654-004-0158-5; Brownell MD, 2010, CAN J PUBLIC HEALTH, V101, pS28; Bulik CM, 2001, INT J OBESITY, V25, P1517, DOI 10.1038/sj.ijo.0801742; Carter CW, 2011, BRIT J SPORT MED, V45, P880, DOI 10.1136/bjsports-2011-090201; Davis-Kean PE, 2005, J FAM PSYCHOL, V19, P294, DOI 10.1037/0893-3200.19.2.294; de Mutsert R, 2011, NEPHRON CLIN PRACT, V119, pC154, DOI 10.1159/000327596; de Mutsert R, 2009, KIDNEY INT, V75, P677, DOI 10.1038/ki.2008.645; Dvorak J, 2009, BRIT J SPORT MED, V43, P317, DOI 10.1136/bjsm.2009.059618; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Faude O, 2010, SCAND J MED SCI SPOR, V20, P103, DOI 10.1111/j.1600-0838.2009.01087.x; Froholdt A, 2009, AM J SPORT MED, V37, P1155, DOI 10.1177/0363546508330132; Fuller CW, 2012, BRIT J SPORT MED, V46, P11, DOI 10.1136/bjsports-2011-090634; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; GOFFMAN E, 1977, THEOR SOC, V4, P301; Jones EG, 1999, J NATL MED ASSOC, V91, P27; Kakavelakis KN, 2003, SCAND J MED SCI SPOR, V13, P175, DOI 10.1034/j.1600-0838.2003.00294.x; Karlberg J, 2001, ACTA PAEDIATR, V90, P1427, DOI 10.1080/08035250152708851; Knowles SB, 2010, BRIT J SPORT MED, V44, P38, DOI 10.1136/bjsm.2009.065763; Krustrup P, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01108.x; Lundy T, 2010, GLOB HEALTH PROMOT, V17, P44, DOI 10.1177/1757975910375169; McHugh MP, 2010, BRIT J SPORT MED, V44, P45, DOI 10.1136/bjsm.2009.068106; McNoe BM, 2010, AM J SPORT MED, V38, P2542, DOI 10.1177/0363546510377415; NIXON HL, 1993, SOCIOL SPORT J, V10, P183, DOI 10.1123/ssj.10.2.183; PELLICCIA A, 1995, AM J CARDIOL, V75, P827, DOI 10.1016/S0002-9149(99)80421-4; Peterson L, 2000, AM J SPORT MED, V28, pS51; Pickett W, 2005, INJURY PREV, V11, P213, DOI 10.1136/ip.2004.007021; Rothman K, 2002, EPIDEMIOLOGY INTRO, V1, P168; Soderman K, 2001, SCAND J MED SCI SPOR, V11, P299, DOI 10.1034/j.1600-0838.2001.110508.x; Thompson PD, 2009, CIRCULATION, V119, P1072, DOI 10.1161/CIRCULATIONAHA.108.843862; Timpka T, 2008, EUR J PUBLIC HEALTH, V18, P19, DOI 10.1093/eurpub/ckm050; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002; Zonfrillo MR, 2008, AMBUL PEDIATR, V8, P66, DOI 10.1016/j.ambp.2007.08.003	35	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43795	10.1371/journal.pone.0043795	http://dx.doi.org/10.1371/journal.pone.0043795			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999CI	22928035	Green Published, gold			2022-12-25	WOS:000308286300091
J	Bennett, JA; Cahill, JF				Bennett, Jonathan A.; Cahill, James F., Jr.			Evaluating the Relationship between Competition and Productivity within a Native Grassland	PLOS ONE			English	Article							STRESS-GRADIENT HYPOTHESIS; BELOW-GROUND COMPETITION; PLANT STRATEGY THEORIES; RESOURCE AVAILABILITY; POSITIVE INTERACTIONS; SHOOT COMPETITION; ABIOTIC STRESS; INTENSITY; DIVERSITY; FACILITATION	Ideas about how plant competition varies with productivity are rooted in classic theories that predict either increasing (Grime) or invariant (Tilman) competition with increasing productivity. Both predictions have received experimental support, although a decade-old meta-analysis supports neither. Attempts to reconcile the conflicting predictions and evidence include: expanding the theory to include other conditions (e. g. stress gradient hypothesis), development of indices to differentiate either the 'intensity' or 'importance' of competition, a focus on resource supply and demand, and explicit recognition that both growth and survival may exhibit different relationships with productivity. To determine which of these theories accurately predict how competition varies with productivity within a native grassland site, we estimated competitive intensity and relative competitive importance using 22 species across the range of productivity naturally occurring within that site. Plant performance was measured as survival and size with and without neighbours and the local environment was quantified according to variability in standing crop, gross water supply, and net water supply. On average, neighbours weakly facilitated seedling survival, but strongly reduced seedling growth. For both seedling survival and growth, relative competitive importance and competitive intensity declined with some measure of productivity; neighbour effects on survival declined with standing crop, while effects on growth declined with gross water supply. These results add to the growing evidence that plant-plant interactions vary among life history components with different life history components contingent upon separate environmental factors. Although the range of productivity measured in this study was not large, our results do not support the theories of Grime or Tilman. However, our results are consistent with the meta-analysis and parts of other theories, although no single theory is capable of explaining the entirety of these results. This suggests that, at least in moderately productive grasslands, new theory needs to be developed.	[Bennett, Jonathan A.; Cahill, James F., Jr.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Bennett, JA (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	jon.bennett@ualberta.ca	Bennett, Jonathan A/J-5839-2013; Bennett, Jonathan/AAH-3191-2021; Bennett, Jonathan/K-4405-2014; Cahill, James/B-6147-2015	Bennett, Jonathan A/0000-0001-5617-7524; Bennett, Jonathan/0000-0001-5617-7524; Bennett, Jonathan/0000-0001-5617-7524; Cahill, James/0000-0002-4110-1516	NSERC Discovery Grant; NSERC Post-Graduate Scholarship	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Post-Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a NSERC Discovery Grant to JFC Jr. and a NSERC Post-Graduate Scholarship to JAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 2002, OIKOS, V96, P531, DOI 10.1034/j.1600-0706.2002.960314.x; ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; [Anonymous], 2001, PLANT STRATEGIES VEG; Arii K, 2001, CAN J BOT, V79, P1486, DOI 10.1139/b01-118; BELCHER JW, 1995, J ECOL, V83, P673, DOI 10.2307/2261635; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brooker R, 2005, OIKOS, V109, P63, DOI 10.1111/j.0030-1299.2005.13557.x; Brooker RW, 2008, J ECOL, V96, P703, DOI 10.1111/j.1365-2745.2008.01373.x; Cahill JF, 1999, ECOLOGY, V80, P466, DOI 10.1890/0012-9658(1999)080[0466:FEOIBA]2.0.CO;2; Cahill JF, 2003, J ECOL, V91, P532, DOI 10.1046/j.1365-2745.2003.00792.x; Cahill JF, 2003, ECOL LETT, V6, P599, DOI 10.1046/j.1461-0248.2003.00476.x; Cahill JF, 2002, J ECOL, V90, P201, DOI 10.1046/j.0022-0477.2001.00658.x; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; CAMPBELL BD, 1992, ECOLOGY, V73, P15, DOI 10.2307/1938717; Coupe MD, 2009, J VEG SCI, V20, P121, DOI 10.1111/j.1654-1103.2009.05506.x; Craine JM, 2005, J ECOL, V93, P1041, DOI 10.1111/j.1365-2745.2005.01043.x; Craine JM., 2009, RESOURCE STRATEGIES; Craine JM, 2007, J ECOL, V95, P235, DOI 10.1111/j.1365-2745.2007.01212.x; Damgaard C, 2010, J ECOL, V98, P1, DOI 10.1111/j.1365-2745.2009.01587.x; Davis MA, 1998, J ECOL, V86, P652, DOI 10.1046/j.1365-2745.1998.00087.x; Dickson TL, 2011, ECOL LETT, V14, P380, DOI 10.1111/j.1461-0248.2011.01599.x; Dyer AR, 2001, FUNCT ECOL, V15, P85, DOI 10.1046/j.1365-2435.2001.00487.x; Freckleton RP, 2009, J ECOL, V97, P379, DOI 10.1111/j.1365-2745.2009.01497.x; Goldberg D, 1997, J ECOL, V85, P409, DOI 10.2307/2960565; Goldberg D. E., 1990, Perspectives on plant competition., P27; Goldberg DE, 1996, PHILOS T R SOC B, V351, P1377, DOI 10.1098/rstb.1996.0121; Goldberg DE, 1999, ECOLOGY, V80, P1118, DOI 10.2307/177059; Gomez-Aparicio L, 2009, J ECOL, V97, P1202, DOI 10.1111/j.1365-2745.2009.01573.x; GRACE JB, 1991, FUNCT ECOL, V5, P583, DOI 10.2307/2389475; GRACE JB, 1995, ECOLOGY, V76, P305, DOI 10.2307/1940651; Grime J. P., 2001, PLANT STRATEGIES VEG; Grime JP, 2007, J ECOL, V95, P227, DOI 10.1111/j.1365-2745.2006.01163.x; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Haag JJ, 2004, J ECOL, V92, P156, DOI 10.1111/j.1365-2745.2004.00847.x; Hacker SD, 2008, ECOLOGY; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Howard TG, 2001, ECOLOGY, V82, P979, DOI 10.1890/0012-9658(2001)082[0979:CRHFGG]2.0.CO;2; Kikvidze Z, 2011, TRENDS ECOL EVOL, V26, P383, DOI 10.1016/j.tree.2011.04.003; Lamb EG, 2008, AM NAT, V171, P777, DOI 10.1086/587528; Lamb EG, 2007, PLANT ECOL, V192, P21, DOI 10.1007/s11258-006-9222-4; Lamb EG, 2009, J ECOL, V97, P155, DOI 10.1111/j.1365-2745.2008.01454.x; Lortie CJ, 2006, J ECOL, V94, P7, DOI 10.1111/j.1365-2745.2005.01066.x; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Maestre FT, 2006, J ECOL, V94, P17, DOI 10.1111/j.1365-2745.2005.01089.x; Malkinson D, 2010, OIKOS, V119, P1546, DOI 10.1111/j.1600-0706.2010.18375.x; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Molles Jr MC, 2011, ECOLOGY CONCEPTS APP; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Neytcheva MS, 2008, OIKOS, V117, P1298, DOI 10.1111/j.0030-1299.2008.16695.x; Peltzer DA, 1998, AM NAT, V151, P465, DOI 10.1086/286133; READER RJ, 1994, ECOLOGY, V75, P1753, DOI 10.2307/1939634; Rees M, 2012, J ECOL, V100, P577, DOI 10.1111/j.1365-2745.2011.01946.x; Ricklefs R.E., 2008, EC NATURE; Schiffers K, 2006, J ECOL, V94, P336, DOI 10.1111/j.1365-2745.2006.01097.x; Seifan M, 2010, J ECOL, V98, P356, DOI 10.1111/j.1365-2745.2009.01621.x; Stiling PD, 2002, ECOLOGY THEORIES APP; TAYLOR DR, 1990, OIKOS, V58, P239, DOI 10.2307/3545432; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1988; Tilman D, 2007, J ECOL, V95, P231, DOI 10.1111/j.1365-2745.2007.01201.x; TwolanStrutt L, 1996, ECOLOGY, V77, P259, DOI 10.2307/2265675; Weaver JE., 1938, PLANT ECOL, V2; Wilson MV, 2007, J ECOL, V95, P301, DOI 10.1111/j.1365-2745.2007.01215.x; WILSON SD, 1995, ECOLOGY, V76, P1169, DOI 10.2307/1940924; WILSON SD, 1993, ECOLOGY, V74, P599, DOI 10.2307/1939319; WILSON SD, 1991, ECOLOGY, V72, P1050, DOI 10.2307/1940605; WILSON SD, 1993, J ECOL, V81, P445, DOI 10.2307/2261523; Yuan ZY, 2006, OECOLOGIA, V148, P564, DOI 10.1007/s00442-006-0409-0	75	13	15	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43703	10.1371/journal.pone.0043703	http://dx.doi.org/10.1371/journal.pone.0043703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928021	gold, Green Submitted, Green Published			2022-12-25	WOS:000307789700048
J	Gao, HW; Wang, LP; Liang, S; Liu, YX; Tong, SL; Wang, JJ; Li, YP; Wang, XF; Yang, H; Ma, JQ; Fang, LQ; Cao, WC				Gao, Hong-Wei; Wang, Li-Ping; Liang, Song; Liu, Yong-Xiao; Tong, Shi-Lu; Wang, Jian-Jun; Li, Ya-Pin; Wang, Xiao-Feng; Yang, Hong; Ma, Jia-Qi; Fang, Li-Qun; Cao, Wu-Chun			Change in Rainfall Drives Malaria Re-Emergence in Anhui Province, China	PLOS ONE			English	Article							CLIMATE-CHANGE; AFRICAN HIGHLANDS; HUMAN HEALTH; TIME-SERIES; TRANSMISSION; RISK; RESURGENCE; CHILDREN; DISEASES; FUTURE	Malaria is re-emerging in Anhui Province, China after a decade long' low level of endemicity. The number of human cases has increased rapidly since 2000 and reached its peak in 2006. That year, the malaria cases accounted for 54.5% of total cases in mainland China. However, the spatial and temporal patterns of human cases and factors underlying the re-emergence remain unclear. We established a database containing 20 years' (1990-2009) records of monthly reported malaria cases and meteorological parameters. Spearman correlations were used to assess the crude association between malaria incidence and meteorological variables, and a polynomial distributed lag (PDL) time-series regression was performed to examine contribution of meteorological factors to malaria transmission in three geographic regions (northern, mid and southern Anhui Province), respectively. Then, a two-year (2008-2009) prediction was performed to validate the PDL model that was created by using the data collected from 1990 to 2007. We found that malaria incidence decreased in Anhui Province in 1990s. However, the incidence has dramatically increased in the north since 2000, while the transmission has remained at a relatively low level in the mid and south. Spearman correlation analyses showed that the monthly incidences of malaria were significantly associated with temperature, rainfall, relative humidity, and the multivariate El Nino/Southern Oscillation index with lags of 0-2 months in all three regions. The PDL model revealed that only rainfall with a 1-2 month lag was significantly associated with malaria incidence in all three regions. The model validation showed a high accuracy for the prediction of monthly incidence over a 2-year predictive period. Malaria epidemics showed a high spatial heterogeneity in Anhui Province during the 1990-2009 study periods. The change in rainfall drives the reemergence of malaria in the northern Anhui Province.	[Gao, Hong-Wei; Li, Ya-Pin; Yang, Hong; Fang, Li-Qun; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Li-Ping; Wang, Xiao-Feng; Ma, Jia-Qi] Chinese Ctr Dis Control & Prevent, Natl Ctr Publ Hlth Surveillance & Informat Serv, Beijing, Peoples R China; [Liang, Song] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Liang, Song] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Liu, Yong-Xiao; Wang, Jian-Jun] Anhui Ctr Dis Control & Prevent, Hefei, Peoples R China; [Tong, Shi-Lu] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia	Beijing Institute of Microbiology & Epidemiology; Chinese Center for Disease Control & Prevention; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Queensland University of Technology (QUT)	Gao, HW (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	fanglq@bmi.ac.cn; caowc@bmi.ac.cn	Fang, Li-Qun/GWD-0296-2022		National Science Fund for Distinguished Young Scholars [30725032]; Natural Science Foundation of China [81172728, 30972521]; Special Program for Prevention and Control of Infectious Diseases [2008ZX10004-012]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Prevention and Control of Infectious Diseases	The study was funded by the National Science Fund for Distinguished Young Scholars (30725032), Natural Science Foundation of China (81172728, 30972521) and Special Program for Prevention and Control of Infectious Diseases (2008ZX10004-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop Z, 2007, LANCET, V370, P925, DOI 10.1016/S0140-6736(07)61428-7; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Batten DS, 1983, POLYNOMIAL DISTRIBUT; Bi P, 2003, PUBLIC HEALTH REP, V118, P65, DOI 10.1016/S0033-3549(04)50218-2; China Meteorological Data Sharing Service System, 2011, CHIN MET DAT SHAR SE; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Gomez-Elipe A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-129; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Gupta R, 1996, J Assoc Physicians India, V44, P385; Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; Haque U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014341; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hu WB, 2006, ECOL MODEL, V196, P505, DOI 10.1016/j.ecolmodel.2006.02.028; Kar S, 2010, NAT REV DRUG DISCOV, V9, P511, DOI 10.1038/nrd3207; Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8; Krefis AC, 2011, AM J TROP MED HYG, V84, P285, DOI 10.4269/ajtmh.2011.10-0381; Le Menach A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00093; Ledford H, 2010, NATURE, V465, P280, DOI 10.1038/465280a; Li BK, 2010, ANHUI J PRE MED, V116, P427; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; Mackinnon MJ, 2010, SCIENCE, V328, P866, DOI 10.1126/science.1185410; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; National Oceanic and Atmospheric Administration, 2011, MULT ENSO IND; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Shen YZ, 2006, PATHOGEN BIOL, V1, P301; Singh N, 2002, ANN TROP MED PARASIT, V96, P349, DOI 10.1179/000349802125001113; Small J, 2003, P NATL ACAD SCI USA, V100, P15341, DOI 10.1073/pnas.2236969100; Stefani A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-246; Tang LH, 2000, CHINESE MED J-PEKING, V113, P89; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Thomson MC, 2011, NATURE, V471, P440, DOI 10.1038/471440a; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; van der Hoek W, 1997, ANN TROP MED PARASIT, V91, P945, DOI 10.1080/00034989760347; Wang LP, 2008, CHIN J DIS CONTROL P, V12, P156; Wangdi K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-251; World Health Organization, 2012, DIAGN MAL; Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504; Zhou Shui-Sen, 2007, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V25, P439; Zhou Shui-sen, 2006, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V24, P1; 黄荣辉, 1989, Advances in Atmospheric Sciences, V6, P21	46	34	35	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43686	10.1371/journal.pone.0043686	http://dx.doi.org/10.1371/journal.pone.0043686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928015	Green Published, gold			2022-12-25	WOS:000307789700045
J	Szucs, A; Berton, F; Sanna, PP; Francesconi, W				Szuecs, Attila; Berton, Fulvia; Sanna, Pietro Paolo; Francesconi, Walter			Excitability of jcBNST Neurons Is Reduced in Alcohol-Dependent Animals during Protracted Alcohol Withdrawal	PLOS ONE			English	Article							CENTRAL EXTENDED AMYGDALA; CHRONIC ETHANOL EXPOSURE; STRIA TERMINALIS; BED NUCLEUS; DOPAMINE NEURONS; IN-VIVO; BEHAVIORAL SENSITIZATION; JUXTACAPSULAR NUCLEUS; INDUCED PLASTICITY; PYRAMIDAL NEURONS	Alcohol dependence and withdrawal has been shown to cause neuroadaptive changes at multiple levels of the nervous system. At the neuron level, adaptations of synaptic connections have been extensively studied in a number of brain areas and accumulating evidence also shows the importance of alcohol dependence-related changes in the intrinsic cellular properties of neurons. At the same time, it is still largely unknown how such neural adaptations impact the firing and integrative properties of neurons. To address these problems, here, we analyze physiological properties of neurons in the bed nucleus of stria terminalis (jcBNST) in animals with a history of alcohol dependence. As a comprehensive approach, first we measure passive and active membrane properties of neurons using conventional current clamp protocols and then analyze their firing responses under the action of simulated synaptic bombardment via dynamic clamp. We find that most physiological properties as measured by DC current injection are barely affected during protracted withdrawal. However, neuronal excitability as measured from firing responses under simulated synaptic inputs with the dynamic clamp is markedly reduced in all 3 types of jcBNST neurons. These results support the importance of studying the effects of alcohol and drugs of abuse on the firing properties of neurons with dynamic clamp protocols designed to bring the neurons into a high conductance state. Since the jcBNST integrates excitatory inputs from the basolateral amygdala (BLA) and cortical inputs from the infralimbic and the insular cortices and in turn is believed to contribute to the inhibitory input to the central nucleus of the amygdala (CeA) the reduced excitability of the jcBNST during protracted withdrawal in alcohol-dependent animals will likely affect ability of the jcBNST to shape the activity and output of the CeA.	[Szuecs, Attila] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Szuecs, Attila] Hungarian Acad Sci, Balaton Limnol Res Inst, H-8237 Tihany, Hungary; [Berton, Fulvia; Sanna, Pietro Paolo; Francesconi, Walter] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; [Berton, Fulvia] Univ Pisa, Dept Biol, Pisa, Italy	University of California System; University of California San Diego; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute; Scripps Research Institute; University of Pisa	Szucs, A (corresponding author), Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA.	aszucs@ucsd.edu			National Institute of Health [RC1AA019195, DA03156601, AA016587, AA013191, AA006420]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC1AA019195, P60AA006420, R01AA016587, R01AA013191, P50AA006420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031566] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institute of Health (Grants RC1AA019195, DA03156601 AA016587 AA013191 AA006420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHEID GF, 1988, NEUROSCIENCE, V27, P1, DOI 10.1016/0306-4522(88)90217-5; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Cooper DC, 2003, J NEUROSCI, V23, P9937; Destexhe A, 2009, DYNAMIC CLAMP; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; Dong HW, 2000, BRAIN RES, V859, P1, DOI 10.1016/S0006-8993(99)02246-5; Dumont EC, 2005, NAT NEUROSCI, V8, P413, DOI 10.1038/nn1414; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Faber ESL, 2004, J NEUROSCI, V24, P3031, DOI 10.1523/JNEUROSCI.4496-03.2004; Fellous JM, 2003, CEREB CORTEX, V13, P1232, DOI 10.1093/cercor/bhg098; Francesconi W, 2009, J NEUROSCI; Francesconi W, 2009, PROG NEURO-PSYCHOPH, V33, P1347, DOI 10.1016/j.pnpbp.2009.08.003; Gilpin Nicholas W, 2008, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0929s44; Hammack SE, 2007, J NEUROPHYSIOL, V98, P638, DOI 10.1152/jn.00382.2007; Hazra R, 2011, MOL CELL NEUROSCI, V46, P699, DOI 10.1016/j.mcn.2011.01.011; HEIMER L, 1991, ADV EXP MED BIOL, V295, P1; Higgs MH, 2011, J PHYSIOL-LONDON, V589, P5125, DOI 10.1113/jphysiol.2011.216721; Hopf FW, 2007, J NEUROPHYSIOL, V98, P2297, DOI 10.1152/jn.00824.2007; Hur EE, 2005, J COMP NEUROL, V483, P351, DOI 10.1002/cne.20444; Kash TL, 2009, NEUROPSYCHOPHARMACOL, V34, P2420, DOI 10.1038/npp.2009.69; Krawczyk M, 2011, J NEUROSCI, V31, P8928, DOI 10.1523/JNEUROSCI.0377-11.2011; Larriva-Sahd J, 2004, J COMP NEUROL, V475, P220, DOI 10.1002/cne.20185; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Lee S, 2000, ALCOHOL CLIN EXP RES, V24, P110, DOI 10.1111/j.1530-0277.2000.tb04560.x; MCDONALD AJ, 1983, BRAIN RES BULL, V10, P111, DOI 10.1016/0361-9230(83)90082-5; McDonald AJ, 1999, ANN NY ACAD SCI, V877, P309, DOI 10.1111/j.1749-6632.1999.tb09275.x; Melis M, 2002, J NEUROSCI, V22, P2074, DOI 10.1523/JNEUROSCI.22-06-02074.2002; Michaelevski I, 2007, PFLUG ARCH EUR J PHY, V454, P477, DOI 10.1007/s00424-007-0223-5; Mulholland PJ, 2009, ALCOHOL CLIN EXP RES, V33, P1125, DOI 10.1111/j.1530-0277.2009.00936.x; Nowotny T, 2006, J NEUROSCI METH, V158, P287, DOI 10.1016/j.jneumeth.2006.05.034; O'Dell LE, 2004, ALCOHOL CLIN EXP RES, V28, P1676, DOI 10.1097/01.ALC.0000145781.11923.4E; Parkis MA, 2000, J NEUROSCI METH, V96, P77, DOI 10.1016/S0165-0270(99)00186-7; Petrovich GD, 1997, BRAIN RES, V763, P247, DOI 10.1016/S0006-8993(96)01361-3; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Platkiewicz J, PLOS COMPUT BIOL, V7; Prescott SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000198; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Repunte-Canonigo V, 2007, BRAIN RES, V1138, P48, DOI 10.1016/j.brainres.2006.09.115; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sanna PP, 2002, BRAIN RES, V948, P186, DOI 10.1016/S0006-8993(02)03191-8; Shammah-Lagnado SJ, 1999, ANN NY ACAD SCI, V877, P655, DOI 10.1111/j.1749-6632.1999.tb09295.x; Shen WX, 2004, J NEUROPHYSIOL, V91, P1337, DOI 10.1152/jn.00414.2003; Slawecki CJ, 1999, ALCOHOL ALCOHOLISM, V34, P289, DOI 10.1093/alcalc/34.3.289; SUN N, 1993, J COMP NEUROL, V330, P381, DOI 10.1002/cne.903300308; Szucs A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011920; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Veinante P, 1997, NEUROREPORT, V8, P2985, DOI 10.1097/00001756-199709080-00035; Vervaeke K, 2006, NEURON, V49, P257, DOI 10.1016/j.neuron.2005.12.022; Welsh JP, 2011, P NATL ACAD SCI USA, V108, P10314, DOI 10.1073/pnas.1017079108; Wills TA, 2012, P NATL ACAD SCI US; Zsiros V, 2005, J NEUROPHYSIOL, V93, P3248, DOI 10.1152/jn.01027.2004	55	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42313	10.1371/journal.pone.0042313	http://dx.doi.org/10.1371/journal.pone.0042313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927925	gold, Green Published, Green Submitted			2022-12-25	WOS:000307789700009
J	Zhuo, JL; Tan, EH; Yan, B; Tochhawng, L; Jayapal, M; Koh, S; Tay, HK; Maciver, SK; Hooi, SC; Salto-Tellez, M; Kumar, AP; Goh, YC; Lim, YC; Yap, CT				Zhuo, Jingli; Tan, Ee Hong; Yan, Benedict; Tochhawng, Lalchhandami; Jayapal, Manikandan; Koh, Shiuan; Tay, Hwee Kee; Maciver, Sutherland K.; Hooi, Shing Chuan; Salto-Tellez, Manuel; Kumar, Alan Prem; Goh, Yaw Chong; Lim, Yaw Chyn; Yap, Celestial T.			Gelsolin Induces Colorectal Tumor Cell Invasion via Modulation of the Urokinase-Type Plasminogen Activator Cascade	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX DEGRADATION; ACTIN-BINDING PROTEINS; PROSTATE-CANCER; PROGNOSTIC-FACTOR; CARCINOMA-CELLS; DOWN-REGULATION; GROWTH-FACTOR; EXPRESSION; COLON; PROGRESSION	Gelsolin is a cytoskeletal protein which participates in actin filament dynamics and promotes cell motility and plasticity. Although initially regarded as a tumor suppressor, gelsolin expression in certain tumors correlates with poor prognosis and therapy-resistance. In vitro, gelsolin has anti-apoptotic and pro-migratory functions and is critical for invasion of some types of tumor cells. We found that gelsolin was highly expressed at tumor borders infiltrating into adjacent liver tissues, as examined by immunohistochemistry. Although gelsolin contributes to lamellipodia formation in migrating cells, the mechanisms by which it induces tumor invasion are unclear. Gelsolin's influence on the invasive activity of colorectal cancer cells was investigated using overexpression and small interfering RNA knockdown. We show that gelsolin is required for invasion of colorectal cancer cells through matrigel. Microarray analysis and quantitative PCR indicate that gelsolin overexpression induces the upregulation of invasion-promoting genes in colorectal cancer cells, including the matrix-degrading urokinase-type plasminogen activator (uPA). Conversely, gelsolin knockdown reduces uPA levels, as well as uPA secretion. The enhanced invasiveness of gelsolin-overexpressing cells was attenuated by treatment with function-blocking antibodies to either uPA or its receptor uPAR, indicating that uPA/uPAR activity is crucial for gelsolin-dependent invasion. In summary, our data reveals novel functions of gelsolin in colorectal tumor cell invasion through its modulation of the uPA/uPAR cascade, with potentially important roles in colorectal tumor dissemination to metastatic sites.	[Zhuo, Jingli; Tochhawng, Lalchhandami; Koh, Shiuan; Hooi, Shing Chuan; Lim, Yaw Chyn; Yap, Celestial T.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Tan, Ee Hong] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Yan, Benedict; Lim, Yaw Chyn] Natl Univ Singapore Hosp, Dept Pathol, Singapore, Singapore; [Jayapal, Manikandan] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia; [Tay, Hwee Kee] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Maciver, Sutherland K.] Univ Edinburgh, Dept Biomed Sci, Edinburgh, Midlothian, Scotland; [Salto-Tellez, Manuel; Kumar, Alan Prem] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Salto-Tellez, Manuel] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Kumar, Alan Prem] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Kumar, Alan Prem] Curtin Univ Technol, Fac Hlth Sci, Sch Biomed Sci, Bentley, WA 6102, Australia; [Kumar, Alan Prem] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Goh, Yaw Chong] Singapore Gen Hosp, Dept Surg, Singapore 0316, Singapore	National University of Singapore; Beatson Institute; National University of Singapore; King Abdulaziz University; University of Glasgow; University of Edinburgh; National University of Singapore; Queens University Belfast; National University of Singapore; Curtin University; University of North Texas System; University of North Texas Denton; Singapore General Hospital	Zhuo, JL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore.	yawchyn_lim@nuhs.edu.sg; phsyapc@nus.edu.sg	Maciver, Sutherland Kester/H-6284-2019; Kumar, Alan Prem/ABE-7492-2020; Jayapal, Manikandan/H-9847-2012	Maciver, Sutherland Kester/0000-0001-8234-6061; Kumar, Alan Prem/0000-0002-3754-5712; J, manikandan/0000-0001-6744-8852; Tan, Ee Hong/0000-0002-5971-6455; Hooi, Shing Chuan/0000-0003-3249-903X; Salto-Tellez, Manuel/0000-0001-8586-282X	National Medical Research Council (NMRC) [NMRC/1235/2009, NMRC/1058/2006]	National Medical Research Council (NMRC)(National Medical Research Council, Singapore)	This work was funded by the National Medical Research Council (NMRC) (Grant nos: NMRC/1235/2009, NMRC/1058/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHBAROU A, 1994, CANCER RES, V54, P2372; Ambrosino C, 2010, MOL CELL PROTEOMICS, V9, P1352, DOI 10.1074/mcp.M900519-MCP200; Ambrosio EP, 2011, HUM PATHOL; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Archer SK, 2005, BIOESSAYS, V27, P388, DOI 10.1002/bies.20200; Arora PD, 1996, J BIOL CHEM, V271, P20516, DOI 10.1074/jbc.271.34.20516; ASHTONRICKARDT PG, 1989, ONCOGENE, V4, P1169; Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; Baker EA, 2000, J CLIN PATHOL-MOL PA, V53, P307; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chellaiah MA, 2001, J BIOL CHEM, V276, P47434, DOI 10.1074/jbc.M107494200; Chou J, 2002, INT J BIOCHEM CELL B, V34, P776, DOI 10.1016/S1357-2725(01)00177-7; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; De Corte V, 2004, J CELL SCI, V117, P5283, DOI 10.1242/jcs.01410; De Corte V, 2002, EMBO J, V21, P6781, DOI 10.1093/emboj/cdf680; Delektorskaya VV, 2008, B EXP BIOL MED+, V146, P616, DOI 10.1007/s10517-009-0343-3; Dosaka-Akita H, 1998, CANCER RES, V58, P322; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gay F, 2008, HUM PATHOL, V39, P1420, DOI 10.1016/j.humpath.2008.02.020; Gettemans J, 2005, TRAFFIC, V6, P847, DOI 10.1111/j.1600-0854.2005.00326.x; GRONDAHLHANSEN J, 1991, AM J PATHOL, V138, P111; Harvey SR, 1999, AM J PATHOL, V155, P1115, DOI 10.1016/S0002-9440(10)65214-5; Herszenyi L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-194; HOLLAS W, 1991, CANCER RES, V51, P3690; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Jankun J, 2001, INT J MOL MED, V8, P365; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Kalwat MA, 2012, MOL ENDOCRINOL, V26, P128, DOI 10.1210/me.2011-1112; Katerinaki E, 2003, BRIT J CANCER, V89, P1123, DOI 10.1038/sj.bjc.6601257; Kim MJ, 2010, BIOCHEM PHARMACOL, V80, P2092, DOI 10.1016/j.bcp.2010.08.014; Le DM, 2003, J NEUROSCI, V23, P4034; Monea S, 2002, J CELL PHYSIOL, V192, P160, DOI 10.1002/jcp.10126; Nishimura K, 2003, CANCER RES, V63, P4888; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; PORTER RM, 1993, J PATHOL, V170, P435, DOI 10.1002/path.1711700406; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Rao JY, 2002, MODERN PATHOL, V15, p177A; Renoult C, 2001, EUR J BIOCHEM, V268, P6165, DOI 10.1046/j.0014-2956.2001.02574.x; Shariat SF, 2007, J CLIN ONCOL, V25, P349, DOI 10.1200/JCO.2006.05.6853; Shieh DB, 2006, ORAL ONCOL, V42, P599, DOI 10.1016/j.oraloncology.2005.10.021; Shieh DB, 1999, CANCER-AM CANCER SOC, V85, P47, DOI 10.1002/(SICI)1097-0142(19990101)85:1<47::AID-CNCR7>3.0.CO;2-L; Skelly MM, 1997, CLIN CANCER RES, V3, P1837; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Tanaka H, 2006, INT J CANCER, V118, P1680, DOI 10.1002/ijc.21559; Tapia T, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-6; Tay PN, 2010, INT J ONCOL, V37, P909, DOI 10.3892/ijo_00000742; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thor AD, 2001, CLIN CANCER RES, V7, P2415; van den Abbeele A, 2007, CANCER LETT, V255, P57, DOI 10.1016/j.canlet.2007.03.023; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Visapaa H, 2003, UROLOGY, V61, P845, DOI 10.1016/S0090-4295(02)02404-4; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Webber MM, 1995, CLIN CANCER RES, V1, P755; Winston JS, 2001, BREAST CANCER RES TR, V65, P11, DOI 10.1023/A:1006446108411; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0	62	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43594	10.1371/journal.pone.0043594	http://dx.doi.org/10.1371/journal.pone.0043594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927998	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000307789700042
J	Rivero, MR; Miras, SL; Feliziani, C; Zamponi, N; Quiroga, R; Hayes, SF; Ropolo, AS; Touz, MC				Rivero, Maria R.; Miras, Silvana L.; Feliziani, Constanza; Zamponi, Nahuel; Quiroga, Rodrigo; Hayes, Stanley F.; Ropolo, Andrea S.; Touz, Maria C.			Vacuolar Protein Sorting Receptor in Giardia lamblia	PLOS ONE			English	Article							ACID-PHOSPHATASE-ACTIVITY; CRYSTALLOID ENDOPLASMIC-RETICULUM; COMBINED TRANSMEMBRANE TOPOLOGY; SIGNAL PEPTIDE PREDICTION; CYST WALL PROTEINS; PRIMITIVE EUKARYOTE; LEISHMANIA-DONOVANI; MEMBRANE-PROTEIN; SURFACE PROTEIN; QUANTITATIVE-ANALYSIS	In Giardia, lysosome-like peripheral vacuoles (PVs) need to specifically coordinate their endosomal and lysosomal functions to be able to successfully perform endocytosis, protein degradation and protein delivery, but how cargo, ligands and molecular components generate specific routes to the PVs remains poorly understood. Recently, we found that delivering membrane Cathepsin C and the soluble acid phosphatase (AcPh) to the PVs is adaptin (AP1)-dependent. However, the receptor that links AcPh and AP1 was never described. We have studied protein-binding to AcPh by using H6-tagged AcPh, and found that a membrane protein interacted with AcPh. This protein, named GlVps (for Giardia lamblia Vacuolar protein sorting), mainly localized to the ER-nuclear envelope and in some PVs, probably functioning as the sorting receptor for AcPh. The tyrosine-binding motif found in the C-terminal cytoplasmic tail domain of GlVps was essential for its exit from the endoplasmic reticulum and transport to the vacuoles, with this motif being necessary for the interaction with the medium subunit of AP1. Thus, the mechanism by which soluble proteins, such as AcPh, reach the peripheral vacuoles in Giardia appears to be very similar to the mechanism of lysosomal protein-sorting in more evolved eukaryotic cells.	[Rivero, Maria R.; Miras, Silvana L.; Feliziani, Constanza; Zamponi, Nahuel; Ropolo, Andrea S.; Touz, Maria C.] Univ Nacl Cordoba, Inst Invest Med Mercedes & Martin Ferreyra, RA-5000 Cordoba, Argentina; [Quiroga, Rodrigo] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina; [Hayes, Stanley F.] NIAID, Rocky Mt Lab, NIH, Hamilton, MT 59840 USA	National University of Cordoba; National University of Cordoba; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rivero, MR (corresponding author), Univ Nacl Cordoba, Inst Invest Med Mercedes & Martin Ferreyra, RA-5000 Cordoba, Argentina.	ctouz@immf.uncor.edu	Quiroga, Rodrigo/GLT-7145-2022	Quiroga, Rodrigo/0000-0001-5015-0531; TOUZ, MARIA/0000-0002-6769-6896	Fogarty International Center [R01TW00724]; Argentine National Agency for the Promotion of Science and Technology (FONCyT); National Council for Sciences and Technology (CONICET)	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Argentine National Agency for the Promotion of Science and Technology (FONCyT); National Council for Sciences and Technology (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The project was supported by Grant Number R01TW00724 from the Fogarty International Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Fogarty International Center or the National Institutes of Health. This research was also supported in part by the Argentine National Agency for the Promotion of Science and Technology (FONCyT), and the National Council for Sciences and Technology (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abodeely M, 2009, EUKARYOT CELL, V8, P1665, DOI 10.1128/EC.00123-09; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Aguirre-Garcia MM, 2007, PARASITOL RES, V101, P85, DOI 10.1007/s00436-006-0457-8; BACA OG, 1993, INFECT IMMUN, V61, P4232, DOI 10.1128/IAI.61.10.4232-4239.1993; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; CEREGHINO JL, 1995, MOL BIOL CELL, V6, P1089, DOI 10.1091/mbc.6.9.1089; CHIN DJ, 1982, P NATL ACAD SCI-BIOL, V79, P1185, DOI 10.1073/pnas.79.4.1185; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Cox WG, 1999, J HISTOCHEM CYTOCHEM, V47, P1443, DOI 10.1177/002215549904701110; Elmendorf HG, 2001, NUCLEIC ACIDS RES, V29, P4674, DOI 10.1093/nar/29.22.4674; Faso C, 2011, INT J PARASITOL, V41, P471, DOI 10.1016/j.ijpara.2010.12.014; FEELY DE, 1987, J PROTOZOOL, V34, P80, DOI 10.1111/j.1550-7408.1987.tb03137.x; Filgueira L, 2004, J HISTOCHEM CYTOCHEM, V52, P411, DOI 10.1177/002215540405200312; Gabernet-Castello C, 2009, TRAFFIC, V10, P894, DOI 10.1111/j.1600-0854.2009.00910.x; Goder V, 2001, FEBS LETT, V504, P87, DOI 10.1016/S0014-5793(01)02712-0; GOTTLIEB M, 1981, EXP PARASITOL, V52, P117, DOI 10.1016/0014-4894(81)90067-9; Hehl AB, 2004, MOL MICROBIOL, V53, P19, DOI 10.1111/j.1365-2958.2004.04115.x; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Hirst J, 2001, MOL BIOL CELL, V12, P3573, DOI 10.1091/mbc.12.11.3573; House SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002167; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jeffries TR, 2004, MOL BIOL CELL, V15, P2652, DOI 10.1091/mbc.E03-10-0732; Jorgensen MU, 1999, EUR J BIOCHEM, V260, P461, DOI 10.1046/j.1432-1327.1999.00176.x; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Lakkaraju A, 2009, J CELL BIOL, V187, P161, DOI 10.1083/jcb.200909100; Lanfredi-Rangel A, 1998, J STRUCT BIOL, V123, P225, DOI 10.1006/jsbi.1998.4035; Leibowitz MP, 2009, VET PARASITOL, V166, P21, DOI 10.1016/j.vetpar.2009.08.005; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Lujan HD, 1996, BIOL CELL, V86, P11, DOI 10.1016/0248-4900(96)89519-0; LUJAN HD, 1995, J BIOL CHEM, V270, P4612, DOI 10.1074/jbc.270.9.4612; Lujan HD, 2003, CELL MICROBIOL, V5, P427, DOI 10.1046/j.1462-5822.2003.00284.x; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; MCCAFFERY JM, 1994, EXP PARASITOL, V79, P220, DOI 10.1006/expr.1994.1086; Meagher J, 2005, J HISTOCHEM CYTOCHEM, V53, P665, DOI 10.1369/jhc.4A6476.2005; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Mowbrey K, 2009, FEBS LETT, V583, P3738, DOI 10.1016/j.febslet.2009.10.025; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; NASH TE, 1995, J EUKARYOT MICROBIOL, V42, P604, DOI 10.1111/j.1550-7408.1995.tb05914.x; NASH TE, 1988, J IMMUNOL, V141, P636; Obara K, 2008, J BIOL CHEM, V283, P23972, DOI 10.1074/jbc.M803180200; ORCI L, 1984, CELL, V36, P835, DOI 10.1016/0092-8674(84)90033-3; Papanastasiou P, 1997, BIOCHEM J, V322, P49, DOI 10.1042/bj3220049; Penarrubia PG, 2005, IEEE T IMAGE PROCESS, V14, P1151, DOI 10.1109/TIP.2005.851699; Quistgaard EM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-46; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; REINER DS, 1990, EUR J CELL BIOL, V53, P142; Ringqvist E, 2008, MOL BIOCH PARASITOL; Rivero M. R., 2010, BIOCH J; Rivero MR, 2011, MOL MICROBIOL, V79, P1204, DOI 10.1111/j.1365-2958.2010.07512.x; Rodriguez-Boulan E, 2005, BBA-MOL CELL RES, V1744, P455, DOI 10.1016/j.bbamcr.2005.04.007; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Shakarian AM, 2002, J BIOL CHEM, V277, P17994, DOI 10.1074/jbc.M200114200; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; SINGLA N, 1992, FEMS MICROBIOL LETT, V94, P221, DOI 10.1111/j.1574-6968.1992.tb05322.x; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Slavin I, 2002, MOL BIOCHEM PARASIT, V122, P95, DOI 10.1016/S0166-6851(02)00065-8; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sun H, 2000, ANAT RECORD, V260, P158, DOI 10.1002/1097-0185(20001001)260:2<158::AID-AR60>3.0.CO;2-V; Thornton C, 2004, J BIOL CHEM, V279, P31357, DOI 10.1074/jbc.M402316200; Touz Maria C, 2012, Front Biosci (Elite Ed), V4, P1898; Touz MC, 2005, MOL MICROBIOL, V58, P999, DOI 10.1111/j.1365-2958.2005.04891.x; Touz MC, 2004, MOL BIOL CELL, V15, P3053, DOI 10.1091/mbc.E03-10-0744; Touz MC, 2003, J BIOL CHEM, V278, P6420, DOI 10.1074/jbc.M208354200; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; van Aarle IM, 2005, NEW PHYTOL, V166, P611, DOI 10.1111/j.1469-8137.2005.01340.x; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; von Heijne G, 1999, Q REV BIOPHYS, V32, P285, DOI 10.1017/S0033583500003541; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WAHEED A, 1988, EMBO J, V7, P2351, DOI 10.1002/j.1460-2075.1988.tb03079.x; Ward W, 1997, CELL, V89, P437, DOI 10.1016/S0092-8674(00)80224-X; WINTHER JR, 1991, EUR J BIOCHEM, V197, P681, DOI 10.1111/j.1432-1033.1991.tb15959.x; YEE J, 1995, P NATL ACAD SCI USA, V92, P5615, DOI 10.1073/pnas.92.12.5615; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhu C, 2005, MICROSC MICROANAL, V11, P244, DOI 10.1017/S143192760505049X; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	85	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43712	10.1371/journal.pone.0043712	http://dx.doi.org/10.1371/journal.pone.0043712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916299	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800097
J	Schneider, RD; Fogaca, NDS; Kmetzsch, L; Schrank, A; Vainstein, MH; Staats, CC				Schneider, Rafael de Oliveira; Sueffert Fogaca, Natully de Souza; Kmetzsch, Livia; Schrank, Augusto; Vainstein, Marilene Henning; Staats, Charley Christian			Zap1 Regulates Zinc Homeostasis and Modulates Virulence in Cryptococcus gattii	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR; FUNGAL PATHOGENESIS; GENE-EXPRESSION; NEOFORMANS; IRON; IDENTIFICATION; ACQUISITION; DEFICIENCY; TRANSPORT; REGULON	Zinc homeostasis is essential for fungal growth, as this metal is a critical structural component of several proteins, including transcription factors. The fungal pathogen Cryptococcus gattii obtains zinc from the stringent zinc-limiting milieu of the host during the infection process. To characterize the zinc metabolism in C. gattii and its relationship to fungal virulence, the zinc finger protein Zap1 was functionally characterized. The C. gattii ZAP1 gene is an ortholog of the master regulatory genes zafA and ZAP1 that are found in Aspergillus fumigatus and Saccharomyces cerevisiae, respectively. There is some evidence to support an association between Zap1 and zinc metabolism in C. gattii: (i) ZAP1 expression is highly induced during zinc deprivation, (ii) ZAP1 knockouts demonstrate impaired growth in zinc-limiting conditions, (iii) Zap1 regulates the expression of ZIP zinc transporters and distinct zinc-binding proteins and (iv) Zap1 regulates the labile pool of intracellular zinc. In addition, the deletion of ZAP1 reduces C. gattii virulence in a murine model of cryptococcosis infection. Based on these observations, we postulate that proper zinc metabolism plays a crucial role in cryptococcal virulence.	[Schneider, Rafael de Oliveira; Sueffert Fogaca, Natully de Souza; Kmetzsch, Livia; Schrank, Augusto; Vainstein, Marilene Henning; Staats, Charley Christian] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Schrank, Augusto; Vainstein, Marilene Henning; Staats, Charley Christian] Univ Fed Rio Grande do Sul, Dept Biol Mol & Biotecnol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Schneider, RD (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.	staats@cbiot.ufrgs.br	Schrank, Augusto/G-4688-2012; Kmetzsch, Livia/H-4033-2015; Vainstein, Marilene H/J-5452-2014; Staats, Charley Christian/J-4283-2014	Schrank, Augusto/0000-0002-5248-4620; Kmetzsch, Livia/0000-0003-3766-5869; Vainstein, Marilene H/0000-0002-3914-2300; Staats, Charley Christian/0000-0002-2433-6903	Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [476029/2010-4]; Financiadora de Estudos e Projetos (FINEP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)	Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This work was supported by grants from the Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ 476029/2010-4), Financiadora de Estudos e Projetos (FINEP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrnes E.J., 2009, F1000 BIOL REP; Byrnes EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005851; Chaturvedi V, 2011, TRENDS MICROBIOL, V19, P564, DOI 10.1016/j.tim.2011.07.010; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029; Ding C, 2011, MOL MICROBIOL, V81, P1560, DOI 10.1111/j.1365-2958.2011.07794.x; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Eide DJ, 2003, J NUTR, V133, p1532S, DOI 10.1093/jn/133.5.1532S; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; Flohe L, 2011, ANTIOXID REDOX SIGN, V15, P763, DOI 10.1089/ars.2010.3397; Gross NT, 1999, MED MYCOL, V37, P151, DOI 10.1046/j.1365-280X.1999.00209.x; Howard DH, 1999, CLIN MICROBIOL REV, V12, P394, DOI 10.1128/CMR.12.3.394; Huffnagle GB, 1998, J IMMUNOL, V160, P2393; Idnurm A, 2004, EUKARYOT CELL, V3, P420, DOI 10.1128/EC.3.2.420-429.2004; Jung WH, 2008, CELL MICROBIOL, V10, P277, DOI 10.1111/j.1462-5822.2007.01077.x; Jung WH, 2006, PLOS BIOL, V4, P2282, DOI 10.1371/journal.pbio.0040410; Jung WH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001209; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kim MJ, 2008, J MICROBIOL BIOTECHN, V18, P242; Kmetzsch L, 2011, FUNGAL GENET BIOL, V48, P192, DOI 10.1016/j.fgb.2010.07.011; Kmetzsch L, 2010, EUKARYOT CELL, V9, P1798, DOI 10.1128/EC.00114-10; Kronstad JW, 2011, NAT REV MICROBIOL, V9, P193, DOI 10.1038/nrmicro2522; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; Ma HS, 2009, ADV APPL MICROBIOL, V67, P131, DOI 10.1016/S0065-2164(08)01005-8; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Mambula SS, 2000, INFECT IMMUN, V68, P6257, DOI 10.1128/IAI.68.11.6257-6264.2000; Maret W, 2010, METALLOMICS, V2, P117, DOI 10.1039/b915804a; Meinicke P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-409; Missall TA, 2005, MICROBIOL-SGM, V151, P2573, DOI 10.1099/mic.0.28132-0; Moreno MA, 2007, MOL MICROBIOL, V64, P1182, DOI 10.1111/j.1365-2958.2007.05726.x; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perrone GG, 2005, MOL BIOL CELL, V16, P218, DOI 10.1091/mbc.E04-07-0560; Prado M, 2009, MEM I OSWALDO CRUZ, V104, P513, DOI 10.1590/S0074-02762009000300019; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Waterman SR, 2007, J CLIN INVEST, V117, P794, DOI 10.1172/JCI30006; Waters BM, 2002, J BIOL CHEM, V277, P33749, DOI 10.1074/jbc.M206214200; Winters MS, 2010, J INFECT DIS, V202, P1136, DOI 10.1086/656191; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Wu CY, 2009, J BIOL CHEM, V284, P27544, DOI 10.1074/jbc.M109.042036; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	56	64	64	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43773	10.1371/journal.pone.0043773	http://dx.doi.org/10.1371/journal.pone.0043773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916306	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800103
J	Tsagogiorgas, C; Wedel, J; Hottenrott, M; Schneider, MO; Binzen, U; Greffrath, W; Treede, RD; Theisinger, B; Theisinger, S; Waldherr, R; Kramer, BK; Thiel, M; Schnuelle, P; Yard, BA; Hoeger, S				Tsagogiorgas, Charalambos; Wedel, Johannes; Hottenrott, Maximilia; Schneider, Michael O.; Binzen, Uta; Greffrath, Wolfgang; Treede, Rolf-Detlef; Theisinger, Bastian; Theisinger, Sonja; Waldherr, Ruediger; Kraemer, Bernhard K.; Thiel, Manfred; Schnuelle, Peter; Yard, Benito A.; Hoeger, Simone			N-octanoyl-Dopamine Is an Agonist at the Capsaicin Receptor TRPV1 and Mitigates Is Chemia-Induced Acute Kidney Injury in Rat	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; LOW-DOSE DOPAMINE; KAPPA-B ACTIVATION; ISCHEMIA/REPERFUSION-INJURY; IMMUNOSUPPRESSIVE ACTIVITY; POTENTIAL VANILLOID-1; SUBSTANCE-P; IN-VIVO; PRETREATMENT; DYSFUNCTION	Since stimulation of transient receptor potential channels of the vanilloid receptor subtype 1 (TRPV1) mitigates acute kidney injury (AKI) and endogenous N-acyl dopamine derivatives are able to activate TRPV1, we tested if synthetic N-octanoyl-dopamine (NOD) activates TRPV1 and if it improves AKI. These properties of NOD and its intrinsic anti-inflammatory character were compared with those of dopamine (DA). TRPV1 activation and anti-inflammatory properties of NOD and DA were tested using primary cell cultures in vitro. The influence of NOD and DA on AKI was tested in a prospective, randomized, controlled animal study with 42 inbred male Lewis rats (LEW, RT1), treated intravenously with equimolar concentrations of DA or NOD one hour before the onset of warm ischemia and immediately before clamp release. NOD, but not DA, activates TRPV1 channels in isolated dorsal root ganglion neurons (DRG) that innervate several tissues including kidney. In TNF alpha stimulated proximal tubular epithelial cells, inhibition of NFkB and subsequent inhibition of VCAM1 expression by NOD was significantly stronger than by DA. NOD improved renal function compared to DA and saline controls. Histology revealed protective effects of NOD on tubular epithelium at day 5 and a reduced number of monocytes in renal tissue of DA and NOD treated rats. Our data demonstrate that NOD but not DA activates TRPV1 and that NOD has superior anti-inflammatory properties in vitro. Although NOD mitigates deterioration in renal function after AKI, further studies are required to assess to what extend this is causally related to TRPV1 activation and/or desensitization.	[Tsagogiorgas, Charalambos; Hottenrott, Maximilia; Thiel, Manfred] Heidelberg Univ, Fac Med, Univ Med Ctr, Dept Anaesthesiol & Intens Care Med, D-6800 Mannheim, Germany; [Wedel, Johannes; Schneider, Michael O.; Waldherr, Ruediger; Kraemer, Bernhard K.; Schnuelle, Peter; Yard, Benito A.; Hoeger, Simone] Heidelberg Univ, Fac Med, Univ Med Ctr, Dept Med Nephrol Endocrinol Rheumatol 5, D-6800 Mannheim, Germany; [Binzen, Uta; Greffrath, Wolfgang; Treede, Rolf-Detlef] Heidelberg Univ, Fac Med, Ctr Biomed & Med Technol CBTM, Div Neurophysiol, D-6800 Mannheim, Germany; [Theisinger, Bastian; Theisinger, Sonja] Novaliq GmbH, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Tsagogiorgas, C (corresponding author), Heidelberg Univ, Fac Med, Univ Med Ctr, Dept Anaesthesiol & Intens Care Med, D-6800 Mannheim, Germany.	charalambos.tsagogiorgas@medma.uni-heidelberg.de	Treede, Rolf-Detlef/I-3632-2014	Treede, Rolf-Detlef/0000-0001-8065-1708; Wedel, Johannes/0000-0002-3490-8477	Novaliq GmbH, Heidelberg, Germany; Deutsche Forschungsgemeinschaft [INST 91027/10-1 FUGG]; Novaliq GmbH	Novaliq GmbH, Heidelberg, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Novaliq GmbH	This study was partially supported by grants from Novaliq GmbH, Heidelberg, Germany and by the Deutsche Forschungsgemeinschaft (INST 91027/10-1 FUGG). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BT and ST are employed by Novaliq GmbH, Heidelberg. BAY is financially supported by Novaliq GmbH. All other submitting authors declare that they do not have any conflict of interest with this publication. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Alawi K, 2010, PHARMACOL THERAPEUT, V125, P181, DOI 10.1016/j.pharmthera.2009.10.005; Almasi R, 2008, LIFE SCI, V82, P644, DOI 10.1016/j.lfs.2007.12.022; Azuma H, 2003, GENE THER, V10, P415, DOI 10.1038/sj.gt.3301882; Beck GC, 2004, CRIT CARE, V8, P485, DOI 10.1186/cc2879; Bellomo R, 2000, LANCET, V356, P2139; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Brinkkoetter PT, 2006, TRANSPLANTATION, V82, P534, DOI 10.1097/01.tp.0000229396.34362.e2; Cao CC, 2004, KIDNEY INT, V65, P834, DOI 10.1111/j.1523-1755.2004.00463.x; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chatterjee PK, 2000, KIDNEY INT, V58, P658, DOI 10.1046/j.1523-1755.2000.00212.x; Chen CW, 2003, BRIT J PHARMACOL, V140, P1077, DOI 10.1038/sj.bjp.0705533; Chertow GM, 2006, KIDNEY INT, V70, P1120, DOI 10.1038/sj.ki.5001579; Connor M, 2010, BRIT J PHARMACOL, V160, P1857, DOI 10.1111/j.1476-5381.2010.00862.x; Demirbilek S, 2004, ANESTH ANALG, V99, P1501, DOI 10.1213/01.ANE.0000132975.02854.65; Ditting T, 2009, AM J PHYSIOL-RENAL, V297, pF1427, DOI 10.1152/ajprenal.90599.2008; DUKE GJ, 1992, ANAESTH INTENS CARE, V20, P277, DOI 10.1177/0310057X9202000302; EDELSTEIN CL, 2007, PATHOPHYSIOLOGY ISCH; Feng NH, 2008, AM J PHYSIOL-RENAL, V294, pF316, DOI 10.1152/ajprenal.00308.2007; Friedewald JJ, 2004, KIDNEY INT, V66, P486, DOI 10.1111/j.1523-1755.2004.761_3.x; Friedrich JO, 2005, ANN INTERN MED, V142, P510, DOI 10.7326/0003-4819-142-7-200504050-00010; Gottmann U, 2006, KIDNEY INT, V70, P321, DOI 10.1038/sj.ki.5001501; Greffrath W, 2003, NEUROREPORT, V14, P2251, DOI 10.1097/00001756-200312020-00023; Greffrath W, 2001, NEUROSCIENCE, V104, P539, DOI 10.1016/S0306-4522(01)00088-4; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo QN, 1996, BBA-LIPID LIPID MET, V1304, P210, DOI 10.1016/S0005-2760(96)00122-1; Hoeger S, 2007, TRANSPL INT, V20, P790, DOI 10.1111/j.1432-2277.2007.00510.x; Holmes CL, 2003, CHEST, V123, P1266, DOI 10.1378/chest.123.4.1266; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Joannidis M, 2010, INTENS CARE MED, V36, P392, DOI 10.1007/s00134-009-1678-y; Kapper S, 2002, TRANSPLANTATION, V74, P253, DOI 10.1097/00007890-200207270-00017; Katki KA, 2001, HYPERTENSION, V38, P679, DOI 10.1161/hy09t1.095761; Keeble J, 2005, ARTHRITIS RHEUM, V52, P3248, DOI 10.1002/art.21297; Kellum JA, 2001, CRIT CARE MED, V29, P1526, DOI 10.1097/00003246-200108000-00005; Kellum JA, 2008, CRIT CARE MED, V36, pS141, DOI 10.1097/CCM.0b013e318168c4a4; Kim CS, 2003, CELL SIGNAL, V15, P299, DOI 10.1016/S0898-6568(02)00086-4; KindgenMilles D, 1997, ANASTH INTENSIV NOTF, V32, P333, DOI 10.1055/s-2007-995065; Lameire N, 2008, LANCET, V372, P1863, DOI 10.1016/S0140-6736(08)61794-8; Legrand M, 2008, MOL MED, V14, P502, DOI 10.2119/2008-00006.Legrand; Losel RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009713; Nath KA, 2000, AM J MED, V109, P665, DOI 10.1016/S0002-9343(00)00612-4; Navarrete CM, 2010, BIOCHEM PHARMACOL, V79, P1805, DOI 10.1016/j.bcp.2010.02.014; Rayamajhi S, 2009, CURR OPIN INVEST DR, V10, P963; Sancho R, 2004, J IMMUNOL, V172, P2341, DOI 10.4049/jimmunol.172.4.2341; Sancho R, 2002, EUR J IMMUNOL, V32, P1753, DOI 10.1002/1521-4141(200206)32:6<1753::AID-IMMU1753>3.0.CO;2-2; Schnuelle P, 2009, JAMA-J AM MED ASSOC, V302, P1067, DOI 10.1001/jama.2009.1310; Singh D, 2006, J MED FOOD, V9, P443, DOI 10.1089/jmf.2006.9.443; Singh S, 1996, J IMMUNOL, V157, P4412; Song H, 2009, BR J PHARM; Surh YJ, 2000, BIOFACTORS, V12, P107, DOI 10.1002/biof.5520120117; Szabo A, 2005, J PHARMACOL EXP THER, V314, P111, DOI 10.1124/jpet.104.082487; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Ueda K, 2008, J CARDIOVASC PHARM, V51, P513, DOI 10.1097/FJC.0b013e31816f6884; Wang H, 2010, AM J PHYSIOL-REG I, V298, pR1634, DOI 10.1152/ajpregu.00235.2009; Wang M, 2010, J SURG RES; Yamanobe T, 2007, FREE RADICAL RES, V41, P200, DOI 10.1080/10715760601038791; Zhong BH, 2008, AM J PHYSIOL-HEART C, V295, pH728, DOI 10.1152/ajpheart.00022.2008; Zoja C, 2009, FRONT BIOSCI-LANDMRK, V14, P1815, DOI 10.2741/3343	60	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43525	10.1371/journal.pone.0043525	http://dx.doi.org/10.1371/journal.pone.0043525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916273	Green Published, gold, Green Submitted			2022-12-25	WOS:000307733800076
J	Masiewicz, P; Brzostek, A; Wolanski, M; Dziadek, J; Zakrzewska-Czerwinska, J				Masiewicz, Pawel; Brzostek, Anna; Wolanski, Marcin; Dziadek, Jaroslaw; Zakrzewska-Czerwinska, Jolanta			A Novel Role of the PrpR as a Transcription Factor Involved in the Regulation of Methylcitrate Pathway in Mycobacterium tuberculosis	PLOS ONE			English	Article							CHOLESTEROL CATABOLISM; ISOCITRATE LYASE-1; MACROPHAGES; METABOLISM; SURVIVAL; REQUIRES; GROWTH; PERSISTENCE; EXPRESSION; GLYOXYLATE	Mycobacterium tuberculosis, the pathogen that causes tuberculosis, presumably utilizes fatty acids as a major carbon source during infection within the host. Metabolism of even-chain-length fatty acids yields acetyl-CoA, whereas metabolism of odd-chain-length fatty acids additionally yields propionyl-CoA. Utilization of these compounds by tubercle bacilli requires functional glyoxylate and methylcitrate cycles, respectively. Enzymes involved in both pathways are essential for M. tuberculosis viability and persistence during growth on fatty acids. However, little is known about regulatory factors responsible for adjusting the expression of genes encoding these enzymes to particular growth conditions. Here, we characterized the novel role of PrpR as a transcription factor that is directly involved in regulating genes encoding the key enzymes of methylcitrate (methylcitrate dehydratase [PrpD] and methylcitrate synthase [PrpC]) and glyoxylate (isocitrate lyase [Icl1]) cycles. Using cell-free systems and intact cells, we demonstrated an interaction of PrpR protein with prpDC and icl1 promoter regions and identified a consensus sequence recognized by PrpR. Moreover, we showed that an M. tuberculosis prpR-deletion strain exhibits impaired growth in vitro on propionate as the sole carbon source. Real-time quantitative reverse transcription-polymerase chain reaction confirmed that PrpR acts as a transcriptional activator of prpDC and icl1 genes when propionate is the main carbon source. Similar results were also obtained for a non-pathogenic Mycobacterium smegmatis strain. Additionally, we found that ramB, a prpR paralog that controls the glyoxylate cycle, is negatively regulated by PrpR. Our data demonstrate that PrpR is essential for the utilization of odd-chain-length fatty acids by tubercle bacilli. Since PrpR also acts as a ramB repressor, our findings suggest that it plays a key role in regulating expression of enzymes involved in both glyoxylate and methylcitrate pathways.	[Masiewicz, Pawel; Zakrzewska-Czerwinska, Jolanta] Polish Acad Sci, Dept Microbiol, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland; [Brzostek, Anna; Dziadek, Jaroslaw] Polish Acad Sci, Lab Mycobacterium Genet & Physiol, Inst Med Biol, Lodz, Poland; [Wolanski, Marcin; Zakrzewska-Czerwinska, Jolanta] Univ Wroclaw, Dept Mol Microbiol, Fac Biotechnol, PL-50138 Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; University of Wroclaw	Masiewicz, P (corresponding author), Polish Acad Sci, Dept Microbiol, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland.	jolanta.zakrzewska@uni.wroc.pl	Wolański, Marcin/K-8452-2013	Wolański, Marcin/0000-0003-4714-0716; Dziadek, Jaroslaw/0000-0003-1427-884X	WCB EIT+ (POIG 1.1. EIT+) [3.1. BioMed]; Foundation for Polish Science (MISTRZ Programme)	WCB EIT+ (POIG 1.1. EIT+); Foundation for Polish Science (MISTRZ Programme)	This work was supported by the WCB EIT+ (POIG 1.1. EIT+, Project 3.1. BioMed) (http://www.eitplus.pl/language/en/). JZC and PM gratefully acknowledge financial support received from the Foundation for Polish Science (MISTRZ Programme) (http://www.fnp.org.pl/index.php?lng = en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Datta P, 2011, J BACTERIOL, V193, P1154, DOI 10.1128/JB.00459-10; Gould TA, 2006, MOL MICROBIOL, V61, P940, DOI 10.1111/j.1365-2958.2006.05297.x; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Horswill AR, 2001, J BIOL CHEM, V276, P19094, DOI 10.1074/jbc.M100244200; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Jakimowicz D, 2007, MICROBIOL-SGM, V153, P4050, DOI 10.1099/mic.0.2007/011619-0; Joshi SM, 2006, P NATL ACAD SCI USA, V103, P11760, DOI 10.1073/pnas.0603179103; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; Klinkenberg LG, 2008, J INFECT DIS, V198, P275, DOI 10.1086/589515; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Micklinghoff JC, 2009, J BACTERIOL, V191, P7260, DOI 10.1128/JB.01009-09; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tran SL, 2005, MICROBIOL-SGM, V151, P665, DOI 10.1099/mic.0.27624-0; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344	35	37	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43651	10.1371/journal.pone.0043651	http://dx.doi.org/10.1371/journal.pone.0043651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916289	Green Published, gold, Green Submitted			2022-12-25	WOS:000307824300056
J	Kim, TH; Song, J; Llaguno, SRA; Murnan, E; Liyanarachchi, S; Palanichamy, K; Yi, JY; Viapiano, MS; Nakano, I; Yoon, SO; Wu, H; Parada, LF; Kwon, CH				Kim, Tae Hyong; Song, Jieun; Llaguno, Sheila R. Alcantara; Murnan, Eric; Liyanarachchi, Sandya; Palanichamy, Kamalakannan; Yi, Ji-Yeun; Viapiano, Mariano Sebastian; Nakano, Ichiro; Yoon, Sung Ok; Wu, Hong; Parada, Luis F.; Kwon, Chang-Hyuk			Suppression of Peroxiredoxin 4 in Glioblastoma Cells Increases Apoptosis and Reduces Tumor Growth	PLOS ONE			English	Article							OXIDATIVE STRESS; SIGNAL-TRANSDUCTION; PROTECTS CELLS; GLIOMA-CELLS; P53; EXPRESSION; RADIATION; CANCER; DIFFERENTIATION; PROLIFERATION	Glioblastoma multiforme (GBM), the most common and aggressive primary brain malignancy, is incurable despite the best combination of current cancer therapies. For the development of more effective therapies, discovery of novel candidate tumor drivers is urgently needed. Here, we report that peroxiredoxin 4 (PRDX4) is a putative tumor driver. PRDX4 levels were highly increased in a majority of human GBMs as well as in a mouse model of GBM. Reducing PRDX4 expression significantly decreased GBM cell growth and radiation resistance in vitro with increased levels of ROS, DNA damage, and apoptosis. In a syngenic orthotopic transplantation model, Prdx4 knockdown limited GBM infiltration and significantly prolonged mouse survival. These data suggest that PRDX4 can be a novel target for GBM therapies in the future.	[Kim, Tae Hyong; Song, Jieun; Murnan, Eric; Yi, Ji-Yeun; Viapiano, Mariano Sebastian; Nakano, Ichiro; Kwon, Chang-Hyuk] Ohio State Univ, Dardinger Ctr Neurooncol & Neurosci, Dept Neurol Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Kim, Tae Hyong; Song, Jieun; Murnan, Eric; Yi, Ji-Yeun; Kwon, Chang-Hyuk] Ohio State Univ, Solid Tumor Program, James Comprehens Canc Ctr, Wexner Med Ctr, Columbus, OH 43210 USA; [Llaguno, Sheila R. Alcantara; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Liyanarachchi, Sandya] Ohio State Univ, Human Canc Genet Program, Wexner Med Ctr, Columbus, OH 43210 USA; [Palanichamy, Kamalakannan] Ohio State Univ, Dept Radiat Oncol, Wexner Med Ctr, Columbus, OH 43210 USA; [Yoon, Sung Ok] Ohio State Univ, Dept Mol & Cellular Biochem, Wexner Med Ctr, Columbus, OH 43210 USA; [Wu, Hong] Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Wu, Hong] Univ Calif Los Angeles, Sch Med, Inst Mol Med, Los Angeles, CA USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kim, TH (corresponding author), Ohio State Univ, Dardinger Ctr Neurooncol & Neurosci, Dept Neurol Surg, Wexner Med Ctr, Columbus, OH 43210 USA.	Chang-Hyuk.Kwon@osumc.edu	Nakano, Ichiro/AAR-9562-2020; Palanichamy, Kamalakannan/E-3807-2011; Nakano, Ichiro/F-2076-2014; Kwon, Chang-hyuk/E-3450-2011; Song, Jieun/A-3567-2013; Yoon, Sung Ok/C-5992-2012; Palanichamy, Kamalakannan/Z-1376-2019; Parada, luis F/B-9400-2014; Viapiano, Mariano/AAE-5787-2019	Nakano, Ichiro/0000-0002-0916-3207; Nakano, Ichiro/0000-0002-6734-3468; Song, Jieun/0000-0001-7886-1765; Viapiano, Mariano/0000-0002-8756-388X; Alcantara, Sheila/0000-0002-1586-4384	OSU CCC Start-up Fund; American Cancer Society Institutional Research Seed Grant; NATIONAL CANCER INSTITUTE [R01CA152065] Funding Source: NIH RePORTER	OSU CCC Start-up Fund; American Cancer Society Institutional Research Seed Grant(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by OSU CCC Start-up Fund and American Cancer Society Institutional Research Seed Grant (to C.-H.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2010, ONCOGENE, V29, P5095, DOI 10.1038/onc.2010.249; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Dal-Pizzol F, 2003, J NEURO-ONCOL, V61, P89, DOI 10.1023/A:1022168805198; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gao Z, 2008, FREE RADICAL BIO MED, V45, P1501, DOI 10.1016/j.freeradbiomed.2008.08.009; Gridley DS, 2011, INT J RADIAT BIOL, V87, P1173, DOI 10.3109/09553002.2011.624393; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; Jijiwa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024217; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang DH, 2011, MOL CELL, V44, P545, DOI 10.1016/j.molcel.2011.08.040; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Kim HS, 2003, AM J PHYSIOL-LUNG C, V285, pL363, DOI 10.1152/ajplung.00078.2003; Kwon C-H, 2009, CNS CANC MODELS MARK, P77; Kwon CH, 2008, CANCER RES, V68, P3286, DOI 10.1158/0008-5472.CAN-07-6867; Lee HC, 2004, INT J MOL MED, V13, P883; Li MH, 2004, INT J ONCOL, V24, P305; Lin SCJ, 2004, CANCER RES, V64, P3525, DOI 10.1158/0008-5472.CAN-03-3524; Liu XD, 2009, CANCER INVEST, V27, P345, DOI 10.1080/07357900802438577; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Martin V, 2007, FREE RADICAL BIO MED, V42, P1715, DOI 10.1016/j.freeradbiomed.2007.02.028; Morgan C, 2003, BRIT J CANCER, V89, P1314, DOI 10.1038/sj.bjc.6601302; Park HJ, 2008, J PROTEOME RES, V7, P1138, DOI 10.1021/pr7007237; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Polytarchou C, 2008, MOL CELL BIOL, V28, P7451, DOI 10.1128/MCB.00688-08; Pritchard C, 2009, CANCER RES, V69, P1739, DOI 10.1158/0008-5472.CAN-07-6817; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schulte Janin, 2011, BMC Med, V9, P137, DOI 10.1186/1741-7015-9-137; Sheng Z, 2010, NAT MED, V16, P671, DOI 10.1038/nm.2158; Smith PS, 2007, FREE RADICAL BIO MED, V42, P787, DOI 10.1016/j.freeradbiomed.2006.11.032; Smith-Pearson PS, 2008, FREE RADICAL BIO MED, V45, P1178, DOI 10.1016/j.freeradbiomed.2008.07.015; Stresing V, 2012, ONCOGENE; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Verhaak RG, 2009, REPRODUCIBLE GENE EX; Wang HQ, 2009, FEBS LETT, V583, P1511, DOI 10.1016/j.febslet.2009.04.009; Wei QO, 2011, P NATL ACAD SCI USA, V108, P7004, DOI 10.1073/pnas.1013012108; Won H, 2012, ANTIOXID REDOX SIGN, V16, P245, DOI 10.1089/ars.2011.3952; Wurdak H, 2010, CELL STEM CELL, V6, P37, DOI 10.1016/j.stem.2009.11.002; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zheng HW, 2010, CANCER CELL, V17, P497, DOI 10.1016/j.ccr.2010.03.020; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	54	30	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42818	10.1371/journal.pone.0042818	http://dx.doi.org/10.1371/journal.pone.0042818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916164	Green Published, Green Submitted, gold			2022-12-25	WOS:000307823600030
J	Morzaria-Luna, HN; Ainsworth, CH; Kaplan, IC; Levin, PS; Fulton, EA				Morzaria-Luna, Hem Nalini; Ainsworth, Cameron H.; Kaplan, Isaac C.; Levin, Phillip S.; Fulton, Elizabeth A.			Exploring Trade-Offs between Fisheries and Conservation of the Vaquita Porpoise (Phocoena sinus) Using an Atlantis Ecosystem Model	PLOS ONE			English	Article							MARINE ECOSYSTEMS; MANAGEMENT; CALIFORNIA; LONG; BIODIVERSITY; OBJECTIVES; MAMMALS	Background: Minimizing fishery bycatch threats might involve trade-offs between maintaining viable populations and economic benefits. Understanding these trade-offs can help managers reconcile conflicting goals. An example is a set of bycatch reduction measures for the Critically Endangered vaquita porpoise (Phocoena sinus), in the Northern Gulf of California, Mexico. The vaquita is an endemic species threatened with extinction by artisanal net bycatch within its limited range; in this area fisheries are the chief source of economic productivity. Methodology/Principal Findings: We analyze trade-offs between conservation of the vaquita and fisheries, using an end-to-end Atlantis ecosystem model for the Northern Gulf of California. Atlantis is a spatially-explicit model intended as a strategic tool to test alternative management strategies. We simulated increasingly restrictive fisheries regulations contained in the vaquita conservation plan: implementing progressively larger spatial management areas that exclude gillnets, shrimp driftnets and introduce a fishing gear that has no vaquita bycatch. We found that only the most extensive spatial management scenarios recovered the vaquita population above the threshold necessary to downlist the species from Critically Endangered. The scenario that excludes existing net gear from the 2008 area of vaquita distribution led to moderate decrease in net present value (US$ 42 million) relative to the best-performing scenario and a two-fold increase in the abundance of adult vaquita over the course of 30 years. Conclusions/Significance: Extended spatial management resulted in the highest recovery of the vaquita population. The economic cost of proposed management actions was unequally divided between fishing fleets; the loss of value from finfish gillnet fisheries was never recovered. Our analysis shows that managers will have to confront difficult trade-offs between management scenarios for vaquita conservation.	[Morzaria-Luna, Hem Nalini; Ainsworth, Cameron H.] Marine Resources Assessment Grp Amer Inc, Seattle, WA USA; [Kaplan, Isaac C.; Levin, Phillip S.] NOAA, Conservat Biol Div, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Fulton, Elizabeth A.] Commonwealth Sci & Ind Res Org Wealth Oceans Flag, Div Marine & Atmospher Res, Hobart, Tas, Australia	National Oceanic Atmospheric Admin (NOAA) - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Morzaria-Luna, HN (corresponding author), Marine Resources Assessment Grp Amer Inc, Seattle, WA USA.	HemNalini.MorzariaLuna@noaa.gov	Fulton, Beth/AAJ-1398-2021; Fulton, Beth/A-2871-2008	Fulton, Beth/0000-0002-5904-7917; Fulton, Beth/0000-0002-5904-7917	David and Lucile Packard Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This project was funded by The David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuacorp de Hidalgo, 2009, PESCA RIBERENA MULTI; Ainsworth CH, 2008, ECOL MODEL, V214, P361, DOI 10.1016/j.ecolmodel.2008.02.039; Ainsworth C. H., 2011, NMFSNWFSC110 NOAA; Ainsworth CH, 2012, J APPL ECOL, V49, P63, DOI 10.1111/j.1365-2664.2011.02064.x; Ainsworth CH, 2005, CAN J FISH AQUAT SCI, V62, P1104, DOI 10.1139/F05-010; Aragon-Noriega EA, 2010, INT J SUST DEV WORLD, V17, P410, DOI 10.1080/13504509.2010.500823; Avila-Forcada S, 2012, MAR POLICY, V36, P613, DOI 10.1016/j.marpol.2011.10.012; Barlow J, 1997, MAR MAMMAL SCI, V13, P44, DOI 10.1111/j.1748-7692.1997.tb00611.x; Bobadilla M, 2011, ENVIRON SCI POLICY, V14, P998, DOI 10.1016/j.envsci.2011.06.003; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Boyd IL, 2010, BIOL CONSERV, V143, P1664, DOI 10.1016/j.biocon.2010.04.006; Chan KMA, 2007, CONSERV BIOL, V21, P59, DOI 10.1111/j.1523-1739.2006.00570.x; Cheung WWL, 2008, ECOL ECON, V66, P193, DOI 10.1016/j.ecolecon.2007.09.001; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; CIRVA, 2012, 4 M INT COMM REC VAQ; D'Agrosa C, 1995, R INT WHAL COM; Fulton EA, 2004, ECOL MODEL, V173, P371, DOI 10.1016/j.ecolmodel.2003.09.024; Fulton EA, 2007, ALTERNATIVE MANAGEME; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Diaz-Uribe JG, 2012, ECOL MODEL, V230, P73, DOI 10.1016/j.ecolmodel.2012.01.009; Gerrodette T, 2011, MAR MAMMAL SCI, V27, pE101, DOI 10.1111/j.1748-7692.2010.00449.x; Gerrodette T, 2011, MAR MAMMAL SCI, V27, pE79, DOI 10.1111/j.1748-7692.2010.00438.x; Gerrodette Tim, 1995, V16, P273; Hohn AA, 1996, J ZOOL, V239, P235, DOI 10.1111/j.1469-7998.1996.tb05450.x; Homewood K., 2010, TRADE OFFS CONSERVAT; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Hutton T., 2010, USE EC INCENTIVES MA; INAPESCA, 2011, EV BIOT RED ARR PROT; INAPESCA NMFS, 2012, FISH TECHN RES COLL; INE WWF, 2006, CONS VAQ HAB ALT GOL; IUCN, 2010, IUCN RED LIS; Jaramillo-Legorreta AM, 1999, MAR MAMMAL SCI, V15, P957, DOI 10.1111/j.1748-7692.1999.tb00872.x; Jaramillo-Legorreta A, 2007, CONSERV BIOL, V21, P1653, DOI 10.1111/j.1523-1739.2007.00825.x; Levin PS, 2009, J APPL ECOL, V46, P735, DOI 10.1111/j.1365-2664.2009.01667.x; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lluch-Cota SE, 2007, PROG OCEANOGR, V73, P1, DOI 10.1016/j.pocean.2007.01.013; Lluch-Cota SE, 2010, PROG OCEANOGR, V87, P114, DOI 10.1016/j.pocean.2010.09.007; LOZANO H, 2006, THESIS U BRIT COLUMB; Mardle S, 2002, J ENVIRON MANAGE, V65, P49, DOI 10.1006/jema.2001.0518; Marquez-Farias J. F., 2006, SUSTENTABILIDAD PESC, P303; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Morales-Zarate MV, 2004, ECOL MODEL, V174, P331, DOI 10.1016/j.ecolmodel.2003.09.028; Munguia-Vega A, 2007, MOL ECOL, V16, P4051, DOI 10.1111/j.1365-294X.2007.03319.x; ORTIZ I, 2002, THESIS U WASHINGTON; Perez-Valencia S, 2011, MANIFESTACION IMPACT; PRONATURA, 2010, PESC EXP CAM RED ARR; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Rojas-Bracho L, 2008, PHOCOENA SINUS; Rojas-Bracho L, 2006, MAMMAL REV, V36, P179, DOI 10.1111/j.1365-2907.2006.00088.x; Rose KA, 2010, MAR COAST FISH, V2, P115, DOI 10.1577/C09-059.1; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Sanchirico JN, 2006, ECOL APPL, V16, P1643, DOI 10.1890/1051-0761(2006)016[1643:WANZAE]2.0.CO;2; SEMARNAT, 2008, PROGR ACC CONS EXP V; [SEMARNAT CONANP], 2010, LIN OT AP PROGR ACC; SGPA, 2010, RES MAN IMP MOD REG; SGPA, 2009, RES MAN IMP MOD REG; TAYLOR BL, 1993, CONSERV BIOL, V7, P489, DOI 10.1046/j.1523-1739.1993.07030489.x; Trites AW, 1998, CAN J ZOOL, V76, P886, DOI 10.1139/cjz-76-5-886; Vidal Omar, 1995, Reports of the International Whaling Commission Special Issue, V16, P247	60	18	18	1	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42917	10.1371/journal.pone.0042917	http://dx.doi.org/10.1371/journal.pone.0042917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916180	gold, Green Published, Green Submitted			2022-12-25	WOS:000307823600033
J	Naseeb, S; Delneri, D				Naseeb, Samina; Delneri, Daniela			Impact of Chromosomal Inversions on the Yeast DAL Cluster	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE ORDER; HUMAN GENOME; EVOLUTION; PROTEIN; TRANSCRIPTION; INDUCTION; DROSOPHILA; CASSETTES; SELECTION	Chromosomal rearrangements occur readily in nature and are a major reshaping force during genome evolution. Such large scale modifications are usually deleterious causing several fitness defects, but sometimes can confer an advantage and become adaptive. For example the DAL metabolic cluster in yeast was assembled in recent evolutionary times in the Hemiascomycetes lineage, through a set of rearrangements that brought together the genes involved in the allantoin degradation pathway. In eukaryotes, the existence of physical clustering of genes with related functions supports the notion that neighbouring ORFs tend to be co-expressed and that the order of genes along the chromosomes may have biological significance, rather than being random as previously believed. In this study, we investigate the phenotypic effect that inversions have on the DAL gene cluster, expressed during nitrogen starvation. In all Saccharomyces "sensu stricto" species the order of the DAL cluster is conserved, while in the "sensu lato" species Naumovia castellii, which grows significantly worse than S. cerevisiae on allantoin, the cluster includes two nested inversions encompassing three DAL genes. We constructed several inverted and non-inverted S. cerevisiae strains possessing different inversions including those to mimic the configuration of the N. castellii DAL cluster. We showed that the inversion of DAL2 lower its own expression and reduces yeast fitness during nitrogen starvation. This rearrangement also altered the expression of the neighbouring genes DAL1 and DAL4. Moreover, we showed that the expression of the DAL4 anti-sense transcript (SUT614) does not change upon inversions of DAL2 and therefore is unlikely to be involved in its regulation. These results show that the order of the DAL cluster has an impact on the phenotype and gene expression, suggesting that these rearrangements may have been adaptive in the "sensu stricto" group in relation to the low availability of nitrogen in the environment.	[Naseeb, Samina; Delneri, Daniela] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Naseeb, S (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	d.delneri@manchester.ac.uk		Delneri, Daniela/0000-0001-8070-411X; Naseeb, Samina/0000-0003-3599-5813	Higher Education Commission Pakistan; Faculty of Life Sciences, University of Manchester; Natural Environment Research Council (NERC); Natural Environment Research Council [NE/B500190/1] Funding Source: researchfish	Higher Education Commission Pakistan(Higher Education Commission of Pakistan); Faculty of Life Sciences, University of Manchester; Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	S. Naseeb was funded by Higher Education Commission Pakistan and a bursary from the Faculty of Life Sciences, University of Manchester. Work on chromosomal inversions in D. Delneri's laboratory was supported by Natural Environment Research Council (NERC) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baganz F, 1998, YEAST, V14, P1417, DOI 10.1002/(SICI)1097-0061(199811)14:15<1417::AID-YEA334>3.0.CO;2-N; BONIERBALE MW, 1988, GENETICS, V120, P1095; Carter Z, 2010, YEAST, V27, P765, DOI 10.1002/yea.1774; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Coffman JA, 1996, MOL CELL BIOL, V16, P847; COOPER TG, 1987, J BACTERIOL, V169, P4660, DOI 10.1128/jb.169.10.4660-4667.1987; Cooper TG, 1996, MYCOTA, V3, P139; CUNNINGHAM TS, 1993, J BACTERIOL, V175, P5851, DOI 10.1128/JB.175.18.5851-5861.1993; Delneri D, 2000, GENE, V252, P127, DOI 10.1016/S0378-1119(00)00217-1; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; DORRINGTON RA, 1993, NUCLEIC ACIDS RES, V21, P3777, DOI 10.1093/nar/21.16.3777; Du T, 2004, CURRENT PROTOCOLS MO; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Feder JL, 2003, GENETICS, V163, P939; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kahm M, 2010, J STAT SOFTWARE, V33; Kensche PR, 2008, TRENDS GENET, V24, P207, DOI 10.1016/j.tig.2008.02.003; Kruglyak S, 2000, TRENDS GENET, V16, P109, DOI 10.1016/S0168-9525(99)01941-1; Lang GI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025290; LARUE TA, 1968, A VAN LEEUW J MICROB, V34, P153, DOI 10.1007/BF02046425; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Meadows LA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000552; Mezey JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-2; NEI M, 1967, GENETICS, V57, P625; Oliver Brian, 2002, J Biol, V1, P4; Pal C, 2003, NAT GENET, V33, P392, DOI 10.1038/ng1111; Seoighe C, 2000, P NATL ACAD SCI USA, V97, P14433, DOI 10.1073/pnas.240462997; SHAW DD, 1983, SCIENCE, V220, P1165, DOI 10.1126/science.6407107; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Sturtevant AH, 1921, P NATL ACAD SCI USA, V7, P235, DOI 10.1073/pnas.7.8.235; SUMRADA R, 1978, J BACTERIOL, V135, P498, DOI 10.1128/JB.135.2.498-510.1978; van Driel R, 2003, J CELL SCI, V116, P4067, DOI 10.1242/jcs.00779; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WARNER JW, 1976, J MAMMAL, V57, P10, DOI 10.2307/1379509; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yerushalmi U, 2007, B MATH BIOL, V69, P2261, DOI 10.1007/s11538-007-9219-8	45	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42022	10.1371/journal.pone.0042022	http://dx.doi.org/10.1371/journal.pone.0042022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916115	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500800007
J	Chen, XJ; Liu, YK; Zhou, YH; Wang, L; Perc, M				Chen, Xiaojie; Liu, Yongkui; Zhou, Yonghui; Wang, Long; Perc, Matjaz			Adaptive and Bounded Investment Returns Promote Cooperation in Spatial Public Goods Games	PLOS ONE			English	Article							RISK SOCIAL DILEMMA; PRISONERS-DILEMMA; REPLICATOR DYNAMICS; EVOLUTIONARY GAMES; DIVERSITY PROMOTES; EMERGENCE; SELECTION; NETWORKS; TRAGEDY; REWARD	The public goods game is one of the most famous models for studying the evolution of cooperation in sizable groups. The multiplication factor in this game can characterize the investment return from the public good, which may be variable depending on the interactive environment in realistic situations. Instead of using the same universal value, here we consider that the multiplication factor in each group is updated based on the differences between the local and global interactive environments in the spatial public goods game, but meanwhile limited to within a certain range. We find that the adaptive and bounded investment returns can significantly promote cooperation. In particular, full cooperation can be achieved for high feedback strength when appropriate limitation is set for the investment return. Also, we show that the fraction of cooperators in the whole population can become larger if the lower and upper limits of the multiplication factor are increased. Furthermore, in comparison to the traditionally spatial public goods game where the multiplication factor in each group is identical and fixed, we find that cooperation can be better promoted if the multiplication factor is constrained to adjust between one and the group size in our model. Our results highlight the importance of the locally adaptive and bounded investment returns for the emergence and dominance of cooperative behavior in structured populations.	[Chen, Xiaojie] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria; [Liu, Yongkui] Beihang Univ, Sch Automat Sci & Elect Engn, Beijing, Peoples R China; [Liu, Yongkui] Changan Univ, Sch Elect & Control Engn, Xian, Peoples R China; [Liu, Yongkui] Changan Univ, Ctr Rd Traff Intelligent Detect & Equipment Engn, Xian, Peoples R China; [Zhou, Yonghui] Guizhou Normal Univ, Sch Math & Comp Sci, Guiyang, Peoples R China; [Wang, Long] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China; [Perc, Matjaz] Univ Maribor, Dept Phys, Fac Nat Sci & Math, Maribor, Slovenia	International Institute for Applied Systems Analysis (IIASA); Beihang University; Chang'an University; Chang'an University; Guizhou Normal University; Peking University; University of Maribor	Chen, XJ (corresponding author), Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria.	chenx@iiasa.ac.at; matjaz.perc@uni-mb.si	Perc, Matjaz/A-5148-2009; Liu, Yongkui/R-9307-2017; Wang, Long/A-7798-2010; Gao, Y./GWZ-3665-2022	Perc, Matjaz/0000-0002-3087-541X; Liu, Yongkui/0000-0003-2165-775X; Wang, Long/0000-0001-5600-8157; 	Special Fund for the Basic Scientific Research of Central Colleges, Chang'an University; Special Fund for the Basic Research Support Planning of Chang'an University; Open Fund of Road Traffic Intelligent Detection and Equipment Engineering Research Center, Shaanxi Province [CHD2010JC134]; National Natural Science Foundation of China (NSFC) [11161011]; 973 Program [2012CB821203]; NSFC [61020106005, 10972002]; Slovenian Research Agency [J1-4055]	Special Fund for the Basic Scientific Research of Central Colleges, Chang'an University; Special Fund for the Basic Research Support Planning of Chang'an University; Open Fund of Road Traffic Intelligent Detection and Equipment Engineering Research Center, Shaanxi Province; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	YL acknowledges the financial support from the Special Fund for the Basic Scientific Research of Central Colleges, Chang'an University, the Special Fund for the Basic Research Support Planning of Chang'an University, and the Open Fund of Road Traffic Intelligent Detection and Equipment Engineering Research Center, Shaanxi Province (Grant no. CHD2010JC134). YZ acknowledges the financial support from the National Natural Science Foundation of China (NSFC) (grant no. 11161011). LW acknowledges the financial support from 973 Program (2012CB821203) and the NSFC (grant nos. 61020106005 and 10972002). MP acknowledges the financial support from the Slovenian Research Agency (grant J1-4055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Assenza S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.017101; Baldassarri D, 2011, P NATL ACAD SCI USA, V108, P11023, DOI 10.1073/pnas.1105456108; Boza G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-336; Brandt H, 2006, P NATL ACAD SCI USA, V103, P495, DOI 10.1073/pnas.0507229103; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Cardillo A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103034; Cressman R, 2012, J THEOR BIOL, V299, P144, DOI 10.1016/j.jtbi.2011.07.030; Deng KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025496; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; Fort H, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48008; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; Gomez-Gardenes J, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/68003; Gomez-Gardenes J, 2008, J THEOR BIOL, V253, P296, DOI 10.1016/j.jtbi.2008.03.007; Gomez-Gardenes J, 2011, CHAOS, V21, DOI 10.1063/1.3535579; Greenwood G, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/40006; Guan JY, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056101; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2002, J THEOR BIOL, V218, P187, DOI 10.1006/jtbi.2002.3067; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Hauert C, 2006, P R SOC B, V273, P2565, DOI 10.1098/rspb.2006.3600; Hauert C, 2010, J THEOR BIOL, V267, P22, DOI 10.1016/j.jtbi.2010.08.009; Heitzig J, 2011, P NATL ACAD SCI USA, V108, P15739, DOI 10.1073/pnas.1106265108; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Huang ZG, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/28001; Janssen MA, 2006, J THEOR BIOL, V243, P134, DOI 10.1016/j.jtbi.2006.06.012; Kamimura Y, 2008, J THEOR BIOL, V252, P277, DOI 10.1016/j.jtbi.2008.02.017; Kogan L, 2004, J FINANC ECON, V73, P411, DOI 10.1016/j.jfineco.2003.12.002; Lee S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028702; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; Moyano LG, 2009, J THEOR BIOL, V259, P84, DOI 10.1016/j.jtbi.2009.03.002; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037102; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Pestelacci E, 2008, LECT NOTES COMPUT SC, V5199, P539, DOI 10.1007/978-3-540-87700-4_54; Pestelacci E, 2010, LECT NOTES COMPUT SC, V6239, P512, DOI 10.1007/978-3-642-15871-1_52; Poncela J, 2009, NEW J PHYS, V11; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rong ZH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.047101; Rong ZH, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/30001; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Santos FC, 2011, P NATL ACAD SCI USA, V108, P10421, DOI 10.1073/pnas.1015648108; Sasaki T, 2007, P ROY SOC B-BIOL SCI, V274, P2639, DOI 10.1098/rspb.2007.0673; Sasaki T, 2011, J THEOR BIOL, V287, P109, DOI 10.1016/j.jtbi.2011.07.026; Shi DM, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/58003; Short MB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066114; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18007; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.047102; Szolnoki A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046106; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Szolnoki A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057101; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056112; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tomochi M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026112; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; Vukov J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026109; Vukov J, 2011, J THEOR BIOL, V287, P37, DOI 10.1016/j.jtbi.2011.07.022; Wakano JY, 2007, J THEOR BIOL, V247, P616, DOI 10.1016/j.jtbi.2007.04.008; Wakano JY, 2009, P NATL ACAD SCI USA, V106, P7910, DOI 10.1073/pnas.0812644106; Wang J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016101; Wu T, 2009, EPL, V90, P20001; Wu T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026121; Wu ZX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021107; Xu Z, 2010, EPL, V88, P30011; Yang HX, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056107; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	80	68	68	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36895	10.1371/journal.pone.0036895	http://dx.doi.org/10.1371/journal.pone.0036895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22928023	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000305341300038
J	Sejdic, E; Steele, CM; Chau, T				Sejdic, Ervin; Steele, Catriona M.; Chau, Tom			A Method for Removal of Low Frequency Components Associated with Head Movements from Dual-Axis Swallowing Accelerometry Signals	PLOS ONE			English	Article							ACCELERATION; DYSPHAGIA; CHARACTERIZE; ASPIRATION; DIAGNOSIS; DESIGN; PHASE	Head movements can greatly affect swallowing accelerometry signals. In this paper, we implement a spline-based approach to remove low frequency components associated with these motions. Our approach was tested using both synthetic and real data. Synthetic signals were used to perform a comparative analysis of the spline-based approach with other similar techniques. Real data, obtained data from 408 healthy participants during various swallowing tasks, was used to analyze the processing accuracy with and without the spline-based head motions removal scheme. Specifically, we analyzed the segmentation accuracy and the effects of the scheme on statistical properties of these signals, as measured by the scaling analysis. The results of the numerical analysis showed that the spline-based technique achieves a superior performance in comparison to other existing techniques. Additionally, when applied to real data, we improved the accuracy of the segmentation process by achieving a 27% drop in the number of false negatives and a 30% drop in the number of false positives. Furthermore, the anthropometric trends in the statistical properties of these signals remained unaltered as shown by the scaling analysis, but the strength of statistical persistence was significantly reduced. These results clearly indicate that any future medical devices based on swallowing accelerometry signals should remove head motions from these signals in order to increase segmentation accuracy.	[Sejdic, Ervin] Univ Pittsburgh, Dept Elect & Comp Engn, Pittsburgh, PA 15260 USA; [Steele, Catriona M.] Univ Toronto, Dept Speech Language Pathol, Toronto, ON, Canada; [Steele, Catriona M.] Univ Toronto, Toronto Rehabil Inst, Toronto, ON, Canada; [Steele, Catriona M.; Chau, Tom] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Steele, Catriona M.; Chau, Tom] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital	Sejdic, E (corresponding author), Univ Pittsburgh, Dept Elect & Comp Engn, Pittsburgh, PA 15260 USA.	esejdic@ieee.org	Chau, Tom TK/C-8426-2009	Chau, Tom TK/0000-0002-7486-0316; Steele, Catriona/0000-0002-4294-6561; Sejdic, Ervin/0000-0003-4987-8298	Ontario Centres of Excellence; Toronto Rehabilitation Institute; Bloorview Kids Rehab; Canada Research Chairs	Ontario Centres of Excellence; Toronto Rehabilitation Institute(University of Toronto); Bloorview Kids Rehab; Canada Research Chairs(Canada Research ChairsCGIAR)	This research was funded in part by the Ontario Centres of Excellence, the Toronto Rehabilitation Institute, Bloorview Kids Rehab, and the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chau T, 2005, IEEE T NEUR SYS REH, V13, P99, DOI 10.1109/TNSRE.2004.841384; Das A, 2001, COMPUT METH PROG BIO, V64, P87, DOI 10.1016/S0169-2607(00)00099-7; Ekberg O, 2002, DYSPHAGIA, V17, P139, DOI 10.1007/s00455-001-0113-5; Ghaffari A, 2009, COMPUTER METHODS BIO; Hung D, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-25; Ishida R, 2002, DYSPHAGIA, V17, P262, DOI 10.1007/s00455-002-0064-5; Karczewicz M, 1997, SIGNAL PROCESS, V59, P43, DOI 10.1016/S0165-1684(97)00037-6; Kim YS, 2008, DYSPHAGIA, V23, P274, DOI 10.1007/s00455-007-9135-y; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lee J, 2008, PHYSIOL MEAS, V29, P1105, DOI 10.1088/0967-3334/29/9/008; Lee J, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-14; Liang HL, 2005, IEEE T BIO-MED ENG, V52, P1692, DOI 10.1109/TBME.2005.855719; Logemann J., 1998, EVALUATION TREATMENT, V2nd, DOI DOI 10.1097/00020840-199812000-00008; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Miller A.J., 1999, NEUROSCIENTIFIC PRIN; Ramsey DJC, 2006, STROKE, V37, P2984, DOI 10.1161/01.STR.0000248758.32627.3b; REDDY NP, 1991, J BIOMED ENG, V13, P379, DOI 10.1016/0141-5425(91)90018-3; Reddy NP, 2000, MED ENG PHYS, V22, P405, DOI 10.1016/S1350-4533(00)00047-3; REDDY NP, 1990, IEEE T BIO-MED ENG, V37, P392, DOI 10.1109/10.52346; REDDY NP, 1988, IEEE ENG MED BIOL, V7, P16, DOI 10.1109/51.7929; Sejdic E., 2010, BMC RES, V3, DOI DOI 10.1186/1756-0500-3-269; Sejdic E, 2011, COMPUT METH PROG BIO, V103, P113, DOI 10.1016/j.cmpb.2010.06.010; Sejdic E, 2010, COMPUT BIOL MED, V40, P839, DOI 10.1016/j.compbiomed.2010.09.002; Sejdic E, 2010, MED ENG PHYS, V32, P668, DOI 10.1016/j.medengphy.2010.04.008; Sejdic E, 2010, PHYSIOL MEAS, V31, pN1, DOI 10.1088/0967-3334/31/1/N01; Sejdic E, 2009, IEEE T BIO-MED ENG, V56, P1090, DOI 10.1109/TBME.2008.2010504; Smithard DG, 1996, STROKE, V27, P1200, DOI 10.1161/01.STR.27.7.1200; Steele CM, 2007, CAN J SPEECH-LANG PA, V31, P166; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; UNSER M, 1991, IEEE T PATTERN ANAL, V13, P277, DOI 10.1109/34.75515; UNSER M, 1992, IEEE T INFORM THEORY, V38, P95, DOI 10.1109/18.108253; Unser M, 2002, PROC SPIE, V4684, P225, DOI 10.1117/12.467162; UNSER M, 1993, IEEE T SIGNAL PROCES, V41, P834, DOI 10.1109/78.193221; UNSER M, 1993, IEEE T SIGNAL PROCES, V41, P821, DOI 10.1109/78.193220; Unser M, 1999, IEEE SIGNAL PROC MAG, V16, P22, DOI 10.1109/79.799930	35	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33464	10.1371/journal.pone.0033464	http://dx.doi.org/10.1371/journal.pone.0033464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479402	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000304523400024
